PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Casar, B; Rimann, I; Kato, H; Shattil, SJ; Quigley, JP; Deryugina, EI				Casar, B.; Rimann, I.; Kato, H.; Shattil, S. J.; Quigley, J. P.; Deryugina, E. I.			In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated beta 1 integrin and induction of FAK/PI3K/Akt motility signaling	ONCOGENE			English	Article						metastasis; intravasation; invasion; transendothelial migration; Src kinase; prostate cancer	DOMAIN-CONTAINING PROTEIN-1; FOCAL ADHESION KINASE; CUB-DOMAIN; TYROSINE PHOSPHORYLATION; CELL-MIGRATION; PKC-DELTA; SRC; SUBSTRATE; IDENTIFICATION; METASTASIS	Specific cleavage of the transmembrane molecule, CUB domain-containing protein-1 (CDCP1), by plasmin-like serine proteases induces outside-in signal transduction that facilitates early stages of spontaneous metastasis leading to tumor cell intravasation, namely cell escape from the primary tumor, stromal invasion and transendothelial migration. We identified active beta 1 integrin as a biochemical and functional partner of the membrane-retained 70-kDa CDCP1 fragment, newly generated from its full-length 135-kDa precursor though proteolytic cleavage by serine proteases. Both in cell cultures and in live animals, active beta 1 integrin complexed preferentially with functionally activated, phosphorylated 70-kDa CDCP1. Complexing of beta 1 integrin the 70-kDa with CDCP1 fragment induced intracellular phosphorylation signaling, involving focal adhesion kinase-1 (FAK) and PI3 kinase (PI3K)-dependent Akt activation. Thus, inhibition of FAK/PI3K activities by specific inhibitors as well as short-hairpin RNA downregulation of beta 1 integrin significantly reduced FAK/Akt phosphorylation under conditions where CDCP1 was processed by serine proteases, indicating that FAK/PI3K/Akt pathway operates downstream of cleaved CDCP1 complexed with beta 1 integrin. Furthermore, this complex-dependent signaling correlated positively with high levels of tumor cell intravasation and dissemination. Correspondingly, abrogation in vivo of CDCP1 cleavage either by unique cleavage-blocking monoclonal antibody 10-D7 or by inhibition of proteolytic activity of plasmin-like serine proteases with aprotinin prevented beta 1 integrin/CDCP1 complexing and downstream FAK/Akt signaling concomitant with significant reduction of stromal invasion and spontaneous metastasis. Therefore, beta 1 integrin appears to serve as a motility-regulating partner mediating cross-talk between proteolytically cleaved, membrane-retained CDCP1 and members of FAK/PI3K/Akt pathway. This CDCP1 cleavage-induced signaling cascade constitutes a unique mechanism, independent of extracellular matrix remodeling, whereby a proteolytically cleaved CDCP1 regulates in vivo locomotion and metastasis of tumor cells through beta 1 integrin partnering. Our findings indicate that CDCP1 cleavage, occurring at the apex of a beta 1 integrin/FAK/PI3K/Akt signaling cascade, may represent a therapeutic target for CDCP1-positive cancers.	[Casar, B.; Rimann, I.; Quigley, J. P.; Deryugina, E. I.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Kato, H.; Shattil, S. J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Shattil, S. J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Quigley, JP (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 North Torrey Pines Rd,SP3030 3120, La Jolla, CA 92037 USA.	jquigley@scripps.edu; deryugin@scripps.edu	CASAR, BERTA/M-2291-2014	CASAR, BERTA/0000-0002-3058-5631	NIH [R01 CA 129484, R01 CA 105412, HL56595, HL57900]; NIH/NCRR/STSI [RR 025774]; Science and Innovation Ministry of Spain; Nachwuchsforderungskredit/Stiefel-Zangger Foundation, University of Zurich; NATIONAL CANCER INSTITUTE [R01CA129484, R01CA157792, R01CA105412] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057900, R01HL056595] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR/STSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Science and Innovation Ministry of Spain(Spanish Government); Nachwuchsforderungskredit/Stiefel-Zangger Foundation, University of Zurich; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH grants R01 CA 129484 and R01 CA 105412 (to JPQ), NIH/NCRR/STSI Grant RR 025774 (Pilot Award to EID), Postdoctoral Fellowship from the Science and Innovation Ministry of Spain (to BC), Research Fellowships from Nachwuchsforderungskredit/Stiefel-Zangger Foundation, University of Zurich (to IR), and NIH grants HL56595 and HL57900 (to SJS).	Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Bekes EM, 2011, NEOPLASIA, V13, P806, DOI 10.1593/neo.11704; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; Conn EM, 2009, AM J PATHOL, V175, P1638, DOI 10.2353/ajpath.2009.090384; Deryugina EI, 2005, CANCER RES, V65, P10959, DOI 10.1158/0008-5472.CAN-05-2228; Deryugina EI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/564259; Deryugina EI, 2009, MOL CANCER RES, V7, P1197, DOI 10.1158/1541-7786.MCR-09-0100; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Perry SE, 2007, FEBS LETT, V581, P1137, DOI 10.1016/j.febslet.2007.02.025; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Siva AC, 2008, CANCER RES, V68, P3759, DOI 10.1158/0008-5472.CAN-07-1657; Spassov DS, 2011, MOL CELL BIOL, V31, P766, DOI 10.1128/MCB.00841-10; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Wong CH, 2009, CLIN CANCER RES, V15, P2311, DOI 10.1158/1078-0432.CCR-08-2533; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Yang LF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007294; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4; Zhao X, 2011, ADV DRUG DELIVER REV, V63, P610, DOI 10.1016/j.addr.2010.11.001	35	80	80	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 9	2014	33	2					255	268		10.1038/onc.2012.547	http://dx.doi.org/10.1038/onc.2012.547			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	286BY	23208492	Green Accepted			2022-12-25	WOS:000329440700013
J	Okudaira, N; Okamura, T; Tamura, M; Iijma, K; Goto, M; Matsunaga, A; Ochiai, M; Nakagama, H; Kano, S; Fujii-Kuriyama, Y; Ishizaka, Y				Okudaira, N.; Okamura, T.; Tamura, M.; Iijma, K.; Goto, M.; Matsunaga, A.; Ochiai, M.; Nakagama, H.; Kano, S.; Fujii-Kuriyama, Y.; Ishizaka, Y.			Long interspersed element-1 is differentially regulated by food-borne carcinogens via the aryl hydrocarbon receptor	ONCOGENE			English	Article						PhIP; MeIQx; aryl hydrocarbon receptor; breast carcinomas; ER alpha	HUMAN L1 RETROTRANSPOSITION; NON-LTR RETROTRANSPOSONS; HUMAN LINE-1 PROTEIN; SOMATIC RETROTRANSPOSITION; NUCLEOTIDE ELEMENT-1; HETEROCYCLIC AMINES; DIOXIN RECEPTOR; MICE LACKING; COOKED FOOD; EXPRESSION	A single human cell contains more than 5.0 x 10(5) copies of long interspersed element-1 (L1), 80-100 of which are competent for retrotransposition (L1-RTP). Recent observations have revealed the presence of de novo L1 insertions in various tumors, but little is known about its mechanism. Here, we found that 2-amino-1-methyl-6-phenylimidazo[ 4,5-b] pyridine (PhIP) and 2-amino-3, 8-dimethyl-imidazo[ 4,5-f] quinoxaline (MeIQx), food-borne carcinogens that are present in broiled meats, induced L1-RTP. This induction was dependent on a cellular cascade comprising the aryl hydrocarbon receptor (AhR), a mitogen-activated protein kinase, and CCAAT/ enhancer-binding protein b. Notably, these compounds exhibited differential induction of L1-RTP. MeIQx-induced L1-RTP was dependent on AhR nuclear translocator 1 (ARNT1), a counterpart of AhR required for gene expression in response to environmental pollutants. By contrast, PhIP-induced L1-RTP did not require ARNT1 but was dependent on estrogen receptor a (ERa) and AhR repressor. In vivo studies using transgenic mice harboring the human L1 gene indicated that PhIP-induced L1-RTP was reproducibly detected in the mammary gland, which is a target organ of PhIP-induced carcinoma. Moreover, picomolar levels of each compound induced L1-RTP, which is comparable to the PhIP concentration detected in human breast milk. Data suggest that somatic cells possess machineries that induce L1-RTP in response to the carcinogenic compounds. Together with data showing that micromolar levels of heterocyclic amines (HCAs) were non-genotoxic, our observations indicate that L1-RTP by environmental compounds is a novel type of genomic instability, further suggesting that analysis of L1-RTP by HCAs is a novel approach to clarification of modes of carcinogenesis.	[Okudaira, N.; Tamura, M.; Iijma, K.; Matsunaga, A.; Ishizaka, Y.] Natl Ctr Global Hlth & Med NCGM, Dept Intractable Dis, Shinjuku Ku, Tokyo 1628655, Japan; [Okudaira, N.; Kano, S.] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Okamura, T.; Goto, M.] Natl Ctr Global Hlth & Med NCGM, Dept Lab Anim Med, Shinjuku Ku, Tokyo 1628655, Japan; [Ochiai, M.; Nakagama, H.] Natl Canc Ctr, Div Canc Dev Syst, Chuo Ku, Tokyo, Japan; [Kano, S.] Natl Ctr Global Hlth & Med NCGM, Dept Trop Med & Malaria, Shinjuku Ku, Tokyo 1628655, Japan; [Fujii-Kuriyama, Y.] Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; [Okamura, T.] Dept Infect Dis, Sect Anim Model, Tokyo, Japan	University of Tsukuba; National Cancer Center - Japan; University of Tokyo	Ishizaka, Y (corresponding author), Natl Ctr Global Hlth & Med NCGM, Dept Intractable Dis, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	zakay@ri.ncgm.go.jp		yuan ren, hou teng/0000-0001-6288-4583	Ministry of Health, Labor and Welfare of Japan [09156296]; Log-range Research Initiative (LRI) from Japan; Chemical Industry Association (JCIA); Tokyo Biochemical Research Foundation; JointUse Research facility, Hyogo College of Medicine	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Log-range Research Initiative (LRI) from Japan; Chemical Industry Association (JCIA); Tokyo Biochemical Research Foundation; JointUse Research facility, Hyogo College of Medicine	We are grateful to Drs Elena. T Luning Prak (University of Pennsylvania Medical Center), Gilbert Nicolas (University of Michigan Medical School) and Gabriele Vielhaber (Symrise, Germany) for providing pEF06R, pCEP4/L1mneoI/ColE1 and MNF, respectively. An antibody to AhRR was a kind gift from Dr Mark E Hahn (Woods Hole Oceanographic Institution). This work was supported in parts by a Grant-in-Aid for Research from the Ministry of Health, Labor and Welfare of Japan (09156296), and a research grant for the Log-range Research Initiative (LRI) from Japan Chemical Industry Association (JCIA). NO was an applicant supported by Grant-in-Aid from the Tokyo Biochemical Research Foundation. This work was supported in part by a JointUse Research facility, Hyogo College of Medicine.	Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Bannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Belancio VP, 2010, SEMIN CANCER BIOL, V20, P200, DOI 10.1016/j.semcancer.2010.06.001; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Coufal NG, 2011, P NATL ACAD SCI USA, V108, P20382, DOI 10.1073/pnas.1100273108; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Ema M, 1996, MOL CELL BIOL, V16, P5865; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Georgiou I, 2009, HUM MOL GENET, V18, P1221, DOI 10.1093/hmg/ddp022; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Ishizaka Y, PROTEIN KINASES, P187; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; ITO N, 1991, CARCINOGENESIS, V12, P1503, DOI 10.1093/carcin/12.8.1503; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kale Shubha P, 2005, Int J Environ Res Public Health, V2, P14, DOI 10.3390/ijerph2005010014; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Karchner SI, 2009, MOL CELL BIOL, V29, P3465, DOI 10.1128/MCB.00206-09; Kazazian HH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-62; KLEMAN MI, 1992, CARCINOGENESIS, V13, P1619, DOI 10.1093/carcin/13.9.1619; Konkel MK, 2010, SEMIN CANCER BIOL, V20, P211, DOI 10.1016/j.semcancer.2010.03.001; Lauber SN, 2007, CANCER RES, V67, P9597, DOI 10.1158/0008-5472.CAN-07-1661; Lauber SN, 2004, CARCINOGENESIS, V25, P2509, DOI 10.1093/carcin/bgh268; LAYTON DW, 1995, CARCINOGENESIS, V16, P39, DOI 10.1093/carcin/16.1.39; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Martin SL, 2005, J MOL BIOL, V348, P549, DOI 10.1016/j.jmb.2005.03.003; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; MIKI Y, 1992, CANCER RES, V52, P643; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Nakai Y, 2007, CANCER RES, V67, P1378, DOI 10.1158/0008-5472.CAN-06-1336; Nishikawa A, 2005, TOXICOL SCI, V84, P243, DOI 10.1093/toxsci/kfi079; OHGAKI H, 1987, CARCINOGENESIS, V8, P665, DOI 10.1093/carcin/8.5.665; Okudaira N, 2011, CANCER SCI, V102, P2000, DOI 10.1111/j.1349-7006.2011.02060.x; Okudaira N, 2010, P NATL ACAD SCI USA, V107, P18487, DOI 10.1073/pnas.1001252107; Oricchio E, 2007, ONCOGENE, V26, P4226, DOI 10.1038/sj.onc.1210214; Osborne CK, 2004, BRIT J CANCER, V90, pS2, DOI 10.1038/sj.bjc.6601629; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Raiz J, 2012, NUCLEIC ACIDS RES, V40, P1666, DOI 10.1093/nar/gkr863; Schut HAJ, 1999, CARCINOGENESIS, V20, P353, DOI 10.1093/carcin/20.3.353; Scott KA, 2007, CHEM RES TOXICOL, V20, P88, DOI 10.1021/tx0601861; Shimizu Y, 2000, P NATL ACAD SCI USA, V97, P779, DOI 10.1073/pnas.97.2.779; Shirai T, 1997, CANCER RES, V57, P195; Stribinskis V, 2006, CANCER RES, V66, P2616, DOI 10.1158/0008-5472.CAN-05-3478; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vitullo P, 2012, MOL REPROD DEV, V79, P118, DOI 10.1002/mrd.22003; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Weiss C, 2005, ONCOGENE, V24, P4975, DOI 10.1038/sj.onc.1208679; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Woodcock DM, 1997, J BIOL CHEM, V272, P7810, DOI 10.1074/jbc.272.12.7810	77	21	21	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2013	32	41					4903	4912		10.1038/onc.2012.516	http://dx.doi.org/10.1038/onc.2012.516			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	235KQ	23208499	hybrid, Green Published			2022-12-25	WOS:000325717800006
J	Dexter, JP; Gunawardena, J				Dexter, Joseph P.; Gunawardena, Jeremy			Dimerization and Bifunctionality Confer Robustness to the Isocitrate Dehydrogenase Regulatory System in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-BINDING-SITE; X-RAY ANALYSIS; KINASE PHOSPHATASE; MULTISITE PHOSPHORYLATION; KINASE/PHOSPHATASE; ENZYME; CYCLE; PURIFICATION; PROTEIN; CRYSTALLIZATION	An important goal of systems biology is to develop quantitative models that explain how specific molecular features give rise to systems-level properties. Metabolic and regulatory pathways that contain multifunctional proteins are especially interesting to study from this perspective because they have frequently been observed to exhibit robustness: the ability for a system to perform its proper function even as levels of its components change. In this study, we use extensive biochemical data and algebraic modeling to develop and analyze a model that shows how robust behavior arises in the isocitrate dehydrogenase (IDH) regulatory system of Escherichia coli, which was shown in 1985 to experimentally exhibit robustness. E. coli IDH is regulated by reversible phosphorylation catalyzed by the bifunctional isocitrate dehydrogenase kinase/phosphatase (IDHKP), and the level of IDH activity determines whether carbon flux is directed through the glyoxylate bypass (for growth on two-carbon substrates) or the full tricarboxylic acid cycle. Our model, which incorporates recent structural data on IDHKP, identifies several specific biochemical features of the system (including homodimerization of IDH and bifunctionality of IDHKP) that provide a potential explanation for robustness. Using algebraic techniques, we derive an invariant that summarizes the steady-state relationship between the phospho-forms of IDH. We use the invariant in combination with kinetic data on IDHKP to calculate IDH activity at a range of total IDH levels and find that our model predicts robustness. Our work unifies much of the known biochemistry of the IDH regulatory system into a single quantitative framework and highlights the importance of constructing biochemically realistic models in systems biology.	[Dexter, Joseph P.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Dexter, Joseph P.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Gunawardena, Jeremy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Princeton University; Princeton University; Harvard University; Harvard Medical School	Dexter, JP (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, 1566 1st Ctr, Princeton, NJ 08544 USA.	jdexter@princeton.edu			National Science Foundation [0856285]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 0856285 (to J. G.)	Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; BORTHWICK AC, 1984, EUR J BIOCHEM, V141, P393, DOI 10.1111/j.1432-1033.1984.tb08204.x; Cornish-Bowden A, 2012, FUNDAMENTALS ENZYME, V4th; Cozzone AJ, 2005, J MOL MICROB BIOTECH, V9, P132, DOI 10.1159/000089642; DEAN AM, 1989, J BIOL CHEM, V264, P20482; GARNAK M, 1979, SCIENCE, V203, P1111, DOI 10.1126/science.34215; Gunawardena J., 2009, ELEMENTS COMPUTATION, P21; Gunawardena J, 2010, SCIENCE, V328, P581, DOI 10.1126/science.1188974; Hart Y, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-171; Hart Y, 2011, MOL CELL, V41, P117, DOI 10.1016/j.molcel.2010.12.023; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KORNBERG HL, 1966, BIOCHEM J, V99, P1; LAPORTE DC, 1983, NATURE, V305, P286, DOI 10.1038/305286a0; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; LAPORTE DC, 1989, BIOCHIMIE, V71, P1051, DOI 10.1016/0300-9084(89)90110-7; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; Manrai AK, 2008, BIOPHYS J, V95, P5533, DOI 10.1529/biophysj.108.140632; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MCKEE JS, 1989, BIOCHIMIE, V71, P1059, DOI 10.1016/0300-9084(89)90111-9; Miller SP, 1996, J BIOL CHEM, V271, P19124, DOI 10.1074/jbc.271.32.19124; NIMMO GA, 1984, EUR J BIOCHEM, V141, P401, DOI 10.1111/j.1432-1033.1984.tb08205.x; Ohta S, 2006, MOL BREEDING, V18, P29, DOI 10.1007/s11032-006-9011-8; Oudot C, 1999, EUR J BIOCHEM, V262, P224, DOI 10.1046/j.1432-1327.1999.00395.x; Prabakaran S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.15; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; SENIOR PJ, 1975, J BACTERIOL, V123, P407, DOI 10.1128/JB.123.2.407-418.1975; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Shinar G, 2011, MATH BIOSCI, V231, P39, DOI 10.1016/j.mbs.2011.02.012; Shinar G, 2010, SCIENCE, V327, P1389, DOI 10.1126/science.1183372; Shinar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000297; Singh SK, 2002, J BIOL CHEM, V277, P7567, DOI 10.1074/jbc.M107908200; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; STUELAND CS, 1989, J BIOL CHEM, V264, P13775; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; VARELA I, 1988, FEBS LETT, V231, P361, DOI 10.1016/0014-5793(88)80850-0; WAMPLER DE, 1985, P NATL ACAD SCI USA, V82, P6830, DOI 10.1073/pnas.82.20.6830; Xu YQ, 2012, J THEOR BIOL, V311, P139, DOI 10.1016/j.jtbi.2012.07.012; Yates SP, 2011, BIOCHEMISTRY-US, V50, P8103, DOI 10.1021/bi200809p; Zheng JM, 2010, NATURE, V465, P961, DOI 10.1038/nature09088; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P1153, DOI 10.1107/S1744309109038718; Zheng JM, 2009, ACTA CRYSTALLOGR F, V65, P536, DOI 10.1107/S1744309109014729	45	20	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2013	288	8					5770	5778		10.1074/jbc.M112.339226	http://dx.doi.org/10.1074/jbc.M112.339226			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095NY	23192354	Green Published, hybrid			2022-12-25	WOS:000315342500048
J	Arlinghaus, FT; Eble, JA				Arlinghaus, Franziska T.; Eble, Johannes A.			The Collagen-binding Integrin alpha 2 beta 1 Is a Novel Interaction Partner of the Trimeresurus flavoviridis Venom Protein Flavocetin-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; HIGH-MOLECULAR-MASS; VONWILLEBRAND-FACTOR; PLATELET-ADHESION; RHODOCETIN; GPIB; PURIFICATION; INHIBITOR; ECHICETIN; TARGET	Many snake venoms are known for their antithrombotic activity. They contain components that specifically target different platelet-activating receptors such as the collagen-binding integrin alpha 2 beta 1 and the von Willebrand factor receptor GPIb. In a search for an alpha 2 beta 1 integrin-blocking component from the venom of the habu snake (Trimeresurus flavoviridis), we employed two independent purification protocols. First, we used the integrin alpha 2A domain, a major collagen-binding domain, as bait for affinity purification of an alpha 2 beta 1 integrin-binding toxin from the crude venom. Second, in parallel, we used classical protein separation protocols and tested for alpha 2 beta 1 integrin-inhibiting capabilities by ELISA. Using both approaches, we identified flavocetin-A as an inhibitor of alpha 2 beta 1 integrin. Hitherto, flavocetin-A has been reported as a GPIb inhibitor. However, flavocetin-A inhibited collagen-induced platelet aggregation even after GPIb was blocked with other inhibitors. Moreover, flavocetin-A antagonized alpha 2 beta 1 integrin-mediated adhesion and migration of HT1080 human fibrosarcoma cells, which lack any GPIb, on collagen. Protein chemical analyses proved that flavocetin-A binds to alpha 2 beta 1 integrin and its alpha 2A domain with high affinity and in a cooperative manner, which most likely is due to its quaternary structure. Kinetic measurements confirmed the formation of a strong complex between integrin and flavocetin-A, which dissociates very slowly. This study proves that flavocetin-A, which has long been known as a GPIb inhibitor, efficiently targets alpha 2 beta 1 integrin and thus blocks collagen-induced platelet activation. Moreover, our findings suggest that the separation of GPIb-and alpha 2 beta 1 integrin-blocking members within the C-type lectin-related protein family is less strict than previously assumed.	[Arlinghaus, Franziska T.; Eble, Johannes A.] Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Eble, JA (corresponding author), Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	eble@med.uni-frankfurt.de						ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8317, DOI 10.1021/bi00447a009; Arlinghaus FT, 2012, TOXICON, V60, P512, DOI 10.1016/j.toxicon.2012.03.001; CANFIELD VA, 1987, BIOCHEM BIOPH RES CO, V147, P526, DOI 10.1016/0006-291X(87)90963-6; Clemetson KJ, 2008, THROMB HAEMOSTASIS, V99, P473, DOI 10.1160/TH07-12-0718; Clemetson KJ, 2010, TOXICON, V56, P1236, DOI 10.1016/j.toxicon.2010.03.011; Clemetson KJ, 2001, HAEMOSTASIS, V31, P148; Du XY, 2001, THROMB HAEMOSTASIS, V86, P1277, DOI 10.1055/s-0037-1616062; Eble JA, 2005, CURR PHARM DESIGN, V11, P867, DOI 10.2174/1381612053381738; Eble JA, 2002, MATRIX BIOL, V21, P547, DOI 10.1016/S0945-053X(02)00068-9; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; Eble JA, 2009, FASEB J, V23, P2917, DOI 10.1096/fj.08-126763; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Fukuda K, 2000, BIOCHEMISTRY-US, V39, P1915, DOI 10.1021/bi992134z; Fukuda K, 1999, ACTA CRYSTALLOGR D, V55, P1911, DOI 10.1107/S0907444999009622; Hamako J, 1996, BIOCHEM BIOPH RES CO, V226, P273, DOI 10.1006/bbrc.1996.1345; Marcinkiewicz C, 2000, BIOCHEMISTRY-US, V39, P9859, DOI 10.1021/bi000428a; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; Navdaev A, 2001, BLOOD, V97, P2333, DOI 10.1182/blood.V97.8.2333; Nuyttens BP, 2011, THROMB RES, V127, pS26, DOI 10.1016/S0049-3848(10)70151-1; PENG ML, 1991, BIOCHEMISTRY-US, V30, P11529, DOI 10.1021/bi00113a007; PENG ML, 1993, BLOOD, V81, P2321; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; Staniszewska I, 2009, CANCER BIOL THER, V8, P1507, DOI 10.4161/cbt.8.15.8999; TANIUCHI Y, 1995, BBA-GEN SUBJECTS, V1244, P331, DOI 10.1016/0304-4165(95)00052-D; Taniuchi Y, 2000, THROMB RES, V97, P69, DOI 10.1016/S0049-3848(99)00143-7	25	11	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					947	955		10.1074/jbc.M112.399618	http://dx.doi.org/10.1074/jbc.M112.399618			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204528	hybrid, Green Published			2022-12-25	WOS:000313570300019
J	Quy, PN; Kuma, A; Pierre, P; Mizushima, N				Pham Nguyen Quy; Kuma, Akiko; Pierre, Philippe; Mizushima, Noboru			Proteasome-dependent Activation of Mammalian Target of Rapamycin Complex 1 (mTORC1) Is Essential for Autophagy Suppression and Muscle Remodeling Following Denervation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; AMINO-ACIDS; PROTEIN; GROWTH; DEGRADATION; METABOLISM; PATHWAY; HYPERTROPHY; INHIBITION; GLUTAMINE	Drastic protein degradation occurs during muscle atrophy induced by denervation, fasting, immobility, and various systemic diseases. Although the ubiquitin-proteasome system is highly up-regulated in denervated muscles, the involvement of autophagy and protein synthesis has been controversial. Here, we report that autophagy is rather suppressed in denervated muscles even under autophagy-inducible starvation conditions. This is due to a constitutive activation of mammalian target of rapamycin complex 1 (mTORC1). We further reveal that denervation-induced mTORC1 activation is dependent on the proteasome, which is likely mediated by amino acids generated from proteasomal degradation. Protein synthesis and ribosome biogenesis are paradoxically increased in denervated muscles in an mTORC1-dependent manner, and mTORC1 activation plays an anabolic role against denervation-induced muscle atrophy. These results suggest that denervation induces not only muscle degradation but also adaptive muscle response in a proteasome- and mTORC1-dependent manner.	[Pham Nguyen Quy; Kuma, Akiko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Pierre, Philippe] Aix Marseille Univ, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Pierre, Philippe] INSERM, U1104, F-13288 Marseille, France; [Pierre, Philippe] CNRS, UMR 7280, F-13288 Marseille, France; [Mizushima, Noboru] Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Bunkyo Ku, Tokyo 1130033, Japan; [Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 1130033, Japan	Tokyo Medical & Dental University (TMDU); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Tokyo; University of Tokyo	Mizushima, N (corresponding author), Univ Tokyo, Dept Biochem & Mol Biol, Grad Sch, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444; pierre, philippe/0000-0003-0863-8255	Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for Next Generation World-Leading Researchers	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Funding Program for Next Generation World-Leading Researchers (to N. M.).	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Argadine HM, 2011, AM J PHYSIOL-CELL PH, V300, pC318, DOI 10.1152/ajpcell.00172.2010; Argadine HM, 2009, J APPL PHYSIOL, V107, P438, DOI 10.1152/japplphysiol.91247.2008; Batt J, 2005, FASEB J, V19, P115, DOI 10.1096/fj.04-3640fje; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; CHANG TW, 1978, J BIOL CHEM, V253, P3685; DAVIS TA, 1988, BIOCHEM J, V254, P667, DOI 10.1042/bj2540667; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; FURUNO K, 1990, J BIOL CHEM, V265, P8550; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; GOLDSPINK DF, 1976, BIOCHEM J, V156, P71, DOI 10.1042/bj1560071; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Hornberger TA, 2001, AM J PHYSIOL-CELL PH, V281, pC179, DOI 10.1152/ajpcell.2001.281.1.C179; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimball SR, 2008, J BIOL CHEM, V283, P3465, DOI 10.1074/jbc.M706643200; KING PA, 1983, BIOCHEM J, V216, P523, DOI 10.1042/bj2160523; Kostrominova TY, 2005, PHYSIOL GENOMICS, V22, P227, DOI 10.1152/physiolgenomics.00210.2004; Koyama S, 2008, J MOL BIOL, V376, P1224, DOI 10.1016/j.jmb.2007.11.049; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Murakami M, 2008, DEV GROWTH DIFFER, V50, P121, DOI [10.1111/j.1440-169x.2007.00982.x, 10.1111/j.1440-169X.2007.00982.x]; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sadiq F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-23; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Sun HL, 2012, MOL CELL BIOCHEM, V364, P193, DOI 10.1007/s11010-011-1218-2; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; TANAKA K, 1986, J BIOL CHEM, V261, P5197; TURINSKY J, 1990, AM J PHYSIOL, V258, pE485, DOI 10.1152/ajpendo.1990.258.3.E485; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	76	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1125	1134		10.1074/jbc.M112.399949	http://dx.doi.org/10.1074/jbc.M112.399949			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209294	Green Published, hybrid			2022-12-25	WOS:000313570300035
J	Kwon, H; Lu, HL; Longnecker, MT; Pietrantonio, PV				Kwon, Hyeogsun; Lu, Hsiao-Ling; Longnecker, Michael T.; Pietrantonio, Patricia V.			Role in Diuresis of a Calcitonin Receptor (GPRCAL1) Expressed in a Distal-Proximal Gradient in Renal Organs of the Mosquito Aedes aegypti (L.)	PLOS ONE			English	Article							MALPIGHIAN TUBULES; DIURETIC HORMONE; H+-ATPASE; PEPTIDE; DROSOPHILA; GENE; MECHANISMS; ADRENOMEDULLIN; BLOODMEAL; TRANSPORT	Evolution of anthropophilic hematophagy in insects resulted in the coordination of various physiological processes for survival. In female mosquitoes, a large blood meal provides proteins for egg production and as a trade-off, rapid elimination of the excess water and solutes (Na+, Cl-) is critical for maintaining homeostasis and removing excess weight to resume flight and avoid predation. This post-prandial excretion is achieved by the concerted action of multiple hormones. Diuresis and natriuresis elicited by the calcitonin-like diuretic hormone 31 (DH31) are believed to be mediated by a yet uncharacterized calcitonin receptor (GPRCAL) in the mosquito Malpighian tubules (MTs), the renal organs. To contribute knowledge on endocrinology of mosquito diuresis we cloned GPRCAL1 from MT cDNA. This receptor is the ortholog of the DH31 receptor from Drosophila melanogaster that is expressed in principal cells of the fruit fly MT. Immunofluorescence similarly showed AaegGPRCAL1 is present in MT principal cells in A. aegypti, however, exhibiting an overall gradient-like pattern along the tubule novel for a GPCR in insects. Variegated, cell-specific receptor expression revealed a subpopulation of otherwise phenotypically similar principal cells. To investigate the receptor contribution to fluid elimination, RNAi was followed by urine measurement assays. In vitro, MTs from females that underwent AaegGPRcal1 knock-down exhibited up to 57% decrease in the rate of fluid secretion in response to DH31. Live females treated with AaegGPRcal1 dsRNA exhibited 30% reduction in fluid excreted after a blood meal. The RNAi-induced phenotype demonstrates the critical contribution of this single secretin-like family B GPCR to fluid excretion in invertebrates and highlights its relevance for the blood feeding adaptation. Our results with the mosquito AaegGPRCAL1 imply that the regulatory function of calcitonin-like receptors for ion and fluid transport in renal organs arose early in evolution.	[Kwon, Hyeogsun; Lu, Hsiao-Ling; Pietrantonio, Patricia V.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Longnecker, Michael T.] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Pietrantonio, PV (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	p-pietrantonio@tamu.edu	Kwon, Hyeogsun/AAL-2536-2021	Kwon, Hyeogsun/0000-0002-4141-4061	Texas AgriLife Research	Texas AgriLife Research	Research was funded by a grant from Texas AgriLife Research to PVP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar N, 1996, J BIOL CHEM, V271, P11325, DOI 10.1074/jbc.271.19.11325; Beyenbach KW, 2011, ACTA PHYSIOL, V202, P387, DOI 10.1111/j.1748-1716.2010.02195.x; Beyenbach KW, 2012, ANN NY ACAD SCI, V1258, P166, DOI 10.1111/j.1749-6632.2012.06527.x; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; BEYENBACH KW, 1993, J INSECT PHYSIOL, V39, P639, DOI 10.1016/0022-1910(93)90069-4; Beyenbach KW, 2003, J EXP BIOL, V206, P3845, DOI 10.1242/jeb.00639; BLACKBURN MB, 1991, BIOCHEM BIOPH RES CO, V181, P927, DOI 10.1016/0006-291X(91)92025-F; BRIN VB, 1991, B EXP BIOL MED+, V111, P128, DOI 10.1007/BF00842658; Brugge VAT, 2008, PEPTIDES, V29, P206, DOI 10.1016/j.peptides.2007.10.031; Buhlmann N, 2000, FEBS LETT, V486, P320, DOI 10.1016/S0014-5793(00)02259-6; Butcher AJ, 2011, J BIOL CHEM, V286, P11506, DOI 10.1074/jbc.M110.154526; Cabrero P, 2002, J EXP BIOL, V205, P3799; Cardoso JCR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-108; Clark TM, 1998, J EXP BIOL, V201, P1753; Coast GM, 2009, J EXP BIOL, V212, P378, DOI 10.1242/jeb.024109; Coast GM, 2005, J EXP BIOL, V208, P3281, DOI 10.1242/jeb.01760; Coast GM, 2004, J INSECT PHYSIOL, V50, P455, DOI 10.1016/j.jinsphys.2004.03.004; Coast GM, 2001, J EXP BIOL, V204, P1795; Diaz E, 2001, BRAIN RES BULL, V55, P29, DOI 10.1016/S0361-9230(01)00461-0; FLUHMANN B, 1995, BIOCHEM BIOPH RES CO, V206, P341, DOI 10.1006/bbrc.1995.1047; Furuya K, 2000, P NATL ACAD SCI USA, V97, P6469, DOI 10.1073/pnas.97.12.6469; GALUN R, 1967, B WORLD HEALTH ORGAN, V36, P590; GREEN FR, 1987, P NATL ACAD SCI USA, V84, P8340, DOI 10.1073/pnas.84.23.8340; Harmar AJ, 2001, GENOME BIOL, V2; Jackson RR, 2005, P NATL ACAD SCI USA, V102, P15155, DOI 10.1073/pnas.0507398102; Jagge CL, 2008, INSECT MOL BIOL, V17, P413, DOI 10.1111/j.1365-2583.2008.00817.x; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Kang'ethe W, 2007, AM J PHYSIOL-RENAL, V292, pF1501, DOI 10.1152/ajprenal.00487.2005; Karas K, 2005, J INSECT PHYSIOL, V51, P1041, DOI 10.1016/j.jinsphys.2005.05.002; Lang M, 2006, J MED CHEM, V49, P616, DOI 10.1021/jm050613s; Lu HL, 2011, INSECT BIOCHEM MOLEC, V41, P135, DOI 10.1016/j.ibmb.2010.10.003; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; MADDRELL SHP, 1976, PHYSIOL ENTOMOL, V1, P265, DOI 10.1111/j.1365-3032.1976.tb00974.x; MADDRELL SHP, 1991, J EXP BIOL, V156, P557; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mocellin Simone, 2004, J Transl Med, V2, P39, DOI 10.1186/1479-5876-2-39; Nelson XJ, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000132; NIJHOUT HF, 1978, J INSECT PHYSIOL, V24, P293, DOI 10.1016/0022-1910(78)90025-2; Padilla BE, 2007, J CELL BIOL, V179, P981, DOI 10.1083/jcb.200704053; Patrick ML, 2006, J EXP BIOL, V209, P4638, DOI 10.1242/jeb.02551; PETZEL DH, 1987, AM J PHYSIOL, V253, pR701, DOI 10.1152/ajpregu.1987.253.5.R701; PETZEL DH, 1985, AM J PHYSIOL, V249, pR379, DOI 10.1152/ajpregu.1985.249.4.R379; Piermarini PM, 2009, AM J PHYSIOL-RENAL, V296, pF730, DOI 10.1152/ajprenal.90564.2008; Pietrantonio PV, 2001, INSECT MOL BIOL, V10, P357, DOI 10.1046/j.0962-1075.2001.00274.x; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Predel R, 2010, J PROTEOME RES, V9, P2006, DOI 10.1021/pr901187p; Pullikuth AK, 2006, J EXP BIOL, V209, P3529, DOI 10.1242/jeb.02419; RAMSAY JA, 1954, J EXP BIOL, V31, P104; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Schooley D.A., 2012, INSECT ENDOCRINOLOGY, P366, DOI DOI 10.1016/B978-0-12-384749-2.10009-3; Sozen MA, 1997, P NATL ACAD SCI USA, V94, P5207, DOI 10.1073/pnas.94.10.5207; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Vandenborre G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016682; Wieczorek H, 2009, J EXP BIOL, V212, P1611, DOI 10.1242/jeb.030007; WILLIAMS JC, 1983, J COMP PHYSIOL, V153, P257, DOI 10.1007/BF00689629	55	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50374	10.1371/journal.pone.0050374	http://dx.doi.org/10.1371/journal.pone.0050374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209727	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900045
J	Wessells, KR; Singh, GM; Brown, KH				Wessells, K. Ryan; Singh, Gitanjali M.; Brown, Kenneth H.			Estimating the Global Prevalence of Inadequate Zinc Intake from National Food Balance Sheets: Effects of Methodological Assumptions	PLOS ONE			English	Article							DIETARY ZINC; PEARL-MILLET; CHILDREN; IRON; BIOAVAILABILITY; DEFICIENCY; NUTRITION; ADEQUACY; PHYTATE	Background: The prevalence of inadequate zinc intake in a population can be estimated by comparing the zinc content of the food supply with the population's theoretical requirement for zinc. However, assumptions regarding the nutrient composition of foods, zinc requirements, and zinc absorption may affect prevalence estimates. These analyses were conducted to: (1) evaluate the effect of varying methodological assumptions on country-specific estimates of the prevalence of dietary zinc inadequacy and (2) generate a model considered to provide the best estimates. Methodology and Principal Findings: National food balance data were obtained from the Food and Agriculture Organization of the United Nations. Zinc and phytate contents of these foods were estimated from three nutrient composition databases. Zinc absorption was predicted using a mathematical model (Miller equation). Theoretical mean daily per capita physiological and dietary requirements for zinc were calculated using recommendations from the Food and Nutrition Board of the Institute of Medicine and the International Zinc Nutrition Consultative Group. The estimated global prevalence of inadequate zinc intake varied between 12-66%, depending on which methodological assumptions were applied. However, country-specific rank order of the estimated prevalence of inadequate intake was conserved across all models (r = 0.57-0.99, P < 0.01). A "best-estimate'' model, comprised of zinc and phytate data from a composite nutrient database and IZiNCG physiological requirements for absorbed zinc, estimated the global prevalence of inadequate zinc intake to be 17.3%. Conclusions and Significance: Given the multiple sources of uncertainty in this method, caution must be taken in the interpretation of the estimated prevalence figures. However, the results of all models indicate that inadequate zinc intake may be fairly common globally. Inferences regarding the relative likelihood of zinc deficiency as a public health problem in different countries can be drawn based on the country-specific rank order of estimated prevalence of inadequate zinc intake. Citation: Wessells KR, Singh GM, Brown KH (2012) Estimating the Global Prevalence of Inadequate Zinc Intake from National Food Balance Sheets: Effects of Methodological Assumptions. PLoS ONE 7(11): e50565. doi:10.1371/journal.pone.0050565	[Wessells, K. Ryan; Brown, Kenneth H.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Singh, Gitanjali M.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	University of California System; University of California Davis; Harvard University; Harvard T.H. Chan School of Public Health	Brown, KH (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	khbrown@ucdavis.edu		Wessells, K. Ryan/0000-0002-5485-7144	Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by a grant from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AA, 1998, FOOD CHEM, V63, P243, DOI 10.1016/S0308-8146(97)00228-8; Abebe Y, 2007, J FOOD COMPOS ANAL, V20, P161, DOI 10.1016/j.jfca.2006.09.003; Allen L, 2006, GUIDELINES FOOD FORT; [Anonymous], 2011, WORLD POP PROSP 2010; Barikmo I, 2007, J FOOD COMPOS ANAL, V20, P681, DOI 10.1016/j.jfca.2007.04.002; BROWN K, 1998, WHONUT981; Brown KH, 2010, FOOD NUTR BULL, V31, pS62, DOI 10.1177/15648265100311S106; Brown KH, 2009, FOOD NUTR BULL, V30, pS144, DOI 10.1177/15648265090301S108; Brown KH, 2001, FOOD NUTR BULL, V22, P113, DOI DOI 10.1177/156482650102200201; Buerkert A, 2001, FIELD CROP RES, V69, P1, DOI 10.1016/S0378-4290(00)00127-1; Calloway D, 1994, USERS GUIDE INT MINI; Chakravarty I, 2002, NUTR REV, V60, pS53, DOI 10.1301/00296640260130740; de Benoist B., 2007, Food and Nutrition Bulletin, V28, pS399; FAO, 2001, FOOD BALANCE SHEETS; FERGUSON EL, 1993, J NUTR, V123, P1487, DOI 10.1093/jn/123.9.1487; Food and Agriculture Organization of the United Nations, FISH STAT COLL GLOB; Food and Agriculture Organization of the United Nations (FAO), FOOD BAL 1970 2007; Gibson RS, 2011, BRIT J NUTR, V105, P436, DOI 10.1017/S0007114510003569; Gibson RS, 1998, AM J CLIN NUTR, V68, p430S, DOI 10.1093/ajcn/68.2.430S; GREGORY J, 2000, NATL DIET NUTR SURVE, V1; Gustavsson J, 2011, INT C SAV FOOD DUSS; Hambidge KM, 2011, INT J VITAM NUTR RES, V81, P72, DOI [10.1024/0300-9831/a000052, 10.1024/0300-9831/a00052]; Hambidge KM, 2010, AM J CLIN NUTR, V91, p1478S, DOI 10.3945/ajcn.2010.28674I; Hotz C, 2005, INT J VITAM NUTR RES, V75, P423, DOI 10.1024/0300-9831.75.6.423; Hotz C, 2007, FOOD NUTR BULL, V28, pS430, DOI 10.1177/15648265070283S304; *I MED FOOD NUTR B, 2001, DIET REF INT VIT A V; Institute of Medicine Food and Nutrition Board, 2000, US EST AV REQ NUTR A, P73; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; Karunaratne AM, 2008, J FOOD COMPOS ANAL, V21, P481, DOI 10.1016/j.jfca.2008.02.006; Labadarios D, 2005, PUBLIC HEALTH NUTR, V8, P533, DOI 10.1079/PHN2005816; Ma GS, 2007, PUBLIC HEALTH NUTR, V10, P848, DOI 10.1017/S136898000744143X; Mayer AMB, 2007, J HUNGER ENVIRON NUT, V2, P19, DOI 10.1080/19320240802077797; Miller LV, 2007, J NUTR, V137, P135, DOI 10.1093/jn/137.1.135; MURPHY SP, 1992, AM J CLIN NUTR, V56, P565, DOI 10.1093/ajcn/56.3.565; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Reddy NR, 2002, FOOD PHYTATES; Ruz M, 1997, AM J CLIN NUTR, V66, P1406, DOI 10.1093/ajcn/66.6.1406; Schakel SF, 2001, J FOOD COMPOS ANAL, V14, P315, DOI 10.1006/jfca.2001.0992; Stadlmayr B., 2010, COMPOSITION SELECTED; Sunanda L, 1995, PLANT FOOD HUM NUTR, V48, P201, DOI 10.1007/BF01088441; Villalpando S, 2003, SALUD PUBLICA MEXICO, V45, pS520; World Health Organization (WHO), 1996, TRAC EL HUM NUTR HLT, P265; Wuehler SE, 2005, PUBLIC HEALTH NUTR, V8, P812, DOI 10.1079/PHN2005724	43	73	75	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50565	10.1371/journal.pone.0050565	http://dx.doi.org/10.1371/journal.pone.0050565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209781	gold, Green Submitted, Green Published			2022-12-25	WOS:000312104900067
J	Zhan, J; Zhu, X; Guo, YQ; Wang, YL; Wang, YX; Qiang, GL; Niu, MM; Hu, JX; Du, J; Li, ZL; Cui, J; Ma, B; Fang, WG; Zhang, HQ				Zhan, Jun; Zhu, Xiang; Guo, Yongqing; Wang, Yunling; Wang, Yuxiang; Qiang, Guangliang; Niu, Miaomiao; Hu, Jinxia; Du, Juan; Li, Zhilun; Cui, Jia; Ma, Bo; Fang, Weigang; Zhang, Hongquan			Opposite Role of Kindlin-1 and Kindlin-2 in Lung Cancers	PLOS ONE			English	Article							KINDLER-SYNDROME; ADHESION; PROTEIN; FAMILY; METASTASIS; MUTATIONS; GROWTH; DOMAIN	Lung cancer is highly heterogenous and is composed of various subtypes that are in diverse differential stages. The newly identified integrin-interacting proteins Kindlin-1 and Kindlin-2 are the activators of transmembrane receptor integrins that play important roles in cancer progression. In this report we present the expression profiles of Kindlin-1 and Kindlin-2 in lung cancers using patient specimens and established their correlation with lung cancer progression. We found that Kindlin-1 was expressed in epithelia-derived non-small-cell lung cancer, especially in squamous cell lung cancer but expressed at low levels in poorly differentiated large cell lung cancer. However, Kindlin-2 was highly expressed in large cell lung cancer. Both Kindlin-1 and Kindlin-2 were found not expressed or expressed at very low levels in neuroendocrine-derived small cell lung cancer. Importantly, the Kindlin-1 expression level was positively correlated with the differentiation of squamous cell lung cancer. Surprisingly, we found that the very homologous Kindlin family proteins, Kindlin-1 and Kindlin-2, displayed counteracting functional roles in lung cancer cells. Ectopic expression of Kindlin-1 in non-small-cell lung cancer cells inhibited in vitro cell migration and in vivo tumor growth, while Kindlin-2 promoted these functions. Mechanistically, Kindlin-1 prohibited epithelail to mesenchymal transition in non-small-cell lung cancer cells, while Kindlin-2 enhanced epithelail to mesenchymal transition in these cells. Taken together, we demonstrated that Kindlin-1 and Kindlin-2 differentially regulate lung cancer cell progression. Further, the expression levels of Kindlin-1 might be potentially used as a marker for lung cancer differentiation and targeting Kindlin-2 might block the invasive growth of large cell lung cancer.	[Guo, Yongqing; Qiang, Guangliang] Sino Japan Friendship Hosp, Dept Thorac Surg, Beijing, Peoples R China; [Zhan, Jun; Zhu, Xiang; Wang, Yunling; Wang, Yuxiang; Niu, Miaomiao; Hu, Jinxia; Du, Juan; Cui, Jia; Ma, Bo; Fang, Weigang; Zhang, Hongquan] Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China; [Zhan, Jun; Niu, Miaomiao; Hu, Jinxia; Du, Juan; Cui, Jia; Ma, Bo; Zhang, Hongquan] Peking Univ, Hlth Sci Ctr, Lab Mol Cell Biol & Tumor Biol, Dept Anat Histol & Embryol, Beijing 100871, Peoples R China; [Zhu, Xiang; Wang, Yuxiang; Fang, Weigang] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100871, Peoples R China; [Wang, Yunling] Peking Univ, Hlth Sci Ctr, Inst Cardiovasc Res, Beijing 100871, Peoples R China; [Li, Zhilun] Karolinska Inst, Unit Clin Mol Biol, Dept Biosci & Nutr, Huddinge, Sweden	Peking University; Peking University; Peking University; Karolinska Institutet	Guo, YQ (corresponding author), Sino Japan Friendship Hosp, Dept Thorac Surg, Beijing, Peoples R China.	guoyongqing@yahoo.com; Hongquan.Zhang@bjmu.edu.cn	Zhan, Jun/AAH-5499-2020; Cui, Jia/N-8285-2019	Cui, Jia/0000-0003-3299-8795	National Natural Science Foundation of China (NSFC) [30830048]; Ministry of Science and Technology of China [2010CB912203, 2010CB529402, NSFC31170711]; 111 Project of the Ministry of Education; Beijing Natural Science Foundation [7120002]; Center for Biosciences at Karolinska Institutet	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); 111 Project of the Ministry of Education(Ministry of Education, China - 111 Project); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Center for Biosciences at Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from National Natural Science Foundation of China (NSFC) key project 30830048, the Ministry of Science and Technology of China 2010CB912203 and 2010CB529402, NSFC31170711, the 111 Project of the Ministry of Education and Beijing Natural Science Foundation 7120002 to H.Z., and also by a grant to Staffan Stromblad from the Center for Biosciences at Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZW, 2010, INT J CANCER, V127, P1999, DOI 10.1002/ijc.25223; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Gong XW, 2010, CANCER LETT, V299, P54, DOI 10.1016/j.canlet.2010.08.003; Harris ES, 2012, AM J HEMATOL, V87, P311, DOI 10.1002/ajh.22253; Jobard F, 2003, HUM MOL GENET, V12, P925, DOI 10.1093/hmg/ddg097; KINDLER T, 1954, BRIT J DERMATOL, V66, P104, DOI 10.1111/j.1365-2133.1954.tb12598.x; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Shen ZL, 2012, AM J SURG, V203, P222, DOI 10.1016/j.amjsurg.2011.06.050; SHIN MS, 1986, CHEST, V89, P366, DOI 10.1378/chest.89.3.366; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; Sin S, 2011, J NATL CANCER I, V103, P1323, DOI 10.1093/jnci/djr290; Talaat S, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.02.040; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; van de Vijver E, 2012, BLOOD CELL MOL DIS, V48, P53, DOI 10.1016/j.bcmd.2011.10.004; Vaporciyan AA, 2000, CANC MED, P1227; Weinstein EJ, 2003, BBA-MOL BASIS DIS, V1637, P207, DOI 10.1016/S0925-4439(03)00035-8; Wu Wen-Bin, 2012, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V20, P7	23	36	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50313	10.1371/journal.pone.0050313	http://dx.doi.org/10.1371/journal.pone.0050313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209705	Green Submitted, gold, Green Published			2022-12-25	WOS:000312104900038
J	Crespo, I; San-Miguel, B; Prause, C; Marroni, N; Cuevas, MJ; Gonzalez-Gallego, J; Tunon, MJ				Crespo, Irene; San-Miguel, Beatriz; Prause, Carolina; Marroni, Norma; Cuevas, Maria J.; Gonzalez-Gallego, Javier; Tunon, Maria J.			Glutamine Treatment Attenuates Endoplasmic Reticulum Stress and Apoptosis in TNBS-Induced Colitis	PLOS ONE			English	Article							HEME OXYGENASE-1 INDUCTION; EARLY COLONIC INFLAMMATION; CELL-DEATH; ER STRESS; STIMULATES APOPTOSIS; LIVER-DAMAGE; IN-VITRO; EXPRESSION; ACTIVATION; CASPASE-12	Endoplasmic reticulum (ER) stress and apoptotic cell death play an important role in the pathogenesis and perpetuation of inflammatory bowel disease (IBD). We aimed to explore the potential of glutamine to reduce ER stress and apoptosis in a rat model of experimental IBD. Colitis was induced in male Wistar rats by intracolonic administration of 30 mg of 2,4,6-trinitrobenzene sulfonic acid (TNBS). Glutamine (25 mg/dL) was given by rectal route daily for 2 d or 7 d. Both oxidative stress (TBARS concentration and oxidised/reduced glutathione ratio) and ER stress markers (CHOP, BiP, calpain-1 and caspase-12 expression) increased significantly within 48 h of TNBS instillation, and glutamine attenuated the extent of the changes. Glutamine also inhibited the significant increases of ATF6, ATF4 and spliced XBP-1 mRNA levels induced by TNBS instillation. TNBS-colitis resulted in a significant increase in p53 and cytochrome c expression, and a reduced Bcl-xL expression and Bax/Bcl-2 ratio. These effects were significantly inhibited by glutamine. Treatment with the amino acid also resulted in significant decreases of caspase-9, caspase-8 and caspase-3 activities. Double immunofluorescence staining showed co-localization of CHOP and cleaved caspase-3 in colon sections. Phospho-JNK and PARP-1 expression was also significantly higher in TNBS-treated rats, and treatment with glutamine significantly decreased JNK phosphorylation and PARP-1 proteolysis. To directly address the effect of glutamine on ER stress and apoptosis in epithelial cells, the ER stress inducers brefeldin A and tunicamycin were added to Caco-2 cells that were treated with glutamine (5 mM and 10 mM). The significant enhancement in PERK, ATF6 phosphorylated IRE1, BiP and cleaved caspase-3 expression induced by brefeldin A and tunicamycin was partly prevented by glutamine. Data obtained indicated that modulation of ER stress signalling and anti-apoptotic effects contribute to protection by glutamine against damage in TNBS-induced colitis.	[Crespo, Irene; Cuevas, Maria J.; Gonzalez-Gallego, Javier; Tunon, Maria J.] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Leon, Spain; [Crespo, Irene; San-Miguel, Beatriz; Prause, Carolina; Cuevas, Maria J.; Gonzalez-Gallego, Javier; Tunon, Maria J.] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain; [Marroni, Norma] Univ Fed Rio Grande do Sul, Porto Alegre Clin Hosp, Porto Alegre, RS, Brazil	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de Leon; Universidade Federal do Rio Grande do Sul	Tunon, MJ (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Leon, Spain.	mjtung@unileon.es	San-Miguel, Beatriz/D-8244-2015; Gonzalez-Gallego, Javier/D-8219-2012; Tuñón, María Jesús/L-2456-2017; Cuevas, Maria J/M-4927-2015	San-Miguel, Beatriz/0000-0002-4890-6309; Gonzalez-Gallego, Javier/0000-0002-4386-9342; Cuevas, Maria J/0000-0002-9122-8443; Possa Marroni, Norma/0000-0001-7856-7953; Tunon, Maria Jesus/0000-0001-7827-5918	Instituto de Salud Carlos III, Spain	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	CIBERehd is funded by Instituto de Salud Carlos III, Spain. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett HL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.50; Bogaert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025589; Carneiro BA, 2006, INFECT IMMUN, V74, P81, DOI 10.1128/IAI.74.1.81-87.2006; Cheung HH, 2006, EXP CELL RES, V312, P2347, DOI 10.1016/j.yexcr.2006.03.027; Crespo I, 2008, BRIT J NUTR, V100, P968, DOI 10.1017/S0007114508966083; Crespo I, 2008, FOOD CHEM TOXICOL, V46, P1555, DOI 10.1016/j.fct.2007.12.014; Csala M, 2010, ANTIOXID REDOX SIGN, V13, P77, DOI 10.1089/ars.2009.2529; Erbil Y, 2007, J GASTROEN HEPATOL, V22, P1852, DOI 10.1111/j.1440-1746.2007.04838.x; Fillmann H, 2007, TOXICOLOGY, V236, P217, DOI 10.1016/j.tox.2007.04.012; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; Giris M, 2006, AM J SURG, V191, P503, DOI 10.1016/j.amjsurg.2005.11.004; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P949, DOI 10.1097/01.WCB.0000077641.41248.EA; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Kaser A, 2010, CURR OPIN GASTROEN, V26, P318, DOI 10.1097/MOG.0b013e32833a9ff1; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Kim CJ, 2009, BBA-GEN SUBJECTS, V1790, P1161, DOI 10.1016/j.bbagen.2009.05.018; Kim CJ, 2010, J NUTR BIOCHEM, V21, P468, DOI 10.1016/j.jnutbio.2009.01.019; Kishi S, 2010, NEUROSCI RES, V66, P14, DOI 10.1016/j.neures.2009.09.003; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Kretzmann NA, 2008, INFLAMM BOWEL DIS, V14, P1504, DOI 10.1002/ibd.20543; Lenaerts K, 2005, FEBS J, V272, P3350, DOI 10.1111/j.1742-4658.2005.04750.x; Lipson KL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001648; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Martin AR, 2004, BIOCHEM PHARMACOL, V67, P1399, DOI 10.1016/j.bcp.2003.12.024; Martinez JA, 2010, APOPTOSIS, V15, P1480, DOI 10.1007/s10495-010-0526-4; Mauriz JL, 2003, SHOCK, V19, P33, DOI 10.1097/00024382-200301000-00007; Mazzon E, 2006, J PINEAL RES, V41, P363, DOI 10.1111/j.1600-079X.2006.00378.x; Melis GC, 2004, CURR OPIN CLIN NUTR, V7, P59, DOI 10.1097/00075197-200401000-00011; Mondello S, 2010, EUR J PHARMACOL, V643, P304, DOI 10.1016/j.ejphar.2010.06.044; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Natsume Y, 2009, TOXICOLOGY, V258, P164, DOI 10.1016/j.tox.2009.01.021; NIELSEN OH, 1994, MEDIAT INFLAMM, V3, P161, DOI 10.1155/S0962935194000219; Papaconstantinou HT, 1998, SURGERY, V124, P152, DOI 10.1067/msy.1998.90562; Pastor A, 1996, J HEPATOL, V24, P353, DOI 10.1016/S0168-8278(96)80016-X; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; San-Miguel B, 2006, APOPTOSIS, V11, P1945, DOI 10.1007/s10495-006-0090-0; San-Miguel B, 2010, J NUTR, V140, P1065, DOI 10.3945/jn.110.121525; Segui J, 2004, J LEUKOCYTE BIOL, V76, P537, DOI 10.1189/jlb.0304196; Shiraishi H, 2006, J CELL SCI, V119, P3958, DOI 10.1242/jcs.03160; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tardieu D, 2000, CARCINOGENESIS, V21, P973, DOI 10.1093/carcin/21.5.973; Tavender TJ, 2010, ANTIOXID REDOX SIGN, V13, P1177, DOI 10.1089/ars.2010.3230; Tunon MJ, 2011, J PINEAL RES, V50, P38, DOI 10.1111/j.1600-079X.2010.00807.x; Garcia-Mediavilla MV, 2012, LAB INVEST, V92, P1191, DOI 10.1038/labinvest.2012.88; Wang WW, 2009, AMINO ACIDS, V37, P105, DOI 10.1007/s00726-008-0152-4; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P188, DOI 10.1177/0148607110381407; Yue G, 2001, J PHARMACOL EXP THER, V297, P915; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zingarelli B, 2004, IMMUNOLOGY, V113, P509, DOI 10.1111/j.1365-2567.2004.01991.x; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	55	87	90	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50407	10.1371/journal.pone.0050407	http://dx.doi.org/10.1371/journal.pone.0050407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209735	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700067
J	Dutta, P; Tanti, GK; Sharma, S; Goswami, SK; Komath, SS; Mayo, MW; Hockensmith, JW; Muthuswami, R				Dutta, Popy; Tanti, Goutam Kumar; Sharma, Soni; Goswami, Shyamal K.; Komath, Sneha Sudha; Mayo, Marty W.; Hockensmith, Joel W.; Muthuswami, Rohini			Global Epigenetic Changes Induced by SWI2/SNF2 Inhibitors Characterize Neomycin-Resistant Mammalian Cells	PLOS ONE			English	Article							AMINOGLYCOSIDE-MODIFYING ENZYMES; DNA-DEPENDENT ATPASE; PROTEIN; CHROMATIN; FAMILY; MOUSE; HYDROLYSIS; MECHANISMS; EXPRESSION; COMPLEXES	Background: Previously, we showed that aminoglycoside phosphotransferases catalyze the formation of a specific inhibitor of the SWI2/SNF2 proteins. Aminoglycoside phosphotransferases, for example neomycin-resistant genes, are used extensively as selection markers in mammalian transfections as well as in transgenic studies. However, introduction of the neomycin-resistant gene is fraught with variability in gene expression. We hypothesized that the introduction of neomycin-resistant genes into mammalian cells results in inactivation of SWI2/SNF2 proteins thereby leading to global epigenetic changes. Methodology: Using fluorescence spectroscopy we have shown that the inhibitor, known as Active DNA-dependent ATPase A Domain inhibitor (ADAADi), binds to the SWI2/SNF2 proteins in the absence as well as presence of ATP and DNA. This binding occurs via a specific region known as Motif Ia leading to a conformational change in the SWI2/SNF2 proteins that precludes ATP hydrolysis. ADAADi is produced from a plethora of aminoglycosides including G418 and Streptomycin, two commonly used antibiotics in mammalian cell cultures. Mammalian cells are sensitive to ADAADi; however, cells stably transfected with neomycin-resistant genes are refractory to ADAADi. In resistant cells, endogenous SWI2/SNF2 proteins are inactivated which results in altered histone modifications. Microarray data shows that the changes in the epigenome are reflected in altered gene expression. The microarray data was validated using real-time PCR. Finally, we show that the epigenetic changes are quantized. Significance: The use of neomycin-resistant genes revolutionized mammalian transfections even though questions linger about efficacy. In this study, we have demonstrated that selection of neomycin-resistant cells results in survival of only those cells that have undergone epigenetic changes, and therefore, data obtained using these resistant genes as selection markers need to be cautiously evaluated.	[Mayo, Marty W.; Hockensmith, Joel W.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Dutta, Popy; Tanti, Goutam Kumar; Sharma, Soni; Goswami, Shyamal K.; Komath, Sneha Sudha; Muthuswami, Rohini] Jawaharlal Nehru Univ, Sch Life Sci, Delhi, India	University of Virginia; Jawaharlal Nehru University, New Delhi	Hockensmith, JW (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	jwh6f@virginia.edu; rohini_m@mail.jnu.ac.in	KOMATH, SNEHA SUDHA/AAE-6359-2020; Tanti, Goutam Kumar/AAG-1366-2020; Muthuswami, Rohini/Q-9841-2019	KOMATH, SNEHA SUDHA/0000-0002-0491-7102; Tanti, Goutam Kumar/0000-0002-1761-6077; Muthuswami, Rohini/0000-0002-0559-9484	Scientific and Industrial Research; University Grants Commission; Department of Science and Technology-PURSE; University of Virginia School of Medicine; Jeffress Memorial Trust; National Cancer Institute [CA132580, CA104397]; Rajiv Gandhi Fellowship; Council for Scientific and Industrial Research; University Grants Commission-capacity build up; NATIONAL CANCER INSTITUTE [R01CA104397, R01CA132580] Funding Source: NIH RePORTER	Scientific and Industrial Research; University Grants Commission(University Grants Commission, India); Department of Science and Technology-PURSE; University of Virginia School of Medicine; Jeffress Memorial Trust; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rajiv Gandhi Fellowship(University Grants Commission, India); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission-capacity build up; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R.M. was supported by grants from Council for Scientific and Industrial Research, University Grants Commission, University Grants Commission-capacity build up, and Department of Science and Technology-PURSE; J.W.H. was supported by grants from the University of Virginia School of Medicine, and the Jeffress Memorial Trust; and M.W.M was supported by grants from National Cancer Institute (CA132580 & CA104397). P.D. was supported by funds from Rajiv Gandhi Fellowship, G.K.T. and S.S. were supported by funds from Council for Scientific and Industrial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillat G, 2001, MOL BIOL CELL, V12, P663, DOI 10.1091/mbc.12.3.663; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Coleman MA, 2000, GENOMICS, V65, P274, DOI 10.1006/geno.2000.6174; Felle M, 2010, NUCLEIC ACIDS RES, V38, P5304, DOI 10.1093/nar/gkq263; Fiordalisi JJ, 2001, METHOD ENZYMOL, V332, P3; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Kanaar R, 1996, CURR BIOL, V6, P828, DOI 10.1016/S0960-9822(02)00606-1; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kotra LP, 2000, ANTIMICROB AGENTS CH, V44, P3249, DOI 10.1128/AAC.44.12.3249-3256.2000; Madigan C, 2006, ERM, V8; MCKAY GA, 1995, J BIOL CHEM, V270, P24686, DOI 10.1074/jbc.270.42.24686; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Morettini S, 2008, FRONT BIOSCI-LANDMRK, V13, P5522; Muthuswami R, 2000, BIOCHEMISTRY-US, V39, P4358, DOI 10.1021/bi992503r; Nongkhlaw M, 2012, BIOCHEMISTRY-US, V51, P3711, DOI 10.1021/bi2014757; Nongkhlaw M, 2009, NUCLEIC ACIDS RES, V37, P3332, DOI 10.1093/nar/gkp178; Sanghamitra M, 2008, GENE, V420, P48, DOI 10.1016/j.gene.2008.04.016; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Swagemakers SMA, 1998, J BIOL CHEM, V273, P28292, DOI 10.1074/jbc.273.43.28292; Trotter Kevin W, 2008, Nucl Recept Signal, V6, pe004, DOI 10.1621/nrs.06004; VALERA A, 1994, HUM GENE THER, V5, P449, DOI 10.1089/hum.1994.5.4-449; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wright GD, 1999, CURR OPIN MICROBIOL, V2, P499, DOI 10.1016/S1369-5274(99)00007-7; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	30	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49822	10.1371/journal.pone.0049822	http://dx.doi.org/10.1371/journal.pone.0049822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209606	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700022
J	Sano, H; Ichioka, S; Sekiya, N				Sano, Hitomi; Ichioka, Shigeru; Sekiya, Naomi			Influence of Oxygen on Wound Healing Dynamics: Assessment in a Novel Wound Mouse Model under a Variable Oxygen Environment	PLOS ONE			English	Article							SKELETAL-MUSCLE; ARTERIOLES; METABOLISM; PERFUSION; HYPOXIA	Introduction: Although oxygen is essential for the wound healing process, tissue hypoxia is known to stimulate angiogenesis. To explore these inconsistent findings, we estimated the influence of the oxygen environment on wound healing with our original model. Methods: Experiment 1 (Establishment of the model): To modify the topical oxygen tension, oxygen impermeable (polyvinylidene chloride) and permeable (polymethylpentene) membranes were applied to symmetrical excisional wounds in ddy mice (n = 6). Oxygen tension under the membrane was quantified with a device using photo-quenching technique. Experiment 2 (Influence of oxygen environment on wound healing): The wound area, granulation thickness and vascular density were analyzed under different oxygen environments (n = 24). Results: Experiment 1: The permeable group maintained equivalent oxygen level to atmosphere (114.1 +/- 29.8 mmHg on day 7), while the impermeable group showed extremely low oxygen tension (5.72 +/- 2.99 mmHg on day 7). Accordingly, each group was defined as the normoxia group and the hypoxia group. Experiment 2: Percent decrease in wound size was significantly enhanced in the normoxia group (11.1 +/- 1.66% on day 7) in comparison with the hypoxia group (27.6 +/- 3.47% on day 7). The normoxia group showed significantly thicker granulation tissue than the hypoxia group (491.8 +/- 243.2 vs. 295.3 +/- 180.9 mu m). Contrarily, the vascular density of the hypoxia group significantly increased on day 7 (0.046 +/- 0.025 vs. 0.011 +/- 0.008 mm(2)/mm(2)). Conclusions: Our original model successfully controlled local oxygen concentration around the wound, and the hypoxic wounds showed increased angiogenesis but with a smaller amount of granulation tissue and delayed wound closure. Enhanced neovascularization in the hypoxic group likely implies compensative response to an insufficient ambient oxygen supply.	[Sano, Hitomi] Univ Tokyo, Grad Sch Med, Dept Surg Sci, Tokyo, Japan; [Sano, Hitomi; Ichioka, Shigeru; Sekiya, Naomi] Saitama Med Univ Hosp, Dept Plast & Reconstruct Surg, Saitama, Japan	University of Tokyo; Saitama Medical University	Sano, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Surg Sci, Tokyo, Japan.	sasasa116sasasa@hotmail.com						Asmis R, 2010, INT WOUND J, V7, P349, DOI 10.1111/j.1742-481X.2010.00716.x; Cherry GW, 1984, ROYAL SOC MED INT C, V88, P61; Fries RB, 2005, MUTAT RES-FUND MOL M, V579, P172, DOI 10.1016/j.mrfmmm.2005.02.023; Heise HM, 2003, SKIN RES TECHNOL, V9, P295, DOI 10.1034/j.1600-0846.2003.00036.x; HOHN DC, 1976, SURG FORUM, V27, P18; HUNT TK, 1972, SURG GYNECOL OBSTETR, V135, P561; JONSSON K, 1991, ANN SURG, V214, P605, DOI 10.1097/00000658-199111000-00011; KIVISAARI J, 1975, ANN SURG, V181, P823, DOI 10.1097/00000658-197506000-00011; KNIGHTON DR, 1981, SURGERY, V90, P262; NIINIKOS.J, 1969, ACTA PHYSIOL SCAND, P1; Said HK, 2005, ARCH SURG-CHICAGO, V140, P998, DOI 10.1001/archsurg.140.10.998; Semenza GL, 2010, ARTERIOSCL THROM VAS, V30, P648, DOI 10.1161/ATVBAHA.108.181644; Shibata M, 2006, EUR J APPL PHYSIOL, V97, P327, DOI 10.1007/s00421-006-0200-2; Shibata M, 2005, AM J PHYSIOL-HEART C, V289, pH295, DOI 10.1152/ajpheart.00830.2004; Shibata M, 2005, EUR J APPL PHYSIOL, V94, P352, DOI 10.1007/s00421-005-1315-6; Shibata M, 2001, J APPL PHYSIOL, V91, P321, DOI 10.1152/jappl.2001.91.1.321; Shibata M, 2006, J APPL PHYSIOL, V100, P1793, DOI 10.1152/japplphysiol.01632.2005; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497	18	23	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50212	10.1371/journal.pone.0050212	http://dx.doi.org/10.1371/journal.pone.0050212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	120QE	23209678	Green Published, Green Submitted, gold			2022-12-25	WOS:000317185400005
J	Xu, LL; Rainey, JK; Meng, Q; Liu, XQ				Xu, Lingling; Rainey, Jan K.; Meng, Qing; Liu, Xiang-Qin			Recombinant Minimalist Spider Wrapping Silk Proteins Capable of Native-Like Fiber Formation	PLOS ONE			English	Article							EXPRESSION; DOMAIN; SOLUBILITY; MECHANISMS; TOUGHNESS; STRENGTH; FIBRILS; CELLS; LINE	Spider silks are desirable biomaterials characterized by high tensile strength, elasticity, and biocompatibility. Spiders produce different types of silks for different uses, although dragline silks have been the predominant focus of previous studies. Spider wrapping silk, made of the aciniform protein (AcSp1), has high toughness because of its combination of high elasticity and tensile strength. AcSp1 in Argiope trifasciata contains a 200-aa sequence motif that is repeated at least 14 times. Here, we produced in E. coli recombinant proteins consisting of only one to four of the 200-aa AcSp1 repeats, designated W-1 to W-4. We observed that purified W-2, W-3 and W-4 proteins could be induced to form silk-like fibers by shear forces in a physiological buffer. The fibers formed by W-4 were similar to 3.4 mu m in diameter and up to 10 cm long. They showed an average tensile strength of 115 MPa, elasticity of 37%, and toughness of 34 J cm(-3). The smaller W-2 protein formed fewer fibers and required a higher protein concentration to form fibers, whereas the smallest W-1 protein did not form silk-like fibers, indicating that a minimum of two of the 200-aa repeats was required for fiber formation. Microscopic examinations revealed structural features indicating an assembly of the proteins into spherical structures, fibrils, and silk-like fibers. CD and Raman spectral analysis of protein secondary structures suggested a transition from predominantly alpha-helical in solution to increasingly beta-sheet in fibers.	[Xu, Lingling; Meng, Qing] Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China; [Xu, Lingling; Rainey, Jan K.; Liu, Xiang-Qin] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Rainey, Jan K.] Dalhousie Univ, Dept Chem, Halifax, NS, Canada	Donghua University; Dalhousie University; Dalhousie University	Meng, Q (corresponding author), Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai, Peoples R China.	mengqing@dhu.edu.cn; paul.liu@dal.ca	Rainey, Jan K/C-1927-2008	Rainey, Jan K/0000-0003-0793-5573	Canadian Institutes of Health Research; National Science and Engineering Research Council of Canada; National Science and Engineering Research Council of Canada Discovery Grant; National High Technology Research and Development Program 863 [2006AA03Z451]; National Natural Science Foundation of China [31070698]; Shanghai key projects of basic research [10JC1400300]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science and Engineering Research Council of Canada Discovery Grant; National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai key projects of basic research	This work was supported by research grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and National Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) to XQL, National Science and Engineering Research Council of Canada Discovery Grant (http://www.nserc-crsng.gc.ca/index_eng.asp) to JKR, research grants to QM from the National High Technology Research and Development Program 863 (NO 2006AA03Z451) (http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), the National Natural Science Foundation of China (NO 31070698) (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm) and the Shanghai key projects of basic research (NO 10JC1400300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884; Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f; Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; Grip S, 2009, PROTEIN SCI, V18, P1012, DOI 10.1002/pro.111; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204; Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y; Heim M, 2010, J STRUCT BIOL, V170, P420, DOI 10.1016/j.jsb.2009.12.025; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005; Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q; Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k; Ittah S, 2010, BIOPOLYMERS, V93, P458, DOI 10.1002/bip.21362; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030; Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780; Lefevre T, 2011, J MOL BIOL, V405, P238, DOI 10.1016/j.jmb.2010.10.052; Lin Z, 2009, P NATL ACAD SCI USA, V106, P8906, DOI 10.1073/pnas.0813255106; Miao YG, 2006, APPL MICROBIOL BIOT, V71, P192, DOI 10.1007/s00253-005-0127-2; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x; Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105; Rousseau ME, 2009, BIOMACROMOLECULES, V10, P2945, DOI 10.1021/bm9007919; Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14; Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y; Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833; Widhe M, 2012, BIOPOLYMERS, V97, P468, DOI 10.1002/bip.21715; Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107; Xu HT, 2007, ANIM BIOTECHNOL, V18, P1, DOI 10.1080/10495390601091024; Zhang YS, 2008, MOL BIOL REP, V35, P329, DOI 10.1007/s11033-007-9090-6	34	47	50	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50227	10.1371/journal.pone.0050227	http://dx.doi.org/10.1371/journal.pone.0050227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209681	gold, Green Published			2022-12-25	WOS:000312601700045
J	Yu, KK; Aguilar, K; Tsai, J; Galimidi, R; Gnanapragasam, P; Yang, LL; Baltimore, D				Yu, Kenneth K.; Aguilar, Kiefer; Tsai, Jonathan; Galimidi, Rachel; Gnanapragasam, Priyanthi; Yang, Lili; Baltimore, David			Use of Mutated Self-Cleaving 2A Peptides as a Molecular Rheostat to Direct Simultaneous Formation of Membrane and Secreted Anti-HIV Immunoglobulins	PLOS ONE			English	Article							B-CELL DEVELOPMENT; HEMATOPOIETIC STEM-CELLS; S MESSENGER-RNA; HEAVY-CHAIN; MU-CHAIN; REGULATED PRODUCTION; TARGETED DISRUPTION; 3 ENDS; CLEAVAGE; GENE	In nature, B cells produce surface immunoglobulin and secreted antibody from the same immunoglobulin gene via alternative splicing of the pre-messenger RNA. Here we present a novel system for genetically programming B cells to direct the simultaneous formation of membrane-bound and secreted immunoglobulins that we term a "Molecular Rheostat'', based on the use of mutated "self-cleaving'' 2A peptides. The Molecular Rheostat is designed so that the ratio of secreted to membrane-bound immunoglobulins can be controlled by selecting appropriate mutations in the 2A peptide. Lentiviral transgenesis of Molecular Rheostat constructs into B cell lines enables the simultaneous expression of functional b12-based IgM-like BCRs that signal to the cells and mediate the secretion of b12 IgG broadly neutralizing antibodies that can bind and neutralize HIV-1 pseudovirus. We show that these b12-based Molecular Rheostat constructs promote the maturation of EU12 B cells in an in vitro model of B lymphopoiesis. The Molecular Rheostat offers a novel tool for genetically manipulating B cell specificity for B-cell based gene therapy.	[Yu, Kenneth K.; Aguilar, Kiefer; Tsai, Jonathan; Galimidi, Rachel; Gnanapragasam, Priyanthi; Yang, Lili; Baltimore, David] CALTECH, Pasadena, CA 91125 USA; [Yu, Kenneth K.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	California Institute of Technology; University of Southern California	Baltimore, D (corresponding author), CALTECH, Pasadena, CA 91125 USA.	baltimo@caltech.edu		Yu, Kenneth/0000-0003-2547-5566	Bill and Melinda Gates Foundation [37866]; Office of the President of the Universities of California [UCOP.D08-CT-305]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Office of the President of the Universities of California	This work is supported by the following two sources of funding: 1. The Grand Challenges in Global Health Program, The Bill and Melinda Gates Foundation, award # 37866 (http://www.grandchallenges.org/CureInfection/ Challenges/ImmunologicalMethods/Pages/HIV.aspx), 2. The California HIV/AIDS Research Program, The Office of the President of the Universities of California, award # UCOP.D08-CT-305 (http://chrp.ucop.edu/funded_research/abstracts/2009_yu.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Atkins JF, 2007, RNA, V13, P803, DOI 10.1261/rna.487907; BURROWS PD, 1993, CURR OPIN IMMUNOL, V5, P201, DOI 10.1016/0952-7915(93)90005-D; CHEN JZ, 1993, CURR OPIN IMMUNOL, V5, P194, DOI 10.1016/0952-7915(93)90004-C; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Doronina VA, 2008, BIOCHEM SOC T, V36, P712, DOI 10.1042/BST0360712; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; GALLI G, 1988, P NATL ACAD SCI USA, V85, P2439, DOI 10.1073/pnas.85.8.2439; GALLI G, 1987, GENE DEV, V1, P471, DOI 10.1101/gad.1.5.471; GRUPP SA, 1995, J EXP MED, V181, P161, DOI 10.1084/jem.181.1.161; HARRISON PT, 1994, NUCLEIC ACIDS RES, V22, P3813, DOI 10.1093/nar/22.18.3813; Joseph A, 2010, J VIROL, V84, P6645, DOI 10.1128/JVI.02339-09; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Kumar M, 2001, HUM GENE THER, V12, P1893, DOI 10.1089/104303401753153947; Luo XM, 2009, BLOOD, V113, P1422, DOI 10.1182/blood-2008-09-177139; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; O'Connell RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012009; Peterson ML, 2007, IMMUNOL RES, V37, P33, DOI 10.1007/BF02686094; PETERSON ML, 1986, P NATL ACAD SCI USA, V83, P8883, DOI 10.1073/pnas.83.23.8883; PETERSON ML, 1989, MOL CELL BIOL, V9, P726, DOI 10.1128/MCB.9.2.726; PETERSON ML, 1991, MOL CELL BIOL, V11, P2324, DOI 10.1128/MCB.11.4.2324; ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; TWEEDDALE ME, 1987, BLOOD, V69, P1307; WAGNER SD, 1994, NUCLEIC ACIDS RES, V22, P1389, DOI 10.1093/nar/22.8.1389; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043; Zhang ZX, 2007, TRENDS IMMUNOL, V28, P132, DOI 10.1016/j.it.2007.01.003; Zhang ZX, 2003, ANN NY ACAD SCI, V987, P270, DOI 10.1111/j.1749-6632.2003.tb06060.x	40	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50438	10.1371/journal.pone.0050438	http://dx.doi.org/10.1371/journal.pone.0050438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209743	gold, Green Accepted, Green Published			2022-12-25	WOS:000312601700071
J	Blackmore, DG; Vukovic, J; Waters, MJ; Bartlett, PF				Blackmore, Daniel G.; Vukovic, Jana; Waters, Michael J.; Bartlett, Perry F.			GH Mediates Exercise-Dependent Activation of SVZ Neural Precursor Cells in Aged Mice	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GROWTH-HORMONE REPLACEMENT; STIMULATED NEUROGENESIS; TARGETED DISRUPTION; PROLIFERATION; BRAIN; MOUSE; IRRADIATION; PROLACTIN; STEM	Here we demonstrate, both in vivo and in vitro, that growth hormone (GH) mediates precursor cell activation in the subventricular zone (SVZ) of the aged (12-month-old) brain following exercise, and that GH signaling stimulates precursor activation to a similar extent to exercise. Our results reveal that both addition of GH in culture and direct intracerebroventricular infusion of GH stimulate neural precursor cells in the aged brain. In contrast, no increase in neurosphere numbers was observed in GH receptor null animals following exercise. Continuous infusion of a GH antagonist into the lateral ventricle of wild-type animals completely abolished the exercise-induced increase in neural precursor cell number. Given that the aged brain does not recover well after injury, we investigated the direct effect of exercise and GH on neural precursor cell activation following irradiation. This revealed that physical exercise as well as infusion of GH promoted repopulation of neural precursor cells in irradiated aged animals. Conversely, infusion of a GH antagonist during exercise prevented recovery of precursor cells in the SVZ following irradiation.	[Blackmore, Daniel G.; Vukovic, Jana; Bartlett, Perry F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Waters, Michael J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Bartlett, PF (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	p.bartlett@uq.edu.au	waters, michael j/C-9582-2014; Blackmore, Daniel G/C-2450-2013; Vukovic, Jana/B-4845-2013; Bartlett, Perry/F-3813-2012	Blackmore, Daniel G/0000-0003-1153-1707; Vukovic, Jana/0000-0002-3739-1688; 	National Health and Medical Research Council (Australia) [APP569575]; Australian Research Council [DP0985145]; Queensland Government	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Queensland Government	This study was supported by a National Health and Medical Research Council (Australia) Program grant (APP569575) to PFB, and an Australian Research Council Discovery Project grant (DP0985145) to MJW. A Smart Futures Fellowship from The Queensland Government supported JV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajo R, 2003, ENDOCRINOLOGY, V144, P1086, DOI 10.1210/en.2002-220667; Blackmore DG, 2012, SCI REP-UK, V2, DOI 10.1038/srep00250; Blackmore DG, 2009, STEM CELLS, V27, P2044, DOI 10.1002/stem.120; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; FELSING NE, 1992, J CLIN ENDOCR METAB, V75, P157, DOI 10.1210/jcem.75.1.1619005; Frank SJ, 2008, J MAMMARY GLAND BIOL, V13, P119, DOI 10.1007/s10911-008-9065-9; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Han TR, 2007, J KOREAN MED SCI, V22, P122, DOI 10.3346/jkms.2007.22.1.122; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Jenkins PJ, 1999, CLIN ENDOCRINOL, V50, P683, DOI 10.1046/j.1365-2265.1999.00784.x; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Le Greves M, 2006, EXP BRAIN RES, V173, P267, DOI 10.1007/s00221-006-0438-2; Li E, 2011, ENDOCR J, V58, P257, DOI 10.1507/endocrj.K11E-006; Lyuh E, 2007, GROWTH HORM IGF RES, V17, P315, DOI 10.1016/j.ghir.2007.03.002; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; McLenachan S, 2009, GROWTH HORM IGF RES, V19, P212, DOI 10.1016/j.ghir.2008.09.003; Mizumatsu S, 2003, CANCER RES, V63, P4021; Naylor AS, 2008, P NATL ACAD SCI USA, V105, P14632, DOI 10.1073/pnas.0711128105; Nieves-Martinez E, 2010, J ENDOCRINOL, V204, P31, DOI 10.1677/JOE-09-0323; Pathipati P, 2011, NEUROSCIENCE, V190, P409, DOI 10.1016/j.neuroscience.2011.05.029; Pathipati P, 2009, BEHAV BRAIN RES, V204, P93, DOI 10.1016/j.bbr.2009.05.023; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Scheepens A, 2001, NEUROSCIENCE, V104, P677, DOI 10.1016/S0306-4522(01)00109-9; Shin DH, 2004, NEUROSCI LETT, V354, P64, DOI 10.1016/j.neulet.2003.09.070; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Soares Michael J, 2004, Reprod Biol Endocrinol, V2, P51, DOI 10.1186/1477-7827-2-51; SUTTON J, 1976, J APPL PHYSIOL, V41, P523; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Walker TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044371; Wallace JD, 1999, J CLIN ENDOCR METAB, V84, P3591, DOI 10.1210/jc.84.10.3591; Webb EA, 2012, BRAIN, V135, P216, DOI 10.1093/brain/awr305; Wong-Goodrich SJE, 2010, CANCER RES, V70, P9329, DOI 10.1158/0008-5472.CAN-10-1854; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	41	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49912	10.1371/journal.pone.0049912	http://dx.doi.org/10.1371/journal.pone.0049912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209615	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800031
J	Campregher, C; Schmid, G; Ferk, F; Knasmuller, S; Khare, V; Kortum, B; Dammann, K; Lang, M; Scharl, T; Spittler, A; Roig, AI; Shay, JW; Gerner, C; Gasche, C				Campregher, Christoph; Schmid, Gerald; Ferk, Franziska; Knasmueller, Siegfried; Khare, Vineeta; Kortuem, Benedikt; Dammann, Kyle; Lang, Michaela; Scharl, Theresa; Spittler, Andreas; Roig, Andres I.; Shay, Jerry W.; Gerner, Christopher; Gasche, Christoph			MSH3-Deficiency Initiates EMAST without Oncogenic Transformation of Human Colon Epithelial Cells	PLOS ONE			English	Article							MISMATCH REPAIR DEFICIENCY; DOUBLE-STRAND BREAKS; MICROSATELLITE INSTABILITY; TETRANUCLEOTIDE REPEATS; COLORECTAL-CANCER; BLADDER-CANCER; DNA-DAMAGE; HEPATOCELLULAR-CARCINOMA; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL INTERACTION	Background/Aim: Elevated microsatellite instability at selected tetranucleotide repeats (EMAST) is a genetic signature in certain cases of sporadic colorectal cancer and has been linked to MSH3-deficiency. It is currently controversial whether EMAST is associated with oncogenic properties in humans, specifically as cancer development in Msh3-deficient mice is not enhanced. However, a mutator phenotype is different between species as the genetic positions of repetitive sequences are not conserved. Here we studied the molecular effects of human MSH3-deficiency. Methods: HCT116 and HCT116+chr3 (both MSH3-deficient) and primary human colon epithelial cells (HCEC, MSH3-wildtype) were stably transfected with an EGFP-based reporter plasmid for the detection of frameshift mutations within an [AAAG]17 repeat. MSH3 was silenced by shRNA and changes in protein expression were analyzed by shotgun proteomics. Colony forming assay was used to determine oncogenic transformation and double strand breaks (DSBs) were assessed by Comet assay. Results: Despite differential MLH1 expression, both HCT116 and HCT116+chr3 cells displayed comparable high mutation rates (about 4 x 10(-4)) at [AAAG]17 repeats. Silencing of MSH3 in HCECs leads to a remarkable increased frameshift mutations in [AAAG]17 repeats whereas [CA]13 repeats were less affected. Upon MSH3-silencing, significant changes in the expression of 202 proteins were detected. Pathway analysis revealed overexpression of proteins involved in double strand break repair (MRE11 and RAD50), apoptosis, L1 recycling, and repression of proteins involved in metabolism, tRNA aminoacylation, and gene expression. MSH3-silencing did not induce oncogenic transformation and DSBs increased 2-fold. Conclusions: MSH3-deficiency in human colon epithelial cells results in EMAST, formation of DSBs and significant changes of the proteome but lacks oncogenic transformation. Thus, MSH3-deficiency alone is unlikely to drive human colon carcinogenesis.	[Campregher, Christoph; Schmid, Gerald; Khare, Vineeta; Kortuem, Benedikt; Dammann, Kyle; Lang, Michaela; Gasche, Christoph] Med Univ Vienna, Christian Doppler Lab Mol Canc Chemoprevent, Div Gastroenterol & Hepatol, Dept Med 3, Vienna, Austria; [Ferk, Franziska; Knasmueller, Siegfried] Med Univ Vienna, Inst Canc Res, Dept Med 1, Vienna, Austria; [Knasmueller, Siegfried; Scharl, Theresa] Univ Nat Resources & Life Sci, ACIB GmbH, Dept Biotechnol, Vienna, Austria; [Scharl, Theresa] Vienna Univ Technol, Dept Stat & Probabil Theory, A-1040 Vienna, Austria; [Spittler, Andreas] Med Univ Vienna, Dept Surg, Res Labs, Vienna, Austria; [Spittler, Andreas] Med Univ Vienna, Core Facil Flow Cytometry, Vienna, Austria; [Roig, Andres I.; Shay, Jerry W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Gerner, Christopher] Med Univ Vienna, Ctr Comprehens Canc, Dept Med 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Austrian Centre of Industrial Biotechnology; University of Natural Resources & Life Sciences, Vienna; Technische Universitat Wien; Medical University of Vienna; Medical University of Vienna; University of Texas System; University of Texas Southwestern Medical Center Dallas; Medical University of Vienna	Gasche, C (corresponding author), Med Univ Vienna, Christian Doppler Lab Mol Canc Chemoprevent, Div Gastroenterol & Hepatol, Dept Med 3, Vienna, Austria.	christoph.gasche@meduniwien.ac.at	Gasche, Christoph W/A-5139-2013; Knasmueller, Siegfried/P-4347-2014	Knasmueller, Siegfried/0000-0002-1638-4438; Lang, Michaela/0000-0002-8444-3719; Gasche, Christoph/0000-0002-3752-6685; Scharl, Theresa/0000-0001-8850-3312; Spittler, Andreas/0000-0003-2657-6836; Kortum, Benedikt/0000-0003-3734-6665; Gerner, Christopher/0000-0003-4964-0642	Austrian Science Fund (FWF) [P18270]; Christian Doppler Research Association; Federal Ministry of Economy, Family and Youth; National Foundation for Research, Technology and Development; AOP Orphan Pharmaceuticals; Biogena Naturstoffe GmbH; Shire Pharmaceuticals; AstraZeneca Austria; Ferring Int.; Dr. Falk Pharma; Fresenius Medical Care; Minos Medical Inc.; Pharmacosmos A/S; Renapharma Sweden; Shire Inc.; Vifor Int.; Vifor Osterreich; Austrian Science Fund (FWF) [P 24121] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Christian Doppler Research Association; Federal Ministry of Economy, Family and Youth; National Foundation for Research, Technology and Development; AOP Orphan Pharmaceuticals; Biogena Naturstoffe GmbH; Shire Pharmaceuticals; AstraZeneca Austria(AstraZeneca); Ferring Int.; Dr. Falk Pharma; Fresenius Medical Care; Minos Medical Inc.; Pharmacosmos A/S; Renapharma Sweden; Shire Inc.; Vifor Int.; Vifor Osterreich; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF grant P18270) and the Christian Doppler Research Association. The financial support by the Federal Ministry of Economy, Family and Youth, and the National Foundation for Research, Technology and Development is gratefully acknowledged. CG received research support from AOP Orphan Pharmaceuticals, Biogena Naturstoffe GmbH, and Shire Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CG has ongoing research collaborations with AOP Orphan Pharmaceuticals, Biogena Naturstoffe GmbH, and Shire Pharmaceuticals, and received research support, lecturing or consulting honoraria from AstraZeneca Austria, Ferring Int., Dr. Falk Pharma, Fresenius Medical Care, Minos Medical Inc., Pharmacosmos A/S, Renapharma Sweden, Shire Inc., Vifor Int., and Vifor Osterreich. This does not alter the authors' adherence to the PLOS ONE policies on sharing data and materials.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Ahrendt SA, 2000, CANCER RES, V60, P2488; Azzouzi AR, 2007, BJU INT, V99, P1031, DOI 10.1111/j.1464-410X.2006.06723.x; Bi XZ, 2006, MOL CELL PROTEOMICS, V5, P1119, DOI 10.1074/mcp.M500432-MCP200; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; BRYANT PE, 1989, BRIT J CANCER, V60, P852, DOI 10.1038/bjc.1989.378; Burger M, 2006, J MOL MED, V84, P833, DOI 10.1007/s00109-006-0074-0; Burger M, 2006, EUR UROL, V50, P770, DOI 10.1016/j.eururo.2006.04.010; Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011; Campregher C, 2008, GUT, V57, P780, DOI 10.1136/gut.2007.141556; Campregher C, 2010, HUM MOL GENET, V19, P2648, DOI 10.1093/hmg/ddq175; Catto JWF, 2003, ONCOGENE, V22, P8699, DOI 10.1038/sj.onc.1206964; Choi YD, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-88; Choudhury A, 2010, CANCER RES, V70, P7017, DOI 10.1158/0008-5472.CAN-10-1202; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Danaee H, 2002, ONCOGENE, V21, P4894, DOI 10.1038/sj.onc.1205619; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Dietmaier W, 1997, CANCER RES, V57, P4749; Edelmann W, 2000, CANCER RES, V60, P803; Galindo CL, 2011, BREAST CANCER RES TR, V130, P41, DOI 10.1007/s10549-010-1237-9; Garcia M, 2012, GASTROENTEROLOGY, V143, P48, DOI 10.1053/j.gastro.2012.03.034; Gasche C, 2003, P NATL ACAD SCI USA, V100, P1914, DOI 10.1073/pnas.0437965100; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Goel A, 2011, INT J CANCER, V128, P869, DOI 10.1002/ijc.25422; Griss J, 2011, PROTEOMICS, V11, P1000, DOI 10.1002/pmic.201000507; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; HENDERSON ST, 1992, MOL CELL BIOL, V12, P2749, DOI 10.1128/MCB.12.6.2749; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Huang JQ, 2001, CANCER RES, V61, P1619; INOKUCHI K, 1995, BIOCHEM BIOPH RES CO, V214, P171, DOI 10.1006/bbrc.1995.2271; Kantelinen J, 2010, BRIT J CANCER, V102, P1068, DOI 10.1038/sj.bjc.6605531; Kitamura Y, 2011, ANTICANCER RES, V31, P1289; Kloor M, 2006, J MOL MED, V84, P329, DOI 10.1007/s00109-005-0012-6; KOI M, 1994, CANCER RES, V54, P4308; Laghi L, 2012, CLIN CANCER RES, V18, P3142, DOI 10.1158/1078-0432.CCR-12-0175; Lai YL, 2003, MOL BIOL EVOL, V20, P2123, DOI 10.1093/molbev/msg228; Lee Karen Ying, 2004, J Med, V35, P141; Lee SY, 2012, DIGEST DIS SCI, V57, P72, DOI 10.1007/s10620-011-1825-5; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Liu Yi-Hsiang, 2007, Research Communications in Molecular Pathology and Pharmacology, V120-21, P43; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Loeb LA, 2001, CANCER RES, V61, P3230; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Miquel C, 2007, ONCOGENE, V26, P5919, DOI 10.1038/sj.onc.1210419; Natarajan L, 2003, BIOMETRICS, V59, P555, DOI 10.1111/1541-0420.00065; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Panigrahi GB, 2010, P NATL ACAD SCI USA, V107, P12593, DOI 10.1073/pnas.0909087107; Plaschke J, 2004, CANCER RES, V64, P864, DOI 10.1158/0008-5472.CAN-03-2807; REITMAIR AH, 1995, NAT GENET, V11, P64, DOI 10.1038/ng0995-64; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Schmutte C, 2001, J BIOL CHEM, V276, P33011, DOI 10.1074/jbc.M102670200; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Singer G, 2004, INT J CANCER, V112, P643, DOI 10.1002/ijc.20455; Slebos RJC, 2002, CANCER RES, V62, P6052; STREISINGER G, 1985, GENETICS, V109, P633; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takahashi M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198804; TALBOT CC, 1995, HUM MOL GENET, V4, P1193, DOI 10.1093/hmg/4.7.1193; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Umar A, 1998, GENETICS, V148, P1637; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Wang Q, 2001, ONCOGENE, V20, P4640, DOI 10.1038/sj.onc.1204625; Woenckhaus M, 2003, INT J ONCOL, V23, P1357; Yamada K, 2010, ONCOL REP, V23, P551, DOI 10.3892/or_00000669; Yashiro M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-303	71	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50541	10.1371/journal.pone.0050541	http://dx.doi.org/10.1371/journal.pone.0050541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209772	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800081
J	Le Borgne, F; Guyot, S; Logerot, M; Beney, L; Gervais, P; Demarquoy, J				Le Borgne, Francoise; Guyot, Stephane; Logerot, Morgan; Beney, Laurent; Gervais, Patrick; Demarquoy, Jean			Exploration of Lipid Metabolism in Relation with Plasma Membrane Properties of Duchenne Muscular Dystrophy Cells: Influence of L-Carnitine	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SKELETAL-MUSCLE; MASS-SPECTROMETRY; GENE-THERAPY; STEM-CELLS; IN-VITRO; FLUIDITY; EXPRESSION; REGENERATION; CHOLESTEROL	Duchenne muscular dystrophy (DMD) arises as a consequence of mutations in the dystrophin gene. Dystrophin is a membrane-spanning protein that connects the cytoskeleton and the basal lamina. The most distinctive features of DMD are a progressive muscular dystrophy, a myofiber degeneration with fibrosis and metabolic alterations such as fatty infiltration, however, little is known on lipid metabolism changes arising in Duchenne patient cells. Our goal was to identify metabolic changes occurring in Duchenne patient cells especially in terms of L-carnitine homeostasis, fatty acid metabolism both at the mitochondrial and peroxisomal level and the consequences on the membrane structure and function. In this paper, we compared the structural and functional characteristics of DMD patient and control cells. Using radiolabeled L-carnitine, we found, in patient muscle cells, a marked decrease in the uptake and the intracellular level of L-carnitine. Associated with this change, a decrease in the mitochondrial metabolism can be seen from the analysis of mRNA encoding for mitochondrial proteins. Probably, associated with these changes in fatty acid metabolism, alterations in the lipid composition of the cells were identified: with an increase in poly unsaturated fatty acids and a decrease in medium chain fatty acids, mono unsaturated fatty acids and in cholesterol contents. Functionally, the membrane of cells lacking dystrophin appeared to be less fluid, as determined at 37 degrees C by fluorescence anisotropy. These changes may, at least in part, be responsible for changes in the phospholipids and cholesterol profile in cell membranes and ultimately may reduce the fluidity of the membrane. A supplementation with L-carnitine partly restored the fatty acid profile by increasing saturated fatty acid content and decreasing the amounts of MUFA, PUFA, VLCFA. L-carnitine supplementation also restored muscle membrane fluidity. This suggests that regulating lipid metabolism in DMD cells may improve the function of cells lacking dystrophin.	[Le Borgne, Francoise; Logerot, Morgan; Demarquoy, Jean] Univ Bourgogne, Fac Sci Gabriel, Lab BioperoxIL Biochim Peroxysome Inflammat & Met, Dijon, France; [Guyot, Stephane; Beney, Laurent; Gervais, Patrick] Univ Bourgogne, AgroSup Dijon, Equipe Proc Microbiol & Biotechnol, UMR A Proc Alimentaires & Microbiol 02 102, Dijon, France	Universite de Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Demarquoy, J (corresponding author), Univ Bourgogne, Fac Sci Gabriel, Lab BioperoxIL Biochim Peroxysome Inflammat & Met, Dijon, France.	jean.demarquoy@u-bourgogne.fr	Guyot, Stéphane/A-3482-2012	Guyot, Stéphane/0000-0002-2316-234X; Laurent, Beney/0000-0002-2757-2506	Association Francaise contre les Myophaties	Association Francaise contre les Myophaties(Association Francaise contre les Myopathies)	Funding came from Association Francaise contre les Myophaties. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaanse EML, 1997, CARDIOVASC RES, V33, P272, DOI 10.1016/S0008-6363(96)00193-9; Benabdellah F, 2009, NEUROBIOL DIS, V36, P252, DOI 10.1016/j.nbd.2009.07.013; Beney L, 2001, APPL MICROBIOL BIOT, V57, P34; BERTHILLIER G, 1982, CLIN CHIM ACTA, V122, P369, DOI 10.1016/0009-8981(82)90140-1; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Broad EM, 2011, INT J SPORT NUTR EXE, V21, P385, DOI 10.1123/ijsnem.21.5.385; Camina F, 1995, CLIN CHIM ACTA, V243, P151, DOI 10.1016/0009-8981(95)06164-9; Cardenas C, 2010, FASEB J, V24, P3210, DOI 10.1096/fj.09-152017; CARROLL JE, 1983, NEUROLOGY, V33, P1507, DOI 10.1212/WNL.33.11.1507; CHABANEL A, 1986, J NEUROL SCI, V76, P131, DOI 10.1016/0022-510X(86)90163-2; Chamberlain JS, 2002, HUM MOL GENET, V11, P2355, DOI 10.1093/hmg/11.20.2355; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Demarquoy J, 2004, FOOD CHEM, V86, P137, DOI 10.1016/j.foodchem.2003.09.023; Demarquoy J, 2010, HDB ANAL ACTIVE COMP; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; EVEN PC, 1994, BIOCHEM J, V304, P649, DOI 10.1042/bj3040649; FISCHBECK KH, 1983, ANN NEUROL, V13, P532, DOI 10.1002/ana.410130510; FOLCH J, 1957, J BIOL CHEM, V226, P497; Georges B, 2000, BIOCHEM PHARMACOL, V59, P1357, DOI 10.1016/S0006-2952(00)00265-3; Guevel L, 2011, J PROTEOME RES, V10, P2465, DOI 10.1021/pr2001385; HUBNER C, 1987, PEDIATR RES, V22, P488, DOI 10.1203/00006450-198710000-00027; IMBERT N, 1995, CELL CALCIUM, V18, P177, DOI 10.1016/0143-4160(95)90062-4; Kapsa R, 2003, LANCET NEUROL, V2, P299, DOI 10.1016/S1474-4422(03)00382-X; Kawashima H, 2012, PEDIATR INT, V54, DOI 10.1111/j.1442-200X.2011.03401.x; Khairallah M, 2007, J MOL CELL CARDIOL, V43, P119, DOI 10.1016/j.yjmcc.2007.05.015; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Lamhonwah AM, 2006, BIOCHEM BIOPH RES CO, V345, P1315, DOI 10.1016/j.bbrc.2006.05.026; Le Borgne F, 2011, BIOCHEM BIOPH RES CO, V409, P699, DOI 10.1016/j.bbrc.2011.05.068; Lee D C, 1987, Symp Soc Exp Biol, V41, P35; Mora MP, 1999, CHEM PHYS LIPIDS, V101, P255, DOI 10.1016/S0009-3084(99)00067-5; Mouly V, 2005, Acta Myol, V24, P128; Muir LA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001100; Negroni E, 2006, PATHOL BIOL, V54, P100, DOI 10.1016/j.patbio.2005.09.001; NISHIO H, 1990, BRAIN DEV-JPN, V12, P390, DOI 10.1016/S0387-7604(12)80071-4; Parthasarathy R, 2006, LANGMUIR, V22, P5095, DOI 10.1021/la060390o; Patel A, 2010, PFLUG ARCH EUR J PHY, V460, P571, DOI 10.1007/s00424-010-0847-8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Piperi C, 2004, IN VIVO, V18, P799; POULOS A, 1995, LIPIDS, V30, P1, DOI 10.1007/BF02537036; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Rigault C, 2006, BBA-MOL CELL BIOL L, V1761, P1469, DOI 10.1016/j.bbalip.2006.09.014; ROWLAND LP, 1980, MUSCLE NERVE, V3, P3, DOI 10.1002/mus.880030103; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Sharma U, 2003, MAGN RESON IMAGING, V21, P145, DOI 10.1016/S0730-725X(02)00646-X; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; SHUMATE JB, 1982, MUSCLE NERVE, V5, P226, DOI 10.1002/mus.880050309; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Spiekerkoetter U, 2010, J INHERIT METAB DIS, V33, P539, DOI 10.1007/s10545-010-9121-7; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; Tahallah N, 2008, J LIPID RES, V49, P438, DOI 10.1194/jlr.M700421-JLR200; Tamai I, 2012, BIOPHARM DRUG DISPOS; Touboul D, 2004, EUR J MASS SPECTROM, V10, P657, DOI 10.1255/ejms.671; Tuazon MA, 2012, METABOLISM, V61, P801, DOI 10.1016/j.metabol.2011.10.019	54	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49346	10.1371/journal.pone.0049346	http://dx.doi.org/10.1371/journal.pone.0049346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209572	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800009
J	Wierer, M; Schrey, AK; Kuhne, R; Ulbrich, SE; Meyer, HHD				Wierer, Michael; Schrey, Anna K.; Kuehne, Ronald; Ulbrich, Susanne E.; Meyer, Heinrich H. D.			A Single Glycine-Alanine Exchange Directs Ligand Specificity of the Elephant Progestin Receptor	PLOS ONE			English	Article							LOXODONTA-AFRICANA; GLUCOCORTICOID-RECEPTOR; MOLECULAR-DYNAMICS; MACROPUS-EUGENII; TAMMAR WALLABY; AMINO-ACID; EVOLUTION; BINDING; PREGNANCY; ESTROGEN	The primary gestagen of elephants is 5 alpha-dihydroprogesterone (DHP), which is unlike all other mammals studied until now. The level of DHP in elephants equals that of progesterone in other mammals, and elephants are able to bind DHP with similar affinity to progesterone indicating a unique ligand-binding specificity of the elephant progestin receptor (PR). Using site-directed mutagenesis in combination with in vitro binding studies we here report that this change in specificity is due to a single glycine to alanine exchange at position 722 (G722A) of PR, which specifically increases DHP affinity while not affecting binding of progesterone. By conducting molecular dynamics simulations comparing human and elephant PR ligand-binding domains (LBD), we observed that the alanine methyl group at position 722 is able to push the DHP A-ring into a position similar to progesterone. In the human PR, the DHP A-ring position is twisted towards helix 3 of PR thereby disturbing the hydrogen bond pattern around the C3-keto group, resulting in a lower binding affinity. Furthermore, we observed that the elephant PR ligand-binding pocket is more rigid than the human analogue, which probably explains the higher affinity towards both progesterone and DHP. Interestingly, the G722A substitution is not elephant-specific, rather it is also present in five independent lineages of mammalian evolution, suggesting a special role of the substitution for the development of distinct mammalian gestagen systems.	[Wierer, Michael; Ulbrich, Susanne E.; Meyer, Heinrich H. D.] Tech Univ Munich, Freising Weihenstephan, Germany; [Schrey, Anna K.; Kuehne, Ronald] Leibniz Inst Mol Pharmacol FMP, Berlin, Germany	Technical University of Munich; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wierer, M (corresponding author), Tech Univ Munich, Freising Weihenstephan, Germany.	michael.wierer@wzw.tum.de	Ulbrich, Susanne E/D-1815-2014	Ulbrich, Susanne E/0000-0003-0355-3869				Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X; BENHAMOU B, 1992, SCIENCE, V255, P206, DOI 10.1126/science.1372753; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; BUCHANAN GD, 1986, BIOL REPROD, V34, P878, DOI 10.1095/biolreprod34.5.878; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Greyling MD, 1997, J REPROD FERTIL, V109, P199, DOI 10.1530/jrf.0.1090199; HAMON M, 1991, J REPROD FERTIL, P529; Hillisch A, 2003, STEROIDS, V68, P869, DOI 10.1016/j.steroids.2003.08.009; Hodges JK, 1997, BIOL REPROD, V56, P640, DOI 10.1095/biolreprod56.3.640; Hodges JK, 1998, ANIM REPROD SCI, V53, P3, DOI 10.1016/S0378-4320(98)00123-7; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jewgenow K, 1998, GEN COMP ENDOCR, V110, P118, DOI 10.1006/gcen.1997.7054; Killian JK, 2001, MAMM GENOME, V12, P513, DOI 10.1007/s003350020026; LimTio SS, 1996, MOL CELL ENDOCRINOL, V119, P169, DOI 10.1016/0303-7207(96)03807-5; Meyer HHD, 1997, GEN COMP ENDOCR, V105, P164, DOI 10.1006/gcen.1996.6813; Mordasini T, 2003, CHEMBIOCHEM, V4, P155, DOI 10.1002/cbic.200390026; Mulac-Jericevic B, 2004, REPRODUCTION, V128, P139, DOI 10.1530/rep.1.00189; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; PEPPLER RD, 1980, LAB ANIM SCI, V30, P188; RENFREE MB, 1979, J REPROD FERTIL, V57, P131; Schutzer WE, 1996, STEROIDS, V61, P94, DOI 10.1016/0039-128X(95)00199-Z; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Tan GH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni124; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298; von Langen J, 2005, CHEMBIOCHEM, V6, P1110, DOI 10.1002/cbic.200400361; Weatherman RV, 1999, ANNU REV BIOCHEM, V68, P559, DOI 10.1146/annurev.biochem.68.1.559; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775	35	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50350	10.1371/journal.pone.0050350	http://dx.doi.org/10.1371/journal.pone.0050350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209719	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800066
J	Nogueira, T; Touchon, M; Rocha, EPC				Nogueira, Teresa; Touchon, Marie; Rocha, Eduardo P. C.			Rapid Evolution of the Sequences and Gene Repertoires of Secreted Proteins in Bacteria	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; ANTIGENIC DIVERSITY; SUBSTITUTION RATES; ESCHERICHIA-COLI; SOCIAL EVOLUTION; ARMS RACES; GENOME; PATHOGENS; LIFE; RECOMBINATION	Proteins secreted to the extracellular environment or to the periphery of the cell envelope, the secretome, play essential roles in foraging, antagonistic and mutualistic interactions. We hypothesize that arms races, genetic conflicts and varying selective pressures should lead to the rapid change of sequences and gene repertoires of the secretome. The analysis of 42 bacterial pan-genomes shows that secreted, and especially extracellular proteins, are predominantly encoded in the accessory genome, i.e. among genes not ubiquitous within the clade. Genes encoding outer membrane proteins might engage more frequently in intra-chromosomal gene conversion because they are more often in multi-genic families. The gene sequences encoding the secretome evolve faster than the rest of the genome and in particular at non-synonymous positions. Cell wall proteins in Firmicutes evolve particularly fast when compared with outer membrane proteins of Proteobacteria. Virulence factors are over-represented in the secretome, notably in outer membrane proteins, but cell localization explains more of the variance in substitution rates and gene repertoires than sequence homology to known virulence factors. Accordingly, the repertoires and sequences of the genes encoding the secretome change fast in the clades of obligatory and facultative pathogens and also in the clades of mutualists and free-living bacteria. Our study shows that cell localization shapes genome evolution. In agreement with our hypothesis, the repertoires and the sequences of genes encoding secreted proteins evolve fast. The particularly rapid change of extracellular proteins suggests that these public goods are key players in bacterial adaptation.	[Touchon, Marie; Rocha, Eduardo P. C.] Inst Pasteur, Dept Genomes & Genet, Paris, France; [Nogueira, Teresa] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental Evolutionary Ecol Microorganis, Lisbon, Portugal; [Nogueira, Teresa] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Nogueira, Teresa] Inst Politecn Porto, Escola Super Tecnol Saude Porto, Ctr Invest Saude & Ambiente, Vila Nova De Gaia, Portugal; [Touchon, Marie; Rocha, Eduardo P. C.] CNRS, UMR3525, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Polytechnic Institute of Porto; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rocha, EPC (corresponding author), Inst Pasteur, Dept Genomes & Genet, Paris, France.	erocha@pasteur.fr	Rocha, Eduardo/B-7009-2009; Nogueira, Teresa/G-2273-2010	Rocha, Eduardo/0000-0001-7704-822X; Nogueira, Teresa/0000-0002-0059-5177; Touchon, marie/0000-0001-7389-447X	CNRS; Institut Pasteur; ERC (grant EVOMOBILOME) [281605]; FCT [SFRH/BPD/41863/2007]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); ERC (grant EVOMOBILOME); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by the CNRS, the Institut Pasteur and the ERC (grant EVOMOBILOME, no281605). T.N. was a recipient of a post-doc grant from FCT (SFRH/BPD/41863/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumdicker F, 2012, GENOME BIOL EVOL, V4, P443, DOI 10.1093/gbe/evs016; Bayliss CD, 2009, FEMS MICROBIOL REV, V33, P504, DOI 10.1111/j.1574-6976.2009.00162.x; Brown SP, 2008, CELL, V135, P600, DOI 10.1016/j.cell.2008.10.030; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Campanaro S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-313; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Cerdeno-Tarraga AM, 2005, SCIENCE, V307, P1463, DOI 10.1126/science.1107008; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Collins RE, 2012, MOL BIOL EVOL, V29, P3413, DOI 10.1093/molbev/mss163; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; Daubin V, 2004, GENOME RES, V14, P1036, DOI 10.1101/gr.2231904; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Dotsch A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-234; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Epstein B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002868; Friehs K, 2004, ADV BIOCHEM ENG BIOT, V86, P47; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gardy JL, 2006, NAT REV MICROBIOL, V4, P741, DOI 10.1038/nrmicro1494; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Hall AR, 2011, ECOL LETT, V14, P635, DOI 10.1111/j.1461-0248.2011.01624.x; Hao WL, 2006, GENOME RES, V16, P636, DOI 10.1101/gr.4746406; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Heinz E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-634; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Jordan IK, 2001, GENOME BIOL, V2; Julenius K, 2006, MOL BIOL EVOL, V23, P2039, DOI 10.1093/molbev/msl081; Kirkup BC, 2004, NATURE, V428, P412, DOI 10.1038/nature02429; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; Ma WB, 2008, CURR OPIN PLANT BIOL, V11, P412, DOI 10.1016/j.pbi.2008.05.001; Ma WB, 2006, PLOS GENET, V2, P2131, DOI 10.1371/journal.pgen.0020209; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Mc Ginty SE, 2011, EVOLUTION, V65, P21, DOI 10.1111/j.1558-5646.2010.01121.x; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Namouchi A, 2012, GENOME RES, V22, P721, DOI 10.1101/gr.129544.111; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nogueira T, 2009, CURR BIOL, V19, P1683, DOI 10.1016/j.cub.2009.08.056; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Preston GM, 2005, FEMS MICROBIOL REV, V29, P331, DOI 10.1016/j.femsre.2004.12.004; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Rocha EPC, 2003, GENOME RES, V13, P1123, DOI 10.1101/gr.966203; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Smet A, 2010, FEMS MICROBIOL REV, V34, P295, DOI 10.1111/j.1574-6976.2009.00198.x; Smith DR, 2010, MBIO, V1, DOI 10.1128/mBio.00131-10; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; Sturm A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002143; Sui SJH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008094; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; TUKEY JW, 1953, T NEW YORK ACAD SCI, V16, P88, DOI 10.1111/j.2164-0947.1953.tb01326.x; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vink C, 2012, FEMS MICROBIOL REV, V36, P917, DOI 10.1111/j.1574-6976.2011.00321.x; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Werren JH, 2011, P NATL ACAD SCI USA, V108, P10863, DOI 10.1073/pnas.1102343108; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Wooldridge K, 2009, BACTERIAL SECRETED P; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	81	27	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49403	10.1371/journal.pone.0049403	http://dx.doi.org/10.1371/journal.pone.0049403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189144	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800023
J	Biswas, K; Yoshioka, K; Asanuma, K; Okamoto, Y; Takuwa, N; Sasaki, T; Takuwa, Y				Biswas, Kuntal; Yoshioka, Kazuaki; Asanuma, Ken; Okamoto, Yasuo; Takuwa, Noriko; Sasaki, Takehiko; Takuwa, Yoh			Essential Role of Class II Phosphatidylinositol-3-kinase-C2 alpha in Sphingosine 1-Phosphate Receptor-1-mediated Signaling and Migration in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RHO GTPASES; SPHINGOSINE-1-PHOSPHATE; RAC; ACTIVATION; ANGIOGENESIS; MEMBRANE; CLATHRIN; MOTILITY; KINASE	The phosphatidylinositol (PtdIns) 3-kinase (PI3K) family regulates diverse cellular processes, including cell proliferation, migration, and vesicular trafficking, through catalyzing 3'-phosphorylation of phosphoinositides. In contrast to class I PI3Ks, including p110 alpha and p110 beta, functional roles of class II PI3Ks, comprising PI3K-C2 alpha, PI3K-C2 beta, and PI3K-C2 gamma, are little understood. The lysophospholipid mediator sphingosine 1-phosphate (S1P) plays the important roles in regulating vascular functions, including vascular formation and barrier integrity, via the G-protein-coupled receptors S1P(1-3). We studied the roles of PI3K-C2 alpha in S1P-induced endothelial cell (EC) migration and tube formation. S1P stimulated cell migration and activation of Akt, ERK, and Rac1, the latter of which acts as a signaling molecule essential for cell migration and tube formation, via S1P(1) in ECs. Knockdown of either PI3K-C2 alpha or class I p110 beta markedly inhibited S1P-induced migration, lamellipodium formation, and tube formation, whereas that of p110 alpha or Vps34 did not. Only p110 beta was necessary for S1P-iduced Akt activation, but both PI3K-C2 alpha and p110 beta were required for Rac1 activation. FRET imaging showed that S1P induced Rac1 activation in both the plasma membrane and PtdIns 3-phosphate (PtdIns(3) P)-enriched endosomes. Knockdown of PI3K-C2 alpha but not p110 beta markedly reduced PtdIns(3) P-enriched endosomes and suppressed endosomal Rac1 activation. Also, knockdown of PI3K-C2 alpha but not p110 beta suppressed S1P-induced S1P(1) internalization into PtdIns(3) P-enriched endosomes. Finally, pharmacological inhibition of endocytosis suppressed S1P-induced S1P(1) internalization, Rac1 activation, migration, and tube formation. These observations indicate that PI3K-C2 alpha plays the crucial role in S1P(1) internalization into the intracellular vesicular compartment, Rac1 activation on endosomes, and thereby migration through regulating vesicular trafficking in ECs.	[Biswas, Kuntal; Yoshioka, Kazuaki; Okamoto, Yasuo; Takuwa, Noriko; Takuwa, Yoh] Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan; [Asanuma, Ken; Sasaki, Takehiko] Akita Univ, Grad Sch Med, Dept Med Biol, Akita 0108543, Japan; [Asanuma, Ken; Sasaki, Takehiko] Akita Univ, Biosignal Res Ctr, Akita 0108543, Japan; [Takuwa, Noriko] Ishikawa Prefectural Nursing Univ, Dept Hlth & Med Sci, Kahoku, Ishikawa 9291210, Japan	Kanazawa University; Akita University; Akita University	Yoshioka, K (corresponding author), Kanazawa Univ, Sch Med, Dept Physiol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	yoshioka@med.kanazawa-u.ac.jp; ytakuwa@med.kanazawa-u.ac.jp	OKAMOTO, Yasuo/J-8438-2015; Yoshioka, Kazuaki/G-1038-2013	Yoshioka, Kazuaki/0000-0002-8631-3846; TAKUWA, Noriko/0000-0002-4278-2704; Sasaki, Takehiko/0000-0003-1837-3748	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Honjin Foundation; Mitsubishi Pharma Research Foundation; SENSIN Medical Research Foundation; Grants-in-Aid for Scientific Research [23590257] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Honjin Foundation; Mitsubishi Pharma Research Foundation; SENSIN Medical Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; the Japan Society for the Promotion of Science; the Honjin Foundation; the Mitsubishi Pharma Research Foundation; and the SENSIN Medical Research Foundation.	Beningo KA, 2006, ARCH BIOCHEM BIOPHYS, V456, P224, DOI 10.1016/j.abb.2006.09.025; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Broussard JA, 2012, MOL BIOL CELL, V23, P1486, DOI 10.1091/mbc.E11-02-0124; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Domin J, 2005, J CELL PHYSIOL, V205, P452, DOI 10.1002/jcp.20478; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Du W, 2010, CANCER RES, V70, P772, DOI 10.1158/0008-5472.CAN-09-2722; Eccles Suzanne A., 2009, V467, P159, DOI 10.1007/978-1-59745-241-0_9; El Sheikh Soha Salama, 2003, BMC Clin Pathol, V3, P4, DOI 10.1186/1472-6890-3-4; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Falasca M, 2012, BIOCHEM J, V443, P587, DOI 10.1042/BJ20120008; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Higuchi M, 2001, CURR BIOL, V11, P1958, DOI 10.1016/S0960-9822(01)00599-1; Igarashi J, 2001, J BIOL CHEM, V276, P36281, DOI 10.1074/jbc.M105628200; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Lee JF, 2009, AM J PHYSIOL-HEART C, V296, pH33, DOI 10.1152/ajpheart.00097.2008; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Mazza Simona, 2011, Int J Biochem Mol Biol, V2, P168; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Ryu Y, 2002, CIRC RES, V90, P325, DOI 10.1161/hh0302.104455; Sakurada S, 2001, AM J PHYSIOL-CELL PH, V281, pC571, DOI 10.1152/ajpcell.2001.281.2.C571; Sasaki J, 2005, J EXP MED, V201, P859, DOI 10.1084/jem.20041891; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sasaki T, 2009, PROG LIPID RES, V48, P307, DOI 10.1016/j.plipres.2009.06.001; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Sugimoto N, 2003, MOL CELL BIOL, V23, P1534, DOI 10.1128/MCB.23.5.1534-1545.2003; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Usui S, 2004, J BIOL CHEM, V279, P12300, DOI 10.1074/jbc.M305025200; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang Y, 2006, BIOCHEM J, V394, P581, DOI 10.1042/BJ20051471; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wertheimer E, 2012, CELL SIGNAL, V24, P353, DOI 10.1016/j.cellsig.2011.08.011; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zoncu R, 2009, CELL, V136, P1110, DOI 10.1016/j.cell.2009.01.032	64	41	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2325	2339		10.1074/jbc.M112.409656	http://dx.doi.org/10.1074/jbc.M112.409656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23192342	Green Published, hybrid			2022-12-25	WOS:000314211500022
J	Zhu, L; Zhong, XW; Chen, SRW; Banavali, N; Liu, Z				Zhu, Li; Zhong, Xiaowei; Chen, S. R. Wayne; Banavali, Nilesh; Liu, Zheng			Modeling a Ryanodine Receptor N-terminal Domain Connecting the Central Vestibule and the Corner Clamp Region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; SKELETAL-MUSCLE; CRYOELECTRON MICROSCOPY; FK506-BINDING PROTEIN; DEFECTIVE REGULATION; CA2+ RELEASE; STRUCTURAL-CHARACTERIZATION; 3-DIMENSIONAL LOCALIZATION; PHOSPHORYLATION SITE; MOLECULAR-DYNAMICS	Ryanodine receptors (RyRs) form a class of intracellular calcium release channels in various excitable tissues and cells such as muscles and neurons. They are the major cellular mediators of the release of calcium ions from the sarcoplasmic reticulum, an essential step in muscle excitation-contraction coupling. Several crystal structures of skeletal muscle RyR1 peptide fragments have been solved, but these cover less than 15% of the full-length RyR1 sequence. In this study, by combining modeling techniques with sub-nanometer resolution cryo-electron microscopy (cryo-EM) maps, we obtained pseudo-atomic models for RyR fragments consisting of residues 850-1,056 in rabbit RyR1 or residues 861-1,067 in mouse RyR2. These fragments are docked into a domain that connects the central vestibule and corner clamp region of RyR, resulting in a good match of the secondary structure elements in the cryo-EM map and the pseudo-atomic models, which is also consistent with our previous mappings of GFP insertions by cryo-EM and with FRET measurements involving RyR and FK506-binding protein (FKBP). A combined model of the RyR fragment and FKBP docked into the cryo-EM map suggests that the fragment is positioned adjacent to the FKBP-binding site. Its predicted binding interface with FKBP consists primarily of electrostatic contacts and contains several disease-associated mutations. A dynamic interaction between the fragment and an RyR phosphorylation domain, characterized by FRET experiments, also supports the structural predictions of the pseudo-atomic models.	[Zhu, Li; Banavali, Nilesh; Liu, Zheng] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Zhong, Xiaowei; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Zhong, Xiaowei; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	State University of New York (SUNY) System; Wadsworth Center; University of Calgary; University of Calgary	Liu, Z (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	liuz@wadsworth.org		Banavali, Nilesh/0000-0003-2206-7049; Liu, Zheng/0000-0001-6952-3406	National Institutes of Health [R01HL095541]; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095541] Funding Source: NIH RePORTER; Alberta Innovates [201001238] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Alberta Innovates	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL095541 (to Z. L.). This work was also supported by a Canadian Institutes of Health Research grant (to S. R. W. C.).	Amador FJ, 2009, P NATL ACAD SCI USA, V106, P11040, DOI 10.1073/pnas.0905186106; Blunck R, 2008, P NATL ACAD SCI USA, V105, P20263, DOI 10.1073/pnas.0807056106; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Du GG, 2005, DEV CARDIOVASC MED, V254, P9; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; HAKAMATA Y, 1992, FEBS LETT, V312, P229, DOI 10.1016/0014-5793(92)80941-9; Herren T, 2009, CLIN RES CARDIOL, V98, P141, DOI 10.1007/s00392-009-0751-4; Huang XJ, 2012, J BIOL CHEM, V287, P30328, DOI 10.1074/jbc.M112.383109; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikemoto N, 2005, DEV CARDIOVASC MED, V254, P53; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Jeyakumar LH, 2001, BIOCHEM BIOPH RES CO, V281, P979, DOI 10.1006/bbrc.2001.4444; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laver DR, 2010, CURR TOP MEMBR, V66, P69, DOI 10.1016/S1063-5823(10)66004-8; Lee EH, 2004, J BIOL CHEM, V279, P26481, DOI 10.1074/jbc.M309574200; Li YX, 2002, CIRC RES, V90, P309, DOI 10.1161/hh0302.105660; Liu NA, 2008, PROG CARDIOVASC DIS, V51, P23, DOI 10.1016/j.pcad.2007.10.005; Liu Z, 2010, J CELL SCI, V123, P1775, DOI 10.1242/jcs.064071; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Marjamaa A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-12; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Masumiya H, 2003, J BIOL CHEM, V278, P3786, DOI 10.1074/jbc.M210962200; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Meissner G, 2010, CURR TOP MEMBR, V66, P91, DOI 10.1016/S1063-5823(10)66005-X; Meng X, 2007, J BIOL CHEM, V282, P25929, DOI 10.1074/jbc.M704474200; Meng X, 2009, J MOL BIOL, V387, P320, DOI 10.1016/j.jmb.2009.01.059; Oda T, 2005, CIRCULATION, V111, P3400, DOI 10.1161/CIRCULATIONAHA.104.507921; OTSU K, 1990, J BIOL CHEM, V265, P13472; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Rusu M, 2012, J STRUCT BIOL, V177, P410, DOI 10.1016/j.jsb.2011.11.029; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 1999, J CELL BIOL, V146, P493, DOI 10.1083/jcb.146.2.493; Samso M, 2002, J BIOL CHEM, V277, P1349, DOI 10.1074/jbc.M109196200; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Sharma MR, 2000, J BIOL CHEM, V275, P9485, DOI 10.1074/jbc.275.13.9485; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Sharma MR, 1998, J BIOL CHEM, V273, P18429, DOI 10.1074/jbc.273.29.18429; Sharma P, 2012, FEBS J, V279, P3952, DOI 10.1111/j.1742-4658.2012.08755.x; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Trabuco LG, 2009, METHODS, V49, P174, DOI 10.1016/j.ymeth.2009.04.005; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wang RW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194316; Wehrens XDHT, 2005, DEV CARDIOVASC MED, V254, P151; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V291, P1102, DOI 10.1006/bbrc.2002.6569; Yang ZK, 2006, CARDIOVASC RES, V70, P475, DOI 10.1016/j.cardiores.2006.03.001; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou Q, 2008, BIOPHYS J, V95, P4289, DOI 10.1529/biophysj.108.137224; Zissimopoulos S, 2005, J BIOL CHEM, V280, P5475, DOI 10.1074/jbc.M412954200; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	68	10	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					903	914		10.1074/jbc.M112.429670	http://dx.doi.org/10.1074/jbc.M112.429670			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204524	hybrid, Green Published			2022-12-25	WOS:000313570300015
J	Adams, AC; Cheng, CC; Coskun, T; Kharitonenkov, A				Adams, Andrew C.; Cheng, Christine C.; Coskun, Tamer; Kharitonenkov, Alexei			FGF21 Requires beta klotho to Act In Vivo	PLOS ONE			English	Article							PPAR-ALPHA ACTIVATION; METABOLIC-ACTIVITY; GROWTH; EXPRESSION; OBESITY; FGF19	FGF21 has gradually become a focal point in metabolic research given its intriguing and complex biology and relevance to drug discovery. Despite the large amount of accumulated data, there remains a dearth of understanding of FGF21 physiology at the molecular/whole organism level. The scaffold protein bklotho (KLB) has previously been demonstrated in vitro to function as a co-factor permitting FGF21 mediated FGF receptor activation. However, the requirement for KLB in the propagation of FGF21 action in living animals has yet to be evaluated. To answer this question, we tested FGF21 in mice with total body ablation of KLB (KLBKO) and found no detectable activity. Firstly, we demonstrate that the disruption of KLB entirely abrogates acute FGF21 signaling in adipose tissue. We go on to show that this signaling defect translates to the absence of FGF21 mediated metabolic improvements in DIO mice. Indeed, KLBKO mice are totally refractory to FGF21-induced normalization of glucose homeostasis, attenuation of dyslipidemia, elevation of energy expenditure and weight loss. The lack of FGF21-driven effects was further substantiated at the transcriptional level with no FGF21 target gene signature detectable in adipose tissue and liver of KLBKO animals. Taken together our data show that KLB is a vital component of the FGF21 in vivo signaling machinery and is critically required for FGF21 action at the whole organism level.	[Adams, Andrew C.; Cheng, Christine C.; Coskun, Tamer; Kharitonenkov, Alexei] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	Eli Lilly	Kharitonenkov, A (corresponding author), Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA.	a.kharch@lilly.com	Coskun, Tamer/AAR-8422-2021					Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Chartoumpekis DV, 2011, MOL MED, V17, P736, DOI 10.2119/molmed.2011.00075; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Erickson SK, 2003, J LIPID RES, V44, P1001, DOI 10.1194/jlr.M200489-JLR200; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Hale C, 2012, ENDOCRINOLOGY, V153, P69, DOI 10.1210/en.2010-1262; Holland WL, 2012, INT S AD BIOL MED; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2011, TRENDS ENDOCRIN MET, V22, P81, DOI 10.1016/j.tem.2010.11.003; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Muller TD, 2012, J PEPT SCI, V18, P383, DOI 10.1002/psc.2408; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Oishi K, 2008, FEBS LETT, V582, P3639, DOI 10.1016/j.febslet.2008.09.046; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tomiyama K, 2010, P NATL ACAD SCI USA, V107, P1666, DOI 10.1073/pnas.0913986107; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Yang CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033870; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	36	134	141	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49977	10.1371/journal.pone.0049977	http://dx.doi.org/10.1371/journal.pone.0049977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209629	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800038
J	Ghoshal, S; Loftin, CD				Ghoshal, Sarbani; Loftin, Charles D.			Cyclooxygenase-2 Inhibition Attenuates Abdominal Aortic Aneurysm Progression in Hyperlipidemic Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MYOCARDIAL-INFARCTION; MATRIX; MUTATIONS; CELECOXIB; RISK; SUPPRESSES; EXPRESSION; EXPANSION	Abdominal aortic aneurysms (AAAs) are a chronic inflammatory disease that increase the risk of life-threatening aortic rupture. In humans, AAAs have been characterized by increased expression of cyclooxygenase-2 and the inactivation of COX-2 prior to disease initiation reduces AAA incidence in a mouse model of the disease. The current study examined the effectiveness of selective cyclooxygenase-2 (COX-2) inhibition on reducing AAA progression when administered after the initiation of AAA formation. AAAs were induced in hyperlipidemic apolipoprotein E-deficient mice by chronic angiotensin II (AngII) infusion and the effect of treatment with the COX-2 inhibitor celecoxib was examined when initiated at different stages of the disease. Celecoxib treatment that was started 1 week after initiating AngII infusion reduced AAA incidence by 61% and significantly decreased AAA severity. Mice treated with celecoxib also showed significantly reduced aortic rupture and mortality. Treatment with celecoxib that was started at a late stage of AAA development also significantly reduced AAA incidence and severity. Celecoxib treatment significantly increased smooth muscle alpha-actin expression in the abdominal aorta and did not reduce expression of markers of macrophage-dependent inflammation. These findings indicate that COX-2 inhibitor treatment initiated after formation of AngII-induced AAAs effectively reduces progression of the disease in hyperlipidemic mice.	[Ghoshal, Sarbani; Loftin, Charles D.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA	University of Kentucky	Loftin, CD (corresponding author), Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40506 USA.	cdloft2@email.uky.edu			National Institutes of Health [HL083122]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CDL is supported by the National Institutes of Health [HL083122]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Becker MC, 2009, AM HEART J, V157, P606, DOI 10.1016/j.ahj.2008.12.014; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625, DOI 10.1161/01.ATV.18.10.1625; Drew E, 2002, EXP HEMATOL, V30, P1211, DOI 10.1016/S0301-472X(02)00890-1; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Gilsbach R, 2006, BIOTECHNIQUES, V40, P173, DOI 10.2144/000112052; Gitlin JM, 2007, CARDIOVASC RES, V73, P227, DOI 10.1016/j.cardiores.2006.10.015; Goergen CJ, 2011, ARTERIOSCL THROM VAS, V31, P270, DOI 10.1161/ATVBAHA.110.216481; Goodall S, 2002, EUR J VASC ENDOVASC, V24, P72, DOI 10.1053/ejvs.2002.1675; Goodall S, 2001, CIRCULATION, V104, P304, DOI 10.1161/01.CIR.104.3.304; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; HultgardhNilsson A, 1997, CARDIOVASC RES, V34, P418, DOI 10.1016/S0008-6363(97)00030-8; Inamoto S, 2010, CARDIOVASC RES, V88, P520, DOI 10.1093/cvr/cvq230; Jain M, 1996, J CLIN INVEST, V97, P596, DOI 10.1172/JCI118455; Jung HO, 2010, BIOCHEM BIOPH RES CO, V402, P577, DOI 10.1016/j.bbrc.2010.10.019; King VL, 2006, ARTERIOSCL THROM VAS, V26, P1137, DOI 10.1161/01.ATV.0000216119.79008.ac; KUJUBU DA, 1993, J BIOL CHEM, V268, P5425; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Miralles M, 1999, J VASC SURG, V29, P884, DOI 10.1016/S0741-5214(99)70216-8; OWENS GK, 1995, PHYSIOL REV, V75, P487; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Papakonstantinou E, 1998, ATHEROSCLEROSIS, V138, P79, DOI 10.1016/S0021-9150(98)00006-9; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Risinger GM, 2010, AM J PHYSIOL-CELL PH, V298, pC191, DOI 10.1152/ajpcell.00417.2008; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Turner GH, 2008, CIRC-CARDIOVASC IMAG, V1, P220, DOI 10.1161/CIRCIMAGING.108.787358; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vorp DA, 2005, ARTERIOSCL THROM VAS, V25, P1558, DOI 10.1161/01.ATV.0000174129.77391.55; Wang M, 2008, CIRCULATION, V117, P1302, DOI 10.1161/CIRCULATIONAHA.107.731398; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	41	26	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e44369	10.1371/journal.pone.0044369	http://dx.doi.org/10.1371/journal.pone.0044369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209546	gold, Green Published			2022-12-25	WOS:000311885800002
J	Liu, J; Qu, B; Ezeakile, MC; Zhang, Y				Liu, Jie; Qu, Bo; Ezeakile, Moses C.; Zhang, Yang			Factors Associated with Unprotected Anal Intercourse among Men Who Have Sex with Men in Liaoning Province, China	PLOS ONE			English	Article							INCONSISTENT CONDOM USE; HIV-INFECTION; BEHAVIORAL INTERVENTIONS; SYPHILIS INFECTIONS; RISK BEHAVIOR; HEPATITIS-B; PREVALENCE; HIV/AIDS; MSM; PREVENTION	Background: HIV prevalence among men who have sex with men (MSM) has increased rapidly. MSM may play a bridging role in the spread of HIV and other STDs from the high-risk population to the general population. Interventions to reduce high-risk behavior are the key to controlling the spreading of HIV in the MSM population and the primary strategy for reducing the spread of AIDS in China. The purpose of the study was to examine the demographic characteristics of MSM, evaluate the HIV-related knowledge of MSM, and identify factors associated with unprotected anal intercourse (UAI) among MSM to make recommendations for future research. Methodology/Principal Finding: A cross-sectional survey was conducted among 293 MSM in Fushun and Huludao City, China. A total of 91 participants (34.0%) reported engagement in UAI with a male partner during the previous six months. The results of univariate analysis showed that UAI was associated with older age, lower levels of education, less knowledge about HIV, and not receiving condoms, lubricant, peer education, AIDS counseling, STD checks, and informational materials (p<0.05). In a multivariate logistic regression model, awareness of the major HIV transmission routes (OR = 2.191; 95% CI: 0.869 to 5.524), receiving condoms (OR = 2.164; 95% CI: 1.149 to 4.076), receiving peer education (OR = 2.632; 95% CI: 1.566 to 4.426), and AIDS counseling (OR = 2.347; 95% CI: 1.260 to 4.372) were independently associated with a lower risk of UAI. Conclusions/Significance: The study suggested that UAI could be decreased by improving education about AIDS, increasing the promotion of voluntary counseling and testing (VCT), and improving the accessibility and convenience of service.	[Liu, Jie; Qu, Bo; Ezeakile, Moses C.; Zhang, Yang] China Med Univ, Fac Hlth Stat, Sch Publ Hlth, Shenyang, Peoples R China	China Medical University	Qu, B (corresponding author), China Med Univ, Fac Hlth Stat, Sch Publ Hlth, Shenyang, Peoples R China.	qubo6666@163.com			National Natural Science Foundation of China [81273186, 71103200, 30700690]; Foundation of the Educational Department of Liaoning Province of China [L2010577]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of the Educational Department of Liaoning Province of China	This study was supported by the National Natural Science Foundation of China (No. 81273186, No.71103200 and 30700690) and the Foundation of the Educational Department of Liaoning Province of China (No. L2010577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Begley K, 2009, INT J STD AIDS, V20, P704, DOI 10.1258/ijsa.2009.009137; Chakrapani V, 2010, AIDS PATIENT CARE ST, V24, P49, DOI 10.1089/apc.2009.0214; Chan PA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-153; China Ministry of Health, 2009, CHIN HLTH MIN MEN WH; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Cong L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-250; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Gao MY, 2007, AIDS CARE, V19, P799, DOI 10.1080/09540120601114832; Guo Y, 2012, AIDS CARE, V24, P451, DOI 10.1080/09540121.2011.613914; Guo Y, 2011, AIDS BEHAV, V15, P521, DOI 10.1007/s10461-010-9808-7; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; Hong Y, 2009, AIDS BEHAV, V13, P603, DOI 10.1007/s10461-008-9483-0; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Lau JTF, 2009, AIDS EDUC PREV, V21, P325, DOI 10.1521/aeap.2009.21.4.325; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li XF, 2012, AIDS BEHAV, V16, P499, DOI 10.1007/s10461-012-0161-x; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Liu HJ, 2009, AIDS PATIENT CARE ST, V23, P885, DOI 10.1089/apc.2009.0043; Liu SY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-250; Ma W, 2007, AIDS, V21, pS129, DOI 10.1097/01.aids.0000304708.64294.3f; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mansergh G, 2006, AIDS BEHAV, V10, P743, DOI 10.1007/s10461-006-9108-4; Reisner SL, 2009, AIDS PATIENT CARE ST, V23, P545, DOI 10.1089/apc.2008.0249; Ruan SM, 2008, AIDS BEHAV, V12, P469, DOI 10.1007/s10461-008-9361-9; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Ruan YH, 2009, AIDS PATIENT CARE ST, V23, P315, DOI 10.1089/apc.2008.0199; Sun YH, 2009, INT J STD AIDS, V20, P255, DOI 10.1258/ijsa.2008.008348; Vergidis PI, 2009, INFECT DIS CLIN N AM, V23, P309, DOI 10.1016/j.idc.2009.02.001; Wong WCW, 2006, SEX TRANSM INFECT, V82, P127, DOI 10.1136/sti.2005.016790; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Zargooshi J, 2008, J SEX MED, V5, P2895, DOI 10.1111/j.1743-6109.2008.01004.x; Zhang DP, 2008, AIDS CARE, V20, P1128, DOI 10.1080/09540120701842829; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhou L, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-23	43	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50493	10.1371/journal.pone.0050493	http://dx.doi.org/10.1371/journal.pone.0050493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048BS	23209757	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885800078
J	Pardinas, AF; Roca, A; Garcia-Vazquez, E; Lopez, B				Pardinas, Antonio F.; Roca, Agustin; Garcia-Vazquez, Eva; Lopez, Belen			Assessing the Genetic Influence of Ancient Sociopolitical Structure: Micro-differentiation Patterns in the Population of Asturias (Northern Spain)	PLOS ONE			English	Article							CONTROL REGION SEQUENCES; Y-CHROMOSOME VARIATION; MITOCHONDRIAL-DNA; MTDNA; NEUTRALITY; EASTERN; HUMANS; NUMBER; GROWTH; TESTS	The human populations of the Iberian Peninsula are the varied result of a complex mixture of cultures throughout history, and are separated by clear social, cultural, linguistic or geographic barriers. The stronger genetic differences between closely related populations occur in the northern third of Spain, a phenomenon commonly known as "micro-differentiation". It has been argued and discussed how this form of genetic structuring can be related to both the rugged landscape and the ancient societies of Northern Iberia, but this is difficult to test in most regions due to the intense human mobility of previous centuries. Nevertheless, the Spanish autonomous community of Asturias shows a complex history which hints of a certain isolation of its population. This, joined together with a difficult terrain full of deep valleys and steep mountains, makes it suitable for performing a study of genetic structure, based on mitochondrial DNA and Y-Chromosome markers. Our analyses do not only show that there are micro-differentiation patterns inside the Asturian territory, but that these patterns are strikingly similar between both uniparental markers. The inference of barriers to gene flow also indicates that Asturian populations from the coastal north and the mountainous south seem to be relatively isolated from the rest of the territory. These findings are discussed in light of historic and geographic data and, coupled with previous evidence, show that the origin of the current genetic patterning might indeed lie in Roman and Pre-Roman sociopolitical divisions. Citation: Pardinas AF, Roca A, Garcia-Vazquez E, Lopez B (2012) Assessing the Genetic Influence of Ancient Sociopolitical Structure: Micro-differentiation Patterns in the Population of Asturias (Northern Spain). PLoS ONE 7(11): e50206. doi: 10.1371/journal.pone.0050206	[Pardinas, Antonio F.; Lopez, Belen] Univ Oviedo, Dept Biol Organismos & Sistemas, Asturias, Spain; [Roca, Agustin; Garcia-Vazquez, Eva] Univ Oviedo, Dept Biol Func, Asturias, Spain	University of Oviedo; University of Oviedo	Lopez, B (corresponding author), Univ Oviedo, Dept Biol Organismos & Sistemas, Asturias, Spain.	lopezbelen@uniovi.es	Garcia-Vazquez, Eva/Y-7293-2019	Roca-Martinez, Agustin Antonio/0000-0003-2117-0132; Lopez-Martinez, Belen/0000-0003-4542-9129; Pardinas, Antonio/0000-0001-6845-7590; Garcia-Vazquez, Eva/0000-0002-8429-838X	"Severo Ochoa" FICYT-PCTI Grant from the Asturias Regional Government [BP09038]	"Severo Ochoa" FICYT-PCTI Grant from the Asturias Regional Government	Antonio F. Pardinas is currently supported by a "Severo Ochoa" FICYT-PCTI Grant from the Asturias Regional Government (ref. BP09038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J. Carlos, 2007, Legal Medicine, V9, P293, DOI 10.1016/j.legalmed.2007.05.005; Ando C, 2000, IMPERIAL IDEOLOGY AN; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Arbaiza-Vilallonga M, 1994, B ASOCIACION DEMOGRA, V12, P93; Beleza S, 2006, ANN HUM GENET, V70, P181, DOI 10.1111/j.1529-8817.2005.00221.x; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Brandstatter A, 2007, FORENSIC SCI INT, V166, P164, DOI 10.1016/j.forsciint.2006.05.006; Brion M, 2004, GENE, V329, P17, DOI 10.1016/j.gene.2003.12.035; Capelli C, 2006, ANN HUM GENET, V70, P207, DOI 10.1111/j.1529-8817.2005.00224.x; Cardoso S, 2010, J FORENSIC SCI, V55, P1196, DOI 10.1111/j.1556-4029.2010.01440.x; Caro-Baroja J, 1977, LOS PUEBLOS DEL NORT; Castellanos Santiago, 2005, EARLY MEDIEV EUR, V13, P1, DOI DOI 10.1111/J.1468-0254.2005.00147.X; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Delgado Vinas C., 2007, INVESTIGACIONES GEOG, V42, P35, DOI DOI 10.14198/INGE02007.42.02; Destro-Bisol G, 2004, MOL BIOL EVOL, V21, P1673, DOI 10.1093/molbev/msh186; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Egocheaga JE, 1973, TRAB ANTROP, V17, P29; Escorza-Trevino S, 2005, CONSERV GENET, V6, P587, DOI 10.1007/s10592-005-9013-9; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FASSMANN H, 1994, INT MIGR REV, V28, P520, DOI 10.2307/2546819; Faya MA, 1992, LOS SENORIOS ECLESIA; Fernandez JW, 1990, CULTURE TIME ANTHR A, P94; Fu YX, 1997, GENETICS, V147, P915; Garcia O, 2004, FORENSIC SCI INT, V145, P65, DOI 10.1016/j.forsciint.2004.03.004; Garrigan D, 2007, GENETICS, V177, P2195, DOI 10.1534/genetics.107.077495; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gayan J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-326; Gomez P, 1980, BOL CIEN NAT RIDEA, V25, P41; Gomez-Carballa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032851; Gomez-Pellon E, 1991, REV ANTROPOLOGIA SOC, P31; Gomez-Perez L, 2011, AM J HUM BIOL, V23, P790, DOI 10.1002/ajhb.21216; International Society of Genetic Genealogy, 2012, Y DNA HAPL TREE 2012; Irwin J, 2008, INT J LEGAL MED, V122, P87, DOI 10.1007/s00414-007-0173-7; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; Koch JT, 2006, CELTIC CULTURE A HIS, P276; Lappalainen T, 2009, ANN HUM GENET, V73, P61, DOI 10.1111/j.1469-1809.2008.00487.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Parra AM, 2009, ANN HUM GENET, V73, P42, DOI 10.1111/j.1469-1809.2008.00478.x; Lopez-Soto M, 2006, INT C SER, V1288, P106; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Martinez-Cruz B, 2012, MOL BIOL EVOL, V29, P2211, DOI 10.1093/molbev/mss091; Moler C, 2009, MATLAB 2009A; Nasidze I, 2004, ANN HUM GENET, V68, P205, DOI 10.1046/j.1529-8817.2004.00092.x; Nei M., 1987, MOL EVOLUTIONARY GEN; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Pardinas AF, 2012, J HUM GENET, V57, P717, DOI 10.1038/jhg.2012.100; Pilkington MM, 2008, MOL BIOL EVOL, V25, P517, DOI 10.1093/molbev/msm279; Pistis G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004654; Pons O, 1996, GENETICS, V144, P1237; Puerta MC, 2005, HISTORIA DE ASTURIAS; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; RUIZ DE LA PENA SOLAR J. I., 2000, REV HIST MEDIEVAL, V11, P41; Sampietro ML, 2005, ANN HUM GENET, V69, P535, DOI 10.1111/j.1529-8817.2005.00194.x; Sanmarti J., 2009, COLONIAL ENCOUNTERS, P49; Santos-Yanguas N, 2006, ASTURIAS LOS ASTURES; Scapoli C, 2007, THEOR POPUL BIOL, V71, P37, DOI 10.1016/j.tpb.2006.06.010; SLATKIN M, 1995, GENETICS, V139, P457; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tillmar AO, 2010, INT J LEGAL MED, V124, P91, DOI 10.1007/s00414-009-0354-7; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wilkins JF, 2006, BIOESSAYS, V28, P290, DOI 10.1002/bies.20378; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264	71	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50206	10.1371/journal.pone.0050206	http://dx.doi.org/10.1371/journal.pone.0050206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209673	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800053
J	Joh, EH; Hollenbaugh, JA; Kim, B; Kim, DH				Joh, Eun-Ha; Hollenbaugh, Joseph A.; Kim, Baek; Kim, Dong-Hyun			Pleckstrin Homology Domain of Akt Kinase: A Proof of Principle for Highly Specific and Effective Non-Enzymatic Anti-Cancer Target	PLOS ONE			English	Article							CODONOPSIS-LANCEOLATA; 3-KINASE INHIBITOR; SIGNALING PATHWAY; PI3K/AKT PATHWAY; DRUG DISCOVERY; CANCER-CELLS; SURVIVAL; GROWTH; PHOSPHORYLATION; ACTIVATION	While pharmacological inhibition of Akt kinase has been regarded as a promising anti-cancer strategy, most of the Akt inhibitors that have been developed are enzymatic inhibitors that target the kinase active site of Akt. Another key cellular regulatory event for Akt activation is the translocation of Akt kinase to the cell membrane from the cytoplasm, which is accomplished through the pleckstrin homology (PH) domain of Akt. However, compounds specifically interacting with the PH domain of Akt to inhibit Akt activation are currently limited. Here we identified a compound, lancemaside A (LAN-A), which specifically binds to the PH domain of Akt kinase. First, our mass spectra analysis of cellular Akt kinase isolated from cells treated with LAN-A revealed that LAN-A specifically binds to the PH domain of cellular Akt kinase. Second, we observed that LAN-A inhibits the translocation of Akt kinase to the membrane and thus Akt activation, as examined by the phosphorylation of various downstream targets of Akt such as GSK3 beta, mTOR and BAD. Third, in a co-cultured cell model containing human lung epithelial cancer cells (A549) and normal human primary lung fibroblasts, LAN-A specifically restricts the growth of the A549 cells. LAN-A also displayed anti-proliferative effects on various human cancer cell lines. Finally, in the A549-luciferase mouse transplant model, LAN-A effectively inhibited A549 cell growth with little evident cytotoxicity. Indeed, the therapeutic index of LAN-A in this mouse model was >250, supporting that LAN-A is a potential lead compound for PH domain targeting as a safe anti-cancer Akt inhibitor.	[Hollenbaugh, Joseph A.; Kim, Baek] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Joh, Eun-Ha; Kim, Dong-Hyun] Kyung Hee Univ, Dept Pharm, Seoul, South Korea	University of Rochester; Kyung Hee University	Kim, B (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	baek_kim@urmc.rochester.edu; dhkim@khu.ac.kr			National Institutes of Health [A1077401, T32 DA07232]; World Class University Program through National Research Foundation of Korea; Ministry of Education, Science and Technology [R33-2008-000-10018-0]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Class University Program through National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grants from the National Institutes of Health A1077401 (BK), National Institutes of Health grant T32 DA07232 (JAH), and the World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R33-2008-000-10018-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Billottet C, 2009, CANCER RES, V69, P1027, DOI 10.1158/0008-5472.CAN-08-2608; Blake JF, 2012, J MED CHEM; Chae S, 2009, J AGR FOOD CHEM, V57, P5777, DOI 10.1021/jf900331g; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dienstmann R, 2011, RECENT PAT ANTI-CANC, V6, P210, DOI 10.2174/157489211795328503; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Fasolo A, 2008, EXPERT OPIN INV DRUG, V17, P1717, DOI [10.1517/13543784.17.11.1717, 10.1517/13543784.17.11.1717 ]; Garcia-Echeverria C, 2008, ONCOGENE, V27, P5511, DOI 10.1038/onc.2008.246; Garlich JR, 2008, CANCER RES, V68, P206, DOI 10.1158/0008-5472.CAN-07-0669; Hafsi S, 2011, INT J ONCOL; Harris TK, 2003, IUBMB LIFE, V55, P117, DOI 10.1080/1521654031000115951; Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698; Ihle NT, 2004, MOL CANCER THER, V3, P763; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Jo H, 2011, P NATL ACAD SCI USA, V108, P6486, DOI 10.1073/pnas.1019062108; Joh EH, 2010, J CELL BIOCHEM, V111, P865, DOI 10.1002/jcb.22773; Joh EH, 2010, J CHROMATOGR B, V878, P1875, DOI 10.1016/j.jchromb.2010.05.003; Joh EH, 2010, INT J COLORECTAL DIS, V25, P545, DOI 10.1007/s00384-009-0858-0; Kawakami Y, 2004, J BIOL CHEM, V279, P47720, DOI 10.1074/jbc.M408797200; Kim D, 2010, J BIOL CHEM, V285, P8383, DOI 10.1074/jbc.M109.094060; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021781; Knowles MA, 2009, CANCER METAST REV, V28, P305, DOI 10.1007/s10555-009-9198-3; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Lee KT, 2002, J AGR FOOD CHEM, V50, P4190, DOI 10.1021/jf011647l; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Lindsley CW, 2008, CURR CANCER DRUG TAR, V8, P7, DOI 10.2174/156800908783497096; Liu Y, 2001, ONCOGENE, V20, P2514, DOI 10.1038/sj.onc.1204364; Lynch DK, 1999, ONCOGENE, V18, P8024, DOI 10.1038/sj.onc.1203258; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Martelli AM, 2010, ONCOTARGET, V1, P89, DOI 10.18632/oncotarget.114; Meuillet EJ, 2011, CURR MED CHEM, V18, P2727; Mohan AL, 2012, ANTICANCER RES, V32, P3141; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Nalbantsoy A, 2011, J ETHNOPHARMACOL; Noh KH, 2009, MOL THER, V17, P439, DOI 10.1038/mt.2008.255; Okuzumi T, 2010, MOL BIOSYST, V6, P1389, DOI 10.1039/c003917a; Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503; Redaelli C, 2006, MINI-REV MED CHEM, V6, P1127, DOI 10.2174/138955706778560139; Ruggeri BA, 1998, MOL CARCINOGEN, V21, P81, DOI 10.1002/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Sato S, 2002, ONCOGENE, V21, P1727, DOI 10.1038/sj.onc.1205225; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang P, 2011, MINI-REV MED CHEM, V11, P1093, DOI 10.2174/138955711797655380; Xu LP, 2008, PLANTA MED, V74, P1412, DOI 10.1055/s-2008-1081318; Yu K, 2005, CANCER BIOL THER, V4, P538, DOI 10.4161/cbt.4.5.1660; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	57	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50424	10.1371/journal.pone.0050424	http://dx.doi.org/10.1371/journal.pone.0050424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189201	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800078
J	Lanitis, E; Dangaj, D; Hagemann, IS; Song, DG; Best, A; Sandaltzopoulos, R; Coukos, G; Powell, DJ				Lanitis, Evripidis; Dangaj, Denarda; Hagemann, Ian S.; Song, De-Gang; Best, Andrew; Sandaltzopoulos, Raphael; Coukos, George; Powell, Daniel J., Jr.			Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels	PLOS ONE			English	Article							HUMAN BREAST-CANCER; REDIRECTED ANTITUMOR-ACTIVITY; HER-2/NEU GENE AMPLIFICATION; CHIMERIC ANTIGEN RECEPTOR; PROGNOSTIC-SIGNIFICANCE; T-LYMPHOCYTES; IN-VIVO; OVEREXPRESSION; ANTIBODY; TUMORS	The breadth of HER2 expression by primary human ovarian cancers remains controversial, which questions its suitability as a universal antigen in this malignancy. To address these issues, we performed extensive HER2 expression analysis on a wide panel of primary tumors as well as established and short-term human ovarian cancer cell lines. Conventional immunohistochemical (IHC) analysis of multiple tumor sites in 50 cases of high-grade ovarian serous carcinomas revealed HER2 overexpression in 29% of evaluated sites. However, more sensitive detection methods including flow cytometry, western blot analysis and q-PCR revealed HER2 expression in all fresh tumor cells derived from primary ascites or solid tumors as well as all established and short-term cultured cancer cell lines. Cancer cells generally expressed HER2 at higher levels than that found in normal ovarian surface epithelial (OSE) cells. Accordingly, genetically-engineered human T cells expressing an HER2-specific chimeric antigen receptor (CAR) recognized and reacted against all established or primary ovarian cancer cells tested with minimal or no reactivity against normal OSE cells. In conclusion, all human ovarian cancers express immunologically-detectable levels of HER2, indicating that IHC measurement underestimates the true frequency of HER2-expressing ovarian cancers and may limit patient access to otherwise clinically meaningful HER2-targeted therapies.	[Lanitis, Evripidis; Dangaj, Denarda; Song, De-Gang; Best, Andrew; Coukos, George; Powell, Daniel J., Jr.] Univ Penn, Dept Obstet & Gynecol, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA; [Lanitis, Evripidis; Dangaj, Denarda; Sandaltzopoulos, Raphael] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Hagemann, Ian S.; Powell, Daniel J., Jr.] Univ Penn, Dept Pathol & Lab Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Democritus University of Thrace; University of Pennsylvania; Pennsylvania Medicine	Powell, DJ (corresponding author), Univ Penn, Dept Obstet & Gynecol, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA.	poda@mail.med.upenn.edu	Hagemann, Ian/ABB-2854-2021; Lanitis, Evripidis/AAD-2260-2022; Coukos, George/ABG-7389-2020	Hagemann, Ian/0000-0002-3855-9745; Lanitis, Evripidis/0000-0002-8194-5414; Coukos, George/0000-0001-8813-7367	Ovarian Cancer Research Fund; Sandy Rollman Ovarian Cancer Foundation; National Institutes of Health [1R21CA152540]; Joint Fox Chase Cancer Center; University of Pennsylvania Ovarian Cancer SPORE [P50 CA083638]; NATIONAL CANCER INSTITUTE [R21CA152540, P50CA083638] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; Sandy Rollman Ovarian Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Joint Fox Chase Cancer Center; University of Pennsylvania Ovarian Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Ovarian Cancer Research Fund, Sandy Rollman Ovarian Cancer Foundation, National Institutes of Health (1R21CA152540) and the Joint Fox Chase Cancer Center and University of Pennsylvania Ovarian Cancer SPORE (P50 CA083638). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Bartsch R, 2007, BIODRUGS, V21, P69, DOI 10.2165/00063030-200721020-00001; Baselga J, 2001, SEMIN ONCOL, V28, P4, DOI 10.1053/sonc.2001.28544; Bertozzi CC, 2006, IN VITRO CELL DEV-AN, V42, P58; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108; Chmielewski M, 2004, J IMMUNOL, V173, P7647, DOI 10.4049/jimmunol.173.12.7647; Chu CS, 2011, CANC IMMUNOL IMMUNOT; Diederichsen ACP, 1998, APMIS, V106, P562, DOI 10.1111/j.1699-0463.1998.tb01385.x; Engel RH, 2007, DRUGS, V67, P1329, DOI 10.2165/00003495-200767090-00006; FAJAC A, 1995, INT J CANCER, V64, P146, DOI 10.1002/ijc.2910640213; FELIP E, 1995, CANCER, V75, P2147, DOI 10.1002/1097-0142(19950415)75:8<2147::AID-CNCR2820750818>3.0.CO;2-8; GROSS G, 1989, P NATL ACAD SCI USA, V86, P10024, DOI 10.1073/pnas.86.24.10024; Hellstrom I, 2001, CANCER RES, V61, P2420; Hogdall EVS, 2003, CANCER-AM CANCER SOC, V98, P66, DOI 10.1002/cncr.11476; IOANNIDES CG, 1993, CELL IMMUNOL, V151, P225, DOI 10.1006/cimm.1993.1233; Johnson LA, 2006, J IMMUNOL, V177, P6548, DOI 10.4049/jimmunol.177.9.6548; Juhl H, 1997, J BIOL CHEM, V272, P29482, DOI 10.1074/jbc.272.47.29482; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kershaw MH, 2004, J IMMUNOL, V173, P2143, DOI 10.4049/jimmunol.173.3.2143; Lal G, 2008, J SURG RES, V149, P62, DOI 10.1016/j.jss.2007.10.014; Lanitis E, 2012, MOL THER, V20, P633, DOI 10.1038/mt.2011.256; Le Tourneau A, 2005, GYNECOL ONCOL, V95, P89; Lee CH, 2005, INT J GYNECOL PATHOL, V24, P147, DOI 10.1097/01.PGP.0000152026.39268.57; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Mayr D, 2006, HISTOPATHOLOGY, V48, P149, DOI 10.1111/j.1365-2559.2005.02306.x; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; MORITZ D, 1994, P NATL ACAD SCI USA, V91, P4318, DOI 10.1073/pnas.91.10.4318; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Nielsen JS, 2004, INT J GYNECOL CANCER, V14, P1086, DOI 10.1111/j.1048-891X.2004.14606.x; Pauletti G, 2000, J CLIN ONCOL, V18, P3651, DOI 10.1200/JCO.2000.18.21.3651; Pauletti G, 1996, ONCOGENE, V13, P63; PENAULTLLORCA F, 1994, J PATHOL, V173, P65, DOI 10.1002/path.1711730111; Perez EA, 2002, MAYO CLIN PROC, V77, P148; PIETRAS RJ, 1994, ONCOGENE, V9, P1829; Pinthus JH, 2003, CANCER RES, V63, P2470; Scardino A, 2007, CANCER RES, V67, P7028, DOI 10.1158/0008-5472.CAN-06-3998; SCHIER R, 1995, IMMUNOTECHNOLOGY, V1, P73, DOI 10.1016/1380-2933(95)00007-0; STANCOVSKI I, 1993, J IMMUNOL, V151, P6577; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Turatti F, 2005, J GENE MED, V7, P158, DOI 10.1002/jgm.647; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Verri E, 2005, ONCOLOGY-BASEL, V68, P154, DOI 10.1159/000086958; Vinatzer U, 2005, CLIN CANCER RES, V11, P8348, DOI 10.1158/1078-0432.CCR-05-0841; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; WONG YF, 1995, GYNECOL OBSTET INVES, V40, P209, DOI 10.1159/000292337; Zhao YB, 2009, J IMMUNOL, V183, P5563, DOI 10.4049/jimmunol.0900447; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	49	58	63	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49829	10.1371/journal.pone.0049829	http://dx.doi.org/10.1371/journal.pone.0049829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189165	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800042
J	Riddell, JR; Maier, P; Sass, SN; Moser, MT; Foster, BA; Gollnick, SO				Riddell, Jonah R.; Maier, Patricia; Sass, Stephanie N.; Moser, Michael T.; Foster, Barbara A.; Gollnick, Sandra O.			Peroxiredoxin 1 Stimulates Endothelial Cell Expression of VEGF via TLR4 Dependent Activation of HIF-1 alpha	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR VEGF; HYPOXIA-INDUCIBLE FACTOR; A(2A) RECEPTOR AGONISTS; SYNERGISTIC UP-REGULATION; PROSTATE-CANCER CELLS; TRANSCRIPTIONAL REGULATION; DENDRITIC CELLS; SIGNAL-TRANSDUCTION; MURINE MACROPHAGES	Chronic inflammation leads to the formation of a pro-tumorigenic microenvironment that can promote tumor development, growth and differentiation through augmentation of tumor angiogenesis. Prostate cancer (CaP) risk and prognosis are adversely correlated with a number of inflammatory and angiogenic mediators, including Toll-like receptors (TLRs), NF-kappa B and vascular endothelial growth factor (VEGF). Peroxiredoxin 1 (Prx1) was recently identified as an endogenous ligand for TLR4 that is secreted from CaP cells and promotes inflammation. Inhibition of Prx1 by CaP cells resulted in reduced expression of VEGF, diminished tumor vasculature and retarded tumor growth. The mechanism by which Prx1 regulates VEGF expression in normoxic conditions was investigated in the current study. Our results show that incubation of mouse vascular endothelial cells with recombinant Prx1 caused increases in VEGF expression that was dependent upon TLR4 and required hypoxia inducible factor-1 (HIF-1) interaction with the VEGF promoter. The induction of VEGF was also dependent upon NF-kappa B; however, NF-kappa B interaction with the VEGF promoter was not required for Prx1 induction of VEGF suggesting that NF-kappa B was acting indirectly to induce VEGF expression. The results presented here show that Prx1 stimulation increased NF-kappa B interaction with the HIF-1 alpha promoter, leading to enhanced promoter activity and increases in HIF-1 alpha mRNA levels, as well as augmented HIF-1 activity that resulted in VEGF expression. Prx1 induced HIF-1 also promoted NF-kappa B activity, suggesting the presence of a positive feedback loop that has the potential to perpetuate Prx1 induction of angiogenesis. Strikingly, inhibition of Prx1 expression in CaP was accompanied with reduced expression of HIF1 alpha. The combined findings of the current study and our previous study suggest that Prx1 interaction with TLR4 promotes CaP growth potentially through chronic activation of tumor angiogenesis.	[Riddell, Jonah R.; Maier, Patricia; Gollnick, Sandra O.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA; [Riddell, Jonah R.; Sass, Stephanie N.; Gollnick, Sandra O.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Moser, Michael T.; Foster, Barbara A.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Gollnick, SO (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA.	Sandra.gollnick@roswellpark.org			NIH [CA109480, CA98156, CA095367, CA111846]; Roswell Park Cancer Center [CA16056]; NATIONAL CANCER INSTITUTE [R01CA109480, P30CA016056, R01CA111846, R01CA095367, R01CA098156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roswell Park Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grants CA109480 (SOG), CA98156 (SOG), CA095367 (BAF), CA111846 (BAF) and in part by the Roswell Park Cancer Center Support Grant CA16056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HZ, 2002, IMMUNOLOGY, V106, P38, DOI 10.1046/j.1365-2567.2002.01401.x; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Bast A, 2009, BIOCHIM BIOPHYS ACTA, V1799, P402; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Brunelle JK, 2004, J BIOL CHEM, V279, P4305, DOI 10.1074/jbc.M312241200; Catena R, 2007, INT J CANCER, V120, P2096, DOI 10.1002/ijc.22461; Chang JW, 2006, BIOCHEM BIOPH RES CO, V345, P118, DOI 10.1016/j.bbrc.2006.04.073; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Domingo-Domenech J, 2005, BRIT J CANCER, V93, P1285, DOI 10.1038/sj.bjc.6602851; Epstein JI, 2009, VIRCHOWS ARCH, V454, P1, DOI 10.1007/s00428-008-0707-5; Ferrer FA, 1997, J UROLOGY, V157, P2329, DOI 10.1016/S0022-5347(01)64775-X; Fradet V, 2004, CLIN CANCER RES, V10, P8460, DOI 10.1158/1078-0432.CCR-04-0764; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Godoy A, 2008, ENDOCRINOLOGY, V149, P2959, DOI 10.1210/en.2007-1078; Gonzalez-Moreno O, 2010, EXP CELL RES, V316, P554, DOI 10.1016/j.yexcr.2009.11.020; Green MML, 2007, INT J RADIAT ONCOL, V67, P84, DOI 10.1016/j.ijrobp.2006.08.077; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; HENDERSON BW, 1995, PHOTOCHEM PHOTOBIOL, V62, P780, DOI 10.1111/j.1751-1097.1995.tb08730.x; Huss WJ, 2001, CANCER RES, V61, P2736; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kandel ES, 1997, SOMAT CELL MOLEC GEN, V23, P325, DOI 10.1007/BF02674280; Kandel ES, 2009, CELL CYCLE, V8, P1819; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Kim SY, 2010, IMMUNOLOGY, V129, P516, DOI 10.1111/j.1365-2567.2009.03203.x; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Leibovich SJ, 2002, AM J PATHOL, V160, P2231, DOI 10.1016/S0002-9440(10)61170-4; Loureiro RMB, 2005, CYTOKINE GROWTH F R, V16, P77, DOI 10.1016/j.cytogfr.2005.01.005; Loureiro RMB, 2005, BIOCHEM BIOPH RES CO, V326, P455, DOI 10.1016/j.bbrc.2004.11.053; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mazzucchelli R, 2000, PROSTATE, V45, P72; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pallares J, 2006, HISTOL HISTOPATHOL, V21, P857, DOI 10.14670/HH-21.857; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Payne SJL, 2011, FUTURE ONCOL, V7, P395, DOI [10.2217/FON.11.13, 10.2217/fon.11.13]; Peyromaure M, 2007, BJU INT, V99, P1150, DOI 10.1111/j.1464-410X.2007.06734.x; Poon RTP, 2001, J CLIN ONCOL, V19, P1207, DOI 10.1200/JCO.2001.19.4.1207; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Qian C, 2006, BLOOD, V108, P2307, DOI 10.1182/blood-2006-03-005595; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Ramanathan M, 2009, J LEUKOCYTE BIOL, V86, P681, DOI 10.1189/jlb.0109021; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Rodriguez-Martinez S, 2006, EXP EYE RES, V83, P1373, DOI 10.1016/j.exer.2006.07.015; Scortegagna M, 2008, BLOOD, V111, P3343, DOI 10.1182/blood-2007-10-115758; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Shukla S, 2005, PROSTATE, V64, P224, DOI 10.1002/pros.20217; Shukla S, 2004, NEOPLASIA, V6, P390, DOI 10.1593/neo.04112; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Soker S, 2001, AM J PATHOL, V159, P651, DOI 10.1016/S0002-9440(10)61736-1; Spirig R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010983; Takata K, 2008, MOL CANCER THER, V7, P1551, DOI 10.1158/1535-7163.MCT-07-0428; VanCleave TT, 2010, PROSTATE, V70, P341, DOI 10.1002/pros.21067; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624	72	53	58	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50394	10.1371/journal.pone.0050394	http://dx.doi.org/10.1371/journal.pone.0050394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185615	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000228
J	Blickley, JL; Word, KR; Krakauer, AH; Phillips, JL; Sells, SN; Taff, CC; Wingfield, JC; Patricelli, GL				Blickley, Jessica L.; Word, Karen R.; Krakauer, Alan H.; Phillips, Jennifer L.; Sells, Sarah N.; Taff, Conor C.; Wingfield, John C.; Patricelli, Gail L.			Experimental Chronic Noise Is Related to Elevated Fecal Corticosteroid Metabolites in Lekking Male Greater Sage-Grouse (Centrocercus urophasianus)	PLOS ONE			English	Article							CHRONIC ANTHROPOGENIC NOISE; WEST-NILE-VIRUS; ENERGY DEVELOPMENT; STRESS RESPONSES; URBAN NOISE; AGE; BEHAVIOR; INCREASES; HABITAT; ROADS	There is increasing evidence that individuals in many species avoid areas exposed to chronic anthropogenic noise, but the impact of noise on those who remain in these habitats is unclear. One potential impact is chronic physiological stress, which can affect disease resistance, survival and reproductive success. Previous studies have found evidence of elevated stress-related hormones (glucocorticoids) in wildlife exposed to human activities, but the impacts of noise alone are difficult to separate from confounding factors. Here we used an experimental playback study to isolate the impacts of noise from industrial activity (natural gas drilling and road noise) on glucocorticoid levels in greater sage-grouse (Centrocercus urophasianus), a species of conservation concern. We non-invasively measured immunoreactive corticosterone metabolites from fecal samples (FCMs) of males on both noise-treated and control leks (display grounds) in two breeding seasons. We found strong support for an impact of noise playback on stress levels, with 16.7% higher mean FCM levels in samples from noise leks compared with samples from paired control leks. Taken together with results from a previous study finding declines in male lek attendance in response to noise playbacks, these results suggest that chronic noise pollution can cause greater sage-grouse to avoid otherwise suitable habitat, and can cause elevated stress levels in the birds who remain in noisy areas.	[Blickley, Jessica L.; Krakauer, Alan H.; Phillips, Jennifer L.; Taff, Conor C.; Patricelli, Gail L.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Word, Karen R.; Wingfield, John C.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Sells, Sarah N.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Montana System; University of Montana	Patricelli, GL (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	GPatricelli@ucdavis.edu	Taff, Conor/I-4649-2019; Patricelli, Gail L/L-3730-2017	Sells, Sarah/0000-0003-4859-7160; Krakauer, Alan/0000-0001-9177-7963; Blickley, Jessica/0000-0001-7841-5642; Word, Karen/0000-0002-7294-7231; Patricelli, Gail/0000-0003-3397-8390	National Parks Service; US Bureau of Land Management; Wyoming Sage-Grouse Conservation Fund (State of Wyoming); National Fish and Wildlife Foundation; Wyoming Community Foundation Tom Thorne Sage-Grouse Conservation Fund; UC Davis; National Science Foundation [IOS-0925038]; Office of Polar Programs (OPP) [0750540] Funding Source: National Science Foundation	National Parks Service; US Bureau of Land Management; Wyoming Sage-Grouse Conservation Fund (State of Wyoming); National Fish and Wildlife Foundation; Wyoming Community Foundation Tom Thorne Sage-Grouse Conservation Fund; UC Davis; National Science Foundation(National Science Foundation (NSF)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by the National Parks Service, US Bureau of Land Management, Wyoming Sage-Grouse Conservation Fund (State of Wyoming), National Fish and Wildlife Foundation, the Wyoming Community Foundation Tom Thorne Sage-Grouse Conservation Fund, UC Davis, and the National Science Foundation (IOS-0925038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARIO P, 1987, PHYSIOL BEHAV, V40, P29, DOI 10.1016/0031-9384(87)90181-8; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Angelier F, 2007, J ANIM ECOL, V76, P1181, DOI 10.1111/j.1365-2656.2007.01295.x; Angelier F, 2006, GEN COMP ENDOCR, V149, P1, DOI 10.1016/j.ygcen.2006.04.006; Atkinson HC, 2006, J NEUROENDOCRINOL, V18, P526, DOI 10.1111/j.1365-2826.2006.01444.x; Babisch W, 2003, Noise Health, V5, P1; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; BARRETT AM, 1963, J ENDOCRINOL, V26, P97, DOI 10.1677/joe.0.0260097; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; Blickley J.L., 2010, J INT WILDL LAW POL, V13, P274, DOI [10.1080/13880292.2010.524564, DOI 10.1080/13880292.2010.524564]; Blickley Jessica L., 2012, Ornithological Monographs, V74, P23; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Connelly J.W., 2004, CONSERVATION ASSESSM; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Davis M, 1997, PHILOS T ROY SOC B, V352, P1675, DOI 10.1098/rstb.1997.0149; Delaney DK, 1999, J WILDLIFE MANAGE, V63, P60, DOI 10.2307/3802487; Dickens MJ, 2010, WILSON J ORNITHOL, V122, P762, DOI 10.1676/09-185.1; Dooling R.J., 2007, EFFECTS HIGHWAY NOIS; Evans GW, 1998, PSYCHOL SCI, V9, P75, DOI 10.1111/1467-9280.00014; Evans GW, 2001, J ACOUST SOC AM, V109, P1023, DOI 10.1121/1.1340642; Forman RTT, 2000, CONSERV BIOL, V14, P36, DOI 10.1046/j.1523-1739.2000.99088.x; Francis CD, 2012, P ROY SOC B-BIOL SCI, V279, P2727, DOI 10.1098/rspb.2012.0230; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; FREEMAN BM, 1982, COMP BIOCHEM PHYS A, V72, P251, DOI 10.1016/0300-9629(82)90041-X; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Habib L, 2007, J APPL ECOL, V44, P176, DOI 10.1111/j.1365-2664.2006.01234.x; Holloran M., 2005, THESIS U WYOMING LAR; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Hu Y, 2009, BEHAV ECOL, V20, P1268, DOI 10.1093/beheco/arp131; Ingelfinger F, 2004, WEST N AM NATURALIST, V64, P385; Ising Hartmut, 2002, Noise Health, V4, P13; Jankowski MD, 2009, PHYSIOL BIOCHEM ZOOL, V82, P190, DOI 10.1086/596513; Jankowski MD, 2010, TOXICOLOGY, V269, P81, DOI 10.1016/j.tox.2010.01.010; Jankowski MD, 2007, INFLUENCE HABITAT DI; Kight CR, 2011, ECOL LETT, V14, P1052, DOI 10.1111/j.1461-0248.2011.01664.x; Knick ST, 2011, STUD AVIAN BIOL, P1; Kuitunen M, 1998, ENVIRON MANAGE, V22, P297, DOI 10.1007/s002679900105; Lucas JR, 2006, HORM BEHAV, V49, P634, DOI 10.1016/j.yhbeh.2005.12.012; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Naugle DE, 2004, ECOL LETT, V7, P704, DOI 10.1111/j.1461-0248.2004.00631.x; Oppliger A, 1998, ECOL LETT, V1, P129; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Peris SJ, 2004, APPL ACOUST, V65, P357, DOI 10.1016/j.apacoust.2003.10.005; Quinn JL, 2006, J AVIAN BIOL, V37, P601; Rabin LA, 2006, BIOL CONSERV, V131, P410, DOI 10.1016/j.biocon.2006.02.016; Rheindt FE, 2003, J ORNITHOL, V144, P295, DOI 10.1046/j.1439-0361.2003.03004.x; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; ROST GR, 1979, J WILDLIFE MANAGE, V43, P634, DOI 10.2307/3808741; Rubenstein DR, 2007, P ROY SOC B-BIOL SCI, V274, P967, DOI 10.1098/rspb.2006.0051; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Schwabl H, 1999, GEN COMP ENDOCR, V116, P403, DOI 10.1006/gcen.1999.7379; Sheriff MJ, 2012, J ZOOL, V287, P65, DOI 10.1111/j.1469-7998.2011.00888.x; SINGER FJ, 1978, J WILDLIFE MANAGE, V42, P591, DOI 10.2307/3800822; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Swaddle JP, 2007, ANIM BEHAV, V74, P363, DOI 10.1016/j.anbehav.2007.01.004; Tempel DJ, 2003, WILDLIFE SOC B, V31, P698; Thiel D, 2005, ANN NY ACAD SCI, V1046, P96, DOI 10.1196/annals.1343.009; Thiel D, 2011, IBIS, V153, P122, DOI 10.1111/j.1474-919X.2010.01083.x; US Fish and Wildlife Service [USFWS], 2010, FED REGISTER, V75, P13910; VANDERZANDE AN, 1980, BIOL CONSERV, V18, P299, DOI 10.1016/0006-3207(80)90006-3; VEHRENCAMP SL, 1989, ANIM BEHAV, V38, P885, DOI 10.1016/S0003-3472(89)80120-4; Wada H, 2007, GEN COMP ENDOCR, V150, P405, DOI 10.1016/j.ygcen.2006.10.002; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; WEISS JM, 1970, PSYCHOSOM MED, V32, P397, DOI 10.1097/00006842-197007000-00008; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Wingfield JC, 2005, J MAMMAL, V86, P248, DOI 10.1644/BHE-004.1; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191	76	93	95	7	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50462	10.1371/journal.pone.0050462	http://dx.doi.org/10.1371/journal.pone.0050462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185627	Green Published, gold, Green Submitted			2022-12-25	WOS:000311535700085
J	Freewan, M; Rees, MD; Plaza, TSS; Glaros, E; Lim, YJ; Wang, XS; Yeung, AWS; Witting, PK; Terentis, AC; Thomas, SR				Freewan, Mohammed; Rees, Martin D.; Plaza, Tito S. Sempertegui; Glaros, Elias; Lim, Yean J.; Wang, Xiao Suo; Yeung, Amanda W. S.; Witting, Paul K.; Terentis, Andrew C.; Thomas, Shane R.			Human Indoleamine 2,3-Dioxygenase Is a Catalyst of Physiological Heme Peroxidase Reactions IMPLICATIONS FOR THE INHIBITION OF DIOXYGENASE ACTIVITY BY HYDROGEN PEROXIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOCHLOROUS ACID PRODUCTION; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; TRYPTOPHAN 2,3-DIOXYGENASE; NITRIC-OXIDE; N-FORMYLKYNURENINE; POSTTRANSLATIONAL REGULATION; STRUCTURAL-PROPERTIES; LIPID-PEROXIDATION; TYROSINE NITRATION	The heme enzyme indoleamine 2,3-dioxygenase (IDO) is a key regulator of immune responses through catalyzing L-tryptophan (L-Trp) oxidation. Here, we show that hydrogen peroxide (H2O2) activates the peroxidase function of IDO to induce protein oxidation and inhibit dioxygenase activity. Exposure of IDO-expressing cells or recombinant human IDO (rIDO) to H2O2 inhibited dioxygenase activity in a manner abrogated by L-Trp. Dioxygenase inhibition correlated with IDO-catalyzed H2O2 consumption, compound I-mediated formation of protein-centered radicals, altered protein secondary structure, and opening of the distal heme pocket to promote nonproductive substrate binding; these changes were inhibited by L-Trp, the heme ligand cyanide, or free radical scavengers. Protection by L-Trp coincided with its oxidation into oxindolylalanine and kynurenine and the formation of a compound II-type ferryl-oxo heme. Physiological peroxidase substrates, ascorbate or tyrosine, enhanced rIDO-mediated H2O2 consumption and attenuated H2O2-induced protein oxidation and dioxygenase inhibition. In the presence of H2O2, rIDO catalytically consumed nitric oxide (NO) and utilized nitrite to promote 3-nitrotyrosine formation on IDO. The promotion of H2O2 consumption by peroxidase substrates, NO consumption, and IDO nitration was inhibited by L-Trp. This study identifies IDO as a heme peroxidase that, in the absence of substrates, self-inactivates dioxygenase activity via compound I-initiated protein oxidation. L-Trp protects against dioxygenase inactivation by reacting with compound I and retarding compound II reduction to suppress peroxidase turnover. Peroxidase-mediated dioxygenase inactivation, NO consumption, or protein nitration may modulate the biological actions of IDO expressed in inflammatory tissues where the levels of H2O2 and NO are elevated and L-Trp is low.	[Freewan, Mohammed; Rees, Martin D.; Glaros, Elias; Lim, Yean J.; Yeung, Amanda W. S.; Thomas, Shane R.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Freewan, Mohammed; Rees, Martin D.; Glaros, Elias; Lim, Yean J.; Yeung, Amanda W. S.; Thomas, Shane R.] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Plaza, Tito S. Sempertegui; Terentis, Andrew C.] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Wang, Xiao Suo; Witting, Paul K.] Univ Sydney, Discipline Pathol, Sydney Med Sch, Bosch Inst, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of New South Wales Sydney; State University System of Florida; Florida Atlantic University; University of Sydney	Terentis, AC (corresponding author), Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA.	terentis@fau.edu; shane.thomas@unsw.edu.au	Witting, Paul/ABD-2053-2020; Terentis, Andrew/N-9188-2019; Witting, Paul/L-9786-2019	Witting, Paul/0000-0003-2237-7004; Terentis, Andrew/0000-0001-6137-8275; Lim, Yean Jin/0000-0003-1874-2662; Sempertegui Plaza, Tito/0000-0003-0958-1780; Wang, Xiao Suo/0000-0003-3487-4614; Rees, Martin/0000-0002-3564-5736	Australian National Health and Medical Research Council [568774]; American Chemical Society [46549-G4]; Australian Research Council [DP0878559]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); American Chemical Society(American Chemical Society); Australian Research Council(Australian Research Council)	This work was supported in part by Australian National Health and Medical Research Council Project Grant 568774 (to S. R. T.), American Chemical Society Petroleum Research Fund Grant 46549-G4 (to A. C. T.), and Australian Research Council Discovery Grant DP0878559 (to P. K. W.).	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Austin C, 2009, AMINO ACIDS, V36, P99, DOI 10.1007/s00726-008-0037-6; Basran J, 2008, BIOCHEMISTRY-US, V47, P4752, DOI 10.1021/bi702393b; Basran J, 2011, J AM CHEM SOC, V133, P16251, DOI 10.1021/ja207066z; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; Bove PF, 2006, FREE RADICAL BIO MED, V41, P515, DOI 10.1016/j.freeradbiomed.2006.05.011; Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200; Capece L, 2012, J PHYS CHEM B, V116, P1401, DOI 10.1021/jp2082825; Capece L, 2010, J BIOL INORG CHEM, V15, P811, DOI 10.1007/s00775-010-0646-x; Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a; Chung LW, 2010, J AM CHEM SOC, V132, P11993, DOI 10.1021/ja103530v; CORNFORTH JW, 1951, BIOCHEM J, V48, P598, DOI 10.1042/bj0480598; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; De Marinis E, 2009, IUBMB LIFE, V61, P62, DOI 10.1002/iub.149; DeGray JA, 1997, J BIOL CHEM, V272, P2359; Efimov I, 2011, BIOCHEMISTRY-US, V50, P2717, DOI 10.1021/bi101732n; Ehrenshaft M, 2009, FREE RADICAL BIO MED, V46, P1260, DOI 10.1016/j.freeradbiomed.2009.01.020; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Ferry G, 2005, BIOCHEM J, V388, P205, DOI 10.1042/BJ20042075; Forouhar F, 2007, P NATL ACAD SCI USA, V104, P473, DOI 10.1073/pnas.0610007104; Fu R, 2011, J BIOL CHEM, V286, P26541, DOI 10.1074/jbc.M111.253237; Galijasevic S, 2008, FREE RADICAL BIO MED, V44, P1570, DOI 10.1016/j.freeradbiomed.2008.01.003; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Gen JF, 2012, J AM CHEM SOC, V134, P12209, DOI 10.1021/ja304164b; Giessauf A, 1996, FEBS LETT, V389, P136; Glover RE, 1999, NITRIC OXIDE-BIOL CH, V3, P439, DOI 10.1006/niox.1999.0256; Herold S, 2001, J BIOL INORG CHEM, V6, P543, DOI 10.1007/s007750100231; Holt S, 1999, LANCET, V353, P1241, DOI 10.1016/S0140-6736(98)05768-7; Hsuanyu Y, 1999, ARCH BIOCHEM BIOPHYS, V368, P413, DOI 10.1006/abbi.1999.1328; Irwin JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P94, DOI 10.1006/abbi.1998.0987; ITAKURA K, 1994, CHEM RES TOXICOL, V7, P185, DOI 10.1021/tx00038a011; Kettle AJ, 2000, REDOX REP, V5, P179, DOI 10.1179/135100000101535726; Kettle AJ, 2001, BIOCHEMISTRY-US, V40, P10204, DOI 10.1021/bi010940b; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Kilinc K, 2001, BIOCHEM BIOPH RES CO, V285, P273, DOI 10.1006/bbrc.2001.5168; King NJC, 2007, INT J BIOCHEM CELL B, V39, P2167, DOI 10.1016/j.biocel.2007.01.004; Kuo HH, 2012, P NATL ACAD SCI USA, V109, P13966, DOI 10.1073/pnas.1207191109; LABROO RB, 1990, J ORG CHEM, V55, P4901, DOI 10.1021/jo00303a027; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Littlejohn TK, 2003, J BIOL CHEM, V278, P29525, DOI 10.1074/jbc.M301700200; Liu XP, 2001, FREE RADICAL BIO MED, V31, P894, DOI 10.1016/S0891-5849(01)00665-7; Lu CY, 2011, J BIOL CHEM, V286, P21220, DOI 10.1074/jbc.M111.221507; MARQUEZ LA, 1994, BIOCHEMISTRY-US, V33, P1447, DOI 10.1021/bi00172a022; Marquez LA, 1995, J BIOL CHEM, V270, P30434, DOI 10.1074/jbc.270.51.30434; MASKOS Z, 1992, ARCH BIOCHEM BIOPHYS, V296, P514, DOI 10.1016/0003-9861(92)90605-V; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; Matsui T, 1999, J AM CHEM SOC, V121, P9952, DOI 10.1021/ja9914846; MAYO SL, 1986, SCIENCE, V233, P948, DOI 10.1126/science.3016897; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Moore KP, 1998, J BIOL CHEM, V273, P31731, DOI 10.1074/jbc.273.48.31731; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; Pogni R, 2006, J BIOL CHEM, V281, P9517, DOI 10.1074/jbc.M510424200; Poljak A, 2006, ARCH BIOCHEM BIOPHYS, V450, P9, DOI 10.1016/j.abb.2006.03.003; Poulos TL, 2010, ARCH BIOCHEM BIOPHYS, V500, P3, DOI 10.1016/j.abb.2010.02.008; Prendergast GC, 2010, AM J PATHOL, V176, P2082, DOI 10.2353/ajpath.2010.091173; Queiroz RF, 2011, BIOCHEM J, V439, P423, DOI 10.1042/BJ20110555; Rafice SA, 2009, BIOCHEM SOC T, V37, P408, DOI 10.1042/BST0370408; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Rees MD, 2009, BIOCHEM J, V421, P79, DOI 10.1042/BJ20090309; Rosell FI, 2011, J BIOL CHEM, V286, P29273, DOI 10.1074/jbc.M111.262139; Sampson JB, 1998, ARCH BIOCHEM BIOPHYS, V356, P207, DOI 10.1006/abbi.1998.0772; Simat TJ, 1998, J AGR FOOD CHEM, V46, P490, DOI 10.1021/jf970818c; SONO M, 1980, J BIOL CHEM, V255, P1339; SONO M, 1989, J BIOL CHEM, V264, P1616; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; Takikawa O, 2005, BIOCHEM BIOPH RES CO, V338, P12, DOI 10.1016/j.bbrc.2005.09.032; TAKIKAWA O, 1983, J BIOL CHEM, V258, P6808; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terentis AC, 2002, J BIOL CHEM, V277, P15788, DOI 10.1074/jbc.M200457200; Terentis AC, 2010, BIOCHEMISTRY-US, V49, P591, DOI 10.1021/bi901546e; Thomas SR, 2007, J BIOL CHEM, V282, P23778, DOI 10.1074/jbc.M700669200; Thomas SR, 2001, J IMMUNOL, V166, P6332, DOI 10.4049/jimmunol.166.10.6332; Thomas SR, 1999, REDOX REP, V4, P199, DOI 10.1179/135100099101534927; van Dalen CJ, 2000, J BIOL CHEM, V275, P11638, DOI 10.1074/jbc.275.16.11638; vanderVliet A, 1997, J BIOL CHEM, V272, P7617, DOI 10.1074/jbc.272.12.7617; Vetter SW, 2009, J BIOL INORG CHEM, V14, P179, DOI 10.1007/s00775-008-0436-x; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; Witting PK, 1999, CHEM RES TOXICOL, V12, P1173, DOI 10.1021/tx9900472; Yanagisawa S, 2011, FARADAY DISCUSS, V148, P239, DOI 10.1039/c004552g; Yanagisawa S, 2010, BIOCHEMISTRY-US, V49, P10081, DOI 10.1021/bi1009997; Zelante T, 2009, MICROBES INFECT, V11, P133, DOI 10.1016/j.micinf.2008.10.007; Zhang Y, 2007, BIOCHEMISTRY-US, V46, P145, DOI 10.1021/bi0620095	88	39	39	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1548	1567		10.1074/jbc.M112.410993	http://dx.doi.org/10.1074/jbc.M112.410993			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23209301	hybrid, Green Published			2022-12-25	WOS:000313751400012
J	Rai, AK; Paul, K; Chattopadhyay, K				Rai, Anand Kumar; Paul, Karan; Chattopadhyay, Kausik			Functional Mapping of the Lectin Activity Site on the beta-Prism Domain of Vibrio cholerae Cytolysin IMPLICATIONS FOR THE MEMBRANE PORE-FORMATION MECHANISM OF THE TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOTYPE EL-TOR; HEPTAMERIC TRANSMEMBRANE PORE; CRYSTAL-STRUCTURE; FORMING TOXINS; HEMOLYSIN; COMPLEX; BINDING; MODE; O1; PURIFICATION	Vibrio cholerae cytolysin (VCC) is a prominent member in the family of beta-barrel pore-forming toxins. It induces lysis of target eukaryotic cells by forming transmembrane oligomeric beta-barrel channels. VCC also exhibits prominent lectin-like activity in interacting with beta 1-galactosyl-terminated glycoconjugates. Apart from the cytolysin domain, VCC harbors two lectin-like domains: the beta-Trefoil and the beta-Prism domains; however, precise contribution of these domains in the lectin property of VCC is not known. Also, role(s) of these lectin-like domains in the mode of action of VCC remain obscure. In the present study, we show that the beta-Prism domain of VCC acts as the structural scaffold to determine the lectin activity of the protein toward beta 1-galactosyl-terminated glycoconjugates. Toward exploring the physiological implication of the beta-Prism domain, we demonstrate that the presence of the beta-Prism domain-mediated lectin activity is crucial for an efficient interaction of the toxin toward the target cells. Our results also suggest that such lectin activity may act to regulate the oligomerization ability of the membrane-bound VCC toxin. Based on the data presented here, and also consistent with the existing structural information, we propose a novel mechanism of regulation imposed by the beta-Prism domain's lectin activity, implicated in the process of membrane pore formation by VCC.	[Rai, Anand Kumar; Paul, Karan; Chattopadhyay, Kausik] IISER, Dept Biol Sci, Manauli 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Chattopadhyay, K (corresponding author), IISER, Dept Biol Sci, Sect 81, Manauli 140306, Punjab, India.	kausik@iisermohali.ac.in	Chattopadhyay, Kausik/H-5044-2015; Paul, Karan/GZK-9033-2022	Chattopadhyay, Kausik/0000-0001-8529-9475; Paul, Karan/0000-0002-4921-6799	Department of Biotechnology (DBT), India [BT/PR13350/BRB/10/751/2009]; IISER Mohali	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); IISER Mohali	This work was supported by a grant from the Department of Biotechnology (DBT), India (DBT Grant No. BT/PR13350/BRB/10/751/2009) and IISER Mohali.	Alouf J., 2006, COMPREHENSIVE SOURCE; Chattopadhyay K, 2003, J BIOL CHEM, V278, P38470, DOI 10.1074/jbc.M305965200; Chattopadhyay K, 2002, EUR J BIOCHEM, V269, P4351, DOI 10.1046/j.1432-1033.2002.03137.x; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; GOLDBERG SL, 1984, J BACTERIOL, V160, P239, DOI 10.1128/JB.160.1.239-244.1984; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; Ikigai H, 1996, INFECT IMMUN, V64, P2968, DOI 10.1128/IAI.64.8.2968-2973.1996; KRASILNIKOV OV, 1992, BIOCHIM BIOPHYS ACTA, V1111, P7, DOI 10.1016/0005-2736(92)90268-Q; Lee X, 1998, J BIOL CHEM, V273, P6312, DOI 10.1074/jbc.273.11.6312; Mazumdar B, 2011, INDIAN J MED RES, V133, P131; Menzl K, 1996, EUR J BIOCHEM, V240, P646, DOI 10.1111/j.1432-1033.1996.0646h.x; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Paul K, 2012, FEBS J, V279, P4039, DOI 10.1111/j.1742-4658.2012.08809.x; Paul K, 2011, BIOCHEMISTRY-US, V50, P3936, DOI 10.1021/bi200332g; Saha N, 1997, J BIOL CHEM, V272, P162, DOI 10.1074/jbc.272.1.162; Sankaranarayanan R, 1996, NAT STRUCT BIOL, V3, P596, DOI 10.1038/nsb0796-596; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; YAMAMOTO K, 1990, INFECT IMMUN, V58, P4106, DOI 10.1128/IAI.58.12.4106-4116.1990; YAMAMOTO K, 1984, INFECT IMMUN, V45, P192, DOI 10.1128/IAI.45.1.192-196.1984; Yuldasheva LN, 2001, BBA-BIOMEMBRANES, V1512, P53, DOI 10.1016/S0005-2736(01)00302-9; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x	31	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1665	1673		10.1074/jbc.M112.430181	http://dx.doi.org/10.1074/jbc.M112.430181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23209283	hybrid, Green Published			2022-12-25	WOS:000313751400022
J	Choy, CA; Davison, PC; Drazen, JC; Flynn, A; Gier, EJ; Hoffman, JC; McClain-Counts, JP; Miller, TW; Popp, BN; Ross, SW; Sutton, TT				Choy, C. Anela; Davison, Peter C.; Drazen, Jeffrey C.; Flynn, Adrian; Gier, Elizabeth J.; Hoffman, Joel C.; McClain-Counts, Jennifer P.; Miller, Todd W.; Popp, Brian N.; Ross, Steve W.; Sutton, Tracey T.			Global Trophic Position Comparison of Two Dominant Mesopelagic Fish Families (Myctophidae, Stomiidae) Using Amino Acid Nitrogen Isotopic Analyses	PLOS ONE			English	Article							STOMACH CONTENTS; STABLE-ISOTOPES; FOOD-WEB; PACIFIC; PISCES; DIET; ASSEMBLAGE; ABUNDANCE; CARBON; N-15	The delta N-15 values of organisms are commonly used across diverse ecosystems to estimate trophic position and infer trophic connectivity. We undertook a novel cross-basin comparison of trophic position in two ecologically well-characterized and different groups of dominant mid-water fish consumers using amino acid nitrogen isotope compositions. We found that trophic positions estimated from the delta N-15 values of individual amino acids are nearly uniform within both families of these fishes across five global regions despite great variability in bulk tissue delta N-15 values. Regional differences in the delta N-15 values of phenylalanine confirmed that bulk tissue delta N-15 values reflect region-specific water mass biogeochemistry controlling delta N-15 values at the base of the food web. Trophic positions calculated from amino acid isotopic analyses (AA-TP) for lanternfishes (family Myctophidae) (AA-TP similar to 2.9) largely align with expectations from stomach content studies (TP similar to 3.2), while AA-TPs for dragonfishes (family Stomiidae) (AA-TP similar to 3.2) were lower than TPs derived from stomach content studies (TP similar to 4.1). We demonstrate that amino acid nitrogen isotope analysis can overcome shortcomings of bulk tissue isotope analysis across biogeochemically distinct systems to provide globally comparative information regarding marine food web structure.	[Choy, C. Anela; Drazen, Jeffrey C.] Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA; [Davison, Peter C.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Flynn, Adrian] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Flynn, Adrian] Commonwealth Sci & Ind Res Org, Marine & Atmospher Res, Hobart, Tas, Australia; [Gier, Elizabeth J.; Popp, Brian N.] Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Hoffman, Joel C.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN USA; [McClain-Counts, Jennifer P.] US Geol Survey, SE Ecol Sci Ctr, Gainesville, FL USA; [Miller, Todd W.] Ehime Univ, Global Ctr Excellence, Ctr Marine Environm Studies, Matsuyama, Ehime, Japan; [Ross, Steve W.] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA; [Sutton, Tracey T.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	University of Hawaii System; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Hawaii System; United States Environmental Protection Agency; United States Department of the Interior; United States Geological Survey; Ehime University; University of North Carolina; University of North Carolina Wilmington; William & Mary; Virginia Institute of Marine Science	Choy, CA (corresponding author), Univ Hawaii, Dept Oceanog, Honolulu, HI 96822 USA.	cachoy@hawaii.edu	Drazen, Jeffrey/C-1197-2013; Sutton, Tracey/AAW-7644-2021; Ross, Steve W./AAH-5583-2020	Drazen, Jeffrey/0000-0001-9613-3833; Sutton, Tracey/0000-0002-5280-7071; McClain-Counts, Jennifer/0000-0002-3383-5472; Choy, Anela/0000-0002-0305-1159; Popp, Brian/0000-0001-7021-5478	National Science Foundation (NSF) [OCE-1041329, OCE-0623551]; Joint Institute for Marine and Atmospheric Research [NA17RJ123]; National Oceanic and Atmospheric Administration [NA17RJ123]; Department of the Interior U.S.G.S. [05HQAG0009, 05099HS004, 5099HS0013]; Directorate For Geosciences [1040810] Funding Source: National Science Foundation; Division Of Ocean Sciences [1041329] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Joint Institute for Marine and Atmospheric Research; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Department of the Interior U.S.G.S.; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by National Science Foundation (NSF) grant # OCE-1041329 to B.N.P. and J.C.D., NSF grant # OCE-0623551 to T.T.S., and by the Pelagic Fisheries Research Program via Cooperative Agreement NA17RJ123 between the Joint Institute for Marine and Atmospheric Research and the National Oceanic and Atmospheric Administration to J.C.D. and B.N.P. Field collections and data analyses for GOM samples were supported by grants to S.W.R. by the Department of the Interior U.S.G.S. (Cooperative Agreement 05HQAG0009, subagreements 05099HS004 and 5099HS0013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Brodeur R., 2005, 30 PICES N PAC MAR S; Casini M, 2009, P NATL ACAD SCI USA, V106, P197, DOI 10.1073/pnas.0806649105; Cherel Y, 2004, DEEP-SEA RES PT I, V51, P17, DOI 10.1016/j.dsr.2003.09.009; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; CHILDRESS JJ, 1980, MAR BIOL, V61, P27, DOI 10.1007/BF00410339; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; De Forest L, 2009, DEEP-SEA RES PT I, V56, P232, DOI 10.1016/j.dsr.2008.09.007; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Gartner JV, 2008, MAR BIOL, V153, P825, DOI 10.1007/s00227-007-0855-1; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; Hidaka K, 2001, DEEP-SEA RES PT I, V48, P1923, DOI 10.1016/S0967-0637(01)00003-6; Hoffman JC, 2010, DEEP-SEA RES PT I, V57, P956, DOI 10.1016/j.dsr.2010.05.003; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jennings S, 2008, RAPID COMMUN MASS SP, V22, P1673, DOI 10.1002/rcm.3497; KAWAGUCHI K, 1982, Biological Oceanography, V1, P337; Macko SA, 1997, ANAL CHEM, V69, P926, DOI 10.1021/ac960956l; McClain-Counts J, 2010, THESIS U N CAROLINA; McClelland JW, 2002, ECOLOGY, V83, P2173, DOI 10.1890/0012-9658(2002)083[2173:TRATNI]2.0.CO;2; Nam NT, 2011, FISH RES, V110, P268, DOI 10.1016/j.fishres.2011.04.014; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pilling GM, 2001, J FISH BIOL, V59, P1370, DOI 10.1006/jfbi.2001.1748; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; ROSECCHI E, 1988, MAR BIOL, V99, P293, DOI 10.1007/BF00391992; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; Sutton TT, 1996, MAR BIOL, V127, P179, DOI 10.1007/BF00942102; Sutton TT, 1996, B MAR SCI, V59, P530; TORRES JJ, 1979, DEEP-SEA RES, V26, P185, DOI 10.1016/0198-0149(79)90075-X; Vander Zanden MJ, 1997, CAN J FISH AQUAT SCI, V54, P1142, DOI 10.1139/cjfas-54-5-1142; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; WADA E, 1976, GEOCHIM COSMOCHIM AC, V40, P249, DOI 10.1016/0016-7037(76)90183-6	35	82	83	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50133	10.1371/journal.pone.0050133	http://dx.doi.org/10.1371/journal.pone.0050133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209656	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700034
J	Macwan, AS; Kukshal, V; Srivastava, N; Javed, S; Kumar, A; Ramachandran, R				Macwan, Ankit S.; Kukshal, Vandna; Srivastava, Nidhi; Javed, Saleem; Kumar, Ashwani; Ramachandran, Ravishankar			Crystal Structure of the Hexachlorocyclohexane Dehydrochlorinase (LinA-Type2): Mutational Analysis, Thermostability and Enantioselectivity	PLOS ONE			English	Article							DEGRADATION; ENZYMES; BIODEGRADATION; PROTEINS; ISOMERS; CLONING; LINA	Hexachlorocyclohexane dehydrochlorinase (LinA) mediates dehydrochlorination of gamma-HCH to 1, 3, 4, 6-tetrachloro-1,4-cyclohexadiene that constitutes first step of the aerobic degradation pathway. We report the 3.5 angstrom crystal structure of a thermostable LinA-type2 protein, obtained from a soil metagenome, in the hexagonal space group P6(3)22 with unit cell parameters a = b = 162.5, c = 186.3 angstrom, respectively. The structure was solved by molecular replacement using the coordinates of LinA-type1 that exhibits mesophile-like properties. Structural comparison of LinA-type2 and -type1 proteins suggests that thermostability of LinA-type2 might partly arise due to presence of higher number of ionic interactions, along with 4% increase in the intersubunit buried surface area. Mutational analysis involving the differing residues between the type1 and -type2 proteins, circular dichroism experiments and functional assays suggest that Q20 and G23 are determinants of stability for LinA-type2. It was earlier reported that LinA-type1 exhibits enantioselectivity for the (2) enantiomer of alpha-HCH. Contrastingly, we identified that -type2 protein prefers the (+) enantiomer of alpha-HCH. Structural analysis and molecular docking experiments suggest that changed residues K20Q, L96C and A131G, vicinal to the active site are probably responsible for the altered enantioselectivity of LinA-type2. Overall the study has identified features responsible for the thermostability and enantioselectivity of LinA-type2 that can be exploited for the design of variants for specific biotechnological applications.	[Macwan, Ankit S.; Srivastava, Nidhi; Kumar, Ashwani] CSIR Indian Inst Toxicol Res, Environm Biotechnol Div, Lucknow, Uttar Pradesh, India; [Javed, Saleem] Hamdard Univ, Dept Biochem, New Delhi, India; [Kukshal, Vandna; Ramachandran, Ravishankar] CSIR Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Jamia Hamdard University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Kumar, A (corresponding author), CSIR Indian Inst Toxicol Res, Environm Biotechnol Div, Mahatma Gandhi Marg, Lucknow, Uttar Pradesh, India.	ashwani.iitr26@gmail.com; r_ravishankar@cdri.res.in	Macwan, Ankit/A-5647-2019; Javed, Saleem/ABA-3845-2020	Macwan, Ankit/0000-0003-1063-2960; Ramachandran, Ravishankar/0000-0002-0723-9861; kukshal, vandna/0000-0002-6207-2638	Department of Biotechnology, India [GAP0083]; Council of Scientific & Industrial Research (CSIR), India;  [MLP007M]	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific & Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); 	This work was supported by grants from the Department of Biotechnology, India, GAP0083, and intramural funds, MLP007M, respectively. AM, VK and NS acknowledge fellowships from the Council of Scientific & Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CUDNEY B, 1994, ACTA CRYSTALLOGR D, V50, P414, DOI 10.1107/S0907444994002660; Evans PR, 1997, RECENT ADV PHASING, P6; Garcia-Ruiz E, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-17; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; IMAI R, 1991, J BACTERIOL, V173, P6811, DOI 10.1128/jb.173.21.6811-6819.1991; Jaeger KE, 2004, CURR OPIN BIOTECH, V15, P305, DOI 10.1016/j.copbio.2004.06.007; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Karshikoff A, 2001, TRENDS BIOCHEM SCI, V26, P550, DOI 10.1016/S0968-0004(01)01918-1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar M, 2005, ENVIRON SCI TECHNOL, V39, P4005, DOI 10.1021/es048497q; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Kumari R, 2002, APPL ENVIRON MICROB, V68, P6021, DOI 10.1128/AEM.68.12.6021-6028.2002; Lal R, 2010, MICROBIOL MOL BIOL R, V74, P58, DOI 10.1128/MMBR.00029-09; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Liebeton K, 2000, CHEM BIOL, V7, P709, DOI 10.1016/S1074-5521(00)00015-6; LUNDQVIST T, 1994, STRUCTURE, V2, P937, DOI 10.1016/S0969-2126(94)00095-6; Macwan AS, 2011, 3 BIOTECH, V1, P193, DOI 10.1007/s13205-011-0012-x; Majeed S, 2003, STRUCTURE, V11, P1061, DOI 10.1016/S0969-2126(03)00185-0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nagata Y, 1993, BIOSCI BIOTECH BIOCH, V57, P2; Nagata Y, 2007, APPL MICROBIOL BIOT, V76, P741, DOI 10.1007/s00253-007-1066-x; Okai M, 2010, J MOL BIOL, V403, P260, DOI 10.1016/j.jmb.2010.08.043; Salminen T, 1996, PROTEIN SCI, V5, P1014; Suar M, 2005, APPL ENVIRON MICROB, V71, P8514, DOI 10.1128/AEM.71.12.8514-8518.2005; Torrez M, 2003, BIOPHYS J, V85, P2845, DOI 10.1016/S0006-3495(03)74707-9; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Willett KL, 1998, ENVIRON SCI TECHNOL, V32, P2197, DOI 10.1021/es9708530; Wu J, 2007, ENVIRON MICROBIOL, V9, P2331, DOI 10.1111/j.1462-2920.2007.01350.x; ZAMOST BL, 1991, J IND MICROBIOL, V8, P71, DOI 10.1007/BF01578757	34	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50373	10.1371/journal.pone.0050373	http://dx.doi.org/10.1371/journal.pone.0050373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209726	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800069
J	Reinholdt, LG; Howell, GR; Czechanski, AM; Macalinao, DG; MacNicoll, KH; Lin, CS; Donahue, LR; John, SWM				Reinholdt, Laura G.; Howell, Gareth R.; Czechanski, Anne M.; Macalinao, Danilo G.; MacNicoll, Katharine H.; Lin, Chyuan-Sheng; Donahue, Leah Rae; John, Simon W. M.			Generating Embryonic Stem Cells from the Inbred Mouse Strain DBA/2J, a Model of Glaucoma and Other Complex Diseases	PLOS ONE			English	Article							OPTIC-NERVE DEGENERATION; HOST RESPONSE; GROUND-STATE; MICE; NEURODEGENERATION; INFECTION; C57BL/6J; GENETICS	Mouse embryonic stem (ES) cells are derived from the inner cell mass of blastocyst stage embryos and are used primarily for the creation of genetically engineered strains through gene targeting. While some inbred strains of mice are permissive to the derivation of embryonic stem cell lines and are therefore easily engineered, others are nonpermissive or recalcitrant. Genetic engineering of recalcitrant strain backgrounds requires gene targeting in a permissive background followed by extensive backcrossing of the engineered allele into the desired strain background. The inbred mouse strain DBA/2J is a recalcitrant strain that is used as a model of many human diseases, including glaucoma, deafness and schizophrenia. Here, we describe the generation of germ-line competent ES cell lines derived from DBA/2J mice. We also demonstrate the utility of DBA/2J ES cells with the creation of conditional knockout allele for Endothelin-2 (Edn2) directly on the DBA/2J strain background.	[Reinholdt, Laura G.; Howell, Gareth R.; Czechanski, Anne M.; Macalinao, Danilo G.; MacNicoll, Katharine H.; Donahue, Leah Rae; John, Simon W. M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Howell, Gareth R.; John, Simon W. M.] Howard Hughes Med Inst, Bar Harbor, ME USA; [Lin, Chyuan-Sheng] Columbia Univ, Dept Pathol & Cell Biol, Irving Canc Res Ctr, New York, NY USA; [John, Simon W. M.] Tufts Univ Med, Dept Ophthalmol, Boston, MA USA	Jackson Laboratory; Howard Hughes Medical Institute; Columbia University; Tufts University	John, SWM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	simon.john@jax.org		Czechanski, Anne/0000-0003-3210-4210	SWMJ [EY011721]; Barbara and Joseph Cohen Foundation; Pew Charitable Trust; Kathryn W. Davis and family; National Glaucoma Research - a program of the American Health Assistance Foundation; NATIONAL EYE INSTITUTE [R01EY021525, R29EY011721, R01EY011721] Funding Source: NIH RePORTER	SWMJ; Barbara and Joseph Cohen Foundation; Pew Charitable Trust; Kathryn W. Davis and family; National Glaucoma Research - a program of the American Health Assistance Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by EY011721 (SWMJ), The Barbara and Joseph Cohen Foundation, The Pew Charitable Trust, Kathryn W. Davis and family, and donors of National Glaucoma Research - a program of the American Health Assistance Foundation (GRH). SWMJ is an Investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2010, MICROBES INFECT, V12, P309, DOI 10.1016/j.micinf.2010.01.008; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-1; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Boughter JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038169; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Calkins DJ, 2008, INVEST OPHTH VIS SCI, V49, P5083, DOI 10.1167/iovs.08-2205; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; CHUNG SH, 1984, PROC R SOC SER B-BIO, V221, P145, DOI 10.1098/rspb.1984.0028; Connolly PM, 2003, BRAIN RES, V992, P85, DOI 10.1016/j.brainres.2003.08.035; Davis RC, 2005, GENOMICS, V86, P259, DOI 10.1016/j.ygeno.2005.05.010; Drake TA, 2001, PHYSIOL GENOMICS, V5, P205, DOI 10.1152/physiolgenomics.2001.5.4.205; Gardner RL, 1997, INT J DEV BIOL, V41, P235; GILBERT DJ, 1993, J VIROL, V67, P2083, DOI 10.1128/JVI.67.4.2083-2090.1993; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Hsu Hui-Chen, 2007, Methods Mol Biol, V371, P321; Inman DM, 2007, GLIA, V55, P942, DOI 10.1002/glia.20516; Jellen LC, 2009, BIOCHIMIE, V91, P1255, DOI 10.1016/j.biochi.2009.04.009; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; May CA, 2006, ACTA NEUROPATHOL, V111, P158, DOI 10.1007/s00401-005-0011-2; McKnite AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039191; Mountz JD, 2001, SCAND J IMMUNOL, V54, P10, DOI 10.1046/j.1365-3083.2001.00943.x; Nagaraju M, 2007, INVEST OPHTH VIS SCI, V48, P4573, DOI 10.1167/iovs.07-0582; Nedelko T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-411; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; PAIGEN B, 1995, AM J CLIN NUTR, V62, p458S, DOI 10.1093/ajcn/62.2.458S; PANAGIS L, 2009, INVEST OPHTH VIS SCI, V51, P2024; PHILIP VM, 2009, GENES BRAIN BEHAV; Pichard C, 2009, ALCOHOL, V43, P593, DOI 10.1016/j.alcohol.2009.10.007; Schlamp CL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-66; Schuettauf F, 2004, ACTA NEUROPATHOL, V107, P352, DOI 10.1007/s00401-003-0816-9; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith RS, 2000, HUM MOL GENET, V9, P1021, DOI 10.1093/hmg/9.7.1021; Wang X, EXP AGING RES, V36, P79; Willott JF, 2006, HEARING RES, V216, P138, DOI 10.1016/j.heares.2006.01.010; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	40	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50081	10.1371/journal.pone.0050081	http://dx.doi.org/10.1371/journal.pone.0050081			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209647	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800046
J	Stringer, JR; Counter, CM				Stringer, Jay R.; Counter, Christopher M.			Snm1B Interacts with PSF2	PLOS ONE			English	Article							INTERSTRAND CROSS-LINKS; DNA-REPLICATION FORK; HUMAN GINS COMPLEX; S-PHASE; PROTEIN; REPAIR; TRF2; ENDONUCLEASE; MUS81-EME1; TELOMERES	The protein Snm1B plays a key role in interstrand crosslink (ICL) repair. In a yeast two-hybrid screen we identified the protein PSF2 to bind Snm1B. PSF2 is a member of the GINS complex involved in replication initiation and elongation, and is known to play a role in ICL repair. Snm1B was shown to bind PSF2 in human cells through two regions, strongly to a 144 amino acid N-terminal region and weakly to a second smaller 37 amino acid C-terminal region. Ectopic expression of PSF2 increased the amount of Mus81, a protein component of the endonucleolytic complex involved in ICL repair, co-immunoprecipitating with Snm1B. Moreover, deleting the N-terminal, but not C-terminal region of Snm1B reduced the amount of co-immunoprecipitated Mus81. Conversely, the telomere-binding protein TRF2 competed with PSF2 for binding to the C-terminus of Snm1B, and deletion of this region, but not the N-terminal region, reduced Snm1B chromatin association. We speculate that the N-terminal region of Snm1B forms a complex containing PSF2 and Mus81, while the C-terminal region is important for PSF2-mediated chromatin association.	[Stringer, Jay R.; Counter, Christopher M.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA	Duke University	Counter, CM (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	count004@mc.duke.edu		Counter, Christopher M/0000-0003-0748-3079	National Institutes of Health [CA082481, CA123031]; NATIONAL CANCER INSTITUTE [R01CA123031, R01CA082481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants CA082481 and CA123031 to CMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Bae JB, 2008, ONCOGENE, V27, P5045, DOI 10.1038/onc.2008.139; Bauerschmidt C, 2007, GENES CELLS, V12, P745, DOI 10.1111/j.1365-2443.2007.01090.x; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Choi JM, 2007, GENE DEV, V21, P1316, DOI 10.1101/gad.1548107; Ciccia A, 2003, J BIOL CHEM, V278, P25172, DOI 10.1074/jbc.M302882200; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Freibaum BD, 2008, J BIOL CHEM, V283, P23671, DOI 10.1074/jbc.M800388200; Freibaum BD, 2006, J BIOL CHEM, V281, P15033, DOI 10.1074/jbc.C600038200; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Marinsek N, 2006, EMBO REP, V7, P539, DOI 10.1038/sj.embor.7400649; Mason JM, 2011, HUM MOL GENET, V20, P2549, DOI 10.1093/hmg/ddr153; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Sengerova B, 2012, J BIOL CHEM, V287, P26254, DOI 10.1074/jbc.M112.367243; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Touzot F, 2010, P NATL ACAD SCI USA, V107, P10097, DOI 10.1073/pnas.0914918107; Tumini E, 2011, DNA REPAIR, V10, P149, DOI 10.1016/j.dnarep.2010.10.006; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49626	10.1371/journal.pone.0049626	http://dx.doi.org/10.1371/journal.pone.0049626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189151	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800028
J	Pfabigan, DM; Alexopoulos, J; Sailer, U				Pfabigan, Daniela M.; Alexopoulos, Johanna; Sailer, Uta			Exploring the Effects of Antisocial Personality Traits on Brain Potentials during Face Processing	PLOS ONE			English	Article							SELECTIVE ATTENTION; PSYCHOPATHY; P300; CATEGORIZATION; RECOGNITION; PERCEPTION; CORTEX; ERP; MS	Antisocial individuals are characterized to display self-determined and inconsiderate behavior during social interaction. Furthermore, recognition deficits regarding fearful facial expressions have been observed in antisocial populations. These observations give rise to the question whether or not antisocial behavioral tendencies are associated with deficits in basic processing of social cues. The present study investigated early visual stimulus processing of social stimuli in a group of healthy female individuals with antisocial behavioral tendencies compared to individuals without these tendencies while measuring event-related potentials (P1, N170). To this end, happy and angry faces served as feedback stimuli which were embedded in a gambling task. Results showed processing differences as early as 88-120 ms after feedback onset. Participants low on antisocial traits displayed larger P1 amplitudes than participants high on antisocial traits. No group differences emerged for N170 amplitudes. Attention allocation processes, individual arousal levels as well as face processing are discussed as possible causes of the observed group differences in P1 amplitudes. In summary, the current data suggest that sensory processing of facial stimuli is functionally intact but less ready to respond in healthy individuals with antisocial tendencies.	[Pfabigan, Daniela M.; Sailer, Uta] Univ Vienna, Social Cognit & Affect Neurosci Unit, Fac Psychol, Vienna, Austria; [Alexopoulos, Johanna] Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria; [Sailer, Uta] Univ Gothenburg, Dept Psychol, S-40020 Gothenburg, Sweden	University of Vienna; Medical University of Vienna; University of Gothenburg	Pfabigan, DM (corresponding author), Univ Vienna, Social Cognit & Affect Neurosci Unit, Fac Psychol, Vienna, Austria.	daniela.pfabigan@univie.ac.at	Pfabigan, Daniela/H-8282-2019	Pfabigan, Daniela/0000-0002-4043-1695	University of Vienna	University of Vienna	"Participants" financial remuneration was funded by a scholarship of the University of Vienna awarded to DMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APA, 1994, DIAGN STAT MAN MENT; Bates E., 2000, CTR RES LANGUAGE NEW, V12; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; BAUER H, 1979, BIOFEEDBACK SELF-REG, V4, P145, DOI 10.1007/BF01007109; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benning SD, 2005, ASSESSMENT, V12, P3, DOI 10.1177/1073191104271223; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Berger K.S., 2003, DEV PERSON CHILDHOOD; Bernat EM, 2007, INT J PSYCHOPHYSIOL, V66, P161, DOI 10.1016/j.ijpsycho.2007.03.021; BOTZEL K, 1995, EXP BRAIN RES, V104, P135, DOI 10.1007/BF00229863; Brocke B, 1997, PERS INDIV DIFFER, V22, P447, DOI 10.1016/S0191-8869(96)00226-7; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Coid J, 2010, COMPR PSYCHIAT, V51, P426, DOI 10.1016/j.comppsych.2009.09.006; Deeley Q, 2006, BRIT J PSYCHIAT, V189, P533, DOI 10.1192/bjp.bp.106.021410; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Di Russo F, 2005, NEUROIMAGE, V24, P874, DOI 10.1016/j.neuroimage.2004.09.029; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Eimer M, 1998, NEUROREPORT, V9, P2945, DOI 10.1097/00001756-199809140-00005; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; EIMER M, 1993, ELECTROEN CLIN NEURO, V88, P408, DOI 10.1016/0168-5597(93)90017-J; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Ekman P., 1976, PICTURES FACIAL AFFE; Ellis HD., 1989, HDB RES FACE PROCESS; Ferguson CJ, 2010, J SOC PSYCHOL, V150, P160, DOI 10.1080/00224540903366503; Fitzgerald Katherine L, 2007, Dis Mon, V53, P177, DOI 10.1016/j.disamonth.2007.04.010; Gao Y, 2009, BIOL PSYCHOL, V82, P199, DOI 10.1016/j.biopsycho.2009.06.006; Grant BF, 2004, J CLIN PSYCHIAT, V65, P948; Hart SD, 1996, CURR OPIN PSYCHIATR, V9, P129, DOI 10.1097/00001504-199603000-00007; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; JOHNSON R, 1980, PSYCHOPHYSIOLOGY, V17, P167, DOI 10.1111/j.1469-8986.1980.tb00131.x; Kazen M, 2009, PERSONLICHKEITS STIL; Keil A, 2005, CEREB CORTEX, V15, P1187, DOI 10.1093/cercor/bhi001; Kuhl J, 2001, MOTIVATION PERSONLIC; Lamm C, 2005, COGNITIVE BRAIN RES, V25, P900, DOI 10.1016/j.cogbrainres.2005.09.025; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; LEVENSON MR, 1995, J PERS SOC PSYCHOL, V68, P151, DOI 10.1037/0022-3514.68.1.151; Linkenkaer-Hansen K, 1998, NEUROSCI LETT, V253, P147, DOI 10.1016/S0304-3940(98)00586-2; Liu J, 2000, NEUROREPORT, V11, P337, DOI 10.1097/00001756-200002070-00023; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Lorber MF, 2004, PSYCHOL BULL, V130, P531, DOI 10.1037/0033-2909.130.4.531; Luck S.J., 2005, INTRO EVENT RELATED; Luck SJ, 1998, P NATL ACAD SCI USA, V95, P825, DOI 10.1073/pnas.95.3.825; Lynam DR, 2007, J ABNORM PSYCHOL, V116, P155, DOI 10.1037/0021-843X.116.1.155; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Novitskiy N, 2011, NEUROIMAGE, V54, P824, DOI 10.1016/j.neuroimage.2010.09.041; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pfabigan DM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00100; PICTON TW, 1972, ELECTROEN CLIN NEURO, V33, P419, DOI 10.1016/0013-4694(72)90122-8; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RAINE A, 1988, PSYCHOPHYSIOLOGY, V25, P30, DOI 10.1111/j.1469-8986.1988.tb00954.x; RAINE A, 1997, HDB ANTISOCIAL BEHAV, P289; Rodrigo C, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-31; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Roth WE, 1998, CHILD ADOLESCENT SOC, V15, P133; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Sadeh N, 2012, COGN AFFECT BEHAV NE, V12, P346, DOI 10.3758/s13415-011-0079-1; Shirtcliff EA, 2009, BEHAV SCI LAW, V27, P137, DOI 10.1002/bsl.862; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; STEPHENSON WA, 1951, ELECTROEN CLIN NEURO, V3, P237, DOI 10.1016/0013-4694(51)90017-X; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; Verona E, 2012, J ABNORM PSYCHOL, V121, P498, DOI 10.1037/a0025308; Walters GD, 2009, J PERS DISORD, V23, P647, DOI 10.1521/pedi.2009.23.6.647; World Health Organisation, 1993, ICD 10 CLASS MENT BE	71	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50283	10.1371/journal.pone.0050283	http://dx.doi.org/10.1371/journal.pone.0050283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185597	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000212
J	Zhang, SM; Wang, X; Iqbal, S; Wang, YR; Osunkoya, AO; Chen, ZJ; Chen, Z; Shin, DM; Yuan, HW; Wang, YQA; Zhau, HYE; Chung, LWK; Ritenour, C; Kucuk, O; Wu, DQ				Zhang, Shumin; Wang, Xu; Iqbal, Shareen; Wang, Yanru; Osunkoya, Adeboye O.; Chen, Zhengjia; Chen, Zhuo; Shin, Dong M.; Yuan, Hongwei; Wang, Yongqiang A.; Zhau, Haiyen E.; Chung, Leland W. K.; Ritenour, Chad; Kucuk, Omer; Wu, Daqing			Epidermal Growth Factor Promotes Protein Degradation of Epithelial Protein Lost in Neoplasm (EPLIN), a Putative Metastasis Suppressor, during Epithelial-mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROSTATE-CANCER; TUMOR-CELL INVASION; ANDROGEN-INDEPENDENCE; GENE-EXPRESSION; BONE METASTASIS; DOWN-REGULATION; ENDOTHELIAL-CELLS; ALPHA EXPRESSION; REACTIVE STROMA; CROSS-LINKING	Aberrant expression of EGF receptors has been associated with hormone-refractory and metastatic prostate cancer (PCa). However, the molecular mechanism for EGF signaling in promoting PCa metastasis remains elusive. Using experimental models of PCa metastasis, we demonstrated that EGF could induce robust epithelial-mesenchymal transition (EMT) and increase invasiveness. Interestingly, EGF was found to be capable of promoting protein turnover of epithelial protein lost in neoplasm (EPLIN), a putative suppressor of EMT and tumor metastasis. Mechanistic study revealed that EGF could activate the phosphorylation, ubiquitination, and degradation of EPLIN through an extracellular signal-regulated kinase 1/2 (ERK1/2)-dependent signaling cascade. Pharmacological inhibition of the ERK1/2 pathway effectively antagonized EGF-induced EPLIN degradation. Two serine residues, i.e. serine 362 and serine 604, were identified as putative ERK1/2 phosphorylation sites in human EPLIN, whose point mutation rendered resistance to EGF-induced protein turnover. This study elucidated a novel molecular mechanism for EGF regulation of EMT and invasiveness in PCa cells, indicating that blockade of EGF signaling could be beneficial in preventing and retarding PCa metastasis at early stages.	[Zhang, Shumin; Iqbal, Shareen; Wang, Yanru; Osunkoya, Adeboye O.; Ritenour, Chad; Kucuk, Omer; Wu, Daqing] Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; [Wang, Xu; Chen, Zhuo; Shin, Dong M.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Osunkoya, Adeboye O.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Chen, Zhengjia] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Yuan, Hongwei] Inner Mongolia Med Coll, Dept Pathol, Affiliated Hosp, Hohhot 10050, Inner Mongolia, Peoples R China; [Wang, Yongqiang A.] Ocean NanoTech LLC, Springdale, AR 72764 USA; [Zhau, Haiyen E.; Chung, Leland W. K.] Cedars Sinai Med Ctr, Urooncol Res Program, Los Angeles, CA 90048 USA	Emory University; Emory University; Emory University; Emory University; Rollins School Public Health; Inner Mongolia Medical University; Cedars Sinai Medical Center	Wu, DQ (corresponding author), Emory Univ, Sch Med, Dept Urol, 1365 Clifton Rd NE,Clin B,B5107, Atlanta, GA 30322 USA.	dwu2@emory.edu	Ray, Dana M/C-3470-2013; Shin, Dong Moon/G-9649-2013	Shin, Dong Moon/0000-0002-8245-4174; , Shareen/0000-0002-9489-7781	NCI, National Institutes of Health [1R21CA164612-01A1, 1R43CA141870, P01 CA098912, R01 CA122602]; Georgia Cancer Coalition Distinguished Scholar Grant; American Cancer Society [RSG-10-140-01]; NATIONAL CANCER INSTITUTE [R21CA164612, P01CA098912, R01CA122602, R43CA141870] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Georgia Cancer Coalition Distinguished Scholar Grant; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants 1R21CA164612-01A1 (to D. W), 1R43CA141870 (to Y. A. W), P01 CA098912 and R01 CA122602 (to L. W. K. C), and Georgia Cancer Coalition Distinguished Scholar Grant (to O. K). This work was also supported by American Cancer Society Grant RSG-10-140-01 (to D. W.).	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Angelucci A, 2006, ENDOCR-RELAT CANCER, V13, P197, DOI 10.1677/erc.1.01100; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Bailey JM, 2007, J CELL BIOCHEM, V102, P829, DOI 10.1002/jcb.21509; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Chen SX, 2000, GENE, V248, P69, DOI 10.1016/S0378-1119(00)00144-X; Chervin-Petinot A, 2012, J BIOL CHEM, V287, P7556, DOI 10.1074/jbc.M111.328682; CHUNG LWK, 1991, CANCER METAST REV, V10, P263, DOI 10.1007/BF00050797; Dakhova O, 2009, CLIN CANCER RES, V15, P3979, DOI 10.1158/1078-0432.CCR-08-1899; DeHaan AM, 2009, PROSTATE, V69, P528, DOI 10.1002/pros.20903; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; GLEAVE M, 1991, CANCER RES, V51, P3753; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Hernes E, 2004, BRIT J CANCER, V90, P449, DOI 10.1038/sj.bjc.6601536; Jiang WG, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-71; Josson S, 2011, CANCER RES, V71, P2600, DOI 10.1158/0008-5472.CAN-10-3382; Leitner L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-60; Liu YN, 2012, ANTICANCER RES, V32, P1283; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; Maul RS, 1999, ONCOGENE, V18, P7838, DOI 10.1038/sj.onc.1203206; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Mimeault M, 2003, GROWTH FACTORS, V21, P1, DOI 10.1080/0897719031000094921; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Sanders AJ, 2011, J UROLOGY, V186, P295, DOI 10.1016/j.juro.2011.03.038; Sanders AJ, 2010, ANGIOGENESIS, V13, P317, DOI 10.1007/s10456-010-9188-7; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shah RB, 2006, PROSTATE, V66, P1437, DOI 10.1002/pros.20460; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Small EJ, 2007, BJU INT, V100, P765, DOI 10.1111/j.1464-410X.2007.07121.x; Song YH, 2002, MOL BIOL CELL, V13, P1408, DOI 10.1091/mbc.01-08-0414; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Teixeira AL, 2008, CLIN CANCER RES, V14, P3367, DOI 10.1158/1078-0432.CCR-07-5119; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Xu ZH, 2010, BIOCHEM BIOPH RES CO, V401, P376, DOI 10.1016/j.bbrc.2010.09.059; Yanagisawa N, 2008, HUM PATHOL, V39, P282, DOI 10.1016/j.humpath.2007.04.025; Zellweger T, 2005, INT J CANCER, V113, P619, DOI 10.1002/ijc.20615; Zhang S, 2011, ONCOGENE, V30, P4941, DOI 10.1038/onc.2011.199; Zhang X, 2006, CLIN EXP METASTAS, V23, P209, DOI 10.1007/s10585-006-9031-0; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	50	29	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1469	1479		10.1074/jbc.M112.438341	http://dx.doi.org/10.1074/jbc.M112.438341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188829	hybrid, Green Published			2022-12-25	WOS:000313751400005
J	Bauer, R; Plieschnig, JA; Finkes, T; Riegler, B; Hermann, M; Schneider, WJ				Bauer, Raimund; Plieschnig, Julia A.; Finkes, Thomas; Riegler, Barbara; Hermann, Marcela; Schneider, Wolfgang J.			The Developing Chicken Yolk Sac Acquires Nutrient Transport Competence by an Orchestrated Differentiation Process of Its Endodermal Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; ENDOTHELIAL TUBE FORMATION; IN-SITU HYBRIDIZATION; APOLIPOPROTEIN-A-V; VISCERAL-ENDODERM; EXTRAEMBRYONIC TISSUES; LIPOPROTEIN RECEPTORS; DENSITY-LIPOPROTEIN; AMNIONLESS GENE; OOCYTE GROWTH	During chicken yolk sac (YS) growth, mesodermal cells in the area vasculosa follow the migrating endodermal epithelial cell (EEC) layer in the area vitellina. Ultimately, these cells form the vascularized YS that functions in nutrient transfer to the embryo. How and when EECs, with their apical aspect directly contacting the oocytic yolk, acquire the ability to take up yolk macromolecules during the vitellina-to-vasculosa transition has not been investigated. In addressing these questions, we found that with progressive vascularization, the expression level in EECs of the nutrient receptor triad, LRP2-cubilin-amnionless, changes significantly. The receptor complex, competent for uptake of yolk proteins, is produced by EECs in the area vasculosa but not in the area vitellina. Yolk components endocytosed by LRP2-cubilin-amnionless, preformed and newly formed lipid droplets, and yolk-derived very low density lipoprotein, shown to be efficiently endocytosed and lysosomally processed by EECs, probably provide substrates for resynthesis and secretion of nutrients, such as lipoproteins. In fact, as directly demonstrated by pulse-chase experiments, EECs in the vascularized, but not in the avascular, region efficiently produce and secrete lipoproteins containing apolipoprotein A-I (apoA-I), apoB, and/or apoA-V. In contrast, perilipin 2, a lipid droplet-stabilizing protein, is produced exclusively by the EECs of the area vitellina. These data suggest a differentiation process that orchestrates the vascularization of the developing YS with the induction of yolk uptake and lipoprotein secretion by EECs to ensure embryo nutrition.	[Bauer, Raimund; Plieschnig, Julia A.; Finkes, Thomas; Riegler, Barbara; Hermann, Marcela; Schneider, Wolfgang J.] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Schneider, WJ (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	wolfgang.schneider@meduniwien.ac.at		Hermann, Marcela/0000-0003-2298-4269; Oberle, Raimund/0000-0001-6701-4130	Austrian Science Fund (FWF) [P20218-B11, P19680-B11]; Austrian Ministry of Science and Research GEN-AU Grant GOLD-Genomics of Lipid-associated Disorders; DOC-fFORTE-fellowship of the Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 20218] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research GEN-AU Grant GOLD-Genomics of Lipid-associated Disorders; DOC-fFORTE-fellowship of the Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grants P20218-B11 (to W. J. S.) and P19680-B11 (to M. H.), by the Austrian Ministry of Science and Research GEN-AU Grant GOLD-Genomics of Lipid-associated Disorders (to W. J. S.), and by a DOC-fFORTE-fellowship of the Austrian Academy of Sciences (to J. A. P.).	Acloque H, 2008, METHOD CELL BIOL, V87, P169, DOI 10.1016/S0091-679X(08)00209-4; Ahuja R, 2008, BIOCHEM J, V410, P301, DOI 10.1042/BJ20070919; Artus J, 2012, DEV BIOL, V361, P245, DOI 10.1016/j.ydbio.2011.10.015; Assemat E, 2005, BIOL REPROD, V72, P1079, DOI 10.1095/biolreprod.104.036913; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; BARAKAT HA, 1985, J LIPID RES, V26, P1252; BELLAIRS R, 1963, J EMBRYOL EXP MORPH, V11, P201; BENSADOUN A, 1972, P SOC EXP BIOL MED, V141, P814, DOI 10.3181/00379727-141-36878; BROWN EM, 1990, J CHROMATOGR, V512, P203, DOI 10.1016/S0021-9673(01)89486-3; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Coudroy G, 2005, J AM SOC NEPHROL, V16, P2330, DOI 10.1681/ASN.2004110925; DASTON GP, 1991, TERATOLOGY, V43, P253, DOI 10.1002/tera.1420430309; DAWSON PA, 1986, J BIOL CHEM, V261, P5681; Dichlberger A, 2007, J LIPID RES, V48, P1451, DOI 10.1194/jlr.C600026-JLR200; Dunn NR, 2001, NAT GENET, V27, P351, DOI 10.1038/86829; Farese RV, 1996, J LIPID RES, V37, P347; Fisher CE, 2006, DEV BIOL, V296, P279, DOI 10.1016/j.ydbio.2006.06.007; FRASER R, 1986, BRIT J EXP PATHOL, V67, P783; Gerhartz B, 1997, COMP BIOCHEM PHYS B, V118, P159, DOI 10.1016/S0305-0491(97)00034-5; Hermann M, 2000, J BIOL CHEM, V275, P16837, DOI 10.1074/jbc.M000163200; Hermann M, 1997, J LIPID RES, V38, P1308; HERMIER D, 1985, BIOCHIM BIOPHYS ACTA, V836, P105, DOI 10.1016/0005-2760(85)90226-7; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Hummel S, 2003, J LIPID RES, V44, P1633, DOI 10.1194/jlr.M300014-JLR200; Hussain MM, 2008, CURR OPIN LIPIDOL, V19, P572, DOI 10.1097/MOL.0b013e328312707c; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Kalantry S, 2001, NAT GENET, V27, P412, DOI 10.1038/86912; Kanai M, 1996, MICROSC RES TECHNIQ, V35, P340, DOI 10.1002/(SICI)1097-0029(19961101)35:4<340::AID-JEMT5>3.0.CO;2-Q; Kozyraki R, 2007, CURR PHARM DESIGN, V13, P3038, DOI 10.2174/138161207782110507; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; LAEMMLI UK, 1974, VIROLOGY, V62, P483, DOI 10.1016/0042-6822(74)90409-7; LAMBSON RO, 1970, AM J ANAT, V129, P1, DOI 10.1002/aja.1001290102; Listenberger LL, 2007, J LIPID RES, V48, P2751, DOI 10.1194/jlr.M700359-JLR200; MACLACHLAN I, 1994, J BIOL CHEM, V269, P24127; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; MATO M, 1964, EXP CELL RES, V35, P426, DOI 10.1016/0014-4827(64)90111-9; MOBBS IG, 1981, AM J ANAT, V160, P285, DOI 10.1002/aja.1001600307; MOBBS IG, 1979, AM J ANAT, V155, P287, DOI 10.1002/aja.1001550302; Nakazawa F, 2011, DEV DYNAM, V240, P2002, DOI 10.1002/dvdy.22690; Nilsson SK, 2011, ATHEROSCLEROSIS, V219, P15, DOI 10.1016/j.atherosclerosis.2011.07.019; Paca A, 2012, DEV BIOL, V361, P90, DOI 10.1016/j.ydbio.2011.10.013; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; PARDANAUD L, 1989, DEVELOPMENT, V105, P473; Plieschnig JA, 2012, GENE, V508, P49, DOI 10.1016/j.gene.2012.07.041; RAJAVASHISTH TB, 1987, J BIOL CHEM, V262, P7058; RETZEK H, 1992, DNA CELL BIOL, V11, P661, DOI 10.1089/dna.1992.11.661; Schneider WJ, 1998, BIOL CHEM, V379, P965; Schneider WJ, 2009, GEN COMP ENDOCR, V163, P18, DOI 10.1016/j.ygcen.2008.11.032; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; Shelness GS, 2005, CURR OPIN LIPIDOL, V16, P325, DOI 10.1097/01.mol.0000169353.12772.eb; SHEN XY, 1993, CELL TISSUE RES, V272, P459, DOI 10.1007/BF00318552; Sheng GJ, 2012, ANN NY ACAD SCI, V1271, P97, DOI 10.1111/j.1749-6632.2012.06726.x; Sheng GJ, 2010, INT J DEV BIOL, V54, P1033, DOI 10.1387/ijdb.103105gs; Stern CD, 2012, DEVELOPMENT, V139, P1059, DOI 10.1242/dev.070730; STIFANI S, 1988, BIOCHEM J, V250, P467, DOI 10.1042/bj2500467; STIFANI S, 1990, P NATL ACAD SCI USA, V87, P1955, DOI 10.1073/pnas.87.5.1955; Streit A, 2001, METHODS, V23, P339, DOI 10.1006/meth.2000.1146; van Greevenbroek MMJ, 1998, ATHEROSCLEROSIS, V141, pS9; VIEIRA AV, 1993, BIOCHIM BIOPHYS ACTA, V1169, P250, DOI 10.1016/0005-2760(93)90248-8; VIEIRA PM, 1995, J LIPID RES, V36, P601; Vokes SA, 2004, DEVELOPMENT, V131, P4371, DOI 10.1242/dev.01304; Vokes SA, 2002, DEVELOPMENT, V129, P775; Walzem RL, 1999, J NUTR, V129, p467S, DOI 10.1093/jn/129.2.467S; WETTERAU JR, 1992, SCIENCE, V258, P999; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; WILT FH, 1965, SCIENCE, V147, P1588, DOI 10.1126/science.147.3665.1588; Yoshizaki N, 2004, DEV GROWTH DIFFER, V46, P229, DOI 10.1111/j.1440-169X.2004.00740.x; Zohn IE, 2010, BIRTH DEFECTS RES A, V88, P593, DOI 10.1002/bdra.20705	68	51	51	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1088	1098		10.1074/jbc.M112.393090	http://dx.doi.org/10.1074/jbc.M112.393090			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209291	hybrid, Green Published			2022-12-25	WOS:000313570300032
J	Jain, M; Rivera, S; Monclus, EA; Synenki, L; Zirk, A; Eisenbart, J; Feghali-Bostwick, C; Mutlu, GM; Budinger, GRS; Chandel, NS				Jain, Manu; Rivera, Stephanie; Monclus, Elena A.; Synenki, Lauren; Zirk, Aaron; Eisenbart, James; Feghali-Bostwick, Carol; Mutlu, Gokhan M.; Budinger, G. R. Scott; Chandel, Navdeep S.			Mitochondrial Reactive Oxygen Species Regulate Transforming Growth Factor-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; HUMAN LUNG FIBROBLASTS; TGF-BETA; ACTIVATION; EXPRESSION; DIFFERENTIATION; MYOFIBROBLAST; ROS; GENERATION; APOPTOSIS	TGF-beta signaling is required for normal tissue repair; however, excessive TGF-beta signaling can lead to robust profibrotic gene expression in fibroblasts, resulting in tissue fibrosis. TGF-beta binds to cell-surface receptors, resulting in the phosphorylation of the Smad family of transcription factors to initiate gene expression. TGF-beta also initiates Smad-independent pathways, which augment gene expression. Here, we report that mitochondrial reactive oxygen species (ROS) generated at complex III are required for TGF-beta-induced gene expression in primary normal human lung fibroblasts. TGF-beta-induced ROS could be detected in both the mitochondrial matrix and cytosol. Mitochondrially targeted antioxidants markedly attenuated TGF-beta-induced gene expression without affecting Smad phosphorylation or nuclear translocation. Genetically disrupting mitochondrial complex III-generated ROS production attenuated TGF-beta-induced profibrotic gene expression. Furthermore, inhibiting mitochondrial ROS generation attenuated NOX4 (NADPH oxidase 4) expression, which is required for TGF-beta induced myofibroblast differentiation. Lung fibroblasts from patients with pulmonary fibrosis generated more mitochondrial ROS than normal human lung fibroblasts, and mitochondrially targeted antioxidants attenuated profibrotic gene expression in both normal and fibrotic lung fibroblasts. Collectively, our results indicate that mitochondrial ROS are essential for normal TGF-beta-mediated gene expression and that targeting mitochondrial ROS might be beneficial in diseases associated with excessive fibrosis.	[Jain, Manu; Rivera, Stephanie; Monclus, Elena A.; Synenki, Lauren; Zirk, Aaron; Eisenbart, James; Mutlu, Gokhan M.; Budinger, G. R. Scott; Chandel, Navdeep S.] Northwestern Univ, Sch Med, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA; [Chandel, Navdeep S.] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Feghali-Bostwick, Carol] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Feghali-Bostwick, Carol] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA	Northwestern University; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jain, M (corresponding author), Northwestern Univ, Sch Med, Dept Med, Div Pulm & Crit Care, McGaw M-332,240 E Huron Ave, Chicago, IL 60611 USA.	m-jain@northwestern.edu	Rivera, Eleanor/K-1127-2019	Rivera, Eleanor/0000-0002-3111-0611	NCATS NIH HHS [UL1 TR000150] Funding Source: Medline; NCI NIH HHS [P30 CA060553] Funding Source: Medline; NIEHS NIH HHS [R01 ES013995] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bhattacharyya S, 2005, ARTHRITIS RHEUM-US, V52, P1248, DOI 10.1002/art.20996; Black D, 2007, BIOCHIMIE, V89, P1464, DOI 10.1016/j.biochi.2007.09.001; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Collins Y, 2012, J CELL SCI, V125, P801, DOI 10.1242/jcs.098475; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Emerling BM, 2005, MOL CELL BIOL, V25, P4853, DOI 10.1128/MCB.25.12.4853-4862.2005; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Heneberg P, 2005, CURR MED CHEM, V12, P1859, DOI 10.2174/0929867054546636; Jennings MT, 1998, J NEURO-ONCOL, V36, P123, DOI 10.1023/A:1005863419880; Michaeloudes C, 2011, AM J PHYSIOL-LUNG C, V300, pL295, DOI 10.1152/ajplung.00134.2010; Mishra R, 2007, AM J PHYSIOL-CELL PH, V292, pC1361, DOI 10.1152/ajpcell.00370.2006; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Soberanes S, 2009, J BIOL CHEM, V284, P2176, DOI 10.1074/jbc.M808844200; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107	24	237	244	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					770	777		10.1074/jbc.M112.431973	http://dx.doi.org/10.1074/jbc.M112.431973			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204521	hybrid, Green Published			2022-12-25	WOS:000313570300002
J	Poggiolini, I; Legname, G				Poggiolini, Ilaria; Legname, Giuseppe			Mapping the Prion Protein Distribution in Marsupials: Insights from Comparing Opossum with Mouse CNS	PLOS ONE			English	Article							FATAL FAMILIAL INSOMNIA; CENTRAL-NERVOUS-SYSTEM; SHORT-TAILED OPOSSUM; DEVELOPMENTAL EXPRESSION; NMR STRUCTURE; GENE; PRP; LOCALIZATION; EVOLUTION; DISEASES	The cellular form of the prion protein (PrPC) is a sialoglycoprotein widely expressed in the central nervous system (CNS) of mammalian species during neurodevelopment and in adulthood. The location of the protein in the CNS may play a role in the susceptibility of a species to fatal prion diseases, which are also known as the transmissible spongiform encephalopathies (TSEs). To date, little is known about PrPC distribution in marsupial mammals, for which no naturally occurring prion diseases have been reported. To extend our understanding of varying PrPC expression profiles in different mammals we carried out a detailed expression analysis of PrPC distribution along the neurodevelopment of the metatherian South American short-tailed opossum (Monodelphis domestica). We detected lower levels of PrPC in white matter fiber bundles of opossum CNS compared to mouse CNS. This result is consistent with a possible role for PrPC in the distinct neurodevelopment and neurocircuitry found in marsupials compared to other mammalian species.	[Legname, Giuseppe] Sincrotrone Trieste SCpA, ELETTRA Lab, Trieste, Italy; [Poggiolini, Ilaria; Legname, Giuseppe] Scuola Int Super Studi Avanzati SISSA, Dept Neurosci, Lab Prion Biol, Trieste, Italy	Elettra Sincrotrone Trieste; International School for Advanced Studies (SISSA)	Legname, G (corresponding author), Sincrotrone Trieste SCpA, ELETTRA Lab, Trieste, Italy.	legname@sissa.it	Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393				Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Atoji Y, 2009, J CHEM NEUROANAT, V38, P292, DOI 10.1016/j.jchemneu.2009.09.001; Bailly Y, 2004, J COMP NEUROL, V473, P244, DOI 10.1002/cne.20117; Benvegnu S, 2010, J COMP NEUROL, V518, P1879, DOI 10.1002/cne.22357; Biljan I, 2011, J MOL BIOL, V412, P660, DOI 10.1016/j.jmb.2011.07.067; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Chianini F, 2012, P NATL ACAD SCI USA, V109, P5080, DOI 10.1073/pnas.1120076109; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Filley CM, 2010, NEUROPSYCHOL REV, V20, P158, DOI 10.1007/s11065-010-9127-9; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; GAMBETTI P, 1995, BRAIN PATHOL, V5, P43, DOI 10.1111/j.1750-3639.1995.tb00576.x; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Guillery RW, 2003, J COMP NEUROL, V463, P360, DOI 10.1002/cne.10738; Gustiananda M, 2002, FEBS LETT, V512, P38, DOI 10.1016/S0014-5793(01)03298-7; Ilc G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011715; Jan JE, 2009, J PINEAL RES, V46, P1, DOI 10.1111/j.1600-079X.2008.00628.x; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Karlen SJ, 2006, J COMP NEUROL, V499, P990, DOI 10.1002/cne.21156; Keyte AL, 2008, CSH PROTOC 2008, V2008; Kordek R, 1999, ACTA NEUROPATHOL, V98, P597, DOI 10.1007/s004010051124; Laffont-Proust I, 2007, J COMP NEUROL, V504, P646, DOI 10.1002/cne.21475; Lee H, 2012, AJNR AM J NEURORADIO; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Legname G, 2012, STRUCTURAL STUDIES P, P289; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu T, 2001, BRAIN RES, V896, P118, DOI 10.1016/S0006-8993(01)02050-9; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; MANSON J, 1992, DEVELOPMENT, V115, P117; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mihrshahi R, 2006, J EXP ZOOL PART B, V306B, P8, DOI 10.1002/jez.b.21067; MONTAGNA P, 1995, ADV NEUROIMMUNOL, V5, P13, DOI 10.1016/0960-5428(94)00042-M; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Perez DR, 2010, J MOL BIOL, V400, P121, DOI 10.1016/j.jmb.2010.04.066; Premzl M, 2005, GENE, V349, P121, DOI 10.1016/j.gene.2004.11.049; PRUSINER SB, 1994, ANNU REV NEUROSCI, V17, P311, DOI 10.1146/annurev.ne.17.030194.001523; Puzzolo E, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-8; RIVKEES SA, 1988, J NEUROSCI, V8, P4269; Rossetti G, 2010, PROTEINS, V78, P3270, DOI 10.1002/prot.22834; Russelakis-Carneiro M, 2002, J BIOL CHEM, V277, P36872, DOI 10.1074/jbc.M202229200; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Sales N, 2002, EUR J NEUROSCI, V15, P1163, DOI 10.1046/j.1460-9568.2002.01953.x; Samollow PB, 2008, GENOME RES, V18, P1199, DOI 10.1101/gr.065326.107; SAUNDERS NR, 1989, ANAT EMBRYOL, V180, P227, DOI 10.1007/BF00315881; Sigurdson CJ, 2010, J CLIN INVEST, V120, P2590, DOI 10.1172/JCI42051; Smith KK, 2001, J ANAT, V199, P121, DOI 10.1017/S0021878201008202; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Thumdee P, 2007, GENE EXPRESSION, V13, P283; Vagliasindi LI, 2011, DALTON T, V40, P2441, DOI 10.1039/c0dt01425g; Velayos JL, 2010, NEUROLOGIA, V25, P228, DOI 10.1016/j.nrl.2009.12.004; Viles JH, 2008, BIOCHEM SOC T, V36, P1288, DOI 10.1042/BST0361288; Wen Y, 2010, J BIOL CHEM, V285, P31682, DOI 10.1074/jbc.M110.118844; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831	56	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50370	10.1371/journal.pone.0050370	http://dx.doi.org/10.1371/journal.pone.0050370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209725	Green Submitted, Green Published, gold			2022-12-25	WOS:000312104900044
J	Lange, CPE; Campan, M; Hinoue, T; Schmitz, RF; van der Meulen-de Jong, AE; Slingerland, H; Kok, PJMJ; van Dijk, CM; Weisenberger, DJ; Shen, H; Tollenaar, RAEM; Laird, PW				Lange, Christopher P. E.; Campan, Mihaela; Hinoue, Toshinori; Schmitz, Roderick F.; van der Meulen-de Jong, Andrea E.; Slingerland, Hilde; Kok, Peter J. M. J.; van Dijk, Cornelis M.; Weisenberger, Daniel J.; Shen, Hui; Tollenaar, Robertus A. E. M.; Laird, Peter W.			Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal Cancer	PLOS ONE			English	Article							PROMOTER METHYLATION; NUCLEIC-ACIDS; SERUM; PLASMA; MARKER; CHALLENGES; GUIDELINES; DISEASE; GENES; SEPT9	Background: There is an increasing demand for accurate biomarkers for early non-invasive colorectal cancer detection. We employed a genome-scale marker discovery method to identify and verify candidate DNA methylation biomarkers for blood-based detection of colorectal cancer. Methodology/Principal Findings: We used DNA methylation data from 711 colorectal tumors, 53 matched adjacent-normal colonic tissue samples, 286 healthy blood samples and 4,201 tumor samples of 15 different cancer types. DNA methylation data were generated by the Illumina Infinium HumanMethylation27 and the HumanMethylation450 platforms, which determine the methylation status of 27,578 and 482,421 CpG sites respectively. We first performed a multistep marker selection to identify candidate markers with high methylation across all colorectal tumors while harboring low methylation in healthy samples and other cancer types. We then used pre-therapeutic plasma and serum samples from 107 colorectal cancer patients and 98 controls without colorectal cancer, confirmed by colonoscopy, to verify candidate markers. We selected two markers for further evaluation: methylated THBD (THBD-M) and methylated C9orf50 (C9orf50-M). When tested on clinical plasma and serum samples these markers outperformed carcinoembryonic antigen (CEA) serum measurement and resulted in a high sensitive and specific test performance for early colorectal cancer detection. Conclusions/Significance: Our systematic marker discovery and verification study for blood-based DNA methylation markers resulted in two novel colorectal cancer biomarkers, THBD-M and C9orf50-M. THBD-M in particular showed promising performance in clinical samples, justifying its further optimization and clinical testing.	[Campan, Mihaela; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Surg, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Hinoue, Toshinori; Weisenberger, Daniel J.; Shen, Hui; Laird, Peter W.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA USA; [Lange, Christopher P. E.; Schmitz, Roderick F.] Groene Hart Hosp, Dept Surg, Gouda, Netherlands; [Kok, Peter J. M. J.] Groene Hart Hosp, Dept Clin Chem, Gouda, Netherlands; [van Dijk, Cornelis M.] Groene Hart Hosp, Dept Pathol, Gouda, Netherlands; [Lange, Christopher P. E.; Tollenaar, Robertus A. E. M.] Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands; [van der Meulen-de Jong, Andrea E.; Slingerland, Hilde] Leiden Univ, Dept Gastroenterol & Hepatol, Med Ctr, Leiden, Netherlands	University of Southern California; University of Southern California; University of Southern California; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Laird, PW (corresponding author), Univ So Calif, Keck Sch Med, Dept Surg, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA.	plaird@usc.edu	Shen, Hui/AAO-4387-2020; Weisenberger, Daniel/AAA-8314-2020; Laird, Peter W/G-8683-2012; van der Meulen, Andrea/AAU-9430-2020	Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641; van der Meulen, Andrea/0000-0001-9353-5431; Shen, Hui/0000-0001-9767-4084	NATIONAL CANCER INSTITUTE [R01CA118699] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahlquist DA, 2011, CLINICAL GASTROENTER; Bast RC, 1996, J CLIN ONCOL, V14, P2843; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Bennett KL, 2010, GENE CHROMOSOME CANC, V49, P319, DOI 10.1002/gcc.20742; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Campan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028141; Campan Mihhaela, 2009, V507, P325, DOI 10.1007/978-1-59745-522-0_23; Cancer Genome Atlas Network, 2012, NATURE, V487, P330, DOI [DOI 10.1038/NATURE11252, 10.1038/nature11252]; Carvalho RH, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-9; Connolly D, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2924; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Devos T, 2009, CLIN CHEM, V30, P30; Duffy MJ, 2003, EUR J CANCER, V39, P718, DOI 10.1016/S0959-8049(02)00811-0; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Grady WM, 2001, CANCER RES, V61, P900; Herbst A, 2011, AM J GASTROENTEROL, V106, P1110, DOI 10.1038/ajg.2011.6; Herbst A, 2009, EUR J GASTROEN HEPAT, V21, P565, DOI 10.1097/MEG.0b013e328318ecf2; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Howlader N, 2012, SEER CANCER STATISTI; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kievit J, 2002, EUR J CANCER, V38, P986, DOI 10.1016/S0959-8049(02)00061-8; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Leung WK, 2005, AM J GASTROENTEROL, V100, P2274, DOI 10.1111/j.1572-0241.2005.50412.x; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Muller HM, 2003, EXPERT REV MOL DIAGN, V3, P443, DOI 10.1586/14737159.3.4.443; Nakayama H, 2003, INT J CANCER, V105, P491, DOI 10.1002/ijc.11117; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shin CM, 2010, CANCER SCI, V101, P1337, DOI 10.1111/j.1349-7006.2010.01535.x; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; Tang D, 2011, CLIN INVEST MED, V34, pE88; To EWH, 2003, CLIN CANCER RES, V9, P3254; Trinh BN, 2001, METHODS, V25, P456, DOI 10.1006/meth.2001.1268; Umetani N, 2006, ANN NY ACAD SCI, V1075, P299, DOI 10.1196/annals.1368.040; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zou HZ, 2002, CLIN CANCER RES, V8, P188	45	74	79	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50266	10.1371/journal.pone.0050266	http://dx.doi.org/10.1371/journal.pone.0050266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209692	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700049
J	Qin, C; Tan, KL; Zhang, CL; Tan, CY; Chen, YZ; Jiang, YY				Qin, Chu; Tan, Kai Leng; Zhang, Cun Long; Tan, Chun Yan; Chen, Yu Zong; Jiang, Yu Yang			What Does It Take to Synergistically Combine Sub-Potent Natural Products into Drug-Level Potent Combinations?	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; NETWORK PERSPECTIVES; SIGNALING PATHWAYS; CLINICAL-TRIALS; CANCER-THERAPY; IN-VITRO; SYNERGY; INHIBITOR; MECHANISMS; RESISTANCE	There have been renewed interests in natural products as drug discovery sources. In particular, natural product combinations have been extensively studied, clinically tested, and widely used in traditional, folk and alternative medicines. But opinions about their therapeutic efficacies vary from placebo to synergistic effects. The important questions are whether synergistic effects can sufficiently elevate therapeutic potencies to drug levels, and by what mechanisms and at what odds such combinations can be assembled. We studied these questions by analyzing literature-reported cell-based potencies of 190 approved anticancer and antimicrobial drugs, 1378 anticancer and antimicrobial natural products, 99 natural product extracts, 124 synergistic natural product combinations, and 122 molecular interaction profiles of the 19 natural product combinations with collective potency enhanced to drug level or by >10-fold. Most of the evaluated natural products and combinations are sub-potent to drugs. Sub-potent natural products can be assembled into combinations of drug level potency at low probabilities by distinguished multi-target modes modulating primary targets, their regulators and effectors, and intracellular bioavailability of the active natural products.	[Qin, Chu; Zhang, Cun Long; Tan, Chun Yan; Chen, Yu Zong; Jiang, Yu Yang] Tsinghua Univ, Dept Pharmacol & Pharmaceut Sci, Sch Med, Beijing 100084, Peoples R China; [Qin, Chu; Zhang, Cun Long; Tan, Chun Yan; Chen, Yu Zong; Jiang, Yu Yang] Tsinghua Univ, Minist Prov Jointly Constructed Base State Key La, Shenzhen 518057, Peoples R China; [Qin, Chu; Tan, Kai Leng; Chen, Yu Zong] Natl Univ Singapore, Bioinformat & Drug Design Grp, Dept Pharm, Singapore 117548, Singapore; [Qin, Chu; Tan, Kai Leng; Chen, Yu Zong] Natl Univ Singapore, Ctr Computat Sci & Engn, Singapore 117548, Singapore; [Qin, Chu] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	Tsinghua University; Tsinghua University; National University of Singapore; National University of Singapore; National University of Singapore	Chen, YZ (corresponding author), Tsinghua Univ, Dept Pharmacol & Pharmaceut Sci, Sch Med, Beijing 100084, Peoples R China.	phacyz@nus.edu.sg; Jiangyy@sz.tsinghua.edu.cn	Tan, Chunyan/F-2785-2012; jiang, yu/HGU-0029-2022	Tan, Chunyan/0000-0002-4263-2175; Chen, Yu Zong/0000-0002-5473-8022	Ministry of Science and Technology of China [2012ZX09506001-010, 2012CB722605]; National Natural Science Foundation of China [21272134]; Academic Research Fund, Singapore [R-148-000-141-750]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Research Fund, Singapore(Ministry of Education, Singapore)	The authors acknowledge support from The Ministry of Science and Technology of China (2012ZX09506001-010 and 2012CB722605), The National Natural Science Foundation of China (21272134) and Academic Research Fund, Singapore (R-148-000-141-750). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bausell RB, 2009, EVAL HEALTH PROF, V32, P349, DOI 10.1177/0163278709346810; Carvalho-Netto EF, 2006, PHARMACOL BIOCHEM BE, V85, P140, DOI 10.1016/j.pbb.2006.07.022; Chiu PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031648; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cochrane Zara Risoldi, 2011, Journal of Dietary Supplements, V8, P135, DOI 10.3109/19390211.2011.561823; Cordell GA, 2012, J NAT PROD, V75, P514, DOI 10.1021/np200803m; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Dancey JE, 2006, NAT REV DRUG DISCOV, V5, P649, DOI 10.1038/nrd2089; Dinan L, 2001, CELL MOL LIFE SCI, V58, P321, DOI 10.1007/PL00000859; Efferth T, 2010, PLANTA MED, V76, P1143, DOI 10.1055/s-0030-1249937; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; FANTIN B, 1991, ANTIMICROB AGENTS CH, V35, P1413, DOI 10.1128/AAC.35.7.1413; Georgakis GV, 2006, EXP HEMATOL, V34, P1670, DOI 10.1016/j.exphem.2006.07.002; Gertsch J, 2011, PLANTA MED, V77, P1086, DOI 10.1055/s-0030-1270904; Harvey AL, 2010, PLANTA MED, V76, P1080, DOI 10.1055/s-0030-1250162; Hayashi K, 2010, J NAT MED-TOKYO, V64, P70, DOI 10.1007/s11418-009-0375-z; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Junio HA, 2011, J NAT PROD, V74, P1621, DOI 10.1021/np200336g; Kaiser J, 2011, SCIENCE, V331, P1542, DOI 10.1126/science.331.6024.1542; Kassouf W, 2005, CANCER RES, V65, P10524, DOI 10.1158/0008-5472.CAN-05-1536; Kim HS, 2007, P NATL ACAD SCI USA, V104, P19387, DOI 10.1073/pnas.0708194104; Kumar N, 2008, MOL PHARM; LARDER BA, 1995, SCIENCE, V269, P696, DOI 10.1126/science.7542804; Lewith GT, 2002, AM J PUBLIC HEALTH, V92, P1604, DOI 10.2105/AJPH.92.10.1604; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; [李丽静 LI Lijing], 2005, [中国中医基础医学杂志, Chinese Journal of Basic Medicine in Traditional Chinese Medicine], V11, P585; Ma XH, 2009, DRUG DISCOV TODAY, V14, P579, DOI 10.1016/j.drudis.2009.03.012; MACINDOE JH, 1982, CANCER RES, V42, P3378; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Muller R, 2004, J CANCER RES CLIN, V130, P429, DOI 10.1007/s00432-004-0570-y; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Quach H, 2010, LEUKEMIA, V24, P22, DOI 10.1038/leu.2009.236; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shabbir M, 2008, ONCOL REP, V19, P831; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Sivachenko Andrey, 2006, Curr Drug Discov Technol, V3, P269, DOI 10.2174/157016306780368117; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Staud R, 2011, RHEUM DIS CLIN N AM, V37, P9, DOI 10.1016/j.rdc.2010.11.009; Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597; Tabernero J, 2008, J CLIN ONCOL; Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9; Tong Xiaolin, 2004, J Tradit Chin Med, V24, P266; Wagner H, 2011, FITOTERAPIA, V82, P34, DOI 10.1016/j.fitote.2010.11.016; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037; Xiong H, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-9; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; ZHANG GG, 2005, J ALTERN COMPLEM MED, V11, P415; Zhou XueMeng, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P1351; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zhu F, 2011, P NATL ACAD SCI USA, V108, P12943, DOI 10.1073/pnas.1107336108; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	60	16	16	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49969	10.1371/journal.pone.0049969	http://dx.doi.org/10.1371/journal.pone.0049969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209627	Green Submitted, gold, Green Published			2022-12-25	WOS:000312601700030
J	Shin, JY; Ahn, YH; Paik, MJ; Park, HJ; Sohn, YH; Lee, PH				Shin, Jin Young; Ahn, Young-Hwan; Paik, Man-Jeong; Park, Hyun Jung; Sohn, Young H.; Lee, Phil Hyu			Elevated Homocysteine by Levodopa Is Detrimental to Neurogenesis in Parkinsonian Model	PLOS ONE			English	Article							SIGNAL-REGULATED KINASE; NMDA RECEPTOR; SUBVENTRICULAR ZONE; RAT HIPPOCAMPUS; DENTATE GYRUS; ADULT BRAIN; IN-VITRO; L-DOPA; DISEASE; NEURONS	Background: Modulation of neurogenesis that acts as an endogenous repair mechanism would have a significant impact on future therapeutic strategies for Parkinson's disease (PD). Several studies demonstrated dopaminergic modulation of neurogenesis in the subventricular zone (SVZ) of the adult brain. Levodopa, the gold standard therapy for PD, causes an increase in homocysteine levels that induces neuronal death via N-methyl-D-aspartate (NMDA) receptor. The present study investigated whether elevated homocysteine by levodopa treatment in a parkinsonian model would modulate neurogenesis via NMDA receptor signal cascade and compared the effect of levodopa and pramipexol (PPX) on neurogenic activity. Methodology/Principal Findings: Neurogenesis was assessed in vitro using neural progenitor cells (NPCs) isolated from the SVZ and in vivo with the BrdU-injected animal model of PD using 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Modulation of homocysteine levels was evaluated using co-cultures of NPCs and astrocytes and PD animals. Immunochemical and Western blot analyses were used to measure neurogenesis and determine the cell death signaling. Levodopa treatment increased release of homocysteine on astrocytes culture media as well as in plasma and brain of PD animals. Increased homocysteine by levodopa led to increased apoptosis of NPCs through the NMDA receptor-dependent the extracellular signal-regulated kinase (ERK) signaling pathways. The administration of a NMDA antagonist significantly attenuated apoptotic cell death in levodopa-treated NPCs and markedly increased the number of BrdU-positive cells in the SVZ of levodopa-treated PD animals. Comparative analysis revealed that PPX treatment significantly increased the number of NPCs and BrdU-positive cells in the SVZ of PD animals compared to levodopa treatment. Our present study demonstrated that increased homocysteine by levodopa has a detrimental effect on neurogenesis through NMDA receptor-mediated ERK signaling pathway. Conclusions/Significance: Modulation of levodopa-induced elevated homocysteine by NMDA antagonist or dopamine agonist has a clinical relevance for PD treatment in terms of adult neurogenesis.	[Shin, Jin Young; Park, Hyun Jung; Sohn, Young H.; Lee, Phil Hyu] Yonsei Univ, Coll Med, Brain Res Inst, Seoul, South Korea; [Ahn, Young-Hwan] Ajou Univ, Sch Med, Dept Neurosurg, Suwon 441749, South Korea; [Paik, Man-Jeong] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Park, Hyun Jung; Lee, Phil Hyu] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Ajou University; Ajou University; Yonsei University	Lee, PH (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	phisland@chol.net		Sohn, Young H./0000-0001-6533-2610; Lee, Phil Hyu/0000-0001-9931-8462	Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A091159]	Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A091159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdipranoto A, 2008, CNS NEUROL DISORD-DR, V7, P187, DOI 10.2174/187152708784083858; Anderson DW, 2001, BRAIN RES, V905, P44, DOI 10.1016/S0006-8993(01)02466-0; Brazel CY, 2005, NEUROSCIENCE, V131, P55, DOI 10.1016/j.neuroscience.2004.10.038; BUTELMAN ER, 1991, BEHAV PHARMACOL, V2, P79; Cacciapuoti F, 2011, J THROMB THROMBOLYS, V32, P82, DOI 10.1007/s11239-011-0550-4; Crews L, 2008, J NEUROSCI, V28, P4250, DOI 10.1523/JNEUROSCI.0066-08.2008; Deierborg T, 2008, PROG NEUROBIOL, V85, P407, DOI 10.1016/j.pneurobio.2008.05.001; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1422, DOI 10.1001/archneur.57.10.1422; Geraerts M, 2007, STEM CELLS, V25, P263, DOI 10.1634/stemcells.2006-0364; Haddad JJ, 2005, PROG NEUROBIOL, V77, P252, DOI 10.1016/j.pneurobio.2005.10.008; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Hu M, 2008, J NEUROCHEM, V106, P1900, DOI 10.1111/j.1471-4159.2008.05554.x; Hu M, 2009, EUR J PHARMACOL, V622, P37, DOI 10.1016/j.ejphar.2009.09.031; Jara-Prado A, 2003, NEUROTOX RES, V5, P237, DOI 10.1007/BF03033381; Jenner P, 2002, NEUROLOGY, V58, pS1, DOI 10.1212/WNL.58.suppl_1.S1; Jiang Q, 2000, BRAIN RES, V887, P285, DOI 10.1016/S0006-8993(00)03003-1; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Kralic JE, 2005, EUR J NEUROSCI, V22, P1916, DOI 10.1111/j.1460-9568.2005.04386.x; Kruman II, 2000, J NEUROSCI, V20, P6920, DOI 10.1523/JNEUROSCI.20-18-06920.2000; Lee ESY, 2005, NEUROTOXICOLOGY, V26, P945, DOI 10.1016/j.neuro.2005.04.005; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Mori Mayra, 2008, J Neurosci, V28, P5867, DOI 10.1523/JNEUROSCI.1782-08.2008; Muller T, 2004, ARCH NEUROL-CHICAGO, V61, P657, DOI 10.1001/archneur.61.5.657; Murer MG, 1998, ANN NEUROL, V43, P561, DOI 10.1002/ana.410430504; Nacher J, 2007, NEUROSCIENCE, V144, P855, DOI 10.1016/j.neuroscience.2006.10.021; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Nakaso K, 2003, J NEUROL SCI, V207, P19, DOI 10.1016/S0022-510X(02)00353-2; O'Keeffe GC, 2009, CELL CYCLE, V8, P2888, DOI 10.4161/cc.8.18.9512; O'Sullivan SS, 2011, MOVEMENT DISORD, V26, P45, DOI 10.1002/mds.23340; Poddar R, 2009, J NEUROCHEM, V110, P1095, DOI 10.1111/j.1471-4159.2009.06207.x; Postuma RB, 2004, NEUROLOGY, V63, P886, DOI 10.1212/01.WNL.0000137886.74175.5A; Rabaneda LG, 2008, FASEB J, V22, P3823, DOI 10.1096/fj.08-109306; Robert K, 2005, NEUROSCIENCE, V133, P925, DOI 10.1016/j.neuroscience.2005.03.034; Rogers JD, 2003, ARCH NEUROL-CHICAGO, V60, P59, DOI 10.1001/archneur.60.1.59; saller Charles F, 1986, J PHARM EXPT THERAPE, V236, P714; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Shepherd KR, 2006, PHARMACOL BIOCHEM BE, V83, P349, DOI 10.1016/j.pbb.2006.02.013; Sun LX, 2000, SYNAPSE, V35, P212, DOI 10.1002/(SICI)1098-2396(20000301)35:3<212::AID-SYN6>3.0.CO;2-O; Tjiattas L, 2004, AGING CELL, V3, P71, DOI 10.1111/j.1474-9728.2004.00086.x; Van Kampen JM, 2006, J NEUROSCI, V26, P7272, DOI 10.1523/JNEUROSCI.0837-06.2006; Wegner F, 2009, J NEUROCHEM, V111, P204, DOI 10.1111/j.1471-4159.2009.06315.x; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Winner B, 2009, EXP NEUROL, V219, P543, DOI 10.1016/j.expneurol.2009.07.013; Yong SW, 2010, PARKINSONISM RELAT D, V16, P225, DOI 10.1016/j.parkreldis.2009.09.003; Zoccolella S, 2010, CURR MED CHEM, V17, P213, DOI 10.2174/092986710790149774	46	13	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50496	10.1371/journal.pone.0050496	http://dx.doi.org/10.1371/journal.pone.0050496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209759	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700076
J	Pilatova, M; Dionne, MS				Pilatova, Martina; Dionne, Marc S.			Burkholderia thailandensis Is Virulent in Drosophila melanogaster	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA INFECTION; ACTIN-BASED MOTILITY; MODEL HOST; CELLULAR-IMMUNITY; RISK-FACTORS; PSEUDOMALLEI; MELIOIDOSIS; MALLEI; GENES; IDENTIFICATION	Melioidosis is a serious infectious disease endemic to Southeast Asia and Northern Australia. This disease is caused by the Gram-negative bacterium Burkholderia pseudomallei; Burkholderia thailandensis is a closely-related organism known to be avirulent in humans. B. thailandensis has not previously been used to infect Drosophila melanogaster. We examined the effect of B. thailandensis infection on fly survival, on antimicrobial peptide expression, and on phagocytic cells. In the fruit fly, which possesses only an innate immune system, B. thailandensis is highly virulent, causing rapid death when injected or fed. One intriguing aspect of this infection is its temperature dependence: infected flies maintained at 25 degrees C exhibit rapid bacterial proliferation and death in a few days, while infected animals maintained at 18 degrees C exhibit very slow bacterial proliferation and take weeks to die; this effect is due in part to differences in immune activity of the host. Death in this infection is likely due at least in part to a secreted toxin, as injection of flies with sterile B. thailandensis-conditioned medium is able to kill. B. thailandensis infection strongly induces the expression of antimicrobial peptides, but this is insufficient to inhibit bacterial proliferation in infected flies. Finally, the function of fly phagocytes is not affected by B. thailandensis infection. The high virulence of B. thailandensis in the fly suggests the possibility that this organism is a natural pathogen of one or more invertebrates.	[Pilatova, Martina; Dionne, Marc S.] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, Dept Immunobiol, DIIID,Sch Med, London WC2R 2LS, England; [Pilatova, Martina] Kings Coll London, Sch Med, Inst Dent, Dept Craniofacial Dev, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Dionne, MS (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, Dept Immunobiol, DIIID,Sch Med, London WC2R 2LS, England.	marc.dionne@kcl.ac.uk	Dionne, Marc/J-2572-2013	Dionne, Marc/0000-0002-8283-1750	King's College London Dental Institute; Wellcome Trust; BBSRC [BB/E02128X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E02128X/1] Funding Source: researchfish	King's College London Dental Institute; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a PhD studentship from the King's College London Dental Institute and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2009, NAT PROTOC, V4, P1285, DOI 10.1038/nprot.2009.124; Avet-Rochex A, 2005, CELL MICROBIOL, V7, P799, DOI 10.1111/j.1462-5822.2005.00512.x; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; Brett PJ, 1997, EPIDEMIOL INFECT, V118, P137, DOI 10.1017/S095026889600739X; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Castonguay-Vanier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011467; Chamilos G, 2008, P NATL ACAD SCI USA, V105, P9367, DOI 10.1073/pnas.0709578105; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cho YS, 2005, GENOMICS, V86, P606, DOI 10.1016/j.ygeno.2005.07.007; Currie BJ, 2000, ACTA TROP, V74, P121, DOI 10.1016/S0001-706X(99)00060-1; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Glass MB, 2006, J CLIN MICROBIOL, V44, P4601, DOI 10.1128/JCM.01585-06; Haase A, 1997, J MED MICROBIOL, V46, P557, DOI 10.1099/00222615-46-7-557; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Haussler S, 1998, INFECT IMMUN, V66, P1588; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kim HS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-174; Lertpatanasuwan N, 1999, CLIN INFECT DIS, V28, P927, DOI 10.1086/517253; Limmer S, 2011, P NATL ACAD SCI USA, V108, P17378, DOI 10.1073/pnas.1114907108; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mansfield BE, 2003, CELL MICROBIOL, V5, P901, DOI 10.1046/j.1462-5822.2003.00329.x; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; Pilatz S, 2006, INFECT IMMUN, V74, P3576, DOI 10.1128/IAI.01262-05; Ranz JM, 2001, GENOME RES, V11, P230, DOI 10.1101/gr.162901; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Sarkar-Tyson M, 2009, VACCINE, V27, P4447, DOI 10.1016/j.vaccine.2009.05.040; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Schweizer HP, 2008, EMERG INFECT DIS, V14, P1689, DOI [10.3201/eid1411.080431, 10.3201/eid1407.071501]; SMITH MD, 1995, T ROY SOC TROP MED H, V89, P488, DOI 10.1016/0035-9203(95)90078-0; Stevens JM, 2005, J BACTERIOL, V187, P7857, DOI 10.1128/JB.187.22.7857-7862.2005; Stevens MP, 2005, MOL MICROBIOL, V56, P40, DOI 10.1111/j.1365-2958.2004.04528.x; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; VANDEURS B, 1987, EXP CELL RES, V171, P137, DOI 10.1016/0014-4827(87)90257-6; VORACHIT M, 1993, ANTIMICROB AGENTS CH, V37, P2000, DOI 10.1128/AAC.37.9.2000; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2008, CELL MICROBIOL, V10, P81, DOI 10.1111/j.1462-5822.2007.01016.x; Yu YT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-46	46	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49745	10.1371/journal.pone.0049745	http://dx.doi.org/10.1371/journal.pone.0049745			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209596	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885800021
J	Desselle, A; Chaumette, T; Gaugler, MH; Cochonneau, D; Fleurence, J; Dubois, N; Hulin, P; Aubry, J; Birkle, S; Paris, F				Desselle, Ariane; Chaumette, Tanguy; Gaugler, Marie-Helene; Cochonneau, Denis; Fleurence, Julien; Dubois, Nolwenn; Hulin, Philippe; Aubry, Jacques; Birkle, Stephane; Paris, Francois			Anti-Gb3 Monoclonal Antibody Inhibits Angiogenesis and Tumor Development	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; HEMOLYTIC-UREMIC SYNDROME; FATTY-ACID CONTENT; CENTER B-CELLS; SHIGA TOXIN; INDUCED APOPTOSIS; IN-VITRO; RECEPTOR; ANTIGEN; GANGLIOSIDES	Inhibiting the growth of tumor vasculature represents one of the relevant strategies against tumor progression. Between all the different pro-angiogenic molecular targets, plasma membrane glycosphingolipids have been under-investigated. In this present study, we explore the anti-angiogenic therapeutic advantage of a tumor immunotherapy targeting the globotriaosylceramide Gb3. In this purpose, a monoclonal antibody against Gb3, named 3E2 was developed and characterized. We first demonstrate that Gb3 is over-expressed in proliferative endothelial cells relative to quiescent cells. Then, we demonstrate that 3E2 inhibits endothelial cell proliferation in vitro by slowing endothelial cell proliferation and by increasing mitosis duration. Antibody 3E2 is further effective in inhibiting ex vivo angiogenesis in aorta ring assays. Moreover, 3E2 treatment inhibits NXS2 neuroblastoma development and liver metastases spreading in A/J mice. Immunohistology examination of the NXS2 metastases shows that only endothelial cells, but not cancer cells express Gb3. Finally, 3E2 treatment diminishes tumor vessels density, proving a specific therapeutic action of our monoclonal antibody to tumor vasculature. Our study demonstrates that Gb3 is a viable alternative target for immunotherapy and angiogenesis inhibition.	[Desselle, Ariane; Chaumette, Tanguy; Gaugler, Marie-Helene; Cochonneau, Denis; Fleurence, Julien; Dubois, Nolwenn; Aubry, Jacques; Birkle, Stephane; Paris, Francois] INSERM, UMR892, Nantes, France; [Desselle, Ariane; Chaumette, Tanguy; Gaugler, Marie-Helene; Cochonneau, Denis; Fleurence, Julien; Dubois, Nolwenn; Aubry, Jacques; Birkle, Stephane; Paris, Francois] Univ Nantes, UFR Sci Pharmaceut & Biol, Nantes, France; [Desselle, Ariane; Chaumette, Tanguy; Gaugler, Marie-Helene; Cochonneau, Denis; Fleurence, Julien; Dubois, Nolwenn; Aubry, Jacques; Birkle, Stephane; Paris, Francois] CNRS, UMR 6299, Nantes, France; [Gaugler, Marie-Helene] Inst Radioprotect & Surete Nucl, Fontenay Aux Roses, France; [Hulin, Philippe] SFR Sante UMS 016, Nantes, France; [Dubois, Nolwenn; Paris, Francois] Inst Cancerol Ouest, St Herblain, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Paris, F (corresponding author), INSERM, UMR892, Nantes, France.	francois.paris@inserm.fr	Gaugler, Marie-Helene/M-5377-2015; Chaumette, Tanguy/C-4219-2019; Paris, francois E/L-4915-2015	Gaugler, Marie-Helene/0000-0003-2932-9443; Paris, francois E/0000-0002-0176-7348; Chaumette, Tanguy/0000-0002-5830-8767	La Ligue Nationale Contre le Cancer; Fondation de l'Universite de Nantes (Aair Lichens)	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation de l'Universite de Nantes (Aair Lichens)	The present work was supported by La Ligue Nationale Contre le Cancer and the Fondation de l'Universite de Nantes (Aair Lichens). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Rueda N, 2007, CLIN CANCER RES, V13, p5613S, DOI 10.1158/1078-0432.CCR-07-1057; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025220; Arab S, 1997, ONCOL RES, V9, P553; Argraves KM, 2004, J BIOL CHEM, V279, P50580, DOI 10.1074/jbc.M404432200; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Binnington B, 2002, NEUROCHEM RES, V27, P807, DOI 10.1023/A:1020261125008; Birkle S, 2003, BIOCHIMIE, V85, P455, DOI 10.1016/S0300-9084(03)00006-3; Bonnaud S, 2007, CANCER RES, V67, P1803, DOI 10.1158/0008-5472.CAN-06-2802; Chlenski A, 2003, CANCER LETT, V197, P47, DOI 10.1016/S0304-3835(03)00082-X; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; Distler U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006813; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gaugler MH, 2007, RADIAT RES, V167, P185, DOI 10.1667/RR0702.1; GILLARD BK, 1987, ARCH BIOCHEM BIOPHYS, V256, P435, DOI 10.1016/0003-9861(87)90600-X; Heath-Engel Hannah M., 2003, Angiogenesis, V6, P129, DOI 10.1023/B:AGEN.0000011799.47529.fd; Irie RF, 2004, CANCER IMMUNOL IMMUN, V53, P110, DOI 10.1007/s00262-003-0436-1; Ishitoya S, 2004, J UROLOGY, V171, P1309, DOI 10.1097/01.ju.0000100110.11129.85; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kanda T, 2004, J NEUROSCI RES, V78, P141, DOI 10.1002/jnr.20228; KANNAGI R, 1982, J BIOL CHEM, V257, P4438; KAYE SA, 1993, INFECT IMMUN, V61, P3886, DOI 10.1128/IAI.61.9.3886-3891.1993; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kolmakova A, 2009, GLYCOCONJUGATE J, V26, P547, DOI 10.1007/s10719-008-9206-9; Kondo Y, 2011, GLYCOCONJUGATE J, V28, P371, DOI 10.1007/s10719-011-9335-4; KORELITZ BI, 1975, AM J GASTROENTEROL, V64, P365; LaCasse EC, 1999, BLOOD, V94, P2901; Ladisch S, 2000, METHOD ENZYMOL, V312, P135; LINGWOOD CA, 1994, NEPHRON, V66, P21, DOI 10.1159/000187761; Lingwood CA, 1999, BIOSCIENCE REP, V19, P345, DOI 10.1023/A:1020299819637; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lode HN, 1999, P NATL ACAD SCI USA, V96, P1591, DOI 10.1073/pnas.96.4.1591; Ludwig K, 2001, J CLIN MICROBIOL, V39, P2272, DOI 10.1128/JCM.39.6.2272-2279.2001; Malyukova I, 2009, AM J PHYSIOL-GASTR L, V296, pG78, DOI 10.1152/ajpgi.90347.2008; MANGENEY M, 1991, EUR J IMMUNOL, V21, P1131, DOI 10.1002/eji.1830210507; Marcato P, 2002, INFECT IMMUN, V70, P1279, DOI 10.1128/IAI.70.3.1279-1286.2002; MURRAY JL, 1994, J CLIN ONCOL, V12, P184, DOI 10.1200/JCO.1994.12.1.184; MURRAY LJ, 1985, INT J CANCER, V36, P561, DOI 10.1002/ijc.2910360508; Muthing J, 1999, GLYCOBIOLOGY, V9, P459, DOI 10.1093/glycob/9.5.459; NUDELMAN E, 1983, SCIENCE, V220, P509, DOI 10.1126/science.6836295; Oancea Marcela, 2006, V129, P279; OBRIG TG, 1988, INFECT IMMUN, V56, P2373, DOI 10.1128/IAI.56.9.2373-2378.1988; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; PELLIZZARI A, 1992, BIOCHEMISTRY-US, V31, P1363, DOI 10.1021/bi00120a011; Reymond D, 1996, J CLIN MICROBIOL, V34, P2053, DOI 10.1128/JCM.34.9.2053-2057.1996; RUMPOLD H, 1981, IMMUNOLOGY, V43, P161; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; Sugawara S, 2009, BBA-GEN SUBJECTS, V1790, P101, DOI 10.1016/j.bbagen.2008.10.005; SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x; Tagawa Y, 2002, NEUROCHEM RES, V27, P847, DOI 10.1023/A:1020221410895; Tetaud C, 2003, J BIOL CHEM, V278, P45200, DOI 10.1074/jbc.M303868200; Viel T, 2008, MOL IMAGING, V7, P239, DOI 10.2310/7290.2008.00022; Vollmers HP, 2005, METHOD FIND EXP CLIN, V27, P185, DOI 10.1358/mf.2005.27.3.890876; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zachary I, 2003, BIOCHEM SOC T, V31, P1171	56	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e45423	10.1371/journal.pone.0045423	http://dx.doi.org/10.1371/journal.pone.0045423			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189121	Green Submitted, gold, Green Published			2022-12-25	WOS:000311929800002
J	Zha, BB; Wang, LM; Liu, XM; Liu, J; Chen, ZP; Xu, J; Sheng, L; Li, YM; Chu, YW				Zha, Bingbing; Wang, Luman; Liu, Xiaoming; Liu, Jun; Chen, Zaoping; Xu, Jiong; Sheng, Li; Li, Yiming; Chu, Yiwei			Decrease in Proportion of CD19(+)CD24(hi)CD27(+) B Cells and Impairment of Their Suppressive Function in Graves' Disease	PLOS ONE			English	Article							REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; B10 CELLS; LYMPHOCYTE DEPLETION; THYROID-DISEASE; IN-VITRO; ANTIBODY; THERAPY; MICE; OPHTHALMOPATHY	IL-10-producing B cells (B10 cells) have been shown to play a suppressive role in the peripheral blood of humans, with their numbers and function altered in several autoimmune diseases. However, the role of B10 cells in Graves' disease (GD) remains unknown. In this study, we demonstrated that B10 cells in human peripheral blood belonged to a CD24(hi)CD27(+)B cell subpopulation. The proportion of B10 cells along with the CD19(+)CD24(hi)CD27(+) B cell subset was significantly lower in new-onset patients compared with healthy individuals. In recovered patients, these proportions were restored to levels similar to those seen in healthy individuals. Additionally, we found that CD19(+)CD24(hi)CD27(+) B cells from healthy individuals inhibited proliferation and TNF-alpha production of CD4(+) T cells via an IL-10-independent pathway. They also inhibited IFN-gamma production by CD4(+) T cells, through an IL-10-dependent pathway. In contrast, their suppressive function on CD4(+) T cell proliferation and cytokine production was impaired in new-onset and recovered patients compared with healthy individuals. Our study provides evidence that CD19(+)CD24(hi)CD27(+) B cells may possess the capacity to downregulate immune responses, partially by production of IL-10 in human peripheral blood. Impairment of their immunosuppressive function may contribute to GD pathogenesis and relapse.	[Zha, Bingbing; Li, Yiming] Fudan Univ, Dept Endocrinol & Metab, Huashan Hosp, Shanghai 200433, Peoples R China; [Wang, Luman; Liu, Xiaoming; Chu, Yiwei] Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Wang, Luman; Liu, Xiaoming; Chu, Yiwei] Fudan Univ, Biotherapy Res Ctr, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zha, Bingbing; Liu, Jun; Chen, Zaoping; Xu, Jiong; Sheng, Li] Fudan Univ, Dept Endocrinol & Metab, Shanghai Peoples Hosp 5, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Li, YM (corresponding author), Fudan Univ, Dept Endocrinol & Metab, Huashan Hosp, Shanghai 200433, Peoples R China.	yimingli@fudan.edu.cn; yiwei_chu@126.com			National Science Foundation in China [81072408]; Science and Technology Commission of Shanghai Municipality in China [10JC1401100]; National 973 project in China [2011CB910404]	National Science Foundation in China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality in China(Science & Technology Commission of Shanghai Municipality (STCSM)); National 973 project in China(National Basic Research Program of China)	This work was supported by: 1) National Science Foundation in China (81072408) (http://www.nsfc.gov.cn/); 2) The Science and Technology Commission of Shanghai Municipality in China (10JC1401100) (http://www.stcsm.gov.cn/structure/index.htm); 3) The National 973 project in China (2011CB910404) (http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 1997, EUR J IMMUNOL, V27, P2073, DOI 10.1002/eji.1830270835; Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Banga JP, 2008, THYROID, V18, P973, DOI 10.1089/thy.2007.0406; Bayry J, 2005, J IMMUNOL, V175, P15, DOI 10.4049/jimmunol.175.1.15; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; Chen XJ, 2007, J IMMUNOL, V179, P2046, DOI 10.4049/jimmunol.179.4.2046; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; El Fassi D, 2007, J CLIN ENDOCR METAB, V92, P1769, DOI 10.1210/jc.2006-2388; El Fassi D, 2006, EUR J ENDOCRINOL, V154, P623, DOI 10.1530/eje.1.02140; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; Gonnella PA, 2001, J IMMUNOL, V166, P4456, DOI 10.4049/jimmunol.166.7.4456; Hussain S, 2007, J IMMUNOL, V179, P7225, DOI 10.4049/jimmunol.179.11.7225; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Kalergis AM, 2002, J EXP MED, V195, P1653, DOI 10.1084/jem.20020338; Kirkland D, 2012, IMMUNITY, V36, P228, DOI 10.1016/j.immuni.2011.11.019; Lehmann-Horn K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-146; Lemoine S, 2011, J AUTOIMMUN, V36, P228, DOI 10.1016/j.jaut.2011.01.005; Marazuela M, 2006, J CLIN ENDOCR METAB, V91, P3639, DOI 10.1210/jc.2005-2337; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mizoguchi E, 2000, INT IMMUNOL, V12, P597, DOI 10.1093/intimm/12.5.597; Nielsen CH, 2007, EXPERT OPIN BIOL TH, V7, P1061, DOI 10.1517/14712598.7.7.1061; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; Pan DS, 2009, CLIN ENDOCRINOL, V71, P587, DOI 10.1111/j.1365-2265.2009.03544.x; Parekh VV, 2003, J IMMUNOL, V170, P5897, DOI 10.4049/jimmunol.170.12.5897; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Rapoport B, 2007, THYROID, V17, P911, DOI 10.1089/thy.2007.0170; Ray A, 2012, J IMMUNOL, V188, P3188, DOI 10.4049/jimmunol.1103354; Rehnberg M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2789; Ren XF, 2011, J NEUROSCI, V31, P8556, DOI 10.1523/JNEUROSCI.1623-11.2011; Sfikakis PP, 2005, ARTHRITIS RHEUM-US, V52, P501, DOI 10.1002/art.20858; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Sun JB, 2012, J IMMUNOL, V188, P1686, DOI 10.4049/jimmunol.1101771; Tedder TF, 2010, J ALLERGY CLIN IMMUN, V125, P1125, DOI 10.1016/j.jaci.2010.03.024; Weetman AP, 2004, AUTOIMMUNITY, V37, P337, DOI 10.1080/08916930410001705394; WEETMAN AP, 1990, J CLIN INVEST, V86, P723, DOI 10.1172/JCI114768; Wilson MS, 2010, EUR J IMMUNOL, V40, P1682, DOI 10.1002/eji.200939721; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yanaba K, 2011, AM J PATHOL, V178, P735, DOI 10.1016/j.ajpath.2010.10.022	44	55	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49835	10.1371/journal.pone.0049835	http://dx.doi.org/10.1371/journal.pone.0049835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189166	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800043
J	Huang, YX; Zhao, XY; Zhou, DW; Zhang, HX; Zheng, W				Huang, Yingxin; Zhao, Xueyong; Zhou, Daowei; Zhang, Hongxiang; Zheng, Wei			Phenotypic Plasticity of Early and Late Successional Forbs in Response to Shifts in Resources	PLOS ONE			English	Article							HORQIN SANDY LAND; EASTERN INNER-MONGOLIA; AGRIOPHYLLUM-SQUARROSUM; REPRODUCTIVE EFFORT; SOIL PROPERTIES; CARAGANA-MICROPHYLLA; POLYGONUM-PERSICARIA; POPULATION-DENSITY; WIND EROSION; GROWTH	We compared the phenotypic plasticity of two early successional forbs of nutrient-poor mobile dunes (Agriophyllum squarrosum and Corispermum macrocarpum) and two later successional forbs (weeds) of stabilized, higher nutrient dunes and cropland (Chenopodium acuminatum and Salsola collina) to variations in environmental factors. A controlled (including soil nutrients, water, and population density) greenhouse experiment was conducted in Horqin sandy land, China. Late successional species had high plasticity in growth response to nutrients and water or high performance in high soil nutrients and water, reflecting their higher nutrient habitat. In contrast, the early successional species have low plasticity, reflecting their adaptation to resource-poor early successional soil. Late successional species did not always have higher reproductive effort than early successional species. Plants did not have a uniform strategy of increasing reproductive effort with any environmental stressors. Reproductive effort increased with increasing water availability and decreasing nutrient levels, while density had no effect. Patterns of plasticity traits for late successional species exhibited a complex of Master-of-some and Jack-of-all-trades. Late successional species had higher performance or higher plasticity than early successional species.	[Huang, Yingxin; Zhou, Daowei; Zhang, Hongxiang; Zheng, Wei] Chinese Acad Sci, NE Inst Geog & Agroecol, Changchun, Peoples R China; [Zhao, Xueyong] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS	Huang, YX (corresponding author), Chinese Acad Sci, NE Inst Geog & Agroecol, Changchun, Peoples R China.	huangyx@neigae.ac.cn	Zhang, Hongxiang/GMW-5541-2022		Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-EW-QN315]; National Science Foundation of China [31000216]; Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences [KZCX3-SW-NA09-]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by the Knowledge Innovation Program of the Chinese Academy of Sciences (NO. KZCX2-EW-QN315), the National Science Foundation of China (31000216), and Northeast Institute of Geography and Agroecology, Chinese Academy of Sciences (KZCX3-SW-NA09-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON WG, 1973, AM NAT, V107, P651, DOI 10.1086/282864; Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; [Anonymous], 1986, ECOLOGY BIOL INVASIO; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; Bouvet JM, 2005, ANN BOT-LONDON, V96, P811, DOI 10.1093/aob/mci231; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; Coleman JS, 1995, FUNCT ECOL, V9, P951; Dechaine JM, 2007, NEW PHYTOL, V176, P874, DOI 10.1111/j.1469-8137.2007.02210.x; Dorken ME, 2004, J ECOL, V92, P32, DOI 10.1111/j.1365-2745.2004.00857.x; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; Durand LZ, 2001, OECOLOGIA, V126, P345, DOI 10.1007/s004420000535; Elberse IAM, 2003, J ECOL, V91, P371, DOI 10.1046/j.1365-2745.2003.00776.x; Falster D. S., 2006, SMATR STANDARDISED M; FICHTNER K, 1992, OECOLOGIA, V92, P236, DOI 10.1007/BF00317370; Funk JL, 2008, J ECOL, V96, P1162, DOI 10.1111/j.1365-2745.2008.01435.x; Guo K., 2000, ACTA ECOL SIN, V24, P275; Haeberli W, 1998, AMBIO, V27, P258; HARTNETT DC, 1990, OECOLOGIA, V84, P254, DOI 10.1007/BF00318281; Hawkes CV, 2007, AM NAT, V170, P832, DOI 10.1086/522842; HICKMAN JC, 1977, J ECOL, V65, P317, DOI 10.2307/2259080; Huang YX, 2010, BOTANY, V88, P13, DOI 10.1139/B09-095; Huang YX, 2009, NORD J BOT, V27, P539, DOI 10.1111/j.1756-1051.2009.00382.x; Huang YX, 2009, ECOL RES, V24, P1335, DOI 10.1007/s11284-009-0615-4; Huang YX, 2009, J PLANT BIOL, V52, P210, DOI 10.1007/s12374-009-9027-9; Jiang MY, 2001, ECOL RES, V16, P687, DOI 10.1046/j.1440-1703.2001.00439.x; Johnson HA, 2001, BASIC APPL ECOL, V2, P127, DOI 10.1078/1439-1791-00044; KINDSCHER K, 1995, VEGETATIO, V117, P29, DOI 10.1007/BF00033257; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Li Bo, 2001, Plant Species Biology, V16, P193, DOI 10.1046/j.1442-1984.2001.00064.x; Li FR, 2009, PLANT SOIL, V317, P79, DOI 10.1007/s11104-008-9789-8; Li FR, 2005, J ARID ENVIRON, V62, P567, DOI 10.1016/j.jaridenv.2005.01.014; Li FR, 2004, SOIL TILL RES, V75, P121, DOI 10.1016/j.still.2003.08.001; Liu Z, 2007, J ARID ENVIRON, V71, P236, DOI 10.1016/j.jaridenv.2007.03.003; McDowell SCL, 2002, AM J BOT, V89, P1431, DOI 10.3732/ajb.89.9.1431; Meekins JF, 2000, J ECOL, V88, P447, DOI 10.1046/j.1365-2745.2000.00461.x; Muth NZ, 2007, J ECOL, V95, P1001, DOI 10.1111/j.1365-2745.2007.01268.x; NEMOTO M, 1992, ECOL RES, V7, P183, DOI 10.1007/BF02348498; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Peng Y, 2005, ENVIRON MANAGE, V35, P453, DOI 10.1007/s00267-004-0064-3; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Portes MT, 2010, BRAZ J BIOL, V70, P75, DOI 10.1590/S1519-69842010000100011; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Ronce O, 1997, AM NAT, V150, P220, DOI 10.1086/286064; Sans FX, 2004, ACTA OECOL, V26, P167, DOI 10.1016/j.actao.2004.04.001; SCHEINER SM, 1989, EVOLUTION, V43, P548, DOI 10.1111/j.1558-5646.1989.tb04251.x; SNELL TW, 1975, ECOLOGY, V56, P742, DOI 10.2307/1935512; Stastny M, 2005, J ECOL, V93, P27, DOI 10.1111/j.1365-2745.2004.00962.x; Strand JA, 2004, NEW PHYTOL, V163, P449, DOI 10.1111/j.1469-8137.2004.01144.x; Su YZ, 2005, ENVIRON MANAGE, V36, P272, DOI 10.1007/s00267-004-4083-x; Su YZ, 2004, GEODERMA, V122, P43, DOI 10.1016/j.geoderma.2003.12.003; Su YZ, 2003, ECOL ENG, V20, P223, DOI 10.1016/S0925-8574(03)00042-9; Sultan SE, 2001, ECOLOGY, V82, P328, DOI 10.1890/0012-9658(2001)082[0328:PPFFCI]2.0.CO;2; SULTAN SE, 1993, EVOLUTION, V47, P1032, DOI 10.2307/2409973; SULTAN SE, 1993, EVOLUTION, V47, P1050, DOI [10.2307/2409974, 10.1111/j.1558-5646.1993.tb02134.x]; Throop HL, 2005, OIKOS, V111, P91, DOI 10.1111/j.0030-1299.2005.14026.x; van Kleunen M, 2001, OIKOS, V94, P515, DOI 10.1034/j.1600-0706.2001.940313.x; Volis S, 2002, BIOL J LINN SOC, V75, P301, DOI 10.1111/j.1095-8312.2002.tb02071.x; Wang TH, 2006, CAN J BOT, V84, P485, DOI 10.1139/B06-011; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Weiner J, 1988, INFLUENCE COMPETITIO; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; WILLIAMS DG, 1995, ECOLOGY, V76, P1569, DOI 10.2307/1938158; Williams H, 1999, CAN J FOREST RES, V29, P222, DOI 10.1139/cjfr-29-2-222; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; WU KK, 1979, OECOLOGIA, V39, P337, DOI 10.1007/BF00345444; Zhao WZ, 2005, CATENA, V59, P173, DOI 10.1016/j.catena.2004.06.004; Zhou DW, 2005, CAN J BOT, V83, P28, DOI [10.1139/b04-148, 10.1139/B04-148]; Zuo XA, 2008, SOIL TILL RES, V99, P202, DOI 10.1016/j.still.2008.02.008; Zuo XA, 2009, ENVIRON GEOL, V58, P1227, DOI 10.1007/s00254-008-1617-1	73	7	8	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50304	10.1371/journal.pone.0050304	http://dx.doi.org/10.1371/journal.pone.0050304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185600	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000213
J	Ohno, M; Tsuda, K; Sakaguchi, M; Sugahara, Y; Oyama, F				Ohno, Misa; Tsuda, Kyoko; Sakaguchi, Masayoshi; Sugahara, Yasusato; Oyama, Fumitaka			Chitinase mRNA Levels by Quantitative PCR Using the Single Standard DNA: Acidic Mammalian Chitinase Is a Major Transcript in the Mouse Stomach	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN CHITOTRIOSIDASE; GENE-EXPRESSION; HUMAN LUNG; DISEASE; QUANTIFICATION; INFLAMMATION; ACTIVATION; EVOLUTION; CLONING	Chitinases hydrolyze the beta-1-4 glycosidic bonds of chitin, a major structural component of fungi, crustaceans and insects. Although mammals do not produce chitin or its synthase, they express two active chitinases, chitotriosidase (Chit1) and acidic mammalian chitinase (AMCase). These mammalian chitinases have attracted considerable attention due to their increased expression in individuals with a number of pathological conditions, including Gaucher disease, Alzheimer's disease and asthma. However, the contribution of these enzymes to the pathophysiology of these diseases remains to be determined. The quantification of the Chit1 and AMCase mRNA levels and the comparison of those levels with the levels of well-known reference genes can generate useful and biomedically relevant information. In the beginning, we established a quantitative real-time PCR system that uses standard DNA produced by ligating the cDNA fragments of the target genes. This system enabled us to quantify and compare the expression levels of the chitinases and the reference genes on the same scale. We found that AMCase mRNA is synthesized at extraordinarily high levels in the mouse stomach. The level of this mRNA in the mouse stomach was 7- to 10-fold higher than the levels of the housekeeping genes and was comparable to that the level of the mRNA for pepsinogen C (progastricsin), a major component of the gastric mucosa. Thus, AMCase mRNA is a major transcript in mouse stomach, suggesting that AMCase functions as a digestive enzyme that breaks down polymeric chitin and as part of the host defense against chitin-containing pathogens in the gastric contents. Our methodology is applicable to the quantification of mRNAs for multiple genes across multiple specimens using the same scale.	[Ohno, Misa; Tsuda, Kyoko; Sakaguchi, Masayoshi; Sugahara, Yasusato; Oyama, Fumitaka] Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo, Japan	Kogakuin University	Oyama, F (corresponding author), Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo, Japan.	f-oyama@cc.kogakuin.ac.jp	Oyama, Fumitaka/Q-4268-2019	Oyama, Fumitaka/0000-0002-1095-8306	Research Institute of Science and Technology, Kogakuin University	Research Institute of Science and Technology, Kogakuin University	This work was supported by the Project Research Grant from the Research Institute of Science and Technology, Kogakuin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boot RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1283, DOI 10.1369/jhc.4A6547.2005; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Bussink AP, 2006, INT REV CYTOL, V252, P71, DOI 10.1016/S0074-7696(06)52001-7; Eide KB, 2012, BIOCHEMISTRY-US, V51, P487, DOI 10.1021/bi2015585; Goldman DL, 2012, MBIO, V3, DOI 10.1128/mBio.00056-12; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Leong DT, 2007, BIOMATERIALS, V28, P203, DOI 10.1016/j.biomaterials.2006.09.011; Letuve S, 2010, AM J PATHOL, V176, P638, DOI 10.2353/ajpath.2010.090455; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; Saito A, 1999, GENE, V239, P325, DOI 10.1016/S0378-1119(99)00394-7; Seibold MA, 2008, J ALLERGY CLIN IMMUN, V122, P944, DOI 10.1016/j.jaci.2008.08.023; Tiziano FD, 2010, EUR J HUM GENET, V18, P52, DOI 10.1038/ejhg.2009.116; Vandenbroucke I I, 2001, Nucleic Acids Res, V29, pE68, DOI 10.1093/nar/29.13.e68; Wada K, 2007, J CLIN MICROBIOL, V45, P1426, DOI 10.1128/JCM.01515-06; Watabe-Rudolph M, 2012, NEUROLOGY, V78, P569, DOI 10.1212/WNL.0b013e318247caa1; Zheng T, 2005, GENE, V357, P37, DOI 10.1016/j.gene.2005.05.006; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	27	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50381	10.1371/journal.pone.0050381	http://dx.doi.org/10.1371/journal.pone.0050381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185612	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000225
J	Li, D; Takao, T; Tsunematsu, R; Morokuma, S; Fukushima, K; Kobayashi, H; Saito, T; Furue, M; Wake, N; Asanoma, K				Li, D.; Takao, T.; Tsunematsu, R.; Morokuma, S.; Fukushima, K.; Kobayashi, H.; Saito, T.; Furue, M.; Wake, N.; Asanoma, K.			Inhibition of AHR transcription by NF1C is affected by a single-nucleotide polymorphism, and is involved in suppression of human uterine endometrial cancer	ONCOGENE			English	Article						NF1C; AHR; single-nucleotide polymorphism; uterine endometrial cancer	ARYL-HYDROCARBON-RECEPTOR; ADENOVIRUS DNA-REPLICATION; MAMMARY-GLAND; CYP1A1 LEVELS; LUNG-CANCER; FACTOR 1-C2; IN-VIVO; EXPRESSION; GENE; OVEREXPRESSION	Involvement of the aryl hydrocarbon receptor (AHR) in carcinogenesis has been suggested in many studies. Upregulation of AHR has been reported in some cancer species, and an association between single-nucleotide polymorphisms (SNPs) of AHR and cancer risk or cancer development has also been reported. This evidence suggests the involvement of some specific SNPs in AHR transcriptional regulation in the process of carcinogenesis or cancer development, but there have been no studies to elucidate the mechanism involved. In this study, we identified the transcription factor Nuclear Factor 1-C (NF1C) as a candidate to regulate AHR transcription in a polymorphism-dependent manner. SNP rs10249788 was included in a consensus binding site for NF1C. Our results suggested that NF1C preferred the C allele to the T allele at rs10249788 for binding. Forced expression of NF1C suppressed the activity of the AHR promoter with C at rs10249788 stronger than that with T. Moreover, expression analysis of human uterine endometrial cancer (HEC) specimens showed greater upregulation of AHR and downregulation of NF1C than those of normal endometrium specimens. Sequence analysis showed HEC patients at advanced stages tended to possess T/T alleles more frequently than healthy women. We also demonstrated that NF1C suppressed proliferation, motility and invasion of HEC cells. This function was at least partially mediated by AHR. This study is the first to report that a polymorphism on the AHR regulatory region affected transcriptional regulation of the AHR gene in vitro. Because NF1C is a tumor suppressor, our new insights into AHR deregulation and its polymorphisms could reveal novel mechanisms of genetic susceptibility to cancer.	[Li, D.; Tsunematsu, R.; Fukushima, K.; Kobayashi, H.; Wake, N.; Asanoma, K.] Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Fukuoka 8128582, Japan; [Takao, T.; Morokuma, S.; Wake, N.] Kyushu Univ, Grad Sch Med Sci, Res Ctr Environm & Dev Med Sci, Dept Genom Epidemiol, Fukuoka 8128582, Japan; [Saito, T.] Kyushu Natl Canc Ctr, Dept Gynecol, Fukuoka, Japan; [Furue, M.] Kyushu Univ, Grad Sch Med Sci, Dept Dermatol, Fukuoka 8128582, Japan	Kyushu University; Kyushu University; Kyushu University	Asanoma, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	asanoma@med.kyushu-u.ac.jp	Takao, Tomoka/K-1568-2015	Takao, Tomoka/0000-0002-6519-2301	Ministry of Education, Culture, Sports, Science and Technology, Japan [23249075, 23591596, 23791847, 23592405]; Ministry of Health, Labor and Welfare; Environment Technology Development Fund of the Ministry of the Environment, Japan; Grants-in-Aid for Scientific Research [23592405] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Environment Technology Development Fund of the Ministry of the Environment, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr Suminori Kono at the Division of Environmental and Social Medicine, Kyushu University for kindly providing us with DNA from blood samples. We appreciate the technical support from Kanako Okamoto, Dr Tomoko Yoneda and the Research Support Center, Graduate School of Medical Sciences, Kyushu University. We also thank Drs Kiyoko Kato and Kiyomi Tsukimori for their valuable discussions. This work was supported by a Grant-in-Aid (23249075, 23591596, 23791847 and 23592405) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This work was also partly supported by grants from The Ministry of Health, Labor and Welfare, and the Environment Technology Development Fund of the Ministry of the Environment, Japan.	ABBOTT BD, 1995, DEV DYNAM, V204, P133, DOI 10.1002/aja.1002040204; Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Anttila S, 2001, PHARMACOGENETICS, V11, P501, DOI 10.1097/00008571-200108000-00005; Asanoma K, 2012, J BIOL CHEM, V287, P2257, DOI 10.1074/jbc.M111.287128; Belguise K, 2007, CANCER RES, V67, P11742, DOI 10.1158/0008-5472.CAN-07-2730; Bradshaw TD, 2002, CURR PHARM DESIGN, V8, P2475, DOI 10.2174/1381612023392784; Cauchi S, 2001, CARCINOGENESIS, V22, P1819, DOI 10.1093/carcin/22.11.1819; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; EGUCHI H, 1994, BIOCHEM BIOPH RES CO, V203, P615, DOI 10.1006/bbrc.1994.2227; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; HAY RT, 1985, EMBO J, V4, P421, DOI 10.1002/j.1460-2075.1985.tb03645.x; Higasa K, 2007, NUCLEIC ACIDS RES, V35, pD685, DOI 10.1093/nar/gkl848; Ikuta T, 2006, EXP CELL RES, V312, P3585, DOI 10.1016/j.yexcr.2006.08.002; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Johansson EM, 2003, ONCOGENE, V22, P6061, DOI 10.1038/sj.onc.1206884; Khorram O, 2002, MOL HUM REPROD, V8, P75, DOI 10.1093/molehr/8.1.75; Kim JH, 2007, LUNG CANCER, V56, P9, DOI 10.1016/j.lungcan.2006.11.010; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Koliopanos A, 2002, ONCOGENE, V21, P6059, DOI 10.1038/sj.onc.1205633; Kondo H, 2004, INVEST OPHTH VIS SCI, V45, P4433, DOI 10.1167/iovs.04-0544; Kuchenhoff A, 1999, FERTIL STERIL, V71, P354, DOI 10.1016/S0015-0282(98)00437-3; Kukita Y, 2005, GENOME RES, V15, P1511, DOI 10.1101/gr.4371105; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Lin PP, 2003, TOXICOL PATHOL, V31, P22, DOI 10.1080/01926230309746; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JR, 2006, PHARMACOGENET GENOM, V16, P237, DOI 10.1097/01.fpc.0000189803.34339.ed; Marconett CN, 2010, MOL BIOL CELL, V21, P1166, DOI 10.1091/mbc.E09-08-0689; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P4266, DOI 10.1073/pnas.80.14.4266; NEBL G, 1994, J BIOL CHEM, V269, P7371; Nilsson J, 2010, CANCER RES, V70, P2020, DOI 10.1158/0008-5472.CAN-09-1677; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Rafty LA, 2002, EMBO J, V21, P334, DOI 10.1093/emboj/21.3.334; Rozen S, 2000, Methods Mol Biol, V132, P365; Schlezinger JJ, 2006, BIOL CHEM, V387, P1175, DOI 10.1515/BC.2006.145; Shehu A, 2011, MOL ENDOCRINOL, V25, P754, DOI 10.1210/me.2010-0261; Smart J, 2000, PHARMACOGENETICS, V10, P11, DOI 10.1097/00008571-200002000-00003; Tang TA, 2010, FREE RADICAL BIO MED, V49, P487, DOI 10.1016/j.freeradbiomed.2010.05.007; Ueoka Y, 2003, MOL CELL ENDOCRINOL, V202, P81, DOI 10.1016/S0303-7207(03)00067-4; Wong JMY, 2001, BIOCHEM BIOPH RES CO, V288, P990, DOI 10.1006/bbrc.2001.5861; Wormke M, 2000, J STEROID BIOCHEM, V72, P197, DOI 10.1016/S0960-0760(00)00030-3; YANG BS, 1993, MOL CELL BIOL, V13, P3093, DOI 10.1128/MCB.13.5.3093	47	23	26	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2013	32	41					4950	4959		10.1038/onc.2012.509	http://dx.doi.org/10.1038/onc.2012.509			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	235KQ	23208493				2022-12-25	WOS:000325717800011
J	Mika, JT; Birkner, JP; Poolman, B; Kocer, A				Mika, Jacek T.; Birkner, Jan P.; Poolman, Bert; Kocer, Armagan			On the role of individual subunits in MscL gating: "All for one, one for all?"	FASEB JOURNAL			English	Article						DCFBA; electrophysiology; functional reconstitution; heterooligomer formation; mechanosensitive channel; pore diameter	MECHANOSENSITIVE CHANNEL MSCL; ION CHANNELS; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; SINGLE RESIDUE; MECHANISM; STATE; HELIX; WATER; GATES	The mechanosensitive channel of large conductance (MscL) is a homopentameric membrane protein that protects bacteria from hypoosmotic stress. Its mechanics are coupled to structural changes in the membrane, yet the molecular mechanism of the transition from closed to open states and the cooperation between subunits are poorly understood. To determine the early stages of channel activation, we have created a chemically addressable heteropentameric MscL, which allows us to selectively trigger only one subunit in the pentameric protein assembly. By employing a liposome leakage assay developed in house, we measured the size-exclusion limits of MscL (G22C(5) homopentamer and WT(4)G22C(1) heteropentamer). Patch-clamp, single-channel conductance recordings were used to electrically characterize the various channel substates. We show that a decrease in the hydrophobicity of a pore residue in only one subunit breaks the energy barrier for gating and increases the pore diameter up to 10 angstrom. A further decrease on the hydrophobicity of the same pore residue in other subunits opens the channel further, up to a diameter of 25 angstrom. However, it is not sufficient for full opening of the channel. This suggests the presence of supplementary mechanisms other than only the hydrophobic gate for MscL opening and closing and/or insufficient expansion of the channel by hydrophobic gating in the absence of applied membrane tension.-Mika, J. T., Birkner, J. P., Poolman, B., Kocer, A. On the role of individual subunits in MscL gating: "All for one, one for all?" FASEB J. 27, 882-892 (2013). www.fasebj.org	[Mika, Jacek T.; Birkner, Jan P.; Poolman, Bert; Kocer, Armagan] Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Poolman, Bert] Univ Groningen, Netherlands Prote Ctr, NL-9747 AG Groningen, Netherlands; [Poolman, Bert] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Poolman, B (corresponding author), Univ Groningen, Dept Biochem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl; a.kocer@rug.nl	Institute, Zernike/W-7033-2019; Kocer, A/M-6371-2013; Birkner, Jan Peter/E-8316-2014	kocer, Armagan/0000-0001-7343-3139; Birkner, Jan Peter/0000-0002-5536-2274	Systems Biology for Microorganisms (SysMo) Consortium via the UK Biotechnology and Biological Sciences Research Council (BBSRC); Ian R. Booth (University of Aberdeen, Aberdeen, UK); Netherlands Organisation for Scientific Research (NWO) [700.56.302]; European Research Council [208814]	Systems Biology for Microorganisms (SysMo) Consortium via the UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ian R. Booth (University of Aberdeen, Aberdeen, UK); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	The authors acknowledge Ms. Duygu Yilmaz for her work on the experimental design and sample preparation for ESI-MS measurements and Annie van Dam for the ESI-MS analysis. This work was supported by the Systems Biology for Microorganisms (SysMo) Consortium via the UK Biotechnology and Biological Sciences Research Council (BBSRC)-funded KosmoBac program, coordinated by Ian R. Booth (University of Aberdeen, Aberdeen, UK), to J.T.M. and B.P.; a Netherlands Organisation for Scientific Research (NWO) Top-Subsidy grant to B.P. (700.56.302); a NWO-VIDI grant to A.K. (700.57.427), and a European Research Council Ideas Program grant to A. K. (ERC-Starting grant 208814). Author contributions: J.T.M., J.P.B., and A.K. conceived and designed the project; J.P.B. prepared the protein samples and carried out patch-clamp experiments and data analysis; J.T.M. performed the DCFBA experiments and data analysis; A. K. supervised the project and performed patch-clamp data analysis; and J.T.M., J.P.B., A.K., and B.P. discussed the data and wrote the manuscript.	Anishkin A, 2005, J GEN PHYSIOL, V125, P155, DOI 10.1085/jgp.200409118; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Anishkin A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454120; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Beckstein O, 2001, J PHYS CHEM B, V105, P12902, DOI 10.1021/jp012233y; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Birkner JP, 2012, P NATL ACAD SCI USA, V109, P12944, DOI 10.1073/pnas.1205270109; Blount P, 1999, TRENDS MICROBIOL, V7, P420, DOI 10.1016/S0966-842X(99)01594-2; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; Doyle DA, 2004, EUR BIOPHYS J BIOPHY, V33, P175, DOI 10.1007/s00249-003-0382-z; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Iscla I, 2007, BIOPHYS J, V92, P1224, DOI 10.1529/biophysj.106.090316; Kocer A, 2007, NAT PROTOC, V2, P1426, DOI 10.1038/nprot.2007.196; Kung C, 2010, ANNU REV MICROBIOL, V64, P313, DOI 10.1146/annurev.micro.112408.134106; Liu ZF, 2009, NATURE, V461, P120, DOI 10.1038/nature08277; Louhivuori M, 2010, P NATL ACAD SCI USA, V107, P19856, DOI 10.1073/pnas.1001316107; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Roth R, 2008, BIOPHYS J, V94, P4282, DOI 10.1529/biophysj.107.120493; Shapovalov G, 2003, BIOPHYS J, V84, P2357, DOI 10.1016/S0006-3495(03)75041-3; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2004, TRENDS NEUROSCI, V27, P345, DOI 10.1016/j.tins.2004.04.006; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; Vasquez V, 2009, NATURE, V461, P47, DOI 10.1038/461047a; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus	35	17	17	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2013	27	3					882	892		10.1096/fj.12-214361	http://dx.doi.org/10.1096/fj.12-214361			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23193173				2022-12-25	WOS:000315585200005
J	Ozyamak, E; Kollman, J; Agard, DA; Komeili, A				Ozyamak, Ertan; Kollman, Justin; Agard, David A.; Komeili, Arash			The Bacterial Actin MamK IN VITRO ASSEMBLY BEHAVIOR AND FILAMENT ARCHITECTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DYNAMIC INSTABILITY; BACILLUS-SUBTILIS; MAGNETOSOME FORMATION; MOLECULAR-MECHANISMS; ELECTRON-MICROSCOPY; HELICAL FILAMENTS; UPTAKE SYSTEM; PROTEIN MAMK; CELL-SHAPE	It is now recognized that actin-like proteins are widespread in bacteria and, in contrast to eukaryotic actins, are highly diverse in sequence and function. The bacterial actin, MamK, represents a clade, primarily found in magnetotactic bacteria, that is involved in the proper organization of subcellular organelles, termed magnetosomes. We have previously shown that MamK from Magnetospirillum magneticum AMB-1 (AMB-1) forms dynamic filaments in vivo. To gain further insights into the molecular mechanisms that underlie MamK dynamics and function, we have now studied the in vitro properties of MamK. We demonstrate that MamK is an ATPase that, in the presence of ATP, assembles rapidly into filaments that disassemble once ATP is depleted. The mutation of a conserved active site residue (E143A) abolishes ATPase activity of MamK but not its ability to form filaments. Filament disassembly depends on both ATPase activity and potassium levels, the latter of which results in the organization of MamK filaments into bundles. These data are consistent with observations indicating that accessory factors are required to promote filament disassembly and for spatial organization of filaments in vivo. We also used cryo-electron microscopy to obtain a high resolution structure of MamK filaments. MamK adopts a two-stranded helical filament architecture, but unlike eukaryotic actin and other actin-like filaments, subunits in MamK strands are unstaggered giving rise to a unique filament architecture. Beyond extending our knowledge of the properties and function of MamK in magnetotactic bacteria, this study emphasizes the functional and structural diversity of bacterial actins in general.	[Ozyamak, Ertan; Komeili, Arash] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Kollman, Justin] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California Berkeley; McGill University; University of California System; University of California San Francisco	Komeili, A (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 261 Koshland Hall, Berkeley, CA 94720 USA.	komeili@berkeley.edu		Ozyamak, Ertan/0000-0002-4081-1268	National Institutes of Health [R01GM084122, GM031627]; Howard Hughes Medical Institute grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084122, R01GM031627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute grant(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM084122 (to A. K.) and GM031627 (to D. A. A.). This work was also supported by a Howard Hughes Medical Institute grant (to D. A. A.).	ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bean GJ, 2008, BIOCHEMISTRY-US, V47, P826, DOI 10.1021/bi701538e; Behrmann E, 2012, J STRUCT BIOL, V177, P302, DOI 10.1016/j.jsb.2011.12.020; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Cabeen MT, 2010, ANNU REV GENET, V44, P365, DOI 10.1146/annurev-genet-102108-134845; Derman AI, 2009, MOL MICROBIOL, V73, P534, DOI 10.1111/j.1365-2958.2009.06771.x; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Draper O, 2011, MOL MICROBIOL, V82, P342, DOI 10.1111/j.1365-2958.2011.07815.x; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; EPSTEIN W, 1965, J GEN PHYSIOL, V49, P221, DOI 10.1085/jgp.49.2.221; Esue O, 2006, J BACTERIOL, V188, P968, DOI 10.1128/JB.188.3.968-976.2006; Esue O, 2005, J BIOL CHEM, V280, P2628, DOI 10.1074/jbc.M410298200; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Frank J., 1996, 3 DIMENSIONAL ELECT, P1; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2002, CURR BIOL, V12, P570, DOI 10.1016/S0960-9822(02)00742-X; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Galkin VE, 2009, STRUCTURE, V17, P1253, DOI 10.1016/j.str.2009.07.008; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Ingerson-Mahar M, 2012, FEMS MICROBIOL REV, V36, P256, DOI 10.1111/j.1574-6976.2011.00316.x; JAHNS T, 1994, ARCH MICROBIOL, V161, P207, DOI 10.1007/s002030050043; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; KABSCH W, 1995, FASEB J, V9, P167, DOI 10.1096/fasebj.9.2.7781919; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katzmann E, 2011, MOL MICROBIOL, V82, P1316, DOI 10.1111/j.1365-2958.2011.07874.x; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; KROLL RG, 1983, BIOCHEM J, V216, P709, DOI 10.1042/bj2160709; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; LUSK JE, 1968, J BIOL CHEM, V243, P2618; MCLAGGAN D, 1994, J BIOL CHEM, V269, P1911; MICHELS M, 1987, J BACTERIOL, V169, P4335, DOI 10.1128/jb.169.9.4335-4341.1987; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murakami K, 2010, CELL, V143, P275, DOI 10.1016/j.cell.2010.09.034; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Popp D, 2012, J BIOL CHEM, V287, P21121, DOI 10.1074/jbc.M112.341016; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Rioux JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009151; Rivera CR, 2011, J BIOL CHEM, V286, P14282, DOI 10.1074/jbc.M110.203828; Roe AJ, 2000, MOL MICROBIOL, V35, P1235, DOI 10.1046/j.1365-2958.2000.01793.x; Roeben A, 2006, J MOL BIOL, V358, P145, DOI 10.1016/j.jmb.2006.01.096; Rosen B. P., 1987, ION TRANSPORT PROKAR, P85; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Shaevitz JW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000364; SHETERLINE P, 1995, PROTEIN PROFILE, V2, P1; Sonkaria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034189; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Taoka A, 2007, J BACTERIOL, V189, P8737, DOI 10.1128/JB.00899-07; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Vorobiev S, 2003, P NATL ACAD SCI USA, V100, P5760, DOI 10.1073/pnas.0832273100; Wen KK, 2002, J BIOL CHEM, V277, P41101, DOI 10.1074/jbc.M204025200; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2521, DOI 10.1099/00221287-136-12-2521	70	48	49	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4265	4277		10.1074/jbc.M112.417030	http://dx.doi.org/10.1074/jbc.M112.417030			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23204522	hybrid, Green Published			2022-12-25	WOS:000314845000055
J	Scaringi, R; Piccoli, M; Papini, N; Cirillo, F; Conforti, E; Bergante, S; Tringali, C; Garatti, A; Gelfi, C; Venerando, B; Menicanti, L; Tettamanti, G; Anastasia, L				Scaringi, Raffaella; Piccoli, Marco; Papini, Nadia; Cirillo, Federica; Conforti, Erika; Bergante, Sonia; Tringali, Cristina; Garatti, Andrea; Gelfi, Cecilia; Venerando, Bruno; Menicanti, Lorenzo; Tettamanti, Guido; Anastasia, Luigi			NEU3 Sialidase Is Activated under Hypoxia and Protects Skeletal Muscle Cells from Apoptosis through the Activation of the Epidermal Growth Factor Receptor Signaling Pathway and the Hypoxia-inducible Factor (HIF)-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED SIALIDASE; GANGLIOSIDE SIALIDASE; TRANSCRIPTION FACTORS; MOLECULAR-CLONING; EGF RECEPTOR; DIFFERENTIATION; EXPRESSION; THERAPY; CANCER; OXYGEN	NEU3 sialidase, a key enzyme in ganglioside metabolism, is activated under hypoxic conditions in cultured skeletal muscle cells (C2C12). NEU3 up-regulation stimulates the EGF receptor signaling pathway, which in turn activates the hypoxia-inducible factor (HIF-1 alpha), resulting in a final increase of cell survival and proliferation. In the same cells, stable overexpression of sialidase NEU3 significantly enhances cell resistance to hypoxia, whereas stable silencing of the enzyme renders cells more susceptible to apoptosis. These data support the working hypothesis of a physiological role played by NEU3 sialidase in protecting cells from hypoxic stress and may suggest new directions in the development of therapeutic strategies against ischemic diseases, particularly of the cerebro-cardiovascular system.	[Scaringi, Raffaella; Papini, Nadia; Bergante, Sonia; Tringali, Cristina; Gelfi, Cecilia; Venerando, Bruno; Anastasia, Luigi] Univ Milan, Dept Biomed Sci Hlth, I-20090 Milan, Italy; [Scaringi, Raffaella; Piccoli, Marco; Papini, Nadia; Cirillo, Federica; Conforti, Erika; Bergante, Sonia; Tringali, Cristina; Garatti, Andrea; Venerando, Bruno; Menicanti, Lorenzo; Tettamanti, Guido; Anastasia, Luigi] Ist Ricovero & Cura Carattere Sci Policlin San Do, Lab Stem Cells Tissue Engn, I-20097 Milan, Italy	University of Milan	Anastasia, L (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Via Flli Cervi 93, I-20090 Milan, Italy.	luigi.anastasia@unimi.it	bergante, sonia/AAI-1215-2019; Gelfi, Cecilia/L-1490-2016; Anastasia, Luigi/AAN-1964-2020; Piccoli, Marco/S-3731-2019; menicanti, lorenzo/K-5649-2018; Cirillo, Federica/ABE-3480-2020; Garatti, Andrea/K-3105-2016; Tringali, Cristina Alessandra/Q-7259-2017; papini, nadia/M-2425-2017	Gelfi, Cecilia/0000-0002-2996-6912; Anastasia, Luigi/0000-0002-0712-2161; Piccoli, Marco/0000-0002-9461-2715; menicanti, lorenzo/0000-0001-8530-6284; Cirillo, Federica/0000-0002-0196-5977; Garatti, Andrea/0000-0002-6744-1850; Tringali, Cristina Alessandra/0000-0002-0632-6197; papini, nadia/0000-0003-4066-4955; Bergante, Sonia/0000-0001-8986-0004				Anastasia L, 2008, J BIOL CHEM, V283, P36265, DOI 10.1074/jbc.M805755200; Bennewith KL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-504; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Haga Y, 2008, BBA-GEN SUBJECTS, V1780, P393, DOI 10.1016/j.bbagen.2007.10.018; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; Huang M, 2011, CIRCULATION, V124, pS46, DOI 10.1161/CIRCULATIONAHA.110.014019; Kanwar JR, 2011, DRUG DISCOV TODAY, V16, P485, DOI 10.1016/j.drudis.2011.04.001; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Miljan Erik A, 2002, Sci STKE, V2002, pre15, DOI 10.1126/stke.2002.160.re15; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyagi T, 2008, J BIOCHEM, V144, P279, DOI 10.1093/jb/mvn089; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Miyata T, 2011, AM J PHYSIOL-CELL PH, V300, pC226, DOI 10.1152/ajpcell.00430.2010; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Papini N, 2012, J CELL BIOCHEM, V113, P2967, DOI 10.1002/jcb.24174; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; Ronkainen VP, 2007, FASEB J, V21, P1821, DOI 10.1096/fj.06-7294com; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2011, AM J PHYSIOL-CELL PH, V301, pC550, DOI 10.1152/ajpcell.00176.2011; Yamaguchi K, 2010, BIOCHEM J, V430, P107, DOI 10.1042/BJ20100350; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503	26	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3153	3162		10.1074/jbc.M112.404327	http://dx.doi.org/10.1074/jbc.M112.404327			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23209287	Green Published, hybrid			2022-12-25	WOS:000314397900023
J	LeGendre, JB; Campbell, ZT; Kroll-Conner, P; Anderson, P; Kimble, J; Wickens, M				LeGendre, Jacqueline Baca; Campbell, Zachary T.; Kroll-Conner, Peggy; Anderson, Phil; Kimble, Judith; Wickens, Marvin			RNA Targets and Specificity of Staufen, a Double-stranded RNA-binding Protein in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BICOID MESSENGER-RNA; C-ELEGANS; SOMATODENDRITIC DOMAIN; GENETIC INTERFERENCE; MAMMALIAN STAUFEN; DISTINCT ROLES; LOCALIZATION; TRANSPORT; INTERACT; PATHWAYS	The Staufen family consists of proteins that possess double-stranded RNA-binding domains (dsRBDs). Staufen proteins of Drosophila and mammals regulate mRNA localization, translation, and decay. We report analysis of Staufen in Caenorhabditis elegans, which we have designated STAU-1. We focus on its biochemical properties, mRNA targets, and possible role in RNAi. We show that STAU-1 is expressed as mRNA and protein at all stages of C. elegans development. The wild-type, full-length protein, purified from bacteria, binds duplex RNA with high affinity in vitro. Purified, mutant proteins lacking single dsRBDs still bind RNA efficiently, demonstrating that no single domain is required for binding to duplex RNA (although dsRBD2 could not be tested). STAU-1 mRNA targets were identified via immunoprecipitation with specific anti-STAU-1 antibodies, followed by microarray analysis (RIP-Chip). These studies define a set of 418 likely STAU-1 mRNA targets. Finally, we demonstrate that stau-1 mutants enhance exogenous RNAi and that stau-1; eri-1 double mutants exhibit sterility and synthetic germ line defects.	[LeGendre, Jacqueline Baca] Univ Wisconsin, Grad Program Cellular & Mol Biol, Madison, WI 53706 USA; [Anderson, Phil; Kimble, Judith] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Campbell, Zachary T.; Kimble, Judith; Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Kroll-Conner, Peggy; Kimble, Judith] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	wickens@biochem.wisc.edu		Campbell, Zachary/0000-0002-3768-6996; Baca LeGendre, Jacqueline/0000-0003-4889-857X	National Institutes of Health [F31 GM084683, GM095169, GM50933, R01GM069454, GM031892, GM050942]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050942, F32GM095169, F31GM084683, R01GM031892, R01GM069454, R01GM050933, R37GM031892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Predoctoral Fellowship F31 GM084683 (to J. B. L.) and Grants GM095169 (to Z. T. C.), GM50933 (to P. A.), R01GM069454 (to J. K.), and GM031892 and GM050942 (to M. W.).	Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaszczyk J, 2004, STRUCTURE, V12, P457, DOI 10.1016/j.str.2004.02.004; Broadus J, 1998, NATURE, V391, P792, DOI 10.1038/35861; Buchon N, 2006, HEREDITY, V96, P195, DOI 10.1038/sj.hdy.6800789; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Campbell ZT, 2012, CELL REP, V1, P570, DOI 10.1016/j.celrep.2012.04.003; Chang KY, 2005, FEBS J, V272, P2109, DOI 10.1111/j.1742-4658.2005.04652.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Duchaine TF, 2002, J CELL SCI, V115, P3285; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Hartig JV, 2009, EMBO J, V28, P2932, DOI 10.1038/emboj.2009.220; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Hook B, 2005, RNA, V11, P227, DOI 10.1261/rna.7202705; Hundley HA, 2010, TRENDS BIOCHEM SCI, V35, P377, DOI 10.1016/j.tibs.2010.02.008; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; LEHMANN R, 1991, DEVELOPMENT, V112, P679; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Mueller Geoffrey A, 2010, Silence, V1, P2, DOI 10.1186/1758-907X-1-2; Nakahara KS, 2012, P NATL ACAD SCI USA, V109, P10113, DOI 10.1073/pnas.1201628109; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Pohludka M, 2008, BIOCHEM BIOPH RES CO, V374, P49, DOI 10.1016/j.bbrc.2008.06.115; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Zhang C, 2011, P NATL ACAD SCI USA, V108, P1201, DOI 10.1073/pnas.1018695108; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	72	40	303	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2532	2545		10.1074/jbc.M112.397349	http://dx.doi.org/10.1074/jbc.M112.397349			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23195953	Green Published, hybrid			2022-12-25	WOS:000314211500039
J	Buffone, A; Mondal, N; Gupta, R; McHugh, KP; Lau, JTY; Neelamegham, S				Buffone, Alexander, Jr.; Mondal, Nandini; Gupta, Rohitesh; McHugh, Kyle P.; Lau, Joseph T. Y.; Neelamegham, Sriram			Silencing alpha 1,3-Fucosyltransferases in Human Leukocytes Reveals a Role for FUT9 Enzyme during E-selectin-mediated Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALYL-LEWIS-X; P-SELECTIN; GLYCOPROTEIN LIGAND-1; FUCOSYL-TRANSFERASE; FUCT-VII; ACCEPTOR-SPECIFICITY; EXPRESSION CLONING; HYDRODYNAMIC SHEAR; MOLECULAR-CLONING; BINDING	Leukocyte adhesion during inflammation is initiated by the binding of sialofucosylated carbohydrates expressed on leukocytes to endothelial E/P-selectin. Although the glycosyltransferases (glycoTs) constructing selectin-ligands have largely been identified using knock-out mice, important differences may exist between humans and mice. To address this, we developed a systematic lentivirus-based shRNA delivery workflow to create human leukocytic HL-60 cell lines that lack up to three glycoTs. Using this, the contributions of all three myeloid alpha 1,3-fucosyltransferases (FUT4, FUT7, and FUT9) to selectin-ligand biosynthesis were evaluated. The cell adhesion properties of these modified cells to L-, E-, and P-selectin under hydrodynamic shear were compared with bone marrow-derived neutrophils from Fut4(-/-)Fut7(-/-) dual knock-out mice. Results demonstrate that predominantly FUT7, and to a lesser extent FUT4, forms the selectin-ligand at the N terminus of leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) in humans and mice. Here, 85% reduction in leukocyte interaction was observed in human FUT4(-)7(-) dual knockdowns on P/L-selectin substrates. Unlike Fut4(-/-)Fut7(-/-) mouse neutrophils, however, human knockdowns lacking FUT4 and FUT7 only exhibited partial reduction in rolling interaction on E-selectin. In this case, the third alpha 1,3-fucosyltransferase FUT9 played an important role because leukocyte adhesion was reduced by 50-60% in FUT9-HL-60, 70-80% in dual knockdown FUT7(-)9(-) cells, and similar to 85% in FUT4(-)7(-)9(-) triple knockdowns. Gene silencing results are in agreement with gain-of-function experiments where all three fucosyltransferases conferred E-selectin-mediated rolling in HEK293T cells. This study advances new tools to study human glycoT function. It suggests a species-specific role for FUT9 during the biosynthesis of human E-selectin ligands.	[Buffone, Alexander, Jr.; Mondal, Nandini; Gupta, Rohitesh; McHugh, Kyle P.; Neelamegham, Sriram] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Neelamegham, Sriram] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Lau, Joseph T. Y.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Neelamegham, S (corresponding author), SUNY Buffalo, Dept Chem & Biol Engn, 906 Furnas Hall, Buffalo, NY 14260 USA.	neel@buffalo.edu		Mondal, Nandini/0000-0001-9508-3280; Neelamegham, Sriram/0000-0002-1371-8500; gupta, rohitesh/0000-0001-8515-5869	National Institutes of Health [HL63014, HL103411, HL107146]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146, R01HL063014, R01HL103411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL63014 (to S. N.), HL103411 (to S. N.), and HL107146 (to J. T. Y. L.).	Aeed PA, 1998, GLYCOCONJUGATE J, V15, P975, DOI 10.1023/A:1006985825141; Beauharnois ME, 2005, BIOCHEMISTRY-US, V44, P9507, DOI 10.1021/bi0507130; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brito C, 2008, BIOCHIMIE, V90, P1279, DOI 10.1016/j.biochi.2008.03.002; Britten CJ, 1998, GLYCOBIOLOGY, V8, P321, DOI 10.1093/glycob/8.4.321; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Huang MC, 2002, J BIOL CHEM, V277, P47786, DOI 10.1074/jbc.M208283200; Jayakumar D, 2009, CYTOM PART A, V75A, P866, DOI 10.1002/cyto.a.20773; Kobzdej MMA, 2002, BLOOD, V100, P4485, DOI 10.1182/blood-2002-06-1799; Konstantopoulos K, 1998, CIRCULATION, V98, P873, DOI 10.1161/01.CIR.98.9.873; LARSEN GR, 1992, J BIOL CHEM, V267, P11104; Liu ZH, 2010, J EXP MED, V207, P2975, DOI 10.1084/jem.20101545; LOWE JB, 1991, J BIOL CHEM, V266, P17467; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; M'Rini C, 2003, J EXP MED, V198, P1301, DOI 10.1084/jem.20030182; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; Marathe DD, 2010, BLOOD, V115, P1303, DOI 10.1182/blood-2009-07-231480; Marathe DD, 2008, FASEB J, V22, P4154, DOI 10.1096/fj.07-104257; Martinez M, 2005, J BIOL CHEM, V280, P5378, DOI 10.1074/jbc.M410899200; Merzaban JS, 2011, BLOOD, V118, P1774, DOI 10.1182/blood-2010-11-320705; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; NATSUKA S, 1994, J BIOL CHEM, V269, P16789; Niemela R, 1998, J BIOL CHEM, V273, P4021, DOI 10.1074/jbc.273.7.4021; Nimrichter L, 2008, BLOOD, V112, P3744, DOI 10.1182/blood-2008-04-149641; Nishihara S, 2003, GLYCOBIOLOGY, V13, P445, DOI 10.1093/glycob/cwg048; Nishihara S, 1999, FEBS LETT, V462, P289, DOI 10.1016/S0014-5793(99)01549-5; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Pan JL, 1998, J BIOL CHEM, V273, P10058, DOI 10.1074/jbc.273.16.10058; Patil SA, 2012, ANAL BIOCHEM, V425, P135, DOI 10.1016/j.ab.2012.03.009; Patnaik SK, 2004, J BIOL CHEM, V279, P49716, DOI 10.1074/jbc.M408755200; POUYANI T, 1995, CELL, V83, P333, DOI 10.1016/0092-8674(95)90174-4; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Sackstein R, 2009, IMMUNOL REV, V230, P51, DOI 10.1111/j.1600-065X.2009.00792.x; SAKO D, 1993, CELL, V75, P1179, DOI 10.1016/0092-8674(93)90327-M; SASAKI K, 1994, J BIOL CHEM, V269, P14730; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Snapp KR, 1997, BLOOD, V89, P896, DOI 10.1182/blood.V89.3.896; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Taylor AD, 1996, BIOPHYS J, V71, P3488, DOI 10.1016/S0006-3495(96)79544-9; Toivonen S, 2002, GLYCOBIOLOGY, V12, P361, DOI 10.1093/glycob/12.6.361; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wagers AJ, 1997, J IMMUNOL, V159, P1917; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Weninger W, 2000, IMMUNITY, V12, P665, DOI 10.1016/S1074-7613(00)80217-4; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zhang Y, 2002, BIOPHYS J, V83, P1934, DOI 10.1016/S0006-3495(02)73956-8	48	57	58	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1620	1633		10.1074/jbc.M112.400929	http://dx.doi.org/10.1074/jbc.M112.400929			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192350	Green Published, hybrid			2022-12-25	WOS:000313751400018
J	Kanuru, M; Raman, R; Aradhyam, GK				Kanuru, Madhavi; Raman, Rajeev; Aradhyam, Gopala Krishna			Serine Protease Activity of Calnuc REGULATION BY Zn2+ AND G PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; NUCLEOBINDIN 1; CALCIUM; YEAST; PURIFICATION; HYDROLYSIS; ACTIVATION; EVOLUTION; DISEASE; SITES	The functions of calnuc, a novel Ca2+-binding protein with multiple structural domains and diverse interacting partners, are yet unknown. We demonstrate unknown facets of calnuc, which is a serine protease in which Ser-378 of GXSXG motif, Asp-328 of DTG motif, and His-339 form the "catalytic triad," locating the enzyme active site in the C-terminal region. Analogous to the active site of Zn2+ carboxypeptidases, calnuc has two high affinity (K-d similar to 20 nM), well conserved Zn2+-binding sites near its N terminus, although it is inactive as a peptidase. Zn2+ binding allosterically and negatively regulates the serine protease activity of calnuc, inhibition being caused by an "open to close" change in its conformation not seen upon Ca2+ binding. Most strikingly, interaction with G protein alpha subunit completely inhibits the enzymatic activity of calnuc. We thus illustrate that G proteins and Zn2+ act as two "keys" that control enzymatic activity of calnuc, arresting it in "locked" state. Calnuc, therefore, exists dynamically in two different forms, (i) as a Ca2+-binding protein in Zn2+-bound form and (ii) as a protease in Zn2+-free form, commissioning it to perform multiple functions.	[Kanuru, Madhavi; Aradhyam, Gopala Krishna] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Raman, Rajeev] CSIR, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Aradhyam, GK (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	agk@iitm.ac.in		Aradhyam, Gopala Krishna/0000-0001-8232-3935	Indian Institute of Technology Madras (IITM); Council of Scientific and Industrial Research (India); Department of Science and Technology (DST); Department of Biotechnology (DBT)	Indian Institute of Technology Madras (IITM); Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India)	This work was supported by Indian Institute of Technology Madras (IITM), Council of Scientific and Industrial Research (India), Department of Science and Technology (DST) and Department of Biotechnology (DBT).	Abian O, 2009, PROTEINS, V77, P624, DOI 10.1002/prot.22475; Aradhyam GK, 2010, IUBMB LIFE, V62, P436, DOI 10.1002/iub.341; Bauer MC, 2008, PROTEIN SCI, V17, P760, DOI 10.1110/ps.073381108; Bergmeyer H. U., 1974, METHOD ENZYMAT AN, P436; Bleackley MR, 2011, BIOMETALS, V24, P785, DOI 10.1007/s10534-011-9451-4; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Garcia-Marcos M, 2011, J BIOL CHEM, V286, P28138, DOI 10.1074/jbc.M110.204099; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; KANAI Y, 1992, IMMUNOL LETT, V32, P43; KANAI Y, 1993, BIOCHEM BIOPH RES CO, V196, P729, DOI 10.1006/bbrc.1993.2310; Kanuru M, 2009, FEBS J, V276, P2529, DOI 10.1111/j.1742-4658.2009.06977.x; Kapoor N, 2010, J BIOL CHEM, V285, P31647, DOI 10.1074/jbc.M110.148429; Karabinos A, 1998, J MOL EVOL, V46, P327, DOI 10.1007/PL00006309; Karabinos A, 1996, MOL BIOL EVOL, V13, P990, DOI 10.1093/oxfordjournals.molbev.a025667; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Leclerc P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002229; Liang J, 2007, PROTEIN SCI, V16, P929, DOI 10.1110/ps.062706007; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Lin P, 2007, J NEUROCHEM, V100, P1505, DOI 10.1111/j.1471-4159.2006.07336.x; Lin P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-15; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; MCDONALD JK, 1966, J BIOL CHEM, V241, P1494; MIURA K, 1992, BIOCHEM BIOPH RES CO, V187, P375, DOI 10.1016/S0006-291X(05)81503-7; MIURA K, 1994, BIOCHEM BIOPH RES CO, V199, P1388, DOI 10.1006/bbrc.1994.1384; MOCHIZUKI N, 1995, FEBS LETT, V373, P155, DOI 10.1016/0014-5793(95)01031-9; Ostermeier M, 2009, CURR OPIN STRUC BIOL, V19, P442, DOI 10.1016/j.sbi.2009.04.007; SARATH G., 1989, PROTEOLYTIC ENZYMES, P22; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Schaub MC, 2008, BIOCHEM BIOPH RES CO, V369, P247, DOI 10.1016/j.bbrc.2007.10.082; TAYLOR EL, 1963, J BIOL CHEM, V238, P734; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; TUNLID A, 1994, MICROBIOL-UK, V140, P1687, DOI 10.1099/13500872-140-7-1687; TWINING SS, 1984, ANAL BIOCHEM, V143, P30, DOI 10.1016/0003-2697(84)90553-0; Valencia CA, 2008, FEBS LETT, V582, P286, DOI 10.1016/j.febslet.2007.12.019; Weiss TS, 2001, P NATL ACAD SCI USA, V98, P14961, DOI 10.1073/pnas.261572098	41	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1762	1773		10.1074/jbc.M112.382846	http://dx.doi.org/10.1074/jbc.M112.382846			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23195954	Green Published, hybrid			2022-12-25	WOS:000313751400032
J	Wu, JW; Herman, M; Liu, L; Simoes, S; Acker, CM; Figueroa, H; Steinberg, JI; Margittai, M; Kayed, R; Zurzolo, C; Di Paolo, G; Duff, KE				Wu, Jessica W.; Herman, Mathieu; Liu, Li; Simoes, Sabrina; Acker, Christopher M.; Figueroa, Helen; Steinberg, Joshua I.; Margittai, Martin; Kayed, Rakez; Zurzolo, Chiara; Di Paolo, Gilbert; Duff, Karen E.			Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PAIRED HELICAL FILAMENTS; ALPHA-SYNUCLEIN OLIGOMERS; IN-VITRO; ALZHEIMERS-DISEASE; AMYLOID-BETA; PROPAGATION; MUTATIONS; MECHANISM; PATHOLOGY	The accumulation of Tau into aggregates is associated with key pathological events in frontotemporal lobe degeneration (FTD-Tau) and Alzheimer disease (AD). Recent data have shown that misfolded Tau can be internalized by cells in vitro (Frost, B., Jacks, R. L., and Diamond, M. I. (2009) J. Biol. Chem. 284, 12845-12852) and propagate pathology in vivo (Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., Jucker, M., Goedert, M., and Tolnay, M. (2009) Nat. Cell Biol. 11, 909-913; Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Sengupta, U., Guerrero-Munoz, M. J., Kiritoshi, T., Neugebauer, V., Jackson, G. R., and Kayed, R. (2012) Sci. Rep. 2, 700). Here we show that recombinant Tau misfolds into low molecular weight (LMW) aggregates prior to assembly into fibrils, and both extracellular LMW Tau aggregates and short fibrils, but not monomers, long fibrils, nor long filaments purified from brain extract are taken up by neurons. Remarkably, misfolded Tau can be internalized at the somatodendritic compartment, or the axon terminals and it can be transported anterogradely, retrogradely, and can enhance tauopathy in vivo. The internalized Tau aggregates co-localize with dextran, a bulk-endocytosis marker, and with the endolysosomal compartments. Our findings demonstrate that exogenous Tau can be taken up by cells, uptake depends on both the conformation and size of the Tau aggregates and once inside cells, Tau can be transported. These data provide support for observations that tauopathy can spread trans-synaptically in vivo, via cell-to-cell transfer.	[Wu, Jessica W.; Herman, Mathieu; Liu, Li; Simoes, Sabrina; Figueroa, Helen; Steinberg, Joshua I.; Di Paolo, Gilbert; Duff, Karen E.] Columbia Univ, Dept Pathol & Cell Biol, Taub Inst Alzheimers Dis Res, New York, NY 10032 USA; [Acker, Christopher M.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Margittai, Martin] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA; [Kayed, Rakez] Univ Texas Med Branch, George P & Cynthia Woods Mitchell Ctr Neurodegene, Dept Neurol, Galveston, TX 77555 USA; [Zurzolo, Chiara] Inst Pasteur, Unite Traff Membranaire & Pathogenese, Paris, France; [Duff, Karen E.] New York State Psychiat Inst & Hosp, Dept Psychiat, New York, NY 10032 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine; University of Denver; University of Texas System; University of Texas Medical Branch Galveston; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; New York State Psychiatry Institute	Duff, KE (corresponding author), Columbia Univ, Med Ctr, Taub Inst Alzheimers Dis Res, Dept Pathol, P&S 12-461,630 W 168th St, New York, NY 10032 USA.	ked2115@columbia.edu	Margittai, Martin/D-5039-2014; Zurzolo, Chiara/AAH-5225-2019	Margittai, Martin/0000-0003-1903-5927; ZURZOLO, Chiara/0000-0001-6048-6602; Duff, Karen/0000-0002-6177-868X	National Institutes of Health from the NINDS [NS074874, NS076619, NS056049]; American Health Assistance Foundation AHAF fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081555, R01NS076619, R01NS074874, R01NS056049] Funding Source: NIH RePORTER	National Institutes of Health from the NINDS; American Health Assistance Foundation AHAF fellowship(BrightFocus Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS074874 (to K. D.), NS076619 (to M. M.), and NS056049 (to G. D. P.) from the NINDS and an American Health Assistance Foundation AHAF fellowship (to J. W. W.).	Acker CM, 2013, NEUROBIOL AGING, V34, P338, DOI 10.1016/j.neurobiolaging.2012.05.010; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn Stefan, 2004, V299, P35; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, J NEURAL TRANSM, V118, P809, DOI 10.1007/s00702-010-0508-2; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gerdes HH, 2009, NAT CELL BIOL, V11, P235, DOI 10.1038/ncb0309-235; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Narayanan S, 2003, P NATL ACAD SCI USA, V100, P9286, DOI 10.1073/pnas.1233535100; OLIVER JM, 1984, METHOD ENZYMOL, V108, P336; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; POLLOCK NJ, 1986, LANCET, V2, P1211; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Raposo G, 1997, HDB EXPT IMMUNOLOGY, V4, P1; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Thompson HM, 2006, NAT CHEM BIOL, V2, P355, DOI 10.1038/nchembio0706-355; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; von Bergen M, 2005, BBA-MOL BASIS DIS, V1739, P158, DOI 10.1016/j.bbadis.2004.09.010; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Voss EW, 1996, BIOTECHNIQUES, V20, P286; Wilson DM, 1997, AM J PATHOL, V150, P2181; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	76	332	338	1	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1856	1870		10.1074/jbc.M112.394528	http://dx.doi.org/10.1074/jbc.M112.394528			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188818	Green Published, hybrid			2022-12-25	WOS:000313751400040
J	Franke, M; Braulke, T; Storch, S				Franke, Mine; Braulke, Thomas; Storch, Stephan			Transport of the GlcNAc-1-phosphotransferase alpha/beta-Subunit Precursor Protein to the Golgi Apparatus Requires a Combinatorial Sorting Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDO-HURLER POLYDYSTROPHY; COPII-DEPENDENT EXPORT; MUCOLIPIDOSIS-II; VESICLE FORMATION; MECHANISMS; MUTATIONS; ENZYME; ER; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; PHOSPHOTRANSFERASE	The Golgi-resident N-acetylglucosamine-1-phosphotransferase (PT) complex is composed of two alpha-, beta-, and gamma-subunits and represents the key enzyme for the biosynthesis of mannose 6-phosphate recognition marker on soluble lysosomal proteins. Mutations in the PT complex cause the lysosomal storage diseases mucolipidosis II and III. A prerequisite for the enzymatic activity is the site-1 protease-mediated cleavage of the PT alpha/beta-subunit precursor protein in the Golgi apparatus. Here, we have investigated structural requirements of the PT alpha/beta-subunit precursor protein for its efficient export from the endoplasmic reticulum (ER). Both wild-type and a cleavage-resistant type III membrane PT alpha/beta-subunit precursor protein are exported whereas coexpressed separate alpha- and beta-subunits failed to reach the cis-Golgi compartment. Mutational analyses revealed combinatorial, non-exchangeable dileucine and dibasic motifs located in a defined sequence context in the cytosolic N- and C-terminal domains that are required for efficient ER exit and subsequent proteolytic activation of the alpha/beta-subunit precursor protein in the Golgi. In the presence of a dominant negative Sar1 mutant the ER exit of the PT alpha/beta-subunit precursor protein is inhibited indicating its transport in coat protein complex II-coated vesicles. Expression studies of missense mutations identified in mucolipidosis III patients that alter amino acids in the N- and C-terminal domains demonstrated that the substitution of a lysine residue in close proximity to the dileucine sorting motif impaired ER-Golgi transport and subsequent activation of the PT alpha/beta-subunit precursor protein. The data suggest that the oligomeric type III membrane protein PT complex requires a combinatorial sorting motif that forms a tertiary epitope to be recognized by distinct sites within the coat protein complex II machinery.	[Franke, Mine; Braulke, Thomas; Storch, Stephan] Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Storch, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, Martinistr 52,Bldg N27, D-20246 Hamburg, Germany.	storch@uke.uni-hamburg.de	Braulke, Thomas/AAV-9121-2020	Braulke, Thomas/0000-0002-2336-8532; Storch, Stephan/0000-0002-8807-5917	Deutsche Forschungsgemeinschaft [STO 761/2-1, GRK1459]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants STO 761/2-1 and GRK1459.	Bao M, 1996, J BIOL CHEM, V271, P31446, DOI 10.1074/jbc.271.49.31446; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Braulke T, 2008, J INHERIT METAB DIS, V31, P253, DOI 10.1007/s10545-008-0862-5; Encarnacao M, 2011, J BIOL CHEM, V286, P5311, DOI 10.1074/jbc.M110.202382; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Kollmann K, 2010, EUR J CELL BIOL, V89, P117, DOI 10.1016/j.ejcb.2009.10.008; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Marschner K, 2011, SCIENCE, V333, P87, DOI 10.1126/science.1205677; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Otte S, 2002, EMBO J, V21, P6095, DOI 10.1093/emboj/cdf598; Qian Y, 2010, FRONT ENVIRON SCI EN, V4, P1, DOI 10.1007/s11783-010-1000-9; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Storch S, 2007, TRAFFIC, V8, P431, DOI 10.1111/j.1600-0854.2007.00537.x; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	31	23	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1238	1249		10.1074/jbc.M112.407676	http://dx.doi.org/10.1074/jbc.M112.407676			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23192343	Green Published, hybrid			2022-12-25	WOS:000313570300044
J	Bauermeister, J; Ramette, A; Dattagupta, S				Bauermeister, Jan; Ramette, Alban; Dattagupta, Sharmishtha			Repeatedly Evolved Host-Specific Ectosymbioses between Sulfur-Oxidizing Bacteria and Amphipods Living in a Cave Ecosystem	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; 16S RIBOSOMAL-RNA; OLIGONUCLEOTIDE PROBES; MICROBIAL COMMUNITIES; SEQUENCE ALIGNMENT; MARINE NEMATODE; FRESH-WATER; DIVERSITY; FRASASSI; PROGRAM	Ectosymbioses between invertebrates and sulfur-oxidizing bacteria are widespread in sulfidic marine environments and have evolved independently in several invertebrate phyla. The first example from a freshwater habitat, involving Niphargus ictus amphipods and filamentous Thiothrix ectosymbionts, was recently reported from the sulfide-rich Frasassi caves in Italy. Subsequently, two new Niphargus species, N. frasassianus and N. montanarius, were discovered within Frasassi and found to co-occur with N. ictus. Using a variety of microscopic and molecular techniques, we found that all three Frasassi-dwelling Niphargus species harbor Thiothrix ectosymbionts, which belong to three distinct phylogenetic clades (named T1, T2, and T3). T1 and T3 Thiothrix dominate the N. frasassianus ectosymbiont community, whereas T2 and T3 are prevalent on N. ictus and N. montanarius. Relative distribution patterns of the three ectosymbionts are host species-specific and consistent over different sampling locations and collection years. Free-living counterparts of T1-T3 are rare or absent in Frasassi cave microbial mats, suggesting that ectosymbiont transmission among Niphargus occurs primarily through inter-or intraspecific inoculations. Phylogenetic analyses indicate that the Niphargus-Thiothrix association has evolved independently at least two times. While ectosymbioses with T1 and T2 may have been established within Frasassi, T3 ectosymbionts seem to have been introduced to the cave system by Niphargus.	[Bauermeister, Jan; Dattagupta, Sharmishtha] Univ Gottingen, Geomicrobiol & Symbiosis Grp, Courant Res Ctr Geobiol, Gottingen, Germany; [Ramette, Alban] Max Planck Inst Marine Microbiol, HGF MPG Grp Deep Sea Ecol & Technol, Bremen, Germany	University of Gottingen; Max Planck Society	Dattagupta, S (corresponding author), Univ Gottingen, Geomicrobiol & Symbiosis Grp, Courant Res Ctr Geobiol, Gottingen, Germany.	sdattag@uni-goettingen.de	Ramette, Alban/E-9197-2016	Ramette, Alban/0000-0002-3437-4639	German Initiative of Excellence; Max Planck Society; National Geographic Committee for Research Exploration [8387-08]	German Initiative of Excellence; Max Planck Society(Max Planck Society); National Geographic Committee for Research Exploration(National Geographic Society)	This study was funded by the German Initiative of Excellence and by the Max Planck Society. Fieldwork was financially supported by the National Geographic Committee for Research & Exploration (grant 8387-08 to SD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This is contribution number 103 from the Courant Research Centre Geobiology of the University of Gottingen.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amann RI, 1995, MOL MICROBIAL ECOLOG, P331; Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Bayer C, 2009, ENV MICROBIOL REP, V1, P136, DOI 10.1111/j.1758-2229.2009.00019.x; Bertolani Roberto, 1994, International Journal of Speleology, V23, P61; Bierne N, 2007, MOL ECOL NOTES, V7, P562, DOI 10.1111/j.1471-8286.2007.01685.x; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; Bulgheresi S, 2006, APPL ENVIRON MICROB, V72, P2950, DOI 10.1128/AEM.72.4.2950-2956.2006; Bulgheresi S, 2011, ISME J, V5, P986, DOI 10.1038/ismej.2010.198; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Chaston J, 2010, FEMS MICROBIOL REV, V34, P41, DOI 10.1111/j.1574-6976.2009.00193.x; Chernousova E, 2009, INT J SYST EVOL MICR, V59, P3128, DOI 10.1099/ijs.0.009456-0; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Dattagupta S, 2009, ISME J, V3, P935, DOI 10.1038/ismej.2009.34; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Fiser C, 2008, ZOOL SCR, V37, P665, DOI 10.1111/j.1463-6409.2008.00347.x; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Flot JF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-171; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Gillan DC, 2004, APPL ENVIRON MICROB, V70, P3772, DOI 10.1128/AEM.70.6.3772-3775.2004; Goffredi SK, 2010, ENV MICROBIOL REP, V2, P479, DOI 10.1111/j.1758-2229.2010.00136.x; Goffredi SK, 2004, APPL ENVIRON MICROB, V70, P3082, DOI 10.1128/AEM.70.5.3082-3090.2004; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hugenholtz P, 2002, Methods Mol Biol, V179, P29; Karaman GS, 2010, ZOOTAXA, P35; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; LARKIN JM, 1983, INT J SYST BACTERIOL, V33, P841, DOI 10.1099/00207713-33-4-841; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Macalady JL, 2008, ISME J, V2, P590, DOI 10.1038/ismej.2008.25; Macalady JL, 2006, APPL ENVIRON MICROB, V72, P5596, DOI 10.1128/AEM.00715-06; Meziti A, 2010, FEMS MICROBIOL ECOL, V74, P472, DOI 10.1111/j.1574-6941.2010.00964.x; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Muyzer G, 1996, MOL MICROBIAL ECOLOG, P3441; Oksanen J., 2016, R PACKAG; Ott J, 2004, OCEANOGR MAR BIOL, V42, P95; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; POLZ MF, 1994, APPL ENVIRON MICROB, V60, P4461, DOI 10.1128/AEM.60.12.4461-4467.1994; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Ruehland C, 2010, ENVIRON MICROBIOL, V12, P2312, DOI 10.1111/j.1462-2920.2010.02256.x; Sapp J, 2004, CAN J BOT, V82, P1046, DOI [10.1139/B04-055, 10.1139/b04-055]; Sarbu SM, 1996, SCIENCE, V272, P1953, DOI 10.1126/science.272.5270.1953; Sarbu SM, 2000, ECOSY WORLD, V30, P359; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Unz RF, 2005, BERGEYS MANUAL SYSTE; Vainola R, 2008, HYDROBIOLOGIA, V595, P241, DOI 10.1007/s10750-007-9020-6; Wahl M, 1999, MAR ECOL PROG SER, V187, P59, DOI 10.3354/meps187059; Watsuji T, 2010, MICROBES ENVIRON, V25, P288, DOI 10.1264/jsme2.ME10135; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	57	14	15	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50254	10.1371/journal.pone.0050254	http://dx.doi.org/10.1371/journal.pone.0050254			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209690	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900035
J	Guenther, CM; Lenihan, HS; Grant, LE; Lopez-Carr, D; Reed, DC				Guenther, Carla M.; Lenihan, Hunter S.; Grant, Laura E.; Lopez-Carr, David; Reed, Daniel C.			Trophic Cascades Induced by Lobster Fishing Are Not Ubiquitous in Southern California Kelp Forests	PLOS ONE			English	Article							TOP-DOWN CONTROL; SEA-URCHINS; COMMUNITY STRUCTURE; SUBTIDAL HABITAT; BASE-LINES; ECOSYSTEMS; PREDATION; OTTERS; BEDS; ASSEMBLAGES	Fishing can trigger trophic cascades that alter community structure and dynamics and thus modify ecosystem attributes. We combined ecological data of sea urchin and macroalgal abundance with fishery data of spiny lobster (Panulirus interruptus) landings to evaluate whether: (1) patterns in the abundance and biomass among lobster (predator), sea urchins (grazer), and macroalgae (primary producer) in giant kelp forest communities indicated the presence of top-down control on urchins and macroalgae, and (2) lobster fishing triggers a trophic cascade leading to increased sea urchin densities and decreased macroalgal biomass. Eight years of data from eight rocky subtidal reefs known to support giant kelp forests near Santa Barbara, CA, USA, were analyzed in three-tiered least-squares regression models to evaluate the relationships between: (1) lobster abundance and sea urchin density, and (2) sea urchin density and macroalgal biomass. The models included reef physical structure and water depth. Results revealed a trend towards decreasing urchin density with increasing lobster abundance but little evidence that urchins control the biomass of macroalgae. Urchin density was highly correlated with habitat structure, although not water depth. To evaluate whether fishing triggered a trophic cascade we pooled data across all treatments to examine the extent to which sea urchin density and macroalgal biomass were related to the intensity of lobster fishing (as indicated by the density of traps pulled). We found that, with one exception, sea urchins remained more abundant at heavily fished sites, supporting the idea that fishing for lobsters releases top-down control on urchin grazers. Macroalgal biomass, however, was positively correlated with lobster fishing intensity, which contradicts the trophic cascade model. Collectively, our results suggest that factors other than urchin grazing play a major role in controlling macroalgal biomass in southern California kelp forests, and that lobster fishing does not always catalyze a top-down trophic cascade.	[Guenther, Carla M.] Univ Calif Santa Barbara, Interdept Grad Program Marine Sci, Santa Barbara, CA 93106 USA; [Lenihan, Hunter S.; Grant, Laura E.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Lopez-Carr, David] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA; [Reed, Daniel C.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Guenther, CM (corresponding author), Penobscot E Resource Ctr, Stonington, ME USA.	lenihan@bren.ucsb.edu			National Science Foundation; University of California Marine Council Coastal Environmental Quality Initiative (CEQI) [SB 060020]; CEQI	National Science Foundation(National Science Foundation (NSF)); University of California Marine Council Coastal Environmental Quality Initiative (CEQI); CEQI	Support was provided by the National Science Foundation's Long Term Ecological Research program, the University of California Marine Council Coastal Environmental Quality Initiative (CEQI grant number SB 060020) to HL, CC, and PD, and a CEQI Graduate Fellowship awarded to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airame S, 2003, ECOL APPL, V13, pS170; Arkema KK, 2009, ECOLOGY, V90, P3126, DOI 10.1890/08-1213.1; BREEN PA, 1976, MAR BIOL, V34, P137, DOI 10.1007/BF00390755; Byrnes JE, 2011, GLOBAL CHANGE BIOL, V17, P2513, DOI 10.1111/j.1365-2486.2011.02409.x; Campbell LM, 2009, ECOL SOC, V14; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; COWEN RK, 1983, OECOLOGIA, V58, P249, DOI 10.1007/BF00399225; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Dayton PK, 1998, ECOL APPL, V8, P309, DOI 10.1890/1051-0761(1998)008[0309:SBGARE]2.0.CO;2; de Lestang S, 2009, NEW ZEAL J MAR FRESH, V43, P443, DOI 10.1080/00288330909510013; DUGGINS DO, 1980, ECOLOGY, V61, P447, DOI 10.2307/1937405; EBELING AW, 1985, MAR BIOL, V84, P287, DOI 10.1007/BF00392498; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Foster MS, 2010, J EXP MAR BIOL ECOL, V393, P59, DOI 10.1016/j.jembe.2010.07.002; FOSTER MS, 1991, OIKOS, V62, P93, DOI 10.2307/3545453; FOSTER MS, 1990, HYDROBIOLOGIA, V192, P21, DOI 10.1007/BF00006225; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Graham MH, 2007, OCEANOGR MAR BIOL, V45, P39; Guenther C., 2010, DISSERTATION; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Halpern BS, 2006, SCIENCE, V312, P1230, DOI 10.1126/science.1128613; Harrer SL, 2011, THESIS U CALIFORNIA; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kay MC, 2012, MAR ECOL PROG SER, V451, P137, DOI 10.3354/meps09592; Kay MC, 2012, ECOL APPL, V22, P322, DOI 10.1890/11-0155.1; Lafferty KD, 2004, ECOL APPL, V14, P1566, DOI 10.1890/03-5088; Leet W.S., 2001, CALIFORNIAS LIVING M; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; McArdle DA, 2008, THESIS U CALIFORNIA; Menge BA, 2003, P NATL ACAD SCI USA, V100, P12229, DOI 10.1073/pnas.1534875100; Neilson D.J., 2011, ASSESSMENT CALIFORNI; Pace ML, 1999, TRENDS ECOL EVOL, V14, P483, DOI 10.1016/S0169-5347(99)01723-1; PAINE RT, 1991, OIKOS, V62, P90, DOI 10.2307/3545452; Pearse JS, 2006, SCIENCE, V314, P940, DOI 10.1126/science.1131888; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Reed D, 2009, MAR BIOL, V156, P2077, DOI 10.1007/s00227-009-1238-6; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Salomon AK, 2008, ECOL APPL, V18, P1874, DOI 10.1890/07-1777.1; SCHIEL DR, 1986, OCEANOGR MAR BIOL, V24, P265; Shears NT, 2008, ECOL APPL, V18, P1860, DOI 10.1890/07-1776.1; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Shears NT, 2002, OECOLOGIA, V132, P131, DOI 10.1007/s00442-002-0920-x; Shester GG, 2010, B MAR SCI, V86, P479; Siddon CE, 2003, MAR ECOL PROG SER, V261, P99, DOI 10.3354/meps261099; Staneck RS, 1998, TRENDS ECOL EVOL, V13, P429, DOI 10.1016/S0169-5347(98)01494-3; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; STRONG DR, 1992, ECOLOGY, V73, P747, DOI 10.2307/1940154; TEGNER MJ, 1983, J EXP MAR BIOL ECOL, V73, P125, DOI 10.1016/0022-0981(83)90079-5; TEGNER MJ, 1991, MAR ECOL PROG SER, V77, P49, DOI 10.3354/meps077049; Tegner MJ, 2000, ICES J MAR SCI, V57, P579, DOI 10.1006/jmsc.2000.0715; Terbourgh J., 2010, TROPHIC CASCADES PRE; Walker JW, 2007, MAR ECOL PROG SER, V331, P109, DOI 10.3354/meps331109; WATANABE JM, 1991, MAR ECOL PROG SER, V71, P125, DOI 10.3354/meps071125	58	15	16	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49396	10.1371/journal.pone.0049396	http://dx.doi.org/10.1371/journal.pone.0049396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209573	gold, Green Published			2022-12-25	WOS:000312104900008
J	Huang, QY; Sun, PD; Zhou, XG; Lei, CL				Huang, Qiuying; Sun, Pengdong; Zhou, Xuguo; Lei, Chaoliang			Characterization of Head Transcriptome and Analysis of Gene Expression Involved in Caste Differentiation and Aggression in Odontotermes formosanus (Shiraki)	PLOS ONE			English	Article							TERMITE; ISOPTERA; RETICULITERMES; TOOL; DROSOPHILA; INSIGHTS; BIOLOGY	Background: The subterranean termite Odontotermes formosanus (Shiraki) is a serious insect pest of trees and dams in China. To date, very little is known about genomic or transcriptomic data for caste differentiation and aggression in O. formosanus. Hence, studies on transcriptome and gene expression profiling are helpful to better understand molecular basis underlying caste differentiation and aggressive behavior in O. formosanus. Methodology and Principal Findings: Using the Illumina sequencing, we obtained more than 57 million sequencing reads derived from the heads of O. formosanus. These reads were assembled into 116,885 unique sequences (mean size = 536 bp). Of the unigenes, 30,646 (26.22%) had significant similarity with proteins in the NCBI nonredundant protein database and Swiss-Prot database (E-value < 10(-5)). Of these annotated unigenes, 10,409 and 9,009 unigenes were assigned to gene ontology categories and clusters of orthologous groups, respectively. In total, 19,611 (25.52%) unigenes were mapped onto 242 pathways using the Kyoto Encyclopedia of Genes and Genomes Pathway database (KEGG). A total of 11,661 simple sequence repeats (SSRs) were predicted from the current transcriptome database. Moreover, we detected seven putative genes involved in caste differentiation and six putative genes involved in aggression. The qPCR analysis showed that there were significant differences in the expression levels of the three putative genes hexamerin 2, beta-glycosidase and bicaudal D involved in caste differentiation and one putative gene Cyp6a20 involved in aggression among workers, soldiers and larvae of O. formosanus. Conclusions: To our knowledge, this is the first study to characterize the complete head transcriptome of a higher fungus-cultivating termite using high-throughput sequencing. Our study has provided the comprehensive sequence resources available for elucidating molecular basis underlying caste differentiation and aggressive behavior in O. formosanus.	[Huang, Qiuying; Sun, Pengdong; Lei, Chaoliang] Univ Kentucky, Dept Entomol, Agr Sci Ctr N S225, Lexington, KY 40546 USA; [Zhou, Xuguo] Huazhong Agr Univ, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China	University of Kentucky; Huazhong Agricultural University	Zhou, XG (corresponding author), Univ Kentucky, Dept Entomol, Agr Sci Ctr N S225, Lexington, KY 40546 USA.	xuguozhou@uky.edu; ioir@mail.hzau.edu.cn	Huang, Qiuying/B-6010-2016	Huang, Qiuying/0000-0001-8689-7370	National Natural Science Foundation of China [31000978]; International Foundation for Science [D/4768-1]; National Department Public Benefit (Agriculture) Research Foundation [201003025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Foundation for Science(International Foundation for Science); National Department Public Benefit (Agriculture) Research Foundation	This work was supported by the National Natural Science Foundation of China (31000978), the International Foundation for Science (D/4768-1), and the National Department Public Benefit (Agriculture) Research Foundation (201003025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Baier A, 2002, J EXP BIOL, V205, P1233; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Cheng ML, 2007, SOCIOBIOLOGY, V50, P45; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Fischman BJ, 2011, P NATL ACAD SCI USA, V108, P10847, DOI 10.1073/pnas.1100301108; FLORVALL L, 1978, J MED CHEM, V21, P56, DOI 10.1021/jm00199a010; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hojo M, 2007, INSECT MOL BIOL, V16, P121, DOI 10.1111/j.1365-2583.2007.00709.x; Huang F.S., 2000, FAUNA SINICA INSECTA, V17; Huang QY, 2007, SOCIOBIOLOGY, V50, P867; Huang QY, 2006, J ECON ENTOMOL, V99, P455, DOI 10.1603/0022-0493-99.2.455; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; Husseneder C, 2012, COMP BIOCHEM PHYS D, V7, P14, DOI 10.1016/j.cbd.2011.10.002; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kaib M, 2004, J CHEM ECOL, V30, P365, DOI 10.1023/B:JOEC.0000017983.89279.c5; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Korb J, 2009, SCIENCE, V324, P758, DOI 10.1126/science.1170660; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Leonardo FC, 2011, B ENTOMOL RES, V101, P383, DOI 10.1017/S0007485310000556; Lienard MA, 2006, J INSECT PHYSIOL, V52, P551, DOI 10.1016/j.jinsphys.2006.02.002; LIU YZ, 1985, ACTA ENTOMOL SINICA, V28, P111; Loeber R, 1997, ANNU REV PSYCHOL, V48, P371, DOI 10.1146/annurev.psych.48.1.371; Miura T, 1999, P NATL ACAD SCI USA, V96, P13874, DOI 10.1073/pnas.96.24.13874; Miura T, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P211, DOI 10.1007/978-90-481-3977-4_9; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Scharf ME, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r62; Scharf ME, 2005, INSECT MOL BIOL, V14, P31, DOI 10.1111/j.1365-2583.2004.00527.x; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tecott LH, 1996, CURR BIOL, V6, P238, DOI 10.1016/S0960-9822(02)00466-9; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weil T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-198; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164; Yuan DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022758; Zhang D, 2012, INSECT MOL BIOL, V21, P235, DOI 10.1111/j.1365-2583.2011.01130.x; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164; Zhou X, 2006, INSECT MOL BIOL, V15, P749, DOI 10.1111/j.1365-2583.2006.00675.x; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103	49	28	40	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50383	10.1371/journal.pone.0050383	http://dx.doi.org/10.1371/journal.pone.0050383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209730	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900046
J	Miller, WE; Zagorski, WA; Brenneman, JD; Avery, D; Miller, JLC; O'Connor, CM				Miller, William E.; Zagorski, William A.; Brenneman, Joanna D.; Avery, Diana; Miller, Jeanette L. C.; O'Connor, Christine M.			US28 Is a Potent Activator of Phospholipase C during HCMV Infection of Clinically Relevant Target Cells	PLOS ONE			English	Article							CHEMOKINE RECEPTOR US28; PROTEIN-COUPLED RECEPTOR; CONGENITAL CYTOMEGALOVIRUS-INFECTION; MURINE CYTOMEGALOVIRUS; FUNCTIONAL-ANALYSIS; NEOINTIMA FORMATION; IN-VIVO; EXPRESSION; IDENTIFICATION; MIGRATION	Members of the cytomegalovirus family each encode two or more genes with significant homology to G-protein coupled receptors (GPCRs). In rodent models of pathogenesis, these viral encoded GPCRs play functionally significant roles, as their deletion results in crippled viruses that cannot traffic properly and/or replicate in virally important target cells. Of the four HCMV encoded GPCRs, US28 has garnered the most attention due to the fact that it exhibits both agonist-independent and agonist-dependent signaling activity and has been demonstrated to promote cellular migration and proliferation. Thus, it appears that the CMV GPCRs play important roles in viral replication in vivo as well as promote the development of virus-associated pathology. In the current study we have utilized a series of HCMV/US28 recombinants to investigate the expression profile and signaling activities of US28 in a number of cell types relevant to HCMV infection including smooth muscle cells, endothelial cells and cells derived from glioblastoma multiforme (GBM) tumors. The results indicate that US28 is expressed and exhibits constitutive agonist-independent signaling activity through PLC-beta in all cell types tested. Moreover, while CCL5/RANTES and CX3CL1/Fractalkine both promote US28-dependent Ca++ release in smooth muscle cells, this agonist-dependent effect appears to be cell-specific as we fail to detect US28 driven Ca++ release in the GBM cells. We have also investigated the effects of US28 on signaling via endogenous GPCRs including those in the LPA receptor family. Our data indicate that US28 can enhance signaling via endogenous LPA receptors. Taken together, our results indicate that US28 induces a variety of signaling events in all cell types tested suggesting that US28 signaling likely plays a significant role during HCMV infection and dissemination in vivo. Citation: Miller WE, Zagorski WA, Brenneman JD, Avery D, Miller JLC, et al. (2012) US28 Is a Potent Activator of Phospholipase C during HCMV Infection of Clinically Relevant Target Cells. PLoS ONE 7(11): e50524. doi:10.1371/journal.pone.0050524	[Miller, William E.; Zagorski, William A.; Brenneman, Joanna D.; Avery, Diana; Miller, Jeanette L. C.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [O'Connor, Christine M.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Virol Sect, Cleveland, OH 44106 USA	University System of Ohio; University of Cincinnati; Cleveland Clinic Foundation	Miller, WE (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	william.miller@uc.edu		Miller, William/0000-0001-6900-4884	National Institutes of Health [R01 AI058159]; March of Dimes Grant [5-FY-04-17]; New Jersey Commission on Cancer Research [09-1960-CC640 E0]; American Cancer Society [PF-10-164-01-MPC]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK060444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Grant(March of Dimes); New Jersey Commission on Cancer Research; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (R01 AI058159) and March of Dimes Grant (5-FY-04-17) awarded to WEM and from grants from the New Jersey Commission on Cancer Research (09-1960-CC640 E0) and the American Cancer Society (PF-10-164-01-MPC) awarded to CMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHUJA SK, 1993, J BIOL CHEM, V268, P20691; Bakker RA, 2004, J BIOL CHEM, V279, P5152, DOI 10.1074/jbc.M309200200; Billstrom MA, 1998, J VIROL, V72, P5535, DOI 10.1128/JVI.72.7.5535-5544.1998; Bodaghi B, 1998, J EXP MED, V188, P855, DOI 10.1084/jem.188.5.855; Bongers G, 2010, J CLIN INVEST, V120, P3969, DOI 10.1172/JCI42563; BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007; Casarosa P, 2005, J BIOL CHEM, V280, P3275, DOI 10.1074/jbc.M407536200; Casarosa P, 2003, J BIOL CHEM, V278, P5172, DOI 10.1074/jbc.M210033200; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Case R, 2008, J VIROL, V82, P1884, DOI 10.1128/JVI.02550-06; Cesarman E, 1996, J VIROL, V70, P8218, DOI 10.1128/JVI.70.11.8218-8223.1996; DavisPoynter NJ, 1997, J VIROL, V71, P1521, DOI 10.1128/JVI.71.2.1521-1529.1997; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; GAO JL, 1994, J BIOL CHEM, V269, P28539; GEBALLE AP, 1986, J VIROL, V57, P864, DOI 10.1128/JVI.57.3.864-874.1986; GIBSON W, 1983, VIROLOGY, V128, P391, DOI 10.1016/0042-6822(83)90265-9; Hahn G, 2002, J VIROL, V76, P9551, DOI 10.1128/JVI.76.18.9551-9555.2002; Hebart H, 1998, Curr Opin Hematol, V5, P483, DOI 10.1097/00062752-199811000-00022; Isegawa Y, 1998, J VIROL, V72, P6104, DOI 10.1128/JVI.72.7.6104-6112.1998; Khanna R, 2006, TRENDS MOL MED, V12, P26, DOI 10.1016/j.molmed.2005.11.006; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; KUHN DE, 1995, BIOCHEM BIOPH RES CO, V211, P325, DOI 10.1006/bbrc.1995.1814; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Ljungman P, 2002, CLIN INFECT DIS, V34, P1094, DOI 10.1086/339329; Magri G, 2011, BLOOD, V117, P848, DOI 10.1182/blood-2010-08-301374; Margulies BJ, 1996, VIROLOGY, V225, P111, DOI 10.1006/viro.1996.0579; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Maussang D, 2009, METHOD ENZYMOL, V460, P151, DOI 10.1016/S0076-6879(09)05207-0; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; McLean KA, 2004, VIROLOGY, V325, P241, DOI 10.1016/j.virol.2004.04.027; Melnychuk RM, 2004, J VIROL, V78, P8382, DOI 10.1128/jvi.78.15.8382-8391.2004; Miller WE, 2003, J BIOL CHEM, V278, P21663, DOI 10.1074/jbc.M303219200; Milne RSB, 2000, J IMMUNOL, V164, P2396, DOI 10.4049/jimmunol.164.5.2396; Minisini R, 2003, J VIROL, V77, P4489, DOI 10.1128/JVI.77.8.4489-4501.2003; Mocarski E.S., 2001, FIELDS VIROLOGY, V4th Edn, P2629; Mokros T, 2002, J BIOL CHEM, V277, P45122, DOI 10.1074/jbc.M208214200; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; O'Connor CM, 2012, J VIROL, V86, P9854, DOI 10.1128/JVI.01278-12; O'Connor CM, 2011, J VIROL, V85, P3700, DOI 10.1128/JVI.02442-10; O'Connor CM, 2012, J VIROL; Passs RF, 2001, FIELDS VIROLOGY, P2675; Pleskoff O, 2005, FEBS J, V272, P4163, DOI 10.1111/j.1742-4658.2005.04829.x; Schempp S, 2011, VIRUS RES, V155, P446, DOI 10.1016/j.virusres.2010.11.014; Schober A, 2012, BR J PHARM; Sharon-Friling R, 2006, P NATL ACAD SCI USA, V103, P19117, DOI 10.1073/pnas.0609353103; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soroceanu L, 2011, CANC RES; STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601; STINSKI MF, 1978, J VIROL, V26, P686, DOI 10.1128/JVI.26.3.686-701.1978; Streblow DN, 2003, J BIOL CHEM, V278, P50456, DOI 10.1074/jbc.M307936200; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Stropes MP, 2009, J VIROL, V83, P10016, DOI 10.1128/JVI.00354-09; Stropes MPM, 2008, J GEN VIROL, V89, P97, DOI 10.1099/vir.0.83226-0; Subramanian P, 2010, CIRC RES, V107, P96, DOI 10.1161/CIRCRESAHA.109.212647; Terhune S, 2007, J VIROL, V81, P3109, DOI 10.1128/JVI.02124-06; Vieira J, 1998, J VIROL, V72, P8158, DOI 10.1128/JVI.72.10.8158-8165.1998; Vischer HF, 2005, TRENDS PHARM SCI; Vomaske J, 2009, INFECT DISORD DRUG T; Vomaske J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000304; Waldhoer M, 2002, J VIROL, V76, P8161, DOI 10.1128/JVI.76.16.8161-8168.2002; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wing BA, 1998, J VIROL, V72, P1814, DOI 10.1128/JVI.72.3.1814-1825.1998; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619; ZHU H, 1995, J VIROL, V69, P7960, DOI 10.1128/JVI.69.12.7960-7970.1995	66	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50524	10.1371/journal.pone.0050524	http://dx.doi.org/10.1371/journal.pone.0050524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209769	Green Submitted, Green Published, gold			2022-12-25	WOS:000312104900063
J	Foerster, S; Cords, M; Monfort, SL				Foerster, Steffen; Cords, Marina; Monfort, Steven L.			Seasonal Energetic Stress in a Tropical Forest Primate: Proximate Causes and Evolutionary Implications	PLOS ONE			English	Article							FECAL GLUCOCORTICOID LEVELS; BABOONS PAPIO-HAMADRYAS; FREE-RANGING MALE; CORTISOL-LEVELS; LIFE-HISTORIES; ENVIRONMENTAL VARIABILITY; INDIVIDUAL-DIFFERENCES; REPRODUCTIVE SUCCESS; FOOD AVAILABILITY; FALLBACK FOODS	Animals facing seasonal variation in food availability experience selective pressures that favor behavioral adjustments such as migration, changes in activity, or shifts in diet. Eclectic omnivores such as many primates can process low-quality fallback food when preferred food is unavailable. Such dietary flexibility, however, may be insufficient to eliminate constraints on reproduction even for species that live in relatively permissive environments, such as moist tropical forests. Focusing on a forest-dwelling primate with a flexible diet (Cercopithecus mitis) we investigated whether females experience seasonal energetic stress and how it may relate to reproductive seasonality. We used fecal glucocorticoids (fGCs) as an indicator of energetic stress, controlling for the potentially confounding effects of social interactions and reproductive state. We modeled within-female fGC variation with General Linear Mixed Models, evaluating changes in feeding behavior and food availability as main effects. Regardless of reproductive state, fGCs increased when females shifted their diet towards fallback foods (mature leaves and other non-preferred items) and when they spent more time feeding, while fGCs decreased with feeding time on preferred items (insects, fruits, young leaves) and with the availability of young leaves. Changes in fruit availability had no general effects on fGCs, likely because fruits were sought out regardless of availability. As predicted, females in the energetically demanding stages of late pregnancy and early lactation showed greater increases in fGCs between periods of low versus high availability of fruits and young leaves than females in other reproductive states. Potential social stressors had no measurable effects on fGCs. Preliminary evidence suggests that seasonal energetic stress may affect the timing of infant independence from mothers and contribute to unusually long inter-birth intervals compared to closely related species of similar body size. Our findings highlight how the study of stress responses can provide insights into the proximate control of reproductive strategies.	[Foerster, Steffen; Cords, Marina] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Foerster, Steffen] Natl Museums Kenya, Inst Primate Res, Nairobi, Kenya; [Monfort, Steven L.] Smithsonian Conservat Biol Inst, Front Royal, VA USA	Columbia University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Foerster, S (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	sf2041@columbia.edu		Foerster, Steffen/0000-0002-6081-1775	National Science Foundation [BCS 0550509, 0554747]; Columbia University; Earthwatch Institute; Animal Behavior Society; American Society of Primatologists; Smithsonian Institution; Friends of the National Zoo	National Science Foundation(National Science Foundation (NSF)); Columbia University; Earthwatch Institute; Animal Behavior Society; American Society of Primatologists; Smithsonian Institution(Smithsonian Institution); Friends of the National Zoo(Smithsonian InstitutionSmithsonian National Zoological Park & Conservation Biology Institute)	This work was supported by the National Science Foundation (BCS 0550509, 0554747 to MC); Columbia University; the Earthwatch Institute; the Animal Behavior Society; the American Society of Primatologists, the Friends of the National Zoo and the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; ALBERTS SC, 1992, HORM BEHAV, V26, P167, DOI 10.1016/0018-506X(92)90040-3; Alberts SC, 2006, DEV PRIMATOL-PROG PR, P277; Altmann J., 1980, BABOON MOTHERS INFAN; Altmann SA, 2009, AM J PHYS ANTHROPOL, V140, P615, DOI 10.1002/ajpa.21097; Angelier F, 2009, GEN COMP ENDOCR, V163, P142, DOI 10.1016/j.ygcen.2009.03.028; [Anonymous], 2007, TERRESTRIAL AIR TEMP; Barrett GM, 2002, HORM BEHAV, V42, P85, DOI 10.1006/hbeh.2002.1804; BARRETT L, 2006, DEV PRIMATOL, P199; Beehner JC, 2008, PHYSIOL BEHAV, V95, P508, DOI 10.1016/j.physbeh.2008.07.022; Beehner JC, 2006, HORM BEHAV, V49, P688, DOI 10.1016/j.yhbeh.2005.12.016; BERCOVITCH FB, 1993, FOLIA PRIMATOL, V61, P115, DOI 10.1159/000156738; Bonier F, 2007, BEHAV ECOL, V18, P121, DOI 10.1093/beheco/arl050; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P1, DOI 10.1017/CBO9780511542343; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; BRONSON FH, 1985, BIOL REPROD, V32, P1, DOI 10.1095/biolreprod32.1.1; Bronson FH, 1989, MAMMALIAN REPROD BIO; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Butynski T.M., 1988, P284; Carnegie SD, 2011, AM J PRIMATOL, V73, P861, DOI 10.1002/ajp.20954; Cavigelli SA, 1999, ANIM BEHAV, V57, P935, DOI 10.1006/anbe.1998.1054; Cavigelli SA, 2003, HORM BEHAV, V43, P166, DOI 10.1016/S0018-506X(02)00031-4; CHAMPOUX M, 1993, PHYSIOL BEHAV, V54, P1091, DOI 10.1016/0031-9384(93)90330-I; CHARNOV EL, 1991, P NATL ACAD SCI USA, V88, P1134, DOI 10.1073/pnas.88.4.1134; Cheney DL, 2006, DEV PRIMATOL-PROG PR, P147; Cords M., 1987, University of California Publications in Zoology, V117, P1; Cords Marina, 2002, P189; Cords M, 2010, INT J PRIMATOL, V31, P409, DOI [10.1007/s10764-010-9400-z, 10.1007/s10764-010-9405-7]; Cords Marina, 2000, P453, DOI 10.1017/CBO9780511542589.018; Crockford C, 2008, HORM BEHAV, V53, P254, DOI 10.1016/j.yhbeh.2007.10.007; DASILVA GL, 1994, INT J PRIMATOL, V15, P655, DOI 10.1007/BF02737426; De Roos AM, 2009, ECOLOGY, V90, P945, DOI 10.1890/07-1153.1; Dunbar R.I.M., 1983, P423; Dunbar RIM, 2002, ANIM BEHAV, V64, P801, DOI 10.1006/anbe.2002.9972; Engh AL, 2006, ANIM BEHAV, V71, P1227, DOI 10.1016/j.anbehav.2005.11.009; Fashing PJ, 2001, INT J PRIMATOL, V22, P579, DOI 10.1023/A:1010737601922; Felig P., 2001, ENDOCRINOLOGY METABO; Fichtel C, 2007, HORM BEHAV, V51, P640, DOI 10.1016/j.yhbeh.2007.03.005; Foerster S, 2011, AM J PRIMATOL, V73, P870, DOI 10.1002/ajp.20955; Foerster S, 2010, HORM BEHAV, V58, P685, DOI 10.1016/j.yhbeh.2010.06.002; Foerster Steffen, 2002, P245; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Forster S, 2005, BEHAVIOUR, V142, P869, DOI 10.1163/1568539055010138; FRISCH RE, 1991, TRENDS ENDOCRIN MET, V2, P191, DOI 10.1016/1043-2760(91)90018-I; Gesquiere LR, 2008, HORM BEHAV, V54, P410, DOI 10.1016/j.yhbeh.2008.04.007; Gesquiere LR, 2011, AM J PHYS ANTHROPOL, V144, P169, DOI 10.1002/ajpa.21374; Gibbons RD, 2010, ANNU REV CLIN PSYCHO, V6, P79, DOI 10.1146/annurev.clinpsy.032408.153550; Girard-Buttoz C, 2009, PHYSIOL BEHAV, V98, P168, DOI 10.1016/j.physbeh.2009.05.005; GOLAND RS, 1992, NEUROENDOCRINOLOGY, V56, P742, DOI 10.1159/000126302; GOUZOULES H, 1982, ANIM BEHAV, V30, P1138, DOI 10.1016/S0003-3472(82)80204-2; Gust DA, 2000, J CLIN ENDOCR METAB, V85, P2556, DOI 10.1210/jc.85.7.2556; Hemingway CA, 2005, CAM S BIO EVOL ANTHR, V44, P57, DOI 10.1017/CBO9780511542343.004; Higham JP, 2011, ANIM BEHAV, V81, P1001, DOI 10.1016/j.anbehav.2011.02.001; Hinde K, 2009, AM J PHYS ANTHROPOL, V138, P148, DOI 10.1002/ajpa.20911; Hinde K, 2011, EVOL ANTHROPOL, V20, P9, DOI 10.1002/evan.20289; Hunt KE, 2003, PHYSIOL BIOCHEM ZOOL, V76, P918, DOI 10.1086/380209; Isbell LA, 2009, INT J PRIMATOL, V30, P103, DOI 10.1007/s10764-009-9332-7; Janson C, 2005, CAM S BIO EVOL ANTHR, V44, P307, DOI 10.1017/CBO9780511542343.012; Jenni-Eiermann S, 2008, GEN COMP ENDOCR, V155, P558, DOI 10.1016/j.ygcen.2007.08.011; Kanaley JA, 2002, ENDOCRINOLOGIST, V12, P421, DOI 10.1097/00019616-200209000-00010; Kitaysky AS, 1999, FUNCT ECOL, V13, P577, DOI 10.1046/j.1365-2435.1999.00352.x; Klass K, 2011, BEHAV PROCESS, V88, P168, DOI 10.1016/j.beproc.2011.09.003; Lac G, 1997, J SPORT MED PHYS FIT, V37, P56; Lambert Joanna E., 2002, P309; LEVINE S, 1993, PSYCHOTHER PSYCHOSOM, V60, P33, DOI 10.1159/000288677; Lycett JE, 1998, BEHAV ECOL SOCIOBIOL, V42, P49, DOI 10.1007/s002650050410; Lynch JW, 2003, GEN COMP ENDOCR, V132, P264, DOI 10.1016/S0016-6480(03)00093-5; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; McCabe GM, 2007, INT J PRIMATOL, V28, P837, DOI 10.1007/s10764-007-9159-z; Mitani J. C., 2002, BEHAV DIVERSITY CHIM; Mitchell N., 2009, KARLRUHER GEOWISSE A, V17, P1; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Nilsen EB, 2009, J ANIM ECOL, V78, P585, DOI 10.1111/j.1365-2656.2009.01523.x; Ortiz RM, 2001, AM J PHYSIOL-REG I, V280, pR790, DOI 10.1152/ajpregu.2001.280.3.R790; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; Pazol Karen, 2002, P217; Pride E, 2005, BEHAV ECOL, V16, P550, DOI 10.1093/beheco/ari025; Pride RE, 2005, INT J PRIMATOL, V26, P295, DOI 10.1007/s10764-005-2926-9; Reeder DM, 2004, GEN COMP ENDOCR, V136, P260, DOI 10.1016/j.ygcen.2003.12.020; Richard AF, 2000, J HUM EVOL, V39, P381, DOI 10.1006/jhev.2000.0427; Ricklefs RE, 2002, TRENDS ECOL EVOL, V17, P462, DOI 10.1016/S0169-5347(02)02578-8; Robinson WD, 2010, AUK, V127, P253, DOI 10.1525/auk.2010.127.2.253; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Ross C, 1998, EVOL ANTHROPOL, V6, P54, DOI 10.1002/(SICI)1520-6505(1998)6:2<54::AID-EVAN3>3.3.CO;2-D; ROWELL TE, 1979, J MAMMAL, V60, P58, DOI 10.2307/1379758; SAPOLSKY RM, 1994, SEMIN NEUROSCI, V6, P261, DOI 10.1006/smns.1994.1033; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapolsky RM, 1995, ANN NY ACAD SCI, V771, P626, DOI 10.1111/j.1749-6632.1995.tb44715.x; Savini T, 2008, AM J PHYS ANTHROPOL, V135, P1, DOI 10.1002/ajpa.20578; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Setchell JM, 2008, AM J PRIMATOL, V70, P1023, DOI 10.1002/ajp.20594; Shutt K, 2007, BIOLOGY LETT, V3, P231, DOI 10.1098/rsbl.2007.0052; Strier KB, 2001, AM J PRIMATOL, V55, P87, DOI 10.1002/ajp.1042; TANAKA I, 1992, ANIM BEHAV, V44, P129, DOI 10.1016/S0003-3472(05)80762-6; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/revreprod/5.2.105; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Schaik CP, 2005, CAM S BIO EVOL ANTHR, V44, P23, DOI 10.1017/CBO9780511542343.003; VANSCHAIK CP, 1985, J ZOOL, V206, P533; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; Watts DP, 1998, INT J PRIMATOL, V19, P929, DOI 10.1023/A:1020366018187; Weingrill T, 2004, HORM BEHAV, V45, P259, DOI 10.1016/j.yhbeh.2003.12.004; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006; Zinner D, 1999, ZOO BIOL, V18, P495, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;495::AID-ZOO4&gt;3.0.CO;2-U	105	45	46	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50108	10.1371/journal.pone.0050108	http://dx.doi.org/10.1371/journal.pone.0050108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209651	Green Submitted, gold, Green Published			2022-12-25	WOS:000312601700033
J	Owens, M; Goodyer, IM; Wilkinson, P; Bhardwaj, A; Abbott, R; Croudace, T; Dunn, V; Jones, PB; Walsh, ND; Ban, M; Sahakian, BJ				Owens, Matthew; Goodyer, Ian M.; Wilkinson, Paul; Bhardwaj, Anupam; Abbott, Rosemary; Croudace, Tim; Dunn, Valerie; Jones, Peter B.; Walsh, Nicholas D.; Ban, Maria; Sahakian, Barbara J.			5-HTTLPR and Early Childhood Adversities Moderate Cognitive and Emotional Processing in Adolescence	PLOS ONE			English	Article							SEROTONIN TRANSPORTER GENE; MAJOR DEPRESSIVE DISORDER; PROMOTER REGION POLYMORPHISM; FUNCTIONAL POLYMORPHISM; FEELINGS QUESTIONNAIRE; BIASED ATTENTION; MOOD DISORDERS; LIFE-STRESS; DIFFERENTIAL SUSCEPTIBILITY; ENVIRONMENT INTERACTIONS	Background: Polymorphisms in the promoter region of the serotonin transporter gene (5-HTTLPR) and exposure to early childhood adversities (CA) are independently associated with individual differences in cognitive and emotional processing. Whether these two factors interact to influence cognitive and emotional processing is not known. Methodology and Principal Findings: We used a sample of 238 adolescents from a community study characterised by the presence of the short allele of 5-HTTLPR (LL, LS, SS) and the presence or absence of exposure to CA before 6 years of age. We measured cognitive and emotional processing using a set of neuropsychological tasks selected predominantly from the CANTAB (R) battery. We found that adolescents homozygous for the short allele (SS) of 5-HTTLPR and exposed to CA were worse at classifying negative and neutral stimuli and made more errors in response to ambiguous negative feedback. In addition, cognitive and emotional processing deficits were associated with diagnoses of anxiety and/or depressions. Conclusion and Significance: Cognitive and emotional processing deficits may act as a transdiagnostic intermediate marker for anxiety and depressive disorders in genetically susceptible individuals exposed to CA.	[Owens, Matthew; Goodyer, Ian M.; Wilkinson, Paul; Bhardwaj, Anupam; Abbott, Rosemary; Croudace, Tim; Dunn, Valerie; Jones, Peter B.; Walsh, Nicholas D.; Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Dev & Lifecourse Res Grp, Cambridge, England; [Goodyer, Ian M.; Wilkinson, Paul; Bhardwaj, Anupam; Jones, Peter B.] Cambridge & Peterborough Natl Hlth Serv NHS Fdn T, Cambridge, England; [Ban, Maria] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Owens, M (corresponding author), Univ Cambridge, Dept Psychiat, Dev & Lifecourse Res Grp, Cambridge, England.	mo344@medschl.cam.ac.uk; ig104@cam.ac.uk	Walsh, Nicholas/E-5809-2013; Owens, Matthew/GPW-7887-2022; Sahakian, Barbara/AAW-1198-2020; Croudace, Tim/ABC-9681-2021	Walsh, Nicholas/0000-0002-8195-7933; Owens, Matthew/0000-0001-7407-6540; Sahakian, Barbara/0000-0001-7352-1745; Croudace, Tim/0000-0001-8346-7463; Jones, Peter Brian/0000-0002-0387-880X	Wellcome Trust [074296]; MRC (UK); NIHR (UK); Department of Health, UK	Wellcome Trust(Wellcome TrustEuropean Commission); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR (UK)(National Institute for Health Research (NIHR)); Department of Health, UK	IMG, PW, TC, PBJ, and BJS are supported by programme and project grants from the Wellcome Trust (Grant no. 074296), MRC (UK) and NIHR (UK). TC held a Senior Research Fellowship from the Department of Health, UK during this study. BJS is a member of the Behavioural and Clinical Neurosciences Institute, University of Cambridge. This work was completed within the NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRC) of which PBJ is Director and IMG and TC are the Adolescent Programme and Methods leaders respectively. The CLAHRC is hosted by the University of Cambridge and the Cambridge and Peterborough NHS Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce E, 2009, J AFFECT DISORDERS, V114, P286, DOI 10.1016/j.jad.2008.08.015; Barnett JH, 2006, PSYCHOL MED, V36, P1053, DOI 10.1017/S0033291706007501; Beats BC, 1996, PSYCHOL MED, V26, P591, DOI 10.1017/S0033291700035662; Beck AT, 2008, AM J PSYCHIAT, V165, P969, DOI 10.1176/appi.ajp.2008.08050721; Beevers CG, 2010, BIOL PSYCHOL, V83, P260, DOI 10.1016/j.biopsycho.2009.08.007; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chamberlain SR, 2006, CURR OPIN NEUROL, V19, P607, DOI 10.1097/01.wco.0000247613.28859.77; Clarke H, 2010, PSYCHOL MED, V40, P1767, DOI 10.1017/S0033291710000516; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collier DA, 1996, MOL PSYCHIATR, V1, P453; COSTELLO EJ, 1988, J AM ACAD CHILD PSY, V27, P726, DOI 10.1097/00004583-198811000-00011; Costello EJ, 2002, BIOL PSYCHIAT, V52, P529, DOI 10.1016/S0006-3223(02)01372-0; Dalgleish T, 2003, J CLIN CHILD ADOLESC, V32, P10, DOI 10.1207/S15374424JCCP3201_02; Daviss WB, 2006, J CHILD PSYCHOL PSYC, V47, P927, DOI 10.1111/j.1469-7610.2006.01646.x; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; Dunn EC, 2011, J CHILD PSYCHOL PSYC, V52, P1223, DOI 10.1111/j.1469-7610.2011.02466.x; Dunn VJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-109; Ehli EA, 2012, MOL PSYCHIATR, V17, P185, DOI 10.1038/mp.2010.130; Elliott R, 1997, J NEUROL NEUROSUR PS, V63, P74, DOI 10.1136/jnnp.63.1.74; Ellis BJ, 2008, CURR DIR PSYCHOL SCI, V17, P183, DOI 10.1111/j.1467-8721.2008.00571.x; Ellis BJ, 2011, DEV PSYCHOPATHOL, V23, P7, DOI 10.1017/S0954579410000611; Finger EC, 2007, NEUROPSYCHOPHARMACOL, V32, P206, DOI 10.1038/sj.npp.1301182; Fisher HL, 2012, J AFFECT DISORDERS, V136, P189, DOI 10.1016/j.jad.2011.09.016; Fox E, 2011, BIOL PSYCHIAT, V70, P1049, DOI 10.1016/j.biopsych.2011.07.004; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Goodyer IM, 2010, INT J EPIDEMIOL, V39, P361, DOI 10.1093/ije/dyp173; Greenberg BD, 1999, AM J MED GENET, V88, P83, DOI 10.1002/(SICI)1096-8628(19990205)88:1<83::AID-AJMG15>3.3.CO;2-S; Heils A, 1996, J NEUROCHEM, V66, P2621; HOLM S, 1979, SCAND J STAT, V6, P65; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Hu XZ, 2005, ALCOHOL CLIN EXP RES, V29, P8, DOI 10.1097/01.ALC.0000150008.68473.62; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Kwang T, 2010, DEPRESS ANXIETY, V27, P746, DOI 10.1002/da.20708; Kyte ZA, 2005, J CHILD PSYCHOL PSYC, V46, P995, DOI 10.1111/j.1469-7610.2004.00400.x; Lasky-Su JA, 2005, AM J MED GENET B, V133B, P110, DOI 10.1016/j.ajmg.b.30104; Lau JYF, 2007, DEV PSYCHOPATHOL, V19, P1129, DOI 10.1017/S0954579407000582; Lau JYF, 2010, ANNU REV CLIN PSYCHO, V6, P313, DOI 10.1146/annurev.clinpsy.121208.131308; Lau JYF, 2009, BIOL PSYCHIAT, V65, P349, DOI 10.1016/j.biopsych.2008.08.037; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 1999, J NEURAL TRANSM, V106, P1223, DOI 10.1007/s007020050236; LEWINSOHN PM, 1981, J ABNORM PSYCHOL, V90, P213, DOI 10.1037//0021-843X.110.2.203; Martin J, 2007, MOL PSYCHIATR, V12, P421, DOI 10.1038/sj.mp.4001952; Monroe SM, 2008, PSYCHOL SCI, V19, P947, DOI 10.1111/j.1467-9280.2008.02181.x; Munafo MR, 2009, BIOL PSYCHIAT, V65, P211, DOI 10.1016/j.biopsych.2008.06.009; Muris P, 2008, COGNITION EMOTION, V22, P395, DOI 10.1080/02699930701843450; Murphy FC, 1999, PSYCHOL MED, V29, P1307, DOI 10.1017/S0033291799001233; Murphy FC, 2003, PSYCHOL MED, V33, P455, DOI 10.1017/S0033291702007018; Murray L, 2006, DEV PSYCHOPATHOL, V18, P489, DOI 10.1017/S0954579406060263; Murray L, 2001, J CHILD PSYCHOL PSYC, V42, P891, DOI 10.1111/1469-7610.00785; Muthen B., 2001, NEW DEV TECHNIQUES S, P1; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Osinsky R, 2008, EMOTION, V8, P584, DOI 10.1037/a0012826; Parsey RV, 2006, AM J PSYCHIAT, V163, P48, DOI 10.1176/appi.ajp.163.1.48; Perez-Edgar K, 2010, BIOL PSYCHOL, V83, P269, DOI 10.1016/j.biopsycho.2009.08.009; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pine DS, 2005, AM J PSYCHIAT, V162, P291, DOI 10.1176/appi.ajp.162.2.291; Quinn CR, 2012, AUST NZ J PSYCHIAT, V46, P55, DOI 10.1177/0004867411430878; Risch, 2009, JAMA-J AM MED ASSOC, V302, P492; Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183; Roiser JP, 2005, AM J PSYCHIAT, V162, P609, DOI 10.1176/appi.ajp.162.3.609; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Sattler J., 1992, ASSESSMENT CHILDREN; Sharp C, 2006, J ABNORM CHILD PSYCH, V34, P379, DOI 10.1007/s10802-006-9027-x; Sharp C, 2008, J AM ACAD CHILD PSY, V47, P565, DOI 10.1097/CHI.0b013e31816765d4; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sugden K, 2010, J AM ACAD CHILD PSY, V49, P830, DOI 10.1016/j.jaac.2010.01.024; Szekely E, 2011, J CHILD PSYCHOL PSYC, V52, P1279, DOI 10.1111/j.1469-7610.2011.02423.x; Tavares JVT, 2008, NEUROIMAGE, V42, P1118, DOI 10.1016/j.neuroimage.2008.05.049; Taylor SE, 2006, BIOL PSYCHIAT, V60, P671, DOI 10.1016/j.biopsych.2006.04.019; Thomason ME, 2010, BIOL PSYCHOL, V85, P38, DOI 10.1016/j.biopsycho.2010.04.009; Uher R, 2008, MOL PSYCHIATR, V13, P131, DOI 10.1038/sj.mp.4002067; Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123; Wechsler DW., 1999, INTELLIGENCE SCALE C; Wendland JR, 2006, MOL PSYCHIATR, V11, P224, DOI 10.1038/sj.mp.4001789; Wichers M, 2010, PSYCHOL MED, V40, P359, DOI 10.1017/S0033291709990420; WOOD A, 1995, J CHILD PSYCHOL PSYC, V36, P327, DOI 10.1111/j.1469-7610.1995.tb01828.x; World Medical Association, 2008, WMA DECL HELS ETH PR	84	34	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e48482	10.1371/journal.pone.0048482	http://dx.doi.org/10.1371/journal.pone.0048482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209555	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700003
J	Caterson, SA; Fox, SE; Tobias, AM; Lee, BT				Caterson, Stephanie A.; Fox, Sharon E.; Tobias, Adam M.; Lee, Bernard T.			Functional MRI To Evaluate "Sense of Self" following Perforator Flap Breast Reconstruction	PLOS ONE			English	Article							QUALITY-OF-LIFE; PATIENT SATISFACTION; PREMOTOR CORTEX; LIMB POSITION; HAND; REPRESENTATION; DETERMINANTS; OWNERSHIP; NEURONS; BODY	Background: Breast reconstruction is associated with high levels of patient satisfaction. Previous patient satisfaction studies have been subjective. This study utilizes functional magnetic resonance imaging (fMRI) to objectively evaluate "sense of self" following deep inferior epigastric perforator (DIEP) flap breast reconstruction in an attempt to better understand patient perception. Methods: Prospective fMRI analysis was performed on four patients before and after delayed unilateral DIEP flap breast reconstruction, and on four patients after immediate unilateral DIEP flap breast reconstruction. Patients were randomly cued to palpate their natural breast, mastectomy site or breast reconstruction, and external silicone models. Three regions of interest (ROIs) associated with self-recognition were examined using a general linear model, and compared using a fixed effects and random effects ANOVA, respectively. Results: In the delayed reconstruction group, activation of the ROIs was significantly lower at the mastectomy site compared to the natural breast (p < 0.01). Ten months following reconstruction, activation of the ROIs in the reconstructed breast was not significantly different from that observed with natural breast palpation. In the immediate reconstruction group, palpation of the reconstructed breast was also similar to the natural breast. This activity was greater than that observed during palpation of external artificial models (p < 0.01). Conclusions: Similar activation patterns were observed during palpation of the reconstructed and natural breasts as compared to the non-reconstructed mastectomy site and artificial models. The cognitive process represented by this pattern may be a mechanism by which breast reconstruction improves self-perception, and thus patient satisfaction following mastectomy.	[Fox, Sharon E.; Tobias, Adam M.; Lee, Bernard T.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Div Plast & Reconstruct Surg, Boston, MA 02215 USA; [Caterson, Stephanie A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02215 USA; [Fox, Sharon E.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Lee, BT (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Div Plast & Reconstruct Surg, Boston, MA 02215 USA.	blee3@bidmc.harvard.edu	Fox, Sharon E./AAR-9236-2020; Lee, Bernard T./K-1106-2016	Lee, Bernard T./0000-0002-5533-3166	Doris Duke Charitable Foundation; Peter Jay Sharp Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Peter Jay Sharp Foundation	Funding for this project was provided by the Doris Duke Charitable Foundation (S.E.F.) and the Peter Jay Sharp Foundation (A.M.T., B.T.L, and S.A.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderman AK, 2000, PLAST RECONSTR SURG, V106, P769, DOI 10.1097/00006534-200009040-00003; Andrade WN, 2001, PLAST RECONSTR SURG, V107, P46, DOI 10.1097/00006534-200101000-00008; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Damen THC, 2010, J PLAST RECONSTR AES, V63, P93, DOI 10.1016/j.bjps.2008.08.019; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; DEAN C, 1983, LANCET, V1, P459; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Hu ES, 2009, PLAST RECONSTR SURG, V124, P1, DOI 10.1097/PRS.0b013e3181ab10b2; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Mitchell R W, 1997, Ann N Y Acad Sci, V818, P38; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; Pusic AL, 2012, EXPERT REV PHARM OUT, V12, P149, DOI [10.1586/ERP.11.105, 10.1586/erp.11.105]; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; Zhong T, 2012, CANCER-AM CANCER SOC, V118, P1701, DOI 10.1002/cncr.26417	20	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49883	10.1371/journal.pone.0049883	http://dx.doi.org/10.1371/journal.pone.0049883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209611	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800029
J	Dalby, AR; Emam, I; Franke, R				Dalby, Andrew R.; Emam, Ibrahim; Franke, Raimo			Analysis of Gene Expression Data from Non-Small Cell Lung Carcinoma Cell Lines Reveals Distinct Sub-Classes from Those Identified at the Phenotype Level	PLOS ONE			English	Article							CANCER-CELLS; DISCOVERY; CLASSIFICATION; DESIGN; TOOLS	Microarray data from cell lines of Non-Small Cell Lung Carcinoma (NSCLC) can be used to look for differences in gene expression between the cell lines derived from different tumour samples, and to investigate if these differences can be used to cluster the cell lines into distinct groups. Dividing the cell lines into classes can help to improve diagnosis and the development of screens for new drug candidates. The micro-array data is first subjected to quality control analysis and then subsequently normalised using three alternate methods to reduce the chances of differences being artefacts resulting from the normalisation process. The final clustering into sub-classes was carried out in a conservative manner such that subclasses were consistent across all three normalisation methods. If there is structure in the cell line population it was expected that this would agree with histological classifications, but this was not found to be the case. To check the biological consistency of the sub-classes the set of most strongly differentially expressed genes was be identified for each pair of clusters to check if the genes that most strongly define sub-classes have biological functions consistent with NSCLC.	[Dalby, Andrew R.] Univ Westminster, Dept Mol Biosci, London W1R 8AL, England; [Emam, Ibrahim] EMBL EBI, Hinxton, England; [Franke, Raimo] Helmholtz Ctr Infect Res, Dept Biol Chem, Braunschweig, Germany	University of Westminster; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Helmholtz-Center for Infection Research	Dalby, AR (corresponding author), Univ Westminster, Dept Mol Biosci, New Cavendish St, London W1R 8AL, England.	A.Dalby@Westminster.ac.uk		Emam, Ibrahim/0000-0002-7561-2787; Franke, Raimo/0000-0002-5407-5521; Dalby, Andrew/0000-0002-3598-8595				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Buache E, 2011, ONCOGENE, V30, P3261, DOI 10.1038/onc.2011.41; Butler SL, 2008, LAB INVEST, V88, P78, DOI 10.1038/labinvest.3700699; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Corona W, 2004, ANTICANCER RES, V24, P1417; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Everett CJ, 2007, J NATL MED ASSOC, V99, P328; Friedman J, 2001, SPRINGER SERIES STAT, V10; Gazdar AF, 2010, JNCI-J NATL CANCER I, V102, P1310, DOI 10.1093/jnci/djq279; Gazdar AF, 2010, LUNG CANCER, V68, P309, DOI 10.1016/j.lungcan.2009.12.005; Gentleman R, GENEFILTER GENEFILTE; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gottschling S, 2012, LUNG CANCER, V75, P45, DOI 10.1016/j.lungcan.2011.05.020; Han N, 2012, INT J ONCOL, V41, P242, DOI 10.3892/ijo.2012.1421; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hochreiter S, 2006, BIOINFORMATICS, V22, P943, DOI 10.1093/bioinformatics/btl033; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Liu L, 2008, BIOCHEM BIOPH RES CO, V372, P756, DOI 10.1016/j.bbrc.2008.05.101; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Lusa L, 2006, INT J BIOL MARKER, V21, P67, DOI 10.1177/172460080602100201; Macmillan Cancer Support, 2012, LIV DIAGN MED CANC S; Murthy SRK, 2010, CELL MOL NEUROBIOL, V30, P1377, DOI 10.1007/s10571-010-9592-y; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Shedden K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-26; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Stekel D, 2003, MICROARRAY BIOINFORM; Verkman AS, 2008, J MOL MED, V86, P523, DOI 10.1007/s00109-008-0303-9; Wu J, GENTRY RI CONTRIBUTI; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863	36	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50253	10.1371/journal.pone.0050253	http://dx.doi.org/10.1371/journal.pone.0050253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209689	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000311885800058
J	Sato, H; Morimoto, S; Hattori, T				Sato, Hirotoshi; Morimoto, Shigeo; Hattori, Tsutomu			A Thirty-Year Survey Reveals That Ecosystem Function of Fungi Predicts Phenology of Mushroom Fruiting	PLOS ONE			English	Article							CLIMATE-CHANGE; FOOD AVAILABILITY; CURRENT PHOTOSYNTHESIS; ECTOMYCORRHIZAL; BIODIVERSITY; SURVIVAL; SUCCESS; FORESTS	Mushroom fruiting, the reproduction of fungi, has broad implications for forest health, terrestrial biomass turnover, and global carbon cycle. However, little is known about the difference in phenology and environmental drivers of mushroom fruiting between functional guilds, e.g., ectomycorrhizal (ECM) mutualists and saprotrophs (SAP). There is a remarkable difference between ECM and SAP fungi in their available carbon sources and lifecycles, and thus these fungal groups are likely to differ in fruiting phenology. We analyzed intra-and inter-annual phenological patterns of mushroom fruiting throughout the year using a long-term census dataset of mushroom-forming fungi in a Japanese oak forest in which a total of 11,923 mushroom counts (668 species) were recorded during monthly intervals from 1982 to 2011. ECM fungi showed a unimodal seasonal fruiting peak from mid-summer to early autumn; litter-decomposing fungi showed moderate fruiting peaks from early summer or early autumn, and the phenology of wood-decomposing fungi varied considerably among the genera. Each functional group was controlled by a different set of external factors; temperature and rainfall increased ECM fungal fruiting, but key factors substantially differed among the genera of litter-and wood-decomposing fungi in taxon-specific ways. Our results suggest that fungal fruiting phenology may be affected by the seasonality of carbohydrate availability. The highly scheduled reproduction of ECM fungi may reflect temperature-dependent increases and drought-induced decreases of photosynthetic activity in host plants rather than improved growth conditions for fungi during the summer. We argue that the way a fungus obtains carbohydrates may explain a substantial fraction of the fruiting phenology, which may make a differential contribution to the community structure of fungus-associated organisms and terrestrial biomass turnover based on fungal functional groups.	[Sato, Hirotoshi] Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan; [Sato, Hirotoshi; Hattori, Tsutomu] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Kyoto, Japan; [Morimoto, Shigeo] Youkin Mycoflora Project, Kyoto, Japan	Kyoto University; Forestry & Forest Products Research Institute - Japan	Sato, H (corresponding author), Kyoto Univ, Grad Sch Global Environm Studies, Kyoto, Japan.	h-sato@sys.bot.kyoto-u.ac.jp	Sato, Hirotoshi/A-2429-2015		Ministry of the Environment, Japan [D-1008]; JSPS	Ministry of the Environment, Japan(Ministry of the Environment, Japan); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by the Global Environment Research Fund (D-1008) of the Ministry of the Environment, Japan and the JSPS Research Fellowship for Young Scientists grant to H. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg B., 2008, PLANT LITTER DECOMPO, DOI DOI 10.1007/978-3-540-74923-3; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Buntgen U, 2012, FRONT ECOL ENVIRON, V10, P14, DOI 10.1890/110064; CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Daan S, 1988, FOOD SUPPLY ANN TIMI; Davis SE, 2005, ECOLOGY, V86, P1047, DOI 10.1890/04-0989; de Aragon JM, 2007, FOREST ECOL MANAG, V252, P239, DOI 10.1016/j.foreco.2007.06.040; DEPUIT EJ, 1973, AM J BOT, V60, P426, DOI 10.2307/2441499; EVELING DW, 1990, MYCOL RES, V94, P998, DOI 10.1016/S0953-7562(09)81320-8; Gange AC, 2007, SCIENCE, V316, P71, DOI 10.1126/science.1137489; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Hanski I., 1989, Insect-fungus interactions. 14th Symposium of the Royal Entomological Society of London in collaboration with the British Mycological Society., P25; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Imazeki R., 1987, COLORED ILLUSTRATION, V1, P160; Imazeki R, 1989, COLORED ILLUSTRATION, VII; JEFFRIES P, 1995, CAN J BOT, V73, pS1284, DOI 10.1139/b95-389; Johnson CN, 1996, TRENDS ECOL EVOL, V11, P503, DOI 10.1016/S0169-5347(96)10053-7; Kauserud H, 2008, P NATL ACAD SCI USA, V105, P3811, DOI 10.1073/pnas.0709037105; Kauserud H, 2010, P ROY SOC B-BIOL SCI, V277, P1169, DOI 10.1098/rspb.2009.1537; Kennish R, 1997, OECOLOGIA, V109, P209, DOI 10.1007/s004420050075; KIKUZAWA K, 1983, CAN J BOT, V61, P2133, DOI 10.1139/b83-230; Krebs CJ, 2008, BOTANY, V86, P1497, DOI 10.1139/B08-094; LAMHAMEDI MS, 1994, CAN J FOREST RES, V24, P1797, DOI 10.1139/x94-232; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; MCGONIGLE TP, 1995, CAN J BOT, V73, pS1370, DOI 10.1139/b95-399; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Miyazawa Y, 2006, TREE PHYSIOL, V26, P249, DOI 10.1093/treephys/26.2.249; Munguia P, 2003, SOUTHWEST NAT, V48, P661, DOI 10.1894/0038-4909(2003)048&lt;0661:MPAIWM&gt;2.0.CO;2; Newbound M, 2010, FUNGAL BIOL-UK, V114, P171, DOI 10.1016/j.funbio.2009.12.001; Nitta I, 1997, PLANT ECOL, V130, P71, DOI 10.1023/A:1009735709258; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Siikamaki P, 1998, ECOLOGY, V79, P1789, DOI 10.1890/0012-9658(1998)079[1789:LORSBF]2.0.CO;2; Sippola AL, 1999, FOREST ECOL MANAG, V115, P183, DOI 10.1016/S0378-1127(98)00398-3; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Straatsma G, 2001, MYCOL RES, V105, P515, DOI 10.1017/S0953756201004154; Tainter F.H., 1996, PRINCIPLES FOREST PA; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x	47	36	38	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49777	10.1371/journal.pone.0049777	http://dx.doi.org/10.1371/journal.pone.0049777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209598	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800023
J	Bode, J; Dutow, P; Sommer, K; Janik, K; Glage, S; Tummler, B; Munder, A; Laudeley, R; Sachse, KW; Klos, A				Bode, Jenny; Dutow, Pavel; Sommer, Kirsten; Janik, Katrin; Glage, Silke; Tuemmler, Burkhard; Munder, Antje; Laudeley, Robert; Sachse, Konrad W.; Klos, Andreas			A New Role of the Complement System: C3 Provides Protection in a Mouse Model of Lung Infection with Intracellular Chlamydia psittaci	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; COMPONENT C3; MYCOBACTERIUM-TUBERCULOSIS; CHLAMYDOPHILA-PSITTACI; EXPRESSION CLONING; DENDRITIC CELLS; C5A RECEPTOR; HOST DEFENSE; MURINE MODEL; ANAPHYLATOXIN	The complement system modulates the intensity of innate and specific immunity. While it protects against infections by extracellular bacteria its role in infection with obligate intracellular bacteria, such as the avian and human pathogen Chlamydia (C.) psittaci, is still unknown. In the present study, knockout mice lacking C3 and thus all main complement effector functions were intranasally infected with C. psittaci strain DC15. Clinical parameters, lung histology, and cytokine levels were determined. A subset of infections was additionally performed with mice lacking C5 or C5a receptors. Complement activation occurred before symptoms of pneumonia appeared. Mice lacking C3 were similar to 100 times more susceptible to the intracellular bacteria compared to wild-type mice, with all C3(-/-) mice succumbing to infection after day 9. At a low infective dose, C3(-/-) mice became severely ill after an even longer delay, the kinetics suggesting a so far unknown link of complement to the adaptive, protective immune response against chlamydiae. The lethal phenotype of C3(-/-) mice is not based on differences in the anti-chlamydial IgG response (which is slightly delayed) as demonstrated by serum transfer experiments. In addition, during the first week of infection, the absence of C3 was associated with partial protection characterized by reduced weight loss, better clinical score and lower bacterial burden, which might be explained by a different mechanism. Lack of complement functions downstream of C5 had little effect. This study demonstrates for the first time a strong and complex influence of complement effector functions, downstream of C3 and upstream of C5, on the outcome of an infection with intracellular bacteria, such as C. psittaci.	[Bode, Jenny; Dutow, Pavel; Sommer, Kirsten; Janik, Katrin; Laudeley, Robert; Klos, Andreas] Hannover Med Sch MHH, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany; [Glage, Silke] Hannover Med Sch MHH, Inst Lab Anim Sci, Hannover, Germany; [Tuemmler, Burkhard; Munder, Antje] Hannover Med Sch MHH, Clin Res Grp, Hannover, Germany; [Sachse, Konrad W.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Jena, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Friedrich Loeffler Institute	Klos, A (corresponding author), Hannover Med Sch MHH, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany.	klos.andreas@mh-hannover.de	Sachse, Konrad/GWC-4999-2022; Janik, Katrin/U-2525-2019	Sachse, Konrad/0000-0003-1230-1786; Janik, Katrin/0000-0003-0878-7402; Munder, Antje/0000-0002-3198-8336	DFG [CRC587]; BMBF	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF))	This project was financially supported by the DFG-funded CRC587 "Immune-reactions of the lung in allergy and infection", as well as partially by the DFG-funded European Research Training Group 1273 "Strategies of human pathogens to establish acute and chronic infections" (P. D.) and the BMBF-funded "Verbund Zoonotic Chlamydia" (K. Sachse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZDOMINGUEZ C, 1993, INFECT IMMUN, V61, P3664, DOI 10.1128/IAI.61.9.3664-3672.1993; Ames RS, 1996, J BIOL CHEM, V271, P20231, DOI 10.1074/jbc.271.34.20231; Bavoil PM, 2007, CHLAMYDIA GENOMICS P; Bohlson SS, 2001, INFECT IMMUN, V69, P7729, DOI 10.1128/IAI.69.12.7729-7735.2001; BOULAY F, 1991, BIOCHEMISTRY-US, V30, P2993, DOI 10.1021/bi00226a002; Braukmann M, 2012, INFECT IMMUN, V80, P2976, DOI 10.1128/IAI.00437-12; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Cortes C, 2011, INFECT IMMUN, V79, P724, DOI 10.1128/IAI.00980-10; Crass T, 1996, EUR J IMMUNOL, V26, P1944, DOI 10.1002/eji.1830260840; DREVETS DA, 1993, J IMMUNOL, V151, P5431; Drouin SM, 2002, J IMMUNOL, V169, P5926, DOI 10.4049/jimmunol.169.10.5926; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gieffers J, 2004, EUR RESPIR J, V23, P506, DOI 10.1183/09031936.04.00093304; Goellner S, 2006, INFECT IMMUN, V74, P4801, DOI 10.1128/IAI.01487-05; Gutzmer R, 2006, J INVEST DERMATOL, V126, P2422, DOI 10.1038/sj.jid.5700416; HALL RT, 1993, INFECT IMMUN, V61, P1829, DOI 10.1128/IAI.61.5.1829-1834.1993; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hu CG, 2000, J IMMUNOL, V165, P2596, DOI 10.4049/jimmunol.165.5.2596; Huang J, 1999, J IMMUNOL, V162, P2217; Kim AHJ, 2004, J IMMUNOL, V173, P2524, DOI 10.4049/jimmunol.173.4.2524; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Kopf M, 2002, NAT MED, V8, P373, DOI 10.1038/nm0402-373; LIN JSL, 1992, INFECT IMMUN, V60, P2547, DOI 10.1128/IAI.60.6.2547-2550.1992; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; Mueller-Ortiz SL, 2004, INFECT IMMUN, V72, P2899, DOI 10.1128/IAI.72.5.2899-2906.2004; Munder A, 2005, MICROBES INFECT, V7, P600, DOI 10.1016/j.micinf.2004.12.021; Nakayama Y, 2009, J IMMUNOL, V183, P2921, DOI 10.4049/jimmunol.0801191; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; RAMSEY KH, 1988, INFECT IMMUN, V56, P1320, DOI 10.1128/IAI.56.5.1320-1325.1988; Reinhold P, 2010, VET J, V189, P257; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Sommer K, 2009, FEMS IMMUNOL MED MIC, V55, P206, DOI 10.1111/j.1574-695X.2008.00503.x; Ward PA, 2009, J CELL MOL MED, V13, P4154, DOI 10.1111/j.1582-4934.2009.00893.x; Weaver DJ, 2010, EUR J IMMUNOL, V40, P710, DOI 10.1002/eji.200939333; Werfel T, 2000, J IMMUNOL, V165, P6599, DOI 10.4049/jimmunol.165.11.6599; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; WILLIAMS DM, 1984, INFECT IMMUN, V45, P674, DOI 10.1128/IAI.45.3.674-678.1984; WILLIAMS DM, 1987, INFECT IMMUN, V55, P2387, DOI 10.1128/IAI.55.10.2387-2390.1987; WILLIAMS DM, 1982, J INFECT DIS, V145, P200, DOI 10.1093/infdis/145.2.200; Zhang X, 2010, EXPERT REV CLIN IMMU, V6, P269, DOI 10.1586/ECI.09.84; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	46	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50327	10.1371/journal.pone.0050327	http://dx.doi.org/10.1371/journal.pone.0050327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189195	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800072
J	Gonzalez, B; Garrido, F; Ortega, R; Martinez-Julvez, M; Revilla-Guarinos, A; Perez-Pertejo, Y; Velazquez-Campoy, A; Sanz-Aparicio, J; Pajares, MA				Gonzalez, Beatriz; Garrido, Francisco; Ortega, Rebeca; Martinez-Julvez, Marta; Revilla-Guarinos, Ainhoa; Perez-Pertejo, Yolanda; Velazquez-Campoy, Adrian; Sanz-Aparicio, Julia; Pajares, Maria A.			NADP(+) Binding to the Regulatory Subunit of Methionine Adenosyltransferase II Increases Intersubunit Binding Affinity in the Hetero-Trimer	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; EXPRESSION; PROTEINS; CLONING; ALPHA; IDENTIFICATION; PURIFICATION; REDUCTASE	Mammalian methionine adenosyltransferase II (MAT II) is the only hetero-oligomer in this family of enzymes that synthesize S-adenosylmethionine using methionine and ATP as substrates. Binding of regulatory beta subunits and catalytic alpha 2 dimers is known to increase the affinity for methionine, although scarce additional information about this interaction is available. This work reports the use of recombinant alpha 2 and beta subunits to produce oligomers showing kinetic parameters comparable to MAT II purified from several tissues. According to isothermal titration calorimetry data and densitometric scanning of the stained hetero-oligomer bands on denatured gels, the composition of these oligomers is that of a hetero-trimer with alpha 2 dimers associated to single beta subunits. Additionally, the regulatory subunit is able to bind NADP(+) with a 1:1 stoichiometry, the cofactor enhancing beta to alpha 2-dimer binding affinity. Mutants lacking residues involved in NADP(+) binding and N-terminal truncations of the beta subunit were able to oligomerize with alpha 2-dimers, although the kinetic properties appeared altered. These data together suggest a role for both parts of the sequence in the regulatory role exerted by the beta subunit on catalysis. Moreover, preparation of a structural model for the hetero-oligomer, using the available crystal data, allowed prediction of the regions involved in beta to alpha 2-dimer interaction. Finally, the implications that the presence of different N-terminals in the beta subunit could have on MAT II behavior are discussed in light of the recent identification of several splicing forms of this subunit in hepatoma cells.	[Garrido, Francisco; Pajares, Maria A.] Inst Invest Biomed Alberto Sols CSIC UAM, Madrid, Spain; [Gonzalez, Beatriz; Ortega, Rebeca; Revilla-Guarinos, Ainhoa; Sanz-Aparicio, Julia] Inst Quim Fis Rocasolano CSIC, Dept Cristalog & Biol Estruct, Madrid, Spain; [Martinez-Julvez, Marta; Velazquez-Campoy, Adrian] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain; [Martinez-Julvez, Marta; Velazquez-Campoy, Adrian] Inst Biocomputac & Fis Complejos, Unidad Asociada IQFR BIFI, Zaragoza, Spain; [Perez-Pertejo, Yolanda] Univ Leon, Dept Farmacol & Toxicol INTOXCAL, E-24071 Leon, Spain; [Velazquez-Campoy, Adrian] Fdn ARAID, Diputac Gen Aragon, Zaragoza, Spain; [Pajares, Maria A.] IdiPAZ, Mol Hepatol Grp, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Universidad de Leon	Pajares, MA (corresponding author), Inst Invest Biomed Alberto Sols CSIC UAM, Madrid, Spain.	mapajares@iib.uam.es	Martinez-Julvez, Marta/G-3839-2017; Sanz-Aparicio, Julia/F-6201-2013; Martinez-Julvez, Marta M/G-5392-2012; Velazquez-Campoy, Adrian/E-7946-2012; Pérez-Pertejo, Yolanda/K-6609-2017; Gonzalez, Beatriz/M-1219-2014; Pajares, Maria Angeles/I-5952-2012	Martinez-Julvez, Marta/0000-0001-9047-0046; Sanz-Aparicio, Julia/0000-0002-6849-8621; Martinez-Julvez, Marta M/0000-0001-9047-0046; Velazquez-Campoy, Adrian/0000-0001-5702-4538; Pérez-Pertejo, Yolanda/0000-0003-2361-3785; Gonzalez, Beatriz/0000-0002-0710-0202; Revilla-Guarinos, Ainhoa/0000-0002-9894-3538; Pajares, Maria Angeles/0000-0002-4714-9051	Ministerio de Economia y Competitividad [BFU2005-00050, BFU2008-00666, BFU2009-08977, BIO2010-20508-C04-03, BFU2011-24982, BIO2010-14983, BFU2010-19451]; Comunidad de Madrid [GR/SAL/0833/2004]; CSIC; Ministerio de Educacion y Ciencia	Ministerio de Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); CSIC; Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by grants of the Ministerio de Economia y Competitividad (BFU2005-00050, BFU2008-00666 and BFU2009-08977 to MAP, BIO2010-20508-C04-03 to JS-A, BFU2011-24982 to BG, BIO2010-14983 to MM-J and BFU2010-19451 to AV-C) and Comunidad de Madrid (GR/SAL/0833/2004 to JSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; B. G. had a J&C appointment from the Spanish Government. R.O. had a Graduate Fellowship from CSIC and A. R-G. was a student of the Universidad Autonoma de Madrid with a scholarship of the Ministerio de Educacion y Ciencia. The pOPTH and pOPTG vectors were generously provided by O. Perisic (MRC-LMB, Cambridge, UK). The authors wish to thank B. Ashley Morris for style and grammatical corrections of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DELAROSA J, 1995, J BIOL CHEM, V270, P21860; Delgado M, 2008, CELL MOL LIFE SCI, V65, P2080, DOI 10.1007/s00018-008-8201-4; Dommaraju SR, 2011, ARCH BIOCHEM BIOPHYS, V512, P167, DOI 10.1016/j.abb.2011.06.006; FRIEDMAN FK, 1979, ANNU REV BIOCHEM, V48, P217, DOI 10.1146/annurev.bi.48.070179.001245; Garrido F, 2011, PROTEIN EXPRES PURIF, V79, P128, DOI 10.1016/j.pep.2011.05.004; Gibson BA, 2011, MOL CELL, V41, P497, DOI 10.1016/j.molcel.2011.02.019; Gil B, 1997, ENDOCRINOLOGY, V138, P1251, DOI 10.1210/en.138.3.1251; Gonzalez B, 2000, J MOL BIOL, V300, P363, DOI 10.1006/jmbi.2000.3858; Gonzalez B, 2003, J MOL BIOL, V331, P407, DOI 10.1016/s0022-2836(03)00728-9; GROSS M, 1994, EUR J BIOCHEM, V221, P617, DOI 10.1111/j.1432-1033.1994.tb18774.x; HALPERN BC, 1974, P NATL ACAD SCI USA, V71, P1133, DOI 10.1073/pnas.71.4.1133; HORIKAWA S, 1992, FEBS LETT, V312, P37, DOI 10.1016/0014-5793(92)81405-B; Kato M, 1998, BIOCHEM J, V331, P871, DOI 10.1042/bj3310871; Katoh Y, 2011, MOL CELL, V41, P554, DOI 10.1016/j.molcel.2011.02.018; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; KOTB M, 1985, J BIOL CHEM, V260, P3923; LANGKAMPHENKEN B, 1994, BBA-GEN SUBJECTS, V1201, P397, DOI 10.1016/0304-4165(94)90068-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeGros HL, 2000, J BIOL CHEM, V275, P2359, DOI 10.1074/jbc.275.4.2359; Lopez-Vara MC, 2000, PROTEIN EXPRES PURIF, V19, P219, DOI 10.1006/prep.2000.1235; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Markham GD, 2009, CELL MOL LIFE SCI, V66, P636, DOI 10.1007/s00018-008-8516-1; MARKHAM GD, 1988, J BIOL CHEM, V263, P8666; Martinez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159; Martinez-Chantar ML, 2003, GASTROENTEROLOGY, V124, P940, DOI 10.1053/gast.2003.50151; Martinez-Julvez M, 2009, BIOPHYS J, V96, P4966, DOI 10.1016/j.bpj.2009.02.061; Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0; MITSUI KI, 1988, J BIOL CHEM, V263, P11211; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Naranjo V, 2007, PROTEOMICS, V7, P220, DOI 10.1002/pmic.200600527; PAJARES MA, 1992, J BIOL CHEM, V267, P17598; Pajares Maria A, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P449; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Reytor E, 2009, FASEB J, V23, P3347, DOI 10.1096/fj.09-130187; Sanae R, 2011, BIOCHEMISTRY-US, V50, P1714, DOI 10.1021/bi101575u; Sanchez-Perez GF, 2004, J MOL BIOL, V335, P693, DOI 10.1016/j.jmb.2003.11.022; Sanchez-Perez GF, 2003, J BIOL CHEM, V278, P7285, DOI 10.1074/jbc.M210177200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Velazquez-Campoy A, 2006, BIOPHYS J, V91, P1887, DOI 10.1529/biophysj.106.086561; Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yang HP, 2008, GASTROENTEROLOGY, V134, P281, DOI 10.1053/j.gastro.2007.10.027; Yang HP, 2003, J BIOL CHEM, V278, P50887, DOI 10.1074/jbc.M307600200	46	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50329	10.1371/journal.pone.0050329	http://dx.doi.org/10.1371/journal.pone.0050329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189196	gold, Green Submitted, Green Published			2022-12-25	WOS:000311929800073
J	Gulvik, CA; Effler, TC; Wilhelm, SW; Buchan, A				Gulvik, Christopher A.; Effler, T. Chad; Wilhelm, Steven W.; Buchan, Alison			De-MetaST-BLAST: A Tool for the Validation of Degenerate Primer Sets and Data Mining of Publicly Available Metagenomes	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENE DIVERSITY; PCR PRIMERS; AMPLIFICATION; ABUNDANCE; BACTERIA; MARINE; POPULATIONS; COMMUNITY; SOFTWARE	Development and use of primer sets to amplify nucleic acid sequences of interest is fundamental to studies spanning many life science disciplines. As such, the validation of primer sets is essential. Several computer programs have been created to aid in the initial selection of primer sequences that may or may not require multiple nucleotide combinations (i.e., degeneracies). Conversely, validation of primer specificity has remained largely unchanged for several decades, and there are currently few available programs that allows for an evaluation of primers containing degenerate nucleotide bases. To alleviate this gap, we developed the program De-MetaST that performs an in silico amplification using user defined nucleotide sequence dataset(s) and primer sequences that may contain degenerate bases. The program returns an output file that contains the in silico amplicons. When De-MetaST is paired with NCBI's BLAST (De-MetaST-BLAST), the program also returns the top 10 nr NCBI database hits for each recovered in silico amplicon. While the original motivation for development of this search tool was degenerate primer validation using the wealth of nucleotide sequences available in environmental metagenome and metatranscriptome databases, this search tool has potential utility in many data mining applications.	[Gulvik, Christopher A.; Effler, T. Chad; Wilhelm, Steven W.; Buchan, Alison] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Effler, T. Chad] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Buchan, A (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	abuchan@utk.edu	Wilhelm, Steven W/B-8963-2008	Wilhelm, Steven W/0000-0001-6283-8077; Gulvik, Christopher/0000-0001-8754-9829; Buchan, Alison/0000-0001-7420-985X	National Science Foundation (NSF) [MCB1112001]; NSF [OCE1061352]; Division Of Ocean Sciences [1061352] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	TCE was supported by an REU award from the National Science Foundation (NSF) (MCB1112001 to SWW). SWW and AB acknowledge NSF award OCE1061352 for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2005, J PHYCOL, V41, P95, DOI 10.1111/j.1529-8817.2005.04090.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Burgmann H, 2004, APPL ENVIRON MICROB, V70, P240, DOI 10.1128/AEM.70.1.240-247.2004; Chadhain SMN, 2006, ENVIRON MICROBIOL, V8, P1746, DOI 10.1111/j.1462-2920.2006.01114.x; Dwivedi B, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-37; El Azhari N, 2008, EUR J SOIL SCI, V59, P665, DOI 10.1111/j.1365-2389.2008.01029.x; Fuchs T, 2002, GENOMICS, V80, P295, DOI 10.1006/geno.2002.6830; Gadberry MD, 2005, BIOINFORMATICS, V21, P1263, DOI 10.1093/bioinformatics/bti134; Hendrickx B, 2006, J MICROBIOL METH, V64, P250, DOI 10.1016/j.mimet.2005.04.018; Iwai S, 2011, APPL ENVIRON MICROB, V77, P3551, DOI 10.1128/AEM.00331-11; Jarman SN, 2004, BIOINFORMATICS, V20, P1644, DOI 10.1093/bioinformatics/bth121; Jarman SN, 2004, MOL ECOL, V13, P1313, DOI 10.1111/j.1365-294X.2004.02109.x; Junca H, 2004, ENVIRON MICROBIOL, V6, P95, DOI 10.1046/j.1462-2920.2003.00541.x; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kirchman DL, 2003, APPL ENVIRON MICROB, V69, P6587, DOI 10.1128/AEM.69.11.6587-6596.2003; KWOK S, 1994, PCR METH APPL, V3, pS39; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linhart Chaim, 2007, V402, P221; LIU H, 1994, BIOTECHNIQUES, V16, P24; Lopez-Lopez A, 2005, ENVIRON MICROBIOL, V7, P649, DOI 10.1111/j.1462-2920.2005.00733.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521; Lyons JI, 2003, MICROB ECOL, V45, P270, DOI 10.1007/s00248-002-1055-7; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Matteson AR, 2011, APPL ENVIRON MICROB, V77, P6772, DOI 10.1128/AEM.05879-11; Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Najafabadi HS, 2008, BIOTECHNIQUES, V44, P519, DOI 10.2144/000112694; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Preston G M, 1997, Methods Mol Biol, V69, P97; Rather LJ, 2010, J BIOL CHEM, V285, P20615, DOI 10.1074/jbc.M110.124156; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Rose TM, 2003, NUCLEIC ACIDS RES, V31, P3763, DOI 10.1093/nar/gkg524; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmalenberger A, 2007, ENVIRON MICROBIOL, V9, P535, DOI 10.1111/j.1462-2920.2006.01172.x; Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x; Staheli JR, 2011, METHODS MOL BIOL, V687, P57, DOI 10.1007/978-1-60761-944-4_5; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; Wang LP, 2010, ENVIRON MICROBIOL, V12, P1230, DOI 10.1111/j.1462-2920.2010.02165.x; Wei XT, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P75, DOI 10.1109/CSB.2003.1227306	46	11	11	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50362	10.1371/journal.pone.0050362	http://dx.doi.org/10.1371/journal.pone.0050362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189198	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800075
J	Scherrer, AU; Boni, J; Yerly, S; Klimkait, T; Aubert, V; Furrer, H; Calmy, A; Cavassini, M; Elzi, L; Vernazza, PL; Bernasconi, E; Ledergerber, B; Gunthard, HF				Scherrer, Alexandra U.; Boeni, Juerg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L.; Bernasconi, Enos; Ledergerber, Bruno; Guenthard, Huldrych F.		Swiss HIV Cohort Study SHCS	Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens	PLOS ONE			English	Article							HIV-1 DRUG-RESISTANCE; RESOURCE-LIMITED SETTINGS; COMBINATION ANTIRETROVIRAL THERAPY; TREATMENT-NAIVE PATIENTS; VIROLOGICAL FAILURE; 1-INFECTED PATIENTS; CONNECTION DOMAIN; INITIAL TREATMENT; INFECTED PATIENTS; VIRAL LOAD	Background: The accumulation of mutations after long-lasting exposure to a failing combination antiretroviral therapy (cART) is problematic and severely reduces the options for further successful treatments. Methods: We studied patients from the Swiss HIV Cohort Study who failed cART with nucleoside reverse transcriptase inhibitors (NRTIs) and either a ritonavir-boosted PI (PI/r) or a non-nucleoside reverse transcriptase inhibitor (NNRTI). The loss of genotypic activity <3, 3-6, >6 months after virological failure was analyzed with Stanford algorithm. Risk factors associated with early emergence of drug resistance mutations (<6 months after failure) were identified with multivariable logistic regression. Results: Ninety-nine genotypic resistance tests from PI/r-treated and 129 from NNRTI-treated patients were analyzed. The risk of losing the activity of >= 1 NRTIs was lower among PI/r-compared to NNRTI-treated individuals <3, 3-6, and >6 months after failure: 8.8% vs. 38.2% (p = 0.009), 7.1% vs. 46.9% (p<0.001) and 18.9% vs. 60.9% (p < 0.001). The percentages of patients who have lost PI/r activity were 2.9%, 3.6% and 5.4% <3, 3-6, >6 months after failure compared to 41.2%, 49.0% and 63.0% of those who have lost NNRTI activity (all p < 0.001). The risk to accumulate an early NRTI mutation was strongly associated with NNRTI-containing cART (adjusted odds ratio: 13.3 (95% CI: 4.1-42.8), p < 0.001). Conclusions: The loss of activity of PIs and NRTIs was low among patients treated with PI/r, even after long-lasting exposure to a failing cART. Thus, more options remain for second-line therapy. This finding is potentially of high relevance, in particular for settings with poor or lacking virological monitoring.	[Scherrer, Alexandra U.; Ledergerber, Bruno; Guenthard, Huldrych F.] Univ Zurich, Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Boeni, Juerg] Univ Zurich, Swiss Natl Ctr Retroviruses, Inst Med Virol, Zurich, Switzerland; [Yerly, Sabine] Univ Hosp Geneva, Virol Lab, Geneva, Switzerland; [Klimkait, Thomas] Univ Basel, Dept Biomed, Basel, Switzerland; [Aubert, Vincent] Univ Lausanne Hosp, Div Immunol & Allergy, Lausanne, Switzerland; [Furrer, Hansjakob] Univ Bern, Univ Hosp Berne, Div Infect Dis, Clin Infect Dis, Bern, Switzerland; [Calmy, Alexandra] Univ Hosp Geneva, Div Infect Dis, Geneva, Switzerland; [Cavassini, Matthias] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Elzi, Luigia] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Vernazza, Pietro L.] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Bernasconi, Enos] Reg Hosp Lugano, Lugano, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Geneva; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; Kantonsspital St. Gallen	Scherrer, AU (corresponding author), Univ Zurich, Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	alexandra.scherrer@usz.ch	Boeni, Juerg/B-8386-2015; gunthard, huldrych f/F-1724-2011; Ledergerber, Bruno/B-5656-2009; Furrer, Hansjakob/G-6768-2013; cavassini, matthias/F-8987-2017	gunthard, huldrych f/0000-0002-1142-6723; Ledergerber, Bruno/0000-0002-6881-4401; Furrer, Hansjakob/0000-0002-1375-3146; Klimkait, Thomas/0000-0003-4945-6511; cavassini, matthias/0000-0003-0933-7833	Swiss HIV Cohort Study; Swiss National Science Foundation (SNF) [33CS30-134277]; SNF [3247B0-112594, 324730-130865]; SHCS [470, 528, 569, 683]; SHCS Research Foundation; European Community under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) [FP7/2007-2013, 223131]; Union Bank of Switzerland; Tibotec, Switzerland; Gilead, Switzerland; Roche; Abbott; Bristol-Myers Squibb; GlaxoSmithKline; Gilead; Tibotec; Merck Sharp Dohme; GSK; MSD; Pfizer; Janssen; ViiV	Swiss HIV Cohort Study; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); SNF; SHCS; SHCS Research Foundation; European Community under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN); Union Bank of Switzerland; Tibotec, Switzerland; Gilead, Switzerland(Gilead Sciences); Roche(Roche Holding); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Gilead(Gilead Sciences); Tibotec; Merck Sharp Dohme(Merck & Company); GSK(GlaxoSmithKline); MSD; Pfizer(Pfizer); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); ViiV	This work was supported in the framework of the Swiss HIV Cohort Study, by the Swiss National Science Foundation (SNF grant #33CS30-134277). Further support was provided by SNF grant #3247B0-112594 (to HFG, SY and BL), SNF grant #324730-130865 and the SHCS projects #470, 528, 569, 683, the SHCS Research Foundation, the European Community's Seventh Framework Programme (grant FP7/2007-2013), under the Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN; grant 223131), and by a further research grant of the Union Bank of Switzerland, in the name of a donor to HFG, and an unrestricted research grant from Tibotec, Switzerland, to HFG and from Gilead, Switzerland, to HFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HFG has been an adviser and/or consultant for the following companies: GlaxoSmithKline, Abbott, Novartis, Boehringer Ingelheim, Roche, Tibotec and Bristol-Myers Squibb, and has received unrestricted research and educational grants from Roche, Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Tibotec and Merck Sharp & Dohme (all money went to institution). SY has participated in advisory boards of BMS and Tibotec, and has received travel grants from GSK and MSD. TK served as advisor for BMS and Pfizer and has received travel grants from Abbott and Pfizer. EB has been adviser and/or consultant for Gilead, Merck Sharp & Dohme, Janssen, ViiV, and Bristol-Myers Squibb. He also received travel grants from Abbott, Gilead, Merck Sharp & Dohme, Janssen, and ViiV. All others reported no conflict of interest.	Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V41, P323; Cole SR, 2010, AM J EPIDEMIOL, V171, P198, DOI 10.1093/aje/kwp347; Cozzi-Lepri A, 2007, AIDS, V21, P721, DOI 10.1097/QAD.0b013e3280141fdf; Daar ES, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00316; Glass TR, 2006, JAIDS-J ACQ IMM DEF, V41, P385, DOI 10.1097/01.qai.0000186371.95301.52; Gupta R, 2008, CLIN INFECT DIS, V47, P712, DOI 10.1086/590943; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Hogg RS, 2006, PLOS MED, V3, P1570, DOI 10.1371/journal.pmed.0030356; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kantor R, 2004, AIDS, V18, P1503, DOI 10.1097/01.aids.0000131358.29586.6b; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; MacArthur RD, 2006, LANCET, V368, P2125, DOI 10.1016/S0140-6736(06)69861-9; Margot NA, 2009, JAIDS-J ACQ IMM DEF, V52, P209, DOI 10.1097/QAI.0b013e3181b05f7c; Metzner KJ, 2007, AIDS, V21, P703, DOI 10.1097/QAD.0b013e3280121ac6; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Mtambo A, 2012, HIV MED, V13, P141, DOI 10.1111/j.1468-1293.2011.00950.x; Murillo W, 2010, HIV MED, V11, P95, DOI 10.1111/j.1468-1293.2009.00747.x; Napravnik S, 2005, JAIDS-J ACQ IMM DEF, V40, P34, DOI 10.1097/01.qai.0000174929.87015.d6; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Reynolds SJ, 2009, ANTIVIR THER, V14, P293; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; Shafer RW, 2003, NEW ENGL J MED, V349, P2304, DOI 10.1056/NEJMoa030265; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sungkanuparph S, 2007, CLIN INFECT DIS, V44, P447, DOI 10.1086/510745; Svicher V, 2010, JAIDS-J ACQ IMM DEF, V55, P336, DOI 10.1097/QAI.0b013e3181e6763f; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van de Vijver DA, 2006, JAIDS-J ACQ IMM DEF, V41, P352, DOI 10.1097/01.qai.0000209899.05126.e4; Von Wyl V, 2007, ARCH INTERN MED, V167, P1782, DOI 10.1001/archinte.167.16.1782; Wallis CL, 2012, ANTIVIR THER, V17, P313, DOI 10.3851/IMP1985; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	43	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50307	10.1371/journal.pone.0050307	http://dx.doi.org/10.1371/journal.pone.0050307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189194	Green Accepted, gold, Green Published			2022-12-25	WOS:000311929800071
J	Boussari, O; Moiroux, N; Iwaz, J; Djenontin, A; Bio-Bangana, S; Corbel, V; Fonton, N; Ecochard, R				Boussari, Olayide; Moiroux, Nicolas; Iwaz, Jean; Djenontin, Armel; Bio-Bangana, Sahabi; Corbel, Vincent; Fonton, Noel; Ecochard, Rene			Use of a Mixture Statistical Model in Studying Malaria Vectors Density	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD ANALYSIS; ANOPHELES-GAMBIAE; INFORMATION-SYSTEMS; TRANSMISSION; CULICIDAE; OVERDISPERSION; DYNAMICS; POISSON; DIPTERA; VILLAGE	Vector control is a major step in the process of malaria control and elimination. This requires vector counts and appropriate statistical analyses of these counts. However, vector counts are often overdispersed. A non-parametric mixture of Poisson model (NPMP) is proposed to allow for overdispersion and better describe vector distribution. Mosquito collections using the Human Landing Catches as well as collection of environmental and climatic data were carried out from January to December 2009 in 28 villages in Southern Benin. A NPMP regression model with "village" as random effect is used to test statistical correlations between malaria vectors density and environmental and climatic factors. Furthermore, the villages were ranked using the latent classes derived from the NPMP model. Based on this classification of the villages, the impacts of four vector control strategies implemented in the villages were compared. Vector counts were highly variable and overdispersed with important proportion of zeros (75%). The NPMP model had a good aptitude to predict the observed values and showed that: i) proximity to freshwater body, market gardening, and high levels of rain were associated with high vector density; ii) water conveyance, cattle breeding, vegetation index were associated with low vector density. The 28 villages could then be ranked according to the mean vector number as estimated by the random part of the model after adjustment on all covariates. The NPMP model made it possible to describe the distribution of the vector across the study area. The villages were ranked according to the mean vector density after taking into account the most important covariates. This study demonstrates the necessity and possibility of adapting methods of vector counting and sampling to each setting.	[Boussari, Olayide; Fonton, Noel] Univ Abomey Calavi, Int Chair Math Phys & Applicat, Abomey Calavi, Benin; [Boussari, Olayide; Iwaz, Jean; Ecochard, Rene] Hosp Civils Lyon, Serv Biostat, Lyon, France; [Boussari, Olayide; Iwaz, Jean; Ecochard, Rene] Univ Lyon, Lyon, France; [Boussari, Olayide; Iwaz, Jean; Ecochard, Rene] Univ Lyon 1, F-69622 Villeurbanne, France; [Boussari, Olayide; Iwaz, Jean; Ecochard, Rene] Ctr Natl Rech Sci, Unite Mixte Rech 5558, Lab Biometrie & Biol Evolut, Villeurbanne, France; [Moiroux, Nicolas] Inst Rech Dev, Montpellier, France; [Moiroux, Nicolas; Corbel, Vincent] Univ Montpellier I, Montpellier, France; [Moiroux, Nicolas; Corbel, Vincent] Univ Montpellier 2, Montpellier, France; [Djenontin, Armel; Corbel, Vincent] Inst Rech Dev, Cotonou, Benin; [Bio-Bangana, Sahabi] Minist Sante, Ctr Rech Entomol Cotonou, Cotonou, Benin	University of Abomey Calavi; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Entomological Research Center of Cotonou (CREC)	Boussari, O (corresponding author), Univ Abomey Calavi, Int Chair Math Phys & Applicat, Abomey Calavi, Benin.	olayide.boussari@chu-lyon.fr	Corbel, VIncent/G-9576-2016; Moiroux, Nicolas/AFT-2925-2022	Moiroux, Nicolas/0000-0001-6755-6167; corbel, vincent/0000-0003-0995-3257	Ministere Francais des Affaires Etrangeres (MAEE) [2006-22]	Ministere Francais des Affaires Etrangeres (MAEE)	The Ministere Francais des Affaires Etrangeres (MAEE) supported the project FSP/REFS No2006-22 that generated the data analyzed in this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkin M, 1999, BIOMETRICS, V55, P117, DOI 10.1111/j.0006-341X.1999.00117.x; Aitkin M, 1996, STAT COMPUT, V6, P251, DOI 10.1007/BF00140869; Akogbeto M, 1995, ANN SOC BELG MED TR, V75, P219; Allain E, 2001, RECHERCHE TRANSPORTS, V72, P3; Amek N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-86; [Anonymous], LANCET INFECT DIS; [Anonymous], 1954, BIOL ANOPHELES GAMBI; [Anonymous], 1968, ANOPHELINAE AFR S SA; Biernacki C, 2000, IEEE T PATTERN ANAL, V22, P719, DOI 10.1109/34.865189; Bio-Bangana S, 2009, CHARACTERIZATION MOS; Bouche G, 2009, REV EPIDEMIOL SANTE, V57, P285, DOI 10.1016/j.respe.2009.02.209; BRESLOW N, 1990, J AM STAT ASSOC, V85, P565, DOI 10.2307/2289799; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Cottrell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028812; Dambach P, 2009, GLOB HLTH ACTION, V2; DEAN C, 1989, J AM STAT ASSOC, V84, P467, DOI 10.2307/2289931; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dennis Jr. J.E., 1996, CLASSICS APPL MATH, V16; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Edillo FE, 2002, J MED ENTOMOL, V39, P70, DOI 10.1603/0022-2585-39.1.70; Einbeck J, 2009, NPMLREG NONPARAMETRI; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Gillies M, 1987, ANOPHELINAE AFRICA S; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Hamon J., 1955, BIOL ANOPHELES FUNES; Hauer E, 1988, TRANSPORTATION RES B; Hay SI, 2000, ADV PARASIT, V47, P173, DOI 10.1016/S0065-308X(00)47009-0; Johnson NL, 1969, DISTRIBUTIONS STAT D; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Klinkenberg E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-151; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223; McCullagh P, 1989, GEN LINEAR MODELS; MCLACHLAN G, 2000, WILEY SER PROB STAT, P1; Moiroux N, 2012, J INFECT DI IN PRESS; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; R Development Core Team and contributors worldwide, R STATS PACK VERS 2; Rabe-Hesketh S, 2004, COUNTS GEN LATENT VA, P349; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Silver JB., 2008, SAMPLING ADULTS ANIM, P493, DOI [10.1007/978-1-4020-6666-5_6, DOI 10.1007/978-1-4020-6666-5_6]; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Thomson MC, 2000, MED VET ENTOMOL, V14, P227, DOI 10.1046/j.1365-2915.2000.00250.x; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yadouleton A, PARASIT VECTORS, V3, P118	47	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50452	10.1371/journal.pone.0050452	http://dx.doi.org/10.1371/journal.pone.0050452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185626	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000239
J	Derin, MT; Vijayagopal, P; Venkatraman, B; Chaubey, RC; Gopinathan, A				Derin, Mary Thomas; Vijayagopal, Perumal; Venkatraman, Balasubramaniam; Chaubey, Ramesh Chandra; Gopinathan, Anilkumar			Radionuclides and Radiation Indices of High Background Radiation Area in Chavara-Neendakara Placer Deposits (Kerala, India)	PLOS ONE			English	Article							NATURAL RADIOACTIVITY; DOSE-RATES; COXS-BAZAR; MONAZITE; EXPOSURE; THORIUM; COAST	The present paper describes a detailed study on the distribution of radionuclides along Chavara - Neendakara placer deposit, a high background radiation area (HBRA) along the Southwest coast of India (Kerala). Judged from our studies using HPGe gamma spectrometric detector, it becomes evident that Uranium (U-238), Thorium (Th-232) and Potassium (K-40) are the major sources for radioactivity prevailing in the area. Our statistical analyses reveal the existence of a high positive correlation between U-238 and Th-232, implicating that the levels of these elements are interdependent. Our SEM-EDAX analyses reveal that titanium (Ti) and zircon (Zr) are the major trace elements in the sand samples, followed by aluminum, copper, iron, ruthenium, magnesium, calcium, sulphur and lead. This is first of its kind report on the radiation hazard indices on this placer deposit. The average absorbed dose rates (9795 nGy h(-1)) computed from the present study is comparable with the top-ranking HBRAs in the world, thus offering the Chavara-Neendakara placer the second position, after Brazil; pertinently, this value is much higher than the World average. The perceptibly high absorbed gamma dose rates, entrained with the high annual external effective dose rates (AEED) and average annual gonadal dose equivalent (AGDE) values existing in this HBRA, encourage us to suggest for a candid assessment of the impact of the background radiation, if any, on the organisms that inhabit along this placer deposit. Future research could effectively address the issue of the possible impact of natural radiation on the biota inhabiting this HBRA.	[Derin, Mary Thomas; Gopinathan, Anilkumar] VIT Univ, Sch Biosci & Technol, Div Med Biotechnol, Vellore, Tamil Nadu, India; [Vijayagopal, Perumal; Venkatraman, Balasubramaniam] Indira Gandhi Ctr Atom Res, Radiol Safety Div, Kalpakkam 603102, Tamil Nadu, India; [Chaubey, Ramesh Chandra] Bhabha Atom Res Ctr, Div Cell Biol, Genet Toxicol & Chromosome Studies Sect, Bombay 400085, Maharashtra, India	Vellore Institute of Technology; Indira Gandhi Centre for Atomic Research (IGCAR); Bhabha Atomic Research Center (BARC)	Gopinathan, A (corresponding author), VIT Univ, Sch Biosci & Technol, Div Med Biotechnol, Vellore, Tamil Nadu, India.	ganilkumar@vit.ac.in		Mary Derin, Derin/0000-0002-1091-5277; gopinathan, anilkumar/0000-0001-9486-9118	Board of Research in Nuclear Sciences (BRNS) [2009/36/22-BRNS/260]	Board of Research in Nuclear Sciences (BRNS)(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	This study has been partially funded by the Board of Research in Nuclear Sciences (BRNS) (Grant No. 2009/36/22-BRNS/260). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. No additional external funding was received for this study.	Al-Hamarneh IF, 2009, RADIAT MEAS, V44, P102, DOI 10.1016/j.radmeas.2008.11.005; Alam MN, 1999, J ENVIRON RADIOACTIV, V46, P243, DOI 10.1016/S0265-931X(98)00143-X; [Anonymous], 1983, EML PROC MAN; Beir V, 1990, HLTH EFFECTS EXPOSUR, DOI DOI 10.17226/1224; Bennett BG, 1997, P 4 INT C HIGH LEV N, P15; Cheriyan VD, 1999, J RADIAT RES, V152, P154; Das B., 2010, BARC NEWS LETT, P28; Delpoux MA, 1997, P 4 INT C HIGH LEV N, P397; ELKHATIB AM, 1988, ISOTOPENPRAXIS, V24, P333, DOI 10.1080/10256018808623990; Forster L, 2002, P NATL ACAD SCI USA, V99, P13950, DOI 10.1073/pnas.202400499; Freitas AC, 2004, J ENVIRON RADIOACTIV, V75, P211, DOI 10.1016/j.jenvrad.2004.01.002; Ghiassi-nejad M, 2002, HEALTH PHYS, V82, P87, DOI 10.1097/00004032-200201000-00011; Hassan AM, 1997, APPL RADIAT ISOTOPES, V48, P149, DOI 10.1016/S0969-8043(96)00063-2; IAEA, 1989, P IAEA TECHN REP SER, V309; ICRP, 2007, ANN ICRP, V103; Jaikrishan G, 1999, RADIAT RES, V152, pS149, DOI 10.2307/3580135; Kannan V, 2003, APPL RADIAT ISOTOPES, V57, P109, DOI 10.1016/S0969-8043(01)00262-7; KOCHUPILLAI N, 1976, NATURE, V262, P60, DOI 10.1038/262060a0; LAL M, 1989, J RADIOAN NUCL CH LE, V137, P127, DOI 10.1007/BF02164575; Mamont-Ciesla K., 1982, NATURAL RAD ENV; Mishra U. C., 1993, IAEA PUBLICATION SER, P29; Mohanty AK, 2004, RADIAT MEAS, V38, P153, DOI 10.1016/j.radmeas.2003.08.003; MOLLAH AS, 1989, RADIAT PROT DOSIM, V27, P43; Moura CL, 2011, APPL RADIAT ISOTOPES, V69, P1094, DOI 10.1016/j.apradiso.2011.03.004; Nair K. R. R., 2000, P 5 INT C HIGH LEV N, P79; Nair KRR, 2000, P 5 INT C HIGH LEV N, P404; Nair RRK, 2009, HEALTH PHYS, V96, P55, DOI 10.1097/01.HP.0000327646.54923.11; Narayana Y, 2005, INT CONGR SER, V1276, P333, DOI 10.1016/j.ics.2004.11.163; Paschoa AS., 2000, TECHNOLOGY, V7, P193; Paul AC, 1998, J ENVIRON RADIOACTIV, V40, P251, DOI 10.1016/S0265-931X(97)00087-8; PFEIFFER WC, 1981, AN ACAD BRAS CIENC, V53, P683; RADHAKRISHNA AP, 1993, HEALTH PHYS, V65, P390, DOI 10.1097/00004032-199310000-00006; Senthilkumar B, 2010, J MED PHYS, V35, P48, DOI 10.4103/0971-6203.55966; Shetty PK, 2010, J ENVIRON RADIOACTIV, V30, P1; Sohrabi M, 1998, APPL RADIAT ISOTOPES, V49, P169, DOI 10.1016/S0969-8043(97)00238-8; Sunta CM, 1982, NATURAL RAD ENV, P35; Suntha C. M., 1993, P INT C HIGH LEVELS, P71; Thampi M.V., 2002, INT CONGR SER, V1225, P207; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, UNSCEAR 2000 REPORT; UNSCEAR, 1993, ION RAD SOURC EFF IO; Veiga L., 1999, 2 S TECHN ENH NAT RA; Wei L, 2000, J Radiat Res, V41 Suppl, P1; Wei L., 1993, P INT C HIGH LEV NAT, P523	43	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50468	10.1371/journal.pone.0050468	http://dx.doi.org/10.1371/journal.pone.0050468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185629	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000241
J	Kanakasabai, S; Pestereva, E; Chearwae, W; Gupta, SK; Ansari, S; Bright, JJ				Kanakasabai, Saravanan; Pestereva, Ecaterina; Chearwae, Wanida; Gupta, Sushil K.; Ansari, Saif; Bright, John J.			PPAR gamma Agonists Promote Oligodendrocyte Differentiation of Neural Stem Cells by Modulating Stemness and Differentiation Genes	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); PROGENITOR CELLS; IN-VITRO; SUBVENTRICULAR ZONE; ALZHEIMERS-DISEASE; GALANIN; NEURONS	Neural stem cells (NSCs) are a small population of resident cells that can grow, migrate and differentiate into neuro-glial cells in the central nervous system (CNS). Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor transcription factor that regulates cell growth and differentiation. In this study we analyzed the influence of PPAR gamma agonists on neural stem cell growth and differentiation in culture. We found that in vitro culture of mouse NSCs in neurobasal medium with B27 in the presence of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) induced their growth and expansion as neurospheres. Addition of all-trans retinoic acid (ATRA) and PPAR gamma agonist ciglitazone or 15-Deoxy-Delta(12,14)-Prostaglandin J(2) (15d-PGJ2) resulted in a dose-dependent inhibition of cell viability and proliferation of NSCs in culture. Interestingly, NSCs cultured with PPAR gamma agonists, but not ATRA, showed significant increase in oligodendrocyte precursor-specific O4 and NG2 reactivity with a reduction in NSC marker nestin, in 3-7 days. In vitro treatment with PPAR gamma agonists and ATRA also induced modest increase in the expression of neuronal beta-III tubulin and astrocyte-specific GFAP in NSCs in 3-7 days. Further analyses showed that PPAR gamma agonists and ATRA induced significant alterations in the expression of many stemness and differentiation genes associated with neuro-glial differentiation in NSCs. These findings highlight the influence of PPAR gamma agonists in promoting neuro-glial differentiation of NSCs and its significance in the treatment of neurodegenerative diseases.	[Kanakasabai, Saravanan; Pestereva, Ecaterina; Chearwae, Wanida; Gupta, Sushil K.; Ansari, Saif; Bright, John J.] Indiana Univ Hlth, Methodist Res Inst, Neurosci Res Lab, Indianapolis, IN 46204 USA; [Bright, John J.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA	Indiana University System; Indiana University System; Indiana University Bloomington	Bright, JJ (corresponding author), Indiana Univ Hlth, Methodist Res Inst, Neurosci Res Lab, Indianapolis, IN 46204 USA.	jbright1@clarian.org	Peterson, Catherine/S-1436-2016	Peterson, Catherine/0000-0003-3505-0174				Allahtavakoli M, 2007, BASIC CLIN PHARMACOL, V101, P309, DOI 10.1111/j.1742-7843.2007.00127.x; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bernardo A, 2000, EUR J NEUROSCI, V12, P2215, DOI 10.1046/j.1460-9568.2000.00110.x; BLASCHKE F, 2006, ENDOCRIN METAB CLIN, V35, pR9; Blaschke F, 2006, ENDOCRIN METAB CLIN, V35, P561, DOI 10.1016/j.ecl.2006.06.001; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Brzozowski Tomasz, 2005, Inflammopharmacology, V13, P317, DOI 10.1163/156856005774423908; Burazin TCD, 1998, J NEUROCHEM, V71, P879; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Chaerkady R, 2009, J PROTEOME RES, V8, P1315, DOI 10.1021/pr8006667; Cheng JD, 2004, BIOCHEM BIOPH RES CO, V322, P458, DOI 10.1016/j.bbrc.2004.07.133; Cho JH, 2004, MOL NEUROBIOL, V30, P35, DOI 10.1385/MN:30:1:035; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; D'Amour KA, 2003, P NATL ACAD SCI USA, V100, P11866, DOI 10.1073/pnas.1834200100; Debril MB, 2001, J MOL MED, V79, P30, DOI 10.1007/s001090000145; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fox MA, 2004, MOL CELL NEUROSCI, V27, P140, DOI 10.1016/j.mcn.2004.06.002; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, CURR OPIN NEUROBIOL, V8, P671, DOI 10.1016/S0959-4388(98)80098-6; GROVES AK, 1993, DEV BIOL, V159, P87, DOI 10.1006/dbio.1993.1223; Hendrickx M, 2009, DEV GROWTH DIFFER, V51, P687, DOI 10.1111/j.1440-169X.2009.01128.x; HOKFELT T, 1987, NEUROSCI LETT, V83, P217, DOI 10.1016/0304-3940(87)90088-7; Holmes FE, 2000, P NATL ACAD SCI USA, V97, P11563, DOI 10.1073/pnas.210221897; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kaneto H, 2008, ENDOCR J, V55, P235, DOI 10.1507/endocrj.K07E-041; Kaneto H, 2008, FRONT BIOSCI-LANDMRK, V13, P6406, DOI 10.2741/3162; Katura T, 2010, MOL PHARMACOL, V77, P601, DOI 10.1124/mol.109.061010; Kielian T, 2003, J NEUROSCI RES, V71, P315, DOI 10.1002/jnr.10501; Klassen H, 2001, NEUROSCI LETT, V312, P180, DOI 10.1016/S0304-3940(01)02215-7; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kubota H, 2002, J BIOL CHEM, V277, P27629, DOI 10.1074/jbc.M202117200; Landreth GE, 2001, NEUROBIOL AGING, V22, P937, DOI 10.1016/S0197-4580(01)00296-2; Lazarovici P, 2006, CURR PHARM DESIGN, V12, P2609, DOI 10.2174/138161206777698738; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Luna-Medina R, 2007, J NEUROSCI, V27, P5766, DOI 10.1523/JNEUROSCI.1004-07.2007; Luskin MB, 1997, MOL CELL NEUROSCI, V8, P351, DOI 10.1006/mcne.1996.0592; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mo CQ, 2010, CELL SIGNAL, V22, P495, DOI 10.1016/j.cellsig.2009.11.003; Mokry J, 1999, Gen Physiol Biophys, V18 Suppl 1, P25; Morales-Garcia JA, 2011, GLIA, V59, P293, DOI 10.1002/glia.21101; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Natarajan C, 2002, GENES IMMUN, V3, P59, DOI 10.1038/sj.gene.6363832; O'Meara G, 2000, P NATL ACAD SCI USA, V97, P11569, DOI 10.1073/pnas.210254597; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Okano Hideyuki, 2002, Keio Journal of Medicine, V51, P115; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Raikwar HP, 2006, J NEUROIMMUNOL, V178, P76, DOI 10.1016/j.jneuroim.2006.05.013; Rajasingh J, 2006, EXP CELL RES, V312, P2538, DOI 10.1016/j.yexcr.2006.04.010; Ricote M, 1999, J LEUKOCYTE BIOL, V66, P733, DOI 10.1002/jlb.66.5.733; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rogister B, 1999, MOL CELL NEUROSCI, V14, P287, DOI 10.1006/mcne.1999.0790; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; RUTHERFURD SD, 1992, MOL BRAIN RES, V14, P261, DOI 10.1016/0169-328X(92)90181-A; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Shihabuddin LS, 1999, MOL MED TODAY, V5, P474, DOI 10.1016/S1357-4310(99)01596-8; Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]; Sun Y, 2011, NEURON, V69, P906, DOI 10.1016/j.neuron.2011.02.005; Sypecka J, 2009, ACTA NEUROBIOL EXP, V69, P37; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wada K, 2006, J BIOL CHEM, V281, P12673, DOI 10.1074/jbc.M513786200; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Yokoyama M, 1996, MOL BRAIN RES, V42, P135, DOI 10.1016/S0169-328X(96)00154-4; Younes-Rapozo V, 2006, INT J DEV NEUROSCI, V24, P445, DOI 10.1016/j.ijdevneu.2006.08.004; Zhang SC, 1999, ACTA NEUROPATHOL, V97, P393, DOI 10.1007/s004010051003	73	46	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50500	10.1371/journal.pone.0050500	http://dx.doi.org/10.1371/journal.pone.0050500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185633	gold, Green Submitted, Green Published			2022-12-25	WOS:000311821000243
J	Zhang, C; Tang, WJ; Li, Y				Zhang, Chi; Tang, Wanjin; Li, Yang			Matrix Metalloproteinase 13 (MMP13) Is a Direct Target of Osteoblast-Specific Transcription Factor Osterix (Osx) in Osteoblasts	PLOS ONE			English	Article							RECEPTOR-MEDIATED TRANSCRIPTION; BONE-FORMATION; COLLAGENASE-3 MMP-13; DIFFERENTIATION; OSSIFICATION; PROTEIN; GROWTH; GENE; CHONDROCYTES; EXPRESSION	Osterix (Osx) is an osteoblast-specific transcription factor required for bone formation and osteoblast differentiation from mesenchymal stem cells. In Osx-null mice, no bone formation occurs. Matrix metalloproteinase 13 (MMP13) is a member of the matrix metalloproteinase family and plays an important role in endochondral ossification and bone remodeling. Transcriptional regulation of MMP13 expression in osteoblasts is not well understood. Here, we provide several lines of evidence which show that MMP13 is a direct target of Osx in osteoblasts. Calvaria obtained from Osx-null embryos displayed dramatic reductions in MMP13 expression compared to wild-type calvaria. Stable overexpression of Osx stimulated MMP13 expression in C2C12 mesenchymal cells. Inhibition of Osx expression by siRNA led to downregulation of MMP13 expression. Mechanistic approaches using transient transfection assays showed that Osx directly activated a 1 kb fragment of the MMP13 promoter in a dose-dependent manner. To define the region of the MMP13 promoter that was responsive to Osx, a series of MMP13 promoter deletion mutants were examined and the minimal Osx-responsive region was refined to the proximal 80 bp of the MMP13 promoter. Additional point mutant analysis was used to identify one GC-rich region that was responsible for MMP13 promoter activation by Osx. Gel Shift Assay showed that Osx bound to MMP13 promoter sequence directly. Chromatin immunoprecipitation assays demonstrated that endogenous Osx was associated with the native MMP13 promoter in primary osteoblasts in vivo. Taken together, these data strongly support a direct regulatory role for Osx in MMP13 gene expression in osteoblasts. They further provide new insight into potential mechanisms and pathways that Osx controls bone formation.	[Zhang, Chi; Tang, Wanjin; Li, Yang] Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75390 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, C (corresponding author), Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75390 USA.	Chi5.Zhang@utsouthwestern.edu	Zhang, Chi/K-4467-2012		Arthritis Foundation; Texas Scottish Rite Hospital for Children	Arthritis Foundation; Texas Scottish Rite Hospital for Children	Work in the Bone Research Laboratory is supported by a Research Grant from the Arthritis Foundation (To Chi Zhang) and RAP01 Grant from Texas Scottish Rite Hospital for Children (To Chi Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Alonzo RC, 2002, J BIOL CHEM, V277, P24788, DOI 10.1074/jbc.M202604200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Tang WJ, 2012, J BIOL CHEM, V287, P1671, DOI 10.1074/jbc.M111.288472; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; Winchester SK, 1999, J CELL PHYSIOL, V181, P479, DOI 10.1002/(SICI)1097-4652(199912)181:3<479::AID-JCP12>3.0.CO;2-D; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026504; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37; Zhou X, 2010, P NATL ACAD SCI USA, V107, P12919, DOI 10.1073/pnas.0912855107	24	33	37	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50525	10.1371/journal.pone.0050525	http://dx.doi.org/10.1371/journal.pone.0050525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185634	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000244
J	Varco-Merth, B; Mirza, K; Alzhanov, DT; Chia, DJ; Rotwein, P				Varco-Merth, Ben; Mirza, Kasim; Alzhanov, Damir T.; Chia, Dennis J.; Rotwein, Peter			Biochemical Characterization of Diverse Stat5b-Binding Enhancers That Mediate Growth Hormone-Activated Insulin-Like Growth Factor-I Gene Transcription	PLOS ONE			English	Article							BINDING-SITES; TYROSINE PHOSPHORYLATION; BODY GROWTH; STAT5B; IDENTIFICATION; EXPRESSION; PROTEINS; LESSONS; LATENT; LIVER	Many of the biological effects of growth hormone (GH) are mediated by insulin-like growth factor I (IGF-I), a 70-amino acid secreted peptide whose gene expression is rapidly induced by GH via the Stat5b transcription factor. We previously identified multiple evolutionarily conserved GH-activated chromosomal binding domains for Stat5b within the rat Igf1 locus, and proposed that they could regulate IGF-I gene activity. Here we investigate the biochemical and functional characteristics of these putative long-range transcriptional enhancers. Each element contained 2 or 3 individual Stat5b recognition sequences that could bind Stat5b in vitro, but with affinities that varied over a >100-fold range. Full transcriptional responsiveness to GH required that all Stat5b sites be intact within an individual enhancer. Replacement of a single lower-affinity Stat5b sequence with a higher-affinity one increased in vitro binding of Stat5b, and boosted transcriptional potency of the entire element to GH. As enhanced transcriptional activity involved changes in only one or two nucleotides within an enhancer DNA segment, there appears to be remarkable specificity and sensitivity in the ability of Stat5b to transform DNA binding activity into transcriptional function. Stat5b was able to stimulate the transcriptional activity of two enhancers in the absence of GH, indicating that individual Stat5b-regulated elements possess distinct functional features. We conclude that combinatorial interplay among multiple Stat5b-binding response elements with distinguishable biochemical properties is responsible for highly regulated control of IGF-I gene activity by GH.	[Varco-Merth, Ben; Mirza, Kasim; Alzhanov, Damir T.; Rotwein, Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA; [Chia, Dennis J.] Mt Sinai Sch Med, Dept Pediat, New York, NY USA	Oregon Health & Science University; Icahn School of Medicine at Mount Sinai	Rotwein, P (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.	rotweinp@ohsu.edu	Rotwein, Peter/R-5783-2019	Rotwein, Peter/0000-0002-9505-1817	National Institutes of Health [T32 DK007680, T32 DK007674, K08 DK077897, K12 HD057588, R01 DK069703]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD057588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069703, T32DK007680, T32DK007674, K08DK077897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the National Institutes of Health: T32 DK007680 (BVM), T32 DK007674 (DTA), K08 DK077897 and K12 HD057588 (DJC), R01 DK069703 (PR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay JL, 2010, MOL ENDOCRINOL, V24, P204, DOI 10.1210/me.2009-0233; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Berryman DE, 2008, GROWTH HORM IGF RES, V18, P455, DOI 10.1016/j.ghir.2008.05.005; BICHELL DP, 1992, MOL ENDOCRINOL, V6, P1899, DOI 10.1210/me.6.11.1899; Chia DJ, 2010, MOL ENDOCRINOL, V24, P2038, DOI 10.1210/me.2010-0234; Chia DJ, 2010, J BIOL CHEM, V285, P17636, DOI 10.1074/jbc.M110.117697; Chia DJ, 2006, J BIOL CHEM, V281, P3190, DOI 10.1074/jbc.M510204200; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Eleswarapu S, 2008, ENDOCRINOLOGY, V149, P2230, DOI 10.1210/en.2007-1344; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hwa V, 2011, BEST PRACT RES CL EN, V25, P61, DOI 10.1016/j.beem.2010.09.003; Ibrahim YH, 2004, GROWTH HORM IGF RES, V14, P261, DOI 10.1016/j.ghir.2004.01.005; Iyer J, 2008, FASEB J, V22, P391, DOI 10.1096/fj.07-8965com; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Laz EV, 2009, MOL ENDOCRINOL, V23, P1242, DOI 10.1210/me.2008-0449; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin JX, 1996, J BIOL CHEM, V271, P10738, DOI 10.1074/jbc.271.18.10738; Nelson EA, 2006, J BIOL CHEM, V281, P26216, DOI 10.1074/jbc.M605001200; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rosenfeld RG, 2009, HORM RES, V71, P36, DOI 10.1159/000192434; Rotwein P, 2010, PEDIATR NEPHROL, V25, P651, DOI 10.1007/s00467-009-1258-y; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schindler C, 2008, SEMIN CELL DEV BIOL, V19, P311, DOI 10.1016/j.semcdb.2008.08.010; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tronche F, 2004, GENE DEV, V18, P492, DOI 10.1101/gad.284704; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Wang Y, 2005, J BIOL CHEM, V280, P10955, DOI 10.1074/jbc.M412808200; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933; Woelfle J, 2004, AM J PHYSIOL-ENDOC M, V286, pE393, DOI 10.1152/ajpendo.00389.2003; Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; Yoo Kyung Hyun, 2011, Genes Cancer, V2, P3, DOI 10.1177/1947601911405046; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11	40	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50278	10.1371/journal.pone.0050278	http://dx.doi.org/10.1371/journal.pone.0050278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185594	gold, Green Submitted, Green Published			2022-12-25	WOS:000311535700083
J	Adhikary, T; Brandt, DT; Kaddatz, K; Stockert, J; Naruhn, S; Meissner, W; Finkernagel, F; Obert, J; Lieber, S; Scharfe, M; Jarek, M; Toth, PM; Scheer, F; Diederich, WE; Reinartz, S; Grosse, R; Muller-Brusselbach, S; Muller, R				Adhikary, T.; Brandt, D. T.; Kaddatz, K.; Stockert, J.; Naruhn, S.; Meissner, W.; Finkernagel, F.; Obert, J.; Lieber, S.; Scharfe, M.; Jarek, M.; Toth, P. M.; Scheer, F.; Diederich, W. E.; Reinartz, S.; Grosse, R.; Mueller-Bruesselbach, S.; Mueller, R.			Inverse PPAR beta/delta agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion	ONCOGENE			English	Article						peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) angiopoietin-like 4 (ANGPTL4); transforming growth factor beta (TGF beta); transcriptional repression; invasion; ChIP-Seq	ANGIOPOIETIN-LIKE 4; ACTIVATED RECEPTOR-DELTA; PROMOTES VENOUS INVASION; TGF-BETA; ANOIKIS RESISTANCE; GAMMA LIGANDS; EXPRESSION; PROTEIN; MIGRATION; METASTASIS	Besides its established functions in intermediary metabolism and developmental processes, the nuclear receptor peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) has a less defined role in tumorigenesis. In the present study, we have identified a function for PPAR beta/delta in cancer cell invasion. We show that two structurally divergent inhibitory ligands for PPAR beta/delta, the inverse agonists ST247 and DG172, strongly inhibit the serum- and transforming growth factor beta (TGF beta)-induced invasion of MDA-MB-231 human breast cancer cells into a three-dimensional matrigel matrix. To elucidate the molecular basis of this finding, we performed chromatin immunoprecipitation sequencing (ChIP-Seq) and microarray analyses, which identified the gene encoding angiopoietin-like 4 (ANGPTL4) as the major transcriptional PPAR beta/delta target in MDA-MB-231 cells, previously implicated in TGF beta-mediated tumor progression and metastatic dissemination. We show that the induction of ANGPTL4 by TGF beta and other oncogenic signals is strongly repressed by ST247 and DG172 in a PPAR beta/delta-dependent fashion, resulting in the inhibition of ANGPTL4 secretion. This effect is attributable to these ligands' ability to induce a dominant transcriptional repressor complex at the site of transcription initiation that blocks preinitiation complex formation through an histone deacetylase-independent, non-canonical mechanism. Repression of ANGPTL4 transcription by inverse PPAR beta/delta agonists is functionally linked to the inhibition of cancer cell invasion into a three-dimensional matrix, as (i) invasion of MDA-MB-231 cells is critically dependent on ANGPTL4 expression, (ii) recombinant ANGPTL4 stimulates invasion, and (iii) reverses the inhibitory effect of ST247 and DG172. These findings indicate that a PPAR beta/delta-ANGPTL4 pathway is involved in the regulation of tumor cell invasion and that its pharmacological manipulation by inverse PPAR beta/delta agonists is feasible.	[Adhikary, T.; Kaddatz, K.; Stockert, J.; Naruhn, S.; Meissner, W.; Finkernagel, F.; Obert, J.; Lieber, S.; Mueller-Bruesselbach, S.; Mueller, R.] Univ Marburg, Inst Mol Biol & Tumor Res IMT, D-35032 Marburg, Germany; [Brandt, D. T.; Grosse, R.] Univ Marburg, Pharmacol Inst, D-35032 Marburg, Germany; [Scharfe, M.; Jarek, M.] Helmholtz Ctr Infect Res HZI, Braunschweig, Germany; [Toth, P. M.; Scheer, F.; Diederich, W. E.] Univ Marburg, Inst Pharmaceut Chem, D-35032 Marburg, Germany; [Reinartz, S.] Univ Marburg, Dept Gynecol Gynecol Endocrinol & Oncol, D-35032 Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Helmholtz Association; Helmholtz-Center for Infection Research; Philipps University Marburg; Philipps University Marburg	Muller, R (corresponding author), Univ Marburg, Inst Mol Biol & Tumor Res IMT, Emil Mannkopff Str 2, D-35032 Marburg, Germany.	rmueller@imt.uni-marburg.de	Müller, Rolf/L-4997-2016; Adhikary, Till/O-5678-2018	Müller, Rolf/0000-0003-3339-4248; Adhikary, Till/0000-0003-1951-5605; Grosse, Robert/0000-0002-3380-5273	Deutsche Forschungsgemeinschaft [SFB/TRR17-A3, MU601/13]; LOEWE research cluster 'Tumor and Inflammation'	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE research cluster 'Tumor and Inflammation'	This work was supported by research grants from the Deutsche Forschungsgemeinschaft to RM (SFB/TRR17-A3 and MU601/13) and by the LOEWE research cluster 'Tumor and Inflammation'.	Adhikary T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016344; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Borland MG, 2011, CELL SIGNAL, V23, P2039, DOI 10.1016/j.cellsig.2011.07.020; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Farrow B, 2003, SURGERY, V134, P206, DOI 10.1067/msy.2003.221; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Gealekman O, 2008, AM J PHYSIOL-ENDOC M, V295, pE1056, DOI 10.1152/ajpendo.90345.2008; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Huang RL, 2011, BLOOD, V118, P3990, DOI 10.1182/blood-2011-01-328716; Huang XF, 2012, ONCOL REP, V27, P1541, DOI 10.3892/or.2012.1672; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Lieber S, 2012, J MED CHEM, V55, P2858, DOI 10.1021/jm2017122; Lim HJ, 2009, ATHEROSCLEROSIS, V202, P446, DOI 10.1016/j.atherosclerosis.2008.05.023; Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Mandard S, 2004, J BIOL CHEM, V279, P34411, DOI 10.1074/jbc.M403058200; Mannelqvist M, 2011, AM J PATHOL, V178, P861, DOI 10.1016/j.ajpath.2010.10.040; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Michalik L, 2011, PROSTAG LEUKOTR ESS, V85, P235, DOI 10.1016/j.plefa.2011.04.016; Muller R, 2008, PPAR RES, V2008; Nakayama T, 2011, ONCOL REP, V25, P929, DOI 10.3892/or.2011.1176; Nakayama T, 2010, ONCOL REP, V24, P599, DOI 10.3892/or_00000897; Naruhn S, 2011, MOL PHARMACOL, V80, P828, DOI 10.1124/mol.111.074039; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Papi A, 2009, ONCOL REP, V21, P1083, DOI 10.3892/or_00000327; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Peters JM, 2009, BBA-REV CANCER, V1796, P230, DOI 10.1016/j.bbcan.2009.06.002; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rieck M, 2008, MOL PHARMACOL, V74, P1269, DOI 10.1124/mol.108.050625; Shearer BG, 2010, J MED CHEM, V53, P1857, DOI 10.1021/jm900464j; Shi YH, 2002, P NATL ACAD SCI USA, V99, P2613, DOI 10.1073/pnas.052707099; Stockert J, 2011, NUCLEIC ACIDS RES, V39, P119, DOI 10.1093/nar/gkq773; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Tan NS, 2007, MOL CELL BIOL, V27, P7161, DOI 10.1128/MCB.00436-07; Tian LF, 2009, CANCER RES, V69, P9236, DOI 10.1158/0008-5472.CAN-09-2067; Toth PM, 2012, CHEMMEDCHEM, V7, P159, DOI 10.1002/cmdc.201100408; Van Ginderachter JA, 2008, PPAR RES, V2008, DOI 10.1155/2008/169414; Verine J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010421; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Zaytseva YY, 2011, ANTICANCER RES, V31, P813; Zhang ZY, 2008, CANCER LETT, V267, P106, DOI 10.1016/j.canlet.2008.03.010; Zhu PC, 2012, BIOSCIENCE REP, V32, P211, DOI 10.1042/BSR20110102; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	59	55	57	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 31	2013	32	44					5241	5252		10.1038/onc.2012.549	http://dx.doi.org/10.1038/onc.2012.549			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	245XH	23208498	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000326497100007
J	Tundo, GR; Sbardella, D; Ciaccio, C; Bianculli, A; Orlandi, A; Desimio, MG; Arcuri, G; Coletta, M; Marini, S				Tundo, Grazia Raffaella; Sbardella, Diego; Ciaccio, Chiara; Bianculli, Antonio; Orlandi, Augusto; Desimio, Maria Giovanna; Arcuri, Gaetano; Coletta, Massimiliano; Marini, Stefano			Insulin-degrading Enzyme (IDE) A NOVEL HEAT SHOCK-LIKE PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADATION; UBIQUITIN; BINDING; CANCER; METALLOENDOPROTEASE; CHAPERONES; EXPRESSION; INHIBITORS; SECRETION; INFECTION	Insulin-degrading enzyme (IDE) is a highly conserved zinc metallopeptidase that is ubiquitously distributed in human tissues, and particularly abundant in the brain, liver, and muscles. IDE activity has been historically associated with insulin and beta-amyloid catabolism. However, over the last decade, several experimental findings have established that IDE is also involved in a wide variety of physiopathological processes, including ubiquitin clearance and Varicella Zoster Virus infection. In this study, we demonstrate that normal and malignant cells exposed to different stresses markedly up-regulate IDE in a heat shock protein (HSP)-like fashion. Additionally, we focused our attention on tumor cells and report that (i) IDE is overexpressed in vivo in tumors of the central nervous system (CNS); (ii) IDE-silencing inhibits neuroblastoma (SHSY5Y) cell proliferation and triggers cell death; (iii) IDE inhibition is accompanied by a decrease of the poly-ubiquitinated protein content and co-immunoprecipitates with proteasome and ubiquitin in SHSY5Y cells. In this work, we propose a novel role for IDE as a heat shock protein with implications in cell growth regulation and cancer progression, thus opening up an intriguing hypothesis of IDE as an anticancer target.	[Tundo, Grazia Raffaella; Sbardella, Diego; Ciaccio, Chiara; Bianculli, Antonio; Coletta, Massimiliano; Marini, Stefano] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, I-00133 Rome, Italy; [Tundo, Grazia Raffaella; Sbardella, Diego; Ciaccio, Chiara; Coletta, Massimiliano; Marini, Stefano] CIRCMSB, I-70125 Bari, Italy; [Orlandi, Augusto; Desimio, Maria Giovanna; Arcuri, Gaetano] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Marini, S (corresponding author), Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Via Montpellier 1, I-00133 Rome, Italy.	stefano.marini@uniroma2.it	Coletta, Massimo/N-9049-2015; Sbardella, Diego/N-9187-2015; Desimio, Maria Giovanna/AAA-7541-2020; Marini, Stefano/B-1161-2012; Orlandi, Augusto/AHE-8753-2022; Coletta, Massimiliano/GSN-5927-2022; Sbardella, Diego/K-7519-2016	Marini, Stefano/0000-0003-1299-6696; Sbardella, Diego/0000-0002-9924-7761; Desimio, Maria Giovanna/0000-0002-6353-7935; TUNDO, Grazia Raffaella/0000-0002-3866-3171; orlandi, augusto/0000-0001-7202-5854; COLETTA, Massimiliano/0000-0002-5489-9467	Italian Ministry for the University and Research [MiUR PRIN 2008L57JXW 002, FIRB RBNE03PX83]	Italian Ministry for the University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by the Italian Ministry for the University and Research (MiUR PRIN 2008L57JXW 002 (to S. M.) and FIRB RBNE03PX83 (to M. C.).	Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Bennett RG, 2000, ENDOCRINOLOGY, V141, P2508, DOI 10.1210/en.141.7.2508; Bennett RG, 2003, J ENDOCRINOL, V177, P399, DOI 10.1677/joe.0.1770399; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Ciaccio C, 2009, J MOL BIOL, V385, P1556, DOI 10.1016/j.jmb.2008.11.025; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; De Maio A, 2011, CELL STRESS CHAPERON, V16, P235, DOI 10.1007/s12192-010-0236-4; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Fernandez-Gamba A, 2009, CURR PHARM DESIGN, V15, P3644, DOI 10.2174/138161209789271799; Garrido C, 2003, CELL DEATH DIFFER, V10, P619, DOI 10.1038/sj.cdd.4401229; Glebov K, 2011, J BIOL CHEM, V286, P22711, DOI 10.1074/jbc.C110.217893; Grasso G, 2008, BBA-PROTEINS PROTEOM, V1784, P1122, DOI 10.1016/j.bbapap.2008.04.011; Hersh LB, 2006, CELL MOL LIFE SCI, V63, P2432, DOI 10.1007/s00018-006-6238-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jolly C, 2000, JNCI-J NATL CANCER I, V92, P1564, DOI 10.1093/jnci/92.19.1564; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Karapanagiotou EM, 2009, EXPERT OPIN INV DRUG, V18, P161, DOI [10.1517/13543780802715792, 10.1517/13543780802715792 ]; KAYALAR C, 1989, J BIOL CHEM, V264, P8928; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; KIRSCHNER RJ, 1983, J BIOL CHEM, V258, P967; KUO WL, 1993, ENDOCRINOLOGY, V132, P604, DOI 10.1210/en.132.2.604; KUPFER SR, 1994, J BIOL CHEM, V269, P20622; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Orlandi A, 2006, MODERN PATHOL, V19, P797, DOI 10.1038/modpathol.3800586; Parmentier N, 2010, NAT IMMUNOL, V11, P449, DOI 10.1038/ni.1862; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ralat LA, 2011, J MOL BIOL, V406, P454, DOI 10.1016/j.jmb.2010.12.026; Rudovich N, 2009, J MOL MED, V87, P1145, DOI 10.1007/s00109-009-0540-6; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Thomas SK, 2004, J BIOL CHEM, V279, P27994, DOI 10.1074/jbc.M312663200; Tundo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034376; Udrisar DP, 2005, EXP BIOL MED, V230, P479; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Yfanti C, 2008, INT J MOL MED, V22, P421, DOI 10.3892/ijmm_00000038; Zhao J, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-4	40	50	52	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2281	2289		10.1074/jbc.M112.393108	http://dx.doi.org/10.1074/jbc.M112.393108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23188819	Green Published, hybrid			2022-12-25	WOS:000314211500018
J	Kober, FX; Koelmel, W; Kuper, J; Drechsler, J; Mais, C; Hermanns, HM; Schindelin, H				Kober, Franz-Xaver; Koelmel, Wolfgang; Kuper, Jochen; Drechsler, Johannes; Mais, Christine; Hermanns, Heike M.; Schindelin, Hermann			The Crystal Structure of the Protein-Disulfide Isomerase Family Member ERp27 Provides Insights into Its Substrate Binding Capabilities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYSIS; ERP57; CALRETICULIN; EXPRESSION; CHAPERONE; CALNEXIN; DOMAINS; ENZYME; MODEL	About one-third of all cellular proteins pass through the secretory pathway and hence undergo oxidative folding in the endoplasmic reticulum (ER). Protein-disulfide isomerase (PDI) and related members of the PDI family assist in the folding of substrates by catalyzing the oxidation of two cysteines and isomerization of disulfide bonds as well as by acting as chaperones. In this study, we present the crystal structure of ERp27, a redox-inactive member of the PDI family. The structure reveals its substrate-binding cleft, which is homologous to PDI, but is able to adapt in size and hydrophobicity. Isothermal titration calorimetry experiments demonstrate that ERp27 is able to distinguish between folded and unfolded substrates, only interacting with the latter. ERp27 is up-regulated during ER stress, thus presumably allowing it to bind accumulating misfolded substrates and present them to ERp57 for catalysis.	[Kober, Franz-Xaver; Koelmel, Wolfgang; Kuper, Jochen; Drechsler, Johannes; Mais, Christine; Hermanns, Heike M.; Schindelin, Hermann] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany	University of Wurzburg	Schindelin, H (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Josef Schneider Str 2, D-97080 Wurzburg, Germany.	hermann.schindelin@virchow.uni-wuerzburg.de	Schindelin, Hermann/Q-2697-2019		Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine) [FZ 82, Schi 425/3-1]	Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Rudolf Virchow Center for Experimental Biomedicine FZ 82 and Schi 425/3-1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alanen HI, 2006, J BIOL CHEM, V281, P33727, DOI 10.1074/jbc.M604314200; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; CAI H, 1994, J BIOL CHEM, V269, P24550; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; Denisov AY, 2009, FEBS J, V276, P1440, DOI 10.1111/j.1742-4658.2009.06884.x; Dixon DP, 2003, ANTIOXID REDOX SIGN, V5, P389, DOI 10.1089/152308603768295122; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gulow K, 2002, J CELL SCI, V115, P2443; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; Kozlov G, 2009, STRUCTURE, V17, P651, DOI 10.1016/j.str.2009.02.016; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Low LK, 2000, FEBS LETT, V472, P67, DOI 10.1016/S0014-5793(00)01432-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRUSINER SB, 1987, NEW ENGL J MED, V317, P1571, DOI 10.1056/NEJM198712173172505; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WANG CC, 1993, FASEB J, V7, P1515, DOI 10.1096/fasebj.7.15.7903263; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; WEISSMAN JS, 1993, NATURE, V365, P185, DOI 10.1038/365185a0; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	47	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2029	2039		10.1074/jbc.M112.410522	http://dx.doi.org/10.1074/jbc.M112.410522			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192347	hybrid, Green Published			2022-12-25	WOS:000313751400054
J	Damanhuri, HA; Burke, PGR; Ong, LK; Bobrovskaya, L; Dickson, PW; Dunkley, PR; Goodchild, AK				Damanhuri, Hanafi A.; Burke, Peter G. R.; Ong, Lin K.; Bobrovskaya, Larisa; Dickson, Phillip W.; Dunkley, Peter R.; Goodchild, Ann K.			Tyrosine Hydroxylase Phosphorylation in Catecholaminergic Brain Regions: A Marker of Activation following Acute Hypotension and Glucoprivation	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; VENTRAL TEGMENTAL AREA; CORTICOTROPIN-RELEASING FACTOR; C-FOS EXPRESSION; LOCUS-COERULEUS; GENE-EXPRESSION; CELL GROUP; RAT-BRAIN; CARDIOVASCULAR REGULATION; FUNCTIONAL-ORGANIZATION	The expression of c-Fos defines brain regions activated by the stressors hypotension and glucoprivation however, whether this identifies all brain sites involved is unknown. Furthermore, the neurochemicals that delineate these regions, or are utilized in them when responding to these stressors remain undefined. Conscious rats were subjected to hypotension, glucoprivation or vehicle for 30, 60 or 120 min and changes in the phosphorylation of serine residues 19, 31 and 40 in the biosynthetic enzyme, tyrosine hydroxylase (TH), the activity of TH and/or, the expression of c-Fos were determined, in up to ten brain regions simultaneously that contain catecholaminergic cell bodies and/or terminals: A1, A2, caudal C1, rostral C1, A6, A8/9, A10, nucleus accumbens, dorsal striatum and medial prefrontal cortex. Glucoprivation evoked phosphorylation changes in A1, caudal C1, rostral C1 and nucleus accumbens whereas hypotension evoked changes A1, caudal C1, rostral C1, A6, A8/9, A10 and medial prefrontal cortex 30 min post stimulus whereas few changes were evident at 60 min. Although increases in pSer19, indicative of depolarization, were seen in sites where c-Fos was evoked, phosphorylation changes were a sensitive measure of activation in A8/9 and A10 regions that did not express c-Fos and in the prefrontal cortex that contains only catecholaminergic terminals. Specific patterns of serine residue phosphorylation were detected, dependent upon the stimulus and brain region, suggesting activation of distinct signaling cascades. Hypotension evoked a reduction in phosphorylation in A1 suggestive of reduced kinase activity. TH activity was increased, indicating synthesis of TH, in regions where pSer31 alone was increased (prefrontal cortex) or in conjunction with pSer40 (caudal C1). Thus, changes in phosphorylation of serine residues in TH provide a highly sensitive measure of activity, cellular signaling and catecholamine utilization in catecholaminergic brain regions, in the short term, in response to hypotension and glucoprivation. Citation: Damanhuri HA, Burke PGR, Ong LK, Bobrovskaya L, Dickson PW, et al. (2012) Tyrosine Hydroxylase Phosphorylation in Catecholaminergic Brain Regions: A Marker of Activation following Acute Hypotension and Glucoprivation. PLoS ONE 7(11): e50535. doi:10.1371/journal.pone.0050535	[Damanhuri, Hanafi A.; Burke, Peter G. R.; Goodchild, Ann K.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia; [Ong, Lin K.; Dickson, Phillip W.; Dunkley, Peter R.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Bobrovskaya, Larisa] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Damanhuri, Hanafi A.] Univ Kebangsaan Malaysia, Fac Med, Dept Biochem, Kuala Lumpur, Malaysia	Macquarie University; University of Newcastle; University of South Australia; Universiti Kebangsaan Malaysia	Goodchild, AK (corresponding author), Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia.	ann.goodchild@mq.edu.au	Damanhuri, Hanafi/J-8373-2015; Burke, Peter/AAF-8728-2020; Bobrovskaya, Larisa/D-3573-2011; Ong, Lin Kooi/H-2797-2012	Burke, Peter/0000-0002-6896-3298; Bobrovskaya, Larisa/0000-0002-5793-6147; Ong, Lin Kooi/0000-0001-8664-0540; Ahmad Damanhuri, Hanafi/0000-0002-6948-8839; Goodchild, Ann/0000-0003-1544-7924	Health and Medical Research Council NHMRC [457068, 1028183]; NHF [G09S4340]; ARC [DP120100920]; Hunter Medical Research Institute; Macquarie University; Hillcrest (Perpetual Foundation)	Health and Medical Research Council NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHF(National Heart Foundation of Australia); ARC(Australian Research Council); Hunter Medical Research Institute; Macquarie University; Hillcrest (Perpetual Foundation)	The following grants supported the writing of this manuscript: National Health and Medical Research Council NHMRC 457068, 1028183; NHF G09S4340, ARC DP120100920, Hunter Medical Research Institute, Macquarie University and Hillcrest (Perpetual Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLIS PH, 1980, ENDOCRINOLOGY, V107, P1970, DOI 10.1210/endo-107-6-1970; Bello NT, 2006, PHYSIOL BEHAV, V88, P138, DOI 10.1016/j.physbeh.2006.03.027; BLESSING WW, 1985, J PHYSIOL-LONDON, V367, P253, DOI 10.1113/jphysiol.1985.sp015823; Bobrovskaya L, 2004, J NEUROCHEM, V90, P857, DOI 10.1111/j.1471-4159.2004.02550.x; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Bobrovskaya L, 2010, NEUROCHEM INT, V57, P162, DOI 10.1016/j.neuint.2010.05.009; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Cammarota M, 2003, J NEUROCHEM, V84, P453, DOI 10.1046/j.1471-4159.2003.01517.x; Card JP, 2006, J COMP NEUROL, V499, P840, DOI 10.1002/cne.21140; CHAN RKW, 1994, J COMP NEUROL, V348, P433, DOI 10.1002/cne.903480309; CORNISH JL, 1994, NEUROSCI LETT, V176, P142, DOI 10.1016/0304-3940(94)90068-X; Dampney RAL, 2003, PROG NEUROBIOL, V71, P359, DOI 10.1016/j.pneurobio.2003.11.001; Dampney RAL, 2003, CELL MOL NEUROBIOL, V23, P597, DOI 10.1023/A:1025080314925; DEV BR, 1992, J NEUROCHEM, V58, P1386, DOI 10.1111/j.1471-4159.1992.tb11354.x; Dodd GT, 2010, J NEUROCHEM, V113, P1123, DOI 10.1111/j.1471-4159.2010.06671.x; Dronjak S, 2004, ANN NY ACAD SCI, V1018, P113, DOI 10.1196/annals.1296.013; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; ENNIS M, 1987, BRAIN RES, V425, P275, DOI 10.1016/0006-8993(87)90510-5; Gonzalez-Cuello A, 2010, N-S ARCH PHARMACOL, V382, P525, DOI 10.1007/s00210-010-0567-9; Gordon SL, 2009, BBA-MOL CELL RES, V1793, P1860, DOI 10.1016/j.bbamcr.2009.10.001; GRAHAM JC, 1995, J AUTONOM NERV SYST, V55, P92, DOI 10.1016/0165-1838(95)00032-S; HAYCOCK JW, 1993, NEUROCHEM RES, V18, P15, DOI 10.1007/BF00966919; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; Hwang KR, 1998, AM J PHYSIOL-HEART C, V274, pH1284, DOI 10.1152/ajpheart.1998.274.4.H1284; Kansy JW, 2004, J NEUROCHEM, V91, P374, DOI 10.1111/j.1471-4159.2004.02723.x; Kawahara Y, 1999, N-S ARCH PHARMACOL, V360, P42, DOI 10.1007/s002109900042; Kawahara Y, 2002, J NEUROCHEM, V81, P285, DOI 10.1046/j.1471-4159.2002.00828.x; Kirouac GJ, 1997, AM J PHYSIOL-HEART C, V273, pH2549, DOI 10.1152/ajpheart.1997.273.6.H2549; Krout KE, 2002, NEUROSCIENCE, V110, P73, DOI 10.1016/S0306-4522(01)00551-6; Kumer SC, 1996, J NEUROCHEM, V67, P443; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Li AJ, 2006, ENDOCRINOLOGY, V147, P3428, DOI 10.1210/en.2006-0235; Li AJ, 2004, EUR J NEUROSCI, V19, P2147, DOI 10.1111/j.1460-9568.2004.03287.x; LI YW, 1994, NEUROSCIENCE, V61, P613, DOI 10.1016/0306-4522(94)90439-1; Lindgren N, 2002, EUR J NEUROSCI, V15, P769, DOI 10.1046/j.1460-9568.2002.01901.x; Liu B, 2010, J ENDOCRINOL, V204, P209, DOI 10.1677/JOE-09-0335; Madden CJ, 2006, AM J PHYSIOL-REG I, V291, pR751, DOI 10.1152/ajpregu.00800.2005; Madden CJ, 2003, AM J PHYSIOL-HEART C, V285, pH2734, DOI 10.1152/ajpheart.00155.2003; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; McMullan S, 2012, BRAIN RES, V1439, P34, DOI 10.1016/j.brainres.2011.12.058; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Nakamoto T, 2011, J APPL PHYSIOL, V110, P1342, DOI 10.1152/japplphysiol.01233.2010; Nunez C, 2007, ENDOCRINOLOGY, V148, P5780, DOI 10.1210/en.2007-0510; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Ong LK, 2011, NEUROSCIENCE, V192, P20, DOI 10.1016/j.neuroscience.2011.06.087; Ong LK, 2011, NEUROCHEM RES, V36, P27, DOI 10.1007/s11064-010-0255-7; PAGE ME, 1994, BRAIN RES BULL, V35, P557, DOI 10.1016/0361-9230(94)90169-4; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PIERIBONE VA, 1988, NEUROSCI LETT, V85, P297, DOI 10.1016/0304-3940(88)90582-4; Potts PD, 1997, NEUROSCIENCE, V77, P503, DOI 10.1016/S0306-4522(96)00459-9; PRALONG FP, 1991, REGUL PEPTIDES, V32, P217, DOI 10.1016/0167-0115(91)90048-L; QUINTIN L, 1987, BRAIN RES, V425, P319, DOI 10.1016/0006-8993(87)90515-4; REINHARD JF, 1986, LIFE SCI, V39, P2185, DOI 10.1016/0024-3205(86)90395-4; RENTERO N, 1993, J PHYSIOL-LONDON, V469, P717, DOI 10.1113/jphysiol.1993.sp019839; RITTER S, 1994, BRAIN RES, V641, P111, DOI 10.1016/0006-8993(94)91822-8; Ritter S, 2003, ENDOCRINOLOGY, V144, P1357, DOI 10.1210/en.2002-221076; Ritter S, 1998, BRAIN RES, V805, P41, DOI 10.1016/S0006-8993(98)00655-6; Ritter S, 2001, J COMP NEUROL, V432, P197, DOI 10.1002/cne.1097; ROBINSON PJ, 1985, J NEUROCHEM, V44, P338, DOI 10.1111/j.1471-4159.1985.tb05422.x; ROWLAND NE, 1985, BRAIN RES BULL, V14, P617, DOI 10.1016/0361-9230(85)90111-X; Rusnak M, 1998, BRAIN RES BULL, V46, P447, DOI 10.1016/S0361-9230(98)00033-1; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Salvatore MF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008466; Schreihofer AM, 2000, AM J PHYSIOL-REG I, V279, pR729, DOI 10.1152/ajpregu.2000.279.2.R729; Sevigny CP, 2008, EUR J NEUROSCI, V28, P1536, DOI 10.1111/j.1460-9568.2008.06445.x; SHIMIZU H, 1989, PHYSIOL BEHAV, V46, P799, DOI 10.1016/0031-9384(89)90040-1; SHIMIZU H, 1990, BRAIN RES, V510, P251, DOI 10.1016/0006-8993(90)91375-Q; SINGEWALD N, 1993, N-S ARCH PHARMACOL, V347, P21; Springell DA, 2005, EUR J NEUROSCI, V22, P2257, DOI 10.1111/j.1460-9568.2005.04413.x; SVED AF, 1994, AM J PHYSIOL, V266, pR361, DOI 10.1152/ajpregu.1994.266.2.R361; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Trembleau A, 1998, BIOL CELL, V90, P39, DOI 10.1016/S0248-4900(98)80231-1; VALENTINO RJ, 1986, NEUROPHARMACOLOGY, V25, P603, DOI 10.1016/0028-3908(86)90212-1; van den Buuse M, 1998, CLIN EXP PHARMACOL P, V25, P624; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Verberne AJM, 2010, AM J PHYSIOL-ENDOC M, V299, pE802, DOI 10.1152/ajpendo.00466.2010; Verberne AJM, 1999, J PHYSIOL-LONDON, V517, P477, DOI 10.1111/j.1469-7793.1999.0477t.x; WOULFE JM, 1990, EXP NEUROL, V109, P308, DOI 10.1016/S0014-4886(05)80022-6; Xu ZQ, 1998, NEUROSCIENCE, V82, P727	80	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50535	10.1371/journal.pone.0050535	http://dx.doi.org/10.1371/journal.pone.0050535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209770	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000312104900064
J	Li, JM; Liu, C; Xu, Z; Zhang, KP; Ke, X; Wang, LD				Li Jingmin; Liu Chong; Xu Zheng; Zhang Kaiping; Ke Xue; Wang Liding			A Microfluidic Pump/Valve Inspired by Xylem Embolism and Transpiration in Plants	PLOS ONE			English	Article							WATER; ARABIDOPSIS; INSIGHTS	In plants, transpiration draws the water upward from the roots to the leaves. However, this flow can be blocked by air bubbles in the xylem conduits, which is called xylem embolism. In this research, we present the design of a biomimetic microfluidic pump/valve based on water transpiration and xylem embolism. This micropump/valve is mainly composed of three parts: the first is a silicon sheet with an array of slit-like micropores to mimic the stomata in a plant leaf; the second is a piece of agarose gel to mimic the mesophyll cells in the sub-cavities of a stoma; the third is a micro-heater which is used to mimic the xylem embolism and its self-repairing. The solution in the microchannels of a microfluidic chip can be driven by the biomimetic "leaf'' composed of the silicon sheet and the agarose gel. The halting and flowing of the solution is controlled by the micro-heater. Results have shown that a steady flow rate of 1.12 mu l/min can be obtained by using this micropump/valve. The time interval between the turning on/off of the micro-heater and the halt (or flow) of the fluid is only 2 similar to 3 s. This micropump/valve can be used as a "plug and play'' fluid-driven unit. It has the potential to be used in many application fields.	[Li Jingmin; Liu Chong; Xu Zheng; Zhang Kaiping; Ke Xue; Wang Liding] Dalian Univ Technol, Key Lab Micro Nano Technol & Syst Liaoning Prov, Sch Mech Engn, Dalian, Liaoning Provin, Peoples R China; [Liu Chong; Wang Liding] Dalian Univ Technol, Key Lab Precis & Nontradit Machining Technol, Minist Educ, Sch Mech Engn, Dalian, Liaoning Provin, Peoples R China	Dalian University of Technology; Dalian University of Technology	Liu, C (corresponding author), Dalian Univ Technol, Key Lab Micro Nano Technol & Syst Liaoning Prov, Sch Mech Engn, Dalian, Liaoning Provin, Peoples R China.	chongl@dlut.edu.cn			National Natural Science Foundation of China [51105060, 91023017, 91023046, 20890024]; China Postdoctoral Science Foundation [20100481237, 201104601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China (51105060; 91023017; 91023046), Major Program of National Natural Science Foundation of China (20890024) and China Postdoctoral Science Foundation (20100481237; 201104601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirouche F, 2009, MICROSYST TECHNOL, V15, P647, DOI 10.1007/s00542-009-0804-7; Domec JC, 2006, PLANT CELL ENVIRON, V29, P26, DOI 10.1111/j.1365-3040.2005.01397.x; Ezkerra A, 2011, LAB CHIP, V11, P3320, DOI 10.1039/c1lc20324j; Hacke UG, 2001, OECOLOGIA, V126, P457, DOI 10.1007/s004420100628; Hao GY, 2009, TREE PHYSIOL, V29, P697, DOI 10.1093/treephys/tpp005; Huang SQ, 2010, LAB CHIP, V10, P2925, DOI 10.1039/c005227b; Kim J, 2012, ANAL CHEM, V84, P2067, DOI 10.1021/ac202934x; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Lawson T, 2009, NEW PHYTOL, V181, P13, DOI 10.1111/j.1469-8137.2008.02685.x; Li JM, 2011, MICROFLUID NANOFLUID, V11, P717, DOI 10.1007/s10404-011-0837-y; Li JM, 2011, LAB CHIP, V11, P2785, DOI 10.1039/c1lc20313d; Li JM, 2012, J MATER PROCESS TECH, V212, P2315, DOI 10.1016/j.jmatprotec.2012.06.022; Liang YK, 2010, PLANT J, V64, P679, DOI 10.1111/j.1365-313X.2010.04362.x; Lovisolo C, 2008, NEW PHYTOL, V180, P642, DOI 10.1111/j.1469-8137.2008.02592.x; Nilson SE, 2007, PLANT PHYSIOL, V143, P19, DOI 10.1104/pp.106.093161; Szabo N, 2008, J PHYS CHEM C, V112, P6313, DOI 10.1021/jp711549c; Tao Q, 2010, ANAL CHEM, V82, P842, DOI 10.1021/ac901855t; Trifilo P, 2008, TREE PHYSIOL, V28, P1505, DOI 10.1093/treephys/28.10.1505; Wu MH, 2010, LAB CHIP, V10, P939, DOI 10.1039/b921695b; Zwieniecki MA, 2009, TRENDS PLANT SCI, V14, P530, DOI 10.1016/j.tplants.2009.07.002	20	16	17	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50320	10.1371/journal.pone.0050320	http://dx.doi.org/10.1371/journal.pone.0050320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209709	gold, Green Published, Green Submitted			2022-12-25	WOS:000312104900039
J	Patnaik, SK; Dahlgaard, J; Mazin, W; Kannisto, E; Jensen, T; Knudsen, S; Yendamuri, S				Patnaik, Santosh K.; Dahlgaard, Jesper; Mazin, Wiktor; Kannisto, Eric; Jensen, Thomas; Knudsen, Steen; Yendamuri, Sai			Expression of MicroRNAs in the NCI-60 Cancer Cell-Lines	PLOS ONE			English	Article							REAL-TIME PCR; GENE-EXPRESSION; MESSENGER-RNA; BREAST-CANCER; PROFILES; TARGETS; MIRNA; NORMALIZATION; SENSITIVITY	The NCI-60 panel of 60 human cancer cell-lines of nine different tissues of origin has been extensively characterized in biological, molecular and pharmacological studies. Analyses of data from such studies have provided valuable information for understanding cellular processes and developing strategies for the diagnosis and treatment of cancer. Here, Affymetrix (R) GeneChip (TM) miRNA version 1 oligonucleotide microarrays were used to quantify 847 microRNAs to generate an expression dataset of 495 (58.4%) microRNAs that were identified as expressed in at least one cell-line of the NCI-60 panel. Accuracy of the microRNA measurements was partly confirmed by reverse transcription and polymerase chain reaction assays. Similar to that seen among the four existing NCI-60 microRNA datasets, the concordance of the new expression dataset with the other four was modest, with mean Pearson correlation coefficients of 0.37-0.54. In spite of this, comparable results with different datasets were noted in clustering of the cell-lines by their microRNA expression, differential expression of microRNAs by the lines' tissue of origin, and correlation of specific microRNAs with the doubling-time of cells or their radiation sensitivity. Mutation status of the cell-lines for the TP53, PTEN and BRAF but not CDKN2A or KRAS cancer-related genes was found to be associated with changes in expression of specific microRNAs. The microRNA dataset generated here should be valuable to those working in the field of microRNAs as well as in integromic studies of the NCI-60 panel.	[Patnaik, Santosh K.; Kannisto, Eric; Yendamuri, Sai] Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA; [Dahlgaard, Jesper; Mazin, Wiktor; Jensen, Thomas; Knudsen, Steen] Med Prognosis Inst, Horsholm, Denmark; [Yendamuri, Sai] SUNY Buffalo, Dept Surg, Buffalo, NY 14260 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yendamuri, S (corresponding author), Roswell Pk Canc Inst, Dept Thorac Surg, Buffalo, NY 14263 USA.	sai.yendamuri@roswellpark.org		Dahlgaard, Jesper/0000-0002-1798-6799; Yendamuri, Sai/0000-0001-6654-3487	Roswell Park Cancer Institute, Buffalo, New York, United States of America; Medical Prognosis Institute, Horsholm, Denmark; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Roswell Park Cancer Institute, Buffalo, New York, United States of America; Medical Prognosis Institute, Horsholm, Denmark; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was funded by Roswell Park Cancer Institute, Buffalo, New York, United States of America, and Medical Prognosis Institute, Horsholm, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bhatt K, 2010, MOL MED, V16, P409, DOI 10.2119/molmed.2010.00002; Bisognin A, 2012, NUCLEIC ACIDS RES, V40, pW13, DOI 10.1093/nar/gks460; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Chaudhry MA, 2010, DNA CELL BIOL, V29, P553, DOI 10.1089/dna.2009.0978; Chaudhry MA, 2009, CANCER BIOTHER RADIO, V24, P49, DOI 10.1089/cbr.2008.0513; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Cui WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022988; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Engelmann JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040634; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jarjanazi H, 2008, HUM MUTAT, V29, P461, DOI 10.1002/humu.20732; LEE JS, 1994, MOL PHARMACOL, V46, P627; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liang Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-61; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liscovitch M, 2007, CANCER LETT, V245, P350, DOI 10.1016/j.canlet.2006.01.013; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Ma XJ, 2006, ARCH PATHOL LAB MED, V130, P465; Meiri E, 2012, ONCOLOGIST, V17, P801, DOI 10.1634/theoncologist.2011-0466; Moes M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035440; Murray MY, 2012, CELL SIGNAL, V24, P363, DOI 10.1016/j.cellsig.2011.09.021; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Niemoeller OM, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-29; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Rauhala HE, 2010, INT J CANCER, V127, P1363, DOI 10.1002/ijc.25162; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Savas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018306; Savas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012601; Shankavaram UT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-277; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Torres-Roca JF, 2005, CANCER RES, V65, P7169, DOI 10.1158/0008-5472.CAN-05-0656; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Weinstein JN, 2006, MOL CANCER THER, V5, P2601, DOI 10.1158/1535-7163.MCT-06-0640; Witkos TM, 2011, CURR MOL MED, V11, P93; Xu JA, 2011, NUCLEIC ACIDS RES, V39, P825, DOI 10.1093/nar/gkq832; Zhao YC, 2011, BREAST CANCER RES TR, V127, P69, DOI 10.1007/s10549-010-0972-2	63	17	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49918	10.1371/journal.pone.0049918	http://dx.doi.org/10.1371/journal.pone.0049918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209617	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700024
J	Ben Bashat, D; Artzi, M; Ben Ami, H; Aizenstein, O; Blumenthal, DT; Bokstein, F; Corn, BW; Ram, Z; Kanner, AA; Lifschitz-Mercer, B; Solar, I; Kolatt, T; Palmon, M; Edrei, Y; Abramovitch, R				Ben Bashat, Dafna; Artzi, Moran; Ben Ami, Haim; Aizenstein, Orna; Blumenthal, Deborah T.; Bokstein, Felix; Corn, Benjamin W.; Ram, Zvi; Kanner, Avraham A.; Lifschitz-Mercer, Biatris; Solar, Irit; Kolatt, Tsafrir; Palmon, Mika; Edrei, Yifat; Abramovitch, Rinat			Hemodynamic Response Imaging: A Potential Tool for the Assessment of Angiogenesis in Brain Tumors	PLOS ONE			English	Article							LEVEL-DEPENDENT MRI; CEREBRAL-BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; BOLD MRI; QUANTITATIVE MEASUREMENT; RESPIRATORY CHALLENGES; RELAXATION RATE; HYPEROXIA; HYPERCAPNIA; PERFUSION	Blood oxygenation level dependence (BOLD) imaging under either hypercapnia or hyperoxia has been used to study neuronal activation and for assessment of various brain pathologies. We evaluated the benefit of a combined protocol of BOLD imaging during both hyperoxic and hypercapnic challenges (termed hemodynamic response imaging (HRI)). Nineteen healthy controls and seven patients with primary brain tumors were included: six with glioblastoma (two newly diagnosed and four with recurrent tumors) and one with atypical-meningioma. Maps of percent signal intensity changes (DS) during hyperoxia (carbogen; 95%O2+5%CO2) and hypercapnia (95%air+5%CO2) challenges and vascular reactivity mismatch maps (VRM; voxels that responded to carbogen with reduced/absent response to CO2) were calculated. VRM values were measured in white matter (WM) and gray matter (GM) areas of healthy subjects and used as threshold values in patients. Significantly higher response to carbogen was detected in healthy subjects, compared to hypercapnia, with a GM/WM ratio of 3.8 during both challenges. In patients with newly diagnosed/treatment-naive tumors (n = 3), increased response to carbogen was detected with substantially increased VRM response (compared to threshold values) within and around the tumors. In patients with recurrent tumors, reduced/absent response during both challenges was demonstrated. An additional finding in 2 of 4 patients with recurrent glioblastoma was a negative response during carbogen, distant from tumor location, which may indicate steal effect. In conclusion, the HRI method enables the assessment of blood vessel functionality and reactivity. Reference values from healthy subjects are presented and preliminary results demonstrate the potential of this method to complement perfusion imaging for the detection and follow up of angiogenesis in patients with brain tumors.	[Ben Bashat, Dafna; Artzi, Moran; Ben Ami, Haim; Aizenstein, Orna; Palmon, Mika] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, IL-69978 Tel Aviv, Israel; [Artzi, Moran; Corn, Benjamin W.; Ram, Zvi; Kanner, Avraham A.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Blumenthal, Deborah T.; Bokstein, Felix; Corn, Benjamin W.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Radiotherapy, Neurooncol Serv, IL-69978 Tel Aviv, Israel; [Ram, Zvi; Kanner, Avraham A.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurosurg, IL-69978 Tel Aviv, Israel; [Lifschitz-Mercer, Biatris; Solar, Irit] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Pathol Diagnost & Res Canc Ctr, IL-69978 Tel Aviv, Israel; [Kolatt, Tsafrir] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel; [Kolatt, Tsafrir] Appl Spectral Imaging, Haifa, Israel; [Kolatt, Tsafrir] Israeli Inst Adv Res, Rehovot, Israel; [Edrei, Yifat; Abramovitch, Rinat] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Ben Bashat, D (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Funct Brain Ctr, IL-69978 Tel Aviv, Israel.	dafnab@tlvmc.gov.il	Artzi, Moran/AAF-5167-2020; Kolatt, Tsafrir/GWV-2619-2022	Kanner, Andrew Ariye/0000-0002-0812-8573; Ben Bashat, Dafna/0000-0001-8396-1031	James S. McDonnell Foundation [220020176]	James S. McDonnell Foundation	This study was funded by the James S. McDonnell Foundation (grant number 220020176), http://www.jsmf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch R, 2004, NEOPLASIA, V6, P480, DOI 10.1593/neo.03520; Armitage PA, 2007, MAGN RESON IMAGING, V25, P303, DOI 10.1016/j.mri.2006.09.002; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bulte DP, 2012, NEUROIMAGE, V60, P582, DOI 10.1016/j.neuroimage.2011.12.017; Feldman SC, 2009, AM J NEURORADIOL, V30, P389, DOI 10.3174/ajnr.A1326; Gauthier CJ, 2012, NEUROIMAGE, V60, P1212, DOI 10.1016/j.neuroimage.2011.12.056; Han JS, 2011, STROKE, V42, P1261, DOI 10.1161/STROKEAHA.110.603225; Hardee ME, 2012, AM J PATHOL; Herzog H, 1996, J CEREBR BLOOD F MET, V16, P645, DOI 10.1097/00004647-199607000-00015; Hsu YY, 2004, J MAGN RESON IMAGING, V19, P160, DOI 10.1002/jmri.10447; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang Z, 2010, NEUROIMAGE, V52, P538, DOI 10.1016/j.neuroimage.2010.04.194; Leontiev O, 2007, NEUROIMAGE, V35, P175, DOI 10.1016/j.neuroimage.2006.10.044; Losert C, 2002, MAGN RESON MED, V48, P271, DOI 10.1002/mrm.10215; Lu J, 2009, NEUROIMAGE, V45, P1126, DOI 10.1016/j.neuroimage.2008.11.037; Lupo JM, 2005, AM J NEURORADIOL, V26, P1446; Mandell DM, 2011, AM J NEURORADIOL, V32, P721, DOI 10.3174/ajnr.A2365; Muller A, 2011, EUR RADIOL, V21, P786, DOI 10.1007/s00330-010-1948-7; Muller A, 2010, J MAGN RESON IMAGING, V32, P17, DOI 10.1002/jmri.22205; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Pathak AP, 2001, MAGNET RESON MED, V46, P735, DOI 10.1002/mrm.1252; Prisman E, 2008, J MAGN RESON IMAGING, V27, P185, DOI 10.1002/jmri.21102; Ren AJ, 2002, CHINESE MED J-PEKING, V115, P247; Rijpkema M, 2002, INT J RADIAT ONCOL, V53, P1185, DOI 10.1016/S0360-3016(02)02825-0; Rijpkema M, 2004, MAGN RESON IMAGING, V22, P761, DOI 10.1016/j.mri.2004.01.055; SECHZER PH, 1960, J APPL PHYSIOL, V15, P454, DOI 10.1152/jappl.1960.15.3.454; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Sourbron S, 2010, EUR J RADIOL, V76, P304, DOI 10.1016/j.ejrad.2010.02.017; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; Symon L., 1968, SCAND J CLIN LA S102, V102, pXIII; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Toyooka V, 2008, CLIN IMAG, V32, P251, DOI 10.1016/j.clinimag.2007.12.006; WATANABE M, 1992, NEURORADIOLOGY, V34, P463, DOI 10.1007/BF00598951; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x; White ML, 2005, AM J NEURORADIOL, V26, P784; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Ziyeh S, 2005, STROKE, V36, P751, DOI 10.1161/01.STR.0000157593.03470.3d	39	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49416	10.1371/journal.pone.0049416	http://dx.doi.org/10.1371/journal.pone.0049416			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209575	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800011
J	Reber, LL; Daubeuf, FO; Nemska, S; Frossard, N				Reber, Laurent L.; Daubeuf, Franc Ois; Nemska, Simona; Frossard, Nelly			The AGC Kinase Inhibitor H89 Attenuates Airway Inflammation in Mouse Models of Asthma	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVITY; MAST-CELLS; MSK1; PHOSPHORYLATION; ACTIVATION; BINDING; CREB; P65	Background: H89 is a potent inhibitor of Protein Kinase A (PKA) and Mitogen-and Stress-Activated protein Kinase 1 (MSK1) with some inhibitory activity on other members of the AGC kinase family. H89 has been extensively used in vitro but its anti-inflammatory potential in vivo has not been reported to date. To assess the anti-inflammatory properties of H89 in mouse models of asthma. Methodology/Principal Findings: Mice were sensitized intraperitoneally (i.p.) to ovalbumin (OVA) with or without alum, and challenged intranasally with OVA. H89 (10 mg/kg) or vehicle was given i.p. two hours before each OVA challenge. Airway hyperresponsiveness (AHR) was assessed by whole-body barometric plethysmography. Inflammation was assessed by the total and differential cell counts and IL-4 and IL-5 levels in bronchoalveolar lavage (BAL) fluid. Lung inflammation, mucus production and mast cell numbers were analyzed after histochemistry. We show that treatment with H89 reduces AHR, lung inflammation, mast cell numbers and mucus production. H89 also inhibits IL-4 and IL-5 production and infiltration of eosinophils, neutrophils and lymphocytes in BAL fluid. Conclusions/Significance: Taken together, our findings implicate that blockade of AGC kinases may have therapeutic potential for the treatment of allergic airway inflammation.	[Reber, Laurent L.; Daubeuf, Franc Ois; Nemska, Simona; Frossard, Nelly] Univ Strasbourg, CNRS, UMR 7200, Fac Pharm,Lab Innovat Therapeut, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Frossard, N (corresponding author), Univ Strasbourg, CNRS, UMR 7200, Fac Pharm,Lab Innovat Therapeut, Illkirch Graffenstaden, France.	nelly.frossard@unistra.fr	Reber, Laurent L/K-4148-2014; Frossard, Nelly/F-8301-2013; Nemska, Simona/Y-1105-2019	Reber, Laurent L/0000-0003-3384-6769; Nemska, Simona/0000-0002-6969-6494				Adcock IM, 2006, EUR J PHARMACOL, V533, P118, DOI 10.1016/j.ejphar.2005.12.054; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes Peter J, 2009, Lancet, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; Beck IME, 2009, BIOCHEM PHARMACOL, V77, P1194, DOI 10.1016/j.bcp.2008.12.008; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Becker M, 2011, J IMMUNOL, V186, P7225, DOI 10.4049/jimmunol.1100676; Bertelsen T, 2011, EXP DERMATOL, V20, P140, DOI 10.1111/j.1600-0625.2010.01153.x; Boyce JA, 2005, J EXP MED, V201, P1869, DOI 10.1084/jem.20050584; Catley MC, 2005, BRIT J PHARMACOL, V145, P114, DOI 10.1038/sj.bjp.0706170; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Corry DB, 1998, MOL MED, V4, P344, DOI 10.1007/BF03401741; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Delayre-Orthez C, 2004, CLIN EXP ALLERGY, V34, P1789, DOI 10.1111/j.1365-2222.2004.02082.x; Delayre-Orthez C, 2008, EUR J PHARMACOL, V581, P177, DOI 10.1016/j.ejphar.2007.11.040; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kawaguchi M, 2009, AM J PHYSIOL-LUNG C, V296, pL804, DOI 10.1152/ajplung.90607.2008; Kips JC, 2003, EUR RESPIR J, V22, P374, DOI 10.1183/09031936.03.00026403; Klein-Hessling S, 2003, J IMMUNOL, V170, P2956, DOI 10.4049/jimmunol.170.6.2956; Leung DY, 2003, J ALLERGY CLIN IMMUN, V111, P3; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Molfino NA, 2011, CLIN EXP ALLERGY; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Ogawa H, 2011, CLIN EXP ALLERGY, V41, P104, DOI 10.1111/j.1365-2222.2010.03564.x; Partridge Martyn R, 2006, BMC Pulm Med, V6, P13, DOI 10.1186/1471-2466-6-13; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; QUINN PG, 1993, J BIOL CHEM, V268, P16999; Reber L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004393; Reber LL, 2012, J IMMUNOL, V188, P3478, DOI 10.4049/jimmunol.1004227; Shimizu K, 2012, CLIN EXP ALLERGY; Sommers CD, 2009, J PHARMACOL EXP THER, V330, P377, DOI 10.1124/jpet.108.147538; Tanaka H, 2001, INFLAMM RES, V50, P616, DOI 10.1007/PL00000243; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	47	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49512	10.1371/journal.pone.0049512	http://dx.doi.org/10.1371/journal.pone.0049512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189147	Green Submitted, gold, Green Published			2022-12-25	WOS:000311929800025
J	Zhu, YL; Eaton, JW; Li, C				Zhu, Yanglong; Eaton, John W.; Li, Chi			Titanium Dioxide (TiO2) Nanoparticles Preferentially Induce Cell Death in Transformed Cells in a Bak/Bax-Independent Fashion	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; OXIDATIVE STRESS; INFLAMMATORY RESPONSE; HYDROGEN-PEROXIDE; BRAIN MICROGLIA; BCL-2 PROTEINS; CROSS-TALK; IN-VITRO; PARTICLES; APOPTOSIS	While the cytotoxic effects of titanium dioxide (TiO2) nanoparticles have been under intense investigation, the molecular mechanisms of this cytotoxicity remain unknown. Here we investigated the influence of oncogenic transformation and a major apoptotic signaling pathway on cellular responses to TiO2 nanoparticles. Isogenic wild-type (WT) and apoptosis-resistant (Bak(-/-)Bax(-/-)) cell lines with and without tumorigenic transformation were examined. TiO2 nanoparticles preferentially reduced viability of tumorigenic cells in a dose-dependent fashion compared with their untransformed counterparts. Importantly, the elevated cytotoxicity of TiO2 nanoparticles was independent of a major Bak/Bax-dependent apoptosis pathway. Because transformation does not affect cellular fluid-phase endocytosis or nanoparticle uptake, it is likely that the increased cytotoxicity in tumor cells is due to the interaction between TiO2 nanoparticles and the lysosomal compartment. Overall, our data indicate that TiO2 nanoparticles induce cytotoxicity preferentially in transformed cells independent of a major apoptotic signaling pathway.	[Zhu, Yanglong; Eaton, John W.; Li, Chi] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Med,Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville	Li, C (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Med,Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.	chi.li@louisville.edu			National Institutes of Health (NIH) [CA106599, RR018733]; Kentucky Lung Cancer Research Program; University of Louisville; NIH [AA018016]; Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL CANCER INSTITUTE [K01CA106599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018016] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Program; University of Louisville; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Kentucky Research Challenge Trust Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institutes of Health (NIH) grants CA106599, RR018733 and funding from the Kentucky Lung Cancer Research Program and the University of Louisville (CL) and NIH grant AA018016 and the Commonwealth of Kentucky Research Challenge Trust Fund (JWE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Algarra Ignacio, 1998, Invasion and Metastasis, V18, P261, DOI 10.1159/000024519; Andersson P, 1980, Adv Cancer Res, V33, P109, DOI 10.1016/S0065-230X(08)60670-3; Baier R, 2000, J ADHESION, V74, P79, DOI 10.1080/00218460008034525; Chen HW, 2006, FASEB J, V20, P2393, DOI 10.1096/fj.06-6485fje; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3; Donaldson K, 2004, OCCUP ENVIRON MED, V61, P727, DOI 10.1136/oem.2004.013243; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Gao XS, 2009, J BIOL CHEM, V284, P4767, DOI 10.1074/jbc.M806235200; Groth-Pedersen L, 2010, CANC LETT; Guerriero JL, 2008, CANCER RES, V68, P9595, DOI 10.1158/0008-5472.CAN-08-2452; Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007; HALEVY O, 1991, ONCOGENE, V6, P1593; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; HEDIN U, 1985, EUR J CELL BIOL, V39, P130; Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kong SJ, 2008, ENVIRON MOL MUTAGEN, V49, P399, DOI 10.1002/em.20399; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Lindsten T, 2006, CELL DEATH DIFFER, V13, P1272, DOI 10.1038/sj.cdd.4401953; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Long TC, 2007, ENVIRON HEALTH PERSP, V115, P1631, DOI 10.1289/ehp.10216; Long TC, 2006, ENVIRON SCI TECHNOL, V40, P4346, DOI 10.1021/es060589n; Luther EM, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/37/375101; Marquis BJ, 2009, ANALYST, V134, P425, DOI 10.1039/b818082b; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Newman MD, 2009, J AM ACAD DERMATOL, V61, P685, DOI 10.1016/j.jaad.2009.02.051; Oberdorster G, 2000, Res Rep Health Eff Inst, P5; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Olmedo DG, 2005, J BIOMED MATER RES A, V73A, P142, DOI 10.1002/jbm.a.30230; Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Repnik U, 2010, MITOCHONDRION, V10, P662, DOI 10.1016/j.mito.2010.07.008; Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197; Selvam R, 2002, UROL RES, V30, P35, DOI 10.1007/s00240-001-0228-z; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Singh S, 2007, TOXICOL APPL PHARM, V222, P141, DOI 10.1016/j.taap.2007.05.001; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22; Somasundaram K, 1997, ONCOGENE, V14, P1047, DOI 10.1038/sj.onc.1201002; Sun PL, 2008, P NATL ACAD SCI USA, V105, P16590, DOI 10.1073/pnas.0807472105; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; TENGVALL P, 1989, BIOMATERIALS, V10, P118, DOI 10.1016/0142-9612(89)90043-4; TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7; Thevenot P, 2008, NANOMED-NANOTECHNOL, V4, P226, DOI 10.1016/j.nano.2008.04.001; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang W, 2008, INT J PHARMACEUT, V356, P239, DOI 10.1016/j.ijpharm.2008.02.011; Zhao M, 2001, FEBS LETT, V509, P405, DOI 10.1016/S0014-5793(01)03185-4; Zhivotovsky B, 2010, EXP CELL RES, V316, P1374, DOI 10.1016/j.yexcr.2010.02.037	55	42	42	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50607	10.1371/journal.pone.0050607	http://dx.doi.org/10.1371/journal.pone.0050607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185639	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000249
J	Broms, JE; Meyer, L; Sun, K; Lavander, M; Sjostedt, A				Broms, Jeanette E.; Meyer, Lena; Sun, Kun; Lavander, Moa; Sjostedt, Anders			Unique Substrates Secreted by the Type VI Secretion System of Francisella tularensis during Intramacrophage Infection	PLOS ONE			English	Article							PROTON MOTIVE FORCE; PROTEIN SECRETION; III SECRETION; PATHOGENICITY ISLAND; ESCHERICHIA-COLI; VIRULENCE DETERMINANTS; AEROMONAS-HYDROPHILA; HUMAN MACROPHAGES; BETA-LACTAMASE; IDENTIFICATION	Gram-negative bacteria have evolved sophisticated secretion machineries specialized for the secretion of macromolecules important for their life cycles. The Type VI secretion system (T6SS) is the most widely spread bacterial secretion machinery and is encoded by large, variable gene clusters, often found to be essential for virulence. The latter is true for the atypical T6SS encoded by the Francisella pathogenicity island (FPI) of the highly pathogenic, intracellular bacterium Francisella tularensis. We here undertook a comprehensive analysis of the intramacrophage secretion of the 17 FPI proteins of the live vaccine strain, LVS, of F. tularensis. All were expressed as fusions to the TEM beta-lactamase and cleavage of the fluorescent substrate CCF2-AM, a direct consequence of the delivery of the proteins into the macrophage cytosol, was followed over time. The FPI proteins IglE, IglC, VgrG, IglI, PdpE, PdpA, IglJ and IglF were all secreted, which was dependent on the core components DotU, VgrG, and IglC, as well as IglG. In contrast, the method was not directly applicable on F. novicida U112, since it showed very intense native beta-lactamase secretion due to FTN_1072. Its role was proven by ectopic expression in trans in LVS. We did not observe secretion of any of the LVS substrates VgrG, IglJ, IglF or IglI, when tested in a FTN_1072 deficient strain of F. novicida, whereas IglE, IglC, PdpA and even more so PdpE were all secreted. This suggests that there may be fundamental differences in the T6S mechanism among the Francisella subspecies. The findings further corroborate the unusual nature of the T6SS of F. tularensis since almost all of the identified substrates are unique to the species.	[Broms, Jeanette E.; Meyer, Lena; Sun, Kun; Lavander, Moa; Sjostedt, Anders] Umea Univ, Dept Clin Microbiol Clin Bacteriol & Lab Mol Infe, Umea, Sweden	Umea University	Broms, JE (corresponding author), Umea Univ, Dept Clin Microbiol Clin Bacteriol & Lab Mol Infe, Umea, Sweden.	jeanette.broms@climi.umu.se	Sjöstedt, Anders/AAC-6575-2020	Sjöstedt, Anders/0000-0002-0768-8405	Swedish Research Council [2009-5026]; Medical Faculty, Umea University, Umea, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty, Umea University, Umea, Sweden	This work was supported by grants 2009-5026 (to AS) from the Swedish Research Council (www.vr.se) and a grant from the Medical Faculty, Umea University, Umea, Sweden. The work was performed in part at the Umea Centre for Microbial Research (UCMR) (www.ucmr.umu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Alam A, 2011, INFECT IMMUN, V79, P1728, DOI 10.1128/IAI.01194-10; Andersson H, 2006, J MED MICROBIOL, V55, P1023, DOI 10.1099/jmm.0.46553-0; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aubert DF, 2008, INFECT IMMUN, V76, P1979, DOI 10.1128/IAI.01338-07; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Bina XWR, 2006, ARCH MICROBIOL, V186, P219, DOI 10.1007/s00203-006-0140-6; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034639; Broms JE, 2011, INFECT IMMUN, V79, P3683, DOI 10.1128/IAI.01344-10; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Chen C, 2010, P NATL ACAD SCI USA, V107, P21755, DOI 10.1073/pnas.1010485107; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; De Maayer P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-576; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Golovliov I, 1997, INFECT IMMUN, V65, P2183, DOI 10.1128/IAI.65.6.2183-2189.1997; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Kuoppa K, 2001, FEMS MICROBIOL LETT, V205, P77, DOI 10.1111/j.1574-6968.2001.tb10928.x; Lara-Tejero M, 2011, SCIENCE, V331, P1188, DOI 10.1126/science.1201476; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Pages JM, 2005, TRENDS MOL MED, V11, P382, DOI 10.1016/j.molmed.2005.06.006; Parret AHA, 2002, MICROBIOL-SGM, V148, P1604, DOI 10.1099/00221287-148-6-1604; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Raffatellu M, 2005, INFECT IMMUN, V73, P7817, DOI 10.1128/IAI.73.12.7817-7826.2005; Rodriguez SA, 2010, GENETIC REGULATION V; Rosales-Reyes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041726; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Schroeder GN, 2007, MICROBIOL-SGM, V153, P2862, DOI 10.1099/mic.0.2007/007427-0; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Suarez G, 2010, MICROBIOL-SGM, V156, P3678, DOI 10.1099/mic.0.041277-0; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Weber B, 2009, ENVIRON MICROBIOL, V11, P3018, DOI 10.1111/j.1462-2920.2009.02005.x; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Wilharm G, 2004, INFECT IMMUN, V72, P4004, DOI 10.1128/IAI.72.7.4004-4009.2004; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	62	49	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50473	10.1371/journal.pone.0050473	http://dx.doi.org/10.1371/journal.pone.0050473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185631	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700086
J	Ueda, Y; Komiya, A				Ueda, Yoshiyuki; Komiya, Asuka			Cultural Adaptation of Visual Attention: Calibration of the Oculomotor Control System in Accordance with Cultural Scenes	PLOS ONE			English	Article							EYE-MOVEMENTS; PSYCHOPHYSICS TOOLBOX; CONTEXT-SENSITIVITY; PERCEPTION; FACE; ENVIRONMENT; JAPANESE	Previous studies have found that Westerners are more likely than East Asians to attend to central objects (i.e., analytic attention), whereas East Asians are more likely than Westerners to focus on background objects or context (i.e., holistic attention). Recently, it has been proposed that the physical environment of a given culture influences the cultural form of scene cognition, although the underlying mechanism is yet unclear. This study examined whether the physical environment influences oculomotor control. Participants saw culturally neutral stimuli (e.g., a dog in a park) as a baseline, followed by Japanese or United States scenes, and finally culturally neutral stimuli again. The results showed that participants primed with Japanese scenes were more likely to move their eyes within a broader area and they were less likely to fixate on central objects compared with the baseline, whereas there were no significant differences in the eye movements of participants primed with American scenes. These results suggest that culturally specific patterns in eye movements are partly caused by the physical environment.	[Ueda, Yoshiyuki] Kyoto Univ, Kokoro Res Ctr, Kyoto, Japan; [Komiya, Asuka] Kobe Univ, Grad Sch Humanities, Kobe, Hyogo 657, Japan	Kyoto University; Kobe University	Ueda, Y (corresponding author), Kyoto Univ, Kokoro Res Ctr, Kyoto, Japan.	ueda@educ.kyoto-u.ac.jp	Ueda, Yoshiyuki/AAO-9361-2020; Komiya, Asuka/W-4701-2017; Komiya, Asuka/AAA-2814-2022	Komiya, Asuka/0000-0002-2847-4684; Komiya, Asuka/0000-0002-2847-4684	Global Centers of Excellence (COE) Program "Revitalizing Education for Dynamic Hearts and Minds'' of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan	Global Centers of Excellence (COE) Program "Revitalizing Education for Dynamic Hearts and Minds'' of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan	This research was supported by the Global Centers of Excellence (COE) Program "Revitalizing Education for Dynamic Hearts and Minds'' of Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boland JE, 2008, COGNITIVE CULTURAL I, P375; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caldara R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009708; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Doherty MJ, 2008, PERCEPTION, V37, P1426, DOI 10.1068/p5946; Evans K, 2009, Q J EXP PSYCHOL, V62, P276, DOI 10.1080/17470210802373720; Goh JO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008238; Ji LJ, 2000, J PERS SOC PSYCHOL, V78, P943, DOI 10.1037/0022-3514.78.5.943; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Kuhnen U, 2002, J EXP SOC PSYCHOL, V38, P492, DOI 10.1016/S0022-1031(02)00011-2; Ludwig CJH, 2005, J NEUROSCI, V25, P9907, DOI 10.1523/JNEUROSCI.2197-05.2005; Masuda T, 2006, COGNITIVE SCI, V30, P381, DOI 10.1207/s15516709cog0000_63; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Masuda T., 2008, JPN J PSYCHOL, V79, P35, DOI [10.4992/jjpsy.79.35, DOI 10.4992/JJPSY.79.35]; Masuda T, 2008, J PERS SOC PSYCHOL, V94, P365, DOI 10.1037/0022-3514.94.3.365; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Miyamoto Y, 2011, COGNITIVE SCI, V35, P563, DOI 10.1111/j.1551-6709.2010.01163.x; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Nisbett RE, 2002, STEVENS HDB EXPT PSY; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rayner K, 2004, J EXP PSYCHOL LEARN, V30, P1290, DOI 10.1037/0278-7393.30.6.1290; Rayner K, 2007, VISION RES, V47, P2714, DOI 10.1016/j.visres.2007.05.007; Rayner K, 2009, J EXP PSYCHOL LEARN, V35, P254, DOI 10.1037/a0013508; Zhou JW, 2008, J VISION, V8, DOI 10.1167/8.12.2	25	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50282	10.1371/journal.pone.0050282	http://dx.doi.org/10.1371/journal.pone.0050282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040PB	23185596	Green Submitted, Green Published, gold			2022-12-25	WOS:000311333800076
J	Yamaguchi, Y; Shao, ZF; Sharif, S; Du, XY; Myles, T; Merchant, M; Harsh, G; Glantz, M; Recht, L; Morser, J; Leung, LLK				Yamaguchi, Yasuto; Shao, Zhifei; Sharif, Shadi; Du, Xiao-Yan; Myles, Timothy; Merchant, Milton; Harsh, Griffith; Glantz, Michael; Recht, Lawrence; Morser, John; Leung, Lawrence L. K.			Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignant Glial Tumors and Provide a Molecular Niche with Survival Advantage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; BREAST-CANCER; PROGENITOR CELLS; TISSUE FACTOR; STEM-CELLS; GLIOBLASTOMA; INTEGRIN; IDENTIFICATION; PROTEIN; GLIOMAS	Osteopontin (OPN), which is highly expressed in malignant glioblastoma (GBM), possesses inflammatory activity modulated by proteolytic cleavage by thrombin and plasma carboxypeptidase B2 (CPB2) at a highly conserved cleavage site. Full-length OPN (OPN-FL) was elevated in cerebrospinal fluid (CSF) samples from all cancer patients compared with noncancer patients. However, thrombin-cleaved OPN (OPN-R) and thrombin/CPB2-double-cleaved OPN (OPN-L) levels were markedly increased in GBM and non-GBM gliomas compared with systemic cancer and noncancer patients. Cleaved OPN constituted similar to 23 and similar to 31% of the total OPN in the GBM and non-GBM CSF samples, respectively. OPN-R was also elevated in GBM tissues. Thrombin-antithrombin levels were highly correlated with cleaved OPN, but not OPN-FL, suggesting that the cleaved OPN fragments resulted from increased thrombin and CPB2 in this extracellular compartment. Levels of VEGF and CCL4 were increased in CSF of GBM and correlated with the levels of cleaved OPN. GBM cell lines were more adherent to OPN-R and OPN-L than OPN-FL. Adhesion to OPN altered gene expression, in particular genes involved with cellular processes, cell cycle regulation, death, and inflammation. OPN and its cleaved forms promoted motility of U-87 MG cells and conferred resistance to apoptosis. Although functional mutation of the RGD motif in OPN largely abolished these functions, OPNRAA-R regained significant cell binding and signaling function, suggesting that the SVVYGLR motif in OPN-R may substitute for the RGD motif if the latter becomes inaccessible. OPN cleavage contributes to GBM development by allowing more cells to bind in niches where they acquire anti-apoptotic properties.	[Yamaguchi, Yasuto; Shao, Zhifei; Sharif, Shadi; Du, Xiao-Yan; Myles, Timothy; Morser, John; Leung, Lawrence L. K.] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Merchant, Milton; Recht, Lawrence] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Harsh, Griffith] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Glantz, Michael] Penn State Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Yamaguchi, Yasuto; Shao, Zhifei; Morser, John; Leung, Lawrence L. K.] Vet Affairs Palo Alto Hlth Care Syst, Med Serv, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Morser, J (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, 3801 Miranda Ave,Bldg 4,Room A236I, Palo Alto, CA 94304 USA.	jmorser@stanford.edu; lawrence.leung@stanford.edu			National Institutes of Health [HL057530]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530, T32HL098049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL057530.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anand M, 2012, THROMB RES, V129, pS46, DOI 10.1016/S0049-3848(12)70015-4; Annabi B, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-8; Atai NA, 2011, IMMUNOLOGY, V132, P39, DOI 10.1111/j.1365-2567.2010.03335.x; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Colin C, 2006, ONCOGENE, V25, P2818, DOI 10.1038/sj.onc.1209305; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; El-Tanani MK, 2006, CYTOKINE GROWTH F R, V17, P463, DOI 10.1016/j.cytogfr.2006.09.010; Formolo CA, 2011, J PROTEOME RES, V10, P3149, DOI 10.1021/pr200210w; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Green PM, 2001, FEBS LETT, V503, P75, DOI 10.1016/S0014-5793(01)02690-4; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hua Y, 2005, ACTA NEUROCHIR SUPPL, V95, P403; Hua Y, 2005, J THROMB HAEMOST, V3, P1917, DOI 10.1111/j.1538-7836.2005.01446.x; Jan HJ, 2010, NEURO-ONCOLOGY, V12, P58, DOI 10.1093/neuonc/nop013; Jijiwa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024217; Lahav J, 2000, FEBS LETT, V475, P89, DOI 10.1016/S0014-5793(00)01630-6; Lamour V, 2010, INT J CANCER, V126, P1797, DOI 10.1002/ijc.24751; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Lu X., 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P29; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Myles T, 2008, J BIOL CHEM, V283, P17789, DOI 10.1074/jbc.M708629200; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Ornstein DL, 2002, SEMIN THROMB HEMOST, V28, P19, DOI 10.1055/s-2002-20561; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Qi B, 2009, CURR PHARM DESIGN, V15, P2336, DOI 10.2174/138161209788682352; Reynes G, 2011, J NEURO-ONCOL, V102, P35, DOI 10.1007/s11060-010-0290-x; Rice J, 2006, J VASC RES, V43, P422, DOI 10.1159/000094884; Rudland PS, 2002, CANCER RES, V62, P3417; Scheinkestel Carlos D, 2004, Emerg Med Australas, V16, P151, DOI 10.1111/j.1742-6723.2004.00567.x; Schuhmann MU, 2010, EJSO-EUR J SURG ONC, V36, P201, DOI 10.1016/j.ejso.2009.07.010; Selistre-de-Araujo HS, 2010, TOXINS, V2, P2606, DOI 10.3390/toxins2112606; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Stanton H, 2011, BBA-MOL BASIS DIS, V1812, P1616, DOI 10.1016/j.bbadis.2011.08.009; Takano S, 2000, BRIT J CANCER, V82, P1967; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Tehrani M, 2008, BRAIN PATHOL, V18, P164, DOI 10.1111/j.1750-3639.2007.00108.x; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Yamaguchi Y, 2011, J BIOL CHEM, V286, P39510, DOI 10.1074/jbc.M111.258921; Yan W, 2010, NEURO-ONCOLOGY, V12, P765, DOI 10.1093/neuonc/noq006; Yao XH, 2008, J PATHOL, V215, P369, DOI 10.1002/path.2356; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328	59	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3097	3111		10.1074/jbc.M112.362954	http://dx.doi.org/10.1074/jbc.M112.362954			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23204518	Green Published, hybrid			2022-12-25	WOS:000314397900019
J	Chaurasia, P; Sen, R; Bhaumik, SR				Chaurasia, Priyasri; Sen, Rwik; Bhaumik, Sukesh R.			Functional Analysis of Rad14p, a DNA Damage Recognition Factor in Nucleotide Excision Repair, in Regulation of Transcription in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PIGMENTOSUM GROUP-A; TERMINAL DOMAIN KINASE; XERODERMA-PIGMENTOSUM; SACCHAROMYCES-CEREVISIAE; CANCER RISK; XPA A23G; POLYMORPHISMS; GENE; YEAST	Rad14p is a DNA damage recognition factor in nucleotide excision repair. Intriguingly, we show here that Rad14p associates with the promoter of a galactose-inducible GAL1 gene after transcriptional induction in the absence of DNA lesion. Such an association of Rad14p facilitates the recruitment of TBP, TFIIH, and RNA polymerase II to the GAL1 promoter. Furthermore, the association of RNA polymerase II with the GAL1 promoter is significantly decreased in the absence of Rad14p, when the coding sequence was deleted. These results support the role of Rad14p in transcriptional initiation. Consistently, the level of GAL1 mRNA is significantly decreased in the absence of Rad14p. Similar results are also obtained at other galactose-inducible GAL genes such as GAL7 and GAL10. Likewise, Rad14p promotes transcription of other non-GAL genes such as CUP1, CTT1, and STL1 after transcriptional induction. However, the effect of Rad14p on the steady-state levels of transcription of GAL genes or constitutively active genes such as ADH1, PGK1, PYK1, and RPS5 is not observed. Thus, Rad14p promotes initial transcription but does not appear to regulate the steady-state level. Collectively, our results unveil a new role of Rad14p in stimulating transcription in addition to its well-known function in nucleotide excision repair.	[Chaurasia, Priyasri; Sen, Rwik; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu		Sen, Rwik/0000-0003-2853-2378	National Institutes of Health [1R15GM088798-01]; American Heart Association (Greater Midwest Affiliate) [10GRNT4300059]; Mallinckrodt Foundation grant; Excellence in Academic Medicine (EAM) grants from Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Greater Midwest Affiliate)(American Heart Association); Mallinckrodt Foundation grant; Excellence in Academic Medicine (EAM) grants from Southern Illinois University School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01. This work was also supported by American Heart Association (Greater Midwest Affiliate) Grant-in-aid 10GRNT4300059, a Mallinckrodt Foundation grant, and Excellence in Academic Medicine (EAM) grants from Southern Illinois University School of Medicine.	Abbasi R, 2009, INT J CANCER, V125, P1431, DOI 10.1002/ijc.24442; ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Andressoo JO, 2006, CELL CYCLE, V5, P2886, DOI 10.4161/cc.5.24.3565; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; BANKMANN M, 1992, NATURE, V355, P555, DOI 10.1038/355555a0; Bau DT, 2007, CHINESE J PHYSIOL, V50, P294; Bergoglio V, 2006, GENOME DYN, V1, P35, DOI 10.1159/000092499; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bhaumik SR, 2011, BBA-GENE REGUL MECH, V1809, P97, DOI 10.1016/j.bbagrm.2010.08.009; Bhaumik SR, 2008, CRIT REV BIOCHEM MOL, V43, P419, DOI 10.1080/10409230802605914 ; Butkiewicz D, 2004, CANCER EPIDEM BIOMAR, V13, P2242; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Costa RMA, 2003, BIOCHIMIE, V85, P1083, DOI 10.1016/j.biochi.2003.10.017; Crew KD, 2007, CANCER EPIDEM BIOMAR, V16, P2033, DOI 10.1158/1055-9965.EPI-07-0096; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Dong ZM, 2008, J CLIN GASTROENTEROL, V42, P910, DOI 10.1097/MCG.0b013e3180f6262c; Guo W, 2008, J CANCER RES CLIN, V134, P263, DOI 10.1007/s00432-007-0283-0; Guzder SN, 1996, J BIOL CHEM, V271, P8903, DOI 10.1074/jbc.271.15.8903; Guzder SN, 2006, MOL CELL BIOL, V26, P1135, DOI 10.1128/MCB.26.3.1135-1141.2006; GUZDER SN, 1993, P NATL ACAD SCI USA, V90, P5433, DOI 10.1073/pnas.90.12.5433; GUZDER SN, 1995, J BIOL CHEM, V270, P12973, DOI 10.1074/jbc.270.22.12973; Habraken Y, 1996, P NATL ACAD SCI USA, V93, P10718, DOI 10.1073/pnas.93.20.10718; HABRAKEN Y, 1993, NATURE, V366, P365, DOI 10.1038/366365a0; Hall J, 2007, CARCINOGENESIS, V28, P665, DOI 10.1093/carcin/bgl160; Hansen RD, 2007, MUTAT RES-FUND MOL M, V619, P68, DOI 10.1016/j.mrfmmm.2007.02.002; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Keogh MC, 2002, MOL CELL BIOL, V22, P1288, DOI 10.1128/MCB.22.5.1288-1297.2002; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee SK, 2002, MOL CELL BIOL, V22, P4383, DOI 10.1128/MCB.22.12.4383-4389.2002; Lee SK, 2002, CELL, V109, P823, DOI 10.1016/S0092-8674(02)00795-X; Leibeling D, 2006, J MOL HISTOL, V37, P225, DOI 10.1007/s10735-006-9041-x; Lichon Vanessa, 2007, J Drugs Dermatol, V6, P281; Lin J, 2008, CARCINOGENESIS, V29, P2112, DOI 10.1093/carcin/bgn189; Liu J, 2012, MOL BIOL REP, V39, P6791, DOI 10.1007/s11033-012-1504-4; Lockett KL, 2005, CANCER LETT, V220, P125, DOI 10.1016/j.canlet.2004.08.019; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Magnaldo T, 2004, CELLS TISSUES ORGANS, V177, P189, DOI 10.1159/000079993; Malik S, 2012, NUCLEIC ACIDS RES, V40, P3348, DOI 10.1093/nar/gkr1244; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Mardiros A, 2011, ACTA HISTOCHEM, V113, P409, DOI 10.1016/j.acthis.2010.03.005; Miller KL, 2006, CARCINOGENESIS, V27, P1670, DOI 10.1093/carcin/bgi376; Nouspikel T, 2008, DNA REPAIR, V7, P1155, DOI 10.1016/j.dnarep.2008.03.015; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Pan J, 2009, CARCINOGENESIS, V30, P785, DOI 10.1093/carcin/bgp058; Park JY, 2002, CANCER EPIDEM BIOMAR, V11, P993; PETERSON CL, 1991, CELL, V64, P1135, DOI 10.1016/0092-8674(91)90268-4; Prakash S, 2000, MUTAT RES-FUND MOL M, V451, P13, DOI 10.1016/S0027-5107(00)00037-3; Qian BY, 2011, LUNG CANCER, V73, P138, DOI 10.1016/j.lungcan.2010.11.018; Raaschou-Nielsen O, 2008, LUNG CANCER, V59, P171, DOI 10.1016/j.lungcan.2007.08.018; Rademakers S, 2003, MOL CELL BIOL, V23, P5755, DOI 10.1128/MCB.23.16.5755-5767.2003; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; Rodriguez CR, 2000, MOL CELL BIOL, V20, P104, DOI 10.1128/MCB.20.1.104-112.2000; Rodriguez K, 1998, J BIOL CHEM, V273, P34180, DOI 10.1074/jbc.273.51.34180; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; SIKORSKI RS, 1989, GENETICS, V122, P19; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; Sugimura T, 2006, J ORAL PATHOL MED, V35, P11, DOI 10.1111/j.1600-0714.2005.00364.x; SUNG P, 1993, J BIOL CHEM, V268, P26391; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Vermeulen W, 2011, DNA REPAIR, V10, P760, DOI 10.1016/j.dnarep.2011.04.015; Vogel U, 2005, CANCER LETT, V222, P67, DOI 10.1016/j.canlet.2004.11.016; Weiss JM, 2005, CANCER EPIDEM BIOMAR, V14, P2524, DOI 10.1158/1055-9965.EPI-05-0414; Wu XF, 2003, CARCINOGENESIS, V24, P505, DOI 10.1093/carcin/24.3.505; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	74	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					793	806		10.1074/jbc.M112.413716	http://dx.doi.org/10.1074/jbc.M112.413716			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188830	hybrid, Green Published			2022-12-25	WOS:000313570300005
J	Ball, C; Krogstad, E; Chaowanachan, T; Woodrow, KA				Ball, Cameron; Krogstad, Emily; Chaowanachan, Thanyanan; Woodrow, Kim A.			Drug-Eluting Fibers for HIV-1 Inhibition and Contraception	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SEXUALLY-TRANSMITTED INFECTIONS; SHOCK-SYNDROME TOXIN-1; GLYCEROL MONOLAURATE; TOPICAL MICROBICIDES; VAGINAL LACTOBACILLI; CONTROLLED-RELEASE; SOLID DISPERSIONS; IN-VITRO; DELIVERY	Multipurpose prevention technologies (MPTs) that simultaneously prevent sexually transmitted infections (STIs) and unintended pregnancy are a global health priority. Combining chemical and physical barriers offers the greatest potential to design effective MPTs, but integrating both functional modalities into a single device has been challenging. Here we show that drug-eluting fiber meshes designed for topical drug delivery can function as a combination chemical and physical barrier MPT. Using FDA-approved polymers, we fabricated nanofiber meshes with tunable fiber size and controlled degradation kinetics that facilitate simultaneous release of multiple agents against HIV-1, HSV-2, and sperm. We observed that drug-loaded meshes inhibited HIV-1 infection in vitro and physically obstructed sperm penetration. Furthermore, we report on a previously unknown activity of glycerol monolaurate (GML) to potently inhibit sperm motility and viability. The application of drug-eluting nanofibers for HIV-1 prevention and sperm inhibition may serve as an innovative platform technology for drug delivery to the lower female reproductive tract.	[Ball, Cameron; Krogstad, Emily; Chaowanachan, Thanyanan; Woodrow, Kim A.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Woodrow, KA (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	woodrow@u.washington.edu		Mudzingwa, Emily/0000-0003-2736-8350	United States National Institutes of Health (NIH) [5U54HD042454]; University of Washington; Creative and Novel Ideas in HIV Research award [AI027767]; NIH [AI094412, AI098648]; NSF Graduate Research Fellowships; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD042454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094412, R33AI094412, P30AI027767, R21AI098648] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); Creative and Novel Ideas in HIV Research award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowships(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Collection of human semen samples from volunteers was performed at the University of Washington Male Fertility Laboratory and was supported by an United States National Institutes of Health (NIH) grant to J. Amory (5U54HD042454). The research was supported by funding to K.A.W. from the University of Washington, the Creative and Novel Ideas in HIV Research award (AI027767), and by partial support from NIH grants AI094412 and AI098648. C.B. and E.K. are partially supported by NSF Graduate Research Fellowships.	Abner SR, 2005, J INFECT DIS, V192, P1545, DOI 10.1086/462424; Akil A, 2011, DRUG DELIV TRANSL RE, V1, P209, DOI 10.1007/s13346-011-0022-6; Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3; [Anonymous], 2012, CAMI MULTIPURPOSE PR, P1; Auras R., 2022, POLY LACTIC ACID SYN; Baeten JM, 2007, CLIN INFECT DIS, V45, P360, DOI 10.1086/519432; Ballagh SA, 2008, CONTRACEPTION, V77, P130, DOI 10.1016/j.contraception.2007.10.003; Blish CA, 2011, AM J REPROD IMMUNOL, V65, P302, DOI 10.1111/j.1600-0897.2010.00930.x; Boulmedarat L, 2005, J PHARM SCI-US, V94, P1300, DOI 10.1002/jps.20350; Cui WG, 2006, BIOMACROMOLECULES, V7, P1623, DOI 10.1021/bm060057z; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Forbes CJ, 2011, J CONTROL RELEASE, V156, P161, DOI 10.1016/j.jconrel.2011.08.006; Free MJ, 1996, CONTRACEPTION, V53, P221, DOI 10.1016/0010-7824(96)00041-8; Friend DR, 2010, ANTIVIR RES, V88, pS47, DOI 10.1016/j.antiviral.2010.09.005; Garg S, 2010, ANTIVIR RES, V88, pS19, DOI 10.1016/j.antiviral.2010.09.010; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Graver MA, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-8; Ham AS, 2012, PHARM RES-DORDR, V29, P1897, DOI 10.1007/s11095-012-0715-7; Ham AS, 2009, PHARM RES-DORDR, V26, P502, DOI 10.1007/s11095-008-9765-2; Han YA, 2007, CONTRACEPTION, V76, P132, DOI 10.1016/j.contraception.2007.04.006; Herrera C, 2009, ANTIMICROB AGENTS CH, V53, P1797, DOI 10.1128/AAC.01096-08; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kieweg SL, 2006, J BIOMECH ENG-T ASME, V128, P540, DOI 10.1115/1.2206198; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Lin YC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007499; Major I, 2010, IEEE ENG MED BIO, P1089, DOI 10.1109/IEMBS.2010.5627333; Malcolm K, 2003, J CONTROL RELEASE, V91, P355, DOI 10.1016/S0168-3659(03)00260-8; Malcolm RK, 2010, ANTIVIR RES, V88, pS30, DOI 10.1016/j.antiviral.2010.09.003; Malcolm RK, 2005, J ANTIMICROB CHEMOTH, V56, P954, DOI 10.1093/jac/dki326; Minnis AM, 2005, SEX TRANSM INFECT, V81, P193, DOI 10.1136/sti.2003.007153; Moench TR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-331; Notari S, 2009, IUBMB LIFE, V61, P470, DOI 10.1002/iub.181; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Patton DL, 1999, AM J OBSTET GYNECOL, V180, P1080, DOI 10.1016/S0002-9378(99)70598-3; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164; PROJAN SJ, 1994, J BACTERIOL, V176, P4204, DOI 10.1128/jb.176.14.4204-4209.1994; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Saxena BB, 2004, CONTRACEPTION, V70, P213, DOI 10.1016/j.contraception.2004.02.015; Schlievert PM, 2008, ANTIMICROB AGENTS CH, V52, P4448, DOI 10.1128/AAC.00989-08; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; Schwartz JL, 2008, CONTRACEPTION, V78, P237, DOI 10.1016/j.contraception.2008.04.118; Singer R, 2011, J VIROL, V85, P5504, DOI 10.1128/JVI.02422-10; Strandberg KL, 2010, ANTIMICROB AGENTS CH, V54, P597, DOI 10.1128/AAC.01151-09; Szentivanyi A, 2011, ADV DRUG DELIVER REV, V63, P209, DOI 10.1016/j.addr.2010.12.002; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Teo Wee-Eong, 2006, Biotechnology Journal, V1, P918, DOI 10.1002/biot.200600044; Teo WE, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/1/013002; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Vetter SM, 2005, ANTIMICROB AGENTS CH, V49, P1302, DOI 10.1128/AAC.49.4.1302-1305.2005; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Watts DH, 1999, J INFECT DIS, V180, P426, DOI 10.1086/314881; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; WHO, 2010, WHO LAB MAN EX PROC, V5th; Yohe ST, 2012, J AM CHEM SOC, V134, P2016, DOI 10.1021/ja211148a; Yu DG, 2010, INT J PHARMACEUT, V400, P158, DOI 10.1016/j.ijpharm.2010.08.010; Yu DG, 2010, AAPS PHARMSCITECH, V11, P809, DOI 10.1208/s12249-010-9438-4; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	62	25	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49792	10.1371/journal.pone.0049792	http://dx.doi.org/10.1371/journal.pone.0049792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209601	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700019
J	Helma, J; Schmidthals, K; Lux, V; Nuske, S; Scholz, AM; Krausslich, HG; Rothbauer, U; Leonhardt, H				Helma, Jonas; Schmidthals, Katrin; Lux, Vanda; Nueske, Stefan; Scholz, Armin M.; Kraeusslich, Hans-Georg; Rothbauer, Ulrich; Leonhardt, Heinrich			Direct and Dynamic Detection of HIV-1 in Living Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; STRUCTURED ILLUMINATION; DIMERIZATION DOMAIN; ASSEMBLY PROPERTIES; CAPSID PROTEIN; LIVE CELLS; IN-VITRO; MICROSCOPY; RESOLUTION; INHIBITORS	In basic and applied HIV research, reliable detection of viral components is crucial to monitor progression of infection. While it is routine to detect structural viral proteins in vitro for diagnostic purposes, it previously remained impossible to directly and dynamically visualize HIV in living cells without genetic modification of the virus. Here, we describe a novel fluorescent biosensor to dynamically trace HIV-1 morphogenesis in living cells. We generated a camelid single domain antibody that specifically binds the HIV-1 capsid protein (CA) at subnanomolar affinity and fused it to fluorescent proteins. The resulting fluorescent chromobody specifically recognizes the CA-harbouring HIV-1 Gag precursor protein in living cells and is applicable in various advanced light microscopy systems. Confocal live cell microscopy and super-resolution microscopy allowed detection and dynamic tracing of individual virion assemblies at the plasma membrane. The analysis of subcellular binding kinetics showed cytoplasmic antigen recognition and incorporation into virion assembly sites. Finally, we demonstrate the use of this new reporter in automated image analysis, providing a robust tool for cell-based HIV research.	[Helma, Jonas; Schmidthals, Katrin; Rothbauer, Ulrich; Leonhardt, Heinrich] Univ Munich, Dept Biol 2, Planegg Martinsried, Germany; [Lux, Vanda; Kraeusslich, Hans-Georg] Univ Heidelberg Hosp, Dept Infect Dis, Heidelberg, Germany; [Nueske, Stefan; Scholz, Armin M.] Univ Munich, Livestock Ctr, Fac Vet Med, Oberschleissheim, Germany; [Helma, Jonas; Leonhardt, Heinrich] Ctr Integrated Prot Sci, Munich, Germany; [Schmidthals, Katrin; Rothbauer, Ulrich] ChromoTek GmbH, Planegg Martinsried, Germany	University of Munich; Ruprecht Karls University Heidelberg; University of Munich; University of Munich	Rothbauer, U (corresponding author), Univ Tubingen, Nat & Med Sci Inst, Reutlingen, Germany.	ulrich.rothbauer@uni-tuebingen.de; h.leonhardt@lmu.de	Leonhardt, Heinrich/B-2791-2014; Scholz, Armin M./AAE-2360-2019; Rothbauer, Ulrich/C-7712-2018	Scholz, Armin M./0000-0001-7075-0067; Rothbauer, Ulrich/0000-0001-5923-8986; Helma, Jonas/0000-0001-6158-452X; Lux, Vanda/0000-0002-0184-8076; Krausslich, Hans-Georg/0000-0002-8756-329X	EpiSys program of the Bundesministerium fur Bildung und Forschung (BMBF); Nanosystems Initiative Munich; BioImaging Network; Deutsche Forschungsgemeinschaft (DFG) [SPP 1230, SFB638]; EU; GO-Bio program (BMBF)	EpiSys program of the Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Nanosystems Initiative Munich; BioImaging Network; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU(European Commission); GO-Bio program (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the EpiSys program of the Bundesministerium fur Bildung und Forschung (BMBF), the Nanosystems Initiative Munich, the BioImaging Network and the Deutsche Forschungsgemeinschaft (DFG, SPP 1230) to HL; (DFG, SFB638) to HGK and grants within the EU FP7 program to HGK (HIV-ACE). HGK is an investigator of the CellNetworks excellence cluster. JH, KS and UR acknowledge support by the GO-Bio program (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartel V, 2011, NAT CELL BIOL; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Eckhardt M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022007; FELBER BK, 1988, SCIENCE, V239, P184, DOI 10.1126/science.3422113; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Gross I, 2000, EMBO J, V19, P103, DOI 10.1093/emboj/19.1.103; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Ivanchenko S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000652; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2011, J MOL BIOL, V410, P501, DOI 10.1016/j.jmb.2011.04.062; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Kirchhofer A, 2010, NAT STRUCT MOL BIOL, V17, P133, DOI 10.1038/nsmb.1727; Kremb S, 2010, ANTIMICROB AGENTS CH, V54, P5257, DOI 10.1128/AAC.00515-10; Lampe M, 2007, VIROLOGY, V360, P92, DOI 10.1016/j.virol.2006.10.005; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Muller B, 2004, J VIROL, V78, P10803, DOI 10.1128/JVI.78.19.10803-10813.2004; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Sandefur S, 2000, J VIROL, V74, P7238, DOI 10.1128/JVI.74.16.7238-7249.2000; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmidthals K, 2010, ANAL BIOANAL CHEM, V397, P3203, DOI 10.1007/s00216-010-3657-0; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Westby M, 2005, ANTIVIR RES, V67, P121, DOI 10.1016/j.antiviral.2005.06.006; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689	34	36	36	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50026	10.1371/journal.pone.0050026	http://dx.doi.org/10.1371/journal.pone.0050026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209635	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700031
J	Lee, CC; Ho, HC; Hsiao, SH; Huang, TT; Lin, HY; Li, SC; Chou, P; Su, YC				Lee, Ching-Chih; Ho, Hsu-Chueh; Hsiao, Shih-Hsuan; Huang, Tza-Ta; Lin, Hon-Yi; Li, Szu-Chin; Chou, Pesus; Su, Yu-Chieh			Infectious Complications in Head and Neck Cancer Patients Treated with Cetuximab: Propensity Score and Instrumental Variable Analysis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; PLUS CETUXIMAB; PHASE-II; RADIOTHERAPY; CISPLATIN; CHEMOTHERAPY; TRIAL; RISK; BIAS	Background: To compare the infection rates between cetuximab-treated patients with head and neck cancers (HNC) and untreated patients. Methodology: A national cohort of 1083 HNC patients identified in 2010 from the Taiwan National Health Insurance Research Database was established. After patients were followed for one year, propensity score analysis and instrumental variable analysis were performed to assess the association between cetuximab therapy and the infection rates. Results: HNC patients receiving cetuximab (n = 158) were older, had lower SES, and resided more frequently in rural areas as compared to those without cetuximab therapy. 125 patients, 32 (20.3%) in the group using cetuximab and 93 (10.1%) in the group not using it presented infections. The propensity score analysis revealed a 2.3-fold (adjusted odds ratio [OR] = 2.27; 95% CI, 1.46-3.54; P = 0.001) increased risk for infection in HNC patients treated with cetuximab. However, using IVA, the average treatment effect of cetuximab was not statistically associated with increased risk of infection (OR, 0.87; 95% CI, 0.61-1.14). Conclusions: Cetuximab therapy was not statistically associated with infection rate in HNC patients. However, older HNC patients using cetuximab may incur up to 33% infection rate during one year. Particular attention should be given to older HNC patients treated with cetuximab.	[Lee, Ching-Chih; Ho, Hsu-Chueh; Hsiao, Shih-Hsuan; Lin, Hon-Yi; Li, Szu-Chin; Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan; [Li, Szu-Chin; Su, Yu-Chieh] Buddhist Dalin Tzu Chi Gen Hosp, Div Hematol Oncol, Dept Internal Med, Chiayi, Taiwan; [Lin, Hon-Yi] Buddhist Dalin Tzu Chi Gen Hosp, Dept Radiat Oncol, Chiayi, Taiwan; [Lee, Ching-Chih; Ho, Hsu-Chueh; Hsiao, Shih-Hsuan] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih; Ho, Hsu-Chueh; Hsiao, Shih-Hsuan; Lin, Hon-Yi; Li, Szu-Chin; Su, Yu-Chieh] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Huang, Tza-Ta] Changhua Chritian Hosp, Dept Oral & Maxillofacial Surg, You Lin Branch, You Lin, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tzu Chi University	Su, YC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Ctr Canc, Chiayi, Taiwan.	hematcd2@hotmail.com	Su, Yu-Chieh/M-7867-2013	Su, Yu-Chieh/0000-0002-1771-9017; Multhoff, Gabriele/0000-0002-2616-3137	Buddhist Dalin Tzu Chi General Hospital [(CTCRD 10092)-I-12]	Buddhist Dalin Tzu Chi General Hospital	This study was funded in part by the Buddhist Dalin Tzu Chi General Hospital ((CTCRD 10092)-I-12) and no additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Argiris A, 2011, ANN ONCOL, V22, P2482, DOI 10.1093/annonc/mdr002; Argiris A, 2011, ORAL ONCOL, V47, P961, DOI 10.1016/j.oraloncology.2011.07.034; Bernier J, 2008, NAT CLIN PRACT ONCOL, V5, P705, DOI 10.1038/ncponc1228; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Chou FHC, 2011, SCHIZOPHR RES, V129, P97, DOI 10.1016/j.schres.2011.02.018; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Earle CC, 2001, J CLIN ONCOL, V19, P1064, DOI 10.1200/JCO.2001.19.4.1064; Hoag JB, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-113; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kang HJ, 2012, RESP MED, V106, P443, DOI 10.1016/j.rmed.2011.11.009; Lewkowicz P, 2005, IMMUNOL LETT, V96, P203, DOI 10.1016/j.imlet.2004.08.012; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Merlano M, 2011, ANN ONCOL, V22, P712, DOI 10.1093/annonc/mdq412; Pfister DG, 2006, J CLIN ONCOL, V24, P1072, DOI 10.1200/JCO.2004.00.1792; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; RUBIN DB, 1993, MED CARE, V31, pYS103, DOI 10.1097/00005650-199305001-00017; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang L, 2011, DRUGS R&D, V11, P317, DOI 10.2165/11598190-000000000-00000	24	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50163	10.1371/journal.pone.0050163	http://dx.doi.org/10.1371/journal.pone.0050163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209663	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700036
J	Morandi, A; Meyre, D; Lobbens, S; Kleinman, K; Kaakinen, M; Rifas-Shiman, SL; Vatin, V; Gaget, S; Pouta, A; Hartikainen, AL; Laitinen, J; Ruokonen, A; Das, S; Khan, AA; Elliott, P; Maffeis, C; Gillman, MW; Jarvelin, MR; Froguel, P				Morandi, Anita; Meyre, David; Lobbens, Stephane; Kleinman, Ken; Kaakinen, Marika; Rifas-Shiman, Sheryl L.; Vatin, Vincent; Gaget, Stefan; Pouta, Anneli; Hartikainen, Anna-Liisa; Laitinen, Jaana; Ruokonen, Aimo; Das, Shikta; Khan, Anokhi Ali; Elliott, Paul; Maffeis, Claudio; Gillman, Matthew W.; Jarvelin, Marjo-Riitta; Froguel, Philippe			Estimation of Newborn Risk for Child or Adolescent Obesity: Lessons from Longitudinal Birth Cohorts	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AMERICAN-CANCER-SOCIETY; WEIGHT-GAIN; PREVALENCE; VARIANTS; LOCI; MASS; INDIVIDUALS; OVERWEIGHT; PREDICTION	Objectives: Prevention of obesity should start as early as possible after birth. We aimed to build clinically useful equations estimating the risk of later obesity in newborns, as a first step towards focused early prevention against the global obesity epidemic. Methods: We analyzed the lifetime Northern Finland Birth Cohort 1986 (NFBC1986) (N = 4,032) to draw predictive equations for childhood and adolescent obesity from traditional risk factors (parental BMI, birth weight, maternal gestational weight gain, behaviour and social indicators), and a genetic score built from 39 BMI/obesity-associated polymorphisms. We performed validation analyses in a retrospective cohort of 1,503 Italian children and in a prospective cohort of 1,032 U.S. children. Results: In the NFBC1986, the cumulative accuracy of traditional risk factors predicting childhood obesity, adolescent obesity, and childhood obesity persistent into adolescence was good: AUROC = 0.78[0.74-0.82], 0.75[0.71-0.79] and 0.85[0.80-0.90] respectively (all p<0.001). Adding the genetic score produced discrimination improvements <= 1%. The NFBC1986 equation for childhood obesity remained acceptably accurate when applied to the Italian and the U. S. cohort (AUROC = 0.70[0.63-0.77] and 0.73[0.67-0.80] respectively) and the two additional equations for childhood obesity newly drawn from the Italian and the U.S. datasets showed good accuracy in respective cohorts (AUROC = 0.74[0.69-0.79] and 0.79[0.73-0.84]) (all p<0.001). The three equations for childhood obesity were converted into simple Excel risk calculators for potential clinical use. Conclusion: This study provides the first example of handy tools for predicting childhood obesity in newborns by means of easily recorded information, while it shows that currently known genetic variants have very little usefulness for such prediction.	[Morandi, Anita; Meyre, David; Lobbens, Stephane; Vatin, Vincent; Gaget, Stefan; Froguel, Philippe] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, Unite Mixte Rech 8199, F-59019 Lille, France; [Morandi, Anita; Maffeis, Claudio] Univ Verona, Reg Ctr Juvenile Diabet Obes & Clin Nutr, I-37100 Verona, Italy; [Meyre, David] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Kleinman, Ken; Rifas-Shiman, Sheryl L.; Gillman, Matthew W.] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA USA; [Kleinman, Ken; Rifas-Shiman, Sheryl L.; Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr, Oulu, Finland; [Pouta, Anneli] Natl Inst Hlth & Welf, Dept Children Young People & Families, Helsinki, Finland; [Pouta, Anneli; Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu, Finland; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Helsinki, Finland; [Ruokonen, Aimo] Univ Oulu, Dept Clin Sci & Clin Chem, Oulu, Finland; [Das, Shikta; Khan, Anokhi Ali; Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Ctr Environm & Hlth, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Life Course & Serv, Oulu, Finland; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Verona; McMaster University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Finnish Institute of Occupational Health; University of Oulu; Imperial College London; Imperial College London; Finland National Institute for Health & Welfare; Imperial College London	Morandi, A (corresponding author), Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, Unite Mixte Rech 8199, F-59019 Lille, France.	anita.morandi@voila.fr; froguel@good.ibl.fr	FROGUEL, Philippe/O-6799-2017; Morandi, Anita/AAC-4067-2022; Maffeis, Claudio/AAG-5347-2020; Meyre, David/D-7315-2011	FROGUEL, Philippe/0000-0003-2972-0784; Meyre, David/0000-0003-4850-7444; MORANDI, Anita/0000-0002-2631-9330; Kaakinen, Marika/0000-0002-9228-0462; Kleinman, Ken/0000-0002-5600-5834; Ali Khan, Anokhi/0000-0003-3671-4550; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Academy of Finland [104781, 120315, 129269, 1114194, SALVE]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; European Commission (EURO-BLCS) [QLG1-CT-2000-01643]; Medical Research Council, UK [G05005539, G0600705, PrevMetSyn]; Divisional Grant Imperial College London [G24038]; Conseil Regional Nord Pas de Calais/FEDER; Agence Nationale de la Recherche; National Institutes of Health; March of Dimes Foundation; U.S. Centers for Disease Control and Prevention; MRC [G0600705, G1002084] Funding Source: UKRI; Medical Research Council [G0600705, G1002084] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD034568] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); University Hospital Oulu, Biocenter, University of Oulu, Finland; European Commission (EURO-BLCS)(European CommissionEuropean Commission Joint Research Centre); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Divisional Grant Imperial College London; Conseil Regional Nord Pas de Calais/FEDER(Region Hauts-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Northern Finland Birth Cohorts program is financially supported by the Academy of Finland (project grants 104781, 120315, 129269, 1114194 and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), the Medical Research Council, UK (G05005539, G0600705, PrevMetSyn) and the Divisional Grant Imperial College London [G24038]. The genotyping was supported by the "Conseil Regional Nord Pas de Calais/FEDER" and the "Agence Nationale de la Recherche." Project Viva is financially supported by the National Institutes of Health, the March of Dimes Foundation, and the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Pediatrics Steering Committee on Quality Improvement and Management, 2008, Pediatrics, V121, P643, DOI 10.1542/peds.2007-3624; Belsky DW, 2012, ARCH PEDIAT ADOL MED, V166, P515, DOI 10.1001/archpediatrics.2012.131; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bethell C, 2009, PEDIATRICS, V123, pS277, DOI 10.1542/peds.2008-2780F; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Daniels LA, 2012, INT J OBESITY, V36, P1292, DOI 10.1038/ijo.2012.96; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Druet C, 2012, PAEDIATR PERINAT EP, V26, P19, DOI 10.1111/j.1365-3016.2011.01213.x; Haemer M, 2011, PEDIATRICS, V128, pS71, DOI 10.1542/peds.2011-0480G; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Ino T, 2010, PEDIATR INT, V52, P94, DOI 10.1111/j.1442-200X.2009.02883.x; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Langkamp DL, 2010, ACAD PEDIATR, V10, P205, DOI 10.1016/j.acap.2010.01.005; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; MAFFEIS C, 1993, INT J OBESITY, V17, P287; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Manco M, 2012, PEDIATRICS, V130, P123, DOI 10.1542/peds.2011-2717; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Plachta-Danielzik S, 2010, PUBLIC HEALTH NUTR, V13, P1870, DOI 10.1017/S1368980010000583; Rattay KT, 2009, PEDIATRICS, V123, pS100, DOI 10.1542/peds.2008-1755J; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Smith GD, 2007, ARCH DIS CHILD, V92, P876, DOI 10.1136/adc.2006.104869; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stocks T, 2011, OBES REV, V12, P637, DOI 10.1111/j.1467-789X.2011.00869.x; Summerbell C, 2011, COCHRANE DB SYST REV, V12; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub2, 10.1002/14651858.CD001871.pub4]; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Waxler JL, 2012, J GENET COUNS; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wojcicki JM, 2010, NEW ENGL J MED, V362, P1457, DOI 10.1056/NEJMp1001857; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x	41	79	80	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49919	10.1371/journal.pone.0049919	http://dx.doi.org/10.1371/journal.pone.0049919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209618	Green Published, gold			2022-12-25	WOS:000312601700025
J	Otten, R; Barker, ED; Huizink, AC; Engels, RCME				Otten, Roy; Barker, Edward D.; Huizink, Anja C.; Engels, Rutger C. M. E.			The Interplay between Parental Monitoring and the Dopamine D4 Receptor Gene in Adolescent Cannabis Use	PLOS ONE			English	Article							DIFFERENTIAL SUSCEPTIBILITY; ENVIRONMENT INTERACTION; SMOKING-BEHAVIOR; USE DISORDERS; DRUG-USE; POLYMORPHISM; IMPACT; ONSET; D4	Background: Both environmental risk and genetic variation is believed to play a role in substance use. A candidate environmental variable is parenting. Recent studies have found support for the idea that the dopamine system affects the susceptibility to environmental influences. In the present study we will examine the interplay between effects of parental monitoring and the presence of the DRD4 7-repeat allele in adolescent lifetime cannabis use and the developmental course of cannabis use. Methods: A total of 311 adolescents participated in a five-wave longitudinal design. First, we conducted logistic regression analyses to examine the prospective associations between parental monitoring, the DRD4 polymorphism, their interaction and lifetime cannabis use. Second, individual growth parameters were calculated for frequency of cannabis use. Linear regression was used to assess the relationship between parental monitoring, the DRD4 polymorphism, their interaction, and the frequency of cannabis use. Results: There were no significant main effects of parental monitoring or the DRD4 polymorphism. However, both analyses showed that over a period of four years, a) when experiencing low levels of parental monitoring, individuals with the 7-repeat allele were more likely to show lifetime cannabis use and a stronger increase in frequency of cannabis use than individuals without this allele; b) when experiencing high levels of parental monitoring, individuals with the 7-repeat allele were less likely to show lifetime cannabis use and they showed a smaller increase in frequency of cannabis use than individuals without the 7-repeat allele. Conclusions: This study shows that carriers of the DRD4 7-repeat allele are disproportionally affected by the negative and positive effects of parental monitoring such that carriers of the DRD4 7-repeat allele, as compared to non-carriers, are more likely to use cannabis when levels of parental monitoring are low, and less likely to use cannabis when parental monitoring levels are high.	[Otten, Roy; Huizink, Anja C.; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Barker, Edward D.] Univ London Birkbeck Coll, London WC1E 7HX, England; [Huizink, Anja C.] Vrije Univ Amsterdam, Amsterdam, Netherlands	Radboud University Nijmegen; University of London; Birkbeck University London; Vrije Universiteit Amsterdam	Otten, R (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	R.Otten@bsi.ru.nl		Barker, Edward/0000-0002-9914-8958; Engels, Rutger/0000-0003-1944-9126	Dutch Organization for Scientific Research [400-05-051]	Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Dutch Organization for Scientific Research (no. 400-05-051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2006, ADDICTION, V101, P801, DOI 10.1111/j.1360-0443.2006.01399.x; Agrawal A, 2009, ADDICTION, V104, P518, DOI 10.1111/j.1360-0443.2009.02504.x; Arseneault L, 2002, BRIT MED J, V325, P1212, DOI 10.1136/bmj.325.7374.1212; Bakermans-Kranenburg MJ, 2008, DEV PSYCHOL, V44, P293, DOI 10.1037/0012-1649.44.1.293; Barker ED, 2011, J ABNORM PSYCHOL, V120, P981, DOI 10.1037/a0022878; Beach SRH, 2010, J FAM PSYCHOL, V24, P513, DOI 10.1037/a0020835; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Belsky J, 2009, PSYCHOL BULL, V135, P885, DOI 10.1037/a0017376; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bohnert KM, 2012, J STUD ALCOHOL DRUGS, V73, P173, DOI 10.15288/jsad.2012.73.173; Buchan BJ, 2002, ADDICTION, V97, P98, DOI 10.1046/j.1360-0443.97.s01.1.x; Byrne B.M., 2013, STRUCTURAL EQUATION, DOI 10.4324/9781410600219; Chilcoat HD, 1996, J AM ACAD CHILD PSY, V35, P91, DOI 10.1097/00004583-199601000-00017; Creemers HE, 2011, DRUG ALCOHOL DEPEN, V115, P35, DOI 10.1016/j.drugalcdep.2010.10.008; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Eaves LJ, 2006, TWIN RES HUM GENET, V9, P1, DOI 10.1375/183242706776403073; Engels RCME, 2005, J APPL SOC PSYCHOL, V35, P1912, DOI 10.1111/j.1559-1816.2005.tb02202.x; Ensminger ME, 2003, MON PARENT, P13; Harakeh Z, 2005, ADDICTION, V100, P862, DOI 10.1111/j.1360-0443.2005.01067.x; Hemovich V, 2009, SUBST USE MISUSE, V44, P2099, DOI 10.3109/10826080902858375; Jaffee SR, 2007, MOL PSYCHIATR, V12, P432, DOI 10.1038/sj.mp.4001950; Legleye S, 2012, J ADOLESCENT HEALTH, V50, P395, DOI 10.1016/j.jadohealth.2011.08.004; McGeary J, 2009, PHARMACOL BIOCHEM BE, V93, P222, DOI 10.1016/j.pbb.2009.03.010; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Otten R, 2008, SUBST USE MISUSE, V43, P341, DOI 10.1080/10826080701202833; Otten R, 2007, NICOTINE TOB RES, V9, P109, DOI 10.1080/14622200601078426; Otten R, 2013, ADDICT BIOL, V18, P826, DOI 10.1111/j.1369-1600.2011.00380.x; Otten R, 2010, DRUG ALCOHOL DEPEN, V112, P201, DOI 10.1016/j.drugalcdep.2010.06.007; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rutter M, 2002, ANNU REV PSYCHOL, V53, P463, DOI 10.1146/annurev.psych.53.100901.135223; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Schoots O, 2003, PHARMACOGENOMICS J, V3, P343, DOI 10.1038/sj.tpj.6500208; Sheese BE, 2007, DEV PSYCHOPATHOL, V19, P1039, DOI 10.1017/S0954579407000521; Sher KJ, 2000, J CONSULT CLIN PSYCH, V68, P818, DOI 10.1037/0022-006X.68.5.818; Sieverding JA, 2005, ARCH PEDIAT ADOL MED, V159, P724, DOI 10.1001/archpedi.159.8.724; Smetana JG, 2002, CHILD DEV, V73, P563, DOI 10.1111/1467-8624.00424; Stattin H, 2000, CHILD DEV, V71, P1072, DOI 10.1111/1467-8624.00210; STEINBERG L, 1994, PEDIATRICS, V93, P1060; STEINBERG L, 1992, CHILD DEV, V63, P1266, DOI 10.2307/1131532; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; United Nations Office on Drugs and Crime, 2010, WORLD DRUG REPORT; van der Zwaluw CS, 2010, MOL PSYCHIATR, V15, P727, DOI 10.1038/mp.2009.4; VANTOL HHM, 1992, NATURE, V358, P149; Vermulst AA, 2005, QUICK BIG FIVE PERSO; Wang E, 2004, AM J HUM GENET, V74, P931, DOI 10.1086/420854; Zuckerman M., 1999, VULNERABILITY TO PSY	49	6	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49432	10.1371/journal.pone.0049432	http://dx.doi.org/10.1371/journal.pone.0049432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209577	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700013
J	Bonizzoni, M; Dunn, WA; Campbell, CL; Olson, KE; Marinotti, O; James, AA				Bonizzoni, Mariangela; Dunn, W. Augustine; Campbell, Corey L.; Olson, Ken E.; Marinotti, Osvaldo; James, Anthony A.			Complex Modulation of the Aedes aegypti Transcriptome in Response to Dengue Virus Infection	PLOS ONE			English	Article							MIDGUT SERINE PROTEASES; YELLOW-FEVER MOSQUITO; VECTOR COMPETENCE; RNA INTERFERENCE; GENE-REGULATION; SALIVARY-GLAND; TRANSMISSION; TYPE-2; EXPRESSION; SEQUENCE	Dengue fever is the most important arboviral disease world-wide, with Aedes aegypti being the major vector. Interactions between the mosquito host and dengue viruses (DENV) are complex and vector competence varies among geographically-distinct Ae. aegypti populations. Additionally, dengue is caused by four antigenically-distinct viral serotypes (DENV1-4), each with multiple genotypes. Each virus genotype interacts differently with vertebrate and invertebrate hosts. Analyses of alterations in mosquito transcriptional profiles during DENV infection are expected to provide the basis for identifying networks of genes involved in responses to viruses and contribute to the molecular-genetic understanding of vector competence. In addition, this knowledge is anticipated to support the development of novel disease-control strategies. RNA-seq technology was used to assess genome-wide changes in transcript abundance at 1, 4 and 14 days following DENV2 infection in carcasses, midguts and salivary glands of the Ae. aegypti Chetumal strain. DENV2 affected the expression of 397 Ae. aegypti genes, most of which were down-regulated by viral infection. Differential accumulation of transcripts was mainly tissue-and time-specific. Comparisons of our data with other published reports reveal conservation of functional classes, but limited concordance of specific mosquito genes responsive to DENV2 infection. These results indicate the necessity of additional studies of mosquito-DENV interactions, specifically those focused on recently-derived mosquito strains with multiple dengue virus serotypes and genotypes.	[Bonizzoni, Mariangela; Dunn, W. Augustine; Marinotti, Osvaldo; James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Bonizzoni, Mariangela] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA; [Dunn, W. Augustine] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA USA; [Campbell, Corey L.; Olson, Ken E.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO USA; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Colorado State University; University of California System; University of California Irvine	James, AA (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	aajames@uci.edu	bonizzoni, mariangela/AAM-9035-2021; Pacific-Southwest, RCE/B-6155-2009	bonizzoni, mariangela/0000-0003-0568-8564; James, Anthony/0000-0001-5577-3308; Marinotti, Osvaldo/0000-0002-7173-7160; Dunn, Augustine/0000-0002-8683-1459	National Institute of Allergy and Infectious Diseases [U54AI065359]; National Library of Medicine, United States National Institutes of Health (NIH) [T15LM07443]; Foundation for the NIH through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007443] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Library of Medicine, United States National Institutes of Health (NIH); Foundation for the NIH through the Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by grant U54AI065359 from the National Institute of Allergy and Infectious Diseases. WAD is supported in part by T15LM07443 from the National Library of Medicine, United States National Institutes of Health (NIH). C. L. Campbell and K. E. Olson are supported in part by a grant to the Regents of the University of California from the Foundation for the NIH through the Grand Challenges in Global Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863; Agawa Y, 2007, MOL CELL BIOL, V27, P8739, DOI 10.1128/MCB.01304-07; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56; Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769; Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385; Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85; Bernhardt SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044198; Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Bonizzoni M, 2012, G3-GENES GENOM GENET, V2, P103, DOI 10.1534/g3.111.001107; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003; Chase GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002187; Cho WL, 1999, J BIOL CHEM, V274; Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189; Conus S, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13042; Cox J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001172; Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274; DEUBEL V, 1986, VIROLOGY, V155, P365, DOI 10.1016/0042-6822(86)90200-X; Flajollet S, 2009, J IMMUNOL, V183, P6948, DOI 10.4049/jimmunol.0902053; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; GUBLER DJ, 1976, AM J TROP MED HYG, V25, P146, DOI 10.4269/ajtmh.1976.25.146; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Gunther J, 2007, INTERVIROLOGY, V50, P347, DOI 10.1159/000107272; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; Hansen IA, 2007, INSECT BIOCHEM MOLEC, V37, P985, DOI 10.1016/j.ibmb.2007.05.008; Heinz FX, 2003, ADV VIRUS RES, V59, P63, DOI 10.1016/S0065-3527(03)59003-0; Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45; James Anthony A, 2007, J Vis Exp, P231, DOI 10.3791/231; Kanlaya R, 2009, J PROTEOME RES, V8, P2551, DOI 10.1021/pr900060g; Kent JR, 2004, J VIROL, V78, P10178, DOI 10.1128/JVI.78.18.10178-10186.2004; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0; Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Liu HS, 2009, BIOCHEM J, V422, P543, DOI 10.1042/BJ20090342; Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mercado-Curiel RF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-118; Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164; Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Rajeswari MR, 2002, CURR SCI INDIA, V82, P838; Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sandstrom DJ, 1997, DEV BIOL, V181, P168, DOI 10.1006/dbio.1996.8469; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; Sieglaff DH, 2009, P NATL ACAD SCI USA, V106, P3053, DOI 10.1073/pnas.0813264106; Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106; Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Wang H, 2012, J VIROL, V86, P6546, DOI 10.1128/JVI.00125-12; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Wei H, 2010, BBA-GENE REGUL MECH, V1799, P296, DOI 10.1016/j.bbagrm.2009.08.007; WHO, 2009, DENGUE GUIDELINES FO; Xi Z, 2008, PLOS PATHOG; Xie WW, 2011, GENETICS, V188, P823, DOI 10.1534/genetics.111.128470	74	94	95	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50512	10.1371/journal.pone.0050512	http://dx.doi.org/10.1371/journal.pone.0050512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209765	Green Published, gold			2022-12-25	WOS:000311885800079
J	Jagadamma, S; Mayes, MA; Phillips, JR				Jagadamma, Sindhu; Mayes, Melanie A.; Phillips, Jana R.			Selective Sorption of Dissolved Organic Carbon Compounds by Temperate Soils	PLOS ONE			English	Article							FOREST SOILS; STERILIZATION METHODS; VERTICAL-DISTRIBUTION; CHEMICAL-COMPOSITION; GAMMA-STERILIZATION; MINERAL SURFACES; MATTER FRACTIONS; PHENOLIC-ACIDS; AMINO-ACIDS; ADSORPTION	Background: Physico-chemical sorption onto soil minerals is one of the major processes of dissolved organic carbon (OC) stabilization in deeper soils. The interaction of DOC on soil solids is related to the reactivity of soil minerals, the chemistry of sorbate functional groups, and the stability of sorbate to microbial degradation. This study was conducted to examine the sorption of diverse OC compounds (D-glucose, L-alanine, oxalic acid, salicylic acid, and sinapyl alcohol) on temperate climate soil orders (Mollisols, Ultisols and Alfisols). Methodology: Equilibrium batch experiments were conducted using 0-100 mg C L-1 at a solid-solution ratio of 1:60 for 48 hrs on natural soils and on soils sterilized by c-irradiation. The maximum sorption capacity, Q(max) and binding coefficient, k were calculated by fitting to the Langmuir model. Results: Ultisols appeared to sorb more glucose, alanine, and salicylic acid than did Alfisols or Mollisols and the isotherms followed a non-linear pattern (higher k). Sterile experiments revealed that glucose and alanine were both readily degraded and/or incorporated into microbial biomass because the observed Q(max) under sterile conditions decreased by 22-46% for glucose and 17-77% for alanine as compared to non-sterile conditions. Mollisols, in contrast, more readily reacted with oxalic acid (Q(max) of 886 mg kg(-1)) and sinapyl alcohol (Q(max) of 2031 mg kg(-1)), and no degradation was observed. The reactivity of Alfisols to DOC was intermediate to that of Ultisols and Mollisols, and degradation followed similar patterns as for Ultisols. Conclusion: This study demonstrated that three common temperate soil orders experienced differential sorption and degradation of simple OC compounds, indicating that sorbate chemistry plays a significant role in the sorptive stabilization of DOC.	[Jagadamma, Sindhu] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN USA; Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Jagadamma, S (corresponding author), Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN USA.	jagadammas@ornl.gov	Jagadamma, Sindhu/F-7168-2012	Jagadamma, Sindhu/0000-0003-4831-3308	United States Department of Energy's Office of Biological and Environmental Research-Climate and Environmental Sciences Division; U.S. DOE [DE-AC05-00OR22725]; U.S. Government [DE-AC05-00OR22725]	United States Department of Energy's Office of Biological and Environmental Research-Climate and Environmental Sciences Division(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); U.S. Government	Funding was provided by the United States Department of Energy's Office of Biological and Environmental Research-Climate and Environmental Sciences Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Katherine Heal for collecting and sharing the soil samples used this study. We greatly appreciate the help from Mark Baldwin and Denise Lee of ORNL for gamma irradiation. We would also like to thank Prasesh Sharma and Vijay Loganathan of ORNL and Kim Magrini of NREL for providing useful comments on the manuscript. Oak Ridge National Laboratory is managed by UT-Battelle, LLC, under contract DE-AC05-00OR22725 with the U.S. DOE.; The submitted manuscript has been authored by a contractor of the U.S. Government under contract DE-AC05-00OR22725. Accordingly, the U.S. Government retains a nonexclusive, royalty-free license to publish or reproduce the published form of this contribution, or allow others to do so, for U.S. Government purposes.	[Anonymous], 1996, METHODS SOIL ANAL CH; Aufdenkampe AK, 2001, LIMNOL OCEANOGR, V46, P1921, DOI 10.4319/lo.2001.46.8.1921; Balajee S.R., 1969, T AIME, V244, P407; Baldock JA, 2000, ORG GEOCHEM, V31, P697, DOI 10.1016/S0146-6380(00)00049-8; Bank TL, 2008, CHEM GEOL, V251, P1, DOI 10.1016/j.chemgeo.2008.01.003; Basile-Doelsch I, 2007, GEODERMA, V137, P477, DOI 10.1016/j.geoderma.2006.10.006; Berns AE, 2008, EUR J SOIL SCI, V59, P540, DOI 10.1111/j.1365-2389.2008.01016.x; Bolster CH, 2007, SOIL SCI SOC AM J, V71, P1796, DOI 10.2136/sssaj2006.0304; Cecchi AM, 2004, BIOL FERT SOILS, V39, P235, DOI 10.1007/s00374-003-0710-6; Celis R, 2005, EUR J SOIL SCI, V56, P287, DOI 10.1111/j.1365-2389.2004.00676.x; CHENU C, 2006, ENCY SOIL SCI, DOI DOI 10.1081/E-ESS-120006622; Currie WS, 1996, BIOGEOCHEMISTRY, V35, P471, DOI 10.1007/BF02183037; DALTON BR, 1989, SOIL SCI SOC AM J, V53, P757, DOI 10.2136/sssaj1989.03615995005300030021x; Dane JD, 2004, HYDROMETER METHOD 4, P278; Dubus IG, 2001, CHEMOSPHERE, V45, P767, DOI 10.1016/S0045-6535(01)00108-4; Endo S, 2008, ENVIRON SCI TECHNOL, V42, P5897, DOI 10.1021/es8001426; Fischer H, 2010, EUR J SOIL SCI, V61, P504, DOI 10.1111/j.1365-2389.2010.01244.x; Fischer H, 2007, SOIL BIOL BIOCHEM, V39, P2926, DOI 10.1016/j.soilbio.2007.06.014; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Fujii K, 2010, PLANT SOIL, V334, P475, DOI 10.1007/s11104-010-0398-y; GU BH, 1995, GEOCHIM COSMOCHIM AC, V59, P219, DOI 10.1016/0016-7037(94)00282-Q; GU BH, 1994, ENVIRON SCI TECHNOL, V28, P38, DOI 10.1021/es00050a007; Guggenberger G, 2003, GEODERMA, V113, P293, DOI 10.1016/S0016-7061(02)00366-X; Jardine PM, 2006, VADOSE ZONE J, V5, P140, DOI 10.2136/vzj2005.0036; JARDINE PM, 1989, SOIL SCI SOC AM J, V53, P1378, DOI 10.2136/sssaj1989.03615995005300050013x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jones DL, 1998, EUR J SOIL SCI, V49, P447, DOI 10.1046/j.1365-2389.1998.4930447.x; Jones DL, 2003, PLANT SOIL, V248, P31, DOI 10.1023/A:1022304332313; Jones DL, 1996, PLANT SOIL, V180, P57, DOI 10.1007/BF00015411; Jones DL, 1996, PLANT SOIL, V182, P229, DOI 10.1007/BF00029054; Jones DL, 1998, SOIL BIOL BIOCHEM, V30, P1895, DOI 10.1016/S0038-0717(98)00060-1; Kaiser K, 1996, GEODERMA, V74, P281, DOI 10.1016/S0016-7061(96)00071-7; Kaiser K, 1999, SOIL SCI SOC AM J, V63, P1157, DOI 10.2136/sssaj1999.6351157x; Kaiser K, 1997, SOIL SCI SOC AM J, V61, P64, DOI 10.2136/sssaj1997.03615995006100010011x; Kaiser K, 2000, ORG GEOCHEM, V31, P711, DOI 10.1016/S0146-6380(00)00046-2; Kaiser K, 2001, BIOGEOCHEMISTRY, V55, P103, DOI 10.1023/A:1010694032121; Kalbitz K, 2005, SOIL BIOL BIOCHEM, V37, P1319, DOI 10.1016/j.soilbio.2004.11.028; Keil RG, 1998, GEOCHIM COSMOCHIM AC, V62, P1347, DOI 10.1016/S0016-7037(98)00080-5; Kothawala DN, 2009, SOIL SCI SOC AM J, V73, P1831, DOI 10.2136/sssaj2008.0254; Kothawala DN, 2008, GEODERMA, V148, P43, DOI 10.1016/j.geoderma.2008.09.004; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P851, DOI 10.1016/j.soilbio.2005.07.012; LEHMANN RG, 1988, SOIL SCI SOC AM J, V52, P1304, DOI 10.2136/sssaj1988.03615995005200050017x; Liu Q, 2000, INT J MINER PROCESS, V60, P229, DOI 10.1016/S0301-7516(00)00018-1; LOTRARIO JB, 1995, B ENVIRON CONTAM TOX, V54, P668; Mayes MA, 2012, SOIL SCI SOC AM J, V76, P1027, DOI 10.2136/sssaj2011.0340; McNamara NP, 2003, APPL SOIL ECOL, V24, P117, DOI 10.1016/S0929-1393(03)00073-8; McPherson BJ, 2009, GEOPHYS MONOGR SER, V183, P1, DOI 10.1029/GM183; MOORE TR, 1992, SOIL SCI, V154, P120, DOI 10.1097/00010694-199208000-00005; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Olsson R, 2011, J COLLOID INTERF SCI, V353, P263, DOI 10.1016/j.jcis.2010.09.023; Rumpel C, 2002, ORG GEOCHEM, V33, P1131, DOI 10.1016/S0146-6380(02)00088-8; *SAS I, 2002, SAS SYST MICR WIND R; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Sheremata TW, 1997, COMMUN SOIL SCI PLAN, V28, P1177, DOI 10.1080/00103629709369864; Smeck NE, 2007, ENCY SOIL SCI, P1648; Soukup DA, 2006, ENCY SOIL SCI, V2, P1088; Strahm BD, 2008, SOIL SCI SOC AM J, V72, P1653, DOI 10.2136/sssaj2007.0318; Strom L, 2001, SOIL BIOL BIOCHEM, V33, P2125, DOI 10.1016/S0038-0717(01)00146-8; Thevenot M, 2010, SOIL BIOL BIOCHEM, V42, P1200, DOI 10.1016/j.soilbio.2010.03.017; Thomas G.W., 1996, SOIL PH SOIL ACIDI 3, P475, DOI DOI 10.2136/SSSABOOKSER5.3.C16; Trumbore SE, 1997, P NATL ACAD SCI USA, V94, P8284, DOI 10.1073/pnas.94.16.8284; van Hees PAW, 2005, SOIL BIOL BIOCHEM, V37, P1, DOI 10.1016/j.soilbio.2004.06.010; van Hees PAW, 2003, SOIL BIOL BIOCHEM, V35, P1015, DOI 10.1016/S0038-0717(03)00144-5; van Hees PAW, 2002, SOIL BIOL BIOCHEM, V34, P1261, DOI 10.1016/S0038-0717(02)00068-8; WANG TSC, 1978, SOIL SCI, V126, P15, DOI 10.1097/00010694-197807000-00003; Wattel-Koekkoek EJW, 2003, EUR J SOIL SCI, V54, P269, DOI 10.1046/j.1365-2389.2003.00512.x; Wie J.M., 1974, INT J MINER PROCESS, V1, P17, DOI [10.1016/0301-7516(74)90024-6, DOI 10.1016/0301-7516(74)90024-6]; WOLF DC, 1989, J ENVIRON QUAL, V18, P39, DOI 10.2134/jeq1989.00472425001800010007x	68	28	30	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50434	10.1371/journal.pone.0050434	http://dx.doi.org/10.1371/journal.pone.0050434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209742	gold, Green Submitted, Green Published			2022-12-25	WOS:000311885800072
J	Gough, CA; Homma, K; Yamaguchi-Kabata, Y; Shimada, MK; Chakraborty, R; Fujii, Y; Iwama, H; Minoshima, S; Sakamoto, S; Sato, Y; Suzuki, Y; Tada-Umezaki, M; Nishikawa, K; Imanishi, T; Gojobori, T				Gough, Craig Alan; Homma, Keiichi; Yamaguchi-Kabata, Yumi; Shimada, Makoto K.; Chakraborty, Ranajit; Fujii, Yasuyuki; Iwama, Hisakazu; Minoshima, Shinsei; Sakamoto, Shigetaka; Sato, Yoshiharu; Suzuki, Yoshiyuki; Tada-Umezaki, Masahito; Nishikawa, Ken; Imanishi, Tadashi; Gojobori, Takashi			Prediction of Protein-Destabilizing Polymorphisms by Manual Curation with Protein Structure	PLOS ONE			English	Article							ONCOGENIC POINT MUTATIONS; NONSENSE-MEDIATED DECAY; NON-SYNONYMOUS SNPS; RB1 GENE; H-INVDB; DATABASE; ANNOTATION; RESISTANCE; ATAXIN-1	The relationship between sequence polymorphisms and human disease has been studied mostly in terms of effects of single nucleotide polymorphisms (SNPs) leading to single amino acid substitutions that change protein structure and function. However, less attention has been paid to more drastic sequence polymorphisms which cause premature termination of a protein's sequence or large changes, insertions, or deletions in the sequence. We have analyzed a large set (n = 512) of insertions and deletions (indels) and single nucleotide polymorphisms causing premature termination of translation in disease-related genes. Prediction of protein-destabilization effects was performed by graphical presentation of the locations of polymorphisms in the protein structure, using the Genomes TO Protein (GTOP) database, and manual annotation with a set of specific criteria. Protein-destabilization was predicted for 44.4% of the nonsense SNPs, 32.4% of the frameshifting indels, and 9.1% of the non-frameshifting indels. A prediction of nonsense-mediated decay allowed to infer which truncated proteins would actually be translated as defective proteins. These cases included the proteins linked to diseases inherited dominantly, suggesting a relation between these diseases and toxic aggregation. Our approach would be useful in identifying potentially aggregation-inducing polymorphisms that may have pathological effects.	[Gough, Craig Alan; Yamaguchi-Kabata, Yumi; Shimada, Makoto K.; Fujii, Yasuyuki; Sato, Yoshiharu; Imanishi, Tadashi] Natl Inst Adv Ind Sci & Technol, Integrated Database Grp, Biol Informat Res Ctr, Tokyo, Japan; [Gough, Craig Alan] Japan Biol Informat Res Ctr, Integrated Database Grp, Tokyo, Japan; [Gough, Craig Alan] Reconesis, Tokyo, Japan; [Homma, Keiichi; Tada-Umezaki, Masahito; Nishikawa, Ken] Natl Inst Genet, Lab Gene Prod Informat, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Homma, Keiichi; Tada-Umezaki, Masahito; Nishikawa, Ken] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 411, Japan; [Homma, Keiichi] Maebashi Inst Technol, Dept Bioinformat, Maebashi, Gunma, Japan; [Yamaguchi-Kabata, Yumi] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Lab Med Informat, Yokohama, Kanagawa, Japan; [Shimada, Makoto K.] Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi, Japan; [Chakraborty, Ranajit] Univ N Texas, Hlth Sci Ctr, Inst Appl Genet, Dept Forens & Investigat Genet, Ft Worth, TX USA; [Fujii, Yasuyuki] Okayama Univ, Innovat Ctr Okayama Nanobiotargeted Therapy, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Kagawa, Japan; [Minoshima, Shinsei] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Basic Med Photon Lab, Dept Photomed Genom, Hamamatsu, Shizuoka 4313192, Japan; [Sakamoto, Shigetaka] Holon Co, Numazu, Japan; [Sato, Yoshiharu] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Microbiol & Mol Genet, Chiba, Japan; [Suzuki, Yoshiyuki; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 411, Japan; [Suzuki, Yoshiyuki; Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 411, Japan; [Suzuki, Yoshiyuki] Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi, Japan; [Gough, Craig Alan; Shimada, Makoto K.; Fujii, Yasuyuki; Sato, Yoshiharu] Biol Informat Consortium, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; RIKEN; Fujita Health University; University of North Texas System; University of North Texas Health Science Center; Okayama University; Kagawa University; Hamamatsu University School of Medicine; Chiba University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Nagoya City University	Imanishi, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Integrated Database Grp, Biol Informat Res Ctr, Tokyo, Japan.	t.imanishi@aist.go.jp	Imanishi, Tadashi/R-3076-2019; SHIMADA, Makoto K./K-4613-2015	SHIMADA, Makoto K./0000-0003-0067-0082; Imanishi, Tadashi/0000-0002-1182-9127; Minoshima, Satoshi/0000-0002-0043-3047	Ministry of Economy, Trade, and Industry of Japan; Grants-in-Aid for Scientific Research [23592562] Funding Source: KAKEN	Ministry of Economy, Trade, and Industry of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the Ministry of Economy, Trade, and Industry of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Barenboim M, 2005, HUM MUTAT, V26, P471, DOI 10.1002/humu.20238; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; COLLINGWOOD TN, 1994, MOL ENDOCRINOL, V8, P1262, DOI 10.1210/me.8.9.1262; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Daehmlow S, 2002, BIOCHEM BIOPH RES CO, V298, P116, DOI 10.1016/S0006-291X(02)02374-4; DESBOIS C, 1991, CELL, V67, P731, DOI 10.1016/0092-8674(91)90068-A; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Hojlund K, 2004, DIABETES, V53, P1592, DOI 10.2337/diabetes.53.6.1592; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Homma K, 2004, J MOL BIOL, V343, P1207, DOI 10.1016/j.jmb.2004.09.028; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; Kawabata T, 2002, NUCLEIC ACIDS RES, V30, P294, DOI 10.1093/nar/30.1.294; Kaytor MD, 2005, HUM MOL GENET, V14, P1095, DOI 10.1093/hmg/ddi122; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; ONADIM Z, 1992, P NATL ACAD SCI USA, V89, P6177, DOI 10.1073/pnas.89.13.6177; Orpiszewski J, 2000, FASEB J, V14, P1255, DOI 10.1096/fasebj.14.9.1255; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Saunders CT, 2002, J MOL BIOL, V322, P891, DOI 10.1016/S0022-2836(02)00813-6; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shimada MK, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-122; Shimada MK, 2009, NUCLEIC ACIDS RES, V37, pD810, DOI 10.1093/nar/gkn798; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Yamaguchi-Kabata Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003393; Yamasaki C, 2008, NUCLEIC ACIDS RES, V36, pD793, DOI 10.1093/nar/gkm999; YANDELL DW, 1989, NEW ENGL J MED, V321, P1689, DOI 10.1056/NEJM198912213212501; Zhang J, 1998, MOL CELL BIOL, V18, P5272, DOI 10.1128/MCB.18.9.5272	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50445	10.1371/journal.pone.0050445	http://dx.doi.org/10.1371/journal.pone.0050445			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189203	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800080
J	Kong, SS; Liu, JJ; Hwang, TC; Yu, XJ; Zhao, M; Zhao, M; Yuan, BX; Lu, Y; Kang, YM; Wang, B; Zang, WJ				Kong, Shan-Shan; Liu, Jin-Jun; Hwang, Tyzh-Chang; Yu, Xiao-Jiang; Zhao, Mei; Zhao, Ming; Yuan, Bing-Xiang; Lu, Yi; Kang, Yu-Ming; Wang, Bing; Zang, Wei-Jin			Optimizing the Parameters of Vagus Nerve Stimulation by Uniform Design in Rats with Acute Myocardial Infarction	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; CONGESTIVE-HEART-FAILURE; NECROSIS-FACTOR-ALPHA; VAGAL-STIMULATION; REPERFUSION INJURY; ISCHEMIA; ACTIVATION; PROTECTS; ACETYLCHOLINE; INFLAMMATION	Vagus nerve stimulation (VNS) has been shown to improve left ventricular function and survival in rats with acute myocardial infarction (AMI), and this maneuver has also been adopted clinically for the treatment of patients with chronic heart failure (CHF). Recent in vitro and in vivo studies have suggested that VNS can modulate the level of pro-inflammatory factors. Despite the beneficial effects of VNS, the stimulation parameters for obtaining favorable outcomes appear highly variable. To optimize VNS parameters, we set up different stimulation protocols with different pulse width (1-2 ms), frequency (1-6 Hz), voltage (1-6 V) and duration (40-240 min) of VNS by uniform design (UD). Rats were divided into seven groups with (Group1-Group6) or without VNS (MI group). Our results demonstrate that (1) the parameter sets in Group1, Group2 and Group3 yield the best post-MI protection by VNS, while the protective role were not observed in Group4, Group5 and Group6; (2) baroreflex sensitivity and the alpha 7 nicotinic acetylcholine receptor level were also increased in Group1, Group2 and Group3. (3) the parameter set in Group1 (G1:1 ms, 2 Hz, 3 V, 240 min) is judged the most optimal parameter in this study as rats in this group not only showed a reduced myocardial injury with better-preserved cardiac function compared with other groups, more important, but also exhibited minimal heart rate (HR) reduction. (4) the duration of VNS plays an important role in determining the protection effect of VNS. In conclusion, VNS displays a beneficial role in Group1, Group2 and Group3. Of note, the parameter set in Group1 provides the most optimal cardioprotective effect. These results may provide insight into development of novel treatment for ischemic heart diseases.	[Kong, Shan-Shan; Liu, Jin-Jun; Yu, Xiao-Jiang; Zhao, Mei; Zhao, Ming; Yuan, Bing-Xiang; Lu, Yi; Zang, Wei-Jin] Xi An Jiao Tong Univ, Dept Pharmacol, Coll Med, Xian 710049, Peoples R China; [Hwang, Tyzh-Chang] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Hwang, Tyzh-Chang] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA; [Kang, Yu-Ming] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Coll Med, Xian 710049, Peoples R China; [Wang, Bing] Xi An Jiao Tong Univ, Dept Pathol, Coll Med, Xian 710049, Peoples R China	Xi'an Jiaotong University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Xi'an Jiaotong University; Xi'an Jiaotong University	Zang, WJ (corresponding author), Xi An Jiao Tong Univ, Dept Pharmacol, Coll Med, Xian 710049, Peoples R China.	zwj@mail.xjtu.edu.cn			Key Project of National Natural Science Foundation of China (NSFC) [30930105]; Major International (Regional) Joint Research Project of NSFC [81120108002]; CMB (China Medical Board) Distinguished Professorships Award [F510000/G16916404]	Key Project of National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major International (Regional) Joint Research Project of NSFC; CMB (China Medical Board) Distinguished Professorships Award	This work is supported by Key Project of National Natural Science Foundation of China (NSFC) (No. 30930105), Major International (Regional) Joint Research Project of NSFC (No. 81120108002) and CMB (China Medical Board) Distinguished Professorships Award (No. F510000/G16916404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2005, CIRCULATION, V112, P164, DOI 10.1161/CIRCULATIONAHA.104.525493; Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Aukrust P, 1999, AM J CARDIOL, V83, P376, DOI 10.1016/S0002-9149(98)00872-8; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Daosukho C, 2007, FREE RADICAL BIO MED, V42, P1818, DOI 10.1016/j.freeradbiomed.2007.03.007; De Ferrari GM, 2011, HEART FAIL REV, V16, P195, DOI 10.1007/s10741-010-9216-0; Fang K, 1980, ACTA ATHEMATICAE APP, P363; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Haq S, 2003, NAT MED, V9, P944, DOI 10.1038/nm891; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Irwin MW, 1999, CIRCULATION, V99, P1492, DOI 10.1161/01.CIR.99.11.1492; Jankowska EA, 2006, CARDIOVASC RES, V70, P434, DOI 10.1016/j.cardiores.2006.01.013; Jardine DL, 2005, J PHYSIOL-LONDON, V565, P325, DOI 10.1113/jphysiol.2004.082198; Kakinuma Y, 2005, FEBS LETT, V579, P2111, DOI 10.1016/j.febslet.2005.02.065; Katare RG, 2009, J THORAC CARDIOV SUR, V137, P223, DOI 10.1016/j.jtcvs.2008.08.020; Kawada T, 2006, LIFE SCI, V78, P882, DOI 10.1016/j.lfs.2005.05.087; Kawada T, 2008, LIFE SCI, V83, P490, DOI 10.1016/j.lfs.2008.07.013; Kong SS, 2011, CLIN EXP PHARMACOL P, V38, P300, DOI 10.1111/j.1440-1681.2011.05505.x; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Liakopoulos OJ, 2006, EUR J CARDIO-THORAC, V30, P263, DOI 10.1016/j.ejcts.2006.04.019; Mariappan N, 2009, FREE RADICAL BIO MED, V46, P462, DOI 10.1016/j.freeradbiomed.2008.10.049; Mioni C, 2005, CRIT CARE MED, V33, P2621, DOI 10.1097/01.CCM.0000186762.05301.13; Nakahara T, 1998, AM J PHYSIOL-HEART C, V275, pH562, DOI 10.1152/ajpheart.1998.275.2.H562; SAPER CB, 1990, CIRC RES, V67, P1345, DOI 10.1161/01.RES.67.6.1345; Schachter SC, 1998, EPILEPSIA, V39, P677, DOI 10.1111/j.1528-1157.1998.tb01151.x; Schwartz PJ, 2008, EUR J HEART FAIL, V10, P884, DOI 10.1016/j.ejheart.2008.07.016; Shames BD, 2002, SHOCK, V17, P114, DOI 10.1097/00024382-200202000-00006; Tsutsumi T, 2008, CARDIOVASC RES, V77, P713, DOI 10.1093/cvr/cvm092; Uemura K, 2007, AM J PHYSIOL-HEART C, V293, pH2254, DOI 10.1152/ajpheart.00490.2007; Uemura K, 2010, J CARD FAIL, V16, P689, DOI 10.1016/j.cardfail.2010.03.001; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Yao YY, 2007, J CARD FAIL, V13, P588, DOI 10.1016/j.cardfail.2007.04.009; Yu JG, 2011, EUR HEART J	35	20	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e42799	10.1371/journal.pone.0042799	http://dx.doi.org/10.1371/journal.pone.0042799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189120	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800001
J	Links, MG; Dumonceaux, TJ; Hemmingsen, SM; Hill, JE				Links, Matthew G.; Dumonceaux, Tim J.; Hemmingsen, Sean M.; Hill, Janet E.			The Chaperonin-60 Universal Target Is a Barcode for Bacteria That Enables De Novo Assembly of Metagenomic Sequence Data	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; COMPLEX MICROBIAL COMMUNITY; GENE-SEQUENCES; PREDICTING RELATEDNESS; SPECIES IDENTIFICATION; HSP60 GENE; CPN60; QUANTIFICATION; HELICOBACTER; MICROFLORA	Barcoding with molecular sequences is widely used to catalogue eukaryotic biodiversity. Studies investigating the community dynamics of microbes have relied heavily on gene-centric metagenomic profiling using two genes (16S rRNA and cpn60) to identify and track Bacteria. While there have been criteria formalized for barcoding of eukaryotes, these criteria have not been used to evaluate gene targets for other domains of life. Using the framework of the International Barcode of Life we evaluated DNA barcodes for Bacteria. Candidates from the 16S rRNA gene and the protein coding cpn60 gene were evaluated. Within complete bacterial genomes in the public domain representing 983 species from 21 phyla, the largest difference between median pairwise inter- and intra-specific distances ("barcode gap") was found from cpn60. Distribution of sequence diversity along the similar to 555 bp cpn60 target region was remarkably uniform. The barcode gap of the cpn60 universal target facilitated the faithful de novo assembly of full-length operational taxonomic units from pyrosequencing data from a synthetic microbial community. Analysis supported the recognition of both 16S rRNA and cpn60 as DNA barcodes for Bacteria. The cpn60 universal target was found to have a much larger barcode gap than 16S rRNA suggesting cpn60 as a preferred barcode for Bacteria. A large barcode gap for cpn60 provided a robust target for species-level characterization of data. The assembly of consensus sequences for barcodes was shown to be a reliable method for the identification and tracking of novel microbes in metagenomic studies.	[Links, Matthew G.; Dumonceaux, Tim J.; Hill, Janet E.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada; [Links, Matthew G.; Dumonceaux, Tim J.] Agr & AgriFood Canada, Saskatoon, SK, Canada; [Hemmingsen, Sean M.] Natl Res Council Canada, Saskatoon, SK, Canada; [Hemmingsen, Sean M.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; Agriculture & Agri Food Canada; National Research Council Canada; University of Saskatchewan	Hill, JE (corresponding author), Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada.	Janet.Hill@usask.ca	Hill, Janet E./B-5001-2011; Dumonceaux, Tim/H-4751-2019; Links, Matthew/K-6624-2012; Links, Matthew G./P-4949-2019	Hill, Janet E./0000-0002-2187-6277; Dumonceaux, Tim/0000-0001-5165-0343; Links, Matthew G./0000-0003-1917-6789	Agriculture and AgriFood Canada; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes for Health Research	Agriculture and AgriFood Canada(Agriculture & Agri Food Canada); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from Agriculture and AgriFood Canada, the Natural Sciences and Engineering Research Council of Canada, and the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaiotta G, 2008, APPL ENVIRON MICROB, V74, P208, DOI 10.1128/AEM.01711-07; Brousseau R, 2001, APPL ENVIRON MICROB, V67, P4828, DOI 10.1128/AEM.67.10.4828-4833.2001; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Chaban B, 2012, MICROB ECOL, V63, P348, DOI 10.1007/s00248-011-9931-7; Chaban B, 2012, ISME J, V6, P430, DOI 10.1038/ismej.2011.96; Chaban B, 2009, APPL ENVIRON MICROB, V75, P3055, DOI 10.1128/AEM.00101-09; COATES ARM, 1993, MOL MICROBIOL, V8, P787, DOI 10.1111/j.1365-2958.1993.tb01624.x; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Desai AR, 2009, VET MICROBIOL, V137, P120, DOI 10.1016/j.vetmic.2008.12.019; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dumonceaux TJ, 2006, CAN J MICROBIOL, V52, P494, DOI 10.1139/W05-160; Dumonceaux Tim J, 2009, J Clin Microbiol, V47, P4067, DOI 10.1128/JCM.00112-09; Dumonceaux TJ, 2006, J MICROBIOL METH, V64, P46, DOI 10.1016/j.mimet.2005.04.006; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Goh SH, 1997, J CLIN MICROBIOL, V35, P3116, DOI 10.1128/JCM.35.12.3116-3121.1997; Goh SH, 1996, J CLIN MICROBIOL, V34, P818, DOI 10.1128/JCM.34.4.818-823.1996; Goh SH, 1998, J CLIN MICROBIOL, V36, P2164, DOI 10.1128/JCM.36.7.2164-2166.1998; Goh SH, 2000, J CLIN MICROBIOL, V38, P3953, DOI 10.1128/JCM.38.11.3953-3959.2000; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Hill JE, 2006, ENVIRON MICROBIOL, V8, P741, DOI 10.1111/j.1462-2920.2005.00944.x; Hill JE, 2005, AM J OBSTET GYNECOL, V193, P682, DOI 10.1016/j.ajog.2005.02.094; Hill JE, 2005, APPL ENVIRON MICROB, V71, P867, DOI 10.1128/AEM.71.2.867-875.2005; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Hill JE, 2002, APPL ENVIRON MICROB, V68, P3055, DOI 10.1128/AEM.68.6.3055-3066.2002; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Jayaprakash TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043009; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lund PA, 2009, FEMS MICROBIOL REV, V33, P785, DOI 10.1111/j.1574-6976.2009.00178.x; Masson L, 2006, GENOMICS, V87, P104, DOI 10.1016/j.ygeno.2005.06.014; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Oliver KL, 2008, APPL ENVIRON MICROB, V74, P5340, DOI 10.1128/AEM.02836-07; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Post AF, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00131; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Sakamoto M, 2010, INT J SYST EVOL MICR, V60, P2984, DOI 10.1099/ijs.0.021154-0; Sakamoto M, 2010, J MED MICROBIOL, V59, P1293, DOI 10.1099/jmm.0.020420-0; Schellenberg J, 2011, METHODS MOL BIOL, V733, P143, DOI 10.1007/978-1-61779-089-8_10; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schellenberg JJ, 2011, APPL ENVIRON MICROB, V77, P4066, DOI 10.1128/AEM.02943-10; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Sundquist A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-108; Sylvan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00279-11; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Verbeke TJ, 2011, SYST APPL MICROBIOL, V34, P171, DOI 10.1016/j.syapm.2010.11.019; Vermette CJ, 2010, MICROB ECOL, V59, P14, DOI 10.1007/s00248-009-9601-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0	60	83	84	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49755	10.1371/journal.pone.0049755	http://dx.doi.org/10.1371/journal.pone.0049755			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189159	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800036
J	Ridhuan, NS; Razak, KA; Lockman, Z; Aziz, AA				Ridhuan, Nur Syafinaz; Razak, Khairunisak Abdul; Lockman, Zainovia; Aziz, Azlan Abdul			Structural and Morphology of ZnO Nanorods Synthesized Using ZnO Seeded Growth Hydrothermal Method and Its Properties as UV Sensing	PLOS ONE			English	Article							OPTICAL-PROPERTIES; BUFFER LAYER; PHOTODETECTORS; TEMPERATURE; ARRAYS	In this study, zinc oxide (ZnO) nanorod arrays were synthesized using a simple hydrothermal reaction on ZnO seeds/nsilicon substrate. Several parameters were studied, including the heat-treatment temperature to produce ZnO seeds, zinc nitrate concentration, pH of hydrothermal reaction solution, and hydrothermal reaction time. The optimum heat-treatment temperature to produce uniform nanosized ZnO seeds was 400 degrees C. The nanorod dimensions depended on the hydrothermal reaction parameters. The optimum hydrothermal reaction parameters to produce blunt tip-like nanorods (770 nm long and 80 nm in top diameter) were 0.1 M zinc nitrate, pH 7, and 4 h of growth duration. Phase analysis studies showed that all ZnO nanorods exhibited a strong (002) peak. Thus, the ZnO nanorods grew in a c-axis preferred orientation. A strong ultraviolet (UV) emission peak was observed for ZnO nanorods grown under optimized parameters with a low, deep-level emission peak, which indicated high optical property and crystallinity of the nanorods. The produced ZnO nanorods were also tested for their UV-sensing properties. All samples responded to UV light but with different sensing characteristics. Such different responses could be attributed to the high surface-to-volume ratio of the nanorods that correlated with the final ZnO nanorods morphology formed at different synthesis parameters. The sample grown using optimum synthesis parameters showed the highest responsivity of 0.024 A/W for UV light at 375 nm under a 3 V bias.	[Ridhuan, Nur Syafinaz; Razak, Khairunisak Abdul; Lockman, Zainovia] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal, Penang, Malaysia; [Razak, Khairunisak Abdul; Aziz, Azlan Abdul] Univ Sains Malaysia, Inst Res Mol Med, Georgetown, Penang, Malaysia; [Aziz, Azlan Abdul] Univ Sains Malaysia, Sch Phys, Georgetown, Penang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Razak, KA (corresponding author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal, Penang, Malaysia.	khairunisak@usm.my	Razak, Khairunisak Abdul/A-6378-2010; Razak, Khairunisak Abdul/M-9602-2019; Aziz, Azlan Abdul/A-6888-2010; Lockman, Zainovia/F-5260-2011; Ridhuan, Nur Syafinaz Syafinaz/AAX-6797-2021; Aziz, Azlan Abdul/O-8681-2019	Razak, Khairunisak Abdul/0000-0003-0140-2418; Aziz, Azlan Abdul/0000-0002-7977-4249; Lockman, Zainovia/0000-0002-1535-8035; Aziz, Azlan Abdul/0000-0002-7977-4249	Universiti Sains Malaysia [304/PBahan/6035267, 1001/PBahan/8034052]; Loreal Malaysia; L'Oreal Malaysia	Universiti Sains Malaysia(Universiti Sains Malaysia); Loreal Malaysia(L'Oreal Group); L'Oreal Malaysia(L'Oreal Group)	This research was supported by Universiti Sains Malaysia research grants (304/PBahan/6035267, 1001/PBahan/8034052) and Loreal Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to confirm that this research was partly supported by L'Oreal Malaysia in terms of Loreal fellowship award (not research grant/contract research). There are no patents, products in development or marketed products to declare for potential commercialization. Any IP generated through this research only belongs to Universiti Sains Malaysia (NOT Loreal). The paper does not not have conflict of interest with any party including Loreal Malaysia. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Baruah S, 2009, J SOL-GEL SCI TECHN, V50, P456, DOI 10.1007/s10971-009-1917-2; Baruah S, 2009, J CRYST GROWTH, V311, P2549, DOI 10.1016/j.jcrysgro.2009.01.135; Chen J, 2011, J ALLOY COMPD, V509, P740, DOI 10.1016/j.jallcom.2010.09.043; Ghosh T, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/37/375202; Gimenez AJ, 2011, J PHYS CHEM C, V115, P282, DOI 10.1021/jp107812w; Govender K, 2004, J MATER CHEM, V14, P2575, DOI 10.1039/b404784b; Guo M, 2005, J SOLID STATE CHEM, V178, P1864, DOI 10.1016/j.jssc.2005.03.031; Ji LW, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3141447; Khusaimi Z, 2010, SYNTH REACT INORG M, V40, P190, DOI 10.1080/15533171003629147; Kondela T, 2010, IOP CONF SER-MAT SCI, V15, DOI 10.1088/1757-899X/15/1/012041; Li QW, 2010, APPL SURF SCI, V256, P1698, DOI 10.1016/j.apsusc.2009.09.097; Li Y, 2009, J SEMICOND, V30, P063004; Liu NS, 2010, ACS APPL MATER INTER, V2, P1973, DOI 10.1021/am100277q; Liu SY, 2009, APPL PHYS A-MATER, V94, P775, DOI [10.1007/s00339-008-4957-5, 10.1007/s00339-008-49575]; Lockman Z, 2010, J ALLOY COMPD, V493, P699, DOI 10.1016/j.jallcom.2009.12.196; Mamat MH, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.06GF05; Meng XQ, 2005, SOLID STATE COMMUN, V135, P179, DOI 10.1016/j.ssc.2005.04.015; Quang LH, 2006, J CRYST GROWTH, V287, P157, DOI 10.1016/j.jcrysgro.2005.10.060; Ridhuan NS, 2011, APPL MECH MATER, V83, P116, DOI 10.4028/www.scientific.net/AMM.83.116; Shin CM, 2009, APPL SURF SCI, V255, P8501, DOI 10.1016/j.apsusc.2009.06.004; Song J, 2008, J CHEM TECHNOL BIOT, V83, P345, DOI 10.1002/jctb.1817; Tan WK, 2011, J ALLOY COMPD, V509, P820, DOI 10.1016/j.jallcom.2010.09.099; Wang SF, 2008, INT J APPL CERAM TEC, V5, P419, DOI 10.1111/j.1744-7402.2008.02242.x; Zhao XQ, 2009, APPL SURF SCI, V255, P5861, DOI 10.1016/j.apsusc.2009.01.022; Zhao XQ, 2009, APPL SURF SCI, V255, P4461, DOI 10.1016/j.apsusc.2008.11.051; Zhao X, 2009, PHYSICA E, V41, P1423, DOI 10.1016/j.physe.2009.04.012	26	107	107	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50405	10.1371/journal.pone.0050405	http://dx.doi.org/10.1371/journal.pone.0050405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189199	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800076
J	Zaman, MS; Thamminana, S; Shahryari, V; Chiyomaru, T; Deng, GR; Saini, S; Majid, S; Fukuhara, S; Chang, I; Arora, S; Hirata, H; Ueno, K; Singh, K; Tanaka, Y; Dahiya, R				Zaman, Mohd Saif; Thamminana, Sobha; Shahryari, Varahram; Chiyomaru, Takeshi; Deng, Guoren; Saini, Sharanjot; Majid, Shahana; Fukuhara, Shinichiro; Chang, Inik; Arora, Sumit; Hirata, Hiroshi; Ueno, Koji; Singh, Kamaldeep; Tanaka, Yuichiro; Dahiya, Rajvir			Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer	PLOS ONE			English	Article							CARCINOMA; PROTEIN; MYOFIBROBLASTS; PROGRESSION; MICRORNAS; GENISTEIN; PATHWAY; KINASE; BREAST; CELLS	Background: miR-23b is located on chromosome number 9 and plays different roles in different organs especially with regards to cancer development. However, the functional significance of miR-23b-3p in renal cell carcinoma (RCC) has not been reported. Methods and Results: We measured miR-23b-3p levels in 29 pairs of renal cell carcinoma and their normal matched tissues using real-time PCR. The expression level of miR-23b-3p was correlated with the 5 year survival rate of renal cancer patients. In 15 cases (52%), miR-23b-3p expression was found to be high. All patients with moderate to low miR-23b-3p expression survived 5 years, while those with high miR-23b-3p expression, only 50% survived. After knocking down miRNA-23b-3p expression in RCC cell lines, there was an induction of apoptosis and reduced invasive capabilities. MiR-23b-3p was shown to directly target PTEN gene through 3'UTR reporter assays. Inhibition of miR-23b-3p induces PTEN gene expression with a concomitant reduction in PI3-kinase, total Akt and IL-32. Immunohistochemistry showed the lack of PTEN protein expression in cancerous regions of tissue samples where the expression of miR-23b-3p was high. We studied the in vitro effects of the dietary chemo preventive agent genistein on miR-23b-3p expression and found that it inhibited expression of miR-23b-3p in RCC cell lines. Conclusions: The current study shows that miR-23b-3p is an oncogenic miRNA and inhibits PTEN tumor suppressor gene in RCC. Therefore, inhibition of miR-23b-3p may be a useful therapeutic target for the treatment of renal cell carcinoma.	[Dahiya, Rajvir] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Dahiya, R (corresponding author), San Francisco VA Med Ctr, Dept Urol, San Francisco, CA USA.	rdahiya@urology.ucsf.edu			VA Merit Review; VA Program Project; NIH [RO1CA130860]; NATIONAL CANCER INSTITUTE [R01CA130860] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); VA Program Project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the VA Merit Review, VA Program Project and NIH Grant RO1CA130860 (PI: R. Dahiya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bektic Jasmin, 2005, Clin Prostate Cancer, V4, P124, DOI 10.3816/CGC.2005.n.021; Bhatt K, 2011, AM J PHYSIOL-RENAL, V300, pF602, DOI 10.1152/ajprenal.00727.2010; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Hillman GG, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-4; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Ko NY, 2011, IMMUNOBIOLOGY, V216, P32, DOI 10.1016/j.imbio.2010.03.007; Lee S, 2011, IMMUNOLOGY, V132, P410, DOI 10.1111/j.1365-2567.2010.03377.x; Liu W, 2010, ONCOGENE, V29, P4914, DOI 10.1038/onc.2010.237; Magee PJ, 2004, BRIT J NUTR, V91, P513, DOI 10.1079/BJN20031075; Nishida A, 2008, AM J PHYSIOL-GASTR L, V294, pG831, DOI 10.1152/ajpgi.00535.2007; Nishida A, 2009, J BIOL CHEM, V284, P17868, DOI 10.1074/jbc.M900368200; Oudit GY, 2004, J MOL CELL CARDIOL, V37, P449, DOI 10.1016/j.yjmcc.2004.05.015; Paris O, 2012, ONCOGENE, V31, P4196, DOI 10.1038/onc.2011.583; Qian JQ, 2012, AM J PHYSIOL-HEART C, V302, pH1806, DOI 10.1152/ajpheart.00929.2011; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Seo EH, 2008, J MICROBIOL BIOTECHN, V18, P1606; Sorrentino C, 2009, AM J RESP CRIT CARE, V180, P769, DOI 10.1164/rccm.200903-0400OC; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Yagi Y, 2011, INT J MOL MED, V27, P263, DOI 10.3892/ijmm.2010.575; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031060; Zava DT, 1997, NUTR CANCER, V27, P31, DOI 10.1080/01635589709514498; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	29	96	99	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50203	10.1371/journal.pone.0050203	http://dx.doi.org/10.1371/journal.pone.0050203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189187	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800064
J	Kim, SY; Rhee, JG; Song, X; Prochownik, EV; Spitz, DR; Lee, YJ				Kim, Seog-Young; Rhee, Juong G.; Song, Xinxin; Prochownik, Edward V.; Spitz, Douglas R.; Lee, Yong J.			Breast Cancer Stem Cell-Like Cells Are More Sensitive to Ionizing Radiation than Non-Stem Cells: Role of ATM	PLOS ONE			English	Article							HISTONE H2AX; DNA-REPAIR; DAMAGE; RESISTANCE; RADIOSENSITIVITY; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; CLEAVAGE; HYPOXIA	There are contradictory observations about the different radiosensitivities of cancer stem cells and cancer non-stem cells. To resolve these contradictory observations, we studied radiosensitivities by employing breast cancer stem cell (CSC)-like MDA-MB231 and MDA-MB453 cells as well as their corresponding non-stem cells. CSC-like cells proliferate without differentiating and have characteristics of tumor-initiating cells [1]. These cells were exposed to gamma-rays (1.25-8.75 Gy) and survival curves were determined by colony formation. A final slope, D-0, of the survival curve for each cell line was determined to measure radiosensitivity. The D-0 of CSC-like and non-stem MDA-MB-453 cells were 1.16 Gy and 1.55 Gy, respectively. Similar results were observed in MDA-MB-231 cells (0.94 Gy vs. 1.56 Gy). After determination of radiosensitivity, we investigated intrinsic cellular determinants which influence radiosensitivity including cell cycle distribution, free-radical scavengers and DNA repair. We observed that even though cell cycle status and antioxidant content may contribute to differential radiosensitivity, differential DNA repair capacity may be a greater determinant of radiosensitivity. Unlike non-stem cells, CSC-like cells have little/no sublethal damage repair, a low intracellular level of ataxia telangiectasia mutated (ATM) and delay of gamma-H2AX foci removal (DNA strand break repair). These results suggest that low DNA repair capacity is responsible for the high radiosensitivity of these CSC-like cells.	[Kim, Seog-Young; Song, Xinxin; Lee, Yong J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Rhee, Juong G.] Univ Maryland, Sch Med, Dept Radiat Oncol, Radiat Oncol Res Lab, Baltimore, MD 21201 USA; [Prochownik, Edward V.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Prochownik, Edward V.] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; [Spitz, Douglas R.] Univ Iowa, Free Rad & Radiat Biol Program, Dept Radiat Oncol, Holden Comprehens Canc Ctr, Iowa City, IA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa	Lee, YJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	leeyj@upmc.edu		Song, Xinxin/0000-0003-3868-2644; Spitz, Douglas/0000-0002-1254-8765	United States National Institutes of Health (NIH) [R01 CA140554]; DOD [BC103217]; NIH [P30 CA086862, R01CA133114]; NATIONAL CANCER INSTITUTE [P30CA086862, R01CA116430, R01CA123484, R01CA140554, R01CA133114, R01CA100045, R01CA094858, R01CA121904] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grants: United States National Institutes of Health (NIH) R01 CA140554 (YJL), DOD Breast Cancer Program BC103217 (YJL & EVP), NIH P30 CA086862 (DRS) and NIH R01CA133114 (DRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Assar O, 2011, CANCER BIOL THER, V11, P1028, DOI 10.4161/cbt.11.12.15699; Al-Assar O, 2009, INT J RADIAT ONCOL, V75, P1216, DOI 10.1016/j.ijrobp.2009.07.001; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson ME, 1985, HDB METHODS OXYGEN R, P317; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Boivin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014558; Bravard A, 2002, CARCINOGENESIS, V23, P705, DOI 10.1093/carcin/23.5.705; Canman CE, 1998, ONCOGENE, V17, P3301, DOI 10.1038/sj.onc.1202577; Chen MS, 2007, J CELL SCI, V120, P468, DOI 10.1242/jcs.03348; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Chiou SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002090; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dittfeld C, 2009, RADIOTHER ONCOL, V92, P353, DOI 10.1016/j.radonc.2009.06.034; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Friesner JD, 2005, MOL BIOL CELL, V16, P2566, DOI 10.1091/mbc.E04-10-0890; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; GUICHARD M, 1983, RADIAT RES, V95, P602, DOI 10.2307/3576103; Iida H, 2012, INT J ONCOL, V40, P71, DOI 10.3892/ijo.2011.1207; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; Milas L, 2009, SEMIN RADIAT ONCOL, V19, P96, DOI 10.1016/j.semradonc.2008.11.004; MURTHY MSS, 1975, RADIAT RES, V64, P376, DOI 10.2307/3574273; Nguyen NP, 2010, CANCER TREAT REV, V36, P485, DOI 10.1016/j.ctrv.2010.02.016; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; RANTANEN V, 1994, J CANCER RES CLIN, V120, P712, DOI 10.1007/BF01194268; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Ropolo M, 2009, MOL CANCER RES, V7, P383, DOI 10.1158/1541-7786.MCR-08-0409; Sajithlal GB, 2010, STEM CELLS, V28, P1008, DOI 10.1002/stem.424; SINCLAIR WK, 1966, RADIAT RES, V29, P450, DOI 10.2307/3572025; vandenAardweg GJMJ, 1996, RADIAT RES, V145, P586, DOI 10.2307/3579277; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang SC, 2011, INT J RADIAT BIOL, V87, P432, DOI 10.3109/09553002.2011.538128; Wei QY, 1996, CANCER EPIDEM BIOMAR, V5, P199; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104	41	31	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50423	10.1371/journal.pone.0050423	http://dx.doi.org/10.1371/journal.pone.0050423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185620	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000233
J	Thibert, KA; Raymond, GV; Nascene, DR; Miller, WP; Tolar, J; Orchard, PJ; Lund, TC				Thibert, Kathryn A.; Raymond, Gerald V.; Nascene, David R.; Miller, Weston P.; Tolar, Jakub; Orchard, Paul J.; Lund, Troy C.			Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; INFLAMMATION; EXPRESSION	Background: X-linked adrenoleukodystrophy results from mutations in the ABCD1 gene disrupting the metabolism of very-long-chain fatty acids. The most serious form of ALD, cerebral adrenoleukodystrophy (cALD), causes neuroinflammation and demyelination. Neuroimaging in cALD shows inflammatory changes and indicates blood-brain-barrier (BBB) disruption. We hypothesize that disruption may occur through the degradation of the extracellular matrix defining the BBB by matrix metalloproteinases (MMPs). MMPs have not been evaluated in the setting of cALD. Methodology/Principal Findings: We used a multiplex assay to correlate the concentration of MMPs in cerebrospinal fluid and plasma to the severity of brain inflammation as determined by the ALD MRI (Loes) score and the neurologic function score. There were significant elevations of MMP2, MMP9, MMP10, TIMP1, and total protein in the CSF of boys with cALD compared to controls. Levels of MMP10, TIMP1, and total protein in CSF showed significant correlation [p<0.05 for each with pre-transplant MRI Loes Loes scores (R-2 = 0.34, 0.20, 0.55 respectively). Levels of TIMP1 and total protein in CSF significantly correlated with pre-transplant neurologic functional scores (R-2 = 0.22 and 0.48 respectively), and levels of MMP10 and total protein in CSF significantly correlated with one-year post-transplant functional scores (R-2 = 0.38 and 0.69). There was a significant elevation of MMP9 levels in plasma compared to control, but did not correlate with the MRI or neurologic function scores. Conclusions/Significance: MMPs were found to be elevated in the CSF of boys with cALD and may mechanistically contribute to the breakdown of the blood-brain-barrier. MMP concentrations directly correlate to radiographic and clinical neurologic severity. Interestingly, increased total protein levels showed superior correlation to MRI score and neurologic function score before and at one year after transplant.	[Thibert, Kathryn A.; Miller, Weston P.; Tolar, Jakub; Orchard, Paul J.; Lund, Troy C.] Univ Minnesota, Div Pediat Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Raymond, Gerald V.] Kennedy Krieger Inst, Dept Neurogenet, Baltimore, MD USA; [Nascene, David R.] Univ Minnesota, Dept Radiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Kennedy Krieger Institute; University of Minnesota System; University of Minnesota Twin Cities	Lund, TC (corresponding author), Univ Minnesota, Div Pediat Blood & Marrow Transplantat, Minneapolis, MN 55455 USA.	lundx072@umn.edu		Tolar, Jakub/0000-0002-0957-4380; Nascene, David/0000-0002-2468-7359	University Pediatrics Foundation, University of Minnesota	University Pediatrics Foundation, University of Minnesota	Funded by the University Pediatrics Foundation, University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bora A, 2012, J PROTEOME RES; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Castro MM, 2011, PHARMACOL RES, V64, P551, DOI 10.1016/j.phrs.2011.05.005; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Deon M, 2006, J NEUROL SCI, V247, P157, DOI 10.1016/j.jns.2006.04.004; Eichler FS, 2008, ANN NEUROL, V63, P729, DOI 10.1002/ana.21391; Ferrer I, 2010, BRAIN PATHOL, V20, P817, DOI 10.1111/j.1750-3639.2010.00390.x; Fuvesi J, 2012, INT J MOL SCI, V13, P7676, DOI 10.3390/ijms13067676; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kieseier BC, 1999, NEUROLOGY, V53, P20, DOI 10.1212/WNL.53.1.20; Leppert D, 2001, BRAIN RES REV, V36, P249, DOI 10.1016/S0165-0173(01)00101-1; Liu Y, 2011, ONCOL LETT, V2, P1171, DOI 10.3892/ol.2011.384; LOES DJ, 1994, AM J NEURORADIOL, V15, P1761; Lund TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032218; Maeda A, 1996, J NEUROPATH EXP NEUR, V55, P300, DOI 10.1097/00005072-199603000-00005; Mandal M, 2003, MOL CELL BIOCHEM, V252, P305, DOI 10.1023/A:1025526424637; Mandler RN, 2001, BRAIN, V124, P493, DOI 10.1093/brain/124.3.493; Mandler RN, 1997, J NEUROIMMUNOL, V84, P143; Miller WP, 2011, BLOOD; Orchard PJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-144; Paintlia AS, 2003, NEUROBIOL DIS, V14, P425, DOI 10.1016/j.nbd.2003.08.013; Peters C, 2004, BLOOD, V104, P881, DOI 10.1182/blood-2003-10-3402; PHILLIPS JP, 1994, PEDIATR NEUROL, V10, P289, DOI 10.1016/0887-8994(94)90124-4; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; ROSENBERG GA, 1995, J NEUROTRAUM, V12, P833, DOI 10.1089/neu.1995.12.833; Rosenberg GA, 1996, NEUROLOGY, V46, P1626, DOI 10.1212/WNL.46.6.1626; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Schletz A., 2011, HUM MOL GENET, P1; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Yong VW, 1998, TRENDS NEUROSCI, V21, P75	30	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50430	10.1371/journal.pone.0050430	http://dx.doi.org/10.1371/journal.pone.0050430			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185624	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000237
J	Zhang, N; Li, X; Wu, CW; Dong, Y; Cai, M; Mok, MTS; Wang, H; Chen, J; Ng, SSM; Chen, M; Sung, JJY; Yu, J				Zhang, N.; Li, X.; Wu, C. W.; Dong, Y.; Cai, M.; Mok, M. T. S.; Wang, H.; Chen, J.; Ng, S. S. M.; Chen, M.; Sung, J. J. Y.; Yu, J.			microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis	ONCOGENE			English	Article						miR-7; YY1; p53; Wnt; colorectal cancer	COLON-CANCER CELLS; NEGATIVE REGULATOR; CERVICAL CANCERS; P53; APOPTOSIS; EXPRESSION; GENE; ACTIVATION; YIN-YANG-1; PROGRESSION	Using microRNA (miRNA) expression array, we identified that miR-7 was deregulated in colorectal cancer (CRC). We studied the biological role and molecular target of miR-7 in CRC. miR-7 was downregulated in six out of seven colon cancer cell lines. Ectopic expression of miR-7 suppressed colon cancer cell proliferation (P<0.05), induced apoptosis (P<0.05) and caused cell-cycle arrest in G1 phase (P<0.05). The tumor suppressive function of miR-7 was further confirmed in nude mice (P<0.05). The 3'-untranslated region (3'UTR) of Yin Yang 1 (YY1) mRNA contains an evolutionarily conserved miR-7 binding site using in silico searches, luciferase reporter assay and western blot analysis confirmed that miR-7 directly bound to YY1 3'UTR to negatively regulate the protein expression of YY1 in colon cancer cell lines HCT116 and LOVO. Intriguingly, knock-down of YY1 in three colon cancer cell lines (HCT116, LOVO and DLD1) consistently suppressed cell proliferation (P<0.01) and induced apoptosis (P<0.01), indicating the opposite functions of miR-7 and YY1 in CRC. Consistent with these data, ectopic expression of YY1 promoted cell growth by increasing proliferation (P<0.01) and suppressing apoptosis (P<0.001). The tumorigenic ability of YY1 was further confirmed in vivo in xenograft-nude mouse model (P<0.01). In addition, pathway analyses revealed that the oncogenic effect by YY1 was associated with inhibiting p53 and modulating its downstream effectors p15, caspase cascades and C-Jun, and activating Wnt signaling pathway through activating beta-catenin, anti-apoptotic survivin and fibroblast growth factor 4. Furthermore, multivariate analysis revealed that patients with YY1 protein high expression had a significant decrease in overall survival, and Kaplan-Meier survival curves showed that these patients had significantly shorter survival than others (P<0.0001). In conclusion, MiR-7 is a novel miRNA with tumor suppressive function in colon cancer by targeting oncogenic YY1. YY1 promotes colon cancer growth through inhibiting p53 and promoting Wnt signaling pathways and serves as an independent prognostic biomarker for CRC patients.	[Zhang, N.; Li, X.; Wu, C. W.; Dong, Y.; Mok, M. T. S.; Sung, J. J. Y.; Yu, J.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Zhang, N.; Chen, J.; Chen, M.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou 510275, Guangdong, Peoples R China; [Dong, Y.; Ng, S. S. M.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Dept Surg, Shatin, Hong Kong, Peoples R China; [Cai, M.] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, H.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University; Chinese University of Hong Kong; Sun Yat Sen University; Chinese University of Hong Kong	Yu, J (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Inst Digest Dis, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	chenminhu@vip.163.com; junyu@cuhk.edu.hk	Yu, Jun/D-8569-2015; Sung, Joseph J. Y./R-3203-2018; Li, Xiao-xing/B-9114-2008; Mok, Myth/M-2958-2013; Ng, Simon S. M./M-1219-2018; Wang, Huating/C-6719-2014	Yu, Jun/0000-0001-5008-2153; Sung, Joseph J. Y./0000-0003-3125-5199; Li, Xiao-xing/0000-0001-8791-7505; Mok, Myth/0000-0003-3156-4944; Ng, Simon S. M./0000-0002-5389-9297; Wang, Huating/0000-0001-5474-2905	National High-tech R&D Program of China (863 program) [2012AA02A203, 2012AA02A506]; Innovation and Technology Fund Hong Kong [ITS/276/11]; CUHK [2010.1.085]; National Natural Science Foundation of China [81072048]	National High-tech R&D Program of China (863 program)(National High Technology Research and Development Program of China); Innovation and Technology Fund Hong Kong; CUHK(Chinese University of Hong Kong); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National High-tech R&D Program of China (863 program, 2012AA02A203; 863 program, 2012AA02A506), Innovation and Technology Fund Hong Kong (ITS/276/11), CUHK direct grant (2010.1.085) and National Natural Science Foundation of China (81072048).	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Baritaki S, 2007, INT J ONCOL, V31, P69; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Begon DY, 2005, J BIOL CHEM, V280, P24428, DOI 10.1074/jbc.M503790200; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Buckland RA, 1998, MECH DEVELOP, V71, P143, DOI 10.1016/S0925-4773(98)00008-2; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dale TC, 1998, BIOCHEM J, V329, P209; DONG XP, 1994, INT J CANCER, V58, P803, DOI 10.1002/ijc.2910580609; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gronroos E, 2004, P NATL ACAD SCI USA, V101, P12165, DOI 10.1073/pnas.0402283101; Jiang L, 2010, BIOCHEM J, V432, P199, DOI 10.1042/BJ20100859; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kimura Y, 1997, GENOMICS, V41, P477, DOI 10.1006/geno.1997.4680; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; MAY M, 1994, EMBO J, V13, P1460, DOI 10.1002/j.1460-2075.1994.tb06400.x; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nugent M, 2011, EJSO-EUR J SURG ONC, V37, P649, DOI 10.1016/j.ejso.2011.05.005; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Pritchard CC, 2011, GUT, V60, P116, DOI 10.1136/gut.2009.206250; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Seligson D, 2005, INT J ONCOL, V27, P131; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Tago K, 2000, GENE DEV, V14, P1741; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Wieler S, 2003, J BIOL CHEM, V278, P18914, DOI 10.1074/jbc.M211641200; Wu CW, 2012, GUT, V61, P739, DOI 10.1136/gut.2011.239236; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Yokoyama NN, 2010, NUCLEIC ACIDS RES, V38, P6375, DOI 10.1093/nar/gkq492	40	159	180	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2013	32	42					5078	5088		10.1038/onc.2012.526	http://dx.doi.org/10.1038/onc.2012.526			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	238IB	23208495				2022-12-25	WOS:000325937900009
J	Skora, L; Fonseca-Ornelas, L; Hofele, RV; Riedel, D; Giller, K; Watzlawik, J; Schulz-Schaeffer, WJ; Urlaub, H; Becker, S; Zweckstetter, M				Skora, Lukasz; Fonseca-Ornelas, Luis; Hofele, Romina V.; Riedel, Dietmar; Giller, Karin; Watzlawik, Jens; Schulz-Schaeffer, Walter J.; Urlaub, Henning; Becker, Stefan; Zweckstetter, Markus			Burial of the Polymorphic Residue 129 in Amyloid Fibrils of Prion Stop Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; HYDROGEN/DEUTERIUM EXCHANGE; MASS-SPECTROMETRY; MAMMALIAN PRIONS; Y145STOP VARIANT; BETA-SHEET; PROTEIN; CONFORMATION; SPECTROSCOPY; CONVERSION	Misfolding of the natively alpha-helical prion protein into a beta-sheet rich isoform is related to various human diseases such as Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker syndrome. In humans, the disease phenotype is modified by a methionine/valine polymorphism at codon 129 of the prion protein gene. Using a combination of hydrogen/deuterium exchange coupled to NMR spectroscopy, hydroxyl radical probing detected by mass spectrometry, and site-directed mutagenesis, we demonstrate that stop mutants of the human prion protein have a conserved amyloid core. The 129 residue is deeply buried in the amyloid core structure, and its mutation strongly impacts aggregation. Taken together the data support a critical role of the polymorphic residue 129 of the human prion protein in aggregation and disease.	[Skora, Lukasz; Fonseca-Ornelas, Luis; Hofele, Romina V.; Riedel, Dietmar; Giller, Karin; Urlaub, Henning; Becker, Stefan; Zweckstetter, Markus] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Watzlawik, Jens; Schulz-Schaeffer, Walter J.] Univ Med Ctr Gottingen, Prion & Dementia Res Unit, Dept Neuropathol, D-37075 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Dept Clin Chem, D-37075 Gottingen, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen; University of Gottingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Zweckstetter, M (corresponding author), German Ctr Neurodegenerat Dis DZNE, Fassberg 11, D-37077 Gottingen, Germany.	markus.zweckstetter@dzne.de	Fonseca-Ornelas, Luis/GPX-3085-2022	Fonseca-Ornelas, Luis/0000-0001-7810-5564; Zweckstetter, Markus/0000-0002-2536-6581; Watzlawik, Jens/0000-0003-0610-0267	VolkswagenStiftung [ZN1294]; Deutsche Forschungsgemeinschaft [ZW 71/2-2, ZW 71/3-2, SFB 860, INST 186/859-1]; European Community [238316]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission)	This work was supported by the VolkswagenStiftung (Grant ZN1294 to W. J. S.-S.), the Deutsche Forschungsgemeinschaft (Heisenberg scholarship to M. Z., ZW 71/2-2 and 3-2; Grant SFB 860 to M. Z., R. V. H., and H. U., INST 186/859-1), and the European Community's Seventh Framework Programme FP7/2009 under Grant Agreement 238316.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; Charvatova O, 2008, J AM SOC MASS SPECTR, V19, P1692, DOI 10.1016/j.jasms.2008.07.013; Cho MK, 2011, PROTEIN SCI, V20, P387, DOI 10.1002/pro.570; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Damo SM, 2010, J BIOL CHEM, V285, P32303, DOI 10.1074/jbc.M110.114504; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeMarco ML, 2004, P NATL ACAD SCI USA, V101, P2293, DOI 10.1073/pnas.0307178101; Ghetti B, 1996, P NATL ACAD SCI USA, V93, P744, DOI 10.1073/pnas.93.2.744; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Heinemann U, 2007, BRAIN, V130, P1350, DOI 10.1093/brain/awm063; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Helmus JJ, 2011, J AM CHEM SOC, V133, P13934, DOI 10.1021/ja206469q; Helmus JJ, 2010, J AM CHEM SOC, V132, P2393, DOI 10.1021/ja909827v; Holscher C, 1998, J VIROL, V72, P1153; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; Jayadev S, 2011, ANN NEUROL, V69, P712, DOI 10.1002/ana.22264; Jones EM, 2006, J BIOL CHEM, V281, P8190, DOI 10.1074/jbc.M513417200; Kundu B, 2003, P NATL ACAD SCI USA, V100, P12069, DOI 10.1073/pnas.2033281100; Kunes KC, 2008, PRION, V2, P81, DOI 10.4161/pri.2.2.7059; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Nazabal A, 2009, J MASS SPECTROM, V44, P965, DOI 10.1002/jms.1572; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Perrin F, 1934, J PHYS-PARIS, V5, P497, DOI 10.1051/jphysrad:01934005010049700; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; SchulzSchaeffer WJ, 1996, CLIN NEUROPATHOL, V15, P353; Sharp JS, 2003, ANAL BIOCHEM, V313, P216, DOI 10.1016/S0003-2697(02)00612-7; Skora L, 2012, PROTEIN SCI, V21, P1948, DOI 10.1002/pro.2170; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Tahiri-Alaoui A, 2004, J BIOL CHEM, V279, P31390, DOI 10.1074/jbc.M401754200; Tateishi J, 1996, CLIN NEUROPATHOL, V15, P358; Telling GC, 2011, TOP CURR CHEM, V305, P79, DOI 10.1007/128_2011_166; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Watzlawik J, 2006, J BIOL CHEM, V281, P30242, DOI 10.1074/jbc.M605141200; Wemheuer WM, 2009, AM J PATHOL, V175, P2566, DOI 10.2353/ajpath.2009.090623; Wille H, 2007, ARCH BIOCHEM BIOPHYS, V467, P239, DOI 10.1016/j.abb.2007.08.010; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Wuthrich K, 2001, ADV PROTEIN CHEM, V57, P55; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047	51	15	15	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2994	3002		10.1074/jbc.M112.423715	http://dx.doi.org/10.1074/jbc.M112.423715			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23209282	Green Published, hybrid			2022-12-25	WOS:000314397900010
J	Asad, N; Aw, WY; Timmons, L				Asad, Nadeem; Aw, Wen Yih; Timmons, Lisa			Natural and Unanticipated Modifiers of RNAi Activity in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; GENETIC INTERFERENCE; DISTINCT ROLES; DSRNA; RDE-4; REQUIREMENTS; PATHWAYS; DCR-1; AMPLIFICATION; TRANSPORTERS	Organisms used as model genomics systems are maintained as isogenic strains, yet evidence of sequence differences between independently maintained wild-type stocks has been substantiated by whole-genome resequencing data and strain-specific phenotypes. Sequence differences may arise from replication errors, transposon mobilization, meiotic gene conversion, or environmental or chemical assault on the genome. Low frequency alleles or mutations with modest effects on phenotypes can contribute to natural variation, and it has proven possible for such sequences to become fixed by adapted evolutionary enrichment and identified by resequencing. Our objective was to identify and analyze single locus genetic defects leading to RNAi resistance in isogenic strains of Caenorhabditis elegans. In so doing, we uncovered a mutation that arose de novo in an existing strain, which initially frustrated our phenotypic analysis. We also report experimental, environmental, and genetic conditions that can complicate phenotypic analysis of RNAi pathway defects. These observations highlight the potential for unanticipated mutations, coupled with genetic and environmental phenomena, to enhance or suppress the effects of known mutations and cause variation between wild-type strains.	[Asad, Nadeem; Aw, Wen Yih; Timmons, Lisa] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Aw, Wen Yih] Univ Kansas, Undergrad Honors Program, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Timmons, L (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	timmons@ku.edu		Aw, Wen Yih/0000-0002-1724-412X	National Science Foundation [0951296]; United States Educational Foundation in Pakistan/Fulbright Scholarship Program; KU Honors Program; University of Kansas General Research Fund allocation [2301303-906]; Div Of Molecular and Cellular Bioscience [0951296] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Educational Foundation in Pakistan/Fulbright Scholarship Program; KU Honors Program; University of Kansas General Research Fund allocation; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (www.nsf.gov), Grant No. 0951296 to LT; by the United States Educational Foundation in Pakistan/Fulbright Scholarship Program (http://www.iie.org/en/Fulbright/ and http://www.usefpakistan.org/) to NA; and the KU Honors Program (http://www.kuub.ku.edu/honors/) to WYA. Publication costs were supported by the University of Kansas General Research Fund allocation #2301303-906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; Blanchard D, 2011, RNA BIOL, V8, P458, DOI 10.4161/rna.8.3.14657; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gu SG, 2012, NAT GENET, V44, P157, DOI 10.1038/ng.1039; Habig JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004052; Han W, 2008, GENETICS, V178, P1875, DOI 10.1534/genetics.107.085472; Hull Dawn, 2004, Methods Mol Biol, V265, P23; Kelly WG, 1997, GENETICS, V146, P227; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Parrish S, 2001, RNA, V7, P1397; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Staleva LS, 2001, MUTAT RES-FUND MOL M, V474, P93, DOI 10.1016/S0027-5107(00)00165-2; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Sundaram P, 2008, GENETICS, V178, P801, DOI 10.1534/genetics.107.081588; Sundaram P, 2006, MOL BIOL CELL, V17, P3678, DOI 10.1091/mbc.E06-03-0192; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2003, MOL BIOL CELL, V14, P2972, DOI 10.1091/mbc.E03-01-0858; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Timmons Lisa, 2006, V351, P119; Zhang C, 2011, P NATL ACAD SCI USA, V108, P1201, DOI 10.1073/pnas.1018695108	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50191	10.1371/journal.pone.0050191	http://dx.doi.org/10.1371/journal.pone.0050191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209671	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700039
J	Cerone, L; Novak, B; Neufeld, Z				Cerone, Luca; Novak, Bela; Neufeld, Zoltan			Mathematical Model for Growth Regulation of Fission Yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							FAMILY KINASE POM1; CELL MORPHOGENESIS; FORMIN FOR3P; DYNAMICS; ESTABLISHMENT; POLARIZATION; MICROTUBULES; GRADIENTS; POLARITY; SHAPES	Regulation of polarised cell growth is essential for many cellular processes including spatial coordination of cell morphology changes during the division cycle. We present a mathematical model of the core mechanism responsible for the regulation of polarised growth dynamics during the fission yeast cell cycle. The model is based on the competition of growth zones localised at the cell tips for a common substrate distributed uniformly in the cytosol. We analyse the bifurcations in this model as the cell length increases, and show that the growth activation dynamics provides an explanation for the new-end take-off (NETO) as a saddle-node bifurcation at which the cell sharply switches from monopolar to bipolar growth. We study the parameter sensitivity of the bifurcation diagram and relate qualitative changes of the growth pattern, e. g. delayed or absent NETO, to previously observed mutant phenotypes. We investigate the effects of imperfect asymmetric cell division, and show that this leads to distinct growth patterns that provide experimentally testable predictions for validating the presented competitive growth zone activation model. Finally we discuss extension of the model for describing mutant cells with more than two growth zones.	[Novak, Bela] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Cerone, Luca] Univ Coll Dublin, Sch Math Sci, Dublin 2, Ireland; [Cerone, Luca] Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 2, Ireland; [Neufeld, Zoltan] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University of Oxford; University College Dublin; University College Dublin; University of Queensland	Novak, B (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	bela.novak@bioch.ox.ac.uk	Neufeld, Zoltan/C-3008-2011; Novak, Bela/D-5365-2009	Novak, Bela/0000-0002-6961-1366; Cerone, Luca/0000-0003-2902-9416; Neufeld, Zoltan/0000-0003-3236-9278	Irish Research Council for Science, Engineering and Technology	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	L.C. was supported by a postgraduate scholarship from the Irish Research Council for Science, Engineering and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 2005, J THEOR BIOL, V237, P210, DOI 10.1016/j.jtbi.2005.04.008; Castagnetti S, 2007, J CELL SCI, V120, P2205, DOI 10.1242/jcs.03464; Chang F, 2009, COLD SPRING HARBOR P, V1; Csikasz-Nagy A, 2008, YEAST, V25, P59, DOI 10.1002/yea.1571; Das M, 2012, SCIENCE, V337, P239, DOI 10.1126/science.1218377; Drake T, 2010, HFSP J, V4, P122, DOI 10.2976/1.3385659; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Ermentrout B, 2002, SIMULATING ANAL ANIM, V14; Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Hachet O, 2011, CELL, V145, P1116, DOI 10.1016/j.cell.2011.05.014; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Huisman SM, 2011, SEMINARS CELL DEV BI, V22; Kelly FD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027977; Liu P, 2007, J FUNCT ANAL, V251, P573, DOI 10.1016/j.jfa.2007.06.015; Martin SG, 2005, CELL CYCLE, V4, P1046, DOI 10.4161/cc.4.8.1853; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MITCHISON JM, 1985, J CELL SCI, V75, P357; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Orlando K, 2009, COLD SPRING HARBOR P, V1; Perez P, 2010, BIOCH J; Riveline D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006205; Rupes I, 1999, MOL BIOL CELL, V10, P1495, DOI 10.1091/mbc.10.5.1495; Sawin KE, 2004, J CELL SCI, V117, P689, DOI 10.1242/jcs.00925; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529	30	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49675	10.1371/journal.pone.0049675	http://dx.doi.org/10.1371/journal.pone.0049675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209589	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800015
J	Hecht, R; Li, YS; Sun, JH; Belouski, E; Hall, M; Hager, T; Yie, JM; Wang, W; Winters, D; Smith, S; Spahr, C; Tam, LT; Shen, ZN; Stanislaus, S; Chinookoswong, N; Lau, Y; Sickmier, A; Michaels, ML; Boone, T; Veniant, MM; Xu, J				Hecht, Randy; Li, Yue-Sheng; Sun, Jeonghoon; Belouski, Ed; Hall, Michael; Hager, Todd; Yie, Junming; Wang, Wei; Winters, Dwight; Smith, Stephen; Spahr, Chris; Tam, Lei-Ting; Shen, Zhongnan; Stanislaus, Shanaka; Chinookoswong, Narumol; Lau, Yvonne; Sickmier, Allen; Michaels, Mark Leo; Boone, Thomas; Veniant, Murielle M.; Xu, Jing			Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes	PLOS ONE			English	Article							GROWTH-FACTOR 21; INCREASES ENERGY-EXPENDITURE; INDUCED OBESE MICE; INSULIN SENSITIVITY; BETA-KLOTHO; ACTIVATION; MUTATIONS; FACTOR-21; RESISTANT; RECEPTOR	Fibroblast growth factor 21 (FGF21) is a promising drug candidate for the treatment of type 2 diabetes. However, the use of wild type native FGF21 is challenging due to several limitations. Among these are its short half-life, its susceptibility to in vivo proteolytic degradation and its propensity to in vitro aggregation. We here describe a rationale-based protein engineering approach to generate a potent long-acting FGF21 analog with improved resistance to proteolysis and aggregation. A recombinant Fc-FGF21 fusion protein was constructed by fusing the Fc domain of human IgG1 to the N-terminus of human mature FGF21 via a linker peptide. The Fc positioned at the N-terminus was determined to be superior to the C-terminus as the N-terminal Fc fusion retained the beta Klotho binding affinity and the in vitro and in vivo potency similar to native FGF21. Two specific point mutations were introduced into FGF21. The leucine to arginine substitution at position 98 (L98R) suppressed FGF21 aggregation at high concentrations and elevated temperatures. The proline to glycine replacement at position 171 (P171G) eliminated a site-specific proteolytic cleavage of FGF21 identified in mice and cynomolgus monkeys. The derived Fc-FGF21(RG) molecule demonstrated a significantly improved circulating half-life while maintaining the in vitro activity similar to that of wild type protein. The half-life of Fc-FGF21(RG) was 11 h in mice and 30 h in monkeys as compared to 1-2 h for native FGF21 or Fc-FGF21 wild type. A single administration of Fc-FGF21(RG) in diabetic mice resulted in a sustained reduction in blood glucose levels and body weight gains up to 5-7 days, whereas the efficacy of FGF21 or Fc-FGF21 lasted only for 1 day. In summary, we engineered a potent and efficacious long-acting FGF21 analog with a favorable pharmaceutical property for potential clinical development.	[Yie, Junming; Stanislaus, Shanaka; Chinookoswong, Narumol; Veniant, Murielle M.; Xu, Jing] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA; [Hecht, Randy; Li, Yue-Sheng; Sun, Jeonghoon; Belouski, Ed; Wang, Wei; Winters, Dwight; Smith, Stephen; Spahr, Chris; Tam, Lei-Ting; Shen, Zhongnan; Sickmier, Allen; Michaels, Mark Leo; Boone, Thomas] Amgen Inc, Dept Prot Sci, Thousand Oaks, CA 91320 USA; [Hall, Michael; Hager, Todd; Lau, Yvonne] Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA	Amgen; Amgen; Amgen	Xu, J (corresponding author), Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA.	jingx@amgen.com	LI, Yue/GRS-8071-2022	Sickmier, Allen/0000-0002-5595-9257	Amgen Inc.	Amgen Inc.(Amgen)	All authors are Amgen employees, and the studies were supported by Amgen Inc. All authors are Amgen stock holders. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Carter PJ, 2011, EXP CELL RES, V317, P1261, DOI 10.1016/j.yexcr.2011.02.013; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Garringer HJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE929, DOI 10.1152/ajpendo.90456.2008; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Hall MP, 2010, AAPS J, V12, P576, DOI 10.1208/s12248-010-9218-9; Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; Long YC, 2011, BBA-MOL BASIS DIS, V1812, P791, DOI 10.1016/j.bbadis.2011.04.002; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Sarruf DA, 2010, DIABETES, V59, P1817, DOI 10.2337/db09-1878; Shimada T, 2002, ENDOCRINOLOGY, V143, P3179, DOI 10.1210/en.143.8.3179; Stein S, 2009, DIABETES CARE, V32, P126, DOI 10.2337/dc08-1054; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Zhang Y, 2011, MOL CELL ENDOCRINOL, V342, P41, DOI 10.1016/j.mce.2011.05.003	26	108	127	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49345	10.1371/journal.pone.0049345	http://dx.doi.org/10.1371/journal.pone.0049345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209571	gold, Green Submitted, Green Published			2022-12-25	WOS:000311885800008
J	Parca, L; Gherardini, PF; Truglio, M; Mangone, I; Ferre, F; Helmer-Citterich, M; Ausiello, G				Parca, Luca; Gherardini, Pier Federico; Truglio, Mauro; Mangone, Iolanda; Ferre, Fabrizio; Helmer-Citterich, Manuela; Ausiello, Gabriele			Identification of Nucleotide-Binding Sites in Protein Structures: A Novel Approach Based on Nucleotide Modularity	PLOS ONE			English	Article							ATP-BINDING; DATA-BANK; P-LOOP; DATABASE; CLASSIFICATION; ADENINE; MOTIF; COMPLEXES; RECOGNIZE; COMMON	Nucleotides are involved in several cellular processes, ranging from the transmission of genetic information, to energy transfer and storage. Both sequence and structure based methods have been developed to predict the location of nucleotide-binding sites in proteins. Here we propose a novel methodology that leverages the observation that nucleotide-binding sites have a modular structure. Nucleotides are composed of identifiable fragments, i.e. the phosphate, the nucleobase and the carbohydrate moieties. These fragments are bound by specific structural motifs that recur in proteins of different fold. Moreover these motifs behave as modules and are found in different combinations across fold space. Our method predicts binding sites for each nucleotide fragment by comparing a query protein with a database of templates extracted from proteins of known structure. Whenever a similarity is found the fragment bound by the template is transferred on the query protein, thus identifying a putative binding site. Predictions falling inside the surface of the protein are discarded, and the remaining ones are scored using clustering and conservation. The method is able to rank as first a correct prediction in the 48%, 48% and 68% of the analyzed proteins for the nucleobase, carbohydrate and phosphate respectively, while considering the first five predictions the performances change to 71%, 65% and 86% respectively. Furthermore we attempted to reconstruct the full structure of the binding site, starting from the predicted positions of the fragments. We calculated that in the 59% of the analyzed proteins the method ranks as first a reconstructed binding site or a part of it. Finally we tested the reliability of our method in a real world case in which it has to predict nucleotide-binding sites in unbound proteins. We analyzed proteins whose structure has been solved with and without the nucleotide and observed only little variations in the method performance.	[Parca, Luca; Gherardini, Pier Federico; Truglio, Mauro; Mangone, Iolanda; Ferre, Fabrizio; Helmer-Citterich, Manuela; Ausiello, Gabriele] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	University of Rome Tor Vergata	Helmer-Citterich, M (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	citterich@uniroma2.it	Mangone, Iolanda/AAH-1987-2021; Truglio, Mauro/GWC-0198-2022; Parca, Luca/AAN-7665-2020	Mangone, Iolanda/0000-0002-6716-091X; Truglio, Mauro/0000-0003-3046-3922; Parca, Luca/0000-0002-0924-8518; FERRE', FABRIZIO/0000-0003-2768-5305; Helmer-Citterich, Manuela/0000-0001-9530-7504	FIRB 'Futuro in ricerca' Project [E81J10000030001]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	FIRB 'Futuro in ricerca' Project(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	AIRC to MHC. FIRB 'Futuro in ricerca' Project (number E81J10000030001) to GA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; Ausiello G, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S5; Ausiello G, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-182; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brakoulias A, 2004, PROTEINS, V56, P250, DOI 10.1002/prot.20123; Cappello V, 2002, PROTEINS, V47, P106, DOI 10.1002/prot.10070; Chauhan JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-301; Chauhan JS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-434; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Denessiouk KA, 2003, J MOL BIOL, V333, P1025, DOI 10.1016/j.jmb.2003.09.017; Dessailly BH, 2008, NUCLEIC ACIDS RES, V36, pD667, DOI 10.1093/nar/gkm839; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gherardini PF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011988; Gherardini PF, 2010, NUCLEIC ACIDS RES, V38, P3809, DOI 10.1093/nar/gkq090; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Ji HF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r176; Kasahara K, 2010, BIOINFORMATICS, V26, P1493, DOI 10.1093/bioinformatics/btq232; Kellenberger E, 2006, J CHEM INF MODEL, V46, P717, DOI 10.1021/ci050372x; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Mao LS, 2004, J MOL BIOL, V336, P787, DOI 10.1016/j.jmb.2003.12.056; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nobeli I, 2001, NUCLEIC ACIDS RES, V29, P4294, DOI 10.1093/nar/29.21.4294; Parca L, 2011, NUCLEIC ACIDS RES, V39, pW278, DOI 10.1093/nar/gkr389; Parca L, 2011, NUCLEIC ACIDS RES, V39, P1231, DOI 10.1093/nar/gkq987; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saito M, 2006, PROTEIN ENG DES SEL, V19, P67, DOI 10.1093/protein/gzj002; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Via A, 2000, J MOL BIOL, V303, P455, DOI 10.1006/jmbi.2000.4151; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50240	10.1371/journal.pone.0050240	http://dx.doi.org/10.1371/journal.pone.0050240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209685	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800056
J	Tatura, R; Zeschnigk, M; Adamzik, M; Probst-Kepper, M; Buer, J; Kehrmann, J				Tatura, Roman; Zeschnigk, Michael; Adamzik, Michael; Probst-Kepper, Michael; Buer, Jan; Kehrmann, Jan			Quantification of Regulatory T Cells in Septic Patients by Real-Time PCR-Based Methylation Assay and Flow Cytometry	PLOS ONE			English	Article							FOXP3 EXPRESSION; PERIPHERAL-BLOOD; SEPSIS; POPULATIONS; PERCENTAGES; MECHANISMS; PHENOTYPE; LOCUS; SHOCK	During sepsis, a relative increase of regulatory T (Treg) cells has been reported. Its persistence is associated with lymphocyte anergy, immunoparalysis and a poor prognosis. Currently, an exact quantification of human Treg cells based on protein expression of marker molecules is ambiguous, as these molecules are expressed also by activated non-regulatory T cells. Furthermore, no firm criteria for flow cytometer gate settings exist so far. Recently, a specific DNA methylation pattern within FOXP3-TSDR has been reported that allows distinguishing Treg and non-regulatory T cells, independent of their activation status. Using this epigenetic marker, we established a single-tube real-time PCR based methylation assay (QAMA) for relative quantification of Treg cells. Validation was performed on defined ratios of methylated and unmethylated target sequence and on mixtures of Treg and non-regulatory T cells. DNA-methylation was measured in CD4(+) T cells isolated from blood samples of 30 septic patients and 30 healthy subjects and compared with results of Treg cell quantification by flow cytometry based on CD4(+) CD25(hi)CD127(low) measurement. In septic patients both methods showed an increased ratio of Treg cells to all CD4(+) T cells. In healthy individuals, the results obtained by both methods were clearly positively correlated. However, the correlation between both methods in septic patients was only weak. We showed that quantification of Treg cells by QAMA detects CD4(+) T cells with unmethylated FOXP3-TSDR, hidden in the CD25(med/low) fraction of flow cytometry. Given that unmethylated FOXP3-TSDR is the most specific feature of Treg cells to date, our assay precisely quantifies Treg cells, as it additionally detects those committed Treg cells, hidden in the CD25(med/low) fraction of CD4(+) cells. Furthermore, QAMA is a reliable method, which is easier to standardize among laboratories and can thus improve reproducibility of Treg cell quantification.	[Tatura, Roman; Buer, Jan; Kehrmann, Jan] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Zeschnigk, Michael] Univ Hosp Essen, Inst Human Genet, Essen, Germany; [Adamzik, Michael] Univ Hosp Essen, Dept Anaesthesiol & Intens Care Med, Essen, Germany; [Probst-Kepper, Michael] Stadtisches Klinikum Braunschweig gGmbH, Inst Clin Transfus Med, Braunschweig, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Kehrmann, J (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany.	jan.kehrmann@uk-essen.de	Adamzik, Michael/HGE-9286-2022	Buer, Jan/0000-0002-7602-1698	Mercator Stiftung	Mercator Stiftung	This work was supported by grants from the Mercator Stiftung. None of the authors has any potential financial conflict of interest related to this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; [Anonymous], 2009, CHEST; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Brunkhorst FM, 2006, ANASTH INTENSIV NOTF, V41, P43, DOI 10.1055/s-2005-921227; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hein F, 2010, CRIT CARE, V14, DOI 10.1186/cc8876; Hiraki S, 2012, SURGERY, V151, P313, DOI 10.1016/j.surg.2011.07.019; Hwang KA, 2009, MECH AGEING DEV, V130, P509, DOI 10.1016/j.mad.2009.06.003; Lages CS, 2008, J IMMUNOL, V181, P1835, DOI 10.4049/jimmunol.181.3.1835; Liu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013267; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Monneret G, 2003, CRIT CARE MED, V31, P2068, DOI 10.1097/01.CCM.0000069345.78884.0F; Nascimento DC, 2010, CRIT CARE MED, V38, P1718, DOI 10.1097/CCM.0b013e3181e78ad0; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; Probst-Kepper M, 2009, J CELL MOL MED, V13, P3343, DOI 10.1111/j.1582-4934.2009.00782.x; Raynor J, 2012, CURR OPIN IMMUNOL, V24, P482, DOI 10.1016/j.coi.2012.04.005; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rosenkranz D, 2007, J NEUROIMMUNOL, V188, P117, DOI 10.1016/j.jneuroim.2007.05.011; Saito K, 2008, TOHOKU J EXP MED, V216, P61, DOI 10.1620/tjem.216.61; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Santner-Nanan B, 2008, INT IMMUNOL, V20, P375, DOI 10.1093/intimm/dxm151; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Sehouli J, 2011, EPIGENETICS-US, V6, P236, DOI 10.4161/epi.6.2.13755; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Venet F, 2004, CRIT CARE MED, V32, P2329, DOI 10.1097/01.CCM.0000145999.42971.4B; Venet F, 2008, J LEUKOCYTE BIOL, V83, P523, DOI 10.1189/jlb.0607371; Venet F, 2011, METHODS MOL BIOL, V761, P261, DOI 10.1007/978-1-61779-182-6_18; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Yende Sachin, 2007, Curr Infect Dis Rep, V9, P382, DOI 10.1007/s11908-007-0059-3; Zeschnigk M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh122; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929	38	20	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49962	10.1371/journal.pone.0049962	http://dx.doi.org/10.1371/journal.pone.0049962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209626	Green Submitted, gold, Green Published			2022-12-25	WOS:000311885800036
J	Fibriansah, G; Kovacs, AT; Pool, TJ; Boonstra, M; Kuipers, OP; Thunnissen, AMWH				Fibriansah, Guntur; Kovacs, Akos T.; Pool, Trijntje J.; Boonstra, Mirjam; Kuipers, Oscar P.; Thunnissen, Andy-Mark W. H.			Crystal Structures of Two Transcriptional Regulators from Bacillus cereus Define the Conserved Structural Features of a PadR Subfamily	PLOS ONE			English	Article							PHENOLIC-ACID DECARBOXYLASE; STREPTOMYCES-PEUCETIUS; MULTIDRUG-RESISTANCE; VIBRIO-CHOLERAE; STRESS-RESPONSE; ACTIVATOR APHA; GENE; EXPRESSION; REPRESSOR; LACTOCOCCUS	PadR-like transcriptional regulators form a structurally-related family of proteins that control the expression of genes associated with detoxification, virulence and multi-drug resistance in bacteria. Only a few members of this family have been studied by genetic, biochemical and biophysical methods, and their structure/function relationships are still largely undefined. Here, we report the crystal structures of two PadR-like proteins from Bacillus cereus, which we named bcPadR1 and bcPadR2 (products of gene loci BC4206 and BCE3449 in strains ATCC 14579 and ATCC 10987, respectively). BC4206, together with its neighboring gene BC4207, was previously shown to become significantly upregulated in presence of the bacteriocin AS-48. DNA mobility shift assays reveal that bcPadR1 binds to a 250 bp intergenic region containing the putative BC4206-BC4207 promoter sequence, while in-situ expression of bcPadR1 decreases bacteriocin tolerance, together suggesting a role for bcPadR1 as repressor of BC4206-BC4207 transcription. The function of bcPadR2 (48% identical in sequence to bcPadR1) is unknown, but the location of its gene just upstream from genes encoding a putative antibiotic ABC efflux pump, suggests a role in regulating antibiotic resistance. The bcPadR proteins are structurally similar to LmrR, a PadR-like transcription regulator in Lactococcus lactis that controls expression of a multidrug ABC transporter via a mechanism of multidrug binding and induction. Together these proteins define a subfamily of conserved, relatively small PadR proteins characterized by a single C-terminal helix for dimerization. Unlike LmrR, bcPadR1 and bcPadR2 lack a central pore for ligand binding, making it unclear whether the transcriptional regulatory roles of bcPadR1 and bcPadR2 involve direct ligand recognition and induction.	[Fibriansah, Guntur; Pool, Trijntje J.; Thunnissen, Andy-Mark W. H.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, Groningen, Netherlands; [Kovacs, Akos T.; Boonstra, Mirjam; Kuipers, Oscar P.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Genet, Groningen, Netherlands	University of Groningen; University of Groningen	Thunnissen, AMWH (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Biophys Chem Lab, Groningen, Netherlands.	a.m.w.h.thunnissen@rug.nl	Fibriansah, Guntur/P-1201-2015; Kovács, Ákos T/A-9433-2015; Thunnissen, Andy-Mark/A-1777-2010; Kuipers, Oscar/B-6752-2009	Fibriansah, Guntur/0000-0002-9990-3335; Kovács, Ákos T/0000-0002-4465-1636; Thunnissen, Andy-Mark/0000-0002-1915-9850; Kuipers, Oscar/0000-0001-5596-7735	University of Groningen; Ubbo Emmius Bursary (University of Groningen)	University of Groningen; Ubbo Emmius Bursary (University of Groningen)	Funding was provided by the University of Groningen. Work was supported in part by an Ubbo Emmius Bursary (University of Groningen) awarded to GF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agustiandari H, 2008, J BACTERIOL, V190, P759, DOI 10.1128/JB.01151-07; Agustiandari H, 2011, MICROBIOL-SGM, V157, P1519, DOI 10.1099/mic.0.048025-0; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; Arita K, 2007, J BIOL CHEM, V282, P1128, DOI 10.1074/jbc.M608148200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; De Silva RS, 2005, J BIOL CHEM, V280, P13779, DOI 10.1074/jbc.M413781200; Duggin IG, 1999, J MOL BIOL, V286, P1325, DOI 10.1006/jmbi.1999.2553; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Burgos MJG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-227; GUILFOILE PG, 1991, P NATL ACAD SCI USA, V88, P8553, DOI 10.1073/pnas.88.19.8553; Gury J, 2004, APPL ENVIRON MICROB, V70, P2146, DOI 10.1128/AEM.70.4.2146-2153.2004; Gury J, 2009, APPL ENVIRON MICROB, V75, P5273, DOI 10.1128/AEM.00774-09; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huillet E, 2006, FEMS MICROBIOL LETT, V254, P87, DOI 10.1111/j.1574-6968.2005.00014.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kaur P, 1997, J BACTERIOL, V179, P569, DOI 10.1128/jb.179.3.569-575.1997; Kleerebezem M, 1997, APPL ENVIRON MICROB, V63, P4581, DOI 10.1128/AEM.63.11.4581-4584.1997; Kovacikova G, 2003, J BACTERIOL, V185, P4825, DOI 10.1128/JB.185.16.4825-4836.2003; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KUIPERS OP, 1992, J BIOL CHEM, V267, P24340; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Licandro-Seraut H, 2008, J MOL MICROB BIOTECH, V14, P41, DOI 10.1159/000106081; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lubelski J, 2004, J BIOL CHEM, V279, P34449, DOI 10.1074/jbc.M404072200; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; Madoori PK, 2009, EMBO J, V28, P156, DOI 10.1038/emboj.2008.263; Maqueda M, 2004, CURR PROTEIN PEPT SC, V5, P399, DOI 10.2174/1389203043379567; Safo MK, 2005, J BACTERIOL, V187, P1833, DOI 10.1128/JB.187.5.1833-1844.2005; Susanna KA, 2004, J BACTERIOL, V186, P1120, DOI 10.1128/JB.186.4.1120-1128.2004; Takai N, 2006, J BIOL RHYTHM, V21, P235, DOI 10.1177/0748730406289400; Thi KCN, 2011, J BACTERIOL, V193, P4180, DOI 10.1128/JB.00385-11; Tran NP, 2008, J BACTERIOL, V190, P3213, DOI 10.1128/JB.01936-07; Wilce JA, 2001, NAT STRUCT BIOL, V8, P206, DOI 10.1038/84934; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	41	28	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e48015	10.1371/journal.pone.0048015	http://dx.doi.org/10.1371/journal.pone.0048015			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189126	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800007
J	Lin, WZ; Fang, JA; Xiao, X; Chou, KC				Lin, Wei-Zhong; Fang, Jian-An; Xiao, Xuan; Chou, Kuo-Chen			Predicting Secretory Proteins of Malaria Parasite by Incorporating Sequence Evolution Information into Pseudo Amino Acid Composition via Grey System Model	PLOS ONE			English	Article							DNA-BINDING PROTEINS; FUSING FUNCTIONAL DOMAIN; WEB SERVER; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; STRUCTURAL CLASS; GENE ONTOLOGY; IDENTIFICATION; DATABASE; CLASSIFIER	The malaria disease has become a cause of poverty and a major hindrance to economic development. The culprit of the disease is the parasite, which secretes an array of proteins within the host erythrocyte to facilitate its own survival. Accordingly, the secretory proteins of malaria parasite have become a logical target for drug design against malaria. Unfortunately, with the increasing resistance to the drugs thus developed, the situation has become more complicated. To cope with the drug resistance problem, one strategy is to timely identify the secreted proteins by malaria parasite, which can serve as potential drug targets. However, it is both expensive and time-consuming to identify the secretory proteins of malaria parasite by experiments alone. To expedite the process for developing effective drugs against malaria, a computational predictor called "iSMP-Grey" was developed that can be used to identify the secretory proteins of malaria parasite based on the protein sequence information alone. During the prediction process a protein sample was formulated with a 60D (dimensional) feature vector formed by incorporating the sequence evolution information into the general form of PseAAC (pseudo amino acid composition) via a grey system model, which is particularly useful for solving complicated problems that are lack of sufficient information or need to process uncertain information. It was observed by the jackknife test that iSMP-Grey achieved an overall success rate of 94.8%, remarkably higher than those by the existing predictors in this area. As a user-friendly web-server, iSMP-Grey is freely accessible to the public at http://www.jci-bioinfo.cn/iSMP-Grey. Moreover, for the convenience of most experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated mathematical equations involved in this paper.	[Lin, Wei-Zhong; Xiao, Xuan] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China; [Lin, Wei-Zhong; Fang, Jian-An] Donghua Univ, Informat Sci & Technol Sch, Shanghai, Peoples R China; [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Jingdezhen Ceramic Institute; Donghua University	Xiao, X (corresponding author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.	xxiao@gordonlifescience.org; kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60961003, 31260273]; Key Project of Chinese Ministry of Education [210116]; department of education of Jiang-Xi Province [GJJ11557, GJJ12490]; Jiangxi Provincial Foundation for Leaders of Disciplines in Science [20113BCB22008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China); department of education of Jiang-Xi Province; Jiangxi Provincial Foundation for Leaders of Disciplines in Science	This work was supported by the grants from the National Natural Science Foundation of China (No. 60961003, 31260273), the Key Project of Chinese Ministry of Education (No. 210116), and the department of education of Jiang-Xi Province (No. GJJ11557, GJJ12490), and the Jiangxi Provincial Foundation for Leaders of Disciplines in Science (No. 20113BCB22008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Birkholtz LM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-197; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chang DTH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S12; Chen C, 2012, PROTEIN PEPTIDE LETT, V19, P422, DOI 10.2174/092986612799789332; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, FEBS LETT, V363, P123, DOI 10.1016/0014-5793(95)00240-A; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2001, PROTEIN ENG, V14, P75, DOI 10.1093/protein/14.2.75; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Deng Julong, 1989, Journal of Grey Systems, V1, P1; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Guo JX, 2011, J COMPUT CHEM, V32, P1612, DOI 10.1002/jcc.21740; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayakawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007412; Hayat M, 2012, PROTEIN PEPTIDE LETT, V19, P411, DOI 10.2174/092986612799789387; Hayat M, 2012, J THEOR BIOL, V292, P93, DOI 10.1016/j.jtbi.2011.09.026; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Khosravian M, 2012, PROTEIN PEPT LETT; Kumar KK, 2009, J BIOMOL STRUCT DYN, V26, P679, DOI 10.1080/07391102.2009.10507281; Kumar M, 2011, J MOL RECOGNIT, V24, P303, DOI 10.1002/jmr.1061; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Mei SY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S17; Mohabatkar H, 2012, MED CHEM; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; Mundra P, 2007, PATTERN RECOGN LETT, V28, P1610, DOI 10.1016/j.patrec.2007.04.001; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; Nguyen MN, 2006, PROTEINS, V63, P542, DOI 10.1002/prot.20883; Oyelade J, 2011, INFECT GENET EVOL, V11, P755, DOI 10.1016/j.meegid.2010.11.006; RAMANA J, 2010, PLOS ONE, V5; Saffari B, 2008, PROTEIN PEPTIDE LETT, V15, P280; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Shen HB, 2009, J PROTEOME RES, V8, P1577, DOI 10.1021/pr800957q; Shen HB, 2009, J THEOR BIOL, V256, P441, DOI 10.1016/j.jtbi.2008.10.007; Shi SP, 2012, MOL BIOSYST, DOI [10.1039/c1032mb25280e, DOI 10.1039/C1032MB25280E]; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tedder PMR, 2010, BIOINFORMATICS, V26, P2431, DOI 10.1093/bioinformatics/btq450; Tonkin CJ, 2008, TRAFFIC, V9, P166, DOI 10.1111/j.1600-0854.2007.00660.x; Verma R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-201; Wang L, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-220, 10.1186/1471-2164-10-S1-S1]; Wu ZC, 2012, PROTEIN PEPTIDE LETT, V19, P4, DOI 10.2174/092986612798472839; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2008, J THEOR BIOL, V254, P691, DOI 10.1016/j.jtbi.2008.06.016; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026; Zhang VM, 2012, CURR TOP MED CHEM, V12, P456; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616; Zuo YC, 2010, AMINO ACIDS, V38, P859, DOI 10.1007/s00726-009-0292-1	68	60	60	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49040	10.1371/journal.pone.0049040	http://dx.doi.org/10.1371/journal.pone.0049040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189138	Green Submitted, gold, Green Published			2022-12-25	WOS:000311929800017
J	Gao, YZ; Li, H; Gong, SS				Gao, Yanzheng; Li, Hui; Gong, Shuaishuai			Ascorbic Acid Enhances the Accumulation of Polycyclic Aromatic Hydrocarbons (PAHs) in Roots of Tall Fescue (Festuca arundinacea Schreb.)	PLOS ONE			English	Article							MANGANESE PEROXIDASE; PLANT UPTAKE; PHANEROCHAETE-CHRYSOSPORIUM; MONOOXYGENASE INHIBITORS; POLYPHENOL OXIDASE; BENTAZON UPTAKE; METABOLISM; DEGRADATION; WATER; PHENANTHRENE	Plant contamination by polycyclic aromatic hydrocarbons (PAHs) is crucial to food safety and human health. Enzyme inhibitors are commonly utilized in agriculture to control plant metabolism of organic components. This study revealed that the enzyme inhibitor ascorbic acid (AA) significantly reduced the activities of peroxidase (POD) and polyphenol oxidase (PPO), thus enhancing the potential risks of PAH contamination in tall fescue (Festuca arundinacea Schreb.). POD and PPO enzymes in vitro effectively decomposed naphthalene (NAP), phenanthrene (PHE) and anthracene (ANT). The presence of AA reduced POD and PPO activities in plants, and thus was likely responsible for enhanced PAH accumulation in tall fescue. This conclusion is supported by the significantly enhanced uptake of PHE in plants in the presence of AA, and the positive correlation between enzyme inhibition efficiencies and the rates of metabolism of PHE in tall fescue roots. This study provides a new perspective, that the common application of enzyme inhibitors in agricultural production could increase the accumulation of organic contaminants in plants, hence enhancing risks to food safety and quality.	[Gao, Yanzheng; Gong, Shuaishuai] Nanjing Agr Univ, Coll Resource & Environm Sci, Inst Organ Contaminant Control & Soil Remediat, Nanjing, Jiangsu, Peoples R China; [Li, Hui] Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA	Nanjing Agricultural University; Michigan State University	Gao, YZ (corresponding author), Nanjing Agr Univ, Coll Resource & Environm Sci, Inst Organ Contaminant Control & Soil Remediat, Nanjing, Jiangsu, Peoples R China.	gaoyanzheng@njau.edu.cn	Gao, Yanzheng/G-6391-2010	Gao, Yanzheng/0000-0002-3814-3555	National Natural Science Foundation of China [41171380, 21077056]; Key Technology R&D Program of Jiangsu Province [BE2011780]; Fundamental Research Funds for the Central Universities of China [KYZ201109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technology R&D Program of Jiangsu Province; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (41171380, 21077056), the Key Technology R&D Program of Jiangsu Province (BE2011780), and the Fundamental Research Funds for the Central Universities of China (KYZ201109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baborova P, 2006, RES MICROBIOL, V157, P248, DOI 10.1016/j.resmic.2005.09.001; BOGAN BW, 1995, APPL ENVIRON MICROB, V61, P2631, DOI 10.1128/AEM.61.7.2631-2635.1995; Burken JG, 1997, ENVIRON SCI TECHNOL, V31, P1399, DOI 10.1021/es960629v; Burken JG, 2003, PHYTOREMEDIATION TRA, P987; Cajthaml T, 2002, J CHROMATOGR A, V974, P213, DOI 10.1016/S0021-9673(02)00904-4; Chiou CT, 2001, ENVIRON SCI TECHNOL, V35, P1437, DOI 10.1021/es0017561; Collins C, 2006, ENVIRON SCI TECHNOL, V40, P45, DOI 10.1021/es0508166; Debiane D, 2009, PHYTOCHEMISTRY, V70, P1421, DOI 10.1016/j.phytochem.2009.07.002; Earl N, 2005, P5079TR1 ENV AG; Gao YZ, 2008, PLANT SOIL, V311, P201, DOI 10.1007/s11104-008-9671-8; Gao YZ, 2006, BIOL FERT SOILS, V42, P387, DOI 10.1007/s00374-006-0081-x; Gao YZ, 2013, PLANT SOIL, V365, P171, DOI 10.1007/s11104-012-1386-1; Gao YZ, 2010, BIORESOURCE TECHNOL, V101, P6895, DOI 10.1016/j.biortech.2010.03.122; Gao YZ, 2009, ENVIRON SCI TECHNOL, V43, P6190, DOI 10.1021/es900662d; GRONWALD JW, 1991, PESTIC BIOCHEM PHYS, V40, P284, DOI 10.1016/0048-3575(91)90100-Z; Hannink NK, 2002, CRIT REV PLANT SCI, V21, P511, DOI 10.1080/0735-260291044340; HAO ZB, 2004, EXPT GUIDE PLANT PHY, P115; Harms HH, 1996, SCI TOTAL ENVIRON, V185, P83, DOI 10.1016/0048-9697(96)05044-9; Henriksen A, 1999, J BIOL CHEM, V274, P35005, DOI 10.1074/jbc.274.49.35005; Hofrichter M, 1998, APPL ENVIRON MICROB, V64, P399; John KS, 2011, J MOL CATAL B-ENZYM, V68, P30, DOI 10.1016/j.molcatb.2010.09.004; Kang FX, 2010, ENVIRON SCI TECHNOL, V44, P8891, DOI 10.1021/es103215b; Kang FX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-210; Karim Z, 2010, J MOL CATAL B-ENZYM, V66, P302, DOI 10.1016/j.molcatb.2010.06.007; Kipopoulou AM, 1999, ENVIRON POLLUT, V106, P369, DOI 10.1016/S0269-7491(99)00107-4; Li H, 2002, CHEMOSPHERE, V48, P335, DOI 10.1016/S0045-6535(02)00093-0; Li Y, 2001, CHEMOSPHERE, V45, P67, DOI 10.1016/S0045-6535(00)00605-6; Ling WT, 2012, J ENVIRON QUAL, V41, P807, DOI 10.2134/jeq2011.0461; [卢晓丹 LU Xiaodan], 2008, [农业环境科学学报, Journal of Agro-Environment Science], V27, P1969; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; MOEN MA, 1994, APPL ENVIRON MICROB, V60, P1956, DOI 10.1128/AEM.60.6.1956-1961.1994; Nepovim A, 2004, ENG LIFE SCI, V4, P46, DOI 10.1002/elsc.200420004; ROMANO ML, 1993, PESTIC BIOCHEM PHYS, V46, P181, DOI 10.1006/pest.1993.1049; Sarkar S, 1997, BBA-PROTEIN STRUCT M, V1339, P23, DOI 10.1016/S0167-4838(96)00201-4; SHERMAN TD, 1991, PHYTOCHEMISTRY, V30, P2499, DOI 10.1016/0031-9422(91)85089-I; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; STERLING TM, 1990, PESTIC BIOCHEM PHYS, V38, P66, DOI 10.1016/0048-3575(90)90150-Z; Sung KJ, 2001, J ENVIRON QUAL, V30, P2081, DOI 10.2134/jeq2001.2081; Tao S, 2004, SCI TOTAL ENVIRON, V320, P11, DOI 10.1016/S0048-9697(03)00453-4; Torne JM, 1994, PLANT SCI, V100, P15; Ugrekhelidze D, 1997, ECOTOX ENVIRON SAFE, V37, P24, DOI 10.1006/eesa.1996.1512; Wild E, 2006, ENVIRON SCI TECHNOL, V40, P907, DOI 10.1021/es0515046; Wild E, 2005, ENVIRON SCI TECHNOL, V39, P3695, DOI 10.1021/es048136a; Wild E, 2005, ENVIRON SCI TECHNOL, V39, P268, DOI 10.1021/es0494196; Zhang Yi, 2010, China Environmental Science, V30, P544	45	17	19	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50467	10.1371/journal.pone.0050467	http://dx.doi.org/10.1371/journal.pone.0050467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185628	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000240
J	Lu, Y; Lee, JS; Nemke, B; Graf, BK; Royalty, K; Illgen, R; Vanderby, R; Markel, MD; Murphy, WL				Lu, Yan; Lee, Jae Sung; Nemke, Brett; Graf, Ben K.; Royalty, Kevin; Illgen, Richard, III; Vanderby, Ray, Jr.; Markel, Mark D.; Murphy, William L.			Coating with a Modular Bone Morphogenetic Peptide Promotes Healing of a Bone-Implant Gap in an Ovine Model	PLOS ONE			English	Article							STEM-CELL DIFFERENTIATION; ENDOTHELIAL-GROWTH-FACTOR; TITANIUM-ALLOY IMPLANTS; IN-VIVO; PROTEIN-2 BMP-2; FUSION; HYDROXYAPATITE; SHEEP; OSTEOINTEGRATION; SUBSTITUTE	Despite the potential for growth factor delivery strategies to promote orthopedic implant healing, there is a need for growth factor delivery methods that are controllable and amenable to clinical translation. We have developed a modular bone growth factor, herein termed "modular bone morphogenetic peptide (mBMP)", which was designed to efficiently bind to the surface of orthopedic implants and also stimulate new bone formation. The purpose of this study was to coat a hydroxyapatite-titanium implant with mBMP and evaluate bone healing across a bone-implant gap in the sheep femoral condyle. The mBMP molecules efficiently bound to a hydroxyapatite-titanium implant and 64% of the initially bound mBMP molecules were released in a sustained manner over 28 days. The results demonstrated that the mBMP-coated implant group had significantly more mineralized bone filling in the implant-bone gap than the control group in C-arm computed tomography (DynaCT) scanning (25% more), histological (35% more) and microradiographic images (50% more). Push-out stiffness of the mBMP group was nearly 40% greater than that of control group whereas peak force did not show a significant difference. The results of this study demonstrated that mBMP coated on a hydroxyapatite-titanium implant stimulates new bone formation and may be useful to improve implant fixation in total joint arthroplasty applications.	[Lu, Yan; Nemke, Brett; Markel, Mark D.] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Lee, Jae Sung; Royalty, Kevin; Vanderby, Ray, Jr.; Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Murphy, William L.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; [Lu, Yan; Graf, Ben K.; Illgen, Richard, III; Markel, Mark D.; Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Lu, Y (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	luy@svm.vetmed.wisc.edu; wlmurphy@wisc.edu	Murphy, William L/I-4096-2014	Nemke, Brett/0000-0003-0329-1387	Wallace H. Coulter Foundation; Wisconsin Alumni Research Foundation	Wallace H. Coulter Foundation; Wisconsin Alumni Research Foundation	This study was funded by the Wallace H. Coulter Foundation and by the Wisconsin Alumni Research Foundation: "A Translational Research Partnership Grant from the Wallace H. Coulter Foundation" and "A Technology Accelerator Grant from the Wisconsin Alumni Research Foundation". There is no grant number from either. Smith & Nephew, Inc., provided implants for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; Campbell AW, 2003, BONE, V33, P540, DOI 10.1016/S8756-3282(03)00228-X; Carragee EJ, 2011, SPINE J, V11, P511, DOI 10.1016/j.spinee.2011.02.013; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Daugaard H, 2008, J BIOMED MATER RES A, V87A, P434, DOI 10.1002/jbm.a.31748; Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039; Elmengaard B, 2005, J BIOMED MATER RES A, V75A, P249, DOI 10.1002/jbm.a.30301; Elmengaard B, 2009, J ORTHOP RES, V27, P996, DOI 10.1002/jor.20850; Faria MLE, 2007, VET SURG, V36, P122, DOI 10.1111/j.1532-950X.2007.00242.x; Fini M, 2003, J BIOMED MATER RES A, V66A, P176, DOI 10.1002/jbm.a.10605; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Hollister SJ, 2011, TISSUE ENG PART B-RE, V17, P459, DOI [10.1089/ten.teb.2011.0251, 10.1089/ten.TEB.2011.0251]; Kanayama M, 2006, SPINE, V31, P1067, DOI 10.1097/01.brs.0000216444.01888.21; Kessler S, 2003, Z ORTHOP GRENZGEB, V141, P472, DOI 10.1055/s-2003-41569; Lamberg A, 2006, ACTA ORTHOP, V77, P799, DOI 10.1080/17453670610013024; Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003; Lee JS, 2009, ANGEW CHEM INT EDIT, V48, P6266, DOI 10.1002/anie.200901618; Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970; Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005; Liu Y, 2007, BIOMATERIALS, V28, P2677, DOI 10.1016/j.biomaterials.2007.02.003; Lu Y, 2009, ARTHROSCOPY, V25, P1427, DOI 10.1016/j.arthro.2009.06.008; Lu Y, 2009, VET SURG, V38, P467, DOI 10.1111/j.1532-950X.2009.00517.x; Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105; Rammelt S, 2007, J ORTHOP RES, V25, P1052, DOI 10.1002/jor.20403; Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011; Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8; Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095; Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014	32	27	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50378	10.1371/journal.pone.0050378	http://dx.doi.org/10.1371/journal.pone.0050378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185610	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000223
J	Tseng, TW; Wu, JT; Chen, YC; Urban, PL				Tseng, Te-Wei; Wu, June-Tai; Chen, Yu-Chie; Urban, Pawel L.			Isotope Label-Aided Mass Spectrometry Reveals the Influence of Environmental Factors on Metabolism in Single Eggs of Fruit Fly	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; CIRCADIAN-RHYTHMS; CLOCKS; SLEEP; CELLS; GENETICS; SEQUENCE; ALLELES; PERIOD; GENES	In order to investigate the influence of light/dark cycle on the biosynthesis of metabolites during oogenesis, here we demonstrate a simple experimental protocol which combines in-vivo isotopic labeling of primary metabolites with mass spectrometric analysis of single eggs of fruit fly (Drosophila melanogaster). First, fruit flies were adapted to light/dark cycle using artificial white light. Second, female flies were incubated with an isotopically labeled sugar (C-13(6)-glucose) for 12 h - either during the circadian day or the circadian night, at light or at dark. Third, eggs were obtained from the incubated female flies, and analyzed individually by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (MS): this yielded information about the extent of labeling with carbon-13. Since the incorporation of carbon-13 to uridine diphosphate glucose (UDP-glucose) in fruit fly eggs is very fast, the labeling of this metabolite was used as an indicator of the biosynthesis of metabolites flies/eggs during 12-h periods, which correspond to circadian day or circadian night. The results reveal that once the flies adapted to the 12-h-light/12-h-dark cycle, the incorporation of carbon-13 to UDP-glucose present in fruit fly eggs was not markedly altered by an acute perturbation to this cycle. This effect may be due to a relationship between biosynthesis of primary metabolites in developing eggs and an alteration to the intake of the labeled substrate - possibly related to the change of the feeding habit. Overall, the study shows the possibility of using MALDI-MS in conjunction with isotopic labeling of small metazoans to unravel the influence of environmental cues on primary metabolism.	[Tseng, Te-Wei; Chen, Yu-Chie; Urban, Pawel L.] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan; [Wu, June-Tai] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10764, Taiwan; [Wu, June-Tai] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Wu, June-Tai] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan; [Chen, Yu-Chie; Urban, Pawel L.] Natl Chiao Tung Univ, Inst Mol Sci, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University	Chen, YC (corresponding author), Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan.	yuchie@mail.nctu.edu.tw; plurban@nctu.edu.tw	Urban, Pawel L/F-8483-2010	Urban, Pawel L/0000-0003-3471-045X; WU, JUNE-TAI/0000-0002-4023-7315	National Science Council of Taiwan [100-2113-M-009-014-MY2]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Funding was provided by the National Science Council of Taiwan (http://web1.nsc.gov.tw/mp.aspx?mp = 7), Grant No. 100-2113-M-009-014-MY2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bae K, 2006, J BIOCHEM, V140, P609, DOI 10.1093/jb/mvj198; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Chatterjee A, 2010, FLY, V4, P283, DOI 10.4161/fly.4.4.13010; Edwards JL, 2005, ANAL CHEM, V77, P2201, DOI 10.1021/ac048323r; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Gouw JW, 2009, MOL CELL PROTEOMICS, V8, P1566, DOI 10.1074/mcp.M900114-MCP200; Grant SC, 2000, MAGNET RESON MED, V44, P19, DOI 10.1002/1522-2594(200007)44:1<19::AID-MRM4>3.0.CO;2-F; Hillenkamp F., 2014, MALDI MS PRACTICAL G; Hu JB, 2012, ANAL CHEM, V84, P5110, DOI 10.1021/ac300903x; KARAS M, 1985, ANAL CHEM, V57, P2935, DOI 10.1021/ac00291a042; Kiessling S, 2010, J CLIN INVEST, V120, P2600, DOI 10.1172/JCI41192; Merrow M, 2005, EMBO REP, V6, P930, DOI 10.1038/sj.embor.7400541; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; PARKER CG, 1995, EMBO J, V14, P1294, DOI 10.1002/j.1460-2075.1995.tb07115.x; Peschel N, 2011, FEBS LETT, V585, P1435, DOI 10.1016/j.febslet.2011.02.028; Prasad M, 2007, NAT PROTOC, V2, P2467, DOI 10.1038/nprot.2007.363; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Rogulja D, 2012, SCIENCE, V335, P1617, DOI 10.1126/science.1212476; Rothenfluh A, 2000, GENETICS, V156, P665; Rubakhin SS, 2011, NAT METHODS, V8, pS20, DOI [10.1038/NMETH.1549, 10.1038/nmeth.1549]; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Sezgin E, 2004, GENETICS, V168, P923, DOI 10.1534/genetics.104.027649; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Svatos A, 2011, ANAL CHEM, V83, P5037, DOI 10.1021/ac2003592; TSUBOI KK, 1969, J BIOL CHEM, V244, P1008; Urban PL, 2011, MOL BIOSYST, V7, P2837, DOI 10.1039/c1mb05248a; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006	32	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50258	10.1371/journal.pone.0050258	http://dx.doi.org/10.1371/journal.pone.0050258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185587	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000207
J	Chang, J; Chen, D; Ye, XP; Li, SH; Liang, W; Zhang, ZW; Li, M				Chang, Jiang; Chen, De; Ye, Xinping; Li, Shouhsien; Liang, Wei; Zhang, Zhengwang; Li, Ming			Coupling Genetic and Species Distribution Models to Examine the Response of the Hainan Partridge (Arborophila ardens) to Late Quaternary Climate	PLOS ONE			English	Article							SOUTHEAST-ASIA; ECOLOGICAL NICHES; SEA LEVELS; ELDS DEER; DIFFERENTIATION; PHYLOGEOGRAPHY; PATTERNS; CONSERVATION; BIOGEOGRAPHY; SPECIATION	Understanding the historical dynamics of animal species is critical for accurate prediction of their response to climate changes. During the late Quaternary period, Southeast Asia had a larger land area than today due to lower sea levels, and its terrestrial landscape was covered by extensive forests and savanna. To date, however, the distribution fluctuation of vegetation and its impacts on genetic structure and demographic history of local animals during the Last Glacial Maximum (LGM) are still disputed. In addition, the responses of animal species on Hainan Island, located in northern Southeast Asia, to climate changes during the LGM are poorly understood. Here, we combined phylogeographic analysis, paleoclimatic evidence, and species distribution models to examine the response of the flightless Hainan Partridge (Arborophila ardens) to climate change. We concluded that A. ardens survived through LGM climate changes, and its current distribution on Hainan Island was its in situ refuge. Range model results indicated that A. ardens once covered a much larger area than its current distribution. Demographic history described a relatively stable pattern during and following the LGM. In addition, weak population genetic structure suggests a role in promoting gene flow between populations with climate-induced elevation shifts. Human activities must be considered in conservation planning due to their impact on fragmented habitats. These first combined data for Hainan Partridge demonstrate the value of paired genetic and SDMs study. More related works that might deepen our understanding of the responses of the species in Southeast Asia to late Quaternary Climate are needed.	[Chang, Jiang; Zhang, Zhengwang] Beijing Normal Univ, Coll Life Sci, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China; [Chang, Jiang; Li, Ming] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Ye, Xinping] Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Li, Shouhsien] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Liang, Wei] Hainan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Trop Plant & Anim Ecol, Haikou, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Twente; National Taiwan Normal University; Hainan Normal University	Zhang, ZW (corresponding author), Beijing Normal Univ, Coll Life Sci, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China.	zzw@bnu.edu.cn; lim@ioz.ac.cn		Chang, Jiang/0000-0001-7064-9321; Zhang, Zhengwang/0000-0003-1063-7198	National Natural Science Foundation of China- Guangdong Joint Fund [U0833005]; China Postdoctoral Science Foundation [2012M510543]; National Natural Science Foundation of China [30360015, 30860044]; program for New Century Excellent Talents in University [NCET-10-0111]; Forestry Department of Hainan Province; Hainan Bawangling; Yinggeling Nature Reserves	National Natural Science Foundation of China- Guangdong Joint Fund; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Forestry Department of Hainan Province; Hainan Bawangling; Yinggeling Nature Reserves	This study was supported by the National Natural Science Foundation of China- Guangdong Joint Fund (U0833005), China Postdoctoral Science Foundation (2012M510543), National Natural Science Foundation of China (Nos. 30360015 and 30860044), and program for New Century Excellent Talents in University (NCET-10-0111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Biao Wang, Canchao Yang, Yan Cai and Yu Zhang for their help in the sampling and data collection, and thank the Forestry Department of Hainan Province, Hainan Bawangling and Yinggeling Nature Reserves for support and permission.	Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; BirdLife International, 2012, SPEC FACTSH ARB ARD; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Cannon CH, 2009, P NATL ACAD SCI USA, V106, P11188, DOI 10.1073/pnas.0809865106; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Chang J., 2010, THESIS BEIJING NORMA; Chang J, 2008, ZOOL SCI, V25, P30, DOI 10.2108/zsj.25.30; China State Forestry Administration, 2009, REP NAT WILDL SURV C; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fay JC, 2000, GENETICS, V155, P1405; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Gao Y, 1998, BIRD CONSERV INT, V9, P411, DOI DOI 10.1017/S0959270900002161; Gathorne-Hardy FJ, 2002, BIOL J LINN SOC, V75, P453, DOI 10.1046/j.1095-8312.2002.00031.x; Gorog AJ, 2004, BIOL J LINN SOC, V81, P91, DOI 10.1111/j.1095-8312.2004.00281.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanebuth TJJ, 2009, GLOBAL PLANET CHANGE, V66, P76, DOI 10.1016/j.gloplacha.2008.03.011; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hope G., 2005, PHYS GEOGRAPHY SE AS; Horton BP, 2005, HOLOCENE, V15, P1199, DOI 10.1191/0959683605hl891rp; Jakob SS, 2007, MOL ECOL, V16, P1713, DOI 10.1111/j.1365-294X.2007.03228.x; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; Kershaw A.P., 2007, TROPICAL RAINFOREST, P77, DOI DOI 10.1007/978-3-540-48842-2_4; Li T, 2011, GENETICA, V139, P511, DOI 10.1007/s10709-011-9573-1; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Y, 2010, MOL PHYLOGENET EVOL, V55, P409, DOI 10.1016/j.ympev.2009.12.026; Lu T, 1991, RARE ENDANGERED GAME; Ma HY, 2011, BIOCHEM SYST ECOL, V39, P434, DOI 10.1016/j.bse.2011.06.005; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Mindell P, 1997, AVIAN MOL EVOLUTION; Monda K, 2007, AM J PRIMATOL, V69, P1285, DOI 10.1002/ajp.20439; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pang JF, 2003, CONSERV GENET, V4, P109, DOI 10.1023/A:1021817925740; Paoli GD, 2008, OECOLOGIA, V155, P287, DOI 10.1007/s00442-007-0906-9; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2004, DIVERS DISTRIB, V10, P237, DOI 10.1111/j.1366-9516.2004.00097.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 4; Ruegg KC, 2006, J BIOGEOGR, V33, P1172, DOI 10.1111/j.1365-2699.2006.01517.x; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Su YJ, 2010, AUST J BOT, V58, P318, DOI 10.1071/BT09106; Sun XJ, 2000, PALAEOGEOGR PALAEOCL, V160, P301, DOI 10.1016/S0031-0182(00)00078-X; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang XM, 2009, PALAEOGEOGR PALAEOCL, V278, P88, DOI 10.1016/j.palaeo.2009.04.008; Wei L, 2006, J ORNITHOL, V147, P270; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wilting A, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-15; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3; Woodruff DS, 2009, J BIOGEOGR, V36, P803, DOI 10.1111/j.1365-2699.2008.02071.x; Wurster CM, 2010, P NATL ACAD SCI USA, V107, P15508, DOI 10.1073/pnas.1005507107; Xu LJ, 2010, J HERED, V101, P562, DOI 10.1093/jhered/esq039; [颜家安 Yan Jia＇an], 2006, [古地理学报, Journal of palaeogeography], V8, P103; Yang C, 2007, THESIS HAINAN NORMAL; Yang CC, 2011, ZOOL SCI, V28, P249, DOI 10.2108/zsj.28.249; Zhang Q, 2008, CONSERV GENET, V9, P507, DOI 10.1007/s10592-007-9359-2; Zhang YW, 2001, J MOL EVOL, V52, P516, DOI 10.1007/s002390010182; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x	71	14	17	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50286	10.1371/journal.pone.0050286	http://dx.doi.org/10.1371/journal.pone.0050286			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185599	Green Published, gold, Green Submitted			2022-12-25	WOS:000311333800077
J	Dai, BB; Gong, AH; Jing, ZT; Aldape, KD; Kang, SH; Sawaya, R; Huang, SY				Dai, Bingbing; Gong, Aihua; Jing, Zhitao; Aldape, Kenneth D.; Kang, Shin-Hyuk; Sawaya, Raymond; Huang, Suyun			Forkhead Box M1 Is Regulated by Heat Shock Factor 1 and Promotes Glioma Cells Survival under Heat Shock Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR HSF1; MITOTIC PROGRESSION; TARGETED DISRUPTION; OXIDATIVE STRESS; GENE-EXPRESSION; S-PHASE; FOXM1; CANCER; THERMOTOLERANCE; PHOSPHORYLATION	The forkhead box M1 (FoxM1) is a key transcription factor regulating multiple aspects of cell biology. Prior studies have shown that FoxM1 is overexpressed in a variety of human tumors, including brain tumor, and plays a critical role in cancer development and progression. In this study we found that FoxM1 was up-regulated by heat shock factor 1 (HSF1) under heat shock stress condition in multiple cell lines. Knockdown of HSF1 with HSF1 siRNA or inhibition of HSF1 with a HSF1 inhibitor abrogated heat shock-induced expression of FoxM1. Genetic deletion of HSF1 in mouse embryo fibroblast cells also abolished heat shock stress-induced FoxM1 expression. Moreover, we showed that HSF1 directly bound to FoxM1 promoter and increased FoxM1 promoter activity. Furthermore, we demonstrated that FoxM1 was required for the G(2)-M phase progression through regulating Cdc2, Cdc20, and Cdc25B under a mild heat shock stress but enhanced cell survival under lethal heat shock stress condition. Finally, in human glioblastoma specimens, FoxM1 overexpression correlated with elevated HSF1 expression. Our results indicate that FoxM1 is regulated by HSF1 and is critical for HSF1-mediated heat shock response. We demonstrated a novel mechanism of stress resistance controlled by HSF1 and a new HSF-FoxM1 connection that mediates cellular thermotolerance.	[Dai, Bingbing; Gong, Aihua; Jing, Zhitao; Kang, Shin-Hyuk; Sawaya, Raymond; Huang, Suyun] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Huang, Suyun] Univ Texas Grad Sch Biomed Sci Houston, Program Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dai, BB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Unit 0023, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bdai@mdanderson.org; suhuang@mdanderson.org		gang, sinhyeog/0000-0002-8912-7985	National Institutes of Health [R01CA157933, R21CA152623, P50CA127001, CA-16672 (NCI)]; Center for Targeted Therapy; Multidisciplinary Research Program at M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P50CA127001, R21CA152623, R01CA157933, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Targeted Therapy; Multidisciplinary Research Program at M.D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA157933, R21CA152623, P50CA127001, and CA-16672 (NCI). This work was also supported by research grants from the Center for Targeted Therapy and the Multidisciplinary Research Program at M.D. Anderson Cancer Center.	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Behren A, 2010, ONCOGENE, V29, P1519, DOI 10.1038/onc.2009.436; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Jones TJ, 2004, MOL ENDOCRINOL, V18, P509, DOI 10.1210/me.2003-0366; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Karapanagiotou EM, 2009, EXPERT OPIN INV DRUG, V18, P161, DOI [10.1517/13543780802715792, 10.1517/13543780802715792 ]; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; Komarova EA, 2003, J BIOL CHEM, V278, P15465, DOI 10.1074/jbc.C300011200; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Laoukili J, 2008, MOL CELL BIOL, V28, P3076, DOI 10.1128/MCB.01710-07; Lee YJ, 2008, CANCER RES, V68, P7550, DOI 10.1158/0008-5472.CAN-08-0129; Leung TWC, 2001, FEBS LETT, V507, P59, DOI 10.1016/S0014-5793(01)02915-5; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Li SKM, 2008, J BIOL CHEM, V283, P16545, DOI 10.1074/jbc.M709604200; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Luft JC, 2001, CELL STRESS CHAPERON, V6, P326, DOI 10.1379/1466-1268(2001)006<0326:HSFMTP>2.0.CO;2; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Neckers Len, 2002, Expert Opin Emerg Drugs, V7, P277, DOI 10.1517/14728214.7.2.277; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Pirkkala L, 2001, FASEB J, V15, P1118, DOI 10.1096/fj00-0294rev; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Sherman M, 2007, ANN NY ACAD SCI, V1113, P192, DOI 10.1196/annals.1391.030; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang JD, 2006, J BIOL CHEM, V281, P2451, DOI 10.1074/jbc.M505890200; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Ye HG, 1999, MOL CELL BIOL, V19, P8570; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968; Zhao YY, 2006, J CLIN INVEST, V116, P2333, DOI 10.1172/JCI27154	48	39	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1634	1642		10.1074/jbc.M112.379362	http://dx.doi.org/10.1074/jbc.M112.379362			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192351	hybrid, Green Published			2022-12-25	WOS:000313751400019
J	Herbst, DA; Boll, B; Zocher, G; Stehle, T; Heide, L				Herbst, Dominik A.; Boll, Bjoern; Zocher, Georg; Stehle, Thilo; Heide, Lutz			Structural Basis of the Interaction of MbtH-like Proteins, Putative Regulators of Nonribosomal Peptide Biosynthesis, with Adenylating Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE INHIBITOR STREPTOLYDIGIN; CRYSTAL-STRUCTURE; NRPS ADENYLATION; DOMAIN; ACTIVATION; INSIGHTS; SYNTHETASE; REFINEMENT; ALLOSTERY; CLUSTER	The biosynthesis of nonribosomally formed peptides (NRPs), which include important antibiotics such as vancomycin, requires the activation of amino acids through adenylate formation. The biosynthetic gene clusters of NRPs frequently contain genes for small, so-called MbtH-like proteins. Recently, it was discovered that these MbtH-like proteins are required for some of the adenylation reactions in NRP biosynthesis, but the mechanism of their interaction with the adenylating enzymes has remained unknown. In this study, we determined the structure of SlgN1, a 3-methylaspartate-adenylating enzyme involved in the biosynthesis of the hybrid polyketide/NRP antibiotic streptolydigin. SlgN1 contains an MbtH-like domain at its N terminus, and our analysis defines the parameters required for an interaction between MbtH-like domains and an adenylating enzyme. Highly conserved tryptophan residues of the MbtH-like domain critically contribute to this interaction. Trp-25 and Trp-35 form a cleft on the surface of the MbtH-like domain, which accommodates the alanine side chain of Ala-433 of the adenylating domain. Mutation of Ala-433 to glutamate abolished the activity of SlgN1. Mutation of Ser-23 of the MbtH-like domain to tyrosine resulted in strongly reduced activity. However, the activity of this S23Y mutant could be completely restored by addition of the intact MbtH-like protein CloY from another organism. This suggests that the interface found in the structure of SlgN1 is the genuine interface between MbtH-like proteins and adenylating enzymes.	[Herbst, Dominik A.; Zocher, Georg; Stehle, Thilo] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; [Boll, Bjoern; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Vanderbilt University	Stehle, T (corresponding author), Univ Tubingen, Interfak Inst Biochem, Hoppe Seyler Str 4, D-72076 Tubingen, Germany.	thilo.stehle@uni-tuebingen.de	Boll, Björn/AAJ-2892-2020	Heide, Lutz/0000-0001-7809-7453; Herbst, Dominik A./0000-0003-4671-5493	Deutsche Forschungsgemeinschaft [SFB 766]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 766 (to L. H. and T. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Buchko GW, 2010, TUBERCULOSIS, V90, P245, DOI 10.1016/j.tube.2010.04.002; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Drake EJ, 2007, J BIOL CHEM, V282, P20425, DOI 10.1074/jbc.M611833200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Gomez C, 2012, J ANTIBIOT, V65, P341, DOI 10.1038/ja.2012.37; Gomez C, 2011, J BACTERIOL, V193, P4214, DOI 10.1128/JB.05062-11; Goyal A, 2006, ACTA CRYSTALLOGR F, V62, P350, DOI 10.1107/S1744309106005938; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Horna DH, 2011, J BACTERIOL, V193, P2647, DOI 10.1128/JB.00108-11; Imker HJ, 2010, CHEM BIOL, V17, P1077, DOI 10.1016/j.chembiol.2010.08.007; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lautru S, 2007, MICROBIOL-SGM, V153, P1405, DOI 10.1099/mic.0.2006/003145-0; Marsh ENG, 2009, BIOCHEM SOC T, V37, P336, DOI 10.1042/BST0370336; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon MD, 2012, J BACTERIOL, V194, P2809, DOI 10.1128/JB.00088-12; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Olano C, 2009, CHEM BIOL, V16, P1031, DOI 10.1016/j.chembiol.2009.09.015; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Schrodinger L., 2020, PYMOL; Siddiqui N, 2012, J MOL BIOL, V415, P781, DOI 10.1016/j.jmb.2011.12.002; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stanger K, 2012, NAT CHEM BIOL, V8, P655, DOI [10.1038/nchembio.967, 10.1038/NCHEMBIO.967]; Stegmann E, 2006, FEMS MICROBIOL LETT, V262, P85, DOI 10.1111/j.1574-6968.2006.00368.x; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Tatham E, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-118; Ten L., 1973, ACTA CRYSTALLOGR A, V29, P183; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wolpert M, 2007, MICROBIOL-SGM, V153, P1413, DOI 10.1099/mic.0.2006/002998-0; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b	52	69	71	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1991	2003		10.1074/jbc.M112.420182	http://dx.doi.org/10.1074/jbc.M112.420182			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192349	Green Published, hybrid			2022-12-25	WOS:000313751400051
J	Huang, FY; Mei, WL; Li, YN; Tan, GH; Dai, HF; Guo, JL; Wang, H; Huang, YH; Zhao, HG; Zhou, SL; Lin, YY				Huang, Feng-ying; Mei, Wen-li; Li, Yue-nan; Tan, Guang-hong; Dai, Hao-fu; Guo, Jun-li; Wang, Hua; Huang, Yong-hao; Zhao, Huan-ge; Zhou, Song-lin; Lin, Ying-ying			Toxicarioside A Inhibits Tumor Growth and Angiogenesis: Involvement of TGF-beta/Endoglin Signaling	PLOS ONE			English	Article							HUMAN SOLID TUMORS; CARDIAC-GLYCOSIDES; ANTIARIS-TOXICARIA; ENDOGLIN CD105; CANCER-CELLS; ENDOTHELIAL-CELLS; RECEPTOR COMPLEX; PROSTATE-CANCER; UP-REGULATION; DART POISONS	Toxicarioside A is a cardenolide isolated mainly from plants and animals. Emerging evidence demonstrate that cardenolides not only have cardiac effects but also anticancer effects. In this study, we used in vivo models to investigate the antitumor activities of toxicarioside A and the potential mechanisms behind them. Murine colorectal carcinoma (CT26) and Lewis lung carcinoma (LL/2) models were established in syngeneic BALB/c and C57BL/6 mice, respectively. We found that the optimum effective dose of toxicarioside A treatment significantly suppressed tumor growth and angiogenesis in CT and LL/2 tumor models in vivo. Northern and Western blot analysis showed significant inhibition of endoglin expression in toxicarioside A-treated human umbilical vein endothelial cells (HUVECs) in vitro and tumor tissues in vivo. Toxicarioside A treatment significantly inhibited cell proliferation, migration and invasion, but did not cause significant cell apoptosis and affected other membrane protein (such as CD31 and MHC I) expression. In addition, TGF-beta expression was also significantly inhibited in CT26 and LL/2 tumor cells treated with toxicarioside A. Western blot analysis indicated that Smad1 and phosphorylated Smad1 but not Smad2/3 and phosphorylated Smad2/3 were attenuated in HUVECs treated with toxicarioside A. Smad1 and Smad2/3 signaling remained unchanged in CT26 and LL/2 tumor cells treated with toxicarioside A. Endoglin knockout by small interfering RNA against endoglin induced alternations in Smad1 and Smad2/3 signaling in HUVECs. Our results indicate that toxicarioside A suppresses tumor growth through inhibition of endoglin-related tumor angiogenesis, which involves in the endoglin/TGF-beta signal pathway.	[Huang, Feng-ying; Li, Yue-nan; Tan, Guang-hong; Guo, Jun-li; Wang, Hua; Huang, Yong-hao; Zhao, Huan-ge; Zhou, Song-lin; Lin, Ying-ying] Hainan Med Coll, Hainan Prov Key Lab Trop Med, Haikou, Peoples R China; [Mei, Wen-li; Dai, Hao-fu] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China	Hainan Medical University; Chinese Academy of Tropical Agricultural Sciences	Tan, GH (corresponding author), Hainan Med Coll, Hainan Prov Key Lab Trop Med, Haikou, Peoples R China.	tanhoho@163.com; hfdai@yahoo.cn	MQ, Li/HGU-6545-2022		National Basic Research Program of China [2010CB534909]; National Natural Science Foundation of China [30960411, 81160288]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was partly funded by National Basic Research Program of China (2010CB534909) and National Natural Science Foundation of China (30960411, 81160288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte RS, 2001, ARCH OPHTHALMOL-CHIC, V119, P1805, DOI 10.1001/archopht.119.12.1805; Barbara NP, 1999, J BIOL CHEM, V274, P584, DOI 10.1074/jbc.274.2.584; Blanco FJ, 2005, J CELL PHYSIOL, V204, P574, DOI 10.1002/jcp.20311; Bodey B, 1998, ANTICANCER RES, V18, P2701; Bodey B, 1998, ANTICANCER RES, V18, P3621; Burrows FJ, 1995, CLIN CANCER RES, V1, P1623; Dai HF, 2009, J ASIAN NAT PROD RES, V11, P832, DOI 10.1080/10286020903164285; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Dong WH, 2011, J ASIAN NAT PROD RES, V13, P561, DOI 10.1080/10286020.2011.573479; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Frese S, 2006, CANCER RES, V66, P5867, DOI 10.1158/0008-5472.CAN-05-3544; FUJIMOTO Y, 1983, J PHARMACOBIO-DYNAM, V6, P128; Gheorghiade M, 2006, CIRCULATION, V113, P2556, DOI 10.1161/CIRCULATIONAHA.105.560110; Guo JL, 2012, WORLD J GASTROENTERO, V18, P1602, DOI 10.3748/wjg.v18.i14.1602; Hamad E, 2007, AM J CARDIOVASC DRUG, V7, P235, DOI 10.2165/00129784-200707040-00002; Hao JG, 2006, DIGEST LIVER DIS, V38, P578, DOI 10.1016/j.dld.2006.04.014; Huang FY, 2012, EUR J CANCER, V48, P2260, DOI 10.1016/j.ejca.2011.12.018; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jiang MM, 2008, CHEM PHARM BULL, V56, P1005, DOI 10.1248/cpb.56.1005; KOPP B, 1992, J ETHNOPHARMACOL, V36, P57, DOI 10.1016/0378-8741(92)90061-U; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Li YN, 2012, ASIAN PAC J TROP MED, V5, P91, DOI 10.1016/S1995-7645(12)60002-9; Lin J, 2009, CURR CANCER DRUG TAR, V9, P881, DOI 10.2174/156800909789760249; McConkey DJ, 2000, CANCER RES, V60, P3807; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; O'Connor JC, 2007, MOL CANCER RES, V5, P585, DOI 10.1158/1541-7786.MCR-06-0408; OTTENSMEYER FP, 1972, J ULTRA MOL STRUCT R, V40, P546, DOI 10.1016/S0022-5320(72)80042-X; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Prassas I, 2011, MOL CANCER THER, V10, P2083, DOI 10.1158/1535-7163.MCT-11-0421; Santibanez JF, 2007, J CELL PHYSIOL, V210, P456, DOI 10.1002/jcp.20878; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Seon BK, 1997, CLIN CANCER RES, V3, P1031; Shi LS, 2010, J NAT PROD, V73, P1214, DOI 10.1021/np9005212; SHRESTHA T, 1992, J ETHNOPHARMACOL, V37, P129, DOI 10.1016/0378-8741(92)90071-X; Sreenivasan Y, 2003, BIOCHEM PHARMACOL, V66, P2223, DOI 10.1016/j.bcp.2003.07.010; Takahashi N, 2001, CANCER RES, V61, P7846; Tan GH, 2004, EUR J IMMUNOL, V34, P2012, DOI 10.1002/eji.200424933; WANG JM, 1993, INT J CANCER, V54, P363, DOI 10.1002/ijc.2910540303; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Zhang LY, 2011, BLOOD, V118, P88, DOI 10.1182/blood-2010-12-325019; Zhong NT, 2010, ASIAN PAC J TROP MED	43	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50351	10.1371/journal.pone.0050351	http://dx.doi.org/10.1371/journal.pone.0050351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209720	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700063
J	Silajdzic, E; Minthon, L; Bjorkqvist, M; Hansson, O				Silajdzic, Edina; Minthon, Lennart; Bjorkqvist, Maria; Hansson, Oskar			No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ACUTE-PHASE PROTEINS; CEREBROSPINAL-FLUID; IDENTIFIES VARIANTS; NEURONAL APOPTOSIS; VASCULAR DEMENTIA; WORK GROUP; BIOMARKERS; BRAIN; RISK	There is an urgent need for biomarkers to enable early diagnosis of Alzheimer's disease (AD). It has recently been shown that a variant within the clusterin gene is associated with increased risk of AD and plasma levels of clusterin have been found to be associated with the risk of AD. We, therefore, investigated the diagnostic value of clusterin by quantifying clusterin using an ELISA in plasma from 171 controls, 127 patients with AD, 82 patients with other dementias and 30 patients with depression. We observed similar plasma clusterin levels in controls, AD patients and patients with other dementias, suggesting that plasma clusterin levels have no diagnostic value for AD. There was a slight, but significant, increase in plasma clusterin in patients with depression compared to all other groups tested, which may warrant further investigation.	[Silajdzic, Edina; Bjorkqvist, Maria] Lund Univ, Brain Dis Biomarker Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden; [Minthon, Lennart; Hansson, Oskar] Lund Univ, Clin Memory Res Unit, Dept Clin Sci Malmo, Malmo, Sweden; [Minthon, Lennart; Hansson, Oskar] Skane Univ Hosp, Memory Clin, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital	Silajdzic, E (corresponding author), Lund Univ, Brain Dis Biomarker Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden.	Edina.Silajdzic@med.lu.se	Hansson, Oskar/A-7134-2013	Hansson, Oskar/0000-0001-8467-7286; Bjorkqvist, Maria/0000-0001-8550-0431	Swedish Research Council; Regional Agreement on Medical Training and Clinical Research between Skane County Council and Lund University; Torsten and Ragnar Soderberg Foundation; Bagadilico	Swedish Research Council(Swedish Research CouncilEuropean Commission); Regional Agreement on Medical Training and Clinical Research between Skane County Council and Lund University; Torsten and Ragnar Soderberg Foundation; Bagadilico	This work was supported by the Swedish Research Council; the Regional Agreement on Medical Training and Clinical Research between Skane County Council and Lund University and the Torsten and Ragnar Soderberg Foundation; and Bagadilico (http://www.med.lu.se/bagadilico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP, 1987, DIAGN STAT MAN MENT; Berk M, 1997, J PSYCHOSOM RES, V43, P529, DOI 10.1016/S0022-3999(97)00139-6; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Cubedo J, 2011, J PROTEOME RES, V10, P211, DOI 10.1021/pr100805h; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; Erkinjuntti T, 2000, J NEURAL TRANSM-SUPP, P23; Hampel H, 2011, PROG NEUROBIOL, V95, P579, DOI 10.1016/j.pneurobio.2010.11.005; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Ijsselstijn L, 2011, J PROTEOME RES, V10, P2006, DOI 10.1021/pr101221h; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Kim N, 2012, ALCOHOL CLIN EXP RES, V36, P72, DOI 10.1111/j.1530-0277.2011.01588.x; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Maes M, 1997, PSYCHIAT RES, V66, P1, DOI 10.1016/S0165-1781(96)02915-0; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; McDonald JF, 1997, BIOCHEMISTRY-US, V36, P7464, DOI 10.1021/bi962895r; McKeith IG, 1999, NEUROLOGY, V53, P902, DOI 10.1212/WNL.53.5.902; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Michel D, 1997, J CELL SCI, V110, P1635; Murphy B F, 1989, Int Immunol, V1, P551, DOI 10.1093/intimm/1.5.551; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; ODA T, 1994, BIOCHEM BIOPH RES CO, V204, P1131, DOI 10.1006/bbrc.1994.2580; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Schurmann B, 2011, J ALZHEIMERS DIS, V25, P421, DOI 10.3233/JAD-2011-110251; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Thambisetty M, 2012, NEUROIMAGE, V59, P212, DOI 10.1016/j.neuroimage.2011.07.056; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Xing YY, 2012, J ALZHEIMERS DIS, V29, P515, DOI 10.3233/JAD-2011-111844	34	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50237	10.1371/journal.pone.0050237	http://dx.doi.org/10.1371/journal.pone.0050237			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209684	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700046
J	Arshi, S; Bazargani, HS; Mohammadi, R				Arshi, Shahnam; Bazargani, Homayoun Sadeghi; Mohammadi, Reza			Burn Injury-Specific Home Safety Assessment: A Cross-Sectional Study in Iran	PLOS ONE			English	Article							TANDIR; STOVE; WOMEN	Background: The aim of this study was to assess the feasibility of injury specific home safety investigation and to examine the home safety status focused on burn related safety in a rural population in the North-West of Iran. Methods: A cross-sectional study was conducted on 265 rural households of rural Meshkinshahr, Iran. Cluster sampling method was used in 38 clusters with 7 households in each cluster. Clusters were selected on a probability proportional to size (PPS) basis using the available health census database called D-Tarh. Data were analyzed using the statistical software package STATA 8. Results: Possible risks were explored in fields of house structure; cooking and eating attitudes and behaviors; cooking appliances, specific appliances such as picnic gas burners, valors (traditional heaters), samovars (traditional water boilers), and air-heating appliances. Many safety concerns were explored needing to draw the attention of researchers and public health policy makers. Conclusion: Injury specific home safety surveys are useful and may provide useful information for safety promotion interventions.	[Bazargani, Homayoun Sadeghi] Tabriz Univ Med Sci, Neurosci Res Ctr, Dept Stat & Epidemiol, Tabriz, Iran; [Arshi, Shahnam] Shahid Beheshti Univ Med Sci, Dept Publ Hlth Sci, Tehran, Iran; [Mohammadi, Reza] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Tabriz University of Medical Science; Shahid Beheshti University Medical Sciences; Karolinska Institutet	Bazargani, HS (corresponding author), Tabriz Univ Med Sci, Neurosci Res Ctr, Dept Stat & Epidemiol, Tabriz, Iran.	Homayoun.sadeghi@gmail.com	arshi, shahnam/N-5514-2017; Sadeghi-Bazargani, Homayoun/M-5522-2017	arshi, shahnam/0000-0003-0103-7596; Mohammadi, Reza/0000-0003-2294-9316; Sadeghi-Bazargani, Homayoun/0000-0002-0396-8709				Ahuja RB, 2002, BURNS, V28, P555, DOI 10.1016/S0305-4179(02)00069-4; Akcay MN, 2008, BURNS, V34, P268, DOI 10.1016/j.burns.2007.03.007; Arshi S, 2006, BURNS, V32, P366, DOI 10.1016/j.burns.2005.10.026; Bekerecioglu M, 1998, BURNS, V24, P654, DOI 10.1016/S0305-4179(98)00086-2; Branche C., 2008, WORLD REPORT CHILD I; Deljavan R, 2012, INT J GEN MED, V5, P621, DOI 10.2147/IJGM.S34394; Desouches C, 2006, BURNS, V32, P1028, DOI 10.1016/j.burns.2006.03.019; Dixon JJ, 1997, BURNS, V23, P268, DOI 10.1016/S0305-4179(96)00127-1; EICHELBERGER MR, 1990, AM J DIS CHILD, V144, P714, DOI 10.1001/archpedi.1990.02150300112029; Eyal AS, 2007, BURNS, V33, P393, DOI 10.1016/j.burns.2006.07.011; Fardiazar Z, 2012, INT J GEN MED, V5, P547, DOI 10.2147/IJGM.S31429; Greenhalgh DG, 2006, J BURN CARE RES, V27, P476, DOI 10.1097/01.BCR.0000226021.78139.49; GUPTA RK, 1988, FORENSIC SCI INT, V37, P81, DOI 10.1016/0379-0738(88)90096-5; HUDSON DA, 1994, BURNS, V20, P251, DOI 10.1016/0305-4179(94)90193-7; Kendrick D, 2001, J EPIDEMIOL COMMUN H, V55, P845, DOI 10.1136/jech.55.11.845; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lowell G, 2008, PEDIATRICS, V122, P799, DOI 10.1542/peds.2007-2979; Mabrouk A, 2000, BURNS, V26, P474, DOI 10.1016/S0305-4179(99)00180-1; Mashreky SR, 2011, BURNS, V37, P770, DOI 10.1016/j.burns.2011.02.005; Mashreky SR, 2010, HLTH POLICY, P2; Mashreky SR, 2009, INJURY, P21; Mulat Tesfaye, 2006, Ethiop Med J, V44, P369; Peck MD, 2008, BURNS, V34, P303, DOI 10.1016/j.burns.2007.08.014; POWELL EC, 1993, PEDIATRICS, V91, P344; Sadeghi-Bazargani H, 2011, Ann Burns Fire Disasters, V24, P191; Sadeghi-Bazargani H, 2008, BURNS, V34, P1149, DOI 10.1016/j.burns.2008.01.023; Sadeghi-Bazargani H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-340; Sadeghi-Bazargani H, 2012, BURNS, V38, P319, DOI 10.1016/j.burns.2011.09.025; Sadeghi-Bazargani H, 2010, BURNS, V36, P933, DOI 10.1016/j.burns.2009.10.022; SALEH S, 1986, BURNS, V12, P241, DOI 10.1016/0305-4179(86)90123-3; SAWHNEY CP, 1989, BURNS, V15, P362, DOI 10.1016/0305-4179(89)90099-5; SAXBY PJ, 1985, BURNS, V11, P427, DOI 10.1016/0305-4179(85)90148-2; Stewart J, 2001, J R SOC PROMO HEALTH, V121, P16, DOI 10.1177/146642400112100106; Stone KE, 2007, PEDIATRICS, V120, pE346, DOI 10.1542/peds.2006-2169; Warda L, 1999, Inj Prev, V5, P145; Ytterstad B, 1998, Inj Prev, V4, P176	36	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49412	10.1371/journal.pone.0049412	http://dx.doi.org/10.1371/journal.pone.0049412			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209574	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800010
J	Bond-Lamberty, B; Bunn, AG; Thomson, AM				Bond-Lamberty, Ben; Bunn, Andrew G.; Thomson, Allison M.			Multi-Year Lags between Forest Browning and Soil Respiration at High Northern Latitudes	PLOS ONE			English	Article							TREE MORTALITY; VARIABLE IMPORTANCE; GLOBAL DATABASE; CARBON RELEASE; BLACK SPRUCE; PLANT-GROWTH; CO2 FLUX; CLIMATE; DROUGHT; FIRE	High-latitude northern ecosystems are experiencing rapid climate changes, and represent a large potential climate feedback because of their high soil carbon densities and shifting disturbance regimes. A significant carbon flow from these ecosystems is soil respiration (R-S, the flow of carbon dioxide, generated by plant roots and soil fauna, from the soil surface to atmosphere), and any change in the high-latitude carbon cycle might thus be reflected in R-S observed in the field. This study used two variants of a machine-learning algorithm and least squares regression to examine how remotely-sensed canopy greenness (NDVI), climate, and other variables are coupled to annual R-S based on 105 observations from 64 circumpolar sites in a global database. The addition of NDVI roughly doubled model performance, with the best-performing models explaining similar to 62% of observed RS variability. We show that early-summer NDVI from previous years is generally the best single predictor of RS, and is better than current-year temperature or moisture. This implies significant temporal lags between these variables, with multi-year carbon pools exerting large-scale effects. Areas of decreasing R-S are spatially correlated with browning boreal forests and warmer temperatures, particularly in western North America. We suggest that total circumpolar R-S may have slowed by similar to 5% over the last decade, depressed by forest stress and mortality, which in turn decrease R-S. Arctic tundra may exhibit a significantly different response, but few data are available with which to test this. Combining large-scale remote observations and small-scale field measurements, as done here, has the potential to allow inferences about the temporal and spatial complexity of the large-scale response of northern ecosystems to changing climate.	[Bond-Lamberty, Ben; Thomson, Allison M.] Univ Maryland, Joint Global Change Res Inst, Pacific NW Natl Lab, College Pk, MD 20742 USA; [Bunn, Andrew G.] Western Washington Univ, Huxley Coll, Dept Environm Sci, Bellingham, WA 98225 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; Western Washington University	Bond-Lamberty, B (corresponding author), Univ Maryland, Joint Global Change Res Inst, Pacific NW Natl Lab, College Pk, MD 20742 USA.	bondlamberty@pnnl.gov	Thomson, Allison/GRO-3207-2022; Bond-Lamberty, Benjamin/C-6058-2008; Thomson, Allison M/B-1254-2010	Bond-Lamberty, Benjamin/0000-0001-9525-4633; Thomson, Allison M/0000-0001-5326-1755; Bunn, Andrew/0000-0001-9027-2162	US Department of Energy Office of Science; NASA's Land Cover/Land Use Change program [08-LCLUC08-1-0043]	US Department of Energy Office of Science(United States Department of Energy (DOE)); NASA's Land Cover/Land Use Change program(National Aeronautics & Space Administration (NASA))	This research was supported by the US Department of Energy Office of Science, and the authors gratefully acknowledge support from NASA's Land Cover/Land Use Change program (award 08-LCLUC08-1-0043) to AGB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study would not have been possible without the many researchers who collected and published the data used here.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Amiro BD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001390; Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Beck PSA, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045501; Beck PSA, 2011, ECOL LETT, V14, P373, DOI 10.1111/j.1461-0248.2011.01598.x; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Berner LT, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001475; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown ME, 2004, EOS T, V85, P565, DOI DOI 10.1029/2004EO520003; Bunn AG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023646; Bunn AG, 2006, EARTH INTERACT, V10; Burton AJ, 1998, ECOL APPL, V8, P771, DOI 10.1890/1051-0761(1998)008[0771:DRRRIS]2.0.CO;2; Carbone MS, 2007, GLOBAL CHANGE BIOL, V13, P466, DOI 10.1111/j.1365-2486.2006.01300.x; DAGOSTIN.RB, 1970, BIOMETRIKA, V57, P679, DOI 10.1093/biomet/57.3.679; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Dulamsuren C, 2010, GLOBAL CHANGE BIOL, V16, P3024, DOI 10.1111/j.1365-2486.2009.02147.x; Field CB, 2007, ANNU REV ENV RESOUR, V32, P1, DOI 10.1146/annurev.energy.32.053006.141119; Frey BR, 2004, CAN J FOREST RES, V34, P1379, DOI 10.1139/X04-062; Galiano L, 2011, NEW PHYTOLOGIST; Goetz SJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001733; Goetz SJ, 2005, P NATL ACAD SCI USA, V102, P13521, DOI 10.1073/pnas.0506179102; Goulden ML, 2006, GLOBAL CHANGE BIOL, V12, P1; Hogg EH, 2005, CAN J FOREST RES, V35, P610, DOI 10.1139/X04-211; Hothorn T, 2006, BIOSTATISTICS, V7, P355, DOI 10.1093/biostatistics/kxj011; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Johnstone JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00102.1; Kasischke ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025677; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Li S, 2012, NATURAL SCI IN PRESS; Masson V, 2003, J CLIMATE, V16, P1261, DOI 10.1175/1520-0442-16.9.1261; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; O'Neill KP, 2002, CAN J FOREST RES, V32, P1525, DOI [10.1139/x02-077, 10.1139/X02-077]; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; R Core Team, 2021, R LANG ENV STAT COMP; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Rocha AV, 2006, GLOBAL CHANGE BIOL, V12, P1378, DOI 10.1111/j.1365-2486.2006.01179.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schaefer K, 2011, TELLUS B, V63, P165, DOI 10.1111/j.1600-0889.2011.00527.x; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Schwalm CR, 2010, GLOBAL CHANGE BIOL, V16, P657, DOI 10.1111/j.1365-2486.2009.01991.x; Silva LCR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011543; Solomon S., 2007, Climate change 2007: the Physical Science Basis. Contribution of Working Group I to the Fourth Assessment Report of the Intergovernmental Panel on Climate Change. Summary for Policymakers; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tucker CJ, 2005, INT J REMOTE SENS, V26, P4485, DOI 10.1080/01431160500168686; Turetsky MR, 2011, NAT GEOSCI, V4, P27, DOI 10.1038/NGEO1027; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Vargas R, 2011, NEW PHYTOLO IN PRESS; Vargas R, 2010, ECOLOGICAL APPL; Wang CK, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000861; WILLMOTT CJ, 1992, PROF GEOGR, V44, P84, DOI 10.1111/j.0033-0124.1992.00084.x; Wu X, 2012, PLOS ONE IN PRESS	59	18	19	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50441	10.1371/journal.pone.0050441	http://dx.doi.org/10.1371/journal.pone.0050441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189202	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800079
J	Liu, XQ; Zhang, ZJ; Ribelayga, CP				Liu, Xiaoqin; Zhang, Zhijing; Ribelayga, Christophe P.			Heterogeneous Expression of the Core Circadian Clock Proteins among Neuronal Cell Types in Mouse Retina	PLOS ONE			English	Article							MAMMALIAN RETINA; RAT RETINA; GENE-EXPRESSION; PHOTORECEPTOR DEGENERATION; SUPRACHIASMATIC NUCLEUS; LIGHT RESPONSIVENESS; GANGLION-CELLS; MELATONIN; DOPAMINE; RHYTHMS	Circadian rhythms in metabolism, physiology, and behavior originate from cell-autonomous circadian clocks located in many organs and structures throughout the body and that share a common molecular mechanism based on the clock genes and their protein products. In the mammalian neural retina, despite evidence supporting the presence of several circadian clocks regulating many facets of retinal physiology and function, the exact cellular location and genetic signature of the retinal clock cells remain largely unknown. Here we examined the expression of the core circadian clock proteins CLOCK, BMAL1, NPAS2, PERIOD 1(PER1), PERIOD 2 (PER2), and CRYPTOCHROME2 (CRY2) in identified neurons of the mouse retina during daily and circadian cycles. We found concurrent clock protein expression in most retinal neurons, including cone photoreceptors, dopaminergic amacrine cells, and melanopsin-expressing intrinsically photosensitive ganglion cells. Remarkably, diurnal and circadian rhythms of expression of all clock proteins were observed in the cones whereas only CRY2 expression was found to be rhythmic in the dopaminergic amacrine cells. Only a low level of expression of the clock proteins was detected in the rods at any time of the daily or circadian cycle. Our observations provide evidence that cones and not rods are cell-autonomous circadian clocks and reveal an important disparity in the expression of the core clock components among neuronal cell types. We propose that the overall temporal architecture of the mammalian retina does not result from the synchronous activity of pervasive identical clocks but rather reflects the cellular and regional heterogeneity in clock function within retinal tissue.	[Liu, Xiaoqin; Zhang, Zhijing; Ribelayga, Christophe P.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Ophthalmol & Visual Sci, Houston, TX 77225 USA; [Ribelayga, Christophe P.] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Ribelayga, CP (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Ophthalmol & Visual Sci, Houston, TX 77225 USA.	Christophe.P.Ribelayga@uth.tmc.edu			National Eye Institute [R01 EY018640, P30 EY010608]; Research to Prevent Blindness; Hermann Eye Fund; NATIONAL EYE INSTITUTE [P30EY010608, R01EY018640] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Hermann Eye Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was funded by the National Eye Institute (R01 EY018640 and P30 EY010608), www.nei.nih.gov/, a Challenge Grant from Research to Prevent Blindness, http://www.rpbusa.org/rpb/, and the Hermann Eye Fund, http://www.cizikeye.org/hermann_eye_fund.htm/. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Barlow R, 2001, Prog Brain Res, V131, P487; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Besharse JC, 2004, EUR J NEUROSCI, V20, P167, DOI 10.1111/j.1460-9568.2004.03479.x; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; CAHILL GM, 1991, J NEUROSCI, V11, P2959; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dorenbos R, 2007, VISUAL NEUROSCI, V24, P573, DOI 10.1017/S0952523807070538; Dowling J. E., 2012, RETINA APPROACHABLE; Dunlap J. C., 2003, CHRONOBIOLOGY BIOL T; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Green CB, 2004, J BIOL RHYTHM, V19, P91, DOI 10.1177/0748730404263002; Gustincich S, 2004, P NATL ACAD SCI USA, V101, P5069, DOI 10.1073/pnas.0400913101; Hankins MW, 2002, CURR BIOL, V12, P191, DOI 10.1016/S0960-9822(02)00659-0; Hannibal L, 2005, J MOL NEUROSCI, V27, P147, DOI 10.1385/JMN:27:02:147; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kamphuis W, 2005, BIOCHEM BIOPH RES CO, V330, P18, DOI 10.1016/j.bbrc.2005.02.118; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee HS, 2003, NAT NEUROSCI, V6, P111, DOI 10.1038/nn1006; LeSauter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035938; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Mangel SC, 2010, ENCY EYE, V1, P283; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Namihira M, 1999, NEUROSCI LETT, V271, P1, DOI 10.1016/S0304-3940(99)00407-3; Namihira M, 2001, NEUROREPORT, V12, P471, DOI 10.1097/00001756-200103050-00010; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Rodieck RW, 1998, 1 STEP SEEING; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038985; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; Sandu C, 2011, EUR J NEUROSCI, V34, P507, DOI 10.1111/j.1460-9568.2011.07772.x; Schmidt TM, 2011, J NEUROSCI, V31, P16094, DOI 10.1523/JNEUROSCI.4132-11.2011; Schneider K, 2010, J NEUROCHEM, V115, P585, DOI 10.1111/j.1471-4159.2010.06953.x; Sengupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024483; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Steenhard BM, 2000, J NEUROSCI, V20, P8572; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Torres-Farfan C, 2006, J PINEAL RES, V40, P64, DOI 10.1111/j.1600-079X.2005.00279.x; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2002, CELL TISSUE RES, V309, P119, DOI 10.1007/s00441-002-0578-z; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Tosini G, 2007, BRAIN RES, V1159, P134, DOI 10.1016/j.brainres.2007.05.023; Van Hook MJ, 2012, EUR J NEUROSCI, V35, P507, DOI 10.1111/j.1460-9568.2011.07975.x; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Weng SJ, 2009, J BIOL RHYTHM, V24, P391, DOI 10.1177/0748730409343767; Witkovsky P, 2003, J NEUROSCI, V23, P7670; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Zele AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017860; Zhuang MH, 2000, MOL BRAIN RES, V82, P52, DOI 10.1016/S0169-328X(00)00177-7	55	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50602	10.1371/journal.pone.0050602	http://dx.doi.org/10.1371/journal.pone.0050602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189207	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800084
J	Kim, S; Hill, A; Warman, ML; Smits, P				Kim, Susie; Hill, Adele; Warman, Matthew L.; Smits, Patrick			Golgi Disruption and Early Embryonic Lethality in Mice Lacking USO1	PLOS ONE			English	Article							RETROGRADE TRANSPORT; RIBBON FORMATION; GAMMA-TUBULIN; VESICLE; PROTEIN; GENE; P115; MEMBRANES; GMAP-210; GIANTIN	Golgins are a family of long rod-like proteins characterized by the presence of central coiled-coil domains. Members of the golgin family have important roles in membrane trafficking, where they function as tethering factors that capture transport vesicles and facilitate membrane fusion. Golgin family members also have essential roles in maintaining the organization of the Golgi apparatus. Knockdown of individual golgins in cultured cells resulted in the disruption of the Golgi structure and the dispersal of Golgi marker proteins throughout the cytoplasm. However, these cellular phenotypes have not always been recapitulated in vivo. For example, embryonic development proceeds much further than expected and Golgi disruption was observed in only a subset of cell types in mice lacking the ubiquitously expressed golgin GMAP-210. Cell-type specific functional compensation among golgins may explain the absence of global cell lethality when a ubiquitously expressed golgin is missing. In this study we show that functional compensation does not occur for the golgin USO1. Mice lacking this ubiquitously expressed protein exhibit disruption of Golgi structure and early embryonic lethality, indicating that USO1 is indispensable for early embryonic development.	[Kim, Susie; Hill, Adele; Warman, Matthew L.; Smits, Patrick] Boston Childrens Hosp, Dept Orthopaed Surg, Orthopaed Res Labs, Boston, MA USA; [Warman, Matthew L.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Smits, P (corresponding author), Boston Childrens Hosp, Dept Orthopaed Surg, Orthopaed Res Labs, Boston, MA USA.	patrick.smits@childrens.harvard.edu		Hill, Adele/0000-0003-2696-0731	Manton Center for Orphan Diseases; Boston Children's Hospital Faculty Career Development Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104937] Funding Source: NIH RePORTER	Manton Center for Orphan Diseases; Boston Children's Hospital Faculty Career Development Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by a grant from the Manton Center for Orphan Diseases (P. S.) and a Boston Children's Hospital Faculty Career Development Fellowship (P. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; De Matteis MA, 2011, NEW ENGL J MED, V365, P927, DOI 10.1056/NEJMra0910494; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Grabski R, 2012, J CELL SCI, V125, P1896, DOI 10.1242/jcs.090571; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Johannes L, 2011, TRAFFIC, V12, P956, DOI 10.1111/j.1600-0854.2011.01200.x; Katayama K, 2011, BONE, V49, P1027, DOI 10.1016/j.bone.2011.08.001; Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136; Lorente-Rodriguez A, 2011, COLD SPRING HARB PER, P3; Munro S, 2011, COLD SPRING HARB PER, V3; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Radulescu AE, 2011, J BIOL CHEM, V286, P21915, DOI 10.1074/jbc.M110.209460; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; Rios RM, 2004, CELL, V118, P323; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Smits P, 2010, NEW ENGL J MED, V362, P206, DOI 10.1056/NEJMoa0900158; Sohda M, 2005, BIOCHEM BIOPH RES CO, V338, P1268, DOI 10.1016/j.bbrc.2005.10.084; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038	25	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50530	10.1371/journal.pone.0050530	http://dx.doi.org/10.1371/journal.pone.0050530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185636	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000246
J	Lee, J; Gardiner, DM				Lee, Jangwoo; Gardiner, David M.			Regeneration of Limb Joints in the Axolotl (Ambystoma mexicanum)	PLOS ONE			English	Article							NEUROTROPHIC REGULATION; XENOPUS-LAEVIS; MODEL; DEDIFFERENTIATION; EXPRESSION; CARTILAGE; CELLS	In spite of numerous investigations of regenerating salamander limbs, little attention has been paid to the details of how joints are reformed. An understanding of the process and mechanisms of joint regeneration in this model system for tetrapod limb regeneration would provide insights into developing novel therapies for inducing joint regeneration in humans. To this end, we have used the axolotl (Mexican Salamander) model of limb regeneration to describe the morphology and the expression patterns of marker genes during joint regeneration in response to limb amputation. These data are consistent with the hypothesis that the mechanisms of joint formation whether it be development or regeneration are conserved. We also have determined that defects in the epiphyseal region of both forelimbs and hind limbs in the axolotl are regenerated only when the defect is small. As is the case with defects in the diaphysis, there is a critical size above which the endogenous regenerative response is not sufficient to regenerate the joint. This non-regenerative response in an animal that has the ability to regenerate perfectly provides the opportunity to screen for the signaling pathways to induce regeneration of articular cartilage and joints.	[Lee, Jangwoo; Gardiner, David M.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Lee, Jangwoo; Gardiner, David M.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Gardiner, DM (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	dmgardin@uci.edu			Defense Advanced Research Projects Agency (DARPA) from Tulane University [TUL 519-05/06]; US Army Multidisciplinary University Research Initiative (MURI) from Tulane University [TUL 589-09/10]; National Science Foundation through Ambystoma Genetic Stock Center at the University of Kentucky, Lexington	Defense Advanced Research Projects Agency (DARPA) from Tulane University; US Army Multidisciplinary University Research Initiative (MURI) from Tulane University; National Science Foundation through Ambystoma Genetic Stock Center at the University of Kentucky, Lexington	Research funded by a Defense Advanced Research Projects Agency (DARPA) subcontract from Tulane University (TUL 519-05/06),a US Army Multidisciplinary University Research Initiative (MURI) subcontract from Tulane University (TUL 589-09/10), and the National Science Foundation through its support of the Ambystoma Genetic Stock Center at the University of Kentucky, Lexington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant SV, 2002, INT J DEV BIOL, V46, P887; BRYANT SV, 1981, SCIENCE, V212, P993, DOI 10.1126/science.212.4498.993; Carlson MRJ, 1998, J EXP ZOOL, V282, P715, DOI 10.1002/(SICI)1097-010X(19981215)282:6<715::AID-JEZ7>3.0.CO;2-F; Cosden RS, 2011, OSTEOARTHR CARTILAGE, V19, P200, DOI 10.1016/j.joca.2010.11.005; Cosden-Decker RS, 2012, STRUCTURAL FUNCTIONA; Crotwell PL, 2007, DEV DYNAM, V236, P3111, DOI 10.1002/dvdy.21352; Endo T, 2004, DEV BIOL, V270, P135, DOI 10.1016/j.ydbio.2004.02.016; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; Goss RJ., 1969, PRINCIPLES REGENERAT; Hutchison C, 2007, BONE, V40, P45, DOI 10.1016/j.bone.2006.07.005; Khan IM, 2007, CURR TOP DEV BIOL, V79, P1, DOI 10.1016/S0070-2153(06)79001-9; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Lorenz H, 2006, PROG HISTOCHEM CYTO, V40, P135, DOI 10.1016/j.proghi.2006.02.003; MUNEOKA K, 1986, J EXP ZOOL, V240, P47, DOI 10.1002/jez.1402400107; MUNEOKA K, 1982, NATURE, V298, P369, DOI 10.1038/298369a0; Page RB, 2009, COLD SPRING HARB PRO; Satoh A, 2008, DEV BIOL, V319, P321, DOI 10.1016/j.ydbio.2008.04.030; Satoh A, 2005, DEV DYNAM, V233, P1444, DOI 10.1002/dvdy.20484; Satoh A, 2010, DEV BIOL, V337, P444, DOI 10.1016/j.ydbio.2009.11.023; SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299, DOI 10.1097/00003086-198604000-00036; Wallace, 1981, VERTEBRATE LIMB REGE	21	6	6	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50615	10.1371/journal.pone.0050615	http://dx.doi.org/10.1371/journal.pone.0050615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185640	Green Published, gold			2022-12-25	WOS:000311821000250
J	Monaghan-Benson, E; Burridge, K				Monaghan-Benson, E.; Burridge, K.			Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma	ONCOGENE			English	Article						B-RAF; melanoma; Rac; cadherin; Tiam1	CELL-CELL ADHESION; SMALL-MOLECULE INHIBITOR; MALIGNANT-MELANOMA; EPITHELIAL-CELLS; SMALL GTPASES; RATIONAL DESIGN; MDCK CELLS; RHO; MIGRATION; INVASION	The ability of cells to invade into the dermis is a critical event in the development of cutaneous melanoma and ultimately an indicator of poor prognosis. However, the molecular events surrounding the acquisition of this invasive phenotype remain incompletely understood. Mutations in B-RAF are frequent in melanoma and are known to regulate the invasive phenotype. In this study, we sought to determine the molecular mechanisms controlling melanoma invasion. We found that mutant B-RAF signaling regulates a cadherin switch. In melanoma cells expressing mutant B-RAF we observed high levels of N-cadherin and low levels of E-cadherin. Depletion of mutant B-RAF, by small interfering RNA, caused a decrease in the levels of N-cadherin and an increase in the levels of E-cadherin. Mechanistically, we found that this cadherin switch required the activity of Rac1 and its GEF, Tiam1, both of which show suppressed activity in the presence of mutant B-RAF. Consistent with the work of others, we found that depletion of mutant B-RAF decreased the invasive capacity of the melanoma cells. However, simultaneous depletion of B-RAF and Rac or Tiam1 resulted in invasive capacity similar to that of control cells. Taken together, our results suggest that mutant B-RAF signaling downregulates Tiam1/Rac activity resulting in an increase in N-cadherin levels and a decrease in E-cadherin levels and ultimately enhanced invasion.	[Monaghan-Benson, E.; Burridge, K.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Monaghan-Benson, E.; Burridge, K.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Monaghan-Benson, E (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, 12-026 Lineberger,CB 7295, Chapel Hill, NC 27599 USA.	ebenson@med.unc.edu			NIH [GM029860, HL080166]; American Cancer Society [PF-09_119-01-CSM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM029860 and HL080166 to KB. E M-B is supported by American Cancer Society PF-09_119-01-CSM.	Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; ALBINO AP, 1989, ONCOGENE, V4, P1363; Alsina J, 2003, CLIN CANCER RES, V9, P6419; Arozarena I, 2011, CANCER CELL, V19, P45, DOI 10.1016/j.ccr.2010.10.029; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Calipel A, 2003, J BIOL CHEM, V278, P42409, DOI 10.1074/jbc.M308709200; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dong JL, 2003, CANCER RES, V63, P3883; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Engers R, 2001, J BIOL CHEM, V276, P41889, DOI 10.1074/jbc.M105049200; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hsu MY, 2000, J CELL SCI, V113, P1535; Hsu MY, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 2, APRIL 1996, P188; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Klein RM, 2008, MOL BIOL CELL, V19, P498, DOI 10.1091/mbc.E07-09-0895; Klein RM, 2009, CANCER RES, V69, P2224, DOI 10.1158/0008-5472.CAN-08-3201; Kuroda S, 1997, BIOCHEM BIOPH RES CO, V240, P430, DOI 10.1006/bbrc.1997.7675; Li G, 2002, CRIT REV ORAL BIOL M, V13, P62, DOI 10.1177/154411130201300107; Li G, 2001, CANCER RES, V61, P3819; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Michiels Frits, 1999, P125; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Poser I, 2001, J BIOL CHEM, V276, P24661, DOI 10.1074/jbc.M011224200; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Sandig M, 1997, CELL MOTIL CYTOSKEL, V38, P351, DOI 10.1002/(SICI)1097-0169(1997)38:4<351::AID-CM5>3.3.CO;2-Z; Sauter ER, 1998, MOL CARCINOGEN, V23, P132, DOI 10.1002/(SICI)1098-2744(199811)23:3<132::AID-MC2>3.0.CO;2-1; Silye R, 1998, J PATHOL, V186, P350, DOI 10.1002/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K; Smalley KSM, 2003, INT J CANCER, V104, P527, DOI 10.1002/ijc.10978; Stam JC, 1997, J BIOL CHEM, V272, P28447, DOI 10.1074/jbc.272.45.28447; Stam JC, 1998, EMBO J, V17, P4066, DOI 10.1093/emboj/17.14.4066; Sumimoto H, 2004, ONCOGENE, V23, P6031, DOI 10.1038/sj.onc.1207812; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; TANG A, 1994, J CELL SCI, V107, P983; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Uhlenbrock K, 2004, J CELL SCI, V117, P4863, DOI 10.1242/jcs.01367; Vleminckx K, 1999, BIOESSAYS, V21, P211, DOI 10.1002/(SICI)1521-1878(199903)21:3<211::AID-BIES5>3.3.CO;2-G; Zhang JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022176; Zhong CL, 1997, MOL BIOL CELL, V8, P2329, DOI 10.1091/mbc.8.11.2329; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	47	18	19	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2013	32	40					4836	4844		10.1038/onc.2012.492	http://dx.doi.org/10.1038/onc.2012.492			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23208503	Green Accepted, Green Submitted			2022-12-25	WOS:000325274700012
J	Sun, S; Zhang, W; Mannervik, B; Andersson, DI				Sun, Song; Zhang, Wei; Mannervik, Bengt; Andersson, Dan I.			Evolution of Broad Spectrum beta-Lactam Resistance in an Engineered Metallo-beta-lactamase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STABILITY-FUNCTION TRADEOFFS; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; STRUCTURAL BASES; ENZYME; COMPLEX; GENES	The extensive use and misuse of antibiotics during the last seven decades has led to the evolution and global spread of a variety of resistance mechanisms in bacteria. Of high medical importance are beta-lactamases, a group of enzymes inactivating beta-lactam antibiotics. Metallo-beta-lactamases (MBLs) are particularly problematic because of their ability to act on virtually all classes of beta-lactam antibiotics. An engineered MBL (evMBL9) characterized by low level activity with several beta-lactam antibiotics was constructed and employed as a parental MBL in an experiment to examine how an enzyme can evolve toward increased activity with a variety of beta-lactam antibiotics. We designed and synthesized a mutant library in which the substrate activity profile was varied by randomizing six active site amino acid residues. The library was expressed in Salmonella typhimurium, clones with increased resistance against seven different beta-lactam antibiotics (penicillin G, ampicillin, cephalothin, cefaclor, cefuroxime, cefoperazone, and cefotaxime) were isolated, and the MBL variants were characterized. For the majority of the mutants, bacterial resistance was significantly increased despite marked reductions in both mRNA and protein levels relative to those of parental evMBL9, indicating that the catalytic activities of these mutant MBLs were highly increased. Multivariate analysis showed that the majority of the mutant enzymes were generalists, conferring increased resistance against most of the examined beta-lactams.	[Sun, Song; Andersson, Dan I.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Zhang, Wei; Mannervik, Bengt] Uppsala Univ, Dept Chem BMC, SE-75123 Uppsala, Sweden; [Mannervik, Bengt] Stockholm Univ, Dept Neurochem, SE-10961 Stockholm, Sweden	Uppsala University; Uppsala University; Stockholm University	Andersson, DI (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	Dan.Anderssson@imbim.uu.se		Andersson, Dan/0000-0001-6640-2174	Swedish Research Council; Vinnova; Swedish Foundation for Strategic Research; European Union [PAR 241476]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Vinnova(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Union(European Commission)	This work was supported by grants from the Swedish Research Council (to B. M.) and by the Swedish Research Council, Vinnova, Swedish Foundation for Strategic Research, and European Union Project PAR 241476 (to D. I. A.).	Alcolombri U, 2011, J MOL BIOL, V411, P837, DOI 10.1016/j.jmb.2011.06.037; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Cameron AD, 1999, STRUCTURE, V7, P1067, DOI 10.1016/S0969-2126(99)80174-9; Crameri A, 1998, NATURE, V391, P288, DOI 10.1038/34663; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Demain AL, 1999, ANTON LEEUW INT J G, V75, P5, DOI 10.1023/A:1001738823146; Elander RP, 2003, APPL MICROBIOL BIOT, V61, P385, DOI 10.1007/s00253-003-1274-y; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Helfand Marion S., 2003, Current Drug Targets - Infectious Disorders, V3, P9, DOI 10.2174/1568005033342181; Jochens H, 2010, CHEMBIOCHEM, V11, P1861, DOI 10.1002/cbic.201000284; Kurtovic S, 2009, BIOCHEMISTRY-US, V48, P9330, DOI 10.1021/bi901168q; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; MEDEIROS AA, 1984, BRIT MED BULL, V40, P18, DOI 10.1093/oxfordjournals.bmb.a071942; Park HS, 2006, SCIENCE, V311, P535, DOI 10.1126/science.1118953; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Peimbert M, 2003, PROTEIN ENG, V16, P27, DOI 10.1093/proeng/gzg008; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; Rice LB, 2006, AM J MED, V119, pS11, DOI 10.1016/j.amjmed.2006.03.012; Rice LB, 2012, MAYO CLIN PROC, V87, P198, DOI 10.1016/j.mayocp.2011.12.003; Sideraki V, 2001, P NATL ACAD SCI USA, V98, P283, DOI 10.1073/pnas.011454198; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Thomas VL, 2010, J MOL BIOL, V396, P47, DOI 10.1016/j.jmb.2009.11.005; Thomson JM, 2005, CURR OPIN MICROBIOL, V8, P518, DOI 10.1016/j.mib.2005.08.014; Tomatis PE, 2005, P NATL ACAD SCI USA, V102, P13761, DOI 10.1073/pnas.0503495102; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Vakulenko S, 2002, ANTIMICROB AGENTS CH, V46, P646, DOI 10.1128/AAC.46.3.646-653.2002; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Wang ZG, 1999, BIOCHEMISTRY-US, V38, P10013, DOI 10.1021/bi990356r; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; Zhang W, 2012, BIOCHEM J, V445, P39, DOI 10.1042/BJ20120136	40	11	11	0	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2314	2324		10.1074/jbc.M112.430199	http://dx.doi.org/10.1074/jbc.M112.430199			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209299	Green Published, hybrid			2022-12-25	WOS:000314211500021
J	Thakran, S; Sharma, P; Attia, RR; Hori, RT; Deng, X; Elam, MB; Park, EA				Thakran, Shalini; Sharma, Pragya; Attia, Ramy R.; Hori, Roderick T.; Deng, Xiong; Elam, Marshall B.; Park, Edwards A.			Role of Sirtuin 1 in the Regulation of Hepatic Gene Expression by Thyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA COACTIVATOR; FATTY-ACID OXIDATION; CPT-I-ALPHA; BINDING PROTEIN BETA; KINASE 4 PDK4; MITOCHONDRIAL-FUNCTION; TRANSCRIPTION FACTORS; METABOLIC DISEASE; C/EBP-ALPHA; 1ST INTRON	Sirtuin 1 (SIRT1) is a nuclear deacetylase that modulates lipid metabolism and enhances mitochondrial activity. SIRT1 targets multiple transcription factors and coactivators. Thyroid hormone (T-3) stimulates the expression of hepatic genes involved in mitochondrial fatty acid oxidation and gluconeogenesis. We reported that T-3 induces genes for carnitine palmitoyltransferase (cpt1a), pyruvate dehydrogenase kinase 4 (pdk4), and phosphoenolpyruvate carboxykinase (pepck). SIRT1 increases the expression of these genes via the activation of several factors, including peroxisome proliferator-activated receptor alpha, estrogen-related receptor alpha, and peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha). Previously, we reported that PGC-1 alpha participates in the T-3 induction of cpt1a and pdk4 in the liver. Given the overlapping targets of T-3 and SIRT1, we investigated whether SIRT1 participated in the T-3 regulation of these genes. Resveratrol is a small phenolic compound whose actions include the activation of SIRT1. Addition of resveratrol increased the T-3 induction of the pdk4 and cpt1a genes in hepatocytes. Furthermore, expression of SIRT1 in hepatocytes mimicked resveratrol in the regulation of gene expression by T-3. The deacetylase activity of SIRT1 was required and PGC-1 alpha was deacetylated following addition of T-3. We found that SIRT1 interacted directly with T-3 receptor (TR beta). Knockdown of SIRT1 decreased the T-3 induction of cpt1a and pdk4 and reduced the T-3 inhibition of sterol response element binding protein (srebp-1c) both in isolated hepatocytes and in rat liver. Our results indicate that SIRT1 contributes to the T-3 regulation of hepatic genes.	[Thakran, Shalini; Sharma, Pragya; Attia, Ramy R.; Deng, Xiong; Elam, Marshall B.; Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, Memphis, TN 38163 USA; [Hori, Roderick T.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Deng, Xiong; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Park, EA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	epark@uthsc.edu			National Institutes of Health [DK0059368, DK075504]; American Heart Association [4590018]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075504, R01DK059368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health Grants DK0059368 (to E. A. P.) and DK075504 (to M. B. E.). This work was also supported by American Heart Association Grant 4590018 (to E. A. P.).	Amat R, 2007, J BIOL CHEM, V282, P34066, DOI 10.1074/jbc.M707114200; Attia RR, 2011, J BIOL CHEM, V286, P23799, DOI 10.1074/jbc.M111.246389; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Cioffi F, 2010, FASEB J, V24, P3451, DOI 10.1096/fj.10-157115; Cook GA, 2001, J MOL CELL CARDIOL, V33, P317, DOI 10.1006/jmcc.2000.1304; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; Engel N, 2008, INT J MOL MED, V21, P223; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fullerton MD, 2010, DIABETES, V59, P551, DOI 10.2337/db09-1732; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Jackson-Hayes L, 2003, J BIOL CHEM, V278, P7964, DOI 10.1074/jbc.M211062200; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Jurado LA, 2002, J BIOL CHEM, V277, P27606, DOI 10.1074/jbc.M201429200; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Lin HY, 2005, STEROIDS, V70, P444, DOI 10.1016/j.steroids.2005.03.001; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu Y, 2006, MOL ENDOCRINOL, V20, P483, DOI 10.1210/me.2005-0101; Ma K, 2005, J BIOL CHEM, V280, P29525, DOI 10.1074/jbc.M502236200; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; MYNATT RL, 1994, BIOCHEM BIOPH RES CO, V201, P932, DOI 10.1006/bbrc.1994.1791; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park EA, 1999, J BIOL CHEM, V274, P211, DOI 10.1074/jbc.274.1.211; Park EA, 1997, BIOCHEM J, V322, P343, DOI 10.1042/bj3220343; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rosenson RS, 2010, ATHEROSCLEROSIS, V213, P1, DOI 10.1016/j.atherosclerosis.2010.03.038; Sanchez-Pacheco A, 2009, ENDOCRINOLOGY, V150, P5143, DOI 10.1210/en.2009-0117; Song SL, 2010, MOL CELL ENDOCRINOL, V325, P54, DOI 10.1016/j.mce.2010.05.019; Song SL, 2004, BBA-GENE STRUCT EXPR, V1679, P164, DOI 10.1016/j.bbaexp.2004.06.006; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Yang JQ, 2009, J BIOL CHEM, V284, P27042, DOI 10.1074/jbc.M109.047340; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104	55	50	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					807	818		10.1074/jbc.M112.437970	http://dx.doi.org/10.1074/jbc.M112.437970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209300	hybrid, Green Published			2022-12-25	WOS:000313570300006
J	Dai, Y; Chen, JS; Li, HY; Li, SY; Chen, J; Ding, Y; Wu, J; Wang, C; Tan, MH				Dai, Ying; Chen, Jiansu; Li, Hongyang; Li, Shanyi; Chen, Jian; Ding, Yong; Wu, Jing; Wang, Chan; Tan, Meihua			Characterizing the Effects of VPA, VC and RCCS on Rabbit Keratocytes onto Decellularized Bovine Cornea	PLOS ONE			English	Article							STEM-CELLS; ASCORBIC-ACID; TISSUES; MATRIX; PROLIFERATION; CULTURE	To investigate the morphological and growth characteristics of rabbit keratocytes when cultured on decellularized cornea under simulate microgravity (SMG) rotary cell culture system (RCCS) and static culture or in plastic culture supplemented with small molecules of valproic acid (VPA) and vitamin C (VC). Bovine corneas were firstly decellularized with Triton X-100 and NH4OH and through short-term freezing process. Then cell count kit-8 (CCK-8) and flow cytometry were used to test the effects of VPA and VC on the proliferation, cell cycle and apoptosis of rabbit keratocytes. Hematoxylin-eosin (H&E) staining and scanning electron microscopy (SEM) imaging showed that cells were eliminated in the decellularized bovine corneas. The proliferation of cultured keratocytes was promoted by VPA and VC in the cell proliferation assay. VPA and VC moderately decreased the number of apoptotic cells and obviously promoted cell-cycle entrance of keratocytes. Rabbit keratocytes in plastic displayed spindle shape and rare interconnected with or without VPA and VC. Cells revealed dendritic morphology and reticular cellular connections when cultured on the carriers of decellularized corneas supplemented with VPA and VC even in the presence of 10% fetal bovine serum (FBS). When cultured in RCCS supplemented with VPA, VC and 10% FBS, keratocytes displayed round shape with many prominences and were more prone to grow into the pores of carriers with aggregation. Reverse transcription-polymerase chain reaction (RT-PCR) analysis proved that the keratocytes cultured on decellularized bovine cornea under SMG with VPA and VC expressed keratocan and lumican. Keratocytes cultured on plastic expressed lumican but not keratocan. Immunofluorescence identification revealed that cells in all groups were positively immunostained for vimentin. Keratocytes on decellularized bovine cornea under SMG or in static culture were positively immunostained for keratocan and lumican. Thus, we reasonably made a conclusion that the combination of VPA, VC, RCCS and decellularized corneal carriers provide a good condition for keratocytes to well grow. Keratocytes can be manipulated to be aggregates or physiological morphological growth in vitro, which are important for the research of corneal stem cells and corneal tissue engineering. Citation: Dai Y, Chen J, Li H, Li S, Chen J, et al. (2012) Characterizing the Effects of VPA, VC and RCCS on Rabbit Keratocytes onto Decellularized Bovine Cornea. PLoS ONE 7(11): e50114. doi:10.1371/journal.pone.0050114	[Dai, Ying; Chen, Jiansu; Li, Shanyi; Wang, Chan] Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Chen, Jiansu; Wu, Jing] Jinan Univ, Inst Ophthalmol, Coll Med, Guangzhou, Guangdong, Peoples R China; [Li, Hongyang; Chen, Jian; Ding, Yong; Tan, Meihua] Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Chen, JS (corresponding author), Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Guangdong, Peoples R China.	chenjiansu2000@163.com	Li, Shanyi/W-5833-2019	Li, Shanyi/0000-0003-0208-0481; Chen, Jiansu/0000-0001-6703-9573	National Natural Science Foundation of China [30973244]; Science and Technology Bureau of Guangdong Province [2010B031200006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Guangdong Province	This work was supported by the National Natural Science Foundation of China (30973244) and the Science and Technology Bureau of Guangdong Province (2010B031200006). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biermann J, 2011, MOL VIS, V17, P395; Chen J, 2004, CHIN J BIOMED ENG, V13, P118; Chen JS, 2007, ARTIF ORGANS, V31, P722, DOI 10.1111/j.1525-1594.2007.00440.x; Chen JS, 2005, ARTIF ORGANS, V29, P104, DOI 10.1111/j.1525-1594.2005.29021.x; Cormier JT, 2006, TISSUE ENG, V12, P3233, DOI 10.1089/ten.2006.12.3233; Dabos K, 2001, BBA-GEN SUBJECTS, V1526, P119, DOI 10.1016/S0304-4165(01)00097-6; Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5136, DOI 10.1167/iovs.03-0484; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gonzalez-Andrades M, 2011, INVEST OPHTH VIS SCI, V52, P215, DOI 10.1167/iovs.09-4773; GOODWIN TJ, 1993, J CELL BIOCHEM, V51, P301, DOI 10.1002/jcb.240510309; GOODWIN TJ, 1993, P SOC EXP BIOL MED, V202, P181; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Huang YY, 2011, CELL REPROGRAM, V13, P513, DOI 10.1089/cell.2011.0032; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jester JV, 2003, EXP EYE RES, V77, P581, DOI 10.1016/S0014-4835(03)00188-X; Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973; Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; Kuo SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032957; Lei XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026603; Li S, 2009, STEM CELLS DEV, V18, P1273, DOI 10.1089/scd.2008.0371; Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041; Meyers VE, 2005, J BONE MINER RES, V20, P1858, DOI 10.1359/JBMR.050611; Moteki H, 2012, EUR J PHARMACOL, V2, P1; SAIKA S, 1992, OPHTHALMIC RES, V24, P68, DOI 10.1159/000267149; SAIKA S, 1993, CORNEA, V12, P191, DOI 10.1097/00003226-199305000-00002; Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4; Serbecic N, 2005, CELL TISSUE RES, V320, P465, DOI 10.1007/s00441-004-1030-3; Shafiq MA, 2012, TISSUE ENG PART C-ME, V18, P340, DOI [10.1089/ten.tec.2011.0072, 10.1089/ten.TEC.2011.0072]; Takacs L, 2009, CYTOM PART A, V75A, P54, DOI 10.1002/cyto.a.20671; Unsworth BR, 1998, NAT MED, V4, P901, DOI 10.1038/nm0898-901; Vunjak-Novakovic G, 1999, J ORTHOP RES, V17, P130, DOI 10.1002/jor.1100170119; Wang T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-42; Yan J, 2012, J BIOMED MATER RES A, V100A, P527, DOI 10.1002/jbm.a.33301; Yoeruek E, 2012, ACTA OPHTHALMOL, V90, pe125, DOI 10.1111/j.1755-3768.2011.02261.x; Zhao ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033953	37	13	13	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50114	10.1371/journal.pone.0050114	http://dx.doi.org/10.1371/journal.pone.0050114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209652	Green Submitted, Green Published, gold			2022-12-25	WOS:000312104900025
J	Lee, C; Hu, JQ; Ralls, S; Kitamura, T; Loh, YP; Yang, YQ; Mukouyama, Y; Ahn, S				Lee, Cheol; Hu, Jingqiong; Ralls, Sherry; Kitamura, Toshio; Loh, Y. Peng; Yang, Yanqin; Mukouyama, Yohsuke; Ahn, Sohyun			The Molecular Profiles of Neural Stem Cell Niche in the Adult Subventricular Zone	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; BINDING GROWTH-FACTOR; CARBOXYPEPTIDASE E; THYROID-HORMONES; PRECURSOR CELLS; VASCULAR NICHE; CHOROID-PLEXUS; DENTATE GYRUS; SELF-RENEWAL; RADIAL GLIA	Neural stem cells (NSCs) reside in a unique microenvironment called the neurogenic niche and generate functional new neurons. The neurogenic niche contains several distinct types of cells and interacts with the NSCs in the subventricular zone (SVZ) of the lateral ventricle. While several molecules produced by the niche cells have been identified to regulate adult neurogenesis, a systematic profiling of autocrine/paracrine signaling molecules in the neurogenic regions involved in maintenance, self-renewal, proliferation, and differentiation of NSCs has not been done. We took advantage of the genetic inducible fate mapping system (GIFM) and transgenic mice to isolate the SVZ niche cells including NSCs, transit-amplifying progenitors (TAPs), astrocytes, ependymal cells, and vascular endothelial cells. From the isolated cells and microdissected choroid plexus, we obtained the secretory molecule expression profiling (SMEP) of each cell type using the Signal Sequence Trap method. We identified a total of 151 genes encoding secretory or membrane proteins. In addition, we obtained the potential SMEP of NSCs using cDNA microarray technology. Through the combination of multiple screening approaches, we identified a number of candidate genes with a potential relevance for regulating the NSC behaviors, which provide new insight into the nature of neurogenic niche signals.	[Hu, Jingqiong; Mukouyama, Yohsuke] NHLBI, Lab Stem Cell & Neurovasc Biol, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Lee, Cheol; Ralls, Sherry; Ahn, Sohyun] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA; [Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Div Cellular Therapy, Adv Clin Res Ctr, Tokyo, Japan; [Loh, Y. Peng] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cellular Neurobiol Sect, Program Dev Neurosci, NIH, Bethesda, MD USA; [Yang, Yanqin] NHLBI, DNA Sequencing & Genom Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Tokyo; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mukouyama, Y (corresponding author), NHLBI, Lab Stem Cell & Neurovasc Biol, Genet & Dev Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	mukoyamay@nhlbi.nih.gov; ahnsohyun@mail.nih.gov	Kitamura, Toshio/AAA-2071-2021	Mukouyama, Yoh-suke/0000-0002-9084-4922	Intramural Research Program of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056, ZIAHD008781] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIGHL006020, ZIAHL006115] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2010, NATURE, V467, P323, DOI 10.1038/nature09347; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Altaba ARI, 2002, NAT REV NEUROSCI, V3, P24; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ambrogini P, 2005, NEUROENDOCRINOLOGY, V81, P244, DOI 10.1159/000087648; Barraud P, 2005, EUR J NEUROSCI, V22, P1555, DOI 10.1111/j.1460-9568.2005.04352.x; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bolton K, 2009, INT J OBESITY, V33, P1153, DOI 10.1038/ijo.2009.148; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Caronia G, 2010, J NEUROSCI, V30, P6291, DOI 10.1523/JNEUROSCI.0550-10.2010; Carrel D, 2009, J NEUROSCI, V29, P8248, DOI 10.1523/JNEUROSCI.5287-08.2009; Cawley NX, 2012, ENDOCR REV; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Claeskens A, 2000, BRIT J CANCER, V82, P1123, DOI 10.1054/bjoc.1999.1051; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Craig CG, 1996, J NEUROSCI, V16, P2649; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DICKSON PW, 1987, J BIOL CHEM, V262, P13907; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; DUSSAULT JH, 1987, ANNU REV PHYSIOL, V49, P321, DOI 10.1146/annurev.ph.49.030187.001541; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; FINA L, 1990, BLOOD, V75, P2417; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202; Gomez-Gaviro MV, 2012, P NATL ACAD SCI US; Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Horing E, 2012, ACTA NEUROPATHOL; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Ikeda Y, 2004, P NATL ACAD SCI USA, V101, P10732, DOI 10.1073/pnas.0404117101; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Isodono K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009746; Jacobs KA, 1997, GENE, V198, P289, DOI 10.1016/S0378-1119(97)00330-2; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Johanson CE, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-10; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kojima T, 1999, NAT BIOTECHNOL, V17, P487, DOI 10.1038/8666; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Koshimizu H, 2009, J MOL NEUROSCI, V39, P1, DOI 10.1007/s12031-008-9164-5; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lee TK, 2011, J CLIN INVEST, V121, P880, DOI 10.1172/JCI40433; Lemkine GF, 2005, FASEB J, V19, P863, DOI 10.1096/fj.04-2916fje; Lim DA, 1999, P NATL ACAD SCI USA, V96, P7526, DOI 10.1073/pnas.96.13.7526; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lively S, 2008, J NEUROCHEM, V107, P1335, DOI 10.1111/j.1471-4159.2008.05696.x; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Matsubara A, 2005, J EXP MED, V202, P1483, DOI 10.1084/jem.20051325; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Onishi M, 1996, BLOOD, V88, P1399, DOI 10.1182/blood.V88.4.1399.bloodjournal8841399; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; Palha JA, 2000, ENDOCRINOLOGY, V141, P3267; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pennartz S, 2004, MOL CELL NEUROSCI, V25, P692, DOI 10.1016/j.mcn.2003.12.011; Pierfelice TJ, 2008, COLD SH Q B, V73, P367, DOI 10.1101/sqb.2008.73.013; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Richardson SJ, 2007, NEUROSCI LETT, V421, P234, DOI 10.1016/j.neulet.2007.05.040; Richardson SJ, 2007, INT REV CYTOL, V258, P137, DOI 10.1016/S0074-7696(07)58003-4; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Smith DE, 2004, ADV DRUG DELIVER REV, V56, P1765, DOI 10.1016/j.addr.2004.07.008; Soderling JA, 1997, J HISTOCHEM CYTOCHEM, V45, P823, DOI 10.1177/002215549704500607; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Sullivan MM, 2004, INT J BIOCHEM CELL B, V36, P991, DOI 10.1016/j.biocel.2004.01.017; Svetlov SI, 2004, STEM CELLS DEV, V13, P685, DOI 10.1089/scd.2004.13.685; Taft RA, 2002, BIOL REPROD, V67, P953, DOI 10.1095/biolreprod.102.005546; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tham M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015341; Toda H, 2003, J BIOL CHEM, V278, P35491, DOI 10.1074/jbc.M305342200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Woronowicz A, 2010, J NEUROSCI RES, V88, P64, DOI 10.1002/jnr.22174; Zhang Y, 2007, AM J RESP CELL MOL, V36, P515, DOI 10.1165/rcmb.2006-0475RC; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684; Zou P, 2006, J NEUROCHEM, V99, P1470, DOI 10.1111/j.1471-4159.2006.04138.x	114	41	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50501	10.1371/journal.pone.0050501	http://dx.doi.org/10.1371/journal.pone.0050501			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209762	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900059
J	Liu, XQ; Li, F; Tang, JY; Wang, WH; Zhang, FX; Wang, GD; Chu, JF; Yan, CY; Wang, TQ; Chu, CC; Li, CY				Liu, Xiaoqiang; Li, Feng; Tang, Jiuyou; Wang, Weihong; Zhang, Fengxia; Wang, Guodong; Chu, Jinfang; Yan, Cunyu; Wang, Taoqing; Chu, Chengcai; Li, Chuanyou			Activation of the Jasmonic Acid Pathway by Depletion of the Hydroperoxide Lyase OsHPL3 Reveals Crosstalk between the HPL and AOS Branches of the Oxylipin Pathway in Rice	PLOS ONE			English	Article							ALLENE OXIDE SYNTHASE; ARABIDOPSIS MUTANT CEV1; PHYTOALEXIN PRODUCTION; FUNGAL-INFECTION; DEFENSE-RESPONSE; GENE-EXPRESSION; MALE-STERILE; CELL-DEATH; RESISTANCE; METABOLISM	The allene oxide synthase (AOS) and hydroperoxide lyase (HPL) branches of the oxylipin pathway, which underlie the production of jasmonates and aldehydes, respectively, function in plant responses to a range of stresses. Regulatory crosstalk has been proposed to exist between these two signaling branches; however, there is no direct evidence of this. Here, we identified and characterized a jasmonic acid (JA) overproduction mutant, cea62, by screening a rice T-DNA insertion mutant library for lineages that constitutively express the AOS gene. Map-based cloning was used to identify the underlying gene as hydroperoxide lyase OsHPL3. HPL3 expression and the enzyme activity of its product, (E)-2-hexenal, were depleted in the cea62 mutant, which resulted in the dramatic overproduction of JA, the activation of JA signaling, and the emergence of the lesion mimic phenotype. A time-course analysis of lesion formation and of the induction of defense responsive genes in the cea62 mutant revealed that the activation of JA biosynthesis and signaling in cea62 was regulated in a developmental manner, as was OsHPL3 activity in the wild-type plant. Microarray analysis showed that the JA-governed defense response was greatly activated in cea62 and this plant exhibited enhanced resistance to the T1 strain of the bacterial blight pathogen Xanthomonasoryzaepvoryzae (Xoo). The wounding response was attenuated in cea62 plants during the early stages of development, but partially recovered when JA levels were elevated during the later stages. In contrast, the wounding response was not altered during the different developmental stages of wild-type plants. These findings suggest that these two branches of the oxylipin pathway exhibit crosstalk with regards to biosynthesis and signaling and cooperate with each other to function in diverse stress responses. Citation: Liu X, Li F, Tang J, Wang W, Zhang F, et al. (2012) Activation of the Jasmonic Acid Pathway by Depletion of the Hydroperoxide Lyase OsHPL3 Reveals Crosstalk between the HPL and AOS Branches of the Oxylipin Pathway in Rice. PLoS ONE 7(11): e50089. doi:10.1371/journal.pone.0050089	[Liu, Xiaoqiang; Li, Feng; Tang, Jiuyou; Wang, Weihong; Zhang, Fengxia; Wang, Guodong; Chu, Jinfang; Yan, Cunyu; Wang, Taoqing; Chu, Chengcai; Li, Chuanyou] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chu, CC (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Genom, Beijing, Peoples R China.	ccchu@genetics.ac.cn; cyli@genetics.ac.cn	Li, Chuanyou/ABF-4143-2020; Wang, Guodong/AAW-5987-2020; Tang, Jiuyou/J-7224-2015; Chu, Chengcai/AAF-6083-2019	Wang, Guodong/0000-0001-9917-0656; Tang, Jiuyou/0000-0002-9059-2139; Chu, Chengcai/0000-0001-8097-6115; Yan, Cunyu/0000-0002-3603-2421	National Natural Science Foundation of China [31270323, 30971544, 30825029]; 973 Project from the Ministry of Sciences and Technology of China [2010CB126202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project from the Ministry of Sciences and Technology of China	This work was supported by the National Natural Science Foundation of China (31270323, 30971544 and 30825029) and the 973 Project from the Ministry of Sciences and Technology of China (2010CB126202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2003, BIOCHEM BIOPH RES CO, V310, P1073, DOI 10.1016/j.bbrc.2003.09.123; Bai W, 2011, PLANT BIOTECHNOL J, V9, P205, DOI 10.1111/j.1467-7652.2010.00544.x; Baldwin Ian T., 2002, Current Opinion in Plant Biology, V5, P351, DOI 10.1016/S1369-5266(02)00263-7; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Bate NJ, 1998, PLANT PHYSIOL, V117, P1393, DOI 10.1104/pp.117.4.1393; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Chehab EW, 2006, PLANT PHYSIOL, V141, P121, DOI 10.1104/pp.106.078592; Creelman Robert A, 2002, Arabidopsis Book, V1, pe0012, DOI 10.1199/tab.0012; Deng HQ, 2012, PLANT PHYSIOL, V158, P876, DOI 10.1104/pp.111.191379; Dong F, 2011, J AGR FOOD CHEM, V59, P13131, DOI 10.1021/jf203396a; Duan H, 2005, PLANT PHYSIOL, V139, P1529, DOI 10.1104/pp.105.067249; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Froehlich JE, 2001, PLANT PHYSIOL, V125, P306, DOI 10.1104/pp.125.1.306; Gobel C, 2002, BBA-MOL CELL BIOL L, V1584, P55, DOI 10.1016/S1388-1981(02)00268-8; Gomi K, 2003, J PLANT PHYSIOL, V160, P1219, DOI 10.1078/0176-1617-01177; Gomi K, 2010, PLANT J, V61, P46, DOI 10.1111/j.1365-313X.2009.04031.x; Halitschke R, 2004, PLANT J, V40, P35, DOI 10.1111/j.1365-313X.2004.02185.x; Howe GA, 2000, PLANT PHYSIOL, V123, P711, DOI 10.1104/pp.123.2.711; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Howe GA, 1999, GENETICS, V153, P1411; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kim SG, 2011, MOL CELLS, V31, P25, DOI 10.1007/s10059-011-0004-z; Kishimoto K, 2005, PLANT CELL PHYSIOL, V46, P1093, DOI 10.1093/pcp/pci122; Laudert D, 2000, PLANTA, V211, P163, DOI 10.1007/s004250000316; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006; Liu XQ, 2005, CELL RES, V15, P593, DOI 10.1038/sj.cr.7290329; Ma YM, 2009, J GENET GENOMICS, V36, P267, DOI 10.1016/S1673-8527(08)60114-9; Matsui K, 1999, PLANT CELL PHYSIOL, V40, P477, DOI 10.1093/oxfordjournals.pcp.a029567; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Mei CS, 2006, MOL PLANT MICROBE IN, V19, P1127, DOI 10.1094/MPMI-19-1127; Nojiri H, 1996, PLANT PHYSIOL, V110, P387, DOI 10.1104/pp.110.2.387; Pieterse C. M, 2012, ANN REV CELL DEV BIO; Qiao Y, 2010, NEW PHYTOL, V185, P258, DOI 10.1111/j.1469-8137.2009.03047.x; Schweizer P, 1997, PLANT PHYSIOL, V114, P79, DOI 10.1104/pp.114.1.79; Sivasankar S, 2000, PLANT PHYSIOL, V122, P1335, DOI 10.1104/pp.122.4.1335; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Takeuchi K, 2011, PLANT CELL PHYSIOL, V52, P1686, DOI 10.1093/pcp/pcr105; Tamogami S, 1997, FEBS LETT, V412, P61, DOI 10.1016/S0014-5793(97)00743-6; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Tong XH, 2012, PLANT J, V71, P763, DOI 10.1111/j.1365-313X.2012.05027.x; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; ZERINGUE HJ, 1991, APPL ENVIRON MICROB, V57, P2433, DOI 10.1128/AEM.57.8.2433-2434.1991; Zhu BQ, 2012, MOL BIOL REP	49	54	63	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50089	10.1371/journal.pone.0050089	http://dx.doi.org/10.1371/journal.pone.0050089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209649	Green Submitted, Green Published, gold			2022-12-25	WOS:000312104900024
J	Tsai, HC; Boucher, DL; Martinez, A; Tepper, CG; Kung, HJ				Tsai, Hui-Chi; Boucher, David L.; Martinez, Anthony; Tepper, Clifford G.; Kung, Hsing-Jien			Modeling Truncated AR Expression in a Natural Androgen Responsive Environment and Identification of RHOB as a Direct Transcriptional Target	PLOS ONE			English	Article							PROSTATE-CANCER PROGRESSION; RECEPTOR GENE-EXPRESSION; SPLICE VARIANTS; CODING REGION; CELL-LINE; ACTIVATION; MUTATION; THERAPY; DEMETHYLASE; RESISTANCE	Recent studies identifying putative truncated androgen receptor isoforms with ligand-independent activity have shed new light on the acquisition of androgen depletion independent (ADI) growth of prostate cancer. In this study, we present a model system in which a C-terminally truncated variant of androgen receptor (TC-AR) is inducibly expressed in LNCaP, an androgen-dependent cell line, which expresses little truncated receptor. We observed that when TC-AR is overexpressed, the endogenous full length receptor (FL-AR) is transcriptionally downmodulated. This in essence allows us to "replace" FL-AR with TC-AR and compare their individual properties in exactly the same genetic and cellular background, which has not been performed before. We show that the TC-AR translocates to the nucleus, activates transcription of AR target genes in the absence of DHT and is sufficient to confer ADI growth to the normally androgen dependent LNCaP line. We also show that while there is significant overlap in the genes regulated by FL- and TC-AR there are also differences in the respective suites of target genes with each AR form regulating genes that the other does not. Among the genes uniquely activated by TC-AR is RHOB which is shown to be involved in the increased migration and morphological changes observed in LN/TC-AR, suggesting a role of RHOB in the regulation of androgen-independent behavior of prostate cancer cells.	[Tsai, Hui-Chi; Martinez, Anthony; Tepper, Clifford G.; Kung, Hsing-Jien] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Tsai, Hui-Chi; Martinez, Anthony; Tepper, Clifford G.; Kung, Hsing-Jien] Univ Calif Davis, Ctr Canc, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Boucher, David L.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Tsai, HC (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA.	hkung@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013		National Institutes of Health [NIH CA165263, NIH CA150197]; NATIONAL CANCER INSTITUTE [P30CA093373, R01CA150197, R01CA165263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project is supported by funding from National Institutes of Health grants NIH CA165263 and CA150197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOK LJ, 1992, MOL CELL ENDOCRINOL, V88, P153, DOI 10.1016/0303-7207(92)90020-7; Bourboulia D, 2010, SEMIN CANC BIOL; Bousquet E, 2009, CANCER RES, V69, P6092, DOI 10.1158/0008-5472.CAN-08-4147; Burnstein KL, 2005, J CELL BIOCHEM, V95, P657, DOI 10.1002/jcb.20460; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Ceraline J, 2004, INT J CANCER, V108, P152, DOI 10.1002/ijc.11404; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chlenski A, 2001, PROSTATE, V47, P66; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Ding XF, 1998, MOL ENDOCRINOL, V12, P302, DOI 10.1210/me.12.2.302; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Grad JM, 1999, MOL ENDOCRINOL, V13, P1896, DOI 10.1210/me.13.11.1896; Guo ZY, 2011, INT J BIOL SCI, V7, P815, DOI 10.7150/ijbs.7.815; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haile S, 2011, CELL MOL LIFE SCI; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Hu R, 2011, PROSTATE, V71, P1656, DOI 10.1002/pros.21382; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; JENSTER G, 1995, J BIOL CHEM, V270, P7341, DOI 10.1074/jbc.270.13.7341; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; KUMAR MV, 1994, NUCLEIC ACIDS RES, V22, P3693, DOI 10.1093/nar/22.18.3693; Li YM, 2011, CANCER RES, V71, P2108, DOI 10.1158/0008-5472.CAN-10-1998; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shen R, 1997, Urol Oncol, V3, P67, DOI 10.1016/S1078-1439(97)00039-2; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tan J, 1997, MOL ENDOCRINOL, V11, P450, DOI 10.1210/me.11.4.450; Tararova ND, 2007, PROSTATE, V67, P1801, DOI 10.1002/pros.20662; Tepper CG, 2002, CANCER RES, V62, P6606; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Wang LG, 2004, ONCOGENE, V23, P5175, DOI 10.1038/sj.onc.1207654; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; WOLF DA, 1993, MOL ENDOCRINOL, V7, P924, DOI 10.1210/me.7.7.924; Yoneda M, 2010, EXP MOL PATHOL, V88, P90, DOI 10.1016/j.yexmp.2009.09.010; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	43	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49887	10.1371/journal.pone.0049887	http://dx.doi.org/10.1371/journal.pone.0049887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209612	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900014
J	Carpeggiani, C; Landi, P; Michelassi, C; Marraccini, P; Picano, E				Carpeggiani, Clara; Landi, Patrizia; Michelassi, Claudio; Marraccini, Paolo; Picano, Eugenio			Trends of Increasing Medical Radiation Exposure in a Population Hospitalized for Cardiovascular Disease (1970-2009)	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CHROMOSOMAL DNA-DAMAGE; IONIZING-RADIATION; STRESS ECHOCARDIOGRAPHY; NUCLEAR-MEDICINE; CARDIOLOGY; CATHETERIZATION; ANGIOPLASTY; RADIOLOGY; RISK	Background: High radiation doses employed in cardiac imaging may increase cancer frequency in exposed patients after decades. The aim of this study was to evaluate the relative trends in medical radiation exposure in a population hospitalized for cardiovascular disease. Methods and Results: An observational single-center study was conducted to examine 16,431 consecutive patients with heart disease admitted to the Italian National Research Council Institute of Clinical Physiology between January 1970 and December 2009. In all patients, the cumulative estimated effective dose was obtained from data mining of electronic records of hospital admissions, adopting the effective dose typical values of the American Heart Association 2009 statement and Mettler's 2008 catalog of doses. Cumulative estimated effective dose per patient in the last 5 years was 22 (12-42) mSv (median, 25th-75th percentiles), with higher values in ischemic heart disease (IHD), 37 (20-59) vs non-IHD, 13 (8-22) mSv, p<0.001. Trends in radiation exposure showed a steady increase in IHD and a flat trend in non-IHD patients, with variation from 1970-74 to 2005-2009 of +155% for IHD (p<0.001) and -1% in non-IHD (NS). The relative contribution of different imaging techniques was remodeled over time, with nuclear cardiology dominating in 1970s (23% of individual exposure) and invasive fluoroscopy in the last decade (90% of individual exposure). Conclusion: A progressive increase in cumulative estimated effective dose is observed in hospitalized IHD patients. The growing medical radiation exposure may encourage a more careful justification policy regarding ionizing imaging in cardiology patients applying the two main principles of radiation protection: appropriate justification for ordering and performing each procedure, and careful optimization of the radiation dose used during each procedure.	[Carpeggiani, Clara; Landi, Patrizia; Michelassi, Claudio; Marraccini, Paolo; Picano, Eugenio] CNR, Inst Clin Physiol, I-56100 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Carpeggiani, C (corresponding author), CNR, Inst Clin Physiol, Via Savi 8, I-56100 Pisa, Italy.	clara@ifc.cnr.it	Picano, E/G-2261-2014		ITT - Istituto Toscano Tumori of the Tuscany Region [59959]	ITT - Istituto Toscano Tumori of the Tuscany Region	The study was made possible by the SUIT-Heart (Stop Useless Imaging Testing in Heart Disease) grant of the ITT - Istituto Toscano Tumori of the Tuscany Region approved by the ethical Committee of Pisa University (Prot. N. 59959, October 1, 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ali L, 2010, HEART, V96, P269, DOI 10.1136/hrt.2008.160309; Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Andreassi MG, 2007, EUR HEART J, V28, P2195, DOI 10.1093/eurheartj/ehm225; [Anonymous], 2007, ANN ICRP, V37, P1, DOI [10.1016/j.icrp.2007.10.003, DOI 10.1016/J.ICRP.2007.10.003]; Bedetti G, 2008, BRIT J RADIOL, V81, P699, DOI 10.1259/bjr/29507259; Brenner DJ, 2008, BRIT J RADIOL, V81, P521, DOI 10.1259/bjr/22942198; Carpeggiani C, 2010, ATHEROSCLEROSIS, V211, P461, DOI 10.1016/j.atherosclerosis.2010.03.012; Dietze G, 2009, BRIT J RADIOL, V82, P348, DOI 10.1259/bjr/91937653; Dondi M, 2011, J NUCL MED, V52, p16S, DOI 10.2967/jnumed.111.089193; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2012, J AM COLL CARDIOL, V59, P553, DOI 10.1016/j.jacc.2011.08.079; Einstein AJ, 2010, JAMA-J AM MED ASSOC, V304, P2137, DOI 10.1001/jama.2010.1664; European Commission, 2001, RAD PROT 118 REF GUI; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; FDA, 2010, IN RED UNN RAD EXP M; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Gibbons RJ, 2008, J AM COLL CARDIOL, V51, P1283, DOI 10.1016/j.jacc.2007.10.064; IAEA. International Atomic Energy Agency (IAEA), 2011, JUST MED EXP DIAGN I; Kaufmann PA, 2011, EUR HEART J, V32, P269, DOI 10.1093/eurheartj/ehq298; Kaul P, 2010, CIRCULATION, V122, P2160, DOI 10.1161/CIRCULATIONAHA.110.973339; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kocinaj D, 2006, INT J CARDIOL, V113, P283, DOI 10.1016/j.ijcard.2005.09.035; Linet MS, 2012, CA-CANCER J CLIN, V62, P75, DOI 10.3322/caac.21132; Martin CJ, 2007, BRIT J RADIOL, V80, P639, DOI 10.1259/bjr/25922439; MASERI A, 1976, CIRCULATION, V54, P280, DOI 10.1161/01.CIR.54.2.280; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; National Research Council of the National Academies NRC, 2006, HLTH RISKS EXP LOW L; Picano E, 2004, BMJ-BRIT MED J, V328, P578, DOI 10.1136/bmj.328.7439.578; PICANO E, 1992, CIRCULATION, V85, P1604, DOI 10.1161/01.CIR.85.4.1604; PICANO E, 1989, CIRCULATION, V80, P450, DOI 10.1161/01.CIR.80.3.450; Picano E, 2007, AM HEART J, V154, P285, DOI 10.1016/j.ahj.2007.04.032; President's Cancer Panel, 2010, ENV CAUS CANC GROSSL; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; The Royal College of Radiologists, 2007, REF GUID; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; Vano E, 2006, BRIT J RADIOL, V79, P383, DOI 10.1259/bjr/26829723; Wijns W, 2010, CIRCULATION, V122, P2113, DOI 10.1161/CIRCULATIONAHA.110.986984; Zorzetto M, 1997, CATHETER CARDIO DIAG, V40, P348	40	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50168	10.1371/journal.pone.0050168	http://dx.doi.org/10.1371/journal.pone.0050168			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209665	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700038
J	Flegr, J; Geryk, J; Volny, J; Klose, J; Cernochova, D				Flegr, Jaroslav; Geryk, Jan; Volny, Jindra; Klose, Jiri; Cernochova, Dana			Rhesus Factor Modulation of Effects of Smoking and Age on Psychomotor Performance, Intelligence, Personality Profile, and Health in Czech Soldiers	PLOS ONE			English	Article							LATENT TOXOPLASMOSIS; PARASITE TOXOPLASMA; TRAFFIC ACCIDENTS; CIGARETTE-SMOKE; RHD MOLECULE; GONDII; RISK; ABILITIES; HUMANS; WOMEN	Background: Rhesus-positive and rhesus-negative persons differ in the presence-absence of highly immunogenic RhD protein on the erythrocyte membrane. This protein is a component of NH3 or CO2 pump whose physiological role is unknown. Several recent studies have shown that RhD positivity protects against effects of latent toxoplasmosis on motor performance and personality. It is not known, however, whether the RhD phenotype modifies exclusively the response of the body to toxoplasmosis or whether it also influences effects of other factors. Methodology/Principal Findings: In the present cohort study, we searched for the effects of age and smoking on performance, intelligence, personality and self-estimated health and wellness in about 3800 draftees. We found that the positive effect of age on performance and intelligence was stronger in RhD-positive soldiers, while the negative effect of smoking on performance and intelligence was of similar size regardless of the RhD phenotype. The effect of age on four Cattell's personality factors, i.e., dominance (E), radicalism (Q(1)), self-sentiment integration (Q(3)), and ergic tension (Q(4)), and on Cloninger's factor reward dependency (RD) was stronger for RhD-negative than RhD-positive subjects, while the effect of smoking on the number of viral and bacterial diseases was about three times stronger for RhD-negative than RhD-positive subjects. Conclusions: RhD phenotype modulates the influence not only of latent toxoplasmosis, but also of at least two other potentially detrimental factors, age and smoking, on human behavior and physiology. The negative effect of smoking on health (estimated on the basis of the self-rated number of common viral and bacterial diseases in the past year) was much stronger in RhD-negative than RhD-positive subjects. It is critically needed to confirm the differences in health response to smoking between RhD-positive and RhD-negative subjects by objective medical examination in future studies.	[Flegr, Jaroslav; Geryk, Jan; Volny, Jindra] Charles Univ Prague, Fac Sci, Prague, Czech Republic; [Klose, Jiri] Mil Univ Hosp Prague, Cent Med Psychol Dept, Prague, Czech Republic; [Cernochova, Dana] Hogrefe Testctr, Prague, Czech Republic	Charles University Prague; Military University Hospital Prague	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Prague, Czech Republic.	flegr@cesnet.cz	Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126	Grand Agency of the Czech Republic [P303/11/1398]; Charles University of Prague [GAUK 18810, UNCE 204004]	Grand Agency of the Czech Republic; Charles University of Prague	The authors' work was supported by the Grand Agency of the Czech Republic (grant number P303/11/1398) and Charles University of Prague (GAUK 18810, grant UNCE 204004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkjaer T, 2005, SCAND J WORK ENV HEA, V31, P152, DOI 10.5271/sjweh.862; Biernacki M, 2011, INT J OCCUP MED ENV, V24, P367, DOI 10.2478/s13382-011-0035-x; Biver S, 2006, TRANSFUS CLIN BIOL, V13, P167, DOI 10.1016/j.tracli.2006.03.003; Carritt B, 1997, HUM MOL GENET, V6, P843, DOI 10.1093/hmg/6.6.843; Cattell HEP, 2008, SAGE HDB PERSONALITY, P295; CLONINGER CR, 1994, CURR OPIN NEUROBIOL, V4, P266, DOI 10.1016/0959-4388(94)90083-3; Dabritz HA, 2010, ZOONOSES PUBLIC HLTH, V57, P34, DOI 10.1111/j.1863-2378.2009.01273.x; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P27, DOI 10.1111/j.1574-695X.1999.tb01713.x; Fekadu A, 2010, FOLIA PARASIT, V57, P105, DOI 10.14411/fp.2010.013; Fisher RA, 1944, NATURE, V153, P106, DOI 10.1038/153106b0; Flegel WA, 2006, TRANSFUS CLIN BIOL, V13, P4, DOI 10.1016/j.tracli.2006.02.011; Flegr J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-11; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2012, NEUROENDOCRINOL LETT, V33, P224; Flegr J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001389; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-72; Formann AK., 1979, WIENER MATRIZEN TEST; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Gur RC, 2012, NEUROPSYCHOLOGY, V26, P251, DOI 10.1037/a0026712; Haldane JBS, 1944, NATURE, V153, P106, DOI 10.1038/153106a0; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Heishman SJ, 2010, PSYCHOPHARMACOLOGY, V210, P453, DOI 10.1007/s00213-010-1848-1; Holub D., 2011, PSYCHIATRIE, V15, P37, DOI DOI 10.6084/M9.FIGSHARE.5593999; Kankova S, 2007, NATURWISSENSCHAFTEN, V94, P122, DOI 10.1007/s00114-006-0166-2; Kankova S, 2010, PARASITOLOGY, V137, P1773, DOI 10.1017/S0031182010000661; Kankova S, 2010, PARASITOL RES, V107, P1421, DOI 10.1007/s00436-010-2013-9; Kustu S, 2006, TRANSFUS CLIN BIOL, V13, P103, DOI 10.1016/j.tracli.2006.03.001; Lester D, 2010, PSYCHOL REP, V107, P713, DOI 10.2466/12.19.PR0.107.6.713-714; Lindova J, 2012, EUR J PERSONALITY, V26, P285, DOI 10.1002/per.838; Murin S, 2000, CLIN CHEST MED, V21, P121, DOI 10.1016/S0272-5231(05)70012-5; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Otis A. S., 1954, OTIS QUICK SCORING M; Payne JB, 1996, J PERIODONTAL RES, V31, P99, DOI 10.1111/j.1600-0765.1996.tb00470.x; Perrot A, 2007, PERCEPT MOTOR SKILL, V104, P91, DOI 10.2466/PMS.104.1.91-101; Prandota J, 2012, NEUROINFLAMMATION PA; Prandota Joseph, 2004, Am J Ther, V11, P517, DOI 10.1097/01.mjt.0000140648.30948.bd; Prandota J, 2010, INT J NEUROSCI, V120, P81, DOI 10.3109/00207450903458647; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; Raza MW, 1999, FEMS IMMUNOL MED MIC, V25, P145, DOI 10.1111/j.1574-695X.1999.tb01338.x; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Thomas F, 2012, BIOL LETTERS, V8, P101, DOI 10.1098/rsbl.2011.0588; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Wagner FF, 2000, BLOOD, V95, P3662; Yagmur F, 2010, FORENSIC SCI INT, V199, P15, DOI 10.1016/j.forsciint.2010.02.020	45	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49478	10.1371/journal.pone.0049478	http://dx.doi.org/10.1371/journal.pone.0049478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209579	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700015
J	Gordon, DM				Gordon, Deborah M.			The Dynamics of Foraging Trails in the Tropical Arboreal Ant Cephalotes goniodontus	PLOS ONE			English	Article							EXTRAFLORAL NECTARIES; HARVESTER ANTS; FOREST CANOPY; EVOLUTION; MICROORGANISMS; CONNECTIVITY; COMMUNITIES; HERBIVORY; BEHAVIOR; ECOLOGY	The foraging behavior of the arboreal turtle ant, Cephalotes goniodontus, was studied in the tropical dry forest of western Mexico. The ants collected mostly plant-derived food, including nectar and fluids collected from the edges of wounds on leaves, as well as caterpillar frass and lichen. Foraging trails are on small pieces of ephemeral vegetation, and persist in exactly the same place for 4-8 days, indicating that food sources may be used until they are depleted. The species is polydomous, occupying many nests which are abandoned cavities or ends of broken branches in dead wood. Foraging trails extend from trees with nests to trees with food sources. Observations of marked individuals show that each trail is travelled by a distinct group of foragers. This makes the entire foraging circuit more resilient if a path becomes impassable, since foraging in one trail can continue while a different group of ants forms a new trail. The colony's trails move around the forest from month to month; from one year to the next, only one colony out of five was found in the same location. There is continual searching in the vicinity of trails: ants recruited to bait within 3 bifurcations of a main foraging trail within 4 hours. When bait was offered on one trail, to which ants recruited, foraging activity increased on a different trail, with no bait, connected to the same nest. This suggests that the allocation of foragers to different trails is regulated by interactions at the nest.	Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Gordon, DM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dmgordon@stanford.edu			NSF Evolutionary Ecology of a Multi-Species Mutualism at a Regional Scale [DEB-0918848-001]; Division Of Environmental Biology [0918848] Funding Source: National Science Foundation	NSF Evolutionary Ecology of a Multi-Species Mutualism at a Regional Scale; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF Evolutionary Ecology of a Multi-Species Mutualism at a Regional Scale DEB-0918848-001.	ADAMS ES, 1990, BIOTROPICA, V22, P200, DOI 10.2307/2388413; Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Apple JL, 2001, OECOLOGIA, V127, P409, DOI 10.1007/s004420000605; Baroni Urbani C., 1997, Naturwissenschaften, V84, P256; BENTLEY B L, 1981, Tropical Ecology, V22, P127; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; Bluthgen N, 2000, OECOLOGIA, V125, P229, DOI 10.1007/s004420000449; Bution ML, 2008, MICRON, V39, P1179, DOI 10.1016/j.micron.2008.05.003; Byk J, 2010, ACTA ETHOL, V13, P33, DOI 10.1007/s10211-010-0071-8; Clay NA, 2010, ECOL ENTOMOL, V35, P417, DOI 10.1111/j.1365-2311.2010.01197.x; CREIGHTON WM. S., 1967, PSYCHE J ENTOMOL, V74, P34, DOI 10.1155/1967/54234; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; de Andrade Maria L., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V271, P1; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Gonzalez-Teuber M, 2009, J CHEM ECOL, V35, P459, DOI 10.1007/s10886-009-9618-4; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; GORDON DM, 1992, ECOL ENTOMOL, V17, P114, DOI 10.1111/j.1365-2311.1992.tb01167.x; GORDON DM, 1993, OECOLOGIA, V95, P479, DOI 10.1007/BF00317431; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heller NE, 2008, INSECT SOC, V55, P397, DOI 10.1007/s00040-008-1019-0; Jaffe K, 2001, CAN J ZOOL, V79, P1120, DOI 10.1139/cjz-79-6-1120; Paul J, 2003, J INSECT PHYSIOL, V49, P347, DOI 10.1016/S0022-1910(03)00019-2; Philpott SM, 2008, ENVIRON ENTOMOL, V37, P181, DOI 10.1603/0046-225X(2008)37[181:BDOPAA]2.0.CO;2; Powell S, 2009, J EVOLUTION BIOL, V22, P1004, DOI 10.1111/j.1420-9101.2009.01710.x; Powell S, 2008, FUNCT ECOL, V22, P902, DOI 10.1111/j.1365-2435.2008.01436.x; Powell S, 2011, J ANIM ECOL, V80, P352, DOI 10.1111/j.1365-2656.2010.01779.x; RICOGRAY V, 1980, BIOTROPICA, V12, P223, DOI 10.2307/2387977; Rosengren R., 1971, Acta Zoologica Fennica, V133, P1; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Sanders NJ, 2007, BIOTROPICA, V39, P422, DOI 10.1111/j.1744-7429.2007.00263.x; Seidl T, 2011, ALGORITHMS UNPLUGGED, DOI [10.1007/978-3-642-15328-0, DOI 10.1007/978-3-642-15328-0]; Tanaka HO, 2010, POPUL ECOL, V52, P147, DOI 10.1007/s10144-009-0172-2; Yanoviak SP, 2000, OIKOS, V89, P259, DOI 10.1034/j.1600-0706.2000.890206.x; Yanoviak SP, 2005, NATURE, V433, P624, DOI 10.1038/nature03254	35	21	21	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50472	10.1371/journal.pone.0050472	http://dx.doi.org/10.1371/journal.pone.0050472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209749	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700074
J	Hartlerode, AJ; Guan, YH; Rajendran, A; Ura, K; Schotta, G; Xie, AY; Shah, JV; Scully, R				Hartlerode, Andrea J.; Guan, Yinghua; Rajendran, Anbazhagan; Ura, Kiyoe; Schotta, Gunnar; Xie, Anyong; Shah, Jagesh V.; Scully, Ralph			Impact of Histone H4 Lysine 20 Methylation on 53BP1 Responses to Chromosomal Double Strand Breaks	PLOS ONE			English	Article							SISTER-CHROMATID RECOMBINATION; DNA-DAMAGE RESPONSE; METHYLTRANSFERASE SET8; CELLULAR-RESPONSES; GENOMIC STABILITY; MDC1; H2AX; PR-SET7; REPAIR; SITES	Recruitment of 53BP1 to chromatin flanking double strand breaks (DSBs) requires gamma H2AX/MDC1/RNF8-dependent ubiquitination of chromatin and interaction of 53BP1 with histone H4 methylated on lysine 20 (H4K20me). Several histone methyltransferases have been implicated in 53BP1 recruitment, but their quantitative contributions to the 53BP1 response are unclear. We have developed a multi-photon laser (MPL) system to target DSBs to subfemtoliter nuclear volumes and used this to mathematically model DSB response kinetics of MDC1 and of 53BP1. In contrast to MDC1, which revealed first order kinetics, the 53BP1 MPL-DSB response is best fitted by a Gompertz growth function. The 53BP1 MPL response shows the expected dependency on MDC1 and RNF8. We determined the impact of altered H4K20 methylation on 53BP1 MPL response kinetics in mouse embryonic fibroblasts (MEFs) lacking key H4K20 histone methyltransferases. This revealed no major requirement for the known H4K20 dimethylases Suv4-20h1 and Suv4-20h2 in 53BP1 recruitment or DSB repair function, but a key role for the H4K20 monomethylase, PR-SET7. The histone methyltransferase MMSET/WHSC1 has recently been implicated in 53BP1 DSB recruitment. We found that WHSC1 homozygous mutant MEFs reveal an alteration in balance of H4K20 methylation patterns; however, 53BP1 DSB responses in these cells appear normal.	[Hartlerode, Andrea J.; Rajendran, Anbazhagan; Xie, Anyong; Scully, Ralph] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hartlerode, Andrea J.; Rajendran, Anbazhagan; Xie, Anyong; Scully, Ralph] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Guan, Yinghua; Shah, Jagesh V.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Guan, Yinghua; Shah, Jagesh V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Ura, Kiyoe] Osaka Univ, Sch Med, Div Gene Therapy Sci, Osaka, Japan; [Schotta, Gunnar] Univ Munich, Munich, Germany; [Schotta, Gunnar] Munich Ctr Integrated Prot Sci CiPSM, Adolf Butenandt Inst, Munich, Germany	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Osaka University; University of Munich; University of Munich	Shah, JV (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA.	jagesh_shah@hms.harvard.edu; rscully@bidmc.harvard.edu	Guan, Yinghua/K-1504-2013; Scully, Ralph/F-5008-2013	Schotta, Gunnar/0000-0003-4940-6135	National Institutes of Health [R01GM073894, R01GM077238]; CDMRP Breast Cancer Research Program [BC085852]; Beckman Laser Institute Foundation; NIH Common Fund grant [RL9 EB008539]; BMBF (EPISYS);  [SFB-TR5];  [SFB684]; NATIONAL CANCER INSTITUTE [R01CA095175, RC1CA145867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [RL9EB008539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077238, R01GM073894] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CDMRP Breast Cancer Research Program; Beckman Laser Institute Foundation; NIH Common Fund grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BMBF (EPISYS)(Federal Ministry of Education & Research (BMBF)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health R01GM073894 (to RS), R01GM077238 (to JVS), the CDMRP Breast Cancer Research Program BC085852 (to RS), a Young Faculty Award from the Beckman Laser Institute Foundation (to JVS) and NIH Common Fund grant RL9 EB008539 (to YG). GS is funded by SFB-TR5, SFB684 and BMBF (EPISYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Botchway SW, 2010, MUTAT RES-REV MUTAT, V704, P38, DOI 10.1016/j.mrrev.2010.01.003; Botchway SW, 2012, METHOD ENZYMOL, V504, P3, DOI 10.1016/B978-0-12-391857-4.00001-X; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Botvinick EL, 2007, METHOD CELL BIOL, V82, P81, DOI 10.1016/S0091-679(06)82003-0; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Ferguson DO, 2000, COLD SPRING HARB SYM, V65, P395, DOI 10.1101/sqb.2000.65.395; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Hajdu I, 2011, P NATL ACAD SCI US; Harper JV, 2008, PHOTOCHEM PHOTOBIOL, V84, P1506, DOI 10.1111/j.1751-1097.2008.00378.x; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Huen MS, 2007, CELL; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Kalies S, 2011, BIOMED OPT EXPRESS, V2, P805, DOI 10.1364/BOE.2.000816; Kolas NK, 2007, SCIENCE; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milligan JR, 2000, INT J RADIAT BIOL, V76, P1475; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; NORTON L, 1988, CANCER RES, V48, P7067; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Oikawa S, 1996, BIOCHEMISTRY-US, V35, P4584, DOI 10.1021/bi9527000; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Puget N, 2005, DNA REPAIR, V4, P149, DOI 10.1016/j.dnarep.2004.08.010; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tripathi V, 2007, J CELL BIOL, V178, P9, DOI 10.1083/jcb.200610051; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Xie AY, 2004, MOL CELL, V16, P1017, DOI 10.1016/j.molcel.2004.12.007; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	52	42	45	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49211	10.1371/journal.pone.0049211	http://dx.doi.org/10.1371/journal.pone.0049211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209566	Green Submitted, gold, Green Published			2022-12-25	WOS:000312601700010
J	Nakagawa, T; Mitsui, R; Tani, A; Sasa, K; Tashiro, S; Iwama, T; Hayakawa, T; Kawai, K				Nakagawa, Tomoyuki; Mitsui, Ryoji; Tani, Akio; Sasa, Kentaro; Tashiro, Shinya; Iwama, Tomonori; Hayakawa, Takashi; Kawai, Keiichi			A Catalytic Role of XoxF1 as La3+-Dependent Methanol Dehydrogenase in Methylobacterium extorquens Strain AM1	PLOS ONE			English	Article							OXIDATION MUTANT CLASSES; RARE-EARTH-ELEMENTS; GENE; METHYLOTROPHY; PHYLLOSPHERE; METABOLISM; REVEALS; SYSTEM; SOIL	In the methylotrophic bacterium Methylobacterium extorquens strain AM1, MxaF, a Ca2+-dependent methanol dehydrogenase (MDH), is the main enzyme catalyzing methanol oxidation during growth on methanol. The genome of strain AM1 contains another MDH gene homologue, xoxF1, whose function in methanol metabolism has remained unclear. In this work, we show that XoxF1 also functions as an MDH and is La3+-dependent. Despite the absence of Ca2+ in the medium strain AM1 was able to grow on methanol in the presence of La3+. Addition of La3+ increased MDH activity but the addition had no effect on mxaF or xoxF1 expression level. We purified MDH from strain AM1 grown on methanol in the presence of La3+, and its N-terminal amino acid sequence corresponded to that of XoxF1. The enzyme contained La3+ as a cofactor. The Delta mxaF mutant strain could not grow on methanol in the presence of Ca2+, but was able to grow after supplementation with La3+. Taken together, these results show that XoxF1 participates in methanol metabolism as a La3+-dependent MDH in strain AM1.	[Nakagawa, Tomoyuki; Sasa, Kentaro; Tashiro, Shinya; Iwama, Tomonori; Hayakawa, Takashi] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Mitsui, Ryoji] Okayama Univ Sci, Fac Sci, Dept Biochem, Kita Ku, Okayama, Japan; [Tani, Akio] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Kawai, Keiichi] Tokai Gakuin Univ, Gifu, Japan	Gifu University; Okayama University of Science; Okayama University	Nakagawa, T (corresponding author), Gifu Univ, Fac Appl Biol Sci, Gifu, Japan.	t_nakaga@gifu-u.ac.jp	TANI, Akio/B-2516-2011	Nakagawa, Tomoyuki/0000-0003-0112-0349; Tani, Akio/0000-0001-7685-9063				Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Anthony C, 2003, BBA-PROTEINS PROTEOM, V1647, P18, DOI 10.1016/S1570-9639(03)00042-6; Anthony C, 2000, Subcell Biochem, V35, P73; ANTHONY C, 1964, BIOCHEM J, V92, P614, DOI 10.1042/bj0920614; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown P.H., 1990, HDB PHYS CHEM RARE E, V13, ed., P423, DOI DOI 10.1016/S0168-1273(05)80135-7; Chistoserdova L, 1997, MICROBIOL-UK, V143, P1729, DOI 10.1099/00221287-143-5-1729; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; DAY DJ, 1990, METHOD ENZYMOL, V188, P210; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Erdmann F, 2009, FEBS LETT, V583, P2359, DOI 10.1016/j.febslet.2009.06.032; Fitriyanto NA, 2011, J BIOSCI BIOENG, V111, P613, DOI 10.1016/j.jbiosc.2011.01.015; Gourion B, 2006, P NATL ACAD SCI USA, V103, P13186, DOI 10.1073/pnas.0603530103; HARDER W, 1973, J GEN MICROBIOL, V78, P155, DOI 10.1099/00221287-78-1-155; Hibi Y, 2011, J BIOSCI BIOENG, V111, P547, DOI 10.1016/j.jbiosc.2010.12.017; Holland MA, 2002, PHYLLOSPHERE MICROBIOLOGY, P125; Kawaguchi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025257; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; LIDSTROM ME, 1994, FEMS MICROBIOL LETT, V117, P103, DOI 10.1111/j.1574-6968.1994.tb06749.x; Liu P, 2004, J INORG BIOCHEM, V98, P68, DOI 10.1016/j.jinorgbio.2003.08.012; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; NUNN DN, 1986, J BACTERIOL, V166, P591, DOI 10.1128/jb.166.2.591-597.1986; NUNN DN, 1986, J BACTERIOL, V166, P581, DOI 10.1128/jb.166.2.581-590.1986; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Schmidt S, 2010, MICROBIOL-SGM, V156, P2575, DOI 10.1099/mic.0.038570-0; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skovran E, 2011, J BACTERIOL, V193, P6032, DOI 10.1128/JB.05367-11; Springer AL, 1997, MICROBIOL-UK, V143, P1737, DOI 10.1099/00221287-143-5-1737; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; Tyler G, 2005, BIOL TRACE ELEM RES, V106, P177, DOI 10.1385/BTER:106:2:177; Tyler G, 2004, PLANT SOIL, V267, P191, DOI 10.1007/s11104-005-4888-2; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Wang LH, 2010, J BIOL INORG CHEM, V15, P1063, DOI 10.1007/s00775-010-0665-7; Williams PA, 2005, ACTA CRYSTALLOGR D, V61, P75, DOI 10.1107/S0907444904026964	38	118	120	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50480	10.1371/journal.pone.0050480	http://dx.doi.org/10.1371/journal.pone.0050480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209751	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800074
J	Rizzo, G; Tozer, KR; Tonon, C; Manners, D; Testa, C; Malucelli, E; Valentino, ML; La Morgia, C; Barboni, P; Randhawa, RS; Ross-Cisneros, FN; Sadun, AA; Carelli, V; Lodi, R				Rizzo, Giovanni; Tozer, Kevin R.; Tonon, Caterina; Manners, David; Testa, Claudia; Malucelli, Emil; Valentino, Maria Lucia; La Morgia, Chiara; Barboni, Piero; Randhawa, Ruvdeep S.; Ross-Cisneros, Fred N.; Sadun, Alfredo A.; Carelli, Valerio; Lodi, Raffaele			Secondary Post-Geniculate Involvement in Leber's Hereditary Optic Neuropathy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; FIBER LAYER EVALUATION; OPHTHALMOLOGIC FINDINGS; COHERENCE TOMOGRAPHY; MULTIPLE-SCLEROSIS; VISUAL-SYSTEM; BRAIN; ATROPHY; NERVE; DEGENERATION	Leber's hereditary optic neuropathy (LHON) is characterized by retinal ganglion cell (RGC) degeneration with the preferential involvement of those forming the papillomacular bundle. The optic nerve is considered the main pathological target for LHON. Our aim was to investigate the possible involvement of the post-geniculate visual pathway in LHON patients. We used diffusion-weighted imaging for in vivo evaluation. Mean diffusivity maps from 22 LHON visually impaired, 11 unaffected LHON mutation carriers and 22 healthy subjects were generated and compared at level of optic radiation (OR). Prefrontal and cerebellar white matter were also analyzed as internal controls. Furthermore, we studied the optic nerve and the lateral geniculate nucleus (LGN) in post-mortem specimens obtained from a severe case of LHON compared to an age-matched control. Mean diffusivity values of affected patients were higher than unaffected mutation carriers (P<0.05) and healthy subjects (P<0.01) in OR and not in the other brain regions. Increased OR diffusivity was associated with both disease duration (B = 0.002; P<0.05) and lack of recovery of visual acuity (B = 0.060; P<0.01). Post-mortem investigation detected atrophy (41.9% decrease of neuron soma size in the magnocellular layers and 44.7% decrease in the parvocellular layers) and, to a lesser extent, degeneration (28.5% decrease of neuron density in the magnocellular layers and 28.7% decrease in the parvocellular layers) in the LHON LGN associated with extremely severe axonal loss (99%) in the optic nerve. The post-geniculate involvement in LHON patients is a downstream post-synaptic secondary phenomenon, reflecting deafferentation rather than a primary neurodegeneration due to mitochondrial dysfunction of LGN neurons. Citation: Rizzo G, Tozer KR, Tonon C, Manners D, Testa C, et al. (2012) Secondary Post-Geniculate Involvement in Leber's Hereditary Optic Neuropathy. PLoS ONE 7(11): e50230. doi: 10.1371/journal.pone.0050230	[Rizzo, Giovanni; Tonon, Caterina; Manners, David; Testa, Claudia; Malucelli, Emil; Valentino, Maria Lucia; La Morgia, Chiara; Carelli, Valerio; Lodi, Raffaele] Univ Bologna, Dept Biomed & NeuroMotor Sci DiBiNeM, Bologna, Italy; [Rizzo, Giovanni; Valentino, Maria Lucia; La Morgia, Chiara; Carelli, Valerio] IRCCS Ist Sci Neurol, Bologna, Italy; [Tozer, Kevin R.; Randhawa, Ruvdeep S.; Ross-Cisneros, Fred N.; Sadun, Alfredo A.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Tozer, Kevin R.; Randhawa, Ruvdeep S.; Ross-Cisneros, Fred N.; Sadun, Alfredo A.] Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Barboni, Piero] Studio Oculistico Azeglio, Bologna, Italy	University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Southern California; Doheny Eye Institute; University of Southern California	Carelli, V (corresponding author), Univ Bologna, Dept Biomed & NeuroMotor Sci DiBiNeM, Bologna, Italy.	valerio.carelli@unibo.it; raffaele.lodi@unibo.it	Tonon, Caterina/K-6680-2016; Lodi, Raffaele/K-4984-2016; Rizzo, Giovanni/AAB-9888-2020; Malucelli, Emil/I-3991-2017; Manners, David N/J-2415-2012; La Morgia, Chiara/H-6765-2012; Barboni, Piero/AAA-9936-2020	Rizzo, Giovanni/0000-0002-9718-2044; Malucelli, Emil/0000-0002-1077-0098; Manners, David N/0000-0002-2404-1101; Barboni, Piero/0000-0002-0118-4177; TONON, CATERINA/0000-0002-0506-499X; TESTA, CLAUDIA/0000-0002-8591-9803; VALENTINO, MARIA LUCIA/0000-0001-5323-0115; Lodi, Raffaele/0000-0003-3878-304X; LA MORGIA, Chiara/0000-0002-4639-8929; CARELLI, VALERIO/0000-0003-4923-6404	Telethon-Italy [GGP06233]; Research to Prevent Blindness; Struggling Within Leber's; Eierman Foundation; Poincenot C.U.R.E. LHON Campaign; National Institute on Aging [P50-AG05142-27]; National Institutes of Health [EY03040]; International Foundation for Optic Nerve Diseases (IFOND); NATIONAL EYE INSTITUTE [P30EY003040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005142] Funding Source: NIH RePORTER	Telethon-Italy(Fondazione Telethon); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Struggling Within Leber's; Eierman Foundation; Poincenot C.U.R.E. LHON Campaign; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Foundation for Optic Nerve Diseases (IFOND); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by Telethon-Italy, grant GGP06233 (V.C.), Research to Prevent Blindness (K.R.T., F.N.R.-C. and A.A.S.), Struggling Within Leber's (K.R.T., F.N.R.-C. and A.A.S.), the Eierman Foundation (K.R.T., F.N.R.-C. and A.A.S.), the Poincenot C.U.R.E. LHON Campaign (K.R.T., F.N.R.-C. and A.A.S.), the National Institute on Aging grant P50-AG05142-27, the National Institutes of Health grant EY03040 (K.R.T., F.N.R.-C. and A.A.S.) and the International Foundation for Optic Nerve Diseases (IFOND) (K.R.T., F.N.R.-C. and A.A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1966, BRAIN, V89, P15, DOI 10.1093/brain/89.1.15; Aperio Technologies, 2005, SCANSC CS US GUID; Aubert-Broche B, 2011, NEUROIMAGE, V58, P409, DOI 10.1016/j.neuroimage.2011.03.025; BARBIROLI B, 1995, NEUROLOGY, V45, P1364, DOI 10.1212/WNL.45.7.1364; Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034; Barcella V, 2010, HUM BRAIN MAPP, V31, P1900, DOI 10.1002/hbm.20985; BEATTY RM, 1982, J NEUROL NEUROSUR PS, V45, P143, DOI 10.1136/jnnp.45.2.143; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Carelli V, 2011, BRAIN, V134, DOI 10.1093/brain/awr180; Ciccarelli O, 2005, HUM BRAIN MAPP, V25, P308, DOI 10.1002/hbm.20101; Concha L, 2006, NEUROIMAGE, V32, P1090, DOI 10.1016/j.neuroimage.2006.04.187; CORTELLI P, 1991, NEUROLOGY, V41, P1211, DOI 10.1212/WNL.41.8.1211; Cowan W. M., 1970, CONT RES METHODS NEU, P217, DOI 10.1007/978-3-642-85986-1_11; Fortuna F, 2009, BRAIN, V132, P116, DOI 10.1093/brain/awn269; Haselgrove JC, 1996, MAGNET RESON MED, V36, P960, DOI 10.1002/mrm.1910360620; Inglese M, 2001, J NEUROL SCI, V188, P33, DOI 10.1016/S0022-510X(01)00542-1; Inglese M, 2001, J NEUROL NEUROSUR PS, V70, P444, DOI 10.1136/jnnp.70.4.444; JOHNSON BM, 1987, AGE, V10, P5, DOI 10.1007/BF02431765; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; KWITTKEN J, 1958, AM J PATHOL, V34, P185; La Morgia C, 2010, BRAIN, V133, P2426, DOI 10.1093/brain/awq155; Lodi R, 2000, BRAIN, V123, P1896, DOI 10.1093/brain/123.9.1896; Lodi R, 2002, J NEUROL NEUROSUR PS, V72, P805, DOI 10.1136/jnnp.72.6.805; Milesi J, 2012, J NEUROL, V259, P1801, DOI 10.1007/s00415-011-6406-1; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rizzo G, 2008, BRAIN, V131, P2690, DOI 10.1093/brain/awn195; Rizzo G, 2011, MOVEMENT DISORD, V26, P705, DOI 10.1002/mds.23518; Sacai PY, 2010, DOC OPHTHALMOL, V121, P147, DOI 10.1007/s10633-010-9241-2; Sadun A A, 2000, Trans Am Ophthalmol Soc, V98, P223; Sadun F, 2004, AM J OPHTHALMOL, V137, P271, DOI 10.1016/j.ajo.2003.08.010; Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033; Sepulcre J, 2009, ARCH NEUROL-CHICAGO, V66, P173, DOI 10.1001/archneurol.2008.562; WILSON J, 1963, BRAIN, V86, P347, DOI 10.1093/brain/86.2.347; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Yucel Y, 2008, PROG BRAIN RES, V173, P465, DOI 10.1016/S0079-6123(08)01132-1	38	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50230	10.1371/journal.pone.0050230	http://dx.doi.org/10.1371/journal.pone.0050230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209682	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800055
J	Siddall, NA; Kalcina, M; Johanson, TM; Monk, AC; Casagranda, F; Been, RP; McLaughlin, EA; Hime, GR				Siddall, Nicole A.; Kalcina, Marina; Johanson, Timothy M.; Monk, Adrian C.; Casagranda, Franca; Been, Reeva P.; McLaughlin, Eileen A.; Hime, Gary R.			Drosophila Rbp6 Is an Orthologue of Vertebrate Msi-1 and Msi-2, but Does Not Function Redundantly with dMsi to Regulate Germline Stem Cell Behaviour	PLOS ONE			English	Article							BINDING PROTEIN MUSASHI1; PEDIATRIC BRAIN-TUMORS; GENE-EXPRESSION; PROGENITOR CELLS; NEURAL STEM; MYELOID-LEUKEMIA; MESSENGER-RNA; MAMMALIAN CNS; SELF-RENEWAL; MARKER	The vertebrate RNA-binding proteins, Musashi-1 (Msi-1) and Musashi-2 (Msi-2) are expressed in multiple stem cell populations. A role for Musashi proteins in preventing stem cell differentiation has been suggested from genetic analysis of the Drosophila family member, dMsi, and both vertebrate Msi proteins function co-operatively to regulate neural stem cell behaviour. Here we have identified a second Drosophila Msi family member, Rbp6, which shares more amino acid identity with vertebrate Msi-1 and Msi-2 than dMsi. We generated an antibody that detects most Rbp6 splice isoforms and show that Rbp6 is expressed in multiple tissues throughout development. However, Rbp6 deletion mutants generated in this study are viable and fertile, and show only minor defects. We used Drosophila spermatogonial germline stem cells (GSC's) as a model to test whether Drosophila Msi proteins function redundantly to regulate stem cell behaviour. However, like vertebrate Msi-1 and Msi-2, Rbp6 and Msi do not appear to be co-expressed in spermatogenic GSC's and do not function co-operatively in the regulation of GSC maintenance. Thus while two Msi family members are present in Drosophila, the function of the family members have diverged.	[Siddall, Nicole A.; Kalcina, Marina; Johanson, Timothy M.; Monk, Adrian C.; Casagranda, Franca; Been, Reeva P.; Hime, Gary R.] Univ Melbourne, Parkville, Vic 3052, Australia; [Siddall, Nicole A.; Kalcina, Marina; Monk, Adrian C.; McLaughlin, Eileen A.; Hime, Gary R.] ARC Ctr Excellence Biotechnol & Dev, Callaghan, NSW, Australia; [McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Melbourne; University of Newcastle	Hime, GR (corresponding author), Univ Melbourne, Parkville, Vic 3052, Australia.	g.hime@unimelb.edu.au	McLaughlin, Eileen A/G-7620-2013; Hime, Gary/B-7162-2015; McLaughlin, Eileen/AAF-5588-2021	Hime, Gary/0000-0003-4732-3184; McLaughlin, Eileen/0000-0002-5837-3876	Australian Research Council Centre of Excellence in Biotechnology and Development; National Health and Medical Research Council [569234]	Australian Research Council Centre of Excellence in Biotechnology and Development(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian Research Council Centre of Excellence in Biotechnology and Development, www.arc.gov.au, and the National Health and Medical Research Council Project Grant No. 569234, www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka Y, 2005, HISTOPATHOLOGY, V47, P348, DOI 10.1111/j.1365-2559.2005.02223.x; Akindahunsi AA, 2005, COMPUT BIOL CHEM, V29, P13, DOI 10.1016/j.compbiolchem.2004.11.002; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Callan MA, 2011, GENESIS, V49, P424, DOI 10.1002/dvg.20745; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; Djiane A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011228; FULLER MT, 1993, DEV DROSOPHILA MELAN, V1, P71; Gotte M, 2008, J PATHOL, V215, P317, DOI 10.1002/path.2364; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harris RE, 2011, EMBO REP, V12, P519, DOI 10.1038/embor.2011.80; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hime GR, 1996, J CELL SCI, V109, P2779; Hirota Y, 1999, MECH DEVELOP, V87, P93, DOI 10.1016/S0925-4773(99)00143-4; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Hope KJ, 2011, CURR OPIN HEMATOL, V18, P203, DOI 10.1097/MOH.0b013e328347888a; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; McCall K, 2004, METH MOL B, V247, P431; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Nakano A, 2007, PEDIATR NEUROSURG, V43, P279, DOI 10.1159/000103307; Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sakakibara S, 2001, J NEUROSCI, V21, P8091, DOI 10.1523/JNEUROSCI.21-20-08091.2001; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Schierwater B, 2005, BIOESSAYS, V27, P1294, DOI 10.1002/bies.20320; Schulenburg A, 2007, J PATHOL, V213, P152, DOI 10.1002/path.2220; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Siddall NA, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-64; Spradling A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002642; Sugiyama-Nakagiri Y, 2006, AM J PATHOL, V168, P80, DOI 10.2353/ajpath.2006.050469; Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Toda M, 2001, GLIA, V34, P1, DOI 10.1002/glia.1034; Van Doren M, 1998, CURR BIOL, V8, P243; Walker E, 2011, CELL CYCLE, V10, P45, DOI 10.4161/cc.10.1.14389; Wuebben EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034827; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475	52	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49810	10.1371/journal.pone.0049810	http://dx.doi.org/10.1371/journal.pone.0049810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209605	gold, Green Published			2022-12-25	WOS:000311885800024
J	Li, WL; Gao, Y; Xu, H; Zhang, Y; Wang, JB				Li, Wenlan; Gao, Yi; Xu, Hong; Zhang, Yu; Wang, Jianbo			A Proteomic Analysis of Seed Development in Brassica campestri L	PLOS ONE			English	Article							LEGUME LOTUS-JAPONICUS; PLANT EMBRYOGENESIS; MICROARRAY ANALYSIS; REVEALS DIFFERENCES; ENDOSPERM PROTEOME; PATTERN-FORMATION; GENE-EXPRESSION; ARABIDOPSIS; EMBRYO; METABOLISM	To gain insights into the protein dynamics during seed development, a proteomic study on the developing Brassica campestri L. seeds with embryos in different embryogenesis stages was carried out. The seed proteins at 10, 16, 20, 25 and 35 DAP (days after pollination), respectively, were separated using two-dimensional gel electrophoresis and identities of 209 spots with altered abundance were determined by matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry (MALDI-TOF/TOF MS). These proteins were classified into 16 groups according to their functions. The most abundant proteins were related to primary metabolism, indicating the heavy demand of materials for rapid embryo growth. Besides, the high amount of proteins involved in protein processing and destination indicated importance of protein renewal during seed development. The remaining were those participated in oxidation/detoxification, energy, defense, transcription, protein synthesis, transporter, cell structure, signal transduction, secondary metabolism, transposition, DNA repair, storage and so on. Protein abundance profiles of each functional class were generated and hierarchical cluster analysis established 8 groups of dynamic patterns. Our results revealed novel characters of protein dynamics in seed development in Brassica campestri L. and provided valuable information about the complex process of seed development in plants.	[Li, Wenlan; Gao, Yi; Xu, Hong; Zhang, Yu; Wang, Jianbo] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China; [Li, Wenlan] Guilin Univ Technol, Coll Chem & Bioengn, Guilin, Peoples R China	Wuhan University; Guilin University of Technology	Wang, JB (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	jbwang@whu.edu.cn			National Key Basic Research Program of China [2013CB126900]; National Natural Science Foundation of China [31070204]; Chinese 111 Project	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Key Basic Research Program of China (2013CB126900), National Natural Science Foundation of China (31070204) and the Chinese 111 Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2008, PLANT PHYSIOL, V148, P504, DOI 10.1104/pp.108.119222; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Beers EP, 2004, PHYTOCHEMISTRY, V65, P43, DOI 10.1016/j.phytochem.2003.09.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chaudhury AM, 1998, CURR OPIN PLANT BIOL, V1, P26, DOI 10.1016/S1369-5266(98)80123-4; Chaudhury AM, 2001, ANNU REV CELL DEV BI, V17, P677, DOI 10.1146/annurev.cellbio.17.1.677; Chen GH, 2002, PLANT CELL PHYSIOL, V43, P984, DOI 10.1093/pcp/pcf125; Chen SX, 2006, PROTEOMICS, V6, P5504, DOI 10.1002/pmic.200600143; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; Chua YL, 2004, PLANT J, V37, P789, DOI 10.1111/j.1365-313X.2004.02007.x; Cordewener J, 2009, ADVANCES IN HAPLOID PRODUCTION IN HIGHER PLANTS, P135, DOI 10.1007/978-1-4020-8854-4_10; DALGALARRONDO M, 1986, PLANT SCI, V43, P115, DOI 10.1016/0168-9452(86)90151-2; Dam S, 2009, PLANT PHYSIOL, V149, P1325, DOI 10.1104/pp.108.133405; Dong JZ, 2004, PLANTA, V218, P483, DOI 10.1007/s00425-003-1124-2; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; FONTES EBP, 1991, PLANT CELL, V3, P483, DOI 10.1105/tpc.3.5.483; Gallardo K, 2003, PLANT PHYSIOL, V133, P664, DOI 10.1104/pp.103.025254; Gallardo K, 2001, PLANT PHYSIOL, V126, P835, DOI 10.1104/pp.126.2.835; Girke T, 2000, PLANT PHYSIOL, V124, P1570, DOI 10.1104/pp.124.4.1570; GOLDBERG RB, 1994, SCIENCE, V266, P605, DOI 10.1126/science.266.5185.605; Guo HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022255; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hajduch M, 2006, PLANT PHYSIOL, V141, P32, DOI 10.1104/pp.105.075390; Hajduch M, 2011, PROTEOMICS, V11, P1619, DOI 10.1002/pmic.201000644; Hajduch M, 2010, PLANT PHYSIOL, V152, P2078, DOI 10.1104/pp.109.152413; Harada JJ, 1999, CURR OPIN PLANT BIOL, V2, P23, DOI 10.1016/S1369-5266(99)80005-3; Hochholdinger F, 2006, PROTEOMICS, V6, P4076, DOI 10.1002/pmic.200500851; HOGLUND AS, 1992, PLANT PHYSIOL, V98, P509, DOI 10.1104/pp.98.2.509; Houston NL, 2005, PLANT PHYSIOL, V137, P762, DOI 10.1104/pp.104.056507; Houston NL, 2009, PLANT PHYSIOL, V151, P857, DOI 10.1104/pp.109.141622; Irar S, 2010, J PROTEOMICS, V73, P1707, DOI 10.1016/j.jprot.2010.05.003; Ivashikina N, 2005, J GEN PHYSIOL, V125, P483, DOI 10.1085/jgp.200409211; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kim ST, 2008, PROTEOMICS, V8, P3577, DOI 10.1002/pmic.200800183; Kim ST, 2009, J PROTEOME RES, V8, P3598, DOI 10.1021/pr900358s; Li WL, 2012, ACTA PHYSIOL PLANT, V34, P669, DOI 10.1007/s11738-011-0867-9; Liu H, 2009, J INTEGR PLANT BIOL, V51, P850, DOI 10.1111/j.1744-7909.2009.00839.x; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; Mayer U, 1998, SEMIN CELL DEV BIOL, V9, P187, DOI 10.1006/scdb.1997.0210; Mechin V, 2007, PLANT PHYSIOL, V143, P1203, DOI 10.1104/pp.106.092148; Miernyk JA, 2011, J PROTEOMICS, V74, P389, DOI 10.1016/j.jprot.2010.12.004; Nautrup-Pedersen G, 2010, J PROTEOME RES, V9, P5715, DOI 10.1021/pr100511u; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Schwender J, 2003, J BIOL CHEM, V278, P29442, DOI 10.1074/jbc.M303432200; Sheoran IS, 2007, J EXP BOT, V58, P3525, DOI 10.1093/jxb/erm199; Spencer MWB, 2007, PLANT PHYSIOL, V143, P924, DOI 10.1104/pp.106.087668; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vitale A, 2004, PLANT PHYSIOL, V136, P3420, DOI 10.1104/pp.104.050351; WEST MAL, 1993, PLANT CELL, V5, P1361, DOI 10.1105/tpc.5.10.1361; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Xue LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031081	56	15	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50290	10.1371/journal.pone.0050290	http://dx.doi.org/10.1371/journal.pone.0050290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189193	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800070
J	Garcia-Perez, D; Laorden, ML; Milanes, MV; Nunez, C				Garcia-Perez, Daniel; Luisa Laorden, M.; Victoria Milanes, M.; Nunez, Cristina			Glucocorticoids Regulation of FosB/Delta FosB Expression Induced by Chronic Opiate Exposure in the Brain Stress System	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; DELTA-FOSB; PARAVENTRICULAR NUCLEUS; MORPHINE-WITHDRAWAL; GENE-EXPRESSION; MESSENGER-RNA; DRUG-ADDICTION; EPIGENETIC MECHANISMS; INDUCTION; COCAINE	Chronic use of drugs of abuse profoundly alters stress-responsive system. Repeated exposure to morphine leads to accumulation of the transcription factor Delta FosB, particularly in brain areas associated with reward and stress. The persistent effects of Delta FosB on target genes may play an important role in the plasticity induced by drugs of abuse. Recent evidence suggests that stress-related hormones (e. g., glucocorticoids, GC) may induce adaptations in the brain stress system that is likely to involve alteration in gene expression and transcription factors. This study examined the role of GC in regulation of FosB/Delta FosB in both hypothalamic and extrahypothalamic brain stress systems during morphine dependence. For that, expression of FosB/Delta FosB was measured in control (sham-operated) and adrenalectomized (ADX) rats that were made opiate dependent after ten days of morphine treatment. In sham-operated rats, FosB/Delta FosB was induced after chronic morphine administration in all the brain stress areas investigated: nucleus accumbens(shell) (NAc), bed nucleus of the stria terminalis (BNST), central amygdala (CeA), hypothalamic paraventricular nucleus (PVN) and nucleus of the solitary tract noradrenergic cell group (NTS-A(2)). Adrenalectomy attenuated the increased production of FosB/Delta FosB observed after chronic morphine exposure in NAc, CeA, and NTS. Furthermore, ADX decreased expression of FosB/Delta FosB within CRH-positive neurons of the BNST, PVN and CeA. Similar results were obtained in NTS-A(2) TH-positive neurons and NAc pro-dynorphin-positive neurons. These data suggest that neuroadaptation (estimated as accumulation of FosB/Delta FosB) to opiates in brain areas associated with stress is modulated by GC, supporting the evidence of a link between brain stress hormones and addiction.	[Garcia-Perez, Daniel; Luisa Laorden, M.; Victoria Milanes, M.; Nunez, Cristina] Univ Sch Med, Dept Pharmacol, Grp Cellular & Mol Pharmacol, Murcia, Spain	University of Murcia	Nunez, C (corresponding author), Univ Sch Med, Dept Pharmacol, Grp Cellular & Mol Pharmacol, Murcia, Spain.	crisnp@um.es	Milanés, M Victoria/K-6591-2017; Núñez, Cristina/O-8288-2015; Milanés, M. Victoria/AGB-4075-2022	Milanés, M Victoria/0000-0002-0984-2218; Núñez, Cristina/0000-0002-0773-4950; Milanés, M. Victoria/0000-0002-0984-2218	Ministerio de Ciencia e Imnovacion, Spain [SAF/FEDER 2009-07178, SAF/FEDER 2010-17907]; Red de Trastornos Adictivos, Spain [RD06/0001/1006, RD06/0001/1001]; Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia, Spain [15405/PI10]; Ministerio de Ciencia e Innovacion [AP2009-2379]	Ministerio de Ciencia e Imnovacion, Spain; Red de Trastornos Adictivos, Spain; Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia, Spain; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the following grants: Ministerio de Ciencia e Imnovacion (SAF/FEDER 2009-07178 and SAF/FEDER 2010-17907), Spain; Red de Trastornos Adictivos (RD06/0001/1006 and RD06/0001/1001), Spain; Fundacion Seneca, Agencia Regional de Ciencia y Tecnologia Region de Murcia (15405/PI10), Spain. DG-P is supported by a fellowship from the Ministerio de Ciencia e Innovacion (AP2009-2379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Carrasco GA, 2003, EUR J PHARMACOL, V463, P235, DOI 10.1016/S0014-2999(03)01285-8; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; Chen JS, 1997, J NEUROSCI, V17, P4933; Cleck JN, 2008, J CLIN INVEST, V118, P454, DOI 10.1172/JCI33946; Crespo JA, 2003, MOL BRAIN RES, V117, P160, DOI 10.1016/s0169-328X(03)00316-4; Deroche-Gamonet V, 2003, J NEUROSCI, V23, P4785; Dunn AJ, 2008, EUR J PHARMACOL, V583, P186, DOI 10.1016/j.ejphar.2007.11.069; Frenois F, 2002, EUR J NEUROSCI, V16, P1377, DOI 10.1046/j.1460-9568.2002.02187.x; Gago B, 2011, BRAIN RES, V1407, P47, DOI 10.1016/j.brainres.2011.06.046; GOLD LH, 1994, EUR J PHARMACOL, V253, P45, DOI 10.1016/0014-2999(94)90755-2; Goodman A, 2008, BIOCHEM PHARMACOL, V75, P266, DOI 10.1016/j.bcp.2007.07.030; HUGHES P, 1995, PHARMACOL REV, V47, P133; Hutchison ER, 2009, NEUROMOL MED, V11, P153, DOI 10.1007/s12017-009-8086-x; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kaplan GB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023574; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Koob GF, 2008, PHILOS T R SOC B, V363, P3113, DOI 10.1098/rstb.2008.0094; Koob GF, 2008, NEURON, V59, P11, DOI 10.1016/j.neuron.2008.06.012; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; Koob GF, 2006, ADDICTION, V101, P23, DOI 10.1111/j.1360-0443.2006.01586.x; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; KOVACS GL, 1988, BRAIN RES BULL, V20, P893, DOI 10.1016/0361-9230(88)90107-4; Kovacs KJ, 2000, J NEUROSCI, V20, P3843, DOI 10.1523/JNEUROSCI.20-10-03843.2000; Li MD, 2011, MOL PSYCHIATR, V16, P1159, DOI 10.1038/mp.2011.58; Laorden ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036871; Maj M, 2003, NEUROPEPTIDES, V37, P105, DOI 10.1016/S0143-4179(03)00021-0; MAKINO S, 1994, BRAIN RES, V640, P105, DOI 10.1016/0006-8993(94)91862-7; MAKINO S, 1994, BRAIN RES, V657, P141, DOI 10.1016/0006-8993(94)90961-X; McClung CA, 2005, J NEUROSCI, V25, P6005, DOI 10.1523/JNEUROSCI.0062-05.2005; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; Moratalla R, 1996, NEURON, V17, P147, DOI 10.1016/S0896-6273(00)80288-3; MUMBERG D, 1991, GENE DEV, V5, P1212, DOI 10.1101/gad.5.7.1212; Muschamp JW, 2012, BIOL PSYCHIAT, V71, P44, DOI 10.1016/j.biopsych.2011.08.011; Navarro-Zaragoza J, 2012, BRIT J PHARMACOL, V166, P2136, DOI 10.1111/j.1476-5381.2012.01918.x; Navarro-Zaragoza J, 2011, BRIT J PHARMACOL, V162, P851, DOI 10.1111/j.1476-5381.2010.01090.x; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Nunez C, 2007, J NEUROCHEM, V101, P1060, DOI 10.1111/j.1471-4159.2006.04421.x; Nunez C, 2010, J NEUROCHEM, V114, P475, DOI 10.1111/j.1471-4159.2010.06765.x; Nunez C, 2009, ENDOCRINOLOGY, V150, P3118, DOI 10.1210/en.2008-1732; Nye HE, 1996, MOL PHARMACOL, V49, P636; Palkovits M, 1998, NEUROSCIENCE, V85, P135, DOI 10.1016/S0306-4522(97)00621-0; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Perrotti LI, 2004, J NEUROSCI, V24, P10594, DOI 10.1523/JNEUROSCI.2542-04.2004; Piazza PV, 1997, BRAIN RES REV, V25, P359, DOI 10.1016/S0165-0173(97)00025-8; Rani CSS, 2009, MOL PHARMACOL, V75, P589, DOI 10.1124/mol.108.051219; Renthal W, 2008, TRENDS MOL MED, V14, P341, DOI 10.1016/j.molmed.2008.06.004; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Roozendaal B, 2006, NEUROSCIENCE, V138, P901, DOI 10.1016/j.neuroscience.2005.07.049; Sabban EL, 1995, ANN NY ACAD SCI, V771, P327, DOI 10.1111/j.1749-6632.1995.tb44692.x; Sim-Selley LJ, 2011, NEUROPHARMACOLOGY, V61, P1470, DOI 10.1016/j.neuropharm.2011.08.046; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Smith RJ, 2008, BRAIN STRUCT FUNCT, V213, P43, DOI 10.1007/s00429-008-0191-3; SWANSON LW, 1989, J COMP NEUROL, V285, P413, DOI 10.1002/cne.902850402; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Viau V, 2001, J NEUROENDOCRINOL, V13, P442, DOI 10.1046/j.1365-2826.2001.00653.x; Volkow ND, 2012, NEUROPSYCHOPHARMACOL, V37, P290, DOI 10.1038/npp.2011.84; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636	60	27	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50264	10.1371/journal.pone.0050264	http://dx.doi.org/10.1371/journal.pone.0050264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185589	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000209
J	Le, DT; Nishiyama, R; Watanabe, Y; Tanaka, M; Seki, M; Ham, LH; Yamaguchi-Shinozaki, K; Shinozaki, K; Tran, LSP				Dung Tien Le; Nishiyama, Rie; Watanabe, Yasuko; Tanaka, Maho; Seki, Motoaki; Le Huy Ham; Yamaguchi-Shinozaki, Kazuko; Shinozaki, Kazuo; Lam-Son Phan Tran			Differential Gene Expression in Soybean Leaf Tissues at Late Developmental Stages under Drought Stress Revealed by Genome-Wide Transcriptome Analysis	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; REGULATORY NETWORKS; PLANT IMMUNITY; ABSCISIC-ACID; HIGH-SALINITY; SALT STRESS; TOLERANCE; RESPONSES; DEHYDRATION; CYTOKININS	The availability of complete genome sequence of soybean has allowed research community to design the 66 K Affymetrix Soybean Array GeneChip for genome-wide expression profiling of soybean. In this study, we carried out microarray analysis of leaf tissues of soybean plants, which were subjected to drought stress from late vegetative V6 and from full bloom reproductive R2 stages. Our data analyses showed that out of 46093 soybean genes, which were predicted with high confidence among approximately 66000 putative genes, 41059 genes could be assigned with a known function. Using the criteria of a ratio change >= 2 and a q-value <0.05, we identified 1458 and 1818 upregulated and 1582 and 1688 downregulated genes in drought-stressed V6 and R2 leaves, respectively. These datasets were classified into 19 most abundant biological categories with similar proportions. There were only 612 and 463 genes that were overlapped among the upregulated and downregulated genes, respectively, in both stages, suggesting that both conserved and unconserved pathways might be involved in regulation of drought response in different stages of plant development. A comparative expression analysis using our datasets and that of drought stressed Arabidopsis leaves revealed the existence of both conserved and species-specific mechanisms that regulate drought responses. Many upregulated genes encode either regulatory proteins, such as transcription factors, including those with high homology to Arabidopsis DREB, NAC, AREB and ZAT/STZ transcription factors, kinases and two-component system members, or functional proteins, e. g. late embryogenesis-abundant proteins, glycosyltransferases, glycoside hydrolases, defensins and glyoxalase I family proteins. A detailed analysis of the GmNAC family and the hormone-related gene category showed that expression of many GmNAC and hormone-related genes was altered by drought in V6 and/or R2 leaves. Additionally, the downregulation of many photosynthesis-related genes, which contribute to growth retardation under drought stress, may serve as an adaptive mechanism for plant survival. This study has identified excellent drought-responsive candidate genes for in-depth characterization and future development of improved drought-tolerant transgenic soybeans.	[Dung Tien Le; Nishiyama, Rie; Watanabe, Yasuko; Lam-Son Phan Tran] RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan; [Dung Tien Le; Le Huy Ham] Vietnamese Acad Agr Sci, Natl Key Lab Plant Cell Biotechnol, Hanoi, Vietnam; [Dung Tien Le; Le Huy Ham] Vietnamese Acad Agr Sci, Agr Genet Inst, Hanoi, Vietnam; [Tanaka, Maho; Seki, Motoaki] RIKEN Plant Sci Ctr, Plant Genom Network Res Team, Yokohama, Kanagawa, Japan; [Yamaguchi-Shinozaki, Kazuko] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki, Japan; [Shinozaki, Kazuo] RIKEN Plant Sci Ctr, Gene Discovery Res Grp, Yokohama, Kanagawa, Japan	RIKEN; RIKEN; Japan International Research Center for Agricultural Sciences; RIKEN	Tran, LSP (corresponding author), RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan.	tran@psc.riken.jp	Shinozaki, Kazuo/G-4202-2013; Tran, Lam-Son P/A-1346-2009; Seki, Motoaki/I-2854-2012; Shinozaki, Kazuo/AAB-4945-2019; Yamaguchi-Shinozaki, Kazuko/K-9004-2015; Le, Dung Tien/A-7276-2008	Shinozaki, Kazuo/0000-0002-6317-9867; Tran, Lam-Son P/0000-0001-9883-9768; Seki, Motoaki/0000-0001-8288-0467; Shinozaki, Kazuo/0000-0002-6317-9867; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Le, Dung Tien/0000-0002-5117-3476	RIKEN Strategic Research Program (Japan) [AP24-1-0076]; RIKEN Foreign Postdoctoral Fellowship (Japan)	RIKEN Strategic Research Program (Japan); RIKEN Foreign Postdoctoral Fellowship (Japan)	This work was supported by a RIKEN Foreign Postdoctoral Fellowship (Japan; http://www.riken.go.jp/engn/) to DTL and by a grant (No. AP24-1-0076) from the RIKEN Strategic Research Program for R & D (Japan; http://www.riken.go.jp/engn/) to L-SPT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Choi J, 2011, TRENDS PLANT SCI, V16, P388, DOI 10.1016/j.tplants.2011.03.003; Choudhary SP, 2012, TRENDS PLANT SCI, V17, P594, DOI 10.1016/j.tplants.2012.05.012; Choudhary SP, 2012, J EXP BOT, V63, P5659, DOI 10.1093/jxb/ers219; Choudhary SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033210; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042411; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Jogaiah S, 2012, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2012.659174, DOI 10.3109/07388551.2012.659174]; Krishnaswamy SS, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-91; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Ma Y, 2012, MOL PLANT, V5, P1176, DOI 10.1093/mp/sss085; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mochida K, 2010, BIOINFORMATICS, V26, P290, DOI 10.1093/bioinformatics/btp645; Mochida K, 2009, DNA RES, V16, P353, DOI 10.1093/dnares/dsp023; Mochida K, 2010, DNA RES, V17, P303, DOI 10.1093/dnares/dsq021; Nakashima K, 2011, BIOCH BIOPHYS ACTA; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Puranik S., 2012, TRENDS PLANT SCI; Qin F, 2011, PLANT PHYSIOL, V157, P1900, DOI 10.1104/pp.111.187302; Redillas MC, 2012, PLANT BIOTECHNOL J; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sulieman S, 2012, CRIT REV BIOTECHNOL; Takahashi F, 2011, MOL CELL, V41, P649, DOI 10.1016/j.molcel.2011.02.029; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tran LSP, 2009, MOL GENET GENOMICS, V281, P647, DOI 10.1007/s00438-009-0436-8; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Wang SK, 2010, FUNCT INTEGR GENOMIC, V10, P533, DOI 10.1007/s10142-010-0174-3; Wang ZY, 2012, P NATL ACAD SCI USA, V109, P7, DOI 10.1073/pnas.1118600109; Wu YR, 2009, CELL RES, V19, P1279, DOI 10.1038/cr.2009.108; Xu F, 2011, PLANT PHYSIOL, V157, P2131, DOI 10.1104/pp.111.182899; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SJ, 2010, MOL PLANT, V3, P469, DOI 10.1093/mp/ssq016; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhou JL, 2007, PLANT MOL BIOL, V63, P591, DOI 10.1007/s11103-006-9111-1	53	106	115	5	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e49522	10.1371/journal.pone.0049522	http://dx.doi.org/10.1371/journal.pone.0049522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23189148	gold, Green Submitted, Green Published			2022-12-25	WOS:000311333800028
J	Yamada, T; Umeyama, S; Matsuda, K				Yamada, Toru; Umeyama, Shinji; Matsuda, Keiji			Separation of fNIRS Signals into Functional and Systemic Components Based on Differences in Hemodynamic Modalities	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CEREBRAL-BLOOD-FLOW; DIFFUSE OPTICAL TOMOGRAPHY; OXYGEN-METABOLISM; NEURONAL-ACTIVITY; BRAIN ACTIVATION; VISUAL-CORTEX; BALLOON MODEL; ADULT HEAD; BOLD FMRI	In conventional functional near-infrared spectroscopy (fNIRS), systemic physiological fluctuations evoked by a body's motion and psychophysiological changes often contaminate fNIRS signals. We propose a novel method for separating functional and systemic signals based on their hemodynamic differences. Considering their physiological origins, we assumed a negative and positive linear relationship between oxy- and deoxyhemoglobin changes of functional and systemic signals, respectively. Their coefficients are determined by an empirical procedure. The proposed method was compared to conventional and multi-distance NIRS. The results were as follows: (1) Nonfunctional tasks evoked substantial oxyhemoglobin changes, and comparatively smaller deoxyhemoglobin changes, in the same direction by conventional NIRS. The systemic components estimated by the proposed method were similar to the above finding. The estimated functional components were very small. (2) During finger-tapping tasks, laterality in the functional component was more distinctive using our proposed method than that by conventional fNIRS. The systemic component indicated task-evoked changes, regardless of the finger used to perform the task. (3) For all tasks, the functional components were highly coincident with signals estimated by multi-distance NIRS. These results strongly suggest that the functional component obtained by the proposed method originates in the cerebral cortical layer. We believe that the proposed method could improve the reliability of fNIRS measurements without any modification in commercially available instruments.	[Yamada, Toru; Umeyama, Shinji; Matsuda, Keiji] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Yamada, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan.	toru.yamada@aist.go.jp	Yamada, Toru/N-5232-2016; Matsuda, Keiji/N-2784-2016	Yamada, Toru/0000-0002-1654-5166; Matsuda, Keiji/0000-0003-2529-0019	 [22500374]		This work was partly supported by Grant-in-Aid for Scientific Research 22500374. The funders (http://www.jsps.go.jp/english/index.html) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berwick J, 2002, J CEREBR BLOOD F MET, V22, P670, DOI 10.1097/00004647-200206000-00005; Blasi A, 2007, PHYS MED BIOL, V52, P6849, DOI 10.1088/0031-9155/52/23/005; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Boden S, 2007, NEUROIMAGE, V36, P100, DOI 10.1016/j.neuroimage.2007.01.045; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Colier WNJM, 2001, VISION RES, V41, P97, DOI 10.1016/S0042-6989(00)00219-4; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Dunn AK, 2005, NEUROIMAGE, V27, P279, DOI 10.1016/j.neuroimage.2005.04.024; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Franceschini MA, 2003, PSYCHOPHYSIOLOGY, V40, P548, DOI 10.1111/1469-8986.00057; Franceschini MA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2363365; Henderson LA, 2002, J NEUROPHYSIOL, V88, P3477, DOI 10.1152/jn.00107.2002; Huppert TJ, 2007, J CEREBR BLOOD F MET, V27, P1262, DOI 10.1038/sj.jcbfm.9600435; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jasdzewski G, 2003, NEUROIMAGE, V20, P479, DOI 10.1016/S1053-8119(03)00311-2; Jelzow A, 2011, PROC SPIE, V8088, DOI 10.1117/12.889484; Jin T, 2008, NEUROIMAGE, V43, P1, DOI 10.1016/j.neuroimage.2008.06.029; Kawaguchi H, 2007, APPL OPTICS, V46, P1658, DOI 10.1364/AO.46.001658; Kida I, 2007, J CEREBR BLOOD F MET, V27, P690, DOI 10.1038/sj.jcbfm.9600409; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kohno S, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2814249; Lee SP, 2001, MAGNET RESON MED, V45, P791, DOI 10.1002/mrm.1107; Lindauer U, 2003, BRAIN RES, V975, P135, DOI 10.1016/S0006-8993(03)02602-7; Lindauer Ute, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00025; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Madsen PL, 1999, PROG NEUROBIOL, V58, P541, DOI 10.1016/S0301-0082(98)00093-8; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; MATCHER SJ, 1995, ANAL BIOCHEM, V227, P54, DOI 10.1006/abio.1995.1252; McIntosh MA, 2010, INVEST OPHTH VIS SCI, V51, P4856, DOI 10.1167/iovs.09-4940; Minati L, 2011, J NEUROSCI METH, V197, P283, DOI 10.1016/j.jneumeth.2011.02.029; Moody M, 2005, AM J PHYSIOL-REG I, V288, pR1581, DOI 10.1152/ajpregu.00837.2004; Obrig H, 2000, INT J PSYCHOPHYSIOL, V35, P125, DOI 10.1016/S0167-8760(99)00048-3; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Okui N, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846076; Orihuela-Espina F, 2010, PHYS MED BIOL, V55, P3701, DOI 10.1088/0031-9155/55/13/009; Popel AS, 2005, ANNU REV FLUID MECH, V37, P43, DOI 10.1146/annurev.fluid.37.042604.133933; Roy C S, 1890, J Physiol, V11, P85; Saager RB, 2005, J OPT SOC AM A, V22, P1874, DOI 10.1364/JOSAA.22.001874; Saager RB, 2011, NEUROIMAGE, V55, P1679, DOI 10.1016/j.neuroimage.2011.01.043; Sakatani K, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2823036; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Siegel AM, 2003, PHYS MED BIOL, V48, P1391, DOI 10.1088/0031-9155/48/10/311; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P307, DOI 10.1007/978-0-387-85998-9_46; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Tang L, 2009, MAGN RESON IMAGING, V27, P449, DOI 10.1016/j.mri.2008.07.017; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Umeyama S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253350; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Yamada T, 2010, BIOS INT SOC OPTICS; Yamada T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275469; Yamamoto T, 2002, PHYS MED BIOL, V47, P3429, DOI 10.1088/0031-9155/47/18/311; Yamamoto T, 2002, PHYS MED BIOL, V47, P1121, DOI 10.1088/0031-9155/47/7/309; Zeff BW, 2007, P NATL ACAD SCI USA, V104, P12169, DOI 10.1073/pnas.0611266104; Zhang Q, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3615248; Zhang Q, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2754714; Zhao HJ, 2002, PHYS MED BIOL, V47, P2075, DOI 10.1088/0031-9155/47/12/306; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	60	95	95	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50271	10.1371/journal.pone.0050271	http://dx.doi.org/10.1371/journal.pone.0050271			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185590	Green Published, Green Submitted, gold			2022-12-25	WOS:000311333800075
J	Shamanna, RA; Hoque, M; Pe'ery, T; Mathews, MB				Shamanna, R. A.; Hoque, M.; Pe'ery, T.; Mathews, M. B.			Induction of p53, p21 and apoptosis by silencing the NF90/NF45 complex in human papilloma virus-transformed cervical carcinoma cells	ONCOGENE			English	Article						Apoptosis; human papilloma virus; transcription; p53; p21; NF90/NF45	DOUBLE-STRANDED-RNA; TUMOR-SUPPRESSOR P53; IL-2 MESSENGER-RNA; BINDING-PROTEIN; GENE-EXPRESSION; NUCLEAR EXPORT; TRANSLATIONAL CONTROL; NEGATIVE REGULATOR; E6 ONCOPROTEIN; CYCLE ARREST	The heterodimeric nuclear factor (NF) 90/NF45 complex (NF90/NF45) binds nucleic acids and is a multifunctional regulator of gene expression. Here we report that depletion of NF90/NF45 restores the expression of the p53 and p21 proteins in cervical carcinoma cells infected with high-risk human papillomaviruses (HPVs). Knockdown of either NF90 or NF45 by RNA interference led to greatly elevated levels of p53 and p21 proteins in HPV-derived HeLa and SiHa cells but not in other cancerous or normal cell lines. In HeLa cells, p21 messenger-RNA (mRNA) increased concomitantly but the level of p53 mRNA was unaffected. RNA interference directed against p53 prevented the induction of both proteins. These results indicated that the upregulation of p21 is due to p53-dependent transcription, whereas p53 is regulated post-transcriptionally. Proteasome-mediated turnover of p53 is accelerated by the HPV E6 and cellular E6AP proteins. We therefore examined the hypothesis that this pathway is regulated by NF90/NF45. Indeed, depletion of NF90 attenuated the expression of E6 RNA and inhibited transcription from the HPV early promoter, revealing a new role for NF90/NF45 in HPV gene expression. The transcription inhibition was largely independent of the reduction of P-TEFb (positive transcription elongation factor b) levels caused by NF90 depletion. Consistent with p53 derepression, NF90/NF45-depleted HeLa cells displayed elevated poly ADP-ribose polymerase (PARP) cleavage and susceptibility to camptothecin-induced apoptosis. We conclude that high-risk strains of HPV utilize the cellular NF90/NF45 complex for viral E6 expression in infected cervical carcinoma cell lines. Interference with NF90/NF45 function could assist in controlling cervical carcinoma.	[Shamanna, R. A.; Hoque, M.; Mathews, M. B.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07101 USA; [Shamanna, R. A.; Pe'ery, T.; Mathews, M. B.] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA; [Pe'ery, T.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Mathews, MB (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, POB 1709, Newark, NJ 07101 USA.	mathews@umdnj.edu			NIH [R01 AI034552]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034552] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr Edward Goodwin for pGL3-HPV18URR-Firefly luciferase plasmid and Dr Betsy Barnes for HCT 116 cell lines. We are indebted to Dr Raymond Birge and Dr Edouard Azzam for discussions and helpful suggestions. The early stages of this work were supported by NIH Grant R01 AI034552 to MBM.	Agbottah ET, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-41; Austin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036327; Barber GN, 2009, RNA BIOL, V6, P35, DOI 10.4161/rna.6.1.7565; BAUKNECHT T, 1995, J VIROL, V69, P1; Bednarek PH, 1998, J VIROL, V72, P708, DOI 10.1128/JVI.72.1.708-716.1998; Bose SK, 2006, BIOCHEM J, V396, P99, DOI 10.1042/BJ20051548; Brantley-Finley C, 2003, BIOCHEM PHARMACOL, V66, P459, DOI 10.1016/S0006-2952(03)00255-7; Cazanove O, 2008, BIOCHEMISTRY-US, V47, P8350, DOI 10.1021/bi7008486; Chang JTC, 2010, CANCER GENE THER, V17, P827, DOI 10.1038/cgt.2010.38; Chen T, 2004, MOL CELL BIOL, V24, P6608, DOI 10.1128/mcb.24.15.6608-6619.2004; Chesnokov IN, 2003, P NATL ACAD SCI USA, V100, P9150, DOI 10.1073/pnas.1633580100; Chow LT, 2010, APMIS, V118, P422, DOI 10.1111/j.1600-0463.2010.02625.x; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Corso C, 2011, NUCLEIC ACIDS RES, V39, P7263, DOI 10.1093/nar/gkr278; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Dey A, 2008, BRIT J CANCER, V98, P4, DOI 10.1038/sj.bjc.6604098; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26; Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687; Goodwin EC, 1998, J VIROL, V72, P3925, DOI 10.1128/JVI.72.5.3925-3934.1998; Graber TE, 2010, CELL DEATH DIFFER, V17, P719, DOI 10.1038/cdd.2009.164; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Gwizdek C, 2004, J BIOL CHEM, V279, P884, DOI 10.1074/jbc.M306808200; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Harashima A, 2010, GENE DEV, V24, P2640, DOI 10.1101/gad.1965010; Hoque M, 2011, J MOL BIOL, V410, P917, DOI 10.1016/j.jmb.2011.03.060; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Isken O, 2004, RNA, V10, P1637, DOI 10.1261/rna.7290904; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Karmakar S, 2010, EMBO J, V29, P3260, DOI 10.1038/emboj.2010.204; Kiesler P, 2010, J BIOL CHEM, V285, P8256, DOI 10.1074/jbc.M109.041004; Krasnoselskaya-Riz I, 2002, AIDS RES HUM RETROV, V18, P591, DOI 10.1089/088922202753747941; Kreis NN, 2010, ONCOGENE, V29, P5591, DOI 10.1038/onc.2010.290; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Lace MJ, 2009, J VIROL, V83, P7457, DOI 10.1128/JVI.00285-09; Lan KH, 2002, ONCOGENE, V21, P4801, DOI 10.1038/sj.onc.1205589; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Lee CH, 2007, CANCER SCI, V98, P795, DOI 10.1111/j.1349-7006.2007.00473.x; Li FZ, 1999, NAT CELL BIOL, V1, P461, DOI 10.1038/70242; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Lopez-Saavedra A, 2009, ARCH VIROL, V154, P747, DOI 10.1007/s00705-009-0362-4; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Merrill MK, 2006, J VIROL, V80, P6936, DOI 10.1128/JVI.00243-06; Merrill MK, 2006, J VIROL, V80, P3147, DOI 10.1128/JVI.80.7.3147-3156.2006; Molchadsky A, 2010, CARCINOGENESIS, V31, P1501, DOI 10.1093/carcin/bgq101; Munoz-Fontela C, 2011, J IMMUNOL, V187, P6428, DOI 10.4049/jimmunol.1101459; Nair JS, 2009, MOL BIOL CELL, V20, P2218, DOI 10.1091/mbc.E08-08-0885; Narisawa-Saito M, 2007, CANCER SCI, V98, P1505, DOI 10.1111/j.1349-7006.2007.00546.x; Nie YZ, 2005, MOL CELL BIOL, V25, P6956, DOI 10.1128/MCB.25.16.6956-6963.2005; Pajunk HS, 1997, J GEN VIROL, V78, P3287, DOI 10.1099/0022-1317-78-12-3287; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Ranpura SA, 2008, J ANDROL, V29, P186, DOI 10.2164/jandrol.107.003756; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Reichman TW, 2003, CELL SIGNALING HDB, V3, P335; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Saha B, 2012, ONCOGENE, V31, P173, DOI 10.1038/onc.2011.234; Sakamoto S, 1999, BIOCHEMISTRY-US, V38, P3355, DOI 10.1021/bi982099g; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Shabman RS, 2011, J INFECT DIS, V204, pS911, DOI 10.1093/infdis/jir343; Shamanna RA, 2011, MOL CELL BIOL, V31, P4832, DOI 10.1128/MCB.05849-11; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Shin HJ, 2002, ARCH VIROL, V147, P471, DOI 10.1007/s007050200001; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Smith NL, 2011, CELL PROLIFERAT, V44, P147, DOI 10.1111/j.1365-2184.2011.00742.x; Stricker RLO, 2010, J VIROL, V84, P10592, DOI 10.1128/JVI.02506-09; Suzuki K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/978312; Tan S, 2012, MOL PHARMACOL, V81, P701, DOI 10.1124/mol.111.076539; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Ulke-Lemee A, 2007, BBA-PROTEINS PROTEOM, V1774, P1339, DOI 10.1016/j.bbapap.2007.07.015; Urcuqui-Inchima S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-83; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wang XH, 2011, J VIROL, V85, P8080, DOI 10.1128/JVI.00670-11; WANG XW, 1995, CANCER RES, V55, P6012; Yan JP, 2010, J VIROL, V84, P76, DOI 10.1128/JVI.01647-09; Zheltukhin AO, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1692, DOI 10.1134/S0006297910130110; Zhu P, 2010, J IMMUNOL, V185, P5140, DOI 10.4049/jimmunol.1000849; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	105	53	55	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 24	2013	32	43					5176	5185		10.1038/onc.2012.533	http://dx.doi.org/10.1038/onc.2012.533			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	240JY	23208500	Green Accepted			2022-12-25	WOS:000326093200005
J	Bansal, A; Singh, S; More, KR; Hans, D; Nangalia, K; Yogavel, M; Sharma, A; Chitnis, CE				Bansal, Abhisheka; Singh, Shailja; More, Kunal R.; Hans, Dhiraj; Nangalia, Kuldeep; Yogavel, Manickam; Sharma, Amit; Chitnis, Chetan E.			Characterization of Plasmodium falciparum Calcium-dependent Protein Kinase 1 (PfCDPK1) and Its Role in Microneme Secretion during Erythrocyte Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITOPHOROUS VACUOLE; ACTIVATION; MECHANISMS; REVEALS; RELEASE; EGRESS	Calcium-dependent protein kinases (CDPKs) play important roles in the life cycle of Plasmodium falciparum and other api-complexan parasites. CDPKs commonly have an N-terminal kinase domain (KD) and a C-terminal calmodulin-like domain (CamLD) with calcium-binding EF hands. The KD and CamLD are separated by a junction domain (JD). Previous studies on Plasmodium and Toxoplasma CDPKs suggest a role for the JD and CamLD in the regulation of kinase activity. Here, we provide direct evidence for the binding of the CamLD with the P3 region (Leu(356) to Thr(370)) of the JD in the presence of calcium (Ca2+). Moreover, site-directed mutagenesis of conserved hydrophobic residues in the JD (F363A/I364A, L356A, and F350A) abrogates functional activity of PfCDPK1, demonstrating the importance of these residues in PfCDPK1 function. Modeling studies suggest that these residues play a role in interaction of the CamLD with the JD. The P3 peptide, which specifically inhibits the functional activity of PfCDPK1, blocks microneme discharge and erythrocyte invasion by P. falciparum merozoites. Purfalcamine, a previously identified specific inhibitor of PfCDPK1, also inhibits microneme discharge and erythrocyte invasion, confirming a role for PfCDPK1 in this process. These studies validate PfCDPK1 as a target for drug development and demonstrate that interfering with its mechanistic regulation may provide a novel approach to design-specific PfCDPK1 inhibitors that limit blood stage parasite growth and clear malaria parasite infections.	[Bansal, Abhisheka; Singh, Shailja; More, Kunal R.; Hans, Dhiraj; Nangalia, Kuldeep; Yogavel, Manickam; Sharma, Amit; Chitnis, Chetan E.] ICGEB, New Delhi 110067, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Chitnis, CE (corresponding author), ICGEB, Aruna Asaf Ali Marg, New Delhi 110067, India.	cchitnis@icgeb.res.in	More, Kunal Ravindra/AFT-2566-2022; Manickam, Yogavel/O-4570-2015; Bansal, Abhisheka/ABC-7871-2020	More, Kunal Ravindra/0000-0001-5152-5104; Manickam, Yogavel/0000-0002-2119-062X; Bansal, Abhisheka/0000-0002-2959-8494; Chitnis, Chetan/0000-0002-8773-9865	European Commission (MALSIG) [HEALTH-F3-2009-223044]; European Commission "Network of Excellence: European Virtual Institute for Malaria Research" (EviMalaR) [Health-2009-2.3.2-1-242095]; Department of Biotechnology, Government of India	European Commission (MALSIG)(European CommissionEuropean Commission Joint Research Centre); European Commission "Network of Excellence: European Virtual Institute for Malaria Research" (EviMalaR); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by European Commission Framework Program 7 (FP7) projects titled "Signaling in Malaria" (MALSIG, HEALTH-F3-2009-223044) and "Network of Excellence: European Virtual Institute for Malaria Research" (EviMalaR, Health-2009-2.3.2-1-242095) and a Program Support grant from Department of Biotechnology, Government of India.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DELPLACE P, 1988, BIOL CELL, V64, P215, DOI 10.1016/0248-4900(88)90080-9; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gaur D, 2011, CURR OPIN MICROBIOL, V14, P422, DOI 10.1016/j.mib.2011.07.018; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Huang JF, 1996, BIOCHEMISTRY-US, V35, P13222, DOI 10.1021/bi960498a; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jones ML, 2012, CELL HOST MICROBE, V12, P246, DOI 10.1016/j.chom.2012.06.005; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ranjan R, 2009, J BIOL CHEM, V284, P15267, DOI 10.1074/jbc.M900656200; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Sugi T, 2010, EUKARYOT CELL, V9, P667, DOI 10.1128/EC.00351-09; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vitart V, 2000, BIOCHEMISTRY-US, V39, P4004, DOI 10.1021/bi992373m; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7	30	69	70	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1590	1602		10.1074/jbc.M112.411934	http://dx.doi.org/10.1074/jbc.M112.411934			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23204525	Green Published, hybrid			2022-12-25	WOS:000313751400015
J	Dai, XH; Mashiguchi, K; Chen, QG; Kasahara, H; Kamiya, Y; Ojha, S; DuBois, J; Ballou, D; Zhao, YD				Dai, Xinhua; Mashiguchi, Kiyoshi; Chen, Qingguo; Kasahara, Hiroyuki; Kamiya, Yuji; Ojha, Sunil; DuBois, Jennifer; Ballou, David; Zhao, Yunde			The Biochemical Mechanism of Auxin Biosynthesis by an Arabidopsis YUCCA Flavin-containing Monooxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING MONO-OXYGENASE; DEPENDENT MONOOXYGENASES; HALF-REACTION; TRYPTOPHAN; PATHWAY; CATALYSIS; PLANTS; FAD; MAIZE; RICE	Auxin regulates every aspect of plant growth and development. Previous genetic studies demonstrated that YUCCA (YUC) flavin-containing monooxygenases (FMOs) catalyze a rate-limiting step in auxin biosynthesis and that YUCs are essential for many developmental processes. We proposed that YUCs convert indole-3-pyruvate (IPA) to indole-3-acetate (IAA). However, the exact biochemical mechanism of YUCs has remained elusive. Here we present the biochemical characterization of recombinant Arabidopsis YUC6. Expressed in and purified from Escherichia coli, YUC6 contains FAD as a cofactor, which has peaks at 448 nm and 376 nm in the UV-visible spectrum. We show that YUC6 uses NADPH and oxygen to convert IPA to IAA. The first step of the YUC6-catalyzed reaction is the reduction of the FAD cofactor to FADH(-) by NADPH. Subsequently, FADH(-) reacts with oxygen to form a flavin-C4a-(hydro) peroxy intermediate, which we show has a maximum absorbance at 381 nm in its UV-visible spectrum. The final chemical step is the reaction of the C4a-intermediate with IPA to produce IAA. Although the sequences of the YUC enzymes are related to those of the mammalian FMOs, which oxygenate nucleophilic substrates, YUC6 oxygenates an electrophilic substrate (IPA). Nevertheless, both classes of enzymes form quasistable C4a-(hydro)peroxyl FAD intermediates. The YUC6 intermediate has a half-life of similar to 20 s whereas that of some FMOs is >30 min. This work reveals the catalytic mechanism of the first known plant flavin monooxygenase and provides a foundation for further investigating how YUC activities are regulated in plants.	[Dai, Xinhua; Mashiguchi, Kiyoshi; Chen, Qingguo; Zhao, Yunde] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Kasahara, Hiroyuki; Kamiya, Yuji] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Ojha, Sunil; DuBois, Jennifer] SRI Int, Harrisonburg, VA 22802 USA; [Ballou, David] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; RIKEN; SRI International; University of Michigan System; University of Michigan	Zhao, YD (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yundezhao@ucsd.edu	Zhao, Yunde/AAC-5360-2019; Kasahara, Hiroyuki/F-6445-2012; Kamiya, Yuji/F-9420-2010; Chen, Qingguo/E-4346-2014; Mashiguchi, Kiyoshi/AAN-3854-2020	Kasahara, Hiroyuki/0000-0002-4858-0978; Kamiya, Yuji/0000-0003-4415-520X; Mashiguchi, Kiyoshi/0000-0002-7234-887X	National Institutes of Health [R01GM68631]; Japan Society for the Promotion of Science KAKENHI Grant [24370027]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090260, R01GM068631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM68631 (to Y.Z.). This work was also supported by Japan Society for the Promotion of Science KAKENHI Grant 24370027 (to H. K.).	Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; BEATY NB, 1981, J BIOL CHEM, V256, P4619; BEATY NB, 1981, J BIOL CHEM, V256, P4611; BENTLEY JA, 1956, BIOCHEM J, V64, P44, DOI 10.1042/bj0640044; BESSEY OA, 1949, J BIOL CHEM, V180, P755; Cashman JR, 2006, ANNU REV PHARMACOL, V46, P65, DOI 10.1146/annurev.pharmtox.46.120604.141043; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Exposito-Rodriguez M, 2007, J PLANT GROWTH REGUL, V26, P329, DOI 10.1007/s00344-007-9019-2; Gallavotti A, 2008, P NATL ACAD SCI USA, V105, P15196, DOI 10.1073/pnas.0805596105; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; JEAN M, 1968, CAN J MICROBIOL, V14, P429, DOI 10.1139/m68-068; Kim JI, 2007, PLANT PHYSIOL, V145, P722, DOI 10.1104/pp.107.104935; LeClere S, 2010, PLANT PHYSIOL, V153, P306, DOI 10.1104/pp.110.155226; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Mayfield JA, 2010, J BIOL CHEM, V285, P30375, DOI 10.1074/jbc.M110.157578; MUH U, 1994, J BIOL CHEM, V269, P7989; Ooi T, 2012, J MOL CATAL B-ENZYM, V74, P204, DOI 10.1016/j.molcatb.2011.10.006; Palfey BA, 2010, ARCH BIOCHEM BIOPHYS, V493, P26, DOI 10.1016/j.abb.2009.11.028; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; WALSH CT, 1988, ANGEW CHEM INT EDIT, V27, P333, DOI 10.1002/anie.198803331; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Woo YM, 2007, PLANT MOL BIOL, V65, P125, DOI 10.1007/s11103-007-9203-6; Yamamoto Y, 2007, PLANT PHYSIOL, V143, P1362, DOI 10.1104/pp.106.091561; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308; Ziegler DM, 2002, DRUG METAB REV, V34, P503, DOI 10.1081/DMR-120005650	34	131	141	1	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1448	1457		10.1074/jbc.M112.424077	http://dx.doi.org/10.1074/jbc.M112.424077			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188833	Green Published, hybrid			2022-12-25	WOS:000313751400003
J	Cavaliere, S; Gillespie, JM; Hodge, JJL				Cavaliere, Sonia; Gillespie, John M.; Hodge, James J. L.			KCNQ Channels Show Conserved Ethanol Block and Function in Ethanol Behaviour	PLOS ONE			English	Article							NEURONAL EXCITABILITY; POTASSIUM CHANNELS; DROSOPHILA; ALCOHOL; DOPAMINE; PROTEIN; EXPRESSION; RECEPTOR; COCAINE; SUSCEPTIBILITY	In humans, KCNQ2/3 channels form an M-current that regulates neuronal excitability, with mutations in these channels causing benign neonatal familial convulsions. The M-current is important in mechanisms of neural plasticity underlying associative memory and in the response to ethanol, with KCNQ controlling the release of dopamine after ethanol exposure. We show that dKCNQ is broadly expressed in the nervous system, with targeted reduction in neuronal KCNQ increasing neural excitability and KCNQ overexpression decreasing excitability and calcium signalling, consistent with KCNQ regulating the resting membrane potential and neural release as in mammalian neurons. We show that the single KCNQ channel in Drosophila (dKCNQ) has similar electrophysiological properties to neuronal KCNQ2/3, including conserved acute sensitivity to ethanol block, with the fly channel (IC50 = 19.8 mM) being more sensitive than its mammalian ortholog (IC50 = 42.1 mM). This suggests that the role of KCNQ in alcohol behaviour can be determined for the first time by using Drosophila. We present evidence that loss of KCNQ function in Drosophila increased sensitivity and tolerance to the sedative effects of ethanol. Acute activation of dopaminergic neurons by heat-activated TRP channel or KCNQ-RNAi expression produced ethanol hypersensitivity, suggesting that both act via a common mechanism involving membrane depolarisation and increased dopamine signalling leading to ethanol sedation.	[Cavaliere, Sonia; Gillespie, John M.; Hodge, James J. L.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Bristol	Hodge, JJL (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England.	james.hodge@bristol.ac.uk		Hodge, James/0000-0003-4741-2363	EU [IRG200632]; Royal Society [2008/R1]; BBSRC [BB/G008973/1]; Wellcome PhD program [083361]; Biotechnology and Biological Sciences Research Council [BB/G008973/1] Funding Source: researchfish	EU(European Commission); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome PhD program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the EU FP7 Marie-Curie (IRG200632), Royal Society (2008/R1), BBSRC (BB/G008973/1), and from a Wellcome PhD program (083361). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Atkinson NS, 2009, J NEUROGENET, V23, P293, DOI 10.1080/01677060802572937; Bainton RJ, 2000, CURR BIOL, V10, P187, DOI 10.1016/S0960-9822(00)00336-5; Cavaliere S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023898; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; COVARRUBIAS M, 1993, P NATL ACAD SCI USA, V90, P6957, DOI 10.1073/pnas.90.15.6957; Dzitoyeva S, 2003, P NATL ACAD SCI USA, V100, P5485, DOI 10.1073/pnas.0830111100; Hansen HH, 2007, EUR J PHARMACOL, V570, P77, DOI 10.1016/j.ejphar.2007.05.029; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; Hodge JJL, 2006, NEURON, V51, P327, DOI 10.1016/j.neuron.2006.06.020; Hodge JJL, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.013.2009; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kapfhamer D, 2010, J NEUROSCI, V30, P8830, DOI 10.1523/JNEUROSCI.1292-10.2010; Kaun KR, 2012, HUM GENET, V131, P959, DOI 10.1007/s00439-012-1146-6; Kaun KR, 2011, NAT NEUROSCI, V14, P612, DOI 10.1038/nn.2805; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Koob GF, 2004, BIOCHEM PHARMACOL, V68, P1515, DOI 10.1016/j.bcp.2004.07.031; Koyama S, 2007, J NEUROPHYSIOL, V97, P1977, DOI 10.1152/jn.00270.2006; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Mayfield RD, 2008, BRIT J PHARMACOL, V154, P275, DOI 10.1038/bjp.2008.88; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Morozova TV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r231; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Ogueta M, 2010, CHEM SENSES, V35, P813, DOI 10.1093/chemse/bjq084; Peabody NC, 2009, J NEUROSCI, V29, P3343, DOI 10.1523/JNEUROSCI.4241-08.2009; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pulver SR, 2009, J NEUROPHYSIOL, V101, P3075, DOI 10.1152/jn.00071.2009; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Treistman SN, 2009, TRENDS NEUROSCI, V32, P629, DOI 10.1016/j.tins.2009.08.001; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Wen H, 2005, J NEUROSCI, V25, P10147, DOI 10.1523/JNEUROSCI.3086-05.2005; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207	46	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50279	10.1371/journal.pone.0050279	http://dx.doi.org/10.1371/journal.pone.0050279			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209695	Green Submitted, gold, Green Published			2022-12-25	WOS:000312104900036
J	Hallersund, P; Sjostrom, L; Olbers, T; Lonroth, H; Jacobson, P; Wallenius, V; Naslund, I; Carlsson, LM; Fandriks, L				Hallersund, Peter; Sjostrom, Lars; Olbers, Torsten; Lonroth, Hans; Jacobson, Peter; Wallenius, Ville; Naslund, Ingmar; Carlsson, Lena M.; Fandriks, Lars			Gastric Bypass Surgery Is Followed by Lowered Blood Pressure and Increased Diuresis - Long Term Results from the Swedish Obese Subjects (SOS) Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BARIATRIC SURGERY; GASTROINTESTINAL-TRACT; RANDOMIZED-TRIAL; HYPERTENSION; DISEASE; SODIUM	Objective: To compare two bariatric surgical principles with regard to effects on blood pressure and salt intake. Background: In most patients bariatric surgery induces a sustained weight loss and a reduced cardiovascular risk profile but the long-term effect on blood pressure is uncertain. Methods: Cohort study with data from the prospective, controlled Swedish Obese Subjects (SOS) study involving 480 primary health care centres and 25 surgical departments in Sweden. Obese patients treated with non-surgical methods (Controls, n = 1636 and n = 1132 at 2 y and 10 y follow up, respectively) were compared to patients treated with gastric bypass (GBP, n = 245 and n = 277, respectively) or purely restrictive procedures (vertical banded gastroplasty or gastric banding; VBG/B, n = 1534 and n = 1064, respectively). Results: At long-term follow-up (median 10 y) GBP was associated with lowered systolic (mean: -5.1 mm Hg) and diastolic pressure (-5.6 mmHg) differing significantly from both VBG/B (-1.5 and -2.1 mmHg, respectively; p<0.001) and Controls (+1.2 and -3.8 mmHg, respectively; p<0.01). Diurnal urinary output was +100 ml (P<0.05) and +170 ml (P<0.001) higher in GBP subjects than in weight-loss matched VBG/B subjects at the 2 y and 10 y follow-ups, respectively. Urinary output was linearly associated with blood pressure only after GBP and these patients consumed approximately 1 g salt per day more at the follow-ups than did VBG/B (P<0.01). Conclusions: The purely restrictive techniques VBG/B exerted a transient blood pressure lowering effect, whereas gastric bypass was associated with a sustained blood pressure reduction and an increased diuresis. The daily salt consumption was higher after gastric bypass than after restrictive bariatric surgery.	[Hallersund, Peter; Olbers, Torsten; Lonroth, Hans; Wallenius, Ville; Fandriks, Lars] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Gastrosurg Res & Educ, Gothenburg, Sweden; [Sjostrom, Lars; Jacobson, Peter; Naslund, Ingmar; Carlsson, Lena M.] Univ Gothenburg, Sahlgrenska Acad, Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Sjostrom, Lars; Jacobson, Peter; Naslund, Ingmar; Carlsson, Lena M.] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Hallersund, P (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Gastrosurg Res & Educ, Gothenburg, Sweden.	lars.fandriks@gastro.gu.se	Carlsson, Lena/F-7570-2018; Wallenius, Ville Raymond/C-5486-2014	Carlsson, Lena/0000-0003-4145-6242; Wallenius, Ville Raymond/0000-0001-8668-3196; Olbers, Torsten/0000-0002-7218-3390; Jacobson, Peter/0000-0002-1769-1827	Swedish Research Council [K2010-55X-21432-01-2, K2010-55X-11285-13]; University of Gothenburg and Sahlgrenska University Hospital (ALF); Gothenburg Medical Association; Research Council of the Western Region of Sweden (VGR); Ethicon Endosurgery; Swedish Foundation for Strategic Research; Hoffmann-La Roche; AstraZeneca; Cederroth; Swedish Medical Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Gothenburg and Sahlgrenska University Hospital (ALF); Gothenburg Medical Association; Research Council of the Western Region of Sweden (VGR); Ethicon Endosurgery; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Hoffmann-La Roche(Hoffmann-La Roche); AstraZeneca(AstraZeneca); Cederroth; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This study received financial support by the Swedish Research Council (grant no K2010-55X-21432-01-2, K2010-55X-11285-13), the University of Gothenburg and Sahlgrenska University Hospital (ALF), the Gothenburg Medical Association, the Research Council of the Western Region of Sweden (VGR), Ethicon Endosurgery and the Swedish Foundation for Strategic Research to the Sahlgrenska Center for Cardiovascular and Metabolic Research. The SOS study is supported by grants from Hoffmann-La Roche, AstraZeneca, Cederroth, and the Swedish Medical Research Council (to Dr. L. Sjostrom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AR, 2009, OBES SURG, V19, P845, DOI 10.1007/s11695-008-9671-z; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Bueter M, 2011, SURG OBES RELAT DIS, V7, P68, DOI 10.1016/j.soard.2010.03.286; Burton PR, 2011, OBES SURG, V21, P217, DOI 10.1007/s11695-010-0312-y; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Hall JE, 2003, HYPERTENSION, V41, P625, DOI 10.1161/01.HYP.0000052314.95497.78; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; He FJ, 2005, HYPERTENSION, V45, P98, DOI 10.1161/01.HYP.0000149431.79450.a2; Heneghan HM, 2011, AM J CARDIOL, V108, P1499, DOI 10.1016/j.amjcard.2011.06.076; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Law M, 2003, Health Technol Assess, V7, P1; Michell AR, 2008, ANNU REV PHYSIOL, V70, P379, DOI 10.1146/annurev.physiol.69.040705.141330; Mu J. Y., 1995, Blood Pressure, V4, P77, DOI 10.3109/08037059509077573; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Poirier P, 2011, CIRCULATION, V123, P1683, DOI 10.1161/CIR.0b013e3182149099; Pontiroli AE, 2005, DIABETES CARE, V28, P2703, DOI 10.2337/diacare.28.11.2703; Rubino F, 2010, NAT REV ENDOCRINOL, V6, P102, DOI 10.1038/nrendo.2009.268; Sacks FM, 2010, NEW ENGL J MED, V362, P2102, DOI 10.1056/NEJMct0911013; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Stricker EM, 2007, PHYSIOL BEHAV, V91, P404, DOI 10.1016/j.physbeh.2007.04.007; Tichansky David S, 2006, Surg Obes Relat Dis, V2, P440, DOI 10.1016/j.soard.2006.02.014; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351	26	66	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49696	10.1371/journal.pone.0049696	http://dx.doi.org/10.1371/journal.pone.0049696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209592	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900013
J	Lauring, AS; Lee, TH; Martin, JN; Hunt, PW; Deeks, SG; Busch, M				Lauring, Adam S.; Lee, Tzong-Hae; Martin, Jeffrey N.; Hunt, Peter W.; Deeks, Steven G.; Busch, Michael			Lack of Evidence for mtDNA as a Biomarker of Innate Immune Activation in HIV Infection	PLOS ONE			English	Article							T-CELL-ACTIVATION; BLOOD PLATELET SUBPOPULATIONS; ANTIRETROVIRAL THERAPY; TYPE-1 INFECTION; INFLAMMATION; HETEROGENEITY; RELEASE; DENSITY; DISEASE; VIREMIA	Many human immunodeficiency virus (HIV) infected individuals suffer from persistent immune activation. Chronic inflammation and immune dysregulation have been associated with an increased risk of age-related diseases even among patients on highly active antiretroviral therapy. The factors leading to immune activation are complex, but have been hypothesized to include persistent viral replication with cellular death as well as microbial translocation across the gastrointestinal tract. Both processes may trigger innate immune responses since many native molecules released from dying cells are similar in structure to pathogen associated molecular patterns. These damage associated molecular patterns include mitochondrial DNA and formylated peptides. We hypothesized that circulating mitochondrial nucleic acid could serve as a biomarker for HIV-associated cell death and drive innate immune activation in infected individuals. We developed a quantitative polymerase chain reaction assay for plasma mitochondrial DNA and validated it on normal blood donors. We then measured mitochondrial DNA levels in acute and chronic HIV infection. While the assay proved to be accurate with a robust dynamic range, we did not find a significant association between HIV disease status and circulating mitochondrial DNA. We did, however, observe a negative correlation between age and plasma mitochondrial DNA levels in individuals with well-controlled HIV. Citation: Lauring AS, Lee T-H, Martin JN, Hunt PW, Deeks SG, et al. (2012) Lack of Evidence for mtDNA as a Biomarker of Innate Immune Activation in HIV Infection. PLoS ONE 7(11): e50486. doi:10.1371/journal.pone.0050486	[Lauring, Adam S.; Martin, Jeffrey N.; Hunt, Peter W.; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Busch, Michael] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Lauring, Adam S.; Lee, Tzong-Hae; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Vitalant; Vitalant Research Institute	Lauring, AS (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA.	alauring@med.umich.edu	Hunt, Peter W./P-2976-2017	Hunt, Peter W./0000-0002-4571-4870	National Institutes of Health (NIH) [K08 AI081754, R01 AI087145, K24AI069994]; University of California San Francisco (UCSF) Centers for AIDS Research (CFAR) [P0 AI27763]; UCSF Clinical & Translational Science Institute (CTSI) [UL1 RR024131]; NIH/National Institute of Allergy and Infectious Diseases (NIAID) CFAR Network of Integrated Clinical Systems (CNICS) [1 R24 AI067039-1]; Ragon Institute;  [106710-40-RGRL]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087145, P30AI027763, K08AI081754, K24AI069994, R24AI067039] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco (UCSF) Centers for AIDS Research (CFAR); UCSF Clinical & Translational Science Institute (CTSI); NIH/National Institute of Allergy and Infectious Diseases (NIAID) CFAR Network of Integrated Clinical Systems (CNICS); Ragon Institute; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (NIH) to ASL (K08 AI081754), to SD (R01 AI087145, K24AI069994), University of California San Francisco (UCSF) Centers for AIDS Research (CFAR) (P0 AI27763), UCSF Clinical & Translational Science Institute (CTSI) (UL1 RR024131), NIH/National Institute of Allergy and Infectious Diseases (NIAID) CFAR Network of Integrated Clinical Systems (CNICS; grant 1 R24 AI067039-1). Additional support was provided to SD amfAR (106710-40-RGRL), and the Ragon Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Cherry CL, 2003, J ANTIMICROB CHEMOTH, V51, P1091, DOI 10.1093/jac/dkg203; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; CORASH L, 1984, BLOOD, V64, P185; CORASH L, 1977, BLOOD, V49, P71; Cote HCF, 2002, CHANGES MITOCHONDRIA; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Fiebig EW, 2005, JAIDS-J ACQ IMM DEF, V39, P133; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2011, AIDS, V25, P2123, DOI 10.1097/QAD.0b013e32834c4ac1; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Plaeger SF, 2011, AIDS RES HUM RETROV; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Valdez H, 1997, AIDS Clin Rev, P187; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	30	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50486	10.1371/journal.pone.0050486	http://dx.doi.org/10.1371/journal.pone.0050486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209754	gold, Green Submitted, Green Published			2022-12-25	WOS:000312104900055
J	Tubo, NJ; Wurbel, MA; Charvat, TT; Schall, TJ; Walters, MJ; Campbell, JJ				Tubo, Noah J.; Wurbel, Marc A.; Charvat, Trevor T.; Schall, Thomas J.; Walters, Matthew J.; Campbell, James J.			A Systemically-Administered Small Molecule Antagonist of CCR9 Acts as a Tissue-Selective Inhibitor of Lymphocyte Trafficking	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; CROHNS-DISEASE; ACCUMULATION; CCX282-B; CELLS	A goal for developers of immunomodulatory drugs has long been a systemically administered small molecule that can selectively inhibit inflammation in specific tissues. The chemokine receptor CCR9 is an attractive target for this approach, as entry of T cells into the small intestine from blood requires interaction between CCR9 and its ligand CCL25. We have tested the ability of a small molecule CCR9 antagonist, CCX8037, to inhibit antigen-mediated T cell accumulation in the intestine. This compound prevented accumulation of gut-imprinted antigen-specific CD8 T cells within epithelium of the small intestine. Interestingly, the antagonist did not affect the robust generation of gut-imprinted CD8 T cells within mesenteric lymph nodes. To distinguish "gut-selective'' from "general'' T cell inhibition, we tested the drug's ability to influence accumulation of T cells within skin, a tissue in which CCR9 plays no known role, and we found no appreciable effect. This study demonstrates the feasibility of creating systemically-administered pharmaceuticals capable of tissue-selective immune modulation. This proof of concept is of utmost importance for designing effective treatments against various autoimmune disorders localized to a specific tissue.	[Tubo, Noah J.; Wurbel, Marc A.; Campbell, James J.] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Tubo, Noah J.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA USA; [Charvat, Trevor T.; Schall, Thomas J.; Walters, Matthew J.] ChemoCentryx Inc, Mountain View, CA USA; [Campbell, James J.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Campbell, James J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Campbell, JJ (corresponding author), Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA.	jcampbell@bwh.rics.harvard.edu		Campbell, James/0000-0003-4252-5182				Baekkevold ES, 2005, J EXP MED, V201, P1045, DOI 10.1084/jem.20041059; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 2007, J IMMUNOL, V178, P3358, DOI 10.4049/jimmunol.178.6.3358; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Eksteen B, 2010, IDRUGS, V13, P472; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Keshav S, 2009, GASTROENTEROLOGY, V136, pA65; Reiss Y, 2001, J EXP MED, V194, P1541, DOI 10.1084/jem.194.10.1541; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Tubo NJ, 2011, AM J PATHOL, V178, P2496, DOI 10.1016/j.ajpath.2011.02.031; Villablanca EJ, 2011, GASTROENTEROLOGY, V140, P1776, DOI 10.1053/j.gastro.2011.02.015; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; Zollner TM, 2007, EXP DERMATOL, V16, P1, DOI 10.1111/j.1600-0625.2006.00503.x	14	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50498	10.1371/journal.pone.0050498	http://dx.doi.org/10.1371/journal.pone.0050498			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209760	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900057
J	Katayama, T; Uchida, H; Ohta, A; Horiuchi, H				Katayama, Takuya; Uchida, Hirotaka; Ohta, Akinori; Horiuchi, Hiroyuki			Involvement of Protein Kinase C in the Suppression of Apoptosis and in Polarity Establishment in Aspergillus nidulans under Conditions of Heat Stress	PLOS ONE			English	Article							CELL-WALL INTEGRITY; MOTOR-LIKE DOMAIN; SACCHAROMYCES-CEREVISIAE; MAP KINASE; SIGNALING PATHWAY; NEUROSPORA-CRASSA; OXIDATIVE STRESS; CHITIN SYNTHASES; BLUE-LIGHT; F-ACTIN	The pkcA gene, which encodes a protein kinase C (PKC) in the filamentous fungus Aspergillus nidulans, is essential for its viability. However, little is known about its functions. To address this issue, we constructed and characterized temperature-sensitive mutants of pkcA. The conidia of these mutants swelled slightly and exhibited apoptotic phenotypes at 42 degrees C. The apoptotic phenotypes were suppressed by an osmotic stabilizer. Under these conditions, the conidia swelled extensively and did not form germ tubes. Moreover, polarized distribution of F-actin was not observed. We then utilized deletion mutants of bckA, an ortholog of Saccharomyces cerevisiae bck1 that encodes a mitogen-activated protein (MAP) kinase kinase kinase and functions downstream of PKC in the cell wall integrity pathway. These mutants exhibited apoptotic phenotypes at 42 degrees C, but they did not show defects in polarity establishment under osmotically stabilized conditions. These results suggest that PkcA plays multiple roles during germination under conditions of heat stress. The first of these roles is the suppression of apoptosis induction, while the other involves polarity establishment. The former depends on the MAP kinase cascade, whereas the latter does not. In addition, repolarization, which was observed after depolarization in the wildtype strain and the bckA deletion mutant under conditions of heat stress, was not observed in the pkcA-ts mutant. This suggests that PkcA also plays role in polarity establishment during hyphal growth independent of the MAP kinase cascade under these conditions.	[Katayama, Takuya; Uchida, Hirotaka; Ohta, Akinori; Horiuchi, Hiroyuki] Univ Tokyo, Dept Biotechnol, Tokyo, Japan	University of Tokyo	Horiuchi, H (corresponding author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.	ahhoriu@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23380048] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was performed using the facilities of the Biotechnology Reseach Center of the University of Tokyo. It was suppored by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambra R, 2000, FEMS MICROBIOL LETT, V189, P45, DOI 10.1111/j.1574-6968.2000.tb09204.x; Arpaia G, 1999, MOL GEN GENET, V262, P314, DOI 10.1007/s004380051089; Berepiki A, 2010, EUKARYOT CELL, V9, P547, DOI 10.1128/EC.00253-09; Carmona-Gutierrez D, 2010, CELL DEATH DIFFER, V17, P763, DOI 10.1038/cdd.2009.219; Chellegatti MASC, 2010, FOLIA MICROBIOL, V55, P228, DOI 10.1007/s12223-010-0033-6; Colabardini AC, 2010, MOL MICROBIOL, V78, P1259, DOI 10.1111/j.1365-2958.2010.07403.x; de Groot PWJ, 2009, FUNGAL GENET BIOL, V46, pS72, DOI 10.1016/j.fgb.2008.07.022; Delgado-Alvarez DL, 2010, FUNGAL GENET BIOL, V47, P573, DOI 10.1016/j.fgb.2010.03.004; Dichtl K, 2010, MOL MICROBIOL, V76, P1191, DOI 10.1111/j.1365-2958.2010.07170.x; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; Franchi L, 2005, MOL MICROBIOL, V56, P334, DOI 10.1111/j.1365-2958.2005.04545.x; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; Guo SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006089; Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474; Herrmann M, 2006, APPL ENVIRON MICROB, V72, P2957, DOI 10.1128/AEM.72.4.2957-2970.2006; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Juvvadi PR, 2007, BIOCHEM J, V405, P533, DOI 10.1042/BJ20061678; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Khatun R, 2011, FUNGAL GENET BIOL, V48, P465, DOI 10.1016/j.fgb.2010.11.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Mizutani O, 2004, EUKARYOT CELL, V3, P1036, DOI 10.1128/EC.3.4.1036-1048.2004; Morawetz R, 1996, MOL GEN GENET, V250, P17, DOI 10.1007/s004380050047; Motoyama T, 1997, MOL GEN GENET, V253, P520, DOI 10.1007/s004380050353; Oeser B, 1998, FEMS MICROBIOL LETT, V165, P273, DOI 10.1111/j.1574-6968.1998.tb13157.x; Ohno S, 2002, J BIOCHEM, V132, P509, DOI 10.1093/oxfordjournals.jbchem.a003249; Reeves EP, 2006, FEBS J, V273, P3038, DOI 10.1111/j.1742-4658.2006.05315.x; Reinoso-Martin C, 2003, EUKARYOT CELL, V2, P1200, DOI 10.1128/EC.2.6.1200-1210.2003; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ronen R, 2007, CURR GENET, V51, P321, DOI 10.1007/s00294-007-0129-y; ROWLANDS RT, 1973, MOL GEN GENET, V126, P201, DOI 10.1007/BF00267531; Semighini CP, 2006, MOL MICROBIOL, V59, P753, DOI 10.1111/j.1365-2958.2005.04976.x; Slaughter BD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003384; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; Takeshita N, 2002, BIOCHEM BIOPH RES CO, V298, P103, DOI 10.1016/S0006-291X(02)02418-X; Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001; Zanelli CF, 2005, GENETICS, V171, P1571, DOI 10.1534/genetics.105.048082; Zarzov P, 1996, EMBO J, V15, P83, DOI 10.1002/j.1460-2075.1996.tb00336.x	43	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50503	10.1371/journal.pone.0050503	http://dx.doi.org/10.1371/journal.pone.0050503			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	120QE	23209763	gold, Green Published, Green Submitted			2022-12-25	WOS:000317185400006
J	Oberfeld, D; Heeren, W; Rennies, J; Verhey, J				Oberfeld, Daniel; Heeren, Wiebke; Rennies, Jan; Verhey, Jesko			Spectro-Temporal Weighting of Loudness	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; SAMPLE DISCRIMINATION; TEMPORAL INTEGRATION; LEVEL DISCRIMINATION; PERCEPTUAL WEIGHTS; SPECTRAL WEIGHTS; CRITICAL BANDS; COMPLEX SOUND; SUMMATION; MODEL	Real-world sounds like speech or traffic noise typically exhibit spectro-temporal variability because the energy in different spectral regions evolves differently as a sound unfolds in time. However, it is currently not well understood how the energy in different spectral and temporal portions contributes to loudness. This study investigated how listeners weight different temporal and spectral components of a sound when judging its overall loudness. Spectral weights were measured for the combination of three loudness-matched narrowband noises with different center frequencies. To measure temporal weights, 1,020-ms stimuli were presented, which randomly changed in level every 100 ms. Temporal weights were measured for each narrowband noise separately, and for a broadband noise containing the combination of the three noise bands. Finally, spectro-temporal weights were measured with stimuli where the level of the three narrowband noises randomly and independently changed every 100 ms. The data consistently showed that (i) the first 300 ms of the sounds had a greater influence on overall loudness perception than later temporal portions (primacy effect), and (ii) the lowest noise band contributed significantly more to overall loudness than the higher bands. The temporal weights did not differ between the three frequency bands. Notably, the spectral weights and temporal weights estimated from the conditions with only spectral or only temporal variability were very similar to the corresponding weights estimated in the spectro-temporal condition. The results indicate that the temporal and the spectral weighting of the loudness of a time-varying sound are independent processes. The spectral weights remain constant across time, and the temporal weights do not change across frequency. The results are discussed in the context of current loudness models.	[Oberfeld, Daniel] Johannes Gutenberg Univ Mainz, Dept Psychol, Sect Expt Psychol, D-55122 Mainz, Germany; [Heeren, Wiebke; Verhey, Jesko] Univ Magdeburg, Dept Expt Audiol, D-39106 Magdeburg, Germany; [Rennies, Jan] Fraunhofer Inst Digitale Medientechnol IDMT, Oldenburg, Germany	Johannes Gutenberg University of Mainz; Otto von Guericke University; Fraunhofer Gesellschaft	Oberfeld, D (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychol, Sect Expt Psychol, D-55122 Mainz, Germany.	oberfeld@uni-mainz.de	Oberfeld, Daniel/A-7997-2008; Rennies, Jan/AAW-3923-2020	Oberfeld, Daniel/0000-0002-6710-3309; Verhey, Jesko/0000-0002-2742-9187; Rennies, Jan/0000-0002-0291-7723	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich/Transregio 31]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (www.dfg.de), Sonderforschungsbereich/Transregio 31: The active auditory system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AGRESTI A, 1989, PSYCHOL BULL, V105, P290, DOI 10.1037/0033-2909.105.2.290; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Alexander JM, 2004, J ACOUST SOC AM, V116, P2234, DOI 10.1121/1.1784437; [Anonymous], 1970, 318 IEC; [Anonymous], 2003, 1996 ISO; [Anonymous], 2009, 389 IEC; [Anonymous], 2010, 45631A1 DIN; Anweiler AK, 2006, J ACOUST SOC AM, V119, P2919, DOI 10.1121/1.2184224; BERG BG, 1989, J ACOUST SOC AM, V86, P1743, DOI 10.1121/1.398605; BERG BG, 1990, J ACOUST SOC AM, V88, P149, DOI 10.1121/1.399962; BERG BG, 1987, J ACOUST SOC AM, V81, pS33, DOI 10.1121/1.2024197; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; BRAIDA LD, 1972, J ACOUST SOC AM, V51, P483, DOI 10.1121/1.1912868; Buus S, 1997, J ACOUST SOC AM, V101, P669, DOI 10.1121/1.417959; CACACE AT, 1985, J ACOUST SOC AM, V78, P1568, DOI 10.1121/1.392793; Calandruccio L, 2008, J ACOUST SOC AM, V123, P2367, DOI 10.1121/1.2887857; Chalupper J, 2002, ACTA ACUST UNITED AC, V88, P378; DAI HP, 1992, J ACOUST SOC AM, V92, P1346, DOI 10.1121/1.403928; Dittrich K, 2009, J ACOUST SOC AM, V126, P3168, DOI 10.1121/1.3238233; Doherty KA, 1996, J ACOUST SOC AM, V99, P1053, DOI 10.1121/1.414634; DORFMAN DD, 1969, J MATH PSYCHOL, V6, P487, DOI 10.1016/0022-2496(69)90019-4; Ellermeier W, 2000, FECHNER DAY 2000, P169; Epstein M, 2005, J ACOUST SOC AM, V118, P907, DOI 10.1121/1.1954547; Fastl H., 2007, PSYCHOACOUSTICS FACT, V3rd; Fletcher H, 1933, J ACOUST SOC AM, V5, P82, DOI 10.1121/1.1915637; Fletcher H, 1924, PHYS REV, V24, P306, DOI 10.1103/PhysRev.24.306; Florentine M, 1996, J ACOUST SOC AM, V99, P1633, DOI 10.1121/1.415236; GILKEY RH, 1986, J ACOUST SOC AM, V79, P1499, DOI 10.1121/1.393676; Glasberg BR, 2002, J AUDIO ENG SOC, V50, P331; GREEN DM, 1964, PSYCHOL REV, V71, P392, DOI 10.1037/h0044520; GREEN DM, 1958, J ACOUST SOC AM, V30, P904, DOI 10.1121/1.1909400; GREEN DM, 1966, PSYCHOL BULL, V66, P228, DOI 10.1037/h0023645; Green DM, 1966, SIGNAL DETECTION THE; HANLEY JA, 1988, MED DECIS MAKING, V8, P197, DOI 10.1177/0272989X8800800308; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; Hartmann W. M., 2005, SIGNALS SOUND SENSAT; Heeren W, 2011, J ACOUST SOC AM, V130, P3905, DOI 10.1121/1.3652866; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUBNER R, 1993, PERCEPT PSYCHOPHYS, V54, P185, DOI 10.3758/BF03211754; Iverson G, 1997, CHOICE, DECISION, AND MEASUREMENT: ESSAYS IN HONOR OF R. DUNCAN LUCE, P301; Jesteadt W, 2011, 34 ANN MIDW RES M AS; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; KESELMAN HJ, 1994, J EDUC STAT, V19, P127, DOI 10.3102/10769986019002127; Kiang NYS, 1965, DISCHARGE PATTERNS S; Kohlrausch A, 1997, ACUSTICA, V83, P659; Kortekaas R, 2003, J ACOUST SOC AM, V113, P3306, DOI 10.1121/1.1570441; Leibold LJ, 2007, J ACOUST SOC AM, V121, P2822, DOI 10.1121/1.2715456; Leibold LJ, 2009, J ACOUST SOC AM, V125, P339, DOI 10.1121/1.3033741; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LUTFI RA, 1989, J ACOUST SOC AM, V86, P934, DOI 10.1121/1.398728; Lutfi RA, 2006, J ACOUST SOC AM, V120, P3853, DOI 10.1121/1.2361184; Macmillan N. A., 2005, DETECTION THEORY USE; Macmillan NA, 2004, PERCEPT PSYCHOPHYS, V66, P406, DOI 10.3758/BF03194889; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; MCFARLAND DJ, 1992, AUDIOLOGY, V31, P342; Metz CE, 1998, STAT MED, V17, P1033, DOI 10.1002/(SICI)1097-0258(19980515)17:9<1033::AID-SIM784>3.3.CO;2-Q; Mondor TA, 2004, CAN J EXP PSYCHOL, V58, P206, DOI 10.1037/h0087445; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; MUNSON WA, 1947, J ACOUST SOC AM, V19, P584, DOI 10.1121/1.1916525; Oberfeld D., 2009, FECHNER DAY 2009, P261; Oberfeld D, 2012, BEHAV RES METH; Oberfeld D, 2008, CAN J EXP PSYCHOL, V62, P24, DOI 10.1037/1196-1961.62.1.24; Oberfeld D, 2011, ATTEN PERCEPT PSYCHO, V73, P189, DOI 10.3758/s13414-010-0011-8; Pavlov I.P., 1927, CONDITIONED REFLEXES; Pedersen B, 2006, THESIS AALBORG U AAL; Pedersen B, 2008, J ACOUST SOC AM, V123, P963, DOI 10.1121/1.2822883; Plank T, 2005, THESIS U REGENSBURG; Plank T, 2004, P JOINT C CFA DAGA 0, P397; Port E, 1963, ACUSTICA, P212; POSTMAN L, 1965, Q J EXP PSYCHOL, V17, P132, DOI 10.1080/17470216508416422; POULSEN T, 1981, J ACOUST SOC AM, V69, P1786, DOI 10.1121/1.385915; Rennies J, 2009, ACTA ACUST UNITED AC, V95, P1112, DOI 10.3813/AAA.918243; Rennies J, 2009, J ACOUST SOC AM, V126, P951, DOI 10.1121/1.3192348; SCHARF B, 1959, J ACOUST SOC AM, V31, P783, DOI 10.1121/1.1907785; SCHARF B, 1962, J ACOUST SOC AM, V34, P228, DOI 10.1121/1.1909174; SCHNEIDER B, 1988, PERCEPT PSYCHOPHYS, V43, P211, DOI 10.3758/BF03214203; Sechenov IM, 1965, REFLEXES BRAIN; SMITH RL, 1977, J NEUROPHYSIOL, V40, P1098, DOI 10.1152/jn.1977.40.5.1098; Sorkin R. D., 1987, Proceedings of the Human Factors Society 31st Annual Meeting: Rising to New Heights with Technology, P1184; Stecker GC, 2010, J ACOUST SOC AM, V127, P3092, DOI 10.1121/1.3377088; Stecker GC, 2002, J ACOUST SOC AM, V112, P1046, DOI 10.1121/1.1497366; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; STEVENS SS, 1956, AM J PSYCHOL, V69, P1, DOI 10.2307/1418112; Suzuki Y, 2004, J ACOUST SOC AM, V116, P918, DOI 10.1121/1.1763601; SWETS JA, 1986, PSYCHOL BULL, V99, P100, DOI 10.1037/0033-2909.99.1.100; Turner MD, 2007, J ACOUST SOC AM, V121, P1848, DOI 10.1121/1.2710345; Ulrich R, 2009, ATTEN PERCEPT PSYCHO, V71, P1219, DOI 10.3758/APP.71.6.1219; Verhey J. L., 1999, PSYCHOACOUSTICS SPEC; Verhey JL, 2008, J ACOUST SOC AM, V123, P925, DOI 10.1121/1.2822318; Verhey JL, 2002, J ACOUST SOC AM, V111, P1349, DOI 10.1121/1.1451065; World Health Organization, 1999, GUID COMM NOIS; Yeshurun Y, 2008, VISION RES, V48, P1837, DOI 10.1016/j.visres.2008.05.008; ZWICKER E, 1957, J ACOUST SOC AM, V29, P548, DOI 10.1121/1.1908963; ZWICKER E, 1965, PSYCHOL REV, V72, P3, DOI 10.1037/h0021703; Zwicker E., 1999, PSYCHOACOUSTICS FACT	97	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50184	10.1371/journal.pone.0050184	http://dx.doi.org/10.1371/journal.pone.0050184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	095SN	23209670	Green Published, Green Submitted, gold			2022-12-25	WOS:000315355100001
J	Jin, D; Li, R; Mao, DX; Luo, N; Wang, YF; Chen, SY; Zhang, SP				Jin, Da; Li, Rui; Mao, Dongxue; Luo, Nan; Wang, Yifeng; Chen, Shaoyong; Zhang, Shuping			Mitochondria-Localized Glutamic Acid-Rich Protein (MGARP) Gene Transcription Is Regulated by Sp1	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SEX DETERMINATION; SYNERGISTIC ACTIVATION; EXPRESSION; 17-BETA-ESTRADIOL; SRY; COMPLEXES; DOMAINS; HYPOXIA; GROWTH	Background: Mitochondria-localized glutamic acid-rich protein (MGARP) is a novel mitochondrial transmembrane protein expressed mainly in steroidogenic tissues and in the visual system. Previous studies showed that MGARP functions in hormone biosynthesis and its expression is modulated by the HPG axis. Methodology/Principal Findings: By bioinformatics, we identified two characteristic GC-rich motifs that are located proximal to the transcription start site (TSS) of MGARP, and each contains two Specificity protein 1 (Sp1) binding elements. We then determined that the -3 kb proximal MGARP promoter is activated in a Sp1-dependent manner using reporter assays and knockdown of Sp1 led to decreased expression of endogenous MGARP messages. We also demonstrated that one of the two GC-rich motifs, GC-Box1, harbors prominent promoter activity mediated by Sp1, and that it requires both GC boxes for full transcriptional activation. These findings suggest a dominant role for these GC boxes and Sp1 in activating the MGARP promoter through a synergistic mechanism. Consistently, the results of an Electrophoretic Mobility Gel Shift Assay (EMSA) and Chromatin Immunoprecipitation (ChIP) confirmed that Sp1 specifically interacts with the GC-rich region. We further found that estrogen receptor a (ERa), a known Sp1 co-activator, could potentiate GC-boxes containing MGARP promoter activity and this effect is mediated by Sp1. Knockdown of Sp1 significantly diminished the MGARP promoter transactivation and the expression of endogenous MGARP mediated by both Sp1 and ERa. Conclusions/Significance: The present study identified a proximal core sequence in the MGARP promoter that is composed of two enriched Sp1 binding motifs and established Sp1 as one major MGARP transactivator whose functions are synergistic with ERa, providing a novel understanding of the mechanisms of MGARP gene transcriptional regulation.	[Jin, Da; Li, Rui; Mao, Dongxue; Luo, Nan; Wang, Yifeng; Zhang, Shuping] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Chen, Shaoyong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	Tsinghua University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Zhang, SP (corresponding author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	bczhang@tsinghua.edu.cn	CHEN, Shaoyong/ABF-3357-2021	Luo, Nan/0000-0002-4363-6637	National Natural Science Foundation of China [81171063, 81072167]; Tsinghua University Initiative Scientific Research Program [2009THZ01005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	This work was supported by grants from the National Natural Science Foundation of China (No. 81171063 and 81072167) and the Tsinghua University Initiative Scientific Research Program (No. 2009THZ01005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGMAN MD, 1989, J STEROID BIOCHEM, V33, P1027, DOI 10.1016/0022-4731(89)90405-6; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Danesh SM, 2011, J BIOL CHEM, V286, P31064, DOI 10.1074/jbc.M111.235457; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; Eddy EM, 1996, ENDOCRINOLOGY, V137, P4796, DOI 10.1210/en.137.11.4796; Fleming JGW, 2006, ENDOCRINOLOGY, V147, P899, DOI 10.1210/en.2005-1120; GIBBS RB, 1994, ANN NY ACAD SCI, V743, P165, DOI 10.1111/j.1749-6632.1994.tb55792.x; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; Gorodeski GI, 2005, J CLIN ENDOCR METAB, V90, P345, DOI 10.1210/jc.2004-1223; Hennebold JD, 2000, ENDOCRINOLOGY, V141, P2725, DOI 10.1210/en.141.8.2725; Hu P, 2008, J BIOL CHEM, V283, P6752, DOI 10.1074/jbc.M705937200; Jin W, 2008, J BIOL CHEM, V283, P29671, DOI 10.1074/jbc.M802785200; Khan S, 2003, ENDOCRINOLOGY, V144, P2325, DOI 10.1210/en.2002-0149; Khan S, 2006, MOL ENDOCRINOL, V20, P2199, DOI 10.1210/me.2006-0100; Kinouchi R, 2006, INVEST OPHTH VIS SCI, V47, P1397, DOI 10.1167/iovs.05-0602; Koopman P, 1995, REPROD FERT DEVELOP, V7, P713, DOI 10.1071/RD9950713; KRISHNAN V, 1994, J BIOL CHEM, V269, P15912; Li DL, 2007, ENDOCRINOLOGY, V148, P4821, DOI 10.1210/en.2007-0154; LI R, 1991, CELL, V65, P493, DOI 10.1016/0092-8674(91)90467-D; Li Y, 2010, CELL CYCLE, V9, P50, DOI 10.4161/cc.9.1.10318; Li Y, 2009, J CELL BIOL, V185, P1065, DOI 10.1083/jcb.200811033; Marin M, 1997, CELL, V89, P619, DOI 10.1016/S0092-8674(00)80243-3; Martino A, 2001, J IMMUNOL, V166, P1723, DOI 10.4049/jimmunol.166.3.1723; Matsumoto T, 2009, ENDOCRINOLOGY, V150, P3353, DOI 10.1210/en.2008-1584; McEwen BS, 2010, ANN NY ACAD SCI, V1204, pE38, DOI 10.1111/j.1749-6632.2010.05568.x; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Qi SL, 2011, MOL BIOL REP, V38, P2869, DOI 10.1007/s11033-010-9948-x; Safe S, 2004, PROG NUCLEIC ACID RE, V77, P1, DOI 10.1016/S0079-6603(04)77001-4; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; SAFFER JD, 1991, MOL CELL BIOL, V11, P2189, DOI 10.1128/MCB.11.4.2189; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sugimoto H, 2005, J BIOL CHEM, V280, P40857, DOI 10.1074/jbc.M503578200; Suzuki A, 2010, J BIOL CHEM, V285, P13444, DOI 10.1074/jbc.M109.062430; Wallis MC, 2008, CELL MOL LIFE SCI, V65, P3182, DOI 10.1007/s00018-008-8109-z; Wang WL, 1999, MOL ENDOCRINOL, V13, P1373, DOI 10.1210/me.13.8.1373; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; Yuan X, 2001, J BIOL CHEM, V276, P46647, DOI 10.1074/jbc.M108404200; Zhou MX, 2011, ENDOCRINOLOGY, V152, P2311, DOI 10.1210/en.2011-0050	43	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50053	10.1371/journal.pone.0050053	http://dx.doi.org/10.1371/journal.pone.0050053			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209644	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800044
J	Cino, EA; Karttunen, M; Choy, WY				Cino, Elio A.; Karttunen, Mikko; Choy, Wing-Yiu			Effects of Molecular Crowding on the Dynamics of Intrinsically Disordered Proteins	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; HUMAN PROTHYMOSIN-ALPHA; CELL NMR-SPECTROSCOPY; MODEL-FREE APPROACH; GROMOS FORCE-FIELD; ESCHERICHIA-COLI; PHYSIOLOGICAL CONSEQUENCES; UNSTRUCTURED PROTEINS; BACKBONE DYNAMICS; GLOBULAR PROTEIN	Inside cells, the concentration of macromolecules can reach up to 400 g/L. In such crowded environments, proteins are expected to behave differently than in vitro. It has been shown that the stability and the folding rate of a globular protein can be altered by the excluded volume effect produced by a high density of macromolecules. However, macromolecular crowding effects on intrinsically disordered proteins (IDPs) are less explored. These proteins can be extremely dynamic and potentially sample a wide ensemble of conformations under non-denaturing conditions. The dynamic properties of IDPs are intimately related to the timescale of conformational exchange within the ensemble, which govern target recognition and how these proteins function. In this work, we investigated the macromolecular crowding effects on the dynamics of several IDPs by measuring the NMR spin relaxation parameters of three disordered proteins (ProT alpha, TC1, and alpha-synuclein) with different extents of residual structures. To aid the interpretation of experimental results, we also performed an MD simulation of ProT alpha. Based on the MD analysis, a simple model to correlate the observed changes in relaxation rates to the alteration in protein motions under crowding conditions was proposed. Our results show that 1) IDPs remain at least partially disordered despite the presence of high concentration of other macromolecules, 2) the crowded environment has differential effects on the conformational propensity of distinct regions of an IDP, which may lead to selective stabilization of certain target-binding motifs, and 3) the segmental motions of IDPs on the nanosecond timescale are retained under crowded conditions. These findings strongly suggest that IDPs function as dynamic structural ensembles in cellular environments.	[Cino, Elio A.; Choy, Wing-Yiu] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Karttunen, Mikko] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	Western University (University of Western Ontario); University of Waterloo	Choy, WY (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	jchoy4@uwo.ca	Karttunen, Mikko/G-4531-2010; Choy, Wing-Yiu/O-7608-2017	Karttunen, Mikko/0000-0002-8626-3033; Choy, Wing-Yiu/0000-0002-2124-7278	Canadian Institutes of Health Research (CIHR) [74679]; Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Early Researcher Award program; Ontario Graduate Scholarship in Science and Technology (OGSST)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Early Researcher Award program(Ministry of Research and Innovation, Ontario); Ontario Graduate Scholarship in Science and Technology (OGSST)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR; MOP#74679; WYC), the Natural Sciences and Engineering Research Council of Canada (NSERC; MK) and the Ontario Early Researcher Award program (WYC, MK). An Ontario Graduate Scholarship in Science and Technology (OGSST) was awarded to EAC. Computational resources were provided by SHARCNET (Shared Hierarchical Academic Research Computing Network - www.sharcnet.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Batra J, 2009, BIOPHYS J, V97, P906, DOI 10.1016/j.bpj.2009.05.032; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, V11, P331, DOI DOI 10.1111/J.1574-695X.1996.TB00128.X; Bremi T, 1997, J AM CHEM SOC, V119, P4272, DOI 10.1021/ja9636505; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Choy WY, 2003, J BIOMOL NMR, V25, P325, DOI 10.1023/A:1023065310430; Christiansen A, 2010, BIOCHEMISTRY-US, V49, P6519, DOI 10.1021/bi100578x; Chua EL, 2000, GENOMICS, V69, P342, DOI 10.1006/geno.2000.6348; Cino EA, 2012, J CHEM THEORY COMPUT, V8, P2725, DOI 10.1021/ct300323g; Cino EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027371; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Elcock AH, 2010, CURR OPIN STRUC BIOL, V20, P196, DOI 10.1016/j.sbi.2010.01.008; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Evstafieva AG, 2003, EXP CELL RES, V284, P211, DOI 10.1016/S0014-4827(02)00047-2; Flaugh SL, 2001, BIOMACROMOLECULES, V2, P538, DOI 10.1021/bm015502z; Gall C, 2007, PROTEIN SCI, V16, P2510, DOI 10.1110/ps.073062707; GAST K, 1995, BIOCHEMISTRY-US, V34, P13211, DOI 10.1021/bi00040a037; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang LQ, 2010, FASEB J, V24, P3536, DOI 10.1096/fj.09-150987; Istratov AA, 1999, REV SCI INSTRUM, V70, P1233, DOI 10.1063/1.1149581; Ito Y, 2010, CURR OPIN STRUC BIOL, V20, P640, DOI 10.1016/j.sbi.2010.07.006; Johansen D, 2011, BIOPHYS J, V100, P1120, DOI 10.1016/j.bpj.2011.01.020; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung YS, 2006, CANCER RES, V66, P723, DOI 10.1158/0008-5472.CAN-05-3124; Karttunen M, 2008, CURR TOP MEMBR, V60, P49, DOI 10.1016/S1063-5823(08)00002-1; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Lee AL, 1999, J BIOMOL NMR, V13, P101, DOI 10.1023/A:1008304220445; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; Li CG, 2010, J AM CHEM SOC, V132, P321, DOI 10.1021/ja907966n; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Nederveen AJ, 2005, J CHEM THEORY COMPUT, V1, P363, DOI 10.1021/ct0498829; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Padmanabhan B, 2008, ACTA CRYSTALLOGR F, V64, P233, DOI 10.1107/S1744309108004995; Pielak GJ, 2009, BIOCHEMISTRY-US, V48, P226, DOI 10.1021/bi8018948; Pineiro A, 2000, PEPTIDES, V21, P1433, DOI 10.1016/S0196-9781(00)00288-6; Polakis P, 2000, GENE DEV, V14, P1837; Rahman Parrinello, 1981, J APPL PHYS, V52, P7182; Reardon PN, 2005, J AM CHEM SOC, V127, P10848, DOI 10.1021/ja053145k; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Schlesinger AP, 2011, J AM CHEM SOC, V133, P8082, DOI 10.1021/ja201206t; Schneider R, 2012, MOL BIOSYST, V8, P58, DOI 10.1039/c1mb05291h; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; SHEVCHIK VE, 1994, EMBO J, V13, P2007, DOI 10.1002/j.1460-2075.1994.tb06470.x; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Showalter SA, 2007, J CHEM THEORY COMPUT, V3, P961, DOI 10.1021/ct7000045; Simorellis AK, 2006, J AM CHEM SOC, V128, P9580, DOI 10.1021/ja061705p; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Szasz C, 2011, BIOCHEMISTRY-US, V50, P5834, DOI [10.1021/bi200365j, 10.1021/bi200365J]; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tang XJ, 2012, P NATL ACAD SCI USA, V109, P3287, DOI 10.1073/pnas.1116455109; Teilum K, 2009, CELL MOL LIFE SCI, V66, P2231, DOI 10.1007/s00018-009-0014-6; Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4; Wang YQ, 2010, J AM CHEM SOC, V132, P9392, DOI 10.1021/ja102296k; Wong-ekkabut J, 2012, J CHEM THEORY COMPUT, V8, P2905, DOI 10.1021/ct3001359; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wu KP, 2008, J MOL BIOL, V378, P1104, DOI 10.1016/j.jmb.2008.03.017; Xue Y, 2011, J AM CHEM SOC, V133, P14614, DOI 10.1021/ja201605c; Yi SL, 2008, PROTEIN EXPRES PURIF, V57, P1, DOI 10.1016/j.pep.2007.09.005; Yi SL, 2007, BIOCHEMISTRY-US, V46, P13120, DOI 10.1021/bi7014822; Yokota O, 2002, ACTA NEUROPATHOL, V104, P637, DOI 10.1007/s0041-002-0596-7; Zhang DL, 2012, ACTA BIOCH BIOPH SIN, V44, P703, DOI 10.1093/abbs/gms052; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou Z, 2011, BIOPHYS J, V101, P1483, DOI 10.1016/j.bpj.2011.08.018; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	92	73	73	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49876	10.1371/journal.pone.0049876	http://dx.doi.org/10.1371/journal.pone.0049876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189168	gold, Green Submitted, Green Published			2022-12-25	WOS:000311929800045
J	Pfahler, S; Distl, O				Pfahler, Sophia; Distl, Ottmar			Identification of Quantitative Trait Loci (QTL) for Canine Hip Dysplasia and Canine Elbow Dysplasia in Bernese Mountain Dogs	PLOS ONE			English	Article							OSTEOCHONDROSIS; ASSOCIATION; PREVALENCE; BREEDS; OSTEOARTHRITIS; LAXITY; TRENDS; JOINT	A genome-wide association study for canine hip dysplasia (CHD) and canine elbow dysplasia (CED) using the Illumina canine high density bead chip had been performed for 174 Bernese mountain dogs. General and mixed linear model analysis identified two different regions with single nucleotide polymorphisms (SNPs) on dog chromosome (CFA) 14 significantly associated with CHD and a further significantly CHD-associated region on CFA37. For CED, four SNPs on CFA11 and 27 were significantly associated. The identified SNPs of four associated regions included nearby candidate genes. These possible positional candidates were the genes PON2 on CFA14 and FN1 on CFA37 for CHD and the genes LMNB1 on CFA11 and WNT10B on CFA27 for CED.	[Pfahler, Sophia; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de			German Breeding Association for Swiss Mountain Dogs [SSV-DI/1-2]	German Breeding Association for Swiss Mountain Dogs	The study was supported by a grant of the German Breeding Association for Swiss Mountain Dogs (SSV-DI/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brass W, 1993, KLEINTIERPRAXIS, V38, P191; Burton-Wurster N, 1999, OSTEOARTHR CARTILAGE, V7, P486, DOI 10.1053/joca.1999.0244; Chase K, 2005, AM J MED GENET A, V135A, P334, DOI 10.1002/ajmg.a.30719; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Comhaire FH, 2008, AM J VET RES, V69, P330, DOI 10.2460/ajvr.69.3.330; Coopman F, 2008, VET REC, V163, P654, DOI 10.1136/vr.163.22.654; Fluckiger M., 2007, EUROPEAN J COMPANION, V17, P135; Friedenberg SG, 2011, AM J VET RES, V72, P530, DOI 10.2460/ajvr.72.4.530; Genevois JP, 2008, VET COMP ORTHOPAED, V21, P21, DOI 10.3415/VCOT-07-02-0014; GUTHRIE S, 1990, J SMALL ANIM PRACT, V31, P93, DOI 10.1111/j.1748-5827.1990.tb00730.x; Hartmann P, 2010, BERL MUNCH TIERARZTL, V123, P488, DOI 10.2376/0005-9366-123-488; Janutta V, 2006, J HERED, V97, P13, DOI 10.1093/jhered/esi128; Lee YH, 2012, MOL BIOL REP, V39, P8099, DOI 10.1007/s11033-012-1657-1; MacLeod JN, 1996, J BIOL CHEM, V271, P18954, DOI 10.1074/jbc.271.31.18954; Maki K, 2002, ANIM SCI, V75, P197, DOI 10.1017/S1357729800052966; Malm S, 2008, J ANIM BREED GENET, V125, P403, DOI 10.1111/j.1439-0388.2008.00725.x; Marschall Y, 2007, MAMM GENOME, V18, P861, DOI 10.1007/s00335-007-9071-z; Mateescu RG, 2005, BIOCHEM BIOPH RES CO, V332, P482, DOI 10.1016/j.bbrc.2005.04.144; Nakabayashi K, 2004, J MED GENET, V41, P601, DOI 10.1136/jmg.2003.014142; Saig KG, 2006, AM J VET RES, V67, P1713, DOI 10.2460/ajvr.67.10.1713; Stock KF, 2011, J ANIM BREED GENET, V128, P219, DOI 10.1111/j.1439-0388.2010.00901.x; Sturaro E, 2005, ITAL J ANIM SCI, V4, P233, DOI 10.4081/ijas.2005.233; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Vergnes L, 2004, P NATL ACAD SCI USA, V101, P10428, DOI 10.1073/pnas.0401424101; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219; Zhu L, 2008, ANIM GENET, V39, P141, DOI 10.1111/j.1365-2052.2007.01691.x; Zmuda JM, 2009, J BONE MINER RES, V24, P437, DOI 10.1359/JBMR.081106	29	28	29	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49782	10.1371/journal.pone.0049782	http://dx.doi.org/10.1371/journal.pone.0049782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189162	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800039
J	Sohrab, M; Wu, K; Fawzi, AA				Sohrab, Mahsa; Wu, Katherine; Fawzi, Amani A.			A Pilot Study of Morphometric Analysis of Choroidal Vasculature In Vivo, Using En Face Optical Coherence Tomography	PLOS ONE			English	Article							MACULAR DEGENERATION; BRUCHS MEMBRANE; AXIAL LENGTH; THICKNESS; EYES; CHORIOCAPILLARIS; DRUSEN; RPE	Purpose: To study the ability of volumetric spectral domain optical coherence tomography (SD-OCT) to perform quantitative measurement of the choroidal vasculature in vivo. Methods: Choroidal vascular density and vessel size were quantified using en face choroidal scans from various depths below the retinal pigment epithelium (RPE) in 58 eyes of 58 patients with either epiretinal membranes (ERM), early age-related macular degeneration (AMD), or reticular pseudo-drusen (RPD). For each patient, we used the macular volume scan (666 mm cube) for vessel quantification, while high-definition (HD) cross-section raster scans were used to qualitatively assess vascularity of the choroidal sub-layers, and measure choroidal thickness. Results: Of the 58 patients, more were female (66% versus 34% male), of whom 14 (24%) had ERM, 11 (19%) early AMD, and 33 (57%) RPD. Compared to intact choriocapillaris in all ERM (100%), none of the RPD and only 5/11 (45%) early AMD eyes had visible choriocapillaris on either cross section or C-scans (p-value<0.001). When comparing select regions from the most superficial C-scans, early AMD group had lowest vascular density and RPD had highest (p-value 0.04). Qualitative evaluation of C-scans from all three groups revealed a more granular appearance of the choriocapillaris in ERM versus increased stroma and larger vessels in the RPD eyes. Conclusions: SD-OCT can be used to qualitatively and quantitatively assess choroidal vascularity in vivo. Our findings correlate to previously reported histopathologic studies. Lack of choriocapillaris on HD cross-sections or C-scans in all RPD and about half of early AMD eyes suggests earlier choroidal involvement in AMD and specifically, RPD.	[Sohrab, Mahsa; Wu, Katherine; Fawzi, Amani A.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Fawzi, AA (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	Afawzimd@gmail.com	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558	National Eye Institute [EY03040, EY021470]; NATIONAL EYE INSTITUTE [R01EY021470, P30EY003040] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute EY03040 and EY021470. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JS, 2009, INVEST OPHTH VIS SCI, V50, P5, DOI 10.1167/iovs.08-1779; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Hogan MJ, 1971, HISTOLOGY HUMAN EYE, P320; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Kim SW, 2011, RETINA-J RET VIT DIS, V31, P1904, DOI 10.1097/IAE.0b013e31821801c5; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Lengyel I, 2004, INVEST OPHTH VIS SCI, V45, P2886, DOI 10.1167/iovs.03-1083; Li XQ, 2011, INVEST OPHTH VIS SCI, V52, P8438, DOI 10.1167/iovs.11-8108; Lutty G, 1999, MOL VIS, V5; Manjunath V, 2011, AM J OPHTHALMOL, V152, P663, DOI 10.1016/j.ajo.2011.03.008; Margolis R, 2009, AM J OPHTHALMOL, V147, P811, DOI 10.1016/j.ajo.2008.12.008; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; McLeod DS, 2002, INVEST OPHTH VIS SCI, V43, P1986; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Sohrab MA, 2011, INVEST OPHTH VIS SCI, V52, P5743, DOI 10.1167/iovs.10-6942; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Spraul CW, 1999, SURV OPHTHALMOL, V44, pS10, DOI 10.1016/S0039-6257(99)00086-7; Stanga PE, 2003, OPHTHALMOLOGY, V110, P15, DOI 10.1016/S0161-6420(02)01563-4; Wang RKK, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3582159	22	85	86	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e48631	10.1371/journal.pone.0048631	http://dx.doi.org/10.1371/journal.pone.0048631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189132	Green Submitted, gold, Green Published			2022-12-25	WOS:000311929800011
J	Tervaniemi, MH; Siitonen, HA; Soderhall, C; Minhas, G; Vuola, J; Tiala, I; Sormunen, R; Samuelsson, L; Suomela, S; Kere, J; Elomaa, O				Tervaniemi, Mari H.; Siitonen, H. Annika; Soderhall, Cilla; Minhas, Gurinder; Vuola, Jyrki; Tiala, Inkeri; Sormunen, Raija; Samuelsson, Lena; Suomela, Sari; Kere, Juha; Elomaa, Outi			Centrosomal Localization of the Psoriasis Candidate Gene Product, CCHCR1, Supports a Role in Cytoskeletal Organization	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; BETA-CATENIN; FACTOR RECEPTOR; PSORS1 LOCUS; KERATIN 17; TRANSGENIC MICE; SKIN BIOLOGY; CANCER-CELLS; IN-VITRO; STAT3	CCHCR1 (Coiled-Coil alpha-Helical Rod protein 1), within the major psoriasis susceptibility locus PSORS1, is a plausible candidate gene with the psoriasis associated risk allele CCHCR1*WWCC. Although its expression pattern in psoriatic skin differs from healthy skin and its overexpression influences cell proliferation in transgenic mice, its role as a psoriasis effector gene has remained unsettled. The 5'-region of the gene contains a SNP (rs3130453) that controls a 5'-extended open reading frame and thus the translation of alternative isoforms. We have now compared the function of two CCHCR1 isoforms: the novel longer isoform 1 and the previously studied isoform 3. In samples of Finnish and Swedish families, the allele generating only isoform 3 shows association with psoriasis (P<10(-7)). Both isoforms localize at the centrosome, a cell organelle playing a role in cell division. In stably transfected cells the isoform 3 affects cell proliferation and with the CCHCR1*WWCC allele, also apoptosis. Furthermore, cells overexpressing CCHCR1 show isoform-and haplotype-specific influences in the cell size and shape and alterations in the organization and expression of the cytoskeletal proteins actin, vimentin, and cytokeratins. The isoform 1 with the non-risk allele induces the expression of keratin 17, a hallmark for psoriasis; the silencing of CCHCR1 reduces its expression in HEK293 cells. CCHCR1 also regulates EGF-induced STAT3 activation in an isoform-specific manner: the tyrosine phosphorylation of STAT3 is disturbed in isoform 3-transfected cells. The centrosomal localization of CCHCR1 provides a connection to the abnormal cell proliferation and offers a link to possible cellular pathways altered in psoriasis.	[Tervaniemi, Mari H.; Siitonen, H. Annika; Minhas, Gurinder; Tiala, Inkeri; Kere, Juha; Elomaa, Outi] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland; [Tervaniemi, Mari H.; Siitonen, H. Annika; Minhas, Gurinder; Tiala, Inkeri; Kere, Juha; Elomaa, Outi] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Tervaniemi, Mari H.; Siitonen, H. Annika; Minhas, Gurinder; Tiala, Inkeri; Kere, Juha; Elomaa, Outi] Folkhalsan Inst Genet, Helsinki, Finland; [Soderhall, Cilla; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Vuola, Jyrki] Univ Helsinki, Cent Hosp, Helsinki Burn Ctr, Dept Plast Surg, Helsinki, Finland; [Kere, Juha] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [Sormunen, Raija] Univ Oulu, Dept Pathol, Bioctr Oulu, Oulu, Finland; [Samuelsson, Lena] Sahlgrens Univ Hosp, Dept Clin Genet, Gothenburg, Sweden; [Suomela, Sari] Univ Helsinki, Dept Dermatol, Helsinki, Finland	University of Helsinki; University of Helsinki; Karolinska Institutet; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet; University of Oulu; Sahlgrenska University Hospital; University of Helsinki	Kere, J (corresponding author), Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland.	juha.kere@ki.se	Kere, Juha/AAX-9117-2021; Söderhäll, Cilla/E-3940-2012; Kere, Juha/A-9179-2008	Kere, Juha/0000-0003-1974-0271; Söderhäll, Cilla/0000-0002-8397-3080; Kere, Juha/0000-0003-1974-0271	Academy of Finland [130360, 1255560]; Finska Lakaresallskapet; Helsinki University; Sigrid Juselius Foundation; Helsinki University Hospital [TYH2009233]; Swedish Research Council; Swedish Governmental Agency for Innovation Systems Vinnova	Academy of Finland(Academy of Finland); Finska Lakaresallskapet; Helsinki University; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki University Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Governmental Agency for Innovation Systems Vinnova(Vinnova)	This study was supported by Academy of Finland (grant no. 130360; no. 1255560), Finska Lakaresallskapet, Helsinki University Research Funds, Sigrid Juselius Foundation, Helsinki University Hospital Research Funds (TYH2009233), Swedish Research Council and Swedish Governmental Agency for Innovation Systems Vinnova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Maghrebi M, 2002, NUCLEIC ACIDS RES, V30, P5017, DOI 10.1093/nar/gkf656; Amin HM, 2004, ONCOGENE, V23, P5426, DOI 10.1038/sj.onc.1207703; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Asumalahti K, 2002, HUM MOL GENET, V11, P589, DOI 10.1093/hmg/11.5.589; Asumalahti K, 2000, HUM MOL GENET, V9, P1533, DOI 10.1093/hmg/9.10.1533; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chang T, 2011, EXP DERMATOL, V20, P555, DOI 10.1111/j.1600-0625.2010.01235.x; Chang YT, 2006, BRIT J DERMATOL, V155, P663, DOI 10.1111/j.1365-2133.2006.07420.x; Cook PW, 2004, EXP DERMATOL, V13, P347, DOI 10.1111/j.0906-6705.2004.00183.x; Corbi N, 2005, J CELL SCI, V118, P4253, DOI 10.1242/jcs.02545; Corbi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014481; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; DEJONG EMGJ, 1991, ARCH DERMATOL RES, V283, P480, DOI 10.1007/BF00371788; DePianto D, 2010, NAT GENET, V42, P910, DOI 10.1038/ng.665; Elomaa O, 2004, HUM MOL GENET, V13, P1551, DOI 10.1093/hmg/ddh178; Enomoto T, 1996, CELL STRUCT FUNCT, V21, P317, DOI 10.1247/csf.21.317; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1849, DOI 10.1038/jid.2010.67; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; Gudmundsdottir AS, 1999, CLIN EXP IMMUNOL, V117, P580; Hall PF, 1997, STEROIDS, V62, P185, DOI 10.1016/S0039-128X(96)00179-1; Hampton PJ, 2007, BRIT J DERMATOL, V157, P1168, DOI 10.1111/j.1365-2133.2007.08195.x; Henno A, 2009, BRIT J DERMATOL, V160, P581, DOI 10.1111/j.1365-2133.2008.08889.x; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Inerot A, 2005, BMC DERMATOL, V5, DOI 10.1186/1471-5945-5-10; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Junker C, 2011, EMBO J, V30, P1187, DOI 10.1038/emboj.2011.72; Jurczyk A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011812; Kainu K, 2009, EXP DERMATOL, V18, P109, DOI 10.1111/j.1600-0625.2008.00769.x; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lund N, 2010, BIOCHEM BIOPH RES CO, V395, P401, DOI 10.1016/j.bbrc.2010.04.033; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Metge B, 2004, J BIOL CHEM, V279, P41801, DOI 10.1074/jbc.M407094200; Minner F, 2009, J INVEST DERMATOL, V129, P770, DOI 10.1038/jid.2008.247; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nekrasova OE, 2011, MOL BIOL CELL, V22, P2282, DOI 10.1091/mbc.E10-09-0766; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Okamoto M, 2002, BBA-GENE STRUCT EXPR, V1574, P24, DOI 10.1016/S0167-4781(01)00345-1; Paccione RJ, 2008, MOL CANCER THER, V7, P2894, DOI 10.1158/1535-7163.MCT-08-0450; Pacholska-Bogalska J, 2012, INT J MOL MED, V29, P669, DOI 10.3892/ijmm.2012.877; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Riveira-Munoz E, 2011, J INVEST DERMATOL, V131, P1105, DOI 10.1038/jid.2010.350; Roberson EDO, 2010, TRENDS GENET, V26, P415, DOI 10.1016/j.tig.2010.06.006; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Schneider MR, 2008, AM J PATHOL, V173, P14, DOI 10.2353/ajpath.2008.070942; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Shen Z, 2006, J AM ACAD DERMATOL, V54, P992, DOI 10.1016/j.jaad.2006.02.033; Shi XW, 2011, J INVEST DERMATOL, V131, P2401, DOI 10.1038/jid.2011.222; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Sugawara T, 2003, J BIOL CHEM, V278, P42487, DOI 10.1074/jbc.M302291200; Suomela S, 2003, J INVEST DERMATOL, V121, P1360, DOI 10.1046/j.1523-1747.2003.12642.x; Suomela S, 2007, ACTA DERM-VENEREOL, V87, P127, DOI 10.2340/00015555-0184; Suomela S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006030; Tiala I, 2008, HUM MOL GENET, V17, P1043, DOI 10.1093/hmg/ddm377; Tiala I, 2007, J MOL MED, V85, P589, DOI 10.1007/s00109-006-0155-0; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; Walker SR, 2010, MOL PHARMACOL, V78, P903, DOI 10.1124/mol.110.066316; Yoshida A, 2008, ARCH DERMATOL RES, V300, P37, DOI 10.1007/s00403-007-0809-y; Zhang XJ, 2009, NAT GENET, V41, P205, DOI 10.1038/ng.310; Zheng HF, 2011, J DERMATOL SCI, V61, P124, DOI 10.1016/j.jdermsci.2010.12.001	72	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49920	10.1371/journal.pone.0049920	http://dx.doi.org/10.1371/journal.pone.0049920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189171	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800048
J	Tsang, YH; Han, XX; Man, WY; Lee, N; Poon, RYC				Tsang, Yiu Huen; Han, Xianxian; Man, Wing Yu; Lee, Nelson; Poon, Randy Y. C.			Novel Functions of the Phosphatase SHP2 in the DNA Replication and Damage Checkpoints	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE; CYCLIN-A; G2/M CHECKPOINT; CELL SURVIVAL; KINASE; CHK1; PHOSPHORYLATION; ACTIVATION; APOPTOSIS; REQUIRES	Replication stress-and DNA damage-induced cell cycle checkpoints are critical for maintaining genome stability. To identify protein phosphatases involved in the activation and maintenance of the checkpoints, we have carried out RNA interference-based screens with a human phosphatome shRNA library. Several phosphatases, including SHP2 (also called PTPN11) were found to be required for cell survival upon hydroxyurea-induced replicative stress in HeLa cells. More detailed studies revealed that SHP2 was also important for the maintenance of the checkpoint after DNA damage induced by cisplatin or ionizing radiation in HeLa cells. Furthermore, SHP2 was activated after replicative stress and DNA damage. Although depletion of SHP2 resulted in a delay in cyclin E accumulation and an extension of G(1) phase, these cell cycle impairments were not responsible for the increase in apoptosis after DNA damage. Depletion of SHP2 impaired CHK1 activation, checkpoint-mediated cell cycle arrest, and DNA repair. These effects could be rescued with a shRNA-resistant SHP2. These results underscore the importance of protein phosphatases in checkpoint control and revealed a novel link between SHP2 and cell cycle checkpoints.	[Poon, Randy Y. C.] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Poon, RYC (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China.	rycpoon@ust.hk		Poon, Randy/0000-0001-5571-6231	Hong Kong University of Science and Technology; Research Grants Council [CA06/07.sc02]	Hong Kong University of Science and Technology; Research Grants Council(Hong Kong Research Grants Council)	This work was supported by the Hong Kong University of Science and Technology and the Research Grants Council grant CA06/07.sc02 to R.Y.C.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin ARMR, 2007, P NATL ACAD SCI USA, V104, P5419, DOI 10.1073/pnas.0700642104; Arooz T, 2000, BIOCHEMISTRY-US, V39, P9494, DOI 10.1021/bi0009643; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan YW, 2008, J BIOL CHEM, V283, P15716, DOI 10.1074/jbc.M800629200; Chan YW, 2008, CELL CYCLE, V7, P1449, DOI 10.4161/cc.7.10.5880; Chen J, 2004, ONCOGENE, V23, P3659, DOI 10.1038/sj.onc.1207471; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Chow JPH, 2003, J BIOL CHEM, V278, P40815, DOI 10.1074/jbc.M306683200; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Fung TK, 2007, MOL BIOL CELL, V18, P1861, DOI 10.1091/mbc.E06-12-1092; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Ho CC, 2005, EXP CELL RES, V304, P1, DOI 10.1016/j.yexcr.2004.10.016; Kuo CC, 2010, BIOCHEM BIOPH RES CO, V391, P230, DOI 10.1016/j.bbrc.2009.11.037; Le Guezennec X, 2010, TRENDS BIOCHEM SCI, V35, P109, DOI 10.1016/j.tibs.2009.09.005; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; Lu XY, 2009, J BIOL CHEM, V284, P35325, DOI 10.1074/jbc.M109.035949; Ma HT, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1109; Ma HT, 2009, MOL CELL BIOL, V29, P6500, DOI 10.1128/MCB.00669-09; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nguyen L, 1997, J BIOL CHEM, V272, P20811, DOI 10.1074/jbc.272.33.20811; On KF, 2011, MOL CANCER THER, V10, P784, DOI 10.1158/1535-7163.MCT-10-0809; Ostman A, 2006, NAT REV CANCER, V6, P307, DOI 10.1038/nrc1837; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Puc J, 2005, CELL CYCLE, V4, P927, DOI 10.4161/cc.4.7.1795; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Shi ZQ, 1998, J BIOL CHEM, V273, P4904, DOI 10.1074/jbc.273.9.4904; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Tartaglia M, 2004, CURR OPIN HEMATOL, V11, P44, DOI 10.1097/00062752-200401000-00007; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Yam CH, 1999, CANCER RES, V59, P5075; Yam CH, 2000, J BIOL CHEM, V275, P3158, DOI 10.1074/jbc.275.5.3158; Yam CH, 2001, P NATL ACAD SCI USA, V98, P497, DOI 10.1073/pnas.240461397; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu WM, 2003, ONCOGENE, V22, P5995, DOI 10.1038/sj.onc.1206846; Yuan LP, 2003, J BIOL CHEM, V278, P42812, DOI 10.1074/jbc.M305075200; Yuan LP, 2003, J BIOL CHEM, V278, P15208, DOI 10.1074/jbc.M211327200; Zito CI, 2004, J CELL PHYSIOL, V199, P227, DOI 10.1002/jcp.10446	47	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49943	10.1371/journal.pone.0049943	http://dx.doi.org/10.1371/journal.pone.0049943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189174	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800051
J	Hahn, MA; van Kleunen, M; Muller-Scharer, H				Hahn, Min A.; van Kleunen, Mark; Mueller-Schaerer, Heinz			Increased Phenotypic Plasticity to Climate May Have Boosted the Invasion Success of Polyploid Centaurea stoebe	PLOS ONE			English	Article							SPOTTED KNAPWEED; PLOIDY LEVEL; LEAF-AREA; PLANT; EVOLUTION; GROWTH; INVASIVENESS; POPULATIONS; MECHANISMS; ASTERACEAE	Phenotypic plasticity may allow organisms to cope with altered environmental conditions as e. g. after the introduction into a new range. In particular polyploid organisms, containing more than two sets of chromosomes, may show high levels of plasticity, which could in turn increase their environmental tolerance and invasiveness. Here, we studied the role of phenotypic plasticity in the invasion of Centaurea stoebe (Asteraceae), which in the native range in Europe occurs as diploids and tetraploids, whereas in the introduced range in North America so far only tetraploids have been found. In a common garden experiment at two sites in the native range, we grew half-sibs of the three geo-cytotypes (native European diploids, European tetraploids and invasive North American tetraploids) from a representative sample of 27 populations. We measured the level and the adaptive significance of phenotypic plasticity in eco-physiological and life-history traits in response to the contrasting climatic conditions at the two study sites as well as three different soil conditions in pots, simulating the most crucial abiotic differences between the native and introduced range. European tetraploids showed increased levels of phenotypic plasticity as compared to diploids in response to the different climatic conditions in traits associated with rapid growth and fast phenological development. Moreover, we found evidence for adaptive plasticity in these traits, which suggests that increased plasticity may have contributed to the invasion success of tetraploid C. stoebe by providing an advantage under the novel climatic conditions. However, in invasive tetraploids phenotypic plasticity was similar to that of native tetraploids, indicating no evolution of increased plasticity during invasions. Our findings provide the first empirical support for increased phenotypic plasticity associated with polyploids, which may contribute to their success as invasive species in novel environments.	[Hahn, Min A.; Mueller-Schaerer, Heinz] Univ Fribourg, Dept Biol Ecol & Evolut, CH-1700 Fribourg, Switzerland; [van Kleunen, Mark] Univ Konstanz, Dept Biol, Constance, Germany	University of Fribourg; University of Konstanz	Hahn, MA (corresponding author), Univ Fribourg, Dept Biol Ecol & Evolut, CH-1700 Fribourg, Switzerland.	min.hahn@unifr.ch	Mueller-Schaerer, Heinz/H-5277-2011; van Kleunen, Mark/B-3769-2009	van Kleunen, Mark/0000-0002-2861-3701; Muller-Scharer, heinz/0000-0003-0936-1470	Swiss National Science foundation [31003A_125314]; National Centre of Competence in Research (NCCR) Plant Survival	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research (NCCR) Plant Survival(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science foundation (grant no. 31003A_125314 to H.M.S.; www.snf.ch) and the National Centre of Competence in Research (NCCR) Plant Survival (www.unine.ch/nccr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JM, 2012, J ECOLOGY; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Atkin OK, 2006, J EXP BOT, V57, P267, DOI 10.1093/jxb/erj029; BAKER H. G., 1965, The genetics of colonizing species: Proc. 1st Internat, Union biol Sci., Asilomar, California., P147; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Bretagnolle F, 2001, INT J PLANT SCI, V162, P309, DOI 10.1086/319572; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Broz AK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-33; Burns JH, 2008, ECOL APPL, V18, P335, DOI 10.1890/07-0568.1; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Grigulis K, 2001, J APPL ECOL, V38, P281, DOI 10.1046/j.1365-2664.2001.00587.x; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; Hahn MA, 2012, ECOL LETT, V15, P947, DOI 10.1111/j.1461-0248.2012.01813.x; Henery ML, 2010, J ECOL, V98, P800, DOI 10.1111/j.1365-2745.2010.01672.x; Hulme PE, 2008, FUNCT ECOL, V22, P3, DOI 10.1111/j.1365-2435.2007.01369.x; Lacaze X, 2009, HEREDITY, V102, P163, DOI 10.1038/hdy.2008.76; Lafuma L, 2003, PLANT SYST EVOL, V243, P59, DOI 10.1007/s00606-003-0075-0; Levin D. A, 2002, OX ECOL EV; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Lowry E, 2006, J BIOGEOGR, V33, P1975, DOI 10.1111/j.1365-2699.2006.01562.x; Marrs RA, 2008, MOL ECOL, V17, P4197, DOI 10.1111/j.1365-294X.2008.03903.x; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Matesanz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044955; Mraz P, 2012, ANN BOT-LONDON, V110, P615, DOI 10.1093/aob/mcs120; Mraz P, 2012, MOL PHYLOGENET EVOL, V62, P612, DOI 10.1016/j.ympev.2011.11.006; Mraz P, 2011, INT J PLANT SCI, V172, P386, DOI 10.1086/658151; Munzbergova Z, 2007, BIOL J LINN SOC, V92, P211, DOI 10.1111/j.1095-8312.2007.00820.x; MULLER H, 1989, WEED RES, V29, P103, DOI 10.1111/j.1365-3180.1989.tb00847.x; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Palacio-Lopez K, 2011, OIKOS, V120, P1393, DOI 10.1111/j.1600-0706.2010.19114.x; Pandit MK, 2011, J ECOL, V99, P1108, DOI 10.1111/j.1365-2745.2011.01838.x; Petit C, 1997, J ECOL, V85, P657, DOI 10.2307/2960536; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Development Core Team, 2009, R FDN STAT COMP; Ren MX, 2009, WEED RES, V49, P449, DOI 10.1111/j.1365-3180.2009.00723.x; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schlaepfer DR, 2008, J BIOGEOGR, V35, P2119, DOI 10.1111/j.1365-2699.2008.01937.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Sheley RL, 1998, WEED TECHNOL, V12, P353, DOI 10.1017/S0890037X00043931; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Soria-Hernanz DF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-344; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Story JM, 2006, BIOL CONTROL, V38, P227, DOI 10.1016/j.biocontrol.2005.12.018; Sultan SE, 1995, ACTA BOT NEERL, V44, P363; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Van Kleunen M, 2001, ECOLOGY, V82, P3309, DOI 10.1890/0012-9658(2001)082[3309:AEOPFR]2.0.CO;2; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Weiner J, 1997, J ECOL, V85, P133, DOI 10.2307/2960645; Wells W., 2008, REGNITZ FLORA, V2, P44; Yue JX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-242	63	68	68	1	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50284	10.1371/journal.pone.0050284	http://dx.doi.org/10.1371/journal.pone.0050284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185598	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700084
J	Fieramonti, L; Bassi, A; Foglia, EA; Pistocchi, A; D'Andrea, C; Valentini, G; Cubeddu, R; De Silvestri, S; Cerullo, G; Cotelli, F				Fieramonti, Luca; Bassi, Andrea; Foglia, Efrem Alessandro; Pistocchi, Anna; D'Andrea, Cosimo; Valentini, Gianluca; Cubeddu, Rinaldo; De Silvestri, Sandro; Cerullo, Giulio; Cotelli, Franco			Time-Gated Optical Projection Tomography Allows Visualization of Adult Zebrafish Internal Structures	PLOS ONE			English	Article							TOOL; SCATTERING; DISEASE; DEEP	Optical imaging through biological samples is compromised by tissue scattering and currently various approaches aim to overcome this limitation. In this paper we demonstrate that an all optical technique, based on non-linear upconversion of infrared ultrashort laser pulses and on multiple view acquisition, allows the reduction of scattering effects in tomographic imaging. This technique, namely Time-Gated Optical Projection Tomography (TGOPT), is used to reconstruct three dimensionally the internal structure of adult zebrafish without staining or clearing agents. This method extends the use of Optical Projection Tomography to optically diffusive samples yielding reconstructions with reduced artifacts, increased contrast and improved resolution with respect to those obtained with non-gated techniques. The paper shows that TGOPT is particularly suited for imaging the skeletal system and nervous structures of adult zebrafish.	[Fieramonti, Luca; Bassi, Andrea; D'Andrea, Cosimo; Valentini, Gianluca; Cubeddu, Rinaldo; De Silvestri, Sandro; Cerullo, Giulio] Politecn Milan, Dept Phys, I-20133 Milan, Italy; [Foglia, Efrem Alessandro; Pistocchi, Anna; Cotelli, Franco] Politecn Milan, Dept Biosci, I-20133 Milan, Italy; [D'Andrea, Cosimo; Valentini, Gianluca; De Silvestri, Sandro; Cerullo, Giulio] CNR, Ist Foton & Nanotecnol, I-20133 Milan, Italy; [D'Andrea, Cosimo] IIT, Milan, Italy	Polytechnic University of Milan; Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR)	Bassi, A (corresponding author), Politecn Milan, Dept Phys, I-20133 Milan, Italy.	andreabassi@polimi.it	Foglia, Efrem Alessandro/AGW-8220-2022; Foglia, Efrem Alessandro/AAF-1840-2020; Pistocchi, Anna/A-6228-2014; Bassi, Andrea/I-4542-2012; Valentini, Gianluca/G-4594-2011	Foglia, Efrem Alessandro/0000-0002-7446-8365; Pistocchi, Anna/0000-0001-9467-2542; Bassi, Andrea/0000-0002-5017-0775; Valentini, Gianluca/0000-0002-6340-3021; Cerullo, Giulio/0000-0002-9534-2702	European Union [284464]; Cariplo Foundation [2009-2626]; Adriano Buzzati-Traverso Foundation	European Union(European Commission); Cariplo Foundation(Fondazione Cariplo); Adriano Buzzati-Traverso Foundation	This research was partially supported by the European Union under Contract N.284464 LASERLABEurope III (JRA-BIOPTICHAL) and by Cariplo Foundation under Grant N. 2009-2626. EAF acknowledges support from Adriano Buzzati-Traverso Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3640808; Bassi A, 2010, OPT LETT, V35, P2732, DOI 10.1364/OL.35.002732; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Girard B, 2007, LASER SURG MED, V39, P273, DOI 10.1002/lsm.20466; Hsieh J., 2003, COMPUTED TOMOGRAPHY; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Leblond F, 2009, J OPT SOC AM A, V26, P1444, DOI 10.1364/JOSAA.26.001444; LeTolguenec G, 1997, APPL OPTICS, V36, P8292, DOI 10.1364/AO.36.008292; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Loesel FH, 1998, APPL PHYS B-LASERS O, V66, P121, DOI 10.1007/s003400050365; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Niedre MJ, 2008, P NATL ACAD SCI USA, V105, P19126, DOI 10.1073/pnas.0804798105; Popov AP, 2002, P SOC PHOTO-OPT INS, V5068, P299; Razansky D, 2009, NAT PHOTONICS, V3, P412, DOI 10.1038/NPHOTON.2009.98; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Spoorendonk KM, 2010, J APPL ICHTHYOL, V26, P219, DOI 10.1111/j.1439-0426.2010.01409.x; Vasquez SX, 2008, ANAT REC, V291, P475, DOI 10.1002/ar.20670; Vellekoop IM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.120601; WANG L, 1991, SCIENCE, V253, P769, DOI 10.1126/science.253.5021.769; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; YOO KM, 1990, OPT LETT, V15, P320, DOI 10.1364/OL.15.000320	22	29	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2012	7	11							e50744	10.1371/journal.pone.0050744	http://dx.doi.org/10.1371/journal.pone.0050744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040PB	23185643	Green Published, gold			2022-12-25	WOS:000311333800078
J	Ullisch, MG; Scheins, JJ; Weirich, C; Kops, ER; Celik, A; Tellmann, L; Stocker, T; Herzog, H; Shah, NJ				Ullisch, Marcus Goerge; Scheins, Juergen Johann; Weirich, Christoph; Kops, Elena Rota; Celik, Abdullah; Tellmann, Lutz; Stoecker, Tony; Herzog, Hans; Shah, Nadim Jon			MR-Based PET Motion Correction Procedure for Simultaneous MR-PET Neuroimaging of Human Brain	PLOS ONE			English	Article							NORMALIZATION; REGISTRATION; REDUCTION; IMAGES	Positron Emission Tomography (PET) images are prone to motion artefacts due to the long acquisition time of PET measurements. Recently, simultaneous magnetic resonance imaging (MRI) and PET have become available in the first generation of Hybrid MR-PET scanners. In this work, the elimination of artefacts due to head motion in PET neuroimages is achieved by a new approach utilising MR-based motion tracking in combination with PET list mode data motion correction for simultaneous MR-PET acquisitions. The method comprises accurate MR-based motion measurements, an intra-frame motion minimising and reconstruction time reducing temporal framing algorithm, and a list mode based PET reconstruction which utilises the Ordinary Poisson Algorithm and avoids axial and transaxial compression. Compared to images uncorrected for motion, an increased image quality is shown in phantom as well as in vivo images. In vivo motion corrected images show an evident increase of contrast at the basal ganglia and a good visibility of uptake in tiny structures such as superior colliculi.	[Ullisch, Marcus Goerge; Scheins, Juergen Johann; Weirich, Christoph; Kops, Elena Rota; Celik, Abdullah; Tellmann, Lutz; Stoecker, Tony; Herzog, Hans; Shah, Nadim Jon] Forschungszentrum Julich, Inst Neurosci & Med 4, D-52425 Julich, Germany; [Shah, Nadim Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Shah, Nadim Jon] JARA Brain Translat Brain Med, Aachen Julich, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	Shah, NJ (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med 4, D-52425 Julich, Germany.	n.j.shah@fz-juelich.de	Scheins, Juergen/AAV-4647-2020; Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Tellmann, Lutz/0000-0002-1154-2847; Scheins, Juergen/0000-0003-3474-430X	Helmholtz Association of German Research Centres	Helmholtz Association of German Research Centres(Helmholtz Association)	This study was supported by the Helmholtz Association of German Research Centres (http://www.helmholtz.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi RD, 1999, PHYS MED BIOL, V44, P571, DOI 10.1088/0031-9155/44/2/020; Buhler P, 2004, IEEE T MED IMAGING, V23, P1176, DOI 10.1109/TMI.2004.831214; Byars LG, 2005, IEEE NUCL SCI CONF R, P2622; Casey M., 1995, P 3 INT M FULL 3 DIM, P67; Catana C, 2011, J NUCL MED, V52, P154, DOI 10.2967/jnumed.110.079343; Costes N, 2009, NEUROIMAGE, V47, P1496, DOI 10.1016/j.neuroimage.2009.05.052; Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Fulton RR, 2002, IEEE T NUCL SCI, V49, P116, DOI 10.1109/TNS.2002.998691; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Heiss WD, 2009, EUR J NUCL MED MOL I, V36, P105, DOI 10.1007/s00259-008-0962-3; Herzog H, 2005, J NUCL MED, V46, P1059; Herzog H, 2011, NUKLEARMED-NUCL MED, V50, P74, DOI 10.3413/Nukmed-0347-10-09; Herzog H, 2002, APPL RADIAT ISOTOPES, V56, P673, DOI 10.1016/S0969-8043(01)00283-4; Herzog Hans, 2010, Neuroimage, V49, P2072, DOI 10.1016/j.neuroimage.2009.10.036; Iida H, 2009, J CEREBR BLOOD F MET, V29, pS343; Kops ER, 2008, IEEE NUCL SCI S, P3786, DOI [10.1109/NSSMIC.2008.4774281, DOI 10.1109/NSSMIC.2008.4774281]; Langner J, 2008, THESIS TU DRESDEN DR; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; MANSFIELD P, 1977, J PHYS C SOLID STATE, V10, pL55, DOI 10.1088/0022-3719/10/3/004; Michel C., 1998, 1998 IEEE Nuclear Science Symposium Conference Record. 1998 IEEE Nuclear Science Symposium and Medical Imaging Conference (Cat. No.98CH36255), P1323, DOI 10.1109/NSSMIC.1998.774398; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Olesen OV, 2012, IEEE T MED IMAGING, V31, P79, DOI 10.1109/TMI.2011.2165157; Picard Y, 1997, IEEE T MED IMAGING, V16, P137, DOI 10.1109/42.563659; Scheins JJ, 2011, IEEE T MED IMAGING, V30, P879, DOI 10.1109/TMI.2011.2109732; Scheins JJ, 2011, C P 11 INT M FULL 3, P44; Scheins JJ, 2006, IEEE T MED IMAGING, V25, P1363, DOI 10.1109/TMI.2006.880679; Schlemmer HPW, 2008, RADIOLOGY, V248, P1028, DOI 10.1148/radiol.2483071927; Tellmann L, 2006, Z MED PHYS, V16, P67, DOI 10.1078/0939-3889-00293; Thielemans K, 2008, IEEE T NUCL SCI, V55, P543, DOI 10.1109/TNS.2007.914207; Ullisch MG, 2009, P INT SOC MAG RESON, V17, P4650; van der Kouwe AJW, 2006, MAGN RESON MED, V56, P1019, DOI 10.1002/mrm.21038; Watson CC, 2000, IEEE T NUCL SCI, V47, P1587, DOI 10.1109/23.873020; Zhou VW, 2009, PHYS MED BIOL, V54, P5321, DOI 10.1088/0031-9155/54/17/016	36	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48149	10.1371/journal.pone.0048149	http://dx.doi.org/10.1371/journal.pone.0048149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23189127	gold, Green Published, Green Submitted			2022-12-25	WOS:000311234000008
J	Losonczy, G; Vajas, A; Takacs, L; Dzsudzsak, E; Fekete, A; Marhoffer, E; Kardos, L; Ajzner, E; Hurtado, B; de Frutos, PG; Berta, A; Balogh, I				Losonczy, Gergely; Vajas, Attila; Takacs, Lili; Dzsudzsak, Erika; Fekete, Agnes; Marhoffer, Eva; Kardos, Laszlo; Ajzner, Eva; Hurtado, Begona; Garcia de Frutos, Pablo; Berta, Andras; Balogh, Istvan			Effect of the Gas6 c.834+7G > A Polymorphism and the Interaction of Known Risk Factors on AMD Pathogenesis in Hungarian Patients	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; HTRA1 PROMOTER POLYMORPHISM; AGE-RELATED MACULOPATHY; APOLIPOPROTEIN-E GENE; MACULAR DEGENERATION; FACTOR-XIII; DRUSEN FORMATION; FACTOR-I; VARIANT; SUSCEPTIBILITY	Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly in the developed world. Numerous genetic factors contribute to the development of the multifactorial disease. We performed a case-control study to assess the risk conferred by known and candidate genetic polymorphisms on the development of AMD. We searched for genetic interactions and for differences in dry and wet AMD etiology. We enrolled 213 patients with exudative, 67 patients with dry AMD and 106 age and ethnically matched controls. Altogether 12 polymorphisms in Apolipoprotein E, complement factor H, complement factor I, complement component 3, blood coagulation factor XIII, HTRA1, LOC387715, Gas6 and MerTK genes were tested. No association was found between either the exudative or the dry form and the polymorphisms in the Apolipoprotein E, complement factor I, FXIII and MerTK genes. Gas6 c. 834+7G>A polymorphism was found to be significantly protective irrespective of other genotypes, reducing the odds of wet type AMD by a half (OR = 0.50, 95% CI: 0.26-0.97, p = 0.04). Multiple regression models revealed an interesting genetic interaction in the dry AMD subgroup. In the absence of C3 risk allele, mutant genotypes of both CFH and HTRA1 behaved as strongly significant risk factors (OR = 7.96, 95% CI: 2.39 = 26.50, p = 0.0007, and OR = 36.02, 95% CI: 3.30-393.02, p = 0.0033, respectively), but reduced to neutrality otherwise. The risk allele of C3 was observed to carry a significant risk in the simultaneous absence of homozygous CFH and HTRA1 polymorphisms only, in which case it was associated with a near-five-fold relative increase in the odds of dry type AMD (OR = 4.93, 95% CI: 1.98-12.25, p = 0.0006). Our results suggest a protective role of Gas6 c. 834+7G>A polymorphism in exudative AMD development. In addition, novel genetic interactions were revealed between CFH, HTRA1 and C3 polymorphisms that might contribute to the pathogenesis of dry AMD.	[Losonczy, Gergely; Vajas, Attila; Takacs, Lili; Marhoffer, Eva; Berta, Andras] Univ Debrecen, Dept Ophthalmol, H-4012 Debrecen, Hungary; [Dzsudzsak, Erika; Balogh, Istvan] Univ Debrecen, Dept Lab Med, H-4012 Debrecen, Hungary; [Fekete, Agnes] Univ Debrecen, Dept Anesthesiol & Intens Care, H-4012 Debrecen, Hungary; [Kardos, Laszlo] Kenezy Gyula Cty Hosp, Hyg & Infect Control Serv, Debrecen, Hungary; [Ajzner, Eva] Josa Andras Teaching Hosp, Cent Lab, Nyiregyhaza, Hungary; [Hurtado, Begona; Garcia de Frutos, Pablo] Inst Biomed Res Barcelona IIBB CSIC, IDIBAPS, Dept Cell Death & Proliferat, Barcelona, Spain	University of Debrecen; University of Debrecen; University of Debrecen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Losonczy, G (corresponding author), Univ Debrecen, Dept Ophthalmol, H-4012 Debrecen, Hungary.	losigeri@gmail.com	Balogh, Istvan/N-2990-2019; Takács, Lili/L-6660-2014; de Frutos, Pablo García/B-8594-2011; Balogh, Istvan/A-4752-2013; Vajas, Attila/AAA-3014-2021	Balogh, Istvan/0000-0003-3397-2829; Takács, Lili/0000-0003-1641-0154; de Frutos, Pablo García/0000-0003-1547-1190; Balogh, Istvan/0000-0003-3397-2829; 	Hungarian Research Fund OTKA [K68616]; Social Renewal Operational Programme TAMOP [4.2.1./B-091/1/KONV-2010-0007]	Hungarian Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Social Renewal Operational Programme TAMOP	This study was supported by by the Hungarian Research Fund OTKA K68616 (to A.B.) and by the Social Renewal Operational Programme TAMOP 4.2.1./B-091/1/KONV-2010-0007 project (to A.B. and I.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MKM, 2012, AM J EPIDEMIOL, V175, P511, DOI 10.1093/aje/kwr329; An E, 2010, INVEST OPHTH VIS SCI, V51, P3379, DOI 10.1167/iovs.09-4853; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Ariens RAS, 2000, BLOOD, V96, P988, DOI 10.1182/blood.V96.3.988.015k57_988_995; Asensio-Sánchez V.M., 2006, Arch Soc Esp Oftalmol, V81, P09; Baird PN, 2006, HUM MUTAT, V27, P337, DOI 10.1002/humu.20288; Baird PN, 2004, INVEST OPHTH VIS SCI, V45, P1311, DOI 10.1167/iovs.03-1121; Balogh I, 2000, BLOOD, V96, P2479; Balogh I, 2005, ARTERIOSCL THROM VAS, V25, P1280, DOI 10.1161/01.ATV.0000163845.07146.48; Cameron DJ, 2007, CELL CYCLE, V6, P1122, DOI 10.4161/cc.6.9.4157; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Chen YY, 2011, CHINESE MED J-PEKING, V124, P1145, DOI 10.3760/cma.j.issn.0366-6999.2011.08.005; Chi ZL, 2010, ADV EXP MED BIOL, V703, P127, DOI 10.1007/978-1-4419-5635-4_9; Cipriani V, 2012, EUR J HUM GENET, V20, P1, DOI 10.1038/ejhg.2011.118; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Dardik R, 2006, J THROMB HAEMOST, V4, P19, DOI 10.1111/j.1538-7836.2005.01473.x; Despriet DDG, 2009, OPHTHALMOLOGY, V116, P474, DOI 10.1016/j.ophtha.2008.09.055; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Duncan JL, 2003, INVEST OPHTH VIS SCI, V44, P826, DOI 10.1167/iovs.02-0438; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ennis S, 2010, EUR J HUM GENET, V18, P15, DOI 10.1038/ejhg.2009.113; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fernandez-Fernandez L, 2008, THROMB HAEMOSTASIS, V100, P604, DOI 10.1160/TH08-04-0253; Francis PJ, 2009, J MED GENET, V46, P300, DOI 10.1136/jmg.2008.062737; Francis PJ, 2011, CLIN OPHTHALMOL, V5, P1127, DOI 10.2147/OPTH.S11627; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Friedman DS, 1999, OPHTHALMOLOGY, V106, P1049, DOI 10.1016/S0161-6420(99)90267-1; Gallicchio M, 2005, BLOOD, V105, P1970, DOI 10.1182/blood-2004-04-1469; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hall MO, 2005, EXP EYE RES, V81, P581, DOI 10.1016/j.exer.2005.03.017; Ho L, 2008, INVEST OPHTH VIS SCI, V49, P4795, DOI 10.1167/iovs.08-2066; Hurtado B, 2010, THROMB HAEMOSTASIS, V104, P592, DOI 10.1160/TH09-11-0787; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jiang L, 2009, AM J CLIN PATHOL, V131, P738, DOI 10.1309/AJCP3CX3AUVRBHCF; Johnson LR, 2000, IEEE ANN HIST COMPUT, V22, P70; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondo N, 2010, EUR J HUM GENET, V18, P634, DOI 10.1038/ejhg.2009.243; Kovar FM, 2009, WIEN KLIN WOCHENSCHR, V121, P515, DOI 10.1007/s00508-009-1182-y; Lee CH, 2012, DIABETES RES CLIN PR, V95, P201, DOI 10.1016/j.diabres.2011.09.013; Losonczy G, 2011, ACTA OPHTHALMOL, V89, P255, DOI 10.1111/j.1755-3768.2009.01687.x; Lutgens E, 2008, J PATHOL, V216, P55, DOI 10.1002/path.2381; McKay GJ, 2011, HUM MUTAT, V32, P1407, DOI 10.1002/humu.21577; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Munoz X, 2007, THROMB HAEMOSTASIS, V98, P406, DOI 10.1160/TH06-12-0681; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2010, MOL VIS, V16, P2412; Shemirani AH, 2004, CLIN CHEM LAB MED, V42, P877, DOI 10.1515/CCLM.2004.142; Sofat R, 2012, INT J EPIDEMIOL, V41, P250, DOI 10.1093/ije/dyr204; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Thakkinstian A, 2011, AM J EPIDEMIOL, V173, P1365, DOI 10.1093/aje/kwr025; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yoshida T, 2007, MOL VIS, V13, P545; Yu Y, 2011, INVEST OPHTH VIS SCI, V52, P4663, DOI 10.1167/iovs.10-7070	64	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50181	10.1371/journal.pone.0050181	http://dx.doi.org/10.1371/journal.pone.0050181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209669	gold, Green Published, Green Submitted			2022-12-25	WOS:000312104900032
J	Mitchell, JA; Clay, I; Umlauf, D; Chen, CY; Moir, CA; Eskiw, CH; Schoenfelder, S; Chakalova, L; Nagano, T; Fraser, P				Mitchell, Jennifer A.; Clay, Ieuan; Umlauf, David; Chen, Chih-yu; Moir, Catherine A.; Eskiw, Christopher H.; Schoenfelder, Stefan; Chakalova, Lyubomira; Nagano, Takashi; Fraser, Peter			Nuclear RNA Sequencing of the Mouse Erythroid Cell Transcriptome	PLOS ONE			English	Article							PRE-MESSENGER-RNA; LONG-RANGE INTERACTIONS; LOCUS-CONTROL REGION; POLYMERASE-II; IN-VIVO; GENE-EXPRESSION; NONCODING RNA; INTERGENIC TRANSCRIPTION; DROSOPHILA-MELANOGASTER; COMPUTATIONAL IDENTIFICATION	In addition to protein coding genes a substantial proportion of mammalian genomes are transcribed. However, most transcriptome studies investigate steady-state mRNA levels, ignoring a considerable fraction of the transcribed genome. In addition, steady-state mRNA levels are influenced by both transcriptional and posttranscriptional mechanisms, and thus do not provide a clear picture of transcriptional output. Here, using deep sequencing of nuclear RNAs (nucRNA-Seq) in parallel with chromatin immunoprecipitation sequencing (ChIP-Seq) of active RNA polymerase II, we compared the nuclear transcriptome of mouse anemic spleen erythroid cells with polymerase occupancy on a genome-wide scale. We demonstrate that unspliced transcripts quantified by nucRNA-seq correlate with primary transcript frequencies measured by RNA FISH, but differ from steady-state mRNA levels measured by poly(A)-enriched RNA-seq. Highly expressed protein coding genes showed good correlation between RNAPII occupancy and transcriptional output; however, genome-wide we observed a poor correlation between transcriptional output and RNAPII association. This poor correlation is due to intergenic regions associated with RNAPII which correspond with transcription factor bound regulatory regions and a group of stable, nuclear-retained long non-coding transcripts. In conclusion, sequencing the nuclear transcriptome provides an opportunity to investigate the transcriptional landscape in a given cell type through quantification of unspliced primary transcripts and the identification of nuclear-retained long non-coding RNAs.	[Mitchell, Jennifer A.; Chen, Chih-yu] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Mitchell, Jennifer A.; Clay, Ieuan; Umlauf, David; Moir, Catherine A.; Eskiw, Christopher H.; Schoenfelder, Stefan; Chakalova, Lyubomira; Nagano, Takashi; Fraser, Peter] Babraham Inst, Lab Nucl Dynam, Cambridge, England; [Eskiw, Christopher H.] Brunel Univ, Sch Hlth Sci & Social Care, Ctr Cell & Chromosome Biol, Progeria Res Team, London, England	University of Toronto; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Brunel University	Mitchell, JA (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	ja.mitchell@utoronto.ca	Chen, Chih-yu/AAX-3735-2020	Chen, Chih-yu/0000-0003-4790-0025; Fraser, Peter/0000-0002-0041-1227; Clay, Ieuan/0000-0001-9722-8834; Mitchell, Jennifer/0000-0002-7147-4604	Medical Research Council; Biotechnology and Biological Sciences Research Council, UK; Natural Sciences and Engineering Research Council of Canada; EMBO; Ontario Graduate Scholarship; National Human Genome Research Institute; National Institutes of Health, Bethesda, MD, USA; Medical Research Council [G0800036] Funding Source: researchfish; MRC [G0800036] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); EMBO(European Molecular Biology Organization (EMBO)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council and the Biotechnology and Biological Sciences Research Council, UK (operating grants held by PF) and the Natural Sciences and Engineering Research Council of Canada (Discovery Grant held by JAM). DU was supported by an EMBO fellowship, and CYC was supported in part by an Ontario Graduate Scholarship. The ENCODE project is funded by the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Babraham Bioinformatics website, SEQMONK TOOL VIS AN; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-152; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Cheng Y, 2008, GENOME RES, V18, P1896, DOI 10.1101/gr.083089.108; Cho EJ, 1997, GENE DEV, V11, P3319, DOI 10.1101/gad.11.24.3319; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DICKERMAN HW, 1976, ARCH BIOCHEM BIOPHYS, V177, P1, DOI 10.1016/0003-9861(76)90408-2; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Fang H, 2010, DEV CELL, V19, P174, DOI 10.1016/j.devcel.2010.06.014; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Gribnau J, 1998, EMBO J, V17, P6020, DOI 10.1093/emboj/17.20.6020; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Ho CK, 1998, J BIOL CHEM, V273, P9577, DOI 10.1074/jbc.273.16.9577; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Hu X, 2007, BLOOD, V109, P2210, DOI 10.1182/blood-2006-06-029868; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DY, 2004, NUCLEIC ACIDS RES, V32, P3935, DOI 10.1093/nar/gkh719; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kim JH, 2005, LAB INVEST, V85, P532, DOI 10.1038/labinvest.3700250; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kong SM, 1997, MOL CELL BIOL, V17, P3955, DOI 10.1128/MCB.17.7.3955; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levings PP, 2006, FEBS J, V273, P746, DOI 10.1111/j.1742-4658.2005.05107.x; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Long QM, 1998, GENOMICS, V54, P542, DOI 10.1006/geno.1998.5608; Margulies EH, 2008, NAT REV GENET, V9, P303, DOI 10.1038/nrg2185; Marini MG, 2010, BRIT J HAEMATOL, V149, P748, DOI 10.1111/j.1365-2141.2010.08130.x; Marziali G, 2002, ONCOGENE, V21, P7933, DOI 10.1038/sj.onc.1205925; McCracken S, 1997, GENE DEV, V11, P3306, DOI 10.1101/gad.11.24.3306; McKinlay A, 2011, G3-GENES GENOM GENET, V1, P549, DOI 10.1534/g3.111.000810; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miles J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000630; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Morris DP, 2005, J BIOL CHEM, V280, P31368, DOI 10.1074/jbc.M501546200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Ott CJ, 2009, J CELL MOL MED, V13, P680, DOI 10.1111/j.1582-4934.2008.00621.x; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Perry RP, 2007, GENE, V401, P1, DOI 10.1016/j.gene.2007.07.007; Pilon AM, 2011, BLOOD; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Prakash A, 2005, NAT BIOTECHNOL, V23, P1249, DOI 10.1038/nbt1140; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sambrook J, 2001, MOL CLONING LAB MANU; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schoenfelder S, 2010, CURR OPIN GENET DEV, V20, P127, DOI 10.1016/j.gde.2010.02.002; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; SESHADRI T, 1993, J BIOL CHEM, V268, P18474; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Szymanski M, 2002, GENOME BIOL, V3; Tallack MR, 2010, GENOME RES; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Theoleyre O, 2004, ONCOGENE, V23, P920, DOI 10.1038/sj.onc.1207206; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tsai MC, 2010, SCIENCE; TUAN D, 1992, P NATL ACAD SCI USA, V89, P11219, DOI 10.1073/pnas.89.23.11219; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang H, 2006, GENOME RES, V16, P1480, DOI 10.1101/gr.5353806; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	112	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49274	10.1371/journal.pone.0049274	http://dx.doi.org/10.1371/journal.pone.0049274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209567	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900005
J	ArunKumar, G; Soria-Hernanz, DF; Kavitha, VJ; Arun, VS; Syama, A; Ashokan, KS; Gandhirajan, KT; Vijayakumar, K; Narayanan, M; Jayalakshmi, M; Ziegle, JS; Royyuru, AK; Parida, L; Wells, RS; Renfrew, C; Schurr, TG; Smith, CT; Platt, DE; Pitchappan, R				ArunKumar, GaneshPrasad; Soria-Hernanz, David F.; Kavitha, Valampuri John; Arun, Varatharajan Santhakumari; Syama, Adhikarla; Ashokan, Kumaran Samy; Gandhirajan, Kavandanpatti Thangaraj; Vijayakumar, Koothapuli; Narayanan, Muthuswamy; Jayalakshmi, Mariakuttikan; Ziegle, Janet S.; Royyuru, Ajay K.; Parida, Laxmi; Wells, R. Spencer; Renfrew, Colin; Schurr, Theodore G.; Smith, Chris Tyler; Platt, Daniel E.; Pitchappan, Ramasamy		Genographic Consortium	Population Differentiation of Southern Indian Male Lineages Correlates with Agricultural Expansions Predating the Caste System	PLOS ONE			English	Article							Y-CHROMOSOME; GENETIC-VARIATION; HLA ANTIGENS; ASIA; MITOCHONDRIAL; INFERENCES; ORIGINS; PERSPECTIVE; AFFINITIES; HAPLOTYPES	Previous studies that pooled Indian populations from a wide variety of geographical locations, have obtained contradictory conclusions about the processes of the establishment of the Varna caste system and its genetic impact on the origins and demographic histories of Indian populations. To further investigate these questions we took advantage that both Y-chromosome and caste designation are paternally inherited, and genotyped 1,680 Y-chromosomes representing 12 tribal and 19 non-tribal (caste) endogamous populations from the predominantly Dravidian-speaking Tamil Nadu state in the southernmost part of India. Tribes and castes were both characterized by an overwhelming proportion of putatively Indian autochthonous Y-chromosomal haplogroups (H-M69, F-M89, R1a1-M17, L1-M27, R2-M124, and C5-M356; 81% combined) with a shared genetic heritage dating back to the late Pleistocene (10-30 Kya), suggesting that more recent Holocene migrations from western Eurasia contributed <20% of the male lineages. We found strong evidence for genetic structure, associated primarily with the current mode of subsistence. Coalescence analysis suggested that the social stratification was established 4-6 Kya and there was little admixture during the last 3 Kya, implying a minimal genetic impact of the Varna (caste) system from the historically-documented Brahmin migrations into the area. In contrast, the overall Y-chromosomal patterns, the time depth of population diversifications and the period of differentiation were best explained by the emergence of agricultural technology in South Asia. These results highlight the utility of detailed local genetic studies within India, without prior assumptions about the importance of Varna rank status for population grouping, to obtain new insights into the relative influences of past demographic events for the population structure of the whole of modern India.	[ArunKumar, GaneshPrasad; Kavitha, Valampuri John; Arun, Varatharajan Santhakumari; Syama, Adhikarla; Jayalakshmi, Mariakuttikan; Pitchappan, Ramasamy] Madurai Kamaraj Univ, Sch Biol Sci, Genog Lab, Madurai 625021, Tamil Nadu, India; [Soria-Hernanz, David F.; Wells, R. Spencer] Natl Geog Soc, Washington, DC USA; [Soria-Hernanz, David F.] Univ Pompeu Fabra, Inst Biol Evolut CSIC UPF, Dept Ciencies Expt & Salut, Barcelona, Spain; [Kavitha, Valampuri John] Mother Teresa Womens Univ, Dept Biotechnol, Kodaikanal, Tamil Nadu, India; [Ashokan, Kumaran Samy; Vijayakumar, Koothapuli] Nilgiri Adivasi Welf Assoc, Kothagiri, Tamil Nadu, India; [Gandhirajan, Kavandanpatti Thangaraj] Govt Coll Fine Arts, Madras, Tamil Nadu, India; [Narayanan, Muthuswamy] St Xaviers Coll, Dept Zool, Palayankottai, Tamil Nadu, India; [Ziegle, Janet S.] Appl Biosyst Inc, Foster City, CA 94404 USA; [Royyuru, Ajay K.; Parida, Laxmi; Platt, Daniel E.] IBM Thomas J Watson Res Ctr, Computat Biol Grp, New York, NY USA; [Renfrew, Colin] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Schurr, Theodore G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Smith, Chris Tyler] Wellcome Trust Sanger Inst, Hinxton, England; [Pitchappan, Ramasamy] Chettinad Acad Res & Educ, Madras, Tamil Nadu, India	Madurai Kamaraj University; National Geographic Society; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; Mother Teresa Women's University; Thermo Fisher Scientific; Applied Biosystems; International Business Machines (IBM); University of Cambridge; University of Pennsylvania; Wellcome Trust Sanger Institute	Pitchappan, R (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Genog Lab, Madurai 625021, Tamil Nadu, India.	pitchappanrm@yahoo.co.uk	Santos, Fabrício Rodrigues/H-2370-2011; Cooper, Alan/E-8171-2012; Haber, Marc/Y-5090-2019; Balanovsky, Oleg/G-1549-2014; Haak, Wolfgang/C-2362-2014; Comas, David/D-5382-2014	Santos, Fabrício Rodrigues/0000-0001-9088-1750; Cooper, Alan/0000-0002-7738-7851; Haber, Marc/0000-0003-1000-1448; Haak, Wolfgang/0000-0003-2475-2007; Comas, David/0000-0002-5075-0956; mele, marta/0000-0001-8874-6453; Royyuru, Ajay/0000-0003-4440-4755; ArunKumar, GaneshPrasad/0000-0002-3108-0491; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Quintana-Murci, Lluis/0000-0003-2429-6320	"The Genographic Project"; National Geographic Society, IBM; Waitt Family Foundation; Wellcome Trust [098051]	"The Genographic Project"; National Geographic Society, IBM(National Geographic Society); Waitt Family Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	The study is supported by "The Genographic Project" funded by The National Geographic Society, IBM and Waitt Family Foundation. CTS was supported by The Wellcome Trust (Grant number 098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan K, 1996, HUM BIOL, V68, P523; Balakrishnan V., 1981, BIOL PEOPLE TAMIL NA; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Brahmachari SK, 2008, J GENET, V87, P3; Carvalho-Silva DR, 2008, INT J HUM GENET, V8, P21, DOI 10.1080/09723757.2008.11886016; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Champakalakshmi R., 2001, STRUCTURE SOC EARLY, P59; Chanda Committee, 1969, REP JOINT COMM SCHED; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Constituent Assembly, 1949, CONST IND; Cordaux R, 2004, CURR BIOL, V14, P231, DOI 10.1016/j.cub.2004.01.024; Dirks Nicholas, 2001, CASTES MIND COLONIAL; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Fuller DQ, 2007, VERTEBR PALEOBIOL PA, P393, DOI 10.1007/1-4020-5562-5_18; Haber M, 2011, EUR J HUM GENET, V19, P334, DOI 10.1038/ejhg.2010.177; Haslam M, 2010, SOUTH ASIAN STUD, V26, P1, DOI 10.1080/02666031003719115; Jolliffe I, 1986, PRINCIPAL COPONENTS; Kanakasabhai V, 1904, TAMILS 1800 YEARS AG; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Keay J., 2001, INDIA HIST; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Krishnan KG, 1984, KARANDAI TAMIL SANGA; Krithika S, 2009, AM J PHYS ANTHROPOL, V139, P533, DOI 10.1002/ajpa.21018; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Majumder PP, 2008, CURR OPIN GENET DEV, V18, P280, DOI 10.1016/j.gde.2008.07.003; Majumder PP, 2010, CURR BIOL, V20, pR184, DOI 10.1016/j.cub.2009.11.053; Mandal BP, 1979, 1 BACKWARD CLASSES C; McCrindle JW., 2000, ANCIENT INDIA DESCRI; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Misra VN, 2001, J BIOSCIENCES, V26, P491, DOI 10.1007/BF02704749; Morrison KD, 2007, VERTEBR PALEOBIOL PA, P321, DOI 10.1007/1-4020-5562-5_14; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Pappu S, 2003, CURR ANTHROPOL, V44, P591, DOI 10.1086/377652; Pitchappan RM, 1997, HUM BIOL, V69, P59; PITCHAPPAN RM, 1984, TISSUE ANTIGENS, V24, P190, DOI 10.1111/j.1399-0039.1984.tb02126.x; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; RAJASEKAR R, 1987, TISSUE ANTIGENS, V30, P113; Ramana GV, 2001, EUR J HUM GENET, V9, P695, DOI 10.1038/sj.ejhg.5200708; Ramaswamy V, 1994, INDIAN J HIST SCI, V29, P445; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sahoo S, 2006, P NATL ACAD SCI USA, V103, P843, DOI 10.1073/pnas.0507714103; Selvakumar V., 2002, ASIAN PERSPECT, P71; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Sharma S, 2009, J HUM GENET, V54, P47, DOI 10.1038/jhg.2008.2; Shastri KAN, 1976, HIST S INDIA PREHIST, Vxii; Silverberg J, 1969, AM J SOCIOL, V75, P443; Singh K.S, 2003, PEOPLE INDIA; Srinivas M. N., 1952, RELIG SOC COORGS S I; Sturrock K., 2000, FIELD METHOD, V12, P49, DOI DOI 10.1177/1525822X0001200104; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; Thurston Edgar, 1909, CASTES TRIBES SO IND; Trivedi R, 2008, INT J HUM GENET, V8, P97, DOI 10.1080/09723757.2008.11886023; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Watkins WS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-86; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zhao ZZ, 2009, ANN HUM BIOL, V36, P46, DOI 10.1080/03014460802558522; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	68	31	32	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50269	10.1371/journal.pone.0050269	http://dx.doi.org/10.1371/journal.pone.0050269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057YW	23209694	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700051
J	Carrier, JL; Javadi, P; Bourrier, E; Camus, C; Segal-Bendirdjian, E; Karniguian, A				Carrier, Jean-Luc; Javadi, Pasha; Bourrier, Emilie; Camus, Celine; Segal-Bendirdjian, Evelyne; Karniguian, Aida			cFos Mediates cAMP-Dependent Generation of ROS and Rescue of Maturation Program in Retinoid-Resistant Acute Promyelocytic Leukemia Cell Line NB4-LR1	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; OSTEOCLAST DIFFERENTIATION; CROSS-TALK; CD44 GENE; C-FOS; NB4; ACTIVATION; EXPRESSION; PHOSPHORYLATION; MECHANISMS	A determining role has been assigned to cAMP in the signaling pathways that relieve resistance to anti-leukemia differentiation therapy. However, the underlying mechanisms have not been elucidated yet. Here, we identify cFos as a critical cAMP effector, able to regulate the re-expression and splicing of epigenetically silenced genes associated with maturation (CD44) in retinoid- resistant NB4-LR1 leukemia cells. Furthermore, using RNA interference approach, we show that cFos mediates cAMP-induced ROS generation, a critical mediator of neutrophil maturation, and in fine differentiation. This study highlights some of the mechanisms by which cAMP acts to overcome resistance, and reveals a new alternative cFos-dependent pathway which, though nonexistent in retinoid- sensitive NB4 cells, is essential to rescue the maturation program of resistant cells.	[Carrier, Jean-Luc; Javadi, Pasha; Bourrier, Emilie; Camus, Celine; Segal-Bendirdjian, Evelyne; Karniguian, Aida] INSERM, UMR S 1007, Paris, France; [Carrier, Jean-Luc; Javadi, Pasha; Bourrier, Emilie; Camus, Celine; Segal-Bendirdjian, Evelyne; Karniguian, Aida] Univ Paris 05, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Karniguian, A (corresponding author), INSERM, UMR S 1007, Paris, France.	aida.karniguian@inserm.fr	Karniguian, Aida/M-3136-2018	Karniguian, Aida/0000-0002-2308-6236; Segal-Bendirdjian, Evelyne/0000-0001-9813-4880	Institut National de la Sante et de la Recherche Medicale (INSERM); Ligue Nationale Contre le Cancer (Comite de Paris)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer (Comite de Paris)	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale (INSERM, www.inserm.fr/) and the Ligue Nationale Contre le Cancer (Comite de Paris, http://www.ligue-cancer.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecassis I, 2008, LEUKEMIA, V22, P511, DOI 10.1038/sj.leu.2405071; Altucci L, 2005, CANCER RES, V65, P8754, DOI 10.1158/0008-5472.CAN-04-3569; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bemmo A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011981; Bendall LJ, 2000, LEUKEMIA, V14, P1239, DOI 10.1038/sj.leu.2401830; Benoit G, 2001, ONCOGENE, V20, P7161, DOI 10.1038/sj.onc.1204760; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Duprez E, 1996, ONCOGENE, V12, P2451; DUPREZ E, 1992, LEUKEMIA, V6, P1281; Goodison S, 1998, AM J PATHOL, V153, P1221, DOI 10.1016/S0002-9440(10)65666-0; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guillemin MC, 2002, J EXP MED, V196, P1373, DOI 10.1084/jem.20021129; Han BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036941; Hayes GM, 2004, CANCER GENE THER, V11, P797, DOI 10.1038/sj.cgt.7700759; Jack GD, 2009, BLOOD, V114, P2172, DOI 10.1182/blood-2008-11-191536; Kamashev D, 2004, J EXP MED, V199, P1163, DOI 10.1084/jem.20032226; Lai HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028280; LANOTTE M, 1991, BLOOD, V77, P1080; Legras S, 1998, BLOOD, V91, P3401, DOI 10.1182/blood.V91.9.3401.3401_3401_3413; Lo Coco F, 1999, HAEMATOLOGICA, V84, P961; LORD KA, 1993, MOL CELL BIOL, V13, P841, DOI 10.1128/MCB.13.2.841; Mullenbrock S, 2011, J BIOL CHEM, V286, P45131, DOI 10.1074/jbc.M111.274076; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Ohkubo Y, 2005, J IMMUNOL, V174, P7703, DOI 10.4049/jimmunol.174.12.7703; Roussel MJS, 2001, ONCOGENE, V20, P7287, DOI 10.1038/sj.onc.1204863; RUCHAUD S, 1994, P NATL ACAD SCI USA, V91, P8428, DOI 10.1073/pnas.91.18.8428; Shafarenko M, 2004, BLOOD, V103, P4259, DOI 10.1182/blood-2002-09-2704; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Vela E, 2006, BIOCHEM BIOPH RES CO, V343, P167, DOI 10.1016/j.bbrc.2006.02.128; Yu Q, 1996, J BIOL CHEM, V271, P20603, DOI 10.1074/jbc.271.34.20603	32	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50408	10.1371/journal.pone.0050408	http://dx.doi.org/10.1371/journal.pone.0050408			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209736	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700068
J	Wall, M; Schmidt, GM; Janjang, P; Khokiattiwong, S; Richter, C				Wall, Marlene; Schmidt, Gertraud Maria; Janjang, Pornpan; Khokiattiwong, Somkiat; Richter, Claudio			Differential Impact of Monsoon and Large Amplitude Internal Waves on Coral Reef Development in the Andaman Sea	PLOS ONE			English	Article							SCLERACTINIAN CORALS; SOUTHERN MOLOKAI; GROWTH; VARIABILITY; SEDIMENT; LEVEL; SHELF; COMMUNITIES; TEMPERATURE; PATTERNS	The Andaman Sea and other macrotidal semi-enclosed tropical seas feature large amplitude internal waves (LAIW). Although LAIW induce strong fluctuations i.e. of temperature, pH, and nutrients, their influence on reef development is so far unknown. A better-known source of disturbance is the monsoon affecting corals due to turbulent mixing and sedimentation. Because in the Andaman Sea both, LAIW and monsoon, act from the same westerly direction their relative contribution to reef development is difficult to discern. Here, we explore the framework development in a number of offshore island locations subjected to differential LAIW- and SW-monsoon impact to address this open question. Cumulative negative temperature anomalies - a proxy for LAIW impact - explained a higher percentage of the variability in coral reef framework height, than sedimentation rates which resulted mainly from the monsoon. Temperature anomalies and sediment grain size provided the best correlation with framework height suggesting that so far neglected subsurface processes (LAIW) play a significant role in shaping coral reefs.	[Wall, Marlene; Schmidt, Gertraud Maria; Richter, Claudio] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Janjang, Pornpan; Khokiattiwong, Somkiat] Phuket Marine Biol Ctr, Phuket 83000, Thailand	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Wall, M (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	marlene.wall@awi.de	Richter, Claudio/AAT-1212-2020	Richter, Claudio/0000-0002-8182-6896; Wall, Marlene/0000-0003-2885-1301	Marie Curie Action: CalMarO (Calcification by Marine Organisms) [PEOPLE-2007-1-1-ITN, 215157]; German Research Foundation (DFG) [RI 1074/7-1]; Ocean-Reef coupling in the Andaman Sea, ORCAS; German Federal Ministry of Education and Research (BMBF) [03F0608B, BIOACID 3.2.3]	Marie Curie Action: CalMarO (Calcification by Marine Organisms); German Research Foundation (DFG)(German Research Foundation (DFG)); Ocean-Reef coupling in the Andaman Sea, ORCAS; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was funded by the PEOPLE-2007-1-1-ITN Marie Curie Action: CalMarO (Calcification by Marine Organisms, 215157), the German Research Foundation (DFG, Grant number: RI 1074/7-1, Ocean-Reef coupling in the Andaman Sea, ORCAS), and the German Federal Ministry of Education and Research (BMBF, Grant number 03F0608B, BIOACID 3.2.3 Coral calcification in marginal reefs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GR, 2005, RAPID ASSESSMENT SUR; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; APEL JR, 1985, J PHYS OCEANOGR, V15, P1625, DOI 10.1175/1520-0485(1985)015<1625:TSSISE>2.0.CO;2; Bak RPM, 2000, P 9 INT COR REEF S B, V1, P265; Benzoni F, 2003, CORAL REEFS, V22, P475, DOI 10.1007/s00338-003-0342-1; BLANCHON P, 1995, J COASTAL RES, V11, P1; Bothner MH, 2006, MAR POLLUT BULL, V52, P1034, DOI 10.1016/j.marpolbul.2006.01.008; Brown BE, 2007, OCEANOGR MAR BIOL, V45, P173; Buranapratheprat A., 2010, COAST MAR SCI, V34, P68; COLES SL, 1991, CORAL REEFS, V9, P231, DOI 10.1007/BF00290427; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Fabricius KE, 2000, ESTUAR COAST SHELF S, V50, P115, DOI 10.1006/ecss.1999.0538; Gagan M.K., 1988, P 6 INT COR REEF S A, P595; GISCHLER E, 1995, PALAIOS, V10, P180, DOI 10.2307/3515181; Glynn Peter W., 1993, Atoll Research Bulletin, V379, P1; Grigg RW, 1998, CORAL REEFS, V17, P263, DOI 10.1007/s003380050127; Hoitink AJF, 2003, ESTUAR COAST SHELF S, V58, P743, DOI 10.1016/S0272-7714(03)00181-1; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Jackson C., 2004, ATLAS INTERNAL SOLIT; Jimenez C, 2003, B MAR SCI, V72, P187; Jokiel Paul L., 2004, Pacific Science, V58, P159, DOI 10.1353/psc.2004.0018; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Kleypas JA, 1996, CORAL REEFS, V15, P153, DOI 10.1007/BF01145886; Klymak JM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017706; Krumbein W.C., 1934, J SEDIMENT RES, V4, P65, DOI [10.1306/D4268EB9-2B26-11D7-8648000102C1865D, DOI 10.1306/D4268EB9-2B26-11D7-8648000102C1865D]; Latief H., 2008, INT C TSUN WARN ICTW; Leichter JJ, 2006, MAR ECOL PROG SER, V316, P95, DOI 10.3354/meps316095; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Leichter JJ, 2005, J PHYS OCEANOGR, V35, P1945, DOI 10.1175/JPO2808.1; Lovholt F, 2006, NAT HAZARD EARTH SYS, V6, P979, DOI 10.5194/nhess-6-979-2006; Lowe RJ, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002789; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; MASSEL SR, 1993, CORAL REEFS, V12, P153, DOI 10.1007/BF00334475; Murdoch TJT, 1999, CORAL REEFS, V18, P341, DOI 10.1007/s003380050210; OSBORNE AR, 1980, SCIENCE, V208, P451, DOI 10.1126/science.208.4443.451; Perry CT, 2010, GEOLOGY, V38, P119, DOI 10.1130/G30444.1; Philipp E, 2003, J EXP MAR BIOL ECOL, V287, P57, DOI 10.1016/S0022-0981(02)00495-1; Phongsuwan N, 1992, P 7 INT COR REEF S, V1, P114; Phongsuwan Niphon, 1991, Phuket Marine Biological Center Research Bulletin, V56, P75; PINEDA J, 1994, J MAR RES, V52, P427, DOI 10.1357/0022240943077046; Piniak GA, 2008, ESTUAR COAST SHELF S, V77, P56, DOI 10.1016/j.ecss.2007.08.023; Pomar L, 2012, EARTH-SCI REV, V111, P56, DOI 10.1016/j.earscirev.2011.12.005; Porter-Smith R, 2004, MAR GEOL, V211, P1, DOI 10.1016/j.margeo.2004.05.031; Riegl Bernhardt, 1995, Beitraege zur Palaeontologie, V20, P51; Roder C, 2011, CORAL REEFS, V30, P57, DOI 10.1007/s00338-011-0722-x; Roder C, 2010, MAR ECOL PROG SER, V412, P113, DOI 10.3354/meps08707; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Satapoomin S, 2004, MAR ECOL PROG SER, V274, P99, DOI 10.3354/meps274099; Sawall Y, 2010, HELGOLAND MAR RES, V64, P357, DOI 10.1007/s10152-010-0192-5; Saxby T, 2003, MAR ECOL PROG SER, V248, P85, DOI 10.3354/meps248085; Schmidt GM, 2012, MAR ECOL PROG SER, V456, P113, DOI 10.3354/meps09682; Schmidt GM, 2010, THESIS U BREMEN; Scoffin TP, 1998, CORAL REEFS, V17, P273, DOI 10.1007/s003380050128; SCOFFIN TP, 1993, CORAL REEFS, V12, P203, DOI 10.1007/BF00334480; SCOFFIN TP, 1992, CORAL REEFS, V11, P1, DOI 10.1007/BF00291929; SHEPPARD CRC, 1988, J NAT HIST, V22, P263, DOI 10.1080/00222938800770201; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Spalding M. D., 2001, WORLD ATLAS CORAL RE; STODDART DR, 1969, BIOL REV, V44, P433, DOI 10.1111/j.1469-185X.1969.tb00609.x; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Storlazzi CD, 2004, CONT SHELF RES, V24, P1397, DOI 10.1016/j.csr.2004.02.010; Storlazzi CD, 2008, ESTUAR COAST SHELF S, V77, P549, DOI 10.1016/j.ecss.2007.10.012; Subrahmanyam B, 2005, PURE APPL GEOPHYS, V162, P1643, DOI 10.1007/s00024-005-2687-6; THORPE SA, 1975, J GEOPHYS RES, V80, P328, DOI 10.1029/JC080i003p00328; vanWoesik R, 1997, CORAL REEFS, V16, P103, DOI 10.1007/s003380050064; Vlasenko V, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004107; WALLACE BC, 1988, J FLUID MECH, V191, P419, DOI 10.1017/S0022112088001636; Wang B, 2002, J CLIMATE, V15, P386, DOI 10.1175/1520-0442(2002)015<0386:RSOTAP>2.0.CO;2; Wang YH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030658; Weber M, 2006, J EXP MAR BIOL ECOL, V336, P18, DOI 10.1016/j.jembe.2006.04.007; WELLINGTON GM, 1982, ECOL MONOGR, V52, P223, DOI 10.2307/2937329; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wolanski E, 2004, ESTUAR COAST SHELF S, V60, P705, DOI 10.1016/j.ecss.2004.03.009; WOLANSKI E, 1983, AUST J MAR FRESH RES, V34, P65; WOLANSKI E, 1995, CONT SHELF RES, V15, P357, DOI 10.1016/0278-4343(93)E0004-R; Woolfe KJ, 1999, MAR GEOL, V155, P331, DOI 10.1016/S0025-3227(98)00131-5; Wu GX, 1998, MON WEATHER REV, V126, P913, DOI 10.1175/1520-0493(1998)126<0913:TPFATT>2.0.CO;2; Yamano H, 2003, SEDIMENT GEOL, V159, P27, DOI 10.1016/S0037-0738(03)00093-9	80	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50207	10.1371/journal.pone.0050207	http://dx.doi.org/10.1371/journal.pone.0050207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209674	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000312601700040
J	Krishnan, E				Krishnan, Eswar			Reduced Glomerular Function and Prevalence of Gout: NHANES 2009-10	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SERUM URIC-ACID; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RENAL-DISEASE; ALLOPURINOL; HYPERURICEMIA; RISK; POPULATION; UK	Background: The renal tubule is a major route of clearance of uric acid, a product of purine metabolism. The links between reduced glomerular filtration rate (GFR), hyperuricemia, and gout in the general population are not well understood. The objective of the present study was to estimate prevalence of gout and hyperuricemia among people with impaired GFR in the US general population. Study Design: Cross-sectional, survey-weighted analyses of data on adults (age. 20 years) in the 2009-10 cycle of the US National Health and Nutrition Examination Surveys (n = 5,589). Associations between self-reported physician diagnosis of gout and degrees of renal impairment were the primary focus of the present analyses. Results: In the 2009-2010 period, there was an estimated 7.5 million people with gout in the US. There were 1.25 million men and 0.78 million women with moderate or severe renal impairment and gout. The age standardized prevalence of gout was 2.9% among those with normal GFR compared to 24% among those with GFR < 60 ml/min/1.73 m(2). In multivariable logistic regression analyses that adjusted for age, gender, body mass index, hypertension, diabetes, hypertension medications, including diuretics, blood lead levels, and hyperlipidemia, the odds ratios of gout and hyperuricemia were 5.9 (2.2, 15.7) and 9.58 (4.3, 22.0) respectively among those with severe renal impairment compared to those with no renal impairment. Approximately 2-3 fold increase in prevalence of gout was observed for each 30 ml/min/1.73 m(2) decrease in GFR, after accounting for the above factors. Conclusions: Renal glomerular function is an important risk factor for gout. The prevalence of hyperuricemia and gout increases with decreasing glomerular function independent of other factors. This association is non-linear and an eGFR of 60 ml/min/1.73 m(2) appears to be a threshold for the dramatic increase in the prevalence of gout.	Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	Stanford University	Krishnan, E (corresponding author), Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA.	e.krishnan@stanford.edu	krishnan, Eswar/AAY-1269-2020; KRISHNAN, ESWAR/A-1072-2009		URL; ARDEA biosciences; Takeda	URL; ARDEA biosciences; Takeda(Takeda Pharmaceutical Company Ltd)	EK has served as a consultant to Takeda Pharmaceuticals, Inc., URL Pharmaceuticals Inc., Metabolic, Inc., and UCB Pharmaceuticals, Inc., and has received grant support from URL, ARDEA biosciences and Takeda. However, these entities did not sponsor this study or have access to the contents prior to publication. EK was responsible for all aspects of this manuscript from concept to finalizing the manuscript. He serves as the guarantor for this paper. There are no patents, products in development or marketed products to declare. This does not alter the author's adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ahmad A, 2006, QJM-INT J MED, V99, P245, DOI 10.1093/qjmed/hcl029; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Anderson R, 1998, NATL VITAL STAT REPO; Baker JF, 2005, AM J MED, V118, P816, DOI 10.1016/j.amjmed.2005.03.043; Soriano LC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3272; Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC), 2010, NAT CTR HLTH STAT NC; Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS), 2004, NHANES LAB PROC MAN; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Collins A, 2004, SCI EDUC, V88, P1, DOI 10.1002/sce.10140; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dalbeth N, 2007, SEMIN DIALYSIS, V20, P391, DOI 10.1111/j.1525-139X.2007.00270.x; Dalbeth N, 2006, J RHEUMATOL, V33, P1646; Enomoto A, 2002, NATURE, V417, P447, DOI 10.1038/nature742; Fuldeore MJ, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-36; Gelber AC, 1997, ARCH INTERN MED, V157, P1436, DOI 10.1001/archinte.157.13.1436; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kanbay M, 2007, INT UROL NEPHROL, V39, P1227, DOI 10.1007/s11255-007-9253-3; Krishnan E LB, 2010, AM COLL REH ANN SCI; Krishnan E, 2012, ANN INTERN MED, V157, P233, DOI 10.7326/0003-4819-157-4-201208210-00003; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liote F, 2012, JOINT BONE SPINE; Lipkowitz MS, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0240-z; Liu Q, 2011, RHEUMATOLOGY OXFORD; McAdams MA, 2011, J RHEUMATOL, V38, P135, DOI 10.3899/jrheum.100418; Mikuls TR, 2005, ANN RHEUM DIS, V64, P267, DOI 10.1136/ard.2004.024091; Nzerue CM, 2002, J NATL MED ASSOC, V94, p28S; RICHET G., 1965, PRESSE MED, V73, P633; RIESELBA.RE, 1970, ANN INTERN MED, V73, P359, DOI 10.7326/0003-4819-73-3-359; Rodriguez G, 2010, ANN RHEUM DIS, V69, P2090, DOI 10.1136/ard.2010.130013; Sarre H, 1964, TRAV C INT GOUTT LIT, P244; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; SORENSEN LB, 1980, ANN RHEUM DIS, V39, P424, DOI 10.1136/ard.39.5.424; STEELE TH, 1967, AM J MED, V43, P876, DOI 10.1016/0002-9343(67)90246-X; US Census Bureau: Social E and Housing Statistics Division, 2011, CENS BUR MEAS POV; Whelton A, 2011, JCR-J CLIN RHEUMATOL, V17, P7, DOI 10.1097/RHU.0b013e318204aab4; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; YU T-F, 1975, Seminars in Arthritis and Rheumatism, V4, P293, DOI 10.1016/0049-0172(75)90014-1; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	42	80	85	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50046	10.1371/journal.pone.0050046	http://dx.doi.org/10.1371/journal.pone.0050046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209642	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800043
J	Mayer, C; Michez, D; Chyzy, A; Bredat, E; Jacquemart, AL				Mayer, Carolin; Michez, Denis; Chyzy, Alban; Bredat, Elise; Jacquemart, Anne-Laure			The Abundance and Pollen Foraging Behaviour of Bumble Bees in Relation to Population Size of Whortleberry (Vaccinium uliginosum)	PLOS ONE			English	Article							PLANT-POLLINATOR INTERACTIONS; HABITAT FRAGMENTATION; REPRODUCTIVE SUCCESS; FLOWER CONSTANCY; DIET BREADTH; HYMENOPTERA; CONSEQUENCES; COMMUNITIES; DIVERSITY; DENSITY	Habitat fragmentation can have severe effects on plant pollinator interactions, for example changing the foraging behaviour of pollinators. To date, the impact of plant population size on pollen collection by pollinators has not yet been investigated. From 2008 to 2010, we monitored nine bumble bee species (Bombus campestris, Bombus hortorum s.l., Bombus hypnorum, Bombus lapidarius, Bombus pascuorum, Bombus pratorum, Bombus soroensis, Bombus terrestris s.l., Bombus vestalis s.l.) on Vaccinium uliginosum (Ericaceae) in up to nine populations in Belgium ranging in size from 80 m 2 to over 3.1 ha. Bumble bee abundance declined with decreasing plant population size, and especially the proportion of individuals of large bumble bee species diminished in smaller populations. The most remarkable and novel observation was that bumble bees seemed to switch foraging behaviour according to population size: while they collected both pollen and nectar in large populations, they largely neglected pollen collection in small populations. This pattern was due to large bumble bee species, which seem thus to be more likely to suffer from pollen shortages in smaller habitat fragments. Comparing pollen loads of bumble bees we found that fidelity to V. uliginosum pollen did not depend on plant population size but rather on the extent shrub cover and/or openness of the site. Bumble bees collected pollen only from three plant species (V. uliginosum, Sorbus aucuparia and Cytisus scoparius). We also did not discover any pollination limitation of V. uliginosum in small populations. We conclude that habitat fragmentation might not immediately threaten the pollination of V. uliginosum, nevertheless, it provides important nectar and pollen resources for bumble bees and declining populations of this plant could have negative effects for its pollinators. The finding that large bumble bee species abandon pollen collection when plant populations become small is of interest when considering plant and bumble bee conservation.	[Mayer, Carolin; Jacquemart, Anne-Laure] Catholic Univ Louvain, Earth & Life Inst, B-3000 Louvain, Belgium; [Michez, Denis; Chyzy, Alban; Bredat, Elise] Univ Mons, Zool Lab, B-7000 Mons, Belgium	Universite Catholique Louvain; University of Mons	Mayer, C (corresponding author), Catholic Univ Louvain, Earth & Life Inst, B-3000 Louvain, Belgium.	carolin.mayer@uclouvain.be	Michez, Denis/L-1370-2019	Michez, Denis/0000-0001-8880-1838	Belgian Fund for Scientific Research [FRS-FNRS] [2.4540.09]	Belgian Fund for Scientific Research [FRS-FNRS](Fonds de la Recherche Scientifique - FNRS)	The authors thank the Belgian Fund for Scientific Research [FRS-FNRS, www.frs-fnrs.be, contract no. 2.4540.09] for providing funding for this research and C. Mayer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2006, ECOL LETT, V9, P968, DOI 10.1111/j.1461-0248.2006.00927.x; AIZEN MA, 1994, ECOL APPL, V4, P378, DOI 10.2307/1941941; Aizen MA, 2007, ECOLOGY, V88, P271, DOI 10.1890/06-1017; Albert T, 2005, CAN J BOT, V83, P211, DOI [10.1139/B04-164, 10.1139/b04-164]; Andrieu E, 2009, ACTA OECOL, V35, P1, DOI 10.1016/j.actao.2008.07.002; Benton T., 2006, BUMBLEBEES NATURAL H; Bernhardt CE, 2008, INT J PLANT SCI, V169, P944, DOI 10.1086/589698; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bournerias M, 2001, GUIDE GROUPEMENTS VE; Bredat E, 2010, THESIS U MONS MONS; Brosi BJ, 2008, J APPL ECOL, V45, P773, DOI 10.1111/j.1365-2664.2007.01412.x; Bruckmann SV, 2010, J APPL ECOL, V47, P799, DOI 10.1111/j.1365-2664.2010.01828.x; Bruna EM, 2009, J VEG SCI, V20, P569, DOI 10.1111/j.1654-1103.2009.01060.x; Buchmann S.L., 1983, P73; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; Carvell C, 2006, APIDOLOGIE, V37, P326, DOI 10.1051/apido:2006002; Cheptou PO, 2006, NEW PHYTOL, V172, P774, DOI 10.1111/j.1469-8137.2006.01880.x; Cristofoli S, 2010, LANDSCAPE URBAN PLAN, V98, P92, DOI 10.1016/j.landurbplan.2010.07.014; Dafni A., 2005, PRACTICAL POLLINATIO; Donaldson J, 2002, CONSERV BIOL, V16, P1267, DOI 10.1046/j.1523-1739.2002.99515.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Fontaine C, 2008, J ECOL, V96, P1002, DOI 10.1111/j.1365-2745.2008.01405.x; Franzen M, 2009, NORD J BOT, V27, P274, DOI 10.1111/j.1756-1051.2009.00348.x; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Goulson D, 2008, BIODIVERS CONSERV, V17, P3269, DOI 10.1007/s10531-008-9428-y; Goulson D, 2011, J APPL ECOL, V48, P3, DOI 10.1111/j.1365-2664.2010.01929.x; Goverde M, 2002, BIOL CONSERV, V104, P293, DOI 10.1016/S0006-3207(01)00194-X; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Harris L. Fabienne, 2004, International Journal of Tropical Insect Science, V24, P29; Holzschuh A, 2010, J ANIM ECOL, V79, P491, DOI 10.1111/j.1365-2656.2009.01642.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Jacquemart A-L, 1993, THESIS CATHOLIC U LO; Jacquemart AL, 1996, CAN J BOT, V74, P210, DOI 10.1139/b96-025; Jacquemart AL, 2004, BELG J BOT, V136, P154; JACQUEMART AL, 1993, FLORA, V188, P263; Jacquemart AL, 1996, J ECOL, V84, P771, DOI 10.2307/2261339; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kolb A, 2005, J ECOL, V93, P1226, DOI 10.1111/j.1365-2745.2005.01049.x; Kremen C, 2000, CONSERV BIOL, V14, P1226, DOI 10.1046/j.1523-1739.2000.00013.x; Kreyer D, 2004, BIOL CONSERV, V116, P111, DOI 10.1016/S0006-3207(03)00182-4; Kunin W, 1996, THEOR POPUL BIOL, V49, P232, DOI 10.1006/tpbi.1996.0013; Lennartsson T, 2002, ECOLOGY, V83, P3060; Menz MHM, 2011, TRENDS PLANT SCI, V16, P4, DOI 10.1016/j.tplants.2010.09.006; MINCKLEY RL, 1994, ECOLOGY, V75, P1406, DOI 10.2307/1937464; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.1890/0012-9658(2002)083[1131:SCMISE]2.0.CO;2; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; Muller A, 1996, ECOL MONOGR, V66, P235, DOI 10.2307/2963476; Mustajarvi K, 2001, J ECOL, V89, P80, DOI 10.1046/j.1365-2745.2001.00521.x; R Development Core Team, 2009, R FDN STAT COMP; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Raine NE, 2007, ENTOMOL GEN, V29, P179; Rasheed SA, 1997, ECOL ENTOMOL, V22, P209, DOI 10.1046/j.1365-2311.1997.t01-1-00059.x; RATHCKE BJ, 1993, CURR SCI INDIA, V65, P273; Rodriguez-Girones MA, 2012, OIKOS, V121, P1473, DOI 10.1111/j.1600-0706.2011.19473.x; Roulston TH, 2000, ECOL MONOGR, V70, P617, DOI 10.1890/0012-9615(2000)070[0617:WGPCOP]2.0.CO;2; Sipes SD, 2005, BIOL J LINN SOC, V86, P487, DOI 10.1111/j.1095-8312.2005.00544.x; Steffan-Dewenter I, 2003, CONSERV BIOL, V17, P1036, DOI 10.1046/j.1523-1739.2003.01575.x; Taki H, 2008, J INSECT CONSERV, V12, P15, DOI 10.1007/s10841-006-9058-1; Taki H, 2007, BIODIVERS CONSERV, V16, P3147, DOI 10.1007/s10531-007-9168-4; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Westrich P., 1986, Linzer Biologische Beitraege, V18, P341; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Zuur Alain F., 2009, P1	70	27	27	1	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50353	10.1371/journal.pone.0050353	http://dx.doi.org/10.1371/journal.pone.0050353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209721	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800067
J	Ruzafa, D; Morel, B; Varela, L; Azuaga, AI; Conejero-Lara, F				Ruzafa, David; Morel, Bertrand; Varela, Lorena; Azuaga, Ana I.; Conejero-Lara, Francisco			Characterization of Oligomers of Heterogeneous Size as Precursors of Amyloid Fibril Nucleation of an SH3 Domain: An Experimental Kinetics Study	PLOS ONE			English	Article							PROTEIN AGGREGATION KINETICS; BETA-PROTEIN; POLYMERIZATION MODEL; ALZHEIMERS-DISEASE; ALPHA-SPECTRIN; MECHANISM; TOXICITY; GROWTH; BETA(2)-MICROGLOBULIN; NEURODEGENERATION	Understanding the earliest molecular events during nucleation of the amyloid aggregation cascade is of fundamental significance to prevent amyloid related disorders. We report here an experimental kinetic analysis of the amyloid aggregation of the N47A mutant of the alpha-spectrin SH3 domain (N47A Spc-SH3) under mild acid conditions, where it is governed by rapid formation of amyloid nuclei. The initial rates of formation of amyloid structures, monitored by thioflavine T fluorescence at different protein concentrations, agree quantitatively with high-order kinetics, suggesting an oligomerization pre-equilibrium preceding the rate-limiting step of amyloid nucleation. The curves of native state depletion also follow high-order irreversible kinetics. The analysis is consistent with the existence of low-populated and heterogeneous oligomeric precursors of fibrillation that form by association of partially unfolded protein monomers. An increase in NaCl concentration accelerates fibrillation but reduces the apparent order of the nucleation kinetics; and a double mutant (K43A, N47A) Spc-SH3 domain, largely unfolded under native conditions and prone to oligomerize, fibrillates with apparent first order kinetics. On the light of these observations, we propose a simple kinetic model for the nucleation event, in which the monomer conformational unfolding and the oligomerization of an amyloidogenic intermediate are rapidly pre-equilibrated. A conformational change of the polypeptide chains within any of the oligomers, irrespective of their size, is the rate-limiting step leading to the amyloid nuclei. This model is able to explain quantitatively the initial rates of aggregation and the observed variations in the apparent order of the kinetics and, more importantly, provides crucial thermodynamic magnitudes of the processes preceding the nucleation. This kinetic approach is simple to use and may be of general applicability to characterize the amyloidogenic intermediates and oligomeric precursors of other disease-related proteins.	[Conejero-Lara, Francisco] Univ Granada, Dept Quim Fis, Granada, Spain; Univ Granada, Inst Biotecnol, Granada, Spain	University of Granada; University of Granada	Conejero-Lara, F (corresponding author), Univ Granada, Dept Quim Fis, Granada, Spain.	conejero@ugr.es	Varela, Lorena/AHD-5146-2022; Lara, Francisco Conejero/F-2962-2016	Varela, Lorena/0000-0002-0743-9441; Lara, Francisco Conejero/0000-0002-8282-2168; Morel, Bertrand/0000-0002-2708-8589	Andalucia Government [FQM-02838]; Spanish Ministry of Science and Innovation [BIO2009-07317]; European Regional Development Fund of the European Union; F.P.U. program of the Spanish Ministry of Education; G.R.E.I.B. program of the University of Granada	Andalucia Government; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund of the European Union; F.P.U. program of the Spanish Ministry of Education(German Research Foundation (DFG)); G.R.E.I.B. program of the University of Granada	This work was financed by the Andalucia Government (grant FQM-02838), the Spanish Ministry of Science and Innovation (grant BIO2009-07317), and the European Regional Development Fund of the European Union. D. Ruzafa is recipient of a research fellowship from the F.P.U. program of the Spanish Ministry of Education. L. Varela is financed by the G.R.E.I.B. program of the University of Granada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Andrews JM, 2007, J PHYS CHEM B, V111, P7897, DOI 10.1021/jp070212j; Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blanco FJ, 1997, J BIOMOL NMR, V9, P347, DOI 10.1023/A:1018330122908; Bucciantini M, 2004, J BIOL CHEM, V279, P31374, DOI 10.1074/jbc.M400348200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Disanza A, 2005, CELL MOL LIFE SCI, V62, P955, DOI 10.1007/s00018-004-4472-6; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Klement K, 2007, J MOL BIOL, V373, P1321, DOI 10.1016/j.jmb.2007.08.068; Li Y, 2009, J PHYS CHEM B, V113, P7020, DOI 10.1021/jp8083088; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Malisauskas M, 2005, J BIOL CHEM, V280, P6269, DOI 10.1074/jbc.M407273200; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0; Morel B, 2006, J MOL BIOL, V356, P453, DOI 10.1016/j.jmb.2005.11.062; Morel B, 2010, BIOPHYS J, V99, P3801, DOI 10.1016/j.bpj.2010.10.039; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Munishkina LA, 2004, BIOCHEMISTRY-US, V43, P3289, DOI 10.1021/bi034938r; Nettleton EJ, 2000, BIOPHYS J, V79, P1053, DOI 10.1016/S0006-3495(00)76359-4; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Pedersen JS, 2006, BIOPHYS J, V90, P4181, DOI 10.1529/biophysj.105.070912; Plakoutsi G, 2004, J BIOL CHEM, V279, P14111, DOI 10.1074/jbc.M312961200; Powers ET, 2006, BIOPHYS J, V91, P122, DOI 10.1529/biophysj.105.073767; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Roberts CJ, 2007, BIOTECHNOL BIOENG, V98, P927, DOI 10.1002/bit.21627; Sadqi M, 1999, BIOCHEMISTRY-US, V38, P8899, DOI 10.1021/bi990413g; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Sousa MM, 2001, AM J PATHOL, V159, P1993; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Varela L, 2009, FEBS LETT, V583, P801, DOI 10.1016/j.febslet.2009.01.033; Vitalis A, 2011, BIOPHYS CHEM, V159, P14, DOI 10.1016/j.bpc.2011.04.006	45	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49690	10.1371/journal.pone.0049690	http://dx.doi.org/10.1371/journal.pone.0049690			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209591	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885800017
J	Smith, NA; Clarke, JA				Smith, N. Adam; Clarke, Julia A.			Endocranial Anatomy of the Charadriiformes: Sensory System Variation and the Evolution of Wing-Propelled Diving	PLOS ONE			English	Article							RELATIVE BRAIN SIZE; COMPARATIVE MORPHOLOGY; AVIAN CEREBELLUM; LOWER EOCENE; INNER-EAR; BIRDS; AVES; FLIGHTLESSNESS; PHYLOGENY; BEHAVIOR	Just as skeletal characteristics provide clues regarding behavior of extinct vertebrates, phylogenetically-informed evaluation of endocranial morphology facilitates comparisons among extinct taxa and extant taxa with known behavioral characteristics. Previous research has established that endocranial morphology varies across Aves; however, variation of those systems among closely related species remains largely unexplored. The Charadriiformes (shorebirds and allies) are an ecologically diverse clade with a comparatively rich fossil record, and therefore, are well suited for investigating interspecies variation, and potential links between endocranial morphology, phylogeny, ecology and other life history attributes. Endocranial endocasts were rendered from high resolution X-ray computed tomography data for 17 charadriiforms (15 extant and two flightless extinct species). Evaluation of endocranial character state changes on a phylogeny for Charadriiformes resulted in identification of characters that vary in taxa with distinct feeding and locomotor ecologies. In comparison with all other charadriiforms, stem and crown clade wing-propelled diving Pan-Alcidae displayed compressed semicircular canals, and indistinct occipital sinuses and cerebellar fissures. Flightless wing-propelled divers have relatively smaller brains for their body mass and smaller optic lobes than volant pan-alcids. Observed differences between volant and flightless wing-propelled sister taxa are striking given that flightless pan-alcids continue to rely on the flight stroke for underwater propulsion. Additionally, the brain of the Black Skimmer Rynchops niger, a taxon with a unique feeding ecology that involves continuous forward aerial motion and touch-based prey detection used both at day and night, is discovered to be unlike that of any other sampled charadriiform in having an extremely large wulst as well as a small optic lobe and distinct occipital sinus. Notably, the differences between the Black Skimmer and other charadriiforms are more pronounced than between wing-propelled divers and other charadriiforms. Finally, aspects of endosseous labyrinth morphology are remarkably similar between divers and non-divers, and may deserve further evaluation.	[Smith, N. Adam; Clarke, Julia A.] Univ Texas Austin, Dept Geol Sci, Jackson Sch Geosci, Austin, TX USA	University of Texas System; University of Texas Austin	Smith, NA (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC USA.	adam_smith@nescent.org		Smith, N. Adam/0000-0002-0990-3594	National Science Foundation [NSF DEB 0949897]; Jackson School of Geosciences; University of Texas at Austin; National Evolutionary Synthesis Center Postdoctoral Fellowship (NESCent) [NSF EF-0905606]; Direct For Biological Sciences [0949897] Funding Source: National Science Foundation; Division Of Earth Sciences [0948842] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Jackson School of Geosciences; University of Texas at Austin; National Evolutionary Synthesis Center Postdoctoral Fellowship (NESCent); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this research was provided by National Science Foundation Grant "Collaborative research: Wings to flippers-Phylogenetics, character acquisition, and feather biomechanics in the evolution of wing - propelled diving" (NSF DEB 0949897) and The Jackson School of Geosciences, The University of Texas at Austin. N.A.S. also gratefully acknowledges additional support from a National Evolutionary Synthesis Center Postdoctoral Fellowship (NESCent; NSF EF-0905606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P151, DOI 10.1159/000111461; Baker AJ, 2007, BIOL LETTERS, V3, P205, DOI 10.1098/rsbl.2006.0606; BANG BG, 1968, AUK, V85, P55; BENNETT PM, 1985, J ZOOL, V207, P151; Breazile J. E., 1993, HDB AVIAN ANATOMY NO, P493; Burish MJ, 2004, BRAIN BEHAV EVOLUT, V63, P107, DOI 10.1159/000075674; Butler A. B., 2005, COMP VERTEBRATE NEUR; Corfield JR, 2008, BRAIN BEHAV EVOLUT, V71, P87, DOI 10.1159/000111456; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Dunning J., 2008, CRC HDB AVIAN BODY M, V2nd; Elzanowski A., 1991, Journal of Vertebrate Paleontology, V11, P90; Franzosa J, 2004, EVOLUTION BRAIN THER; FUNKE K, 1989, EXP BRAIN RES, V76, P620, DOI 10.1007/BF00248918; Gaston AJ, 2008, AUK, V125, P939, DOI 10.1525/auk.2008.07195; Georgi A, 2008, SEMICIRCULAR CANAL M; Georgi JA, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P233; Gleich O, 2005, NATURWISSENSCHAFTEN, V92, P595, DOI 10.1007/s00114-005-0050-5; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HADZISELIMOVIC H, 1964, ACTA ANAT, V57, P306; Harmening WM, 2011, J COMP PHYSIOL A, V197, P1031, DOI 10.1007/s00359-011-0664-3; HARRISON C J O, 1972, Bulletin of the British Museum (Natural History) Geology, V21, P153; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hetherington T, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P183; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Iwaniuk AN, 2004, J ZOOL, V263, P317, DOI 10.1017/S0952836904005308; Iwaniuk AN, 2003, CAN J ZOOL, V81, P1913, DOI 10.1139/Z03-190; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Iwaniuk AN, 2007, BRAIN BEHAV EVOLUT, V69, P196, DOI 10.1159/000096987; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; Iwaniuk AN, 2006, BRAIN BEHAV EVOLUT, V68, P45, DOI 10.1159/000093530; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Kawabe S, 2009, BRAIN BEHAV EVOLUT, V74, P295, DOI 10.1159/000270906; Koenig E, 1825, ICONES FOSSILUM SECT; Ksepka DT, 2007, PHYLOGENY HISTOLOGY; Ksepka DT, 2012, ZOOLOGICAL IN PRESS; Lefebvre L, 2002, BEHAVIOUR, V139, P939, DOI 10.1163/156853902320387918; LIVEZEY BC, 1988, AUK, V105, P681, DOI 10.1093/auk/105.4.681; Lydekker R., 1891, CATALOGUE FOSSIL BIR; Maddison WP, 2011, MESQUITE MODULAR SYS; Marino L, 2005, P NATL ACAD SCI USA, V102, P5306, DOI 10.1073/pnas.0501695102; Martin GR, 2007, IBIS, V149, P750, DOI 10.1111/j.1474-919X.2007.00706.x; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Mayr G, 2007, NEUES JAHRB GEOL P-A, V244, P207, DOI 10.1127/0077-7749/2007/0244-0207; Mehlhorn J, 2010, BRAIN BEHAV EVOLUT, V75, P63, DOI 10.1159/000295151; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Nealen PM, 2001, J ZOOL, V253, P391, DOI 10.1017/S095283690100036X; Nicolakakis N, 2003, ANIM BEHAV, V65, P445, DOI 10.1006/anbe.2003.2085; Nieder A, 2002, J COMP PHYSIOL A, V188, P249, DOI 10.1007/s00359-002-0306-x; Orme, 2011, CAPER COMP ANAL PHYL; Owen, 1846, HIST BRIT FOSSIL MAM; Paton TA, 2006, MOL PHYLOGENET EVOL, V39, P657, DOI 10.1016/j.ympev.2006.01.011; PEARSON R, 1972, AVIAN BRAIN; PENNYCUICK CJ, 1987, J EXP BIOL, V128, P335; Pennycuick CJ, 1986, SEABIRDS FEEDING ECO, P43; Pereira SL, 2008, MOL PHYLOGENET EVOL, V46, P430, DOI 10.1016/j.ympev.2007.11.020; PETTIGREW JD, 1985, BRAIN BEHAV EVOLUT, V26, P185, DOI 10.1159/000118775; Picasso MBJ, 2010, BRAIN BEHAV EVOLUT, V76, P176, DOI 10.1159/000321173; Picasso MBJ, 2009, J VERTEBR PALEONTOL, V29, P831, DOI 10.1671/039.029.0319; PORTMANN A, 1961, BIOL COMP PHYSL BIRD, P1; R DCT, 2012, R LANG ENV STAT COMP; Rojas LM, 1997, CONDOR, V99, P191, DOI 10.2307/1370237; Scofield RP, 2009, J VERTEBR PALEONTOL, V29, P637, DOI 10.1671/039.029.0325; Sipla J. S., 2007, SEMICIRCULAR CANALS; Smith, 2011, SYSTEMATICS EVOLUTIO; Smith N.A., 2011, ORNITHOL MONOGR, V72, P1, DOI DOI 10.1525/om.2011.72.1.1; Smith NA, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.91.709; Sol D, 2006, J ORNITHOL, V147, P254; Sol D, 2002, ANIM BEHAV, V64, P516, DOI 10.1006/anbe.2002.4005; Stingelin W, 1958, VERGLEICHEND MORPHOT; Swofford D, 2011, PAUP V4 0A122; Thomas GH, 2004, MOL PHYLOGENET EVOL, V30, P516, DOI 10.1016/S1055-7903(03)00222-7; Walsh SA, 2011, LIVING DINOSAURS EVO, P282; Walsh S, 2011, J SYST PALAEONTOL, V9, P173, DOI 10.1080/14772019.2010.513703; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Watanuki Y, 2006, J EXP BIOL, V209, P1217, DOI 10.1242/jeb.02128; Watanuki Y, 2003, P ROY SOC B-BIOL SCI, V270, P483, DOI 10.1098/rspb.2002.2252; Winkler H, 2004, J ORNITHOL, V145, P238, DOI 10.1007/s10336-004-0040-y; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Zelenitsky DK, 2011, P ROYAL SOC B, P1; Zusi RL, 1992, SCI SERIES NATURAL H, P351	84	35	36	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49584	10.1371/journal.pone.0049584	http://dx.doi.org/10.1371/journal.pone.0049584			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209585	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800012
J	Peressotti, F; Pesciarelli, F; Mulatti, C; Dell'Acqua, R				Peressotti, Francesca; Pesciarelli, Francesca; Mulatti, Claudio; Dell'Acqua, Roberto			Event-Related Potential Evidence for Two Functionally Dissociable Sources of Semantic Effects in the Attentional Blink	PLOS ONE			English	Article							SPREADING ACTIVATION; LEXICAL DECISION; TIME-COURSE; PRIME; N400; TASK; WORDS; REPETITION; ACCESS; CONSCIOUSNESS	Three target words (T1, T2, and T3) were embedded in a rapid serial visual presentation (RSVP) stream of non-word distractors, and participants were required to report the targets at the end of each RSVP stream. T2 and T3 were semantically related words in half of the RSVP streams, and semantically unrelated words in the other half of the RSVP streams. Using an identical design, a recent study reported distinct reflections of the T2-T3 semantic relationship on the P2 and N400 components of event-related potentials (ERPs) time-locked to T3, suggesting an early, automatic, source of P2 semantic effects and a late, controlled, source of N400 semantic effects. Here, P2 and N400 semantic effects were examined by manipulating list-wide context. Relative to participants performing in a semantically unbiased context, participants overexposed to filler RSVP streams always including semantically related T2/T3 words reported a dilution of T3-locked P2 semantic effects and a magnification of T3-locked N400 semantic effects. Opposite effects on P2 and N400 ERP components of list-wide semantic context are discussed in relation to recent proposals on the representational status of RSVP targets at processing stages prior to consolidation in visual short-term memory.	[Peressotti, Francesca; Mulatti, Claudio; Dell'Acqua, Roberto] Univ Padua, Dept Dev & Social Psychol, Padua, Italy; [Pesciarelli, Francesca] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Dell'Acqua, Roberto] Univ Padua, Ctr Cognit & Brain Sci, Padua, Italy	University of Padua; Universita di Modena e Reggio Emilia; University of Padua	Peressotti, F (corresponding author), Univ Padua, Dept Dev & Social Psychol, Padua, Italy.	francesca.peressotti@unipd.it	Pesciarelli, Francesca/AAK-1692-2020; Pesciarelli, Francesca/H-5518-2013; Dell'Acqua, Roberto/B-1682-2008; PESCIARELLI, Francesca/ABE-9870-2021; Peressotti, Francesca/AAB-7795-2022	Pesciarelli, Francesca/0000-0003-3007-4775; Pesciarelli, Francesca/0000-0003-3007-4775; Dell'Acqua, Roberto/0000-0002-3393-1907; Peressotti, Francesca/0000-0002-2425-9231	MIUR (Ministero dell'Istruzione Universita e Ricerca) [2008P3WB4P_002]	MIUR (Ministero dell'Istruzione Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR))	The research has been supported by a MIUR (Ministero dell'Istruzione Universita e Ricerca) - PRIN (Progetto di Ricerca di Interesse Nazionale) 2008 grant (code number 2008P3WB4P_002) to F. Peressotti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, VELI VOC EL LING IT; Batterink L, 2010, J COGNITIVE NEUROSCI, V22, P2514, DOI 10.1162/jocn.2009.21361; BESSON M, 1993, J EXP PSYCHOL LEARN, V19, P1115, DOI 10.1037/0278-7393.19.5.1115; Bodner GE, 2003, PSYCHON B REV, V10, P645, DOI 10.3758/BF03196527; Bodner GE, 2001, J MEM LANG, V45, P616, DOI 10.1006/jmla.2001.2791; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; DAVIS C, 1994, Q J EXP PSYCHOL-A, V47, P673, DOI 10.1080/14640749408401133; Deacon D, 2000, COGNITIVE BRAIN RES, V9, P137, DOI 10.1016/S0926-6410(99)00050-6; DEGROOT AMB, 1984, Q J EXP PSYCHOL-A, V36, P253, DOI 10.1080/14640748408402158; Dell'Acqua R, 2007, PSYCHOPHYSIOLOGY, V44, P436, DOI 10.1111/j.1469-8986.2007.00514.x; Dell'Acqua R, 2012, PSYCHON B REV, V19, P232, DOI 10.3758/s13423-011-0209-3; Dell'Acqua R, 1999, COGNITION, V73, pB1, DOI 10.1016/S0010-0277(99)00049-9; Dell'Acqua R, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00177; Dell'Acqua R, 2009, J EXP PSYCHOL HUMAN, V35, P338, DOI 10.1037/a0013555; Di Lollo V, 2000, J EXP PSYCHOL GEN, V129, P481, DOI 10.1037/0096-3445.129.4.481; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; Dux PE, 2005, PSYCHOL SCI, V16, P775, DOI 10.1111/j.1467-9280.2005.01613.x; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; Forster KI, 1998, J PSYCHOLINGUIST RES, V27, P203, DOI 10.1023/A:1023202116609; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grossi G, 2006, PSYCHOPHYSIOLOGY, V43, P21, DOI 10.1111/j.1469-8986.2006.00383.x; Hanslmayr S, 2011, BRAIN RES REV, V67, P331, DOI 10.1016/j.brainresrev.2011.04.002; Holcomb PJ, 2005, COGNITIVE BRAIN RES, V24, P155, DOI 10.1016/j.cogbrainres.2005.01.003; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; KEEFE DE, 1990, MEM COGNITION, V18, P289, DOI 10.3758/BF03213882; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kiefer M, 2000, NEUROREPORT, V11, P2401, DOI 10.1097/00001756-200008030-00013; Kiefer M, 2002, COGNITIVE BRAIN RES, V13, P27, DOI 10.1016/S0926-6410(01)00085-4; Kiefer M, 2010, J EXP PSYCHOL GEN, V139, P464, DOI 10.1037/a0019561; Kinoshita S., 2004, MASKED PRIMING STATE; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kounios J, 2000, MEM COGNITION, V28, P1366, DOI 10.3758/BF03211837; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; MacLean MH, 2011, BRAIN RES, V1387, P99, DOI 10.1016/j.brainres.2011.02.069; Maki WS, 1997, J EXP PSYCHOL HUMAN, V23, P1014, DOI 10.1037/0096-1523.23.4.1014; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; Martens S, 2002, J EXP PSYCHOL HUMAN, V28, P1275, DOI 10.1037//0096-1523.28.6.1275; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Masson MEJ, 1995, J EXPT PSYCHOL LEARN, V25, P776; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; NEELY JH, 1989, J EXP PSYCHOL LEARN, V15, P1003, DOI 10.1037/0278-7393.15.6.1003; Peressotti F, 2003, READ WRIT, V16, P179, DOI DOI 10.1023/A:1022843209384; Pesciarelli F, 2007, BIOL PSYCHOL, V76, P21, DOI 10.1016/j.biopsycho.2007.05.003; Posner M., 1975, INFORM PROCESSING CO; Potter MC, 2005, PSYCHON B REV, V12, P460, DOI 10.3758/BF03193788; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2005, J COGNITIVE NEUROSCI, V17, P884, DOI 10.1162/0898929054021111; Pulvermuller F, 2001, EUR J NEUROSCI, V13, P201, DOI 10.1046/j.0953-816X.2000.01380.x; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Renoult L, 2010, BIOL PSYCHOL, V84, P206, DOI 10.1016/j.biopsycho.2010.01.014; Reynvoet B, 2004, EXP PSYCHOL, V51, P81, DOI 10.1027/1618-3169.51.2.81; Rolke B, 2001, PSYCHOPHYSIOLOGY, V38, P165, DOI 10.1017/S0048577201991504; Rousselet GA, 2003, J VISION, V3, P440, DOI 10.1167/3.6.5; RUGG MD, 1985, PSYCHOPHYSIOLOGY, V22, P642, DOI 10.1111/j.1469-8986.1985.tb01661.x; Rugg MD., 1994, COGNITIVE ELECTROPHY, P124, DOI [10.1007/978-1-4612-0283-7%5F5, DOI 10.1007/978-1-4612-0283-7_5]; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Sergent C, 2005, NAT NEUROSCI, V8, P1391, DOI 10.1038/nn1549; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; Shapiro K, 1997, PSYCHOL SCI, V8, P95, DOI 10.1111/j.1467-9280.1997.tb00689.x; Shapiro KL, 2007, NEUROREPORT, V18, P341, DOI 10.1097/WNR.0b013e32801299e2; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Vachon F, 2007, J EXP PSYCHOL HUMAN, V33, P330, DOI 10.1037/0096-1523.33.2.330; Vachon F, 2011, PSYCHOPHYSIOLOGY, V48, P102, DOI 10.1111/j.1469-8986.2010.01040.x; Van den Bussche E, 2009, EXP PSYCHOL, V56, P295, DOI 10.1027/1618-3169.56.5.295; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; VanRullen R, 2001, PERCEPTION, V30, P655, DOI 10.1068/p3029; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Wyble B, 2011, J EXP PSYCHOL GEN, V140, P488, DOI 10.1037/a0023612	79	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49099	10.1371/journal.pone.0049099	http://dx.doi.org/10.1371/journal.pone.0049099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048RI	23189139	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800018
J	Vinay, DS; Lee, SJ; Kim, CH; Oh, HS; Kwon, BS				Vinay, Dass S.; Lee, Seung J.; Kim, Chang H.; Oh, Ho Sik; Kwon, Byoung S.			Exposure of a Distinct PDCA-1(+) (CD317) B Cell Population to Agonistic Anti-4-1BB (CD137) Inhibits T and B Cell Responses Both In Vitro and In Vivo	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; REGULATORY CELLS; CUTTING EDGE; 4-1BB; EXPRESSION; CHEMOKINES; INNATE; ALPHA; BETA; IFN	4-1BB (CD137) is an important T cell activating molecule. Here we report that it also promotes development of a distinct B cell subpopulation co-expressing PDCA-1. 4-1BB is expressed constitutively, and its expression is increased when PDCA-1(+) B cells are activated. We found that despite a high level of surface expression of 4-1BB on PDCA-1(+) B cells, treatment of these cells with agonistic anti-4-1BB mAb stimulated the expression of only a few activation markers (B7-2, MHC II, PD-L2), cytokines (IL-12p40/p70), and chemokines (MCP-1, RANTES), as well as sTNFR1, and the immunosuppressive enzyme, IDO. Although the PDCA-1(+) B cells stimulated by anti-4-1BB expressed MHC II at high levels and took up antigens efficiently, Ig class switching was inhibited when they were pulsed with T-independent (TI) or T-dependent (TD) Ags and adoptively transferred into syngeneic recipients. Furthermore, when anti-4-1BB-treated PDCA-1(+) B cells were pulsed with OVA peptide and combined with V alpha 2(+)CD4(+) T cells, Ag-specific cell division was inhibited both in vitro and in vivo. Our findings suggest that the 4-1BB signal transforms PDCA-1(+) B cells into propagators of negative immune regulation, and establish an important role for 4-1BB in PDCA-1(+) B cell development and function.	[Vinay, Dass S.; Kwon, Byoung S.] Tulane Univ, Hlth Sci Ctr, Dept Med, Sect Clin Immunol Allergy & Rheumatol, New Orleans, LA 70118 USA; [Lee, Seung J.; Kim, Chang H.; Oh, Ho Sik; Kwon, Byoung S.] Natl Canc Ctr, R&D Ctr Canc Therapeut, Goyang Si, Gyeonggi Do, South Korea	Tulane University; National Cancer Center - Korea (NCC)	Kwon, BS (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Med, Sect Clin Immunol Allergy & Rheumatol, New Orleans, LA 70118 USA.	bkwon@tulane.edu			National Cancer Center, Korea [NCC1210370-1, NCC1130720-1]; National Research Foundation of Korea [NRF2005-0093837, NRF2006-2004212]	National Cancer Center, Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by grants from the National Cancer Center, Korea (NCC1210370-1 and NCC1130720-1) and the National Research Foundation of Korea (NRF2005-0093837 and NRF2006-2004212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Bucktrout SL, 2008, J IMMUNOL, V180, P6457, DOI 10.4049/jimmunol.180.10.6457; Bao Y, 2011, EUR J IMMUNOL, V41, P657, DOI 10.1002/eji.201040840; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Choi BK, 2006, CYTOKINE, V34, P233, DOI 10.1016/j.cyto.2006.04.008; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Croft M, 2003, CYTOKINE GROWTH F R, V14, P265, DOI 10.1016/S1359-6101(03)00025-X; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Henri S, 2001, J IMMUNOL, V167, P741, DOI 10.4049/jimmunol.167.2.741; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jongbloed SL, 2009, J IMMUNOL, V182, P963, DOI 10.4049/jimmunol.182.2.963; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; KWON BS, 1989, P NATL ACAD SCI USA, V86, P1963, DOI 10.1073/pnas.86.6.1963; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee SW, 2009, ADV EXP MED BIOL, V647, P120, DOI 10.1007/978-0-387-89520-8_8; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Menoret A, 2006, J IMMUNOL, V177, P6091, DOI 10.4049/jimmunol.177.9.6091; Myers L, 2005, J IMMUNOL, V174, P7625, DOI 10.4049/jimmunol.174.12.7625; Niu LG, 2007, J IMMUNOL, V178, P4194, DOI 10.4049/jimmunol.178.7.4194; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Schlondorff D, 1997, KIDNEY INT, V51, P610, DOI 10.1038/ki.1997.90; Schrum S, 1996, J IMMUNOL, V157, P3598; Seo SK, 2004, NAT MED, V10, P1088, DOI 10.1038/nm1107; Shriner AK, 2010, J IMMUNOL, V185, P525, DOI 10.4049/jimmunol.0902841; Sun YL, 2002, NAT MED, V8, P1405, DOI 10.1038/nm796; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Vinay D. S., 2006, CD137 PATHWAY IMMUNO, P1; Vinay DS, 2006, J IMMUNOL, V177, P5708, DOI 10.4049/jimmunol.177.8.5708; Vinay DS, 2006, J MOL MED, V84, P726, DOI 10.1007/s00109-006-0072-2; Vinay DS, 2011, CELL MOL IMMUNOL, V8, P281, DOI 10.1038/cmi.2010.82; Vinay DS, 2010, J IMMUNOL, V184, P807, DOI 10.4049/jimmunol.0902528; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Wilcox RA, 2002, J IMMUNOL, V168, P4262, DOI 10.4049/jimmunol.168.9.4262; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Zhang XY, 2010, J IMMUNOL, V184, P787, DOI 10.4049/jimmunol.0901619	42	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50272	10.1371/journal.pone.0050272	http://dx.doi.org/10.1371/journal.pone.0050272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185591	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000210
J	Gracia, E; Farre, D; Cortes, A; Ferrer-Costa, C; Orozco, M; Mallol, J; Lluis, C; Canela, EI; McCormick, PJ; Franco, R; Fanelli, F; Casado, V				Gracia, Eduard; Farre, Daniel; Cortes, Antoni; Ferrer-Costa, Carles; Orozco, Modesto; Mallol, Josefa; Lluis, Carme; Canela, Enric I.; McCormick, Peter J.; Franco, Rafael; Fanelli, Francesca; Casado, Vicent			The catalytic site structural gate of adenosine deaminase allosterically modulates ligand binding to adenosine receptors	FASEB JOURNAL			English	Article						multifunctional proteins; protein-protein interaction; enzyme mutants; in silico docking; immunological synapse	DIPEPTIDYL-PEPTIDASE-IV; T-CELL-ACTIVATION; QUATERNARY STRUCTURE PREDICTIONS; OVARIAN-CARCINOMA CELLS; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; PROTEIN-DOCKING; A(1) RECEPTORS; PIG BRAIN	The enzyme adenosine deaminase (ADA) is a multifunctional protein that can both degrade adenosine and bind extracellularly to adenosine receptors, acting as an allosteric modulator regulating the hormonal effects of adenosine. The molecular regions of ADA responsible for the latter are unknown. In this work, alanine scanning mutagenesis of various ADA amino acid stretches, selected through in silico docking experiments, allowed us to identify regions of the enzyme responsible for modulating both its catalytic activity and its ability to modulate agonist binding to A(1) and A(2A) adenosine receptors (A(1)R and A(2A)R). The combination of computational and in vitro experiments show that the structural gate to the catalytic site; i.e., the alpha-1 helix containing residues L58-I72 and the loop containing residues A184-I188 of ADA, were important to maintain both the catalytic efficiency of the enzyme and its action as an allosteric modulator of the adenosine receptors. These data are consistent with a predicted supramolecular assembly, in which ADA bridges A(2A)R and CD26 and are in line with the notion that the interaction of ADA with adenosine receptors has an important role in the immunosynapse. We propose that it is the ADA open form, but not the closed one, that is responsible for the functional interaction with A1R and A(2A)R.-Gracia, E., Farre, D., Cortes, A., Ferrer-Costa, C., Orozco, M., Mallol, J., Lluis, C., Canela, E. I., McCormick, P. J., Franco, R., Fanelli, F., Casado, V. The catalytic site structural gate of adenosine deaminase allosterically modulates ligand binding to adenosine receptors. FASEB J. 27, 1048-1061 (2013). www.fasebj.org	[Gracia, Eduard; Farre, Daniel; Cortes, Antoni; Mallol, Josefa; Lluis, Carme; Canela, Enric I.; McCormick, Peter J.; Casado, Vicent] Univ Barcelona, Fac Biol, Mol Neurobiol Lab, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-08028 Barcelona, Spain; [Gracia, Eduard; Farre, Daniel; Cortes, Antoni; Orozco, Modesto; Mallol, Josefa; Lluis, Carme; Canela, Enric I.; McCormick, Peter J.; Franco, Rafael; Casado, Vicent] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Ferrer-Costa, Carles; Orozco, Modesto] Inst Res Biomed, Joint Inst Res Biomed Barcelona Comp Ctr IRB BSC, Modena, Italy; [Fanelli, Francesca] Dulbecco Telethon Inst, Modena, Italy; [Fanelli, Francesca] Univ Modena, Dept Chem, I-41100 Modena, Italy	CIBERNED; University of Barcelona; University of Barcelona; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Universita di Modena e Reggio Emilia	Casado, V (corresponding author), Univ Barcelona, Fac Biol, Mol Neurobiol Lab, Dept Biochem & Mol Biol, Av Diagonal 643, E-08028 Barcelona, Spain.	vcasado@ub.edu	Franco, Rafael/C-3694-2015; Casadó, Vicent/K-1660-2014; Mallol, Josefa/I-4194-2015; Canela, Enric I./M-8726-2013; Fanelli, Francesca/O-8807-2014; McCormick, Peter/E-7387-2012	Franco, Rafael/0000-0003-2549-4919; Casadó, Vicent/0000-0002-1764-3825; Mallol, Josefa/0000-0002-2479-4162; Canela, Enric I./0000-0003-4992-7440; Fanelli, Francesca/0000-0002-7620-6895; McCormick, Peter/0000-0002-2225-5181; Orozco Lopez, Modesto/0000-0002-8608-3278	Spanish Ministerio de Ciencia y Tecnologia [SAF2010-18472, SAF2011-23813, SAF2008-3229-E/]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED) [PI2011/02-7]; FIPSE [36750/08]; Telethon-Italy [S00068TELU]	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); FIPSE; Telethon-Italy(Fondazione Telethon)	The authors acknowledge the technical help obtained from Jasmina Jimenez (Laboratory of Molecular Neurobiology, University of Barcelona) and Francesco Raimondi (University of Modena and Reggio Emilia). This study was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (SAF2010-18472, SAF2011-23813 and SAF2008-3229-E/ within the frame of the Era-NET Neuron program), grant for collaborative projects PI2011/02-7 from the Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), and by FIPSE (a non- profit foundation including the Spanish Ministry of Health, Abbott Laboratories, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Merck Sharp and Dohme, and Roche) grant 36750/08. This study was also supported by Telethon-Italy grant S00068TELU (to F.F.). P.J.M. is a Ramon y Cajal Fellow.	Arredondo-Vega FX, 1998, AM J HUM GENET, V63, P1049, DOI 10.1086/302054; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; CASADO V, 1990, J NEUROSCI RES, V26, P461, DOI 10.1002/jnr.490260409; Casciari D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-340; Casciari D, 2008, J CHEM INF MODEL, V48, P1669, DOI 10.1021/ci800048d; CHANDLER D, 1983, SCIENCE, V220, P787, DOI 10.1126/science.220.4599.787; CHANG Z, 1991, BIOCHEMISTRY-US, V30, P2273, DOI 10.1021/bi00222a033; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Cieplak P, 1996, J MOL RECOGNIT, V9, P103, DOI 10.1002/(SICI)1099-1352(199603)9:2<103::AID-JMR246>3.0.CO;2-A; Ciruela F, 1996, FEBS LETT, V380, P219, DOI 10.1016/0014-5793(96)00023-3; Climent N, 2009, IMMUNOL CELL BIOL, V87, P634, DOI 10.1038/icb.2009.53; Cristalli G, 2001, MED RES REV, V21, P105, DOI 10.1002/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO;2-U; Dong R P, 1996, Hum Cell, V9, P153; Dong RP, 1997, J IMMUNOL, V159, P6070; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; Fanelli F, 2007, MOL CELL ENDOCRINOL, V260, P59, DOI 10.1016/j.mce.2005.12.054; Fanelli F, 2011, BBA-BIOMEMBRANES, V1808, P1256, DOI 10.1016/j.bbamem.2010.08.006; Fanelli F, 2011, CELL MOL LIFE SCI, V68, P3109, DOI 10.1007/s00018-010-0615-0; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Franco R, 1998, IMMUNOL REV, V161, P27, DOI 10.1111/j.1600-065X.1998.tb01569.x; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gracia E, 2008, J NEUROCHEM, V107, P161, DOI 10.1111/j.1471-4159.2008.05602.x; Gracia E, 2011, BIOCHEM J, V435, P701, DOI 10.1042/BJ20101749; Harris R, 2008, PROTEINS, V70, P1506, DOI 10.1002/prot.21645; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Herrera C, 2001, MOL PHARMACOL, V59, P127, DOI 10.1124/mol.59.1.127; Hershfield MS, 2003, CURR OPIN IMMUNOL, V15, P571, DOI 10.1016/S0952-7915(03)00104-3; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Kajiyama H, 2003, CANCER RES, V63, P2278; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Kameoka J, 2006, LEUKEMIA LYMPHOMA, V47, P2181, DOI 10.1080/10428190600773396; Kikkawa F, 2003, INT J CANCER, V105, P779, DOI 10.1002/ijc.11177; Kinoshita T, 2005, BIOCHEMISTRY-US, V44, P10562, DOI 10.1021/bi050529e; Kinoshita T, 2003, ACTA CRYSTALLOGR D, V59, P299, DOI 10.1107/S090744490202190X; Kinoshita T, 2008, BIOCHEM BIOPH RES CO, V373, P53, DOI 10.1016/j.bbrc.2008.05.180; Larson ET, 2008, J MOL BIOL, V381, P975, DOI 10.1016/j.jmb.2008.06.048; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Martinez-Navio JM, 2011, J LEUKOCYTE BIOL, V89, P127, DOI 10.1189/jlb.1009696; Martinez-Navio JM, 2009, IMMUNOLOGY, V128, P393, DOI 10.1111/j.1365-2567.2009.03121.x; Meyer T, 2010, STRUCTURE, V18, P1399, DOI 10.1016/j.str.2010.07.013; Pacheco R, 2005, P NATL ACAD SCI USA, V102, P9583, DOI 10.1073/pnas.0501050102; PETERSEN MB, 1987, J MED GENET, V24, P93, DOI 10.1136/jmg.24.2.93; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Resta R, 1997, IMMUNOL TODAY, V18, P371, DOI 10.1016/S0167-5699(97)01047-5; Richard E, 2000, J EXP MED, V192, P1223, DOI 10.1084/jem.192.9.1223; Richard E, 2002, J BIOL CHEM, V277, P19720, DOI 10.1074/jbc.M111901200; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Ruiz MA, 2000, J NEUROCHEM, V75, P656, DOI 10.1046/j.1471-4159.2000.0750656.x; Saura C, 1996, J NEUROCHEM, V66, P1675; Saura CK, 1998, J BIOL CHEM, V273, P17610, DOI 10.1074/jbc.273.28.17610; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sun WC, 2005, ACTA PHARMACOL SIN, V26, P160, DOI 10.1111/j.1745-7254.2005.00524.x; Terasaka T, 2004, J AM CHEM SOC, V126, P34, DOI 10.1021/ja038606l; Torvinen M, 2002, NEUROSCIENCE, V113, P709, DOI 10.1016/S0306-4522(02)00058-1; van Gunsteren W F, 1987, J Comput Aided Mol Des, V1, P171; Wang ZM, 1998, BIOCHEMISTRY-US, V37, P8314, DOI 10.1021/bi980324o; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; Wesley UV, 1999, J EXP MED, V190, P311, DOI 10.1084/jem.190.3.311; WILSON DK, 1993, BIOCHEMISTRY-US, V32, P1689, DOI 10.1021/bi00058a001; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; YORK DM, 1994, P NATL ACAD SCI USA, V91, P8715, DOI 10.1073/pnas.91.18.8715	64	27	33	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					1048	1061		10.1096/fj.12-212621	http://dx.doi.org/10.1096/fj.12-212621			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23193172				2022-12-25	WOS:000315585200019
J	Okumura-Noji, K; Miura, Y; Lu, R; Asai, K; Ohta, N; Brindley, PJ; Yokoyama, S				Okumura-Noji, Kuniko; Miura, Yutaka; Lu, Rui; Asai, Kiyofumi; Ohta, Nobuo; Brindley, Paul J.; Yokoyama, Shinji			CD36-related protein in Schistosoma japonicum: candidate mediator of selective cholesteryl ester uptake from high-density lipoprotein for egg maturation	FASEB JOURNAL			English	Article						CETP deficiency; miracidium; CETP; embryonation; hepatic granulomatosis; HDL	SCAVENGER RECEPTOR; HUMAN PLASMA; SR-BI; DEFICIENCY; IDENTIFICATION; DATABASE; BINDING; GENE; HYPERALPHALIPOPROTEINEMIA; PURIFICATION	Familial cholesteryl ester transfer protein (CETP) deficiency is more common in some East Asian populations than elsewhere, suggesting the possibility of a selective advantage of this genetic defect against regional infectious diseases. Historically, infection with the Asian blood fluke Schistosoma japonicum has been endemic in these regions, including Japan. We previously reported that eggs of S. japonicum require cholesteryl ester uptake from normal high-density lipoprotein (HDL) but not from CETP-deficient HDL for their maturation to miracidia, a critical step of the hepatic pathogenesis of schistosomiasis. Herein we show that cholesteryl ester uptake is selective from HDL, and identified CD36-related protein (CD36RP) as a candidate to mediate the reaction. CD36RP was cloned from the adult and the egg developmental stages of S. japonicum, with 1880 bp encoding 506 amino acid residues exhibiting the CD36 domains and two transmembrane regions. Using antibodies against recombinant peptides representing the potential extracellular domains of CD36RP, Western blotting detected a protein with a molecular mass of 82 kDa in the particulate fraction of the adult parasite cells, which was reduced to 62 kDa after N-glycanase treatment. The extracellular domain peptide bound human HDL, as established by immunoblots following nondenaturing gel electrophoresis. Antibodies against the extracellular domain suppressed HDL cholesteryl ester uptake and maturation of the eggs in vitro. CD36RP is a candidate receptor on eggs of S. japonicum that facilitates uptake of HDL cholesteryl ester necessary for egg embryonation and maturation.-Okumura-Noji, K., Miura, Y., Lu, R., Asai, K., Ohta, N., Brindley, P. J., Yokoyama, S. CD36-related protein in Schistosoma japonicum: candidate mediator of selective cholesteryl ester uptake from high-density lipoprotein for egg maturation. FASEB J. 27, 1236-1244 (2013). www.fasebj.org	[Okumura-Noji, Kuniko; Lu, Rui; Yokoyama, Shinji] Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 4878501, Japan; [Okumura-Noji, Kuniko; Lu, Rui; Yokoyama, Shinji] Chubu Univ, Dept Food & Nutr Sci, Kasugai, Aichi 4878501, Japan; [Okumura-Noji, Kuniko; Yokoyama, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem, Nagoya, Aichi, Japan; [Miura, Yutaka; Asai, Kiyofumi] Nagoya City Univ, Grad Sch Med Sci, Dept Neurosci, Nagoya, Aichi, Japan; [Ohta, Nobuo] Nagoya City Univ, Grad Sch Med Sci, Dept Parasitol, Nagoya, Aichi, Japan; [Ohta, Nobuo] Tokyo Med & Dent Univ, Dept Environm Parasitol, Tokyo, Japan; [Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA	Chubu University; Chubu University; Nagoya City University; Nagoya City University; Nagoya City University; Tokyo Medical & Dental University (TMDU); George Washington University	Yokoyama, S (corresponding author), Chubu Univ, Nutr Hlth Sci Res Ctr, Kasugai, Aichi 4878501, Japan.	syokoyam@med.nagoya-cu.ac.jp	Asai, Kiyofumi/H-2356-2014	Asai, Kiyofumi/0000-0001-7015-2251; Brindley, Paul J./0000-0003-1765-0002	MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Japan)	MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Japan)	This work was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Japan).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; BISGAIER CL, 1991, J LIPID RES, V32, P21; Chiba H, 1997, J LIPID RES, V38, P1204; EISENBERG S, 1972, BIOCHIM BIOPHYS ACTA, V260, P329, DOI 10.1016/0005-2760(72)90045-8; Fan J., 2003, INT J BIOCHEM CELL B, V1507, P1; Fan JJ, 1998, BIOCHEM BIOPH RES CO, V252, P348, DOI 10.1006/bbrc.1998.9491; FURLONG ST, 1995, J LIPID RES, V36, P1; Gray Darren J, 2011, BMJ, V342, pd2651, DOI 10.1136/bmj.d2651; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; HENIKOFF S, 1994, GENOMICS, V19, P97, DOI 10.1006/geno.1994.1018; HIRANO K, 1993, ATHEROSCLEROSIS, V100, P85, DOI 10.1016/0021-9150(93)90070-B; Hirano K, 1997, ARTERIOSCL THROM VAS, V17, P1053, DOI 10.1161/01.ATV.17.6.1053; Hui Shu-Ping, 1997, Hokkaido Journal of Medical Science, V72, P319; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; OHNISHI T, 1990, J LIPID RES, V31, P397; Okumura-Noji K, 2001, BIOCHEM BIOPH RES CO, V286, P305, DOI 10.1006/bbrc.2001.5386; OWHASHI M, 1981, INT ARCH ALLER A IMM, V64, P146; Rinaldi G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002820; ROGERS MV, 1990, MOL BIOCHEM PARASIT, V41, P93, DOI 10.1016/0166-6851(90)90100-Z; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Rost B, 1996, METHOD ENZYMOL, V266, P525; Shao HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002871; Song GJ, 1997, MOL CELLS, V7, P615; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Wynn TA, 2004, IMMUNOL REV, V201, P156, DOI 10.1111/j.0105-2896.2004.00176.x; XU XF, 1992, EUR J CELL BIOL, V57, P229; Yang SH, 2010, MOL BIOCHEM PARASIT, V174, P109, DOI 10.1016/j.molbiopara.2010.07.007; Zhang R, 2000, Parasitol Int, V48, P232; Zhang RL, 2001, INFECT IMMUN, V69, P386, DOI 10.1128/IAI.69.1.386-391.2001	33	9	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2013	27	3					1236	1244		10.1096/fj.12-219816	http://dx.doi.org/10.1096/fj.12-219816			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23195036				2022-12-25	WOS:000315585200035
J	Goessweiner-Mohr, N; Grumet, L; Arends, K; Pavkov-Keller, T; Gruber, CC; Gruber, K; Birner-Gruenberger, R; Kropec-Huebner, A; Huebner, J; Grohmann, E; Keller, W				Goessweiner-Mohr, Nikolaus; Grumet, Lukas; Arends, Karsten; Pavkov-Keller, Tea; Gruber, Christian C.; Gruber, Karl; Birner-Gruenberger, Ruth; Kropec-Huebner, Andrea; Huebner, Johannes; Grohmann, Elisabeth; Keller, Walter			The 2.5 angstrom Structure of the Enterococcus Conjugation Protein TraM resembles VirB8 Type IV Secretion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUCELLA-SUIS; BACTERIAL CONJUGATION; MOLECULAR-DYNAMICS; PLASMID PIP501; COILED COILS; SYSTEM; PREDICTION; DOMAIN; SERVER; DIVERSITY	Conjugative plasmid transfer is the most important means of spreading antibiotic resistance and virulence genes among bacteria and therefore presents a serious threat to human health. The process requires direct cell-cell contact made possible by a multiprotein complex that spans cellular membranes and serves as a channel for macromolecular secretion. Thus far, well studied conjugative type IV secretion systems (T4SS) are of Gram-negative (G-) origin. Although many medically relevant pathogens (e.g., enterococci, staphylococci, and streptococci) are Gram-positive (G+), their conjugation systems have received little attention. This study provides structural information for the transfer protein TraM of the G+ broad host range Enterococcus conjugative plasmid pIP501. Immunolocalization demonstrated that the protein localizes to the cell wall. We then used opsonophagocytosis as a novel tool to verify that TraM was exposed on the cell surface. In these assays, antibodies generated to TraM recruited macrophages and enabled killing of pIP501 harboring Enteroccocus faecalis cells. The crystal structure of the C-terminal, surface-exposed domain of TraM was determined to 2.5 angstrom resolution. The structure, molecular dynamics, and cross-linking studies indicated that a TraM trimer acts as the biological unit. Despite the absence of sequence-based similarity, TraM unexpectedly displayed a fold similar to the T4SS VirB8 proteins from Agrobacterium tumefaciens and Brucella suis (G-) and to the transfer protein TcpC from Clostridium perfringens plasmid pCW3 (G+). Based on the alignments of secondary structure elements of VirB8-like proteins from mobile genetic elements and chromosomally encoded T4SS from G+ and G- bacteria, we propose a new classification scheme of VirB8-like proteins.	[Goessweiner-Mohr, Nikolaus; Grumet, Lukas; Gruber, Karl; Keller, Walter] Karl Franzens Univ Graz, Inst Mol Biosci, A-8010 Graz, Austria; [Arends, Karsten; Grohmann, Elisabeth] Tech Univ Berlin, D-10587 Berlin, Germany; [Arends, Karsten] Robert Koch Inst, D-13086 Berlin, Germany; [Pavkov-Keller, Tea; Gruber, Christian C.] Austrian Ctr Ind Biotechnol GmbH, A-8010 Graz, Austria; [Birner-Gruenberger, Ruth] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria; [Birner-Gruenberger, Ruth] Core Facil Mass Spectrometry, Med Res Ctr, A-8010 Graz, Austria; [Kropec-Huebner, Andrea; Huebner, Johannes; Grohmann, Elisabeth] Univ Med Ctr Freiburg, Div Infect Dis, D-79106 Freiburg, Germany	University of Graz; Technical University of Berlin; Robert Koch Institute; Austrian Centre of Industrial Biotechnology; Medical University of Graz; University of Freiburg	Keller, W (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci Struct Biol, Humboldtstr 50-3, A-8010 Graz, Austria.	walter.keller@uni-graz.at	Gruber, Christian C/B-3818-2011; Birner-Gruenberger, Ruth/X-9433-2019; Gruber, Karl/GPP-6706-2022; Keller, Walter/AAW-1501-2021; Pavkov-Keller, Tea/K-9234-2015; Birner-Gruenberger, Ruth/E-8623-2010	Birner-Gruenberger, Ruth/0000-0003-3950-0312; Gruber, Karl/0000-0002-3485-9740; Keller, Walter/0000-0002-2261-958X; Pavkov-Keller, Tea/0000-0001-7871-6680; Birner-Gruenberger, Ruth/0000-0003-3950-0312; Gruber, Christian/0000-0003-0214-449X; Grohmann, Elisabeth/0000-0003-3061-6490; Huebner, Johannes/0000-0003-1232-4646; Gossweiner-Mohr, Nikolaus/0000-0002-6572-5606	Austrian Science Fund [P19794, F4604]; Federal Ministry of Economy, Family and Youth; Federal Ministry of Traffic, Innovation and Technology; Styrian Business Promotion Agency SFG; Standortagentur Tirol; Technology Promotion Agency of the City of Vienna through the COMET Funding Program; European Union [LSHE-CT-2007-037410]	Austrian Science Fund(Austrian Science Fund (FWF)); Federal Ministry of Economy, Family and Youth; Federal Ministry of Traffic, Innovation and Technology; Styrian Business Promotion Agency SFG; Standortagentur Tirol; Technology Promotion Agency of the City of Vienna through the COMET Funding Program; European Union(European Commission)	This work was supported by Austrian Science Fund Projects P19794 and F4604.; Supported by the Federal Ministry of Economy, Family and Youth, the Federal Ministry of Traffic, Innovation and Technology, the Styrian Business Promotion Agency SFG, the Standortagentur Tirol, and The Technology Promotion Agency of the City of Vienna through the COMET Funding Program managed by the Austrian Research Promotion Agency FFG.; Supported by the European Union Sixth Framework Program LSHE-CT-2007-037410, Approaches to Control Multi-resistant Enterococci ACE.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Andrieux L, 2011, FEBS LETT, V585, P2431, DOI 10.1016/j.febslet.2011.07.004; Anezo C, 2003, J PHYS CHEM B, V107, P9424, DOI 10.1021/jp0348981; Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x; Bailey S, 2006, P NATL ACAD SCI USA, V103, P2582, DOI 10.1073/pnas.0511216103; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Burns DL, 2003, CURR OPIN MICROBIOL, V6, P29, DOI 10.1016/S1369-5274(02)00006-1; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Buttaro BA, 2000, J BACTERIOL, V182, P4926, DOI 10.1128/JB.182.17.4926-4933.2000; Cameron TA, 2012, CHEM BIOL, V19, P934, DOI 10.1016/j.chembiol.2012.08.002; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YQ, 2008, J BACTERIOL, V190, P3632, DOI 10.1128/JB.01999-07; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dror O, 2003, BIOINFORMATICS, V19, pi95, DOI 10.1093/bioinformatics/btg1012; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswar N., 2006, UNIT 2 9 COMP PROTIE; Feldman M, 2005, P NATL ACAD SCI USA, V102, P12206, DOI 10.1073/pnas.0501850102; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; Giraldo AMV, 2012, BIOCHEMISTRY-US, V51, P3881, DOI 10.1021/bi300298v; Gomis-Ruth FX, 2004, CURR PHARM DESIGN, V10, P1551, DOI 10.2174/1381612043384817; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; GURLEY WB, 1979, P NATL ACAD SCI USA, V76, P2828, DOI 10.1073/pnas.76.6.2828; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; Harrison E, 2012, TRENDS MICROBIOL, V20, P262, DOI 10.1016/j.tim.2012.04.003; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HORODNICEANU T, 1979, PLASMID, V2, P197, DOI 10.1016/0147-619X(79)90038-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kopec J, 2005, BIOCHEM J, V387, P401, DOI 10.1042/BJ20041178; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar RB, 2000, MOL MICROBIOL, V36, P608, DOI 10.1046/j.1365-2958.2000.01876.x; Kurenbach B, 2006, MICROBIOL-SGM, V152, P637, DOI 10.1099/mic.0.28468-0; Kurenbach BR, 2003, PLASMID, V50, P86, DOI 10.1016/S0147-619X(03)00044-1; Li M, 2011, MOL MICROBIOL, V79, P1670, DOI 10.1111/j.1365-2958.2011.07553.x; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mossey P, 2010, J BACTERIOL, V192, P2830, DOI 10.1128/JB.01331-09; Neves Petersen MT, 1997, METHOD ENZYMOL, V284, P130; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Parsons JA, 2007, J BACTERIOL, V189, P7782, DOI 10.1128/JB.00783-07; Porter CJ, 2012, MOL MICROBIOL, V83, P275, DOI 10.1111/j.1365-2958.2011.07930.x; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Savvides SN, 2003, EMBO J, V22, P1969, DOI 10.1093/emboj/cdg223; Schrodinger L., 2011, PYMOL MOL GRAPHICS S; Shen HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002399; Sivanesan D, 2010, BIOCHEMISTRY-US, V49, P4483, DOI 10.1021/bi902201y; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Smith MA, 2012, CHEM BIOL, V19, P1041, DOI 10.1016/j.chembiol.2012.07.007; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Steen JA, 2009, J BACTERIOL, V191, P2926, DOI 10.1128/JB.00032-09; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Thanassi DG, 2012, FEMS MICROBIOL REV, V36, P1046, DOI 10.1111/j.1574-6976.2012.00342.x; Theilacker C, 2012, J INFECT DIS, V205, P1076, DOI 10.1093/infdis/jis022; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wallden K, 2012, P NATL ACAD SCI USA, V109, P11348, DOI 10.1073/pnas.1201428109; Wallden K, 2010, CELL MICROBIOL, V12, P1203, DOI 10.1111/j.1462-5822.2010.01499.x; Williams JJ, 2008, CURR OPIN CHEM BIOL, V12, P389, DOI 10.1016/j.cbpa.2008.06.015; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yeo HJ, 2003, P NATL ACAD SCI USA, V100, P15947, DOI 10.1073/pnas.2535211100; Zechner EL, 2012, PHILOS T R SOC B, V367, P1073, DOI 10.1098/rstb.2011.0207	82	47	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2018	2028		10.1074/jbc.M112.428847	http://dx.doi.org/10.1074/jbc.M112.428847			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188825	Green Published, hybrid			2022-12-25	WOS:000313751400053
J	Maga, JA; Zhou, JH; Kambampati, R; Peng, S; Wang, X; Bohnsack, RN; Thomm, A; Golata, S; Tom, P; Dahms, NM; Byrne, BJ; LeBowitz, JH				Maga, John A.; Zhou, Jianghong; Kambampati, Ravi; Peng, Susan; Wang, Xu; Bohnsack, Richard N.; Thomm, Angela; Golata, Sarah; Tom, Peggy; Dahms, Nancy M.; Byrne, Barry J.; LeBowitz, Jonathan H.			Glycosylation-independent Lysosomal Targeting of Acid alpha-Glucosidase Enhances Muscle Glycogen Clearance in Pompe Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; II BINDING-SITE; ALGLUCOSIDASE ALPHA; MOUSE MODEL; INSULIN; STORAGE; RECOMBINANT; DISEASE; INFANTILE; ENZYME	We have used a peptide-based targeting system to improve lysosomal delivery of acid alpha-glucosidase (GAA), the enzyme deficient in patients with Pompe disease. Human GAA was fused to the glycosylation-independent lysosomal targeting (GILT) tag, which contains a portion of insulin-like growth factor II, to create an active, chimeric enzyme with high affinity for the cation-independent mannose 6-phosphate receptor. GILT-tagged GAA was taken up by L6 myoblasts about 25-fold more efficiently than was recombinant human GAA (rhGAA). Once delivered to the lysosome, the mature form of GILT-tagged-GAA was indistinguishable from rhGAA and persisted with a half-life indistinguishable from rhGAA. GILT-tagged GAA was significantly more effective than rhGAA in clearing glycogen from numerous skeletal muscle tissues in the Pompe mouse model. The GILT-tagged GAA enzyme may provide an improved enzyme replacement therapy for Pompe disease patients.	[Maga, John A.; Zhou, Jianghong; Kambampati, Ravi; Peng, Susan; Thomm, Angela; Golata, Sarah; Tom, Peggy; LeBowitz, Jonathan H.] ZyStor Therapeut, Milwaukee, WI 53226 USA; [Wang, Xu; Byrne, Barry J.] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA; [Bohnsack, Richard N.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	BioMarin Pharmaceutical Inc.; ZyStor Therapeutics, Inc.; State University System of Florida; University of Florida; Medical College of Wisconsin	LeBowitz, JH (corresponding author), BioMarin Pharmaceut Inc, 105 Digital Dr, Novato, CA 94949 USA.	jlebowitz@bmrn.com		Byrne, Barry J./0000-0002-7302-1756	BioMarin Pharmaceuticals Inc.; Advancing a Healthier Wisconsin program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667] Funding Source: NIH RePORTER	BioMarin Pharmaceuticals Inc.; Advancing a Healthier Wisconsin program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by ZyStor Therapeutics, Inc. (now BioMarin Pharmaceuticals Inc.).; The BIAcore 3000 instrument was purchased through a grant from the Advancing a Healthier Wisconsin program. The 129-GAA<SUP>-/-</SUP> Pompe mouse line used in these experiments was derived from the original strain kindly provided by Nina Raben. We thank Denise Cloutier for expert technical assistance with in vivo studies and Dr. Richard M. Bittman for statistical analysis. We also acknowledge the many thoughtful comments on the manuscript from colleagues at BioMarin.	Amalfitano A, 2001, GENET MED, V3, P132, DOI 10.1097/00125817-200103000-00008; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRAULKE T, 1989, EMBO J, V8, P681, DOI 10.1002/j.1460-2075.1989.tb03426.x; Bremel R. D., 2005, U. S. Patent, Patent No. 6852510; BROWN BI, 1970, BIOCHEMISTRY-US, V9, P1423, DOI 10.1021/bi00808a017; CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P574, DOI 10.1016/0003-9861(85)90727-1; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Garmroudi F, 1996, MOL ENDOCRINOL, V10, P642, DOI 10.1210/me.10.6.642; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Hirschhorn R., 2001, METABOLIC MOL BASIS, P3389; KIESS W, 1989, J BIOL CHEM, V264, P4710; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; LeBowitz JH, 2004, P NATL ACAD SCI USA, V101, P3083, DOI 10.1073/pnas.0308728100; LEJEUNE N, 1963, BIOCHEM J, V86, P16, DOI 10.1042/bj0860016; Linnell J, 2001, J BIOL CHEM, V276, P23986, DOI 10.1074/jbc.M100700200; Mack GS, 2008, NAT BIOTECHNOL, V26, P1053, DOI [10.1038/nbt1008-1053, 10.1038/nbt0608-592]; McVie-Wylie AJ, 2008, MOL GENET METAB, V94, P448, DOI 10.1016/j.ymgme.2008.04.009; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; MYERS MG, 1994, J BIOL CHEM, V269, P28783; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nicolino M, 2009, GENET MED, V11, P210, DOI 10.1097/GIM.0b013e31819d0996; OSHIMA A, 1988, J BIOL CHEM, V263, P2553; Raben N, 2005, MOL THER, V11, P48, DOI 10.1016/j.ymthe.2004.09.017; Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022; Raben N, 1998, J BIOL CHEM, V273, P19086, DOI 10.1074/jbc.273.30.19086; REUSER AJJ, 1995, MUSCLE NERVE, pS61; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; TONG PY, 1988, J BIOL CHEM, V263, P2585; TONG PY, 1989, J BIOL CHEM, V264, P7970; Valenzano KJ, 1997, J BIOL CHEM, V272, P4804, DOI 10.1074/jbc.272.8.4804; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; VANDERPLOEG AT, 1991, J CLIN INVEST, V87, P513, DOI 10.1172/JCI115025; Villevalois-Cam L, 2000, J CELL BIOCHEM, V77, P310, DOI 10.1002/(SICI)1097-4644(20000501)77:2<310::AID-JCB13>3.0.CO;2-4; Winkel LPF, 2005, J NEUROL, V252, P875, DOI 10.1007/s00415-005-0922-9; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; Yang HW, 1998, PEDIATR RES, V43, P374, DOI 10.1203/00006450-199803000-00011; Zhu YX, 2009, MOL THER, V17, P954, DOI 10.1038/mt.2009.37; Zhu YX, 2005, BIOCHEM J, V389, P619, DOI 10.1042/BJ20050364	40	73	79	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1428	1438		10.1074/jbc.M112.438663	http://dx.doi.org/10.1074/jbc.M112.438663			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188827	hybrid, Green Published			2022-12-25	WOS:000313751400001
J	Wang, X; Xiong, LW; El Ayadi, A; Boehning, D; Putkey, JA				Wang, Xu; Xiong, Liang Wen; El Ayadi, Amina; Boehning, Darren; Putkey, John A.			The Calmodulin Regulator Protein, PEP-19, Sensitizes ATP-induced Ca2+ Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; CALCIUM-BINDING; NITRIC-OXIDE; CELL-DEATH; EXPRESSION; RC3/NEUROGRANIN; NEUROGRANIN; ACTIVATION; CHANNEL; KINASE	PEP-19 is a small, intrinsically disordered protein that binds to the C-domain of calmodulin (CaM) via an IQ motif and tunes its Ca2+ binding properties via an acidic sequence. We show here that the acidic sequence of PEP-19 has intrinsic Ca2+ binding activity, which may modulate Ca2+ binding to CaM by stabilizing an initial Ca2+-CaM complex or by electrostatically steering Ca2+ to and from CaM. Because PEP-19 is expressed in cells that exhibit highly active Ca2+ dynamics, we tested the hypothesis that it influences ligand-dependent Ca2+ release. We show that PEP-19 increases the sensitivity of HeLa cells to ATP-induced Ca2+ release to greatly increase the percentage of cells responding to sub-saturating doses of ATP and increases the frequency of Ca2+ oscillations. Mutations in the acidic sequence of PEP-19 that inhibit or prevent it from modulating Ca2+ binding to CaM greatly inhibit its effect on ATP-induced Ca2+ release. Thus, this cellular effect of PEP-19 does not depend simply on binding to CaM via the IQ motif but requires its acidic metal binding domain. Tuning the activities of Ca2+ mobilization pathways places PEP-19 at the top of CaM signaling cascades, with great potential to exert broad effects on downstream CaM targets, thus expanding the biological significance of this small regulator of CaM signaling.	[Wang, Xu; Xiong, Liang Wen; Putkey, John A.] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wang, Xu; Xiong, Liang Wen; Putkey, John A.] Univ Texas Houston, Sch Med, Struct Biol Imaging Ctr, Houston, TX USA; [El Ayadi, Amina; Boehning, Darren] Univ Texas Med Branch, Dept Neurosci & Cell & Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston	Putkey, JA (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, 6431 Fannin St, Houston, TX 77030 USA.	john.putkey@uth.tmc.edu	Boehning, Darren/I-8539-2015	Boehning, Darren/0000-0001-7920-6922; Wang, Xu/0000-0002-8266-098X	National Institutes of Health [GM081685, GM081685-03S1, GM06961109]; W. M. Keck Center for Interdisciplinary Biosciences [R90 DK071504]; American Heart Association [10POST3110010, GRNT2280427]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Center for Interdisciplinary Biosciences; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081685 and GM081685-03S1 (to D. B.) and GM06961109 (to J. A. P.). This work was also supported by Fellowships R90 DK071504 from the W. M. Keck Center for Interdisciplinary Biosciences, 10POST3110010 from the American Heart Association (to X. W.), and GRNT2280427 from the American Heart Association (to J. A. P.).	ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Carafoli E, 1987, Soc Gen Physiol Ser, V42, P21; Devireddy LR, 2003, MOL CELL BIOL, V23, P4532, DOI 10.1128/MCB.23.13.4532-4541.2003; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; Fallon JL, 2005, STRUCTURE, V13, P1881, DOI 10.1016/j.str.2005.09.021; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; GERENDASY DD, 1994, J BIOL CHEM, V269, P22420; Gerendasy DD, 1997, MOL NEUROBIOL, V15, P131, DOI 10.1007/BF02740632; Glynne R, 2000, IMMUNOL REV, V176, P216; Gui JG, 2007, INT J BIOL SCI, V3, P212; Harashima S, 2011, J NEUROSCI RES, V89, P1519, DOI 10.1002/jnr.22688; Hartmann J, 2005, CELL CALCIUM, V37, P459, DOI 10.1016/j.ceca.2005.01.014; Iwamoto K, 2004, NEUROSCI RES, V49, P379, DOI 10.1016/j.neures.2004.04.002; Kanamori T, 2003, MOL HUM REPROD, V9, P709, DOI 10.1093/molehr/gag088; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kang S, 2011, FASEB J, V25, P840, DOI 10.1096/fj.10-160705; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; LINSE S, 1991, J BIOL CHEM, V266, P8050; MARTIN SR, 1990, BIOCHEMISTRY-US, V29, P4188, DOI 10.1021/bi00469a023; McCullar JS, 2003, J BIOL CHEM, V278, P33708, DOI 10.1074/jbc.M301940200; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; Mouton-Liger F, 2011, J COMP NEUROL, V519, P2779, DOI 10.1002/cne.22651; Persechini A, 1996, J BIOL CHEM, V271, P62, DOI 10.1074/jbc.271.1.62; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Rakhilin SV, 2004, SCIENCE, V306, P698, DOI 10.1126/science.1099961; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Skold K, 2006, J PROTEOME RES, V5, P262, DOI 10.1021/pr050281f; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Stieren E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011992; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Utal AK, 1998, NEUROSCIENCE, V86, P1055, DOI 10.1016/S0306-4522(98)00130-4; van Dalen JJW, 2003, EUR J NEUROSCI, V18, P13, DOI 10.1046/j.1460-9568.2003.02720.x; Wang X, 2010, BIOCHEMISTRY-US, V49, P10287, DOI 10.1021/bi100500m; Wei P, 2011, MOL CELL BIOL, V31, P2838, DOI 10.1128/MCB.05208-11; Xie GX, 2007, J MOL BIOL, V366, P349, DOI 10.1016/j.jmb.2006.11.045; Xiong LW, 2010, J BIOL CHEM, V285, P8094, DOI 10.1074/jbc.M109.065243; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200; Yang W, 2003, J AM CHEM SOC, V125, P6165, DOI 10.1021/ja034724x; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; ZIAI MR, 1988, J NEUROCHEM, V51, P1771, DOI 10.1111/j.1471-4159.1988.tb01158.x	47	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2040	2048		10.1074/jbc.M112.411314	http://dx.doi.org/10.1074/jbc.M112.411314			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23204517	Green Published, hybrid			2022-12-25	WOS:000313751400055
J	Kosoff, R; Chow, HY; Radu, M; Chernoff, J				Kosoff, Rachelle; Chow, Hoi Yee; Radu, Maria; Chernoff, Jonathan			Pak2 Kinase Restrains Mast Cell Fc epsilon RI Receptor Signaling through Modulation of Rho Protein Guanine Nucleotide Exchange Factor (GEF) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE; PHOSPHORYLATION; LOCALIZATION; SECRETION; DEGRANULATION; MOBILIZATION; ACTIVATION; INHIBITOR; ADHESION; BINDING	p21-activated kinase-1 (Pak1) is a serine/threonine kinase that plays a key role in mediating antigen-stimulated extracellular calcium influx and degranulation in mast cells. Another isoform in this kinase family, Pak2, is expressed at very high levels in mast cells, but its function is unknown. Here we show that Pak2 loss in murine bone marrow-derived mast cells, unlike loss of Pak1, induces increased antigen-mediated adhesion, degranulation, and cytokine secretion without changes to extracellular calcium influx. This phenotype is associated with an increase in RhoA-GTPase signaling activity to downstream effectors, including myosin light chain and p38(MAPK), and is reversed upon treatment with a Rho-specific inhibitor. Pak2, but not Pak1, negatively regulates RhoA via phosphorylation of the guanine nucleotide exchange factor GEF-H1 at an inhibitory site, leading to increased GEF-H1 microtubule binding and loss of RhoA stimulation. These data suggest that Pak2 plays a unique inhibitory role in mast cell degranulation by down-regulating RhoA via GEF-H1.	[Kosoff, Rachelle] Univ Penn, Canc Biol Program, Philadelphia, PA 19104 USA; [Kosoff, Rachelle; Chow, Hoi Yee; Radu, Maria; Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA	University of Pennsylvania; Fox Chase Cancer Center	Chernoff, J (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Chernoff, Jonathan/I-7631-2014	Chernoff, Jonathan/0000-0002-4803-7836	National Institutes of Health [P30 CA006927, R01 CA58836, R01 CA098830]; American Asthma Foundation [08-0049]; state of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA058836, R01CA098830, P30CA006927, T32CA009035, R01CA142928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; state of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Celine DerMardirossian for anti-phospho-GEF-H1 antibodies and plasmid constructs and the Flow Cytometry Facility at Fox Chase for assistance with analysis of calcium signaling. The Fox Chase Cancer Center was supported by National Institutes of Health Grant P30 CA006927.; This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA58836 and R01 CA098830 (to J. C.). This work was also supported by American Asthma Foundation Grant 08-0049 and an appropriation from the state of Pennsylvania.	Allen JD, 2009, BLOOD, V113, P2695, DOI 10.1182/blood-2008-06-160861; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bright MD, 2009, CELL SIGNAL, V21, P1738, DOI 10.1016/j.cellsig.2009.07.005; Callow MG, 2005, J CELL SCI, V118, P1861, DOI 10.1242/jcs.02313; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; DASTYCH J, 1994, J IMMUNOL, V152, P213; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eswaran J, 2008, TRENDS BIOCHEM SCI, V33, P394, DOI 10.1016/j.tibs.2008.06.002; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gavet O, 1998, J CELL SCI, V111, P3333; Gibbs BF, 2002, J LEUKOCYTE BIOL, V72, P391; Guo CX, 2012, J MED CHEM, V55, P4728, DOI 10.1021/jm300204j; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Huang ZD, 2003, J BIOL CHEM, V278, P13101, DOI 10.1074/jbc.M212557200; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; McDaniel AS, 2008, BLOOD, V112, P4646, DOI 10.1182/blood-2008-04-155085; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Nishizumi H, 1997, J IMMUNOL, V158, P2350; Norman JC, 1996, MOL BIOL CELL, V7, P1429, DOI 10.1091/mbc.7.9.1429; PRICE LS, 1995, CURR BIOL, V5, P68, DOI 10.1016/S0960-9822(95)00018-2; Roig J, 1999, J BIOL CHEM, V274, P31119, DOI 10.1074/jbc.274.44.31119; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Staser K, 2013, EXP HEMATOL, V41, P56, DOI 10.1016/j.exphem.2012.10.001; Sullivan R, 1999, J BIOL CHEM, V274, P38140, DOI 10.1074/jbc.274.53.38140; Tao J, 2011, MOL ENDOCRINOL, V25, P1565, DOI 10.1210/me.2011-0062; THOMPSON HL, 1993, CLIN EXP ALLERGY, V23, P270, DOI 10.1111/j.1365-2222.1993.tb00321.x; THOMPSON HL, 1990, J IMMUNOL, V145, P3425; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Yamahashi Y, 2011, J BIOL CHEM, V286, P44576, DOI 10.1074/jbc.M111.267021; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200	42	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					974	983		10.1074/jbc.M112.422295	http://dx.doi.org/10.1074/jbc.M112.422295			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204526	Green Published, hybrid			2022-12-25	WOS:000313570300022
J	Van der Meeren, R; Wen, YR; Van Gelder, P; Tommassen, J; Devreese, B; Savvides, SN				Van der Meeren, Ruben; Wen, Yurong; Van Gelder, Patrick; Tommassen, Jan; Devreese, Bart; Savvides, Savvas N.			New Insights into the Assembly of Bacterial Secretins STRUCTURAL STUDIES OF THE PERIPLASMIC DOMAIN OF XcpQ FROM PSEUDOMONAS AERUGINOSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION; PROTEIN-TRANSPORT; OLIGOMERIC RINGS; TERMINAL DOMAIN; OUTER-MEMBRANE; CHOLERA-TOXIN; ELASTASE; BINDING; SYSTEMS; GSPD	The type II secretion system is a multiprotein assembly spanning the inner and outer membranes in Gram-negative bacteria. It is found in almost all pathogenic bacteria where it contributes to virulence, host tissue colonization, and infection. The exoproteins are secreted across the outer membrane via a large translocation channel, the secretin, which typically adopts a dodecameric structure. These secretin channels have large periplasmic N-terminal domains that reach out into the periplasm for communication with the inner membrane platform and with a pseudopilus structure that spans the periplasm. Here we report the crystal structure of the N-terminal periplasmic domain of the secretin XcpQ from Pseudomonas aeruginosa, revealing a two-lobe dimeric assembly featuring parallel subunits engaging in well defined interactions at the tips of each lobe. We have employed structure-based engineering of disulfide bridges and native mass spectrometry to show that the periplasmic domain of XcpQ dimerizes in a concentration-dependent manner. Validation of these insights in the context of cellular full-length XcpQ and further evaluation of the functionality of disulfide-linked XcpQ establishes that the basic oligomerization unit of XcpQ is a dimer. This is consistent with the notion that the dodecameric secretin assembles as a hexamer of dimers to ensure correct projection of the N-terminal domains into the periplasm. Therefore, our studies provide a key conceptual advancement in understanding the assembly principles and dynamic function of type II secretion system secretins and challenge recent studies reporting monomers as the basic subunit of the secretin oligomer.	[Van der Meeren, Ruben; Van Gelder, Patrick; Savvides, Savvas N.] Univ Ghent, Unit Struct Biol, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Wen, Yurong; Devreese, Bart] Univ Ghent, Unit Biol Mass Spectrometry & Prote, Lab Prot Biochem & Biomol Engn, B-9000 Ghent, Belgium; [Tommassen, Jan] Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands; [Tommassen, Jan] Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Ghent University; Ghent University; Utrecht University; Utrecht University	Savvides, SN (corresponding author), Univ Ghent, Unit Struct Biol, Lab Prot Biochem & Biomol Engn, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	savvas.savvides@ugent.be	Devreese, Bart/K-2841-2019; Tommassen, Jan/I-1690-2016; Wen, Yurong/E-3277-2013; Devreese, Bart/B-2011-2009	Devreese, Bart/0000-0002-9764-2581; Tommassen, Jan/0000-0001-7633-4945; Wen, Yurong/0000-0001-8730-5197; Devreese, Bart/0000-0002-9764-2581; Van Gelder, Patrick/0000-0003-1785-4435	Ghent University (Bijzonder Onderzoeksfonds-Geconcentreerde Onderzoeksactie instrument); Hercules Foundation [AUGE019]; BELSPO IAP Grant iPROS [P7/44]; European Commission under the 7th Framework Programme: Research Infrastructures [226716]; CSC bilateral fellowship Ghent University	Ghent University (Bijzonder Onderzoeksfonds-Geconcentreerde Onderzoeksactie instrument); Hercules Foundation; BELSPO IAP Grant iPROS; European Commission under the 7th Framework Programme: Research Infrastructures; CSC bilateral fellowship Ghent University	This work was supported by grants from Ghent University (Bijzonder Onderzoeksfonds-Geconcentreerde Onderzoeksactie instrument and co-funding to the Chinese Scholarship Council grant), Hercules Foundation Grant AUGE019, and BELSPO IAP Grant iPROS, P7/44, and Grant Agreement Number 226716 from the European Commission under the 7th Framework Programme: Research Infrastructures.; Recipient of a CSC bilateral fellowship Ghent University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALEXEYEV MF, 1995, GENE, V160, P63, DOI 10.1016/0378-1119(95)00108-I; [Anonymous], PYMOL MOL GRAPHICS S; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Douzi B, 2011, J BIOL CHEM, V286, P40792, DOI 10.1074/jbc.M111.294843; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filloux A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00155; GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Gu S, 2012, J BIOL CHEM, V287, P9072, DOI 10.1074/jbc.M111.300624; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Indu S, 2011, PROTEINS, V79, P244, DOI 10.1002/prot.22878; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, TRENDS BIOCHEM SCI, V36, P433, DOI 10.1016/j.tibs.2011.04.002; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Krissinel E, 2011, ACTA CRYSTALLOGR D, V67, P376, DOI 10.1107/S0907444911007232; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; LAZDUNSKI A, 1990, BIOCHIMIE, V72, P147, DOI 10.1016/0300-9084(90)90140-C; Lieberman JA, 2012, J BACTERIOL, V194, P1646, DOI 10.1128/JB.06330-11; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reichow SL, 2011, CHANNELS, V5, P215, DOI 10.4161/chan.5.3.15268; Reichow SL, 2010, NAT STRUCT MOL BIOL, V17, P1226, DOI 10.1038/nsmb.1910; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Wang XH, 2012, J BIOL CHEM, V287, P19082, DOI 10.1074/jbc.M112.346338; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; WERB Z, 1975, J EXP MED, V142, P361, DOI 10.1084/jem.142.2.361; WRETLIND B, 1984, J BACTERIOL, V158, P801, DOI 10.1128/JB.158.3.801-808.1984	39	24	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1214	1225		10.1074/jbc.M112.432096	http://dx.doi.org/10.1074/jbc.M112.432096			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188826	Green Published, hybrid			2022-12-25	WOS:000313570300042
J	Ting, HJ; Messing, J; Yasmin-Karim, S; Lee, YF				Ting, Huei-Ju; Messing, James; Yasmin-Karim, Sayeda; Lee, Yi-Fen			Identification of microRNA-98 as a Therapeutic Target Inhibiting Prostate Cancer Growth and a Biomarker Induced by Vitamin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-ALPHA,25-DIHYDROXYVITAMIN D-3 RESPONSIVENESS; 1,25-DIHYDROXYVITAMIN D-3; D-RECEPTOR; D ANALOG; CELLS; EXPRESSION; APOPTOSIS; PROLIFERATION; INDUCTION; CARCINOMA	The anti-tumor effect of vitamin D has been well recognized but its translational application is hindered by side effects induced by supra-physiological concentration of vitamin D required for cancer treatment. Thus, exploring the vitamin D tumor suppressive functional mechanism can facilitate improvement of its clinical application. We screened miRNA profiles in response to vitamin D and found that a tumor suppressive miRNA, miR-98, is transcriptionally induced by 1 alpha,25-dihydroxyvitamin D-3 (1,25-VD) in LNCaP. Mechanistic dissection revealed that 1,25-VD-induced miR-98 is mediated through both a direct mechanism, enhancing the VDR binding response element in the promoter region of miR-98, and an indirect mechanism, down-regulating LIN-28 expression. Knockdown of miR-98 led to a reduction of 1,25-VD anti-growth effect and overexpression of miR-98 suppressed the LNCaP cells growth via inducing G2/M arrest. And CCNJ, a protein controlling cell mitosis, is down-regulated by miR-98 via targeting 3'-untranslated region of CCNJ. Interestingly, miR-98 levels in blood are increased upon 1,25-VD treatment in mice suggesting the biomarker potential of miR-98 in predicting 1,25-VD response. Together, the finding that growth inhibitive miR-98 is induced by 1,25-VD provides a potential therapeutic target for prostate cancer and a potential biomarker for 1,25-VD anti-tumor action.	[Lee, Yi-Fen] Univ Rochester, Med Ctr, Dept Urol, Rochester, NY 14642 USA; [Yasmin-Karim, Sayeda] Univ Rochester, Dept Chem Engn, Rochester, NY 14642 USA; [Ting, Huei-Ju] Natl Univ Tainan, Dept Biol Sci & Technol, Tainan 70005, Taiwan	University of Rochester; University of Rochester; National University Tainan	Lee, YF (corresponding author), Univ Rochester, Med Ctr, Dept Urol, 601 Elmwood Ave,Box 656, Rochester, NY 14642 USA.	yifen_lee@urmc.rochester.edu		Ting, Huei-Ju/0000-0003-3709-5755				Alvarez-Diaz S, 2012, HUM MOL GENET, V21, P2157, DOI 10.1093/hmg/dds031; Bao BY, 2008, INT J CANCER, V122, P2699, DOI 10.1002/ijc.23460; Bao BY, 2006, CARCINOGENESIS, V27, P1883, DOI 10.1093/carcin/bgl041; Bao BY, 2010, J STEROID BIOCHEM, V120, P11, DOI 10.1016/j.jsbmb.2010.02.030; Bao BY, 2006, CARCINOGENESIS, V27, P32, DOI 10.1093/carcin/bgi170; Beer TM, 2008, CANCER, V112, P326, DOI 10.1002/cncr.23163; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Du LQ, 2009, MOL CANCER RES, V7, P1234, DOI 10.1158/1541-7786.MCR-08-0507; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Gocek E, 2011, CANCER RES, V71, P6230, DOI 10.1158/0008-5472.CAN-11-1717; Guzey M, 2002, MOL CANCER THER, V1, P667; Hansen CM, 2000, CURR PHARM DESIGN, V6, P803, DOI 10.2174/1381612003400371; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Heneghan HM, 2010, CURR OPIN PHARMACOL, V10, P543, DOI 10.1016/j.coph.2010.05.010; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Jensen SS, 2001, MOL ENDOCRINOL, V15, P1370, DOI 10.1210/me.15.8.1370; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; Jorde Rolf, 2012, BMC Res Notes, V5, P245, DOI 10.1186/1756-0500-5-245; Kawahara H, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199166; Kolonin MG, 2000, DEV BIOL, V227, P661, DOI 10.1006/dbio.2000.9916; Marchiani S, 2006, J CANCER RES CLIN, V132, P408, DOI 10.1007/s00432-006-0086-8; Mohri T, 2009, INT J CANCER, V125, P1328, DOI 10.1002/ijc.24459; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Polek TC, 2003, ENDOCRINOLOGY, V144, P50, DOI 10.1210/en.2001-210109; Spina CS, 2007, J STEROID BIOCHEM, V103, P757, DOI 10.1016/j.jsbmb.2006.12.040; Ting HJ, 2007, MOL CANCER RES, V5, P967, DOI 10.1158/1541-7786.MCR-06-0318; Ting HJ, 2012, CANCER RES, V72, P958, DOI 10.1158/0008-5472.CAN-11-0042; Trump DL, 2006, ANTICANCER RES, V26, P2551; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang QM, 1996, CANCER RES, V56, P264; Wang WLW, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-58; Ward A., 2012, ONCOGENE IN PRESS; Wouters MD, 2011, MUTAT RES-FUND MOL M, V717, P54, DOI 10.1016/j.mrfmmm.2011.03.012; Zhang LA, 2011, CELL STEM CELL, V8, P294, DOI 10.1016/j.stem.2011.01.014; Zhao YC, 2011, MOL MED, V17, P1233, DOI 10.2119/molmed.2010.00225	40	70	72	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					1	9		10.1074/jbc.M112.395947	http://dx.doi.org/10.1074/jbc.M112.395947			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23188821	hybrid, Green Published			2022-12-25	WOS:000313197200001
J	Campos, M; Peremans, K; Vandermeulen, E; Duchateau, L; Bosmans, T; Polis, I; Daminet, S				Campos, Miguel; Peremans, Kathelijne; Vandermeulen, Eva; Duchateau, Luc; Bosmans, Tim; Polis, Ingeborgh; Daminet, Sylvie			Effect of Recombinant Human Thyrotropin on the Uptake of Radioactive Iodine (I-123) in Dogs with Thyroid Tumors	PLOS ONE			English	Article							STIMULATING HORMONE; HUMAN TSH; RADIOIODINE THERAPY; MEDULLARY CARCINOMA; REMNANT ABLATION; HEALTHY BEAGLES; NODULAR GOITER; I-131; CANCER; TISSUE	In humans, recombinant human thyrotropin (rhTSH) enhances radioactive iodine uptake (RAIU) in patients with differentiated thyroid cancer. No studies have been performed in veterinary medicine to optimize radioiodine treatment of thyroid cancer. The aim of this study was to evaluate the effect of rhTSH on the uptake of radioiodine-123 (I-123) in dogs with thyroid tumors. Nine dogs with thyroid neoplasia were included in this prospective cross-over study. The dogs were divided in 2 groups. In one group, I-123 was administered for a baseline RAIU determination in week 1. In week 2 (after a washout period of 2 weeks), these dogs received rhTSH (100 mu g IV) 24 h before I-123 injection. In the other group the order of the protocol was reversed. For each scan, the dogs received 37 MBq (1 mCi) of I-123 intravenously (IV) and planar scintigraphy was performed after 8 and 24 h for tumor RAIU calculation. Overall, rhTSH administration caused no statistically significant change on thyroid tumor RAIU at 8 h (p = 0.89) or at 24 h (p = 0.98). A significant positive correlation was found between the effect of rhTSH on tumor 8h-RAIU and rhTSH serum concentrations at 6 h (tau = 0.68; p = 0.03), at 12 h (tau = 0.68; p = 0.03) and at 24 h (tau = 0.78; p = 0.02) after rhTSH injection. This study suggests that IV administration of 100 mg rhTSH 24 h before I-123 has an inconsistent effect on thyroid tumor RAIU. Further studies are necessary to determine the best protocol of rhTSH administration to optimize thyroid tumor RAIU.	[Campos, Miguel; Bosmans, Tim; Polis, Ingeborgh; Daminet, Sylvie] Univ Ghent, Dept Med & Clin Biol Small Anim, Fac Vet Med, Merelbeke, Belgium; [Peremans, Kathelijne; Vandermeulen, Eva] Univ Ghent, Dept Vet Med Imaging & Small Anim Orthoped, Fac Vet Med, Merelbeke, Belgium; [Duchateau, Luc] Univ Ghent, Dept Comparat Physiol & Biometr, Fac Vet Med, Merelbeke, Belgium	Ghent University; Ghent University; Ghent University	Campos, M (corresponding author), Univ Ghent, Dept Med & Clin Biol Small Anim, Fac Vet Med, Merelbeke, Belgium.	miguel.campos@ugent.be		Vandermeulen, Eva/0000-0001-9215-2869; Daminet, Sylvie/0000-0001-6733-7925	Department of Medicine and Clinical Biology of Small Animals of Ghent University, Belgium; Special Research Fund of Ghent University, Belgium [01J02510]; Dutch Cancer Foundation for Animals	Department of Medicine and Clinical Biology of Small Animals of Ghent University, Belgium; Special Research Fund of Ghent University, Belgium(Ghent University); Dutch Cancer Foundation for Animals	This study was funded by the Department of Medicine and Clinical Biology of Small Animals of Ghent University, Belgium; the Special Research Fund of Ghent University, Belgium (grant no 01J02510); and by the Dutch Cancer Foundation for Animals. The Dutch Cancer Foundation for Animals participated in the definition of the inclusion criteria. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WH, 1995, VET RADIOL ULTRASOUN, V36, P417, DOI 10.1111/j.1740-8261.1995.tb00288.x; Barber LG, 2007, VET CLIN N AM-SMALL, V37, P755, DOI 10.1016/j.cvsm.2007.03.008; Boretti FS, 2009, J VET INTERN MED, V23, P856, DOI 10.1111/j.1939-1676.2009.0336.x; Braga M, 2001, J CLIN ENDOCR METAB, V86, P5148, DOI 10.1210/jc.86.11.5148; Campos M, 2010, DOMEST ANIM ENDOCRIN, V39, P215, DOI 10.1016/j.domaniend.2010.05.003; Campos M, 2010, VET RADIOL ULTRASOUN, V51, P331, DOI 10.1111/j.1740-8261.2010.01665.x; Cubas ER, 2009, INT J CLIN PRACT, V63, P583, DOI 10.1111/j.1742-1241.2008.01904.x; Daminet S, 2007, CAN VET J, V48, P1273; De Roover K, 2006, J VET INTERN MED, V20, P812, DOI 10.1892/0891-6640(2006)20[812:EOSORR]2.0.CO;2; DERUBERTIS F, 1972, J CLIN INVEST, V51, P1109, DOI 10.1172/JCI106903; Feeney DA, 2007, VET CLIN N AM-SMALL, V37, P799, DOI 10.1016/j.cvsm.2007.03.005; Feldman E. C., 2004, CANINE FELINE ENDOCR; Frates MC, 2006, J CLIN ENDOCR METAB, V91, P3411, DOI 10.1210/jc.2006-0690; Greco DS, 2007, TXB VET PHYSL, P428; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Huysmans DA, 2000, J CLIN ENDOCR METAB, V85, P3592, DOI 10.1210/jc.85.10.3592; KANEKO J. J., 1959, JOUR AMER VET MED ASSOC, V135, P516; KIMURA H, 1992, EXP CELL RES, V203, P402, DOI 10.1016/0014-4827(92)90014-Y; Kogai T, 1997, ENDOCRINOLOGY, V138, P2227, DOI 10.1210/en.138.6.2227; Loar AS, 1986, CURRENT VET THERAPY, P1033; MARKS SL, 1994, J AM VET MED ASSOC, V204, P756; MICHAELS.SM, 1967, RADIAT RES, V30, P38, DOI 10.2307/3572032; Nieuwlaat WA, 2004, J NUCL MED, V45, P626; OHTA K, 1991, BIOCHEM BIOPH RES CO, V174, P1148, DOI 10.1016/0006-291X(91)91540-S; Owen L.N., 1980, TNM CLASSIFICATION T, pp46; Pacini F, 2005, EUR J ENDOCRINOL, V153, P651, DOI 10.1530/eje.1.02014; Panakova L, 2008, J VET INTERN MED, V22, P1144, DOI 10.1111/j.1939-1676.2008.0155.x; PARK HM, 1994, THYROID, V4, P49, DOI 10.1089/thy.1994.4.49; Park HM, 1997, THYROID, V7, P277, DOI 10.1089/thy.1997.7.277; PARTHASARATHY KL, 1980, CLIN NUCL MED, V5, P45, DOI 10.1097/00003072-198002000-00001; Pena S, 2006, J CLIN ENDOCR METAB, V91, P506, DOI 10.1210/jc.2005-1986; Pinilla M, 2009, VET RADIOL ULTRASOUN, V50, P224, DOI 10.1111/j.1740-8261.2009.01521.x; RASMUSSON B, 1982, EUR J NUCL MED, V7, P150, DOI 10.1007/BF00443920; Rawlins ML, 2004, CLIN CHEM, V50, P2338, DOI 10.1373/clinchem.2004.039156; Rijnberk A, 1971, THESIS U UTRECHT NET; Robbins RJ, 2006, THYROID, V16, P1121, DOI 10.1089/thy.2006.16.1121; Rosario PW, 2008, J NUCL MED, V49, P1776, DOI 10.2967/jnumed.108.050591; Sipos JA, 2008, MED MANAGEMENT THYRO, P237; Turrel JM, 2006, JAVMA-J AM VET MED A, V229, P542, DOI 10.2460/javma.229.4.542; van Hoek I, 2008, J VET INTERN MED, V22, P1340, DOI 10.1111/j.1939-1676.2008.0191.x; Vargas GE, 1999, J CLIN ENDOCR METAB, V84, P3867, DOI 10.1210/jc.84.11.3867; VERSCHUEREN CP, 1992, J ENDOCRINOL, V132, P461, DOI 10.1677/joe.0.1320461; WADELEUX PA, 1978, ENDOCRINOLOGY, V102, P889, DOI 10.1210/endo-102-3-889; Worth AJ, 2005, AUST VET J, V83, P208, DOI 10.1111/j.1751-0813.2005.tb11650.x; Wucherer KL, 2010, J AM ANIM HOSP ASSOC, V46, P249, DOI 10.5326/0460249	45	2	2	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50344	10.1371/journal.pone.0050344	http://dx.doi.org/10.1371/journal.pone.0050344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209716	Green Published, gold, Green Submitted			2022-12-25	WOS:000312104900041
J	Lewis, JJ; Chihota, VN; van der Meulen, M; Fourie, PB; Fielding, KL; Grant, AD; Dorman, SE; Churchyard, GJ				Lewis, James J.; Chihota, Violet N.; van der Meulen, Minty; Fourie, P. Bernard; Fielding, Katherine L.; Grant, Alison D.; Dorman, Susan E.; Churchyard, Gavin J.			"Proof-Of-Concept" Evaluation of an Automated Sputum Smear Microscopy System for Tuberculosis Diagnosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; CULTURE	Background: "TBDx" is an innovative smear microscopy system that automatically loads slides onto a microscope, focuses and digitally captures images and then classifies smears as positive or negative using computerised algorithms. Objectives: To determine the diagnostic accuracy of TBDx, using culture as the gold standard, and compare this to a microscopist's diagnostic performance. Methods: This study is nested within a cross-sectional study of tuberculosis suspects from South African gold mines. All tuberculosis suspects had one sputum sample collected, which was decontaminated prior to smear microscopy, liquid culture and organism identification. All slides were auramine-stained and then read by both a research microscopist and by TBDx using fluorescence microscopes, classifying slides based on the WHO classification standard of 100 fields of view (FoV) at 400 x magnification. Results: Of 981 specimens, 269 were culture positive for Mycobacterium tuberculosis (27.4%). TBDx had higher sensitivity than the microscopist (75.8% versus 52.8%, respectively), but markedly lower specificity (43.5% versus 98.6%, respectively). TBDx classified 520/981 smears (53.0%) as scanty positive. Hence, a proposed hybrid software/human approach that combined TBDx examination of all smears with microscopist re-examination of TBDx scanty smears was explored by replacing the "positive" result of slides with 1-9 AFB detected on TBDx with the microscopist's original reading. Compared to using the microscopist's original results for all 981 slides, this hybrid approach resulted in equivalent specificity, a slight reduction in sensitivity from 52.8% to 49.4% (difference of 3.3%; 95% confidence interval: 0.2%, 6.5%), and a reduction in the number of slides to be read by the microscopist by 47.0%. Discussion: Compared to a research microscopist, the hybrid software/human approach had similar specificity and positive predictive value, but sensitivity requires further improvement. Automated microscopy has the potential to substantially reduce the number of slides read by microscopists. Citation: Lewis JJ, Chihota VN, van der Meulen M, Fourie PB, Fielding KL, et al. (2012) "Proof-Of-Concept" Evaluation of an Automated Sputum Smear Microscopy System for Tuberculosis Diagnosis. PLoS ONE 7(11): e50173. doi:10.1371/journal.pone.0050173	[Lewis, James J.; Fielding, Katherine L.; Grant, Alison D.; Churchyard, Gavin J.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Lewis, James J.; Chihota, Violet N.; van der Meulen, Minty; Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Fourie, P. Bernard] Univ Pretoria, ZA-0002 Pretoria, South Africa; [Dorman, Susan E.] Johns Hopkins Univ, Baltimore, MD USA; [Churchyard, Gavin J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Pretoria; Johns Hopkins University; University of Witwatersrand	Lewis, JJ (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	james.lewis@lshtm.ac.uk	FOURIE, Bernard/AAX-3457-2020; Chihota, Violet/DWH-9372-2022; Lewis, James/F-6333-2013	FOURIE, Bernard/0000-0002-1630-3554; Lewis, James/0000-0002-8603-2761; Churchyard, Gavin/0000-0002-4269-3699; Chihota, Violet/0000-0003-1444-9266	Consortium to Respond Effectively to the AIDS TB Epidemic, United States; Bill and Melinda Gates Foundation; South African Mine Health and Safety Council; Foundation for Innovative New Diagnostics, Switzerland; National Institutes of Health (NIH)/National Institutes of Allergy and Infectious Diseases award [AI077486]; United Kingdom Department of Health; NIH Fogarty ICORTA TB/AIDS [5U2RTW007370, 5U2RTW007373]; Aurum Innova; National Union of Mineworkers, Solidarity and United Unions of South Africa; AngloGold Ashanti, Gold Fields and Harmony mining companies; South African Chamber of Mines; Mine Health and Safety Council; African government Department of Mineral Resources; African government Department of Health; African government Department of Labour; FOGARTY INTERNATIONAL CENTER [U2RTW007373, U2RTW007370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077486] Funding Source: NIH RePORTER; Medical Research Council [MR/K007467/1] Funding Source: researchfish; National Institute for Health Research [PHCS/03/01] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	Consortium to Respond Effectively to the AIDS TB Epidemic, United States; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); South African Mine Health and Safety Council; Foundation for Innovative New Diagnostics, Switzerland; National Institutes of Health (NIH)/National Institutes of Allergy and Infectious Diseases award; United Kingdom Department of Health; NIH Fogarty ICORTA TB/AIDS; Aurum Innova; National Union of Mineworkers, Solidarity and United Unions of South Africa; AngloGold Ashanti, Gold Fields and Harmony mining companies; South African Chamber of Mines; Mine Health and Safety Council; African government Department of Mineral Resources; African government Department of Health; African government Department of Labour; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors gratefully acknowledge funding from the Consortium to Respond Effectively to the AIDS TB Epidemic, United States, who received funding from the Bill and Melinda Gates Foundation; the South African Mine Health and Safety Council; the Foundation for Innovative New Diagnostics, Switzerland; National Institutes of Health (NIH)/National Institutes of Allergy and Infectious Diseases award #AI077486; United Kingdom Department of Health (Public Health Career Scientist award to AG); NIH Fogarty ICORTA TB/AIDS (grants 5U2RTW007370 and 5U2RTW007373 to VC). None of these funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Limited additional funding was provided by Aurum Innova, the for-profit arm of the Aurum Institute. Although several employees of the Aurum Institute are authors on this manuscript, no employees of Aurum Innova, nor shareholders in Aurum Innova, had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Several of the authors are employees of the Aurum Institute (including its CEO Gavin Churchyard), a not-for-profit South African company. Aurum Innova was a funder for this study and is the for-profit arm of the Aurum Institute. Aurum Innova is in a partnership with Signature Mapping Medical Sciences, Inc., Herndon, Virginia, United States of America to develop the automated microscopy system TBDx that is evaluated in this paper. As a result of this partnership, Aurum Innova would receive royalties from any sales of TBDx. None of the authors are employees of Aurum Innova and none of the authors have shares in Aurum Innova, but profits from Aurum Innova could be used for the Aurum Institute. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.; We thank the participants who consented to take part in this study. We also thank the many stakeholders for their support for the study to be implemented, particularly: the National Union of Mineworkers, Solidarity and United Unions of South Africa; AngloGold Ashanti, Gold Fields and Harmony mining companies; the South African Chamber of Mines; the Mine Health and Safety Council; and the South African government Departments of Mineral Resources, Health and Labour. We thank the large study team for their commitment and persistent efforts to ensure that the study was successfully implemented, as well as Gerrit Coetzee for his support and assistance with this study. We gratefully acknowledge funding from: the Consortium to Respond Effectively to the AIDS TB Epidemic, United States, who received funding from the Bill and Melinda Gates foundation; the South African Mine Health and Safety Council; the Foundation for Innovative New Diagnostics, Switzerland; National Institutes of Health/National Institutes of Allergy and Infectious Diseases award #AI077486; UK Department of Health (Public Health Career Scientist award to AG); NIH Fogarty ICORTA TB/AIDS (grants 5U2RTW007370 and 5U2RTW007373 to VC).	Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Dorman SE, 2012, J CLIN MICROBIOL, V50, P1189, DOI 10.1128/JCM.05723-11; Fielding KL, 2011, CONTEMP CLIN TRIALS, V32, P382, DOI 10.1016/j.cct.2010.12.008; Global TB Programme World Health Organization, WHOTB98258 GLOB TB P; Khutlang R, 2010, J MICROSC-OXFORD, V237, P96, DOI 10.1111/j.1365-2818.2009.03308.x; Muyoyeta M, 2009, INT J TUBERC LUNG D, V13, P460; Nguyen TNL, 1999, INT J TUBERC LUNG D, V3, P483; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Sadaphal R, 2008, INT J TUBERC LUNG D, V12, P579; Somoskovi A, 1999, INT J TUBERC LUNG D, V3, P354; Stop TB Department, 2011, AUTOMATED REAL TIME; Stop TB Department, 2011, GLOB TUB CONTR WHO R; Van Deun A, 2002, INT J TUBERC LUNG D, V6, P222; Veropoulos K, 1999, ANAL QUANT CYTOL, V21, P277	16	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50173	10.1371/journal.pone.0050173	http://dx.doi.org/10.1371/journal.pone.0050173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209666	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000312104900030
J	den Hartigh, LJ; Altman, R; Hutchinson, R; Petrlova, J; Budamagunta, MS; Tetali, SD; Lagerstedt, JO; Voss, JC; Rutledge, JC				den Hartigh, Laura J.; Altman, Robin; Hutchinson, Romobia; Petrlova, Jitka; Budamagunta, Madhu S.; Tetali, Sarada D.; Lagerstedt, Jens O.; Voss, John C.; Rutledge, John C.			Postprandial apoE Isoform and Conformational Changes Associated with VLDL Lipolysis Products Modulate Monocyte Inflammation	PLOS ONE			English	Article							TRIGLYCERIDE-RICH LIPOPROTEINS; LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-E STRUCTURE; FATTY-ACIDS; CYTOKINE RESPONSE; INTERFERON-GAMMA; GENE-EXPRESSION; MACROPHAGES; ACTIVATION; PLASMA	Objective: Postprandial hyperlipemia, characterized by increased circulating very low-density lipoproteins (VLDL) and circulating lipopolysaccharide (LPS), has been proposed as a mechanism of vascular injury. Our goal was to examine the interactions between postprandial lipoproteins, LPS, and apoE3 and apoE4 on monocyte activation. Methods and Results: We showed that apoE3 complexed to phospholipid vesicles attenuates LPS-induced THP-1 monocyte cytokine expression, while apoE4 increases expression. ELISA revealed that apoE3 binds to LPS with higher affinity than apoE4. Electron paramagnetic resonance (EPR) spectroscopy of site-directed spin labels placed on specific amino acids of apoE3 showed that LPS interferes with conformational changes normally associated with lipid binding. Specifically, compared to apoE4, apoE bearing the E3-like R112 -> Ser mutation displays increased self association when exposed to LPS, consistent with a stronger apoE3-LPS interaction. Additionally, lipolysis of fasting VLDL from normal human donors attenuated LPS-induced TNF alpha secretion from monocytes to a greater extent than postprandial VLDL, an effect partially reversed by blocking apoE. This effect was reproduced using fasting VLDL lipolysis products from e3/e3 donors, but not from e4/e4 subjects, suggesting that apoE3 on fasting VLDL prevents LPS-induced inflammation more readily than apoE4. Conclusion: Postprandial apoE isoform and conformational changes associated with VLDL dramatically modulate vascular inflammation.	[den Hartigh, Laura J.; Altman, Robin; Hutchinson, Romobia; Rutledge, John C.] Univ Calif Davis, Dept Internal Med, Div Cardiol, Davis, CA 95616 USA; [Altman, Robin; Petrlova, Jitka; Budamagunta, Madhu S.; Voss, John C.] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Petrlova, Jitka; Lagerstedt, Jens O.] Lund Univ, Dept Expt Med, Lund, Sweden; [Tetali, Sarada D.] Univ Hyderabad, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of California System; University of California Davis; University of California System; University of California Davis; Lund University; University of Hyderabad	den Hartigh, LJ (corresponding author), Univ Calif Davis, Dept Internal Med, Div Cardiol, Davis, CA 95616 USA.	ljdenhartigh@gmail.com	Lagerstedt, Jens/AAF-9567-2021; Budamagunta, Madhu S/C-4628-2011	Lagerstedt, Jens/0000-0002-4313-2666; Voss, John/0000-0001-9279-209X; Tetali, Sarada/0000-0002-1706-8066	Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research; NHLBI [HL055667]; Training Program in Biomolecular Technology at the University of California, Davis [T32- GM08799]; University of California, Davis Alzheimer's Disease Center [AG010129]; National Institute on Aging (NIA), a component of the NIH [AG029246]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, R01AG029246, R01AG039094] Funding Source: NIH RePORTER	Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Training Program in Biomolecular Technology at the University of California, Davis; University of California, Davis Alzheimer's Disease Center; National Institute on Aging (NIA), a component of the NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to acknowledge the Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research, NHLBI HL055667, and the Training Program in Biomolecular Technology (T32- GM08799) at the University of California, Davis for their financial support. This publication was also made possible by the University of California, Davis Alzheimer's Disease Center (grant AG010129) and grant AG029246 from the National Institute on Aging (NIA), a component of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour A, 2008, ARTERIOSCL THROM VAS, V28, P792, DOI 10.1161/ATVBAHA.107.159749; Bentley NM, 2002, BIOCHEM J, V366, P273, DOI 10.1042/BJ20020207; Berbee JFP, 2005, J ENDOTOXIN RES, V11, P97, DOI 10.1179/096805105X35215; Bharadwaj KG, 2010, J BIOL CHEM, V285, P37976, DOI 10.1074/jbc.M110.174458; Bjorkegren J, 1996, J LIPID RES, V37, P76; BRADLEY WA, 1994, J INTERN MED, V236, P33; Burdge GC, 2005, BRIT J NUTR, V93, P3, DOI 10.1079/BJN20041282; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; CAVAILLON JM, 1990, INFECT IMMUN, V58, P2375, DOI 10.1128/IAI.58.7.2375-2382.1990; Chan JW, 2005, ANAL CHEM, V77, P5870, DOI 10.1021/ac050692f; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; COHN JS, 1990, J CLIN INVEST, V85, P804, DOI 10.1172/JCI114507; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; den Hartigh LJ, 2010, J IMMUNOL, V184, P3927, DOI 10.4049/jimmunol.0903475; Eiselein L, 2007, AM J PHYSIOL-HEART C, V292, pH2745, DOI 10.1152/ajpheart.00686.2006; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; FEINGOLD KR, 1995, INFECT IMMUN, V63, P2041, DOI 10.1128/IAI.63.5.2041-2046.1995; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P34288, DOI 10.1074/jbc.M506044200; Hess JF, 2002, J BIOL CHEM, V277, P35516, DOI 10.1074/jbc.M206500200; Hyson DA, 2002, CLIN APPL THROMB-HEM, V8, P147, DOI 10.1177/107602960200800211; Hyson Dianne, 2003, Curr Atheroscler Rep, V5, P437, DOI 10.1007/s11883-003-0033-y; Jofro-Monseny L, 2007, BIOCHEM BIOPH RES CO, V357, P319, DOI 10.1016/j.bbrc.2007.03.150; Kota RS, 2006, BIOCHEM BIOPH RES CO, V342, P1137, DOI 10.1016/j.bbrc.2006.02.087; Kota RS, 2005, J BIOL CHEM, V280, P31076, DOI 10.1074/jbc.M412189200; MORLEY NH, 1974, LIPIDS, V9, P481, DOI 10.1007/BF02534275; Mullick AE, 2007, ARTERIOSCL THROM VAS, V27, P339, DOI 10.1161/01.ATV.0000253947.70438.99; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Ophir G, 2005, NEUROBIOL DIS, V20, P709, DOI 10.1016/j.nbd.2005.05.002; Petrlova J, 2011, PROTEINS, V79, P402, DOI 10.1002/prot.22891; Pham T, 2005, BIOCHEMISTRY-US, V44, P7577, DOI 10.1021/bi0472696; READ TE, 1995, J EXP MED, V182, P267, DOI 10.1084/jem.182.1.267; Reissig D, 2003, EUR J NUTR, V42, P224, DOI 10.1007/s00394-003-0408-4; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; Tetali SD, 2006, J LIPID RES, V47, P1358, DOI 10.1194/jlr.M500559-JLR200; Tetali SD, 2010, J LIPID RES, V51, P1273, DOI 10.1194/jlr.M000406; Tsoi LM, 2007, ARCH BIOCHEM BIOPHYS, V460, P33, DOI 10.1016/j.abb.2007.01.019; Vitek MP, 2009, NEUROBIOL AGING, V30, P1350, DOI 10.1016/j.neurobiolaging.2007.11.014; VITEK MP, 2007, NEUROBIOL AGING; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; WEISGRABER KH, 1990, J LIPID RES, V31, P1503; Weisgraber KH, 1996, FASEB J, V10, P1485, DOI 10.1096/fasebj.10.13.8940294; Zhang YH, 2007, BIOCHEMISTRY-US, V46, P10722, DOI 10.1021/bi700672v; Zhao GX, 2005, BIOCHEM BIOPH RES CO, V336, P909, DOI 10.1016/j.bbrc.2005.08.204; Zhu YJ, 2010, BIOCHEM J, V428, P47, DOI 10.1042/BJ20100016	47	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50513	10.1371/journal.pone.0050513	http://dx.doi.org/10.1371/journal.pone.0050513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	120QE	23209766	Green Published, gold, Green Submitted			2022-12-25	WOS:000317185400007
J	Kashiwakura, Y; Mimuro, J; Onishi, A; Iwamoto, M; Madoiwa, S; Fuchimoto, D; Suzuki, S; Suzuki, M; Sembon, S; Ishiwata, A; Yasumoto, A; Sakata, A; Ohmori, T; Hashimoto, M; Yazaki, S; Sakata, Y				Kashiwakura, Yuji; Mimuro, Jun; Onishi, Akira; Iwamoto, Masaki; Madoiwa, Seiji; Fuchimoto, Daiichiro; Suzuki, Shunichi; Suzuki, Misae; Sembon, Shoichiro; Ishiwata, Akira; Yasumoto, Atsushi; Sakata, Asuka; Ohmori, Tsukasa; Hashimoto, Michiko; Yazaki, Satoko; Sakata, Yoichi			Porcine Model of Hemophilia A	PLOS ONE			English	Article							FACTOR-VIII GENE; CELL NUCLEAR TRANSFER; COAGULATION SYSTEMS; PIGS; EXPRESSION; THERAPY; LIVER; DISRUPTION; INHIBITORS; GENOMICS	Hemophilia A is a common X chromosome-linked genetic bleeding disorder caused by abnormalities in the coagulation factor VIII gene (F8). Hemophilia A patients suffer from a bleeding diathesis, such as life-threatening bleeding in the brain and harmful bleeding in joints and muscles. Because it could potentially be cured by gene therapy, subhuman animal models have been sought. Current mouse hemophilia A models generated by gene targeting of the F8 have difficulties to extrapolate human disease due to differences in the coagulation and immune systems between mice and humans. Here, we generated a porcine model of hemophilia A by nuclear transfer cloning from F8-targeted fibroblasts. The hemophilia A pigs showed a severe bleeding tendency upon birth, similar to human severe hemophiliacs, but in contrast to hemophilia A mice which rarely bleed under standard breed conditions. Infusion of human factor VIII was effective in stopping bleeding and reducing the bleeding frequency of a hemophilia A piglet but was blocked by the inhibitor against human factor VIII. These data suggest that the hemophilia A pig is a severe hemophilia A animal model for studying not only hemophilia A gene therapy but also the next generation recombinant coagulation factors, such as recombinant factor VIII variants with a slower clearance rate.	[Kashiwakura, Yuji; Mimuro, Jun; Madoiwa, Seiji; Ishiwata, Akira; Yasumoto, Atsushi; Sakata, Asuka; Ohmori, Tsukasa; Sakata, Yoichi] Jichi Med Univ, Ctr Mol Med, Res Div Cell & Mol Med, Shimotsuke, Tochigi, Japan; [Onishi, Akira; Iwamoto, Masaki; Fuchimoto, Daiichiro; Suzuki, Shunichi; Suzuki, Misae; Sembon, Shoichiro] Natl Inst Agrobiol Sci, Transgen Anim Res Ctr, Tsukuba, Ibaraki, Japan; [Iwamoto, Masaki; Hashimoto, Michiko; Yazaki, Satoko] Prime Tech Ltd, Adv Technol Dev Team, Tsuchiura, Ibaraki, Japan	Jichi Medical University; National Institute of Agrobiological Sciences - Japan	Mimuro, J (corresponding author), Jichi Med Univ, Ctr Mol Med, Res Div Cell & Mol Med, Shimotsuke, Tochigi, Japan.	mimuro-j@jichi.ac.jp		Kashiwakura, Yuji/0000-0003-0585-3937; OHMORI, TSUKASA/0000-0001-5082-6394	Strategic Research Infrastructure from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Health, Labour and Science Research Grants for Research on HIV/AIDS and Research on Intractable Diseases from the Japanese Ministry of Health, Labour and Welfare;  [20591155];  [21591249];  [21790920]	Strategic Research Infrastructure from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Health, Labour and Science Research Grants for Research on HIV/AIDS and Research on Intractable Diseases from the Japanese Ministry of Health, Labour and Welfare; ; ; 	This study was supported by Grants-in-Aid for Scientific Research (20591155, 21591249 and 21790920) and the Support Program for Strategic Research Infrastructure from the Japanese Ministry of Education, Culture, Sports, Science and Technology; and Health, Labour and Science Research Grants for Research on HIV/AIDS and Research on Intractable Diseases from the Japanese Ministry of Health, Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow RT, 2006, J THROMB HAEMOST, V4, P2223, DOI 10.1111/j.1538-7836.2006.02135.x; Bendixen E, 2010, BRIEF FUNCT GENOMICS, V9, P208, DOI 10.1093/bfgp/elq004; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Brown BD, 2004, BLOOD, V103, P804, DOI 10.1182/blood-2003-05-1426; Chen YN, 2009, BLOOD CELL MOL DIS, V43, P111, DOI 10.1016/j.bcmd.2009.02.004; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Cho SK, 2007, DEV DYNAM, V236, P3369, DOI 10.1002/dvdy.21308; Finn JD, 2010, BLOOD, V116, P5842, DOI 10.1182/blood-2010-06-288001; Hasbrouck NC, 2008, GENE THER, V15, P870, DOI 10.1038/gt.2008.71; Hickey RD, 2011, HEPATOLOGY; Ishiwata A, 2006, THROMB RES, V118, P627, DOI 10.1016/j.thromres.2005.11.006; Ishiwata A, 2009, J GENE MED, V11, P1020, DOI 10.1002/jgm.1391; Kim YJ, 2011, IN VITRO CELL DEV-AN, V47, P283, DOI 10.1007/s11626-011-9394-7; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307; MASSICOTTE P, 1986, PEDIATR RES, V20, P961, DOI 10.1203/00006450-198610000-00014; Morrison AE, 1991, AM J MED, V91, p23S; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Porada CD, 2010, J THROMB HAEMOST, V8, P276, DOI 10.1111/j.1538-7836.2009.03697.x; Powell JS, 2003, BLOOD, V102, P2038, DOI 10.1182/blood-2003-01-0167; ReverdiauMoalic P, 1996, TRANSPLANT P, V28, P643; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Roth DA, 2001, NEW ENGL J MED, V344, P1735, DOI 10.1056/NEJM200106073442301; Sabatino DE, 2009, BLOOD, V114, P4562, DOI 10.1182/blood-2009-05-220327; Shen CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032812; Shin T, 2002, NATURE, V415, P859, DOI 10.1038/nature723; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Tanaka H, 2009, J AM ASSOC LAB ANIM, V48, P33; Tian XC, 2009, REPROD FERT DEVELOP, V21, P60, DOI 10.1071/RD08214; Toschi V, 2010, CURR OPIN MOL THER, V12, P617; Umeyama K, 2009, TRANSGENIC RES, V18, P697, DOI 10.1007/s11248-009-9262-3; VandenDriessche T, 2003, J THROMB HAEMOST, V1, P1550, DOI 10.1046/j.1538-7836.2003.00265.x; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172	37	23	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49450	10.1371/journal.pone.0049450	http://dx.doi.org/10.1371/journal.pone.0049450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209578	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700014
J	Ramkissoon, S; Mwambi, HG; Matthews, AP				Ramkissoon, Santosh; Mwambi, Henry G.; Matthews, Alan P.			Modelling HIV and MTB Co-Infection Including Combined Treatment Strategies	PLOS ONE			English	Article							HUMAN IMMUNE-RESPONSE; MYCOBACTERIUM-TUBERCULOSIS; ANTIRETROVIRAL THERAPY; HUMAN INFECTION; DYNAMICS; MECHANISMS; CELLS; CHEMOTHERAPY; MACROPHAGES; HIV/AIDS	A new host-pathogen model is described that simulates HIV-MTB co-infection and treatment, with the objective of testing treatment strategies. The model includes CD4+ and CD8+ T cells, resting and activated macrophages, HIV and Mycobacterium tuberculosis (MTB). For TB presentation at various stages of HIV disease in a co-infected individual, combined treatment strategies were tested with different relative timings of treatment for each infection. The stages were early HIV disease, late HIV disease and AIDS. The main strategies were TB treatment followed by anti-retroviral therapy (ART) after delays of 15 days, 2 months and 6 months. ART followed by TB treatment was an additional strategy that was tested. Treatment was simulated with and without drug interaction. Simulation results were that TB treatment first followed by ART after a stage-dependent delay has the best outcome. During early HIV disease a 6 month delay is acceptable. During late HIV disease, a 2 month delay is best. During AIDS it is better to start ART after 15 days. However, drug interaction works against the benefits of early ART. These results agree with expert reviews and clinical trials.	[Ramkissoon, Santosh; Matthews, Alan P.] Univ KwaZulu Natal, Sch Chem & Phys, Phys Durban Acad Grp, Durban, South Africa; [Mwambi, Henry G.] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa	University of Kwazulu Natal; University of Kwazulu Natal	Matthews, AP (corresponding author), Univ KwaZulu Natal, Sch Chem & Phys, Phys Durban Acad Grp, Westville Campus, Durban, South Africa.	matthewsa@ukzn.ac.za	Mwambi, Henry/A-2444-2013		South African Centre for Epidemiological Modelling and Analysis; Medical Research Council of South Africa; NRF [UID 78894]	South African Centre for Epidemiological Modelling and Analysis; Medical Research Council of South Africa(South African Medical Research Council); NRF	SR received funding for MSc studies that formed the basis of this work, from the South African Centre for Epidemiological Modelling and Analysis, and the Medical Research Council of South Africa. Some of the work by APM was done as a Visiting Scientist at the Pasteur Institute, Paris, France, supported by a Knowledge Interchange and Collaboration travel grant from the NRF (UID 78894). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti JB, 2003, J GEN VIROL, V84, P1649, DOI 10.1099/vir.0.19110-0; Althaus CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016468; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Bauer AL, 2008, MATH MODEL NAT PHENO, V3, P229, DOI 10.1051/mmnp:2008051; Bhunu CP, 2009, ACTA BIOTHEOR, V57, P361, DOI 10.1007/s10441-009-9080-2; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Bru A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012985; Burman WJ, 2001, AM J RESP CRIT CARE, V164, P7, DOI 10.1164/ajrccm.164.1.2101133; Day J, 2009, P NATL ACAD SCI USA, V106, P11246, DOI 10.1073/pnas.0904846106; De Boer RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000906; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Duffin RP, 2002, J THEO MED, V4, P215, DOI [10.1080/1027366021000051772, DOI 10.1080/1027366021000051772]; Gammack D, 2005, MULTISCALE MODEL SIM, V3, P312, DOI 10.1137/040603127; Garira W., 2005, ELECT J DIFFERENTIAL, V52, P1; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Johnson LF, 2007, S AFR J SCI, V103, P135; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kirschner D, 2005, TRENDS MICROBIOL, V13, P206, DOI 10.1016/j.tim.2005.03.005; Kirschner D, 1996, B MATH BIOL, V58, P367, DOI 10.1007/BF02458312; Kirschner D, 1999, THEOR POPUL BIOL, V55, P94, DOI 10.1006/tpbi.1998.1382; Kirschner DE., 1997, J THEORETICAL MED, V1, P25, DOI DOI 10.1080/10273669708833004; Kwara A, 2005, INT J TUBERC LUNG D, V9, P248; Leclerc PM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005439; Magombedze G, 2008, J BIOL SYST, V16, P357, DOI 10.1142/S0218339008002551; Magombedze G, 2008, MATH BIOSCI ENG, V5, P485; Magombedze G, 2006, J BIOL SYST, V14, P509, DOI 10.1142/S0218339006001945; Magombedze G, 2006, MATH BIOSCI ENG, V3, P661; Magombedze G, 2009, INT J BIOMATH, V2, P69, DOI 10.1142/S1793524509000534; Magombedze G, 2010, MATH POPUL STUD, V17, P12, DOI 10.1080/08898480903467241; Marino S, 2004, J THEOR BIOL, V227, P463, DOI 10.1016/j.jtbi.2003.11.023; Marino S, 2007, PLOS COMPUT BIOL, V3, P1909, DOI 10.1371/journal.pcbi.0030194; Marino S, 2011, WIRES SYST BIOL MED, V3, P479, DOI 10.1002/wsbm.131; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Pearson JE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001058; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PERELSON AS, 1993, MATH BIOSCI, V114, P81, DOI 10.1016/0025-5564(93)90043-A; Piggott DA, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/103917; Rapin N, 2006, J BIOL PHYS, V32, P335, DOI 10.1007/s10867-006-9019-7; Rong LB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000533; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Shiri T, 2005, MATH BIOSCI ENG, V2, P811; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Toossi Z, 2003, J INFECT DIS, V188, P1146, DOI 10.1086/378676; Wick WD, 2005, J VIROL, V79, P13579, DOI 10.1128/JVI.79.21.13579-13586.2005; Wigginton JE, 2001, J IMMUNOL, V166, P1951, DOI 10.4049/jimmunol.166.3.1951; Witten GQ, 2004, S AFR J SCI, V100, P447; Wodarz D, 1999, J THEOR BIOL, V196, P101, DOI 10.1006/jtbi.1998.0816	52	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49492	10.1371/journal.pone.0049492	http://dx.doi.org/10.1371/journal.pone.0049492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209581	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700016
J	Shah, SHH; Kar, RK; Asmawi, AA; Rahman, MBA; Murad, AMA; Mahadi, NM; Basri, M; Rahman, RNZA; Salleh, AB; Chatterjee, S; Tejo, BA; Bhunia, A				Shah, Syed Hussinien H.; Kar, Rajiv K.; Asmawi, Azren A.; Rahman, Mohd Basyaruddin A.; Murad, Abdul Munir A.; Mahadi, Nor M.; Basri, Mahiran; Rahman, Raja Noor Zaliha A.; Salleh, Abu B.; Chatterjee, Subhrangsu; Tejo, Bimo A.; Bhunia, Anirban			Solution Structures, Dynamics, and Ice Growth Inhibitory Activity of Peptide Fragments Derived from an Antarctic Yeast Protein	PLOS ONE			English	Article							FLOUNDER ANTIFREEZE POLYPEPTIDE; WINTER FLOUNDER; I ANTIFREEZE; SEA RAVEN; ANTIMICROBIAL PEPTIDES; MOLECULAR-DYNAMICS; CHEMICAL-SHIFT; PSI-BLAST; BINDING; SEQUENCE	Exotic functions of antifreeze proteins (AFP) and antifreeze glycopeptides (AFGP) have recently been attracted with much interest to develop them as commercial products. AFPs and AFGPs inhibit ice crystal growth by lowering the water freezing point without changing the water melting point. Our group isolated the Antarctic yeast Glaciozyma antarctica that expresses antifreeze protein to assist it in its survival mechanism at sub-zero temperatures. The protein is unique and novel, indicated by its low sequence homology compared to those of other AFPs. We explore the structure-function relationship of G. antarctica AFP using various approaches ranging from protein structure prediction, peptide design and antifreeze activity assays, nuclear magnetic resonance (NMR) studies and molecular dynamics simulation. The predicted secondary structure of G. antarctica AFP shows several alpha-helices, assumed to be responsible for its antifreeze activity. We designed several peptide fragments derived from the amino acid sequences of alpha-helical regions of the parent AFP and they also showed substantial antifreeze activities, below that of the original AFP. The relationship between peptide structure and activity was explored by NMR spectroscopy and molecular dynamics simulation. NMR results show that the antifreeze activity of the peptides correlates with their helicity and geometrical straightforwardness. Furthermore, molecular dynamics simulation also suggests that the activity of the designed peptides can be explained in terms of the structural rigidity/flexibility, i.e., the most active peptide demonstrates higher structural stability, lower flexibility than that of the other peptides with lower activities, and of lower rigidity. This report represents the first detailed report of downsizing a yeast AFP into its peptide fragments with measurable antifreeze activities.	[Shah, Syed Hussinien H.; Asmawi, Azren A.; Rahman, Mohd Basyaruddin A.; Basri, Mahiran; Tejo, Bimo A.] Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia; [Kar, Rajiv K.; Chatterjee, Subhrangsu; Bhunia, Anirban] Bose Inst, Dept Biophys, Kolkata, W Bengal, India; [Murad, Abdul Munir A.; Mahadi, Nor M.; Salleh, Abu B.] Malaysia Genome Inst, Ukm Bangi, Selangor, Malaysia; [Rahman, Raja Noor Zaliha A.] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Department of Science & Technology (India); Bose Institute; Universiti Kebangsaan Malaysia; Universiti Putra Malaysia	Chatterjee, S (corresponding author), Bose Inst, Dept Biophys, Kolkata, W Bengal, India.	subhro_c@boseinst.ernet.in; bimotejo@science.upm.edu.my; bhunia@bic.boseinst.ernet.in	Rahman, Raja Noor Zaliha Raja Abd/I-5556-2019; Munir, Abdul/L-8575-2017; Murad, Abdul/CAG-9324-2022; Asmawi, Azren Aida/AAN-1609-2021; Tejo, Bimo A/I-2929-2012; Kar, Rajiv Kumar/O-5939-2018	Rahman, Raja Noor Zaliha Raja Abd/0000-0002-6316-6177; Munir, Abdul/0000-0001-6402-7198; Tejo, Bimo A/0000-0002-2890-0938; Kar, Rajiv Kumar/0000-0003-4629-5863; Bhunia, Anirban/0000-0002-8752-2842; Abdul Rahman, Mohd Basyaruddin/0000-0002-5665-2564	Ministry of Science, Technology, and Innovation of Malaysia [UKM-MGINBD0015-2007]; Council of Scientific and Industrial Research (CSIR), the Government of India [02(0005)/11/EMR-II]; Department of Science and Technology (DST), the Government of India	Ministry of Science, Technology, and Innovation of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Council of Scientific and Industrial Research (CSIR), the Government of India; Department of Science and Technology (DST), the Government of India(Department of Science & Technology (India))	BAT would like to thank the Ministry of Science, Technology, and Innovation of Malaysia for financial support to the Malaysia Genome Institute and Universiti Putra Malaysia (UKM-MGINBD0015-2007). AB and SC would like to thank the Director of the Bose Institute for providing the initial research support. AB thanks Council of Scientific and Industrial Research (CSIR), the Government of India for financial support (02(0005)/11/EMR-II). SC would like to thank Department of Science and Technology (DST), the Government of India for the Ramanujan Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Arora A, 2001, CURR OPIN STRUC BIOL, V11, P540, DOI 10.1016/S0959-440X(00)00246-3; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrett J, 2001, INT J BIOCHEM CELL B, V33, P105, DOI 10.1016/S1357-2725(00)00083-2; Bhunia A, 2012, BBA-BIOMEMBRANES, V1818, P1250, DOI 10.1016/j.bbamem.2012.01.008; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Bredenbeck J, 2005, P NATL ACAD SCI USA, V102, P2379, DOI 10.1073/pnas.0406948102; BrookeTaylor CA, 1996, CHEM PHYS, V204, P251, DOI 10.1016/0301-0104(95)00337-1; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; CHAKRABARTTY A, 1991, EUR J BIOCHEM, V202, P1057, DOI 10.1111/j.1432-1033.1991.tb16470.x; CHAKRABARTTY A, 1989, J BIOL CHEM, V264, P11313; CHAKRABARTTY A, 1989, J BIOL CHEM, V264, P11307; Chao H, 1996, PROTEIN SCI, V5, P1150; CHAO H, 1993, PROTEIN SCI, V2, P1411, DOI 10.1002/pro.5560020906; Chao HM, 1996, J EXP BIOL, V199, P2071; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davies PL, 1997, CURR OPIN STRUC BIOL, V7, P828, DOI 10.1016/S0959-440X(97)80154-6; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; DeLuca CI, 1996, BIOPHYS J, V71, P2346, DOI 10.1016/S0006-3495(96)79476-6; Deng GJ, 1997, FEBS LETT, V402, P17, DOI 10.1016/S0014-5793(96)01466-4; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; DUMAN JG, 1974, NATURE, V247, P237, DOI 10.1038/247237a0; DUMAN JG, 1993, CRYOBIOLOGY, V30, P322, DOI 10.1006/cryo.1993.1031; DUMAN JG, 1976, COMP BIOCHEM PHYS B, V54, P375, DOI 10.1016/0305-0491(76)90260-1; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; Ewart KV, 1999, CELL MOL LIFE SCI, V55, P271, DOI 10.1007/s000180050289; Fairley K, 2002, J BIOL CHEM, V277, P24073, DOI 10.1074/jbc.M200307200; Fan Y, 2002, PLANT CELL REP, V21, P296, DOI 10.1007/s00299-002-0495-3; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Garner J, 2007, ORG BIOMOL CHEM, V5, P3577, DOI 10.1039/b710425a; Garner J, 2010, CHEMBIOCHEM, V11, P2489, DOI 10.1002/cbic.201000509; Gilbert JA, 2004, MICROBIOL-SGM, V150, P171, DOI 10.1099/mic.0.26610-0; Goddard T.D., SPARKY 3; GRIFFITH M, 1995, BIOTECHNOL ADV, V13, P375, DOI 10.1016/0734-9750(95)02001-J; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hall DG, 1999, LANGMUIR, V15, P1905, DOI 10.1021/la980657m; Harding MM, 1999, EUR J BIOCHEM, V264, P653, DOI 10.1046/j.1432-1327.1999.00617.x; HARIS PI, 1995, BIOPOLYMERS, V37, P251, DOI 10.1002/bip.360370404; Haymet ADJ, 1999, J AM CHEM SOC, V121, P941, DOI 10.1021/ja9801341; HEW CL, 1985, EUR J BIOCHEM, V151, P167, DOI 10.1111/j.1432-1033.1985.tb09081.x; Hoshino T, 2003, CAN J BOT, V81, P1175, DOI [10.1139/b03-116, 10.1139/B03-116]; Houston ME, 1998, J BIOL CHEM, V273, P11714, DOI 10.1074/jbc.273.19.11714; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; JIA ZC, 1995, PROTEIN SCI, V4, P1236, DOI 10.1002/pro.5560040621; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KNIGHT CA, 1993, BIOPHYS J, V64, P252, DOI 10.1016/S0006-3495(93)81361-4; KNIGHT CA, 1988, CRYOBIOLOGY, V25, P55, DOI 10.1016/0011-2240(88)90020-X; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Koushafar H, 1997, J SURG ONCOL, V66, P114, DOI 10.1002/(SICI)1096-9098(199710)66:2<114::AID-JSO8>3.0.CO;2-G; Kun H, 2007, BIOPOLYMERS, V88, P807, DOI 10.1002/bip.20844; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JH, J BIOL CHEM IN PRESS; Liepinsh E, 2002, EUR J BIOCHEM, V269, P1259, DOI 10.1046/j.1432-1033.2002.02766.x; Liou YC, 2000, ACTA CRYSTALLOGR D, V56, P354, DOI 10.1107/S0907444999016844; Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095; NG NF, 1986, J BIOL CHEM, V261, P5690; NG NFL, 1992, J BIOL CHEM, V267, P16069; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; Park KS, 2010, B KOREAN CHEM SOC, V31, P3791, DOI 10.5012/bkcs.2010.31.12.3791; Ramamoorthy A, 2009, SOLID STATE NUCL MAG, V35, P201, DOI 10.1016/j.ssnmr.2009.03.003; Ritchie DW, 2008, BIOINFORMATICS, V24, P1865, DOI 10.1093/bioinformatics/btn334; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHOLANDER PF, 1957, J CELL COMPAR PHYSL, V49, P5, DOI 10.1002/jcp.1030490103; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; SLAUGHTER D, 1981, J BIOL CHEM, V256, P2022; Sonnichsen FD, 1996, STRUCTURE, V4, P1325, DOI 10.1016/S0969-2126(96)00140-2; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Turchetti B, 2011, EXTREMOPHILES, V15, P573, DOI 10.1007/s00792-011-0388-x; WEN DY, 1992, J BIOL CHEM, V267, P14102; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wishart DS, 1995, 1H 13C 15N RANDOM CO; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; Zhang W, 1998, J BIOL CHEM, V273, P34806, DOI 10.1074/jbc.273.52.34806	82	16	16	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49788	10.1371/journal.pone.0049788	http://dx.doi.org/10.1371/journal.pone.0049788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	120QE	23209600	Green Published, gold, Green Submitted			2022-12-25	WOS:000317185400003
J	Akena, D; Musisi, S; Joska, J; Stein, DJ				Akena, Dickens; Musisi, Seggane; Joska, John; Stein, Dan J.			The Association between Aids Related Stigma and Major Depressive Disorder among HIV-Positive Individuals in Uganda	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; CD4 CELL COUNT; CAPE-TOWN; SYMPTOMS; HIV/AIDS; INFECTION; WOMEN; DISCRIMINATION; PROGRESSION; VALIDATION	Background: Major depressive disorder in people living with HIV/AIDS (PLWHA) is common and may be associated with a number of factors, including AIDS-related stigma, decreased CD4 levels, increased opportunistic infections and sociodemographic variables. The extent to which AIDS-related stigma is associated with major depressive disorder among PLWHA has not been well studied in sub-Saharan Africa. The objective of this study was to examine the associations between major depressive disorder, AIDS-related stigma, immune status, and sociodemographic variables with the aim of making recommendations that can guide clinicians. Methods: We assessed 368 PLWHA for major depressive disorder, as well as for potentially associated factors, including AIDS-related stigma, CD4 levels, presence of opportunistic infections, and sociodemographic variables. Results: The prevalence of major depressive disorder was 17.4%, while 7.9% of the participants had AIDS related stigma. At multivariable analysis, major depressive disorder was significantly associated with AIDS-related stigma [OR = 1.65, CI (1.20-2.26)], a CD4 count of >= 200 [OR 0.52 CI (0.27-0.99)], and being of younger age [0.95, CI (0.92-0.98). Conclusions: Due to the high burden of major depressive disorder, and its association with AIDS related stigma, routine screening of PLWHA for both conditions is recommended. However, more research is required to understand this association.	[Akena, Dickens; Joska, John; Stein, Dan J.] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa; [Akena, Dickens; Musisi, Seggane] Makerere Univ, Dept Psychiat, Kampala, Uganda	University of Cape Town; Makerere University	Akena, D (corresponding author), Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa.	akenadickens@yahoo.co.uk	Stein, Dan/A-1752-2008	Stein, Dan/0000-0001-7218-7810; Joska, John/0000-0003-4260-1181	International Student Scholarship at the University of Cape Town(UCT); African Doctoral Dissertation Research Fellowship(ADDRF); African Doctoral Dissertation Fellowship	International Student Scholarship at the University of Cape Town(UCT); African Doctoral Dissertation Research Fellowship(ADDRF); African Doctoral Dissertation Fellowship	The study received funding from the International Student Scholarship at the University of Cape Town(UCT), and the African Doctoral Dissertation Research Fellowship(ADDRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr Akena was supported by the University of Cape Town (UCT) International Student's Scholarship and the African Doctoral Dissertation Fellowship.	Akena D, 2012, AIDS BEHAV, DOI [10.1007/s10461-10012-10267-10461, DOI 10.1007/S10461-10012-10267-10461]; Akena DH, 2010, AFR J PSYCHIATRY, V13, P43; Akhtar-Danesh Noori, 2007, Int J Ment Health Syst, V1, P4, DOI 10.1186/1752-4458-1-4; Ammassari A, 2004, PSYCHOSOMATICS, V45, P394, DOI 10.1176/appi.psy.45.5.394; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Bond V, 2002, EVAL PROGRAM PLANN, V25, P347, DOI 10.1016/S0149-7189(02)00046-0; Bouhnik AD, 2005, ANTIVIR THER, V10, P53; Bunmi OO, 2006, REV TREATMENT STUDIE, V14; BURACK JH, 1993, JAMA-J AM MED ASSOC, V270, P2568, DOI 10.1001/jama.270.21.2568; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Cook J.A, 2004, AM J PUBLIC HLTH, P94; Cruess DG, 2005, AM J PSYCHIAT, V162, P2125, DOI 10.1176/appi.ajp.162.11.2125; Dewa CS, 2011, CAN J PSYCHIAT, V56, P743, DOI 10.1177/070674371105601206; Evans DL, 2002, AM J PSYCHIAT, V159, P1752, DOI 10.1176/appi.ajp.159.10.1752; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Horberg MA, 2008, JAIDS-J ACQ IMM DEF, V47, P384, DOI 10.1097/QAI.0b013e318160d53e; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P1466, DOI 10.1001/jama.285.11.1466; Ickovics JR, 2001, JAMA-J AM MED ASSOC, V285, P146; Kaharuza FM, 2006, AIDS BEHAV, V10, pS105, DOI 10.1007/s10461-006-9142-2; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Kalichman SC, 2005, AIDS BEHAV, V9; Kinyanda E, 1998, S AFR MED J, V88, P1178; Kinyanda E, 2011, SOC PSYCH PSYCH EPID, V46, P35, DOI 10.1007/s00127-009-0164-8; Leserman J, 2000, AM J PSYCHIAT, V157, P1221, DOI 10.1176/appi.ajp.157.8.1221; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Lichenstein B, 2002, AIDS PATIENT CARE ST; Lichtenstein B, 2002, AIDS PATIENT CARE ST, V16, P27, DOI 10.1089/108729102753429370; MacQuarrie K., 2009, HIV RELATED STIGMA D; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Maling S, 2011, AIDS CARE, V23, P171, DOI 10.1080/09540121.2010.498939; Margaret M, 1992, NATURE PSYCHIAT DISO; Ministry of Health of Uganda, 2012, HIV AIDS SER BEH SUR; Ministry of Health of Uganda, 2005, PREL RES UG HIV AIDS; Mogga S, 2006, BRIT J PSYCHIAT, V189, P241, DOI 10.1192/bjp.bp.105.013417; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Murphy DA, 2006, WOMEN HLTH, V44; Nakasujja N, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-44; Nakimuli-Mpungu E., 2011, AIDS BEHAV, V15, P376, DOI [10.1007/s10461-010-9836-3, DOI 10.1007/S10461-010-9836-3]; Nakimuli-Mpungu E, 2011, NEUROBEHAV HIV MED, V3, P19, DOI DOI 10.2147/NBHIV.S13277; Nakimuli-Mpungu E, 2006, AM J PSYCHIAT, V163, P1349, DOI 10.1176/appi.ajp.163.8.1349; Olley BO, 2004, AIDS PATIENT CARE ST, V18, P481, DOI 10.1089/1087291041703700; RABKIN JG, 1991, ARCH GEN PSYCHIAT, V48, P111; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sherbourne CD, 2000, AM J PSYCHIAT, V157, P248, DOI 10.1176/appi.ajp.157.2.248; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Sorsdahl KR, 2011, INT J SOC PSYCHIAT, VXX, P1; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; STATA, 2011, STATA STAT DATA ANAL; Treisman G, 2007, CLIN INFECT DIS, V45, pS313, DOI 10.1086/522556	49	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e48671	10.1371/journal.pone.0048671	http://dx.doi.org/10.1371/journal.pone.0048671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048BS	23209556	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800006
J	Carvalho, AM; Goncalves, S				Carvalho, Alexsandro M.; Goncalves, Sebastian			Epidemics Scenarios in the "Romantic Network"	PLOS ONE			English	Article							SEXUAL NETWORKS; SPREAD; DYNAMICS; PARTNERSHIPS	The networks of sexual contacts together with temporal interactions play key roles in the spread of sexually transmitted infections. Unfortunately, data for this kind of network is scarce. One of the few exceptions, the "Romantic network", is a complete structure of a real sexual network in a high school. Based on many network measurements the authors of the work have concluded that it does not correspond to any other model network. Regarding the temporal structure, several studies indicate that relationship timing can have an effect on the diffusion throughout networks, as relationship order determines transmission routes. The aim is to check if the particular structure, static and dynamic, of the Romantic network is determinant for the propagation of an STI. We performed simulations in two scenarios: the static network where all contacts are available and the dynamic case where contacts evolve over time. In the static case, we compared the epidemic results in the Romantic network with some paradigmatic topologies. In the dynamic scenario, we considered the dynamics of formation of pairs in the Romantic network and we studied the propagation of the diseases. Our results suggest that although this real network cannot be labeled as a Watts-Strogatz network, it is, in regard to the propagation of an STI, very similar to a high disorder network. Additionally, we found that: the effect that any individual contacting an externally infected subject is to make the network closer to a fully connected one, the higher the contact degree of patient zero the faster the spread of the outbreaks, and the epidemic impact is proportional to the numbers of contacts per unit time. Finally, our simulations confirm that relationship timing severely reduced the final outbreak size, and also, show a clear correlation between the average degree and the outbreak size over time.	[Carvalho, Alexsandro M.; Goncalves, Sebastian] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil; [Carvalho, Alexsandro M.] Univ Caxias do Sul, Ctr Ciencias Exatas & Tecnol, Caxias Do Sul, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Caxias do Sul	Goncalves, S (corresponding author), Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil.	sgonc@if.ufrgs.br	Gonçalves, Sebastian/B-3753-2010; Gonçalves, Sebastián/I-4356-2013; goncalves, sebastian/AAN-5534-2020	Gonçalves, Sebastian/0000-0002-3100-9126; Gonçalves, Sebastián/0000-0002-3100-9126; goncalves, sebastian/0000-0002-3100-9126	Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES); Brazilian agency: Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) through CNPq-PROSUL [490440/2007]; Brazilian agency: Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) through PRONEX-CNPq/FAPERGS [10/0008]	Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian agency: Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) through CNPq-PROSUL; Brazilian agency: Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) through PRONEX-CNPq/FAPERGS	This work was supported by Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://www.cnpq.br/), Coordenacao de Aperfeicoamento de Pessoal de Nivel (CAPES) (http://www.capes.gov.br/) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) (http://www.fapergs.rs.gov.br/) through CNPq-PROSUL #490440/2007 and PRONEX-CNPq/FAPERGS #10/0008 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ALTMANN M, 1995, J MATH BIOL, V33, P661, DOI 10.1007/BF00298647; Bailey NTJ, 1975, MATH THEORY INFECT D; Bajardi P, 2011, PLOS ONE, V106; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bearman PS, 2004, AM J SOCIOL, V110, P44, DOI 10.1086/386272; Bernoulli D., 1766, MEM MATH PHYS ACAD R, p1?45; Doherty IA, 2011, CURR OPIN INFECT DIS, V24, P70, DOI 10.1097/QCO.0b013e3283422647; Erdos P, 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Foxman B, 2006, SEX TRANSM DIS, V33, P209, DOI 10.1097/01.olq.0000191318.95873.8a; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Hamer WH, 1906, LANCET, V1, P569; Helleringer S, 2007, AIDS, V21, P2323, DOI 10.1097/QAD.0b013e328285df98; Jones JH, 2003, P ROY SOC B-BIOL SCI, V270, P1123, DOI 10.1098/rspb.2003.2369; KERMACK WO, 1991, B MATH BIOL, V53, P33, DOI 10.1007/BF02464423; Krapivsky PL, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066123; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; MARSAGLIA G, 1990, STAT PROBABIL LETT, V9, P35, DOI 10.1016/0167-7152(90)90092-L; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Moody J, 2002, SOC FORCES, V81, P25, DOI 10.1353/sof.2002.0056; Moody J., JEFFERSON ROMANTIC T; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Murray J.D., 1993, MATH BIOL, V3rd; Newman MEJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021904; Nordvik MK, 2006, SEX TRANSM DIS, V33, P342, DOI 10.1097/01.olq.0000194601.25488.b8; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Risau-Gusman S, 2012, J R SOC INTERFACE, V9, P1363, DOI 10.1098/rsif.2011.0445; Rocha LEC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001109; Rocha LEC, 2010, P NATL ACAD SCI USA, V107, P5706, DOI 10.1073/pnas.0914080107; Volz E, 2007, P ROY SOC B-BIOL SCI, V274, P2925, DOI 10.1098/rspb.2007.1159; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	34	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49009	10.1371/journal.pone.0049009	http://dx.doi.org/10.1371/journal.pone.0049009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209561	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885800007
J	Sam, IC; Loong, SK; Michael, JC; Chua, CL; Sulaiman, WYW; Vythilingam, I; Chan, SY; Chiam, CW; Yeong, YS; AbuBakar, S; Chan, YF				Sam, I-Ching; Loong, Shih-Keng; Michael, Jasmine Chandramathi; Chua, Chong-Long; Sulaiman, Wan Yusoff Wan; Vythilingam, Indra; Chan, Shie-Yien; Chiam, Chun-Wei; Yeong, Yze-Shiuan; AbuBakar, Sazaly; Chan, Yoke-Fun			Genotypic and Phenotypic Characterization of Chikungunya Virus of Different Genotypes from Malaysia	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; INDIAN-OCEAN; INFECTION; AEGYPTI; SUSCEPTIBILITY; VECTORS; STRAINS; GLYCOPROTEIN; REPLICATION; REEMERGENCE	Background: Mosquito-borne Chikungunya virus (CHIKV) has recently re-emerged globally. The epidemic East/Central/South African (ECSA) strains have spread for the first time to Asia, which previously only had endemic Asian strains. In Malaysia, the ECSA strain caused an extensive nationwide outbreak in 2008, while the Asian strains only caused limited outbreaks prior to this. To gain insight into these observed epidemiological differences, we compared genotypic and phenotypic characteristics of CHIKV of Asian and ECSA genotypes isolated in Malaysia. Methods and Findings: CHIKV of Asian and ECSA genotypes were isolated from patients during outbreaks in Bagan Panchor in 2006, and Johor in 2008. Sequencing of the CHIKV strains revealed 96.8% amino acid similarity, including an unusual 7 residue deletion in the nsP3 protein of the Asian strain. CHIKV replication in cells and Aedes mosquitoes was measured by virus titration. There were no differences in mammalian cell lines. The ECSA strain reached significantly higher titres in Ae. albopictus cells (C6/36). Both CHIKV strains infected Ae. albopictus mosquitoes at a higher rate than Ae. aegypti, but when compared to each other, the ECSA strain had much higher midgut infection and replication, and salivary gland dissemination, while the Asian strain infected Ae. aegypti at higher rates. Conclusions: The greater ability of the ECSA strain to replicate in Ae. albopictus may explain why it spread far more quickly and extensively in humans in Malaysia than the Asian strain ever did, particularly in rural areas where Ae. albopictus predominates. Intergenotypic genetic differences were found at E1, E2, and nsP3 sites previously reported to be determinants of host adaptability in alphaviruses. Transmission of CHIKV in humans is influenced by virus strain and vector species, which has implications for regions with more than one circulating CHIKV genotype and Aedes species.	[Sam, I-Ching; Loong, Shih-Keng; Michael, Jasmine Chandramathi; Chua, Chong-Long; Chan, Shie-Yien; Chiam, Chun-Wei; AbuBakar, Sazaly; Chan, Yoke-Fun] Univ Malaya, Fac Med, Trop Infect Dis Res & Educ Ctr, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Sulaiman, Wan Yusoff Wan; Vythilingam, Indra; Yeong, Yze-Shiuan] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Sam, IC (corresponding author), Univ Malaya, Fac Med, Trop Infect Dis Res & Educ Ctr, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jicsam@ummc.edu.my	Chua, Chong Long/J-3028-2016; sulaiman, wan yusoff wan/C-1030-2010; abubakar, sazaly/B-3957-2010; Sam, Jamal I-Ching/B-8688-2010; Vythilingam, Indra/Q-5019-2016; Chan, Yoke Fun/B-5351-2010; Wan Sulaiman, Wan Yusoff/L-5295-2016; Loong, Shih Keng/G-5899-2015	Chua, Chong Long/0000-0002-8854-4955; abubakar, sazaly/0000-0002-9267-1420; Sam, Jamal I-Ching/0000-0002-1296-7898; Chan, Yoke Fun/0000-0001-7089-0510; Loong, Shih Keng/0000-0001-7511-860X	University Malaya [J-00000-73565, PS222/2010B]; Ministry of Higher Education, Malaysia [FP032/2010A]; European Union [261202]; MyBrain15 scheme of the Ministry of Higher Education, Malaysia; National Science Fellowship scheme of the Ministry of Science, Technology and Innovation, Malaysia	University Malaya(Universiti Malaya); Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); European Union(European Commission); MyBrain15 scheme of the Ministry of Higher Education, Malaysia; National Science Fellowship scheme of the Ministry of Science, Technology and Innovation, Malaysia	This study was funded by grants from University Malaya (J-00000-73565 and PS222/2010B), the Ministry of Higher Education, Malaysia (FP032/2010A), and the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement number 261202. SKL was supported by a University Malaya Fellowship. CLC was supported by the MyBrain15 scheme of the Ministry of Higher Education, Malaysia. SYC and CWC were supported by the National Science Fellowship scheme of the Ministry of Science, Technology and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617; Apandi Y, 2009, J GEN MOL VIROL, V1, P35; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279; Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214; Huang JH, 2009, EMERG INFECT DIS, V15, P1854, DOI 10.3201/eid1511.090398; Kumarasamy V, 2006, Med J Malaysia, V61, P221; Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447; LASTARZA MW, 1994, VIROLOGY, V202, P224, DOI 10.1006/viro.1994.1338; MARCHETTE N J, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P14; Martin Estelle, 2010, BMC Ecology, V10, P8, DOI 10.1186/1472-6785-10-8; Ng LC, 2009, EMERG INFECT DIS, V15, P1243, DOI 10.3201/eid1508.081486; Noridah O, 2007, Med J Malaysia, V62, P323; Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228; Pierro DJ, 2008, J VIROL, V82, P2966, DOI 10.1128/JVI.02060-07; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Raharimalala FN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-56; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rianthavorn P, 2010, INT J INFECT DIS, V14, pE161, DOI 10.1016/j.ijid.2010.01.001; ROSS R. W., 1956, JOUR HYG, V54, P177; Rozilawati H, 2011, INDIAN J MED RES, V133, P670; Sam IC, 2009, J CLIN VIROL, V46, P180, DOI 10.1016/j.jcv.2009.07.016; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; SINGH KRP, 1968, CURR SCI INDIA, V37, P65; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49; Varjak M, 2010, J VIROL, V84, P2352, DOI 10.1128/JVI.01540-09; Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706; Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Wikan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031102; WOODWARD TM, 1991, J GEN VIROL, V72, P2431, DOI 10.1099/0022-1317-72-10-2431	41	49	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50476	10.1371/journal.pone.0050476	http://dx.doi.org/10.1371/journal.pone.0050476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209750	Green Published, Green Accepted, gold			2022-12-25	WOS:000311885800073
J	D'Costa, ZJ; Jolly, C; Androphy, EJ; Mercer, A; Matthews, CM; Hibma, MH				D'Costa, Zarina J.; Jolly, Carol; Androphy, Elliot J.; Mercer, Andrew; Matthews, Charles M.; Hibma, Merilyn H.			Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6	PLOS ONE			English	Article							REGULATES E-CADHERIN; EPIDERMAL LANGERHANS CELLS; DNA METHYLATION; DOWN-REGULATION; GENE-EXPRESSION; TUMOR PROGRESSION; CANCER; ADHESION; ACTIVATION; MECHANISM	There is increasing evidence supporting DNA virus regulation of the cell adhesion and tumour suppressor protein, E-cadherin. We previously reported that loss of E-cadherin in human papillomavirus (HPV) type 16-infected epidermis is contributed to by the major viral proto-oncogene E6 and is associated with reduced Langerhans cells density, potentially regulating the immune response. The focus of this study is determining how the HPV16 E6 protein mediates E-cadherin repression. We found that the E-cadherin promoter is repressed in cells expressing E6, resulting in fewer E-cadherin transcripts. On exploring the mechanism for this, repression by increased histone deacetylase activity or by increased binding of trans-repressors to the E-cadherin promoter Epal element was discounted. In contrast, DNA methyltransferase (DNMT) activity was increased in E6 expressing cells. Upon inhibiting DNMT activity using 5-Aza-2'-deoxycytidine, E-cadherin transcription was restored in the presence of HPV16 E6. The E-cadherin promoter was not directly methylated, however a mutational analysis showed general promoter repression and reduced binding of the transactivators Sp1 and AML1 and the repressor Slug. Expression of E7 with E6 resulted in a further reduction in surface E-cadherin levels. This is the first report of HPV16 E6-mediated transcriptional repression of this adhesion molecule and tumour suppressor protein.	[D'Costa, Zarina J.; Mercer, Andrew; Matthews, Charles M.; Hibma, Merilyn H.] Univ Otago, Dept Microbiol & Immunol, Virus Res Unit, Dunedin, New Zealand; [Jolly, Carol; Androphy, Elliot J.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN USA	University of Otago; Indiana University System; Indiana University Bloomington	Hibma, MH (corresponding author), Univ Otago, Dept Microbiol & Immunol, Virus Res Unit, Dunedin, New Zealand.	merilyn.hibma@otago.ac.nz	Mercer, Andrew A/G-6635-2015	Mercer, Andrew/0000-0003-3697-1071; Androphy, Elliot/0000-0002-8104-0703	Health Research Council of New Zealand; University of Otago; NATIONAL CANCER INSTITUTE [R01CA107394] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a Health Research Council of New Zealand Programme Grant and ZD was supported by a University of Otago Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 2008, CANCER LETT, V261, P244, DOI 10.1016/j.canlet.2007.11.033; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; Burgers WA, 2007, ONCOGENE, V26, P1650, DOI 10.1038/sj.onc.1209950; Caberg JHD, 2008, CARCINOGENESIS, V29, P1441, DOI 10.1093/carcin/bgn145; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carico E, 2001, GYNECOL ONCOL, V80, P156, DOI 10.1006/gyno.2000.6035; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; D'Costa Zarina J, 2012, Invest New Drugs, V30, P2236, DOI 10.1007/s10637-012-9803-0; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Fujii S, 2008, CANCER SCI, V99, P738, DOI 10.1111/j.1349-7006.2008.00743.x; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hajra KM, 2002, CANCER RES, V62, P1613; Hubert P, 2005, J PATHOL, V206, P346, DOI 10.1002/path.1771; Klingelhutz AJ, 1996, NATURE, V380, P79, DOI 10.1038/380079a0; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Krishna Smriti M., 2005, Cancer Biomarkers, V1, P271; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Laurson J, 2010, CARCINOGENESIS, V31, P918, DOI 10.1093/carcin/bgq027; Leonard S, 2011, J VIROL, V85, P9568, DOI 10.1128/JVI.00468-11; Leong CM, 2010, J INVEST DERMATOL, V130, P472, DOI 10.1038/jid.2009.266; Liu J, 2006, ONCOGENE, V25, P1008, DOI 10.1038/sj.onc.1209138; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; Lu Qianjin, 2004, Biol Proced Online, V6, P189, DOI 10.1251/bpo89; Matthews K, 2003, J VIROL, V77, P8378, DOI 10.1128/JVI.77.15.8378-8385.2003; Milutinovic S, 2004, J BIOL CHEM, V279, P27915, DOI 10.1074/jbc.M312823200; Milutinovic S, 2000, J BIOL CHEM, V275, P6353, DOI 10.1074/jbc.275.9.6353; Momparler RL, 2000, ADV EXP MED BIOL, V465, P433; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Naito A, 2001, J SURG ONCOL, V76, P176, DOI 10.1002/jso.1031; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Ravizza R, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-92; Reinhold WC, 2007, MOL CANCER THER, V6, P391, DOI 10.1158/1535-7163.MCT-06-0609; Roger L, 2010, J CELL SCI, V123, P1295, DOI 10.1242/jcs.061002; Saitoh M, 2009, BIOCHEM BIOPH RES CO, V381, P560, DOI 10.1016/j.bbrc.2009.02.098; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Subbaiah VK, 2011, BIOCHEM J, V439, P195, DOI 10.1042/BJ20110903; TANG AM, 1993, NATURE, V361, P82, DOI 10.1038/361082a0; Tsai CN, 2002, P NATL ACAD SCI USA, V99, P10084, DOI 10.1073/pnas.152059399; Tungteakkhun SS, 2008, ARCH VIROL, V153, P397, DOI 10.1007/s00705-007-0022-5; VESSEY CJ, 1995, J PATHOL, V176, P151, DOI 10.1002/path.1711760208; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Wakita H, 2003, ARCH DERMATOL RES, V295, pS71, DOI 10.1007/s00403-002-0377-0; Whiteside MA, 2008, CANCER-AM CANCER SOC, V113, P2981, DOI 10.1002/cncr.23750; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Yeung CLA, 2010, ONCOL REP, V24, P1599, DOI 10.3892/or_00001023; Yu YC, 2006, CLIN EXP METASTAS, V23, P65, DOI 10.1007/s10585-006-9020-3; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	54	65	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e48954	10.1371/journal.pone.0048954	http://dx.doi.org/10.1371/journal.pone.0048954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189137	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800016
J	Maier, S; Szalkowski, A; Kamphausen, S; Perlov, E; Feige, B; Blechert, J; Philipsen, A; van Elst, LT; Kalisch, R; Tuscher, O				Maier, Simon; Szalkowski, Anna; Kamphausen, Susanne; Perlov, Evgeniy; Feige, Bernd; Blechert, Jens; Philipsen, Alexandra; van Elst, Ludger Tebartz; Kalisch, Raffael; Tuescher, Oliver			Clarifying the Role of the Rostral dmPFC/dACC in Fear/Anxiety: Learning, Appraisal or Expression?	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; CONDITIONED FEAR; EXTINCTION; EMOTION; AMYGDALA; ANXIETY; INACTIVATION; METAANALYSIS; DISTRACTION	Recent studies have begun to carve out a specific role for the rostral part of the dorsal medial prefrontal cortex (dmPFC) and adjacent dorsal anterior cingulate cortex (dACC) in fear/anxiety. Within a novel general framework of dorsal mPFC/ACC areas subserving the appraisal of threat and concomitant expression of fear responses and ventral mPFC/ACC areas subserving fear regulation, the rostral dmPFC/dACC has been proposed to specifically mediate the conscious, negative appraisal of threat situations including, as an extreme variant, catastrophizing. An alternative explanation that has not been conclusively ruled out yet is that the area is involved in fear learning. We tested two different fear expression paradigms in separate fMRI studies (study 1: instructed fear, study 2: testing of Pavlovian conditioned fear) with independent groups of healthy adult subjects. In both paradigms the absence of reinforcement precluded conditioning. We demonstrate significant BOLD activation of an identical rostral dmPFC/dACC area. In the Pavlovian paradigm (study 2), the area only activated robustly once prior conditioning had finished. Thus, our data argue against a role of the area in fear learning. We further replicate a repeated observation of a dissociation between peripheral-physiological fear responding and rostral dmPFC/dACC activation, strongly suggesting the area does not directly generate fear responses but rather contributes to appraisal processes. Although we succeeded in preventing extinction of conditioned responding in either paradigm, the data do not allow us to definitively exclude an involvement of the area in fear extinction learning. We discuss the broader implications of this finding for our understanding of mPFC/ACC function in fear and in negative emotion more generally.	[Maier, Simon; Szalkowski, Anna; Kamphausen, Susanne; Perlov, Evgeniy; Feige, Bernd; Philipsen, Alexandra; van Elst, Ludger Tebartz; Tuescher, Oliver] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Maier, Simon] Univ Freiburg, Inst Biol 3, Fac Biol, Freiburg, Germany; [Kamphausen, Susanne] Univ Med Ctr Tuebingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Blechert, Jens] Salzburg Univ, Inst Psychol, Dept Clin Psychol Psychotherapy & Hlth Psychol, A-5020 Salzburg, Austria; [Kalisch, Raffael] Univ Med Ctr Hamburg Eppendorf UKE, Inst Syst Neurosci, Hamburg, Germany; [Tuescher, Oliver] Univ Med Ctr Mainz, Dept Psychiat & Psychotherapy, Mainz, Germany	University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Salzburg University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	Maier, S (corresponding author), Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany.	simon.maier@uniklinik-freiburg.de	Kalisch, Raffael/A-9863-2018; Philipsen, Alexandra/E-4505-2017; Blechert, Jens/X-4040-2019; Feige, Bernd/C-6690-2012; Tuescher, Oliver/F-9903-2014; Maier, Simon/H-6074-2019; Kalisch, Raffael/H-6624-2016	Philipsen, Alexandra/0000-0001-6876-518X; Blechert, Jens/0000-0002-3820-109X; Feige, Bernd/0000-0002-9436-1258; 	German Federal Ministry of Education and Research [BMBF 01GV0606]; Freiburg University Medical School; Deutsche Forschungsgemeinschaft (DFG) [KA 1623/3-1]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Freiburg University Medical School; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the German Federal Ministry of Education and Research (BMBF 01GV0606) to LTvE, a fellowship grant of the Freiburg University Medical School to OT and the Deutsche Forschungsgemeinschaft (DFG Emmy Noether grant KA 1623/3-1) to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; [Anonymous], 1997, SKID 2 STRUKTURIERTE; Beck A.T., 2005, ANXIETY DISORDERS PH; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Butler T, 2007, NEUROSCIENCE, V150, P1, DOI 10.1016/j.neuroscience.2007.09.048; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Feige B, 2005, J NEUROPHYSIOL, V93, P2864, DOI 10.1152/jn.00721.2004; Friston K. J., 2008, STAT PARAMETRIC MAPP; Gentil AF, 2009, BIOL PSYCHIAT, V66, P695, DOI 10.1016/j.biopsych.2009.05.009; Holtz K, 2012, NEUROIMAGE, V61, P857, DOI 10.1016/j.neuroimage.2012.03.019; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kalisch R, 2006, NEUROIMAGE, V30, P1458, DOI 10.1016/j.neuroimage.2005.11.011; Kalisch R, 2006, J COGNITIVE NEUROSCI, V18, P1266, DOI 10.1162/jocn.2006.18.8.1266; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Knight DC, 2005, NEUROIMAGE, V26, P1193, DOI 10.1016/j.neuroimage.2005.03.020; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Laurent V, 2009, LEARN MEMORY, V16, P520, DOI 10.1101/lm.1474609; Lebron K, 2004, LEARN MEMORY, V11, P544, DOI 10.1101/lm.78604; Lee KH, 2012, SOC COGN AFFECT NEUR, V7, P521, DOI 10.1093/scan/nsp001; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Mechias ML, 2010, NEUROIMAGE, V49, P1760, DOI 10.1016/j.neuroimage.2009.09.040; Meyer G., 1973, SURG APPROACHES PSYC, V1973, P39; Milad MR, 2007, BIOL PSYCHIAT, V62, P1191, DOI 10.1016/j.biopsych.2007.04.032; Olsson A, 2004, PSYCHOL SCI, V15, P822, DOI 10.1111/j.0956-7976.2004.00762.x; Paret C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00216; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Raczka KA, 2010, MOL PSYCHIATR, V15, P1067, DOI 10.1038/mp.2010.79; Reiss S, 1985, THEORETICAL ISSUES B; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Robinson OJ, 2012, NEUROIMAGE, V60, P523, DOI 10.1016/j.neuroimage.2011.11.096; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Sierra-Mercado D, 2006, EUR J NEUROSCI, V24, P1751, DOI 10.1111/j.1460-9568.2006.05014.x; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Wittchen H.U., 1997, SKID STRUKTURIERTES; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261	41	56	56	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50120	10.1371/journal.pone.0050120	http://dx.doi.org/10.1371/journal.pone.0050120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189183	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800060
J	Parisod, C; Mhiri, C; Lim, KY; Clarkson, JJ; Chase, MW; Leitch, AR; Grandbastien, MA				Parisod, Christian; Mhiri, Corinne; Lim, K. Yoong; Clarkson, James J.; Chase, Mark W.; Leitch, Andrew R.; Grandbastien, Marie-Angele			Differential Dynamics of Transposable Elements during Long-Term Diploidization of Nicotiana Section Repandae (Solanaceae) Allopolyploid Genomes	PLOS ONE			English	Article							EVOLUTIONARY CONSEQUENCES; TOBACCO; SEQUENCE; DNA; MECHANISMS; RETROTRANSPOSONS; ELIMINATION; PERSPECTIVE; DIVERSITY; GENETICS	Evidence accumulated over the last decade has shown that allopolyploid genomes may undergo drastic reorganization. However, timing and mechanisms of structural diploidization over evolutionary timescales are still poorly known. As transposable elements (TEs) represent major and labile components of plant genomes, they likely play a pivotal role in fuelling genome changes leading to long-term diploidization. Here, we exploit the 4.5 MY old allopolyploid Nicotiana section Repandae to investigate the impact of TEs on the evolutionary dynamics of genomes. Sequence-specific amplified polymorphisms (SSAP) on seven TEs with expected contrasted dynamics were used to survey genome-wide TE insertion polymorphisms. Comparisons of TE insertions in the four allopolyploid species and descendents of the diploid species most closely related to their actual progenitors revealed that the polyploids showed considerable departure from predicted additivity of the diploids. Large numbers of new SSAP bands were observed in polyploids for two TEs, but restructuring for most TE families involved substantial loss of fragments relative to the genome of the diploid representing the paternal progenitor, which could be due to changes in allopolyploids, diploid progenitor lineages or both. The majority of nonadditive bands were shared by all polyploid species, suggesting that significant restructuring occurred early after the allopolyploid event that gave rise to their common ancestor. Furthermore, several gains and losses of SSAP fragments were restricted to N. repanda, suggesting a unique evolutionary trajectory. This pattern of diploidization in TE genome fractions supports the hypothesis that TEs are central to long-term genome turnover and depends on both TE and the polyploid lineage considered.	[Parisod, Christian; Mhiri, Corinne; Grandbastien, Marie-Angele] INRA Versailles, UMR INRA AgroParisTech 1318, Inst Jean Pierre Bourgin, Versailles, France; [Lim, K. Yoong; Leitch, Andrew R.] Queen Mary Univ London, Sch Biol Sci, London, England; [Clarkson, James J.; Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of London; Queen Mary University London; Royal Botanic Gardens, Kew	Grandbastien, MA (corresponding author), INRA Versailles, UMR INRA AgroParisTech 1318, Inst Jean Pierre Bourgin, Versailles, France.	gbastien@versailles.inra.fr	Grandbastien, Marie-Angele/K-5491-2013; Chase, Mark W/A-6642-2011; Parisod, Christian/A-1140-2010; Leitch, Andrew R/J-6385-2014	Parisod, Christian/0000-0001-8798-0897; Leitch, Andrew R/0000-0001-8574-302X; Mhiri, Corinne/0000-0002-1377-6604	project "Effect of polyploidy on plant genome biodiversity and evolution"; French Agence Nationale de la Recherche (ANR) [ANR-05-BDIV-015]; UK Natural Environment Research Council; Swiss National Science Foundation; Natural Environment Research Council [NE/C511964/1] Funding Source: researchfish	project "Effect of polyploidy on plant genome biodiversity and evolution"; French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the project "Effect of polyploidy on plant genome biodiversity and evolution" funded by the French Agence Nationale de la Recherche (ANR Biodiversity program; ANR-05-BDIV-015), the UK Natural Environment Research Council and the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; BUREAU TE, 1994, PLANT CELL, V6, P907, DOI 10.1105/tpc.6.6.907; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Chase MW, 2003, ANN BOT-LONDON, V92, P107, DOI 10.1093/aob/mcg087; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Clarkson JJ, 2010, MOL PHYLOGENET EVOL, V55, P99, DOI 10.1016/j.ympev.2009.10.003; Clarkson JJ, 2004, MOL PHYLOGENET EVOL, V33, P75, DOI 10.1016/j.ympev.2004.05.002; Clarkson JJ, 2005, NEW PHYTOL, V168, P241, DOI 10.1111/j.1469-8137.2005.01480.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Comai L, 2003, PHILOS T R SOC B, V358, P1149, DOI 10.1098/rstb.2003.1305; DELON R, 1999, NICOTIANEES COLLECTI; Doyle JJ, 2008, ANNU REV GENET, V42, P443, DOI 10.1146/annurev.genet.42.110807.091524; Feldman M, 2009, J GENET GENOMICS, V36, P511, DOI 10.1016/S1673-8527(08)60142-3; Gaut BS, 2008, SCIENCE, V320, P484, DOI 10.1126/science.1153586; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRANDBASTIEN MA, 1989, NATURE, V337, P376, DOI 10.1038/337376a0; Grover CE, 2008, MOL BIOL EVOL, V25, P1415, DOI 10.1093/molbev/msn085; Grover CE, 2007, NEW PHYTOL, V175, P599, DOI 10.1111/j.1469-8137.2007.02197.x; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kalendar R, 2011, HEREDITY, V106, P520, DOI 10.1038/hdy.2010.93; Koukalova B, 2010, NEW PHYTOL, V186, P148, DOI 10.1111/j.1469-8137.2009.03101.x; Le Comber SC, 2010, NEW PHYTOL, V186, P113, DOI 10.1111/j.1469-8137.2009.03117.x; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Leitch A, 2007, CHROMOSOME RES, V15, P8; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Lim KY, 2007, NEW PHYTOL, V175, P756, DOI 10.1111/j.1469-8137.2007.02121.x; Lim KY, 2004, BIOL J LINN SOC, V82, P599, DOI 10.1111/j.1095-8312.2004.00344.x; Lim KY, 2004, GENETICS, V166, P1935, DOI 10.1534/genetics.166.4.1935; Lu F, 2009, P NATL ACAD SCI USA, V106, P2071, DOI 10.1073/pnas.0812798106; Martienssen RA, 2010, NEW PHYTOL, V186, P46, DOI 10.1111/j.1469-8137.2010.03193.x; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Melayah D, 2004, BIOL J LINN SOC, V82, P639, DOI 10.1111/j.1095-8312.2004.00348.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Parisod C, 2009, NEW PHYTOL, V184, P1003, DOI 10.1111/j.1469-8137.2009.03029.x; Parisod C, 2010, NEW PHYTOL, V186, P5, DOI 10.1111/j.1469-8137.2009.03142.x; Parisod C, 2010, NEW PHYTOL, V186, P37, DOI 10.1111/j.1469-8137.2009.03096.x; Petit M, 2010, NEW PHYTOL, V186, P135, DOI 10.1111/j.1469-8137.2009.03140.x; Petit M, 2007, MOL GENET GENOMICS, V278, P1, DOI 10.1007/s00438-007-0226-0; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rieseberg LH, 2001, CURR BIOL, V11, pR925, DOI 10.1016/S0960-9822(01)00556-5; Skalicka K, 2005, NEW PHYTOL, V166, P291, DOI 10.1111/j.1469-8137.2004.01297.x; Soltis DE, 2010, TAXON, V59, P1387, DOI 10.1002/tax.595006; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Tam SM, 2005, THEOR APPL GENET, V110, P819, DOI 10.1007/s00122-004-1837-z; Tenaillon MI, 2010, TRENDS PLANT SCI, V15, P471, DOI 10.1016/j.tplants.2010.05.003; Vekemans X., 2002, AFLP SURV VERS 1 0; Waugh R, 1997, MOL GEN GENET, V253, P687, DOI 10.1007/s004380050372; Wenke T, 2011, PLANT CELL, V23, P3117, DOI 10.1105/tpc.111.088682; Whitney KD, 2010, EVOLUTION, V64, P2097, DOI 10.1111/j.1558-5646.2010.00967.x; Witte CP, 2001, P NATL ACAD SCI USA, V98, P13778, DOI 10.1073/pnas.241341898; Yasui Y, 2001, THEOR APPL GENET, P102; YOSHIOKA Y, 1993, P NATL ACAD SCI USA, V90, P6562, DOI 10.1073/pnas.90.14.6562; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	60	23	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50352	10.1371/journal.pone.0050352	http://dx.doi.org/10.1371/journal.pone.0050352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185607	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000220
J	Reissland, N; Francis, B; Mason, J				Reissland, Nadja; Francis, Brian; Mason, James			Development of Fetal Yawn Compared with Non-Yawn Mouth Openings from 24-36 Weeks Gestation	PLOS ONE			English	Article							NORMAL STANDARDS; NEAR-TERM; PRETERM; CLASSIFICATION; MOVEMENTS; BEHAVIOR	Background: Although some research suggests that fetuses yawn, others disagree arguing that is it simple mouth opening. Furthermore there is no developmental account of fetal yawning compared with simple mouth opening. The aim of the present study was to establish in a repeated measures design the development of fetal yawning compared with simple mouth opening. Methodology/Findings: Video recordings were made of the fetal face and upper torso visualized by means of 4D full frontal or facial profile ultrasound recordings. Fifteen healthy fetuses were scanned four times at 24, 28, 32 and 36 weeks gestation. Yawning was distinguished from non-yawning in terms of the length of time it took to reach the apex of the mouth stretch, with yawns being defined as more than 50% of the total time observed. To assess changes in frequency, a Poisson mixed effects model was fitted to the count of number of yawn and simple mouth opening events with age and gender as fixed effects, and person as a random effect. For both yawns and simple mouth openings a smooth varying age effect was significant. The number of yawns observed declined with age from 28 weeks gestation, whereas simple mouth openings were less frequent and the decline was observed from 24 weeks. Gender was not significant either for yawn and simple mouth openings. Conclusions/Significance: Yawning can be reliably distinguished from other forms of mouth opening with the potential of using yawning as an index of fetal healthy development.	[Reissland, Nadja] Univ Durham, Sci Labs, Dept Psychol, Durham DH1 3LE, England; [Francis, Brian] Univ Lancaster, Dept Math & Stat, Lancaster, England; [Mason, James] Univ Durham, Wolfson Res Inst, Stockton On Tees, England	Durham University; Lancaster University; Durham University	Reissland, N (corresponding author), Univ Durham, Sci Labs, Dept Psychol, Durham DH1 3LE, England.	n.n.reissland@durham.ac.uk	Mason, James M/D-9904-2011; Francis, Brian J/A-1953-2011; Reissland, Nadja/B-6079-2008	Mason, James M/0000-0001-9210-4082; Francis, Brian J/0000-0001-7926-9085; Reissland, Nadja/0000-0003-4976-7117	Durham University; Lancaster University; ESRC [RES-576-25-5020]	Durham University; Lancaster University; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Funding was provided by Durham University (http://www.dur.ac.uk) and Lancaster University (http://www.lancs.ac.uk/). The analysis of the data was supported by ESRC grant RES-576-25-5020 (http://www.esrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.R., 2003, CURR PSYCHOL LETT BE, V11, P2003, DOI [10.4000/cpl.390, DOI 10.4000/CPL.390]; ARGIOLAS A, 1986, EUR J PHARMACOL, V130, P265, DOI 10.1016/0014-2999(86)90277-3; Bates D., 2011, IME4 LINEAR MIXED EF; DEVRIES JIP, 1982, EARLY HUM DEV, V7, P301, DOI 10.1016/0378-3782(82)90033-0; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Engle WA, 2006, SEMIN PERINATOL, V30, P2, DOI 10.1053/j.semperi.2006.01.007; Gallup AC, 2011, NEUROSCI BIOBEHAV R, V35, P765, DOI 10.1016/j.neubiorev.2010.09.009; Giganti F, 2007, INFANT BEHAV DEV, V30, P641, DOI 10.1016/j.infbeh.2007.03.005; Guggisberg AG, 2011, NEUROSCI BIOBEHAV R, V35, P1302, DOI 10.1016/j.neubiorev.2010.12.004; Habib Hasina, 2007, Congenital Anomalies, V47, P53, DOI 10.1111/j.1741-4520.2007.00143.x; Hata T, 2010, INFANT CHILD DEV, V19, P99, DOI 10.1002/icd.659; KOCH P, 1987, CHRONOBIOL INT, V4, P525, DOI 10.3109/07420528709078544; Kurjak A, 2006, J PERINAT MED, V34, P56, DOI 10.1515/JPM.2006.007; Kurjak A, 2008, J MATERN-FETAL NEO M, V21, P675, DOI 10.1080/14767050802212166; McManus B, 1997, NEW ENGL J MED, V336, P1329; Millen A, 2011, BIOL LETTERS, V7, P440, DOI 10.1098/rsbl.2010.0966; Petrikovsky B, 1999, ULTRASOUND OBST GYN, V13, P127, DOI 10.1046/j.1469-0705.1999.13020127.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Piontelli A, 2010, DEVELOPMENT OF NORMAL FETAL MOVEMENTS: THE FIRST 25 WEEKS OF GESTATION, P1, DOI 10.1007/978-88-470-1402-2; Platek SM, 2010, FRONT NEUROL NEUROSC, V28, P107, DOI 10.1159/000307086; PRECHTL HFR, 1990, EARLY HUM DEV, V23, P151, DOI 10.1016/0378-3782(90)90011-7; PROVINE RR, 1987, BEHAV NEURAL BIOL, V48, P382, DOI 10.1016/S0163-1047(87)90944-7; Provine RR, 2005, AM SCI, V93, P532, DOI 10.1511/2005.56.980; Reissland N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024081; ROODENBURG PJ, 1991, EARLY HUM DEV, V25, P19, DOI 10.1016/0378-3782(91)90203-F; SHERER DM, 1991, J ULTRAS MED, V10, P68; Shoup-Knox Melanie L, 2010, Front Evol Neurosci, V2, P108, DOI 10.3389/fnevo.2010.00108; Thompson SBN, 2012, PSYCHOL TRAUMA CLIN, P125; Thompson SBN, 2011, MED HYPOTHESES, V77, P861, DOI 10.1016/j.mehy.2011.07.056; Walusinski O, 2010, FRONT NEUROL NEUROSC, V28, P140, DOI 10.1159/000307098; Walusinski O, 2010, FRONT NEUROL NEUROSC, V28, P32, DOI 10.1159/000307075; Yigiter AB, 2006, J MATERN-FETAL NEO M, V19, P707, DOI 10.1080/14767050600924129	32	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50569	10.1371/journal.pone.0050569	http://dx.doi.org/10.1371/journal.pone.0050569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185638	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000311821000248
J	Tweel, AW; Turner, RE				Tweel, Andrew W.; Turner, R. Eugene			Landscape-Scale Analysis of Wetland Sediment Deposition from Four Tropical Cyclone Events	PLOS ONE			English	Article							STORM-SURGE; HURRICANE; MISSISSIPPI; RECORD; COAST; KATRINA	Hurricanes Katrina, Rita, Gustav, and Ike deposited large quantities of sediment on coastal wetlands after making landfall in the northern Gulf of Mexico. We sampled sediments deposited on the wetland surface throughout the entire Louisiana and Texas depositional surfaces of Hurricanes Katrina, Rita, Gustav, and the Louisiana portion of Hurricane Ike. We used spatial interpolation to model the total amount and spatial distribution of inorganic sediment deposition from each storm. The sediment deposition on coastal wetlands was an estimated 68, 48, and 21 million metric tons from Hurricanes Katrina, Rita, and Gustav, respectively. The spatial distribution decreased in a similar manner with distance from the coast for all hurricanes, but the relationship with distance from the storm track was more variable between events. The southeast-facing Breton Sound estuary had significant storm-derived sediment deposition west of the storm track, whereas sediment deposition along the south-facing coastline occurred primarily east of the storm track. Sediment organic content, bulk density, and grain size also decreased significantly with distance from the coast, but were also more variable with respect to distance from the track. On average, eighty percent of the mineral deposition occurred within 20 km from the coast, and 58% was within 50 km of the track. These results highlight an important link between tropical cyclone events and coastal wetland sedimentation, and are useful in identifying a more complete sediment budget for coastal wetland soils.	[Tweel, Andrew W.; Turner, R. Eugene] Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Tweel, AW (corresponding author), Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	atweel1@lsu.edu			Louisiana Board of Regents Graduate Student Fellowship; NSF Division of Geomorphology and Land-Use Dynamics Awards [EAR-0612501, 0900888]	Louisiana Board of Regents Graduate Student Fellowship; NSF Division of Geomorphology and Land-Use Dynamics Awards(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Support was provided to A. T. by a Louisiana Board of Regents (http://regents.state.la.us/) Graduate Student Fellowship. Funds to collect the field data came from the NSF Division of Geomorphology and Land-Use Dynamics Awards #EAR-0612501 and #0900888 (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13690). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison MA, 2005, CONT SHELF RES, V25, P2213, DOI 10.1016/j.csr.2005.08.023; Allison MA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044547; Boldt KV, 2010, MAR GEOL, V275, P127, DOI 10.1016/j.margeo.2010.05.002; Cahoon D.R., 1995, J COASTAL RES, P280; Cahoon DR, 2006, ESTUAR COAST, V29, P889, DOI 10.1007/BF02798648; Carver RE., 1971, PROCEDURES SEDIMENTA; Castaneda-Moya E, 2010, ESTUAR COAST, V33, P45, DOI 10.1007/s12237-009-9242-0; Costanza R, 2008, AMBIO, V37, P241, DOI 10.1579/0044-7447(2008)37[241:TVOCWF]2.0.CO;2; Couvillion B.R., 2011, US GEOLOGICAL SURVEY, V3164; Davis SE, 2004, J COASTAL RES, V20, P1198, DOI 10.2112/03-0072R.1; Dietrich JC, 2011, MON WEATHER REV, V139, P2488, DOI 10.1175/2011MWR3611.1; Dietrich JC, 2010, MON WEATHER REV, V138, P378, DOI 10.1175/2009MWR2907.1; Ebersole BA, 2010, OCEAN ENG, V37, P91, DOI 10.1016/j.oceaneng.2009.08.013; Faulkner S, 2005, LAFAYETTE SCI STORMS, P157; Freeman A, 2009, THESIS LOUISIANA STA; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Goni M.A., 2007, SEDIMENT REC, V5, P4, DOI [DOI 10.2110/sedred.2007.1.4, 10.2110/sedred.2007.1.4]; GonzuYlez J.L., 2006, EOS T, V87, P493, DOI [DOI 10.1029/2006EO450001, 10.1029/2006EO450001]; Guntenspergen G.R., 1995, J COASTAL RES, P324; Horton BP, 2009, QUATERN INT, V195, P15, DOI 10.1016/j.quaint.2008.03.004; Howes NC, 2010, P NATL ACAD SCI USA, V107, P14014, DOI 10.1073/pnas.0914582107; Kearney MS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047847; Keen TR, 2004, MAR GEOL, V210, P79, DOI 10.1016/j.margeo.2004.05.022; Mashriqui HS, 2006, COASTAL ENV WATER QU, P481; Mckee KL, 2009, WETLANDS, V29, P2, DOI 10.1672/08-32.1; Meade RH, 2010, HYDROL PROCESS, V24, P35, DOI 10.1002/hyp.7477; MILLER MC, 1977, SEDIMENTOLOGY, V24, P507, DOI 10.1111/j.1365-3091.1977.tb00136.x; Miner MD, 2009, GEOLOGY, V37, P851, DOI 10.1130/G25466A.1; Morgan JP, 1958, 10 LOUIS STAT U COAS; Morton RA, 2011, J COASTAL RES, V27, P27, DOI 10.2112/JCOASTRES-D-10-00185.1; NYMAN JA, 1995, ESTUAR COAST SHELF S, V40, P665, DOI 10.1006/ecss.1995.0045; Ole Secher M., 1994, COASTAL ENG P, V1, DOI [10.9753/icce.v24, DOI 10.9753/ICCE.V24, DOI 10.1061/9780784400890.030]; Otvos EG, 2011, SEDIMENT GEOL, V239, P10, DOI 10.1016/j.sedgeo.2011.04.014; Parsons ML, 1998, J COASTAL RES, V14, P939; REJMANEK M, 1988, ESTUAR COAST SHELF S, V27, P217, DOI 10.1016/0272-7714(88)90091-1; Risi J., 1995, J COASTAL RES, V1995, P83; Schuerch M, 2012, ESTUAR COAST, V35, P486, DOI 10.1007/s12237-011-9461-z; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Turner RE, 2007, LIMNOL OCEANOGR, V52, P1231, DOI 10.4319/lo.2007.52.3.1231; Turner RE, 2006, SCIENCE, V314, P449, DOI 10.1126/science.1129116; USACE United States Army Corps of Engineers, 1972, HIST HURR OCC COAST; Williams HFL, 2009, J COASTAL RES, P1671; Williams HFL, 2012, EARTH SURF PROC LAND, V37, P901, DOI 10.1002/esp.3252; Williams HFL, 2009, J COASTAL RES, V25, P1041, DOI 10.2112/08-1038.1	44	44	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50528	10.1371/journal.pone.0050528	http://dx.doi.org/10.1371/journal.pone.0050528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185635	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000245
J	Alex, L; Wiklund, AF; Lundman, B; Christianson, M; Hammarstrom, A				Alex, Lena; Wiklund, Anncristine Fjellman; Lundman, Berit; Christianson, Monica; Hammarstrom, Anne			Beyond a Dichotomous View of the Concepts of 'Sex' and 'Gender' Focus Group Discussions among Gender Researchers at a Medical Faculty	PLOS ONE			English	Article							DEPRESSION; HEALTH; MASCULINITY; MENS	Introduction: The concepts of 'sex' and 'gender' are both of vital importance in medicine and health sciences. However, the meaning of these concepts has seldom been discussed in the medical literature. The aim of this study was to explore what the concepts of 'sex' and 'gender' meant for gender researchers based in a medical faculty. Methods: Sixteen researchers took part in focus group discussions. The analysis was performed in several steps. The participating researchers read the text and discussed ideas for analysis in national and international workshops. The data were analysed using qualitative content analysis. The authors performed independent preliminary analyses, which were further developed and intensively discussed between the authors. Results: The analysis of meanings of the concepts of 'sex' and 'gender' for gender researchers based in a medical faculty resulted in three categories; "Sex as more than biology", with the subcategories 'sex' is not simply biological, 'sex' as classification, and 'sex' as fluid and changeable; "Gender as a multiplicity of power-related constructions", with the subcategories: 'gender' as constructions, 'gender' power dimensions, and 'gender' as doing femininities and masculinities; "'Sex and gender as interwoven", with the subcategories: 'sex' and 'gender' as inseparable and embodying 'sex' and 'gender'. Conclusions: Gender researchers within medicine pointed out the importance of looking beyond a dichotomous view of the concepts of 'sex' and 'gender'. The perception of the concepts was that 'sex' and 'gender' were intertwined. Further research is needed to explore how 'sex' and 'gender' interact.	[Alex, Lena; Lundman, Berit] Umea Univ, Dept Nursing, Umea, Sweden; [Wiklund, Anncristine Fjellman] Umea Univ, Dept Community Med & Rehabil, Umea, Sweden; [Hammarstrom, Anne] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Alex, Lena; Wiklund, Anncristine Fjellman; Lundman, Berit; Christianson, Monica; Hammarstrom, Anne] Umea Univ, Umea Ctr Gender Studies Med, Res Programme Challenging Gender, Umea, Sweden	Umea University; Umea University; Umea University; Umea University	Alex, L (corresponding author), Umea Univ, Dept Nursing, Umea, Sweden.	lena.alex@nurs.umu.se		Hammarstrom, Anne/0000-0002-4095-7961	Centre of Gender Excellence, Research Programme Challenging Gender at Umea University	Centre of Gender Excellence, Research Programme Challenging Gender at Umea University	The study was financed by the Centre of Gender Excellence, Research Programme Challenging Gender at Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex L, 2008, J CLIN NURS, V17, P451, DOI 10.1111/j.1365-2702.2007.01961.x; Annandale E, 2011, HEALTH-LONDON, V15, P571, DOI 10.1177/1363459310364157; Bird CE, 2002, WOMEN HEALTH ISS, V12, P113, DOI 10.1016/S1049-3867(02)00133-0; Birke L., 1999, FEMINISM BIOL BODY; Butler J, 1999, EXCITABLE SPEECH POL; Christianson M, 2012, HEALTH CARE WOMEN IN, V33, P739, DOI 10.1080/07399332.2011.645970; Connell R.W., 1995, MASCULINITIES; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; De Beauvoir S., 1949, DEUXIEME SEXE; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Fausto-Sterling A, 2005, SIGNS, V30, P1491, DOI 10.1086/424932; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hammarstrom A, 2000, GENDER HLTH CONCEPTS; Hammarstrom A, 2007, GENDER MED, V4, pS123, DOI 10.1016/S1550-8579(07)80053-2; Harding Sandra, 1986, SCI QUESTION FEMINIS; Katz JD, 2008, WOMEN HEALTH ISS, V18, P151, DOI 10.1016/j.whi.2008.03.002; Kendler KS, 2006, AM J PSYCHIAT, V163, P115, DOI 10.1176/appi.ajp.163.1.115; King B, 2010, AM J PHYSIOL-REG I, V298, P1700; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Krieger N, 2005, J EPIDEMIOL COMMUN H, V59, P350, DOI 10.1136/jech.2004.024562; Krippendorff K., 2004, CONTENT ANAL INTRO I, V2nd ed; Kuehner C, 2003, ACTA PSYCHIAT SCAND, V108, P163, DOI 10.1034/j.1600-0447.2003.00204.x; Legato Marianne J, 2004, Gend Med, V1, P61, DOI 10.1016/S1550-8579(04)80011-1; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Morgan D. L, 1998, FOCUS GROUP GUIDEBOO; ohman O, 1999, ADV PHYSIOTHER, V1, P59; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Verdonk P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-712; Wizeman T.M., 2001, EXPLORING BIOL CONTR	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50275	10.1371/journal.pone.0050275	http://dx.doi.org/10.1371/journal.pone.0050275			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	043II	23185593	Green Published, Green Submitted, gold			2022-12-25	WOS:000311535700082
J	Lee, JM; Kim, B; Lee, SB; Jeong, Y; Oh, YM; Song, YJ; Jung, S; Choi, J; Lee, S; Cheong, KH; Kim, DU; Park, HW; Han, YK; Kim, GW; Choi, H; Song, PH; Kim, KA				Lee, J. M.; Kim, B.; Lee, S. B.; Jeong, Y.; Oh, Y. M.; Song, Y-J; Jung, S.; Choi, J.; Lee, S.; Cheong, K. H.; Kim, D. U.; Park, H. W.; Han, Y. K.; Kim, G. W.; Choi, H.; Song, P. H.; Kim, K. A.			Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody	ONCOGENE			English	Article						Met; Cbl; LRIG1; SAIT301; agonism	RECEPTOR TYROSINE KINASE; HEPATOCYTE GROWTH-FACTOR; C-MET; JUXTAMEMBRANE DOMAIN; DOWN-REGULATION; MUTATIONS; LRIG1; AMPLIFICATION; INHIBITORS; CANCER	The Met receptor tyrosine kinase, found to be constitutively activated in many tumors, has become a leading target for cancer therapy. Disruptions in Met downregulation have been associated with aggressive tumor progression with several therapeutic strategies addressing this aspect of Met biology. Castias B-lineage lymphoma (Cbl) E3 ligase-mediated degradation, which attenuates Met signaling via ligand-dependent Met internalization, is a major negative regulator of Met expression. It is believed that one of the mechanisms by which the therapeutic anti-Met antibodies induce cancer cell death in Met overexpressing tumors is via internalization and subsequent degradation of Met from the cell surface. However, a previously reported Met-targeting antibody demonstrated intrinsic agonistic activity while being capable of inducing Cbl-mediated degradation of Met, suggesting that Cbl-mediated degradation requires receptor activation and impedes therapeutic application. We have developed a potent and selective bivalent Met-targeting antibody (SAIT301) that invokes Met degradation using an alternative regulator LRIG1. In this report, we demonstrate that LRIG1 mediates degradation of Met by SAIT301 and this degradation does not require Met activation. Furthermore, SAIT301 was able to downregulate Met and dramatically inhibit growth of tumors with low or no Cbl expression, as well as tumors with Met exon 14 deletion that prevents Met binding to Cbl. In summary, we demonstrate the enhanced therapeutic potential of a novel tumor-inhibiting anti-Met antibody, SAIT301, which utilizes a Cbl-independent, LRIG1-mediated Met degradation pathway and thereby avoids the agonism that limits the effectiveness of previously reported anti-Met antibodies.	[Lee, J. M.; Kim, B.; Lee, S. B.; Jeong, Y.; Oh, Y. M.; Song, Y-J; Jung, S.; Choi, J.; Lee, S.; Cheong, K. H.; Kim, D. U.; Park, H. W.; Han, Y. K.; Kim, G. W.; Choi, H.; Song, P. H.; Kim, K. A.] Samsung Elect Co Ltd, Samsung Adv Inst Technol, BioTherapeut Lab, Yongin 446712, Gyeonggi Do, South Korea	Samsung	Kim, KA (corresponding author), Samsung Elect Co Ltd, Samsung Adv Inst Technol, BioTherapeut Lab, 95 Samsung2 Ro, Yongin 446712, Gyeonggi Do, South Korea.	ka10.kim@samsung.com	Jeong, Yunju/GRS-0008-2022; Lee, Ji Min/ABE-7494-2021	Lee, Ji Min/0000-0003-2978-2440	Korea Healthcare technology R&D project, Ministry for Health & Welfare Affairs, Republic of Korea [A092255]	Korea Healthcare technology R&D project, Ministry for Health & Welfare Affairs, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D project, Ministry for Health & Welfare Affairs, Republic of Korea (A092255). We thank Dr Sangyeul Han for critical discussion and Dr Ogan Gurel for discussion and editing the manuscript. pcDNA-LRIG1 expression plasmid was kindly provided by Dr Hakan Hedman.	Ancot F, 2012, TRAFFIC, V13, P1261, DOI 10.1111/j.1600-0854.2012.01384.x; Asaoka Y, 2010, BIOCHEM BIOPH RES CO, V394, P1042, DOI 10.1016/j.bbrc.2010.03.120; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Comoglio PM, 2001, SEMIN CANCER BIOL, V11, P153, DOI 10.1006/scbi.2000.0366; CREPALDI T, 1994, J CELL BIOL, V125, P313, DOI 10.1083/jcb.125.2.313; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; Greenall SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034658; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Krumbach R, 2011, EUR J CANCER, V47, P1231, DOI 10.1016/j.ejca.2010.12.019; Lai AZ, 2012, J BIOL CHEM, V287, P8048, DOI 10.1074/jbc.M112.339820; Lefebvre J, 2012, FASEB J, V26, P1387, DOI 10.1096/fj.11-197723; Liu XD, 2010, TRENDS MOL MED, V16, P37, DOI 10.1016/j.molmed.2009.11.005; Ma PC, 2003, CANCER RES, V63, P6272; Nakagawa T, 2010, CANCER SCI, V101, P210, DOI 10.1111/j.1349-7006.2009.01343.x; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Oh YM, MOL CELLS IN PRESS; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Ordonez-Moran P, 2012, EMBO J, V31, P2064, DOI 10.1038/emboj.2012.73; Pacchiana G, 2010, J BIOL CHEM, V285, P36149, DOI 10.1074/jbc.M110.134031; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Qin SA, 2010, J CLIN INVEST, V120, P3617, DOI 10.1172/JCI41531; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Schelter F, 2010, J BIOL CHEM, V285, P26335, DOI 10.1074/jbc.M110.106435; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Stellrecht CM, 2009, CANCER LETT, V280, P1, DOI 10.1016/j.canlet.2008.10.045; Stutz MA, 2008, ONCOGENE, V27, P5741, DOI 10.1038/onc.2008.185; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vigna E, 2008, CANCER RES, V68, P9176, DOI 10.1158/0008-5472.CAN-08-1688; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Zang ZJ, 2011, CANCER RES, V71, P29, DOI 10.1158/0008-5472.CAN-10-1749	42	57	59	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					34	43		10.1038/onc.2012.551	http://dx.doi.org/10.1038/onc.2012.551			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23208509				2022-12-25	WOS:000329212000005
J	Jang, E; Lee, S; Kim, JH; Kim, JH; Seo, JW; Lee, WH; Mori, K; Nakao, K; Suk, K				Jang, Eunha; Lee, Shinrye; Kim, Jong-Heon; Kim, Jae-Hong; Seo, Jung-Wan; Lee, Won-Ha; Mori, Kiyoshi; Nakao, Kazuwa; Suk, Kyoungho			Secreted protein lipocalin-2 promotes microglial M1 polarization	FASEB JOURNAL			English	Article						neuroinflammation; central nervous system; innate immunity; brain	GELATINASE-ASSOCIATED LIPOCALIN; BLOOD-DERIVED MACROPHAGES; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; INFLAMMATORY RESPONSE; TUMOR-DEVELOPMENT; EPITHELIAL-CELLS; ANIMAL-MODELS; LIPOPOLYSACCHARIDE; DISEASE	Activated macrophages are classified into two different forms: classically activated (M1) or alternatively activated (M2) macrophages. The presence of M1/M2 phenotypic polarization has also been suggested for microglia. Here, we report that the secreted protein lipocalin 2 (LCN2) amplifies M1 polarization of activated microglia. LCN2 protein (EC50 1 mu g/ml), but not glutathione S-transferase used as a control, increased the M1-related gene expression in cultured mouse microglial cells after 8-24 h. LCN2 was secreted from M1-polarized, but not M2-polarized, microglia. LCN2 inhibited phosphorylation of STAT6 in IL-4-stimulated microglia, suggesting LCN2 suppression of the canonical M2 signaling. In the lipopolysaccharide (LPS)-induced mouse neuroinflammation model, the expression of LCN2 was notably increased in microglia. Primary microglial cultures derived from LCN2-deficient mice showed a suppressed M1 response and enhanced M2 response. Mice lacking LCN2 showed a markedly reduced M1-related gene expression in microglia after LPS injection, which was consistent with the results of histological analysis. Neuroinflammation-associated impairment in motor behavior and cognitive function was also attenuated in the LCN2-deficient mice, as determined by the rotarod performance test, fatigue test, open-field test, and object recognition task. These findings suggest that LCN2 is an M1-amplifier in brain microglial cells.-Jang, E., Lee, S., Kim, J.-H., Kim, J.-H., Seo, J.-W., Lee, W.-H., Mori, K., Nakao, K., Suk, K. Secreted protein lipocalin-2 promotes microglial M1 polarization. FASEB J. 27, 1176-1190 (2013). www.fasebj.org	[Jang, Eunha; Lee, Shinrye; Kim, Jong-Heon; Kim, Jae-Hong; Seo, Jung-Wan; Suk, Kyoungho] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Brain Sci & Engn Inst,CMRI, Taegu 700422, South Korea; [Lee, Won-Ha] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 700422, South Korea; [Mori, Kiyoshi; Nakao, Kazuwa] Kyoto Univ, Grad Sch Med, Dept Med & Clin Sci, Kyoto, Japan	Kyungpook National University; Kyungpook National University; Kyoto University	Suk, K (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, 680 Gukchaebosang St, Taegu 700422, South Korea.	ksuk@knu.ac.kr	Mori, Kiyoshi/N-1267-2014	Mori, Kiyoshi/0000-0002-7285-8351	National Research Foundation (NRF); Ministry of Education, Science and Technology (MEST) of the Korean government [2012-0009328, 200804090]; Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A111345]	National Research Foundation (NRF); Ministry of Education, Science and Technology (MEST) of the Korean government(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	The authors thank Dr. Shizuo Akira (Osaka University, Osaka, Japan) for generously providing the LCN2-deficient mice. This work was supported by the Basic Science Research Program through the National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology (MEST) of the Korean government (2012-0009328, 200804090). This study was also supported by a grant of the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A111345).	Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Bonow RH, 2009, PHARMACOGENOMICS J, V9, P116, DOI 10.1038/tpj.2008.15; Bruce-Keller AJ, 2001, J NEUROCHEM, V78, P1315, DOI 10.1046/j.1471-4159.2001.00511.x; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Choi J, 2011, J NEUROL SCI, V305, P28, DOI 10.1016/j.jns.2011.03.023; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; El Khoury J, 2008, TRENDS PHARMACOL SCI, V29, P626, DOI 10.1016/j.tips.2008.08.004; Fan XX, 2004, MOL BIOL CELL, V15, P2863, DOI 10.1091/mbc.E03-09-0670; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Ip JPK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-124; Jack CS, 2007, J NEUROPATH EXP NEUR, V66, P848, DOI 10.1097/nen.0b013e3181492a7; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee S, 2007, J IMMUNOL, V179, P3231, DOI 10.4049/jimmunol.179.5.3231; Lee S, 2012, J BIOL CHEM, V287, P9414, DOI 10.1074/jbc.M111.330662; Lee S, 2011, J BIOL CHEM, V286, P43855, DOI 10.1074/jbc.M111.299248; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li MQ, 2007, IMMUNOL LETT, V109, P129, DOI 10.1016/j.imlet.2007.02.002; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MEHEUS LA, 1993, J IMMUNOL, V151, P1535; Michelucci A, 2009, J NEUROIMMUNOL, V210, P3, DOI 10.1016/j.jneuroim.2009.02.003; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Park SY, 2002, MOL BRAIN RES, V107, P9, DOI 10.1016/S0169-328X(02)00421-7; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Raivich G, 2004, BRAIN RES REV, V46, P261, DOI 10.1016/j.brainresrev.2004.06.006; Rathore KI, 2011, J NEUROSCI, V31, P13412, DOI 10.1523/JNEUROSCI.0116-11.2011; Sargsyan SA, 2005, GLIA, V51, P241, DOI 10.1002/glia.20210; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schefer V, 1996, EXP GERONTOL, V31, P387, DOI 10.1016/0531-5565(95)02032-2; Scheffel J, 2012, GLIA, V60, P1930, DOI 10.1002/glia.22409; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Schuetz E, 2004, CURR DRUG TARGETS, V5, P619, DOI 10.2174/1389450043345164; Shah VB, 2008, J IMMUNOL, V180, P2777, DOI 10.4049/jimmunol.180.5.2777; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Suh HS, 2009, VIROLOGY, V392, P246, DOI 10.1016/j.virol.2009.07.001; Sunil VR, 2007, EXP MOL PATHOL, V83, P177, DOI 10.1016/j.yexmp.2007.03.004; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x	66	129	131	2	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					1176	1190		10.1096/fj.12-222257	http://dx.doi.org/10.1096/fj.12-222257			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23207546				2022-12-25	WOS:000315585200030
J	Vartanian, S; Bentley, C; Brauer, MJ; Li, L; Shirasawa, S; Sasazuki, T; Kim, JS; Haverty, P; Stawiski, E; Modrusan, Z; Waldman, T; Stokoe, D				Vartanian, Steffan; Bentley, Carolyn; Brauer, Matthew J.; Li, Li; Shirasawa, Senji; Sasazuki, Takehiko; Kim, Jung-Sik; Haverty, Pete; Stawiski, Eric; Modrusan, Zora; Waldman, Todd; Stokoe, David			Identification of Mutant K-Ras-dependent Phenotypes Using a Panel of Isogenic Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC COLORECTAL-CANCER; ONCOGENIC KRAS; TUMOR-CELLS; EPITHELIAL-CELLS; LUNG-CANCER; KNOCK-IN; ACTIVATION; TRANSFORMATION; INHIBITION; EXPRESSION	To assess the consequences of endogenous mutant K-Ras, we analyzed the signaling and biological properties of a small panel of isogenic cell lines. These include the cancer cell lines DLD1, HCT116, and Hec1A, in which either the WT or mutant K-ras allele has been disrupted, and SW48 colorectal cancer cells and human mammary epithelial cells in which a single copy of mutant K-ras was introduced at its endogenous genomic locus. We find that single copy mutant K-Ras causes surprisingly modest activation of downstream signaling to ERK and Akt. In contrast, a negative feedback signaling loop to EGFR and N-Ras occurs in some, but not all, of these cell lines. Mutant K-Ras also had relatively minor effects on cell proliferation and cell migration but more dramatic effects on cell transformation as assessed by growth in soft agar. Surprisingly, knock-out of the wild type K-ras allele consistently increased growth in soft agar, suggesting tumor-suppressive properties of this gene under these conditions. Finally, we examined the effects of single copy mutant K-Ras on global gene expression. Although transcriptional programs triggered by mutant K-Ras were generally quite distinct in the different cell lines, there was a small number of genes that were consistently overexpressed, and these could be used to monitor K-Ras inhibition in a panel of human tumor cell lines. We conclude that there are conserved components of mutant K-Ras signaling and phenotypes but that many depend on cell context and environmental cues.	[Vartanian, Steffan; Bentley, Carolyn; Stokoe, David] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Brauer, Matthew J.; Li, Li; Haverty, Pete] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Stawiski, Eric; Modrusan, Zora] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Shirasawa, Senji] Fukuoka Univ, Fac Med, Dept Cell Biol, Fukuoka 8140180, Japan; [Sasazuki, Takehiko] Kyushu Univ, Inst Adv Study, Fukuoka 8128581, Japan; [Kim, Jung-Sik; Waldman, Todd] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20037 USA; [Kim, Jung-Sik; Waldman, Todd] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Tumor Biol Training Program, Washington, DC 20037 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Fukuoka University; Kyushu University; Georgetown University; Georgetown University	Stokoe, D (corresponding author), Genentech Inc, Dept Discovery Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	stokoe.david@gene.com			NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arena S, 2007, CANCER RES, V67, P8468, DOI 10.1158/0008-5472.CAN-07-1126; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boykevisch S, 2006, CURR BIOL, V16, P2173, DOI 10.1016/j.cub.2006.09.033; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Del Duca D, 2004, J NEURO-ONCOL, V67, P295, DOI 10.1023/B:NEON.0000024220.07063.70; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Nicolantonio F, 2008, P NATL ACAD SCI USA, V105, P20864, DOI 10.1073/pnas.0808757105; Diaz R, 2004, CARCINOGENESIS, V25, P535, DOI 10.1093/carcin/bgh026; Diaz R, 2002, CANCER RES, V62, P4514; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; GUERRERO I, 1985, P NATL ACAD SCI USA, V82, P7810, DOI 10.1073/pnas.82.23.7810; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim JS, 2004, CANCER RES, V64, P1932, DOI 10.1158/0008-5472.CAN-03-3862; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2011, BLOOD, V117, P2022, DOI 10.1182/blood-2010-04-280750; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Singh A, 2012, CELL, V148, P639, DOI 10.1016/j.cell.2011.12.033; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tchernitsa OI, 2004, ONCOGENE, V23, P4536, DOI 10.1038/sj.onc.1207585; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van Houdt WJ, 2010, NEOPLASIA, V12, P443, DOI 10.1593/neo.92088; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zhi XL, 2010, CANCER SCI, V101, P2561, DOI 10.1111/j.1349-7006.2010.01733.x	44	52	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2403	2413		10.1074/jbc.M112.394130	http://dx.doi.org/10.1074/jbc.M112.394130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23188824	Green Published, hybrid			2022-12-25	WOS:000314211500028
J	Cavazzini, D; Meschi, F; Corsini, R; Bolchi, A; Rossi, GL; Einsle, O; Ottonello, S				Cavazzini, Davide; Meschi, Francesca; Corsini, Romina; Bolchi, Angelo; Rossi, Gian Luigi; Einsle, Oliver; Ottonello, Simone			Autoproteolytic Activation of a Symbiosis-regulated Truffle Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBER-BORCHII; PROPROTEIN CONVERTASE; SIGNAL-TRANSDUCTION; PC12 CELLS; FURIN; MECHANISM; CLONING; PROTEIN; LOCALIZATION; PURIFICATION	Fungal phospholipases are members of the fungal/bacterial group XIV secreted phospholipases A(2) (sPLA(2)s). TbSP1, the sPLA(2) primarily addressed in this study, is up-regulated by nutrient deprivation and is preferentially expressed in the symbiotic stage of the ectomycorrhizal fungus Tuber borchii. A peculiar feature of this phospholipase and of its ortholog from the black truffle Tuber melanosporum is the presence of a 54-amino acid sequence of unknown functional significance, interposed between the signal peptide and the start of the conserved catalytic core of the enzyme. X-ray diffraction analysis of a recombinant TbSP1 form corresponding to the secreted protein previously identified in T. borchii mycelia revealed a structure comprising the five alpha-helices that form the phospholipase catalytic module but lacking the N-terminal 54 amino acids. This finding led to a series of functional studies that showed that TbSP1, as well as its T. melanosporum ortholog, is a self-processing pro-phospholipase A(2), whose phospholipase activity increases up to 80-fold following autoproteolytic removal of the N-terminal peptide. Proteolytic cleavage occurs within a serine-rich, intrinsically flexible region of TbSP1, does not involve the phospholipase active site, and proceeds via an intermolecular mechanism. Autoproteolytic activation, which also takes place at the surface of nutrient-starved, sPLA(2) overexpressing hyphae, may strengthen and further control the effects of phospholipase up-regulation in response to nutrient deprivation, also in the context of symbiosis establishment and mycorrhiza formation.	[Cavazzini, Davide; Meschi, Francesca; Corsini, Romina; Bolchi, Angelo; Rossi, Gian Luigi; Ottonello, Simone] Univ Parma, Lab Funct Genom & Prot Engn, Biochem & Mol Biol Unit, Dept Biosci, I-43124 Parma, Italy; [Einsle, Oliver] Univ Freiburg, Lehrstuhl Biochem, Inst Organ Chem & Biochem, D-79104 Freiburg, Germany	University of Parma; University of Freiburg	Ottonello, S (corresponding author), Univ Parma, Lab Funct Genom & Prot Engn, Biochem & Mol Biol Unit, Dept Biosci, Parco Area Sci 23-A, I-43124 Parma, Italy.	simone.ottonello@unipr.it	Corsini, Romina/ABB-4619-2021; Cavazzini, Davide/C-8154-2014; Bolchi, Angelo/GOJ-9730-2022	Cavazzini, Davide/0000-0002-1743-2390; Einsle, Oliver/0000-0001-8722-2893	Italian Ministry of Education and Research (MIUR-PRIN); Fondazione Cariparma	Italian Ministry of Education and Research (MIUR-PRIN)(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariparma(Fondazione Cariparma)	This work was supported by grants from the Italian Ministry of Education and Research (MIUR-PRIN) (to G. L. R. and S. O.) and by a grant from the Fondazione Cariparma (to S. O.).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ali SA, 1999, TOXICON, V37, P1505, DOI 10.1016/S0041-0101(99)00091-4; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bolchi A, 2005, BIOTECHNOL APPL BIOC, V42, P205, DOI 10.1042/BA20050050; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Buscot F, 2000, FEMS MICROBIOL REV, V24, P601, DOI 10.1111/j.1574-6976.2000.tb00561.x; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; De Maria L, 2007, APPL MICROBIOL BIOT, V74, P290, DOI 10.1007/s00253-006-0775-x; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dippe M, 2011, FUNGAL GENET BIOL, V48, P921, DOI 10.1016/j.fgb.2011.05.008; Drissner D, 2007, SCIENCE, V318, P265, DOI 10.1126/science.1146487; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESKOLA JU, 1983, CLIN CHEM, V29, P1772; Fink DL, 2001, J BIOL CHEM, V276, P39492, DOI 10.1074/jbc.M106913200; Ghosh K, 2004, BIOCHEM J, V379, P325, DOI 10.1042/BJ20031834; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hostetter MK, 2000, CURR OPIN MICROBIOL, V3, P344, DOI 10.1016/S1369-5274(00)00101-6; Jemel I, 2011, J BIOL CHEM, V286, P36509, DOI 10.1074/jbc.M111.268540; Kohler GA, 2006, BBA-MOL CELL BIOL L, V1761, P1391, DOI 10.1016/j.bbalip.2006.09.011; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lee HY, 2005, PROG LIPID RES, V44, P52, DOI 10.1016/j.plipres.2004.10.002; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Matoba Y, 2002, J BIOL CHEM, V277, P20059, DOI 10.1074/jbc.M200263200; Mayer JM, 2000, DIGESTION, V62, P164, DOI 10.1159/000007809; Minder AC, 2001, MOL MICROBIOL, V39, P1186, DOI 10.1111/j.1365-2958.2001.02325.x; Miozzi L, 2005, NEW PHYTOL, V167, P229, DOI 10.1111/j.1469-8137.2005.01400.x; Molloy SS, 1999, TRENDS CELL BIOL, V9, P28, DOI 10.1016/S0962-8924(98)01382-8; Montanini B, 2006, FUNGAL GENET BIOL, V43, P630, DOI 10.1016/j.fgb.2006.04.001; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nakahama T, 2010, FUNGAL GENET BIOL, V47, P318, DOI 10.1016/j.fgb.2009.12.011; NAKANO T, 1994, BIOCHEM BIOPH RES CO, V198, P10, DOI 10.1006/bbrc.1994.1002; Nakashima S, 2003, BIOCHEM J, V376, P655, DOI 10.1042/BJ20030830; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pop C, 2007, BIOCHEMISTRY-US, V46, P4398, DOI 10.1021/bi602623b; Powner D, 1998, MOL CELL BIOL, V18, P400, DOI 10.1128/MCB.18.1.400; PRECIADOPATT L, 1994, EUR J BIOCHEM, V223, P35, DOI 10.1111/j.1432-1033.1994.tb18963.x; Rae D., 1996, SCAND J GASTROENTE S, V219, P24; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soragni E, 2001, EMBO J, V20, P5079, DOI 10.1093/emboj/20.18.5079; Sugiyama M, 2002, J BIOL CHEM, V277, P20051, DOI 10.1074/jbc.M200264200; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Wakatsuki S, 2001, BBA-GENE STRUCT EXPR, V1522, P74, DOI 10.1016/S0167-4781(01)00308-6; Wang XM, 2002, PHYSIOL PLANTARUM, V115, P331, DOI 10.1034/j.1399-3054.2002.1150301.x; Wang YM, 2003, J BIOL CHEM, V278, P3210, DOI 10.1074/jbc.M210431200; Xu W, 2009, J BIOL CHEM, V284, P16659, DOI 10.1074/jbc.M808029200	51	12	12	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1533	1547		10.1074/jbc.M112.384156	http://dx.doi.org/10.1074/jbc.M112.384156			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192346	Green Published, hybrid			2022-12-25	WOS:000313751400011
J	Cowie, CT; Rose, N; Ezz, W; Xuan, W; Cortes-Waterman, A; Belousova, E; Toelle, BG; Sheppeard, V; Marks, GB				Cowie, Christine T.; Rose, Nectarios; Ezz, Wafaa; Xuan, Wei; Cortes-Waterman, Adriana; Belousova, Elena; Toelle, Brett G.; Sheppeard, Vicky; Marks, Guy B.			Respiratory Health before and after the Opening of a Road Traffic Tunnel: A Planned Evaluation	PLOS ONE			English	Article							AIR-POLLUTION; AMBIENT AIR; QUALITY; ASTHMA	Objective: The construction of a new road tunnel in Sydney, Australia, and concomitant reduction in traffic on a major road presented the opportunity to study the effects of this traffic intervention on respiratory health. Methods: We made measurements in a cohort of residents in the year before the tunnel opened (2006) and in each of two years afterwards (2007-2008). Cohort members resided in one of four exposure zones, including a control zone. Each year, a respiratory questionnaire was administered (n = 2,978) and a panel sub-cohort (n = 380) performed spirometry once and recorded peak expiratory flow and symptoms twice daily for nine weeks. Results: There was no consistent evidence of improvement in respiratory health in residents living along the bypassed main road, despite a reduction in traffic from 90,000 to 45,000 vpd. Residents living near tunnel feeder roads reported more upper respiratory symptoms in the survey but not in the panel sub-cohort. Residents living around the tunnel ventilation stack reported more upper and lower respiratory symptoms and had lower spirometric volumes after the tunnel opened. Air pollutant levels measured near the stack did not increase over the study period. Conclusion: The finding of adverse health effects among residents living around the stack is unexpected and difficult to explain, but might be due to unmeasured pollutants or risk factors or an unrecognized pollutant source nearby. The lack of improvement in respiratory health among people living along the bypassed main road probably reflects a minimal change in exposure due to distance of residence from the road.	[Cowie, Christine T.; Rose, Nectarios; Ezz, Wafaa; Xuan, Wei; Cortes-Waterman, Adriana; Belousova, Elena; Toelle, Brett G.; Marks, Guy B.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Cowie, Christine T.; Ezz, Wafaa; Xuan, Wei; Cortes-Waterman, Adriana; Marks, Guy B.] Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia; [Rose, Nectarios] NSW Hlth Dept, Sydney, NSW, Australia; [Sheppeard, Vicky] Western Sydney & Nepean Blue Mt Publ Hlth Unit, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research	Cowie, CT (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	christine.cowie@sydney.edu.au	Cowie, Christine/X-5945-2019; Marks, Guy B./F-5058-2013; Cowie, Christine T/M-2864-2017; Toelle, Brett G/B-1531-2008	Cowie, Christine/0000-0003-1177-4733; Marks, Guy B./0000-0002-8976-8053; Cowie, Christine T/0000-0003-1177-4733; Toelle, Brett G/0000-0002-7375-0019; Rose, Nectarios/0000-0002-7384-9967	Cooperative Research Centre for Asthma Airways; NSW Health Department	Cooperative Research Centre for Asthma Airways; NSW Health Department	The authors acknowledge funding support from the Cooperative Research Centre for Asthma & Airways and the NSW Health Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, other than the contributions made by NR and VS as indicated under Competing Interests.	Australian Bureau of Statistics website, 2006, CENS POP HOUS; Bartonova A, 1999, J ENVIRON MONITOR, V1, P337, DOI 10.1039/a902780g; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Burr ML, 2004, OCCUP ENVIRON MED, V61, P212, DOI 10.1136/oem.2002.003244; Capon A, 2008, ENV HLTH, V7, P10; Cowie CT, 2012, ENVIRON SCI TECHNOL, V46, P2918, DOI 10.1021/es202686r; Fischer PH, 2000, ATMOS ENVIRON, V34, P3713, DOI 10.1016/S1352-2310(00)00067-4; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Karner AA, 2010, ENVIRON SCI TECHNOL, V44, P5334, DOI 10.1021/es100008x; Knibbs LD, 2009, ATMOS ENVIRON, V43, P3510, DOI 10.1016/j.atmosenv.2009.04.029; Kuykendall JR, 2009, INHAL TOXICOL, V21, P747, DOI 10.1080/08958370802524357; Lee JT, 2007, J AIR WASTE MANAGE, V57, P968; Li Y, 2010, SCI TOTAL ENVIRON, V408, P1226, DOI 10.1016/j.scitotenv.2009.11.035; Lin WW, 2011, ENVIRON HEALTH PERSP, V119, P1507, DOI 10.1289/ehp.1103461; Lodovici M, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/487074; MacNeill SJ, 2009, THORAX, V64, P651, DOI 10.1136/thx.2008.101360; Mazzoli-Rocha F, 2010, CELL BIOL TOXICOL, V26, P481, DOI 10.1007/s10565-010-9158-2; National Health and Medical Research Council website, 2008, AIR QUAL TRAFF TUNN; Peel JL, 2010, 148 HEI; Roorda-Knape MC, 1998, ATMOS ENVIRON, V32, P1921, DOI 10.1016/S1352-2310(97)00496-2; Rose N, 2011, ENVIRON SCI TECHNOL, V45, P294, DOI 10.1021/es100683t; RTA, 2010, POST REV M7 MOT CROS; RTA, 2001, LAN COV TUNN ASS ROA; Toelle BG, 2004, BRIT MED J, V328, P386, DOI 10.1136/bmj.328.7436.386; WCC, 2010, COMMUNICATION; Zhou Y, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-89	27	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e48921	10.1371/journal.pone.0048921	http://dx.doi.org/10.1371/journal.pone.0048921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209560	gold, Green Submitted, Green Published			2022-12-25	WOS:000312104900004
J	Kopp, F; Oak, PS; Wagner, E; Roidl, A				Kopp, Florian; Oak, Prajakta S.; Wagner, Ernst; Roidl, Andreas			miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; POLYCOMB GROUP PROTEINS; E-CADHERIN; STEM-CELLS; RT-PCR; MICRORNA DYSREGULATION; DRUG-RESISTANCE; DOWN-REGULATION; FAMILY; ZEB1	Acquired resistance to classical chemotherapeutics is a major obstacle in cancer treatment. Doxorubicin is frequently used in breast cancer therapy either as single-agent or in combination with other drugs like docetaxel and cyclophosphamide. All these chemotherapies have in common that they are administered sequentially and often result in chemoresistance. Here, we mimicked this pulse therapy of breast cancer patients in an in vitro cell culture model, where the epithelial breast cancer cell line BT474 was sequentially treated with doxorubicin for several treatment cycles. In consequence, we obtained chemoresistant cells displaying a mesenchymal-like phenotype with decreased levels of miR-200c. To investigate the involvement of miR-200c in resistance formation, we inhibited and overexpressed miR-200c in different cell lines. Thereby, the cells were rendered more resistant or susceptible to doxorubicin treatment. Moreover, the receptor tyrosine kinase TrkB and the transcriptional repressor Bmi1 were identified as miR-200c targets mediating the drug resistance. Hence, we provide a mechanism of acquired resistance to doxorubicin that is caused by the loss of miR-200c. Along with this, our study demonstrates the complex network of microRNA mediated chemoresistance highlighting the challenges in cancer therapy and the importance of novel microRNA-modulating anticancer agents. Citation: Kopp F, Oak PS, Wagner E, Roidl A (2012) miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression. PLoS ONE 7(11): e50469. doi: 10.1371/journal.pone.0050469	[Kopp, Florian; Oak, Prajakta S.; Wagner, Ernst; Roidl, Andreas] Univ Munich, Dept Pharm, Munich, Germany	University of Munich	Roidl, A (corresponding author), Univ Munich, Dept Pharm, Munich, Germany.	andreas.roidl@cup.uni-muenchen.de	Wagner, Ernst/A-7435-2012; Wagner, Ernst/ABB-5976-2020	Wagner, Ernst/0000-0001-8413-0934; Wagner, Ernst/0000-0001-8413-0934; Kopp, Florian/0000-0001-9952-635X	DFG Cluster of Excellence "Nanosystems Initiative Munich (NIM)" [DFG SFB 1032]	DFG Cluster of Excellence "Nanosystems Initiative Munich (NIM)"(German Research Foundation (DFG))	This work was supported by DFG Cluster of Excellence "Nanosystems Initiative Munich (NIM)", DFG SFB 1032 (Nanoagents). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; American Cancer Society, 2012, CANC FACTS FIG; Bao LL, 2012, AM J PATHOL, V180, P2490, DOI 10.1016/j.ajpath.2012.02.024; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blower PE, 2008, MOL CANCER THER, V7, P1, DOI 10.1158/1535-7163.MCT-07-0573; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Cahill DP, 1999, TRENDS BIOCHEM SCI, V24, pM57, DOI 10.1016/S0968-0004(99)01466-8; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Cochrane DR, 2009, MOL CANCER THER, V8, P1055, DOI 10.1158/1535-7163.MCT-08-1046; Coley HM, 2008, CANCER TREAT REV, V34, P378, DOI 10.1016/j.ctrv.2008.01.007; Crea F, 2011, INT J CANCER, V128, P1946, DOI 10.1002/ijc.25522; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fojo T, 2007, CLIN BREAST CANCER, V7, P749, DOI 10.3816/CBC.2007.n.035; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2012, CANCER J, V18, P215, DOI 10.1097/PPO.0b013e318250c001; Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11; Kim D, 2002, J BIOCHEM MOL BIOL, V35, P106; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Kutanzi KR, 2011, CLIN EPIGENETICS, V2, P171, DOI 10.1007/s13148-011-0040-8; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Martin M, 2006, WOMENS HEALTH, V2, P527, DOI 10.2217/17455057.2.4.527; Mittmann N, 2010, CURR ONCOL, V17, P7; O'Driscoll L, 2006, CURR CANCER DRUG TAR, V6, P365, DOI 10.2174/156800906777723958; Oak P. S., 2012, INT J CANC; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pogribny IP, 2010, INT J CANCER, V127, P1785, DOI 10.1002/ijc.25191; Raguz S, 2008, BRIT J CANCER, V99, P387, DOI 10.1038/sj.bjc.6604510; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Rasband W., 2006, IMAGEJ; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Wu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014648	49	94	98	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50469	10.1371/journal.pone.0050469	http://dx.doi.org/10.1371/journal.pone.0050469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209748	Green Published, gold, Green Submitted			2022-12-25	WOS:000312104900054
J	Stapleton, JT; Chaloner, K; Martenson, JA; Zhang, JY; Klinzman, D; Xiang, JH; Sauter, W; Desai, SN; Landay, A				Stapleton, Jack T.; Chaloner, Kathryn; Martenson, Jeffrey A.; Zhang, Jingyang; Klinzman, Donna; Xiang, Jinhua; Sauter, Wendy; Desai, Seema N.; Landay, Alan			GB Virus C Infection Is Associated with Altered Lymphocyte Subset Distribution and Reduced T Cell Activation and Proliferation in HIV-Infected Individuals	PLOS ONE			English	Article							IMMUNE ACTIVATION; CD38 EXPRESSION; IL-2 PRODUCTION; REPLICATION; PROGRESSION; SURVIVAL; VIREMIA; COINFECTION; DISEASE; RNA	GBV-C infection is associated with prolonged survival and with reduced T cell activation in HIV-infected subjects not receiving combination antiretroviral therapy (cART). The relationship between GBV-C and T cell activation in HIV-infected subjects was examined. HIV-infected subjects on cART with non-detectable HIV viral load (VL) or cART naive subjects were studied. GBV-C VL and HIV VL were determined. Cell surface markers of activation (CD38(+)/HLA-DR+), proliferation (Ki-67+), and HIV entry co-receptor expression (CCR5+ and CXCR4+) on total CD4+ and CD8+ T cells, and on naive, central memory (CM), effector memory (EM), and effector CD4+ and CD8+ subpopulations were measured by flow cytometry. In subjects with suppressed HIV VL, GBV-C was consistently associated with reduced activation in naive, CM, EM, and effector CD4+ cells. GBV-C was associated with reduced CD4+ and CD8+ T cell surface expression of activation and proliferation markers, independent of HIV VL classification. GBV-C was also associated with higher proportions of naive CD4+ and CD8+ T cells, and with lower proportions of EM CD4+ and CD8+ T cells. In conclusion, GBV-C infection was associated with reduced activation of CD4+ and CD8+ T cells in both HIV viremic and HIV RNA suppressed patients. Those with GBV-C infection demonstrated an increased proportion of naive T cells and a reduction in T cell activation and proliferation independent of HIV VL classification, including those with suppressed HIV VL on cART. Since HIV pathogenesis is thought to be accelerated by T cell activation, these results may contribute to prolonged survival among HIV infected individuals co-infected with GBV-C. Furthermore, since cART therapy does not reduce T cell activation to levels seen in HIV-uninfected people, GBV-C infection may be beneficial for HIV-related diseases in those effectively treated with anti-HIV therapy. Citation: Stapleton JT, Chaloner K, Martenson JA, Zhang J, Klinzman D, et al. (2012) GB Virus C Infection Is Associated with Altered Lymphocyte Subset Distribution and Reduced T Cell Activation and Proliferation in HIV-Infected Individuals. PLoS ONE 7(11): e50563. doi:10.1371/journal.pone.0050563	[Stapleton, Jack T.; Klinzman, Donna; Xiang, Jinhua] Iowa City VA Med Ctr, Res & Med Serv, Iowa City, IA USA; [Stapleton, Jack T.; Xiang, Jinhua; Sauter, Wendy] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Stapleton, Jack T.; Xiang, Jinhua; Sauter, Wendy] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Stapleton, Jack T.; Xiang, Jinhua; Sauter, Wendy] Univ Iowa, Dept Immunol, Iowa City, IA USA; [Chaloner, Kathryn; Zhang, Jingyang] Univ Iowa, Dept Biostat, Coll Publ Hlth, Iowa City, IA USA; [Chaloner, Kathryn] Univ Iowa, Dept Stat & Actuarial Sci, Coll Publ Hlth, Iowa City, IA 52242 USA; [Martenson, Jeffrey A.; Desai, Seema N.; Landay, Alan] Rush Univ, Dept Microbiol, Chicago, IL 60612 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Rush University	Stapleton, JT (corresponding author), Iowa City VA Med Ctr, Res & Med Serv, Iowa City, IA USA.	jack-stapleton@uiowa.edu	Chaloner, Kathryn/B-5090-2013	Stapleton, Jack/0000-0002-2302-9055	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; National Institutes of Health [RO1 AI-58740]; John B. Pendleton Charitable Trust; Flow Cytometry Core facility at Rush University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI082151, R01AI058740] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John B. Pendleton Charitable Trust; Flow Cytometry Core facility at Rush University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research work was supported by grants from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Merit Review Grant, JTS) and the National Institutes of Health (RO1 AI-58740, JTS). We also thank the John B. Pendleton Charitable Trust and the Flow Cytometry Core facility at Rush University for support and assistance with these studies. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Sousa VK, 2012, AIDS RES HUM RETROV, V28, P1301, DOI 10.1089/aid.2011.0212; Badley AD, 1999, CELL DEATH DIFFER, V6, P420, DOI 10.1038/sj.cdd.4400509; Baggio-Zappia GL, 2011, MEM I OSWALDO CRUZ, V106, P662, DOI 10.1590/S0074-02762011000600004; Bhattarai N, 2012, J INFECT DIS, V206, P1469, DOI 10.1093/infdis/jis515; Bhattarai N, 2012, J IMMUNOL, V189, P2211, DOI 10.4049/jimmunol.1201324; Bhattarai N, 2012, MEM I OSWALDO CRUZ, V107, P568, DOI 10.1590/S0074-02762012000400023; Bhattarai N, 2012, TRENDS MICROBIOL, V20, P124, DOI 10.1016/j.tim.2012.01.004; Bjorkman P, 2004, AIDS, V18, P877, DOI [10.1097/01.aids.0000125908.52357.4c, 10.1097/00002030-200404090-00005]; Bjorkman P, 2007, AIDS, V21, P1641, DOI 10.1097/QAD.0b013e32823bc9b7; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chambers J.M., 1992, STAT MODELS S, P95, DOI DOI 10.1201/9780203738535; Douek Daniel, 2007, Top HIV Med, V15, P114; Douek Daniel C., 2003, AIDS Reviews, V5, P172; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jung S, 2005, AIDS, V19, P1267, DOI 10.1097/01.aids.0000180097.50393.df; Jung S, 2007, AIDS, V21, P645, DOI 10.1097/QAD.0b013e32803277c7; Kaplan RC, 2011, ATHEROSCLEROSIS, V217, P207, DOI 10.1016/j.atherosclerosis.2011.03.011; Kaplan RC, 2011, J INFECT DIS, V203, P452, DOI 10.1093/infdis/jiq071; KINTER AL, 1995, J IMMUNOL, V154, P2448; Kovacs A, 2010, J INFECT DIS, V201, P823, DOI 10.1086/650997; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Lefrere JJ, 1999, J INFECT DIS, V179, P783, DOI 10.1086/314671; Maidana Giret M. T., 2009, AIDS, V23, P2277; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Mohr EL, 2009, J VIRAL HEPATITIS, V16, P757, DOI 10.1111/j.1365-2893.2009.01194.x; Nattermann J, 2003, AIDS, V17, P1457, DOI 10.1097/00002030-200307040-00006; Nunnari G, 2003, ANN INTERN MED, V139, P26, DOI 10.7326/0003-4819-139-1-200307010-00009; O'Brien PC, 1984, BIOMETRICS, V31, P511; R Development Core Team, 2007, R LANG ENV STAT COMP; Rey D, 2000, EUR J CLIN MICROBIOL, V19, P721, DOI 10.1007/s100960000352; Rydze RT, 2012, J INFECT DIS, V206, P69, DOI 10.1093/infdis/jis312; Rydze RT, 2011, ANTIVIRAL T IN PRESS; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schwarze-Zander C, 2010, ANTIVIR THER, V15, P745, DOI 10.3851/IMP1602; Stapleton JT, 2011, J GEN VIROL, V92, P233, DOI 10.1099/vir.0.027490-0; Stapleton JT, 2009, AIDS, V23, P605, DOI 10.1097/QAD.0b013e32831f1b00; Stapleton JT, 2003, SEMIN LIVER DIS, V23, P137; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Supapol WB, 2008, J INFECT DIS, V197, P1369, DOI 10.1086/587488; Tillmann HL, 2001, NEW ENGL J MED, V345, P715, DOI 10.1056/NEJMoa010398; Vahidnia F, 2012, CLIN INFECT DIS, V55, P1012, DOI 10.1093/cid/cis589; Van der Bij AK, 2005, J INFECT DIS, V191, P678, DOI 10.1086/427559; Williams CF, 2004, NEW ENGL J MED, V350, P981, DOI 10.1056/NEJMoa030107; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xiang JH, 2001, NEW ENGL J MED, V345, P707, DOI 10.1056/NEJMoa003364; Xiang JH, 2000, J VIROL, V74, P9125, DOI 10.1128/JVI.74.19.9125-9133.2000; Xiang JH, 2006, P NATL ACAD SCI USA, V103, P15570, DOI 10.1073/pnas.0604728103; Xiang JH, 2012, VIROLOGY, V430, P53, DOI 10.1016/j.virol.2012.04.019; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang W, 2006, HIV MED, V7, P173, DOI 10.1111/j.1468-1293.2006.00366.x	53	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50563	10.1371/journal.pone.0050563	http://dx.doi.org/10.1371/journal.pone.0050563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209780	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900066
J	Ratanakorn, P; Wiratsudakul, A; Wiriyarat, W; Eiamampai, K; Farmer, AH; Webster, RG; Chaichoune, K; Suwanpakdee, S; Pothieng, D; Puthavathana, P				Ratanakorn, Parntep; Wiratsudakul, Anuwat; Wiriyarat, Witthawat; Eiamampai, Krairat; Farmer, Adrian H.; Webster, Robert G.; Chaichoune, Kridsada; Suwanpakdee, Sarin; Pothieng, Duangrat; Puthavathana, Pilaipan			Satellite Tracking on the Flyways of Brown-Headed Gulls and Their Potential Role in the Spread of Highly Pathogenic Avian Influenza H5N1 Virus	PLOS ONE			English	Article							WILD BIRDS; A H5N1; HONG-KONG; OUTBREAK; WATERFOWL; EVOLUTION; THAILAND; CHINA	Brown-headed gulls (Larus brunnicephalus), winter visitors of Thailand, were tracked by satellite telemetry during 2008-2011 for investigating their roles in the highly pathogenic avian influenza (HPAI) H5N1 virus spread. Eight gulls negative for influenza virus infection were marked with solar-powered satellite platform transmitters at Bang Poo study site in Samut Prakarn province, Thailand; their movements were monitored by the Argos satellite tracking system, and locations were mapped. Five gulls completed their migratory cycles, which spanned 7 countries (China, Bangladesh, India, Myanmar, Thailand, Cambodia, and Vietnam) affected by the HPAI H5N1 virus. Gulls migrated from their breeding grounds in China to stay overwinter in Thailand and Cambodia; while Bangladesh, India, Myanmar, and Vietnam were the places of stopovers during migration. Gulls traveled an average distance of about 2400 km between Thailand and China and spent 1-2 weeks on migration. Although AI surveillance among gulls was conducted at the study site, no AI virus was isolated and no H5N1 viral genome or specific antibody was detected in the 75 gulls tested, but 6.6% of blood samples were positive for pan-influenza A antibody. No AI outbreaks were reported in areas along flyways of gulls in Thailand during the study period. Distance and duration of migration, tolerability of the captive gulls to survive the HPAI H5N1 virus challenge and days at viral shedding after the virus challenging suggested that the Brown-headed gull could be a potential species for AI spread, especially among Southeast Asian countries, the epicenter of H5N1 AI outbreak.	[Puthavathana, Pilaipan] Mahidol Univ, Dept Microbiol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; [Ratanakorn, Parntep; Wiratsudakul, Anuwat; Wiriyarat, Witthawat; Chaichoune, Kridsada; Suwanpakdee, Sarin] Mahidol Univ, Fac Vet Sci, Nakhon Pathom, Thailand; [Eiamampai, Krairat; Pothieng, Duangrat] Minist Nat Resource & Environm, Dept Natl Pk Wildlife & Plant Conservat, Bangkok, Thailand; [Farmer, Adrian H.] Wild Ecol Solut, Ft Collins, CO USA; [Webster, Robert G.] St Jude Childrens Res Hosp, Div Virol, Dept Infect Dis, Memphis, TN USA	Mahidol University; Mahidol University; St Jude Children's Research Hospital	Puthavathana, P (corresponding author), Mahidol Univ, Dept Microbiol, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand.	siput@mahidol.ac.th	Wiratsudakul, Anuwat/V-2619-2019	Wiratsudakul, Anuwat/0000-0002-1112-3220; Chaichoun, Kridsada/0000-0002-3979-5328; Suwanpakdee, Sarin/0000-0002-1679-0751	Centers for Disease Control and Prevention (CDC) [1U19CI000399]; Thailand Research Fund; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U19CI000399] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Thailand Research Fund(Thailand Research Fund (TRF)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was a part of the "Avian Influenza Surveillance in Thailand-Studies at Human-Animal Interface'' project supported by Cooperative Agreement Number 1U19CI000399 from the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. PP, the grant's principal investigator, is supported by Thailand Research Fund for Senior Research Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; BirdLife International, SPEC FACTSH LARUSBR; BirdLife International, IMP BIRD AR FACTSH I; Chaipakdee M, 2009, WILDLIFE YB, V10, P99; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Convention on Biological Diversity, 2012, THREAT BIOD SE AS RI; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Gaidet N, 2008, EMERG INFECT DIS, V14, P1164, DOI 10.3201/eid1407.071477; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; Gutierrez RA, 2009, VIRUSES-BASEL, V1, P335, DOI 10.3390/v1030335; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Lee YJ, 2008, EMERG INFECT DIS, V14, P487, DOI 10.3201/eid1403.070767; Lekagul B, 1991, GUIDE BIRDS THAILAND, P145; Li YB, 2011, EMERG INFECT DIS, V17, P265, DOI 10.3201/eid1702.100732; Louisirirotchanakul S, 2007, J CLIN MICROBIOL, V45, P2284, DOI 10.1128/JCM.00921-07; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Prosser DJ, 2009, IBIS, V151, P568, DOI 10.1111/j.1474-919X.2009.00932.x; Prosser DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017622; Puthavathana P, 2009, EMERG INFECT DIS, V15, P127, DOI 10.3201/eid1501.080524; Recombinomics, 2008, H5N1 SPREAD BANGL; Saad MD, 2007, EMERG INFECT DIS, V13, P1120, DOI 10.3201/eid1307.061222; Sokhem P, 2006, INT J WATER RESOUR D, V22, P399, DOI 10.1080/07900620500482642; Songserm T, 2006, EMERG INFECT DIS, V12, P681, DOI 10.3201/eid1204.051396; Songserm T, 2006, EMERG INFECT DIS, V12, P1744, DOI 10.3201/eid1211.060542; Suwannakarn K, 2009, INFECT GENET EVOL, V9, P896, DOI 10.1016/j.meegid.2009.06.004; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; WEBSTER RG, 2006, MICROBE, V1, P559; WHO, 2012, CUM NUMB CONF HUM CA; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2011, H5N1 AV INFL TIM MAJ	39	13	13	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49939	10.1371/journal.pone.0049939	http://dx.doi.org/10.1371/journal.pone.0049939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209623	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700027
J	Sircely, J; Naeem, S				Sircely, Jason; Naeem, Shahid			Biodiversity and Ecosystem Multi-Functionality: Observed Relationships in Smallholder Fallows in Western Kenya	PLOS ONE			English	Article							COMMUNITY COMPOSITION; SPECIES RICHNESS; SOIL FERTILITY; PLANT TRAITS; DIVERSITY; SERVICES; MANAGEMENT; EVENNESS; INCREASE; BIOMASS	Recent studies indicate that species richness can enhance the ability of plant assemblages to support multiple ecosystem functions. To understand how and when ecosystem services depend on biodiversity, it is valuable to expand beyond experimental grasslands. We examined whether plant diversity improves the capacity of agroecosystems to sustain multiple ecosystem services-production of wood and forage, and two elements of soil formation-in two types of smallholder fallows in western Kenya. In 18 grazed and 21 improved fallows, we estimated biomass and quantified soil organic carbon, soil base cations, sand content, and soil infiltration capacity. For four ecosystem functions (wood biomass, forage biomass, soil base cations, steady infiltration rates) linked to the focal ecosystem services, we quantified ecosystem service multi-functionality as (1) the proportion of functions above half-maximum, and (2) mean percentage excess above mean function values, and assessed whether plant diversity or environmental favorability better predicted multi-functionality. In grazed fallows, positive effects of plant diversity best explained the proportion above half-maximum and mean percentage excess, the former also declining with grazing intensity. In improved fallows, the proportion above half-maximum was not associated with soil carbon or plant diversity, while soil carbon predicted mean percentage excess better than diversity. Grazed fallows yielded stronger evidence for diversity effects on multi-functionality, while environmental conditions appeared more influential in improved fallows. The contrast in diversity-multi-functionality relationships among fallow types appears related to differences in management and associated factors including disturbance and species composition. Complementary effects of species with contrasting functional traits on different functions and multi-functional species may have contributed to diversity effects in grazed fallows. Biodiversity and environmental favorability may enhance the capacity of smallholder fallows to simultaneously provide multiple ecosystem services, yet their effects are likely to vary with fallow management.	[Sircely, Jason; Naeem, Shahid] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA	Columbia University	Sircely, J (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	jas2162@columbia.edu			United States Agency for International Development (USAID) [EPP-A-00-06-00014-00]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This publication is made possible by the generous support of the American people through the United States Agency for International Development (USAID) (www.usaid.gov), under the terms of the TransLinks Leader with Associates Cooperative Agreement No. EPP-A-00-06-00014-00 to The Wildlife Conservation Society (www.wcs.org). TransLinks (www.translinks.org) is a partnership of The Wildlife Conservation Society, The Earth Institute, EnterpriseWorks/VITA, Forest Trends and The Land Tenure Center. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Augustine DJ, 2006, ECOSYSTEMS, V9, P1242, DOI 10.1007/s10021-005-0020-y; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bond W. J., 1996, FIRE PLANTS, DOI DOI 10.2307/2404797; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cardinale BJ, 2002, ECOLOGY, V83, P1915; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Dear BS, 2011, GRASSLAND SPECIES PR; Diaz S, 2006, TERRESTRIAL ECOSYSTE, P81; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Duraiappah A. K., 2005, MILLENNIUM ECOSYSTEM; Fermont AM, 2008, AGR ECOSYST ENVIRON, V128, P239, DOI 10.1016/j.agee.2008.06.009; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; GENIN D, 1993, AGR SYST, V43, P381, DOI 10.1016/0308-521X(93)90030-6; Graff P, 2007, ECOLOGY, V88, P188, DOI 10.1890/0012-9658(2007)88[188:SIPANP]2.0.CO;2; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Horton R.E., 1940, P SOIL SCI SOC AM, V5, P399; Jackson LE, 2007, AGR ECOSYST ENVIRON, V121, P196, DOI 10.1016/j.agee.2006.12.017; Jouseau CF, 2008, ECOSYSTEM FUNCTION S; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Mekonnen K, 1997, PLANT SOIL, V188, P319, DOI 10.1023/A:1004264608576; Montagnac JA, 2009, COMPR REV FOOD SCI F, V8, P181, DOI 10.1111/j.1541-4337.2009.00077.x; Naeem S, 2002, NATURE, V416, P23, DOI 10.1038/416023a; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Palm CA, 2001, AGR ECOSYST ENVIRON, V83, P27, DOI 10.1016/S0167-8809(00)00267-X; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Ponce-Hernandez R., 2004, ASSESSING CARBON STO; Quetier F, 2007, ECOL MONOGR, V77, P33, DOI 10.1890/06-0054; R Core Team, 2022, R LANG ENV STAT COMP; Redford KH, 2009, CONSERV BIOL, V23, P785, DOI 10.1111/j.1523-1739.2009.01271.x; Sanchez P, 2007, P NATL ACAD SCI USA, V104, P16775, DOI 10.1073/pnas.0700423104; Schroth G, 2002, FOREST ECOL MANAG, V163, P131, DOI 10.1016/S0378-1127(01)00537-0; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; Shepherd KD, 2007, J NEAR INFRARED SPEC, V15, P1, DOI 10.1255/jnirs.716; Smit C, 2007, OECOLOGIA, V152, P265, DOI 10.1007/s00442-006-0650-6; Stahl L, 2002, PLANT SOIL, V243, P103, DOI 10.1023/A:1019937408919; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Swan CM, 2009, ECOLOGY, V90, P1650, DOI 10.1890/08-0329.1; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Walsh MG, 2006, LAND DEGRADATION SUR; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	61	8	10	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50152	10.1371/journal.pone.0050152	http://dx.doi.org/10.1371/journal.pone.0050152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209662	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700035
J	Six, JS; Hughes-Riley, T; Stupic, KF; Pavlovskaya, GE; Meersmann, T				Six, Joseph S.; Hughes-Riley, Theodore; Stupic, Karl F.; Pavlovskaya, Galina E.; Meersmann, Thomas			Pathway to Cryogen Free Production of Hyperpolarized Krypton-83 and Xenon-129	PLOS ONE			English	Article							HIGH-DENSITY RB; SPIN-EXCHANGE; POLARIZED XE-129; GAS-EXCHANGE; MOUSE LUNG; LASER; XENON; NMR; RELAXATION; PRESSURE	Hyperpolarized (hp) Xe-129 and hp Kr-83 for magnetic resonance imaging (MRI) are typically obtained through spin-exchange optical pumping (SEOP) in gas mixtures with dilute concentrations of the respective noble gas. The usage of dilute noble gases mixtures requires cryogenic gas separation after SEOP, a step that makes clinical and preclinical applications of hp Xe-129 MRI cumbersome. For hp Kr-83 MRI, cryogenic concentration is not practical due to depolarization that is caused by quadrupolar relaxation in the condensed phase. In this work, the concept of stopped flow SEOP with concentrated noble gas mixtures at low pressures was explored using a laser with 23.3 W of output power and 0.25 nm linewidth. For Xe-129 SEOP without cryogenic separation, the highest obtained MR signal intensity from the hp xenon-nitrogen gas mixture was equivalent to that arising from 15.5 +/- 1.9% spin polarized Xe-129 in pure xenon gas. The production rate of the hp gas mixture, measured at 298 K, was 1.8 cm(3)/min. For hp Kr-83, the equivalent of 4.4 +/- 0.5% spin polarization in pure krypton at a production rate of 2 cm(3)/min was produced. The general dependency of spin polarization upon gas pressure obtained in stopped flow SEOP is reported for various noble gas concentrations. Aspects of SEOP specific to the two noble gas isotopes are discussed and compared with current theoretical opinions. A non-linear pressure broadening of the Rb D-1 transition was observed and taken into account for the qualitative description of the SEOP process.	[Six, Joseph S.; Hughes-Riley, Theodore; Stupic, Karl F.; Pavlovskaya, Galina E.; Meersmann, Thomas] Univ Nottingham, Sch Clin Sci, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England	University of Nottingham	Meersmann, T (corresponding author), Univ Nottingham, Sch Clin Sci, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England.	Thomas.Meersmann@Nottingham.ac.uk	Hughes-Riley, Theodore/I-8167-2019; pavlovskaya, galina/AAA-3732-2021	Hughes-Riley, Theodore/0000-0001-8020-430X; pavlovskaya, galina/0000-0003-4352-3269; Meersmann, Thomas/0000-0003-0243-0672	Medical Research Council [G0900785]; MRC [G0900785] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This material was based upon work supported by the Medical Research Council under Grant No. G0900785. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCOCK CB, 1984, CAN METALL QUART, V23, P309; Anger BC, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.043406; BOUCHIAT MA, 1972, J CHEM PHYS, V56, P3703, DOI 10.1063/1.1677750; Butscher R, 1996, CHEM PHYS LETT, V249, P444, DOI 10.1016/0009-2614(95)01443-8; CATES GD, 1992, PHYS REV A, V45, P4631, DOI 10.1103/PhysRevA.45.4631; Cleveland ZI, 2008, CHEMPHYSCHEM, V9, P1375, DOI 10.1002/cphc.200800134; Cleveland ZI, 2007, J AM CHEM SOC, V129, P1784, DOI 10.1021/ja065994t; Cleveland ZI, 2009, J PHYS CHEM B, V113, P12489, DOI 10.1021/jp9049582; Cleveland ZI, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159493; Comment A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.018104; Couture AH, 2008, J APPL PHYS, V104, DOI 10.1063/1.3018181; COWGILL DF, 1973, PHYS REV B, V8, P4966, DOI 10.1103/PhysRevB.8.4966; COWGILL DF, 1976, PHYS REV B, V13, P2773, DOI 10.1103/PhysRevB.13.2773; Dregely I, 2011, J MAGN RESON IMAGING, V33, P1052, DOI 10.1002/jmri.22533; Driehuys B, 1996, APPL PHYS LETT, V69, P1668, DOI 10.1063/1.117022; Driehuys B, 2009, RADIOLOGY, V252, P386, DOI [10.1148/radiol.2513081550, 10.1148/radiol.2522081550]; Fink A, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.053411; Fink A, 2007, APPL PHYS B-LASERS O, V89, P65, DOI 10.1007/s00340-007-2754-z; Haake M, 1997, J AM CHEM SOC, V119, P11711, DOI 10.1021/ja9713587; HAPPER W, 1972, REV MOD PHYS, V44, P169, DOI 10.1103/RevModPhys.44.169; HAPPER W, 1984, PHYS REV A, V29, P3092, DOI 10.1103/PhysRevA.29.3092; Hersman FW, 2008, ACAD RADIOL, V15, P683, DOI 10.1016/j.acra.2007.09.020; Hori Y, 2009, MAGN RESON MED SCI, V8, P73, DOI 10.2463/mrms.8.73; HRYCYSHYN ES, 1970, CAN J PHYS, V48, P2761, DOI 10.1139/p70-343; Imai H, 2008, CONCEPT MAGN RESON B, V33B, P192, DOI 10.1002/cmr.b.20117; JAMESON CJ, 1988, J CHEM PHYS, V89, P4074, DOI 10.1063/1.454842; Jau YY, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.022720; Jau YY, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052710; Kaushik SS, 2011, MAGN RESON MED, V65, P1155, DOI 10.1002/mrm.22697; Killian TJ, 1926, PHYS REV, V27, P578, DOI 10.1103/PhysRev.27.578; Knagge K, 2004, CHEM PHYS LETT, V397, P11, DOI 10.1016/j.cplett.2004.08.050; Kuzma NN, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.147602; Levron D, 1998, APPL PHYS LETT, V73, P2666, DOI 10.1063/1.122547; Lide D., 2021, CRC HDB CHEM PHYS; Luo J, 1999, APPL MAGN RESON, V17, P587, DOI 10.1007/BF03162088; MICHELS A, 1956, PHYSICA, V22, P17, DOI 10.1016/S0031-8914(56)80005-0; Miller GW, 2009, AIP CONF PROC, V1149, P905, DOI 10.1063/1.3215789; Moller HE, 2002, MAGN RESON MED, V47, P1029, DOI 10.1002/mrm.10173; Mortuza MG, 2003, J CHEM PHYS, V118, P1581, DOI 10.1063/1.1539042; Mugler JP, 2010, P NATL ACAD SCI USA, V107, P21707, DOI 10.1073/pnas.1011912107; Mugler JP, 1997, MAGN RESON MED, V37, P809, DOI 10.1002/mrm.1910370602; Nelson IA, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.012712; Nikolaou P, 2009, J MAGN RESON, V197, P249, DOI 10.1016/j.jmr.2008.12.015; Parnell SR, 2010, J APPL PHYS, V108, DOI 10.1063/1.3478707; Patz S, 2007, EUR J RADIOL, V64, P335, DOI 10.1016/j.ejrad.2007.08.008; Patz S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/015009; Pavlovskaya GE, 2005, P NATL ACAD SCI USA, V102, P18275, DOI 10.1073/pnas.0509419102; Raftery D, 1997, J AM CHEM SOC, V119, P8746, DOI 10.1021/ja972035d; RAFTERY D, 1991, PHYS REV LETT, V66, P584, DOI 10.1103/PhysRevLett.66.584; Romalis MV, 1997, PHYS REV A, V56, P4569, DOI 10.1103/PhysRevA.56.4569; Rosen MS, 1999, REV SCI INSTRUM, V70, P1546, DOI 10.1063/1.1149622; Ruset IC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.053002; SCHAEFER SR, 1990, PHYS REV A, V41, P6063, DOI 10.1103/PhysRevA.41.6063; Schrank G, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.063424; Shah NJ, 2000, NMR BIOMED, V13, P214, DOI 10.1002/1099-1492(200006)13:4<214::AID-NBM634>3.0.CO;2-G; Shao WJ, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.022713; Shea DA, 2010, HELIUM 3 SHORTAGE SU; Steck DA, 2010, RUBIDIUM 87 D LINE D; Stupic KF, 2011, PHYS MED BIOL, V56, P3731, DOI 10.1088/0031-9155/56/13/001; Stupic KF, 2011, J MAGN RESON, V208, P58, DOI 10.1016/j.jmr.2010.10.004; WAGSHUL ME, 1989, PHYS REV A, V40, P4447, DOI 10.1103/PhysRevA.40.4447; WAGSHUL ME, 1994, PHYS REV A, V49, P3854, DOI 10.1103/PhysRevA.49.3854; Wakayama T, 2008, J MAGN RESON IMAGING, V27, P777, DOI 10.1002/jmri.21287; Walker TG, 1997, REV MOD PHYS, V69, P629, DOI 10.1103/RevModPhys.69.629; Walter DK, 2001, PHYS REV LETT, V86, P3264, DOI 10.1103/PhysRevLett.86.3264; Whiting N, 2012, APPL PHYS B-LASERS O, V106, P775, DOI 10.1007/s00340-012-4924-x; Whiting N, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.053428; Whiting N, 2011, J MAGN RESON, V208, P298, DOI 10.1016/j.jmr.2010.11.016; ZENG X, 1985, PHYS REV A, V31, P260, DOI 10.1103/PhysRevA.31.260; Zerger JN, 2000, APPL PHYS LETT, V76, P1798, DOI 10.1063/1.126169; Zook AL, 2002, J MAGN RESON, V159, P175, DOI 10.1016/S1090-7807(02)00030-7	71	37	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49927	10.1371/journal.pone.0049927	http://dx.doi.org/10.1371/journal.pone.0049927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209620	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800033
J	Lieden, A; Winge, MCG; Saaf, A; Kockum, I; Ekelund, E; Rodriguez, E; Folster-Holst, R; Franke, A; Illig, T; Tengvall-Linder, M; Baurecht, H; Weidinger, S; Wahlgren, CF; Nordenskjold, M; Bradley, M				Lieden, Agne; Winge, Marten C. G.; Saaf, Annika; Kockum, Ingrid; Ekelund, Elisabeth; Rodriguez, Elke; Foelster-Holst, Regina; Franke, Andre; Illig, Thomas; Tengvall-Linder, Maria; Baurecht, Hansjoerg; Weidinger, Stephan; Wahlgren, Carl-Fredrik; Nordenskjold, Magnus; Bradley, Maria			Genetic Variation in the Epidermal Transglutaminase Genes Is Not Associated with Atopic Dermatitis	PLOS ONE			English	Article							OF-FUNCTION VARIANTS; LAMELLAR ICHTHYOSIS; SUSCEPTIBILITY LOCI; LINKAGE; ECZEMA; SKIN; MUTATIONS; FILAGGRIN; FAMILIES; POPULATION	Background: Atopic dermatitis (AD) is a common chronic inflammatory skin disorder where epidermal barrier dysfunction is a major factor in the pathogenesis. The identification of AD susceptibility genes related to barrier dysfunction is therefore of importance. The epidermal transglutaminases (TGM1, TGM3 and TGM5) encodes essential cross-linking enzymes in the epidermis. Objective: To determine whether genetic variability in the epidermal transglutaminases contributes to AD susceptibility. Methods: Forty-seven single nucleotide polymorphisms (SNPs) in the TGM1, TGM3 and TGM5 gene region were tested for genetic association with AD, independently and in relation to FLG genotype, using a pedigree disequilibrium test (PDT) in a Swedish material consisting of 1753 individuals from 539 families. In addition, a German case-control material, consisting of 533 AD cases and 1996 controls, was used for in silico analysis of the epidermal TGM regions. Gene expression of the TGM1, TGM3 and TGM5 gene was investigated by relative quantification with Real Time PCR (qRT-PCR). Immunohistochemical (IHC) analysis was performed to detect TG1, TG3 and TG5 protein expression in the skin of patients and healthy controls. Results: PDT analysis identified a significant association between the TGM1 SNP rs941505 and AD with allergen-specific IgE in the Swedish AD family material. However, the association was not replicated in the German case-control material. No significant association was detected for analyzed SNPs in relation to FLG genotype. TG1, TG3 and TG5 protein expression was detected in AD skin and a significantly increased TGM3 mRNA expression was observed in lesional skin by qRT-PCR. Conclusion: Although TGM1 and TGM3 may be differentially expressed in AD skin, the results from the genetic analysis suggest that genetic variation in the epidermal transglutaminases is not an important factor in AD susceptibility.	[Lieden, Agne; Winge, Marten C. G.; Saaf, Annika; Ekelund, Elisabeth; Nordenskjold, Magnus; Bradley, Maria] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Winge, Marten C. G.; Wahlgren, Carl-Fredrik; Bradley, Maria] Karolinska Univ Hosp, Dept Med Solna, Dermatol Unit, Stockholm, Sweden; [Kockum, Ingrid] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Rodriguez, Elke; Foelster-Holst, Regina; Baurecht, Hansjoerg; Weidinger, Stephan] Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Illig, Thomas] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, D-3000 Hannover, Germany; [Tengvall-Linder, Maria] Karolinska Inst, Dept Med Solna, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Kiel; University of Kiel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Karolinska Institutet	Winge, MCG (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	marten.winge@ki.se	Baurecht, Hansjoerg/C-4035-2013; Weidinger, Stephan/C-8461-2011; Franke, Andre/B-2151-2010; Rodríguez, Elke/C-4259-2013; Kockum, Ingrid/O-8781-2018	Baurecht, Hansjoerg/0000-0002-9265-5594; Weidinger, Stephan/0000-0003-3944-252X; Franke, Andre/0000-0003-1530-5811; Rodríguez, Elke/0000-0003-3692-3950; Kockum, Ingrid/0000-0002-0867-4726; Nordenskjold, Magnus/0000-0002-4974-425X; Winge, Marten/0000-0001-6119-6009; Bradley, Maria/0000-0001-7192-5041	Welander-Finsen Foundation; Swedish Asthma and Allergy Association; Centre for Allergy Research (CfA) at Karolinska Institutet; Swedish Research Council; Stockholm County Council; Karolinska Institutet	Welander-Finsen Foundation; Swedish Asthma and Allergy Association; Centre for Allergy Research (CfA) at Karolinska Institutet; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	Financial assistance is acknowledged from the Welander-Finsen Foundation, the Swedish Asthma and Allergy Association, the Centre for Allergy Research (CfA) at Karolinska Institutet, the Swedish Research Council and the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradley M, 2000, ACTA DERM-VENEREOL, V80, P106; Bradley M, 2002, HUM MOL GENET, V11, P1539, DOI 10.1093/hmg/11.13.1539; Broccardo CJ, 2011, J ALLERGY CLIN IMMUN, V127, P186, DOI 10.1016/j.jaci.2010.10.033; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; de Koning HD, 2012, BRIT J DERMATOL, V166, P1245, DOI 10.1111/j.1365-2133.2012.10885.x; de Koning HD, 2012, BR J DERMATOL; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; Ekelund E, 2006, AM J HUM GENET, V78, P1060, DOI 10.1086/504272; Ekelund E, 2008, ACTA DERM-VENEREOL, V88, P15, DOI 10.2340/00015555-0383; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Fohr C, 2005, BRIT J DERMATOL, V152, P202, DOI [10.1111/J.1365-2133.2005.06436.X, 10.1111/j.1365-2133.2004.06436.x]; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hitomi K, 2005, EUR J DERMATOL, V15, P313; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kollerits B, 2009, HUM MOL GENET, V18, P4669, DOI 10.1093/hmg/ddp424; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Melen E, 2005, AM J RESP CRIT CARE, V171, P1089, DOI 10.1164/rccm.200410-1317OC; Morar N, 2006, J ALLERGY CLIN IMMUN, V118, P24, DOI 10.1016/j.jaci.2006.03.037; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Soderhall C, 2001, HUM GENET, V109, P129, DOI 10.1007/s004390100556; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Yamane A, 2010, FEBS J, V277, P3564, DOI 10.1111/j.1742-4658.2010.07765.x; Yano S, 2008, J CELL PHYSIOL, V214, P1, DOI 10.1002/jcp.21300	34	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49694	10.1371/journal.pone.0049694	http://dx.doi.org/10.1371/journal.pone.0049694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189155	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800032
J	Madsen, CB; Petersen, C; Lavrsen, K; Harndahl, M; Buus, S; Clausen, H; Pedersen, AE; Wandall, HH				Madsen, Caroline B.; Petersen, Cecilie; Lavrsen, Kirstine; Harndahl, Mikkel; Buus, Soren; Clausen, Henrik; Pedersen, Anders E.; Wandall, Hans H.			Cancer Associated Aberrant Protein O-Glycosylation Can Modify Antigen Processing and Immune Response	PLOS ONE			English	Article							BLP25 LIPOSOME VACCINE; TANDEM REPEAT SEQUENCE; POXVIRAL-BASED VACCINE; MUC1 PEPTIDE EPITOPES; STAGE BREAST-CANCER; CELL LUNG-CANCER; C-TYPE LECTIN; CLASS-I MHC; DENDRITIC CELLS; T-CELLS	Aberrant glycosylation of mucins and other extracellular proteins is an important event in carcinogenesis and the resulting cancer associated glycans have been suggested as targets in cancer immunotherapy. We assessed the role of O-linked GalNAc glycosylation on antigen uptake, processing, and presentation on MHC class I and II molecules. The effect of GalNAc O-glycosylation was monitored with a model system based on ovalbumin (OVA)-MUC1 fusion peptides (+/- glycosylation) loaded onto dendritic cells co-cultured with IL-2 secreting OVA peptide-specific T cell hybridomas. To evaluate the in vivo response to a cancer related tumor antigen, Balb/c or B6.Cg(CB)-Tg(HLA-A/H2-D)2Enge/J (HLA-A2 transgenic) mice were immunized with a non-glycosylated or GalNAc-glycosylated MUC1 derived peptide followed by comparison of T cell proliferation, IFN-gamma release, and antibody induction. GalNAc-glycosylation promoted presentation of OVA-MUC1 fusion peptides by MHC class II molecules and the MUC1 antigen elicited specific Ab production and T cell proliferation in both Balb/c and HLA-A2 transgenic mice. In contrast, GalNAc-glycosylation inhibited the presentation of OVA-MUC1 fusion peptides by MHC class I and abolished MUC1 specific CD8+ T cell responses in HLA-A2 transgenic mice. GalNAc glycosylation of MUC1 antigen therefore facilitates uptake, MHC class II presentation, and antibody response but might block the antigen presentation to CD8+ T cells.	[Madsen, Caroline B.; Harndahl, Mikkel; Buus, Soren; Pedersen, Anders E.] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Fac Hlth Sci, Copenhagen, Denmark; [Madsen, Caroline B.; Petersen, Cecilie; Lavrsen, Kirstine; Clausen, Henrik; Wandall, Hans H.] Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Pedersen, AE (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Fac Hlth Sci, Copenhagen, Denmark.	andersep@sund.ku.dk; hhw@sund.ku.dk	clausen, henrik/AAD-8016-2021; Buus, Soren/F-5446-2010; Mathiesen, Caroline B K/AAM-7156-2020	Wandall, Hans H./0000-0003-0240-9232; Buus, Soren/0000-0001-8363-1999; Clausen, Henrik/0000-0002-0915-5055; Pedersen, Anders Elm/0000-0003-4705-1801	Novo Nordisk Foundation; Danish Medical Research Council; Danish Cancer Research Foundation; Agnes and Poul Friis Foundation; Danish Cancer Society; University of Copenhagen; EU-FP7; Danish Agency for Science, and Technology and Innovation (FTP)	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Agnes and Poul Friis Foundation; Danish Cancer Society(Danish Cancer Society); University of Copenhagen; EU-FP7(European Commission); Danish Agency for Science, and Technology and Innovation (FTP)	This project was supported by the Novo Nordisk Foundation, the Danish Medical Research Council, the Danish Cancer Research Foundation, the Agnes and Poul Friis Foundation, the Danish Cancer Society, the University of Copenhagen (Program of Excellence), EU-FP7, Danish Agency for Science, and Technology and Innovation (FTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluri S, 1999, BRIT J CANCER, V79, P1806, DOI 10.1038/sj.bjc.6690288; Apostolopoulos V, 2003, P NATL ACAD SCI USA, V100, P15029, DOI 10.1073/pnas.2432220100; Apostolopoulos V, 1997, EUR J IMMUNOL, V27, P2579, DOI 10.1002/eji.1830271017; Apostolopoulos V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1505; Barratt-Boyes SM, 1999, CLIN CANCER RES, V5, P1918; Bennett EP, 1998, J BIOL CHEM, V273, P30472, DOI 10.1074/jbc.273.46.30472; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Brossart P, 2000, BLOOD, V96, P3102, DOI 10.1182/blood.V96.9.3102.h8003102_3102_3108; Butts C, 2005, J CLIN ONCOL, V23, P6674, DOI 10.1200/JCO.2005.13.011; Butts C, 2011, J CANCER RES CLIN, V137, P1337, DOI 10.1007/s00432-011-1003-3; Butts C, 2010, CLIN LUNG CANCER, V11, P391, DOI 10.3816/CLC.2010.n.101; Cho HI, 2009, CANCER RES, V69, P9012, DOI 10.1158/0008-5472.CAN-09-2019; Danielczyk A, 2006, CANCER IMMUNOL IMMUN, V55, P1337, DOI 10.1007/s00262-006-0135-9; Denda-Nagai K, 2010, J BIOL CHEM, V285, P19193, DOI 10.1074/jbc.M110.113613; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Dreicer R, 2009, INVEST NEW DRUG, V27, P379, DOI 10.1007/s10637-008-9187-3; Gelderman KA, 2004, TRENDS IMMUNOL, V25, P158, DOI 10.1016/j.it.2004.01.008; Gilewski T, 2000, CLIN CANCER RES, V6, P1693; GREENBERG PD, 1985, J EXP MED, V161, P1122, DOI 10.1084/jem.161.5.1122; Gulley JL, 2008, CLIN CANCER RES, V14, P3060, DOI 10.1158/1078-0432.CCR-08-0126; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Hanisch FG, 2003, EUR J IMMUNOL, V33, P3242, DOI 10.1002/eji.200324189; Harndahl M, 2011, J IMMUNOL METHODS, V374, P5, DOI 10.1016/j.jim.2010.10.012; Harndahl M, 2009, J BIOMOL SCREEN, V14, P173, DOI 10.1177/1087057108329453; Heukamp LC, 2002, J IMMUNOTHER, V25, P46, DOI 10.1097/00002371-200201000-00005; Heukamp LC, 2001, INT J CANCER, V91, P385, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1051>3.0.CO;2-Z; Hiltbold EM, 1999, CELL IMMUNOL, V194, P143, DOI 10.1006/cimm.1999.1512; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Lavrsen K, 2013, GLYCOCONJUGATE J, V30, P227, DOI 10.1007/s10719-012-9437-7; Loveland BE, 2006, CLIN CANCER RES, V12, P869, DOI 10.1158/1078-0432.CCR-05-1574; Madan RA, 2007, EXPERT OPIN BIOL TH, V7, P543, DOI 10.1517/14712598.7.4.543; Met O, 2003, CELL IMMUNOL, V222, P126, DOI 10.1016/S0008-8749(03)00128-X; Mohebtash M, 2011, CLIN CANCER RES, V17, P7164, DOI 10.1158/1078-0432.CCR-11-0649; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Ninkovic T, 2007, J IMMUNOL, V179, P2380, DOI 10.4049/jimmunol.179.4.2380; Ninkovic T, 2009, MOL IMMUNOL, V47, P131, DOI 10.1016/j.molimm.2008.09.032; Ohyanagi F, 2011, JPN J CLIN ONCOL, V41, P718, DOI 10.1093/jjco/hyr021; Oudard S, 2011, CANCER IMMUNOL IMMUN, V60, P261, DOI 10.1007/s00262-010-0935-9; Palmer M, 2001, Clin Lung Cancer, V3, P49, DOI 10.3816/CLC.2001.n.018; Pedersen JW, 2011, INT J CANCER, V128, P1860, DOI 10.1002/ijc.25778; Pietersz GA, 2000, VACCINE, V18, P2059, DOI 10.1016/S0264-410X(99)00515-0; Pinkhasov J, 2010, CANCER IMMUNOL IMMUN, V59, P1801, DOI 10.1007/s00262-010-0906-1; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Pulko V, 2009, J IMMUNOL, V183, P3634, DOI 10.4049/jimmunol.0900974; Quoix E, 2011, LANCET ONCOL, V12, P1125, DOI 10.1016/S1470-2045(11)70259-5; Ramlau R, 2008, J THORAC ONCOL, V3, P735, DOI 10.1097/JTO.0b013e31817c6b4f; Rittig SM, 2011, MOL THER, V19, P990, DOI 10.1038/mt.2010.289; Rochlitz C, 2003, J GENE MED, V5, P690, DOI 10.1002/jgm.397; ROCK KL, 1990, J IMMUNOL, V145, P804; Rong YF, 2012, CLIN EXP MED, V12, P173, DOI 10.1007/s10238-011-0159-0; Rughetti A, 2005, J IMMUNOL, V174, P7764, DOI 10.4049/jimmunol.174.12.7764; Ryan SO, 2009, BIOL CHEM, V390, P611, DOI 10.1515/BC.2009.070; Sikora AG, 2009, J IMMUNOL, V182, P7398, DOI 10.4049/jimmunol.0802982; Singh SK, 2011, INT J CANCER, V128, P1371, DOI 10.1002/ijc.25458; Sinnathamby G, 2009, J IMMUNOTHER, V32, P856, DOI 10.1097/CJI.0b013e3181b0b125; Snijdewint FGM, 2001, INT J CANCER, V93, P97, DOI 10.1002/ijc.1286; Soares MM, 2001, J IMMUNOL, V166, P6555, DOI 10.4049/jimmunol.166.11.6555; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; Tarp MA, 2007, GLYCOBIOLOGY, V17, P197, DOI 10.1093/glycob/cwl061; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Tenzer S, 2004, J IMMUNOL, V172, P1083, DOI 10.4049/jimmunol.172.2.1083; Tsang KY, 2004, CLIN CANCER RES, V10, P2139, DOI 10.1158/1078-0432.CCR-1011-03; Unger WWJ, 2011, CURR OPIN IMMUNOL, V23, P131, DOI 10.1016/j.coi.2010.11.011; Wandall HH, 2010, CANCER RES, V70, P1306, DOI 10.1158/0008-5472.CAN-09-2893; Wandall HH, 1997, J BIOL CHEM, V272, P23503, DOI 10.1074/jbc.272.38.23503; Wang SY, 2008, EXPERT OPIN BIOL TH, V8, P759, DOI [10.1517/14712598.8.6.759, 10.1517/14712598.8.6.759 ]; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; Xu YF, 2004, J EXP MED, V199, P707, DOI 10.1084/jem.20031865	76	46	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50139	10.1371/journal.pone.0050139	http://dx.doi.org/10.1371/journal.pone.0050139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189185	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800062
J	Matsunaga, Y; Koike, R; Ota, M; Tame, JRH; Kidera, A				Matsunaga, Yasuhiro; Koike, Ryotaro; Ota, Motonori; Tame, Jeremy R. H.; Kidera, Akinori			Influence of Structural Symmetry on Protein Dynamics	PLOS ONE			English	Article							BINDING ATTENUATION PROTEIN; NORMAL-MODE ANALYSIS; MOLECULAR-DYNAMICS; RNA-BINDING; VIBRATIONAL-ENERGY; MASS-SPECTROMETRY; TRAP; ASSEMBLIES; SYSTEMS; STABILITY	Structural symmetry in homooligomeric proteins has intrigued many researchers over the past several decades. However, the implication of protein symmetry is still not well understood. In this study, we performed molecular dynamics (MD) simulations of two forms of trp RNA binding attenuation protein (TRAP), the wild-type 11-mer and an engineered 12-mer, having two different levels of circular symmetry. The results of the simulations showed that the inter-subunit fluctuations in the 11-mer TRAP were significantly smaller than the fluctuations in the 12-mer TRAP while the internal fluctuations were larger in the 11-mer than in the 12-mer. These differences in thermal fluctuations were interpreted by normal mode analysis and group theory. For the 12-mer TRAP, the wave nodes of the normal modes existed at the flexible interface between the subunits, while the 11-mer TRAP had its nodes within the subunits. The principal components derived from the MD simulations showed similar mode structures. These results demonstrated that the structural symmetry was an important determinant of protein dynamics in circularly symmetric homooligomeric proteins.	[Matsunaga, Yasuhiro] RIKEN Adv Inst Computat Sci, Special Postdoctoral Researchers Program, Kobe, Hyogo, Japan; [Matsunaga, Yasuhiro; Kidera, Akinori] RIKEN, Computat Sci Res Program, Wako, Saitama, Japan; [Koike, Ryotaro; Ota, Motonori] Nagoya Univ, Grad Sch Informat Sci, Nagoya, Aichi 4648601, Japan; [Tame, Jeremy R. H.] Yokohama City Univ, Prot Design Lab, Yokohama, Kanagawa 232, Japan; [Kidera, Akinori] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 232, Japan	RIKEN; RIKEN; Nagoya University; Yokohama City University; Yokohama City University	Matsunaga, Y (corresponding author), RIKEN Adv Inst Computat Sci, Special Postdoctoral Researchers Program, Kobe, Hyogo, Japan.	ymatsunaga@riken.jp	Matsunaga, Yasuhiro/C-6774-2016	Matsunaga, Yasuhiro/0000-0003-2872-3908; Jiggins, Francis Michael/0000-0001-7470-8157	Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT, Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Research and Development of the Next-Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). In addition, this research was partially supported by the Grants-in-Aid for scientific research from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2009, ANAL CHEM, V81, P2218, DOI 10.1021/ac802354j; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; Bahadur RP, 2003, PROTEINS, V53, P708, DOI 10.1002/prot.10461; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chen CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025296; Cotton F. A., 1990, CHEM APPL GROUP THEO, V3rd; Cui ZH, 2005, BIOINFORMATION, V1, P28, DOI 10.6026/97320630001028; Dresselhaus M.S., 2008, GROUP THEORY APPL PH; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Heddle JG, 2006, STRUCTURE, V14, P925, DOI 10.1016/j.str.2006.03.013; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Lukatsky DB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.178101; Lyubarskii G.Ya, 1960, APPL GROUP THEORY PH; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCammon MG, 2004, J AM CHEM SOC, V126, P5950, DOI 10.1021/ja0317170; McElroy C, 2002, J MOL BIOL, V323, P463, DOI 10.1016/S0022-2836(02)00940-3; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Murtola T, 2008, PROTEINS, V71, P1995, DOI 10.1002/prot.21878; NISHIKAWA T, 1987, PROTEINS, V2, P308, DOI 10.1002/prot.340020407; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; ROUX B, 1988, BIOPHYS J, V53, P297, DOI 10.1016/S0006-3495(88)83107-2; Schulz GE, 2010, J MOL BIOL, V395, P834, DOI 10.1016/j.jmb.2009.10.044; SIMONSON T, 1992, BIOPHYS J, V61, P410, DOI 10.1016/S0006-3495(92)81847-7; Steinkellner G, 2009, BMC; Tama F, 2003, PROTEIN PEPTIDE LETT, V10, P119, DOI 10.2174/0929866033479077; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; van Vlijmen HWT, 2001, J CHEM PHYS, V115, P691, DOI 10.1063/1.1370956; Watanabe M, 2008, PROTEIN SCI, V17, P518, DOI 10.1110/ps.073059308; Watanabe M, 2009, P NATL ACAD SCI USA, V106, P2176, DOI 10.1073/pnas.0801032106; Wilson E. Bright, 1980, THEORY INFRARED RAMA; Wolynes PG, 1996, P NATL ACAD SCI USA, V93, P14249, DOI 10.1073/pnas.93.25.14249; Yu X, 2003, J PHYS CHEM B, V107, P1698, DOI 10.1021/jp026462b; Yu X, 2003, J CHEM PHYS, V119, P12673, DOI 10.1063/1.1626636	48	14	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50011	10.1371/journal.pone.0050011	http://dx.doi.org/10.1371/journal.pone.0050011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189176	Green Published, gold			2022-12-25	WOS:000311929800053
J	Scherrer, B; Warfield, SK				Scherrer, Benoit; Warfield, Simon K.			Parametric Representation of Multiple White Matter Fascicles from Cube and Sphere Diffusion MRI	PLOS ONE			English	Article							HUMAN BRAIN; FIBER ORIENTATIONS; WATER DIFFUSION; SELF-DIFFUSION; 2-TENSOR MODEL; Q-SPACE; TENSOR; RESOLUTION; PROFILES; TIME	The characterization of the complex diffusion signal arising from the brain remains an open problem. Many representations focus on characterizing the global shape of the diffusion profile at each voxel and are limited to the assessment of connectivity. In contrast, Multiple Fascicle Models (MFM) seek to represent the contribution from each white matter fascicle and may be useful in the investigation of both white matter connectivity and diffusion properties of each individual fascicle. However, the most appropriate representation of multiple fascicles remains unclear. In particular, a multiple tensor representation of multiple fascicles has frequently been reported to be numerically challenging and unstable. We provide here the first analytical demonstration that when using a diffusion MRI acquisition with only one non-zero b-value, such as in conventional single-shell HARDI acquisition, a co-linearity in model parameters makes the precise model estimation impossible. Motivated by this theoretical result, we propose the novel CUSP (CUbe and SPhere) optimal acquisition scheme to achieve multiple non-zero b-values. It combines the gradients of a single-shell HARDI with gradients in its enclosing cube, in which varying b-values can be acquired by modulation of the gradient strength, without modifying the minimum echo time. Compared to a multi-shell HARDI acquisition, our scheme has significantly increased signal-to-noise ratio. We propose a novel estimation algorithm that enables efficient, robust and accurate estimation of the parameters of a multi-tensor model. In conjunction with a CUSP acquisition, it enables full estimation of the multi-tensor model. We present an evaluation of CUSP-MFM on both synthetic phantoms and invivo data. We report qualitative and quantitative experimental evaluations which demonstrate the ability of CUSP-MFM to characterize multiple fascicles from short duration acquisitions. CUSP-MFM enables rapid and effective investigation of multiple white matter fascicles, in both normal development and in disease and injury, in research and clinical practice.	[Scherrer, Benoit; Warfield, Simon K.] Childrens Hosp, Dept Radiol, Computat Radiol Lab, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Scherrer, B (corresponding author), Childrens Hosp, Dept Radiol, Computat Radiol Lab, 300 Longwood Ave, Boston, MA 02115 USA.	benoit.scherrer@childrens.harvard.edu		Warfield, Simon/0000-0002-7659-3880; Scherrer, Benoit/0000-0002-8798-8562; Hess, Christopher/0000-0002-5132-5302	National Institutes of Health [R01 RR021885, R01 EB008015, R03 EB008680, R01 LM010033, R42 MH086984, UL1 RR025758]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR021885, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB008680, R01EB008015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R42MH086984] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This investigation was supported by National Institutes of Health grants R01 RR021885, R01 EB008015, R03 EB008680, R01 LM010033, R42 MH086984 and UL1 RR025758. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2010, MAGN RESON MED, V64, P554, DOI 10.1002/mrm.22365; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Barnett A, 2009, MAGN RESON MED, V62, P910, DOI 10.1002/mrm.22073; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bennett KM, 2003, MAGNET RESON MED, V50, P727, DOI 10.1002/mrm.10581; BESAG J, 1986, J R STAT SOC B, V48, P259; Caan MWA, 2010, IEEE T MED IMAGING, V29, P1504, DOI 10.1109/TMI.2010.2049577; Canales-Rodriguez EJ, 2010, NEUROIMAGE, V49, P1326, DOI 10.1016/j.neuroimage.2009.09.067; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Chung SW, 2006, NEUROIMAGE, V33, P531, DOI 10.1016/j.neuroimage.2006.07.001; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; Conturo TE, 1995, NMR BIOMED, V8, P307, DOI 10.1002/nbm.1940080706; Cook PA, 2007, J MAGN RESON IMAGING, V25, P1051, DOI 10.1002/jmri.20905; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Fillard P, 2007, IEEE T MED IMAGING, V26, P1472, DOI 10.1109/TMI.2007.899173; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Ghosh A, 2011, I S BIOMED IMAGING, P266, DOI 10.1109/ISBI.2011.5872403; Hosey T, 2005, MAGN RESON MED, V54, P1480, DOI 10.1002/mrm.20723; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jian B, 2007, IEEE T MED IMAGING, V26, P1464, DOI 10.1109/TMI.2007.907552; Jones DK, 2004, MAGN RESON MED, V52, P979, DOI 10.1002/mrm.20283; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Jones DK., 2011, VISUALIZATION DIFFUS; Canales-Rodriguez EJ, 2009, MAGN RESON MED, V61, P1350, DOI 10.1002/mrm.21917; Koay CG, 2006, MAGN RESON MED, V55, P930, DOI 10.1002/mrm.20832; Kreher BW, 2005, MAGNET RESON MED, V54, P1216, DOI 10.1002/mrm.20670; KWONG KK, 1991, MAGNET RESON MED, V21, P157, DOI 10.1002/mrm.1910210120; Latour LL, 2002, MAGNET RESON MED, V48, P478, DOI 10.1002/mrm.10238; Le Bihan D, 1991, Magn Reson Q, V7, P1; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Lori NF, 2003, J MAGN RESON, V165, P185, DOI 10.1016/j.jmr.2003.08.011; Maier SE, 2004, MAGN RESON MED, V51, P321, DOI 10.1002/mrm.10685; Malcolm JG, 2010, IEEE T MED IMAGING, V29, P1664, DOI 10.1109/TMI.2010.2048121; MATTIELLO J, 1994, J MAGN RESON SER A, V108, P131, DOI 10.1006/jmra.1994.1103; Melie-Garcia L, 2008, NEUROIMAGE, V42, P750, DOI 10.1016/j.neuroimage.2008.04.242; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Minati L, 2007, CONCEPT MAGN RESON A, V30A, P278, DOI 10.1002/cmr.a.20094; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Mulkern RV, 2009, MAGN RESON IMAGING, V27, P1151, DOI 10.1016/j.mri.2009.05.003; Mulkern RV, 2000, MAGNET RESON MED, V44, P292, DOI 10.1002/1522-2594(200008)44:2<292::AID-MRM17>3.0.CO;2-Q; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Norris DG, 2001, NMR BIOMED, V14, P77, DOI 10.1002/nbm.682; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Ozarslan E, 2003, MAGN RESON MED, V50, P955, DOI 10.1002/mrm.10596; Ozarslan E, 2006, NEUROIMAGE, V31, P1086, DOI 10.1016/j.neuroimage.2006.01.024; Pasternak O, 2008, MAGN RESON IMAGING, V26, P1133, DOI 10.1016/j.mri.2008.01.006; Pasternak O, 2010, NEUROIMAGE, V49, P2190, DOI 10.1016/j.neuroimage.2009.10.071; Peled S, 2006, MAGN RESON IMAGING, V24, P1263, DOI 10.1016/j.mri.2006.07.009; Peled S, 2009, J MAGN RESON IMAGING, V30, P243, DOI 10.1002/jmri.21808; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Powell MJD, 2009, BOBYQA ALGORITHM BOU; Qin W, 2009, MAGN RESON MED, V61, P755, DOI 10.1002/mrm.21920; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Ruiz-Alzola J, 2002, MED IMAGE ANAL, V6, P143, DOI 10.1016/S1361-8415(02)00055-5; Scherrer B, 2011, I S BIOMED IMAGING, P2140, DOI 10.1109/ISBI.2011.5872836; Scherrer B, 2010, I S BIOMED IMAGING, P1389, DOI 10.1109/ISBI.2010.5490257; Schwarcz A, 2004, MAGNET RESON MED, V51, P278, DOI 10.1002/mrm.10702; Sehy JV, 2002, MAGNET RESON MED, V48, P765, DOI 10.1002/mrm.10301; Sotiropoulos SN, 2008, J MAGN RESON IMAGING, V28, P199, DOI 10.1002/jmri.21380; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tristan-Vega A, 2010, MED IMAGE ANAL, V14, P205, DOI 10.1016/j.media.2009.11.001; Tristan-Vega A, 2009, NEUROIMAGE, V47, P638, DOI 10.1016/j.neuroimage.2009.04.049; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wang ZZ, 2004, IEEE T MED IMAGING, V23, P930, DOI 10.1109/TMI.2004.831218; Wedeen V. J., 2000, P INT SOT MAG RESON, V8, P82; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; WESBEY GE, 1984, INVEST RADIOL, V19, P491, DOI 10.1097/00004424-198411000-00005; Whitcher B, 2008, HUM BRAIN MAPP, V29, P346, DOI 10.1002/hbm.20395; Yablonskiy DA, 2003, MAGNET RESON MED, V50, P664, DOI 10.1002/mrm.10578; Yeh CH, 2010, NEUROIMAGE, V51, P743, DOI 10.1016/j.neuroimage.2010.02.041; Zhan W, 2006, J MAGN RESON, V183, P193, DOI 10.1016/j.jmr.2006.08.005	80	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e48232	10.1371/journal.pone.0048232	http://dx.doi.org/10.1371/journal.pone.0048232			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189128	gold, Green Submitted, Green Published			2022-12-25	WOS:000311929800008
J	Elshabrawy, HA; Coughlin, MM; Baker, SC; Prabhakar, BS				Elshabrawy, Hatem A.; Coughlin, Melissa M.; Baker, Susan C.; Prabhakar, Bellur S.			Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; CORONAVIRUS-LIKE VIRUS; IN-VITRO; ESCAPE MUTANTS; STRUCTURAL-CHARACTERIZATION; CELL RESPONSES; FUSION PEPTIDE; CATHEPSIN-L; S2 DOMAIN	Immune sera from convalescent patients have been shown to be effective in the treatment of patients infected with Severe Acute Respiratory Syndrome Virus (SARS-CoV) making passive immune therapy with human monoclonal antibodies an attractive treatment strategy for SARS. Previously, using Xenomouse (Amgen British Columbia Inc), we produced a panel of neutralizing Human monoclonal antibodies (HmAbs) that could specifically bind to the ectodomain of the SARS-CoV spike (S) glycoprotein. Some of the HmAbs were S1 domain specific, while some were not. In this study, we describe non-S1 binding neutralizing HmAbs that can specifically bind to the conserved S2 domain of the S protein. However, unlike the S1 specific HmAbs, the S2 specific HmAbs can neutralize pseudotyped viruses expressing different S proteins containing receptor binding domain sequences of various clinical isolates. These data indicate that HmAbs which bind to conserved regions of the S protein are more suitable for conferring protection against a wide range of SARS-CoV variants and have implications for generating therapeutic antibodies or subunit vaccines against other enveloped viruses.	[Elshabrawy, Hatem A.; Prabhakar, Bellur S.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA; [Coughlin, Melissa M.] Ctr Dis Control & Prevent, Measles Mumps Rubella & Herpes Virus Lab Branch, Atlanta, GA USA; [Baker, Susan C.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centers for Disease Control & Prevention - USA; Loyola University Chicago	Prabhakar, BS (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA.	bprabhak@uic.edu			Public Health Service [1U01AI082296]	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by Public Health Service grant 1U01AI082296. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Chakraborti S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-73; Coughlin M, 2007, VIROLOGY, V361, P93, DOI 10.1016/j.virol.2006.09.029; Coughlin MM, 2009, VIROLOGY, V394, P39, DOI 10.1016/j.virol.2009.07.028; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; He YX, 2005, J IMMUNOL, V174, P4908, DOI 10.4049/jimmunol.174.8.4908; He YX, 2005, VIROLOGY, V334, P74, DOI 10.1016/j.virol.2005.01.034; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Ingallinella P, 2004, P NATL ACAD SCI USA, V101, P8709, DOI 10.1073/pnas.0402753101; Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005; Keng CT, 2005, J VIROL, V79, P3289, DOI 10.1128/JVI.79.6.3289-3296.2005; Lai SC, 2005, J BIOMED SCI, V12, P711, DOI 10.1007/s11373-005-9004-3; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li TS, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000024; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lip KM, 2006, J VIROL, V80, P941, DOI 10.1128/JVI.80.2.941-950.2006; Liu IJ, 2009, ANTIVIR RES, V81, P82, DOI 10.1016/j.antiviral.2008.10.001; Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; MCKEATING JA, 1989, AIDS, V3, P777, DOI 10.1097/00002030-198912000-00001; McLellan JS, 2011, NATURE; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005672; Rockx B, 2008, J VIROL, V82, P3220, DOI 10.1128/JVI.02377-07; Rockx B, 2010, J INFECT DIS, V201, P946, DOI 10.1086/651022; Sainz B, 2005, J VIROL, V79, P7195, DOI 10.1128/JVI.79.11.7195-7206.2005; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Tiffen JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-299; Tripet B, 2004, J BIOL CHEM, V279, P20836, DOI 10.1074/jbc.M400759200; Wong SK, 2004, J BIOL CHEM, V279, P3197, DOI 10.1074/jbc.C300520200; Xu XJ, 2004, CELL MOL IMMUNOL, V1, P119; Yang HX, 2005, HYBRIDOMA, V24, P36, DOI 10.1089/hyb.2005.24.36; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Zhang H, 2004, J VIROL, V78, P6938, DOI 10.1128/JVI.78.13.6938-6945.2004; Zhong XF, 2005, J VIROL, V79, P3401, DOI 10.1128/JVI.79.6.3401-3408.2005	42	110	113	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50366	10.1371/journal.pone.0050366	http://dx.doi.org/10.1371/journal.pone.0050366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185609	Green Published, gold			2022-12-25	WOS:000311821000222
J	Ludynia, K; Dehnhard, N; Poisbleau, M; Demongin, L; Masello, JF; Quillfeldt, P				Ludynia, Katrin; Dehnhard, Nina; Poisbleau, Maud; Demongin, Laurent; Masello, Juan F.; Quillfeldt, Petra			Evaluating the Impact of Handling and Logger Attachment on Foraging Parameters and Physiology in Southern Rockhopper Penguins	PLOS ONE			English	Article							TRIP DURATION; ECOPHYSIOLOGICAL RESPONSE; HEMATOLOGICAL PARAMETERS; SATELLITE TRANSMITTERS; INSTRUMENT ATTACHMENT; EXPERIMENTAL INCREASE; EUDYPTES-CHRYSOCOME; RECORDING DEVICES; FOOD AVAILABILITY; BREEDING SUCCESS	Logger technology has revolutionised our knowledge of the behaviour and physiology of free-living animals but handling and logger attachments may have negative effects on the behaviour of the animals and their welfare. We studied southern rockhopper penguin (Eudyptes chrysocome) females during the guard stage in three consecutive breeding seasons (2008/09-2010/11) to evaluate the effects of handling and logger attachment on foraging trip duration, dive behaviour and physiological parameters. Smaller dive loggers (TDRs) were used in 2010/11 for comparison to larger GPS data loggers used in all three seasons and we included two categories of control birds: handled controls and PIT control birds that were previously marked with passive integrative transponders (PITs), but which had not been handled during this study. Increased foraging trip duration was only observed in GPS birds during 2010/11, the breeding season in which we also found GPS birds foraging further away from the colony and travelling longer distances. Compared to previous breeding seasons, 2010/11 may have been a period with less favourable environmental conditions, which would enhance the impact of logger attachments. A comparison between GPS and TDR birds showed a significant difference in dive depth frequencies with birds carrying larger GPS data loggers diving shallower. Mean and maximum dive depths were similar between GPS and TDR birds. We measured little impact of logger attachments on physiological parameters (corticosterone, protein, triglyceride levels and leucocyte counts). Overall, handling and short-term logger attachments (1-3 days) showed limited impact on the behaviour and physiology of the birds but care must be taken with the size of data loggers on diving seabirds. Increased drag may alter their diving behaviour substantially, thus constraining them in their ability to catch prey. Results obtained in this study indicate that data recorded may also not represent their normal dive behaviour.	[Ludynia, Katrin; Dehnhard, Nina; Poisbleau, Maud; Demongin, Laurent; Masello, Juan F.; Quillfeldt, Petra] Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany; [Ludynia, Katrin] Univ Cape Town, Anim Demog Unit, ZA-7925 Cape Town, South Africa; [Poisbleau, Maud; Demongin, Laurent] Univ Antwerp, Dept Biol Ethol, B-2020 Antwerp, Belgium	Max Planck Society; University of Cape Town; University of Antwerp	Ludynia, K (corresponding author), Max Planck Inst Ornithol, Radolfzell am Bodensee, Germany.	kludynia@gmail.com	Poisbleau, Maud/B-9968-2014; Dehnhard, Nina/H-6160-2016; Quillfeldt, Petra/A-9549-2009; Masello, Juan/C-7133-2009	Poisbleau, Maud/0000-0002-0729-3251; Dehnhard, Nina/0000-0002-4182-2698; Quillfeldt, Petra/0000-0002-4450-8688; Ludynia, Katrin/0000-0002-0353-1929; Masello, Juan/0000-0002-6826-4016	Deutsche Forschungsgemeinschaft [DFG QU148/1ff]; Overseas Territories Environmental Programme [FAL 603]; Falkland Islands Government Environmental Studies Budget; Claude Leon Fellowship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Overseas Territories Environmental Programme; Falkland Islands Government Environmental Studies Budget; Claude Leon Fellowship	The study received financial support from the Deutsche Forschungsgemeinschaft (DFG QU148/1ff.), the Overseas Territories Environmental Programme (FAL 603) and the Falkland Islands Government Environmental Studies Budget. KL benefited from a Claude Leon Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelier F, 2009, J EXP BIOL, V212, P2824, DOI 10.1242/jeb.027722; Ballard G, 2001, CONDOR, V103, P481, DOI 10.1650/0010-5422(2001)103[0481:EOIAAO]2.0.CO;2; BANNASCH R, 1994, J EXP BIOL, V194, P83; Barbraud C, 2012, J ORNITHOL, V153, P375, DOI 10.1007/s10336-011-0752-8; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Beaulieu M, 2010, J EXP BIOL, V213, P33, DOI 10.1242/jeb.035378; Beaulieu M, 2010, J ORNITHOL, V151, P579, DOI 10.1007/s10336-009-0491-2; Buck CL, 2007, GEN COMP ENDOCR, V150, P430, DOI 10.1016/j.ygcen.2006.10.011; Casper RM, 2009, ANIM BEHAV, V78, P1477, DOI 10.1016/j.anbehav.2009.09.023; Cherel Y, 1999, MAR BIOL, V134, P375, DOI 10.1007/s002270050554; Clarke J, 1998, J FIELD ORNITHOL, V69, P149; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Croll DA, 1996, J FIELD ORNITHOL, V67, P1; CROLL DA, 1991, CONDOR, V93, P777, DOI 10.2307/1368216; CULIK B, 1991, J EXP BIOL, V158, P355; Culik B., 1990, P177; CULIK BM, 1992, J COMP PHYSIOL B, V162, P567; Davis AK, 2005, J FIELD ORNITHOL, V76, P334, DOI 10.1648/0273-8570-76.4.334; Dehnhard N, 2011, J ORNITHOL, V152, P759, DOI 10.1007/s10336-011-0658-5; Dugger KM, 2006, AUK, V123, P858, DOI 10.1642/0004-8038(2006)123[858:EOFBOF]2.0.CO;2; Ellenberg U, 2012, J ORNITHOL IN PRESS, DOI [10.1007/s10336-011-0780-4, DOI 10.1007/S10336-011-0780-4.IN]; Ellenberg U, 2007, GEN COMP ENDOCR, V152, P54, DOI 10.1016/j.ygcen.2007.02.022; Ellenberg U, 2009, ANIM BEHAV, V77, P289, DOI 10.1016/j.anbehav.2008.09.021; Elliott KH, 2012, MAR ECOL PROG SER, V466, P1, DOI 10.3354/meps09975; Fowler GS, 1999, BIOL CONSERV, V90, P143, DOI 10.1016/S0006-3207(99)00026-9; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Gladbach A, 2010, COMP BIOCHEM PHYS A, V156, P269, DOI 10.1016/j.cbpa.2010.02.012; Gremillet D, 2010, ECOL APPL, V20, P1498, DOI 10.1890/09-1586.1; Hampton SL, 2009, OSTRICH, V80, P77, DOI 10.2989/OSTRICH.2009.80.2.2.829; Hawkey C.M., 1989, COLOUR ATLAS COMP VE; Hawkins P., 2004, MEM NATL I POLAR RES, V58, P58; Hoi-Leitner M, 2001, BEHAV ECOL SOCIOBIOL, V49, P333, DOI 10.1007/s002650000310; Hull CL, 1997, CONDOR, V99, P530, DOI 10.2307/1369962; Jakubas D, 2011, MAR ECOL PROG SER, V432, P277, DOI 10.3354/meps09082; Jenni-Eiermann Susanne, 1999, Biologia e Conservazione della Fauna, V102, P312; JenniEiermann S, 1996, FUNCT ECOL, V10, P62, DOI 10.2307/2390263; Kitaysky AS, 2007, MAR ECOL PROG SER, V352, P245, DOI 10.3354/meps07074; LEMAHO Y, 1992, AM J PHYSIOL, V263, pR775, DOI 10.1152/ajpregu.1992.263.4.R775; Masello JF, 2004, J AVIAN BIOL, V35, P445, DOI 10.1111/j.0908-8857.2004.03278.x; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; Mattern T, 2007, MAR ECOL PROG SER, V343, P295, DOI 10.3354/meps06954; Merino S, 1999, ANIM BEHAV, V58, P219, DOI 10.1006/anbe.1999.1127; MILLER GD, 1993, BIOL CONSERV, V63, P223, DOI 10.1016/0006-3207(93)90716-E; Mueller C, 2011, FUNCT ECOL, V25, P566, DOI 10.1111/j.1365-2435.2010.01816.x; Murray DL, 2000, METH C CONS, P15; Navarro J, 2008, J EXP MAR BIOL ECOL, V358, P14, DOI 10.1016/j.jembe.2008.01.005; Nelson RJ., 2005, INTRO BEHAV ENDOCRIN; Ots I, 1998, FUNCT ECOL, V12, P700, DOI 10.1046/j.1365-2435.1998.00219.x; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; PIETZ PJ, 1993, J WILDLIFE MANAGE, V57, P696, DOI 10.2307/3809068; Pinheiro J., 2011, NLME LINEAR NONLINEA; Poisbleau M, 2010, ARDEA, V98, P217, DOI 10.5253/078.098.0212; Ponganis PJ, 2007, DEEP-SEA RES PT II, V54, P183, DOI 10.1016/j.dsr2.2006.11.009; Putz K, 2003, J AVIAN BIOL, V34, P139, DOI 10.1034/j.1600-048X.2003.03100.x; Quillfeldt P, 2004, POLAR BIOL, V27, P168, DOI 10.1007/s00300-003-0572-2; Quillfeldt P, 2012, MAR BIOL, V159, P1809, DOI 10.1007/s00227-012-1971-0; R Development Core Team, 2009, R FDN STAT COMP; Renner Martin, 2000, Notornis, V47, P163; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Ropert-Coudert Y, 2000, PHYSIOL BIOCHEM ZOOL, V73, P438, DOI 10.1086/317743; Ropert-Coudert Y, 2007, MAR ECOL PROG SER, V333, P281, DOI 10.3354/meps333281; Ropert-Coudert Y, 2007, DEEP-SEA RES PT II, V54, P415, DOI 10.1016/j.dsr2.2006.11.018; Ruiz G, 2002, CONDOR, V104, P162, DOI 10.1650/0010-5422(2002)104[0162:HPASII]2.0.CO;2; Ryan PG, 2004, MAR BIOL, V145, P215, DOI 10.1007/s00227-004-1328-4; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Schroeder J, 2011, J AVIAN BIOL, V42, P271, DOI 10.1111/j.1600-048X.2010.05271.x; Selye H., 1950, STRESS; Strange I., 2007, NEW ISLAND FALKLAND; STRANGE I J, 1982, Gerfaut, V72, P137; Taylor SS, 2001, J AVIAN BIOL, V32, P369, DOI 10.1111/j.0908-8857.2001.320413.x; Tremblay Y, 2000, MAR ECOL PROG SER, V204, P257, DOI 10.3354/meps204257; Vandenabeele SP, 2011, ANIM WELFARE, V20, P559; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Vleck CM, 2000, CONDOR, V102, P392, DOI 10.1650/0010-5422(2000)102[0392:SCAHTL]2.0.CO;2; WATANUKI Y, 1992, POLAR BIOL, V12, P539; Williams TD, 1995, PENGUINS SPHENISCIDA; Wilson R.P., 1989, Cormorant, V17, P1; Wilson RP, 2012, MAR ECOL PROG SER, V451, P245, DOI 10.3354/meps09608; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; WILSON RP, 1995, POLAR BIOL, V15, P575; WILSON RP, 1989, POLAR BIOL, V10, P77; WILSON RP, 1986, ECOLOGY, V67, P1091, DOI 10.2307/1939832; WINGFIELD JC, 1982, CONDOR, V84, P399, DOI 10.2307/1367443; YDENBERG RC, 1989, J THEOR BIOL, V139, P437, DOI 10.1016/S0022-5193(89)80064-5; Young SS, 2011, SIGNIFICANCE, V8, P116, DOI DOI 10.1111/J.1740-9713.2011.00506.X	87	34	35	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50429	10.1371/journal.pone.0050429	http://dx.doi.org/10.1371/journal.pone.0050429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185623	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000236
J	Xu, C; Fu, H; Gao, L; Wang, L; Wang, W; Li, J; Li, Y; Dou, L; Gao, X; Luo, X; Jing, Y; Chim, CS; Zheng, X; Yu, L				Xu, C.; Fu, H.; Gao, L.; Wang, L.; Wang, W.; Li, J.; Li, Y.; Dou, L.; Gao, X.; Luo, X.; Jing, Y.; Chim, C-S; Zheng, X.; Yu, L.			BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia	ONCOGENE			English	Article						microRNA; imatinib; chronic myeloid leukemia; BCR-ABL	SQUAMOUS-CELL CARCINOMA; CYCLE ARREST; BCR-ABL; MICRORNA; EXPRESSION; DIFFERENTIATION; ONCOGENE; MIR-138; TRANSCRIPTION; GATA-1	Abnormal expression of microRNAs (miRNAs) has been implicated in carcinogenesis. Here we report a novel BCR (breakpoint cluster region)-ABL (c-abl oncogene 1, non-receptor tyrosine kinase)/GATA1/microRNA-138 (miR-138) circuitry in chronic myeloid leukemia (CML). miR-138 expression is downregulated in K562 cells and primary CML samples, which is restored after imatinib treatment. The tumor suppressor activity of miR-138 is demonstrated by the induction of cell cycle arrest at G0/G1, inhibition of cell proliferation and colony forming unit granulocyte-macrophage colony formation and enhanced imatinib-induced apoptosis in K562 and Ku812 cells overexpressing miR-138. Moreover, overexpression of miR-138 led to the downregulation of BCR-ABL. Based on luciferase assay, ABL and BCR-ABL are shown to be the target genes regulated by miR-138. Furthermore, miR-138 binding to ABL was shown to localize to the coding region instead of 30-untranslated regions (30-UTR) of ABL mRNA. In addition, CCND3 is another target of miR-138, which represses CCND3 expression by binding to its 30-UTR. Finally, upregulation of miR-138 upon imatinib treatment is associated with the enhancement of GATA1 activity, which binds to the miR-138 promoter. In conclusion, miR-138 is a tumor suppressor miRNA underexpressed in CML. miR-138 represses expression of both BCR-ABL and CCND3 via binding to the coding region and 30-UTR, respectively. miR-138 expression is activated by GATA1, which in turn is repressed by BCR-ABL. Therefore, miR-138, by virtue of a BCR-ABL/GATA1/miR-138 circuitry, is a tumor suppressor miRNA implicated in the pathogenesis of CML and its clinical response to imatinib.	[Xu, C.; Gao, L.; Wang, L.; Wang, W.; Li, J.; Li, Y.; Dou, L.; Gao, X.; Luo, X.; Jing, Y.; Yu, L.] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China; [Fu, H.; Zheng, X.] Beijing Inst Radiat Med, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Chim, C-S] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China	Chinese People's Liberation Army General Hospital; Academy of Military Medical Sciences - China; University of Hong Kong	Yu, L (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, 28 Fuxing Rd, Beijing 100853, Peoples R China.	xfzheng100@126.com; chunhuiliyu@yahoo.com		Fu, Hanjiang/0000-0002-4352-1178; Yu, Li/0000-0001-6872-2665; Chim, CS/0000-0003-2427-915X	Chinese State Key Projects for Basic Research [2005CB522408, 2010CB912801]; Chinese National Natural Science Foundation [90919044, 81072021, 30971297, 81170518]; High and New Technology Program of PLA [2010gxjs091]; Capital Medical Development Scientific Research Fund [2007-2040]	Chinese State Key Projects for Basic Research; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); High and New Technology Program of PLA; Capital Medical Development Scientific Research Fund	We thank C Li (Beijing Institute of Radiation Medicine, Beijing, China) for kindly providing the GATA1 expression vector. This work was supported partially by Chinese State Key Projects for Basic Research (2005CB522408 and 2010CB912801), Chinese National Natural Science Foundation Projects (90919044, 81072021, 30971297, and 81170518), High and New Technology Program of PLA (2010gxjs091) and Capital Medical Development Scientific Research Fund (no. 2007-2040).	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Huang DY, 2005, NUCLEIC ACIDS RES, V33, P5331, DOI 10.1093/nar/gki838; Jacquel A, 2003, FASEB J, V17, P2160, DOI 10.1096/fj.03-0322fje; Jiang L, 2011, HUM GENET, V129, P189, DOI 10.1007/s00439-010-0915-3; Kisliouk T, 2011, EUR J NEUROSCI, V33, P224, DOI 10.1111/j.1460-9568.2010.07493.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Morceau F, 2008, BIOFACTORS, V34, P313, DOI [10.1002/biof.5520340407, 10.3233/BIO-2009-1085]; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Nana-Sinkam SP, 2006, J THORAC ONCOL, V1, P929, DOI 10.1097/01243894-200611000-00002; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Pope NJ, 2010, NUCLEIC ACIDS RES, V38, P2190, DOI 10.1093/nar/gkp1159; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Spizzo R, 2009, CELL, V137, P586, DOI 10.1016/j.cell.2009.04.040; Suresh S, 2011, J CELL COMMUN SIGNAL, V5, P183, DOI 10.1007/s12079-011-0139-x; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Wang W, 2012, CARCINOGENESIS, V33, P1113, DOI 10.1093/carcin/bgs113; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Xu CW, 2010, EUR J CANCER, V46, P2828, DOI 10.1016/j.ejca.2010.06.127; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zanette DL, 2007, BRAZ J MED BIOL RES, V40, P1435, DOI 10.1590/S0100-879X2007001100003	38	52	55	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					44	54		10.1038/onc.2012.557	http://dx.doi.org/10.1038/onc.2012.557			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23208504				2022-12-25	WOS:000329212000006
J	Villar, VAM; Armando, I; Sanada, H; Frazer, LC; Russo, CM; Notario, PM; Lee, H; Comisky, L; Russell, HA; Yang, Y; Jurgens, JA; Jose, PA; Jones, JE				Villar, Van Anthony M.; Armando, Ines; Sanada, Hironobu; Frazer, Lauren C.; Russo, Christen M.; Notario, Patricia M.; Lee, Hewang; Comisky, Lauren; Russell, Holly Ann; Yang, Yu; Jurgens, Julie A.; Jose, Pedro A.; Jones, John E.			Novel role of sorting nexin 5 in renal D-1 dopamine receptor trafficking and function: implications for hypertension	FASEB JOURNAL			English	Article						GRK4; cAMP; natriuresis; kidney; receptor trafficking	PROTEIN-COUPLED RECEPTOR; AGONIST-INDUCED DESENSITIZATION; KINASE 4; INTRARENAL DOPAMINE; D1; PHOSPHORYLATION; IDENTIFICATION; CELLS; RESPONSIVENESS; ENDOCYTOSIS	The D-1 dopamine receptor (D1R) is widely expressed in the kidney and plays a crucial role in blood pressure regulation. Although much is known about D1R desensitization, especially through G-protein-coupled receptor kinase 4 (GRK4), comparatively little is known about other aspects of D1R trafficking and the proteins involved in the process. We now report the discovery of a dynamic interaction between sorting nexin 5 (SNX5), a component of the mammalian retromer, and D1R in human renal epithelial cells. We show that internalization of agonist-activated D1R is regulated by both SNX5 and GRK4, and that SNX5 is critical to the recycling of the receptor to the plasma membrane. SNX5 depletion increases agonist-activated D1R phosphorylation (>50% at basal condition), prevents D1R internalization and cAMP response, and delays receptor recycling compared to mock siRNA-transfected controls. Moreover, renal restricted subcapsular infusion of Snx5-specific siRNA (vs. mock siRNA) decreases sodium excretion (Delta = -0.2 +/- 0.005 mEq/mg creatinine) and further elevates the systolic blood pressure (Delta = 48 +/- 5 mm Hg) in spontaneously hypertensive rats, indicating that SNX5 depletion impairs renal D1R function. These studies demonstrate an essential role for SNX5 in regulating D1R function, which may have important diagnostic, prognostic, and therapeutic implications in the management of essential hypertension.-Villar, V. A. M., Armando, I., Sanada, H., Frazer, L. C., Russo, C. M., Notario, P. M., Lee, H., Comisky, L., Russell, H. A., Yang, Y., Jurgens, J. A., Jose, P. A., Jones, J. E. Novel role of sorting nexin 5 in renal D-1 dopamine receptor trafficking and function: implications for hypertension. FASEB J. 27, 1808-1819 (2013). www.fasebj.org	[Villar, Van Anthony M.; Armando, Ines; Lee, Hewang; Yang, Yu; Jurgens, Julie A.; Jose, Pedro A.; Jones, John E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Villar, Van Anthony M.; Armando, Ines; Frazer, Lauren C.; Russo, Christen M.; Notario, Patricia M.; Lee, Hewang; Comisky, Lauren; Russell, Holly Ann; Jose, Pedro A.; Jones, John E.] Georgetown Univ, Sch Med, Dept Pediat, Washington, DC 20007 USA; [Sanada, Hironobu] Fukushima Med Univ, Sch Med, Dept Internal Med 3, Fukushima, Japan	University System of Maryland; University of Maryland Baltimore; Georgetown University; Fukushima Medical University	Villar, VAM (corresponding author), Univ Maryland, Sch Med, Dept Med, Div Nephrol, 20 Penn St,Ste S003C, Baltimore, MD 21201 USA.	vvillar@medicine.umaryland.edu		Frazer, Lauren/0000-0003-2366-7409; Lee, Hewang/0000-0003-1338-2573	U.S. National Institutes of Health (NIH) [R37HL023081, R01HL092196]; NIH National Center for Research Resources [UL1RR031988, KL2 RR031987]; Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource [P30CA51008, S10RR15768]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource	The authors are grateful to Dr. Robin A. Felder (Department of Pathology, The University of Virginia School of Medicine, Charlottesville, VA, USA) for providing the immortalized human renal proximal tubule cells and to Dr. Xiaoyan Wang for validating the in-house rabbit polyclonal anti-D<INF>1</INF>R Ab (clone 408) that was used in this work. These experiments were supported, in part, by grants R37HL023081 and R01HL092196 from the U.S. National Institutes of Health (NIH); by trants UL1RR031988 and KL2 RR031987 from the NIH National Center for Research Resources; and by the Lombardi Comprehensive Cancer Center Microscopy and Imaging Shared Resource, grants P30CA51008 and S10RR15768.	Albrecht FE, 1996, J CLIN INVEST, V97, P2283, DOI 10.1172/JCI118670; Aperia AC, 2000, ANNU REV PHYSIOL, V62, P621, DOI 10.1146/annurev.physiol.62.1.621; Banday AA, 2008, CURR HYPERTENS REP, V10, P268, DOI 10.1007/s11906-008-0051-9; Brana C, 1996, J COMP NEUROL, V370, P23, DOI 10.1002/(SICI)1096-9861(19960617)370:1<23::AID-CNE3>3.0.CO;2-N; Brismar H, 2006, PFLUG ARCH EUR J PHY, V451, P793, DOI 10.1007/s00424-005-1510-7; Brismar H, 1998, P NATL ACAD SCI USA, V95, P5573, DOI 10.1073/pnas.95.10.5573; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Costa MZD, 2006, APPL IMMUNOHISTO M M, V14, P348; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; FELDER CC, 1990, AM J PHYSIOL, V259, pF297, DOI 10.1152/ajprenal.1990.259.2.F297; Felder RA, 2002, P NATL ACAD SCI USA, V99, P3872, DOI 10.1073/pnas.062694599; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Gardner B, 2001, MOL PHARMACOL, V59, P310, DOI 10.1124/mol.59.2.310; Guo Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029204; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; He Y, 2009, NEUROSCI BULL, V25, P43, DOI 10.1007/s12264-009-0107-0; Jackson A, 2002, J NEUROCHEM, V82, P683, DOI 10.1046/j.1471-4159.2002.01001.x; Jiang D, 1999, MOL PHARMACOL, V56, P675; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; Kim OJ, 2004, J BIOL CHEM, V279, P7999, DOI 10.1074/jbc.M308281200; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Kurten RC, 1996, SCIENCE, V272, P1008, DOI 10.1126/science.272.5264.1008; Lamey M, 2002, J BIOL CHEM, V277, P9415, DOI 10.1074/jbc.M111811200; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Li HW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2943286; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; NG GYK, 1995, P NATL ACAD SCI USA, V92, P10157, DOI 10.1073/pnas.92.22.10157; Oh P, 2001, MOL BIOL CELL, V12, P685, DOI 10.1091/mbc.12.3.685; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Premont RT, 1996, J BIOL CHEM, V271, P6403, DOI 10.1074/jbc.271.11.6403; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Sanada H, 2006, HYPERTENSION, V47, P1131, DOI 10.1161/01.HYP.0000222004.74872.17; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Teasdale RD, 2001, BIOCHEM J, V358, P7, DOI 10.1042/0264-6021:3580007; Tiberi M, 1996, J BIOL CHEM, V271, P3771; Trivedi M, 2004, AM J PHYSIOL-RENAL, V287, pF921, DOI 10.1152/ajprenal.00023.2004; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Villar VM, 2009, J BIOL CHEM, V284, P21425, DOI 10.1074/jbc.M109.003665; Wassmer T, 2007, J CELL SCI, V120, P45, DOI 10.1242/jcs.03302; Watanabe H, 2002, KIDNEY INT, V62, P790, DOI 10.1046/j.1523-1755.2002.00525.x; Yatabe J, 2008, HYPERTENS RES, V31, P1455, DOI 10.1291/hypres.31.1455; Yoneda M, 2005, HYPERTENSION, V46, P58, DOI 10.1161/01.HYP.0000171587.44736.ba; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Yu PY, 2011, FREE RADICAL BIO MED, V50, P832, DOI 10.1016/j.freeradbiomed.2010.12.027; Yu PY, 2004, KIDNEY INT, V66, P2167, DOI 10.1111/j.1523-1755.2004.66007.x; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324	54	30	30	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2013	27	5					1808	1819		10.1096/fj.12-208439	http://dx.doi.org/10.1096/fj.12-208439			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	134PU	23195037	Green Published			2022-12-25	WOS:000318226100002
J	Fan, JH; Cui, YB; Huang, JK; Wang, WL; Yin, WB; Hu, ZM; Li, YG				Fan, Jianhua; Cui, Yanbin; Huang, Jianke; Wang, Weiliang; Yin, Weibo; Hu, Zanmin; Li, Yuanguang			Suppression Subtractive Hybridization Reveals Transcript Profiling of Chlorella under Heterotrophy to Photoautotrophy Transition	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; MOLECULAR EVIDENCE; SYSTEMS BIOLOGY; GENE-EXPRESSION; GREEN-ALGA; STRESS; PROTEIN; RNA; GROWTH	Background: Microalgae have been extensively investigated and exploited because of their competitive nutritive bioproducts and biofuel production ability. Chlorella are green algae that can grow well heterotrophically and photoautotrophically. Previous studies proved that shifting from heterotrophy to photoautotrophy in light-induced environments causes photooxidative damage as well as distinct physiologic features that lead to dynamic changes in Chlorella intracellular components, which have great potential in algal health food and biofuel production. However, the molecular mechanisms underlying the trophic transition remain unclear. Methodology/Principal Findings: In this study, suppression subtractive hybridization strategy was employed to screen and characterize genes that are differentially expressed in response to the light-induced shift from heterotrophy to photoautotrophy. Expressed sequence tags (ESTs) were obtained from 770 and 803 randomly selected clones among the forward and reverse libraries, respectively. Sequence analysis identified 544 unique genes in the two libraries. The functional annotation of the assembled unigenes demonstrated that 164 (63.1%) from the forward library and 62 (21.8%) from the reverse showed significant similarities with the sequences in the NCBI non-redundant database. The time-course expression patterns of 38 selected differentially expressed genes further confirmed their responsiveness to a diverse trophic status. The majority of the genes enriched in the subtracted libraries were associated with energy metabolism, amino acid metabolism, protein synthesis, carbohydrate metabolism, and stress defense. Conclusions/Significance: The data presented here offer the first insights into the molecular foundation underlying the diverse microalgal trophic niche. In addition, the results can be used as a reference for unraveling candidate genes associated with the transition of Chlorella from heterotrophy to photoautotrophy, which holds great potential for further improving its lipid and nutrient production.	[Yin, Weibo; Hu, Zanmin] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Fan, Jianhua; Cui, Yanbin; Huang, Jianke; Wang, Weiliang; Li, Yuanguang] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; East China University of Science & Technology	Hu, ZM (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.	zmhu@genetics.ac.cn; ygli@ecust.edu.cn		Huang, Jianke/0000-0001-8269-2044	National Natural Science Foundation of China [21076080]; National Basic Research Program of China [2011CB200902]; National Key Technologies RD Program [2011BAD23B04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program)	This research was supported by the National Natural Science Foundation of China 21076080, National Basic Research Program of China 2011CB200902 and National Key Technologies R&D Program 2011BAD23B04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkayal F, 2010, PLANT SCI, V179, P437, DOI 10.1016/j.plantsci.2010.07.001; Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson U, 2003, PLANT PHYSIOL, V132, P811, DOI 10.1104/pp.102.019281; Nguyen AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029364; [Anonymous], MICROALGAL BIOTECHNO; Baldwin JC, 2006, PLANT SCI, V171, P459, DOI 10.1016/j.plantsci.2006.05.003; Biou V, 1997, EMBO J, V16, P3405, DOI 10.1093/emboj/16.12.3405; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Cosgrove DJ, 2001, PLANT PHYSIOL, V125, P131, DOI 10.1104/pp.125.1.131; Couee I, 2006, J EXP BOT, V57, P449, DOI 10.1093/jxb/erj027; De Martino A, 2011, PROTIST, V162, P462, DOI 10.1016/j.protis.2011.02.002; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Drakakaki G, 2006, PLANT PHYSIOL, V142, P1480, DOI 10.1104/pp.106.086363; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; ENDO H, 1974, AGR BIOL CHEM TOKYO, V38, P9, DOI 10.1080/00021369.1974.10861121; FALCONE DL, 1994, PLANT PHYSIOL, V106, P1453, DOI 10.1104/pp.106.4.1453; Fan JH, 2012, BIORESOURCE TECHNOL, V112, P206, DOI 10.1016/j.biortech.2012.02.046; Gao ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042243; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; Gonzalez-Ballester D, 2010, PLANT CELL, V22, P2058, DOI 10.1105/tpc.109.071167; Grabowska A, 2011, ACTA PHYSIOL PLANT, V33, P1981, DOI 10.1007/s11738-011-0801-1; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Hata N, 2001, J APPL PHYCOL, V13, P395, DOI 10.1023/A:1011921329568; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huddleston JE, 2011, NAT REV MICROBIOL, V9, P397, DOI 10.1038/nrmicro2584; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; Kim KY, 2004, J EXP BOT, V55, P1153, DOI 10.1093/jxb/erh125; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; LAROCHE J, 1991, PLANT PHYSIOL, V97, P147, DOI 10.1104/pp.97.1.147; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lightfoot DA, 2007, EUPHYTICA, V156, P103, DOI 10.1007/s10681-007-9357-y; Liu YL, 2008, APPL ENVIRON MICROB, V74, P5023, DOI 10.1128/AEM.00556-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machado CR, 1997, J MOL BIOL, V273, P114, DOI 10.1006/jmbi.1997.1302; Machado CR, 1996, PLANT MOL BIOL, V31, P585, DOI 10.1007/BF00042231; Machida T, 2008, PLANT SCI, V175, P238, DOI 10.1016/j.plantsci.2008.04.002; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Mungur R, 2005, J BIOMED BIOTECHNOL, P198, DOI 10.1155/JBB.2005.198; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ogbonna JC, 1999, J BIOTECHNOL, V70, P213, DOI 10.1016/S0168-1656(99)00075-9; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Phukan MM, 2011, APPL ENERG, V88, P3307, DOI 10.1016/j.apenergy.2010.11.026; Rebrikov Denis V., 2004, V258, P107; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Tokusoglu O, 2003, J FOOD SCI, V68, P1144, DOI 10.1111/j.1365-2621.2003.tb09615.x; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; VAVILIN DV, 1995, J PLANT PHYSIOL, V146, P609, DOI 10.1016/S0176-1617(11)81922-X; Viola RE, 2001, ACCOUNTS CHEM RES, V34, P339, DOI 10.1021/ar000057q; Vrancken G, 2009, FOOD MICROBIOL, V26, P720, DOI 10.1016/j.fm.2009.07.006; Wald FA, 2003, PLANT MOL BIOL, V52, P705, DOI 10.1023/A:1025061324856; Wessler SR, 1996, CURR BIOL, V6, P959, DOI 10.1016/S0960-9822(02)00638-3; Xu H, 2006, J BIOTECHNOL, V126, P499, DOI 10.1016/j.jbiotec.2006.05.002; Yang KS, 2007, PLANTA, V225, P1459, DOI 10.1007/s00425-006-0453-3; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang DH, 2001, APPL MICROBIOL BIOT, V55, P537, DOI 10.1007/s002530000526; ZHANG JX, 1994, PLANT CELL PHYSIOL, V35, P785, DOI 10.1093/oxfordjournals.pcp.a078658; Zhao R, 2011, J PHYCOL, V47, P1454, DOI 10.1111/j.1529-8817.2011.01071.x	64	14	14	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50414	10.1371/journal.pone.0050414	http://dx.doi.org/10.1371/journal.pone.0050414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209737	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900050
J	Fang, W; Fang, ZM; Zhou, P; Chang, F; Hong, YZ; Zhang, XC; Peng, H; Xiao, YZ				Fang, Wei; Fang, Zemin; Zhou, Peng; Chang, Fei; Hong, Yuzhi; Zhang, Xuecheng; Peng, Hui; Xiao, Yazhong			Evidence for Lignin Oxidation by the Giant Panda Fecal Microbiome	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; LACCASE DETOXIFICATION; GASTROINTESTINAL-TRACT; BACTERIAL COMMUNITY; ETHANOL-PRODUCTION; GUT; DEGRADATION; EXPRESSION; VERSATILE; LIBRARY	The digestion of lignin and lignin-related phenolic compounds from bamboo by giant pandas has puzzled scientists because of the lack of lignin-degrading genes in the genome of the bamboo-feeding animals. We constructed a 16S rRNA gene library from the microorganisms derived from the giant panda feces to identify the possibility for the presence of potential lignin-degrading bacteria. Phylogenetic analysis showed that the phylotypes of the intestinal bacteria were affiliated with the phyla Proteobacteria (53%) and Firmicutes (47%). Two phylotypes were affiliated with the known lignin-degrading bacterium Pseudomonas putida and the mangrove forest bacteria. To test the hypothesis that microbes in the giant panda gut help degrade lignin, a metagenomic library of the intestinal bacteria was constructed and screened for clones that contained genes encoding laccase, a lignin-degrading related enzyme. A multicopper oxidase gene, designated as lac51, was identified from a metagenomic clone. Sequence analysis and copper content determination indicated that Lac51 is a laccase rather than a metallo-oxidase and may work outside its original host cell because it has a TAT-type signal peptide and a transmembrane segment at its N-terminus. Lac51 oxidizes a variety of lignin-related phenolic compounds, including syringaldazine, 2,6-dimethoxyphenol, ferulic acid, veratryl alcohol, guaiacol, and sinapinic acid at conditions that simulate the physiologic environment in giant panda intestines. Furthermore, in the presence of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), syringic acid, or ferulic acid as mediators, the oxidative ability of Lac51 on lignin was promoted. The absorbance of lignin at 445 nm decreased to 36% for ABTS, 51% for syringic acid, and 51% for ferulic acid after incubation for 10 h. Our findings demonstrate that the intestinal bacteria of giant pandas may facilitate the oxidation of lignin moieties, thereby clarifying the digestion of bamboo lignin by the animal.	[Fang, Wei; Fang, Zemin; Zhou, Peng; Chang, Fei; Hong, Yuzhi; Zhang, Xuecheng; Peng, Hui; Xiao, Yazhong] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China; [Fang, Wei; Fang, Zemin; Zhou, Peng; Chang, Fei; Hong, Yuzhi; Zhang, Xuecheng; Peng, Hui; Xiao, Yazhong] Anhui Prov Engn Technol Res Ctr Microorganisms &, Hefei, Anhui, Peoples R China	Anhui University	Xiao, YZ (corresponding author), Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China.	xiaoyz@yahoo.cn		Hong, Yuzhi/0000-0003-4277-1834	Scientific Research Foundation for Returned Scholars, Ministry of Education of China; Natural Science Foundation of Anhui Province [11040606Q05]; Natural Science Foundation of the Department of Education of Anhui Province [KJ2010A013]; Introduction Project of Academic and Technology Leaders in Anhui University [32030066]; Innovative Research Team Program of 211 Project in Anhui University	Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China); Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Natural Science Foundation of the Department of Education of Anhui Province; Introduction Project of Academic and Technology Leaders in Anhui University; Innovative Research Team Program of 211 Project in Anhui University	This work was supported by the Scientific Research Foundation for Returned Scholars, Ministry of Education of China (to YX); the Natural Science Foundation of Anhui Province (11040606Q05 to WF); the Natural Science Foundation of the Department of Education of Anhui Province (KJ2010A013 to WF); the Introduction Project of Academic and Technology Leaders in Anhui University (32030066 to ZF) and the Innovative Research Team Program of 211 Project in Anhui University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2010, MOL BIOSYST, V6, P815, DOI 10.1039/b908966g; Ahmad N, 2008, CURR MICROBIOL, V57, P145, DOI 10.1007/s00284-008-9167-z; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Atlas RM., 1998, MICROBIAL ECOLOGY FU, V4; Ausec L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025724; Bandounas L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-94; Bekele AZ, 2011, FEMS MICROBIOL LETT, V316, P51, DOI 10.1111/j.1574-6968.2010.02191.x; Beloqui A, 2006, J BIOL CHEM, V281, P22933, DOI 10.1074/jbc.M600577200; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENNER R, 1984, APPL ENVIRON MICROB, V47, P998, DOI 10.1128/AEM.47.5.998-1004.1984; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Chen YH, 2012, J APPL MICROBIOL, V112, P900, DOI 10.1111/j.1365-2672.2012.05275.x; Chu XM, 2008, APPL MICROBIOL BIOT, V80, P615, DOI 10.1007/s00253-008-1566-3; Crestini C, 2003, CHEM-EUR J, V9, P5371, DOI 10.1002/chem.200304818; Delalibera I, 2007, SYMBIOSIS, V43, P97; Diaz-Gonzalez M, 2011, APPL MICROBIOL BIOT, V89, P1693, DOI 10.1007/s00253-010-3007-3; Durao P, 2008, J BIOL INORG CHEM, V13, P183, DOI 10.1007/s00775-007-0312-0; Fang Z, 2011, APPL MICROBIOL BIOT, V89, P1103, DOI 10.1007/s00253-010-2934-3; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Glad T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-10; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; GUIRAUD P, 1995, ECOTOX ENVIRON SAFE, V32, P29, DOI 10.1006/eesa.1995.1081; Ji L, 2011, BIORESOURCE TECHNOL, V102, P8105, DOI 10.1016/j.biortech.2011.06.057; Jin CZ, 2007, P NATL ACAD SCI USA, V104, P10932, DOI 10.1073/pnas.0704198104; Jin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022602; Jurado M, 2009, BIORESOURCE TECHNOL, V100, P6378, DOI 10.1016/j.biortech.2009.07.049; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; Masai E, 1999, J IND MICROBIOL BIOT, V23, P364, DOI 10.1038/sj.jim.2900747; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; Moreno AD, 2012, BIORESOURCE TECHNOL, V106, P101, DOI 10.1016/j.biortech.2011.11.108; Moya R, 2011, BIORESOURCE TECHNOL, V102, P10006, DOI 10.1016/j.biortech.2011.08.046; Nelson KE, 2003, ENVIRON MICROBIOL, V5, P1212, DOI 10.1046/j.1462-2920.2003.00526.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P17, DOI 10.1016/S0960-8524(99)00160-1; Pointing SB, 2000, BIOFOULING, V15, P221, DOI 10.1080/08927010009386312; Rahouti M, 1999, CHEMOSPHERE, V38, P2549, DOI 10.1016/S0045-6535(98)00462-7; Roberts SA, 2003, J BIOL CHEM, V278, P31958, DOI 10.1074/jbc.M302963200; Rong Hua, 2006, Chinese Journal of Applied and Environmental Biology, V12, P239; Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001; Scharf ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021709; Schauer C, 2012, APPL ENVIRON MICROB, V78, P2758, DOI 10.1128/AEM.07788-11; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Walter J, 2005, APPL ENVIRON MICROB, V71, P2347, DOI 10.1128/AEM.71.5.2347-2354.2005; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Wenzel M, 2002, J APPL MICROBIOL, V92, P32, DOI 10.1046/j.1365-2672.2002.01502.x; Ye M, 2010, APPL MICROBIOL BIOT, V87, P1023, DOI 10.1007/s00253-010-2507-5; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhang XY, 2007, J BIOSCI BIOENG, V104, P149, DOI 10.1263/jbb.104.149; Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108	59	32	41	1	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50312	10.1371/journal.pone.0050312	http://dx.doi.org/10.1371/journal.pone.0050312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209704	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700055
J	Rai, N; Chaubey, G; Tamang, R; Pathak, AK; Singh, VK; Karmin, M; Singh, M; Rani, DS; Anugula, S; Yadav, BK; Singh, A; Srinivasagan, R; Yadav, A; Kashyap, M; Narvariya, S; Reddy, AG; van Driem, G; Underhill, PA; Villems, R; Kivisild, T; Singh, L; Thangaraj, K				Rai, Niraj; Chaubey, Gyaneshwer; Tamang, Rakesh; Pathak, Ajai Kumar; Singh, Vipin Kumar; Karmin, Monika; Singh, Manvendra; Rani, Deepa Selvi; Anugula, Sharath; Yadav, Brijesh Kumar; Singh, Ashish; Srinivasagan, Ramkumar; Yadav, Anita; Kashyap, Manju; Narvariya, Sapna; Reddy, Alla G.; van Driem, George; Underhill, Peter A.; Villems, Richard; Kivisild, Toomas; Singh, Lalji; Thangaraj, Kumarasamy			The Phylogeography of Y-Chromosome Haplogroup H1a1a-M82 Reveals the Likely Indian Origin of the European Romani Populations	PLOS ONE			English	Article							SOUTH-ASIA; DIVERSITY; MUTATION; HISTORY; MIGRATIONS; DIVERGENCE; SUGGESTS; MTDNA	Linguistic and genetic studies on Roma populations inhabited in Europe have unequivocally traced these populations to the Indian subcontinent. However, the exact parental population group and time of the out-of-India dispersal have remained disputed. In the absence of archaeological records and with only scanty historical documentation of the Roma, comparative linguistic studies were the first to identify their Indian origin. Recently, molecular studies on the basis of disease-causing mutations and haploid DNA markers (i.e. mtDNA and Y-chromosome) supported the linguistic view. The presence of Indian-specific Y-chromosome haplogroup H1a1a-M82 and mtDNA haplogroups M5a1, M18 and M35b among Roma has corroborated that their South Asian origins and later admixture with Near Eastern and European populations. However, previous studies have left unanswered questions about the exact parental population groups in South Asia. Here we present a detailed phylogeographical study of Y-chromosomal haplogroup H1a1a-M82 in a data set of more than 10,000 global samples to discern a more precise ancestral source of European Romani populations. The phylogeographical patterns and diversity estimates indicate an early origin of this haplogroup in the Indian subcontinent and its further expansion to other regions. Tellingly, the short tandem repeat (STR) based network of H1a1a-M82 lineages displayed the closest connection of Romani haplotypes with the traditional scheduled caste and scheduled tribe population groups of northwestern India.	[Rai, Niraj; Tamang, Rakesh; Singh, Vipin Kumar; Singh, Manvendra; Rani, Deepa Selvi; Anugula, Sharath; Yadav, Brijesh Kumar; Singh, Ashish; Srinivasagan, Ramkumar; Yadav, Anita; Kashyap, Manju; Narvariya, Sapna; Reddy, Alla G.; Singh, Lalji; Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, CSIR, Hyderabad 500007, Andhra Pradesh, India; [Chaubey, Gyaneshwer; Karmin, Monika; Villems, Richard] Estonian Bioctr, Evolutionary Biol Grp, Tartu, Estonia; [Pathak, Ajai Kumar; Karmin, Monika; Villems, Richard; Kivisild, Toomas] Univ Tartu, Inst Mol & Cell Biol, Dept Evolutionary Biol, EE-50090 Tartu, Estonia; [van Driem, George] Univ Bern, Sprachwissensch Inst, Himalayan Languages Project, Bern, Switzerland; [Underhill, Peter A.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Villems, Richard] Estonian Acad Sci, EE-200103 Tallinn, Estonia; [Kivisild, Toomas] Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England; [Singh, Lalji] Genome Fdn, Hyderabad, Andhra Pradesh, India; [Singh, Lalji] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Estonian Biocentre; University of Tartu; University of Bern; Stanford University; Estonian Academy of Sciences; University of Cambridge; Banaras Hindu University (BHU)	Chaubey, G (corresponding author), Estonian Bioctr, Evolutionary Biol Grp, Tartu, Estonia.	gyanc@ebc.ee; thangs@ccmb.res.in	Anugula, Sharath/AAI-2443-2019; Chaubey, Gyaneshwer/AAC-6409-2019; ANUGULA, SHARATH/N-8362-2015; Kivisild, Toomas/P-5889-2017; Chaubey, Gyaneshwer/H-2753-2012; Pathak, Ajai/S-2032-2017	Chaubey, Gyaneshwer/0000-0003-2899-3852; Kivisild, Toomas/0000-0002-6297-7808; Chaubey, Gyaneshwer/0000-0003-2899-3852; Pathak, Ajai/0000-0003-2088-3616; Thangaraj, Kumarasamy/0000-0002-0075-0106; Karmin, Monika/0000-0001-9827-5579; Singh, Manvendra/0000-0002-8626-5418; Singh, Ashish/0000-0001-8076-0816; van Driem, George/0000-0002-7185-0657	Council of Scientific and Industrial Research (CSIR), India; Department of Biotechnology (DBT), India; Department of Science and Technology (DST), India; Bhatnagar Fellowship (CSIR); Bose Fellowship (DST); UK-India Education and Research Initiative [RG-4772]; European Union European Regional Development Fund through the Centre of Excellence in Genomics; University of Tartu; Estonian Basic Research grant [SF0270177As08]; European Social Fund's Doctoral Studies and Internationalisation Programme DoRa; Carlos D. Bustamante	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), India(Department of Science & Technology (India)); Bhatnagar Fellowship (CSIR); Bose Fellowship (DST); UK-India Education and Research Initiative; European Union European Regional Development Fund through the Centre of Excellence in Genomics; University of Tartu; Estonian Basic Research grant; European Social Fund's Doctoral Studies and Internationalisation Programme DoRa; Carlos D. Bustamante	KT and LS are supported by the Council of Scientific and Industrial Research (CSIR), India. Financial supports to LS and KT from the Department of Biotechnology (DBT), India, and Department of Science and Technology (DST), India, are gratefully acknowledged. LS is also supported by Bhatnagar Fellowship (CSIR) and Bose Fellowship (DST). PAU thanks Carlos D. Bustamante for support. KT and TK acknowledge support from the UK-India Education and Research Initiative (RG-4772). RV, GC and MK thank the European Union European Regional Development Fund through the Centre of Excellence in Genomics to Estonian Biocentre, and University of Tartu. RV was supported by Estonian Basic Research grant SF0270177As08. AKP was supported by the European Social Fund's Doctoral Studies and Internationalisation Programme DoRa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abicht A, 1999, NEUROLOGY, V53, P1564, DOI 10.1212/WNL.53.7.1564; Ali M, 2009, AM J HUM GENET, V84, P664, DOI 10.1016/j.ajhg.2009.03.017; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Berger Hermann, 1959, INDOIRANIAN J, V3, P17, DOI [10.1163/000000059792938071, DOI 10.1163/000000059792938071]; Bouwer S, 2007, GENET TEST, V11, P455, DOI 10.1089/gte.2007.0048; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Chaubey G, 2010, THESIS U TARTUENSIS; Chaubey G, 2007, BIOESSAYS, V29, P91, DOI 10.1002/bies.20525; Chaubey G, 2011, MOL BIOL EVOL, V28, P1013, DOI 10.1093/molbev/msq288; Crawfurd J., 1865, T ETHNOL SOC LOND, V3, P25, DOI [10.2307/3014152, DOI 10.2307/3014152]; Debnath M, 2011, J HUM GENET, V56, P765, DOI 10.1038/jhg.2011.98; Forster P, 1996, AM J HUM GENET, V59, P935; Fraser A., 1992, GYPSIES; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Grellman H, 1783, HIST VERSUCH ZIGEUNE; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Grierson GeorgeA., 1922, LINGUISTIC SURVEY IN; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Gusmao A, 2008, ANN HUM GENET, V72, P215, DOI 10.1111/j.1469-1809.2007.00421.x; Hancock Ian, 1995, HDB VLAX ROMANI; Hancock Ian F., 2002, WE ARE ROMANI PEOPLE; He JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036437; Iovita RP, 2004, AM ANTHROPOL, V106, P267, DOI 10.1525/aa.2004.106.2.267; Kaaydjieva L, 2005, BIOESSAYS, V27, P1084, DOI 10.1002/bies.20287; Kayser M, 2008, MOL BIOL EVOL, V25, P1362, DOI 10.1093/molbev/msn078; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; Klaric IM, 2009, AM J PHYS ANTHROPOL, V138, P333, DOI 10.1002/ajpa.20933; MASTANA S S, 1992, Zeitschrift fuer Morphologie und Anthropologie, V79, P43; Mendizabal I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015988; Mihaylova V, 2007, BRAIN, V130, P1050, DOI 10.1093/brain/awm026; Moreau R, 2002, ROM WALKING PATHS GY; Morgenstierne G., 1973, IRANO DARDICA; Pamjav H, 2011, AM J PHYS ANTHROPOL, V145, P21, DOI 10.1002/ajpa.21454; Pericic M, 2005, MOL BIOL EVOL, V22, P1964, DOI 10.1093/molbev/msi185; Pott August Friedrich, 1844, ZIGEUNER EUROPA ASIE; Regueiro M, 2011, AM J PHYS ANTHROPOL, V144, P80, DOI 10.1002/ajpa.21372; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Trail G, 1828, ASIATIC RES, V16, P137; Trivedi R, 2008, INT J HUM GENET, V8, P97, DOI 10.1080/09723757.2008.11886023; Turner RL., 1926, ROMANI STUD, V5, P145; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Zalan A, 2011, FORENSIC SCI INT-GEN, V5, P109, DOI 10.1016/j.fsigen.2010.08.017; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	47	24	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e48477	10.1371/journal.pone.0048477	http://dx.doi.org/10.1371/journal.pone.0048477			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209554	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700002
J	Tay, WT; Evans, GA; Boykin, LM; De Barro, PJ				Tay, Wee Tek; Evans, Gregory A.; Boykin, Laura M.; De Barro, Paul J.			Will the Real Bemisia tabaci Please Stand Up?	PLOS ONE			English	Article							ASYMMETRIC MATING INTERACTIONS; HEMIPTERA ALEYRODIDAE; INTEGRATIVE TAXONOMY; GENETIC-STRUCTURE; SPECIES COMPLEX; B-BIOTYPE; IDENTIFICATION; INVASION; DNA; POPULATIONS	Since Panayiotis Gennadius first identified the whitefly, Aleyrodes tabaci in 1889, there have been numerous revisions of the taxonomy of what has since become one of the world's most damaging insect pests. Most of the taxonomic revisions have been based on synonymising different species under the name Bemisia tabaci. It is now considered that there is sufficient biological, behavioural and molecular genetic data to support its being a cryptic species complex composed of at least 34 morphologically indistinguishable species. The first step in revising the taxonomy of this complex involves matching the A. tabaci collected in 1889 to one of the members of the species complex using molecular genetic data. To do this we extracted and then amplified a 496 bp fragment from the 3' end of the mitochondrial DNA cytochrome oxidase one (mtCOI) gene belonging to a single whitefly taken from Gennadius' original 1889 collection. The sequence identity of this 123 year-old specimen enabled unambiguous assignment to a single haplotype known from 13 Mediterranean locations across Greece and Tunisia. This enabled us to unambiguously assign the Gennadius A. tabaci to the member of the B. tabaci cryptic species complex known as Mediterranean or as it is commonly, but erroneously referred to, as the 'Q-biotype'. Mediterranean is therefore the real B. tabaci. This study demonstrates the importance of matching museum syntypes with known species to assist in the delimitation of cryptic species based on the organism's biology and molecular genetic data. This study is the first step towards the reclassification of B. tabaci which is central to an improved understanding how best to manage this globally important agricultural and horticultural insect pest complex.	[De Barro, Paul J.] CSIRO Ecosyst Sci, Brisbane, Qld, Australia; [Tay, Wee Tek] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Evans, Gregory A.] USDA APHIS NIS, BARC W, Beltsville, MD USA; [Boykin, Laura M.] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Lincoln University - New Zealand	De Barro, PJ (corresponding author), CSIRO Ecosyst Sci, Brisbane, Qld, Australia.	paul.debarro@csiro.au	De Barro, Paul J/C-1724-2008; Tay, Wee Tek/C-1818-2008; Tay, Wee Tek/GPF-6142-2022; Boykin, Laura/H-8876-2014	Tay, Wee Tek/0000-0002-8451-0811; Tay, Wee Tek/0000-0002-8451-0811; Boykin, Laura/0000-0002-6101-1921				Alemandri V, 2012, J ECON ENTOMOL, V105, P48, DOI 10.1603/EC11161; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; BARINAGA M, 1993, SCIENCE, V259, P30, DOI 10.1126/science.8418492; BARTLETT AC, 1993, SCIENCE, V261, P1333, DOI 10.1126/science.8362245; BEDFORD ID, 1994, ANN APPL BIOL, V125, P311, DOI 10.1111/j.1744-7348.1994.tb04972.x; BELLOWS TS, 1994, ANN ENTOMOL SOC AM, V87, P195, DOI 10.1093/aesa/87.2.195; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; BYRNE FJ, 1995, BIOCHEM GENET, V33, P13, DOI 10.1007/BF00554554; CAMPBELL BC, 1993, SCIENCE, V261, P1333, DOI 10.1126/science.8257524; Castalanelli MA, 2010, J ASIA-PAC ENTOMOL, V13, P243, DOI 10.1016/j.aspen.2010.04.003; COSTA HS, 1993, INSECT SCI APPL, V14, P255, DOI 10.1017/S1742758400014703; Dalmon A, 2008, HEREDITY, V100, P316, DOI 10.1038/sj.hdy.6801080; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Barro PJ, 2008, BIOL INVASIONS, V10, P411, DOI 10.1007/s10530-007-9141-x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2000, B ENTOMOL RES, V90, P103, DOI 10.1017/S0007485300000201; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elbaz M, 2010, B ENTOMOL RES, V100, P581, DOI 10.1017/S0007485309990630; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Gennadius P., 1889, ELLENIKE GEORGIA, V5, P1; Hu J, 2011, PLOS ONE, V6; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Lis JA, 2011, ZOOTAXA, P47, DOI 10.11646/zootaxa.2932.1.5; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Luan JB, 2012, INTEGR ZOOL, V7, P1, DOI [10.1111/j.1749-4877.2012.00271.x, 10.1111/j.1749-4877.2011.00273.x]; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Maruthi MN, 2004, SYST ENTOMOL, V29, P560, DOI 10.1111/j.0307-6970.2004.00272.x; Maruthi MN, 2001, ENTOMOL EXP APPL, V99, P13, DOI 10.1023/A:1018944606924; Mound L. A., 1963, Proceedings of the Royal Entomological Society of London (A), V38, P171; Mound LA, 1978, WHITEFLY OF THE WORL; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Omondi Bonaventure Aman, 2005, International Journal of Tropical Insect Science, V25, P159, DOI 10.1079/IJT200578; Perring T. M., 1991, California Agriculture, V45, P10; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; PERRING TM, 1993, SCIENCE, V261, P1334, DOI 10.1126/science.261.5126.1334; RUSSELL LOUISE M., 1957, BULL BROOKLYN ENT SOC, V52, P122; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Staden R, 2000, Methods Mol Biol, V132, P115; Sun DB, 2011, B ENTOMOL RES, V101, P211, DOI 10.1017/S0007485310000416; Takahashi R., 1936, Tenthredo Kyoto, V1, P109; Tay WT, 2008, B ENTOMOL RES, V98, P509, DOI 10.1017/S000748530800583X; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Thresh JM, 1997, AFRICAN J ROOT TUBER, V2, P13; Tsagkarakou A, 2007, B ENTOMOL RES, V97, P29, DOI 10.1017/S000748530700466X; Tsagkarakou A, 2012, B ENTOMOL RES, V102, P353, DOI 10.1017/S0007485311000757; Wang P, 2011, INSECT SCI, V18, P67, DOI 10.1111/j.1744-7917.2010.01381.x; Xu J, 2010, B ENTOMOL RES, V100, P359, DOI 10.1017/S0007485310000015; Zang LS, 2007, J INSECT BEHAV, V20, P157, DOI 10.1007/s10905-006-9066-8	53	76	83	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50550	10.1371/journal.pone.0050550	http://dx.doi.org/10.1371/journal.pone.0050550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209778	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700079
J	Auerbach, BJ; Reynolds, SJ; Lamorde, M; Merry, C; Kukunda-Byobona, C; Ocama, P; Semeere, AS; Ndyanabo, A; Boaz, I; Kiggundu, V; Nalugoda, F; Gray, RH; Wawer, MJ; Thomas, DL; Kirk, GD; Quinn, TC; Stabinski, L				Auerbach, Brandon J.; Reynolds, Steven J.; Lamorde, Mohammed; Merry, Concepta; Kukunda-Byobona, Collins; Ocama, Ponsiano; Semeere, Aggrey S.; Ndyanabo, Anthony; Boaz, Iga; Kiggundu, Valerian; Nalugoda, Fred; Gray, Ron H.; Wawer, Maria J.; Thomas, David L.; Kirk, Gregory D.; Quinn, Thomas C.; Stabinski, Lara		Rakai Hlth Sci Program	Traditional Herbal Medicine Use Associated with Liver Fibrosis in Rural Rakai, Uganda	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; TRANSIENT ELASTOGRAPHY; VERNONIA-AMYGDALINA; ESSENTIAL OILS; PHARMACOKINETICS; TOXICITY; PLANTS; HEPATOTOXICITY; INFECTION; EXTRACTS	Background: Traditional herbal medicines are commonly used in sub-Saharan Africa and some herbs are known to be hepatotoxic. However little is known about the effect of herbal medicines on liver disease in sub-Saharan Africa. Methods: 500 HIV-infected participants in a rural HIV care program in Rakai, Uganda, were frequency matched to 500 HIV-uninfected participants. Participants were asked about traditional herbal medicine use and assessed for other potential risk factors for liver disease. All participants underwent transient elastography (FibroScanH) to quantify liver fibrosis. The association between herb use and significant liver fibrosis was measured with adjusted prevalence risk ratios (adjPRR) and 95% confidence intervals (CI) using modified Poisson multivariable logistic regression. Results: 19 unique herbs from 13 plant families were used by 42/1000 of all participants, including 9/500 HIV-infected participants. The three most-used plant families were Asteraceae, Fabaceae, and Lamiaceae. Among all participants, use of any herb (adjPRR = 2.2, 95% CI 1.3-3.5, p = 0.002), herbs from the Asteraceae family (adjPRR = 5.0, 95% CI 2.9-8.7, p<0.001), and herbs from the Lamiaceae family (adjPRR = 3.4, 95% CI 1.2-9.2, p = 0.017) were associated with significant liver fibrosis. Among HIV infected participants, use of any herb (adjPRR = 2.3, 95% CI 1.0-5.0, p = 0.044) and use of herbs from the Asteraceae family (adjPRR = 5.0, 95% CI 1.7-14.7, p = 0.004) were associated with increased liver fibrosis. Conclusions: Traditional herbal medicine use was independently associated with a substantial increase in significant liver fibrosis in both HIV-infected and HIV-uninfected study participants. Pharmacokinetic and prospective clinical studies are needed to inform herb safety recommendations in sub-Saharan Africa. Counseling about herb use should be part of routine health counseling and counseling of HIV-infected persons in Uganda.	[Auerbach, Brandon J.; Lamorde, Mohammed; Merry, Concepta; Semeere, Aggrey S.] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Auerbach, Brandon J.; Ocama, Ponsiano] Harvard Univ, Sch Med, Boston, MA USA; [Reynolds, Steven J.; Quinn, Thomas C.; Stabinski, Lara] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Reynolds, Steven J.; Thomas, David L.; Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Lamorde, Mohammed; Merry, Concepta] Univ Dublin Trinity Coll, Dept Pharmacol & Therapeut, Sch Med, Dublin 2, Ireland; [Merry, Concepta] St James Hosp, Dublin, Ireland; [Ocama, Ponsiano; Semeere, Aggrey S.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Kukunda-Byobona, Collins] Makerere Univ, Dept Bot, Kampala, Uganda; [Ndyanabo, Anthony; Boaz, Iga; Kiggundu, Valerian; Nalugoda, Fred; Gray, Ron H.; Wawer, Maria J.] Rakai Hlth Sci Program, Entebbe, Uganda; [Gray, Ron H.; Wawer, Maria J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Kirk, Gregory D.; Stabinski, Lara] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Makerere University; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Trinity College Dublin; Trinity College Dublin; Makerere University; Makerere University; Rakai Health Sciences Program; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Auerbach, BJ (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.	brandon_auerbach@hms.harvard.edu	Merry, Concepta/AAM-7887-2021; Kukunda, Collins B./AAA-3350-2021	Kukunda, Collins B./0000-0002-6586-6468; Semeere, Aggrey/0000-0003-1826-2239; Reynolds, Steven/0000-0002-5403-2759	United States National Institutes of Health (NIH) Bench; Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health; National Institute on Drug Abuse [R01-AI-16078]; American Cancer Society [MRSG-07-284-01-CCE]; Department of the Army, United States Army Medical Research and Material Command [DAMD17-98-2-8007, R01 A134826, R01 A134265]; National Institute of Allergy and Infectious Diseases [R01 016078]; National Institute on Drug Abuse; National Institute of Child and Health Development. BJA [5P30HD06826]; Fogarty International Clinical Research Scholars (FICRS) program of the NIH [R24 TW007988]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001040, ZIAAI000361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016078] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH) Bench; Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); American Cancer Society(American Cancer Society); Department of the Army, United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Child and Health Development. BJA; Fogarty International Clinical Research Scholars (FICRS) program of the NIH; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was primarily funded by the United States National Institutes of Health (NIH) Bench to Bedside Program. Additional support was provided by the Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health. Support was also provided by the National Institute on Drug Abuse (PI: DLT, R01-AI-16078) and the American Cancer Society (PI: GDK, MRSG-07-284-01-CCE). The study was jointly conducted and benefited from close collaboration of researchers from the intramural NIH Laboratory of Immunoregulation, Johns Hopkins University, the Infectious Diseases Institute of Makerere University, and the Rakai Health Sciences Program. Support for the RHSP HIV Care Program was provided by the President's Emergency Fund for AIDS Relief (PEPFAR) and support for the Rakai Community Cohort Study was provided by the Department of the Army, United States Army Medical Research and Material Command Cooperative Agreement DAMD17-98-2-8007; grants R01 A134826 and R01 A134265 from the National Institute of Allergy and Infectious Diseases; grant R01 016078 (DLT) from the National Institute on Drug Abuse; and grant 5P30HD06826 from the National Institute of Child and Health Development. BJA and ASS were funded by the Fogarty International Clinical Research Scholars (FICRS) program of the NIH, administered by the Vanderbilt University Institute for Global Health (R24 TW007988). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesanoye OA, 2010, EXP TOXICOL PATHOL, V62, P197, DOI 10.1016/j.etp.2009.05.008; Adesegun S A, 2008, Pak J Biol Sci, V11, P453, DOI 10.3923/pjbs.2008.453.457; AIDS Clinical Trials Group, 1994, TABL GRAD SEV AD PED; Ajila CM, 2010, FOOD CHEM TOXICOL, V48, P3406, DOI 10.1016/j.fct.2010.09.012; AKAH PA, 1992, PHYTOTHER RES, V6, P171, DOI 10.1002/ptr.2650060318; Al-Duais M, 2009, J AGR FOOD CHEM, V57, P5420, DOI 10.1021/jf9003626; Andersen ES, 2009, EUR J INTERN MED, V20, P339, DOI 10.1016/j.ejim.2008.09.020; Ashafa AOT, 2010, FOOD CHEM TOXICOL, V48, P1886, DOI 10.1016/j.fct.2010.04.029; Asres K, 2007, PHARMAZIE, V62, P709, DOI 10.1691/ph.2007.9.6766; Bakasso S, 2008, Pak J Biol Sci, V11, P1429, DOI 10.3923/pjbs.2008.1429.1435; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Barry M, 1999, CLIN PHARMACOKINET, V36, P289, DOI 10.2165/00003088-199936040-00004; Beaman-Mbaya V, 1976, ANTIBIOTIC ACTION SO; Chen T, 2010, J APPL TOXICOL, V30, P183, DOI 10.1002/jat.1504; Chen Z, 2010, NETH J MED, V68, P252; Dara L, 2008, WORLD J GASTROENTERO, V14, P6999, DOI 10.3748/wjg.14.6999; Dickinson L, 2010, ANTIVIR RES, V85, P176, DOI 10.1016/j.antiviral.2009.07.017; Effraim K, 2002, AFR J BIOMED RES, V6, P21; Foubert K, 2010, TALANTA, V81, P1258, DOI 10.1016/j.talanta.2010.02.018; GUNDIDZA GM, 1992, CENT AFR J MED, V38, P290; Hamill FA, 2000, J ETHNOPHARMACOL, V70, P281, DOI 10.1016/S0378-8741(00)00180-X; Iwalokun BA, 2006, J MED FOOD, V9, P524, DOI 10.1089/jmf.2006.9.524; Kanwal Q, 2010, ANTIFUNGAL ACTIVITY; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Kuiate JR, 1999, FLAVOUR FRAG J, V14, P167, DOI 10.1002/(SICI)1099-1026(199905/06)14:3&lt;167::AID-FFJ802&gt;3.0.CO;2-O; Lamorde M, 2010, J ETHNOPHARMACOL, V130, P43, DOI 10.1016/j.jep.2010.04.004; Langlois-Klassen D, 2008, SOC SCI MED, V67, P165, DOI 10.1016/j.socscimed.2008.02.027; Manguro LOA, 2003, PHYTOCHEMISTRY, V64, P855, DOI 10.1016/S0031-9422(03)00428-X; Matias EF, 2010, BIOMED PHARMACOTHER, V23, P23; Mills E, 2005, AIDS, V19, P95, DOI 10.1097/00002030-200501030-00013; Mukazayire MJ, 2010, EXP TOXICOL PATHOL, V62, P289, DOI 10.1016/j.etp.2009.04.005; Nahdi A, 2010, NUTR RES, V30, P85, DOI 10.1016/j.nutres.2010.01.004; NGOUELA S, 1988, PLANTA MED, P476, DOI 10.1055/s-2006-962516; Njamen D, 2008, PHARMAZIE, V63, P164, DOI 10.1691/ph.2008.7639; Oyedeji OO, 2009, MOLECULES, V14, P1990, DOI 10.3390/molecules14061990; Piscitelli SC, 2002, CLIN INFECT DIS, V34, P234, DOI 10.1086/324351; Prakash AS, 1999, MUTAT RES-GEN TOX EN, V443, P53, DOI 10.1016/S1383-5742(99)00010-1; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; RIDKER PM, 1989, LANCET, V1, P657, DOI 10.1016/S0140-6736(89)92154-5; Ruhl CE, 2012, HEPATOLOGY, V55, P447, DOI 10.1002/hep.24725; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Tabuti JRS, 2010, J ETHNOPHARMACOL, V127, P130, DOI 10.1016/j.jep.2009.09.035; Tabuti JRS, 2003, J ETHNOPHARMACOL, V88, P19, DOI 10.1016/S0378-8741(03)00161-2; Tamokou JD, 2009, INDIAN J PHARMACOL, V41, P60, DOI 10.4103/0253-7613.51340; Taziebou LC, 2007, AFR J TRADIT COMPLEM, V4, P127; Teschke R, 2010, J CLIN PHARM THER, V35, P545, DOI 10.1111/j.1365-2710.2009.01131.x; van den Bout-van den Beukel CJP, 2006, DRUG METAB REV, V38, P477, DOI 10.1080/03602530600754065; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; Yang HN, 2010, J KOREAN MED SCI, V25, P492, DOI 10.3346/jkms.2010.25.3.492; YEONG ML, 1993, INT J EXP PATHOL, V74, P211	50	35	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e41737	10.1371/journal.pone.0041737	http://dx.doi.org/10.1371/journal.pone.0041737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209545	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800001
J	Kadota, R; Koda, M; Kawabe, J; Hashimoto, M; Nishio, Y; Mannoji, C; Miyashita, T; Furuya, T; Okawa, A; Takahashi, K; Yamazaki, M				Kadota, Ryo; Koda, Masao; Kawabe, Junko; Hashimoto, Masayuki; Nishio, Yutaka; Mannoji, Chikato; Miyashita, Tomohiro; Furuya, Takeo; Okawa, Akihiko; Takahashi, Kazuhisa; Yamazaki, Masashi			Granulocyte Colony-Stimulating Factor (G-CSF) Protects Oligpdendrocyte and Promotes Hindlimb Functional Recovery after Spinal Cord Injury in Rats	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; BONE-MARROW; CELLS; DEATH; APOPTOSIS	Background: Granulocyte colony-stimulating factor (G-CSF) is a protein that stimulates differentiation, proliferation, and survival of cells in the granulocytic lineage. Recently, a neuroprotective effect of G-CSF was reported in a model of cerebral infarction and we previously reported the same effect in studies of murine spinal cord injury (SCI). The aim of the present study was to elucidate the potential therapeutic effect of G-CSF for SCI in rats. Methods: Adult female Sprague-Dawley rats were used in the present study. Contusive SCI was introduced using the Infinite Horizon Impactor (magnitude: 200 kilodyne). Recombinant human G-CSF (15.0 mu g/kg) was administered by tail vein injection at 1 h after surgery and daily the next four days. The vehicle control rats received equal volumes of normal saline at the same time points. Results: Using a contusive SCI model to examine the neuroprotective potential of G-CSF, we found that G-CSF suppressed the expression of pro-inflammatory cytokine (IL-1 beta and TNF-alpha) in mRNA and protein levels. Histological assessment with luxol fast blue staining revealed that the area of white matter spared in the injured spinal cord was significantly larger in G-CSF-treated rats. Immunohistochemical analysis showed that G-CSF promoted up-regulation of anti-apoptotic protein Bcl-Xl on oligpodendrocytes and suppressed apoptosis of oligodendrocytes after SCI. Moreover, administration of G-CSF promoted better functional recovery of hind limbs. Conclusions: G-CSF protects oligodendrocyte from SCI-induced cell death via the suppression of inflammatory cytokines and up-regulation of anti-apoptotic protein. As a result, G-CSF attenuates white matter loss and promotes hindlimb functional recovery.	[Koda, Masao; Mannoji, Chikato] Chiba Aoba Municipal Hosp, Dept Orthopaed Surg, Chuo Ku, Chiba, Japan; [Kadota, Ryo; Kawabe, Junko; Nishio, Yutaka; Miyashita, Tomohiro; Furuya, Takeo; Okawa, Akihiko; Takahashi, Kazuhisa; Yamazaki, Masashi] Chiba Univ, Dept Orthopaed Surg, Grad Sch Med, Chuo Ku, Chiba, Japan; [Hashimoto, Masayuki] Chiba Med Ctr, Dept Orthopaed Surg, Chuo Ku, Chiba, Japan	Chiba University	Koda, M (corresponding author), Chiba Aoba Municipal Hosp, Dept Orthopaed Surg, Chuo Ku, Chiba, Japan.	masaokod@gmail.com	Miyashita, Tomohiro/R-7375-2019	Miyashita, Tomohiro/0000-0002-0369-3039	Ministry of Education, Science and Culture of Japan [16591473-00]; Cervical Spine Research Society; Grants-in-Aid for Scientific Research [22591626] Funding Source: KAKEN	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cervical Spine Research Society; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (16591473-00) and 21st Century Development Grant of Cervical Spine Research Society 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bauchet L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P330, DOI 10.1016/j.annrmp.2008.10.004; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; Boneberg EM, 2000, BLOOD, V95, P270, DOI 10.1182/blood.V95.1.270; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1007/BF03206569; Jansen J, 2005, J CELL MOL MED, V9, P37, DOI 10.1111/j.1582-4934.2005.tb00335.x; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Kawabe J, 2011, J NEUROSURG IN PRESS; Koda M, 2007, BRAIN RES, V1149, P223, DOI 10.1016/j.brainres.2007.02.058; Komine-Kobayashi M, 2006, J CEREBR BLOOD F MET, V26, P402, DOI 10.1038/sj.jcbfm.9600195; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lee ST, 2005, BRAIN RES, V1058, P120, DOI 10.1016/j.brainres.2005.07.076; Lee YB, 2000, EXP NEUROL, V166, P190, DOI 10.1006/exnr.2000.7494; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; Nishiki S, 2004, AM J PHYSIOL-CELL PH, V286, pC1302, DOI 10.1152/ajpcell.00387.2003; Nishio Y, 2007, J NEUROPATH EXP NEUR, V66, P724, DOI 10.1097/nen.0b013e3181257176; Osada T, 2010, J NEUROSURG-SPINE, V13, P516, DOI 10.3171/2010.4.SPINE09973; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pitzer C, 2010, J NEUROCHEM, V113, P930, DOI 10.1111/j.1471-4159.2010.06659.x; Roberts AW, 2005, GROWTH FACTORS, V23, P33, DOI 10.1080/08977190500055836; Sanli AM, 2010, J CLIN NEUROSCI, V17, P1548, DOI 10.1016/j.jocn.2010.03.043; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Schneider A, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-36; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Squadrito F, 1997, BRIT J PHARMACOL, V120, P333, DOI 10.1038/sj.bjp.0700904; Stroke Therapy Academic Industry Roundtable (STAIR), 1990, STROKE, V30, P2752; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Zavala F, 2002, J IMMUNOL, V168, P2011, DOI 10.4049/jimmunol.168.4.2011	38	41	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50391	10.1371/journal.pone.0050391	http://dx.doi.org/10.1371/journal.pone.0050391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209732	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800070
J	Zuijdgeest, A; Huettel, M				Zuijdgeest, Alissa; Huettel, Markus			Dispersants as Used in Response to the MC252-Spill Lead to Higher Mobility of Polycyclic Aromatic Hydrocarbons in Oil-Contaminated Gulf of Mexico Sand	PLOS ONE			English	Article							CRUDE-OIL; PETROLEUM-HYDROCARBONS; MICROBIAL-DEGRADATION; MARINE SEDIMENT; PAH COMPOUNDS; SURFACTANT SOLUBILIZATION; SOLUTE EXCHANGE; ORGANIC-MATTER; WEST FALMOUTH; FLOODED SOIL	After the explosion of the Deepwater Horizon oil rig, large volumes of crude oil were washed onto and embedded in the sandy beaches and sublittoral sands of the Northern Gulf of Mexico. Some of this oil was mechanically or chemically dispersed before reaching the shore. With a set of laboratory-column experiments we show that the addition of chemical dispersants (Corexit 9500A) increases the mobility of polycyclic aromatic hydrocarbons (PAHs) in saturated permeable sediments by up to two orders of magnitude. Distribution and concentrations of PAHs, measured in the solid phase and effluent water of the columns using GC/MS, revealed that the mobility of the PAHs depended on their hydrophobicity and was species specific also in the presence of dispersant. Deepest penetration was observed for acenaphthylene and phenanthrene. Flushing of the columns with seawater after percolation of the oiled water resulted in enhanced movement by remobilization of retained PAHs. An in-situ benthic chamber experiment demonstrated that aromatic hydrocarbons are transported into permeable sublittoral sediment, emphasizing the relevance of our laboratory column experiments in natural settings. We conclude that the addition of dispersants permits crude oil components to penetrate faster and deeper into permeable saturated sands, where anaerobic conditions may slow degradation of these compounds, thus extending the persistence of potentially harmful PAHs in the marine environment. Application of dispersants in nearshore oil spills should take into account enhanced penetration depths into saturated sands as this may entail potential threats to the groundwater.	[Huettel, Markus] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Zuijdgeest, Alissa] Univ Utrecht, Dept Earth Sci, Utrecht, Netherlands	State University System of Florida; Florida State University; Utrecht University	Huettel, M (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	mhuettel@fsu.edu	Huettel, Markus/F-8940-2011	Huettel, Markus/0000-0003-4844-7525	National Science Foundation [OCE-1044939, OCE-1057417]; Florida Institute of Oceanography [FIO 4710-1101-00-1]; BP/The Gulf of Mexico Research Initiative	National Science Foundation(National Science Foundation (NSF)); Florida Institute of Oceanography; BP/The Gulf of Mexico Research Initiative	This research was supported by the National Science Foundation (OCE-1044939 and OCE-1057417), the Florida Institute of Oceanography (FIO 4710-1101-00-1), and by a grant from BP/The Gulf of Mexico Research Initiative to the Deep-C consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi-Dey A, 2002, ENVIRON SCI TECHNOL, V36, P21, DOI 10.1021/es010953c; ALBASHIR B, 1990, APPL MICROBIOL BIOT, V34, P414, DOI 10.1007/BF00170071; Allan SE, 2012, ENVIRON SCI TECHNOL, V46, P2033, DOI 10.1021/es202942q; Alonso-Gutierrez J, 2009, APPL ENVIRON MICROB, V75, P3407, DOI 10.1128/AEM.01776-08; [Anonymous], [No title captured]; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; BAUER JE, 1985, APPL ENVIRON MICROB, V50, P81, DOI 10.1128/AEM.50.1.81-90.1985; BAUER JE, 1988, APPL ENVIRON MICROB, V54, P1649, DOI 10.1128/AEM.54.7.1649-1655.1988; Baumard P, 1999, MAR ENVIRON RES, V47, P415, DOI 10.1016/S0141-1136(98)00128-7; Bernabeu AM, 2006, MAR POLLUT BULL, V52, P1156, DOI 10.1016/j.marpolbul.2006.01.013; Boese BL, 1999, ARCH ENVIRON CON TOX, V36, P270, DOI 10.1007/s002449900471; Boese BL, 2000, ARCH ENVIRON CON TOX, V38, P274, DOI 10.1007/s002449910037; Boonchan S, 1998, BIOTECHNOL BIOENG, V59, P482; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Coates JD, 1997, APPL ENVIRON MICROB, V63, P3589, DOI 10.1128/AEM.63.9.3589-3593.1997; Cook PLM, 2007, LIMNOL OCEANOGR, V52, P1943, DOI 10.4319/lo.2007.52.5.1943; Couillard CM, 2005, ENVIRON TOXICOL CHEM, V24, P1496, DOI 10.1897/04-267R.1; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; Doick KJ, 2005, ENVIRON SCI TECHNOL, V39, P3663, DOI 10.1021/es048181i; Doong RA, 2003, J HAZARD MATER, V96, P15, DOI 10.1016/S0304-3894(02)00167-X; Eastcott L., 1988, OIL CHEM POLLUT, V4, P191, DOI DOI 10.1016/S0269-8579(88)80020-0; EDWARDS DA, 1992, WATER SCI TECHNOL, V26, P147, DOI 10.2166/wst.1992.0395; FAKANKUN OA, 1986, ABSTR PAP AM CHEM S, V191, P55; Flin R, 2010, PSYCHOLOGIST, V23, P630; Franco MA, 2006, MAR POLLUT BULL, V53, P260, DOI 10.1016/j.marpolbul.2005.10.004; Gopalan B, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.054501; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; GRATTAN LM, 2011, J SHELLFISH RES, V30, P511; GRIFFITHS RP, 1981, MAR ENVIRON RES, V5, P83, DOI 10.1016/0141-1136(81)90025-8; Griffiths SK, 2012, ENVIRON SCI TECHNOL, V46, P5616, DOI 10.1021/es204569t; Guha S, 1998, ENVIRON SCI TECHNOL, V32, P2317, DOI 10.1021/es971093w; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; HEITKAMP MA, 1987, ENVIRON TOXICOL CHEM, V6, P535, DOI 10.1002/etc.5620060706; HEITKAMP MA, 1987, APPL ENVIRON MICROB, V53, P129, DOI 10.1128/AEM.53.1.129-136.1987; Hinga KR, 2003, MAR POLLUT BULL, V46, P466, DOI 10.1016/S0025-326X(02)00459-9; Horn DP, 2006, CONT SHELF RES, V26, P622, DOI 10.1016/j.csr.2006.02.001; HUETTEL M, 1992, MAR ECOL PROG SER, V89, P253, DOI 10.3354/meps089253; HUETTEL M, 1992, MAR ECOL PROG SER, V82, P187, DOI 10.3354/meps082187; Huettel M, 1996, LIMNOL OCEANOGR, V41, P309, DOI 10.4319/lo.1996.41.2.0309; Huettel M, 2000, BENTHIC BOUNDARY LAY, P144; JAFVERT CT, 1991, ENVIRON SCI TECHNOL, V25, P1039, DOI 10.1021/es00018a004; Janssen F, 2005, LIMNOL OCEANOGR, V50, P768, DOI 10.4319/lo.2005.50.3.0768; Jonker MTO, 2003, ENVIRON SCI TECHNOL, V37, P5197, DOI 10.1021/es0300564; Kim E, 2001, J MICROBIOL BIOTECHN, V11, P716; Kolic PE, 2011, ABSTR PAP AM CHEM S, V241; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; LEAHY JG, 1990, MICROBIOL REV, V54, P305, DOI 10.1128/MMBR.54.3.305-315.1990; LEDUC R, 1992, WATER SCI TECHNOL, V26, P51, DOI 10.2166/wst.1992.0385; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; Li L, 2000, ADV WATER RESOUR, V23, P325, DOI 10.1016/S0309-1708(99)00032-9; Lindstrom JE, 2002, MAR POLLUT BULL, V44, P739, DOI 10.1016/S0025-326X(02)00050-4; LIU ZB, 1991, WATER SCI TECHNOL, V23, P475, DOI 10.2166/wst.1991.0447; MACH R, 1982, ERDOL KOHLE ERDGAS P, V35, P173; MacRae JD, 1998, WATER SCI TECHNOL, V38, P177, DOI 10.2166/wst.1998.0463; Makkar RS, 2003, ENVIRON TOXICOL CHEM, V22, P2280, DOI 10.1897/02-472; McElroy AE, 1989, METABOLISM POLYCYCLI, P2; McIntosh S, 2010, ENVIRON TOXICOL CHEM, V29, P1160, DOI 10.1002/etc.134; MCLACHLAN A, 1989, LIMNOL OCEANOGR, V34, P774, DOI 10.4319/lo.1989.34.4.0774; MCLACHLAN A, 1979, S AFR J SCI, V75, P75; McNaught AD, 1997, COMPENDIUM CHEM TERM, DOI DOI 10.1351/GOLDBOOK; MIHELCIC JR, 1988, APPL ENVIRON MICROB, V54, P1188, DOI 10.1128/AEM.54.5.1188-1198.1988; MIHELCIC JR, 1988, APPL ENVIRON MICROB, V54, P1182, DOI 10.1128/AEM.54.5.1182-1187.1988; Milinkovitch T, 2011, SCI TOTAL ENVIRON, V409, P1643, DOI 10.1016/j.scitotenv.2011.01.009; Mukherjee B, 2012, CHEM ENG SCI, V68, P432, DOI 10.1016/j.ces.2011.10.001; Nelson RK, 2006, ENVIRON FORENSICS, V7, P33, DOI 10.1080/15275920500506758; Nikolaou A, 2009, GLOBAL NEST J, V11, P391; NRC, 2005, OIL SPILL DISP EFF E; Nyman JA, 2007, ENVIRON POLLUT, V149, P227, DOI 10.1016/j.envpol.2006.12.028; OSAT, 2011, OSAT2 USCG; OSAT, 2010, 1 OSAT, P1; Owens EH, 2008, MAR POLLUT BULL, V56, P14, DOI 10.1016/j.marpolbul.2007.08.020; Peacock EE, 2005, ENVIRON FORENSICS, V6, P273, DOI 10.1080/15275920500194480; Peacock EE, 2007, MAR POLLUT BULL, V54, P214, DOI 10.1016/j.marpolbul.2006.10.007; Place B, 2010, ENVIRON SCI TECHNOL, V44, P6016, DOI 10.1021/es102319w; Plata DL, 2008, ENVIRON SCI TECHNOL, V42, P2432, DOI 10.1021/es702384f; Prince RC, 1997, TRENDS BIOTECHNOL, V15, P158, DOI 10.1016/S0167-7799(97)01033-0; RIEDL R, 1971, INT REV GESAMTEN HYD, V56, P923, DOI DOI 10.1002/IROH.19710560604; Rodriguez JG, 2007, MAR POLLUT BULL, V54, P1046, DOI 10.1016/j.marpolbul.2007.03.016; ROSENBAUER R. J., 2010, RECONNAISSANCE MACON; Ryder AG, 2002, SPECTROCHIM ACTA A, V58, P1025, DOI 10.1016/S1386-1425(01)00579-0; SANDERS HL, 1980, J MAR RES, V38, P265; Seim HE, 2011, PROC SPIE, V8029, DOI 10.1117/12.884220; Steffens J, 2011, J FLUORESC, V21, P859, DOI 10.1007/s10895-009-0586-4; Tiehm A, 1997, ENVIRON SCI TECHNOL, V31, P2570, DOI 10.1021/es9609967; TIEHM A, 1994, APPL ENVIRON MICROB, V60, P258, DOI 10.1128/AEM.60.1.258-263.1994; Turner IL, 1998, J GEOPHYS RES-OCEANS, V103, P30813, DOI 10.1029/98JC02606; US Environmental Protection Agency, 2001, METH COLL STOR MAN S; VANDUUREN BL, 1960, ANAL CHEM, V32, P1436, DOI 10.1021/ac60167a019; WEBB JE, 1968, NATURE, V220, P682, DOI 10.1038/220682a0; White HK, 2005, ENVIRON SCI TECHNOL, V39, P8273, DOI 10.1021/es050475w; Wise James, 2011, Reviews on Environmental Health, V26, P281, DOI 10.1515/REVEH.2011.035; Witte R.S., 2009, STATISTICS-ABINGDON; Wu Jun-Wen, 2006, Huanjing Kexue, V27, P2019; Yamada M, 2003, MAR POLLUT BULL, V47, P105, DOI 10.1016/S0025-326X(03)00102-4; Yang K, 2005, CHEMOSPHERE, V61, P116, DOI 10.1016/j.chemosphere.2005.02.095; Yeom IT, 1996, ENVIRON SCI TECHNOL, V30, P1589, DOI 10.1021/es950567t; Zhao BW, 2005, CHEMOSPHERE, V58, P33, DOI 10.1016/j.chemosphere.2004.08.067; Zheng ZM, 2002, WATER RES, V36, P2667, DOI 10.1016/S0043-1354(01)00472-9; Zhou W, 2008, PETROL SCI TECHNOL, V26, P1036, DOI 10.1080/10916460701208348	102	31	31	1	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50549	10.1371/journal.pone.0050549	http://dx.doi.org/10.1371/journal.pone.0050549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209777	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800083
J	Azad, A; Fox, J; Leverrier, S; Storey, A				Azad, Abul; Fox, Joanna; Leverrier, Sabrina; Storey, Alan			Blockade of the BAK Hydrophobic Groove by Inhibitory Phosphorylation Regulates Commitment to Apoptosis	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; SMALL T-ANTIGEN; TYROSINE DEPHOSPHORYLATION; MITOCHONDRIAL APOPTOSIS; CONFORMATIONAL-CHANGES; CELL-TRANSFORMATION; OLIGOMERIZES BAK; CYTOCHROME-C; BH3 DOMAIN; ACTIVATION	The BCL-2 family protein BAK is a key regulator of mitochondrial apoptosis. BAK activation first involves N-terminal conformational changes that lead to the transient exposure of the BAK BH3 domain that then inserts into a hydrophobic groove on another BAK molecule to form symmetric dimers. We showed recently that post-translational modifications are important in the regulation of BAK conformational change and multimerization, with dephosphorylation at tyrosine 108 constituting an initial step in the BAK activation process. We now show that dephosphorylation of serine 117 (S117), located in the BAK hydrophobic groove, is also critical for BAK activation to proceed to completion. Phosphorylation of BAK at S117 has two important regulatory functions: first, it occludes the binding of BH3-containing peptides that bind to BAK causing activation and cytochrome c release from mitochondria; second, it prevents BAK-BH3:BAK-Groove interactions that nucleate dimer formation for subsequent multimerization. Hence, BH3-mediated BAK conformational change and subsequent BAK multimerization for cytochrome c release and cell death is intimately linked to, and dependent on, dephosphorylation at S117. Our study reveals important novel mechanistic and structural insights into the temporal sequence of events governing the process of BAK activation in commitment to cell death and how they are regulated.	[Azad, Abul; Fox, Joanna; Leverrier, Sabrina; Storey, Alan] Univ Oxford, John Radcliffe Hosp, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DU, England	University of Oxford	Storey, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DU, England.	alan.storey@imm.ox.ac.uk		Fox, Joanna/0000-0002-4042-6837; Storey, Alan/0000-0003-2001-9772	Cancer Research UK [C5314/A6695]	Cancer Research UK(Cancer Research UK)	This work was supported by funding from Cancer Research UK, grant C5314/A6695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Fox J, 2011, CELL CYCLE, V10, P598, DOI 10.4161/cc.10.4.14793; Fox JL, 2010, EMBO J, V29, P3853, DOI 10.1038/emboj.2010.244; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kepp O, 2007, EMBO J, V26, P825, DOI 10.1038/sj.emboj.7601533; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Korsmeyer SJ, 2000, CELL DEATH DIFFER, V7, P1166, DOI 10.1038/sj.cdd.4400783; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Neise D, 2008, ONCOGENE, V27, P1387, DOI 10.1038/sj.onc.1210773; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Ruvolo PP, 2002, J BIOL CHEM, V277, P22847, DOI 10.1074/jbc.M201830200; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Shouse GP, 2010, ONCOGENE, V29, P3933, DOI 10.1038/onc.2010.161; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Westermarck J, 2008, TRENDS MOL MED, V14, P152, DOI 10.1016/j.molmed.2008.02.001; Yamaguchi R, 2007, CELL DEATH DIFFER, V14, P616, DOI 10.1038/sj.cdd.4402035; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	39	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49601	10.1371/journal.pone.0049601	http://dx.doi.org/10.1371/journal.pone.0049601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189150	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800027
J	Cordova, A; Toia, F; La Mendola, C; Orlando, V; Meraviglia, S; Rinaldi, G; Todaro, M; Cicero, G; Zichichi, L; Donni, PL; Caccamo, N; Stassi, G; Dieli, F; Moschella, F				Cordova, Adriana; Toia, Francesca; La Mendola, Carmela; Orlando, Valentina; Meraviglia, Serena; Rinaldi, Gaetana; Todaro, Matilde; Cicero, Giuseppe; Zichichi, Leonardo; Donni, Paolo Li; Caccamo, Nadia; Stassi, Giorgio; Dieli, Francesco; Moschella, Francesco			Characterization of Human gamma delta T Lymphocytes Infiltrating Primary Malignant Melanomas	PLOS ONE			English	Article							OVERCOMING IMMUNOLOGICAL-TOLERANCE; PHASE-I; METASTATIC MELANOMA; MEVALONATE PATHWAY; TARGETING CTLA-4; CELL-THERAPY; TUMOR-CELLS; LYMPH-NODES; IMMUNOTHERAPY; CANCER	T lymphocytes are often induced naturally in melanoma patients and infiltrate tumors. Given that gamma delta T cells mediate antigen-specific killing of tumor cells, we studied the representation and the in vitro cytokine production and cytotoxic activity of tumor infiltrating gamma delta T cells from 74 patients with primary melanoma. We found that gamma delta T cells represent the major lymphocyte population infiltrating melanoma, and both V delta 1(+) and V delta 2(+) cells are involved. The majority of melanoma-infiltrating gamma delta cells showed effector memory and terminally-differentiated phenotypes and, accordingly, polyclonal gamma delta T cell lines obtained from tumor-infiltrating immune cells produced IFN-gamma and TNF-alpha and were capable of killing melanoma cell lines in vitro. The cytotoxic capability of V delta 2 cell lines was further improved by pre-treatment of tumor target cells with zoledronate. Moreover, higher rate of gamma delta T cells isolation and percentages of V delta 2 cells correlate with early stage of development of melanoma and absence of metastasis. Altogether, our results suggest that a natural immune response mediated by gamma delta T lymphocytes may contribute to the immunosurveillance of melanoma.	[La Mendola, Carmela; Orlando, Valentina; Meraviglia, Serena; Caccamo, Nadia; Dieli, Francesco] Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy; [Cordova, Adriana; Toia, Francesca; Rinaldi, Gaetana; Todaro, Matilde; Cicero, Giuseppe; Stassi, Giorgio; Moschella, Francesco] Univ Palermo, Dipartimento Discipline Chirurg & Oncol, Palermo, Italy; [Zichichi, Leonardo] Azienda Osped S Antonio Abate, Unita Operativa Dermatol, Trapani, Italy; Univ Palermo, Dipartimento Sci Econ Aziendali & Finanziarie, Palermo, Italy	University of Palermo; University of Palermo; University of Palermo	Dieli, F (corresponding author), Univ Palermo, Dipartimento Biopatol & Biotecnol Med & Forensi, Palermo, Italy.	francesco.dieli@unipa.it	Caccamo, Nadia/J-6808-2018; toia, Francesca/K-5107-2016; Stassi, Giorgio/AAC-1175-2022; todaro, matilde/AAC-1003-2022; Toia, Francesca/AAH-4246-2021; Meraviglia, Serena/K-5164-2016	toia, Francesca/0000-0003-4903-815X; todaro, matilde/0000-0001-8686-8043; Cordova, Adriana/0000-0002-5137-4294; Cicero, Giuseppe/0000-0002-4717-437X; CACCAMO, Nadia Rosalia/0000-0002-1018-5710; Dieli, Francesco/0000-0002-6685-352X	Italian Ministry for Instruction, University and Research [2008L57JXW]; Italian Ministry of Health; University of Palermo	Italian Ministry for Instruction, University and Research; Italian Ministry of Health(Ministry of Health, Italy); University of Palermo	This work has been supported by grants from the Italian Ministry for Instruction, University and Research (contract no. 2008L57JXW to FD), the Italian Ministry of Health (Progetto ricerca finalizzata 2007 "Stem cells in different pathological conditions innovative therapeutical approches" to FD) and the University of Palermo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MB, 2000, CANCER J SCI AM, V6, pS11; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bansal RR, 2012, EUR J IMMUNOL, V42, P110, DOI 10.1002/eji.201142017; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; Bennouna J, 2008, CANCER IMMUNOL IMMUN, V57, P1599, DOI 10.1007/s00262-008-0491-8; Benzaid I, CANC RES, V71, P4562; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Caccamo N, 2006, J IMMUNOL, V177, P5290, DOI 10.4049/jimmunol.177.8.5290; Caccamo N, 2011, BLOOD, V118, P129, DOI 10.1182/blood-2011-01-331298; Ceballos P I, 1993, Adv Dermatol, V8, P229; Cipponi A, 2011, CANCER IMMUNOL IMMUN, V60, P1153, DOI 10.1007/s00262-011-1026-2; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Eberl M, 2003, FEBS LETT, V544, P4, DOI 10.1016/S0014-5793(03)00483-6; Eberl M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000308; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; Guo RT, 2007, P NATL ACAD SCI USA, V104, P10022, DOI 10.1073/pnas.0702254104; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Inman BA, 2008, J IMMUNOL, V180, P3578, DOI 10.4049/jimmunol.180.5.3578; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Kistowska M, 2008, EUR J IMMUNOL, V38, P2200, DOI 10.1002/eji.200838366; Kobayashi H, 2007, CANCER IMMUNOL IMMUN, V56, P469, DOI 10.1007/s00262-006-0199-6; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Li JQ, 2009, J IMMUNOL, V182, P8118, DOI 10.4049/jimmunol.0900101; Ma C, 2012, J IMMUNOL, V189; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; Meraviglia S, 2010, J IMMUNOL, V185, P1770, DOI 10.4049/jimmunol.1000966; MOTULSKY H, 1995, INTUITIVE BIOSTATIST, P199; Nishimura MI, 1999, CANCER RES, V59, P6230; Rao UNM, 2010, AM J CLIN PATHOL, V133, P646, DOI 10.1309/AJCPTXMEFOVYWDA6; Ribas A, 2008, ONCOLOGIST, V13, P10, DOI 10.1634/theoncologist.13-S4-10; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sasada T, 2011, IMMUNOTHERAPY-UK, V3, P1235, DOI [10.2217/imt.11.106, 10.2217/IMT.11.106]; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Sireci G, 2001, EUR J IMMUNOL, V31, P1628, DOI 10.1002/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T; Speeckaert R, 2011, PIGM CELL MELANOMA R, V24, P334, DOI 10.1111/j.1755-148X.2010.00799.x; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Vermijlen D, 2007, J IMMUNOL, V178, P4304, DOI 10.4049/jimmunol.178.7.4304; Weber J, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.13-S4-16; Wesch D, 2001, CELL IMMUNOL, V212, P110, DOI 10.1006/cimm.2001.1850	53	87	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49878	10.1371/journal.pone.0049878	http://dx.doi.org/10.1371/journal.pone.0049878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189169	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800046
J	Gaur, R; Strebel, K				Gaur, Ritu; Strebel, Klaus			Insights into the Dual Activity of SIVmac239 Vif against Human and African Green Monkey APOBEC3G	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE AMINO-ACID; TYPE-1 VIF; HIV-1 VIF; REVERSE TRANSCRIPTION; CBF-BETA; I VIF; DNA; INHIBITION; IDENTIFICATION	Human immunodeficiency virus type 1 (HIV-1) Vif is essential for viral evasion of the host antiviral protein APOBEC3G (APO3G). The Vif protein from a distantly related African green monkey (Agm) simian immunodeficiency virus (SIVagm) is unable to suppress the antiviral activity of human APO3G but is active against Agm APO3G. SIVmac Vif on the other hand, possesses antiviral activity against both human and Agm APO3G. In this study, we were interested in mapping domains in SIVmac Vif that are responsible for its dual activity against human and Agm APO3G. We constructed a series of Vif chimeras by swapping domains in SIVmac Vif with equivalent regions from SIVagm Vif and determined their activity against human and Agm APO3G. We found that replacing any region in SIVmac Vif by corresponding fragments from SIVagm Vif only moderately reduced the activity of the chimeras against Agm APO3G but in all cases resulted in a severe loss of activity against human APO3G. These results suggest that the domains in SIVmac Vif required for targeting human and Agm APO3G are distinct and cannot be defined as linear amino acid motifs but rather appear to depend on the overall structure of full-length SIVmac Vif.	[Gaur, Ritu] S Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India; [Strebel, Klaus] NIAID, Mol Microbiol Lab, Viral Biochem Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gaur, R (corresponding author), S Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	rgaur@sau.ac.in	Gaur, Ritu/AAF-3353-2019	Gaur, Ritu/0000-0002-4243-9623	South Asian University; Department of Biotechnology, Government of India; National Institute of Allergy and Infectious Disease, National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000669] Funding Source: NIH RePORTER	South Asian University; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); National Institute of Allergy and Infectious Disease, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was partly supported by the Intramural Research Funding of South Asian University and Department of Biotechnology, Government of India to RG and Intramural Research Program of the National Institute of Allergy and Infectious Disease, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albin JS, 2010, J BIOL CHEM, V285, P40785, DOI 10.1074/jbc.M110.173161; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bogerd HP, 2004, P NATL ACAD SCI USA, V101, P3770, DOI 10.1073/pnas.0307713101; Chen GY, 2009, J VIROL, V83, P8674, DOI 10.1128/JVI.00653-09; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; *COMM CAR US LAB A, 1985, GUID CAR US LAB AN; Dang Y, 2009, J VIROL, V83, P8544, DOI 10.1128/JVI.00651-09; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Golla-Gaur R, 2008, VIROLOGY, V372, P136, DOI 10.1016/j.virol.2007.10.017; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Hogerkorp CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025684; Igarashi T, 2002, J VIROL, V76, P379, DOI 10.1128/JVI.76.1.379-391.2002; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Kao S, 2007, VIROLOGY, V369, P329, DOI 10.1016/j.virol.2007.08.005; Kar S, 2003, J GEN VIROL, V84, P3227, DOI 10.1099/vir.0.19449-0; Karczewski MK, 1996, J VIROL, V70, P494, DOI 10.1128/JVI.70.1.494-507.1996; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; NAIDU YM, 1988, J VIROL, V62, P4691, DOI 10.1128/JVI.62.12.4691-4696.1988; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Opi S, 2007, J VIROL, V81, P8236, DOI 10.1128/JVI.02694-06; Pery E, 2009, J VIROL, V83, P2374, DOI 10.1128/JVI.01898-08; Roos JW, 2000, VIROLOGY, V273, P307, DOI 10.1006/viro.2000.0431; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Russell RA, 2009, J VIROL, V83, P1992, DOI 10.1128/JVI.01621-08; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Schumacher AJ, 2005, P NATL ACAD SCI USA, V102, P9854, DOI 10.1073/pnas.0501694102; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, EMBO J, V17, P1259, DOI 10.1093/emboj/17.5.1259; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; STREBEL K, 1987, NATURE, V328, P728, DOI 10.1038/328728a0; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Yamashita T, 2008, MICROBES INFECT, V10, P1142, DOI 10.1016/j.micinf.2008.06.003; Yang YL, 2007, VIROLOGY, V365, P92, DOI 10.1016/j.virol.2007.03.022; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhang WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003963; Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889	60	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e48850	10.1371/journal.pone.0048850	http://dx.doi.org/10.1371/journal.pone.0048850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189135	gold, Green Submitted, Green Published			2022-12-25	WOS:000311929800014
J	Seidman, MA; Oduyebo, T; Muto, MG; Crum, CP; Nucci, MR; Quade, BJ				Seidman, Michael A.; Oduyebo, Titilope; Muto, Michael G.; Crum, Christopher P.; Nucci, Marisa R.; Quade, Bradley J.			Peritoneal Dissemination Complicating Morcellation of Uterine Mesenchymal Neoplasms	PLOS ONE			English	Article							SUPRACERVICAL HYSTERECTOMY; LAPAROSCOPIC MYOMECTOMY; PARASITIC MYOMAS; LEIOMYOMATOSIS; LEIOMYOSARCOMA; MALIGNANCY; SURGERY; TISSUE	Background: Power morcellation has become a common technique for the minimally invasive resection of uterine leiomyomas. This technique is associated with dissemination of cellular material throughout the peritoneum. When morcellated uterine tumors are unexpectedly found to be leiomyosarcomas or tumors with atypical features (atypical leiomyoma, smooth muscle tumor of uncertain malignant potential), there may be significant clinical consequences. This study was undertaken to determine the frequency and clinical consequence of intraperitoneal dissemination of these neoplasms. Methodology/Principal Findings: From 2005-2010, 1091 instances of uterine morcellation were identified at BWH. Unexpected diagnoses of leiomyoma variants or atypical and malignant smooth muscle tumors occurred in 1.2% of cases using power morcellation for uterine masses clinically presumed to be "fibroids" over this period, including one endometrial stromal sarcoma (ESS), one cellular leiomyoma (CL), six atypical leiomyomas (AL), three smooth muscle tumor of uncertain malignant potential (STUMPs), and one leiomyosarcoma (LMS). The rate of unexpected sarcoma after the laparoscopic morcellation procedure was 0.09%, 9-fold higher than the rate currently quoted to patients during pre-procedure briefing, and this rate may increase over time as diagnostically challenging or under-sampled tumors manifest their biological potential. Furthermore, when examining follow-up laparoscopies, both from in-house and consultation cases, disseminated disease occurred in 64.3% of all tumors (zero of one ESS, one of one CL, zero of one AL, four of four STUMPs, and four of seven LMS). Only disseminated leiomyosarcoma, however, was associated with mortality. Procedures are proposed for pathologic evaluation of morcellation specimens and associated follow-up specimens. Conclusions/Significance: While additional study is warranted, these data suggest uterine morcellation carries a risk of disseminating unexpected malignancy with apparent associated increase in mortality much higher than appreciated currently.	[Seidman, Michael A.; Crum, Christopher P.; Nucci, Marisa R.; Quade, Bradley J.] Harvard Univ, Brigham & Womens Hosp, Div Womens & Perinatal Pathol, Sch Med,Dept Pathol, Boston, MA 02115 USA; [Oduyebo, Titilope; Muto, Michael G.] Harvard Univ, Brigham & Womens Hosp, Div Gynecol Oncol, Sch Med,Dept Obstet & Gynecol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Seidman, MA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Div Womens & Perinatal Pathol, Sch Med,Dept Pathol, Boston, MA 02115 USA.	mseidman@partners.org	Seidman, Michael/J-4731-2019	Seidman, Michael/0000-0002-9594-827X				Al-Talib A, 2010, GYNECOL OBSTET INVES, V69, P239, DOI 10.1159/000274487; [Anonymous], 2003, WHO CLASSIFICATION T; [Anonymous], 2011, DIAGNOSTIC GYNECOLOG; Cucinella G, 2011, FERTIL STERIL, V96, pE90, DOI 10.1016/j.fertnstert.2011.05.095; Della Badia C, 2010, J MINIM INVAS GYN, V17, P791, DOI 10.1016/j.jmig.2010.07.001; Einstein MH, 2008, INT J GYNECOL CANCER, V18, P1065, DOI 10.1111/j.1525-1438.2007.01126.x; Epstein JH, 2009, FERTIL STERIL, V91, DOI 10.1016/j.fertnstert.2008.08.014; Hagemann IS, 2011, INT J GYNECOL PATHOL, V30, P476, DOI 10.1097/PGP.0b013e3182107ecf; Jonsdottir GM, 2011, OBSTET GYNECOL, V117, P1142, DOI 10.1097/AOG.0b013e3182166055; Kumar S, 2008, ARCH GYNECOL OBSTET, V278, P93, DOI 10.1007/s00404-007-0536-9; LaCoursiere DY, 2005, J MINIM INVAS GYN L, V12, P67, DOI 10.1016/j.jmig.2004.12.021; Larrain D, 2010, J MINIM INVAS GYN, V17, P719, DOI 10.1016/j.jmig.2010.05.013; LEIBSOHN S, 1990, AM J OBSTET GYNECOL, V162, P968, DOI 10.1016/0002-9378(90)91298-Q; Miyake T, 2009, GYNECOL OBSTET INVES, V67, P96, DOI 10.1159/000164949; Moon HS, 2008, FERTIL STERIL, V90, DOI 10.1016/j.fertnstert.2007.08.068; Ordulu Z, 2010, GENE CHROMOSOME CANC, V49, P1152, DOI 10.1002/gcc.20824; Park JY, 2011, GYNECOL ONCOL, V122, P255, DOI 10.1016/j.ygyno.2011.04.021; Paul PG, 2006, FERTIL STERIL, V85, P492, DOI 10.1016/j.fertnstert.2005.10.017; Perri T, 2009, INT J GYNECOL CANCER, V19, P257, DOI 10.1111/IGC.0b013e31819a1f8f; Sepilian V, 2003, OBSTET GYNECOL, V102, P1125, DOI 10.1016/S0029-7844(03)00683-5; STEINER RA, 1993, OBSTET GYNECOL, V81, P471; Takeda A, 2007, J MINIM INVAS GYN, V14, P770, DOI 10.1016/j.jmig.2007.07.004	22	177	182	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50058	10.1371/journal.pone.0050058	http://dx.doi.org/10.1371/journal.pone.0050058			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189178	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800055
J	Smith, SE; Showers-Corneli, P; Dardenne, CN; Harpending, HH; Martin, DP; Beiko, RG				Smith, Silvia E.; Showers-Corneli, Patrice; Dardenne, Caitlin N.; Harpending, Henry H.; Martin, Darren P.; Beiko, Robert G.			Comparative Genomic and Phylogenetic Approaches to Characterize the Role of Genetic Recombination in Mycobacterial Evolution	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; DETECTING RECOMBINATION; SIMULTANEOUS INFECTION; GROWING MYCOBACTERIA; TUBERCLE-BACILLI; MULTIPLE STRAINS; TREE SELECTION; SEQUENCE; TUBERCULOSIS; ALGORITHM	The genus Mycobacterium encompasses over one hundred named species of environmental and pathogenic organisms, including the causative agents of devastating human diseases such as tuberculosis and leprosy. The success of these human pathogens is due in part to their ability to rapidly adapt to their changing environment and host. Recombination is the fastest way for bacterial genomes to acquire genetic material, but conflicting results about the extent of recombination in the genus Mycobacterium have been reported. We examined a data set comprising 18 distinct strains from 13 named species for evidence of recombination. Genomic regions common to all strains (accounting for 10% to 22% of the full genomes of all examined species) were aligned and concatenated in the chromosomal order of one mycobacterial reference species. The concatenated sequence was screened for evidence of recombination using a variety of statistical methods, with each proposed event evaluated by comparing maximum-likelihood phylogenies of the recombinant section with the nonrecombinant portion of the dataset. Incongruent phylogenies were identified by comparing the site-wise log-likelihoods of each tree using multiple tests. We also used a phylogenomic approach to identify genes that may have been acquired through horizontal transfer from non-mycobacterial sources. The most frequent associated lineages (and potential gene transfer partners) in the Mycobacterium lineage-restricted gene trees are other members of suborder Corynebacterinae, but more-distant partners were identified as well. In two examined cases of potentially frequent and habitat-directed transfer (M. abscessus to Segniliparus and M. smegmatis to Streptomyces), observed sequence distances were small and consistent with a hypothesis of transfer, while in a third case (M. vanbaalenii to Streptomyces) distances were larger. The analyses described here indicate that whereas evidence of recombination in core regions within the genus is relatively sparse, the acquisition of genes from non-mycobacterial lineages is a significant feature of mycobacterial evolution.	[Beiko, Robert G.] Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada; [Smith, Silvia E.; Dardenne, Caitlin N.] Univ Utah, Sch Med, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Smith, Silvia E.; Dardenne, Caitlin N.; Harpending, Henry H.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA; [Showers-Corneli, Patrice] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Martin, Darren P.] Univ Cape Town, Computat Biol Grp, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa	Dalhousie University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Cape Town	Beiko, RG (corresponding author), Dalhousie Univ, Fac Comp Sci, Halifax, NS, Canada.	beiko@cs.dal.ca	Martin, Darren/ABE-3614-2021; Martin, Darren P/C-4599-2008	Showers Corneli, Patrice/0000-0003-0136-1775	South African Polio Research Foundation; Canada Foundation for Innovation; Genome Atlantic; Canada Research Chairs program	South African Polio Research Foundation; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Atlantic; Canada Research Chairs program(Canada Research Chairs)	This work was funded in part by the South African Polio Research Foundation (to DPM), and the Canada Foundation for Innovation (to RGB) and Genome Atlantic (to RGB). RGB acknowledges the support of the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banerjee R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019280; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Beiko RG, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-34; Bibb LA, 2002, MOL MICROBIOL, V45, P1515, DOI 10.1046/j.1365-2958.2002.03130.x; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Bradley R. K., 2009, PLOS COMPUT BIOL, V5, P1; Brosch R, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P19; Chan CX, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-412; Coros A, 2008, J BACTERIOL, V190, P3408, DOI 10.1128/JB.00009-08; Dam T, 2006, J MED MICROBIOL, V55, P479, DOI 10.1099/jmm.0.46258-0; Dam T, 2000, J MED MICROBIOL, V49, P392, DOI 10.1099/0022-1317-49-4-392; Das S, 2004, INT J TUBERC LUNG D, V8, P267; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doroghazi JR, 2010, ISME J, V4, P1136, DOI 10.1038/ismej.2010.45; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FELSENSTEIN J, 1974, GENETICS, V78, P737; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fullner KJ, 1997, MOL MICROBIOL, V26, P755, DOI 10.1046/j.1365-2958.1997.6111984.x; Gagneux Sebastien, 2009, P1; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Gordon SV, 1999, MICROBIOL-SGM, V145, P881, DOI 10.1099/13500872-145-4-881; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hatfull GF, 2012, J VIROL, V86, P2382, DOI 10.1128/JVI.06870-11; Hillerich B, 2006, J BACTERIOL, V188, P7477, DOI 10.1128/JB.00898-06; Jung CM, 2011, J APPL MICROBIOL, V110, P1449, DOI 10.1111/j.1365-2672.2011.04995.x; Karboul A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-107; Le Dantec C, 2001, J BACTERIOL, V183, P2157, DOI 10.1128/JB.183.7.2157-2164.2001; Lemey P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-126; Liu XM, 2006, J BACTERIOL, V188, P8169, DOI 10.1128/JB.01062-06; Majewski J, 1999, GENETICS, V153, P1525; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Marri PR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S8; Marri PR, 2006, FEMS MICROBIOL REV, V30, P906, DOI 10.1111/j.1574-6976.2006.00041.x; Marri PR, 2006, CAN J MICROBIOL, V52, P560, DOI 10.1139/W06-001; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; McInerney JO, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-41; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Namouchi A, 2012, GENOME RES; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Schierup MH, 2000, GENETICS, V156, P879; Schierup MH, 2000, MOL BIOL EVOL, V17, P1578, DOI 10.1093/oxfordjournals.molbev.a026256; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schmidt HA, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P181; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sikorski J, 2010, STAND GENOMIC SCI, V2, P203, DOI 10.4056/sigs.791633; Skippington E, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120112; SMITH JM, 1992, J MOL EVOL, V34, P126; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Woese CR, 2000, P NATL ACAD SCI USA, V97, P8392, DOI 10.1073/pnas.97.15.8392; Wu CW, 2006, J BACTERIOL, V188, P711, DOI 10.1128/JB.188.2.711-723.2006	76	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50070	10.1371/journal.pone.0050070	http://dx.doi.org/10.1371/journal.pone.0050070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189179	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800056
J	Stewart, CR; Muthye, V; Cianciotto, NP				Stewart, Catherine R.; Muthye, Viraj; Cianciotto, Nicholas P.			Legionella pneumophila Persists within Biofilms Formed by Klebsiella pneumoniae, Flavobacterium sp., and Pseudomonas fluorescens under Dynamic Flow Conditions	PLOS ONE			English	Article							DRINKING-WATER; POTABLE-WATER; HARTMANNELLA-VERMIFORMIS; LEGIONNAIRES-DISEASE; TWITCHING MOTILITY; MODEL; REPLICATION; COLONIZATION; INTERFERENCE; ADHERENT	Legionella pneumophila, the agent of Legionnaires' disease pneumonia, is transmitted to humans following the inhalation of contaminated water droplets. In aquatic systems, L. pneumophila survives much of time within multi-organismal biofilms. Therefore, we examined the ability of L. pneumophila (clinical isolate 130b) to persist within biofilms formed by various types of aquatic bacteria, using a bioreactor with flow, steel surfaces, and low-nutrient conditions. L. pneumophila was able to intercalate into and persist within a biofilm formed by Klebsiella pneumoniae, Flavobacterium sp. or Pseudomonas fluorescens. The levels of L. pneumophila within these biofilms were as much as 4 x 10(4) CFU per cm(2) of steel coupon and lasted for at least 12 days. These data document that K. pneumoniae, Flavobacterium sp., and P. fluorescens can promote the presence of L. pneumophila in dynamic biofilms. In contrast to these results, L. pneumophila 130b did not persist within a biofilm formed by Pseudomonas aeruginosa, confirming that some bacteria are permissive for Legionella colonization whereas others are antagonistic. In addition to colonizing certain mono-species biofilms, L. pneumophila 130b persisted within a two-species biofilm formed by K. pneumoniae and Flavobacterium sp. Interestingly, the legionellae were also able to colonize a two-species biofilm formed by K. pneumoniae and P. aeruginosa, demonstrating that a species that is permissive for L. pneumophila can override the inhibitory effect(s) of a non-permissive species.	[Stewart, Catherine R.; Muthye, Viraj; Cianciotto, Nicholas P.] Northwestern Univ, Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA	Northwestern University	Cianciotto, NP (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA.	n-cianciotto@northwestern.edu			National Institutes of Health [AI043987, AI034937]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034937, R01AI043987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI043987 and AI034937 awarded to NPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basson A, 2008, MICROB ECOL, V55, P1, DOI 10.1007/s00248-007-9245-y; BEZANSON G, 1992, CAN J MICROBIOL, V38, P328, DOI 10.1139/m92-055; Buse HY, 2012, WATER RES, V46, P921, DOI 10.1016/j.watres.2011.12.022; Carlson HK, 2010, MOL MICROBIOL, V77, P930, DOI 10.1111/j.1365-2958.2010.07259.x; Coil DA, 2010, ARCH MICROBIOL, V192, P625, DOI 10.1007/s00203-010-0590-8; Coil DA, 2009, FEMS MICROBIOL LETT, V293, P271, DOI 10.1111/j.1574-6968.2009.01532.x; Committee on Public Water Supply Distribution Systems: Assessing and Reducing Risks NRC, 2006, PUBL HLTH RISK DISTR, P87; De Buck E, 2005, BIOCHEM BIOPH RES CO, V331, P1413, DOI 10.1016/j.bbrc.2005.04.060; Declerck P, 2007, MICROBIOL RES; Declerck P, 2007, CURR MICROBIOL, V55, P435, DOI 10.1007/s00284-007-9006-7; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Declerck P, 2009, MICROBIOL RES, V164, P593, DOI 10.1016/j.micres.2007.06.001; Donlan RM, 2005, BIOFOULING, V21, P1, DOI 10.1080/08927010500044286; Duncan C, 2011, INFECT IMMUN, V79, P2168, DOI 10.1128/IAI.01304-10; Edelstein PH., 2010, PRINCIPLES PRACTICE, V7th, P2969; Farhat M, 2012, APPL ENVIRON MICROB, DOI [10.1128/AEM.00831-00812, DOI 10.1128/AEM.00831-00812]; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Giao MS, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-57; Goeres DM, 2005, MICROBIOL-SGM, V151, P757, DOI 10.1099/mic.0.27709-0; Guerrieri E, 2008, CURR MICROBIOL, V57, P532, DOI 10.1007/s00284-008-9237-2; Heuner K, 2003, INT J MED MICROBIOL, V293, P133, DOI 10.1078/1438-4221-00259; Hicks Lauri A., 2011, Morbidity and Mortality Weekly Report, V60, P1083; Hilbi H, 2011, ENV MICROBIOL REP, V3, P286, DOI 10.1111/j.1758-2229.2011.00247.x; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; Keevil CW, 2003, WATER SCI TECHNOL, V47, P105, DOI 10.2166/wst.2003.0293; Kimura S, 2009, MICROBIOL-SGM, V155, P1934, DOI 10.1099/mic.0.026641-0; Kives J, 2006, COLLOID SURFACE B, V52, P123, DOI 10.1016/j.colsurfb.2006.04.018; Kuiper MW, 2004, APPL ENVIRON MICROB, V70, P6826, DOI 10.1128/AEM.70.11.6826-6833.2004; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Lehtola MJ, 2007, APPL ENVIRON MICROB, V73, P2854, DOI 10.1128/AEM.02916-06; Li Janet S, 2002, Commun Dis Intell Q Rep, V26, P461; Liu Z, 2006, J APPL MICROBIOL, V101, P437, DOI 10.1111/j.1365-2672.2006.02970.x; Lucas CE, 2006, MICROBIOL-SGM, V152, P3569, DOI 10.1099/mic.0.2006/000497-0; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; MANZ W, 1995, MICROBIOL-SGM, V141, P29, DOI 10.1099/00221287-141-1-29; Merault N, 2011, APPL ENVIRON MICROB, V77, P1708, DOI 10.1128/AEM.02261-10; Messi P, 2011, BIOFOULING, V27, P165, DOI 10.1080/08927014.2010.551190; Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005; Moritz MM, 2010, INT J HYG ENVIR HEAL, V213, P190, DOI 10.1016/j.ijheh.2010.05.003; Murga R, 2001, MICROBIOL-SGM, V147, P3121, DOI 10.1099/00221287-147-11-3121; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Pang CM, 2006, APPL ENVIRON MICROB, V72, P5702, DOI 10.1128/AEM.02982-05; Piao ZY, 2006, APPL ENVIRON MICROB, V72, P1613, DOI 10.1128/AEM.72.2.1613-1622.2006; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; ROGERS J, 1994, APPL ENVIRON MICROB, V60, P1585, DOI 10.1128/AEM.60.5.1585-1592.1994; ROGERS J, 1992, APPL ENVIRON MICROB, V58, P2326, DOI 10.1128/AEM.58.7.2326-2330.1992; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Stewart CR, 2011, J BACTERIOL, V193, P5971, DOI 10.1128/JB.05405-11; Stewart CR, 2009, J BACTERIOL, V191, P1537, DOI 10.1128/JB.01531-08; Stojek NM, 2011, ANN AGR ENV MED, V18, P330; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; Storey MV, 2004, WATER SCI TECHNOL, V49, P269, DOI 10.2166/wst.2004.0859; Taylor M, 2009, MICROB ECOL, V58, P538, DOI 10.1007/s00248-009-9514-z; Temmerman R, 2006, APPL ENVIRON MICROB, V72, P4323, DOI 10.1128/AEM.00070-06; Tiaden A, 2010, ENVIRON MICROBIOL, V12, P1243, DOI 10.1111/j.1462-2920.2010.02167.x; Turetgen I, 2007, ENVIRON MONIT ASSESS, V125, P271, DOI 10.1007/s10661-006-9519-8; van der Kooij D, 2005, WATER RES, V39, P2789, DOI 10.1016/j.watres.2005.04.075; Vervaeren H, 2006, FEMS MICROBIOL ECOL, V58, P583, DOI 10.1111/j.1574-6941.2006.00181.x; Wingender J, 2011, INT J HYG ENVIR HEAL, V214, P417, DOI 10.1016/j.ijheh.2011.05.009; WRIGHT JB, 1989, INFECT CONT HOSP EP, V10, P408, DOI 10.1086/646062; WRIGHT JB, 1991, J APPL BACTERIOL, V71, P531, DOI 10.1111/j.1365-2672.1991.tb03828.x; Wu MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023500	63	52	53	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50560	10.1371/journal.pone.0050560	http://dx.doi.org/10.1371/journal.pone.0050560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185637	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000247
J	Wang, ZW; Zhang, LJ; Guo, Z; Liu, L; Ji, J; Zhang, JN; Chen, XH; Liu, BY; Zhang, J; Ding, QL; Wang, XF; Zhao, W; Zhu, ZG; Yu, YY				Wang, Zhiwei; Zhang, Lijuan; Guo, Zhi; Liu, Lei; Ji, Jun; Zhang, Jianian; Chen, Xuehua; Liu, Bingya; Zhang, Jun; Ding, Qiulan; Wang, Xuefeng; Zhao, Wei; Zhu, Zhenggang; Yu, Yingyan			A Unique Feature of Iron Loss via Close Adhesion of Helicobacter pylori to Host Erythrocytes	PLOS ONE			English	Article							ANTIGEN-BINDING ADHESIN; DEFICIENCY ANEMIA; GASTRIC-CANCER; INFECTION; CHILDREN; METAANALYSIS; ADOLESCENTS; ABSORPTION; STORAGE; RISK	Iron deficiency anemia is an extra-stomach disease experienced in H. pylori carriers. Individuals with type A blood are more prone to suffering from H. pylori infection than other individuals. To clarify the molecular mechanisms underlying H. pylori-associated anemia, we collected erythrocytes from A, B, O, and AB blood donors and analyzed morphology, the number of erythrocytes with H. pylori colonies attached to them, and iron contents in erythrocytes and H. pylori (NCTC11637 and SS1 strains) by means of optical microscopy, scanning electron microscopy, and synchrotron radiation soft X-ray imaging. The number of type A erythrocytes with H. pylori attached to them was significantly higher than that of other erythrocytes (P<0.05). Far more iron distribution was observed in H. pylori bacteria using dual energy analysis near the iron L2, 3 edges by soft X-ray imaging. Iron content was significantly reduced in host erythrocytes after 4 hours of exposure to H. pylori. H. pylori are able to adhere more strongly to type A erythrocytes, and this is related to iron shift from the host to the bacteria. This may explain the reasons for refractory iron deficiency anemia and elevated susceptibility to H. pylori infection in individuals with type A blood.	[Wang, Zhiwei; Liu, Lei; Ji, Jun; Zhang, Jianian; Chen, Xuehua; Liu, Bingya; Zhang, Jun; Zhu, Zhenggang; Yu, Yingyan] Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Sch Med, Shanghai 200030, Peoples R China; [Wang, Zhiwei; Liu, Lei; Ji, Jun; Zhang, Jianian; Chen, Xuehua; Liu, Bingya; Zhang, Jun; Zhu, Zhenggang; Yu, Yingyan] Shanghai Jiao Tong Univ, Dept Surg, Shanghai Ruijin Hosp, Shanghai Key Lab Gastr Neoplasia,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Lijuan; Guo, Zhi] Chinese Acad Sci, Shanghai Synchrotron Radiat Facil, Shanghai Inst Appl Phys, Shanghai, Peoples R China; [Ding, Qiulan; Wang, Xuefeng] Shanghai Ruijin Hosp, Dept Transfus & Clin Biochem, Shanghai, Peoples R China; [Zhao, Wei] Shanghai Jiao Tong Univ, Sch Med, Dept Med Microbiol & Parasitol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhu, ZG (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Sch Med, Shanghai 200030, Peoples R China.	surgeryzhu@yahoo.com.cn; yingyan3y@yahoo.com.cn	Liu, Bingya/GMW-5655-2022; Zhang, Li/GWM-7501-2022	Liu, Bingya/0000-0002-4406-3762	National High Tech Program [2012AA02A504, 2012AA02A203, 2011ZX09307-001-05]; National Natural Science Foundation of China [81172329, 30973486]; Program of Shanghai Subject Chief Scientist [11XD1403600]; Shanghai Science and Technology Commission [09DZ1950101, 09JC1409600]; Shanghai Jiao Tong University School of Medicine [BXJ 201210]	National High Tech Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Jiao Tong University School of Medicine	This work was supported by the National High Tech Program (2012AA02A504, 2012AA02A203 and 2011ZX09307-001-05), National Natural Science Foundation of China (81172329, 30973486), the Program of Shanghai Subject Chief Scientist (11XD1403600), Key Research Project from Shanghai Science and Technology Commission (09DZ1950101, 09JC1409600) and Dr. Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine (BXJ 201210). The authors also thank beamline BL08U1A of the Shanghai Synchrotron Radiation Facilities (SSRF) for providing the beam time. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Ashorn M, 2001, SCAND J GASTROENTERO, V36, P701, DOI 10.1080/003655201300191950; Barabino A, 2002, HELICOBACTER, V7, P71, DOI 10.1046/j.1083-4389.2002.00073.x; BLECKER U, 1991, EUR J PEDIATR, V150, P560, DOI 10.1007/BF02072207; Cardamone M, 2008, J PAEDIATR CHILD H, V44, P647, DOI 10.1111/j.1440-1754.2008.01374.x; Cardoso SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029244; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; DuBois S, 2005, AM J GASTROENTEROL, V100, P453, DOI 10.1111/j.1572-0241.2005.30252.x; Ge RG, 2012, BIOMETALS, V25, P247, DOI 10.1007/s10534-011-9512-8; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Konno M, 2000, J PEDIATR GASTR NUTR, V31, P52, DOI 10.1097/00005176-200007000-00012; Kostaki M, 2003, EUR J PEDIATR, V162, P177, DOI 10.1007/s00431-002-1139-x; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; Lombard M, 1997, GUT, V40, P435, DOI 10.1136/gut.40.4.435; McCord JM, 1998, SEMIN HEMATOL, V35, P5; McGee DJ, 1999, CURR TOP MICROBIOL, V241, P155; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Nahon S, 2003, HELICOBACTER, V8, P573, DOI 10.1111/j.1523-5378.2003.00184.x; Nakao M, 2011, CANCER EPIDEM BIOMAR, V20, P1665, DOI 10.1158/1055-9965.EPI-11-0213; Prinz C, 2001, CANCER RES, V61, P1903; Qu XH, 2010, WORLD J GASTROENTERO, V16, P886, DOI 10.3748/wjg.v16.i7.886; Regvar M, 2011, J EXP BOT, V62, P3929, DOI 10.1093/jxb/err090; RICEEVANS C, 1993, PROG LIPID RES, V32, P71, DOI 10.1016/0163-7827(93)90006-I; Sherman PM, 2005, CAN J GASTROENTEROL, V19, P421, DOI 10.1155/2005/971974; Snelling WJ, 2007, HELICOBACTER, V12, P200, DOI 10.1111/j.1523-5378.2007.00499.x; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Toyokuni S, 2009, CANCER SCI, V100, P9, DOI 10.1111/j.1349-7006.2008.01001.x; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Xue CF, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3491837; Yamaoka Y, 2000, P NATL ACAD SCI USA, V97, P7533, DOI 10.1073/pnas.130079797; Yip R, 1997, JAMA-J AM MED ASSOC, V277, P1135, DOI 10.1001/jama.277.14.1135; Yu J, 2002, GUT, V51, P480, DOI 10.1136/gut.51.4.480; Yuan WZ, 2010, SCAND J GASTROENTERO, V45, P665, DOI 10.3109/00365521003663670; Zhang XZ, 2010, J SYNCHROTRON RADIAT, V17, P804, DOI 10.1107/S0909049510031250; Zhang ZW, 1998, GUT, V43, P322, DOI 10.1136/gut.43.3.322; Zowczak M, 2001, J TRACE ELEM MED BIO, V15, P193, DOI 10.1016/S0946-672X(01)80066-3	37	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50314	10.1371/journal.pone.0050314	http://dx.doi.org/10.1371/journal.pone.0050314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185604	Green Submitted, gold, Green Published			2022-12-25	WOS:000311821000217
J	Zhao, P; Damerow, MS; Stern, P; Liu, AH; Sweet-Cordero, A; Siziopikou, K; Neilson, JR; Sharp, PA; Cheng, C				Zhao, P.; Damerow, M. S.; Stern, P.; Liu, A. H.; Sweet-Cordero, A.; Siziopikou, K.; Neilson, J. R.; Sharp, P. A.; Cheng, C.			CD44 promotes Kras-dependent lung adenocarcinoma	ONCOGENE			English	Article						CD44; Kras; lung adenocarcinoma	BREAST-CANCER CELLS; STEM-CELLS; K-RAS; TUMOR; ACTIVATION; EXPRESSION; IDENTIFICATION; MICE; CARCINOMA	Kras-induced non-small-cell lung adenocarcinoma is the major subtype of lung cancers and is associated with poor prognosis. Using a lung cancer mouse model that expresses a cre-mediated Kras(G12D) mutant, we identified a critical role for the cell surface molecule CD44 in mediating cell proliferation downstream of oncogenic Kras signaling. The deletion of CD44 attenuates lung adenocarcinoma formation and prolongs the survival of these mice. Mechanistically, CD44 is required for the activation of Kras-mediated signaling through the mitogen-activated protein kinase (MAPK) pathway and thus promotes tumor cell proliferation. Together, these results reveal an unrecognized role for CD44 in oncogenic Kras-induced lung adenocarcinoma and suggest that targeting CD44 could be an effective strategy for halting Kras-dependent carcinomas.	[Zhao, P.; Damerow, M. S.; Liu, A. H.; Cheng, C.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med,Div Hematol Oncol, Chicago, IL 60611 USA; [Stern, P.] Sextant Therapeut Inc, Cambridge, MA USA; [Sweet-Cordero, A.] Stanford Univ, Dept Pediat, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Siziopikou, K.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Neilson, J. R.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Sharp, P. A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Stanford University; Northwestern University; Feinberg School of Medicine; Baylor College of Medicine; Massachusetts Institute of Technology (MIT)	Cheng, C (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Dept Med, 303 E Super St, Chicago, IL 60611 USA.	chengc@northwestern.edu		Neilson, Joel R./0000-0002-3408-608X; Liu, Angela/0000-0002-2567-0671	NATIONAL CANCER INSTITUTE [K99CA131474, P30CA014051, R00CA131474, P01CA042063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277] Funding Source: NIH RePORTER; NCI NIH HHS [K99 CA131474, P30 CA014051, R00 CA131474, P01 CA042063] Funding Source: Medline; NIGMS NIH HHS [R01 GM034277] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Cheng CH, 2006, GENE DEV, V20, P1715, DOI 10.1101/gad.1430906; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Davie SA, 2007, TRANSGENIC RES, V16, P193, DOI 10.1007/s11248-006-9056-9; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Girard L, 2000, CANCER RES, V60, P4894; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Hirata T, 1998, CANCER RES, V58, P1108; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; PENNO MB, 1994, CANCER RES, V54, P1381; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Sherman LS, 2000, J CELL BIOL, V150, P1071, DOI 10.1083/jcb.150.5.1071; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	24	32	34	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 24	2013	32	43					5186	5190		10.1038/onc.2012.542	http://dx.doi.org/10.1038/onc.2012.542			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	240JY	23208496	Green Accepted			2022-12-25	WOS:000326093200006
J	Loya, TJ; O'Rourke, TW; Reines, D				Loya, Travis J.; O'Rourke, Thomas W.; Reines, Daniel			Yeast Nab3 Protein Contains a Self-assembly Domain Found in Human Heterogeneous Nuclear Ribonucleoprotein-C (hnRNP-C) That Is Necessary for Transcription Termination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNA; CELL-FREE FORMATION; BINDING PROTEINS; NRD1; ACCUMULATION; EXPRESSION; INTERACTS; FEATURES; GENE	Nab3 is an RNA-binding protein whose function is important for terminating transcription by RNA polymerase II. It co-assembles with Nrd1, and the resulting heterodimer of these heterogeneous nuclear ribonucleoprotein-C (hnRNP)-like proteins interacts with the nascent transcript and RNA polymerase II. Previous genetic analysis showed that a short carboxyl-terminal region of Nab3 is functionally important for termination and is located far from the Nab3 RNA recognition domain in the primary sequence. The domain is structurally homologous to hnRNP-C from higher organisms. Here we provide biochemical evidence that this short region is sufficient to enable self-assembly of Nab3 into a tetrameric form in a manner similar to the cognate region of human hnRNP-C. Within this region, there is a stretch of low complexity protein sequence (16 glutamines) adjacent to a putative alpha-helix that potentiates the ability of the conserved region to self-assemble. The glutamine stretch and the final 18 amino acids of Nab3 are both important for termination in living yeast cells. The findings herein describe an additional avenue by which these hnRNP-like proteins can polymerize on target transcripts. This process is independent of, but acts in concert with, the interactions of the proteins with RNA and RNA polymerase and extends the relationship of Nab3 as a functional orthologue of a higher eukaryotic hnRNP.	[Loya, Travis J.; O'Rourke, Thomas W.; Reines, Daniel] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA	Emory University	Reines, D (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	dreines@emory.edu	excellency, Your/R-2357-2019	excellency, Your/0000-0003-0832-6243	National Institutes of Health [GM46331]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, R01GM046331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46331.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Carroll KL, 2007, RNA, V13, P361, DOI 10.1261/rna.338407; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Jenks MH, 2008, MOL CELL BIOL, V28, P3883, DOI 10.1128/MCB.00380-08; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Loya TJ, 2012, NUCLEIC ACIDS RES, V40, P7476, DOI 10.1093/nar/gks377; Lykke-Andersen S, 2007, BIOCHIMIE, V89, P1177, DOI 10.1016/j.biochi.2007.05.007; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P1212, DOI 10.1021/bi951974k; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Shaw RJ, 2001, J BIOL CHEM, V276, P32905, DOI 10.1074/jbc.M105075200; Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699; Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993; Tan JH, 2001, J MOL BIOL, V305, P829, DOI 10.1006/jmbi.2000.4332; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Whitson SR, 2005, J MOL BIOL, V350, P319, DOI 10.1016/j.jmb.2005.05.002; WILSON SM, 1994, J CELL BIOL, V127, P1173, DOI 10.1083/jcb.127.5.1173; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975	25	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2111	2117		10.1074/jbc.M112.430678	http://dx.doi.org/10.1074/jbc.M112.430678			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23192344	Green Published, hybrid			2022-12-25	WOS:000314211500002
J	Burstenbinder, K; Savchenko, T; Muller, J; Adamson, AW; Stamm, G; Kwong, R; Zipp, BJ; Dinesh, DC; Abel, S				Buerstenbinder, Katharina; Savchenko, Tatyana; Mueller, Jens; Adamson, Aaron W.; Stamm, Gina; Kwong, Raymond; Zipp, Brandon J.; Dinesh, Dhurvas Chandrasekaran; Abel, Steffen			Arabidopsis Calmodulin-binding Protein IQ67-Domain 1 Localizes to Microtubules and Interacts with Kinesin Light Chain-related Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; GLUCOSINOLATE METABOLISM; IQ MOTIFS; CALCIUM; SUPERFAMILY; RECOGNITION; DIVERSITY; THALIANA; VECTORS; NETWORK	Calcium (Ca2+) is a key second messenger in eukaryotes and regulates diverse cellular processes, most notably via calmodulin (CaM). In Arabidopsis thaliana, IQD1 (IQ67 domain 1) is the founding member of the IQD family of putative CaM targets. The 33 predicted IQD proteins share a conserved domain of 67 amino acids that is characterized by a unique arrangement of multiple CaM recruitment motifs, including so-called IQ motifs. Whereas IQD1 has been implicated in the regulation of defense metabolism, the biochemical functions of IQD proteins remain to be elucidated. In this study we show that IQD1 binds to multiple Arabidopsis CaM and CaM-like (CML) proteins in vitro and in yeast two-hybrid interaction assays. CaM overlay assays revealed moderate affinity of IQD1 to CaM2 (K-d similar to 0.6 mu M). Deletion mapping of IQD1 demonstrated the importance of the IQ67 domain for CaM2 binding in vitro, which is corroborated by interaction of the shortest IQD member, IQD20, with Arabidopsis CaM/CMLs in yeast. A genetic screen of a cDNA library identified Arabidopsis kinesin light chain-related protein-1 (KLCR1) as an IQD1 interactor. The subcellular localization of GFP-tagged IQD1 proteins to microtubules and the cell nucleus in transiently and stably transformed plant tissues (tobacco leaves and Arabidopsis seedlings) suggests direct interaction of IQD1 and KLCR1 in planta that is supported by GFP similar to IQD1-dependent recruitment of RFP similar to KLCR1 and RFP similar to CaM2 to microtubules. Collectively, the prospect arises that IQD1 and related proteins provide Ca2+/CaM-regulated scaffolds for facilitating cellular transport of specific cargo along microtubular tracks via kinesin motor proteins.	[Buerstenbinder, Katharina; Mueller, Jens; Stamm, Gina; Dinesh, Dhurvas Chandrasekaran; Abel, Steffen] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, D-06120 Halle, Germany; [Savchenko, Tatyana; Adamson, Aaron W.; Kwong, Raymond; Zipp, Brandon J.; Abel, Steffen] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Abel, Steffen] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany	Leibniz Institut fur Pflanzenbiochemie; University of California System; University of California Davis; Martin Luther University Halle Wittenberg	Abel, S (corresponding author), Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Weinberg 3, D-06120 Halle, Germany.	sabel@ipb-halle.de	Savchenko, Tatyana/E-7091-2014; Dinesh, Dhurvas Chandrasekaran/AAR-1948-2020	Savchenko, Tatyana/0000-0003-0126-4932; Dinesh, Dhurvas Chandrasekaran/0000-0001-9125-4775; Burstenbinder, Katharina/0000-0002-3493-4800	National Research Initiative of the United States Department of Agriculture Cooperative State Research Education and Extension Service Grant [2005-02507]; Deutsche Forschungsgemeinschaft [GRK1026]; state of Saxony-Anhalt; Federal Republic of Germany	National Research Initiative of the United States Department of Agriculture Cooperative State Research Education and Extension Service Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); state of Saxony-Anhalt; Federal Republic of Germany	This work was supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research Education and Extension Service Grant 2005-02507 (to S. A.), by a pre-doctoral fellowship from the Deutsche Forschungsgemeinschaft (GRK1026; to D. C. D.), and by core funding to the Leibniz-Institute of Plant Biochemistry from the state of Saxony-Anhalt and the Federal Republic of Germany.	Abel S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-72; Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Black DJ, 2009, BIOCHEMISTRY-US, V48, P11766, DOI 10.1021/bi9014874; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Choi MS, 2005, J BIOL CHEM, V280, P40820, DOI 10.1074/jbc.M504616200; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Clough SJ, 2005, METH MOL B, V286, P91; Day IS, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-10-research0056; DeFalco TA, 2010, FEBS LETT, V584, P4717, DOI 10.1016/j.febslet.2010.10.059; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dixon DP, 2010, PHYTOCHEMISTRY, V71, P338, DOI 10.1016/j.phytochem.2009.12.012; Dixon DP, 2009, J BIOL CHEM, V284, P21249, DOI 10.1074/jbc.M109.020107; Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kang CH, 2006, CELL DEATH DIFFER, V13, P84, DOI 10.1038/sj.cdd.4401712; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kohler C, 2000, FEBS LETT, V471, P133, DOI 10.1016/S0014-5793(00)01383-1; Koroleva OA, 2010, PLANT J, V64, P456, DOI 10.1111/j.1365-313X.2010.04339.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; McCormack E, 2005, TRENDS PLANT SCI, V10, P383, DOI 10.1016/j.tplants.2005.07.001; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Muller J, 2010, PLANT J, V61, P234, DOI 10.1111/j.1365-313X.2009.04046.x; Munshi HG, 1996, BIOCHEMISTRY-US, V35, P15883, DOI 10.1021/bi962107y; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nutricati E, 2006, PLANT CELL REP, V25, P997, DOI 10.1007/s00299-006-0146-1; Reddy A S, 2001, BMC Genomics, V2, P2, DOI 10.1186/1471-2164-2-2; Reddy ASN, 2011, PHYTOCHEMISTRY, V72, P1007, DOI 10.1016/j.phytochem.2010.12.022; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Reddy VS, 1999, J BIOL CHEM, V274, P31727, DOI 10.1074/jbc.274.44.31727; Reddy VS, 2004, PHYTOCHEMISTRY, V65, P1745, DOI 10.1016/j.phytochem.2004.04.033; Reddy VS, 2004, PLANT CELL, V16, P185, DOI 10.1105/tpc.016600; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Schnapp BJ, 2003, J CELL SCI, V116, P2125, DOI 10.1242/jcs.00488; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wagner U, 2002, PLANT MOL BIOL, V49, P515, DOI 10.1023/A:1015557300450; Weinl S, 2009, NEW PHYTOL, V184, P517, DOI 10.1111/j.1469-8137.2009.02938.x; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu S, 2011, PLANT PHYSIOL, V157, P1175, DOI 10.1104/pp.111.181065; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yang TB, 2000, J BIOL CHEM, V275, P38467, DOI 10.1074/jbc.M003566200; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999; Zhu CM, 2012, PROTOPLASMA, V249, P887, DOI 10.1007/s00709-011-0343-9	62	72	77	6	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1871	1882		10.1074/jbc.M112.396200	http://dx.doi.org/10.1074/jbc.M112.396200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23204523	Green Published, hybrid			2022-12-25	WOS:000313751400041
J	New, LA; Chahi, AK; Jones, N				New, Laura A.; Chahi, Ava Keyvani; Jones, Nina			Direct Regulation of Nephrin Tyrosine Phosphorylation by Nck Adaptor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; KIDNEY SLIT DIAPHRAGM; ACTIN POLYMERIZATION; CELL MORPHOLOGY; KINASE; SRC; FYN; DOMAIN; ACTIVATION; PODOCYTE	The transmembrane protein nephrin is a key component of the kidney slit diaphragm that contributes to the morphology of podocyte foot processes through signaling to the underlying actin cytoskeleton. We have recently reported that tyrosine phosphorylation of the cytoplasmic tail of nephrin facilitates recruitment of Nck SH2/SH3 adaptor proteins and subsequent actin remodeling and that phosphorylation of the Nck binding sites on nephrin is decreased during podocyte injury. We now demonstrate that Nck directly modulates nephrin phosphorylation through formation of a signaling complex with the Src family kinase Fyn. The ability of Nck to enhance nephrin phosphorylation is compromised in the presence of a Src family kinase inhibitor and when the SH3 domains of Nck are mutated. Furthermore, induced loss of Nck expression in podocytes in vivo is associated with a rapid reduction in nephrin tyrosine phosphorylation. Our results suggest that Nck may facilitate dynamic signaling events at the slit diaphragm by promoting Fyn-dependent phosphorylation of nephrin, which may be important in the regulation of foot process morphology and response to podocyte injury.	[New, Laura A.; Chahi, Ava Keyvani; Jones, Nina] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Jones, N (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E,Rm 3461,New Sci Complex, Guelph, ON N1G 2W1, Canada.	jonesmcb@uoguelph.ca			Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC); New Investigator Award from the Kidney Research Scientist Core Education and National Training (KRESCENT) Program	Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Investigator Award from the Kidney Research Scientist Core Education and National Training (KRESCENT) Program	This work was supported by grants from the Kidney Foundation of Canada (to N. J.).; Supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Alexander Graham Bell Canada Graduate Scholarship.; The recipient of a New Investigator Award from the Kidney Research Scientist Core Education and National Training (KRESCENT) Program. Holds a Tier II Canada Research Chair in Eukaryotic Cellular Signaling.	Ashworth S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012626; Barda-Saad M, 2010, EMBO J, V29, P2315, DOI 10.1038/emboj.2010.133; Berger K, 2011, INT UROL NEPHROL, V43, P273, DOI 10.1007/s11255-010-9898-1; Blasutig IM, 2008, MOL CELL BIOL, V28, P2035, DOI 10.1128/MCB.01770-07; Chan B, 2003, NAT CELL BIOL, V5, P155, DOI 10.1038/ncb920; Frese S, 2006, J BIOL CHEM, V281, P18236, DOI 10.1074/jbc.M512917200; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Gonfloni S, 1997, EMBO J, V16, P7261, DOI 10.1093/emboj/16.24.7261; Hake MJ, 2008, BIOCHEMISTRY-US, V47, P3096, DOI 10.1021/bi701549a; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jones N, 2009, J AM SOC NEPHROL, V20, P1533, DOI 10.1681/ASN.2009010056; Kriz W, 1996, KIDNEY INT, V49, P1570, DOI 10.1038/ki.1996.227; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Li CJ, 2009, CELL SIGNAL, V21, P111, DOI 10.1016/j.cellsig.2008.09.014; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li HP, 2006, BIOCHEM BIOPH RES CO, V349, P310, DOI 10.1016/j.bbrc.2006.08.053; Miyoshi-Akiyama T, 2001, ONCOGENE, V20, P4058, DOI 10.1038/sj.onc.1204528; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; PANCHAMOORTHY G, 1994, MOL CELL BIOL, V14, P6372, DOI 10.1128/MCB.14.9.6372; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Quack I, 2006, P NATL ACAD SCI USA, V103, P14110, DOI 10.1073/pnas.0602587103; Simarro M, 2004, INT IMMUNOL, V16, P727, DOI 10.1093/intimm/dxh074; Smith JM, 1999, J BIOL CHEM, V274, P27956, DOI 10.1074/jbc.274.39.27956; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Uchida K, 2008, KIDNEY INT, V73, P926, DOI [10.1038/ki.2008.19, 10.1038/KI.2008.19]; Vaynberg J, 2005, MOL CELL, V17, P513, DOI 10.1016/j.molcel.2004.12.031; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Welsh GI, 2010, J PATHOL, V220, P328, DOI 10.1002/path.2661; Yu CCK, 2001, CURR BIOL, V11, P34, DOI 10.1016/S0960-9822(00)00024-5; Zhang SY, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000678; Zhang Y, 2010, NEPHROL DIAL TRANSPL, V25, P1785, DOI 10.1093/ndt/gfp697; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	39	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1500	1510		10.1074/jbc.M112.439463	http://dx.doi.org/10.1074/jbc.M112.439463			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23188823	hybrid, Green Published			2022-12-25	WOS:000313751400008
J	El Bakkouri, M; Rathore, S; Calmettes, C; Wernimont, AK; Liu, KY; Sinha, D; Asad, M; Jung, P; Hui, R; Mohmmed, A; Houry, WA				El Bakkouri, Majida; Rathore, Sumit; Calmettes, Charles; Wernimont, Amy K.; Liu, Kaiyin; Sinha, Dipto; Asad, Mohd; Jung, Patrick; Hui, Raymond; Mohmmed, Asif; Houry, Walid A.			Structural Insights into the Inactive Subunit of the Apicoplast-localized Caseinolytic Protease Complex of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Malaria; Plasmodium; Protease; Protein Assembly; Protein Degradation; Protein Structure; ClpP; ClpR; X-ray Structure	ERYTHROCYTE BINDING; CLPP; CLASSIFICATION; RECOGNITION; PROTEINS; SWITCH; MODEL	The ATP-dependent caseinolytic protease, ClpP, is highly conserved in bacteria and in the organelles of different organisms. In cyanobacteria, plant plastids, and the apicoplast of the genus Plasmodium, a noncatalytic paralog of ClpP, termed ClpR, has been identified. ClpRs are found to form heterocomplexes with ClpP resulting in a ClpRP tetradecameric cylinder having less than 14 catalytic triads. The exact role of ClpR in such a complex remains enigmatic. Here we describe the x-ray crystal structure of ClpR protein heptamer from (Plasmodium falciparum) ((PfClpR)). This is the first structure of a ClpR protein. The structure shows that the (PfClpR) monomer adopts a fold similar to that of ClpP, but has a unique motif, which we named the (R)-motif, forming a beta turn located near the inactive catalytic triad in a three-dimensional space. The (PfClpR) heptamer exhibits a more open and flat ring than a ClpP heptamer. (PfClpR) was localized in the (P. falciparum) apicoplast as is the case of PfClpP. However, biochemical and structural data suggest that, contrary to what has been observed in other organisms, (PfClpP) and (PfClpR) do not form a stable heterocomplex in the apicoplast of (P. falciparum).	[El Bakkouri, Majida; Calmettes, Charles; Liu, Kaiyin; Jung, Patrick; Houry, Walid A.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Rathore, Sumit; Sinha, Dipto; Asad, Mohd; Mohmmed, Asif] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi 110067, India; [Wernimont, Amy K.; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada	University of Toronto; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Toronto; Structural Genomics Consortium	Mohmmed, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	amohd@icgeb.res.in; walid.houry@utoronto.ca	Sinha, Dipto/GLU-5171-2022	Sinha, Dipto/0000-0001-9118-5079; calmettes, charles/0000-0002-2542-4382	ICMR, Government of India; Department of Biotechnology,Government of India; Canadian Institutes of Health Research (CIHR) [MOP-67210]	ICMR, Government of India(Indian Council of Medical Research (ICMR)); Department of Biotechnology,Government of India(Department of Biotechnology (DBT) India); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We are grateful to Alan Cowman (Walter and Eliza Hall Institute of Medical Research, Australia) for pARL1 vector, and Guy Schiehser and David Jacobus (Jacobus Pharmaceuticals, NJ, USA) for the drug WR99210. We thank Wandy Beatty for help with the immunoelectron microscopic studies and the Rotary blood bank, New Delhi, for providing the human RBCs. SR and MA were supported by research fellowships from ICMR, Government of India. AM is the recipient of National Bioscience Award for Career Development from Department of Biotechnology, Government of India. MEB is the recipient of a fellowship from the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Protein Folding and Interaction Dynamics: Principles and Diseases (TGF-53910). KL is the recipient of the Ontario Graduate Scholarship. This work was supported by a Program support grant from Department of Biotechnology, Government of India to AM and by a grant from CIHR (MOP-67210) to WAH.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Andersson FI, 2009, J BIOL CHEM, V284, P13519, DOI 10.1074/jbc.M809588200; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Blair PL, 2002, NUCLEIC ACIDS RES, V30, P2224, DOI 10.1093/nar/30.10.2224; Choi KH, 2005, BIOCHEMISTRY-US, V44, P13921, DOI 10.1021/bi0505060; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Crabb BS, 2004, METH MOL B, V270, P263; Dasaradhi PVN, 2005, BIOCHEM BIOPH RES CO, V336, P1062, DOI 10.1016/j.bbrc.2005.08.213; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gersch M, 2012, J BIOL CHEM, V287, P9484, DOI 10.1074/jbc.M111.336222; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jennings LD, 2008, BIOCHEMISTRY-US, V47, P11536, DOI 10.1021/bi801101p; Kato Y, 2010, INT REV CEL MOL BIO, V280, P185, DOI 10.1016/S1937-6448(10)80004-8; Kim DY, 2008, J MOL BIOL, V379, P760, DOI 10.1016/j.jmb.2008.04.036; Kimber MS, 2010, STRUCTURE, V18, P798, DOI 10.1016/j.str.2010.04.008; Kress W, 2009, RES MICROBIOL, V160, P618, DOI 10.1016/j.resmic.2009.08.006; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; LJUNGSTROM I, 2004, METH MALARIA RES; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neuwald AF, 1999, GENOME RES, V9, P27; Olinares PDB, 2011, PLANT CELL, V23, P2348, DOI 10.1105/tpc.111.086454; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Ramasamy G, 2007, MOL BIOCHEM PARASIT, V152, P139, DOI 10.1016/j.molbiopara.2007.01.002; Rathore S, 2010, MOL MICROBIOL, V77, P873, DOI 10.1111/j.1365-2958.2010.07251.x; Reed MB, 2000, P NATL ACAD SCI USA, V97, P7509, DOI 10.1073/pnas.97.13.7509; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Wickramarachchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001732; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848	51	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1022	1031		10.1074/jbc.M112.416560	http://dx.doi.org/10.1074/jbc.M112.416560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23192353	hybrid, Green Published			2022-12-25	WOS:000313570300063
J	Qu, YG; Zhou, F; Yu, LD; Yu, CA				Qu, Yuan-Gang; Zhou, Fei; Yu, Linda; Yu, Chang-An			Effect of Mutations of Arginine 94 on Proton Pumping, Electron Transfer, and Superoxide Anion Generation in Cytochrome b of the bc(1) Complex from Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; UBIQUINOL OXIDATION; Q-CYCLE; QUINOL OXIDATION; Q(O) SITE; MECHANISM; TRANSLOCATION; MITOCHONDRIAL; RECONSTITUTION; VESICLES	Proton transfer involving internal water molecules that provide hydrogen bonds and facilitate proton diffusion has been identified in some membrane proteins. Arg-94 in cytochrome b of the Rhodobacter sphaeroides bc(1) complex is fully conserved and is hydrogen-bonded to the heme propionate and a chain of water molecules. To further elucidate the role of Arg-94, we generated the mutations R94A, R94D, and R94N. The wild-type and mutant bc(1) complexes were purified and then characterized. The results show that substitution of Arg-94 decreased electron transfer activity and proton pumping capability and increased O-2(radical anion) production, suggesting the importance of Arg-94 in the catalytic mechanism of the bc(1) complex in R. sphaeroides. This also suggests that the transport of H+, O-2, and O-2(radical anion) in the bc(1) complex may occur by the same pathway.	[Qu, Yuan-Gang; Zhou, Fei; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Qu, YG (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, 255 Noble Res Ctr, Stillwater, OK 74078 USA.	yuangangqu@yahoo.com			National Institutes of Health [GM30721]; National Science Foundation [MCB0077650]; Oklahoma Agricultural Experiment Station Projects from Oklahoma State University [1819, 2372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030721, R37GM030721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Oklahoma Agricultural Experiment Station Projects from Oklahoma State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM30721 (to C.-A. Y.). This work was also supported by National Science Foundation Grant MCB0077650 (to L. Y.) and Oklahoma Agricultural Experiment Station Projects 1819 and 2372 from Oklahoma State University.	ALEXANDRE A, 1979, J BIOL CHEM, V254, P1555; Bartoschek S, 2001, J BIOL CHEM, V276, P35231, DOI 10.1074/jbc.C100365200; BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; BRANDT U, 1994, CRIT REV BIOCHEM MOL, V29, P165, DOI 10.3109/10409239409086800; Brasseur G, 1996, BBA-BIOENERGETICS, V1275, P61, DOI 10.1016/0005-2728(96)00051-5; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; COCCO T, 1992, EUR J BIOCHEM, V209, P475, DOI 10.1111/j.1432-1033.1992.tb17312.x; Covian R, 2001, EUR J BIOCHEM, V268, P5783, DOI 10.1046/j.0014-2956.2001.02521.x; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; Crofts AR, 2004, ANNU REV PHYSIOL, V66, P689, DOI 10.1146/annurev.physiol.66.032102.150251; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; DEGLIESPOSTI M, 1993, BIOCHIM BIOPHYS ACTA, V1143, P243, DOI 10.1016/0005-2728(93)90197-N; DENICOLA A, 1995, FREE RADICAL BIO MED, V19, P11, DOI 10.1016/0891-5849(94)00239-G; DEVRIES S, 1981, J BIOL CHEM, V256, P1996; ERECINSKA M, 1972, P NATL ACAD SCI USA, V69, P50, DOI 10.1073/pnas.69.1.50; Gennis RB, 1999, SCIENCE, V286, P252, DOI 10.1126/science.286.5438.252; GUNER S, 1991, BIOCHIM BIOPHYS ACTA, V1058, P269, DOI 10.1016/S0005-2728(05)80247-6; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Junemann S, 1998, J BIOL CHEM, V273, P21603, DOI 10.1074/jbc.273.34.21603; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; LEUNG KH, 1975, J BIOL CHEM, V250, P8467; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LORUSSO M, 1983, EUR J BIOCHEM, V137, P413, DOI 10.1111/j.1432-1033.1983.tb07844.x; MATHER MW, 1995, J BIOL CHEM, V270, P28668, DOI 10.1074/jbc.270.48.28668; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; NAKANO M, 1990, METHOD ENZYMOL, V186, P585; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; Snyder CH, 2000, J BIOL CHEM, V275, P13535, DOI 10.1074/jbc.275.18.13535; Tian H, 1997, J BIOL CHEM, V272, P23722, DOI 10.1074/jbc.272.38.23722; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; Wikstrom M, 2003, BBA-BIOENERGETICS, V1604, P61, DOI 10.1016/S0005-2728(03)00041-0; WIKSTROM MK, 1972, BIOCHIM BIOPHYS ACTA, V283, P403, DOI 10.1016/0005-2728(72)90258-7; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xiao KH, 2004, BIOCHEMISTRY-US, V43, P1488, DOI 10.1021/bi035378z; Yang SQ, 2008, J BIOL CHEM, V283, P28767, DOI 10.1074/jbc.M803013200; Yin Y, 2010, J BIOL CHEM, V285, P17038, DOI 10.1074/jbc.M110.104364; Yin Y, 2009, BBA-BIOENERGETICS, V1787, P913, DOI 10.1016/j.bbabio.2009.03.018; YU CA, 1972, J BIOL CHEM, V247, P1012; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; YU L, 1986, BIOCHIM BIOPHYS ACTA, V852, P203, DOI 10.1016/0005-2728(86)90225-2; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	45	2	2	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1047	1054		10.1074/jbc.M112.397521	http://dx.doi.org/10.1074/jbc.M112.397521			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209298	Green Published, hybrid			2022-12-25	WOS:000313570300028
J	Cha, YH; Chakrapani, S; Craig, A; Baloh, RW				Cha, Yoon-Hee; Chakrapani, Shruthi; Craig, Alexis; Baloh, Robert W.			Metabolic and Functional Connectivity Changes in Mal de Debarquement Syndrome	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; ENTORHINAL CORTEX; CLINICAL-FEATURES; DEPRESSION SCALE; HOSPITAL ANXIETY; AMYGDALA; MEMORY; DISORDERS; NEURONS; OSCILLATIONS	Background: Individuals with mal de debarquement syndrome (MdDS) experience a chronic illusion of self-motion triggered by prolonged exposure to passive motion, such as from sea or air travel. The experience is one of rocking dizziness similar to when the individual was originally on the motion trigger such as a boat or airplane. MdDS represents a prolonged version of a normal phenomenon familiar to most individuals but which persists for months or years in others. It represents a natural example of the neuroplasticity of motion adaptation. However, the localization of where that motion adaptation occurs is unknown. Our goal was to localize metabolic and functional connectivity changes associated with persistent MdDS. Methods: Twenty subjects with MdDS lasting a median duration of 17.5 months were compared to 20 normal controls with F-18 FDG PET and resting state fMRI. Resting state metabolism and functional connectivity were calculated using age, grey matter volume, and mood and anxiety scores as nuisance covariates. Results: MdDS subjects showed increased metabolism in the left entorhinal cortex and amygdala (z>3.3). Areas of relative hypometabolism included the left superior medial gyrus, left middle frontal gyrus, right amygdala, right insula, and clusters in the left superior, middle, and inferior temporal gyri. MdDS subjects showed increased connectivity between the entorhinal cortex/amygdala cluster and posterior visual and vestibular processing areas including middle temporal gyrus, motion sensitive area MT/V5, superior parietal lobule, and primary visual cortex, while showing decreased connectivity to multiple prefrontal areas. Conclusion: These data show an association between resting state metabolic activity and functional connectivity between the entorhinal cortex and amygdala in a human disorder of abnormal motion perception. We propose a model for how these biological substrates can allow a limited period of motion exposure to lead to chronic perceptions of self-motion.	[Cha, Yoon-Hee; Baloh, Robert W.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Chakrapani, Shruthi] Univ Calif Los Angeles, Semel Resnick Inst, Los Angeles, CA USA; [Craig, Alexis] Univ Calif Irvine, Irvine, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Irvine	Cha, YH (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.	yhcha@mednet.ucla.edu			National Institutes of Health/National Institute on Deafness and Other Communication Disorders; NIH/NIDCD [R03 DC010451]; University of California, Los Angeles UCLA GCRC [M01-RR000865]; Mal de Debarquement Syndrome (MdDS) Balance Foundation Early Career Award; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC010451] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); University of California, Los Angeles UCLA GCRC; Mal de Debarquement Syndrome (MdDS) Balance Foundation Early Career Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the National Institutes of Health/National Institute on Deafness and Other Communication Disorders, NIH/NIDCD R03 DC010451, University of California, Los Angeles UCLA GCRC M01-RR000865, and the Mal de Debarquement Syndrome (MdDS) Balance Foundation Early Career Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; BROWN JJ, 1987, AM J OTOLARYNG, V8, P219, DOI 10.1016/S0196-0709(87)80007-8; Cha YH, 2008, J NEUROL, V255, P1038, DOI 10.1007/s00415-008-0837-3; Cha YH, 2009, SEMIN NEUROL, V29, P520, DOI 10.1055/s-0029-1241038; Cohen H, 1996, ANN NY ACAD SCI, V781, P598, DOI 10.1111/j.1749-6632.1996.tb15734.x; Coutureau E, 2009, PROG NEURO-PSYCHOPH, V33, P753, DOI 10.1016/j.pnpbp.2009.03.038; Damsa C, 2009, CURR OPIN PSYCHIATR, V22, P96, DOI 10.1097/YCO.0b013e328319bd10; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Doeller CF, 2010, NATURE, V463, P657, DOI 10.1038/nature08704; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; GORDON CR, 1995, J VESTIBUL RES-EQUIL, V5, P363, DOI 10.1016/0957-4271(95)00005-Z; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hain TC, 1999, ARCH OTOLARYNGOL, V125, P615, DOI 10.1001/archotol.125.6.615; Hamani C, 2011, BIOL PSYCHIAT, V69, P301, DOI 10.1016/j.biopsych.2010.09.034; Hasselmo ME, 2008, HIPPOCAMPUS, V18, P1213, DOI 10.1002/hipo.20512; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; Irwin J., 1881, LANCET, V118, P907, DOI DOI 10.1016/S0140-6736(02)38129-7; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; JONES E G, 1970, Brain Behavior and Evolution, V93, P793, DOI 10.1093/brain/93.4.793; Kajiwara R, 2003, J NEUROPHYSIOL, V89, P2176, DOI 10.1152/jn.01033.2002; Lowry CA, 2008, ANN NY ACAD SCI, V1148, P86, DOI 10.1196/annals.1410.004; Masdeu JC, 2011, NEUROTHERAPEUTICS, V8, P93, DOI 10.1007/s13311-010-0006-0; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Moeller L, 2007, J NEUROL, V254, P813, DOI 10.1007/s00415-006-0440-4; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pare D, 2002, TRENDS COGN SCI, V6, P306, DOI 10.1016/S1364-6613(02)01924-1; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Reiman EM, 1997, J CLIN PSYCHIAT, V58, P4; ROOM P, 1986, J COMP NEUROL, V251, P451, DOI 10.1002/cne.902510403; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Valenti O, 2009, CEREB CORTEX, V19, P658, DOI 10.1093/cercor/bhn114; VANHOESEN GW, 1972, SCIENCE, V175, P1471, DOI 10.1126/science.175.4029.1471; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	51	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49560	10.1371/journal.pone.0049560	http://dx.doi.org/10.1371/journal.pone.0049560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209584	Green Published, gold			2022-12-25	WOS:000312104900010
J	Pi, HL; Jones, SA; Mercer, LE; Meador, JP; Caughron, JE; Jordan, L; Newton, SM; Conway, T; Klebba, PE				Pi, Hualiang; Jones, Shari A.; Mercer, Lynn E.; Meador, Jessica P.; Caughron, Joyce E.; Jordan, Lorne; Newton, Salete M.; Conway, Tyrrell; Klebba, Phillip E.			Role of Catecholate Siderophores in Gram-Negative Bacterial Colonization of the Mouse Gut	PLOS ONE			English	Article							OUTER-MEMBRANE RECEPTORS; ESCHERICHIA-COLI STRAINS; IRON UPTAKE; SALMONELLA-ENTERICA; TRANSFERRIN-IRON; STAPHYLOCOCCUS-AUREUS; MEDIATED UTILIZATION; FERRIC ENTEROBACTIN; SERUM TRANSFERRIN; LARGE-INTESTINE	We investigated the importance of the production of catecholate siderophores, and the utilization of their iron (III) complexes, to colonization of the mouse intestinal tract by Escherichia coli. First, a Delta tonB strain was completely unable to colonize mice. Next, we compared wild type E. coli MG1655 to its derivatives carrying site-directed mutations of genes for enterobactin synthesis (Delta entA::Cm; strain CAT0), ferric catecholate transport (Delta fiu, Delta fepA, Delta cir, Delta fecA::Cm; CAT4), or both (Delta fiu, Delta fepA, Delta fecA, Delta cir, Delta entA::Cm; CAT40) during colonization of the mouse gut. Competitions between wild type and mutant strains over a 2-week period in vivo showed impairment of all the genetically engineered bacteria relative to MG1655. CAT0, CAT4 and CAT40 colonized mice 10(1)-, 10(5)-, and 10(2)-fold less efficiently, respectively, than MG1655. Unexpectedly, the additional inability of CAT40 to synthesize enterobactin resulted in a 1000-fold better colonization efficiency relative to CAT4. Analyses of gut mucus showed that CAT4 hyperexcreted enterobactin in vivo, effectively rendering the catecholate transport-deficient strain iron-starved. The results demonstrate that, contrary to prior reports, iron acquisition via catecholate siderophores plays a fundamental role in bacterial colonization of the murine intestinal tract.	[Pi, Hualiang; Mercer, Lynn E.; Jordan, Lorne] Univ Oklahoma, Dept Chem & Biochem, Stevenson Life Sci Res Ctr, Norman, OK 73019 USA; [Jones, Shari A.; Meador, Jessica P.; Caughron, Joyce E.; Conway, Tyrrell] Univ Oklahoma, Dept Microbiol & Plant Biol, Stevenson Life Sci Res Ctr, Norman, OK 73019 USA; [Jordan, Lorne; Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Kansas State University	Pi, HL (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Stevenson Life Sci Res Ctr, Norman, OK 73019 USA.	peklebba@ksu.edu			National Institutes of Health [GM53836, GM095370]; National Science Foundation [MCB09522999]; Div Of Molecular and Cellular Bioscience [1316251] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095370, R01GM053836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research reported herein was supported by National Institutes of Health grants GM53836 to PEK and SMN, GM095370 to TC, and National Science Foundation grant MCB09522999 to PEK and SMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISEN P, 1978, J BIOL CHEM, V253, P1930; Bachman MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000622; BEAUMIER DL, 1984, INFECT IMMUN, V46, P489, DOI 10.1128/IAI.46.2.489-494.1984; BENJAMIN WH, 1986, INFECT IMMUN, V51, P872, DOI 10.1128/IAI.51.3.872-878.1986; Bullen J J, 1978, Curr Top Microbiol Immunol, V80, P1; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CORNELISSEN CN, 1992, J BACTERIOL, V174, P5788, DOI 10.1128/jb.174.18.5788-5797.1992; CORNELISSEN CN, 1994, METHOD ENZYMOL, V235, P356; Cornelissen CN, 1998, MOL MICROBIOL, V27, P611, DOI 10.1046/j.1365-2958.1998.00710.x; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; Cowart RE, 2002, ARCH BIOCHEM BIOPHYS, V400, P273, DOI 10.1016/S0003-9861(02)00012-7; COX GB, 1970, J BACTERIOL, V104, P219, DOI 10.1128/JB.104.1.219-226.1970; Crouch MLV, 2008, MOL MICROBIOL, V67, P971, DOI 10.1111/j.1365-2958.2007.06089.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DERVARTANIAN M, 1992, INFECT IMMUN, V60, P2800, DOI 10.1128/IAI.60.7.2800-2807.1992; Dozois CM, 2003, P NATL ACAD SCI USA, V100, P247, DOI 10.1073/pnas.232686799; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hantke K, 2003, P NATL ACAD SCI USA, V100, P3677, DOI 10.1073/pnas.0737682100; HANTKE K, 1990, FEMS MICROBIOL LETT, V67, P5, DOI 10.1111/j.1574-6968.1990.tb13826.x; JALAL MAF, 1989, FEBS LETT, V243, P366, DOI 10.1016/0014-5793(89)80163-2; Jones SA, 2007, INFECT IMMUN, V75, P4891, DOI 10.1128/IAI.00484-07; Jurado RL, 1997, CLIN INFECT DIS, V25, P888, DOI 10.1086/515549; KAMMLER M, 1993, J BACTERIOL, V175, P6212, DOI 10.1128/JB.175.19.6212-6219.1993; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; KOCHAN I, 1977, J INFECT DIS, V135, P623, DOI 10.1093/infdis/135.4.623; KONOPKA K, 1982, BIOCHEMISTRY-US, V21, P6503, DOI 10.1021/bi00268a028; KONOPKA K, 1984, BIOCHEMISTRY-US, V23, P2122, DOI 10.1021/bi00305a003; KRETCHMAR SA, 1988, BIOCHIM BIOPHYS ACTA, V956, P85, DOI 10.1016/0167-4838(88)90301-9; Leatham MP, 2009, INFECT IMMUN, V77, P2876, DOI 10.1128/IAI.00059-09; LODGE JS, 1984, J BACTERIOL, V160, P801, DOI 10.1128/JB.160.2.801-804.1984; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; MARTIN RB, 1987, CLIN CHEM, V33, P405; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; MAZURIER J, 1980, BIOCHIM BIOPHYS ACTA, V629, P399, DOI 10.1016/0304-4165(80)90112-9; Moller AK, 2003, INFECT IMMUN, V71, P2142, DOI 10.1128/IAI.71.4.2142-2152.2003; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; NIKAIDO H, 1990, J BACTERIOL, V172, P1361, DOI 10.1128/jb.172.3.1361-1367.1990; Palmer K, 1997, OCCUP ENVIRON MED, V54, P529, DOI 10.1136/oem.54.8.529; QUE JU, 1985, INFECT IMMUN, V48, P169, DOI 10.1128/IAI.48.1.169-174.1985; Reniere ML, 2007, BIOMETALS, V20, P333, DOI 10.1007/s10534-006-9032-0; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; SEIFFERT A, 1993, BIOTECHNOL BIOENG, V41, P237, DOI 10.1002/bit.260410210; Stojiljkovic I, 1996, J BACTERIOL, V178, P4670, DOI 10.1128/jb.178.15.4670-4678.1996; STOJILJKOVIC I, 1993, FEMS MICROBIOL LETT, V108, P111; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; STOJILJKOVIC I, 1991, FEMS MICROBIOL LETT, V90, P89, DOI 10.1016/0378-1097(91)90652-Q; TIDMARSH GF, 1983, J INORG BIOCHEM, V18, P161, DOI 10.1016/0162-0134(83)80019-1; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; WANG CC, 1971, J BIOL CHEM, V246, P2147; WAYNE R, 1975, J BACTERIOL, V121, P497, DOI 10.1128/JB.121.2.497-503.1975; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Wilks A, 2007, NAT PROD REP, V24, P511, DOI 10.1039/b604193k; Williams PH, 2006, VACCINE, V24, P3840, DOI 10.1016/j.vaccine.2005.07.020; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x; Young I G, 1979, Methods Enzymol, V56, P394; YOUNG IG, 1976, PREP BIOCHEM, V6, P123, DOI 10.1080/00327487608061607	61	31	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50020	10.1371/journal.pone.0050020	http://dx.doi.org/10.1371/journal.pone.0050020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209633	Green Published, gold			2022-12-25	WOS:000312104900017
J	Ashtekar, AR; Katz, J; Xu, QA; Michalek, SM				Ashtekar, Amit R.; Katz, Jannet; Xu, Qingan; Michalek, Suzanne M.			A Mucosal Subunit Vaccine Protects against Lethal Respiratory Infection with Francisella tularensis LVS	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ANTIBODY-MEDIATED PROTECTION; OUTER-MEMBRANE PROTEINS; INNATE IMMUNE-RESPONSE; VIRULENT TYPE-A; GAMMA-INTERFERON; ADAPTIVE IMMUNITY; INTRACELLULAR BACTERIUM; INFLAMMATORY RESPONSES; INTRANASAL VACCINATION	Francisella tularensis (FT) is a highly virulent pathogen for humans and other mammals. Severe morbidity and mortality is associated with respiratory FT infection and there are concerns about intentional dissemination of this organism. Therefore, FT has been designated a category A biothreat agent and there is a growing interest in the development of a protective vaccine. In the present study, we determine the protective potential of a subunit vaccine comprised of the FT heat shock protein DnaK and surface lipoprotein Tul4 against respiratory infection with the live vaccine strain (LVS) of FT in mice. First, we establish an optimal intranasal immunization regimen in C57BL/6 mice using recombinant DnaK or Tul4 together with the adjuvant GPI-0100. The individual immunization regimens induced robust salivary IgA, and vaginal and bronchoalveolar IgA and IgG antigen-specific antibodies. Serum IgG1 and IgG2c antibody responses were also induced, indicative of a mixed type 2 and type 1 response, respectively. Next, we show that immunization with DnaK and Tul4 induces mucosal and systemic antibody responses that are comparable to that seen following immunization with each antigen alone. This immunization regimen also induced IFN-gamma, IL-10 and IL-17A production by splenic CD4(+) T cells in an antigen-specific manner. Importantly, over 80% of the mice immunized with DnaK and Tul4, but not with each antigen alone, were protected against a lethal respiratory challenge with FT LVS. Protection correlated with reduced bacterial burden in the lung, liver and spleen of mice. This study demonstrates the potential of DnaK and Tul4 as protective antigens and lends support to the notion of combining distinct, immunodominant antigens into an effective multivalent tularemia vaccine.	[Ashtekar, Amit R.; Michalek, Suzanne M.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Katz, Jannet; Xu, Qingan] Univ Alabama Birmingham, Dept Pediat Dent, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Michalek, SM (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	suemich@uab.edu	Ashtekar, Amit R/AAD-4365-2020		United States Public Health Service grant [AI-56460]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI056460] Funding Source: NIH RePORTER	United States Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the United States Public Health Service grant AI-56460 (to SMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Ashtekar AR, 2008, J LEUKOCYTE BIOL, V84, P1434, DOI 10.1189/jlb.0308215; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; BLANDER SJ, 1993, J CLIN INVEST, V91, P717, DOI 10.1172/JCI116253; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; Cole LE, 2011, J LEUKOCYTE BIOL, V90, P787, DOI 10.1189/jlb.0111014; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Conlan J.W., 2011, CURR PROTOC IMMUNOL, V93, P19141; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Cox JC, 1997, VACCINE, V15, P248, DOI 10.1016/S0264-410X(96)00183-1; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Elkins KL, 1999, J IMMUNOL, V162, P2291; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Elkins KL, 1996, INFECT IMMUN, V64, P3288, DOI 10.1128/IAI.64.8.3288-3293.1996; Ericsson M, 2001, SCAND J INFECT DIS, V33, P145, DOI 10.1080/003655401750065562; ERICSSON M, 1994, INFECT IMMUN, V62, P178, DOI 10.1128/IAI.62.1.178-183.1994; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Forestal CA, 2008, MICROB PATHOGENESIS, V44, P512, DOI 10.1016/j.micpath.2008.01.003; FULOP M, 1995, VACCINE, V13, P1220, DOI 10.1016/0264-410X(95)00062-6; Fulop M, 2001, VACCINE, V19, P4465, DOI 10.1016/S0264-410X(01)00189-X; GREEN SJ, 1993, INFECT IMMUN, V61, P689, DOI 10.1128/IAI.61.2.689-698.1993; Gursky Elin, 2003, Biosecur Bioterror, V1, P97, DOI 10.1089/153871303766275763; Hartley MG, 2004, INFECT IMMUN, V72, P4109, DOI 10.1128/IAI.72.7.4109-4113.2004; Hazlett KRO, 2008, INFECT IMMUN, V76, P4479, DOI 10.1128/IAI.00610-08; Hickey AJ, 2011, VACCINE, V29, P6941, DOI 10.1016/j.vaccine.2011.07.075; Huntley JF, 2008, INFECT IMMUN, V76, P3664, DOI 10.1128/IAI.00374-08; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kaur R, 2012, CLIN VACCINE IMMUNOL, V19, P359, DOI 10.1128/CVI.05384-11; Kirimanjeswara GS, 2007, J IMMUNOL, V179, P532, DOI 10.4049/jimmunol.179.1.532; Lee BY, 2006, INFECT IMMUN, V74, P4002, DOI 10.1128/IAI.00257-06; Lehner T, 2000, EUR J IMMUNOL, V30, P594, DOI 10.1002/1521-4141(200002)30:2<594::AID-IMMU594>3.3.CO;2-T; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Marciani DJ, 2003, DRUG DISCOV TODAY, V8, P934, DOI 10.1016/S1359-6446(03)02864-2; Marciani DJ, 2003, VACCINE, V21, P3961, DOI 10.1016/S0264-410X(03)00298-6; Matyas BI, 2007, ANN NY ACAD SCI, V1105, P351, DOI 10.1196/annals.1409.013; McGhee J.R.C., 1999, MUCOSAL IMMUNOL, Vsecond, P741; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; Metzger DW, 2007, ANN NY ACAD SCI, V1105, P266, DOI 10.1196/annals.1409.007; Miller MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031359; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Newman MJ, 2000, EXPERT OPIN THER PAT, V10, P1; Ojeda SS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-215; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; Pammit MA, 2006, INFECT IMMUN, V74, P2063, DOI 10.1128/IAI.74.4.2063-2071.2006; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Pyles RB, 2010, INFECT IMMUN, V78, P1700, DOI 10.1128/IAI.00736-09; Rawool DB, 2008, J IMMUNOL, V180, P5548, DOI 10.4049/jimmunol.180.8.5548; Ray HJ, 2009, CLIN VACCINE IMMUNOL, V16, P444, DOI 10.1128/CVI.00405-08; Sebastian S, 2009, VACCINE, V27, P597, DOI 10.1016/j.vaccine.2008.10.079; Sharma J, 2009, INFECT IMMUN, V77, P4314, DOI 10.1128/IAI.00654-09; SJOSTEDT A, 1992, INFECT IMMUN, V60, P2855; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200; Twine SM, 2006, BIOCHEM BIOPH RES CO, V345, P1621, DOI 10.1016/j.bbrc.2006.05.070; Valentino MD, 2011, IMMUNOLOGY, V132, P348, DOI 10.1111/j.1365-2567.2010.03387.x; Valentino MD, 2009, MOL IMMUNOL, V46, P1830, DOI 10.1016/j.molimm.2009.01.008; WILSON KH, 1990, J CLIN MICROBIOL, V28, P1942, DOI 10.1128/JCM.28.9.1942-1946.1990; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Zhang P, 2003, VACCINE, V21, P4459, DOI 10.1016/S0264-410X(03)00438-9; Zhu QS, 2006, BLOOD, V107, P1847, DOI 10.1182/blood-2005-04-1612; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	72	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50460	10.1371/journal.pone.0050460	http://dx.doi.org/10.1371/journal.pone.0050460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209745	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700072
J	Lu, Q; Delproposto, Z; Hu, A; Tran, C; Liu, NF; Li, YL; Xu, JR; Bui, D; Hu, JN				Lu, Qing; Delproposto, Zachary; Hu, Alice; Tran, Christine; Liu, Ningfei; Li, Yulai; Xu, Jianrong; Bui, Duy; Hu, Jiani			MR Lymphography of Lymphatic Vessels in Lower Extremity with Gynecologic Oncology-Related Lymphedema	PLOS ONE			English	Article							MAGNETIC-RESONANCE LYMPHANGIOGRAPHY; LOWER-LIMB LYMPHEDEMA; INITIAL-EXPERIENCE; BYPASS-SURGERY; LYMPHOSCINTIGRAPHY; COMPLICATIONS; DISSECTION; DRAINAGE; HUMANS; EDEMA	Objective: To characterize lymphatic vessel morphology in lower extremity lymphedema using MR lymphography at 3T. Study Design: Forty females with lower extremity lymphedema secondary to gynecologic carcinoma treatment underwent MR lymphography (MRL) at 3T. Lymphatic vessel morphology in normal and affected limbs was compared. Results: The median diameter of the lymphatic vessels in swollen calf and thigh were significantly larger than that in the contralateral calf and thigh, respectively (p<0.05). The median number of lymphatic vessels visualized in normal calf was less than that in the lymphedematous calf (p<0.01), while no significant difference was found between the normal thigh and swollen thigh. Lymphatic vessel number in the affected calf was significantly greater than that in affected thigh and the mean diameter of affected calf was also significantly wider than that of affected thigh (p<0.01). Mean diameter of lymphatic vessels in the affected calf was significantly different between stage I and stage III (p<0.05), but not significantly different between stages I and II, and between stages II and III (p>0.05). The median number of lymphatic vessels for affected calf showed significant difference between stage I and stage III, and between stage II and stage III (p<0.05), but no significant difference between stage I and stage II (p>0.05). There was no significant difference in mean diameter or median number of lymphatic vessels in the affected thigh found between different stages (p>0.05). Conclusion: There are significant differences in the number or diameter of lymphatic vessels between normal and affected limbs and there are significant differences for affected calf between early and late stages of lymphedema; therefore, MR lymphography can be helpful in diagnosis or clinical staging for lower extremity with gynecologic oncology-related lymphedema.	[Lu, Qing; Li, Yulai; Xu, Jianrong] Shanghai Jiao Tong Univ, Dept Radiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Delproposto, Zachary] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Hu, Alice] Michigan State Univ, Dept Nat Sci, E Lansing, MI 48824 USA; [Tran, Christine] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Newark, NJ 07103 USA; [Liu, Ningfei] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Bui, Duy; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA	Shanghai Jiao Tong University; Henry Ford Health System; Henry Ford Hospital; Michigan State University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Shanghai Jiao Tong University; Wayne State University	Xu, JR (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China.	xujian_renji@163.com; jhu@med.wayne.edu			National Natural Science Foundation of China [81271638, 30970819]; National Basic Research Program of China (973 Program) [2012CB932600]; Shanghai Leading Academic Discipline Project [S30203]; Doctor Innovation Fund from Shanghai Jiaotong University School of Medicine [BXJ201118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Doctor Innovation Fund from Shanghai Jiaotong University School of Medicine	This work was supported by National Natural Science Foundation of China (81271638, 30970819); National Basic Research Program of China (973 Program, 2012CB932600); Shanghai Leading Academic Discipline Project (S30203); and the Doctor Innovation Fund (BXJ201118)) from Shanghai Jiaotong University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beesley V, 2007, CANCER, V109, P2607, DOI 10.1002/cncr.22684; Boccardo F, 2012, UPDATES SURG-ITALY, V64, P211, DOI 10.1007/s13304-012-0165-0; Campisi C, 2010, MICROSURG, V30, P256, DOI 10.1002/micr.20737; Francesco B, 2010, MICROSURG, V30, P261, DOI 10.1002/micr.20735; HAAVERSTAD R, 1995, EUR J VASC ENDOVASC, V10, P316, DOI 10.1016/S1078-5884(05)80049-8; Hoffmann JN, 2004, PLAST RECONSTR SURG, V113, P718, DOI 10.1097/01.PRS.0000101506.84361.C9; Karakousis CP, 2006, J SURG ONCOL, V93, P87, DOI 10.1002/jso.20349; KARAKOUSIS CP, 1994, ANN SURG ONCOL, V1, P271, DOI 10.1007/BF02303564; Kashima K, 2010, J OBSTET GYNAECOL RE, V36, P555, DOI 10.1111/j.1447-0756.2010.01174.x; Kerchner K, 2008, J AM ACAD DERMATOL, V59, P324, DOI 10.1016/j.jaad.2008.04.013; Koshima I, 2003, J RECONSTR MICROSURG, V19, P209; Koshima I, 2003, CLIN PLAST SURG, V30, P447, DOI 10.1016/S0094-1298(03)00044-0; Liu NF, 2010, BRIT J SURG, V97, P359, DOI 10.1002/bjs.6893; Liu NF, 2009, J VASC SURG, V49, P980, DOI 10.1016/j.jvs.2008.11.029; Lockwood-Rayermann Suzy, 2007, Cancer Nurs, V30, pE11, DOI 10.1097/01.NCC.0000281734.48479.33; Lohrmann C, 2007, BRIT J RADIOL, V80, P569, DOI 10.1259/bjr/95414884; Lohrmann C, 2008, MICROVASC RES, V76, P42, DOI 10.1016/j.mvr.2008.03.003; Lohrmann C, 2007, ACTA TROP, V104, P8, DOI 10.1016/j.actatropica.2007.07.001; Lohrmann C, 2006, EUR J RADIOL, V59, P401, DOI 10.1016/j.ejrad.2006.02.012; Lohrmann C, 2009, J VASC SURG, V49, P417, DOI 10.1016/j.jvs.2008.08.069; Lu Q, 2010, EUR J RADIOL, V73, P365, DOI 10.1016/j.ejrad.2008.10.041; Mortimer PS, 1995, INT ANGIOL, V14, P32; Murdaca G, 2012, AM J MED, V125, P134, DOI 10.1016/j.amjmed.2011.06.032; Nagase Takashi, 2005, Int J Clin Oncol, V10, P304, DOI 10.1007/s10147-005-0518-5; Piller N, 2009, LYMPHOLOGY, V42, P146; PIZAKATZER H, 1992, VASA-J VASCULAR DIS, V21, P85; Ruehm SG, 2001, RADIOLOGY, V218, P664, DOI 10.1148/radiology.218.3.r01fe21664; Ruehm SG, 2001, RADIOLOGY, V220, P816, DOI 10.1148/radiol.2203010090; Sharma R, 2008, ANN NY ACAD SCI, V1131, P13, DOI 10.1196/annals.1413.002; Shermak MA, 2005, PLAST RECONSTR SURG, V115, P1954, DOI 10.1097/01.PRS.0000165069.15384.E5; Szuba A, 1998, Vasc Med, V3, P145, DOI 10.1177/1358836X9800300209; Tada H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-47; Tiwari A, 2003, ARCH SURG-CHICAGO, V138, P152, DOI 10.1001/archsurg.138.2.152; Todo Y, 2010, GYNECOL ONCOL, V119, P60, DOI 10.1016/j.ygyno.2010.06.018; WEISSLEDER H, 1988, RADIOLOGY, V167, P729, DOI 10.1148/radiology.167.3.3363131; Williams WH, 2000, CLIN NUCL MED, V25, P451, DOI 10.1097/00003072-200006000-00013	36	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50319	10.1371/journal.pone.0050319	http://dx.doi.org/10.1371/journal.pone.0050319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209708	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700057
J	Saito, Y; Suzuki, H; Tsugawa, H; Imaeda, H; Matsuzaki, J; Hirata, K; Hosoe, N; Nakamura, M; Mukai, M; Saito, H; Hibi, T				Saito, Yoshimasa; Suzuki, Hidekazu; Tsugawa, Hitoshi; Imaeda, Hiroyuki; Matsuzaki, Juntaro; Hirata, Kenro; Hosoe, Naoki; Nakamura, Masahiko; Mukai, Makio; Saito, Hidetsugu; Hibi, Toshifumi			Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Resistant to Helicobacter pylori Eradication	PLOS ONE			English	Article							HUMAN CANCER-CELLS; MICRORNA EXPRESSION; DOWN-REGULATION; GENE; ACTIVATION; REGRESSION; PROGNOSIS; PROFILES; T(11/18); JAPAN	microRNAs (miRNAs) are small non-coding RNAs that can function as endogenous silencers of target genes and play critical roles in human malignancies. To investigate the molecular pathogenesis of gastric mucosa-associated lymphoid tissue (MALT) lymphoma, the miRNA expression profile was analyzed. miRNA microarray analysis with tissue specimens from gastric MALT lymphomas and surrounding non-tumor mucosae revealed that a hematopoietic-specific miRNA miR-142 and an oncogenic miRNA miR-155 were overexpressed in MALT lymphoma lesions. The expression levels of miR-142-5p and miR-155 were significantly increased in MALT lymphomas which do not respond to Helicobacter pylori (H. pylori) eradication. The expression levels of miR-142-5p and miR-155 were associated with the clinical courses of gastric MALT lymphoma cases. Overexpression of miR-142-5p and miR-155 was also observed in Helicobacter heilmannii-infected C57BL/6 mice, an animal model of gastric MALT lymphoma. In addition, miR-142-5p and miR-155 suppress the proapoptotic gene TP53INP1 as their target. The results of this study indicate that overexpression of miR-142-5p and miR-155 plays a critical role in the pathogenesis of gastric MALT lymphoma. These miRNAs might have potential application as therapeutic targets and novel biomarkers for gastric MALT lymphoma.	[Saito, Yoshimasa; Suzuki, Hidekazu; Tsugawa, Hitoshi; Imaeda, Hiroyuki; Matsuzaki, Juntaro; Hirata, Kenro; Hosoe, Naoki; Saito, Hidetsugu; Hibi, Toshifumi] Dept Internal Med, Div Gastroenterol & Hepatol, Shinjuku Ku, Tokyo, Japan; [Mukai, Makio] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 160, Japan; [Nakamura, Masahiko] Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 108, Japan; [Saito, Yoshimasa; Saito, Hidetsugu] Keio Univ, Fac Pharm, Div Pharmacotherapeut, Tokyo, Japan	Keio University; Kitasato University; Keio University	Suzuki, H (corresponding author), Dept Internal Med, Div Gastroenterol & Hepatol, Shinjuku Ku, Tokyo, Japan.	hsuzuki@a6.keio.jp	SUZUKI, HIDEKAZU/S-9376-2019; Suzuki, Hidekazu/J-4396-2013; Tsugawa, Hitoshi/J-4941-2013; Tsugawa, Hitoshi/V-9589-2019; Suzuki, Hidekazu/AAO-6330-2020; Matsuzaki, Juntaro/S-4107-2019	Tsugawa, Hitoshi/0000-0002-4344-4475; Tsugawa, Hitoshi/0000-0002-4344-4475; Suzuki, Hidekazu/0000-0002-8994-6163; Matsuzaki, Juntaro/0000-0002-3204-5049	Japan Society for Promotion of Science [22300169, 23680090]; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Smoking Research Foundation; Keio Gijuku Academic Development Funds	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sagawa Foundation for Promotion of Cancer Research; Smoking Research Foundation; Keio Gijuku Academic Development Funds	This work was supported by Grant-in-Aid for Young Scientists A (23680090 to Y.S.) and Grant-in-Aid for Scientific Research B (22300169 to H.S.) from Japan Society for Promotion of Science (www.jsps.go.jp), Takeda Science Foundation (www.takeda-sci.or.jp; to Y.S.), Sagawa Foundation for Promotion of Cancer Research (sagawa-gan.or.jp; to Y.S.), Smoking Research Foundation (www.srf.or.jp; to H.S.), and Keio Gijuku Academic Development Funds (www.keio.ac.jp; to Y.S. and H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 1999, ONCOGENE, V18, P5785, DOI 10.1038/sj.onc.1203018; Akamatsu T, 2006, HELICOBACTER, V11, P86, DOI 10.1111/j.1523-5378.2006.00382.x; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Fang C, 2012, ANN HEMATOL, V91, P553, DOI 10.1007/s00277-011-1350-9; Farinha P, 2005, J CLIN ONCOL, V23, P6370, DOI 10.1200/JCO.2005.05.011; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hosokawa Y, 2004, CANCER RES, V64, P3452, DOI 10.1158/0008-5472.CAN-03-3677; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Liu HX, 2002, GASTROENTEROLOGY, V122, P1286, DOI 10.1053/gast.2002.33047; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Motegi M, 2000, AM J PATHOL, V156, P807, DOI 10.1016/S0002-9440(10)64948-6; Nakamura M, 2007, INFECT IMMUN, V75, P1214, DOI 10.1128/IAI.01459-06; Nakamura S, 2012, GUT, V61, P507, DOI 10.1136/gutjnl-2011-300495; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Ruskone-Fourmestraux A, 2001, GUT, V48, P297, DOI 10.1136/gut.48.3.297; Sackmann M, 1997, GASTROENTEROLOGY, V113, P1087, DOI 10.1053/gast.1997.v113.pm9322502; Saito Y, 2009, ONCOGENE, V28, P2738, DOI 10.1038/onc.2009.140; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Saito Y, 2009, BIOCHEM BIOPH RES CO, V379, P726, DOI 10.1016/j.bbrc.2008.12.098; Saito Y, 2009, J GASTROENTEROL, V44, P18, DOI 10.1007/s00535-008-2285-3; Suzuki H, 2007, J GASTROENTEROL, V42, P1, DOI 10.1007/s00535-006-1990-z; Tomasini R, 2005, ONCOGENE, V24, P8093, DOI 10.1038/sj.onc.1208951; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	35	86	89	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e47396	10.1371/journal.pone.0047396	http://dx.doi.org/10.1371/journal.pone.0047396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209550	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700001
J	Sarntivijai, S; Xiang, ZS; Shedden, KA; Markel, H; Omenn, GS; Athey, BD; He, YQ				Sarntivijai, Sirarat; Xiang, Zuoshuang; Shedden, Kerby A.; Markel, Howard; Omenn, Gilbert S.; Athey, Brian D.; He, Yongqun			Ontology-Based Combinatorial Comparative Analysis of Adverse Events Associated with Killed and Live Influenza Vaccines	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; REPORTING-SYSTEM VAERS; UNITED-STATES; SIGNAL GENERATION; CASE-SERIES; VACCINATION; H1N1; SAFETY; CHILDHOOD; MORTALITY	Vaccine adverse events (VAEs) are adverse bodily changes occurring after vaccination. Understanding the adverse event (AE) profiles is a crucial step to identify serious AEs. Two different types of seasonal influenza vaccines have been used on the market: trivalent (killed) inactivated influenza vaccine (TIV) and trivalent live attenuated influenza vaccine (LAIV). Different adverse event profiles induced by these two groups of seasonal influenza vaccines were studied based on the data drawn from the CDC Vaccine Adverse Event Report System (VAERS). Extracted from VAERS were 37,621 AE reports for four TIVs (Afluria, Fluarix, Fluvirin, and Fluzone) and 3,707 AE reports for the only LAIV (FluMist). The AE report data were analyzed by a novel combinatorial, ontology-based detection of AE method (CODAE). CODAE detects AEs using Proportional Reporting Ratio (PRR), Chi-square significance test, and base level filtration, and groups identified AEs by ontology-based hierarchical classification. In total, 48 TIV-enriched and 68 LAIV-enriched AEs were identified (PRR>2, Chi-square score >4, and the number of cases >0.2% of total reports). These AE terms were classified using the Ontology of Adverse Events (OAE), MedDRA, and SNOMED-CT. The OAE method provided better classification results than the two other methods. Thirteen out of 48 TIV-enriched AEs were related to neurological and muscular processing such as paralysis, movement disorders, and muscular weakness. In contrast, 15 out of 68 LAIV-enriched AEs were associated with inflammatory response and respiratory system disorders. There were evidences of two severe adverse events (Guillain-Barre Syndrome and paralysis) present in TIV. Although these severe adverse events were at low incidence rate, they were found to be more significantly enriched in TIV-vaccinated patients than LAIV-vaccinated patients. Therefore, our novel combinatorial bioinformatics analysis discovered that LAIV had lower chance of inducing these two severe adverse events than TIV. In addition, our meta-analysis found that all previously reported positive correlation between GBS and influenza vaccine immunization were based on trivalent influenza vaccines instead of monovalent influenza vaccines.	[Sarntivijai, Sirarat; Omenn, Gilbert S.; Athey, Brian D.; He, Yongqun] Univ Michigan, Natl Ctr Integrat Biomed Informat, Ann Arbor, MI 48109 USA; [Sarntivijai, Sirarat; Omenn, Gilbert S.; Athey, Brian D.; He, Yongqun] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Xiang, Zuoshuang; He, Yongqun] Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI USA; [Xiang, Zuoshuang; He, Yongqun] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Shedden, Kerby A.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Markel, Howard] Univ Michigan, Ctr Hist Med, Ann Arbor, MI 48109 USA; [Markel, Howard] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Athey, Brian D.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Athey, BD (corresponding author), Univ Michigan, Natl Ctr Integrat Biomed Informat, Ann Arbor, MI 48109 USA.	bleu@umich.edu; yongqunh@umich.edu		Athey, Brian/0000-0002-9793-535X; He, Yongqun/0000-0001-9189-9661; Omenn, Gilbert S./0000-0002-8976-6074; Sarntivijai, Sirarat/0000-0002-2548-641X	National Institutes of Health (NIH) for the National Center for Integrative Biomedical Informatics [U54 DA021519]; NIH National Institute of Allergy and Infectious Diseases (NIAID) [R01AI081062]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	National Institutes of Health (NIH) for the National Center for Integrative Biomedical Informatics; NIH National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (NIH) grant U54 DA021519 for the National Center for Integrative Biomedical Informatics and NIH National Institute of Allergy and Infectious Diseases (NIAID) grant R01AI081062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2011, VACCINE, V29, P7878, DOI 10.1016/j.vaccine.2011.08.069; Banks D, 2005, PHARMACOEPIDEM DR S, V14, P601, DOI 10.1002/pds.1107; Bate A, 1998, EUR J CLIN PHARMACOL, V54, P315, DOI 10.1007/s002280050466; Baxter R, 2012, RECURRENT GUILLAIN B; Botsis T, 2011, STUD HEALTH TECHNOL, V169, P564, DOI 10.3233/978-1-60750-806-9-564; Botsis T, 2011, J AM MED INFORM ASSN, V18, P631, DOI 10.1136/amiajnl-2010-000022; Brown EG, 2003, DRUG SAFETY, V26, P145, DOI 10.2165/00002018-200326030-00002; Burwen DR, 2010, AM J PREV MED, V39, P296, DOI 10.1016/j.amepre.2010.05.022; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Choe YJ, 2011, VACCINE, V29, P7727, DOI 10.1016/j.vaccine.2011.07.129; Die-Kacou H, 2009, Bull Soc Pathol Exot, V102, P21, DOI 10.3185/pathexo3182; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; DuMouchel W., 1999, AM STAT, V53; Egberts ACG, 2002, DRUG SAFETY, V25, P453, DOI 10.2165/00002018-200225060-00010; Evans D, 2009, J INFECT DIS, V200, P321, DOI 10.1086/603560; Evans SJW, 2001, PHARMACOEPIDEM DR S, V10, P483, DOI 10.1002/pds.677; Geier DA, 2006, NEUROENDOCRINOL LETT, V27, P401; Geier MR, 2004, CLIN EXP RHEUMATOL, V22, P749; Geier MR, 2003, CLIN IMMUNOL, V107, P116, DOI 10.1016/S1521-6616(03)00046-9; Haber P, 2007, VACCINE, V25, P8101, DOI 10.1016/j.vaccine.2007.09.029; Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005; HARDELL L, 1991, AM J IND MED, V19, P547, DOI 10.1002/ajim.4700190412; He Y., 2011, ADV EV REPR WORKSH I, P309; Heeley E, 2005, DRUG SAFETY, V28, P901, DOI 10.2165/00002018-200528100-00006; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Izurieta HS, 2005, JAMA-J AM MED ASSOC, V294, P2720, DOI 10.1001/jama.294.21.2720; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; Kao CD, 2004, CLIN NEUROL NEUROSUR, V106, P136, DOI 10.1016/j.clineuro.2003.11.002; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Lee GM, 2011, AM J PREV MED, V41, P121, DOI 10.1016/j.amepre.2011.04.004; Lee SJ, 2012, PEDIAT INT; Lee SJ, 2012, PEDIAT INT OFFICIAL; Liang XF, 2011, NEW ENGL J MED, V364, P638, DOI 10.1056/NEJMoa1008553; Maquet D, 2010, JOINT BONE SPINE, V77, P264, DOI 10.1016/j.jbspin.2010.02.003; McNeil MM, 2012, VACCINE; Moro PL, 2012, POSTLICENSURE SAFETY; Netto AB, 2011, ANN INDIAN ACAD NEUR, V14, P262, DOI 10.4103/0972-2327.91942; Niu MT, 2009, VACCINE, V27, P290, DOI 10.1016/j.vaccine.2008.10.044; Ozkan M, 2011, PEDIATR NEUROL, V45, P72, DOI 10.1016/j.pediatrneurol.2011.02.010; Saunders NR, 1999, CLIN EXP PHARMACOL P, V26, P11, DOI 10.1046/j.1440-1681.1999.02986.x; Sejvar James J, 2011, Curr Infect Dis Rep, V13, P387, DOI 10.1007/s11908-011-0194-8; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Souayah N, 2007, VACCINE, V25, P5253, DOI 10.1016/j.vaccine.2007.03.053; Souayah Nizar, 2009, J Clin Neuromuscul Dis, V11, P1, DOI 10.1097/CND.0b013e3181aaa968; Talukder R K, 2011, Mymensingh Med J, V20, P748; Varricchio F, 2004, PEDIATR INFECT DIS J, V23, P287, DOI 10.1097/00006454-200404000-00002; Vellozzi C, 2010, VACCINE, V28, P7248, DOI 10.1016/j.vaccine.2010.09.021; Vellozzi C, 2009, VACCINE, V27, P2114, DOI 10.1016/j.vaccine.2009.01.125; Verity C, 2011, LANCET, V378, P1545, DOI 10.1016/S0140-6736(11)61665-6; Williams SE, 2011, VACCINE, V29, P8302, DOI 10.1016/j.vaccine.2011.08.093; Woo EJ, 2008, DRUG SAFETY, V31, P667, DOI 10.2165/00002018-200831080-00003; Xiang Zuoshuang, 2010, BMC Res Notes, V3, P175, DOI 10.1186/1756-0500-3-175; Yikilmaz A, 2010, CHILD NERV SYST, V26, P1103, DOI 10.1007/s00381-010-1197-8	53	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49941	10.1371/journal.pone.0049941	http://dx.doi.org/10.1371/journal.pone.0049941			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209624	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700028
J	Vera-Escalona, I; D'Elia, G; Gouin, N; Fontanella, FM; Munoz-Mendoza, C; Sites, JW; Victoriano, PF				Vera-Escalona, Ivan; D'Elia, Guillermo; Gouin, Nicolas; Fontanella, Frank M.; Munoz-Mendoza, Carla; Sites, Jack W., Jr.; Victoriano, Pedro F.			Lizards on Ice: Evidence for Multiple Refugia in Liolaemus pictus (Liolaemidae) during the Last Glacial Maximum in the Southern Andean Beech Forests	PLOS ONE			English	Article							PLEISTOCENE REFUGIA; POPULATION-GENETICS; GROUP SQUAMATA; CLIMATE-CHANGE; HAPLOTYPE RECONSTRUCTION; SOFTWARE PACKAGE; GENUS LIOLAEMUS; COASTAL RANGE; PHYLOGEOGRAPHY; HISTORY	Historical climate changes and orogenesis are two important factors that have shaped intraspecific biodiversity patterns worldwide. Although southern South America has experienced such complex events, there is a paucity of studies examining the effects on intraspecific diversification in this part of the world. Liolaemus pictus is the southernmost distributed lizard in the Chilean temperate forest, whose genetic structure has likely been influenced by Pleistocene glaciations. We conducted a phylogeographic study of L. pictus in Chile and Argentina based on one mitochondrial and two nuclear genes recovering two strongly divergent groups, Northern and Southern clades. The first group is distributed from the northernmost limit of the species to the Araucania region while the second group is distributed throughout the Andes and the Chiloe archipelago in Southern Chile. Our results suggest that L. pictus originated 751 Kya, with divergence between the two clades occurring in the late Pleistocene. Demographic reconstructions for the Northern and Southern clades indicate a decrease in effective population sizes likely associated with Pleistocene glaciations. Surprisingly, patterns of genetic variation, clades age and historical gene flow in populations distributed within the limits of the Last Glacial Maximum (LGM) are not explained by recent colonization. We propose an "intra-Andean multiple refuge" hypothesis, along with the classical refuge hypothesis previously proposed for the biota of the Chilean Coastal range and Eastern Andean Cordillera. Our hypothesis is supported by niche modelling analysis suggesting the persistence of fragments of suitable habitat for the species within the limits of the LGM ice shield. This type of refuge hypothesis is proposed for the first time for an ectothermic species.	[Vera-Escalona, Ivan; Munoz-Mendoza, Carla; Victoriano, Pedro F.] Univ Concepcion, Fac Ciencias Nat & Oceanograf, Dept Zool, Concepcion, Chile; [D'Elia, Guillermo] Univ Austral Chile, Inst Ciencias Ambientales & Evolutivas, Valdivia, Chile; [Gouin, Nicolas] Univ Catolica Norte, Fac Ciencias Mar, Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile; [Fontanella, Frank M.; Sites, Jack W., Jr.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Fontanella, Frank M.; Sites, Jack W., Jr.] Brigham Young Univ, Bean Life Sci Museum, Provo, UT 84602 USA; [Victoriano, Pedro F.] CIEP, Coihaique, Chile	Universidad de Concepcion; Universidad Austral de Chile; Universidad Catolica del Norte; Brigham Young University; Brigham Young University	Victoriano, PF (corresponding author), Univ Concepcion, Fac Ciencias Nat & Oceanograf, Dept Zool, Concepcion, Chile.	pvictori@gmail.cl	D'Elía, Guillermo/AAE-8873-2020; Vera-Escalona, Iván/G-9242-2019; Vera-Escalona, Ivan/A-2608-2015; D'Elía, Guillermo/G-2253-2011	D'Elía, Guillermo/0000-0001-7173-2709; Vera-Escalona, Iván/0000-0002-2452-6694; Vera-Escalona, Ivan/0000-0002-2452-6694; D'Elía, Guillermo/0000-0001-7173-2709; Gouin, Nicolas/0000-0002-7111-2582	FONDECYT [1120872]; DIUC Semilla [2009 016-SP UdeC, 205.113.067-1SP UdeC]; NSF [OISE 0530267]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DIUC Semilla; NSF(National Science Foundation (NSF))	This work was financed by FONDECYT 1120872, DIUC Semilla 2009 016-SP UdeC, DIUC Semilla 205.113.067-1SP UdeC, and NSF-OISE 0530267. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino AM, 2008, AMEGHINIANA, V45, P775; Albino AM, 2005, J VERTEBR PALEONTOL, V25, P185, DOI 10.1671/0272-4634(2005)025[0185:ALQLAF]2.0.CO;2; Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Amigo J, 1998, PLANT ECOL, V136, P9, DOI 10.1023/A:1009714201917; Avila LJ, 2006, BIOL J LINN SOC, V89, P241, DOI 10.1111/j.1095-8312.2006.00666.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Bell RC, 2010, MOL ECOL, V19, P2531, DOI 10.1111/j.1365-294X.2010.04676.x; BERNINGER O, 1929, GEOGRAPHISCHE ABHAND, V3, P1; Cabrera A.L, 1980, BIOGEOGRAFIA AM LATI; Camargo A, 2012, SYST BIOL, V61, P272, DOI 10.1093/sysbio/syr105; Canon C, 2010, J MAMMAL, V91, P1449, DOI 10.1644/10-MAMM-A-027.1; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Codoncode Corporation, 2009, COD COD AL V 3 5; Cronin T.M., 2010, PALEOCLIMATES UNDERS; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Donoso-Barros R., 1966, REPTILES CHILE; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dumeril AMC, 1837, ERPETOLOGIE GEN REPT, V4, P1; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Etheridge R, 2000, HERPETOL MONOGR, V14, P293, DOI 10.2307/1467049; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fontanella FM, 2012, ZOOL J LINN SOC-LOND, V164, P825, DOI 10.1111/j.1096-3642.2011.00786.x; Formas JR, 2000, GENET MOL BIOL, V23, P43, DOI 10.1590/S1415-47572000000100007; Fu YX, 1997, GENETICS, V147, P915; Fuentes-Hurtado M, 2011, STUD NEOTROP FAUNA E, V46, P23, DOI 10.1080/01650521.2010.537906; Gajardo R., 1994, VEGETACION NATURAL C; Garrick RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-118; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; HAIG IT, 1946, FOREST RESOURCES CHI; HARPENDING HC, 1994, HUM BIOL, V66, P591; HARRISON RG, 1991, ANNU REV ECOL SYST, V22, P281, DOI 10.1146/annurev.ecolsys.22.1.281; Heusser CJ, 2003, DEV QUATER SCI, V3; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holling J.T., 1981, LAST GREAT ICE SHEET, P179; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hulton NRJ, 2002, QUATERNARY SCI REV, V21, P233, DOI 10.1016/S0277-3791(01)00103-2; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Kaiser J, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001146; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Lessa EP, 2010, MOL ECOL, V19, P3031, DOI 10.1111/j.1365-294X.2010.04734.x; Lobo F, 2010, ZOOTAXA, P1; Marchelli P, 2010, CONSERV GENET, V11, P951, DOI 10.1007/s10592-009-9938-5; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; Markgraf V., 1984, DISS BOT, V72, P235; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; McCulloch RD, 2005, GEOGR ANN A, V87A, P335, DOI 10.1111/j.0435-3676.2005.00262.x; Meade A, 2009, BAYES TREES V1 0; Miller MP, 2005, J HERED, V96, P722, DOI 10.1093/jhered/esi119; Miller MP, 2006, MOL ECOL, V15, P145, DOI 10.1111/j.1365-294X.2005.02765.x; Miraldo A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-170; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Morando M, 2003, SYST BIOL, V52, P159, DOI 10.1080/10635150390192717; Morando M, 2007, MOL PHYLOGENET EVOL, V43, P952, DOI 10.1016/j.ympev.2006.09.012; MORENO PI, 1994, REV CHIL HIST NAT, V67, P487; Muellner AN, 2005, MOL ECOL, V14, P203, DOI 10.1111/j.1365-294X.2004.02386.x; Nunez JJ, 2011, MOL PHYLOGENET EVOL, V58, P343, DOI 10.1016/j.ympev.2010.11.026; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Pastorino MJ, 2002, J BIOGEOGR, V29, P1167, DOI 10.1046/j.1365-2699.2002.00731.x; Paula M, 2006, CONSERV GENET, V7, P591, DOI 10.1007/s10592-005-9069-6; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pincheira-Donoso D, 2005, MUS NAC HIST NAT CHI, V59, P7486; Pinho C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-63; Portik DM, 2012, CONSERV GENET RESOUR, V4, P1, DOI 10.1007/s12686-011-9460-1; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Premoli AC, 2000, J BIOGEOGR, V27, P251, DOI 10.1046/j.1365-2699.2000.00402.x; RABASSA J, 1990, QUATERNARY SCI REV, V9, P153, DOI 10.1016/0277-3791(90)90016-4; Rambaut A., 2007, TRACER V1 4; RAND AL, 1948, EVOLUTION, V2, P314, DOI 10.2307/2405522; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruiz E, 2007, TAXON, V56, P1221, DOI 10.2307/25065913; Russell GB, 2000, J CHEM ECOL, V26, P41, DOI 10.1023/A:1005433326418; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Schulte JA, 2000, BIOL J LINN SOC, V69, P75, DOI 10.1006/bijl.1999.0346; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Smith-Ramirez C, 2004, BIODIVERS CONSERV, V13, P373, DOI 10.1023/B:BIOC.0000006505.67560.9f; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1995, GENETICS, V140, P767; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorson R, 1999, CIENCIA DIA, V4, P1; Tremetsberger K, 2009, MOL ECOL, V18, P3668, DOI 10.1111/j.1365-294X.2009.04298.x; Vera-Escalona IM, 2010, GAYANA, V74, P139; Victoriano PF, 2008, MOL ECOL, V17, P2397, DOI 10.1111/j.1365-294X.2008.03741.x; Vidal MA, 2006, AMPHIBIA-REPTILIA, V27, P103, DOI 10.1163/156853806776052146; Vidal MA, 2007, THESIS U CHILE CHILE; Vidal MA, 2012, AUSTRAL ECOL, V37, P67, DOI 10.1111/j.1442-9993.2011.02241.x; Villagran C, 2001, REV CHIL HIST NAT, V74, P793; VILLAGRAN C, 1991, REV CHIL HIST NAT, V64, P447; Villagran C, 2005, REGIONALIZACION BIOG, P577; Villagran C., 1995, ECOLOGIA BOSQUES NAT, P51; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xu JW, 2009, MOL ECOL, V18, P904, DOI 10.1111/j.1365-294X.2008.04070.x; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x	109	33	34	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e48358	10.1371/journal.pone.0048358	http://dx.doi.org/10.1371/journal.pone.0048358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209552	gold, Green Published			2022-12-25	WOS:000311885800004
J	Xu, XY; Reinhardt, JM; Hu, Q; Bakall, B; Tlucek, PS; Bertelsen, G; Abramoff, MD				Xu, Xiayu; Reinhardt, Joseph M.; Hu, Qiao; Bakall, Benjamin; Tlucek, Paul S.; Bertelsen, Geir; Abramoff, Michael D.			Retinal Vessel Width Measurement at Branchings Using an Improved Electric Field Theory-Based Graph Approach	PLOS ONE			English	Article							FUNDUS IMAGES; SEGMENTATION; BIFURCATIONS; CROSSOVERS; ALGORITHMS; DIAMETERS; FORMULAS; DISEASE; MODEL	The retinal vessel width relationship at vessel branch points in fundus images is an important biomarker of retinal and systemic disease. We propose a fully automatic method to measure the vessel widths at branch points in fundus images. The method is a graph-based method, in which a graph construction method based on electric field theory is applied which specifically deals with complex branching patterns. The vessel centerline image is used as the initial segmentation of the graph. Branching points are detected on the vessel centerline image using a set of detection kernels. Crossing points are distinguished from branch points and excluded. The electric field based graph method is applied to construct the graph. This method is inspired by the non-intersecting force lines in an electric field. At last, the method is further improved to give a consistent vessel width measurement for the whole vessel tree. The algorithm was validated on 100 artery branchings and 100 vein branchings selected from 50 fundus images by comparing with vessel width measurements from two human experts.	[Xu, Xiayu; Reinhardt, Joseph M.; Abramoff, Michael D.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Hu, Qiao; Abramoff, Michael D.] Univ Iowa, Dept Elect & Comp Engn, Iowa City, IA 52242 USA; [Bakall, Benjamin; Tlucek, Paul S.; Abramoff, Michael D.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Abramoff, Michael D.] Vet Adm Med Ctr, Iowa City, IA USA; [Bertelsen, Geir] Univ Tromso, Dept Community Med, Tromso, Norway	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); UiT The Arctic University of Tromso	Abramoff, MD (corresponding author), Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA.	michael-abramoff@uiowa.edu	Abramoff, Michael D/A-5836-2009; Bertelsen, Geir/ABB-9865-2021	Abramoff, Michael D/0000-0002-3490-0037; Reinhardt, Joseph/0000-0003-3526-3591	National Eye Institute [R01 EY017066]; Research to Prevent Blindness, NY; Department for Veterans Affairs; NATIONAL EYE INSTITUTE [R01EY017066] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, NY(Research to Prevent Blindness (RPB)); Department for Veterans Affairs(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the National Eye Institute (R01 EY017066), Research to Prevent Blindness, NY, and the Department for Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; Bhuiyan A, 2008, SITIS 2007: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGIES & INTERNET BASED SYSTEMS, P711, DOI 10.1109/SITIS.2007.86; Calvo D, 2011, COMPUT METH PROG BIO, V103, P28, DOI 10.1016/j.cmpb.2010.06.002; Chapman N, 2002, CLIN SCI, V103, P111; Chapman N, 2001, BRIT J OPHTHALMOL, V85, P74, DOI 10.1136/bjo.85.1.74; Christopher M, 2012, RETINA, V0, P1; Doubal FN, 2010, INT J STROKE, V5, P434, DOI 10.1111/j.1747-4949.2010.00483.x; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Jacobsen BK, 2011, INT J EPIDEMIOL, P1, DOI DOI 10.1093/IJE/DYR049; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Lee S, 2010, SPIE MED IMAGING, V7623; Lee S, 2010, MED IMAGE ANAL, V14, P539, DOI 10.1016/j.media.2010.04.001; Li K, 2006, IEEE T PATTERN ANAL, V28, P119, DOI 10.1109/TPAMI.2006.19; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; PARR JC, 1974, AM J OPHTHALMOL, V77, P478, DOI 10.1016/0002-9394(74)90458-9; Patton N, 2006, INVEST OPHTH VIS SCI, V47, P1329, DOI 10.1167/iovs.05-1248; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; Quelhas P, 2003, LECT NOTES COMPUT SC, V2652, P802; Shen H, 2001, IEEE T INF TECHNOL B, V5, P77, DOI 10.1109/4233.908405; Sonka M., 1998, IMAGE PROCESSING ANA; Stanton AV, 1995, J HYPERTENS, V13, P1724; Sun C, 2003, SURV OPHTHALMOL, V48, P245; Tsai CL, 2004, IEEE T INF TECHNOL B, V8, P122, DOI 10.1109/TITB.2004.826733; Xu XY, 2011, IEEE T MED IMAGING, V30, P1184, DOI 10.1109/TMI.2010.2103566; Yin Y, 2009, LECT NOTES COMPUT SC, V5534, P334, DOI 10.1007/978-3-642-02124-4_34	26	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49668	10.1371/journal.pone.0049668	http://dx.doi.org/10.1371/journal.pone.0049668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209588	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800014
J	van Schaik, FDM; Gadaleta, RM; Schaap, FG; van Mil, SWC; Siersema, PD; Oldenburg, B; van Erpecum, KJ				van Schaik, Fiona D. M.; Gadaleta, Raffaella M.; Schaap, Frank G.; van Mil, Saskia W. C.; Siersema, Peter D.; Oldenburg, Bas; van Erpecum, Karel J.			Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis	PLOS ONE			English	Article							DISEASE; FXR; IDENTIFICATION; CHOLESTASIS; INTESTINE; LIVER	Background: The bile acid-activated nuclear receptor Farnesoid X Receptor (FXR) is critical in maintaining intestinal barrier integrity and preventing bacterial overgrowth. Patients with Crohn's colitis (CC) exhibit reduced ileal FXR target gene expression. FXR agonists have been shown to ameliorate inflammation in murine colitis models. We here explore the feasibility of pharmacological FXR activation in CC. Methods: Nine patients with quiescent CC and 12 disease controls were treated with the FXR ligand chenodeoxycholic acid (CDCA; 15 mg/kg/day) for 8 days. Ileal FXR activation was assessed in the fasting state during 6 hrs after the first CDCA dose and on day 8, by quantification of serum levels of fibroblast growth factor (FGF) 19. Since FGF19 induces gallbladder (GB) refilling in murine models, we also determined concurrent GB volumes by ultrasound. On day 8 ileal and cecal biopsies were obtained and FXR target gene expression was determined. Results: At baseline, FGF19 levels were not different between CC and disease controls. After the first CDCA dose, there were progressive increases of FGF19 levels and GB volumes during the next 6 hours in CC patients and disease controls (FGF19: 576 resp. 537% of basal; GB volumes: 190 resp. 178% of basal) without differences between both groups, and a further increase at day 8. In comparison with a separate untreated control group, CDCA affected FXR target gene expression in both CC and disease controls, without differences between both groups. Conclusions: Pharmacological activation of FXR is feasible in patients with CC. These data provide a rationale to explore the anti-inflammatory properties of pharmacological activation of FXR in these patients. Trial Registration: TrialRegister.nl NTR2009	[van Schaik, Fiona D. M.; Gadaleta, Raffaella M.; Siersema, Peter D.; Oldenburg, Bas; van Erpecum, Karel J.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Gadaleta, Raffaella M.; van Mil, Saskia W. C.] Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands; [Schaap, Frank G.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	van Schaik, FDM (corresponding author), Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands.	f.d.m.vanschaik@umcutrecht.nl	Siersema, Peter/V-1636-2019; van Mil, Saskia WC/C-3751-2009	van Mil, Saskia WC/0000-0002-7850-5012; Schaap, Frank/0000-0002-1597-572X	Abbott Laboratories, Abbott Park, Illinois, U.S.A; Netherlands Organization for Scientific Research (NWO) [917.11.365]; Utrecht University; Wilhelmina Children's Hospital	Abbott Laboratories, Abbott Park, Illinois, U.S.A(Abbott Laboratories); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Utrecht University; Wilhelmina Children's Hospital	FDMvS is supported by a grant from Abbott Laboratories, Abbott Park, Illinois, U.S.A. SWCvM is supported by the Netherlands Organization for Scientific Research (NWO) Project VIDI (917.11.365), a Utrecht University Support Grant and Wilhelmina Children's Hospital Research Fund. Chenodeoxycholic acid (CDCA) was a gift of Tramedico, Weesp, the Netherlands and Sigma-tau, Dusseldorf, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun A, 2009, INFLAMM BOWEL DIS, V15, P1705, DOI 10.1002/ibd.20993; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; Ehehalt R, 2010, BBA-MOL CELL BIOL L, V1801, P983, DOI 10.1016/j.bbalip.2010.05.014; EVERSON GT, 1980, GASTROENTEROLOGY, V79, P40; Gadaleta RM, 2011, BBA-MOL BASIS DIS, V1812, P851, DOI 10.1016/j.bbadis.2011.04.005; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; HARVEY RF, 1980, LANCET, V1, P514; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Nijmeijer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023745; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Portincasa P, 1996, HEPATOLOGY, V24, P580, DOI 10.1053/jhep.1996.v24.pm0008781328; RUTGEERTS P, 1979, GUT, V20, P1072, DOI 10.1136/gut.20.12.1072; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; TOUGAARD L, 1986, SCAND J GASTROENTERO, V21, P627, DOI 10.3109/00365528609003110; Van Mil SWC, 2007, GASTROENTEROLOGY, V133, P507, DOI 10.1053/j.gastro.2007.05.015; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102	24	16	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49706	10.1371/journal.pone.0049706	http://dx.doi.org/10.1371/journal.pone.0049706			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189156	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800033
J	White, MA; Li, S; Tsalkova, T; Mei, FC; Liu, T; Woods, VL; Cheng, XD				White, Mark A.; Li, Sheng; Tsalkova, Tamara; Mei, Fang C.; Liu, Tong; Woods, Virgil L., Jr.; Cheng, Xiaodong			Structural Analyses of a Constitutively Active Mutant of Exchange Protein Directly Activated by cAMP	PLOS ONE			English	Article							EPAC ACTIVATION; MECHANISM; CRYSTALLOGRAPHY; AUTOINHIBITION; REFINEMENT; DYNAMICS; FAMILY	Exchange proteins directly activated by cAMP (EPACs) are important allosteric regulators of cAMP-mediated signal transduction pathways. To understand the molecular mechanism of EPAC activation, we have combined site-directed mutagenesis, X-ray crystallography, and peptide amide hydrogen/deuterium exchange mass spectrometry (DXMS) to probe the structural and conformational dynamics of EPAC2-F435G, a constitutively active EPAC2 mutant. Our study demonstrates that conformational dynamics plays a critical role in cAMP-induced EPAC activation. A glycine mutation at 435 position shifts the equilibrium of conformational dynamics towards the extended active conformation.	[White, Mark A.; Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [White, Mark A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Li, Sheng; Liu, Tong; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Li, Sheng; Liu, Tong; Woods, Virgil L., Jr.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Tsalkova, Tamara; Mei, Fang C.; Cheng, Xiaodong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Medical Branch Galveston	Cheng, XD (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.	xcheng@utmb.edu	White, Mark Andrew/B-1723-2012; Cheng, Xiaodong/O-8176-2019	White, Mark Andrew/0000-0003-1057-4203; Cheng, Xiaodong/0000-0002-3479-1694	National Institute of Health [GM066170, AI2008031, AI081982, GM020501, NS070899, GM093325, RR029388]; NIEHS Center [ES06676]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066170, R01GM093325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070899] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from the National Institute of Health GM066170 (XC) and AI2008031, AI081982, GM020501, NS070899, GM093325 and RR029388 (VLW), and in part by NIEHS Center Grant ES06676. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Bordoli Lorenza, 2012, Methods Mol Biol, V857, P107, DOI 10.1007/978-1-61779-588-6_5; Brock M, 2007, J BIOL CHEM, V282, P32256, DOI 10.1074/jbc.M706231200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen HJ, 2012, BIOORG MED CHEM LETT, V22, P4038, DOI 10.1016/j.bmcl.2012.04.082; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DRIESSEN HPC, 1991, ACTA CRYSTALLOGR B, V47, P987, DOI 10.1107/S0108768191009163; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Pantazatos D, 2004, P NATL ACAD SCI USA, V101, P751, DOI 10.1073/pnas.0307204101; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Russo AT, 2006, STRUCTURE, V14, P1449, DOI 10.1016/j.str.2006.07.010; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Singh R, 2006, PROTEINS, V64, P101, DOI 10.1002/prot.20988; Tsalkova T, 2012, P NATL ACAD SCI USA, V109, P18613, DOI 10.1073/pnas.1210209109; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x	31	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49932	10.1371/journal.pone.0049932	http://dx.doi.org/10.1371/journal.pone.0049932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189173	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800050
J	Abrego, D; Willis, BL; van Oppen, MJH				Abrego, David; Willis, Bette L.; van Oppen, Madeleine J. H.			Impact of Light and Temperature on the Uptake of Algal Symbionts by Coral Juveniles	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; FUNGIA-SCUTARIA; SCLERACTINIAN CORALS; ELEVATED-TEMPERATURE; ACROPORA-MILLEPORA; SYMBIODINIUM; ZOOXANTHELLAE; LARVAE; ONSET	The effects of temperature and light on the breakdown of the coral-Symbiodinium symbiosis are well documented but current understanding of their roles during initial uptake and establishment of symbiosis is limited. In this study, we investigate how temperature and light affect the uptake of the algal symbionts, ITS1 types C1 and D, by juveniles of the broadcast-spawning corals Acropora tenuis and A. millepora. Elevated temperatures had a strong negative effect on Symbiodinium uptake in both coral species, with corals at 31 degrees C showing as little as 8% uptake compared to 87% at 28 degrees C. Juveniles in high light treatments (390 mu mol photons m(-2) s(-1)) had lower cell counts across all temperatures, emphasizing the importance of the light environment during the initial uptake phase. The proportions of the two Symbiodinium types taken up, as quantified by a real time PCR assay using clade C-and D-specific primers, were also influenced by temperature, although variation in uptake dynamics between the two coral species indicates a host effect. At 28 degrees C, A. tenuis juveniles were dominated by C1 Symbiodinium, and while the number of D Symbiodinium cells increased at 31 degrees C, they never exceeded the number of C1 cells. In contrast, juveniles of A. millepora had approximately equal numbers of C1 and D cells at 28 degrees C, but were dominated by D at 30 degrees C and 31 degrees C. This study highlights the significant role that environmental factors play in the establishment of coral-Symbiodinium symbiosis and provides insights into how potentially competing Symbiodinium types take up residence in coral juveniles.	[Abrego, David; van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Abrego, David; Willis, Bette L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia; [Abrego, David; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia	Australian Institute of Marine Science; James Cook University; James Cook University	Abrego, D (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	d.abrego@aims.gov.au	Abrego, David/AAT-8120-2020; van Oppen, Madeleine JH/C-3261-2008	Abrego, David/0000-0003-3311-2730; van Oppen, Madeleine/0000-0003-4607-0744	Australian Research Council (Center of Excellence for Coral Reef Studies); James Cook University; Australian Institute of Marine Science; CONACYT (Mexico)	Australian Research Council (Center of Excellence for Coral Reef Studies)(Australian Research Council); James Cook University; Australian Institute of Marine Science; CONACYT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding for this study was obtained from the Australian Research Council (Center of Excellence for Coral Reef Studies), James Cook University, and the Australian Institute of Marine Science. DA received financial support from CONACYT (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Abrego D, 2009, MOL ECOL, V18, P3518, DOI 10.1111/j.1365-294X.2009.04275.x; Adams LM, 2009, MAR ECOL PROG SER, V377, P149, DOI 10.3354/meps07834; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2010, P 11 INT COR REEF S, V1, P108; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Cantin NE, 2009, CORAL REEFS, V28, P405, DOI 10.1007/s00338-009-0478-8; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Coffroth MA, 2006, CURR BIOL, V16, pR985, DOI 10.1016/j.cub.2006.10.049; Davy SK, 1997, BIOL BULL, V192, P208, DOI 10.2307/1542715; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Fitt W. K., 1985, P 5 INT COR REEF C T, P131; Glynn PW, 2001, B MAR SCI, V69, P79; Gomez-Cabrera MD, 2008, CORAL REEFS, V27, P219, DOI 10.1007/s00338-007-0315-x; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Harrison P.L., 1990, CORAL REEFS, V25, P133; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hoarau G, 2007, MOL ECOL NOTES, V7, P191, DOI 10.1111/j.1471-8286.2006.01587.x; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; IGLESIASPRIETO R, 1992, P NATL ACAD SCI USA, V89, P10302, DOI 10.1073/pnas.89.21.10302; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Littman RA, 2008, J EXP MAR BIOL ECOL, V364, P48, DOI 10.1016/j.jembe.2008.06.034; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; Puill-Stephan E, 2012, P ROY SOC B-BIOL SCI, V279, P699, DOI 10.1098/rspb.2011.1035; RICHMOND RH, 1990, MAR ECOL PROG SER, V60, P185, DOI 10.3354/meps060185; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Schnitzler CE, 2012, MAR BIOL, V159, P633, DOI 10.1007/s00227-011-1842-0; Schwarz JA, 1999, BIOL BULL-US, V196, P70, DOI 10.2307/1543169; Sofonia JJ, 2008, ESTUAR COAST SHELF S, V78, P748, DOI 10.1016/j.ecss.2008.02.025; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; van Oppen M, 2001, CORAL REEFS, V20, P200, DOI 10.1007/s003380100167; Weis VM, 2001, CORAL REEFS, V20, P301, DOI 10.1007/s003380100179; Yakovleva IM, 2009, MAR ECOL PROG SER, V378, P105, DOI 10.3354/meps07857	51	29	29	0	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50311	10.1371/journal.pone.0050311	http://dx.doi.org/10.1371/journal.pone.0050311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185603	Green Published, gold, Green Accepted			2022-12-25	WOS:000311821000216
J	Borglykke, A; Grarup, N; Sparso, T; Linneberg, A; Fenger, M; Jeppesen, J; Hansen, T; Pedersen, O; Jorgensen, T				Borglykke, Anders; Grarup, Niels; Sparso, Thomas; Linneberg, Allan; Fenger, Mogens; Jeppesen, Jorgen; Hansen, Torben; Pedersen, Oluf; Jorgensen, Torben			Genetic Variant SCL2A2 Is Associated with Risk of Cardiovascular Disease - Assessing the Individual and Cumulative Effect of 46 Type 2 Diabetes Related Genetic Variants	PLOS ONE			English	Article							POPULATION; MORTALITY; TRENDS; LOCI	Aim: To assess the individual and combined effect of 46 type 2 diabetes related risk alleles on incidence of a composite CVD endpoint. Methods: Data from the first Danish MONICA study (N = 3523) and the Inter99 study (N = 6049) was used. Using Cox proportional hazard regression the individual effect of each risk allele on incident CVD was analyzed. Risk was presented as hazard ratios (HR) per risk allele. Results: During 80,859 person years 1441 incident cases of CVD (fatal and non-fatal) occurred in the MONICA study. In Inter99 942 incident cases were observed during 61,239 person years. In the Danish MONICA study four gene variants were significantly associated with incident CVD independently of known diabetes status at baseline; SLC2A2 rs11920090 (HR 1.147, 95% CI 1.027-1.283, P = 0.0154), C2CD4A rs7172432 (1.112, 1.027-1.205, P = 0.0089), GCKR rs780094 (1.094, 1.007-1.188, P = 0.0335) and C2CD4B rs11071657 (1.092, 1.007-1.183, P = 0.0323). The genetic score was significantly associated with increased risk of CVD (1.025, 1.010-1.041, P = 0.0016). In Inter99 two gene variants were associated with risk of CVD independently of diabetes; SLC2A2 (HR 1.180, 95% CI 1.038-1.341 P = 0.0116) and FTO (0.909, 0.827-0.998, P = 0.0463). Analysing the two populations together we found SLC2A2 rs11920090 (HR 1.164, 95% CI 1.070-1.267, P = 0.0004) meeting the Bonferroni corrected threshold for significance. GCKR rs780094 (1.076, 1.010-1.146, P = 0.0229), C2CD4B rs11071657 (1.067, 1.003-1.135, P = 0.0385) and NOTCH2 rs10923931 (1.104 (1.001; 1.217, P = 0.0481) were found associated with CVD without meeting the corrected threshold. The genetic score was significantly associated with increased risk of CVD (1.018, 1.006-1.031, P = 0.0043). Conclusions: This study showed that out of the 46 genetic variants examined only the minor risk allele of SLC2A2 rs11920090 was significantly (P = 0.0005) associated with a composite endpoint of incident CVD below the threshold for statistical significance corrected for multiple testing. This potential pathway needs further exploration.	[Borglykke, Anders; Linneberg, Allan; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Grarup, Niels; Sparso, Thomas; Jeppesen, Jorgen; Hansen, Torben] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Fenger, Mogens] Univ Copenhagen Hosp, Hvidovre, Denmark; [Jeppesen, Jorgen] Glostrup Univ Hosp, Dept Med, Glostrup, Denmark; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Jorgensen, Torben] Aalborg Univ, Fac Med, Aalborg, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Novo Nordisk; Hagedorn Research Institute; Aarhus University; Aalborg University	Borglykke, A (corresponding author), Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark.	anders.borglykke@regionh.dk	Pedersen, Oluf/Z-1731-2019; Jørgensen, Torben/Z-1335-2018; Grarup, Niels/K-2807-2015; Pedersen, Oluf/AAG-8015-2020	Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Linneberg, Allan/0000-0002-0994-0184; Hansen, Torben/0000-0001-8748-3831; Jorgensen, Torben/0000-0001-9453-2830	Lundbeck Foundation; Health Insurance Foundation [2010 B 131]; Lundbeck Foundation [R31-2008-2408] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Health Insurance Foundation; Lundbeck Foundation(Lundbeckfonden)	The study was funded by Lundbeck Foundation and produced by The Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention, and Care (www.LuCAMP.org). Further funding was received from The Health Insurance Foundation (grant number 2010 B 131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Balagopal P, 2011, CIRCULATION, V123, P2749, DOI 10.1161/CIR.0b013e31821c7c64; Bielinski SJ, 2008, DIABETOLOGIA, V51, P968, DOI 10.1007/s00125-008-1004-1; Capewell S, 2008, HEART, V94, P1105, DOI 10.1136/hrt.2008.149930; Dent THS, 2010, ATHEROSCLEROSIS, V213, P352, DOI 10.1016/j.atherosclerosis.2010.06.021; Duesing K, 2008, DIABETOLOGIA, V51, P821, DOI 10.1007/s00125-008-0973-4; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Gerdes LU, 2000, J CLIN EPIDEMIOL, V53, P427, DOI 10.1016/S0895-4356(99)00193-6; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Grarup N, 2010, CURR DIABETES REP, V10, P485, DOI 10.1007/s11892-010-0154-y; Igl W, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000798; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Juel K, 1999, DAN MED BULL, V46, P354; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Pfister R, 2011, DIABETOLOGIA, V54, P2283, DOI 10.1007/s00125-011-2206-5; Ridker PM, 2003, ARTERIOSCL THROM VAS, V23, P859, DOI 10.1161/01.ATV.0000068680.19521.34; Thanassoulis G, 2010, CIRCULATION, V122, P2323, DOI 10.1161/CIRCULATIONAHA.109.909309; TUNSTALLPEDOE H, 1985, WHO CHRON, V39, P3	19	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50418	10.1371/journal.pone.0050418	http://dx.doi.org/10.1371/journal.pone.0050418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185617	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000230
J	Yang, WC; Shih, HM				Yang, W-C; Shih, H-M			The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability	ONCOGENE			English	Article						acute promyelocytic leukemia; deubiquitinating enzyme; USP37; PLZF; RARA	ACUTE PROMYELOCYTIC LEUKEMIA; SMALL-MOLECULE INHIBITOR; PML-RAR-ALPHA; CELLS; PLZF; PATHWAY; CYCLIN; DIFFERENTIATION; PATHOGENESIS; APOPTOSIS	Acute promyelocytic leukemia (APL) is predominantly characterized by chromosomal translocations between the retinoic acid receptor, alpha (RARA) gene and the promyelocytic leukemia (PML) or promyelocytic leukemia zinc finger (PLZF) gene. In APL cells with PML/RARA fusions, arsenic trioxide and all-trans retinoic acid treatments specifically target the fusion protein for proteasome-dependent degradation, thereby promoting cellular differentiation and clinical remission of disease. In contrast, APL cells expressing PLZF/RARA fusion proteins are largely resistant to similar treatments and prognosis for patients with this translocation is poor. Understanding the molecular mechanisms regulating PLZF/RARA protein stability would provide novel therapeutic targets for PLZF/RARA-associated APL. Toward this end, we have performed an RNAi-based screen to identify factors affecting PLZF/RARA stability. Among the factors identified was the ubiquitin-specific peptidase 37 (USP37). We showed that USP37 interacted with PLZF/RARA through the PLZF moiety and sustained PLZF/RARA steady state levels. Domain mapping study revealed that N-terminal domain of USP37 is required for the PLZF/RARA interaction and protein regulation. Furthermore, overexpression or depletion of USP37 caused an increase or decrease of PLZF/RARA protein half-life, correlating with down-or upregulation of PLZF/RARA poly-ubiquitination, respectively. By PLZF/RARA-transduced primary mouse hematopoietic progenitor cells, we demonstrated that Usp37 knockdown alleviated PLZF/RARA-mediated target gene suppression and cell transformation potential. Altogether, our findings of USP37-modulating PLZF/RARA stability and cell transformation suggest that USP37 is a potential therapeutic target for PLZF/RARA-associated APL.	[Yang, W-C; Shih, H-M] Acad Sinica, Taiwan Int Grad Program TIGP, Mol Med Program, Taipei 115, Taiwan; [Yang, W-C; Shih, H-M] Natl Yang Ming Univ, Sch Life Sci, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Yang, W-C; Shih, H-M] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Shih, HM (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Sec 2,Acad Rd, Taipei 115, Taiwan.	hmshih@ibms.sinica.edu.tw	Shih, Hsiu-Ming/S-7023-2018		NSC [NSC100-2321-B-001-004, NSC100-3112-B-001-004]; Academia Sinica Investigator Award	NSC(Ministry of Science and Technology, Taiwan); Academia Sinica Investigator Award(Academia Sinica - Taiwan)	We thank Dr. J Wade Harper for USP37, OTUD6B and USP2 cDNA constructs, Dr Sheng-Chung Lee for anti-ubiquitin antibody, and Dr Yen-Sung Huang for mouse preparation. We also thank for the NRPGM Core RNAi by providing lentiviral constructs for TetOn system and shRNAs of DUBs. We are grateful to Dr Michael J Matunis for comments on the paper. The work was supported by NSC Grants (NSC100-2321-B-001-004; NSC100-3112-B-001-004) and an Academia Sinica Investigator Award to H-M Shih.	Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Chang CC, 2011, MOL CELL, V42, P62, DOI 10.1016/j.molcel.2011.02.022; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Duprez E, 2003, EMBO J, V22, P5806, DOI 10.1093/emboj/cdg556; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Ji P, 2005, ONCOGENE, V24, P2739, DOI 10.1038/sj.onc.1208356; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin RJ, 2001, ONCOGENE, V20, P7204, DOI 10.1038/sj.onc.1204853; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Mistry AR, 2003, BLOOD REV, V17, P71, DOI 10.1016/S0268-960X(02)00075-9; Muller C, 2000, BLOOD, V96, P3894, DOI 10.1182/blood.V96.12.3894.h8003894_3894_3899; Nasr R, 2009, CLIN CANCER RES, V15, P6321, DOI 10.1158/1078-0432.CCR-09-0209; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Yang R, 1999, BLOOD, V93, P2067; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	32	23	24	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 24	2013	32	43					5167	5175		10.1038/onc.2012.537	http://dx.doi.org/10.1038/onc.2012.537			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	240JY	23208507				2022-12-25	WOS:000326093200004
J	Fritz, V; Benfodda, Z; Henriquet, C; Hure, S; Cristol, JP; Michel, F; Carbonneau, MA; Casas, F; Fajas, L				Fritz, V.; Benfodda, Z.; Henriquet, C.; Hure, S.; Cristol, J-P; Michel, F.; Carbonneau, M-A; Casas, F.; Fajas, L.			Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth	ONCOGENE			English	Article						lipids; cancer; FAS; metabolism; prostate	FATTY-ACID SYNTHASE; PROTEIN-KINASE; MALIC ENZYME; CELLS; INHIBITION; TISSUES; TARGET; AMPK; CYTOTOXICITY; LIPOGENESIS	One of the most conserved features of all cancers is a profound reprogramming of cellular metabolism, favoring biosynthetic processes and limiting catalytic processes. With the acquired knowledge of some of these important changes, we have designed a combination therapy in order to force cancer cells to use a particular metabolic pathway that ultimately results in the accumulation of toxic products. This innovative approach consists of blocking lipid synthesis, at the same time that we force the cell, through the inhibition of AMP-activated kinase, to accumulate toxic intermediates, such as malonyl-coenzyme A (malonyl-CoA) or nicotinamide adenine dinucleotide phosphate. This results in excess of oxidative stress and cancer cell death. Our new therapeutic strategy, based on the manipulation of metabolic pathways, will certainly set up the basis for new upcoming studies defining a new paradigm of cancer treatment.	[Fritz, V.; Hure, S.; Fajas, L.] CNRS, IGMM, Inst Genet Mol Montpellier, F-34293 Montpellier, France; [Fritz, V.; Hure, S.; Fajas, L.] CNRS, UMR5535, F-34293 Montpellier, France; [Fritz, V.; Hure, S.; Fajas, L.] Univ Montpellier 2, Montpellier, France; [Benfodda, Z.] Univ Montpellier 2, IBMM, Inst Biomol Max Mousseron, Lab Acides Amines Peptides & Prot,CNRS UMR5247 CC, Montpellier, France; [Benfodda, Z.] Univ Nimes, Chim Bioorgan Lab, Nimes, France; [Henriquet, C.] Inst Rech Cancerol Montpellier, IRCM, Montpellier, France; [Cristol, J-P; Michel, F.] Ctr Hosp Univ Lapeyronie, Biochim Lab, Montpellier, France; [Cristol, J-P; Michel, F.] Inst Univ Rech Clin, UMR Prevent Malnutr & Pathol Associees 204, Montpellier, France; [Carbonneau, M-A] Inst Univ Rech Clin, UMR NUTRIPASS 204, Montpellier, France; [Casas, F.] INRA, UMR 0866, F-34060 Montpellier, France; [Fajas, L.] Ctr Hosp Reg Univ Montpellier, Montpellier, France; [Fajas, L.] Univ Lausanne, Dept Physiol, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Nimes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Universite de Montpellier; CHU de Montpellier; University of Lausanne	Fajas, L (corresponding author), CNRS, IGMM, Inst Genet Mol Montpellier, 1919 Route Mende, F-34293 Montpellier, France.	lluis.fajas@unil.ch	Coll, Lluis Fajas/C-8567-2014; BENFODDA, Zohra/P-4355-2017	BENFODDA, Zohra/0000-0001-7574-4977; Fajas, Lluis/0000-0002-1283-9503; Francois, Casas/0000-0002-5535-8195	Ligue Contre le Cancer; Agence Nationale de la Recherche (ANR); Institut National du Cancer (INCA)	Ligue Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France)	Members of Fajas' lab are acknowledged for support and discussions. This work was supported by grants from Ligue Contre le Cancer, Agence Nationale de la Recherche (ANR) and Institut National du Cancer (INCA).	Brusselmans K, 2005, CANCER RES, V65, P6719, DOI 10.1158/0008-5472.CAN-05-0571; Brusselmans K, 2005, J BIOL CHEM, V280, P5636, DOI 10.1074/jbc.M408177200; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; GEER BW, 1979, BIOCHEM GENET, V17, P867, DOI 10.1007/BF00504309; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Korczynska J, 2004, METABOLISM, V53, P1060, DOI 10.1016/j.metabol.2004.02.015; KUHAJDA FP, 1994, P NATL ACAD SCI USA, V91, P6379, DOI 10.1073/pnas.91.14.6379; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Menendez JA, 2004, INT J ONCOL, V24, P1369; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Pizer ES, 2000, CANCER RES, V60, P213; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Stelmanska E, 2004, ACTA BIOCHIM POL, V51, P805; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Thupari JN, 2001, BIOCHEM BIOPH RES CO, V285, P217, DOI 10.1006/bbrc.2001.5146; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Zhang J, 2008, MOL CARCINOGEN, V47, P974, DOI 10.1002/mc.20450	22	32	32	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2013	32	42					5101	5110		10.1038/onc.2012.523	http://dx.doi.org/10.1038/onc.2012.523			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	238IB	23208508	Green Published, hybrid			2022-12-25	WOS:000325937900011
J	Long, XG; Li, Y; Qi, YM; Xu, J; Wang, ZL; Zhang, XM; Zhang, DD; Zhang, L; Huang, JQ				Long, Xigui; Li, Ying; Qi, Yiming; Xu, Juan; Wang, Zilian; Zhang, Ximeng; Zhang, Duoduo; Zhang, Lin; Huang, Junqi			XAF1 contributes to dengue virus-induced apoptosis in vascular endothelial cells	FASEB JOURNAL			English	Article						XIAP; VECs	X-LINKED INHIBITOR; COLON-CANCER; KAPPA-B; INFECTION; GENE; EXPRESSION; PATHWAY; TRAIL; ALPHA; XIAP	The mechanism of vascular leakage in severe dengue infection remains unclear. Here, we used primary human umbilical vein endothelial cells (HUVECs) and the EA.hy926 cell line to study the molecular events that occur after dengue virus serotype 2 (DENV2) infection. DENV2-induced apoptosis was confirmed using nuclear staining, TUNEL assay, and electron microscopy. A genome-wide transcriptome analysis was performed using a microarray of DENV2-infected HUVECs. Notably, interferon-inducible genes were differentially expressed after DENV2 infection. Prominent among these genes was the X chromosome-linked inhibitor of apoptosis protein (XIAP)-associated factor 1 (XAF1; up-regulated 1.2-fold in the microarray analysis and similar to 8-fold by qRT-PCR after DENV2 infection). XAF1 protein levels were up-regulated after DENV2 infection in both HUVECs and EA.hy926 cells. Evidence indicated interaction between XAF1 and XIAP during DENV2 infection based on their cellular localization, as observed by confocal microscopy and the coimmunoprecipitation of XIAP with an anti-XAF1 antibody. Next, recombinant EA.hy926 cell lines in which XAF1 was either knocked down or overexpressed were constructed. The expression levels of the apoptosis-related genes caspase 3, caspase 8, caspase 9, and poly-(ADP-ribose) polymerase (PARP) were down-regulated in the XAF1 knockdown (24-48 h postinfection) but were up-regulated in XAF1 overexpressing cells (36 h postinfection). This is the first study of the role of XAF1 in promoting apoptosis in vascular endothelial cells after DENV2 infection.-Long, X., Li, Y., Qi, Y., Xu, J., Wang, Z., Zhang, X., Zhang, D., Zhang, L., Huang, J. XAF1 contributes to dengue virus-induced apoptosis in vascular endothelial cells. FASEB J. 27, 1062-1073 (2013). www.fasebj.org	[Long, Xigui; Li, Ying; Qi, Yiming; Xu, Juan; Zhang, Ximeng; Zhang, Duoduo; Zhang, Lin; Huang, Junqi] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Zilian] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Long, Xigui; Li, Ying; Qi, Yiming; Xu, Juan; Zhang, Ximeng; Zhang, Duoduo; Zhang, Lin; Huang, Junqi] Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Huang, JQ (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Inst Immunol, Guangzhou 510080, Guangdong, Peoples R China.	huangjunqi1410@163.com	Zhang, Duo/GYU-8678-2022; ZHANG, LIN/GYD-9123-2022; zhan, lin/AAP-5149-2020		National Natural Science Foundation of China [30872350]; Natural Science Foundation of Guangdong Province [81510008901000017, S2012010009050]; Guangdong Province Scientific Technology Project [2010B050700008, 2011B040300022]; Guangzhou City Scientific Technology Project [2011J4100084, 2008Z1-E221]; Fundamental Research Funds for the Central Universities [10YKPY31]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Province Scientific Technology Project; Guangzhou City Scientific Technology Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors thank Yimin Jiang (Guangzhou Center for Disease Control and Prevention, Guangzhou, China) for providing the clinical DENV2 strain of Guangzhou (06/GZ/D2-156). This work was supported by the National Natural Science Foundation of China (30872350), the Natural Science Foundation of Guangdong Province (81510008901000017, S2012010009050), the Guangdong Province Scientific Technology Project (2010B050700008, 2011B040300022), the Guangzhou City Scientific Technology Project (2011J4100084, 2008Z1-E221), and the Fundamental Research Funds for the Central Universities (10YKPY31). The authors declare no conflicts of interest.	Arevalo MT, 2009, J MED VIROL, V81, P519, DOI 10.1002/jmv.21408; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Byun DS, 2003, CANCER RES, V63, P7068; Chung SK, 2007, GASTROENTEROLOGY, V132, P2459, DOI 10.1053/j.gastro.2007.04.024; Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11; Delong MJ, 1998, ANN NY ACAD SCI, V842, P82, DOI 10.1111/j.1749-6632.1998.tb09635.x; Despres P, 1998, J VIROL, V72, P823; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Giovannetti A, 2008, CURR PHARM DESIGN, V14, P253; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jan JT, 2000, J VIROL, V74, P8680, DOI 10.1128/JVI.74.18.8680-8691.2000; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Leaman DW, 2002, J BIOL CHEM, V277, P28504, DOI 10.1074/jbc.M204851200; Lee MG, 2006, CURR CLIN PHARMACOL, V1, P193, DOI 10.2174/157488406776872569; Liao HW, 2010, J MED VIROL, V82, P1392, DOI 10.1002/jmv.21815; Liew KJL, 2004, J MED VIROL, V72, P597, DOI 10.1002/jmv.20034; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Liu P, 2009, J INFECT DIS, V200, P191, DOI 10.1086/599795; Lovering RC, 2008, IMMUNOLOGY, V125, P154, DOI 10.1111/j.1365-2567.2008.02940.x; Marianneau Philippe, 1998, Acta Cientifica Venezolana, V49, P13; Micali OC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-52; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Morishita R, 2004, CURR GENE THER, V4, P199; Murphy A, 2009, AM J HUM GENET, V85, P87, DOI 10.1016/j.ajhg.2009.06.011; Nathan MB, 2006, RECENT EPIDEMIOLOGIC; Patel A, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-3; Pfeffer LM, 2011, J INTERF CYTOK RES, V31, P553, DOI 10.1089/jir.2011.0028; Plenchette S, 2007, CURR OPIN INVEST DR, V8, P469; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Straszewski-Chavez SL, 2007, J BIOL CHEM, V282, P13059, DOI 10.1074/jbc.M609038200; Sun YW, 2008, CANCER LETT, V260, P62, DOI 10.1016/j.canlet.2007.10.014; Sutejo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033732; Tu SP, 2009, INT J CANCER, V125, P688, DOI 10.1002/ijc.24282; Wang JD, 2006, J BIOL CHEM, V281, P2451, DOI 10.1074/jbc.M505890200; Warke RV, 2008, J VIROL, V82, P555, DOI 10.1128/JVI.01694-06; Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003; Xia Y, 2006, MOL CELL BIOCHEM, V286, P67, DOI 10.1007/s11010-005-9094-2; Yu LF, 2007, CANCER-AM CANCER SOC, V109, P1996, DOI 10.1002/cncr.22624; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050	40	23	27	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2013	27	3					1062	1073		10.1096/fj.12-213967	http://dx.doi.org/10.1096/fj.12-213967			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23207547				2022-12-25	WOS:000315585200020
J	Giang, KTN; Lian, YL; Pang, EWH; Phuong, QTN; Tran, TD; Tam, JP				Giang Kien Truc Nguyen; Lian, Yilong; Pang, Edmund Weng Hou; Phuong Quoc Thuc Nguyen; Tuan Dinh Tran; Tam, James P.			Discovery of Linear Cyclotides in Monocot Plant Panicum laxum of Poaceae Family Provides New Insights into Evolution and Distribution of Cyclotides in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC CYSTINE KNOT; KALATA B1; OLDENLANDIA-AFFINIS; CIRCULAR PROTEINS; ANTIMICROBIAL PEPTIDES; MEMBRANE INTERACTIONS; CYTOTOXIC CYCLOTIDES; MACROCYCLIC PEPTIDES; HYBANTHUS VIOLACEAE; TRYPSIN-INHIBITORS	Cyclotides are disulfide-rich macrocyclic peptides that display a wide range of bioactivities and represent an important group of plant defense peptide biologics. A few linear variants of cyclotides have recently been identified. They share a high sequence homology with cyclotides but are biosynthetically unable to cyclize from their precursors. All hitherto reported cyclotides and their acyclic variants were isolated from dicot plants of the Rubiaceae, Violaceae, Cucurbitaceae, and recently the Fabaceae and Solanaceae families. Although several cyclotide-like genes in the Poaceae family were known from the data mining of the National Center for Biotechnology Information (NCBI) nucleotide database, their expression at the protein level has yet to be proven. Here, we report the discovery and characterization of nine novel linear cyclotides, designated as panitides L1-9, from the Panicum laxum of the Poaceae family and provide the first evidence of linear cyclotides at the protein level in a monocot plant. Disulfide mapping of panitide L3 showed that it possesses a cystine knot arrangement similar to cyclotides. Several panitides were shown to be active against Escherichia coli and cytotoxic to HeLa cells. They also displayed a high stability against heat and proteolytic degradation. Oxidative folding of the disulfide-reduced panitide L1 showed that it can fold efficiently into its native form. The presence of linear cyclotides in both dicots and monocots suggests their ancient origin and existence before the divergence of these two groups of flowering plants. Moreover, the Poaceae family contains many important food crops, and our discovery may open up new avenues of research using cyclotides and their acyclic variants in crop protection.	[Giang Kien Truc Nguyen; Lian, Yilong; Pang, Edmund Weng Hou; Phuong Quoc Thuc Nguyen; Tuan Dinh Tran; Tam, James P.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Tuan Dinh Tran] Korea Adv Inst Sci & Technol, Taejon 305701, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Korea Advanced Institute of Science & Technology (KAIST)	Tam, JP (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	jptam@ntu.edu.sg	Tam, James P/A-2176-2011	Tam, James P/0000-0003-4433-198X; Lian, Yilong/0000-0003-0139-1245	A*STAR Biomedical Research Council Grant [09/1/22/19/612]; Competitive Research Grant by National Research Foundation in Singapore	A*STAR Biomedical Research Council Grant(Agency for Science Technology & Research (A*STAR)); Competitive Research Grant by National Research Foundation in Singapore	This work was supported by A*STAR Biomedical Research Council Grant 09/1/22/19/612 and the Competitive Research Grant by National Research Foundation in Singapore.	Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; CAMPBELL CS, 1985, J ARNOLD ARBORETUM, V66, P123, DOI 10.5962/bhl.part.13181; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Cordain L, 1999, World Rev Nutr Diet, V84, P19; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; Dutton JL, 2004, J BIOL CHEM, V279, P46858, DOI 10.1074/jbc.M407421200; Firth DJ, 2002, TROP GRASSLANDS, V36, P1; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Giang KTN, 2011, J BIOL CHEM, V286, P44833, DOI 10.1074/jbc.M111.290296; Giang KTN, 2011, J BIOL CHEM, V286, P24275, DOI 10.1074/jbc.M111.229922; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939; Gran L, 2000, J ETHNOPHARMACOL, V70, P197, DOI 10.1016/S0378-8741(99)00175-0; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Gustafson KR, 2004, CURR PROTEIN PEPT SC, V5, P331, DOI 10.2174/1389203043379468; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hallock YF, 2000, J ORG CHEM, V65, P124, DOI 10.1021/jo990952r; He WJ, 2011, PEPTIDES, V32, P1719, DOI 10.1016/j.peptides.2011.06.016; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Ireland DC, 2006, J MOL BIOL, V357, P1522, DOI 10.1016/j.jmb.2006.01.051; Desbiez ALJ, 2011, MAMM BIOL, V76, P351, DOI 10.1016/j.mambio.2010.10.008; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Kamimori H, 2005, ANAL BIOCHEM, V337, P149, DOI 10.1016/j.ab.2004.10.028; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Mar RI, 1996, PHYTOCHEMISTRY, V41, P1265, DOI 10.1016/0031-9422(95)00734-2; Mulvenna JP, 2006, PLANT CELL, V18, P2134, DOI 10.1105/tpc.106.042812; Mylne JS, 2012, PLANT CELL, V24, P2765, DOI 10.1105/tpc.112.099085; Mylne JS, 2010, BIOPOLYMERS, V94, P635, DOI 10.1002/bip.21419; Ng KF, 1997, J AGR SCI, V128, P347, DOI 10.1017/S0021859696004248; Nguyen GKT, 2012, J BIOL CHEM, V287, P17598, DOI 10.1074/jbc.M111.338970; Paterson AH, 2005, GENOME RES, V15, P1643, DOI 10.1101/gr.3725905; Poth AG, 2012, J BIOL CHEM, V287, P27033, DOI 10.1074/jbc.M112.370841; Poth AG, 2011, ACS CHEM BIOL, V6, P345, DOI 10.1021/cb100388j; SHANTZ HL, 1954, ECOLOGY, V35, P143, DOI 10.2307/1931110; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Tailor RH, 1997, J BIOL CHEM, V272, P24480, DOI 10.1074/jbc.272.39.24480; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Trabi M, 2009, ORG BIOMOL CHEM, V7, P2378, DOI 10.1039/b823020j; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002	46	79	84	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3370	3380		10.1074/jbc.M112.415356	http://dx.doi.org/10.1074/jbc.M112.415356			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23195955	Green Published, hybrid			2022-12-25	WOS:000314397900042
J	Azarias, G; Kruusmagi, M; Connor, S; Akkuratov, EE; Liu, XL; Lyons, D; Brismar, H; Broberger, C; Aperia, A				Azarias, Guillaume; Kruusmagi, Markus; Connor, Siobhan; Akkuratov, Evgeny E.; Liu, Xiao-Li; Lyons, David; Brismar, Hjalmar; Broberger, Christian; Aperia, Anita			A Specific and Essential Role for Na,K-ATPase alpha 3 in Neurons Co-expressing alpha 1 and alpha 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNEL; DE-NOVO MUTATIONS; ENZYMATIC-PROPERTIES; ALTERNATING HEMIPLEGIA; PROTEIN-KINASE; BINDING SITE; K+-ATPASE; NA+; SODIUM; ISOFORMS	Most neurons co-express two catalytic isoforms of Na,K-ATPase, the ubiquitous alpha 1, and the more selectively expressed alpha 3. Although neurological syndromes are associated with alpha 3 mutations, the specific role of this isoform is not completely understood. Here, we used electrophysiological and Na+ imaging techniques to study the role of alpha 3 in central nervous system neurons expressing both isoforms. Under basal conditions, selective inhibition of alpha 3 using a low concentration of the cardiac glycoside, ouabain, resulted in a modest increase in intracellular Na+ concentration ([Na+](i)) accompanied by membrane potential depolarization. When neurons were challenged with a large rapid increase in [Na+](i), similar to what could be expected following suprathreshold neuronal activity, selective inhibition of alpha 3 almost completely abolished the capacity to restore [Na+](i) in soma and dendrite. Recordings of Na, K-ATPase specific current supported the notion that when [Na+](i) is elevated in the neuron, alpha 3 is the predominant isoform responsible for rapid extrusion of Na+. Low concentrations of ouabain were also found to disrupt cortical network oscillations, providing further support for the importance of alpha 3 function in the central nervous system. The alpha isoforms express a well conserved protein kinase A consensus site, which is structurally associated with an Na+ binding site. Following activation of protein kinase A, both the alpha 3-dependent current and restoration of dendritic [Na+](i) were significantly attenuated, indicating that alpha 3 is a target for phosphorylation and may participate in short term regulation of neuronal function.	[Azarias, Guillaume; Kruusmagi, Markus; Connor, Siobhan; Liu, Xiao-Li; Brismar, Hjalmar; Aperia, Anita] Karolinska Inst, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden; [Connor, Siobhan; Lyons, David; Broberger, Christian] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Akkuratov, Evgeny E.] Moscow MV Lomonosov State Univ, Int Ctr Biotechnol, Moscow 119991, Russia; [Brismar, Hjalmar] Royal Inst Technol, Dept Cell Phys, Sci Life Lab, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Lomonosov Moscow State University; Royal Institute of Technology	Aperia, A (corresponding author), Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden.	anita.aperia@ki.se	Liu, Xiaoli/HGE-7614-2022; Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Lyons, David/0000-0002-3391-5878; Akkuratov, Evgeny/0000-0002-2552-9512	Swedish Research Council; Familjen Erling Perssons Stiftelse; Torsten Soderberg Foundation; Rut and Arvid Wolffs stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Familjen Erling Perssons Stiftelse; Torsten Soderberg Foundation; Rut and Arvid Wolffs stiftelse	This work was supported by grants from the Swedish Research Council (to A. A. and C. B.), Familjen Erling Perssons Stiftelse (to A. A.), The Torsten Soderberg Foundation (to A. A.), and Rut and Arvid Wolffs stiftelse (to C. B.).	Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Bhattacharjee A, 2003, J NEUROSCI, V23, P11681; BLANCO G, 1995, BIOCHEMISTRY-US, V34, P9897, DOI 10.1021/bi00031a011; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; CAMERON R, 1994, MOL BRAIN RES, V21, P333, DOI 10.1016/0169-328X(94)90264-X; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; DRYER SE, 1994, TRENDS NEUROSCI, V17, P155, DOI 10.1016/0166-2236(94)90093-0; FISONE G, 1994, J BIOL CHEM, V269, P9368; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hamada L, 2003, BRIT J PHARMACOL, V138, P1517, DOI 10.1038/sj.bjp.0705170; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; HIEBER V, 1991, CELL MOL NEUROBIOL, V11, P253, DOI 10.1007/BF00769038; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Khan F, 2008, AM J PHYSIOL-RENAL, V295, pF1110, DOI 10.1152/ajprenal.90336.2008; Kim JH, 2007, NAT NEUROSCI, V10, P196, DOI 10.1038/nn1839; Kirshenbaum GS, 2011, GENES BRAIN BEHAV, V10, P542, DOI 10.1111/j.1601-183X.2011.00691.x; Kirshenbaum GS, 2011, P NATL ACAD SCI USA, V108, P18144, DOI 10.1073/pnas.1108416108; Lingrel JB, 2007, J BIOENERG BIOMEMBR, V39, P385, DOI 10.1007/s10863-007-9107-9; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; MARKS MJ, 1978, LIFE SCI, V23, P2735, DOI 10.1016/0024-3205(78)90654-9; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; Munakata M, 1998, BRAIN RES, V800, P282, DOI 10.1016/S0006-8993(98)00533-2; MUNZER JS, 1994, J BIOL CHEM, V269, P16668; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; Poulsen H, 2012, J BIOL CHEM, V287, P15959, DOI 10.1074/jbc.M112.340406; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; Rose CR, 1997, J PHYSIOL-LONDON, V499, P573, DOI 10.1113/jphysiol.1997.sp021951; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Rose CR, 1999, PFLUG ARCH EUR J PHY, V439, P201, DOI 10.1007/s004240051145; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SCHATZMANN HJ, 1953, HELV PHYSIOL PHARM A, V11, P346; SHYJAN AW, 1990, P NATL ACAD SCI USA, V87, P1178, DOI 10.1073/pnas.87.3.1178; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; SWEADNER KJ, 1985, J BIOL CHEM, V260, P1508; SWEADNER KJ, 1979, J BIOL CHEM, V254, P6060; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; URAYAMA O, 1988, BIOCHEM BIOPH RES CO, V156, P796, DOI 10.1016/S0006-291X(88)80914-8; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	47	81	84	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2734	2743		10.1074/jbc.M112.425785	http://dx.doi.org/10.1074/jbc.M112.425785			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23195960	Green Published, hybrid			2022-12-25	WOS:000314211500057
J	Langlois, TJ; Fitzpatrick, BR; Fairclough, DV; Wakefield, CB; Hesp, A; McLean, DL; Harvey, ES; Meeuwig, JJ				Langlois, Timothy J.; Fitzpatrick, Benjamin R.; Fairclough, David V.; Wakefield, Corey B.; Hesp, Alex; McLean, Dianne L.; Harvey, Euan S.; Meeuwig, Jessica J.			Similarities between Line Fishing and Baited Stereo-Video Estimations of Length-Frequency: Novel Application of Kernel Density Estimates	PLOS ONE			English	Article							SNAPPER PAGRUS-AURATUS; REPRODUCTIVE-BIOLOGY; MARINE EMBAYMENT; SIZE SELECTION; VISUAL CENSUS; REEF FISHES; BODY-SIZE; INDICATORS; ASSEMBLAGES; GROWTH	Age structure data is essential for single species stock assessments but length-frequency data can provide complementary information. In south-western Australia, the majority of these data for exploited species are derived from line caught fish. However, baited remote underwater stereo-video systems (stereo-BRUVS) surveys have also been found to provide accurate length measurements. Given that line fishing tends to be biased towards larger fish, we predicted that, stereo-BRUVS would yield length-frequency data with a smaller mean length and skewed towards smaller fish than that collected by fisheries-independent line fishing. To assess the biases and selectivity of stereo-BRUVS and line fishing we compared the length-frequencies obtained for three commonly fished species, using a novel application of the Kernel Density Estimate (KDE) method and the established Kolmogorov-Smirnov (KS) test. The shape of the length-frequency distribution obtained for the labrid Choerodon rubescens by stereo-BRUVS and line fishing did not differ significantly, but, as predicted, the mean length estimated from stereo-BRUVS was 17% smaller. Contrary to our predictions, the mean length and shape of the length-frequency distribution for the epinephelid Epinephelides armatus did not differ significantly between line fishing and stereo-BRUVS. For the sparid Pagrus auratus, the length frequency distribution derived from the stereo-BRUVS method was bi-modal, while that from line fishing was uni-modal. However, the location of the first modal length class for P. auratus observed by each sampling method was similar. No differences were found between the results of the KS and KDE tests, however, KDE provided a data-driven method for approximating length-frequency data to a probability function and a useful way of describing and testing any differences between length-frequency samples. This study found the overall size selectivity of line fishing and stereo-BRUVS were unexpectedly similar.	[Langlois, Timothy J.; Fitzpatrick, Benjamin R.; McLean, Dianne L.; Harvey, Euan S.; Meeuwig, Jessica J.] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Langlois, Timothy J.; McLean, Dianne L.; Harvey, Euan S.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Fitzpatrick, Benjamin R.; Meeuwig, Jessica J.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Fitzpatrick, Benjamin R.; Meeuwig, Jessica J.] Univ Western Australia, Ctr Marine Futures, Perth, WA 6009, Australia; [Fairclough, David V.; Wakefield, Corey B.; Hesp, Alex] Govt Western Australia, Dept Fisheries, Western Australian Fisheries & Marine Res Labs, Perth, WA, Australia; [Fairclough, David V.; Wakefield, Corey B.; Hesp, Alex] Murdoch Univ, Sch Biol Sci & Biotechnol, Ctr Fish & Fisheries Res, Perth, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Western Australian Fisheries & Marine Research Laboratories; Murdoch University	Langlois, TJ (corresponding author), Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia.	timothy.langlois@uwa.edu.au	Langlois, Tim/H-5241-2014; Harvey, Euan/B-2896-2011; McLean, Dianne/H-2449-2012; Fairclough, David V/F-2596-2013	Harvey, Euan/0000-0002-9069-4581; McLean, Dianne/0000-0002-0306-8348; Fairclough, David V/0000-0002-9620-5064; Glenn, Travis/0000-0001-7725-3637; Meeuwig, Jessica/0000-0003-1169-8785; Fitzpatrick, Benjamin R./0000-0003-1916-0939	Western Australian Marine Science Institute; iVEC summer industry internship; Fisheries Research and Development Corporation (FRDC) [2000/137]; Murdoch University; Department of Fisheries	Western Australian Marine Science Institute; iVEC summer industry internship; Fisheries Research and Development Corporation (FRDC)(Fisheries R&D Corp); Murdoch University; Department of Fisheries	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research received funding from the Western Australian Marine Science Institute project to assist with the implementation of an ecosystem approach to the management of fisheries resources (TJL) and from the iVEC summer industry internship (BRF). Stereo-BRUVS data was sourced from 'Securing Western Australia's Marine Futures' a combined Australian and Western Australian Government Natural Heritage Trust (NHT) Strategic Project developed by South Coast Natural Resource Management, 'Monitoring of Reef Observation Areas at the Houtman-Abrolhos Islands' a combined Australian and Western Australian Government NHT initiative through the Northern Agricultural Catchment Council, and 'Benchmarking of the Rottnest Island Marine Reserve' developed by the Rottnest Island Authority. Fisheries Research and Development Corporation (FRDC 2000/137) funded line sampling for C. rubescens. Murdoch University funded line sampling for E. armatus. Pagrus auratus line sampling was funded by both Murdoch University and the Department of Fisheries.	Alos J, 2008, ICES J MAR SCI, V65, P899, DOI 10.1093/icesjms/fsn067; Bowman A., 2010, R PACKAGE SM NONPARA; Bowman AW, 1997, APPL SMOOTHING TECHN; Cappo M, 2009, INFLUENCE ZONING C 2; Cappo M, 2003, POTENTIAL VIDEO TECH; Cossington S, 2010, J FISH BIOL, V77, P600, DOI 10.1111/j.1095-8649.2010.02706.x; Fairclough D.V., 2005, BIOL 4 TUSKFISH SPEC; Fairclough DV, 2011, J EXP MAR BIOL ECOL, V403, P46, DOI 10.1016/j.jembe.2011.04.005; Fisher JAD, 2010, MAR ECOL PROG SER, V405, P1, DOI 10.3354/meps08601; Fletcher WJ, 2010, MAR POLICY, V34, P1226, DOI 10.1016/j.marpol.2010.04.007; Froese R, 2004, FISH FISH, V5, P86, DOI 10.1111/j.1467-2979.2004.00144.x; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; GROENEVELD RA, 1977, AM STAT, V31, P120, DOI 10.2307/2682959; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Harvey ES, 2010, MAR TECHNOL SOC J, V44, P75, DOI 10.4031/MTSJ.44.1.3; Hetrick NJ, 2006, N AM J FISH MANAGE, V26, P13, DOI 10.1577/M04-152.1; JENNINGS S, 1995, J FISH BIOL, V47, P733, DOI 10.1111/j.1095-8649.1995.tb01938.x; Jennings S, 2005, ICES J MAR SCI, V62, P397, DOI 10.1016/j.icesjms.2004.07.030; Jennings S, 2007, J ANIM ECOL, V76, P72, DOI 10.1111/j.1365-2656.2006.01180.x; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Langlois TJ, 2012, ECOL INDIC, V23, P524, DOI 10.1016/j.ecolind.2012.04.030; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Langlois TJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P886, DOI 10.1111/j.1466-8238.2011.00734.x; Lenanton R., 2009, SPATIAL SCALES EXP 2; Lester NP, 2004, P ROY SOC B-BIOL SCI, V271, P1625, DOI 10.1098/rspb.2004.2778; Liao JG, 2010, J NONPARAMETR STAT, V22, P105, DOI 10.1080/10485250903194003; Link JS, 2002, FISHERIES, V27, P10, DOI 10.1577/1548-8446(2002)027<0010:ECIFM>2.0.CO;2; MAGNUSON JJ, 1991, ECOL APPL, V1, P13, DOI 10.2307/1941844; McLean DL, 2010, MAR ECOL PROG SER, V418, P189, DOI 10.3354/meps08834; Miranda LE, 2007, T AM FISH SOC, V136, P409, DOI 10.1577/T06-151.1; Molloy PP, 2007, EVOLUTION, V61, P640, DOI 10.1111/j.1558-5646.2007.00050.x; Moore SE, 2007, J FISH BIOL, V71, P1407, DOI 10.1111/j.1095-8649.2007.01614.x; Morrison M, 2006, FISH RES, V82, P150, DOI 10.1016/j.fishres.2006.06.024; Murawski SA, 2000, ICES J MAR SCI, V57, P649, DOI 10.1006/jmsc.2000.0738; Neat F, 2010, DEEP-SEA RES PT I, V57, P434, DOI 10.1016/j.dsr.2009.12.003; NEWMAN SJ, 1995, FISH RES, V23, P237, DOI 10.1016/0165-7836(94)00353-X; OSENBERG CW, 1989, ECOL MONOGR, V59, P405, DOI 10.2307/1943074; Otway NM, 1996, FISH RES, V28, P119, DOI 10.1016/0165-7836(96)00500-0; PAULIN CD, 1990, NEW ZEAL J MAR FRESH, V24, P259, DOI 10.1080/00288330.1990.9516422; R Development Core Team, 2012, R LANG ENV STAT COMP; Rochet MJ, 2003, CAN J FISH AQUAT SCI, V60, P86, DOI 10.1139/F02-164; Sanvicente-Anorve L, 2003, USE KERNEL DENSITY E, P419; Sekhon JS, 2011, J STAT SOFTW, V42, P1; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Shin YJ, 2001, AQUAT LIVING RESOUR, V14, P65, DOI 10.1016/S0990-7440(01)01106-8; Sogard SM, 1997, B MAR SCI, V60, P1129; Stoner AW, 2004, J FISH BIOL, V64, P1712, DOI 10.1111/j.0022-1112.2004.00434.x; Wakefield CB, 2010, J FISH BIOL, V77, P1359, DOI 10.1111/j.1095-8649.2010.02756.x; Wakefield CB., 2006, LATITUDINAL TEMPORAL; Wakefield CB, 2009, 186 DEP FISH; Wakefield CB, 2007, FISH RES, V85, P37, DOI 10.1016/j.fishres.2006.11.037; Wakefield CB, 2011, FISH RES, V109, P243, DOI 10.1016/j.fishres.2011.02.008; Wand M, 2011, KERNSMOOTH FUNCTIONS; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Welch DJ, 2010, MAR FRESHWATER RES, V61, P1134, DOI 10.1071/MF09278; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Wilson SK, 2010, ECOL APPL, V20, P442, DOI 10.1890/08-2205.1; Wirtz P, 2001, J MAR BIOL ASSOC UK, V81, P187, DOI 10.1017/S0025315401003629; Wise BS, 2007, SPATIAL SCALES EXP 1; Zar JH, 1999, BIOSTATISTICAL ANAL	64	89	92	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e45973	10.1371/journal.pone.0045973	http://dx.doi.org/10.1371/journal.pone.0045973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209547	Green Published, gold			2022-12-25	WOS:000312104900001
J	Rodenburg, GD; Fransen, F; Bogaert, D; Schipper, K; Groenwold, RHH; Hamstra, HJ; Westerhuis, BM; van de Beek, D; van der Ley, P; Sanders, EAM; van der Ende, A				Rodenburg, Gerwin D.; Fransen, Floris; Bogaert, Debby; Schipper, Kim; Groenwold, Rolf H. H.; Hamstra, Hendrik Jan; Westerhuis, Brenda M.; van de Beek, Diederik; van der Ley, Peter; Sanders, Elisabeth A. M.; van der Ende, Arie			Prevalence and Clinical Course in Invasive Infections with Meningococcal Endotoxin Variants	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; IMMUNITY; DISEASE; INNATE; MECHANISMS; LPS	Background: Meningococci produce a penta-acylated instead of hexa-acylated lipid A when their IpxL1 gene is inactivated. Meningococcal strains with such lipid A endotoxin variants have been found previously in adult meningitis patients, where they caused less blood coagulopathy because of decreased TLR4 activation. Methods: A cohort of 448 isolates from patients with invasive meningococcal disease in the Netherlands were screened for the ability to induce IL-6 in monocytic cell Mono Mac 6 cells. The IpxL1 gene was sequenced of isolates, which show poor capacity to induce IL-6.. Clinical characteristics of patients were retrieved from hospital records. Results: Of 448 patients, 29 (6.5%) were infected with meningococci expressing a lipid A variant strain. Lipid A variation was not associated with a specific serogroup or genotype. Infections with lipid A variants were associated with older age (19.3 vs. 5.9 (median) years, p = 0.007) and higher prevalence of underlying comorbidities (39% vs. 17%; p = 0.004) compared to wild-type strains. Patients infected with lipid A variant strains had less severe infections like meningitis or shock (OR 0.23; 95% CI 0.09-0.58) and were less often admitted to intensive care (OR 0.21; 95% CI 0.07-0.60) compared to wild-type strains, independent of age, underlying comorbidities or strain characteristics. Conclusions: In adults with meningococcal disease lipid A variation is rather common. Infection with penta-acylated lipid A variant meningococci is associated with a less severe disease course.	[Rodenburg, Gerwin D.; Bogaert, Debby; Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands; [Fransen, Floris; Hamstra, Hendrik Jan; Westerhuis, Brenda M.; van der Ley, Peter] Natl Inst Publ Hlth & Environm, Unit Vaccinol, NL-3720 BA Bilthoven, Netherlands; [Fransen, Floris] Univ Utrecht, Dept Immunol & Infect Dis, Utrecht, Netherlands; [Schipper, Kim; van der Ende, Arie] Acad Med Ctr Amsterdam, Dept Med Microbiol, Ctr Infect & Immun Amsterdam, Amsterdam, Netherlands; [Groenwold, Rolf H. H.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [van der Ende, Arie] Univ Amsterdam, Acad Med Ctr, Netherlands Reference Lab Bacterial Meningitis, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Netherlands National Institute for Public Health & the Environment; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Rodenburg, GD (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Immunol & Infect Dis, Utrecht, Netherlands.	g.d.rodenburg@umcutrecht.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X; Bogaert, Debby/0000-0003-2651-7000; van der Ende, Arie/0000-0003-1298-3086; Groenwold, Rolf/0000-0001-9238-6999	National Institute for Public Health and the Environment, Bilthoven; Wyeth; Baxter; GlaxoSmithKline	National Institute for Public Health and the Environment, Bilthoven; Wyeth(Wyeth); Baxter; GlaxoSmithKline(GlaxoSmithKline)	National Institute for Public Health and the Environment, Bilthoven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: ES reports receiving unrestricted grants from Wyeth and Baxter for research, consulting fees for Wyeth and GlaxoSmithKline, lecture fees from Wyeth and grant support from Wyeth and GlaxoSmithKline for vaccine studies. AvdE received unrestricted grants from Wyeth and Novartis. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bogaert D, 2009, INFECT IMMUN, V77, P1613, DOI 10.1128/IAI.00871-08; Brandtzaeg P, 2001, J ENDOTOXIN RES, V7, P401, DOI 10.1177/09680519010070060401; Bryant CE, 2010, NAT REV MICROBIOL, V8, P8, DOI 10.1038/nrmicro2266; Claus H, 2005, J INFECT DIS, V191, P1263, DOI 10.1086/428590; de Greeff SC, 2008, EUR J CLIN MICROBIOL, V27, P985, DOI 10.1007/s10096-008-0535-1; Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; Fransen F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000396; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Heckenberg SGB, 2008, MEDICINE, V87, P185, DOI 10.1097/MD.0b013e318180a6b4; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lo H, 2009, LANCET INFECT DIS, V9, P418, DOI 10.1016/S1473-3099(09)70132-X; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Pollard AJ, 2001, VACCINE, V19, P1327, DOI 10.1016/S0264-410X(00)00333-9; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Sprong T, 2001, J LEUKOCYTE BIOL, V70, P283; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P27, DOI 10.1111/j.1574-6976.2006.00060.x; Tully J, 2006, BMJ-BRIT MED J, V332, P445, DOI 10.1136/bmj.38725.728472.BE; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; Wolfe DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004280; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324; Zughaier SM, 2004, INFECT IMMUN, V72, P371, DOI 10.1128/IAI.72.1.371-380.2004	27	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49295	10.1371/journal.pone.0049295	http://dx.doi.org/10.1371/journal.pone.0049295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209568	Green Published, gold, Green Submitted			2022-12-25	WOS:000312104900006
J	Sun, YW; Zhu, ZX; Chen, SP; Balakrishnan, J; Abbott, D; Ahuja, AT; Pickwell-MacPherson, E				Sun, Yiwen; Zhu, Zexuan; Chen, Siping; Balakrishnan, Jega; Abbott, Derek; Ahuja, Anil T.; Pickwell-MacPherson, Emma			Observing the Temperature Dependent Transition of the GP2 Peptide Using Terahertz Spectroscopy	PLOS ONE			English	Article							TIME-DOMAIN SPECTROSCOPY; GLASS-TRANSITION; DIELECTRIC-RELAXATION; MOLECULAR-WEIGHT; HYDRATION WATER; BREAST-CANCER; LIQUID WATER; DYNAMICS; SIMULATION; SPECTRA	The GP2 peptide is derived from the Human Epidermal growth factor Receptor 2 (HER2/nue), a marker protein for breast cancer present in saliva. In this paper we study the temperature dependent behavior of hydrated GP2 at terahertz frequencies and find that the peptide undergoes a dynamic transition between 200 and 220 K. By fitting suitable molecular models to the frequency response we determine the molecular processes involved above and below the transition temperature (T-D). In particular, we show that below T-D the dynamic transition is dominated by a simple harmonic vibration with a slow and temperature dependent relaxation time constant and that above T-D, the dynamic behavior is governed by two oscillators, one of which has a fast and temperature independent relaxation time constant and the other of which is a heavily damped oscillator with a slow and temperature dependent time constant. Furthermore a red shifting of the characteristic frequency of the damped oscillator was observed, confirming the presence of a non-harmonic vibration potential. Our measurements and modeling of GP2 highlight the unique capabilities of THz spectroscopy for protein characterization.	[Sun, Yiwen; Chen, Siping] Shenzhen Univ, Natl Reg Key Technol Engn Lab Med Ultrasound, Guangdong Key Lab Biomed Measurements & Ultrasoun, Dept Biomed Engn,Sch Med, Shenzhen, Peoples R China; [Zhu, Zexuan] Shenzhen Univ, Coll Comp Sci & Software Engn, Shenzhen, Peoples R China; [Balakrishnan, Jega; Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Balakrishnan, Jega; Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia; [Ahuja, Anil T.] Chinese Univ Hong Kong, Diagnost Radiol & Organ Imaging Dept, Shatin, Hong Kong, Peoples R China; [Pickwell-MacPherson, Emma] Chinese Univ Hong Kong, Dept Elect Engn, Shatin, Hong Kong, Peoples R China	Shenzhen University; Shenzhen University; University of Adelaide; University of Adelaide; Chinese University of Hong Kong; Chinese University of Hong Kong	Pickwell-MacPherson, E (corresponding author), Chinese Univ Hong Kong, Dept Elect Engn, Shatin, Hong Kong, Peoples R China.	emma@ee.cuhk.edu.hk	Ahuja, Anil T/H-4031-2017; MacPherson, Emma/AAO-5260-2020; CHEN, SI/GZL-4800-2022; Abbott, Derek/E-8352-2011	Ahuja, Anil T/0000-0002-0726-5402; MacPherson, Emma/0000-0001-6062-5959; Abbott, Derek/0000-0002-0945-2674	Research Grants Council of the Hong Kong Government [419609]; Lee Hysan Foundation Research Grant Scheme, Hong Kong; Australian Research Council [DP0556112]; National Natural Science Foundation of China [61205092, 61001185]; National Science Foundation of SZU [201115]; Guangdong Natural Science Foundation [S2012040007668]	Research Grants Council of the Hong Kong Government(Hong Kong Research Grants Council); Lee Hysan Foundation Research Grant Scheme, Hong Kong; Australian Research Council(Australian Research Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of SZU; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	The authors gratefully acknowledge partial financial support for this work from the Research Grants Council of the Hong Kong Government (No. 419609); Lee Hysan Foundation Research Grant Scheme, Hong Kong; Australian Research Council (No. DP0556112); National Natural Science Foundation of China (No. 61205092 & 61001185); National Science Foundation of SZU (No. 201115) and the Guangdong Natural Science Foundation (No. S2012040007668). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan J, 2009, IEEE PHOTONICS J, V1, P88, DOI 10.1109/JPHOT.2009.2027135; Balakrishnan J, 2009, APPL OPTICS, V48, P2262, DOI 10.1364/AO.48.002262; BARTHEL J, 1990, CHEM PHYS LETT, V165, P369, DOI 10.1016/0009-2614(90)87204-5; Betting H, 2001, PHYS CHEM CHEM PHYS, V3, P1688, DOI 10.1039/b008827g; Billmeyer F.W., 1994, TXB POLYM SCI, V3rd ed., P320; Blundell S, 2006, CONCEPTS MODERN PHYS, P230; BROOKS B, 1985, P NATL ACAD SCI USA, V82, P4995, DOI 10.1073/pnas.82.15.4995; Chantry GW, 1984, LONG WAVE OPTICS SCI, P212; Chen SH, 2006, P NATL ACAD SCI USA, V103, P9012, DOI 10.1073/pnas.0602474103; Clive KS, 2012, J SURG ONCOL, V105, P452, DOI 10.1002/jso.21723; DAWKINS HJS, 1993, PATHOL RES PRACT, V189, P1233, DOI 10.1016/S0344-0338(11)80853-8; Doster W, 2005, BBA-PROTEINS PROTEOM, V1749, P173, DOI 10.1016/j.bbapap.2005.03.010; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; Fischer BM, 2005, THESIS U FREIBURG FR; Fritz GP, 2003, REP PROG PHYS, V66, P103; Frohlich H, 1958, THEORY DIELECTRICS, P109; Grossman M, 2011, NAT STRUCT MOL BIOL, V18, P1102, DOI 10.1038/nsmb.2120; HAVRILIA.S, 1967, POLYMER, V8, P161, DOI 10.1016/0032-3861(67)90021-3; Herbert K, 1980, THERMAL PHYS; Heyden M, 2010, P NATL ACAD SCI USA, V107, P12068, DOI 10.1073/pnas.0914885107; Jepsen PU, 2007, OPT EXPRESS, V15, P14717, DOI 10.1364/OE.15.014717; Kealley CS, 2010, BBA-PROTEINS PROTEOM, V1804, P34, DOI 10.1016/j.bbapap.2009.06.027; Khodadadi S, 2010, BBA-PROTEINS PROTEOM, V1804, P15, DOI 10.1016/j.bbapap.2009.05.006; Kindt JT, 1996, J PHYS CHEM-US, V100, P10373, DOI 10.1021/jp960141g; Knab JR, 2007, P IEEE, V95, P1605, DOI 10.1109/JPROC.2007.898906; Korter TM, 2004, CHEM PHYS LETT, V385, P45, DOI 10.1016/j.cplett.2003.12.060; Kubo R., 1991, STAT PHYS; Kutteruf MR, 2003, CHEM PHYS LETT, V375, P337, DOI 10.1016/S0009-2614(03)00856-X; Martin A, 1991, PHYS PHARM PHYS CHEM, P628; Mittleman D, 2003, SENSING TERAHERTZ RA, P155; PETHIG R, 1992, ANNU REV PHYS CHEM, V43, P177, DOI 10.1146/annurev.physchem.43.1.177; Pickwell E, 2004, APPL PHYS LETT, V84, P2190, DOI 10.1063/1.1688448; Ronne C, 1997, J CHEM PHYS, V107, P5319, DOI 10.1063/1.474242; Roth CB, 2006, EUR PHYS J E, V20, P441, DOI 10.1140/epje/i2006-10034-0; Roudaut G., 2004, Innovative Food Science & Emerging Technologies, V5, P127, DOI 10.1016/j.ifset.2003.12.003; SENO Y, 1990, J MOL BIOL, V216, P95, DOI 10.1016/S0022-2836(05)80063-4; Sun YW, 2011, BIOPHYS J, V100, P225, DOI 10.1016/j.bpj.2010.11.020; Sun YW, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3268439; Suslyaev V. I., 1999, Russian Physics Journal, V42, P935, DOI 10.1007/BF02509685; Tanaka Y, 2001, INT J CANCER, V94, P540, DOI 10.1002/ijc.1508; TILTON RF, 1992, BIOCHEMISTRY-US, V31, P2469, DOI 10.1021/bi00124a006; Tournier AL, 2003, BIOPHYS J, V85, P1871, DOI 10.1016/S0006-3495(03)74614-1; Walther M, 2000, CHEM PHYS LETT, V332, P389, DOI 10.1016/S0009-2614(00)01271-9; Zeng XM, 2001, INT J PHARM, V218, P63, DOI 10.1016/S0378-5173(01)00613-5	44	10	11	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50306	10.1371/journal.pone.0050306	http://dx.doi.org/10.1371/journal.pone.0050306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209703	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700054
J	DeNiro, M; Al-Mohanna, FA				DeNiro, Michael; Al-Mohanna, Futwan A.			Zinc Transporter 8 (ZnT8) Expression Is Reduced by Ischemic Insults: A Potential Therapeutic Target to Prevent Ischemic Retinopathy (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							KAPPA-B; LOCUS; YC-1; POLYMORPHISM; ACTIVATION; APOPTOSIS; HYPOXIA; HOMEOSTASIS; DEFICIENCY; PROTECTS	The zinc (Zn++) transporter ZnT8 plays a crucial role in zinc homeostasis. It's been reported that an acute decrease in ZnT8 levels impairs beta cell function and Zn++ homeostasis, which contribute to the pathophysiology of diabetes mellitus (DM). Although ZnT8 expression has been detected in the retinal pigment epithelium (RPE), its expression profile in the retina has yet to be determined. Furthermore, the link between diabetes and ischemic retinopathy is well documented; nevertheless, the molecular mechanism(s) of such link has yet to be defined. Our aims were to; investigate the expression profile of ZnT8 in the retina; address the influence of ischemia on such expression; and evaluate the influence of YC-1; (3-(50-hydroxymethyl-20-furyl)-1-benzyl indazole), a hypoxia inducible factor-1 (HIF-1) inhibitor, on the status of ZnT8 expression. We used real-time RT-PCR, immunohistochemistry, and Western blot in the mouse model of oxygen-induced retinopathy (OIR) and Muller cells to evaluate the effects of ischemia/hypoxia and YC-1 on ZnT8 expression. Our data indicate that ZnT8 was strongly expressed in the outer nuclear layer (ONL), outer plexiform layer (OPL), ganglion cell layer (GCL), and nerve fiber layer (NFL), whereas the photoreceptor layer (PRL), inner nuclear layer (INL) and inner plexiform layer (IPL) showed moderate ZnT8 immunoreactivity. Furthermore, we demonstrate that retinal ischemic insult induces a significant downregulation of ZnT8 at the message and protein levels, YC-1 rescues the injured retina by restoring the ZnT8 to its basal homeostatic levels in the neovascular retinas. Our data indicate that ischemic retinopathy maybe mediated by aberrant Zn++ homeostasis caused by ZnT8 downregulation, whereas YC-1 plays a neuroprotective role against ischemic insult. Therefore, targeting ZnT8 provides a therapeutic strategy to combat neovascular eye diseases.	[DeNiro, Michael] King Khalid Eye Specialist Hosp, Wilmer Eye Inst Johns Hopkins Med, Res Dept, Riyadh, Saudi Arabia; [DeNiro, Michael] King Faisal Specialist Hosp & Res Ctr, Dept Comparat Med, Riyadh 11211, Saudi Arabia; [Al-Mohanna, Futwan A.] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh 11211, Saudi Arabia; [Al-Mohanna, Futwan A.] Al Faisal Univ, Dept Cell Biol & Mol Physiol, Riyadh, Saudi Arabia	Johns Hopkins University; Johns Hopkins Medicine; King Khaled Eye Specialist Hospital; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Alfaisal University	DeNiro, M (corresponding author), King Khalid Eye Specialist Hosp, Wilmer Eye Inst Johns Hopkins Med, Res Dept, Riyadh, Saudi Arabia.	mdeniro@kkesh.med.sa			King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; King Faisal Specialist Hospital and Research Centre	King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; King Faisal Specialist Hospital and Research Centre	This study was supported by King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia, (http://www.kkesh.med.sa/kkeshweb/en/), and King Faisal Specialist Hospital and Research Centre (http://www.kfshrc.edu.sa/wps/portal/En). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento CF, 2011, DIABETOLOGIA, V54, P1946, DOI 10.1007/s00125-011-2191-8; Bredt DS, 2003, MOL PHARMACOL, V63, P1206, DOI 10.1124/mol.63.6.1206; Cauchi S, 2010, MOL GENET METAB, V100, P77, DOI 10.1016/j.ymgme.2010.01.001; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chien WL, 2005, EUR J NEUROSCI, V21, P1679, DOI 10.1111/j.1460-9568.2005.03993.x; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chimienti F, 2005, BIOMETALS, V18, P313, DOI 10.1007/s10534-005-3687-9; Chou LC, 2007, BIOORGAN MED CHEM, V15, P1732, DOI 10.1016/j.bmc.2006.12.001; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; DeNiro M, 2010, MOL PHARMACOL, V77, P348, DOI 10.1124/mol.109.061366; DeNiro M, 2009, EXP EYE RES, V89, P700, DOI 10.1016/j.exer.2009.06.013; DeNiro M, 2011, OPEN DIABETES J, V4, P60; DeNiro M, 2011, OPEN DIABETES J, V4, P75; DeNiro M, 2012, MED HYPOTHESES, V78, P555, DOI 10.1016/j.mehy.2012.01.026; DeNiro M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022244; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Eng BH, 1998, J MEMBRANE BIOL, V166, P1, DOI 10.1007/s002329900442; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; Garg V K, 1994, J Assoc Physicians India, V42, P720; Garthwaite G, 2002, MOL PHARMACOL, V61, P97, DOI 10.1124/mol.61.1.97; Gnana-Prakasam JP, 2009, BIOCHEM J, V424, P243, DOI 10.1042/BJ20090424; Grahn BH, 2001, J AM COLL NUTR, V20, P106, DOI 10.1080/07315724.2001.10719022; Grunwald JE, 2005, INVEST OPHTH VIS SCI, V46, P1033, DOI 10.1167/iovs.04-1050; Ha KS, 2003, FASEB J, V17, P1036, DOI 10.1096/fj.02-0738com; Hall AG, 2005, J PEDIATR GASTR NUTR, V41, P72, DOI 10.1097/01.mpg.0000166800.54085.9c; Ho E, 2001, EXP BIOL MED, V226, P103, DOI 10.1177/153537020122600207; Kim I, 2008, NEUROREPORT, V19, P1063, DOI 10.1097/WNR.0b013e328304d9ac; Lee JY, 2000, J NEUROSCI, V20; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Leung KW, 2008, INVEST OPHTH VIS SCI, V49, P1221, DOI 10.1167/iovs.07-0781; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lu DY, 2007, BRIT J PHARMACOL, V151, P396, DOI 10.1038/sj.bjp.0707187; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mocchegiani E, 2008, TRENDS MOL MED, V14, P419, DOI 10.1016/j.molmed.2008.08.002; Moustafa SA, 2004, TOXICOL APPL PHARM, V201, P149, DOI 10.1016/j.taap.2004.05.014; Nardinocchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015048; Newsome DA, 1998, ARCH OPHTHALMOL-CHIC, V106, P192; Nusetti S, 2005, NEUROCHEM RES, V30, P1483, DOI 10.1007/s11064-005-8825-9; Ohly P, 2000, DIABETOLOGIA, V43, P1020, DOI 10.1007/s001250050009; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ozaki H, 1999, INVEST OPHTH VIS SCI, V40, P182; Pan SL, 2004, CARDIOVASC RES, V61, P152, DOI 10.1016/j.cardiores.2003.09.013; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Sarthy VP, 1998, INVEST OPHTH VIS SCI, V39, P212; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Staiger H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003962; Stefansson E, 2011, PROG RETIN EYE RES, V30, P72, DOI 10.1016/j.preteyeres.2010.09.003; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tallman DL, 1999, CAN J PHYSIOL PHARM, V77, P919, DOI 10.1139/cjpp-77-12-919; WALLWORK JC, 1983, J NUTR, V113, P1895, DOI 10.1093/jn/113.10.1895; Wenzlau JM, 2008, DIABETES, V57, P2693, DOI 10.2337/db08-0522; Yoo MH, 2004, INVEST OPHTH VIS SCI, V45, P1523, DOI 10.1167/iovs.03-1315; Yu HC, 2007, STUDIES NEUROPROTECT; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	58	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50360	10.1371/journal.pone.0050360	http://dx.doi.org/10.1371/journal.pone.0050360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209723	Green Published, gold			2022-12-25	WOS:000311885800068
J	Goswami, P; Murty, US; Mutheneni, SR; Kukkuthady, A; Krishnan, ST				Goswami, Prashant; Murty, Upadhayula Suryanarayana; Mutheneni, Srinivasa Rao; Kukkuthady, Avinash; Krishnan, Swathi Trithala			A Model of Malaria Epidemiology Involving Weather, Exposure and Transmission Applied to North East India	PLOS ONE			English	Article							VECTOR ANOPHELES-GAMBIAE; GLOBAL CLIMATE-CHANGE; MICROCLIMATE; DYNAMICS; RISK	Background: Quantitative relations between weather variables and malaria vector can enable pro-active control through meteorological monitoring. Such relations are also critical for reliable projections in a changing climate, especially since the vector abundance depends on a combination of weather variables, each in a given range. Further, such models need to be region-specific as vector population and exposure depend on regional characteristics. Methods: We consider days of genesis based on daily temperature, rainfall and humidity in given ranges. We define a single model parameter based on estimates of exposure and transmission to calibrate the model; the model is applied to 12 districts of Arunachal Pradesh, a region endemic to malaria. The epidemiological data is taken as blood samples that test positive. The meteorological data is adopted from NCEP daily Reanalysis on a global grid; population data is used to estimate exposure and transmission coefficients. Results: The observed annual cycles (2006-2010) and the interannual variability (2002-2010) of epidemiology are well simulated for each of the 12 districts by the model. While no single weather variable like temperature can reproduce the observed epidemiology, a combination of temperature, rainfall and humidity provides an accurate description of the annual cycle as well as the inter annual variability over all the 12 districts. Conclusion: Inclusion of the three meteorological variables, along with the expressions for exposure and transmission, can quite accurately represent observed epidemiology over multiple locations and different years. The model is potentially useful for outbreak forecasts at short time scales through high resolution weather monitoring; however, validation with longer and independent epidemiological data is required for more robust estimation of realizable skill. While the model has been examined over a specific region, the basic algorithm is easily applicable to other regions; the model can account for shifting vulnerability due to regional climate change.	[Goswami, Prashant; Kukkuthady, Avinash; Krishnan, Swathi Trithala] CSIR Ctr Math Modelling & Comp Simulat C MMACS, Bengaluru, India; [Murty, Upadhayula Suryanarayana; Mutheneni, Srinivasa Rao] CSIR Indian Inst Chem Technol, Div Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Fourth Paradigm Institute (CSIR 4PI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Goswami, P (corresponding author), CSIR Ctr Math Modelling & Comp Simulat C MMACS, Bengaluru, India.	goswami@cmmacs.ernet.in	Mutheneni, Srinivasa Rao/AAI-2262-2020	Mutheneni, Srinivasa Rao/0000-0003-3263-3905	project Integrated Analysis for Impact, Mitigation and Sustainability; CSIR, India	project Integrated Analysis for Impact, Mitigation and Sustainability; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the project Integrated Analysis for Impact, Mitigation and Sustainability, funded by CSIR, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUMA MJ, 1994, LANCET, V343, P1440, DOI 10.1016/S0140-6736(94)92569-0; Caminade C, 2011, ATMOS SCI LETT, V12, P96, DOI 10.1002/asl.296; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Dhiman R. C., 2008, Regional Health Forum, V12, P27; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; Ermert V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-35; Gaudart J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-61; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Gillett JD, 1974, S BRIT SOC PARASITOL, V12, P79; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Goswami P, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027594; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Hunter PR, 2003, J APPL MICROBIOL, V94, p37S, DOI 10.1046/j.1365-2672.94.s1.5.x; Imbahale SS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-81; Kiszewski AE, 2004, AM J TROP MED HYG, V71, P128, DOI 10.4269/ajtmh.2004.71.128; Koenraadt CJM, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-20; LEAF A, 1989, NEW ENGL J MED, V321, P1577, DOI 10.1056/NEJM198912073212305; Leeson H., 1939, B ENTOMOL RES, V30, P103; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; MACDONALD G, 1968, B WORLD HEALTH ORGAN, V38, P743; *MALERA CONS GROUP, 2011, PLOS MED, V0008; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Matsuoka Y, 1994, J GLOBAL ENV ENG, V1, P1; Mohapatra PK, 2001, NATL MED J INDIA, V14, P139; Paaijmans KP, 2009, PNAS, V106, P33; Paaijmans KP, 2010, PNAS, V107, P34; Paaijmans KP, 2012, BIOL LETTERS, V8, P465, DOI 10.1098/rsbl.2011.1075; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Parham PE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-271; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Sarma NP, 2012, ACTA TROP, V122, P247, DOI 10.1016/j.actatropica.2012.02.065; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Thomson MC, 2000, LANCET, V355, P1559, DOI 10.1016/S0140-6736(05)74616-X; Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014; Yang GJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000385	38	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49713	10.1371/journal.pone.0049713	http://dx.doi.org/10.1371/journal.pone.0049713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209594	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800019
J	Cukras, C; Gaasterland, T; Lee, P; Gudiseva, HV; Chavali, VRM; Pullakhandam, R; Maranhao, B; Edsall, L; Soares, S; Reddy, GB; Sieving, PA; Ayyagari, R				Cukras, Catherine; Gaasterland, Terry; Lee, Pauline; Gudiseva, Harini V.; Chavali, Venkata R. M.; Pullakhandam, Raghu; Maranhao, Bruno; Edsall, Lee; Soares, Sandra; Reddy, G. Bhanuprakash; Sieving, Paul A.; Ayyagari, Radha			Exome Analysis Identified a Novel Mutation in the RBP4 Gene in a Consanguineous Pedigree with Retinal Dystrophy and Developmental Abnormalities	PLOS ONE			English	Article							BINDING-PROTEIN; VITAMIN-A; NIGHT BLINDNESS; SERUM RETINOL; TRANSTHYRETIN; PLASMA; DEFICIENCY; COLOBOMA; THERAPY; DEFECT	Retinitis Pigmentosa (RP) is a common form of retinal degeneration characterized by photoreceptor degeneration and retinal pigment epithelium (RPE) atrophy causing loss of visual field and acuities. Exome sequencing identified a novel homozygous splice site variant (c.111+1G>A) in the gene encoding retinol binding protein 4 (RBP4). This change segregated with early onset, progressive, and severe autosomal recessive retinitis pigmentosa (arRP) in an eight member consanguineous pedigree of European ancestry. Additionally, one patient exhibited developmental abnormalities including patent ductus arteriosus and chorioretinal and iris colobomas. The second patient developed acne from young age and extending into the 5th decade. Both patients had undetectable levels of RBP4 in the serum suggesting that this mutation led to either mRNA or protein instability resulting in a null phenotype. In addition, the patients exhibited severe vitamin A deficiency, and diminished serum retinol levels. Circulating transthyretin levels were normal. This study identifies the RBP4 splice site change as the cause of RP in this pedigree. The presence of developmental abnormalities and severe acne in patients with retinal degeneration may indicate the involvement of genes that regulate vitamin A absorption, transport and metabolism.	[Gudiseva, Harini V.; Chavali, Venkata R. M.; Maranhao, Bruno; Ayyagari, Radha] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Cukras, Catherine; Sieving, Paul A.] NEI, NIH, Bethesda, MD 20892 USA; [Gaasterland, Terry; Edsall, Lee; Soares, Sandra] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Gaasterland, Terry; Edsall, Lee; Soares, Sandra] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Lee, Pauline] Scripps Res Inst, La Jolla, CA 92037 USA; [Pullakhandam, Raghu; Reddy, G. Bhanuprakash] Natl Inst Nutr, Hyderabad, AP, India; [Sieving, Paul A.] NIDCD, NIH, Bethesda, MD USA	University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Research Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Ayyagari, R (corresponding author), Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA.	rayyagari@ucsd.edu	Reddy, G Bhanuprakash/AAJ-3494-2020	Reddy, G Bhanuprakash/0000-0003-4787-3944; Edsall, Lee Elizabeth/0000-0002-0326-2829; Maranhao, Bruno/0000-0002-0224-5488	NIH; National Institutes of Health [EY013198, EY021237, EY022306, EY020678]; Department of Biotechnology:Indo-US Vision Research Program; Department of Science & Technology, Government of India; Foundation Fighting Blindness USA; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [RC2EY020678, R01EY021237, R01EY022306, R01EY013198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Biotechnology:Indo-US Vision Research Program; Department of Science & Technology, Government of India(Department of Science & Technology (India)); Foundation Fighting Blindness USA; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Department of Biotechnology:Indo-US Vision Research Program, Department of Science & Technology, Government of India, Foundation Fighting Blindness USA, Research to Prevent Blindness, the NIH Intramural Research Program, National Institutes of Health grants EY013198, EY021237, EY022306 and EY020678. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; BIERI JG, 1979, AM J CLIN NUTR, V32, P2143, DOI 10.1093/ajcn/32.10.2143; Chavali VRM, 2011, HUM MOL GENET, V20, P2000, DOI 10.1093/hmg/ddr080; Cremers FPM, 2002, HUM MOL GENET, V11, P1169, DOI 10.1093/hmg/11.10.1169; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; HECKENLIVELY JR, 1988, DOC OPHTHALMOL, V68, P257, DOI 10.1007/BF00156432; Lam K, 2011, ARCH OPHTHALMOL-CHIC, V129, P1212, DOI 10.1001/archophthalmol.2011.254; Macdonald IM, 2011, OPHTHALMIC GENET; Malpeli G, 1996, BBA-PROTEIN STRUCT M, V1294, P48, DOI 10.1016/0167-4838(95)00264-2; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; Naylor HM, 1999, BIOCHEMISTRY-US, V38, P2647, DOI 10.1021/bi982291i; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Roak B.J., 2012, NATURE; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Raghu P, 2004, BBA-PROTEINS PROTEOM, V1703, P1, DOI 10.1016/j.bbapap.2004.09.023; Raghu P, 2003, BIOTECHNOL APPL BIOC, V38, P19, DOI 10.1042/BA20020100; Schweigert FJ, 2001, CURR OPIN CLIN NUTR, V4, P477, DOI 10.1097/00075197-200111000-00002; See AWM, 2009, DEV BIOL, V325, P94, DOI 10.1016/j.ydbio.2008.09.030; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; Stephensen CB, 2001, ANNU REV NUTR, V21, P167, DOI 10.1146/annurev.nutr.21.1.167; Thompson DA, 2003, DEV OPHTHALMOL, V37, P141; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; Wolf G, 1999, NUTR REV, V57, P258; Zelinger L, 2011, AM J HUM GENET, V88, P207, DOI 10.1016/j.ajhg.2011.01.002	27	41	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50205	10.1371/journal.pone.0050205	http://dx.doi.org/10.1371/journal.pone.0050205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189188	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800065
J	Tanito, M; Kaidzu, S; Takai, Y; Ohira, A				Tanito, Masaki; Kaidzu, Sachiko; Takai, Yasuyuki; Ohira, Akihiro			Status of Systemic Oxidative Stresses in Patients with Primary Open-Angle Glaucoma and Pseudoexfoliation Syndrome	PLOS ONE			English	Article							TRABECULAR MESHWORK CELLS; REACTIVE OXYGEN METABOLITES; TOTAL ANTIOXIDANT STATUS; D-ROMS TEST; SULFHYDRYL GROUPS; AQUEOUS-HUMOR; SERUM; THIOREDOXIN; PLASMA; PROOXIDANT	Background: The involvement of local and systemic oxidative stress in intraocular pressure (IOP) elevation and optic nerve damage has been hypothesized in the pathogenesis of glaucoma. To test this, we measured the systemic levels of prooxidants and antioxidants by analyzing the blood biochemistry in patients with glaucoma. Methods: Peripheral blood samples were collected from Japanese patients with primary open-angle glaucoma (PG) (n = 206), exfoliation syndrome (EX) (n = 199), and controls (n = 126). Plasma levels of lipid peroxides, ferric-reducing activity, and thiol antioxidant activity were measured by diacron reactive oxygen metabolites (dROM), biological antioxidant potential (BAP), and sulfhydryl (SH) tests, respectively, using a free radical analyzer. Results: In the PG, EX, and control groups, the mean +/- standard deviation values were 355 +/- 63, 357 +/- 69, and 348 +/- 56 (U. Carr), respectively, for dROM; 1,951 +/- 282, 1,969 +/- 252, and 2,033 +/- 252 (mmol/L), respectively, for BAP (mmol/L); and 614 +/- 98, 584 +/- 91, and 617 +/- 99 (mmol/L), respectively, for SH. The differences in the BAP values were significant between the PG and control groups (p = 0.0062), for SH between the EX and control groups (p = 0.0017), and for SH between the PG and EX groups (p = 0.0026). After adjustment for differences in age and sex among groups using multiple regression analysis, lower BAP values were correlated significantly with PG (p = 0.0155) and EX (p = 0.0049). Higher dROM values with and without glaucoma were correlated with female gender, and lower SH values with older age. There were no significant differences between the higher (>= 21 mmHg) and lower (<21 mmHg) baseline IOPs in the PG group or between the presence or absence of glaucoma in the EX group. Conclusions: Lower systemic antioxidant capacity that measured by ferric-reducing activity is involved in the pathogenesis of PG and EX.	[Tanito, Masaki; Kaidzu, Sachiko; Takai, Yasuyuki; Ohira, Akihiro] Shimane Univ, Dept Ophthalmol, Fac Med, Izumo, Shimane, Japan	Shimane University	Tanito, M (corresponding author), Shimane Univ, Dept Ophthalmol, Fac Med, Izumo, Shimane, Japan.	tanito-oph@umin.ac.jp	ohira, akihiro/G-8352-2017	ohira, akihiro/0000-0002-1307-5592; Kaidzu, Sachiko/0000-0002-3324-6678; TAKAI, YASUYUKI/0000-0003-3881-3624	Imai Memorial Glaucoma Research Foundation; Suda Memorial Glaucoma Research Foundation; Japan Society for the Promotion of Science (JSPS)	Imai Memorial Glaucoma Research Foundation; Suda Memorial Glaucoma Research Foundation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by research grants from the Imai Memorial Glaucoma Research Foundation, the Suda Memorial Glaucoma Research Foundation, and a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARADO JA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1769, DOI 10.1001/archopht.1992.01080240109042; Carratelli M, 2001, INT J CLIN PHARM RES, V21, P79; Cornelli U, 2001, J NUTR, V131, P3208, DOI 10.1093/jn/131.12.3208; Cumurcu T, 2010, OPHTHALMIC RES, V43, P169, DOI 10.1159/000272019; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Engin KN, 2010, MOL VIS, V16, P1260; Erdurmus M, 2011, CURR EYE RES, V36, P713, DOI 10.3109/02713683.2011.584370; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Erel O, 2005, CLIN BIOCHEM, V38, P1103, DOI 10.1016/j.clinbiochem.2005.08.008; Fatma N, 2009, FREE RADICAL RES, V43, P783, DOI 10.1080/10715760903062887; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Gherghel D, 2005, INVEST OPHTH VIS SCI, V46, P877, DOI 10.1167/iovs.04-0777; Helbig H, 1994, Ger J Ophthalmol, V3, P148; Inomata Y, 2006, J NEUROCHEM, V98, P372, DOI 10.1111/j.1471-4159.2006.03871.x; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Kitaoka Y, 2011, ENDOCRINOLOGY, V152, P2775, DOI 10.1210/en.2011-0046; Kotani K, 2010, MED PRIN PRACT, V19, P496, DOI 10.1159/000320312; Kumar DM, 2007, J GLAUCOMA, V16, P334; Lamoke F, 2012, FREE RADIC BIOL MED; Li GR, 2007, MOL VIS, V13, P2282; Li L, 2009, EYE, V23, P1464, DOI 10.1038/eye.2008.281; Luna C, 2009, FOOD CHEM TOXICOL, V47, P198, DOI 10.1016/j.fct.2008.10.029; LUTJENDRECOLL E, 1986, EXP EYE RES, V42, P443, DOI 10.1016/0014-4835(86)90004-7; Majsterek I, 2011, EXP MOL PATHOL, V90, P231, DOI 10.1016/j.yexmp.2011.01.001; Marra G, 2002, DIABETES CARE, V25, P370, DOI 10.2337/diacare.25.2.370; Martinovic J, 2009, INT J SPORTS MED, V30, P851, DOI 10.1055/s-0029-1238289; MICHELET F, 1995, CLIN CHEM, V41, P1509; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1055, DOI 10.1167/iovs.10-5777; Munemasa Y, 2009, GENE THER, V16, P17, DOI 10.1038/gt.2008.126; Nakabayashi M, 2004, OPHTHALMOLOGICA, V218, P344, DOI 10.1159/000079477; Nakamura H, 2001, P NATL ACAD SCI USA, V98, P2688, DOI 10.1073/pnas.041624998; Nakayama Keisuke, 2007, Clin Exp Nephrol, V11, P218, DOI 10.1007/s10157-007-0486-3; Pasquini A, 2008, VET RES COMMUN, V32, P137, DOI 10.1007/s11259-007-9014-x; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; Schlotzer-Schrehardt U, 2006, AM J OPHTHALMOL, V141, P921, DOI 10.1016/j.ajo.2006.01.047; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shimano M, 2009, HEART RHYTHM, V6, P935, DOI 10.1016/j.hrthm.2009.03.012; Sorkhabi R, 2011, MOL VIS, V17, P41; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Tezel G, 1998, INVEST OPHTH VIS SCI, V39, P2277; Tezel G, 2011, EXP EYE RES, V93, P178, DOI 10.1016/j.exer.2010.07.009; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Vassalle C, 2008, CLIN BIOCHEM, V41, P1162, DOI 10.1016/j.clinbiochem.2008.07.005; Vassalle C, 2011, CLIN CHEM LAB MED, V49, P1509, DOI 10.1515/CCLM.2011.622; Virgolici Bogdana, 2007, Rom J Intern Med, V45, P59; Wax MB, 1998, AM J OPHTHALMOL, V125, P145, DOI 10.1016/S0002-9394(99)80084-1; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yagci R, 2008, EYE, V22, P128, DOI 10.1038/sj.eye.6702751; Yang JJ, 2001, INVEST OPHTH VIS SCI, V42, P1273; Yildirim O, 2005, EYE, V19, P580, DOI 10.1038/sj.eye.6701565; Yuki K, 2010, ACTA OPHTHALMOL, V88, pe259, DOI 10.1111/j.1755-3768.2010.01997.x	53	69	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49680	10.1371/journal.pone.0049680	http://dx.doi.org/10.1371/journal.pone.0049680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189153	Green Submitted, gold, Green Published			2022-12-25	WOS:000311929800030
J	Zhu, JH; Chen, T; Yang, L; Li, ZB; Wong, MM; Zheng, XY; Pan, XP; Zhang, L; Yan, H				Zhu, Jianhua; Chen, Ting; Yang, Lin; Li, Zhoubin; Wong, Mei Mei; Zheng, Xiaoye; Pan, Xiaoping; Zhang, Li; Yan, Hui			Regulation of MicroRNA-155 in Atherosclerotic Inflammatory Responses by Targeting MAP3K10	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; IMMUNE-RESPONSE; SIGNALING PATHWAY; HEART-DISEASE; LIPID UPTAKE; CYTOKINE; MACROPHAGES; EXPRESSION; INDUCTION	Aims: Accumulating evidence suggest that numerous microRNAs (miRNAs) play important roles in cell proliferation, apoptosis, and differentiation, as well as various diseases that accompany inflammatory responses. Inflammation is known to be a major contributor to atherogenesis. Previous studies provide promising evidence in support of the role of miRNAs in cardiovascular disease. However, mechanistic data on these small molecules in atherosclerosis (AS) are still missing. The present study aims to investigate the potential role of miRNAs in AS. Methods and Results: The miRNA transcriptase was verified by TaqMan real-time polymerase chain reaction assay. Thoracic aorta samples were obtained from Apolipoprotein E knockout mice, and plasma samples were from coronary artery disease (CAD) patients. The results showed that the miR-155 level was the most significantly elevated both in AS mice and CAD patients relative to the normal control. The functional role of miR-155 in the atherosclerotic path physiological process was also observed in vivo and in vitro. The observations suggested that miR-155 is a part of a negative feedback loop, which down-modulates inflammatory cytokine production and decreases AS progression. miR-155 was also found to mediate the inflammatory response and mitogen-activated protein kinase (MAPK) pathway by targeting mitogen-activated protein kinase kinase kinase 10. Conclusions: miR-155 contributes to the prevention of AS development and progression. It may also be involved in the posttranscriptional regulation of the inflammatory response and MAPK pathway by targeting mitogen-activated protein kinase kinase kinase 10.	[Zhu, Jianhua; Chen, Ting; Yang, Lin; Zheng, Xiaoye; Zhang, Li; Yan, Hui] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Pan, Xiaoping] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zhoubin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiothorac Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Wong, Mei Mei] Kings Coll London, Sch Med, Div Cardiovasc, London WC2R 2LS, England	Zhejiang University; Zhejiang University; Zhejiang University; University of London; King's College London	Zhang, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China.	li.zhang.uk@gmail.com			Zhejiang Provincial Natural Science Foundation of China [Y2100372]; National Natural Science Foundation of China [30370570/C03030201, 30670866/C03030201, 81200214/H0215]; Ministry of Education [jiaoyanhan 2011(5)]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education	Zhejiang Provincial Natural Science Foundation of China under Grant No. Y2100372 and National Natural Science Foundation of China (No 30370570/C03030201, 30670866/C03030201 and 81200214/H0215), Scholarship Award for Excellent Doctoral Student granted by Ministry of Education(jiaoyanhan 2011(5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Akbarzadeh S, 2002, J BIOL CHEM, V277, P36280, DOI 10.1074/jbc.M204626200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen T, 2011, INT J CARDIOL, V147, P446, DOI 10.1016/j.ijcard.2010.10.133; Chen T, 2011, FEBS LETT, V585, P657, DOI 10.1016/j.febslet.2011.01.027; Chen T, 2011, FEBS LETT, V585, P567, DOI 10.1016/j.febslet.2011.01.010; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Hoekstra M, 2010, BIOCHEM BIOPH RES CO, V394, P792, DOI 10.1016/j.bbrc.2010.03.075; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Mi SL, 2010, P NATL ACAD SCI USA, V107, P3710, DOI 10.1073/pnas.0914900107; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	35	90	101	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e46551	10.1371/journal.pone.0046551	http://dx.doi.org/10.1371/journal.pone.0046551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189122	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800003
J	Liu, Z; Li, T; Reinhold, MI; Naski, MC				Liu, Z.; Li, T.; Reinhold, M. I.; Naski, M. C.			MEK1-RSK2 contributes to hedgehog signaling by stabilizing GLI2 transcription factor and inhibiting ubiquitination	ONCOGENE			English	Article						Hedgehog; GLI2; MEK1; RSK2; ubiquitination; multiple myeloma	CARCINOMA-CELLS; DOWN-REGULATION; CANCER; DEGRADATION; ACTIVATION; PROLIFERATION; METASTASIS; MECHANISMS; EXPRESSION; PROTEINS	The transcription factor GLI2 has an important role in the transduction of Hedgehog signaling and thereby regulates tumorigenesis in a wide variety of human tumors. However, the mechanisms controlling GLI2 protein expression and stabilization are incompletely understood. In this study, we show that the mitogen-activated protein kinase MEK1 modulates GLI2 both at the mRNA and protein level. Constitutively activated MEK1 prolonged the half-life of GLI2 and increased its nuclear translocation, accompanied by attenuated ubiquitination of GLI2 protein. RSK2, a protein kinase lying downstream of MEK-ERK cascade, mimicked the effect of MEK on GLI2 stabilization. MEK1 and RSK2 failed to augment the half-life of GLI2 lacking GSK-3 beta phosphorylation sites, indicating that MEK-RSK stabilizes GLI2 by controlling targeting GSK-3 beta-mediated phosphorylation and ubiquitination of GLI2. The significance of MEK-RSK stabilization was demonstrated in experiments showing that activation of MEK-RSK paralleled higher protein level of GLI2 in several multiple myelomas (MM) cells relative to normal B cells. Moreover, combined treatment with RSK and GLI inhibitors led to an enhanced apoptosis of MM cells. Thus, our results indicate that MEK-RSK cascade positively regulates GLI2 stabilization and represses its degradation via inhibiting GSK-3 beta-dependent phosphorylation and ubiquitination of GLI2.	[Liu, Z.; Reinhold, M. I.; Naski, M. C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Liu, Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Li, T.] Zhejiang Normal Univ, Coll Chem & Life Sci, Dept Biol, Jinhua, Peoples R China; [Reinhold, M. I.] Grand Valley State Univ, Dept Phys Assistant Studies, Grand Rapids, MI USA; [Naski, M. C.] St Marys Hlth Care, Dept Pathol, Grand Rapids, MI USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; UTMD Anderson Cancer Center; Zhejiang Normal University; Grand Valley State University	Liu, Z (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA.	zliu2@mdanderson.org; mikenaski@yahoo.com	Liu, Zhiqiang/E-6950-2014	Liu, Zhiqiang/0000-0002-0677-8097	National Institutes of Health [R01 (AR053100)]; National Natural Sciences Foundation of China [31101057]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health R01 (AR053100) (M C Naski), the National Natural Sciences Foundation of China (31101057), and the Sciences Foundation of Zhejiang Normal University (ZC304009172). We thank Dr Natalia Riobo from Thomas Jefferson University; Dr John Blenis from Department of Cell Biology of Harvard Medical School; Dr Richard L Huganir from the Department of Neuroscience of Howard Hughes Medical Institute; Dr Fritz Aberger, University of Salzburg; and Dr Baolin Wang, Associate Professor of Cell and Developmental Biology Weill Cornell Medical College, for their generous contributions of the plasmids used in this study.	Alexaki VI, 2010, JNCI-J NATL CANCER I, V102, P1148, DOI 10.1093/jnci/djq257; Aza-Blanc P, 2000, DEVELOPMENT, V127, P4293; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Cai Jiaqin, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P993; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Fujii Katsunori, 2009, No To Hattatsu, V41, P247; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kim Y, 2007, CANCER RES, V67, P3583, DOI 10.1158/0008-5472.CAN-06-3040; Kump E, 2008, ONCOGENE, V27, P3856, DOI 10.1038/onc.2008.5; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lewis M T, 2006, Ernst Schering Found Symp Proc, P181; Liu ZQ, 2009, BBA-MOL CELL RES, V1793, P300, DOI 10.1016/j.bbamcr.2008.08.013; Marini KD, 2011, GROWTH FACTORS, V29, P221, DOI 10.3109/08977194.2011.610756; Onishi H, 2011, CANCER SCI, V102, P1756, DOI 10.1111/j.1349-7006.2011.02010.x; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2009, DEV BIOL, V326, P177, DOI 10.1016/j.ydbio.2008.11.009; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Tam Michael, 2010, J Assoc Genet Technol, V36, P111; Teichert AE, 2011, J INVEST DERMATOL, V131, P2289, DOI 10.1038/jid.2011.196; Thiyagarajan S, 2007, CANCER RES, V67, P10642, DOI 10.1158/0008-5472.CAN-07-2015; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608	28	23	24	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					65	73		10.1038/onc.2012.544	http://dx.doi.org/10.1038/onc.2012.544			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23208494				2022-12-25	WOS:000329212000008
J	Avraham, T; Zampell, JC; Yan, A; Elhadad, S; Weitman, ES; Rockson, SG; Bromberg, J; Mehrara, BJ				Avraham, Tomer; Zampell, Jamie C.; Yan, Alan; Elhadad, Sonia; Weitman, Evan S.; Rockson, Stanley G.; Bromberg, Jacqueline; Mehrara, Babak J.			Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema	FASEB JOURNAL			English	Article						inflammation; lymphangiogenesis; lymphatic endothelial cell	VEGF-C; FILARIAL LYMPHEDEMA; BREAST-CARCINOMA; WOUND REPAIR; LYMPHANGIOGENESIS; INFLAMMATION; REGENERATION; EXPRESSION; CANCER; SKIN	Lymphedema is a dreaded complication of cancer treatment. However, despite the fact that > 5 million Americans are affected by this disorder, the development of effective treatments is limited by the fact that the pathology of lymphedema remains unknown. The purpose of these studies was to determine the role of inflammatory responses in lymphedema pathology. Using mouse models of lymphedema, as well as clinical lymphedema specimens, we show that lymphatic stasis results in a CD4+ T-cell inflammation and T-helper 2 (Th2) differentiation. Using mice deficient in T cells or CD4+ cells, we show that this inflammatory response is necessary for the pathological changes of lymphedema, including fibrosis, adipose deposition, and lymphatic dysfunction. Further, we show that inhibition of Th2 differentiation using interleukin-4 (IL-4) or IL-13 blockade prevents initiation and progression of lymphedema by decreasing tissue fibrosis and significantly improving lymphatic function, independent of lymphangiogenic growth factors. We show that CD4+ inflammation is a critical regulator of tissue fibrosis and lymphatic dysfunction in lymphedema and that inhibition of Th2 differentiation markedly improves lymphatic function independent of lymphangiogenic cytokine expression. Notably, preventing and/or reversing the development of pathological tissue changes that occur in lymphedema may be a viable treatment strategy for this disorder.-Avraham, T., Zampell, J. C., Yan, A., Elhadad, S., Weitman, E. S., Rockson, S. G., Bromberg, J., Mehrara, B. J. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema. FASEB J. 27, 1114-1126 (2013). www.fasebj.org	[Avraham, Tomer; Zampell, Jamie C.; Yan, Alan; Elhadad, Sonia; Weitman, Evan S.; Mehrara, Babak J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, New York, NY 10021 USA; [Bromberg, Jacqueline] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Rockson, Stanley G.] Stanford Univ, Med Ctr, Dept Med, Div Cardiol, Stanford, CA 94305 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Stanford University	Mehrara, BJ (corresponding author), FACS, 1275 York Ave,Rm MRI 1005, New York, NY 10065 USA.	mehrarab@mskcc.org	Elhadad, Sonia/GRF-6466-2022	Elhadad, Sonia/0000-0002-0139-6487; rockson, stanley/0000-0003-1253-474X	Plastic Surgery Educational Foundation; The Society of Memorial Sloan-Kettering Cancer Center; T32 Surgical Oncology Training [NIH T32 CA 009501]; U.S. Department of Defense [BC103691]; National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health (NIH) [R01HL111130]; NIH [R24 CA83084, P30 CA08748]; NATIONAL CANCER INSTITUTE [R24CA083084, P30CA008748, T32CA009501] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111130] Funding Source: NIH RePORTER	Plastic Surgery Educational Foundation; The Society of Memorial Sloan-Kettering Cancer Center; T32 Surgical Oncology Training; U.S. Department of Defense(United States Department of Defense); National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Ronald DeMatteo (Memorial SloanKettering Cancer Center) for his helpful advice regarding planning and execution of the experiments. This work was funded, in part, by the Plastic Surgery Educational Foundation and The Society of Memorial Sloan-Kettering Cancer Center grants to B.J.M. T. A. was funded in part by a fellowship grant from the Plastic Surgery Educational Foundation. T.A., J.Z., and E. W. were also supported by T32 Surgical Oncology Training Grant NIH T32 CA 009501. J.Z. was also partially supported from a grant (BC103691) from the U.S. Department of Defense. Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the U.S. National Institutes of Health (NIH) under award R01HL111130. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Technical services provided by the MSKCC Small-Animal Imaging Core Facility, supported, in part, by NIH Small- Animal Imaging Research Program (SAIRP) grant R24 CA83084 and NIH Center grant P30 CA08748, are gratefully acknowledged.	ABOULENEIN A, 1984, SURGERY, V95, P562; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Avraham T, 2010, AM J PHYSIOL-CELL PH, V299, pC589, DOI 10.1152/ajpcell.00535.2009; Avraham T, 2009, PLAST RECONSTR SURG, V124, P438, DOI 10.1097/PRS.0b013e3181adcf4b; Beesley V, 2007, CANCER, V109, P2607, DOI 10.1002/cncr.22684; Bennuru S, 2010, AM J TROP MED HYG, V83, P884, DOI 10.4269/ajtmh.2010.10-0039; Castelino FV, 2011, ARTHRITIS RHEUM-US, V63, P1405, DOI 10.1002/art.30262; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Foldi E, 2000, LYMPHOLOGY, V33, P19; GALKOWSKA H, 1986, LYMPHOLOGY, V19, P139; Goldman J, 2005, CIRC RES, V96, P1193, DOI 10.1161/01.RES.0000168918.27576.78; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; Hinrichs CS, 2004, ANN SURG ONCOL, V11, P573, DOI 10.1245/ASO.2004.04.017; Karlsen TV, 2006, J PHYSIOL-LONDON, V574, P583, DOI 10.1113/jphysiol.2006.108308; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Mankan AK, 2011, EXPERT OPIN INV DRUG, V20, P1263, DOI 10.1517/13543784.2011.601739; Nakamura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008380; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; OLSZEWSKI WL, 1993, TROP MED PARASITOL, V44, P40; OLSZEWSKI WL, 1992, LYMPHOLOGY, V25, P166; Petrek JA, 1998, CANCER-AM CANCER SOC, V83, P2776, DOI 10.1002/(SICI)1097-0142(19981215)83:12B+<2776::AID-CNCR25>3.0.CO;2-V; Poulsen LK, 2007, ANN MED, V39, P440, DOI 10.1080/07853890701449354; Pyszel A, 2006, LYMPHOLOGY, V39, P185; Rockson SG, 2008, ANN NY ACAD SCI, V1131, P147, DOI 10.1196/annals.1413.014; ROMANI L, 1992, J EXP MED, V176, P19, DOI 10.1084/jem.176.1.19; Rossi A, 2007, LYMPHOLOGY, V40, P102; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; Rutkowski JM, 2010, AM J PATHOL, V176, P1122, DOI 10.2353/ajpath.2010.090733; SCHRIER DJ, 1983, AM REV RESPIR DIS, V127, P614, DOI 10.1164/arrd.1983.127.5.614; Suami H, 2007, PLAST RECONSTR SURG, V120, P982, DOI 10.1097/01.prs.0000277995.25009.3e; Tabibiazar R, 2006, PLOS MED, V3, P1114, DOI 10.1371/journal.pmed.0030254; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu JG, 2006, AM J PHYSIOL-LUNG C, V291, pL658, DOI 10.1152/ajplung.00006.2006; Yang GY, 2004, CYTOKINE, V28, P224, DOI 10.1016/j.cyto.2004.08.007; Yoshizaki A, 2008, AM J PATHOL, V172, P1650, DOI 10.2353/ajpath.2008.071049; Zampell JC, 2012, FASEB J, V26, P1027, DOI 10.1096/fj.11-195321; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC709, DOI 10.1152/ajpcell.00284.2011; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011; Zampell JC, 2011, AM J PHYSIOL-CELL PH, V300, pC1107, DOI 10.1152/ajpcell.00378.2010	42	128	135	4	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2013	27	3					1114	1126		10.1096/fj.12-222695	http://dx.doi.org/10.1096/fj.12-222695			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23193171	Green Published			2022-12-25	WOS:000315585200025
J	Yang, HJ; Youn, H; Seong, KM; Jin, YW; Kim, J; Youn, B				Yang, Hee Jung; Youn, HyeSook; Seong, Ki Moon; Jin, Young-Woo; Kim, Joon; Youn, BuHyun			Phosphorylation of Ribosomal Protein S3 and Antiapoptotic TRAF2 Protein Mediates Radioresistance in Non-small Cell Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIZING-RADIATION; FACTOR RECEPTOR; KINASE CK2; DNA-REPAIR; APOPTOSIS; RPS3; RADIOTHERAPY; RESISTANCE; DAMAGE; ENDONUCLEASE	Radioresistance is considered as a main factor restricting efficacy of radiotherapy. However, the exact molecular mechanism of radioresistance has not been explained yet. In this study, to elucidate radioresistance mechanism in lung cancer, we compared radiation responses in two types of non-small cell lung cancer (NSCLC) cells with different radiosensitivity and identified key molecules conferring radioresistance. In radioresistant NSCLC cells, ionizing radiation (IR) led to casein kinase 2 alpha (CK2 alpha)- and PKC-mediated phosphorylation of rpS3 and TRAF2, respectively, which induced dissociation of rpS3-TRAF2 complex and NF-kappa B activation, resulting in significant up-regulation of prosurvival genes (cIAP1, cIAP2, and survivin). Also, dissociated phospho-rpS3 translocated into nucleus and bound with NF-kappa B complex (p65 and p50), contributing to p65 DNA binding property and specificity. However, in radiosensitive NSCLC cells, IR-mediated rpS3 phosphorylation was not detected due to the absence of CK2 alpha overexpression. Consequently, IR-induced rpS3-TRAF2 complex dissociation, NF-kappa B activation, and prosurvival gene expression were not presented. Taken together, our findings revealed a novel radioresistance mechanism through functional orchestration of rpS3, TRAF2, and NF-kappa B in NSCLC cells. Moreover, we provided the first evidence for the function of rpS3 as a new TRAF2-binding protein and demonstrated that phosphorylation of both rpS3 and TRAF2 is a key control point of radioresistance in NSCLC cells. These results suggest that regulation of rpS3 and TRAF2 in combination with radiotherapy could have high pharmacological therapeutic potency for radioresistance of NSCLC.	[Yang, Hee Jung; Youn, BuHyun] Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea; [Youn, HyeSook] Sejong Univ, Inst Biosci, Dept Biosci & Biotechnol, Seoul 143737, South Korea; [Seong, Ki Moon; Jin, Young-Woo] Korea Hydro & Nucl Power Co Ltd, Div Radiat Effect Res, Radiat Hlth Res Inst, Seoul 132703, South Korea; [Kim, Joon] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Joon] Korea Univ, BioInst, Seoul 136701, South Korea	Pusan National University; Sejong University; Korea Hydro & Nuclear Power; Korea University; Korea University	Youn, B (corresponding author), Pusan Natl Univ, Dept Biol Sci, Pusan 609735, South Korea.	bhyoun72@pusan.ac.kr	Seong, Ki Moon/Y-6083-2019		Nuclear R&D Program through the National Research Foundation of Korea [2011-0030601, 2011-0020777]; Basic Science Research Program through the National Research Foundation of Korea [2011-0007625]; Ministry of Education, Science and Technology	Nuclear R&D Program through the National Research Foundation of Korea(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Nuclear R&D Program (Grants 2011-0030601 and 2011-0020777) and by the Basic Science Research Program (Grant 2011-0007625) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Arch RH, 1998, GENE DEV, V12, P2821, DOI 10.1101/gad.12.18.2821; Baumann M, 2004, LUNG CANCER, V45, pS187, DOI 10.1016/j.lungcan.2004.07.975; Billie Au PY, 2007, ADV EXP MED BIOL, V597, P32; Blackwell K, 2009, MOL CELL BIOL, V29, P303, DOI 10.1128/MCB.00699-08; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Bussink J, 2008, LANCET ONCOL, V9, P288, DOI 10.1016/S1470-2045(08)70073-1; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Das AK, 2006, CANCER RES, V66, P9601, DOI 10.1158/0008-5472.CAN-06-2627; Guo WF, 2005, RADIAT RES, V164, P27, DOI 10.1667/RR3401; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jang CY, 2012, BIOCHEM BIOPH RES CO, V429, P57, DOI 10.1016/j.bbrc.2012.10.093; Jang CY, 2004, FEBS LETT, V560, P81, DOI 10.1016/S0014-5793(04)00074-2; Kim SH, 2005, BIOCHEM BIOPH RES CO, V328, P962, DOI 10.1016/j.bbrc.2005.01.045; Kim TS, 2009, BBA-MOL CELL RES, V1793, P395, DOI 10.1016/j.bbamcr.2008.10.017; Kim W, 2011, RADIAT RES, V176, P539, DOI 10.1667/RR2609.1; Kim WY, 2009, CANCER RES, V69, P1624, DOI 10.1158/0008-5472.CAN-08-0505; Koh PK, 2012, CANCER TREAT REV, V38, P626, DOI 10.1016/j.ctrv.2011.11.003; Koukourakis MI, 2012, BRIT J RADIOL, V85, P313, DOI 10.1259/bjr/16386034; Lee SB, 2010, J BIOL CHEM, V285, P29457, DOI 10.1074/jbc.M110.131367; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Murley JS, 2011, FREE RADICAL BIO MED, V51, P1918, DOI 10.1016/j.freeradbiomed.2011.08.032; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; Olsen BB, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-7; Sause WT, 1999, CHEST, V116, p504S, DOI 10.1378/chest.116.suppl_3.504S; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Shimura T, 2010, ONCOGENE, V29, P4826, DOI 10.1038/onc.2010.238; Trembley JH, 2010, BIOFACTORS, V36, P187, DOI 10.1002/biof.96; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Xia Zong-Ping, 2005, Sci STKE, V2005, ppe7, DOI 10.1126/stke.2722005pe7; Yang HJ, 2011, BIOCHEM PHARMACOL, V82, P524, DOI 10.1016/j.bcp.2011.05.027; Yoshida K, 2010, HEAD NECK-J SCI SPEC, V32, P646, DOI 10.1002/hed.21239; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	38	45	47	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					2965	2975		10.1074/jbc.M112.385989	http://dx.doi.org/10.1074/jbc.M112.385989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23188828	Green Published, hybrid			2022-12-25	WOS:000314397900007
J	Pfeffer, JM; Weadge, JT; Clarke, AJ				Pfeffer, John M.; Weadge, Joel T.; Clarke, Anthony J.			Mechanism of Action of Neisseria gonorrhoeae O-Acetylpeptidoglycan Esterase, an SGNH Serine Esterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; STRUCTURE PREDICTION SERVER; CIRCULAR-DICHROISM SPECTRA; CRYSTAL-STRUCTURE; PEPTIDOGLYCAN; IDENTIFICATION; SEQUENCE; FAMILY; ACETYLATION; DEACETYLASE	O-Acetylpeptidoglycan esterase from Neisseria gonorrhoeae functions to release O-acetyl groups from the C-6 position of muramoyl residues in O-acetylated peptidoglycan, thereby permitting the continued metabolism of this essential cell wall heteropolymer. It has been demonstrated to be a serine esterase with sequence similarity to the family CE-3 carbohydrate esterases of the CAZy classification system. In the absence of a three-dimensional structure for any Ape, further knowledge of its structure and function relationship is dependent on modeling and kinetic studies. In this study, we predicted Neisseria gonorrhoeae Ape1a to be an SGNH hydrolase with an adopted alpha/beta-hydrolase fold containing a central twisted four-stranded parallel beta-sheet flanked by six alpha-helices with the putative catalytic triad, Asp-366, His-369, and Ser-80 appropriately aligned within a pocket. The role of eight invariant and highly conserved residues localized to the active site was investigated by site-directed replacements coupled with kinetic characterization and binding studies of the resultant engineered enzymes. Based on these data and theoretical considerations, Gly-236 and Asn-268 were identified as participating at the oxyanion hole to stabilize the tetrahedral species in the reaction mechanism, whereas Gly-78, Asp-79, His-81, Asn-235, Thr-267, and Val-368 are proposed to position appropriately the catalytic residues and participate in substrate binding.	[Pfeffer, John M.; Weadge, Joel T.; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 1W1, Canada.	a.clarke@exec.uoguelph.ca			Canadian Institutes of Health Research [MOP 81223]; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Operating Grant MOP 81223 (to A. J. C.) from the Canadian Institutes of Health Research and postgraduate scholarships (PGSD; to J. M. P. and J. T. W.) from the Natural Sciences and Engineering Research Council of Canada.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; BLAKE CCF, 1981, J MOL BIOL, V147, P73, DOI 10.1016/0022-2836(81)90080-2; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chang RC, 1996, BIOCHEM BIOPH RES CO, V221, P477, DOI 10.1006/bbrc.1996.0620; CLARKE AJ, 1993, ANAL BIOCHEM, V212, P344, DOI 10.1006/abio.1993.1339; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; DUPONT C, 1991, EUR J BIOCHEM, V195, P763, DOI 10.1111/j.1432-1033.1991.tb15764.x; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lo YC, 2003, J MOL BIOL, V330, P539, DOI 10.1016/S0022-2836(03)00637-5; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Moynihan PJ, 2011, INT J BIOCHEM CELL B, V43, P1655, DOI 10.1016/j.biocel.2011.08.007; Pagotto FJ, 2000, GENE, V244, P13, DOI 10.1016/S0378-1119(99)00557-0; Pfeffer JM, 2012, CHEMBIOCHEM, V13, P722, DOI 10.1002/cbic.201100744; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; Scheurwater EM, 2008, J BIOL CHEM, V283, P8363, DOI 10.1074/jbc.M710135200; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 1999, PROTEIN SCI, V8, P370; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Weadge JT, 2007, BIOCHEMISTRY-US, V46, P4932, DOI 10.1021/bi700254m; Weadge JT, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-49; Weadge JT, 2006, BIOCHEMISTRY-US, V45, P839, DOI 10.1021/bi051679s	32	28	28	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2605	2613		10.1074/jbc.M112.436352	http://dx.doi.org/10.1074/jbc.M112.436352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209280	Green Published, hybrid			2022-12-25	WOS:000314211500045
J	Qanbari, S; Strom, TM; Haberer, G; Weigend, S; Gheyas, AA; Turner, F; Burt, DW; Preisinger, R; Gianola, D; Simianer, H				Qanbari, Saber; Strom, Tim M.; Haberer, Georg; Weigend, Steffen; Gheyas, Almas A.; Turner, Frances; Burt, David W.; Preisinger, Rudolf; Gianola, Daniel; Simianer, Henner			A High Resolution Genome-Wide Scan for Significant Selective Sweeps: An Application to Pooled Sequence Data in Laying Chickens	PLOS ONE			English	Article							POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM; NATURAL-SELECTION; HITCHHIKING; SIGNATURES; OSTEOPONTIN; EGGSHELL; INSULIN; GROWTH; EGG	In most studies aimed at localizing footprints of past selection, outliers at tails of the empirical distribution of a given test statistic are assumed to reflect locus-specific selective forces. Significance cutoffs are subjectively determined, rather than being related to a clear set of hypotheses. Here, we define an empirical p-value for the summary statistic by means of a permutation method that uses the observed SNP structure in the real data. To illustrate the methodology, we applied our approach to a panel of 2.9 million autosomal SNPs identified from re-sequencing a pool of 15 individuals from a brown egg layer line. We scanned the genome for local reductions in heterozygosity, suggestive of selective sweeps. We also employed a modified sliding window approach that accounts for gaps in the sequence and increases scanning resolution by moving the overlapping windows by steps of one SNP only, and suggest to call this a "creeping window'' strategy. The approach confirmed selective sweeps in the region of previously described candidate genes, i.e. TSHR, PRL, PRLHR, INSR, LEPR, IGF1, and NRAMP1 when used as positive controls. The genome scan revealed 82 distinct regions with strong evidence of selection (genome-wide p-value<0.001), including genes known to be associated with eggshell structure and immune system such as CALB1 and GAL cluster, respectively. A substantial proportion of signals was found in poor gene content regions including the most extreme signal on chromosome 1. The observation of multiple signals in a highly selected layer line of chicken is consistent with the hypothesis that egg production is a complex trait controlled by many genes.	[Qanbari, Saber; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, Gottingen, Germany; [Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Haberer, Georg] Helmholtz Zentrum Muchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Weigend, Steffen] Friedrich Loeffler Inst, Inst Farm Anim Genet, Neustadt Mariensee, Germany; [Gheyas, Almas A.; Turner, Frances; Burt, David W.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland; [Gheyas, Almas A.; Turner, Frances; Burt, David W.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Preisinger, Rudolf] Lohmann Tierzucht GmbH, Cuxhaven, Germany; [Gianola, Daniel] Univ Wisconsin, Dept Anim Sci, Madison, WI USA	University of Gottingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Friedrich Loeffler Institute; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Wisconsin System; University of Wisconsin Madison	Qanbari, S (corresponding author), Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, Gottingen, Germany.	sqanbar@gwdg.de	Simianer, Henner/A-6574-2015; Burt, David W/C-7802-2013	Simianer, Henner/0000-0002-7551-3797; Burt, David W/0000-0002-9991-1028; Haberer, Georg/0000-0002-6612-6939	German Federal Ministry of Education and Research (BMBF) within the AgroClustEr "Synbreed - Synergistic plant and animal breeding'' [FKZ 0315528]; German Research Foundation; Gottingen University; BBSRC/DEFRA LINK grant; Alexander von Humboldt Foundation; European Science Foundation (ESF) [3276]; BBSRC [BBS/E/D/20320000, BBS/E/D/20211550, BBS/E/D/20211554, BB/I011005/1] Funding Source: UKRI; MRC [G0900740] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211554, BBS/E/D/20320000, BB/I011005/1, BBS/E/R/00000690, G18647, BB/D523578/1, BBS/E/D/20211550] Funding Source: researchfish; Medical Research Council [G0900740] Funding Source: researchfish	German Federal Ministry of Education and Research (BMBF) within the AgroClustEr "Synbreed - Synergistic plant and animal breeding''; German Research Foundation(German Research Foundation (DFG)); Gottingen University; BBSRC/DEFRA LINK grant; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Science Foundation (ESF)(European Science Foundation (ESF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the German Federal Ministry of Education and Research (BMBF) within the AgroClustEr "Synbreed - Synergistic plant and animal breeding'' (FKZ 0315528). The authors acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University. DWB, AAG and FT acknowledge the BBSRC/DEFRA LINK grant project for its role in SNP discovery and data handling. Part of this work was carried out while DG was visiting Georg-August-University Goettingen as Alexander von Humboldt Foundation Senior Researcher Awardee. SQ thanks the European Science Foundation (ESF) for financial support of the sabbatical stay at the Roslin Institute (grant No: 3276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Arazi H, 2009, POULTRY SCI, V88, P647, DOI 10.3382/ps.2008-00387; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Beccavin C, 2001, J ENDOCRINOL, V168, P297, DOI 10.1677/joe.0.1680297; Bennett AK, 2006, ANIM GENET, V37, P283, DOI 10.1111/j.1365-2052.2006.01439.x; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Calenge F, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-11; CHURCHILL GA, 1994, GENETICS, V138, P963; Cui JX, 2006, POULTRY SCI, V85, P26, DOI 10.1093/ps/85.1.26; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Fay JC, 2000, GENETICS, V155, P1405; Fernandez MS, 2003, J STRUCT BIOL, V143, P171, DOI 10.1016/j.jsb.2003.08.007; Glinka S, 2003, GENETICS, V165, P1269; Hellgren Olof, 2010, Immunome Res, V6, P3, DOI 10.1186/1745-7580-6-3; Herve-Grepinet V, 2010, ANTIMICROB AGENTS CH, V54, P4401, DOI 10.1128/AAC.00204-10; Hincke MT, 2008, J HISTOCHEM CYTOCHEM, V56, P467, DOI 10.1369/jhc.2008.950576; Kamata R, 2009, ARCH TOXICOL, V83, P161, DOI 10.1007/s00204-008-0336-4; KAPLAN NL, 1989, GENETICS, V123, P887; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Kim Y, 2002, GENETICS, V160, P765; Kuraku S, 2011, GENOME BIOL EVOL, V3, P1449, DOI 10.1093/gbe/evr120; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015831; Mulsant P, 2001, P NATL ACAD SCI USA, V98, P5104, DOI 10.1073/pnas.091577598; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; NYS Y, 1989, GEN COMP ENDOCR, V76, P322, DOI 10.1016/0016-6480(89)90164-0; Pavlidis P, 2010, GENETICS, V185, P907, DOI 10.1534/genetics.110.116459; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sambrook J, 2001, MOL CLONING LAB MANU; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Souza CJH, 2001, J ENDOCRINOL, V169, pR1, DOI 10.1677/joe.0.169R001; Stephan W, 2006, GENETICS, V172, P2647, DOI 10.1534/genetics.105.050179; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; STRIEM S, 1991, MOL CELL ENDOCRINOL, V75, P169, DOI 10.1016/0303-7207(91)90232-H; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Twito T, 2011, ANIM GENET, V42, P642, DOI 10.1111/j.1365-2052.2011.02191.x; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Zhou H, 2005, POULTRY SCI, V84, P212, DOI 10.1093/ps/84.2.212	47	46	48	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49525	10.1371/journal.pone.0049525	http://dx.doi.org/10.1371/journal.pone.0049525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209582	Green Published, gold, Green Submitted			2022-12-25	WOS:000312104900009
J	Bos, KI; Stevens, P; Nieselt, K; Poinar, HN; DeWitte, SN; Krause, J				Bos, Kirsten I.; Stevens, Philip; Nieselt, Kay; Poinar, Hendrik N.; DeWitte, Sharon N.; Krause, Johannes			Yersinia pestis: New Evidence for an Old Infection	PLOS ONE			English	Article							GENOME	The successful reconstruction of an ancient bacterial genome from archaeological material presents an important methodological advancement for infectious disease research. The reliability of evolutionary histories inferred by the incorporation of ancient data, however, are highly contingent upon the level of genetic diversity represented in modern genomic sequences that are publicly accessible, and the paucity of available complete genomes restricts the level of phylogenetic resolution that can be obtained. Here we add to our original analysis of the Yersinia pestis strain implicated in the Black Death by consolidating our dataset for 18 modern genomes with single nucleotide polymorphism (SNP) data for an additional 289 strains at over 600 positions. The inclusion of this additional data reveals a cluster of Y. pestis strains that diverge at a time significantly in advance of the Black Death, with divergence dates roughly coincident with the Plague of Justinian (6th to 8th century AD). In addition, the analysis reveals further clues regarding potential radiation events that occurred immediately preceding the Black Death, and the legacy it may have left in modern Y. pestis populations. This work reiterates the need for more publicly available complete genomes, both modern and ancient, to achieve an accurate understanding of the history of this bacterium.	[Bos, Kirsten I.; Krause, Johannes] Univ Tubingen, Inst Archeol Sci, Tubingen, Germany; [Bos, Kirsten I.] Univ Bordeaux, Ecole Prat Hautes Etud, Lab Paleoanthropol, Bordeaux, France; [Stevens, Philip; Nieselt, Kay] Univ Tubingen, Ctr Bioinformat, Tubingen, Germany; [Poinar, Hendrik N.] McMaster Univ, Dept Anthropol, McMaster Ancient DNA Ctr, Hamilton, ON, Canada; [Poinar, Hendrik N.] McMaster Univ, Michael DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [DeWitte, Sharon N.] Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA; [DeWitte, Sharon N.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	Eberhard Karls University of Tubingen; UDICE-French Research Universities; Universite de Bordeaux; Eberhard Karls University of Tubingen; McMaster University; McMaster University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Bos, KI (corresponding author), Univ Tubingen, Inst Archeol Sci, Tubingen, Germany.	kirsten.bos@ifu.uni-tuebingen.de; johannes.krause@uni-tuebingen.de	Krause, Johannes/E-6640-2015; Krause, Johannes/AFP-2642-2022	Krause, Johannes/0000-0001-5475-4690; Krause, Johannes/0000-0001-9144-3920; Bos, Kirsten/0000-0003-2937-3006; DeWitte, Sharon/0000-0003-0754-8485; Nieselt, Kay/0000-0002-1283-7065	Social Sciences and Humanities Research Council of Canada [756-2011-501]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	Funding was provided by the Social Sciences and Humanities Research Council of Canada postdoctoral fellowship 756-2011-501. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; McNeill W.H., 1976, PLAGUES PEOPLES, V1st ed.; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Sherman Irwin W., 2006, POWER PLAGUES; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390	9	30	32	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49803	10.1371/journal.pone.0049803	http://dx.doi.org/10.1371/journal.pone.0049803			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209603	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700021
J	Bressan, E; Ferroni, L; Gardin, C; Pinton, P; Stellini, E; Botticelli, D; Sivolella, S; Zavan, B				Bressan, Eriberto; Ferroni, Letizia; Gardin, Chiara; Pinton, Paolo; Stellini, Edoardo; Botticelli, Daniele; Sivolella, Stefano; Zavan, Barbara			Donor Age-Related Biological Properties of Human Dental Pulp Stem Cells Change in Nanostructured Scaffolds	PLOS ONE			English	Article							BONE; DIFFERENTIATION; REGENERATION; POPULATION	The aim of the present work is to study how biological properties, such as proliferation and commitment ability, of human adult dental pulp stem cells (DPSCs) relate to the age of the donor. Human dental pulps were extracted from molars of healthy adult subjects aged >16 to >66 years. DPSCs were isolated and cultured in the presence of osteogenic, neurogenic, or vasculogenic differentiation medium. Proliferation ability was evaluated by determining doubling time, and commitment ability was evaluated by gene expression and morphological analyses for tissue-specific markers. The results confirm a well-defined proliferative ability for each donor age group at an early in vitro passage (p2). DPSCs from younger donors (up to 35 years) maintain this ability in long-term cultures (p8). Stem cells of all age donor groups maintain their commitment ability during in vitro culture. In vivo tests on the critical size defect repair process confirmed that DPSCs of all donor ages are a potent tool for bone tissue regeneration when mixed with 3D nanostructured scaffolds.	[Bressan, Eriberto; Stellini, Edoardo; Sivolella, Stefano] Univ Padua, Dept Neurosci, Padua, Italy; [Bressan, Eriberto; Pinton, Paolo; Sivolella, Stefano] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, ICSI, I-44100 Ferrara, Italy; [Bressan, Eriberto; Pinton, Paolo; Sivolella, Stefano] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy; [Ferroni, Letizia; Gardin, Chiara; Zavan, Barbara] Univ Padua, Dept Biomed Sci, Padua, Italy; [Botticelli, Daniele] Ariminum Odontol, ARDEC, Rimini, Italy	University of Padua; University of Ferrara; University of Ferrara; University of Padua	Zavan, B (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	barbara.zavan@unipd.it	Pinton, Paolo/J-8025-2012; sivolella, stefano/GLT-2325-2022; Botticelli, Daniele/ABF-6494-2020	Pinton, Paolo/0000-0001-7108-6508; sivolella, stefano/0000-0003-1916-1640; Botticelli, Daniele/0000-0003-2804-1632; Ferroni, Letizia/0000-0002-5457-0338; STELLINI, EDOARDO/0000-0001-6677-2765; Gardin, Chiara/0000-0003-3817-0032	AIRC (Associazione Italiana, Ricerca sul Cancro), Telethon; PRIN (Progetti di Rilevante Interesse Nazionale); Italian Ministry of Health; University of Padova, Progetto di Ateneo	AIRC (Associazione Italiana, Ricerca sul Cancro), Telethon(Fondazione AIRC per la ricerca sul cancro); PRIN (Progetti di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health(Ministry of Health, Italy); University of Padova, Progetto di Ateneo	This research was supported by AIRC (Associazione Italiana, Ricerca sul Cancro), Telethon, PRIN (Progetti di Rilevante Interesse Nazionale) and Italian Ministry of Health to PP and form University of Padova, Progetto di Ateneo, to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54; De Bari C, 2010, BIRTH DEFECTS RES C, V90, P257, DOI 10.1002/bdrc.20189; English K, 2011, J CELL BIOCH; Estrela Carlos, 2011, Braz. Dent. J., V22, P91, DOI 10.1590/S0103-64402011000200001; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Gardin C, 2012, STEM CELLS DEV, V21, P767, DOI 10.1089/scd.2011.0147; Gronthos S, 2011, METHODS MOL BIOL, V698, P107, DOI 10.1007/978-1-60761-999-4_9; Hendrickson ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018535; Hipp J, 2008, STEM CELL REV, V4, P3, DOI 10.1007/s12015-008-9010-8; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]; Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45; Huo N, 2010, STEM CELLS DEV, V19, P93, DOI 10.1089/scd.2009.0048; Kadar K, 2009, J PHYSIOL PHARMACOL, V60, P167; Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617; Kerkis I, 2012, TISSUE ENG PART B-RE, V18, P129, DOI [10.1089/ten.teb.2011.0327, 10.1089/ten.TEB.2011.0327]; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; Liu HC, 2011, TISSUE ENG A; Lizier NF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039885; Lobo SE, 2009, J MATER SCI-MATER M, V20, P1137, DOI 10.1007/s10856-008-3660-6; Mokry J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/673513; Nakashima M, 2009, CYTOKINE GROWTH F R, V20, P435, DOI 10.1016/j.cytogfr.2009.10.012; OFNER D, 1992, PATHOL RES PRACT, V188, P742; Otaki S, 2007, CELL BIOL INT, V31, P1191, DOI 10.1016/j.cellbi.2007.04.001; Perry BC, 2008, TISSUE ENG PART C-ME, V14, P149, DOI 10.1089/ten.tec.2008.0031; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Si YL, 2011, AGEING RES REV, V10, P93, DOI 10.1016/j.arr.2010.08.005; Sloan AJ, 2009, INT J PAEDIATR DENT, V19, P61, DOI 10.1111/j.1365-263X.2008.00964.x; Tomasi C, 2011, DENTOMAXILLOFAC RAD, V40, P244, DOI [10.1259/dmfr/1742330, 10.1259/dmfr/17432330]; Volponi AA, 2010, TRENDS CELL BIOL, V20, P715, DOI 10.1016/j.tcb.2010.09.012; Xiao Y, 2010, INT J ORAL SCI, V2, P127, DOI 10.4248/IJOS10045; Yan M, 2011, STEM CELL REV REP, V7, P161, DOI 10.1007/s12015-010-9155-0; Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535; Zhang WB, 2008, J TISSUE ENG REGEN M, V2, P117, DOI 10.1002/term.71; Zheng Y, 2009, J DENT RES, V88, P249, DOI 10.1177/0022034509333804	35	54	57	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49146	10.1371/journal.pone.0049146	http://dx.doi.org/10.1371/journal.pone.0049146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	120QE	23209565	Green Submitted, Green Published			2022-12-25	WOS:000317185400001
J	Chan, DN; Azghadi, SF; Feng, J; Lowry, WE				Chan, David N.; Azghadi, Soheila F.; Feng, Jun; Lowry, William E.			Ptk7 Marks the First Human Developmental EMT In Vitro	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; OFF-TRACK; CONVERGENT EXTENSION; RECEPTOR; PROTEIN; CANCER; DIFFERENTIATION; SPECIFICATION; MORPHOGENESIS; FIBRONECTIN	Epithelial to mesenchymal transitions (EMTs) are thought to be essential to generate diversity of tissues during early fetal development, but these events are essentially impossible to study at the molecular level in vivo in humans. The first EMT event that has been described morphologically in human development occurs just prior to generation of the primitive streak. Because human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) are thought to most closely resemble cells found in epiblast-stage embryos prior to formation of the primitive streak, we sought to determine whether this first human EMT could be modeled in vitro with pluripotent stem cells. The data presented here suggest that generating embryoid bodies from hESCs or hiPSCs drives a procession of EMT events that can be observed within 24-48 hours after EB generation. These structures possess the typical hallmarks of developmental EMTs, and portions also display evidence of primitive streak and mesendoderm. We identify PTK7 as a novel marker of this EMT population, which can also be used to purify these cells for subsequent analyses and identification of novel markers of human development. Gene expression analysis indicated an upregulation of EMT markers and ECM proteins in the PTK7+ population. We also find that cells that undergo this developmental EMT retain developmental plasticity as sorting, dissociation and re-plating reestablishes an epithelial phenotype.	[Chan, David N.; Azghadi, Soheila F.; Lowry, William E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Chan, David N.; Azghadi, Soheila F.; Lowry, William E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med, Los Angeles, CA USA; [Lowry, William E.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Lowry, William E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Feng, Jun] Univ Calif Los Angeles, Dept Med & Mol Pharmacol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lowry, WE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	blowry@ucla.edu	Chan, David/F-1686-2013; Feng, Jun/F-1196-2013		EEBCRM (Eli and Edythe Broad Center for Regenerative Medicine)	EEBCRM (Eli and Edythe Broad Center for Regenerative Medicine)	This work was supported by a Fuller Foundation award from the EEBCRM (Eli and Edythe Broad Center for Regenerative Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allioli N, 2011, PROSTATE, V71, P1239, DOI 10.1002/pros.21340; Cafferty P, 2004, DEVELOPMENT, V131, P5287, DOI 10.1242/dev.01406; Darribere T, 2000, MECH DEVELOP, V92, P239, DOI 10.1016/S0925-4773(00)00245-8; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Grassot J, 2006, MOL BIOL EVOL, V23, P1232, DOI 10.1093/molbev/msk007; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Heisenberg CP, 2008, CURR OPIN GENET DEV, V18, P311, DOI 10.1016/j.gde.2008.07.011; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kao YR, 2003, CLIN CANCER RES, V9, P2807; Karumbayaram S, 2011, SKIN BIOPSY NEURONS, P1; Kaur S, 2011, ARTERIOSCL THROM VAS, V31, P657, DOI 10.1161/ATVBAHA.110.216341; Kazuki Y, 2010, MOL THER, V18, P386, DOI 10.1038/mt.2009.274; Kojic S, 2010, ARCH BIOCHEM BIOPHYS, V502, P60, DOI 10.1016/j.abb.2010.06.029; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; MOSSIE K, 1995, ONCOGENE, V11, P2179; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Patterson M, 2011, CELL RES; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; Pulina MV, 2011, DEV BIOL, V354, P208, DOI 10.1016/j.ydbio.2011.03.026; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Settleman J, 2004, MOL CELL, V14, P148, DOI 10.1016/S1097-2765(04)00207-2; Sharon N, 2011, STEM CELLS, V29, P600, DOI 10.1002/stem.621; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; WINSTON NJ, 1992, HUM REPROD, V7, P1291, DOI 10.1093/oxfordjournals.humrep.a137844; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuan L, 2011, BLOOD, V118, P1145, DOI 10.1182/blood-2010-10-315275; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x; Zoeller JJ, 2009, J BIOL CHEM, V284, P11728, DOI 10.1074/jbc.M808991200; Zukauskas A, 2011, ANGIOGENESIS, V14, P345, DOI 10.1007/s10456-011-9218-0	50	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50432	10.1371/journal.pone.0050432	http://dx.doi.org/10.1371/journal.pone.0050432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209741	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700070
J	Osborne, DR; Yan, SK; Stuckey, A; Pryer, L; Richey, T; Wall, JS				Osborne, Dustin R.; Yan, Shikui; Stuckey, Alan; Pryer, Lindy; Richey, Tina; Wall, Jonathan S.			Characterization of X-ray Dose in Murine Animals Using microCT, a New Low-Dose Detector and nanoDot Dosimeters	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CT	Background: Dose continues to be an area of concern in preclinical imaging studies, especially for those imaging disease progression in longitudinal studies. To our knowledge, this work is the first to characterize and assess dose from the Inveon CT imaging platform using nanoDot dosimeters. This work is also the first to characterize a new low-dose configuration available for this platform. Methodology/Principal Findings: nanoDot dosimeters from Landauer, Inc. were surgically implanted into 15 wild type mice. Two nanoDots were placed in each animal: one just under the skin behind the spine and the other located centrally within the abdomen. A manufacturer-recommended CT protocol was created with 1 projection per degree of rotation acquired over 360 degrees. For best comparison of the low dose and standard configurations, noise characteristics of the reconstructed images were used to match the acquisition protocol parameters. Results for all dose measurements showed the average dose delivered to the abdomen to be 13.8 cGy +/- 0.74 and 0.97 cGy +/- 0.05 for standard and low dose configurations respectively. Skin measurements of dose averaged 15.99 cGy +/- 0.72 and 1.18 cGy +/- 0.06. For both groups, the standard deviation to mean was less than 5.6%. The maximum dose received for the abdomen was 15.12 cGy and 0.97 cGy while the maximum dose for the skin was 17.3 cGy and 1.32 cGy. Control dosimeters were used for each group to validate that no unwanted additional radiation was present to bias the results. Conclusions/Significance: This study shows that the Inveon CT platform is suitable for imaging mice both for single and longitudinal studies. Use of low-dose detector hardware results in significant reductions in dose to subjects with a > 12x (90%) reduction in delivered dose. Installation of this hardware on another in vivo microCT platform resulted in dose reductions of over 9x (89%).	[Osborne, Dustin R.; Stuckey, Alan; Richey, Tina; Wall, Jonathan S.] Univ Tennessee, Grad Sch Med, Knoxville, TN 37996 USA; [Osborne, Dustin R.; Yan, Shikui; Pryer, Lindy] Siemens Med Solut, Knoxville, TN USA	University of Tennessee System; University of Tennessee Health Science Center; Siemens AG	Osborne, DR (corresponding author), Univ Tennessee, Grad Sch Med, Knoxville, TN 37996 USA.	dosborne@utk.edu	Osborne, Dustin R/B-1585-2012	Osborne, Dustin R/0000-0003-1324-5464; Wall, Jonathan/0000-0002-5516-8578	Siemens Medical Solutions	Siemens Medical Solutions(Siemens AG)	The authors have the following interests. Dustin Osborne, Shikui Yan, and Lindy Pryer are employed by Siemens Medical Solutions, who provided funding for the nanoDot dosimeters for this study. Michael Clark of Siemens Medical Solutions provided his expertise in technical writing. All characterization uses the commercially available Inveon CT platform and available options. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Boone John M, 2004, Mol Imaging, V3, P149, DOI 10.1162/1535350042380326; BUSHBERG J, 2001, ESSENTIAL PHYS MED I; Carlson SK, 2007, MOL IMAGING BIOL, V9, P78, DOI 10.1007/s11307-007-0080-9; Chow P, 2001, IEEE NUCL SCI S, V3, P1678; Daibes S, 2004, 3 ANN SOC MOL IM, P273; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Figueroa SD, 2008, MED PHYS, V35, P3866, DOI 10.1118/1.2959847; Gleason S, 2010, MOL IMAGING PRINCIPL, P54; Goldman LW, 2007, J NUCL MED TECHNOL, V35, P115, DOI 10.2967/jnmt.107.042978; Kalender WA, 2011, SMALL ANIMAL IMAGING: BASICS AND PRACTICAL GUIDE, P125, DOI 10.1007/978-3-642-12945-2_10; Kinahan PE, 1998, MED PHYS, V25, P2046, DOI 10.1118/1.598392; Laforest R, 2004, 3 ANN SOC MOL IM, P434; Obenaus A, 2004, J X-RAY SCI TECHNOL, V12, P241; Osborne D, 2011, J NUCL MED, V52; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; R Core Team, 2022, R LANG ENV STAT COMP; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Turner J. E., 1995, ATOMS RAD RAD PROTEC; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222; Wellek S, 2010, TESTING STAT HYPOTHE, P431	21	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49936	10.1371/journal.pone.0049936	http://dx.doi.org/10.1371/journal.pone.0049936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209622	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800035
J	Almendros, C; Guzman, NM; Diez-Villasenor, C; Garcia-Martinez, J; Mojica, FJM				Almendros, Cristobal; Guzman, Noemi M.; Diez-Villasenor, Cesar; Garcia-Martinez, Jesus; Mojica, Francisco J. M.			Target Motifs Affecting Natural Immunity by a Constitutive CRISPR-Cas System in Escherichia coli	PLOS ONE			English	Article							RNA; DNA; SEQUENCE; BACTERIOPHAGE; TRANSCRIPTION; RESISTANCE; REPEATS; DEFENSE; IDENTIFICATION; INTERFERENCE	Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and CRISPR associated (cas) genes conform the CRISPR-Cas systems of various bacteria and archaea and produce degradation of invading nucleic acids containing sequences (protospacers) that are complementary to repeat intervening spacers. It has been demonstrated that the base sequence identity of a protospacer with the cognate spacer and the presence of a protospacer adjacent motif (PAM) influence CRISPR-mediated interference efficiency. By using an original transformation assay with plasmids targeted by a resident spacer here we show that natural CRISPR-mediated immunity against invading DNA occurs in wild type Escherichia coli. Unexpectedly, the strongest activity is observed with protospacer adjoining nucleotides (interference motifs) that differ from the PAM both in sequence and location. Hence, our results document for the first time native CRISPR activity in E. coli and demonstrate that positions next to the PAM in invading DNA influence their recognition and degradation by these prokaryotic immune systems.	[Almendros, Cristobal; Guzman, Noemi M.; Diez-Villasenor, Cesar; Garcia-Martinez, Jesus; Mojica, Francisco J. M.] Univ Alicante, Fac Ciencias, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain	Universitat d'Alacant	Mojica, FJM (corresponding author), Univ Alicante, Fac Ciencias, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain.	fmojica@ua.es	Guzman, Noemi M/AAA-5348-2019; Díez-Villaseñor, César/AAG-5359-2020; Almendros, Cristobal/Q-1163-2016; García-Martínez, Jesús/K-6557-2014; Mojica, Francisco/M-8478-2019; Mojica, Francisco J.M./K-2414-2014	Díez-Villaseñor, César/0000-0001-6140-9625; Almendros, Cristobal/0000-0002-1582-8906; García-Martínez, Jesús/0000-0002-8149-8052; Mojica, Francisco J.M./0000-0002-6660-4996; Guzman, Noemi M/0000-0002-3789-2095; Mangan, Rachel/0000-0002-2984-3699	Spanish Ministerio de Ciencia e Innovacion [BIO2011-24417]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study was supported by the Spanish Ministerio de Ciencia e Innovacion (BIO2011-24417). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2012, CURR OPIN IMMUNOL, V24, P15, DOI 10.1016/j.coi.2011.10.005; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brown JR, 2004, BIOESSAYS, V26, P463, DOI 10.1002/bies.20030; Cady KC, 2012, J BACTERIOL, V194, P5728, DOI 10.1128/JB.01184-12; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Erdmann S, 2012, MOL MICROBIOL, V85, P1044, DOI 10.1111/j.1365-2958.2012.08171.x; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haurwitz RE, 2012, EMBO J, V31, P2824, DOI 10.1038/emboj.2012.107; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Miquel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012714; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2000, MOL MICROBIOL, V36, P244, DOI 10.1046/j.1365-2958.2000.01838.x; Mojica FJM, 2010, MOL MICROBIOL, V77, P1341, DOI 10.1111/j.1365-2958.2010.07326.x; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Semenova E, 2009, FEMS MICROBIOL LETT, V296, P110, DOI 10.1111/j.1574-6968.2009.01626.x; Shi XZ, 2003, ANAL BIOCHEM, V320, P152, DOI 10.1016/S0003-2697(03)00352-X; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; van Duijn E, 2012, MOL CELL PROTEOMICS, DOI [10.1074/ mcp.M112.02026, DOI 10.1074/MCP.M112.02026]; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zegans ME, 2009, J BACTERIOL, V191, P210, DOI 10.1128/JB.00797-08	47	44	50	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50797	10.1371/journal.pone.0050797	http://dx.doi.org/10.1371/journal.pone.0050797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189210	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800087
J	Alters, SE; McLaughlin, B; Spink, B; Lachinyan, T; Wang, CW; Podust, V; Schellenberger, V; Stemmer, WPC				Alters, Susan E.; McLaughlin, Bryant; Spink, Benjamin; Lachinyan, Tigran; Wang, Chia-wei; Podust, Vladimir; Schellenberger, Volker; Stemmer, Willem P. C.			GLP2-2G-XTEN: A Pharmaceutical Protein with Improved Serum Half-Life and Efficacy in a Rat Crohn's Disease Model	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-2; INFLAMMATORY-BOWEL-DISEASE; INTESTINAL GROWTH-FACTOR; MURINE MODEL; IN-VIVO; GLP-2; TEDUGLUTIDE; ANALOG; PHARMACOKINETICS; PROLIFERATION	Objectives: Glucagon-like peptide 2 (GLP2) is an intestinal growth factor that has been shown to stimulate intestinal growth and reduce disease severity in preclinical models of short bowel syndrome and inflammatory bowel disease. Teduglutide, a recombinant human GLP2 variant (GLP2-2G), has increased half-life and stability as compared to the native GLP2 peptide, but still requires twice daily dosing in preclinical models and daily dosing in the clinic. The goal of this study was to produce and characterize the preclinical pharmacokinetic and therapeutic properties of GLP2-2G-XTEN, a novel, long-acting form of GLP2-2G. Methodology and Results: A GLP2-2G-XTEN fusion protein with extended exposure profile was produced by genetic fusion of GLP2-2G peptide to XTEN, a long, unstructured, non-repetitive, hydrophilic sequence of amino acids. The serum half-life of GLP2-2G-XTEN in mice, rats and monkeys was 34, 38 and 120 hours, respectively. Intestinotrophic effects were demonstrated in normal rats, where GLP2-2G-XTEN administration resulted in a significant increase in both small intestine weight and length. Efficacy of the GLP2-2G-XTEN protein was compared to that of GLP2-2G peptide in a rat Crohn's disease model, indomethacin-induced inflammation. Prophylactic administration of GLP2-2G-XTEN significantly increased the length, reduced the number of trans-ulcerations and adhesions, and reduced the TNF alpha content of the small intestine. GLP2-2G-XTEN demonstrated greater in vivo potency as compared to GLP2-2G peptide, and improvement in histopathology supported the GLP2-2G-XTEN treatment effects. Conclusions and Significance: GLP2-2G-XTEN is intestinotrophic and demonstrates efficacy in a rat Crohn's disease model requiring a lower molar dose and less frequent dosing relative to GLP2-2G peptide. Allometric scaling based on pharmacokinetics from mouse, rat and monkey projects a human half-life of 240 hours. These improvements in preclinical pharmacokinetics and dosing indicate that GLP2-2G-XTEN may offer a superior therapeutic benefit for treatment of gastrointestinal diseases including Crohn's disease.	[Alters, Susan E.; McLaughlin, Bryant; Spink, Benjamin; Lachinyan, Tigran; Wang, Chia-wei; Podust, Vladimir; Schellenberger, Volker; Stemmer, Willem P. C.] Amunix Inc, Mountain View, CA USA		Alters, SE (corresponding author), Amunix Inc, Mountain View, CA USA.	salters@amunix.com	Wang, Chia Wei/GXF-9984-2022		Amunix, Inc.	Amunix, Inc.	The project was supported by funding from Amunix, Inc. Employees of Amunix had a primary role in the design, data collection and analysis, decision to publish, and preparation of the manuscript. No current external funding sources for this study.	Alavi K, 2000, J PEDIATR SURG, V35, P847, DOI 10.1053/jpsu.2000.6861; Boushey RP, 1999, AM J PHYSIOL-ENDOC M, V277, pE937, DOI 10.1152/ajpendo.1999.277.5.E937; Brubaker PL, 1997, AM J PHYSIOL-ENDOC M, V272, pE1050, DOI 10.1152/ajpendo.1997.272.6.E1050; Buchman AL, 2010, INFLAMM BOWEL DIS, V16, P962, DOI 10.1002/ibd.21117; Cleland JL, 2012, J PHARM SCI; Drucker DJ, 1997, AM J PHYSIOL-GASTR L, V273, pG1252, DOI 10.1152/ajpgi.1997.273.6.G1252; Drucker DJ, 1999, AM J PHYSIOL-GASTR L, V276, pG79, DOI 10.1152/ajpgi.1999.276.1.G79; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; Geething NC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010175; Hanauer SB, 2006, GASTROENTEROLOGY, V130, P323, DOI 10.1053/j.gastro.2005.11.030; Hartmann B, 2000, J CLIN ENDOCR METAB, V85, P2884, DOI 10.1210/jc.85.8.2884; Jeppesen PB, 2011, GUT, V60, P902, DOI 10.1136/gut.2010.218271; Jeppesen PB, 2009, GASTROENT RES PRACT, V2009, DOI 10.1155/2009/616054; Jeppesen PB, 2005, GUT, V54, P1224, DOI 10.1136/gut.2004.061440; Jeppesen PB, 2001, GASTROENTEROLOGY, V120, P806, DOI 10.1053/gast.2001.22555; L'Heureux MC, 2003, J PHARMACOL EXP THER, V306, P347, DOI 10.1124/jpet.103.051771; Lichtenstein GR, 2004, AM J GASTROENTEROL, V99, P91, DOI 10.1046/j.1572-0241.2003.04010.x; Mahmood I, 2007, ADV DRUG DELIVER REV, V59, P1177, DOI 10.1016/j.addr.2007.05.015; Marier JF, 2008, J CLIN PHARMACOL, V48, P1289, DOI 10.1177/0091270008320605; Martin GR, 2005, AM J PHYSIOL-GASTR L, V288, pG431, DOI 10.1152/ajpgi.00242.2004; Martin GR, 2004, AM J PHYSIOL-GASTR L, V286, pG964, DOI 10.1152/ajpgi.00509.2003; Sandborn WJ, 2007, NEW ENGL J MED, V357, P228, DOI 10.1056/NEJMoa067594; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Schmidt PT, 2000, SCAND J GASTROENTERO, V35, P522; Scott CE, 1998, AM J PHYSIOL-CELL PH, V275, pC285, DOI 10.1152/ajpcell.1998.275.1.C285; Sigalet DL, 2007, AM J PHYSIOL-GASTR L, V293, pG211, DOI 10.1152/ajpgi.00530.2006; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Targan SR, 2007, GASTROENTEROLOGY, V132, P1672, DOI 10.1053/j.gastro.2007.03.024; Tavares W, 2000, AM J PHYSIOL-ENDOC M, V278, pE134, DOI 10.1152/ajpendo.2000.278.1.E134; Tsai CH, 1997, AM J PHYSIOL-ENDOC M, V273, pE77, DOI 10.1152/ajpendo.1997.273.1.E77; Yusta B, 2000, GASTROENTEROLOGY, V119, P744, DOI 10.1053/gast.2000.16489	32	46	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50630	10.1371/journal.pone.0050630	http://dx.doi.org/10.1371/journal.pone.0050630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189208	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800085
J	Guenther, S; Bethe, A; Fruth, A; Semmler, T; Ulrich, RG; Wieler, LH; Ewers, C				Guenther, Sebastian; Bethe, Astrid; Fruth, Angelika; Semmler, Torsten; Ulrich, Rainer G.; Wieler, Lothar H.; Ewers, Christa			Frequent Combination of Antimicrobial Multiresistance and Extraintestinal Pathogenicity in Escherichia coli Isolates from Urban Rats (Rattus norvegicus) in Berlin, Germany	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; SEQUENCE TYPE ST131; MOLECULAR EPIDEMIOLOGY; ANTIBIOTIC-RESISTANCE; FEEDLOT-CATTLE; VIRULENCE; STRAINS; INFECTIONS; COMMUNITY; ANIMALS	Urban rats present a global public health concern as they are considered a reservoir and vector of zoonotic pathogens, including Escherichia coli. In view of the increasing emergence of antimicrobial resistant E. coli strains and the on-going discussion about environmental reservoirs, we intended to analyse whether urban rats might be a potential source of putatively zoonotic E. coli combining resistance and virulence. For that, we took fecal samples from 87 brown rats (Rattus norvegicus) and tested at least three E. coli colonies from each animal. Thirty two of these E. coli strains were pre-selected from a total of 211 non-duplicate isolates based on their phenotypic resistance to at least three antimicrobial classes, thus fulfilling the definition of multiresistance. As determined by multilocus sequence typing (MLST), these 32 strains belonged to 24 different sequence types (STs), indicating a high phylogenetic diversity. We identified STs, which frequently occur among extraintestinal pathogenic E. coli (ExPEC), such as STs 95, 131, 70, 428, and 127. Also, the detection of a number of typical virulence genes confirmed that the rats tested carried ExPEC-like strains. In particular, the finding of an Extended-spectrum beta-lactamase (ESBL)-producing strain which belongs to a highly virulent, so far mainly human-and avian-restricted ExPEC lineage (ST95), which expresses a serogroup linked with invasive strains (O18:NM:K1), and finally, which produces an ESBL-type frequently identified among human strains (CTX-M-9), pointed towards the important role, urban rats might play in the transmission of multiresistant and virulent E. coli strains. Indeed, using a chicken infection model, this strain showed a high in vivo pathogenicity. Imagining the high numbers of urban rats living worldwide, the way to the transmission of putatively zoonotic, multiresistant, and virulent strains might not be far ahead. The unforeseeable consequences of such an emerging public health threat need careful consideration in the future.	[Guenther, Sebastian; Bethe, Astrid; Semmler, Torsten; Wieler, Lothar H.; Ewers, Christa] Free Univ Berlin, Dept Vet Med, Inst Microbiol & Epizoot, Berlin, Germany; [Fruth, Angelika] Robert Koch Inst, Wernigerode, Germany; [Ulrich, Rainer G.] Inst Novel & Emerging Infect Dis, Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany; [Ewers, Christa] Univ Giessen, Dept Vet Med, Inst Hyg & Infect Dis Anim, Giessen, Germany	Free University of Berlin; Robert Koch Institute; Friedrich Loeffler Institute; Justus Liebig University Giessen	Guenther, S (corresponding author), Free Univ Berlin, Dept Vet Med, Inst Microbiol & Epizoot, Berlin, Germany.	sebastian.guenther@fu-berlin.de	Ewers, Christa/AAL-9186-2020; Semmler, Torsten/Q-7716-2018; Semmler, Torsten/O-9540-2019; Guenther, Sebastian/O-5005-2014	Semmler, Torsten/0000-0002-2225-7267; Semmler, Torsten/0000-0002-2225-7267; Ewers, Christa/0000-0001-6167-1340; Guenther, Sebastian/0000-0003-0173-7314; Wieler, Lothar H./0000-0003-4365-3717	Federal Ministry of Education (BMBF); Research Network Zoonosis (FBI-Zoo) [01KI1012A]; German Research Foundation (DFG) [GRK1673]; Federal Ministry of Education and Research [FKZ 01KI1018]	Federal Ministry of Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Research Network Zoonosis (FBI-Zoo); German Research Foundation (DFG)(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education (BMBF) and Research Network Zoonosis (FBI-Zoo, Grant 01KI1012A), the German Research Foundation (DFG) funded Indo-German Research Training Group (Grant GRK1673), and the Federal Ministry of Education and Research grant to RGU (FKZ 01KI1018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1986, ANNU REV MICROBIOL, V40, P185, DOI 10.1146/annurev.micro.40.1.185; Allen SE, 2011, APPL ENVIRON MICROB, V77, P882, DOI 10.1128/AEM.01111-10; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Battersby SA, 2002, J ENV HLTH RES, V1, P4; Bertrand S, 2006, J CLIN MICROBIOL, V44, P2897, DOI 10.1128/JCM.02549-05; Bonnefoy X, 2008, PUBLIC HLTH SIGNIFIC; Bukh AS, 2009, J ANTIMICROB CHEMOTH, V64, P163, DOI 10.1093/jac/dkp156; Burriel AR, 2008, INT J ENVIRON HEAL R, V18, P159, DOI 10.1080/09603120701358432; Channon D, 2000, EPIDEMIOL INFECT, V125, P441, DOI 10.1017/S095026889900446X; Cizek A, 1999, LETT APPL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2672.1999.00549.x; Clinical and Laboratory Standards Institute, 2020, M100 CLSI, V30th; Costa D, 2008, MICROB DRUG RESIST, V14, P71, DOI 10.1089/mdr.2008.0795; Croxall G, 2011, J ANTIMICROB CHEMOTH, V66, P2501, DOI 10.1093/jac/dkr349; Davis DE, 1951, PHYSIOL ZOOL, V24; Dhanji H, 2011, J ANTIMICROB CHEMOTH, V66, P512, DOI 10.1093/jac/dkq472; Dubois D, 2009, EMERG INFECT DIS, V15, P1988, DOI 10.3201/eid1512.090928; EMLEN JT, 1948, PHYSIOL ZOOL, V21, P59, DOI 10.1086/physzool.21.1.30151981; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Ewers C, 2011, INT J ANTIMICROB AG, V37, P86, DOI 10.1016/j.ijantimicag.2010.09.007; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Feldmann F, 2007, INFECT IMMUN, V75, P3183, DOI 10.1128/IAI.00656-06; Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x; Germon P, 2005, MICROBIOL-SGM, V151, P1179, DOI 10.1099/mic.0.27809-0; Glass GE, 1989, OCCASIONAL PAPERS MU, P130; Grimm V, 2004, J CLIN MICROBIOL, V42, P3766, DOI 10.1128/JCM.42.8.3766-3774.2004; Guenther S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00246; Guenther S, 2010, SCI TOTAL ENVIRON, V408, P3519, DOI 10.1016/j.scitotenv.2010.05.005; Guenther S, 2010, VET MICROBIOL, V144, P219, DOI 10.1016/j.vetmic.2009.12.016; Guenther S, 2010, J ANTIMICROB CHEMOTH, V65, P582, DOI 10.1093/jac/dkp496; Jardine CM, 2012, APPL ENVIRON MICROB, V78, P3873, DOI 10.1128/AEM.00705-12; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2010, ANTIMICROB AGENTS CH, V54, P546, DOI 10.1128/AAC.01089-09; Johnson JR, 2005, INT J MED MICROBIOL, V295, P383, DOI 10.1016/j.ijmm.2005.07.005; Johnson JR, 2001, INFECT IMMUN, V69, P1306, DOI 10.1128/IAI.69.3.1306-1314.2001; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Kim BY, 2005, INT J MED MICROBIOL, V295, P463, DOI 10.1016/j.ijmm.2005.07.004; Literak I, 2009, AFR J MICROBIOL RES, V3, P751; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; Meyer A.N., 1995, ENV HLTH, V103, P127; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; Nielsen EM, 2004, APPL ENVIRON MICROB, V70, P6944, DOI 10.1128/AEM.70.11.6944-6947.2004; Nijsten R, 1995, J ANTIMICROB CHEMOTH, V36, P975, DOI 10.1093/jac/36.6.975; Nkogwe Comfort, 2011, Veterinary Medicine International, V2011, P1, DOI 10.4061/2011/686923; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; ORGAIN H, 1953, ECOLOGY, V34, P467, DOI 10.2307/1929719; Park YJ, 2007, J ANTIMICROB CHEMOTH, V60, P868, DOI 10.1093/jac/dkm266; Pitout JDD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00009; Pitout JDD, 2010, DRUGS, V70, P313, DOI 10.2165/11533040-000000000-00000; Platell JL, 2011, VET MICROBIOL, V153, P99, DOI 10.1016/j.vetmic.2011.05.007; Pomba C, 2009, ANTIMICROB AGENTS CH, V53, P327, DOI 10.1128/AAC.00896-08; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Rodriguez I, 2009, J ANTIMICROB CHEMOTH, V64, P301, DOI 10.1093/jac/dkp195; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Runge M, 2012, PEST MANAG SCI; Sargeant JM, 2004, PREV VET MED, V66, P207, DOI 10.1016/j.prevetmed.2004.09.006; Schierack P, 2008, ENVIRON MICROBIOL, V10, P1742, DOI 10.1111/j.1462-2920.2008.01595.x; Schierack P, 2009, APPL ENVIRON MICROB, V75, P695, DOI 10.1128/AEM.01650-08; Schwarz S, 2010, J ANTIMICROB CHEMOTH, V65, P601, DOI 10.1093/jac/dkq037; SILVER RP, 1980, INFECT IMMUN, V29, P200, DOI 10.1128/IAI.29.1.200-206.1980; Swiecicka I, 2003, J GEN APPL MICROBIOL, V49, P315, DOI 10.2323/jgam.49.315; TAYLOR KD, 1978, MAMMALIA, V42, P63, DOI 10.1515/mamm.1978.42.1.63; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; WEBSTER JP, 1995, PARASITOLOGY, V111, P247, DOI 10.1017/S0031182000081804; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; WINKLE S, 1979, MIKROBIOLOGISCHE SER; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	68	51	52	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50331	10.1371/journal.pone.0050331	http://dx.doi.org/10.1371/journal.pone.0050331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189197	Green Published, gold			2022-12-25	WOS:000311929800074
J	Guerrero, F; Carbonell, V; Cossu, M; Correddu, D; Jones, PR				Guerrero, Fernando; Carbonell, Veronica; Cossu, Matteo; Correddu, Danilo; Jones, Patrik R.			Ethylene Synthesis and Regulated Expression of Recombinant Protein in Synechocystis sp PCC 6803	PLOS ONE			English	Article							FORMING ENZYME; PSEUDOMONAS-SYRINGAE; ESCHERICHIA-COLI; GENE; CYANOBACTERIUM; CONSTRUCTION; CLONING; OVEREXPRESSION; BIOSYNTHESIS; PLASTOCYANIN	The ethylene-forming enzyme (EFE) from Pseudomonas syringae catalyzes the synthesis of ethylene which can be easily detected in the headspace of closed cultures. A synthetic codon-optimized gene encoding N-terminal His-tagged EFE (EFEh) was expressed in Synechocystis sp. PCC 6803 (Synechocystis) and Escherichia coli (E. coli) under the control of diverse promoters in a self-replicating broad host-range plasmid. Ethylene synthesis was stably maintained in both organisms in contrast to earlier work in Synechococcus elongatus PCC 7942. The rate of ethylene accumulation was used as a reporter for protein expression in order to assess promoter strength and inducibility with the different expression systems. Several metal-inducible cyanobacterial promoters did not function in E. coli but were well-regulated in cyanobacteria, albeit at a low level of expression. The E. coli promoter P-trc resulted in constitutive expression in cyanobacteria regardless of whether IPTG was added or not. In contrast, a Lac promoter variant, PA1lacO-1, induced EFE-expression in Synechocystis at a level of expression as high as the Trc promoter and allowed a fine level of IPTG-dependent regulation of protein-expression. The regulation was tight at low cell density and became more relaxed in more dense cultures. A synthetic quorum-sensing promoter system was also constructed and shown to function well in E. coli, however, only a very low level of EFE-activity was observed in Synechocystis, independent of cell density.	[Guerrero, Fernando; Carbonell, Veronica; Cossu, Matteo; Correddu, Danilo; Jones, Patrik R.] Univ Turku, Dept Biochem & Food Chem, Turku, Finland	University of Turku	Jones, PR (corresponding author), Univ Turku, Dept Biochem & Food Chem, Turku, Finland.	patjon@utu.fi	Correddu, Danilo/GQZ-6493-2022; Correddu, Danilo/S-6046-2017	Correddu, Danilo/0000-0003-4945-8904; Correddu, Danilo/0000-0003-4945-8904; Guerrero, Fernando/0000-0003-2215-3115; Jones, Patrik/0000-0001-7618-8204	European Union Seventh Framework Programme [256808]	European Union Seventh Framework Programme(European Commission)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7-ENERGY-2010-1) under grant agreement n. [256808]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; BRIGGS LM, 1990, PLANT MOL BIOL, V15, P633, DOI 10.1007/BF00017837; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chae HS, 2003, PLANT CELL, V15, P545, DOI 10.1105/tpc.006882; Chen X, 2010, INT J BIOL SCI, V6, P96; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; Ducat DC, 2011, P NATL ACAD SCI USA, V108, P3941, DOI 10.1073/pnas.1016026108; Eaton-Rye JJ, 2011, METHODS MOL BIOL, V684, P295, DOI [10.1007/978.1.60761.925.3_22, 10.1007/978-1-60761-925-3_22]; FUKUDA H, 1992, BIOCHEM BIOPH RES CO, V188, P826, DOI 10.1016/0006-291X(92)91131-9; FUKUDA H, 1994, BIOTECHNOL LETT, V16, P1, DOI 10.1007/BF01022614; FUKUDA H, 1993, ADV MICROB PHYSIOL, V35, P275, DOI 10.1016/S0065-2911(08)60101-0; GEERTS D, 1995, MICROBIOL-UK, V141, P831, DOI 10.1099/13500872-141-4-831; GHASSEMIAN M, 1994, MICROBIOL-UK, V140, P1151, DOI 10.1099/13500872-140-5-1151; Hawkins AC, 2007, APPL ENVIRON MICROB, V73, P5775, DOI 10.1128/AEM.00060-07; Heidorn T, 2011, METHOD ENZYMOL, V497, P539, DOI 10.1016/B978-0-12-385075-1.00024-X; Heurlier K, 2003, J BACTERIOL, V185, P2227, DOI 10.1128/JB.185.7.2227-2235.2003; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; Imamura S, 2009, GENE REGUL SYST BIO, V3, P65; ISHIHARA K, 1995, J FERMENT BIOENG, V79, P205, DOI 10.1016/0922-338X(95)90604-X; Kamarainen J, 2012, J BIOTECHNOL, V162, P67, DOI 10.1016/j.jbiotec.2012.07.193; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; Kuchmina E, 2012, J BIOTECHNOL; Lamb JR, 2003, J BACTERIOL, V185, P7129, DOI 10.1128/JB.185.24.7129-7139.2003; Lan EI, 2012, P NATL ACAD SCI USA, V109, P6018, DOI 10.1073/pnas.1200074109; Lan EI, 2011, METAB ENG, V13, P353, DOI 10.1016/j.ymben.2011.04.004; Li N, 1996, J BIOL CHEM, V271, P25738, DOI 10.1074/jbc.271.42.25738; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Lindberg P, 2009, METAB ENG; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Matsuoka M, 2001, MICROBIOL-SGM, V147, P2077, DOI 10.1099/00221287-147-8-2077; NAGAHAMA K, 1991, J GEN MICROBIOL, V137, P2281, DOI 10.1099/00221287-137-10-2281; OGAWA T, 1990, J FERMENT BIOENG, V69, P287, DOI 10.1016/0922-338X(90)90107-8; Peca L, 2008, FEMS MICROBIOL LETT, V289, P258, DOI 10.1111/j.1574-6968.2008.01393.x; Pirkov I, 2008, METAB ENG, V10, P276, DOI 10.1016/j.ymben.2008.06.006; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Sakai M, 1997, J FERMENT BIOENG, V84, P434, DOI 10.1016/S0922-338X(97)82004-1; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; Takahama K, 2003, J BIOSCI BIOENG, V95, P302, DOI 10.1016/S1389-1723(03)80034-8; Tan XM, 2011, METAB ENG, V13, P169, DOI 10.1016/j.ymben.2011.01.001; Tao L, 2008, APPL MICROBIOL BIOT, V80, P573, DOI 10.1007/s00253-008-1562-7; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; Ungerer J, 2012, ENERGY ENV SCI; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001	46	120	122	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50470	10.1371/journal.pone.0050470	http://dx.doi.org/10.1371/journal.pone.0050470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185630	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000242
J	Ward, DF				Ward, Darren F.			More Than Just Records: Analysing Natural History Collections for Biodiversity Planning	PLOS ONE			English	Article							NEW-ZEALAND; CONSERVATION STATUS; HYMENOPTERA; ICHNEUMONIDAE; INFORMATICS; FUTURE; ANTS	Natural History Collections (NHCs) play a central role as sources of data for biodiversity and conservation. Yet, few NHCs have examined whether the data they contain is adequately representative of local biodiversity. I examined over 15,000 databased records of Hymenoptera from 1435 locations across New Zealand collected over the past 90 years. These records are assessed in terms of their geographical, temporal, and environmental coverage across New Zealand. Results showed that the spatial coverage of records was significantly biased, with the top four areas contributing over 51% of all records. Temporal biases were also evident, with a large proportion (40%) of records collected within a short time period. The lack of repeat visits to specific locations indicated that the current set of NHC records would be of limited use for long-term ecological research. Consequently, analyses and interpretation of historical data, for example, shifts in community composition, would be limited. However, in general, NHC records provided good coverage of the diversity of New Zealand habitats and climatic environments, although fewer NHC records were represented at cooler temperatures (<5 degrees C) and the highest rainfalls (>5000 mm/yr). Analyses of NHCs can be greatly enhanced by using simple techniques that examine collection records in terms of environmental and geographical space. NHCs that initiate a systematic sampling strategy will provide higher quality data for biodiversity research than ad hoc or point samples, as is currently the norm. Although NHCs provide a rich source of information they could be far better utilised in a range of large-scale ecological and conservation studies.	Landcare Res, New Zealand Arthropod Collect, Auckland, New Zealand	Landcare Research - New Zealand	Ward, DF (corresponding author), Landcare Res, New Zealand Arthropod Collect, Auckland, New Zealand.	wardda@landcareresearch.co.nz		Ward, Darren/0000-0002-4509-8553	Foundation for Research, Science and Technology [FRST C09X0507]; Core funding for Crown Research Institutes from the Ministry of Business, Innovation and Employment's Science and Innovation Group, through the Defining New Zealand's Land Biota Portfolio	Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Core funding for Crown Research Institutes from the Ministry of Business, Innovation and Employment's Science and Innovation Group, through the Defining New Zealand's Land Biota Portfolio	This research (including database entry and georeferencing) was funded by the Terrestrial and Freshwater Biodiversity Information System Program, the Foundation for Research, Science and Technology (contract FRST C09X0507), and by Core funding for Crown Research Institutes from the Ministry of Business, Innovation and Employment's Science and Innovation Group, through the Defining New Zealand's Land Biota Portfolio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; BERRY JA, 1990, NEW ZEAL J ZOOL, V17, P607, DOI 10.1080/03014223.1990.10422958; BERRY JA, 2007, FAUNA NZ, V58; Berry JA, 2010, NZ INVENTORY BIODIVE, V2, P350; Berry JA, 2007, AUST J ENTOMOL, V46, P99, DOI 10.1111/j.1440-6055.2007.00575.x; Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Clarke K. R., 2005, CHANGE MARINE COMMUN; Crosby TK, 1998, NEW ZEAL J ZOOL, V25, P175, DOI 10.1080/03014223.1998.9518148; Early JW, 2001, INVERTEBR TAXON, V15, P341, DOI 10.1071/IT00053; Fernandez-Triana JL, 2011, ZOOTAXA, P24, DOI 10.11646/zootaxa.2932.1.2; Fernandez-Triana J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023719; Funk VA, 2002, SYST BIOL, V51, P303, DOI 10.1080/10635150252899789; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; HARRIS AC, 1994, FAUNA NZ, V32; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Krishtalka L, 2000, BIOSCIENCE, V50, P611, DOI 10.1641/0006-3568(2000)050[0611:CNHMCT]2.0.CO;2; Kuschel G., 1990, BEETLES SUBURBAN ENV; LEATHWICK JR, 2004, CONSERV BIOL, V17, P1; Lister AM, 2011, TRENDS ECOL EVOL, V26, P153, DOI 10.1016/j.tree.2010.12.009; Mac Nally R, 2002, ECOL APPL, V12, P900, DOI 10.1890/1051-0761(2002)012[0900:HWDEBP]2.0.CO;2; Marske KA, 2011, MOL PHYLOGENET EVOL, V59, P89, DOI 10.1016/j.ympev.2011.01.005; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; NAUMANN ID, 1988, FAUNA NZ, V15; New T. R., 2012, INSECT CONSERVATION; NEW TR, 1993, AM ZOOL, V33, P623; NOYES JS, 1989, FAUNA NZ, V18; Noyes JS, 1989, FAUNA NZ, V17; NOYES JS, 1988, FAUNA NZ, V13; Oliver I, 1996, ECOL APPL, V6, P594, DOI 10.2307/2269394; Overton JM, 2009, DIVERS DISTRIB, V15, P731, DOI 10.1111/j.1472-4642.2009.00589.x; Patterson DJ, 2010, TRENDS ECOL EVOL, V1297, P1; Ponder WF, 2001, CONSERV BIOL, V15, P648, DOI 10.1046/j.1523-1739.2001.015003648.x; Pyke GH, 2010, BIOL REV, V85, P247, DOI 10.1111/j.1469-185X.2009.00098.x; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Stringer IAN, 2012, NZ ENTOMOL, V35, P77, DOI 10.1080/00779962.2012.686309; Suarez AV, 2005, P NATL ACAD SCI USA, V102, P17032, DOI 10.1073/pnas.0506119102; Terralink, 2004, NZ LAND COV DAT LCDB; WALKER AK, 1987, J NAT HIST, V21, P339, DOI 10.1080/00222938700771061; Ward D, 2011, NZ ENTOMOL, V34, P37, DOI 10.1080/00779962.2011.9722206; Ward D, 2011, NZ ENTOMOL, V34, P1; Ward DF, 2012, NZ ENTOMOL, V35, P116, DOI 10.1080/00779962.2012.686315; Ward DF, 2005, SOCIOBIOLOGY, V45, P401; Ward DF, 2004, NEW ZEAL J ECOL, V28, P151	44	25	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50346	10.1371/journal.pone.0050346	http://dx.doi.org/10.1371/journal.pone.0050346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185605	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000218
J	Fan, CD; Lum, MA; Xu, C; Black, JD; Wang, XJ				Fan, Chuan-Dong; Lum, Michelle A.; Xu, Chao; Black, Jennifer D.; Wang, Xinjiang			Ubiquitin-dependent Regulation of Phospho-AKT Dynamics by the Ubiquitin E3 Ligase, NEDD4-1, in the Insulin-like Growth Factor-1 Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; PTEN; DEGRADATION; STABILITY; COMPLEX; PHOSPHORYLATION; PROTOONCOGENE; SENSITIVITY; ACTIVATION; MUTATION	AKT is a critical effector kinase downstream of the PI3K pathway that regulates a plethora of cellular processes including cell growth, death, differentiation, and migration. Mechanisms underlying activated phospho-AKT (pAKT) translocation to its action sites remain unclear. Here we show that NEDD4-1 is a novel E3 ligase that specifically regulates ubiquitin-dependent trafficking of pAKT in insulin-like growth factor (IGF)-1 signaling. NEDD4-1 physically interacts with AKT and promotes HECT domain-dependent ubiquitination of exogenous and endogenous AKT. NEDD4-1 catalyzes K63-type polyubiquitin chain formation on AKT in vitro. Plasma membrane binding is the key step for AKT ubiquitination by NEDD4-1 in vivo. Ubiquitinated pAKT translocates to perinuclear regions, where it is released into the cytoplasm, imported into the nucleus, or coupled with proteasomal degradation. IGF-1 signaling specifically stimulates NEDD4-1-mediated ubiquitination of pAKT, without altering total AKT ubiquitination. A cancer-derived plasma membrane-philic mutant AKT(E17K) is more effectively ubiquitinated by NEDD4-1 and more efficiently trafficked into the nucleus compared with wild type AKT. This study reveals a novel mechanism by which a specific E3 ligase is required for ubiquitin-dependent control of pAKT dynamics in a ligand-specific manner.	[Fan, Chuan-Dong; Lum, Michelle A.; Xu, Chao; Black, Jennifer D.; Wang, Xinjiang] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Wang, XJ (corresponding author), Elm & Carlton St, Buffalo, NY 14263 USA.	xinjiang.wang@roswellpark.org			National Institutes of Health [DK54909, DK60632]; Roswell Park Cancer Institute; American Cancer Society [02-197-04]; Roswell Park Core Grant [CA16056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060632, R56DK060632, R01DK054909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roswell Park Cancer Institute; American Cancer Society(American Cancer Society); Roswell Park Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54909 and DK60632 (to J. B.), start-up funds from Roswell Park Cancer Institute (to X. W.), American Cancer Society Institutional Research Grant 02-197-04 (to X. W.), and Roswell Park Core Grant CA16056.	Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Davies MA, 2008, BRIT J CANCER, V99, P1265, DOI 10.1038/sj.bjc.6604637; Dickey CA, 2008, P NATL ACAD SCI USA, V105, P3622, DOI 10.1073/pnas.0709180105; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Lee JRE, 2009, J BIOL CHEM, V284, P32126, DOI 10.1074/jbc.M109.048629; Maccario H, 2010, J BIOL CHEM, V285, P12620, DOI 10.1074/jbc.M109.072280; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Suizu F, 2009, DEV CELL, V17, P800, DOI 10.1016/j.devcel.2009.09.007; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012	32	75	77	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1674	1684		10.1074/jbc.M112.416339	http://dx.doi.org/10.1074/jbc.M112.416339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23195959	Green Published, hybrid			2022-12-25	WOS:000313751400023
J	Goodreau, SM; Carnegie, NB; Vittinghoff, E; Lama, JR; Sanchez, J; Grinsztejn, B; Koblin, BA; Mayer, KH; Buchbinder, SP				Goodreau, Steven M.; Carnegie, Nicole B.; Vittinghoff, Eric; Lama, Javier R.; Sanchez, Jorge; Grinsztejn, Beatriz; Koblin, Beryl A.; Mayer, Kenneth H.; Buchbinder, Susan P.			What Drives the US and Peruvian HIV Epidemics in Men Who Have Sex with Men (MSM)?	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; BASE-LINE DATA; UNITED-STATES; HOMOSEXUAL-MEN; TRANSMISSION EVENTS; CASUAL PARTNERSHIPS; MALE CIRCUMCISION; CONTROLLED-TRIAL; DRUG-RESISTANCE; PREVENTION	In this work, we estimate the proportions of transmissions occurring in main vs. casual partnerships, and by the sexual role, infection stage, and testing and treatment history of the infected partner, for men who have sex with men (MSM) in the US and Peru. We use dynamic, stochastic models based in exponential random graph models (ERGMs), obtaining inputs from multiple large-scale MSM surveys. Parallel main partnership and casual sexual networks are simulated. Each man is characterized by age, race, circumcision status, sexual role behavior, and propensity for unprotected anal intercourse (UAI); his history is modeled from entry into the adult population, with potential transitions including HIV infection, detection, treatment, AIDS diagnosis, and death. We implemented two model variants differing in assumptions about acute infectiousness, and assessed sensitivity to other key inputs. Our two models suggested that only 4-5% (Model 1) or 22-29% (Model 2) of HIV transmission results from contacts with acute-stage partners; the plurality (80-81% and 49%, respectively) stem from chronic-stage partners and the remainder (14-16% and 27-35%, respectively) from AIDS-stage partners. Similar proportions of infections stem from partners whose infection is undiagnosed (24-31%), diagnosed but untreated (36-46%), and currently being treated (30-36%). Roughly one-third of infections (32-39%) occur within main partnerships. Results by country were qualitatively similar, despite key behavioral differences; one exception was that transmission from the receptive to insertive partner appears more important in Peru (34%) than the US (21%). The broad balance in transmission contexts suggests that education about risk, careful assessment, pre-exposure prophylaxis, more frequent testing, earlier treatment, and risk-reduction, disclosure, and adherence counseling may all contribute substantially to reducing the HIV incidence among MSM in the US and Peru. Citation: Goodreau SM, Carnegie NB, Vittinghoff E, Lama JR, Sanchez J, et al. (2012) What Drives the US and Peruvian HIV Epidemics in Men Who Have Sex with Men (MSM)? PLoS ONE 7(11): e50522. doi:10.1371/journal.pone.0050522	[Goodreau, Steven M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Carnegie, Nicole B.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lama, Javier R.; Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Grinsztejn, Beatriz] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Koblin, Beryl A.] New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA	University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Fundacao Oswaldo Cruz; New York Blood Center; Fenway Health; San Francisco Department of Public Health	Goodreau, SM (corresponding author), Univ Washington, Dept Anthropol, Seattle, WA 98195 USA.	goodreau@uw.edu	Goodreau, Steven/P-2366-2017	Carnegie, Nicole/0000-0001-7664-6682; Goodreau, Steven/0000-0003-1009-5763	National Institute of Allergy and Infectious Disease (NIAID) [R01-AI083060]; National Institute of Mental Health (NIMH), United States National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068395, R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083060] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH), United States National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by a grant (R01-AI083060) from the National Institute of Allergy and Infectious Disease (NIAID) and the National Institute of Mental Health (NIMH), United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MMWR-MORBID MORTAL W, V59, P1201; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P1618; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P597; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Beyrer C, 2011, DIR DEV, P1, DOI 10.1596/978-0-8213-8726-9; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AE, 2009, J INFECT DIS, V199, P427, DOI 10.1086/596049; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Celum C, 2008, LANCET, V371, P2109, DOI 10.1016/S0140-6736(08)60920-4; Chesney MA, 2003, AM J PUBLIC HEALTH, V93, P933, DOI 10.2105/AJPH.93.6.933; Chu HT, 2010, EPIDEMIOLOGY, V21, pS25, DOI 10.1097/EDE.0b013e3181ce9950; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Davidovich U, 2001, AIDS, V15, P1303, DOI 10.1097/00002030-200107060-00013; Eshleman SH, 2009, JAIDS-J ACQ IMM DEF, V52, P121, DOI 10.1097/QAI.0b013e3181ab61e1; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Goicochea P, 2004, 15 INT AIDS C BANGK; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; HANDCOCK MS, 2008, STATNET SOFTWARE TOO; Jansen IAV, 2011, AIDS, V25, P493, DOI 10.1097/QAD.0b013e328342fbe9; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Lama JR, 2006, JAIDS-J ACQ IMM DEF, V42, P501, DOI 10.1097/01.qai.0000221677.29693.dd; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Little SJ, 1999, J EXP MED, V190, P841, DOI 10.1084/jem.190.6.841; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Ma ZM, 2009, J VIROL, V83, P3288, DOI 10.1128/JVI.02423-08; MacKellar DA, 2007, PUBLIC HEALTH REP, V122, P39, DOI 10.1177/00333549071220S107; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Ministry of Health of Peru, 2006, STEP FORW FIGHT AIDS; Pao D, 2005, AIDS, V19, P85, DOI 10.1097/00002030-200501030-00010; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Prabhu VS, 2009, AIDS, V23, P1792, DOI 10.1097/QAD.0b013e32832e7d04; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rapatski BL, 2005, JAIDS-J ACQ IMM DEF, V38, P241; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; Sanchez J, 2011, AIDS, V25, P519, DOI 10.1097/QAD.0b013e328340fd81; Sullivan PS, 2009, AIDS, V23, P1153, DOI 10.1097/QAD.0b013e32832baa34; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; Vaidya NK, 2010, J VIROL, V84, P4302, DOI 10.1128/JVI.02284-09; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wilson DP, 2009, SEX HEALTH, V6, P19, DOI 10.1071/SH08081; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Xiridou M, 2003, AIDS, V17, P1029, DOI 10.1097/00002030-200305020-00012; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010	51	246	248	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50522	10.1371/journal.pone.0050522	http://dx.doi.org/10.1371/journal.pone.0050522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209768	Green Published, gold			2022-12-25	WOS:000312104900062
J	Yang, DF; Du, XH; Liang, X; Han, RL; Liang, ZS; Liu, Y; Liu, FH; Zhao, JJ				Yang, Dongfeng; Du, Xuhong; Liang, Xiao; Han, Ruilian; Liang, Zongsuo; Liu, Yan; Liu, Fenghua; Zhao, Jianjun			Different Roles of the Mevalonate and Methylerythritol Phosphate Pathways in Cell Growth and Tanshinone Production of Salvia miltiorrhiza Hairy Roots	PLOS ONE			English	Article							1-DEOXY-D-XYLULOSE 5-PHOSPHATE REDUCTOISOMERASE; METABOLIC CROSS-TALK; ISOPRENOID BIOSYNTHESIS; CYTOSOLIC MEVALONATE; PLASTIDIAL PATHWAYS; ARABIDOPSIS; GENE; INHIBITORS; CULTURES; CLONING	Salvia miltiorrhiza has been widely used in the treatment of coronary heart disease. Tanshinones, a group of diterpenoids are the main active ingredients in S. miltiorrhiza. Two biosynthetic pathways were involved in tanshinone biosynthesis in plants: the mevalonate (MVA) pathway in the cytosol and the methylerythritol phosphate (MEP) pathway in the plastids. The 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) is the rate-limiting enzyme of the MVA pathway. The 1-deoxy-D-xylulose 5-phosphate synthase (DXS) and 1-deoxy-D-xylulose 5-phosphate reductoisomerase (DXR) are the key enzymes of the MEP pathway. In this study, to reveal roles of the MVA and the MEP pathways in cell growth and tanshinone production of S. miltiorrhiza hairy roots, specific inhibitors of the two pathways were used to perturb metabolic flux. The results showed that the MVA pathway inhibitor (mevinolin, MEV) was more powerful to inhibit the hairy root growth than the MEP pathway inhibitor (fosmidomycin, FOS). Both MEV and FOS could significantly inhibit tanshinone production, and FOS was more powerful than MEV. An inhibitor (D, L-glyceraldehyde, DLG) of IPP translocation strengthened the inhibitory effects of MEV and FOS on cell growth and tanshinone production. Application of MEV resulted in a significant increase of expression and activity of HMGR at 6 h, and a sharp decrease at 24 h. FOS treatment resulted in a significant increase of DXR and DXS expression and DXS activity at 6 h, and a sharp decrease at 24 h. Our results suggested that the MVA pathway played a major role in cell growth, while the MEP pathway was the main source of tanshinone biosynthesis. Both cell growth and tanshinone production could partially depend on the crosstalk between the two pathways. The inhibitor-mediated changes of tanshinone production were reflected in transcript and protein levels of genes of the MVA and MEP pathways.	[Yang, Dongfeng; Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Yang, Dongfeng; Liang, Xiao; Han, Ruilian; Liang, Zongsuo] NW A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Du, Xuhong] Xinxiang Univ, Xinxiang, Peoples R China; [Liu, Yan; Liu, Fenghua] Tianjin Tasly Modern TCM Resources Co Ltd, Tianjin, Peoples R China; [Zhao, Jianjun] NingXia Teachers Univ, Coll Med, Ningxia, Peoples R China	Zhejiang Sci-Tech University; Northwest A&F University - China; Xinxiang University	Liang, ZS (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	liangzs@ms.iswc.ac.cn			Specialized Research Fund for the Doctoral Program of Higher Education [20110204110028]; Science Foundation of Zhejiang Sci-Tech University (ZSTU) [1204806-Y, 1204822-Y]	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science Foundation of Zhejiang Sci-Tech University (ZSTU)	This work was supported by Specialized Research Fund for the Doctoral Program of Higher Education (20110204110028) and Science Foundation of Zhejiang Sci-Tech University (ZSTU) under Grant No. 1204806-Y and No. 1204822-Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACH TJ, 1982, NATURWISSENSCHAFTEN, V69, P242, DOI 10.1007/BF00398646; Bick JA, 2003, ARCH BIOCHEM BIOPHYS, V415, P146, DOI 10.1016/S0003-9861(03)00233-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carretero-Paulet L, 2002, PLANT PHYSIOL, V129, P1581, DOI 10.1104/pp.003798; Dai ZB, 2011, J PLANT PHYSIOL, V168, P148, DOI 10.1016/j.jplph.2010.06.008; Ge XC, 2005, PLANT SCI, V168, P487, DOI 10.1016/j.plantsci.2004.09.012; Hagen C, 2000, J APPL BOT-ANGEW BOT, V74, P137; Hampel D, 2005, PHYTOCHEMISTRY, V66, P305, DOI 10.1016/j.phytochem.2004.12.010; Han JY, 2008, PHARMACOL THERAPEUT, V117, P280, DOI 10.1016/j.pharmthera.2007.09.008; Hemmerlin A, 2003, J BIOL CHEM, V278, P26666, DOI 10.1074/jbc.M302526200; HU ZB, 1993, PHYTOCHEMISTRY, V32, P699, DOI 10.1016/S0031-9422(00)95156-2; Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573; Kai GY, 2011, METAB ENG, V13, P319, DOI 10.1016/j.ymben.2011.02.003; Kasahara H, 2002, J BIOL CHEM, V277, P45188, DOI 10.1074/jbc.M208659200; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Lichtenthaler HK, 2000, BIOCHEM SOC T, V28, P785, DOI 10.1042/BST0280785; Ratsima H, 2011, P NATL ACAD SCI USA, V108, pE914, DOI 10.1073/pnas.1106448108; Roberts SC, 2007, NAT CHEM BIOL, V3, P387, DOI 10.1038/nchembio.2007.8; Rodriguez-Concepcion M, 2004, PLANT CELL, V16, P144, DOI 10.1105/tpc.016204; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepcion M, 2001, PLANT J, V27, P213, DOI 10.1046/j.1365-313x.2001.01089.x; Skorupinska-Tudek K, 2008, J BIOL CHEM, V283, P21024, DOI 10.1074/jbc.M706069200; Towler MJ, 2007, PLANT CELL REP, V26, P2129, DOI 10.1007/s00299-007-0420-x; Wang YD, 2003, PLANT CELL TISS ORG, V74, P283, DOI 10.1023/A:1024019809910; Wu SJ, 2009, BIOTECHNOL APPL BIOC, V52, P89, DOI 10.1042/BA20080004; Zhang Shuncang, 2011, Zhongguo Zhong Yao Za Zhi, V36, P1269	26	47	51	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e46797	10.1371/journal.pone.0046797	http://dx.doi.org/10.1371/journal.pone.0046797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209548	gold, Green Submitted, Green Published			2022-12-25	WOS:000312104900002
J	Conway, RG; Chernet, E; De Rosa, DC; Benschop, RJ; Need, AB; Collins, EC; Bean, JS; Kalbfleisch, JM; Rekhter, MD				Conway, Richard G.; Chernet, Eyassu; De Rosa, David C.; Benschop, Robert J.; Need, Anne B.; Collins, Emily C.; Bean, James S.; Kalbfleisch, J. Michael; Rekhter, Mark D.			Glucose Metabolic Trapping in Mouse Arteries: Nonradioactive Assay of Atherosclerotic Plaque Inflammation Applicable to Drug Discovery	PLOS ONE			English	Article							EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; VASCULAR INFLAMMATION; TC-99M-ANNEXIN A5; FDG-MICROPET; F-18-FDG; FLUORODEOXYGLUCOSE; ACCUMULATION; DEFICIENT; HYPOXIA	Background: F-18-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) imaging of atherosclerosis in the clinic is based on preferential accumulation of radioactive glucose analog in atherosclerotic plaques. FDG-PET is challenging in mouse models due to limited resolution and high cost. We aimed to quantify accumulation of nonradioactive glucose metabolite, FDG-6-phosphate, in the mouse atherosclerotic plaques as a simple alternative to PET imaging. Methodology/Principal Findings: Nonradioactive FDG was injected 30 minutes before euthanasia. Arteries were dissected, and lipids were extracted. The arteries were re-extracted with 50% acetonitrile-50% methanol-0.1% formic acid. A daughter ion of FDG-6-phosphate was quantified using liquid chromatography and mass spectrometry (LC/MS/MS). Thus, both traditional (cholesterol) and novel (FDG-6-phosphate) markers were assayed in the same tissue. FDG-6-phosphate was accumulated in atherosclerotic lesions associated with carotid ligation of the Western diet fed ApoE knockout mice (5.9 times increase compare to unligated carotids, p<0.001). Treatment with the liver X receptor agonist T0901317 significantly (2.1 times, p<0.01) reduced FDG-6-phosphate accumulation 2 weeks after surgery. Anti-atherosclerotic effects were independently confirmed by reduction in lesion size, macrophage number, cholesterol ester accumulation, and macrophage proteolytic activity. Conclusions/Significance: Mass spectrometry of FDG-6-phosphate in experimental atherosclerosis is consistent with plaque inflammation and provides potential translational link to the clinical studies utilizing FDG-PET imaging.	[Conway, Richard G.; Bean, James S.; Rekhter, Mark D.] Eli Lilly & Co, Lilly Res Labs, Cardiometab Dis & Diabet Complicat, Indianapolis, IN 46285 USA; [Chernet, Eyassu] Eli Lilly & Co, Lilly Res Labs, Psychiat Disorders, Indianapolis, IN 46285 USA; [De Rosa, David C.; Benschop, Robert J.] Eli Lilly & Co, Lilly Res Labs, ImmunoModulat, Indianapolis, IN 46285 USA; [Need, Anne B.; Collins, Emily C.; Kalbfleisch, J. Michael] Eli Lilly & Co, Lilly Res Labs, Translat Sci, Indianapolis, IN 46285 USA	Eli Lilly; Eli Lilly; Eli Lilly; Eli Lilly	Rekhter, MD (corresponding author), Eli Lilly & Co, Lilly Res Labs, Cardiometab Dis & Diabet Complicat, Indianapolis, IN 46285 USA.	rekhter_mark@lilly.com			Lilly Research Laboratories	Lilly Research Laboratories(Eli Lilly)	The work is funded by Lilly Research Laboratories that employs all the authors. Lilly Research Laboratories supported preparation of the manuscript and its submission. The funder had no role in study design, data collection and analysis.	Calcagno C, 2008, ARTERIOSCL THROM VAS, V28, P1311, DOI 10.1161/ATVBAHA.108.166173; Charo IF, 2011, NAT REV DRUG DISCOV, V10, P365, DOI 10.1038/nrd3444; Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23; Davies JR, 2010, INT J CARDIOVAS IMAG, V26, P41, DOI 10.1007/s10554-009-9506-6; Figueroa AL, 2011, IMAGING; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; Fryburg DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002029; Ishii H, 2010, CLIN THER, V32, P2337, DOI 10.1016/j.clinthera.2010.12.001; Kim TN, 2010, CIRC-CARDIOVASC IMAG, V3, P142, DOI 10.1161/CIRCIMAGING.109.888909; Kuo MS, 2008, J LIPID RES, V49, P1353, DOI 10.1194/jlr.D700037-JLR200; Laurberg JM, 2007, ATHEROSCLEROSIS, V192, P275, DOI 10.1016/j.atherosclerosis.2006.07.019; Libby P, 2011, CIRC RES, V109, P1100, DOI 10.1161/RES.0b013e31823bdb84; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lindsay AC, 2008, NAT REV DRUG DISCOV, V7, P517, DOI 10.1038/nrd2588; Masteling MG, 2011, J NUCL CARDIOL, V18, P1066, DOI 10.1007/s12350-011-9460-2; Menezes LJ, 2011, J NUCL MED, V52, P1698, DOI 10.2967/jnumed.111.093724; Ogawa M, 2004, J NUCL MED, V45, P1245; Pedersen SF, 2010, NUCL MED COMMUN, V31, P423, DOI 10.1097/MNM.0b013e32833767e0; Rudd JHF, 2007, ATHEROSCLEROSIS, V192, P453, DOI 10.1016/j.atherosclerosis.2006.10.027; Rudd JHF, 2010, J AM COLL CARDIOL, V55, P2527, DOI 10.1016/j.jacc.2009.12.061; Rudd JHF, 2009, CIRC-CARDIOVASC IMAG, V2, P107, DOI 10.1161/CIRCIMAGING.108.811752; Tahara N, 2006, J AM COLL CARDIOL, V48, P1825, DOI 10.1016/j.jacc.2006.03.069; Terasaka N, 2003, FEBS LETT, V536, P6, DOI 10.1016/S0014-5793(02)03578-0; Wasselius J, 2009, INT J CARDIOVAS IMAG, V25, P133, DOI 10.1007/s10554-008-9366-5; Wenning C, 2011, CURR CARDIOVASC IMAG, V4, P190, DOI 10.1007/s12410-011-9083-7; Yoo HJ, 2011, J NUCL MED, V52, P10, DOI 10.2967/jnumed.110.080838; Zhang Zhuangyu, 2006, BMC Nucl Med, V6, P3, DOI 10.1186/1471-2385-6-3; Zhao Y, 2008, J NUCL MED, V49, P1707, DOI 10.2967/jnumed.108.051847; Zhao Y, 2007, EUR J NUCL MED MOL I, V34, P1747, DOI 10.1007/s00259-007-0433-2; Zhao Y, 2011, MOL IMAGING BIOL, V13, P712, DOI 10.1007/s11307-010-0389-7	30	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50349	10.1371/journal.pone.0050349	http://dx.doi.org/10.1371/journal.pone.0050349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209718	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700062
J	Kincheski, GC; Mota-Ortiz, SR; Pavesi, E; Canteras, NS; Carobrez, AP				Kincheski, Grasielle C.; Mota-Ortiz, Sandra R.; Pavesi, Eloisa; Canteras, Newton S.; Carobrez, Antonio P.			The Dorsolateral Periaqueductal Gray and Its Role in Mediating Fear Learning to Life Threatening Events	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ROSTRAL MESENCEPHALIC RETICULOTOMY; DORSAL PREMAMMILLARY NUCLEUS; ANTERIOR CINGULATE CORTEX; ELECTRICAL-STIMULATION; UNCONDITIONED STIMULUS; EFFERENT PROJECTIONS; THALAMIC NUCLEI; DEFENSIVE BEHAVIORS; HYPOTHALAMIC AREA	The dorsolateral column of the periaqueductal gray (dlPAG) integrates aversive emotional experiences and represents an important site responding to life threatening situations, such as hypoxia, cardiac pain and predator threats. Previous studies have shown that the dorsal PAG also supports fear learning; and we have currently explored how the dlPAG influences associative learning. We have first shown that N-methyl-D-aspartate (NMDA) 100 pmol injection in the dlPAG works as a valuable unconditioned stimulus (US) for the acquisition of olfactory fear conditioning (OFC) using amyl acetate odor as conditioned stimulus (CS). Next, we revisited the ascending projections of the dlPAG to the thalamus and hypothalamus to reveal potential paths that could mediate associative learning during OFC. Accordingly, the most important ascending target of the dlPAG is the hypothalamic defensive circuit, and we were able to show that pharmacological inactivation using beta-adrenoceptor blockade of the dorsal premammillary nucleus, the main exit way for the hypothalamic defensive circuit to thalamo-cortical circuits involved in fear learning, impaired the acquisition of the OFC promoted by NMDA stimulation of the dlPAG. Moreover, our tracing study revealed multiple parallel paths from the dlPAG to several thalamic targets linked to cortical-hippocampal-amygdalar circuits involved in fear learning. Overall, the results point to a major role of the dlPAG in the mediation of aversive associative learning via ascending projections to the medial hypothalamic defensive circuit, and perhaps, to other thalamic targets, as well. These results provide interesting perspectives to understand how life threatening events impact on fear learning, and should be useful to understand pathological fear memory encoding in anxiety disorders.	[Kincheski, Grasielle C.; Pavesi, Eloisa; Carobrez, Antonio P.] Univ Fed Santa Catarina, Dept Farmacol, CCB, Florianopolis, SC, Brazil; [Mota-Ortiz, Sandra R.] Univ Cidade Sao Paulo, Lab Bases Neurais Comportamento, Sao Paulo, Brazil; [Canteras, Newton S.] Univ Sao Paulo, Dept Anat, Inst Ciencias Biomed, Sao Paulo, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Cidade de Sao Paulo; Universidade de Sao Paulo	Carobrez, AP (corresponding author), Univ Fed Santa Catarina, Dept Farmacol, CCB, Florianopolis, SC, Brazil.	padua.carobrez@ufsc.br	Carobrez, Antonio Pádua/AAF-3914-2019; Canteras, Newton/F-2402-2013	Carobrez, Antonio Pádua/0000-0002-0354-0948; Pavesi, Eloisa/0000-0003-0428-6694; Canteras, Newton/0000-0002-7205-5372; Kincheski, Grasielle Clotildes/0000-0002-7392-3602; Mota-Ortiz, Sandra Regina/0000-0002-0956-2021	Brazilian public funding agencies CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Brazilian public funding agencies CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Brazilian public funding agencies CAPES (Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior), FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). GCK and EP received doctoral fellowship and NSC and APC research fellowship from CNPq. The funding agencies had no further role in the study design; in the collection, analysis, and interpretation of the data; in the preparation of the manuscript; and in the decision to submit the paper for publication.	Albutaihi IAM, 2004, NEUROSIGNALS, V13, P207, DOI 10.1159/000079336; AMANO K, 1982, APPL NEUROPHYSIOL, V45, P123; AMANO K, 1978, APPL NEUROPHYSIOL, V41, P66; Berquin P, 2000, BRAIN RES, V857, P30, DOI 10.1016/S0006-8993(99)02304-5; Bertoglio LJ, 2006, LIFE SCI, V79, P2238, DOI 10.1016/j.lfs.2006.07.022; Bissiere S, 2008, BIOL PSYCHIAT, V63, P821, DOI 10.1016/j.biopsych.2007.10.022; Bittencourt AS, 2004, NEUROSCIENCE, V125, P71, DOI 10.1016/j.neuroscience.2004.01.026; Broadbent NJ, 2007, LEARN MEMORY, V14, P145, DOI 10.1101/lm.455607; Bucci DJ, 2000, BEHAV NEUROSCI, V114, P882, DOI 10.1037//0735-7044.114.5.882; Burwell RD, 2004, J NEUROSCI, V24, P3826, DOI 10.1523/JNEUROSCI.0410-04.2004; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; CAMERON AA, 1995, J COMP NEUROL, V351, P568, DOI 10.1002/cne.903510407; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; CAROBREZ AP, 1983, PHYSIOL BEHAV, V31, P439, DOI 10.1016/0031-9384(83)90063-X; Carvalho-Netto EF, 2010, NEUROBIOL LEARN MEM, V93, P479, DOI 10.1016/j.nlm.2010.01.005; Castilho VM, 2002, PSYCHOPHARMACOLOGY, V165, P77, DOI 10.1007/s00213-002-1246-4; Castilho VM, 2001, PSYCHOPHARMACOLOGY, V155, P154, DOI 10.1007/s002130100697; Cavalli J, 2009, NEUROBIOL LEARN MEM, V92, P512, DOI 10.1016/j.nlm.2009.06.010; Cezario AF, 2008, EUR J NEUROSCI, V28, P1003, DOI 10.1111/j.1460-9568.2008.06392.x; Chu S, 2000, COGNITION, V75, pB41, DOI 10.1016/S0010-0277(00)00065-2; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DEAKIN J F W, 1991, Journal of Psychopharmacology, V5, P305, DOI 10.1177/026988119100500414; Del-Ben CM, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/108135; Dielenberg RA, 2001, NEUROSCI BIOBEHAV R, V25, P597, DOI 10.1016/S0149-7634(01)00044-6; DISCALA G, 1989, BRAIN RES, V483, P91, DOI 10.1016/0006-8993(89)90038-3; DISCALA G, 1987, PHYSIOL BEHAV, V40, P55, DOI 10.1016/0031-9384(87)90185-5; Do Monte FHM, 2008, J NEUROSCI, V28, P13296, DOI 10.1523/JNEUROSCI.2843-08.2008; Fujiwara A, 2011, PSYCHIAT CLIN NEUROS, V65, P365, DOI 10.1111/j.1440-1819.2011.02219.x; Furlong TM, 2010, BEHAV NEUROSCI, V124, P574, DOI 10.1037/a0020739; Goto M, 2005, J COMP NEUROL, V493, P412, DOI 10.1002/cne.20764; HUNSPERGER R. W., 1956, HELVETICA PHYSIOL ET PHARMACOL ACTA, V14, P70; JENCK F, 1995, PSYCHIAT RES, V57, P181, DOI 10.1016/0165-1781(95)02673-K; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Keene CS, 2008, BEHAV NEUROSCI, V122, P1070, DOI 10.1037/a0012895; Keene CS, 2008, BEHAV NEUROSCI, V122, P89, DOI 10.1037/0735-7044.122.1.89; Kilpatrick L, 2003, BEHAV NEUROSCI, V117, P184, DOI 10.1037/0735-7044.117.1.184; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kroon JAV, 2009, NEUROBIOL LEARN MEM, V91, P32, DOI 10.1016/j.nlm.2008.10.007; Krout KE, 2000, J COMP NEUROL, V424, P111, DOI 10.1002/1096-9861(20000814)424:1<111::AID-CNE9>3.0.CO;2-3; Linke R, 2000, EXP BRAIN RES, V134, P520, DOI 10.1007/s002210000475; Moraes CLK, 2008, BEHAV BRAIN RES, V194, P181, DOI 10.1016/j.bbr.2008.07.005; NASHOLD BS, 1969, J NEUROSURG, V30, P14, DOI 10.3171/jns.1969.30.1.0014; Otto T, 1997, BEHAV NEUROSCI, V111, P1257, DOI 10.1037/0735-7044.111.6.1257; Paschall GY, 2002, BEHAV NEUROSCI, V116, P4, DOI 10.1037//0735-7044.116.1.4; Pavesi E, 2011, NEUROPSYCHOPHARMACOL, V36, P926, DOI 10.1038/npp.2010.231; Paxinos G, 1998, RAT BAIN STEREOTAXIC; Pissiota A, 2002, EUR ARCH PSY CLIN N, V252, P68, DOI 10.1007/s004060200014; Schenberg LC, 2001, NEUROSCI BIOBEHAV R, V25, P647, DOI 10.1016/S0149-7634(01)00060-4; Schimitel FG, 2012, NEUROSCIENCE, V200, P59, DOI 10.1016/j.neuroscience.2011.10.032; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; SHIBATA H, 1993, J COMP NEUROL, V330, P533, DOI 10.1002/cne.903300409; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; Sita LV, 2007, NEUROSCIENCE, V148, P949, DOI 10.1016/j.neuroscience.2007.07.010; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; Swanson LW., 2004, BRAIN MAPS STRUCTURE, V3rd edition; Tang JR, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-6; van Groen T, 2002, BEHAV BRAIN RES, V132, P19, DOI 10.1016/S0166-4328(01)00390-4; VANGROEN T, 1992, J COMP NEUROL, V324, P427, DOI 10.1002/cne.903240310; Vermetten E, 2003, J CLIN PSYCHIAT, V64, P202, DOI 10.4088/JCP.v64n0214; Vermetten E, 2007, PSYCHOPHARMACOL BULL, V40, P8; Vertes RP, 2006, J COMP NEUROL, V499, P768, DOI 10.1002/cne.21135; Vianna DML, 2003, BRAIN RES BULL, V62, P179, DOI 10.1016/j.brainresbull.2003.09.010	63	40	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50361	10.1371/journal.pone.0050361	http://dx.doi.org/10.1371/journal.pone.0050361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209724	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700064
J	Hogg, RS; Heath, K; Lima, VD; Nosyk, B; Kanters, S; Wood, E; Kerr, T; Montaner, JSG				Hogg, Robert S.; Heath, Katherine; Lima, Viviane D.; Nosyk, Bohdan; Kanters, Steve; Wood, Evan; Kerr, Thomas; Montaner, Julio S. G.			Disparities in the Burden of HIV/AIDS in Canada	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; NATURAL-HISTORY; TRANSMISSION; PREVENTION; SURVIVAL; DECLINE; ACCESS; USERS	Background: We aimed to characterize changes in patterns of new HIV diagnoses, HIV-related mortality, and HAART use in Canada from 1995 to 2008. Methods: Data on new HIV diagnoses were obtained from Health Canada, HIV-related mortality statistics were obtained from Statistics Canada, and information on the number of people on HAART was obtained from the single antiretroviral distribution site in British Columbia (BC), and the Intercontinental Marketing Services Health for Ontario and Quebec. Trends of new HIV-positive tests were assessed using Spearman rank correlations and the association between the number of individuals on HAART and new HIV diagnoses were estimated using generalized estimating equations (GEE). Results: A total of 34,502 new HIV diagnoses were observed. Rates of death in BC are higher than those in Ontario and Quebec with the rate being 2.03 versus 1.06 and 1.21 per 100,000 population, respectively. The number of HIV infected individuals on HAART increased from 5,091 in 1996 to 20,481 in 2008 in the three provinces (4 fold increase). BC was the only province with a statistically significant decrease (trend test p<0.0001) in the rate of new HIV diagnoses from 18.05 to 7.94 new diagnoses per 100,000 population. Our analysis showed that for each 10% increment in HAART coverage the rate of new HIV diagnoses decreased by 8% (95% CI: 2.4%, 13.3%) Interpretation: Except for British Columbia, the number of new HIV diagnoses per year has remained relatively stable across Canada over the study period. The decline in the rate of new HIV diagnoses per year may be in part attributed to the greater expansion of HAART coverage in this province.	[Hogg, Robert S.; Heath, Katherine; Lima, Viviane D.; Nosyk, Bohdan; Wood, Evan; Kerr, Thomas; Montaner, Julio S. G.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Hogg, Robert S.; Kanters, Steve] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Lima, Viviane D.; Wood, Evan; Kerr, Thomas; Montaner, Julio S. G.] Univ British Columbia, Fac Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; Simon Fraser University; University of British Columbia	Montaner, JSG (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	jmontaner@cfenet.ubc.ca	Montaner, Julio/K-7621-2012	Hogg, Robert/0000-0003-3463-5488	National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH) [1DP1DA026182-01]; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182, R03DA033851] Funding Source: NIH RePORTER	National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study is funded by: Dr. Montaner's Avant-Garde Award (No. 1DP1DA026182-01) from the National Institute of Drug Abuse (NIDA), at the US National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, INT CLASS DIS 9 REV; [Anonymous], STAT CAN TABL 051 00; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Au-Yeung CG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-642; BC Centre for Disease Control, 2011, ANN REP 2009; Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Government of Canada Health Canada, 2012, CAN HLTH CAR SYST ME; Hall HI, 2009, JAIDS-J ACQ IMM DEF, V51, pS13, DOI 10.1097/QAI.0b013e3181a2639e; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Hogg RS, 1999, CAN MED ASSOC J, V160, P659; Kerr T, 2005, LANCET, V366, P316, DOI 10.1016/S0140-6736(05)66475-6; Lima VD, 2007, AIDS, V21, P685, DOI 10.1097/QAD.0b013e32802ef30c; Miller CL, 2006, AIDS CARE, V18, P968, DOI 10.1080/09540120500481480; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2011, LANCET, V378, P208, DOI 10.1016/S0140-6736(11)60821-0; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Moore RD, 1999, AIDS, V13, P1933, DOI 10.1097/00002030-199910010-00017; MOSS AR, 1989, AIDS, V3, P55, DOI 10.1097/00002030-198902000-00001; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Public Health Agency of Canada, 2006, I TRACK ENH SURV RIS; Public Health Agency of Canada, 2010, HIV AIDS EP UPD JUL; Public Health Agency of Canada, 2011, M TRACK ENH SURV HIV; Public Health Agency of Canada, 2009, HIV AIDS CAN SURV RE; Public Health Agency of Canada, 2011, POP SPEC HIV AIDS ST; Remis RS, 2010, REP HIV AIDS ONTARIO; Saskatchewan Ministry of Health, 2010, ANN REPORT; WHO, 2008, ICD 10 INT STAT CLAS; Wood E, 2005, AM J INFECT DIS, V1, P50, DOI 10.3844/ajidsp.2005.50.54; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Yang QY, 2010, CAN J PUBLIC HEALTH, V101, P486, DOI 10.1007/BF03403969; Yoong D, 2012, ACCESS COVERAGE HIV	36	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e47260	10.1371/journal.pone.0047260	http://dx.doi.org/10.1371/journal.pone.0047260			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209549	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800003
J	Marchal, S; Marabotti, A; Staiano, M; Varriale, A; Domaschke, T; Lange, R; D'Auria, S				Marchal, Stephane; Marabotti, Anna; Staiano, Maria; Varriale, Antonio; Domaschke, Thomas; Lange, Reinhard; D'Auria, Sabato			Under Pressure That Splits a Family in Two. The Case of Lipocalin Family	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; MOLECULAR SIMULATION; STRUCTURAL-CHANGES; STABILITY; DYNAMICS; KINETICS; PH; DISSOCIATION; SPECTROSCOPY; MECHANISM	The lipocalin family is typically composed of small proteins characterized by a range of different molecular recognition properties. Odorant binding proteins (OBPs) are a class of proteins of this family devoted to the transport of small hydrophobic molecules in the nasal mucosa of vertebrates. Among OBPs, bovine OBP (bOBP) is of great interest for its peculiar structural organization, characterized by a domain swapping of its two monomeric subunits. The effect of pressure on unfolding and refolding of native dimeric bOBP and of an engineered monomeric form has been investigated by theoretical and experimental studies under pressure. A coherent model explains the pressure-induced protein structural changes: i) the substrate-bound protein stays in its native configuration up to 330 MPa, where it loses its substrate; ii) the substrate-free protein dissociates into monomers at 200 MPa; and iii) the monomeric substrate-free form unfolds at 120 MPa. Molecular dynamics simulations showed that the pressure-induced tertiary structural changes that accompany the quaternary structural changes are mainly localized at the interface between the monomers. Interestingly, pressure-induced unfolding is reversible, but dimerization and substrate binding can no longer occur. The volume of the unfolding kinetic transition state of the monomer has been found to be similar to that of the folded state. This suggests that its refolding requires relatively large structural and/or hydrational changes, explaining thus the relatively low stability of the monomeric form of this class of proteins.	[Staiano, Maria; Varriale, Antonio; D'Auria, Sabato] IBP CNR, Lab Mol Sensing, Naples, Italy; [Marchal, Stephane; Domaschke, Thomas; Lange, Reinhard] Univ Montpellier 2, INSERM U710, Montpellier, France; [Marabotti, Anna] CNR, Inst Biomed Technol, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	D'Auria, S (corresponding author), IBP CNR, Lab Mol Sensing, Naples, Italy.	s.dauria@ibp.cnr.it	d'auria, sabato/C-3565-2015; Varriale, Antonio/AAL-1439-2020; MARCHAL, stéphane/M-4324-2017; STAIANO, MARIA/B-9584-2015	d'auria, sabato/0000-0001-9320-494X; MARCHAL, stéphane/0000-0002-1101-7890; STAIANO, MARIA/0000-0003-0223-1825; Marabotti, Anna/0000-0002-9510-5205	EDA "Nanocap" project [A-1084-RT-GC]; FLAGSHIP "InterOmics" project [PB.P05]; FIRB project "ItalBioNet" [RBPR05ZK2Z, RBIN064YAT_003]	EDA "Nanocap" project; FLAGSHIP "InterOmics" project; FIRB project "ItalBioNet"	This work is in the frame of the CNR Commessa "Progettazione e Sviluppo di Innovative Metodologie Diagnostiche per la Sicurezza Alimentare e Salute Umana" (SD; MS; AV). This work was funded by EDA "Nanocap" project (A-1084-RT-GC) (SD, MS, AV). This work was also partially funded by FLAGSHIP "InterOmics" project (PB.P05), and FIRB project "ItalBioNet" (RBPR05ZK2Z and RBIN064YAT_003) (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen H., 1981, INTERMOLECULAR FORCE, DOI DOI 10.1007/978-94-015-7658-1_21; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Billeter S.R., 1996, GROMOS96 MANUAL USER; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; D'Auria S, 2008, J PROTEOME RES, V7, P1151, DOI 10.1021/pr700755z; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Gagnon P, 2009, CURR PHARM BIOTECHNO, V10, P347, DOI 10.2174/138920109788488923; Grzyb J, 2006, J PLANT PHYSIOL, V163, P895, DOI 10.1016/j.jplph.2005.12.007; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krawczyk S, 2001, BBA-PROTEIN STRUCT M, V1544, P301, DOI 10.1016/S0167-4838(00)00242-9; Lange R, 1996, EUR BIOPHYS J BIOPHY, V24, P284; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1187, DOI 10.1016/j.ibmb.2004.07.007; Marabotti A, 2008, J PROTEOME RES, V7, P5221, DOI 10.1021/pr800528b; Marchal S, 2009, ACCOUNTS CHEM RES, V42, P778, DOI 10.1021/ar800266r; Mazzini A, 2002, BBA-PROTEINS PROTEOM, V1599, P90, DOI 10.1016/S1570-9639(02)00404-1; Mazzini A, 2007, J STRUCT BIOL, V159, P82, DOI 10.1016/j.jsb.2007.02.007; Pesenti ME, 2009, J MOL BIOL, V390, P981, DOI 10.1016/j.jmb.2009.05.067; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Ramon R, 2001, J BIOL CHEM, V276, P7150, DOI 10.1074/jbc.M010368200; Ramoni R, 2008, BBA-PROTEINS PROTEOM, V1784, P651, DOI 10.1016/j.bbapap.2008.01.010; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scire A, 2009, J PROTEOME RES, V8, P4005, DOI 10.1021/pr900346z; Seefeldt MB, 2009, CURR PHARM BIOTECHNO, V10, P447, DOI 10.2174/138920109788488914; SILVA JL, 1986, BIOCHEMISTRY-US, V25, P5780, DOI 10.1021/bi00367a065; SILVA JL, 1993, ANNU REV PHYS CHEM, V44, P89, DOI 10.1146/annurev.pc.44.100193.000513; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Smeller L, 2006, BBA-PROTEINS PROTEOM, V1764, P329, DOI 10.1016/j.bbapap.2006.02.001; Spinelli S, 1998, BIOCHEMISTRY-US, V37, P7913, DOI 10.1021/bi980179e; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Torrent J, 2006, BBA-PROTEINS PROTEOM, V1764, P489, DOI 10.1016/j.bbapap.2006.01.002; Torrent Joan, 2012, Commun Integr Biol, V5, P30; White SA, 2009, ACTA CRYSTALLOGR D, V65, P403, DOI 10.1107/S090744490900420X; Zerovnik E, 2011, FEBS J, V278, P2263, DOI 10.1111/j.1742-4658.2011.08149.x	46	7	7	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50489	10.1371/journal.pone.0050489	http://dx.doi.org/10.1371/journal.pone.0050489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209756	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800077
J	Assis, FL; Almeida, GMF; Oliveira, DB; Franco-Luiz, APM; Campos, RK; Guedes, MIM; Fonseca, FG; Trindade, GS; Drumond, BP; Kroon, EG; Abrahao, JS				Assis, Felipe L.; Almeida, Gabriel M. F.; Oliveira, Danilo B.; Franco-Luiz, Ana P. M.; Campos, Rafael K.; Guedes, Maria I. M.; Fonseca, Flavio G.; Trindade, Giliane S.; Drumond, Betania P.; Kroon, Erna G.; Abrahao, Jonatas S.			Characterization of a New Vaccinia virus Isolate Reveals the C23L Gene as a Putative Genetic Marker for Autochthonous Group 1 Brazilian Vaccinia virus	PLOS ONE			English	Article							CHEMOKINE ACTIVITY; CANTAGALO VIRUS; ORTHOPOXVIRUS; STRAINS; POXVIRUS; OUTBREAK; CATTLE; DISCRIMINATION; SMALLPOX; PROTEIN	Since 1999, several Vaccinia virus (VACV) isolates, the etiological agents of bovine vaccinia (BV), have been frequently isolated and characterized with various biological and molecular methods. The results from these approaches have grouped these VACV isolates into two different clusters. This dichotomy has elicited debates surrounding the origin of the Brazilian VACV and its epidemiological significance. To ascertain vital information to settle these debates, we and other research groups have made efforts to identify molecular markers to discriminate VACV from other viruses of the genus Orthopoxvirus (OPV) and other VACV-BR groups. In this way, some genes have been identified as useful markers to discriminate between the VACV-BR groups. However, new markers are needed to infer ancestry and to correlate each sample or group with its unique epidemiological and biological features. The aims of this work were to characterize a new VACV isolate (VACV DMTV-2005) molecularly and biologically using conserved and non-conserved gene analyses for phylogenetic inference and to search for new genes that would elucidate the VACV-BR dichotomy. The VACV DMTV-2005 isolate reported in this study is biologically and phylogenetically clustered with other strains of Group 1 VACV-BR, the most prevalent VACV group that was isolated during the bovine vaccinia outbreaks in Brazil. Sequence analysis of C23L, the gene that encodes for the CC-chemokine-binding protein, revealed a ten-nucleotide deletion, which is a new Group 1 Brazilian VACV genetic marker. This deletion in the C23L open reading frame produces a premature stop-codon that is shared by all Group 1 VACV-BR strains and may also reflect the VACV-BR dichotomy; the deletion can also be considered to be a putative genetic marker for non-virulent Brazilian VACV isolates and may be used for the detection and molecular characterization of new isolates.	[Assis, Felipe L.; Almeida, Gabriel M. F.; Oliveira, Danilo B.; Franco-Luiz, Ana P. M.; Campos, Rafael K.; Fonseca, Flavio G.; Trindade, Giliane S.; Kroon, Erna G.; Abrahao, Jonatas S.] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil; [Guedes, Maria I. M.] Univ Fed Minas Gerais, Dept Med Vet Prevent, Belo Horizonte, MG, Brazil; [Drumond, Betania P.] Univ Fed Juiz de Fora, Dept Parasitol Microbiol & Imunol, Juiz De Fora, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Juiz de Fora	Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil.	jonatas.abrahao@gmail.com	Almeida, Gabriel MF/I-8910-2012; Kroon, Erna/V-5444-2019; Abrahão, Jônatas/B-3895-2015; Campos, Rafael Kroon/AAB-5135-2020; Kroon, Erna Geessien/B-3631-2015	Almeida, Gabriel MF/0000-0003-2317-5092; Abrahão, Jônatas/0000-0001-9420-1791; Campos, Rafael Kroon/0000-0002-4852-0449; Kroon, Erna Geessien/0000-0003-2721-3826	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(FAPEMIG); Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria de Pesquisa (PRPq-UFMG); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA); Pro-Reitoria de Pesquisa (PRPq-UFMG); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Financial support was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(FAPEMIG) and Ministerio da Agricultura, Pecuaria e Abastecimento (MAPA) and Pro-Reitoria de Pesquisa (PRPq-UFMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank colleagues from the Laboratory of Virus for their excellent technical support. We thank Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (PRPq-UFMG) and Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG) for the financial support.	Abrahao JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007428; Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617; Abrahao JS, 2009, VIROL J, V6, P1; Alcami A, 1998, J IMMUNOL, V160, P624; Brum MCS, 2010, J VET DIAGN INVEST, V22, P143; CAMPOS MAD, 1993, REV MICROBIOL, V24, P104; Campos RK, 2011, ARCH VIROL, V156, P275, DOI 10.1007/s00705-010-0857-z; Carroll DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023086; Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603; Damon I, 2007, FIELDS VIROLOGY, P2079; Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005; Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423; Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040; Heymann DL, 2006, CURR TOP MICROBIOL, V304, P1; Jezek Z, 1988, HUMAN MONKEYPOX; JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1; Laassri M, 2003, J VIROL METHODS, V112, P67, DOI 10.1016/S0166-0934(03)00193-9; Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773; Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9; Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001; Medaglia MLG, 2009, EMERG INFECT DIS, V15, P1142, DOI 10.3201/eid1507.081702; Megid J, 2008, AM J TROP MED HYG, V79, P647, DOI 10.4269/ajtmh.2008.79.647; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995; Ryabinin VA, 2006, J MED VIROL, V78, P1325, DOI 10.1002/jmv.20698; Sambrook J, 2001, MOL CLONING LAB MANU; Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259; Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Trindade GD, 2003, EMERG INFECT DIS, V9, P155; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486; Trindade GS, 2009, CLIN INFECT DIS, V48, pE37, DOI 10.1086/595856	34	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50413	10.1371/journal.pone.0050413	http://dx.doi.org/10.1371/journal.pone.0050413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189200	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800077
J	Bermond, G; Ciosi, M; Lombaert, E; Blin, A; Boriani, M; Furlan, L; Toepfer, S; Guillemaud, T				Bermond, Gerald; Ciosi, Marc; Lombaert, Eric; Blin, Aurelie; Boriani, Marco; Furlan, Lorenzo; Toepfer, Stefan; Guillemaud, Thomas			Secondary Contact and Admixture between Independently Invading Populations of the Western Corn Rootworm, Diabrotica virgifera virgifera in Europe	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; MULTIPLE TRANSATLANTIC INTRODUCTIONS; GENETIC-VARIATION; MICROSATELLITE LOCI; INVASIVENESS; COLEOPTERA; INFERENCE; INVASION; CHRYSOMELIDAE; HYBRIDIZATION	The western corn rootworm, Diabrotica virgifera virgifera (Coleoptera: Chrysomelidae), is one of the most destructive pests of corn in North America and is currently invading Europe. The two major invasive outbreaks of rootworm in Europe have occurred, in North-West Italy and in Central and South-Eastern Europe. These two outbreaks originated from independent introductions from North America. Secondary contact probably occurred in North Italy between these two outbreaks, in 2008. We used 13 microsatellite markers to conduct a population genetics study, to demonstrate that this geographic contact resulted in a zone of admixture in the Italian region of Veneto. We show that i) genetic variation is greater in the contact zone than in the parental outbreaks; ii) several signs of admixture were detected in some Venetian samples, in a Bayesian analysis of the population structure and in an approximate Bayesian computation analysis of historical scenarios and, finally, iii) allelic frequency clines were observed at microsatellite loci. The contact between the invasive outbreaks in North-West Italy and Central and South-Eastern Europe resulted in a zone of admixture, with particular characteristics. The evolutionary implications of the existence of a zone of admixture in Northern Italy and their possible impact on the invasion success of the western corn rootworm are discussed.	[Bermond, Gerald; Lombaert, Eric; Blin, Aurelie; Guillemaud, Thomas] INRA, UMR Inst Sophia Agrobiotech 1355, Equipe Biol Populat Introduites, Sophia Antipolis, France; [Bermond, Gerald; Lombaert, Eric; Blin, Aurelie; Guillemaud, Thomas] Univ Nice Sophia Antipolis, UMR Inst Sophia Agrobiotech, Equipe Biol Populat Introduites, Sophia Antipolis, France; [Bermond, Gerald; Lombaert, Eric; Blin, Aurelie; Guillemaud, Thomas] CNRS, UMR Inst Sophia Agrobiotech 7254, Equipe Biol Populat Introduites, Sophia Antipolis, France; [Ciosi, Marc] Univ Glasgow, Inst 3, Glasgow Biomed Res Ctr, Glasgow, Lanark, Scotland; [Ciosi, Marc] Int Ctr Insect Physiol & Ecol, MBB Unit, Nairobi, Kenya; [Boriani, Marco] Reg Lombardia, Serv Fitosanit Regionale, Milan, Italy; [Furlan, Lorenzo] Veneto Agricoltura, Legnaro, Italy; [Toepfer, Stefan] CABI Europe Switzerland, Plant Protect Directorate, Hodmezovasarhely, Hungary	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); University of Glasgow; International Centre of Insect Physiology & Ecology (ICIPE)	Bermond, G (corresponding author), INRA, UMR Inst Sophia Agrobiotech 1355, Equipe Biol Populat Introduites, Sophia Antipolis, France.	gerald.bermond@sophia.inra.fr	guillemaud, thomas/B-4899-2012	guillemaud, thomas/0000-0003-0451-1644; Furlan, Lorenzo/0000-0003-4021-4532; Ciosi, Marc/0000-0002-7663-4080	Agence Nationale de la Recherche [ANR-06-BDIV-008-01, ANR-09-BLAN-0145-01]; Agropolis Foundation (RTRA-Montpellier, BIOFIS) [1001-001]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Agropolis Foundation (RTRA-Montpellier, BIOFIS)	This work was supported by grants from the Agence Nationale de la Recherche (ANR-06-BDIV-008-01 and ANR-09-BLAN-0145-01) and from the Agropolis Foundation (RTRA-Montpellier, BIOFIS project number 1001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P13; Baufeld P, 2001, IWGO NEWSLETTER, V22, P14; Beaumont MA, 2002, GENETICS, V162, P2025; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; BRANSON TF, 1981, ENVIRON ENTOMOL, V10, P826, DOI 10.1093/ee/10.6.826; Cheres MT, 2000, THEOR APPL GENET, V100, P889, DOI 10.1007/s001220051366; CHIANG HC, 1973, ANNU REV ENTOMOL, V18, P47, DOI 10.1146/annurev.en.18.010173.000403; Choisy M, 2004, MOL ECOL, V13, P955, DOI 10.1111/j.1365-294X.2004.02107.x; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Ciosi M, 2011, EVOL APPL, V4, P54, DOI 10.1111/j.1752-4571.2010.00133.x; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Crawley M.J., 1993, GLIM ECOLOGISTS; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; De Luigi V, 2011, J APPL ENTOMOL, V135, P38, DOI 10.1111/j.1439-0418.2009.01499.x; Edwards CR, 2010, IWGO NEWSLETTER, P30; Edwards CR, 2008, NEW WCR 2007 GEN SPR; Edwards CR, 2009, IWGO NEWSLETTER, P29; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Endler J.A., 1977, Monographs in Population Biology, pi; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Estoup A, 2012, MOL ECOL RESOUR, V12, P846, DOI 10.1111/j.1755-0998.2012.03153.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2005, J EVOLUTION BIOL, V18, P524, DOI 10.1111/j.1420-9101.2005.00887.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Facon B, 2011, CURR BIOL, V21, P424, DOI 10.1016/j.cub.2011.01.068; Falush D, 2003, GENETICS, V164, P1567; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Guillemaud T, 2010, HEREDITY, V104, P88, DOI 10.1038/hdy.2009.92; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; Kim KS, 2005, MOL ECOL NOTES, V5, P115, DOI 10.1111/j.1471-8286.2004.00853.x; Kim KS, 2008, ENVIRON ENTOMOL, V37, P293, DOI 10.1603/0046-225X(2008)37[293:ACSOMM]2.0.CO;2; Kiss J, 2005, Western Corn Rootworm: Ecology and Management, P29, DOI 10.1079/9780851998176.0029; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; KRYSAN J L, 1987, Entomography, V5, P375; Lombaert E, 2011, MOL ECOL, V20, P4654, DOI 10.1111/j.1365-294X.2011.05322.x; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; MALLET J, 1989, GENETICS, V122, P967; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; Miller NJ, 2007, J APPL ENTOMOL, V131, P378, DOI 10.1111/j.1439-0418.2007.01190.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Pujol B, 2009, P NATL ACAD SCI USA, V106, P15379, DOI 10.1073/pnas.0902257106; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reif JC, 2003, CROP SCI, V43, P1275, DOI 10.2135/cropsci2003.1275; Rieux A, 2011, MOL ECOL, V20, P1661, DOI 10.1111/j.1365-294X.2011.05053.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; SAS Institute Inc, 2008, SAS 9 1 3; SLATKIN M, 1973, GENETICS, V75, P733; SMITH RAY F., 1966, BULL ENTOMOL SOC AMER, V12, P108; Sokal R. R., 2012, BIOMETRY; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Turgeon J, 2011, J EVOLUTION BIOL, V24, P1044, DOI 10.1111/j.1420-9101.2011.02234.x; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	68	27	28	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50129	10.1371/journal.pone.0050129	http://dx.doi.org/10.1371/journal.pone.0050129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189184	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000311929800061
J	Barrell, WB; Szabo-Rogers, HL; Liu, KJ				Barrell, William B.; Szabo-Rogers, Heather L.; Liu, Karen J.			Novel Reporter Alleles of GSK-3 alpha and GSK-3 beta	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SKELETAL-MUSCLE; EXPRESSION; RECOMBINASE; SECONDARY; ISOFORMS; PALATE; GSK3; MICE	Glycogen Synthase Kinase 3 (GSK-3) is a key player in development, physiology and disease. Because of this, GSK-3 inhibitors are increasingly being explored for a variety of applications. In addition most analyses focus on GSK-3 beta and overlook the closely related protein GSK-3 alpha. Here, we describe novel GSK-3 alpha and GSK-3 beta mouse alleles that allow us to visualise expression of their respective mRNAs by tracking beta-galactosidase activity. We used these new lacZ alleles to compare expression in the palate and cranial sutures and found that there was indeed differential expression. Furthermore, both are loss of function alleles and can be used to generate homozygous mutant mice; in addition, excision of the lacZ cassette from GSK-3 alpha creates a Cre-dependent tissue-specific knockout. As expected, GSK3 alpha mutants were viable, while GSK3 beta mutants died after birth with a complete cleft palate. We also assessed the GSK-3 alpha mutants for cranial and sternal phenotypes and found that they were essentially normal. Finally, we observed gestational lethality in compound GSK-3 beta(-/-); GSK3 alpha(+/-) mutants, suggesting that GSK-3 dosage is critical during embryonic development.	[Barrell, William B.; Szabo-Rogers, Heather L.; Liu, Karen J.] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England	University of London; King's College London	Liu, KJ (corresponding author), Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England.	karen.liu@kcl.ac.uk	Liu, Karen/F-2870-2010	Liu, Karen/0000-0002-2483-2165; Barrell, William/0000-0002-2810-2274	Wellcome Trust [WT081880AIA]; BBSRC [BB/E013872, BB/I021922/1]; King's College London Dental Institute; BBSRC [BB/E013872/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013872/1, BB/I021922/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); King's College London Dental Institute; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grants to KJL from the Wellcome Trust (WT081880AIA), the BBSRC (BB/E013872 & BB/I021922/1) and a summer studentship to WBB from the King's College London Dental Institute. www.wellcome.ac.uk, www.bbsrc.ac.uk, www.kcl.ac.uk/dentistry/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Ciaraldi TP, 2006, AM J PHYSIOL-ENDOC M, V291, pE891, DOI 10.1152/ajpendo.00176.2006; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Gillespie JR, 2011, ENDOCRINOLOGY, V152, P1755, DOI 10.1210/en.2010-1412; He FL, 2010, DEV DYNAM, V239, P3235, DOI 10.1002/dvdy.22466; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hurtado DE, 2012, J NEUROSCI, V32, P7392, DOI 10.1523/JNEUROSCI.0889-12.2012; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nelson ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025847; Patel S, 2008, MOL CELL BIOL, V28, P6314, DOI 10.1128/MCB.00763-08; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Wood-Kaczmar A, 2009, MOL CELL NEUROSCI, V42, P184, DOI 10.1016/j.mcn.2009.07.002; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Zhou JB, 2010, J CLIN INVEST, V120, P2280, DOI 10.1172/JCI41407	31	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50422	10.1371/journal.pone.0050422	http://dx.doi.org/10.1371/journal.pone.0050422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185619	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000232
J	Bianco, A; Flotta, D; Lotito, F; Nobile, CGA; Pileggi, C; Pavia, M				Bianco, Aida; Flotta, Domenico; Lotito, Francesca; Nobile, Carmelo G. A.; Pileggi, Claudia; Pavia, Maria		Collaborative Working Grp	Validity and Reliability of a Tool for Determining Appropriateness of Days of Stay: An Observational Study in the Orthopedic Intensive Rehabilitation Facilities in Italy	PLOS ONE			English	Article							HOSPITAL-CARE; VALIDATION; CENTERS	Objectives: To test the validity and reliability of a tool specifically developed for the evaluation of appropriateness in rehabilitation facilities and to assess the prevalence of appropriateness of the days of stay. Methods: The tool underwent a process of cross-cultural translation, content validity, and test-retest validity. Two hospital-based rehabilitation wards providing intensive rehabilitation care located in the Region of Calabria, Southern Italy, were randomly selected. A review of medical records on a random sample of patients aged 18 or more was performed. Results: The process of validation resulted in modifying some of the criteria used for the evaluation of appropriateness. Test-retest reliability showed that the agreement and the k statistic for the assessment of the appropriateness of days of stay were 93.4% and 0.82, respectively. A total of 371 patient days was reviewed, and 22.9% of the days of stay in the sample were judged to be inappropriate. The most frequently selected appropriateness criterion was the evaluation of patients by rehabilitation professionals for at least 3 hours on the index day (40.8%); moreover, the most frequent primary reason accounting for the inappropriate days of stay was social and/or family environment issues (34.1%). Conclusions: The findings showed that the tool used is reliable and have adequate validity to measure the extent of appropriateness of days of stay in rehabilitation facilities and that the prevalence of inappropriateness is contained in the investigated settings. Further research is needed to expand appropriateness evaluation to other rehabilitation settings, and to investigate more thoroughly internal and external causes of inappropriate use of rehabilitation services.	[Bianco, Aida; Flotta, Domenico; Lotito, Francesca; Nobile, Carmelo G. A.; Pileggi, Claudia; Pavia, Maria; Collaborative Working Grp] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro	Pavia, M (corresponding author), Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.	pavia@unicz.it	Bianco, Aida/R-6612-2016; PILEGGI, Claudia/AGU-6397-2022	PILEGGI, Claudia/0000-0002-6288-5540; BIANCO, Aida/0000-0003-4674-0306; NOBILE, Carmelo Giuseppe Angelo/0000-0002-0762-513X; PAVIA, Maria/0000-0003-3879-1322	Programs of Scientific Research of Relevant National Interest by the Italian Ministry of University and Research [MIUR/PRIN2008-H8YFRE]	Programs of Scientific Research of Relevant National Interest by the Italian Ministry of University and Research	This work was supported by the following Research Grants: Programs of Scientific Research of Relevant National Interest by the Italian Ministry of University and Research (MIUR/PRIN2008-H8YFRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelillo IF, 2000, PUBLIC HEALTH, V114, P9, DOI 10.1038/sj.ph.1900609; [Anonymous], 2009, STAT REL 11 STAT SOF; Bianco A, 2003, PUBLIC HEALTH, V117, P250, DOI 10.1016/S0033-3506(03)00069-6; Bianco A, 2003, PEDIATRICS, V112, P124, DOI 10.1542/peds.112.1.124; Bianco A, 2002, PUBLIC HEALTH, V116, P368, DOI 10.1038/sj.ph.1900853; Bianco A, 2006, AGING CLIN EXP RES, V18, P249; Buntin MB, 2007, ARCH PHYS MED REHAB, V88, P1488, DOI 10.1016/j.apmr.2007.07.023; Castaldi S, 2010, J Prev Med Hyg, V51, P116; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen LK, 2010, ANN MED, V42, P630, DOI 10.3109/07853890.2010.521763; GERTMAN PM, 1981, MED CARE, V19, P855, DOI 10.1097/00005650-198108000-00005; Gruppo di Lavoro sulla Riabilitazione Ministero della Salute, 2010, PIAN IND RIAB; Guile R, 2009, INT J QUAL HEALTH C, V21, P198, DOI 10.1093/intqhc/mzp008; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Lim WK, 2003, MED J AUSTRALIA, V178, P262, DOI 10.5694/j.1326-5377.2003.tb05191.x; Ministero della Salute, 2012, PIAN NAZ PREV 2010 2; Paille-Ricolleau C, 2012, INT J QUAL HEALTH C, V24, P121, DOI 10.1093/intqhc/mzr089; Pileggi C, 2004, PUBLIC HEALTH, V118, P284, DOI 10.1016/j.puhe.2003.06.002; Poulos CJ, 2010, J REHABIL MED, V42, P246, DOI 10.2340/16501977-0506; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50260	10.1371/journal.pone.0050260	http://dx.doi.org/10.1371/journal.pone.0050260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185588	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000208
J	Brennan, TJ; Lo, AW				Brennan, Thomas J.; Lo, Andrew W.			An Evolutionary Model of Bounded Rationality and Intelligence	PLOS ONE			English	Article							TIME PREFERENCE; NATURAL-SELECTION; BIOLOGICAL BASIS; SOCIAL-BEHAVIOR; COMMUNICATION; PROBABILITY; UNCERTAINTY; COMPETITION; BACTERIA; MARKETS	Background: Most economic theories are based on the premise that individuals maximize their own self-interest and correctly incorporate the structure of their environment into all decisions, thanks to human intelligence. The influence of this paradigm goes far beyond academia-it underlies current macroeconomic and monetary policies, and is also an integral part of existing financial regulations. However, there is mounting empirical and experimental evidence, including the recent financial crisis, suggesting that humans do not always behave rationally, but often make seemingly random and suboptimal decisions. Methods and Findings: Here we propose to reconcile these contradictory perspectives by developing a simple binary-choice model that takes evolutionary consequences of decisions into account as well as the role of intelligence, which we define as any ability of an individual to increase its genetic success. If no intelligence is present, our model produces results consistent with prior literature and shows that risks that are independent across individuals in a generation generally lead to risk-neutral behaviors, but that risks that are correlated across a generation can lead to behaviors such as risk aversion, loss aversion, probability matching, and randomization. When intelligence is present the nature of risk also matters, and we show that even when risks are independent, either risk-neutral behavior or probability matching will occur depending upon the cost of intelligence in terms of reproductive success. In the case of correlated risks, we derive an implicit formula that shows how intelligence can emerge via selection, why it may be bounded, and how such bounds typically imply the coexistence of multiple levels and types of intelligence as a reflection of varying environmental conditions. Conclusions: Rational economic behavior in which individuals maximize their own self interest is only one of many possible types of behavior that arise from natural selection. The key to understanding which types of behavior are more likely to survive is how behavior affects reproductive success in a given population's environment. From this perspective, intelligence is naturally defined as behavior that increases the probability of reproductive success, and bounds on rationality are determined by physiological and environmental constraints.	[Lo, Andrew W.] CSAIL, MIT Sloan Sch Management, Cambridge, MA USA; [Lo, Andrew W.] EECS, Cambridge, MA USA; [Lo, Andrew W.] AlphaSimplex Grp LLC, Cambridge, MA USA; [Brennan, Thomas J.] Northwestern Univ, Sch Law, Chicago, IL 60611 USA	Massachusetts Institute of Technology (MIT); Northwestern University	Lo, AW (corresponding author), CSAIL, MIT Sloan Sch Management, Cambridge, MA USA.	alo@mit.edu			MIT Laboratory for Financial Engineering; Northwestern University School of Law; AlphaSimplex Group, LLC; National Science Foundation on systemic risk; Citigroup	MIT Laboratory for Financial Engineering; Northwestern University School of Law; AlphaSimplex Group, LLC; National Science Foundation on systemic risk; Citigroup	We thank Henry Cohn, Jayna Cummings, Doyne Farmer, Simon Levin, Tommy Poggio, Arthur Robson, and Jon Wilkins for helpful comments and discussion. The views and opinions expressed in this article are those of the authors only, and do not necessarily represent the views and opinions of: the individuals acknowledged above, Northwestern University, MIT, AlphaSimplex Group, LLC, or any of their affiliates and employees. Research support from the MIT Laboratory for Financial Engineering and the Northwestern University School of Law Faculty Research Program is gratefully acknowledged.; The authors declare the following competing interests. Andrew W. Lo has the following affiliations and research grants: AlphaSimplex Group, LLC, Chairman and Chief Investment Strategist; U.S. Treasury (Office of Financial Research), Consultant; National Bureau of Economic Research, Research Associate; NY Fed Financial Advisory Roundtable, Member; FINRA Economic Advisory Committee, Member; Consortium for Systemic Risk Analysis, Academic Advisory Committee, Member; Beth Israel Deaconess Medical Center Board of Overseers, Member; research grant from the National Science Foundation on systemic risk; research grant from Citigroup; patent pending on cryptographic methods for computing systemic risk; patent awarded (U.S. Patent No. 7,599,876, "Electronic Market-Maker"); patent awarded (U.S. Patent No. 7,562,042, "Data Processor for Implementing Forecasting Algorithms"). According to PLOS ONE, a competing interest is "anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision making, or publication of research or non-research articles submitted to one of the journals." None of the above affiliations are remotely involved with the subject of the submission to PLOS ONE, nor do they or the authors stand to gain from the publication of this manuscript in PLOS ONE. Moreover, these affiliations do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Arthur WB, 1997, EC EVOLVING COMPLEX; Be'er A, 2009, P NATL ACAD SCI USA, V106, P428, DOI 10.1073/pnas.0811816106; BEHREND ER, 1961, AM J PSYCHOL, V74, P542, DOI 10.2307/1419664; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Ben-Jacob E, 2008, EUR PHYS J B, V65, P315, DOI 10.1140/epjb/e2008-00222-x; BENJACOB E, 1994, NATURE, V368, P46, DOI 10.1038/368046a0; BITTERMAN ME, 1958, AM J PSYCHOL, V71, P94, DOI 10.2307/1419199; Brennan TJ, 2011, Q J FINANC, V1, P55, DOI 10.1142/S201013921100002X; Brock WA, 2005, J MATH ECON, V41, P7, DOI 10.1016/j.jmateco.2004.02.002; Buss D. M., 2004, EVOLUTIONARY PSYCHOL; COOPER WS, 1982, J THEOR BIOL, V94, P135, DOI 10.1016/0022-5193(82)90336-8; COSMIDES L, 1994, AM ECON REV, V84, P327; Curry PA, 2001, J ECON THEORY, V98, P357, DOI 10.1006/jeth.2000.2719; DENEUBOURG JL, 1987, EUR J OPER RES, V30, P168, DOI 10.1016/0377-2217(87)90093-2; Dunny GM, 2008, BIOESSAYS, V30, P296, DOI 10.1002/bies.20740; Ehrlich PR, 2005, PLOS BIOL, V3, P943, DOI 10.1371/journal.pbio.0030194; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Farmer JD, 2002, IND CORP CHANGE, V11, P895, DOI 10.1093/icc/11.5.895; Gigerenzer G., 2000, ADAPTIVE THINKING RA; GRAF V, 1964, J EXP ANAL BEHAV, V7, P151, DOI 10.1901/jeab.1964.7-151; GRANT DA, 1951, J EXP PSYCHOL, V42, P1, DOI 10.1037/h0054051; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HANSSON I, 1990, AM ECON REV, V80, P529; HARDER LD, 1987, ECOLOGY, V68, P1104, DOI 10.2307/1938384; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Holldobler B., 1990, pi; Hommes C, 2009, HANDB FINANC, P217, DOI 10.1016/B978-012374258-2.50008-7; Hu H, 2012, ANN REV FINANCIAL EC, V4; Ingham CJ, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-36; Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; Kahneman D., 1982, JUDGMENT UNCERTAINTY; Keasar T, 2002, BEHAV ECOL, V13, P757, DOI 10.1093/beheco/13.6.757; Kenett DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019378; KIRMAN A, 1993, Q J ECON, V108, P137, DOI 10.2307/2118498; Kocherlakota N. R., 2010, REGION, V4, P5; Kogan L, 2006, J FINANC, V61, P195, DOI 10.1111/j.1540-6261.2006.00834.x; LeBaron B, 2002, P NATL ACAD SCI USA, V99, P7201, DOI 10.1073/pnas.072079699; LeBaron B, 2001, MACROECON DYN, V5, P225, DOI 10.1017/S1365100501019058; LeBaron B, 2001, IEEE T EVOLUT COMPUT, V5, P442, DOI 10.1109/4235.956709; Lebaron B, 2012, J ECON BEHAV ORGAN, V83, pXX; LeBaron B, 2008, AM ECON REV, V98, P246, DOI 10.1257/aer.98.2.246; LUCAS RE, 1972, J ECON THEORY, V4, P103, DOI 10.1016/0022-0531(72)90142-1; LUO GY, 1995, J ECON THEORY, V67, P223, DOI 10.1006/jeth.1995.1072; Luo R.G.Y., 2001, J FINANCIAL MARKETS, V4, P73, DOI DOI 10.1016/S1386-4181(00)00014-8; Maynard Smith J., 1982, pi; McDermott R, 2008, J POLIT, V70, P335, DOI 10.1017/S0022381608080341; Nowak Martin A, 2011, SUPERCOOPERATORS WHY; Pasteels JM, 1987, EXPERIENTIA S; PINKER S, 1979, COGNITION, V7, P217, DOI 10.1016/0010-0277(79)90001-5; Robson A, 2001, J POLIT ECON, V109, P900, DOI 10.1086/322083; Robson AJ, 2001, J ECON LIT, V39, P11, DOI 10.1257/jel.39.1.11; Robson AJ, 1996, J ECON THEORY, V68, P397, DOI 10.1006/jeth.1996.0023; Robson AJ, 1996, GAME ECON BEHAV, V14, P190, DOI 10.1006/game.1996.0048; Robson AJ., 2010, EVOLUTIONARY FDN PRE; Robson AJ, 2008, AM ECON REV, V98, P1178, DOI 10.1257/aer.98.3.1178; Robson AJ, 2007, AM ECON REV, V97, P492, DOI 10.1257/aer.97.2.492; Robson AJ, 2009, AM ECON REV, V99, P1925, DOI 10.1257/aer.99.5.1925; ROGERS AR, 1994, AM ECON REV, V84, P460; Samuelson L, 2001, J ECON THEORY, V97, P225, DOI 10.1006/jeth.2000.2753; SAMUELSON PA, 1965, IMR-IND MANAG REV, V6, P41; SAMUELSON PA, 1958, J POLIT ECON, V66, P467, DOI 10.1086/258100; Shapiro JA, 1997, BACTERIA MULTICELLUL; Simon H. A., 1981, SCI ARTIFICIAL, V2nd, DOI 10.7551/mitpress/12107.001.0001; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Sirota-Madi A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-710; SMITH JM, 1984, BEHAV BRAIN SCI, V7, P95, DOI 10.1017/S0140525X00026327; THUIJSMAN F, 1995, J THEOR BIOL, V175, P305, DOI 10.1006/jtbi.1995.0144; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Trivers R., 2002, NATURAL SELECTION SO; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wilson E.O., 1975, P1; Woolverton WL, 1998, PSYCHOPHARMACOLOGY, V138, P102, DOI 10.1007/s002130050651; YOUNG JS, 1981, J EXP ANAL BEHAV, V35, P23, DOI 10.1901/jeab.1981.35-23	75	14	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50310	10.1371/journal.pone.0050310	http://dx.doi.org/10.1371/journal.pone.0050310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185602	Green Published, gold			2022-12-25	WOS:000311821000215
J	Tura, A; Grassi, A; Winhofer, Y; Guolo, A; Pacini, G; Mari, A; Kautzky-Willer, A				Tura, Andrea; Grassi, Angela; Winhofer, Yvonne; Guolo, Annamaria; Pacini, Giovanni; Mari, Andrea; Kautzky-Willer, Alexandra			Progression to Type 2 Diabetes in Women with Former Gestational Diabetes: Time Trajectories of Metabolic Parameters	PLOS ONE			English	Article							BETA-CELL FUNCTION; POSTPARTUM GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; RISK-FACTORS; HISPANIC WOMEN; LATINO WOMEN; C-PEPTIDE; PREDICTORS; ANTEPARTUM; SECRETION	Aim of this study was analyzing the time trajectories of the metabolic parameters in European women with former gestational diabetes (fGDM), and determining predictors of type 2 diabetes onset. A group of seventy-six fGDM women were studied at the outpatient department of the University Clinic of Vienna. They were evaluated yearly with a 3 h-oral glucose tolerance test (OGTT) up to 7-years from delivery. At baseline, women also underwent an intravenous glucose tolerance test (IVGTT). Insulin sensitivity and beta-cell function were assessed by both OGTT and IVGTT. Women were divided into progressors (PROG) to diabetes (n = 19) and non-progressors (n = 57). Time trajectories of glycemia and other parameters were analyzed after synchronization to time of diabetes onset or last OGTT. Then, Cox proportional hazard regression analysis was performed to assess the predictive power of studied variables for diabetes onset. We found that, in PROG, time trajectories of glycemia were flat until diabetes onset, when they showed a marked increase (P < 0.0001). Insulin sensitivity showed similar marked decrease (P < 0.0001) at diabetes onset, together with a tendency to continuous slow decline in the previous years. At contrast, beta-cell function showed only continuous slow decline. Major predictors of diabetes onset were glycemic levels, BMI, insulin resistance, and condition of impaired glucose tolerance. In conclusion, in fGDM, marked deterioration of insulin sensitivity is associated with diabetes onset. Prevention strategies aimed at opposing to the insulin sensitivity derangement may be particularly beneficial.	[Tura, Andrea; Grassi, Angela; Pacini, Giovanni; Mari, Andrea] CNR, Metab Unit, Inst Biomed Engn, Padua, Italy; [Winhofer, Yvonne; Kautzky-Willer, Alexandra] Med Univ Vienna, Unit Gender Med, Div Endocrinol & Metab, Clin Internal Med 3, Vienna, Austria; [Guolo, Annamaria] Univ Verona, Dept Econ, I-37100 Verona, Italy	Consiglio Nazionale delle Ricerche (CNR); Medical University of Vienna; University of Verona	Tura, A (corresponding author), CNR, Metab Unit, Inst Biomed Engn, Padua, Italy.	tura@isib.cnr.it	Guolo, Annamaria/A-1304-2015; Grassi, Angela/N-3085-2013	Guolo, Annamaria/0000-0002-6873-4372; Grassi, Angela/0000-0002-8313-8384; Kautzky-Willer, Alexandra/0000-0002-3520-4105; Winhofer, Yvonne/0000-0002-0555-9044	Austrian "Nationalbank Jubilaumsfonds" [11198]	Austrian "Nationalbank Jubilaumsfonds"	Alexandra Kautzky-Willer was partially supported by the Austrian "Nationalbank Jubilaumsfonds": grant 11198. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Buchanan TA, 1999, DIABETES, V48, P2430, DOI 10.2337/diabetes.48.12.2430; CATALANO PM, 1991, AM J OBSTET GYNECOL, V165, P914, DOI 10.1016/0002-9378(91)90438-W; Caumo A, 2000, J CLIN ENDOCR METAB, V85, P4396, DOI 10.1210/jc.85.11.4396; COUSTAN DR, 1993, AM J OBSTET GYNECOL, V168, P1139, DOI 10.1016/0002-9378(93)90358-P; Dalfra MG, 2001, DIABETES METAB, V27, P675; DAMM P, 1992, AM J OBSTET GYNECOL, V167, P607, DOI 10.1016/S0002-9378(11)91559-2; Ekelund M, 2010, DIABETOLOGIA, V53, P452, DOI 10.1007/s00125-009-1621-3; Ferrannini E, 2004, DIABETES, V53, P160, DOI 10.2337/diabetes.53.1.160; Ferrannini E, 2010, DIABETES, V59, P679, DOI 10.2337/db09-1378; Genuth S, 2003, DIABETES CARE, V26, P3160; Gobl CS, 2011, OBSTET GYNECOL, V118, P71, DOI 10.1097/AOG.0b013e318220e18f; Gunderson EP, 2012, DIABETES CARE, V35, P50, DOI 10.2337/dc11-1409; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; JOHNSTON C, 1987, DIABETES, V36, P829, DOI 10.2337/diabetes.36.7.829; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim SH, 2011, NUTRITION, V27, P782, DOI 10.1016/j.nut.2010.08.019; KJOS SL, 1990, AM J OBSTET GYNECOL, V163, P93, DOI 10.1016/S0002-9378(11)90676-0; KJOS SL, 1995, DIABETES, V44, P586, DOI 10.2337/diabetes.44.5.586; LAM KSL, 1991, DIABETES RES CLIN PR, V12, P181, DOI 10.1016/0168-8227(91)90075-O; Lanting LC, 2005, DIABETES CARE, V28, P2280, DOI 10.2337/diacare.28.9.2280; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Mari A, 2002, DIABETES, V51, pS221, DOI 10.2337/diabetes.51.2007.S221; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Mason CC, 2007, DIABETES, V56, P2054, DOI 10.2337/db07-0053; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Metzger BE, 1998, DIABETES CARE, V21, pB161; METZGER BE, 1993, DIABETES CARE, V16, P1598, DOI 10.2337/diacare.16.12.1598; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Pacini G, 1998, AM J PHYSIOL-ENDOC M, V274, pE592, DOI 10.1152/ajpendo.1998.274.4.E592; Ratner RE, 2008, J CLIN ENDOCR METAB, V93, P4774, DOI 10.1210/jc.2008-0772; Retnakaran R, 2010, CLIN ENDOCRINOL, V73, P476, DOI 10.1111/j.1365-2265.2010.03834.x; Seghieri G, 2010, EXP CLIN ENDOCR DIAB, V118, P485, DOI 10.1055/s-0030-1249634; Steinhart JR, 1997, DIABETES CARE, V20, P943, DOI 10.2337/diacare.20.6.943; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tura A, 2008, CLIN ENDOCRINOL, V69, P237, DOI 10.1111/j.1365-2265.2008.03178.x; Tura A, 2006, EUR J CLIN INVEST, V36, P22, DOI 10.1111/j.1365-2362.2006.01587.x; Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Xiang AH, 2011, DIABETOLOGIA, V54, P3016, DOI 10.1007/s00125-011-2330-2; Xiang AH, 2010, DIABETES, V59, P2625, DOI 10.2337/db10-0521; Xiang AH, 2010, DIABETES CARE, V33, P396, DOI 10.2337/dc09-1493	44	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50419	10.1371/journal.pone.0050419	http://dx.doi.org/10.1371/journal.pone.0050419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185618	gold, Green Published, Green Submitted			2022-12-25	WOS:000311821000231
J	Hendrix, S; Kramer, P; Pehl, D; Warnke, K; Boato, F; Nelissen, S; Lemmens, E; Pejler, G; Metz, M; Siebenhaar, F; Maurer, M				Hendrix, Sven; Kramer, Peter; Pehl, Debora; Warnke, Katharina; Boato, Francesco; Nelissen, Sofie; Lemmens, Evi; Pejler, Gunnar; Metz, Martin; Siebenhaar, Frank; Maurer, Marcus			Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4	FASEB JOURNAL			English	Article						entorhinal cortex lesion; mMCP-4; protease; T cells	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-ISCHEMIA; EARLY RESPONDERS; MICE; ACTIVATION; PROTEASES; BIOLOGY; MOUSE	Mast cells (MCs) are found abundantly in the brain and the meninges and play a complex role in neuroinflammatory diseases, such as stroke and multiple sclerosis. Here, we show that MC-deficient Kit(W)/Kit(W-v) mice display increased neurodegeneration in the lesion area after brain trauma. Furthermore, MC-deficient mice display significantly more brain inflammation, namely an increased presence of macrophages/microglia, as well as dramatically increased T-cell infiltration at days 4 and 14 after injury, combined with increased astrogliosis at day 14 following injury. The number of proliferating Ki67(+) macrophages/microglia and astrocytes around the lesion area is more than doubled in these MC-deficient mice. In parallel, MC-deficient Kit(W-sh/W-sh) mice display increased presence of macrophages/microglia at day 4, and persistent astrogliosis at day 4 and 14 after brain trauma. Further analysis of mice deficient in one of the most relevant MC proteases, i.e., mouse mast cell protease 4 (mMCP-4), revealed that astrogliosis and T-cell infiltration are significantly increased in mMCP-4-knockout mice. Finally, treatment with an inhibitor of mMCP-4 significantly increased macrophage/microglia numbers and astrogliosis. These data suggest that MCs exert protective functions after trauma, at least in part via mMCP-4, by suppressing exacerbated inflammation via their proteases.-Hendrix, S., Kramer, P., Pehl, D., Warnke, K., Boato, F., Nelissen, S., Lemmens, E., Pejler, G., Metz, M., Siebenhaar, F., Maurer, M. Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4. FASEB J. 27, 920-929 (2013). www.fasebj.org	[Hendrix, Sven; Boato, Francesco; Nelissen, Sofie; Lemmens, Evi] Hasselt Univ, Dept Morphol, Diepenbeek, Belgium; [Hendrix, Sven; Boato, Francesco; Nelissen, Sofie; Lemmens, Evi] Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium; [Kramer, Peter; Pehl, Debora; Warnke, Katharina] Charite, Ctr Anat Cell Biol & Neurobiol, D-13353 Berlin, Germany; [Metz, Martin; Siebenhaar, Frank; Maurer, Marcus] Charite, Dept Dermatol, D-13353 Berlin, Germany; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Hasselt University; Hasselt University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swedish University of Agricultural Sciences	Hendrix, S (corresponding author), Dept Morphol, Agoralaan Gebouw D, BE-3590 Diepenbeek, Belgium.	sven.hendrix@uhasselt.be	Maurer, Marcus/ABG-2174-2020; Metz, Martin/B-8799-2009; Metz, Martin/M-5237-2013; Hendrix, Sven/F-4059-2010	Maurer, Marcus/0000-0002-4121-481X; Metz, Martin/0000-0002-4070-9976; Metz, Martin/0000-0002-4070-9976; Hendrix, Sven/0000-0003-2344-7369; Siebenhaar, Frank/0000-0003-4532-1644; Lemmens, Evi/0000-0001-6044-5659; Boato, Francesco/0000-0001-9741-8021; Kramer, Peter/0000-0003-4780-5271	Deutsche Forschungsgemeinschaft [SPP1394]; Fonds Wetenschappelijk Onderzoek-Vlaanderen [G.0834.11N, G.0389.12]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds Wetenschappelijk Onderzoek-Vlaanderen(FWO)	The authors are indebted to Doreen Ludecke and Julia Konig for their engaged and skillful technical assistance, to Nathalie Geurts for performing the FACS analyses and to Dearbhaile Dooley for editing the text. P.K. was a member of GRK1258. This study was supported in part by grants from Deutsche Forschungsgemeinschaft (SPP1394) and from Fonds Wetenschappelijk Onderzoek-Vlaanderen (G.0834.11N, G.0389.12) to S.H. The authors declare no conflicts of interests.	Bennett JL, 2009, J IMMUNOL, V182, P5507, DOI 10.4049/jimmunol.0801485; Berghmans N, 2011, J INTERF CYTOK RES, V31, P575, DOI 10.1089/jir.2010.0137; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; BRENNER T, 1994, J NEUROL SCI, V122, P210, DOI 10.1016/0022-510X(94)90300-X; Brown MA, 2002, MOL IMMUNOL, V38, P1373, DOI 10.1016/S0161-5890(02)00091-3; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Del Turco D, 2003, HIPPOCAMPUS, V13, P685, DOI 10.1002/hipo.10118; DROPP JJ, 1972, ANAT REC, V174, P227, DOI 10.1002/ar.1091740207; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hendrix S, 2006, NEUROSCI LETT, V392, P174, DOI 10.1016/j.neulet.2005.09.029; Hendrix S, 2007, J NEUROIMMUNOL, V184, P100, DOI 10.1016/j.jneuroim.2006.11.019; Henz BM, 2001, EXP DERMATOL, V10, P1, DOI 10.1034/j.1600-0625.2001.100101.x; Jin YX, 2009, STROKE, V40, P3107, DOI 10.1161/STROKEAHA.109.549691; Kwidzinski E, 2003, J NEURAL TRANSM-SUPP, P29, DOI 10.1007/978-3-7091-0643-3_2; Li HM, 2011, J IMMUNOL, V187, P274, DOI 10.4049/jimmunol.1003603; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; Lunemann A, 2006, GLIA, V53, P412, DOI 10.1002/glia.20301; Manni L, 1998, INT J DEV NEUROSCI, V16, P1, DOI 10.1016/S0736-5748(98)00003-3; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Piconese S, 2011, LAB INVEST, V91, P627, DOI 10.1038/labinvest.2011.3; Robbie-Ryan M, 2003, J IMMUNOL, V170, P1630, DOI 10.4049/jimmunol.170.4.1630; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Skaper SD, 2001, J NEUROCHEM, V76, P47, DOI 10.1046/j.1471-4159.2001.00008.x; Skaper SD, 1996, J NEUROCHEM, V66, P1157; Strbian D, 2007, J CEREBR BLOOD F MET, V27, P795, DOI 10.1038/sj.jcbfm.9600387; Strbian D, 2006, J CEREBR BLOOD F MET, V26, P605, DOI 10.1038/sj.jcbfm.9600228; Strbian D, 2009, ANN MED, V41, P438, DOI 10.1080/07853890902887303; Taiwo OB, 2005, PAIN, V114, P131, DOI 10.1016/j.pain.2004.12.002; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Waskow C, 2004, BLOOD, V104, P1688, DOI 10.1182/blood-2004-04-1247; Zappulla JP, 2002, J NEUROIMMUNOL, V131, P5, DOI 10.1016/S0165-5728(02)00250-3; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	38	41	43	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					920	929		10.1096/fj.12-204800	http://dx.doi.org/10.1096/fj.12-204800			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23193170				2022-12-25	WOS:000315585200008
J	Pusic, K; Aguilar, Z; McLoughlin, J; Kobuch, S; Xu, H; Tsang, M; Wang, A; Hui, G				Pusic, Kae; Aguilar, Zoraida; McLoughlin, Jaclyn; Kobuch, Sophie; Xu, Hong; Tsang, Mazie; Wang, Andrew; Hui, George			Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine	FASEB JOURNAL			English	Article						adjuvant; particle-mediated immunizations; inhibitory antibodies	MEROZOITE SURFACE PROTEIN-1; VIRUS-LIKE PARTICLES; C-TERMINAL FRAGMENT; PLASMODIUM-FALCIPARUM; DENDRITIC CELLS; AOTUS MONKEYS; INHIBITORY ANTIBODIES; ADJUVANT FORMULATIONS; EFFICACY; IMMUNOGENICITY	This study explored the novel use of iron oxide (IO) nanoparticles (<20 nm) as a vaccine delivery platform without additional adjuvants. A recombinant malaria vaccine antigen, the merozoite surface protein 1 (rMSP1), was conjugated to IO nanoparticles (rMSP1-IO). Immunizations in outbred mice with rMSP1-IO achieved 100% responsiveness with antibody titers comparable to those obtained with rMSP1 formulated with a clinically acceptable adjuvant, Montanide ISA51 (2.7 x 10(-3) vs. 1.6 x 10(-3); respectively). Only rMSP1-1O could induce significant levels (80%) of parasite inhibitory antibodies. The rMSP1-IO was highly stable at 4 C and was amenable to lyophilization, maintaining its antigenicity, immunogenicity, and ability to induce inhibitory antibodies. Further testing in nonhuman primates, Aotus monkeys, also elicited 100% immune responsiveness and high levels of parasite inhibitory antibodies (55-100% inhibition). No apparent local or systemic toxicity was associated with IO immunizations. Murine macrophages and dendritic cells efficiently (>90%) internalized IO nanoparticles, but only the latter were significantly activated, with elevated expression/secretion of CD86, cytokines (IL-6, TNF-alpha, IL1-b, IFN-gamma, and IL-12), and chemokines (CXCL1, CXCL2, CCL2, CCL3, CCL4, and CXCL10). Thus, the IO nanoparticles is a novel, safe, and effective vaccine platform, with built-in adjuvancy, that is highly stable and field deployable for cost-effective vaccine delivery.-Pusic, K., Aguilar, Z., McLoughlin, J., Kobuch, S., Xu, H., Tsang, M., Wang, A., Hui, G. Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine. FASEB J. 27, 1153-1166 (2013). www.fasebj.org	[Pusic, Kae; McLoughlin, Jaclyn; Kobuch, Sophie; Hui, George] Univ Hawaii, Dept Trop Med, Honolulu, HI 96813 USA; [Tsang, Mazie] Univ Hawaii, Sch Med, Honolulu, HI 96813 USA; [Aguilar, Zoraida; Xu, Hong; Wang, Andrew] Ocean NanoTech LLC, Springdale, AR USA	University of Hawaii System; University of Hawaii System	Pusic, K (corresponding author), Univ Hawaii, Sch Med, Dept Trop Med, 651 Ilalo St,BSB320, Honolulu, HI 96813 USA.	kae@hawaii.edu			U.S. National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [A1076955]; NIH/National Institutes of General Medical Sciences [P20GM103516]; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [DK078386]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK078386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases; NIH/National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Chang, W. Gosnell, K. Kramer, and S. Case for their help with the Aotus monkey immunizations. The authors also thank Dr. Lozanoff and Dr. Somponpun for their help with the toxicity studies. The authors additionally thank D. Clements of Hawaii Biotech Inc. (Aiea, HI, USA) for providing the MSP1 recombinant protein; and D. Clements and A. Stridiron for their technical support. This work was supported by a grant from the U.S. National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (A1076955) and NIH/National Institutes of General Medical Sciences (P20GM103516). K. P. was supported by NIH/National Institute of Diabetes and Digestive and Kidney Diseases (DK078386).	Akagi T, 2007, BIOMATERIALS, V28, P3427, DOI 10.1016/j.biomaterials.2007.04.023; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3; Anzai Yoshimi, 2004, Top Magn Reson Imaging, V15, P103, DOI 10.1097/01.rmr.0000130602.65243.87; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Chackerian B, 2007, EXPERT REV VACCINES, V6, P381, DOI 10.1586/14760584.6.3.381; Chang SP, 1996, INFECT IMMUN, V64, P253, DOI 10.1128/IAI.64.1.253-261.1996; CHANG SP, 1992, J IMMUNOL, V149, P548; CHANG SP, 1989, P NATL ACAD SCI USA, V86, P6343, DOI 10.1073/pnas.86.16.6343; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Figuerola A, 2010, PHARMACOL RES, V62, P126, DOI 10.1016/j.phrs.2009.12.012; Fischer NO, 2010, BIOCONJUGATE CHEM, V21, P1018, DOI 10.1021/bc100083d; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Harro CD, 2001, JNCI-J NATL CANCER I, V93, P284, DOI 10.1093/jnci/93.4.284; Hirosue S, 2010, VACCINE, V28, P7897, DOI 10.1016/j.vaccine.2010.09.077; HOLDER AA, 1984, J EXP MED, V160, P624, DOI 10.1084/jem.160.2.624; HOLDER AA, 1992, MEM I OSWALDO CRUZ, V87, P37, DOI 10.1590/S0074-02761992000700004; Holder AA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P409; Hui G, 2008, CLIN VACCINE IMMUNOL, V15, P1145, DOI 10.1128/CVI.00058-08; Hui G, 2007, VACCINE, V25, P8549, DOI 10.1016/j.vaccine.2007.10.010; Hui G, 2007, VACCINE, V25, P948, DOI 10.1016/j.vaccine.2006.08.041; HUI GSN, 1992, EXP PARASITOL, V75, P155, DOI 10.1016/0014-4894(92)90131-S; HUI GSN, 1994, J IMMUNOL, V153, P2544; HUI GSN, 1991, J IMMUNOL, V147, P3935; HUI GSN, 1994, J IMMUNOL, V153, P1195; HUI GSN, 1994, AM J TROP MED HYG, V50, P41, DOI 10.4269/ajtmh.1994.50.41; HUI GSN, 1987, EXP PARASITOL, V64, P519, DOI 10.1016/0014-4894(87)90068-3; Illum L, 2001, ADV DRUG DELIVER REV, V51, P81, DOI 10.1016/S0169-409X(01)00171-5; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957; Kirkpatrick RB, 1999, GENE EXPRESSION SYSTEMS, P289, DOI 10.1016/B978-012253840-7/50012-2; Kumar S, 2000, INFECT IMMUN, V68, P2215, DOI 10.1128/IAI.68.4.2215-2223.2000; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Leung WH, 2004, BBA-GEN SUBJECTS, V1675, P62, DOI 10.1016/j.bbagen.2004.08.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig C, 2007, CURR OPIN BIOTECH, V18, P537, DOI 10.1016/j.copbio.2007.10.013; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Masotti A, 2009, MINI-REV MED CHEM, V9, P463, DOI 10.2174/138955709787847976; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Pang ALY, 2002, INFECT IMMUN, V70, P2772, DOI 10.1128/IAI.70.6.2772-2779.2002; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pusic K, 2011, VACCINE, V29, P8898, DOI 10.1016/j.vaccine.2011.09.070; Pusic KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024782; Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041; Shahiwala Aliasgar, 2007, Recent Pat Drug Deliv Formul, V1, P1, DOI 10.2174/187221107779814140; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Skene CD, 2006, METHODS, V40, P53, DOI 10.1016/j.ymeth.2006.05.019; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Sun HX, 2009, VACCINE, V27, P4388, DOI 10.1016/j.vaccine.2009.05.032; SZMUNESS W, 1980, NEW ENGL J MED, V303, P833, DOI 10.1056/NEJM198010093031501; Szymczak WA, 2010, INFECT IMMUN, V78, P2125, DOI 10.1128/IAI.00065-10; Ueno Y, 2005, J CONTROL RELEASE, V103, P93, DOI 10.1016/j.jconrel.2004.11.015; van der Lubben IM, 2001, ADV DRUG DELIVER REV, V52, P139, DOI 10.1016/S0169-409X(01)00197-1; Xu H., 2009, BIOMEDICAL ENG INFOR, DOI [10.1109/BMEI.2009.5305551, DOI 10.1109/BMEI.2009.5305551]; Xu HY, 2009, ECS TRANSACTIONS, V25, P69, DOI 10.1149/1.3236409; Xu HYY, 2010, ECS TRANSACTIONS, V25, P1, DOI 10.1149/1.3327196; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	67	50	52	0	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					1153	1166		10.1096/fj.12-218362	http://dx.doi.org/10.1096/fj.12-218362			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23195035	Green Published			2022-12-25	WOS:000315585200028
J	Abrams, CK; Islam, M; Mahmoud, R; Kwon, T; Bargiello, TA; Freidin, MM				Abrams, Charles K.; Islam, Mahee; Mahmoud, Rola; Kwon, Taekyung; Bargiello, Thaddeus A.; Freidin, Mona M.			Functional Requirement for a Highly Conserved Charged Residue at Position 75 in the Gap Junction Protein Connexin 32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH-DISEASE; MOLECULAR-DYNAMICS SIMULATIONS; GREEN FLUORESCENT PROTEIN; ALTERED TRAFFICKING; DOMINANT DEAFNESS; PERIPHERAL-NERVE; SCHWANN-CELLS; MUTATIONS; CHANNELS; EXPRESSION	Charcot Marie Tooth disease (CMT) is a group of inherited disorders characterized clinically by exclusively or predominantly peripheral nerve dysfunction. CMT1X, the most common form of X-linked CMT is caused by mutations in connexin 32 (Cx32). In this work, we used dual whole cell patch clamp recording to examine the functional effects of mutations at the Arg(75) position. This residue is highly conserved among members of the connexin family, and disease-causing mutations have been identified at this (or the corresponding) position in Cx26, Cx43, and Cx46. Thus, a better understanding of the effects of mutations of this position in Cx32 may have relevance to pathogenesis of a number of different human diseases. All three mutants associated with CMT1X (R75P, R75Q, and R75W) showed very low levels of coupling similar to those of the cells transfected with vector alone. Heterotypic pairing with Cx32 WT showed that the absence of coupling for these mutants in the homotypic configuration could be explained by shifts in their hemichannel G(j)-V-j relations. Examination of the expression levels and gating characteristics of seven additional mutants (R75A, R75D, R75E, R75H, R75K, R75L, and R75V) at this position suggest that the positive charge at position 75 in Cx32 is required for normal channel function but not for gap junction assembly. Our studies also suggest that disease treatment strategies for CMT1X, which correct trafficking abnormalities in Cx32, may be ineffective for the group of mutations also conferring changes in gating properties of Cx32 channels.	[Abrams, Charles K.; Islam, Mahee; Mahmoud, Rola; Freidin, Mona M.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Abrams, Charles K.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Kwon, Taekyung; Bargiello, Thaddeus A.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Yeshiva University; Albert Einstein College of Medicine	Abrams, CK (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	charles.abrams@downstate.edu	Mahmoud, Rola/GNP-0681-2022	Freidin, Mona/0000-0002-3162-4858	National Institutes of Health [1R01NS050705]; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant 1R01NS050705 and Muscular Dystrophy Association research grants (to C. K. A.).	Abrams CK, 2003, J NEUROSCI, V23, P10548; Abrams CK, 2001, BRAIN RES, V900, P9, DOI 10.1016/S0006-8993(00)03327-8; Altevogt BM, 2002, J NEUROSCI, V22, P6458; Balice-Gordon RJ, 1998, J CELL BIOL, V142, P1095, DOI 10.1083/jcb.142.4.1095; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Bukauskas FF, 2001, BIOPHYS J, V81, P137, DOI 10.1016/S0006-3495(01)75687-1; BUKAUSKAS FF, 1992, EXP PHYSIOL, V77, P903, DOI 10.1113/expphysiol.1992.sp003657; Burdon KP, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.018333; Chandross KJ, 1996, MOL CELL NEUROSCI, V7, P501, DOI 10.1006/mcne.1996.0036; Chen YY, 2005, FASEB J, V19, P1516, DOI 10.1096/fj.04-3491fje; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Deng YQ, 2006, HEARING RES, V220, P87, DOI 10.1016/j.heares.2006.07.004; Deschenes SM, 1997, J NEUROSCI, V17, P9077; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; JANSSENTIMMEN U, 1983, EMBO J, V2, P295, DOI 10.1002/j.1460-2075.1983.tb01422.x; Kleopa KA, 2002, J NEUROSCI RES, V68, P522, DOI 10.1002/jnr.10255; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Kwon T, 2012, BIOPHYS J, V102, P1341, DOI 10.1016/j.bpj.2012.02.009; Kwon T, 2011, J GEN PHYSIOL, V138, P475, DOI 10.1085/jgp.201110679; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Mambetisaeva ET, 1999, J NEUROSCI RES, V57, P166, DOI 10.1002/(SICI)1097-4547(19990715)57:2<166::AID-JNR2>3.3.CO;2-P; Martin PEM, 2000, J NEUROCHEM, V74, P711, DOI 10.1046/j.1471-4159.2000.740711.x; Matsuyama W, 2001, J HUM GENET, V46, P307, DOI 10.1007/s100380170064; Meier C, 2004, J NEUROSCI, V24, P3186, DOI 10.1523/JNEUROSCI.5146-03.2004; Oh S, 2000, J GEN PHYSIOL, V116, P13, DOI 10.1085/jgp.116.1.13; Oh S, 1999, J GEN PHYSIOL, V114, P339, DOI 10.1085/jgp.114.3.339; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Richard G, 1998, HUM GENET, V103, P393, DOI 10.1007/s004390050839; Scherer SS, 1995, J NEUROSCI, V15, P8281; Siskind CE, 2011, SEMIN NEUROL, V31, P494, DOI 10.1055/s-0031-1299788; Sutor B, 2000, CEREB CORTEX, V10, P684, DOI 10.1093/cercor/10.7.684; Tang QX, 2009, J GEN PHYSIOL, V133, P555, DOI 10.1085/jgp.200910207; VERSELIS VK, 1991, BIOPHYS J, V59, P114, DOI 10.1016/S0006-3495(91)82204-4; Verselis VK, 2009, J BIOL CHEM, V284, P4484, DOI 10.1074/jbc.M807430200; Wang HL, 2004, NEUROBIOL DIS, V15, P361, DOI 10.1016/j.nbd.2003.11.005; WILGENBUS KK, 1992, INT J CANCER, V51, P522, DOI 10.1002/ijc.2910510404; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yum SW, 2002, NEUROBIOL DIS, V11, P43, DOI 10.1006/nbdi.2002.0545	43	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3609	3619		10.1074/jbc.M112.392670	http://dx.doi.org/10.1074/jbc.M112.392670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23209285	Green Published, hybrid			2022-12-25	WOS:000314397900065
J	BasuRay, S; Mukherjee, S; Romero, EG; Seaman, MNJ; Wandinger-Ness, A				BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa G.; Seaman, Matthew N. J.; Wandinger-Ness, Angela			Rab7 Mutants Associated with Charcot-Marie-Tooth Disease Cause Delayed Growth Factor Receptor Transport and Altered Endosomal and Nuclear Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCYTIC TRAFFICKING; MUTATIONS; MOTOR; NEUROPATHIES; LOCALIZATION; RECRUITMENT; REGULATORS; SURVIVAL; SUBUNIT; PATHWAY	Rab7 belongs to the Ras superfamily of small GTPases and is a master regulator of early to late endocytic membrane transport. Four missense mutations in the late endosomal Rab7 GTPase (L129F, K157N, N161T, and V162M) cause the autosomal dominant peripheral neuropathy Charcot-Marie-Tooth type 2B (CMT2B) disease. As yet, the pathological mechanisms connecting mutant Rab7 protein expression to altered neuronal function are undefined. Here, we analyze the effects of Rab7 CMT2B mutants on epidermal growth factor (EGF)-dependent intracellular signaling and trafficking. Three different cell lines expressing Rab7 CMT2B mutants and stimulated with EGF exhibited delayed trafficking of EGF to LAMP1-positive late endosomes and lysosomes and slowed EGF receptor (EGFR) degradation. Expression of all Rab7 CMT2B mutants altered the Rab7 activation cycle, leading to enhanced and prolonged EGFR signaling as well as variable increases in p38 and ERK1/2 activation. However, due to reduced nuclear translocation of p38 and ERK1/2, the downstream nuclear activation of Elk-1 was decreased along with the expression of immediate early genes like c-fos and Egr-1 by the disease mutants. In conclusion, our results demonstrate that Rab7 CMT2B mutants impair growth factor receptor trafficking and, in turn, alter p38 and ERK1/2 signaling from perinuclear, clustered signaling endosomes. The resulting down-regulation of EGFR-dependent nuclear transcription that is crucial for normal axon outgrowth and peripheral innervation offers a crucial new mechanistic insight into disease pathogenesis that is relevant to other neurodegenerative diseases.	[BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa G.; Wandinger-Ness, Angela] Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; [BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa G.; Wandinger-Ness, Angela] Univ New Mexico, Hlth Sci Ctr, Canc Res & Treatment Ctr, Albuquerque, NM 87131 USA; [Seaman, Matthew N. J.] Univ Cambridge, Cambridge Inst Med Res, Dept Clin Biochem, Cambridge CB2 0XY, England	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Cambridge	Wandinger-Ness, A (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Pathol, HSC MSC08-4640,2325 Camino Salud NE,CRF225, Albuquerque, NM 87131 USA.	wness@unm.edu	Wandinger-Ness, Angela/J-9104-2012	Wandinger-Ness, Angela/0000-0003-0613-3157	University of New Mexico; Cancer Center Fluorescence Microscopy Shared Resource; National Science Foundation [425 (MCB0956027)]; Medical Research Council [G0701444]; MRC [G0701444] Funding Source: UKRI	University of New Mexico; Cancer Center Fluorescence Microscopy Shared Resource; National Science Foundation(National Science Foundation (NSF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Images in this paper were generated in the University of New Mexico and Cancer Center Fluorescence Microscopy Shared Resource (funded as detailed on the Web site). We thank Dr. Edward Bedrick for helpful discussions regarding the statistical analyses. We thank the University of New Mexico flow cytometry facility for the selection of GFP-Rab7-expressing stable PC12 cell lines. We are grateful to Jamie Padilla and Genevieve Phillips for excellent technical support and Janet Kelly and Lauren Thal for outstanding administrative support.; This work was supported by National Science Foundation Grant 425 (MCB0956027) (to A. W. N.) and Medical Research Council Grant G0701444 (to M. N. J. S.).	Agola JO, 2011, CLIN GENET, V80, P305, DOI 10.1111/j.1399-0004.2011.01724.x; Ascano M, 2012, TRENDS CELL BIOL, V22, P266, DOI 10.1016/j.tcb.2012.02.005; Barisic N, 2008, ANN HUM GENET, V72, P416, DOI 10.1111/j.1469-1809.2007.00412.x; BasuRay S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015351; Bienfait HME, 2007, NEUROLOGY, V68, P1658, DOI 10.1212/01.wnl.0000263479.97552.94; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Cogli L, 2010, ACTA NEUROPATHOL, V120, P491, DOI 10.1007/s00401-010-0696-8; Cogli L, 2009, BIOCHEM SOC T, V37, P1027, DOI 10.1042/BST0371027; Daniele T, 2011, TRAFFIC, V12, P902, DOI 10.1111/j.1600-0854.2011.01194.x; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Demir O, 2011, BBA-MOL BASIS DIS, V1812, P652, DOI 10.1016/j.bbadis.2011.02.012; Dong JB, 2004, J BIOL CHEM, V279, P21334, DOI 10.1074/jbc.M401022200; Edinger AL, 2003, DEV CELL, V5, P571, DOI 10.1016/S1534-5807(03)00291-0; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Germain M, 2011, EMBO J, V30, P395, DOI 10.1038/emboj.2010.327; Golding JP, 2000, NAT CELL BIOL, V2, P103, DOI 10.1038/35000058; Houlden H, 2004, ANN NEUROL, V56, P586, DOI 10.1002/ana.20281; Jian XY, 2010, TRAFFIC, V11, P732, DOI 10.1111/j.1600-0854.2010.01054.x; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Lu A, 2009, J CELL BIOL, V184, P863, DOI 10.1083/jcb.200807186; Makhortova NR, 2011, NAT CHEM BIOL, V7, P544, DOI [10.1038/NCHEMBIO.595, 10.1038/nchembio.595]; Maklad A, 2009, J INVEST DERMATOL, V129, P690, DOI 10.1038/jid.2008.281; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; Meggouh F, 2006, NEUROLOGY, V67, P1476, DOI 10.1212/01.wnl.0000240068.21499.f5; Mukherjee S, 2005, METHOD ENZYMOL, V403, P650, DOI 10.1016/S0076-6879(05)03056-9; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Schroeder B, 2010, EMBO J, V29, P3039, DOI 10.1038/emboj.2010.190; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Shy ME, 2002, LANCET NEUROL, V1, P110, DOI 10.1016/S1474-4422(02)00042-X; Snider MD, 2003, MOL CELL, V12, P796, DOI 10.1016/S1097-2765(03)00401-5; Sokolova I P, 1998, Tsitologiia, V40, P862; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vardarajan BN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.04.020; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Young P, 2003, CELL MOL LIFE SCI, V60, P2547, DOI 10.1007/s00018-003-3133-5	49	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1135	1149		10.1074/jbc.M112.417766	http://dx.doi.org/10.1074/jbc.M112.417766			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188822	hybrid, Green Published			2022-12-25	WOS:000313570300036
J	Radzyukevich, TL; Neumann, JC; Rindler, TN; Oshiro, N; Goldhamer, DJ; Lingrel, JB; Heiny, JA				Radzyukevich, Tatiana L.; Neumann, Jonathon C.; Rindler, Tara N.; Oshiro, Naomi; Goldhamer, David J.; Lingrel, Jerry B.; Heiny, Judith A.			Tissue-specific Role of the Na,K-ATPase alpha 2 Isozyme in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-K+-ATPASE; NICOTINIC ACETYLCHOLINE-RECEPTOR; BLOOD-PRESSURE; BINDING-SITE; ISOFORM; PUMP; POTASSIUM; SUBUNIT; TRANSPORT; MOUSE	The Na,K-ATPase alpha 2 isozyme is the major Na, K-ATPase of mammalian skeletal muscle. This distribution is unique compared with most other cells, which express mainly the Na, K-ATPase alpha 1 isoform, but its functional significance is not known. We developed a gene-targeted mouse (sk alpha 2(-/-)) in which the alpha 2 gene (Atp1a2) is knocked out in the skeletal muscles, and examined the consequences for exercise performance, membrane potentials, contractility, and muscle fatigue. Targeted knockout was confirmed by genotyping, Western blot, and immunohistochemistry. Skeletal muscle cells of sk alpha 2(-/-) mice completely lack alpha 2 protein and have no alpha 2 in the transverse tubules, where its expression is normally enhanced. The alpha 1 isoform, which is normally enhanced on the outer sarcolemma, is up-regulated 2.5-fold without change in subcellular targeting. sk alpha 2(-/-) mice are apparently normal under basal conditions but show significantly reduced exercise capacity when challenged to run. Their skeletal muscles produce less force, are unable to increase force to match demand, and show significantly increased susceptibility to fatigue. The impairments affect both fast and slow muscle types. The subcellular targeting of alpha 2 to the transverse tubules is important for this role. Increasing Na, K-ATPase alpha 1 content cannot fully compensate for the loss of alpha 2. The increased fatigability of sk alpha 2(-/-) muscles is reproduced in control extensor digitorum longus muscles by selectively inhibiting alpha 2 enzyme activity with ouabain. These results demonstrate that the Na, K-ATPase alpha 2 isoform performs an acute, isoform-specific role in skeletal muscle. Its activity is regulated by muscle use and enables working muscles to maintain contraction and resist fatigue.	[Radzyukevich, Tatiana L.; Heiny, Judith A.] Univ Cincinnati, Dept Mol & Cellular Physiol, Coll Med, Cincinnati, OH 45267 USA; [Neumann, Jonathon C.; Rindler, Tara N.; Oshiro, Naomi; Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Goldhamer, David J.] Univ Connecticut, Stem Cell Inst, Dept Mol & Cell Biol, Ctr Regenerat Biol, Storrs, CT 06269 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Connecticut	Heiny, JA (corresponding author), Univ Cincinnati, Dept Mol Physiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	heinyja@ucmail.uc.edu			National Institutes of Health, NHLBI [5RO1HL28573]; National Institutes of Health, NIAMS [R01AR052777]; University of Cincinnati; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052777] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Cincinnati; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grant 5RO1HL28573 and National Institutes of Health, NIAMS, Grant R01AR052777. This work was also supported by the Physiology Research Fund of the University of Cincinnati.	ALMERS W, 1980, FED PROC, V39, P1527; Blanco G, 2005, SEMIN NEPHROL, V25, P292, DOI 10.1016/j.semnephrol.2005.03.004; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Chibalin AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033719; Clausen T, 2003, ANN NY ACAD SCI, V986, P595, DOI 10.1111/j.1749-6632.2003.tb07258.x; Clausen T, 2003, PHYSIOL REV, V83, P1269, DOI 10.1152/physrev.00011.2003; Clausen T, 1998, ACTA PHYSIOL SCAND, V162, P183, DOI 10.1046/j.1365-201X.1998.0295e.x; CLAUSEN T, 1987, J PHYSIOL-LONDON, V388, P163, DOI 10.1113/jphysiol.1987.sp016608; Clausen T, 2008, J GEN PHYSIOL, V131, P473, DOI 10.1085/jgp.200809971; Clausen T, 2007, J PHYSIOL-LONDON, V584, P295, DOI 10.1113/jphysiol.2007.136044; Cougnon MH, 2002, PFLUG ARCH EUR J PHY, V445, P123, DOI 10.1007/s00424-002-0898-6; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; He SW, 2001, AM J PHYSIOL-REG I, V281, pR917, DOI 10.1152/ajpregu.2001.281.3.R917; Heiny JA, 2010, J BIOL CHEM, V285, P28614, DOI 10.1074/jbc.M110.150961; Ikeda K, 2003, J NEUROSCI, V23, P4667; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Krivoi II, 2006, PFLUG ARCH EUR J PHY, V452, P756, DOI 10.1007/s00424-006-0081-6; Lavoie L, 1997, BIOCHEMISTRY-US, V36, P7726, DOI 10.1021/bi970109s; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; LUFF AR, 1971, J CELL BIOL, V51, P369, DOI 10.1083/jcb.51.2.369; MOERLAND TS, 1994, AM J PHYSIOL, V267, pC127, DOI 10.1152/ajpcell.1994.267.1.C127; Moseley AE, 2003, J BIOL CHEM, V278, P5317, DOI 10.1074/jbc.M211315200; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; Oshiro N, 2010, AM J HYPERTENS, V23, P1279, DOI 10.1038/ajh.2010.195; PRESSLEY TA, 1992, AM J PHYSIOL, V262, pC743, DOI 10.1152/ajpcell.1992.262.3.C743; Pritchard TJ, 2007, AM J PHYSIOL-HEART C, V293, pH1172, DOI 10.1152/ajpheart.00279.2007; Radzyukevich TL, 2009, P NATL ACAD SCI USA, V106, P2565, DOI 10.1073/pnas.0804150106; Radzyukevich TL, 2004, AM J PHYSIOL-CELL PH, V287, pC1300, DOI 10.1152/ajpcell.00231.2004; Rindler TN, 2011, AM J PHYSIOL-HEART C, V301, pH1396, DOI 10.1152/ajpheart.00121.2011; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; Song H, 2006, J BIOL CHEM, V281, P12929, DOI 10.1074/jbc.M507450200; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; Williams MW, 2001, J CELL SCI, V114, P751	37	64	66	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1226	1237		10.1074/jbc.M112.424663	http://dx.doi.org/10.1074/jbc.M112.424663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23192345	Green Published, hybrid			2022-12-25	WOS:000313570300043
J	Chau, DKF; Chen, GG; Zhang, H; Leung, BCS; Chun, S; Lai, PB				Chau, Davor Kin-fan; Chen, George Gong; Zhang, Haitao; Leung, Billy Cheuk Sing; Chun, Sukying; Lai, Paul Bosan			Differential Functions of C- and N-Terminal Hepatitis B x Protein in Liver Cells Treated with Doxorubicin in Normoxic or Hypoxic Condition	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; INDUCED APOPTOSIS; ACTIVATION; CARCINOGENESIS; ANGIOGENESIS; SUFFICIENT; MECHANISMS; PATHWAY; PLAYS; TUMOR	Hepatitis viral B x protein (HBx), a hepatocarcinogen, is frequently mutated. Hypoxia influences the growth of HCC and also the sensitivity of tumor cells to treatments. We aimed to test the role of HBx and acute hypoxia in the efficacy of chemotherapy. In this study, we established 4 Chang liver cell lines with the full-length HBx (HBx), the first 50 amino acids of N-terminal HBx (HBx/50), the last 104 amino acids of C-terminal HBx (HBx/51) and empty vector (CL), respectively. MTT and TNUEL assays were used to assess cell viability and apoptosis respectively. Western blot was used to determine the expression of relevant proteins. Results showed that among 4 cell lines, doxorubicin was most effective in decreasing the viability and enhancing apoptosis in HBx/51 cells, while HBx/50 cells were most resistant to the treatment. Cells in hypoxia were more susceptible to doxorubicin than cells in normoxia. Hypoxia facilitated the Bid cleavage especially in HBx/51 cells via phosphorylating p38 MAPK. p38 MAPK inhibitor significantly reduced the tBid level and increased cell viability. In conclusion, N-terminal HBx and C-terminal HBx function differentially in their ability to regulate cell growth, with the former being promotive but the latter being inhibitory. The acute hypoxia may overcome the HBx-induced resistance and facilitate the chemotherapy. Citation: Chau DK-f, Chen GG, Zhang H, Leung BCS, Chun S, et al. (2012) Differential Functions of C- and N-Terminal Hepatitis B x Protein in Liver Cells Treated with Doxorubicin in Normoxic or Hypoxic Condition. PLoS ONE 7(11): e50118. doi:10.1371/journal.pone.0050118	[Chau, Davor Kin-fan; Chen, George Gong; Zhang, Haitao; Leung, Billy Cheuk Sing; Chun, Sukying; Lai, Paul Bosan] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Chen, GG (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China.	gchen@cuhk.edu.hk	Chen, George Gong/I-2757-2016; Lai, Paul BS/K-8556-2015	Lai, Paul BS/0000-0002-9469-6728	Chinese University of Hong Kong [2008.1.099]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was supported by a direct grant (2008.1.099) from the Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SK, 1998, CANCER LETT, V126, P97, DOI 10.1016/S0304-3835(97)00538-7; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Fang JS, 2008, SEMIN CANCER BIOL, V18, P330, DOI 10.1016/j.semcancer.2008.03.011; Gottlob K, 1998, CANCER RES, V58, P3566; Hu LA, 2011, J VIROL, V85, P3214, DOI 10.1128/JVI.01841-10; Iwaoka S, 2006, J LEUKOCYTE BIOL, V79, P184, DOI 10.1189/jlb.0405181; Kim BM, 2007, BIOCHEM BIOPH RES CO, V363, P745, DOI 10.1016/j.bbrc.2007.09.024; Kim JY, 2010, J MOL BIOL, V397, P917, DOI 10.1016/j.jmb.2010.02.016; Kim JH, 2011, APOPTOSIS, V16, P696, DOI 10.1007/s10495-011-0605-1; Kohler B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002844; Kralova J, 2008, ONCOGENE, V27, P3010, DOI 10.1038/sj.onc.1210960; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; Lee SA, 2011, J MED VIROL, V83, P65, DOI 10.1002/jmv.21938; Liu XH, 2008, WORLD J GASTROENTERO, V14, P1346, DOI 10.3748/wjg.14.1346; Ma NF, 2008, CLIN CANCER RES, V14, P5061, DOI 10.1158/1078-0432.CCR-07-5082; Ma SH, 2010, GENE THER, V17, P905, DOI 10.1038/gt.2010.34; Miao J, 2004, INT J ONCOL, V25, P651; Miao J, 2006, INT J CANCER, V119, P1985, DOI 10.1002/ijc.22040; Moon EJ, 2003, FASEB J, V17, P382, DOI 10.1096/fj.03-0153fje; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Ng SA, 2011, J GASTROENTEROL, V46, P974, DOI 10.1007/s00535-011-0415-9; Oishi N, 2007, CANCER SCI, V98, P1540, DOI 10.1111/j.1349-7006.2007.00579.x; Reeve JLV, 2007, J CELL MOL MED, V11, P509, DOI 10.1111/j.1582-4934.2007.00042.x; Rosmorduc O, 2010, SEMIN LIVER DIS, V30, P258, DOI 10.1055/s-0030-1255355; Tang H, 2005, J VIROL, V79, P5548, DOI 10.1128/JVI.79.9.5548-5556.2005; Vaculova A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-87; Wang F, 2010, CANCER LETT, V298, P64, DOI 10.1016/j.canlet.2010.06.003; Wang Q, 2010, NEOPLASIA, V12, P103, DOI 10.1593/neo.91298; Watson JL, 2010, MOL CARCINOGEN, V49, P13, DOI 10.1002/mc.20571; Wei QQ, 2004, AM J PHYSIOL-RENAL, V286, pF803, DOI 10.1152/ajprenal.00093.2003; Yang ZF, 2006, MOL CANCER THER, V5, P2261, DOI 10.1158/1535-7163.MCT-06-0149; Yoo YG, 2004, FEBS LETT, V577, P121, DOI 10.1016/j.febslet.2004.10.004; Yu JS, 2011, MOL CELLS, V31, P327, DOI 10.1007/s10059-011-0041-7	33	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50118	10.1371/journal.pone.0050118	http://dx.doi.org/10.1371/journal.pone.0050118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209654	gold, Green Submitted, Green Published			2022-12-25	WOS:000312104900027
J	Jiwaji, M; Daly, R; Gibriel, A; Barkess, G; McLean, P; Yang, JL; Pansare, K; Cumming, S; McLauchlan, A; Kamola, PJ; Bhutta, MS; West, AG; West, KL; Kolch, W; Girolami, MA; Pitt, AR				Jiwaji, Meesbah; Daly, Ronan; Gibriel, Abdullah; Barkess, Grainne; McLean, Pauline; Yang, Jingli; Pansare, Kshama; Cumming, Sarah; McLauchlan, Alisha; Kamola, Piotr J.; Bhutta, Musab S.; West, Adam G.; West, Katherine L.; Kolch, Walter; Girolami, Mark A.; Pitt, Andrew R.			Unique Reporter-Based Sensor Platforms to Monitor Signalling in Cells	PLOS ONE			English	Article							REAL-TIME PCR; TRANSCRIPTION FACTORS; GENE-EXPRESSION; GENOME; IDENTIFICATION; PROMOTER; ELEMENTS; QUANTIFICATION; INHIBITION; ACTIVATION	Introduction: In recent years much progress has been made in the development of tools for systems biology to study the levels of mRNA and protein, and their interactions within cells. However, few multiplexed methodologies are available to study cell signalling directly at the transcription factor level. Methods: Here we describe a sensitive, plasmid-based RNA reporter methodology to study transcription factor activation in mammalian cells, and apply this technology to profiling 60 transcription factors in parallel. The methodology uses two robust and easily accessible detection platforms; quantitative real-time PCR for quantitative analysis and DNA microarrays for parallel, higher throughput analysis. Findings: We test the specificity of the detection platforms with ten inducers and independently validate the transcription factor activation. Conclusions: We report a methodology for the multiplexed study of transcription factor activation in mammalian cells that is direct and not theoretically limited by the number of available reporters. Citation: Jiwaji M, Daly R, Gibriel A, Barkess G, McLean P, et al. (2012) Unique Reporter-Based Sensor Platforms to Monitor Signalling in Cells. PLoS ONE 7(11): e50521. doi:10.1371/journal.pone.0050521	[Jiwaji, Meesbah; Gibriel, Abdullah; McLean, Pauline; Yang, Jingli; Pansare, Kshama; Cumming, Sarah; McLauchlan, Alisha; Kamola, Piotr J.; Bhutta, Musab S.; Kolch, Walter; Pitt, Andrew R.] Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Daly, Ronan; Girolami, Mark A.] Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland; [Barkess, Grainne; West, Adam G.; West, Katherine L.] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Kolch, Walter] Univ Coll Dublin, Syst Biol Ireland, Dublin 2, Ireland; [Kolch, Walter] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Girolami, Mark A.] UCL, Dept Stat Sci, London, England; [Jiwaji, Meesbah; Pansare, Kshama; Pitt, Andrew R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Glasgow; University of Glasgow; University of Glasgow; University College Dublin; University College Dublin; University of London; University College London; Aston University	Pitt, AR (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	a.r.pitt@aston.ac.uk	Pansare, Kshama/AAT-3968-2020; Kolch, Walter/ABF-2102-2021; Pitt, Andrew R/E-9083-2010; Admin, SBI/HGB-2738-2022; Jiwaji, Meesbah/D-9509-2014	Pansare, Kshama/0000-0002-8671-7103; Pitt, Andrew R/0000-0003-3619-6503; Gibriel, Abdullah/0000-0002-1318-4510; Kolch, Walter/0000-0001-5777-5016; Jiwaji, Meesbah/0000-0003-3557-4541; Daly, Ronan/0000-0002-1275-6820; West, Katherine/0000-0002-5994-8969; West, Adam/0000-0003-3502-7804; Barkess, Grainne/0000-0003-1742-921X; Girolami, Mark/0000-0003-3008-253X	Engineering and Physical Sciences Research Council (EPSRC) Basic Technology Research Grant [EP/E032745/1]; Science Foundation Ireland [06/CE/B1129]; EPSRC [EP/E032745/1, EP/E032745/2] Funding Source: UKRI; MRC [G0400180] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J008605/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E032745/1, EP/E032745/2] Funding Source: researchfish; Medical Research Council [G0400180] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC) Basic Technology Research Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC) Basic Technology Research Grant [grant number EP/E032745/1]. WK was also supported by Science Foundation Ireland [grant number 06/CE/B1129]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Botvinnik A, 2010, NAT METHODS, V7, P74, DOI [10.1038/nmeth.1407, 10.1038/NMETH.1407]; Calkhoven CF, 1996, BIOCHEM J, V317, P329, DOI 10.1042/bj3170329; Cheng JF, 2007, EXP BIOL MED, V232, P38; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Dhanshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Hanke S, 2006, CELL SIGNAL, V18, P1031, DOI 10.1016/j.cellsig.2005.08.019; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herget S, 2008, CELL SIGNAL, V20, P1423, DOI 10.1016/j.cellsig.2008.03.011; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Jiwaji M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-103; KARIN M, 1987, MOL CELL BIOL, V7, P606, DOI 10.1128/MCB.7.2.606; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; Krappmann D, 2001, MOL CELL BIOL, V21, P6640, DOI 10.1128/MCB.21.19.6640-6650.2001; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; MCCOY C, 1995, MOL CELL BIOL, V15, P6100; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M, 2006, R NEWS, V6, P11; PRESTERA T, 1993, P NATL ACAD SCI USA, V90, P2965, DOI 10.1073/pnas.90.7.2965; Qiao JY, 2008, J PROTEOME RES, V7, P2769, DOI 10.1021/pr700883t; Ramaswamy S, 2002, J CLIN ONCOL, V20, P1932, DOI 10.1200/JCO.2002.20.7.1932; Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Smith AD, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100114; Storhoff JJ, 2005, BIOL MED PHYS BIOMED, P147; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Titus SA, 2008, J BIOMOL SCREEN, V13, P609, DOI 10.1177/1087057108319977; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wasserman WW, 1998, J MOL BIOL, V278, P167, DOI 10.1006/jmbi.1998.1700; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Woolson HD, 2009, CELL SIGNAL, V21, P1706, DOI 10.1016/j.cellsig.2009.07.009; Yan Y, 2007, AM J PHYSIOL-GASTR L, V292, pG535, DOI 10.1152/ajpgi.00385.2006; Yin WX, 2005, ANAL BIOCHEM, V346, P289, DOI 10.1016/j.ab.2005.08.029; Yoo SM, 2009, J MICROBIOL BIOTECHN, V19, P635, DOI 10.4014/jmb.0803.226; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl400	41	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50521	10.1371/journal.pone.0050521	http://dx.doi.org/10.1371/journal.pone.0050521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209767	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000312104900061
J	Malavige, GN; Huang, LC; Salimi, M; Gomes, L; Jayaratne, SD; Ogg, GS				Malavige, Gathsaurie Neelika; Huang, Li-Chieh; Salimi, Maryam; Gomes, Laksiri; Jayaratne, S. D.; Ogg, Graham S.			Cellular and Cytokine Correlates of Severe Dengue Infection	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; CD8(+) T-CELLS; HEMORRHAGIC-FEVER; VIRAL LOAD; IMMUNE-RESPONSE; VIRUS; DISEASE; ADULTS; APOPTOSIS; SEROTYPE	Background: The occurrence of dengue haemorrhagic fever (DHF) is thought to result from a complex interplay between the virus, host genetics and host immune factors. Existing published data are not consistent, in part related to relatively small sample sizes. We set out to determine possible associations between dengue virus (DEN-V) NS3 specific T cells and cytokine and chemokine levels and the pathogenesis of severe disease in a large cohort of individuals with DHF. Methodology/Principal Findings: By using ex vivo IFN gamma ELISpot assays we determined DENV-NS3 specific responses in patients with varying severity of DHF. Other cytokines produced by DENV-NS3 specific T cells were determined by using multiple bead array analysis (MBAA). We also determined the serum cytokine levels using MBAA, lymphocyte subsets and Annexin V expression of lymphocytes in patients with varying severity of DHF. Of the 112 DHF patients studied, 29 developed shock. Serum IL-10 and IP-10 levels positively and significantly correlated with T cell apoptosis while IL-10 levels inversely correlated with T cell numbers. In contrast, TGF beta showed a very significant (P<0.0001) and positive correlation (Spearman's R =0.65) with the platelet counts, consistent with platelet release. We found that whilst patients with severe dengue had lower total T cell numbers, the DV-NS3 specific T cells persisted and produced high levels of IFN gamma but not TNF alpha, IL-3, IL-13, IL-2, IL-10 or IL-17. Conclusions/Significance: Our data suggest that serum IL-10, TNF alpha and TGF beta differentially associate with dengue disease severity.	[Malavige, Gathsaurie Neelika; Huang, Li-Chieh; Salimi, Maryam; Ogg, Graham S.] Oxford NIHR Biomed Res Ctr, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England; [Malavige, Gathsaurie Neelika; Huang, Li-Chieh; Salimi, Maryam; Ogg, Graham S.] Univ Oxford, Oxford, England; [Malavige, Gathsaurie Neelika; Gomes, Laksiri] Univ Sri Jayawardanapura, Dept Microbiol, Fac Med Sci, Nugegoda, Sri Lanka; [Jayaratne, S. D.] Univ Sri Jayawardanapura, Dept Med, Fac Med Sci, Nugegoda, Sri Lanka; [Ogg, Graham S.] Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University Sri Jayewardenepura; University Sri Jayewardenepura; University of Oxford	Ogg, GS (corresponding author), Oxford NIHR Biomed Res Ctr, MRC Human Immunol Unit, Weatherall Inst Mol Med, Oxford, England.	graham.ogg@ndm.ox.ac.uk	Malavige, Gathsaurie/J-5483-2015	Malavige, Gathsaurie/0000-0001-9201-0449; Ogg, Graham/0000-0002-3097-045X	Medical Research Council (UK); National Research Council Sri Lanka [09/10]; MRC [G0701693, MC_UU_12010/5, MC_U137881017] Funding Source: UKRI; Medical Research Council [MC_UU_12010/5, G1000800h, G0701693, MC_U137881017] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Council Sri Lanka; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the Medical Research Council (UK) and the National Research Council Sri Lanka (09/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 1999, INT J EXP PATHOL, V80, P143, DOI 10.1046/j.1365-2613.1999.00107.x; Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; Beaumier CM, 2008, J INFECT DIS, V197, P608, DOI 10.1086/526790; Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Callaway E, 2007, NATURE, V448, P734, DOI 10.1038/448734a; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chaturvedi UC, 1999, J MED VIROL, V59, P335, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;335::AID-JMV13&gt;3.0.CO;2-E; Chen LC, 2006, AM J TROP MED HYG, V74, P142, DOI 10.4269/ajtmh.2006.74.142; Dong T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001192; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805; Hasegawa S, 2011, CYTOKINE, V54, P167, DOI 10.1016/j.cyto.2011.01.006; Jaiyen Y, 2009, MICROBIOL IMMUNOL, V53, P442, DOI 10.1111/j.1348-0421.2009.00148.x; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; Low JG, PLOS NEGL TROP DIS, V5, pe1191; Mabalirajan U, 2005, AM J TROP MED HYG, V72, P783, DOI 10.4269/ajtmh.2005.72.783; Macedo C, 2011, J IMMUNOL, V186, P5854, DOI 10.4049/jimmunol.1001024; Malavige GN, 2010, BRIT J CANCER, V102, P727, DOI 10.1038/sj.bjc.6605542; Malavige GN, 2006, QJM-INT J MED, V99, P299, DOI 10.1093/qjmed/hcl039; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Mathew A, 1998, J VIROL, V72, P3999, DOI 10.1128/JVI.72.5.3999-4004.1998; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Thomas L, 2008, AM J TROP MED HYG, V78, P990; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wang HJ, 2005, CELL IMMUNOL, V235, P117, DOI 10.1016/j.cellimm.2005.08.031; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704; World Health Organization, 2009, DENG GUID DIAGN PREV	43	79	87	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50387	10.1371/journal.pone.0050387	http://dx.doi.org/10.1371/journal.pone.0050387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209731	gold, Green Published, Green Submitted			2022-12-25	WOS:000312104900047
J	Pisciotta, A; Riccio, M; Carnevale, G; Beretti, F; Gibellini, L; Maraldi, T; Cavallini, GM; Ferrari, A; Bruzzesi, G; De Pol, A				Pisciotta, Alessandra; Riccio, Massimo; Carnevale, Gianluca; Beretti, Francesca; Gibellini, Lara; Maraldi, Tullia; Cavallini, Gian Maria; Ferrari, Adriano; Bruzzesi, Giacomo; De Pol, Anto			Human Serum Promotes Osteogenic Differentiation of Human Dental Pulp Stem Cells In Vitro and In Vivo	PLOS ONE			English	Article							HUMAN PLATELET LYSATE; FETAL BOVINE SERUM; MESENCHYMAL STROMAL CELLS; HUMAN AMNIOTIC-FLUID; RICH PLASMA; CALF SERUM; EXPANSION; BONE; PROLIFERATION; ALTERNATIVES	Human dental pulp is a promising alternative source of stem cells for cell-based tissue engineering in regenerative medicine, for the easily recruitment with low invasivity for the patient and for the self-renewal and differentiation potential of cells. So far, in vitro culture of mesenchymal stem cells is usually based on supplementing culture and differentiation media with foetal calf serum (FCS). FCS is known to contain a great quantity of growth factors, and thus to promote cell attachment on plastic surface as well as expansion and differentiation. Nevertheless, FCS as an animal origin supplement may represent a potential means for disease transmission besides leading to a xenogenic immune response. Therefore, a significant interest is focused on investigating alternative supplements, in order to obtain a sufficient cell number for clinical application, avoiding the inconvenients of FCS use. In our study we have demonstrated that human serum (HS) is a suitable alternative to FCS, indeed its addition to culture medium induces a high hDPSCs proliferation rate and improves the in vitro osteogenic differentiation. Furthermore, hDPSCs-collagen constructs, pre-differentiated with HS-medium in vitro for 10 days, when implanted in immunocompromised rats, are able to restore critical size parietal bone defects. Therefore these data indicate that HS is a valid substitute for FCS to culture and differentiate in vitro hDPSCs in order to obtain a successful bone regeneration in vivo. Citation: Pisciotta A, Riccio M, Carnevale G, Beretti F, Gibellini L, et al. (2012) Human Serum Promotes Osteogenic Differentiation of Human Dental Pulp Stem Cells In Vitro and In Vivo. PLoS ONE 7(11): e50542. doi:10.1371/journal.pone.0050542	[Pisciotta, Alessandra; Riccio, Massimo; Carnevale, Gianluca; Beretti, Francesca; Gibellini, Lara; Maraldi, Tullia; Cavallini, Gian Maria; De Pol, Anto] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci Interest Transpl, Modena, Italy; [Ferrari, Adriano] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neurosci, Children Rehabil Special Unit, IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; [Bruzzesi, Giacomo] AUSL Baggiovara, Oromaxillofacial Dept, Modena, Italy	Universita di Modena e Reggio Emilia; IRCCS Arcispedale S. Maria Nuova; Universita di Modena e Reggio Emilia	Riccio, M (corresponding author), Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci Interest Transpl, Modena, Italy.	massimo.riccio@unimore.it	Pisciotta, Alessandra/HDM-9618-2022; Cavallini, Gian Maria/P-9705-2016; Carnevale, Gianluca/ABF-7872-2021; FERRARI, Adriano/J-6440-2016; Carnevale, Gianluca/F-8416-2017; Maraldi, Tullia/J-5264-2016	Cavallini, Gian Maria/0000-0003-0914-2884; Carnevale, Gianluca/0000-0002-5348-5991; FERRARI, Adriano/0000-0002-6166-1350; Carnevale, Gianluca/0000-0002-5348-5991; Maraldi, Tullia/0000-0003-3331-2513; Pisciotta, Alessandra/0000-0001-7818-0003; Beretti, Francesca/0000-0001-6023-5846; DE POL, Anto/0000-0003-4279-5422	Progetto Strategico per lo sviluppo nella sede di Reggio Emilia della Facolta di Medicina e Chirurgia [20100007725]; Arcispedale S. Maria Nuova di Reggio Emilia; MIUR FIRB Accordi di Programma [RBAP10Z7FS]	Progetto Strategico per lo sviluppo nella sede di Reggio Emilia della Facolta di Medicina e Chirurgia; Arcispedale S. Maria Nuova di Reggio Emilia; MIUR FIRB Accordi di Programma(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by grants from "Progetto Strategico per lo sviluppo nella sede di Reggio Emilia della Facolta di Medicina e Chirurgia'' Prot: 20100007725, Arcispedale S. Maria Nuova di Reggio Emilia and MIUR FIRB Accordi di Programma 2010 Prot: RBAP10Z7FS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldahmash A, 2011, STEM CELL REV REP, V7, P860, DOI 10.1007/s12015-011-9274-2; Arthur A, 2008, STEM CELLS, V26, P1787, DOI 10.1634/stemcells.2007-0979; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; Chai Y, 2000, DEVELOPMENT, V127, P1671; Costa AD, 2008, J CRANIOFAC SURG, V19, P204, DOI 10.1097/scs.0b013e31815c8a54; Dimarakis I, 2006, STEM CELLS, V24, P1407, DOI 10.1634/stemcells.2005-0577; Emea E., 2008, EMEACHMP4108692006; Felka T, 2010, CYTOTHERAPY, V12, P143, DOI 10.3109/14653240903470647; Feng Y, 2010, BIOTECHNOL LETT, V32, P635, DOI 10.1007/s10529-009-0198-8; Foreman MA, 2006, J CELL PHYSIOL, V206, P664, DOI 10.1002/jcp.20521; Govindasamy V, 2011, CYTOTHERAPY, V13, P1221, DOI 10.3109/14653249.2011.602337; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gruber R, 2006, CLIN ORAL IMPLAN RES, V17, P188, DOI 10.1111/j.1600-0501.2005.01216.x; Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161; Karbanova J, 2011, CELLS TISSUES ORGANS, V193, P344, DOI 10.1159/000321160; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Laino G, 2006, J CELL PHYSIOL, V206, P693, DOI 10.1002/jcp.20526; Lee JW, 2004, BIOMATERIALS, V25, P1901, DOI 10.1016/j.biomaterials.2003.08.037; Lee UL, 2011, REGEN MED, V6, P67, DOI 10.2217/RME.10.96; Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127; Maraldi T, 2011, TISSUE ENG PT A, V17, P2833, DOI 10.1089/ten.tea.2011.0062; Nimura A, 2008, ARTHRITIS RHEUM, V58, P501, DOI 10.1002/art.23219; Otaki S, 2007, CELL BIOL INT, V31, P1191, DOI 10.1016/j.cellbi.2007.04.001; Prins HJ, 2009, TISSUE ENG PT A, V15, P3741, DOI [10.1089/ten.tea.2008.0666, 10.1089/ten.TEA.2008.0666]; Riccio M, 2010, EUR J HISTOCHEM, V54, P213, DOI 10.4081/ejh.2010.e46; Riccio M, 2012, TISSUE ENG PT A, V18, P1006, DOI [10.1089/ten.tea.2011.0542, 10.1089/ten.TEA.2011.0542]; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Stute N, 2004, EXP HEMATOL, V32, P1212, DOI 10.1016/j.exphem.2004.09.003; Tateishi K, 2008, CELL TRANSPLANT, V17, P549, DOI 10.3727/096368908785096024; Tomoyasu A, 2007, BIOCHEM BIOPH RES CO, V361, P62, DOI 10.1016/j.bbrc.2007.06.142; Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009; Yang XC, 2007, J TISSUE ENG REGEN M, V1, P66, DOI 10.1002/term.16; Zhang WB, 2006, TISSUE ENG, V12, P2813, DOI 10.1089/ten.2006.12.2813	37	76	79	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50542	10.1371/journal.pone.0050542	http://dx.doi.org/10.1371/journal.pone.0050542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209773	Green Submitted, Green Published, gold			2022-12-25	WOS:000312104900065
J	Wu, XG; Liu, JC; Zhang, W; Zhang, LQ				Wu, Xiaogang; Liu, Jiucheng; Zhang, Wei; Zhang, Liqun			Multiple-Level Regulation of 2,4-Diacetylphloroglucinol Production by the Sigma Regulator PsrA in Pseudomonas fluorescens 2P24	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; ANTIBIOTIC PRODUCTION; EXOPRODUCT FORMATION; BIOCONTROL ACTIVITY; BIOLOGICAL-CONTROL; TETR FAMILY; METABOLITE 2,4-DIACETYLPHLOROGLUCINOL; TRANSCRIPTIONAL REGULATOR; SECONDARY METABOLISM	Background: Pseudomonas fluorescens 2P24 is a rhizospheric bacterium that aggressively colonizes the plant roots. It produces the antibiotic 2,4-diacetylphoroglucinol (2,4-DAPG), which contributes to the protection of various crop plants against soil borne diseases caused by bacterial and fungal pathogens. The biosynthesis of 2,4-DAPG is regulated at the transcriptional level in the expression of the phlACBD operon as well as at the posttranscriptional level by the Gac/Rsm signal transduction pathway. However, the detailed mechanism of such regulation is not clear. Methodology/Principal Findings: In this study, we identified a binding site for the sigma regulator PsrA in the promoter region of the phlA gene. Electrophoretic mobility shift experiments revealed direct and specific binding of PsrA to the phlA promoter region. Consistent with the fact that its binding site locates within the promoter region of phlA, PsrA negatively regulates phlA expression, and its inactivation led to significant increase in 2,4-DAPG production. Interestingly, PsrA also activates the expression of the sigma factor RpoS, which negatively regulates 2,4-DAPG production by inducing the expression of the RNA-binding protein RsmA. Conclusions/Significance: These results suggest that PsrA is an important regulator that modulates 2,4-DAPG biosynthesis at both transcriptional and posttranscriptional levels. Citation: Wu X, Liu J, Zhang W, Zhang L (2012) Multiple-Level Regulation of 2,4-Diacetylphloroglucinol Production by the Sigma Regulator PsrA in Pseudomonas fluorescens 2P24. PLoS ONE 7(11): e50149. doi:10.1371/journal.pone.0050149	[Wu, Xiaogang; Liu, Jiucheng; Zhang, Wei; Zhang, Liqun] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [Zhang, Liqun] Minist Agr, Key Lab Plant Pathol, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Zhang, LQ (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China.	zhanglq@cau.edu.cn	Zhang, Liqun/Q-7646-2019	Zhang, Liqun/0000-0002-2103-6294	National High Technology Research and Development Program ("863" Program) of China [2011AA10A205]; National Natural Science Foundation of China [31071725, 30871666]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program ("863" Program) of China (2011AA10A205) and the National Natural Science Foundation of China (31071725, 30871666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2002, J BACTERIOL, V184, P3008, DOI 10.1128/JB.184.11.3008-3016.2002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Baehler E, 2006, MOL PLANT MICROBE IN, V19, P313, DOI 10.1094/MPMI-19-0313; Bangera MG, 1999, J BACTERIOL, V181, P3155, DOI 10.1128/JB.181.10.3155-3163.1999; Brazelton JN, 2008, MOL PLANT MICROBE IN, V21, P1349, DOI 10.1094/MPMI-21-10-1349; Chatterjee A, 2007, APPL ENVIRON MICROB, V73, P3684, DOI 10.1128/AEM.02445-06; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Chin-A-Woeng TFC, 2005, MOL PLANT MICROBE IN, V18, P244, DOI 10.1094/MPMI-18-0244; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; Delany I, 2000, MICROBIOL-UK, V146, P537, DOI 10.1099/00221287-146-2-537; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; HenggeAronis R, 1996, MOL MICROBIOL, V21, P887, DOI 10.1046/j.1365-2958.1996.511405.x; Humair B, 2010, APPL ENVIRON MICROB, V76, P1497, DOI 10.1128/AEM.02014-09; Iavicoli A, 2003, MOL PLANT MICROBE IN, V16, P851, DOI 10.1094/MPMI.2003.16.10.851; Kang Y, 2009, MOL MICROBIOL, V73, P120, DOI 10.1111/j.1365-2958.2009.06757.x; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; KEEL C, 1990, SYMBIOSIS, V9, P327; Keel C, 1996, APPL ENVIRON MICROB, V62, P552, DOI 10.1128/AEM.62.2.552-563.1996; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kojic M, 2005, FEMS MICROBIOL LETT, V246, P175, DOI 10.1016/j.femsle.2005.04.003; Kojic M, 2002, J BACTERIOL, V184, P2324, DOI 10.1128/JB.184.8.2324-2330.2002; Kojic M, 2001, J BACTERIOL, V183, P3712, DOI 10.1128/JB.183.12.3712-3720.2001; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Liaw SJ, 2003, J MED MICROBIOL, V52, P19, DOI 10.1099/jmm.0.05024-0; MAURHOFER M, 1995, PLANT PATHOL, V44, P40, DOI 10.1111/j.1365-3059.1995.tb02714.x; Mavrodi OV, 2006, MICROBIOL-SGM, V152, P863, DOI 10.1099/mic.0.28545-0; Mukherjee A, 1998, J BACTERIOL, V180, P3629, DOI 10.1128/JB.180.14.3629-3634.1998; Mukhopadhyay S, 2000, MOL MICROBIOL, V37, P371, DOI 10.1046/j.1365-2958.2000.01999.x; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Pechy-Tarr M, 2005, MOL PLANT MICROBE IN, V18, P260, DOI 10.1094/MPMI-18-0260; Phillips DA, 2004, PLANT PHYSIOL, V136, P2887, DOI 10.1104/pp.104.044222; Raaijmakers JM, 1997, APPL ENVIRON MICROB, V63, P881, DOI 10.1128/AEM.63.3.881-887.1997; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Reddy T K, 1969, Mikrobiologiia, V38, P909; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Sambrook J, 2001, MOL CLONING LAB MANU; Sarniguet A, 1995, P NATL ACAD SCI USA, V92, P12255, DOI 10.1073/pnas.92.26.12255; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; SHANAHAN P, 1992, APPL ENVIRON MICROB, V58, P353, DOI 10.1128/AEM.58.1.353-358.1992; Shen DK, 2006, INFECT IMMUN, V74, P1121, DOI 10.1128/IAI.74.2.1121-1129.2006; Suh SJ, 1999, J BACTERIOL, V181, P3890, DOI 10.1128/JB.181.13.3890-3897.1999; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Tian T, 2010, MICROBIOL-SGM, V156, P39, DOI 10.1099/mic.0.031161-0; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Wei Hai-lei, 2005, Weishengwu Xuebao, V45, P368; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Wu XG, 2010, FEMS MICROBIOL LETT, V309, P16, DOI 10.1111/j.1574-6968.2010.02009.x; Zhou HY, 2005, CHINESE SCI BULL, V50, P775, DOI 10.1360/982005-84; Zhou YuPing, 2010, Acta Phytopathologica Sinica, V40, P144; Zuber S, 2003, MOL PLANT MICROBE IN, V16, P634, DOI 10.1094/MPMI.2003.16.7.634	64	8	9	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50149	10.1371/journal.pone.0050149	http://dx.doi.org/10.1371/journal.pone.0050149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209661	gold, Green Published, Green Submitted			2022-12-25	WOS:000312104900029
J	Barra, J; Laou, L; Poline, JB; Lebihan, D; Berthoz, A				Barra, Julien; Laou, Laetitia; Poline, Jean-Baptiste; Lebihan, Denis; Berthoz, Alain			Does an Oblique/Slanted Perspective during Virtual Navigation Engage Both Egocentric and Allocentric Brain Strategies?	PLOS ONE			English	Article							GENDER-DIFFERENCES; FUNCTIONAL-ANATOMY; MENTAL NAVIGATION; REFERENCE FRAMES; HIPPOCAMPUS; MEMORY; ACTIVATION; LANDMARKS; ROUTE; RETRIEVAL	Perspective (route or survey) during the encoding of spatial information can influence recall and navigation performance. In our experiment we investigated a third type of perspective, which is a slanted view. This slanted perspective is a compromise between route and survey perspectives, offering both information about landmarks as in route perspective and geometric information as in survey perspective. We hypothesized that the use of slanted perspective would allow the brain to use either egocentric or allocentric strategies during storage and recall. Twenty-six subjects were scanned (3-Tesla fMRI) during the encoding of a path (40-s navigation movie within a virtual city). They were given the task of encoding a segment of travel in the virtual city and of subsequent shortcut-finding for each perspective: route, slanted and survey. The analysis of the behavioral data revealed that perspective influenced response accuracy, with significantly more correct responses for slanted and survey perspectives than for route perspective. Comparisons of brain activation with route, slanted, and survey perspectives suggested that slanted and survey perspectives share common brain activity in the left lingual and fusiform gyri and lead to very similar behavioral performance. Slanted perspective was also associated with similar activation to route perspective during encoding in the right middle occipital gyrus. Furthermore, slanted perspective induced intermediate patterns of activation (in between route and survey) in some brain areas, such as the right lingual and fusiform gyri. Our results suggest that the slanted perspective may be considered as a hybrid perspective. This result offers the first empirical support for the choice to present the slanted perspective in many navigational aids.	[Barra, Julien] Univ Paris 05, Inst Psychol, Lab Memoire & Cognit, Boulogne, France; [Barra, Julien; Laou, Laetitia; Berthoz, Alain] Coll France, Lab Physiol Percept & Act, CNRS, UMR 7152, F-75231 Paris, France; [Poline, Jean-Baptiste; Lebihan, Denis] CEA, NeuroSpin, I2BM, Gif Sur Yvette, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay	Barra, J (corresponding author), Univ Paris 05, Inst Psychol, Lab Memoire & Cognit, Boulogne, France.	julien.barra@parisdescartes.fr			Agence Nationale de la Recherche (ANR)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This research was supported by the Agence Nationale de la Recherche (ANR, projet SCAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, P NATL ACAD SCI USA, V95, P839, DOI 10.1073/pnas.95.3.839; Aguirre GK, 1999, BRAIN, V122, P1613, DOI 10.1093/brain/122.9.1613; Alivisatos B, 1997, NEUROPSYCHOLOGIA, V35, P111, DOI 10.1016/S0028-3932(96)00083-8; Blanch RJ, 2004, CEREB CORTEX, V14, P1207, DOI 10.1093/cercor/bhh081; Bullens J, 2010, J EXP CHILD PSYCHOL, V107, P337, DOI 10.1016/j.jecp.2010.05.010; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; De Goede M, 2008, BRAIN COGNITION, V66, P232, DOI 10.1016/j.bandc.2007.08.004; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5909, DOI 10.1073/pnas.0711433105; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Epstein RA, 2005, J COGNITIVE NEUROSCI, V17, P73, DOI 10.1162/0898929052879987; Foo P, 2007, PSYCHOL RES-PSYCH FO, V71, P240, DOI 10.1007/s00426-006-0080-4; Galati G, 2010, EXP BRAIN RES, V206, P109, DOI 10.1007/s00221-010-2168-8; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; Golledge RG, 1985, J ENVIRON PSYCHOL, V5, P125, DOI DOI 10.1016/S0272-4944(85)80014-1; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; Johnsrude IS, 1999, NEUROPSYCHOLOGIA, V37, P829, DOI 10.1016/S0028-3932(98)00136-5; Kimura Doreen, 1999, SEX COGNITION; Lambrey S, 2008, BRAIN, V131, P523, DOI 10.1093/brain/awm317; Lambrey Simon, 2007, Journal of Integrative Neuroscience, V6, P379, DOI 10.1142/S021963520700157X; Lawton CA, 1996, J ENVIRON PSYCHOL, V16, P137, DOI 10.1006/jevp.1996.0011; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 1997, J NEUROSCI, V17, P7103; Martinelli P, HUM BRAIN MAPP IN PR; Mellet E, 2000, J COGNITIVE NEUROSCI, V12, P98, DOI 10.1162/08989290051137620; Mengue-Topio H, 2011, RES DEV DISABIL, V32, P345, DOI 10.1016/j.ridd.2010.10.014; Montello DR, 2004, HUMAN SPATIAL MEMORY: REMEMBERING WHERE, P251; Nemmi F, CORTEX IN PRESS; Owen AM, 1996, J COGNITIVE NEUROSCI, V8, P588, DOI 10.1162/jocn.1996.8.6.588; Piccardi L, 2010, EXP BRAIN RES, V206, P171, DOI 10.1007/s00221-010-2234-2; Poirel N, 2011, EXP PSYCHOL, V58, P142, DOI 10.1027/1618-3169/a000079; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Schmidt D, 2007, NEUROIMAGE, V36, P955, DOI 10.1016/j.neuroimage.2007.03.050; Shelton AL, 2002, J NEUROSCI, V22, P2711, DOI 10.1523/JNEUROSCI.22-07-02711.2002; Shelton AL, 2007, PSYCHOL RES-PSYCH FO, V71, P333, DOI 10.1007/s00426-006-0088-9; Siegel A W, 1975, Adv Child Dev Behav, V10, P9, DOI 10.1016/S0065-2407(08)60007-5; STREETER LA, 1985, INT J MAN MACH STUD, V22, P549, DOI 10.1016/S0020-7373(85)80017-1; Thompson WL, 2009, PSYCHOL SCI, V20, P1245, DOI 10.1111/j.1467-9280.2009.02440.x; THORNDYKE PW, 1982, COGNITIVE PSYCHOL, V14, P560, DOI 10.1016/0010-0285(82)90019-6; TVERSKY B, 1991, PSYCHOL LEARN MOTIV, V27, P109, DOI 10.1016/S0079-7421(08)60122-X; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Weniger G, 2011, NEUROPSYCHOLOGIA, V49, P518, DOI 10.1016/j.neuropsychologia.2010.12.031; Wiener JM, 2011, EXP BRAIN RES, V208, P61, DOI 10.1007/s00221-010-2460-7	50	15	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49537	10.1371/journal.pone.0049537	http://dx.doi.org/10.1371/journal.pone.0049537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057YW	23209583	gold, Green Submitted, Green Published			2022-12-25	WOS:000312601700017
J	Kaehler, C; Isensee, J; Nonhoff, U; Terrey, M; Hucho, T; Lehrach, H; Krobitsch, S				Kaehler, Christian; Isensee, Joerg; Nonhoff, Ute; Terrey, Markus; Hucho, Tim; Lehrach, Hans; Krobitsch, Sylvia			Ataxin-2-Like Is a Regulator of Stress Granules and Processing Bodies	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-2; MESSENGER-RNA DECAY; ARGININE METHYLATION; TRINUCLEOTIDE REPEAT; SPLICING FACTORS; PROTEIN-PROTEIN; HUMAN PAT1B; P-BODIES; GENE; IDENTIFICATION	Paralogs for several proteins implicated in neurodegenerative disorders have been identified and explored to further facilitate the identification of molecular mechanisms contributing to disease pathogenesis. For the disease-causing protein in spinocerebellar ataxia type 2, ataxin-2, a paralog of unknown function, termed ataxin-2-like, has been described. We discovered that ataxin-2-like associates with known interaction partners of ataxin-2, the RNA helicase DDX6 and the poly(A)-binding protein, and with ataxin-2 itself. Furthermore, we found that ataxin-2-like is a component of stress granules. Interestingly, sole ataxin-2-like overexpression led to the induction of stress granules, while a reduction of stress granules was detected in case of a low ataxin-2-like level. Finally, we observed that overexpression of ataxin-2-like as well as its reduction has an impact on the presence of microscopically visible processing bodies. Thus, our results imply a functional overlap between ataxin-2-like and ataxin-2, and further indicate a role for ataxin-2-like in the regulation of stress granules and processing bodies.	[Kaehler, Christian; Nonhoff, Ute; Terrey, Markus; Krobitsch, Sylvia] Max Planck Inst Mol Genet, Otto Warburg Lab, D-14195 Berlin, Germany; [Isensee, Joerg; Hucho, Tim] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Lehrach, Hans] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Kaehler, Christian] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Isensee, Joerg; Hucho, Tim] Univ Klin Koln, Klin Anasthesiol & Operat Intens Med Expt Anasthe, Cologne, Germany	Max Planck Society; Max Planck Society; Max Planck Society; Free University of Berlin; University of Cologne	Krobitsch, S (corresponding author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany.	krobitsc@molgen.mpg.de	Kaehler, Christian/A-2912-2015; Hucho, Tim/Q-5218-2018; Isensee, Joerg/C-4745-2019	Hucho, Tim/0000-0002-4147-9308; Isensee, Joerg/0000-0002-3390-0051; Terrey, Markus/0000-0002-7359-4810	Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2004, EUR J BIOCHEM, V271, P3155, DOI 10.1111/j.1432-1033.2004.04245.x; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Blackwell E, 2012, MOL REPROD DEV, V79, P163, DOI 10.1002/mrd.22024; Bowman AB, 2007, NAT GENET, V39, P373, DOI 10.1038/ng1977; Braun JE, 2010, EMBO J, V29, P2368, DOI 10.1038/emboj.2010.124; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Chen YC, 2010, MOL CELL BIOL, V30, P5245, DOI 10.1128/MCB.00359-10; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Figueroa KP, 2003, EXP NEUROL, V184, P669, DOI 10.1016/S0014-4886(03)00287-5; Fujimura K, 2012, NUCL ACIDS RES; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Geschwind DH, 1997, AM J HUM GENET, V60, P842; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Hallen L, 2011, HUM MOL GENET, V20, P104, DOI 10.1093/hmg/ddq436; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kozlov G, 2001, P NATL ACAD SCI USA, V98, P4409, DOI 10.1073/pnas.071024998; Lastres-Becker I, 2008, CEREBELLUM, V7, P115, DOI 10.1007/s12311-008-0019-y; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Marnef A, 2012, MOL BIOL CELL, V23, P213, DOI 10.1091/mbc.E11-05-0415; Meunier C, 2002, J BIOL CHEM, V277, P9139, DOI 10.1074/jbc.M105970200; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Orr HT, 2012, J CELL BIOL, V197, P167, DOI 10.1083/jcb.201105092; Ozgur S, 2010, MOL CELL BIOL, V30, P4308, DOI 10.1128/MCB.00429-10; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Ralser M, 2005, HUM MOL GENET, V14, P2893, DOI 10.1093/hmg/ddi321; Ralser M, 2005, J MOL BIOL, V346, P203, DOI 10.1016/j.jmb.2004.11.024; Reddy PS, 1997, CURR OPIN CELL BIOL, V9, P364, DOI 10.1016/S0955-0674(97)80009-9; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Satterfield TF, 2006, HUM MOL GENET, V15, P2523, DOI 10.1093/hmg/ddl173; Scheller N, 2007, BBA-MOL CELL RES, V1773, P1786, DOI 10.1016/j.bbamcr.2007.08.009; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Sinha R, 2010, MOL CELL BIOL, V30, P2762, DOI 10.1128/MCB.01270-09; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Truant R, 2006, CAN J NEUROL SCI, V33, P278, DOI 10.1017/S031716710000514X; van de Loo S, 2009, EXP NEUROL, V215, P110, DOI 10.1016/j.expneurol.2008.09.020; Welzel F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037985; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	53	54	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50134	10.1371/journal.pone.0050134	http://dx.doi.org/10.1371/journal.pone.0050134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209657	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800048
J	Milani, A; Vecchietti, D; Rusmini, R; Bertoni, G				Milani, Andrea; Vecchietti, Davide; Rusmini, Ruggero; Bertoni, Giovanni			TgpA, a Protein with a Eukaryotic-Like Transglutaminase Domain, Plays a Critical Role in the Viability of Pseudomonas aeruginosa	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; GENOME; IDENTIFICATION; GENES; RESISTANCE; STRATEGY	The Gram-negative bacterium Pseudomonas aeruginosa is an important opportunistic pathogen in compromised individuals, such as patients with cystic fibrosis, severe burns or impaired immunity. In this work we aimed to screen novel essential genes of P. aeruginosa by shotgun antisense identification, a technique that was developed a decade ago for the Gram-positive bacterium Staphylococcus aureus and was under-used in Gram-negative bacteria for a considerable period of time. Following antisense screenings in the PAO1 strain of P. aeruginosa, we focused on a locus, PA2873, which was targeted by an antisense RNA construct that can impair cell growth. The PA2873 gene product was annotated as a hypothetical membrane protein endowed with a periplasmic region harbouring a structural domain belonging to the transglutaminase-like superfamily, a group of archaeal, bacterial and eukaryotic proteins homologous to animal transglutaminases. In this study, we show that the periplasmic portion of the PA2873 protein, which we named TgpA, does possess transglutaminase activity in vitro. This is the first report of transglutaminase activity in P. aeruginosa. In addition, we have provided strong evidences that TgpA plays a critical role in the viability of P. aeruginosa.	[Milani, Andrea; Vecchietti, Davide; Rusmini, Ruggero; Bertoni, Giovanni] Univ Milan, Dept Life Sci, Milan, Italy	University of Milan	Bertoni, G (corresponding author), Univ Milan, Dept Life Sci, Milan, Italy.	giovanni.bertoni@unimi.it	BERTONI, GIOVANNI/J-3437-2012	BERTONI, GIOVANNI/0000-0001-5761-9494; Vecchietti, Davide/0000-0002-3140-584X	Italian Cystic Fibrosis Research Foundation [10/2004, 6/2006, 6/2007]; European Commission [NABATIVI, EU-FP7-HEALTH-2007-B, 223670]	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by Italian Cystic Fibrosis Research Foundation (grants FFC#10/2004, FFC#6/2006, FFC#6/2007) and by European Commission (grant NABATIVI, EU-FP7-HEALTH-2007-B contract number 223670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bonomo RA, 2006, CLIN INFECT DIS, V43, pS49, DOI 10.1086/504477; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DERETIC V, 1989, J BACTERIOL, V171, P1278, DOI 10.1128/jb.171.3.1278-1283.1989; Ducret A, 1998, PROTEIN SCI, V7, P706, DOI 10.1002/pro.5560070320; Engdahl HM, 2001, ANTISENSE NUCLEIC A, V11, P29, DOI 10.1089/108729001750072100; FOLK JE, 1966, J BIOL CHEM, V241, P3238; Forsyth RA, 2002, MOL MICROBIOL, V43, P1387, DOI 10.1046/j.1365-2958.2002.02832.x; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; King JD, 2009, J BIOL CHEM, V284, P1474, DOI 10.1074/jbc.M807729200; Klockgether J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00150; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Lim TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028177; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Luo YN, 2002, FEMS MICROBIOL LETT, V208, P47; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Makarova KS, 1999, PROTEIN SCI, V8, P1714, DOI 10.1110/ps.8.8.1714; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Meng J, 2012, FEMS MICROBIOL LETT, V329, P45, DOI 10.1111/j.1574-6968.2012.02503.x; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; Pier GB, 2005, MANDELL DOUGLAS BENN, V6th, P2587; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; Steenbakkers PJM, 2006, MOL MICROBIOL, V62, P1618, DOI 10.1111/j.1365-2958.2006.05483.x; Sze CC, 1999, MOL MICROBIOL, V31, P1217, DOI 10.1046/j.1365-2958.1999.01264.x; Wagner EGH, 2002, TRENDS GENET, V18, P223, DOI 10.1016/S0168-9525(02)02658-6; Wagner Victoria E., 2008, P129; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869	35	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50323	10.1371/journal.pone.0050323	http://dx.doi.org/10.1371/journal.pone.0050323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209712	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800065
J	Park, Y; Hartge, P; Moore, SC; Kitahara, CM; Hollenbeck, AR; de Gonzalez, AB				Park, Yikyung; Hartge, Patricia; Moore, Steven C.; Kitahara, Cari M.; Hollenbeck, Albert R.; de Gonzalez, Amy Berrington			Body Mass Index and Mortality in Non-Hispanic Black Adults in the NIH-AARP Diet and Health Study	PLOS ONE			English	Article							RETIRED-PERSONS DIET; US ADULTS; AMERICAN-ASSOCIATION; WAIST CIRCUMFERENCE; NATIONAL-INSTITUTES; WHITE ADULTS; WOMEN; OBESITY; COHORT; DEATH	Background: Although the prevalence of obesity (body mass index, kg/m(2), BMI >= 30) is higher in non-Hispanic blacks than in non-Hispanic whites, the relation of BMI to total mortality in non-Hispanic blacks is not well defined. Purpose: We investigated the association between BMI and total mortality in 16,471 non-Hispanic blacks in the NIH-AARP Diet and Health Study, a prospective cohort of adults aged 50-71 years. Methods: During an average of 13 years of follow-up, 2,609 deaths were identified using the Social Security Administration Death Master File and the National Death Index. Cox proportional hazard models were used to estimate relative risks and two-sided 95% confidence intervals (CI), adjusting for potential confounders. Results: Among individuals with no history of cancer or heart disease at baseline and had a BMI of 20 or greater, the relative risk for total death was 1.12 (95% CI: 1.05, 1.19, for a 5-unit increase in BMI) in men and 1.09 (95% CI: 1.03, 1.15) in women. Among never smokers with no history of cancer or heart disease at baseline, relative risks for total death for BMI 25-< 30, 30-< 35, 35-< 40, and 40-50, compared with BMI 20-< 25, were 1.27 (95% CI: 0.91, 1.78), 1.56 (95% CI: 1.07, 2.28), 2.48 (95% CI: 1.53, 4.05), and 2.80 (95% CI: 1.46, 5.39), respectively, in men and 0.78 (95% CI: 0.59, 1.04), 1.17 (95% CI: 0.88, 1.57), 1.35 (95% CI: 0.96, 1.90), and 1.93 (95% CI: 1.33, 2.81), respectively, in women. Conclusions: Our findings suggest that overweight is related to an increased risk of death in black men, but not in black women, while obesity is related to an increased risk of death in both black men and women. A large pooled analysis of existing studies is needed to systematically evaluate the association between a wide range of BMIs and total mortality in blacks.	[Park, Yikyung; Hartge, Patricia; Moore, Steven C.; Kitahara, Cari M.; de Gonzalez, Amy Berrington] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Hollenbeck, Albert R.] AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Park, Y (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	yikyung.park@nih.gov	Moore, Steven/D-8760-2016; de gonzalez, amy berrington/L-7017-2017; Kitahara, Cari M/R-8267-2016; Hollenbeck, Albert/AAG-9461-2020	Moore, Steven/0000-0002-8169-1661; de gonzalez, amy berrington/0000-0002-7332-8387; Kitahara, Cari M/0000-0001-6416-4432; Park, Yikyung/0000-0002-6281-489X	National Cancer Institute, United States National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	National Cancer Institute, United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by the Intramural Research Program of the National Cancer Institute, United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; Cohen SS, 2012, AM J EPIDEMIOL, V176, P431, DOI 10.1093/aje/kws032; CONWAY JM, 1995, AM J CLIN NUTR, V61, P765, DOI 10.1093/ajcn/61.4.765; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; DurazoArvizu R, 1997, ANN EPIDEMIOL, V7, P383, DOI 10.1016/S1047-2797(97)00044-6; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Hermansen SW, 2009, AM J EPIDEMIOL, V169, P901, DOI 10.1093/aje/kwn404; Katzmarzyk PT, 2011, OBESITY, V19, P1272, DOI 10.1038/oby.2010.319; Lakoski SG, 2011, J CLIN ENDOCR METAB, V96, P1805, DOI 10.1210/jc.2010-3055; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; McAdams MA, 2007, OBESITY, V15, P188, DOI 10.1038/oby.2007.504; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Park SY, 2012, EUR J EPIDEMIOL, V27, P489, DOI 10.1007/s10654-012-9695-5; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; SMITH PL, 1979, AM STAT, V33, P57, DOI 10.2307/2683222; STEVENS J, 1992, AM J EPIDEMIOL, V135, P1137, DOI 10.1093/oxfordjournals.aje.a116214; STEVENS J, 1992, ARCH INTERN MED, V152, P1257, DOI 10.1001/archinte.152.6.1257; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; WIENPAHL J, 1990, J CLIN EPIDEMIOL, V43, P949, DOI 10.1016/0895-4356(90)90078-4; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50091	10.1371/journal.pone.0050091	http://dx.doi.org/10.1371/journal.pone.0050091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209650	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800047
J	Xia, HW; Wu, N; Su, YJ				Xia, Haiwei; Wu, Nan; Su, Yanjie			Investigating the Genetic Basis of Theory of Mind (ToM): The Role of Catechol-O-Methyltransferase (COMT) Gene Polymorphisms	PLOS ONE			English	Article							ASPERGER-SYNDROME; METHYL-TRANSFERASE; SCHIZOPHRENIA; BRAIN; AUTISM; ASSOCIATION; DISORDERS; DOPAMINE; STORIES; ABILITY	The ability to deduce other persons' mental states and emotions which has been termed 'theory of mind (ToM)' is highly heritable. First molecular genetic studies focused on some dopamine-related genes, while the genetic basis underlying different components of ToM (affective ToM and cognitive ToM) remain unknown. The current study tested 7 candidate polymorphisms (rs4680, rs4633, rs2020917, rs2239393, rs737865, rs174699 and rs59938883) on the catechol-O-methyltransferase (COMT) gene. We investigated how these polymorphisms relate to different components of ToM. 101 adults participated in our study; all were genetically unrelated, non-clinical and healthy Chinese subjects. Different ToM tasks were applied to detect their theory of mind ability. The results showed that the COMT gene rs2020917 and rs737865 SNPs were associated with cognitive ToM performance, while the COMT gene rs5993883 SNP was related to affective ToM, in which a significant gender-genotype interaction was found (p = 0.039). Our results highlighted the contribution of DA-related COMT gene on ToM performance. Moreover, we found out that the different SNP at the same gene relates to the discriminative aspect of ToM. Our research provides some preliminary evidence to the genetic basis of theory of mind which still awaits further studies.	[Xia, Haiwei; Wu, Nan; Su, Yanjie] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China	Peking University	Su, YJ (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	yjsu@pku.edu.cn	Su, Yanjie/E-7003-2019	Su, Yanjie/0000-0003-3508-8674	National Natural Science Foundation of China [30970907, 31170995]; National Basic Research Program (973 Program) [2010CB833904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Project 30970907, 31170995) and National Basic Research Program (973 Program: 2010CB833904).	Abu-Akel A, 2003, MED HYPOTHESES, V60, P382, DOI 10.1016/S0306-9877(02)00406-1; Abu-Akel A, 2011, NEUROPSYCHOLOGIA, V49, P2971, DOI 10.1016/j.neuropsychologia.2011.07.012; Astington JW, 2002, NEW IDEAS PSYCHOL, V20, P131, DOI 10.1016/S0732-118X(02)00005-3; Barnes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033964; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Bassett AS, 2007, BIOL PSYCHIAT, V61, P1135, DOI 10.1016/j.biopsych.2006.07.038; Bodden ME, 2010, MOVEMENT DISORD, V25, P13, DOI 10.1002/mds.22818; Bosacki S, 1999, SOC DEV, V8, P237, DOI 10.1111/1467-9507.00093; Brune M, 2006, NEUROSCI BIOBEHAV R, V30, P437, DOI 10.1016/j.neubiorev.2005.08.001; Brunet-Gouet E, 2006, PSYCHIAT RES-NEUROIM, V148, P75, DOI 10.1016/j.pscychresns.2006.05.001; Calati R, 2011, J PSYCHIATR RES, V45, P309, DOI 10.1016/j.jpsychires.2010.07.004; Chen JY, 2012, NEUROIMAGE, V61, P866, DOI 10.1016/j.neuroimage.2012.03.022; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cleves M., 1999, STAT TECH B, V48, P34; Drury VM, 1998, PSYCHOL MED, V28, P1101, DOI 10.1017/S0033291798006850; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Handoko HY, 2005, MOL PSYCHIATR, V10, P589, DOI 10.1038/sj.mp.4001606; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Hughes C, 1999, PSYCHOL SCI, V10, P429, DOI 10.1111/1467-9280.00181; Jolliffe T, 1999, J AUTISM DEV DISORD, V29, P395, DOI 10.1023/A:1023082928366; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Lackner C, 2012, DEVELOPMENTAL SCI, V15, P272, DOI 10.1111/j.1467-7687.2011.01124.x; Lackner CL, 2010, NEUROPSYCHOLOGIA, V48, P1767, DOI 10.1016/j.neuropsychologia.2010.02.027; Li T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022923; Nieratschker V, 2010, SCHIZOPHR RES, V122, P24, DOI 10.1016/j.schres.2010.06.018; Nyden A, 2011, RES AUTISM SPECT DIS, V5, P191, DOI 10.1016/j.rasd.2010.03.010; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Popolo M, 2004, DEV NEUROSCI-BASEL, V26, P229, DOI 10.1159/000082140; Sarfati Y, 1997, Cogn Neuropsychiatry, V2, P1, DOI 10.1080/135468097396388; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2002, NEUROCASE, V8, P245; Shamay-Tsoory SG, 2006, SOC NEUROSCI-UK, V1, P149, DOI 10.1080/17470910600985589; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Trivers RL., 1972, SEXUAL SELECTION DES; Wellman H. M, 1990, CHILDS THEORY MIND; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	38	18	19	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49768	10.1371/journal.pone.0049768	http://dx.doi.org/10.1371/journal.pone.0049768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209597	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800022
J	Chowdhury, RR; Aachoui, Y; Ghosh, SK				Chowdhury, Roshni Roy; Aachoui, Youssef; Ghosh, Swapan K.			Effects of Small Intestinal Submucosa (SIS) on the Murine Innate Immune Microenvironment Induced by Heat-Killed Staphylococcus aureus	PLOS ONE			English	Article							XENOGENEIC EXTRACELLULAR-MATRIX; COLONY-STIMULATING FACTOR; INFLAMMASOME ACTIVATION; TISSUE-RESPONSE; IN-VIVO; GRAFT; EXPRESSION; GROWTH; IL-1-BETA; EFFICACY	The use of biological scaffold materials for wound healing and tissue remodeling has profoundly impacted regenerative medicine and tissue engineering. The porcine-derived small intestinal submucosa (SIS) is a licensed bioscaffold material regularly used in wound and tissue repair, often in contaminated surgical fields. Complications and failures due to infection of this biomaterial have therefore been a major concern and challenge. SIS can be colonized and infected by wound-associated bacteria, particularly Staphylococcus aureus. In order to address this concern and develop novel intervention strategies, the immune microenvironment orchestrated by the combined action of S. aureus and SIS should be critically evaluated. Since the outcome of tissue remodeling is largely controlled by the local immune microenvironment, we assessed the innate immune profile in terms of cytokine/chemokine microenvironment and inflammasome-responsive genes. BALB/c mice were injected intra-peritoneally with heat-killed S. aureus in the presence or absence of SIS. Analyses of cytokines, chemokines and microarray profiling of inflammasome-related genes were done using peritoneal lavages collected 24 hours after injection. Results showed that unlike SIS, the S. aureus-SIS interactome was characterized by a Th1-biased immune profile with increased expressions of IFN-gamma, IL-12 and decreased expressions of IL-4, IL-13, IL-33 and IL-6. Such modulation of the Th1/Th2 axis can greatly facilitate graft rejections. The S. aureus-SIS exposure also augmented the expressions of pro-inflammatory cytokines like IL-1 beta, Tnf-alpha, CD30L, Eotaxin and Fractalkine. This heightened inflammatory response caused by S. aureus contamination could enormously affect the biocompatibility of SIS. However, the mRNA expressions of many inflammasome-related genes like Nlrp3, Aim2, Card6 and Pycard were down-regulated by heat-killed S. aureus with or without SIS. In summary, our study explored the innate immune microenvironment induced by the combined exposure of SIS and S. aureus. These results have practical implications in developing strategies to contain infection and promote successful tissue repair.	[Chowdhury, Roshni Roy; Aachoui, Youssef; Ghosh, Swapan K.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA	Indiana State University	Chowdhury, RR (corresponding author), Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA.	rroychowdhu@sycamores.indstate.edu; y_aachoui@yahoo.fr; Swapan.Ghosh@indstate.edu		Roy Chowdhury, Roshni/0000-0002-1561-1133; Roy Chowdhury, Roshni/0000-0002-7350-095X	Cook Biotech; Fraternal Order of Eagles Grant; School of graduate and professional studies, Indiana state university	Cook Biotech; Fraternal Order of Eagles Grant; School of graduate and professional studies, Indiana state university	The work was initiated under the sponsorship of Cook Biotech, the Fraternal Order of Eagles Grant, and the School of graduate and professional studies, Indiana state university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aachoui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027083; Aachoui Y, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-61; Ahn HH, 2007, INT J BIOL MACROMOL, V41, P590, DOI 10.1016/j.ijbiomac.2007.07.019; Allman AJ, 2002, TISSUE ENG, V8, P53, DOI 10.1089/107632702753503054; Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024; Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349; Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bates BL, 2008, BIOFILM INHIBITING M; Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028; Bellows CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021228; Blazar BR, 2004, J IMMUNOL, V173, P2933, DOI 10.4049/jimmunol.173.5.2933; Braff MH, 2005, J INVEST DERMATOL, V125, P9, DOI 10.1111/j.0022-202X.2004.23587.x; Budde K, 1994, Transpl Int, V7 Suppl 1, pS97; Carbonell AM, 2005, SURG ENDOSC, V19, P430, DOI 10.1007/s00464-004-8810-4; Champagne BJ, 2006, DIS COLON RECTUM, V49, P1817, DOI 10.1007/s10350-006-0755-3; Cimini M, 2005, J BIOMED MATER RES A, V75A, P895, DOI 10.1002/jbm.a.30493; Crapo PM, 2010, ACTA BIOMATER, V6, P2091, DOI 10.1016/j.actbio.2009.10.048; de la Fuente SG, 2003, J GASTROINTEST SURG, V7, P96, DOI 10.1016/S1091-255X(02)00050-1; DIPIETRO LA, 1995, AM J PATHOL, V146, P868; Dodge IL, 2003, J IMMUNOL, V170, P4457, DOI 10.4049/jimmunol.170.9.4457; DONAHUE RE, 1988, SCIENCE, V241, P1820, DOI 10.1126/science.3051378; Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720; Faustin B, 2008, TRENDS CELL BIOL, V18, P4, DOI 10.1016/j.tcb.2007.10.004; Fluit AC, 2001, EUR J CLIN MICROBIOL, V20, P188, DOI 10.1007/s10096-001-8078-8; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; GRAHAM MF, 1988, GASTROENTEROLOGY, V94, P257, DOI 10.1016/0016-5085(88)90411-8; Graves DT, 2001, J IMMUNOL, V167, P5316, DOI 10.4049/jimmunol.167.9.5316; Harth KC, 2009, SURG INNOV, V16, P324, DOI 10.1177/1553350609353609; Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209; Hodde JP, 2007, AM J CLIN DERMATOL, V8, P61, DOI 10.2165/00128071-200708020-00001; HOLDERBAUM D, 1986, INFECT IMMUN, V54, P359, DOI 10.1128/IAI.54.2.359-364.1986; Holtfreter S, 2010, INT J MED MICROBIOL, V300, P176, DOI 10.1016/j.ijmm.2009.10.002; Hutter G, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-29; Hultgren OH, 2001, ARTHRITIS RES, V3, P41, DOI 10.1186/ar138; Hume EBH, 2006, INVEST OPHTH VIS SCI, V47, P4926, DOI 10.1167/iovs.06-0340; Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014; Knoll LD, 2007, J UROLOGY, V178, P2474, DOI 10.1016/j.juro.2007.08.044; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188; LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Liaskou E, 2012, HEPATOLOGY; Loh SA, 2009, PLAST RECONSTR SURG, V123, p65S, DOI 10.1097/PRS.0b013e318191bdf4; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; McGrory K, 2004, BIOCHEM BIOPH RES CO, V324, P317, DOI 10.1016/j.bbrc.2004.09.056; McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Murdoch C, 2000, BLOOD, V95, P3032; Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3; Nikolic B, 2000, J CLIN INVEST, V105, P1289, DOI 10.1172/JCI7894; Perl TM, 2003, SURGERY, V134, pS10, DOI 10.1016/S0039-6060(03)00391-X; Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2; REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L; Robertson CM, 2008, J SURG RES, V150, P278, DOI 10.1016/j.jss.2008.02.009; Sakata N, 2001, BONE MARROW TRANSPL, V27, P1153, DOI 10.1038/sj.bmt.1703060; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shah BC, 2011, HERNIA, V15, P165, DOI 10.1007/s10029-010-0768-7; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Shin Ok S, 2011, Korean J Hematol, V46, P69, DOI 10.5045/kjh.2011.46.2.69; Suckow MA, 2008, ANTICANCER RES, V28, P2529; Suckow MA, 2007, CANCER IMMUNOL IMMUN, V56, P1275, DOI 10.1007/s00262-006-0278-8; Szeto CC, 2007, CLIN J AM SOC NEPHRO, V2, P245, DOI 10.2215/CJN.03180906; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Ueha S, 2007, J LEUKOCYTE BIOL, V81, P176, DOI 10.1189/jlb.0306231; Ueno T, 2007, J GASTROINTEST SURG, V11, P918, DOI 10.1007/s11605-007-0171-6; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; van den Brink MRM, 2000, TRANSPLANTATION, V70, P184; Vegesna V, 1995, J SURG RES, V59, P699, DOI 10.1006/jsre.1995.1226; Verdrengh M, 1998, INFECT IMMUN, V66, P853, DOI 10.1128/IAI.66.2.853-855.1998; VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2; VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P; Wu LC, 1997, J SURG RES, V72, P162, DOI 10.1006/jsre.1997.5178; Xu J, 2003, J IMMUNOL, V171, P938, DOI 10.4049/jimmunol.171.2.938; Zhao DXM, 2002, J IMMUNOL, V169, P1556, DOI 10.4049/jimmunol.169.3.1556; Zhou HY, 2011, ANN SURG, V253, P1033, DOI 10.1097/SLA.0b013e31821260f3	81	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e48724	10.1371/journal.pone.0048724	http://dx.doi.org/10.1371/journal.pone.0048724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189134	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800013
J	Hunyadi, A; Martins, A; Hsieh, TJ; Seres, A; Zupko, I				Hunyadi, Attila; Martins, Ana; Hsieh, Tusty-Jiuan; Seres, Adrienn; Zupko, Istvan			Chlorogenic Acid and Rutin Play a Major Role in the In Vivo Anti-Diabetic Activity of Morus alba Leaf Extract on Type II Diabetic Rats	PLOS ONE			English	Article							HYPOGLYCEMIC ACTIVITY; BLOOD-GLUCOSE; MULBERRY; STREPTOZOTOCIN; FAGOMINE; L.	The leaves of the white mulberry tree (Morus alba L.) are used worldwide in traditional medicine as anti-diabetics. Various constituents of mulberry leaves, such as iminosugars (i.e. 1-deoxynojirimicin), flavonoids and related compounds, polysaccharides, glycopeptides and ecdysteroids, have been reported to exert anti-diabetic activity, but knowledge about their contribution to the overall activity is limited. The objective of the present work was to determine the in vivo antidiabetic activity of an extract of mulberry leaves (MA), and to examine to what extent three major constituents, chlorogenic acid, rutin and isoquercitrin, might contribute to the observed activity. Quantities of the three constituents of interest in the extract were determined by using HPLC-DAD. Activity was determined by using a type II diabetic rat model. After 11 days of per os administration of 250 or 750 mg/kg of MA or the corresponding amounts of each individual compound, a dose dependent decrease of non-fasting blood glucose levels were found for MA, chlorogenic acid and rutin, but not for isoquercitrin. Based on our results, chlorogenic acid and rutin might account for as much as half the observed anti-diabetic activity of MA, hence they can be considered as excellent markers for the quality control of mulberry products.	[Hunyadi, Attila; Martins, Ana] Univ Szeged, Inst Pharmacognosy, Szeged, Hungary; [Hunyadi, Attila] Commiss European Communities, COST Act Chem Biol Nat Prod CM0804, B-1049 Brussels, Belgium; [Martins, Ana] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Parasitol & Microbiol Med, Grp Micobacterias, P-1200 Lisbon, Portugal; [Martins, Ana] Univ Szeged, Fac Med, Dept Med Microbiol & Immunobiol, Szeged, Hungary; [Hsieh, Tusty-Jiuan] Kaohsiung Med Univ, Dept Med Genet, Kaohsiung, Taiwan; [Seres, Adrienn; Zupko, Istvan] Univ Szeged, Dept Pharmacodynam & Biopharm, Szeged, Hungary	Szeged University; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Szeged University; Kaohsiung Medical University; Szeged University	Hunyadi, A (corresponding author), Univ Szeged, Inst Pharmacognosy, Szeged, Hungary.	hunyadi.a@pharm.u-szeged.hu	Zupkó, István/E-3687-2013	Martins, Ana/0000-0002-8541-7440; Hunyadi, Attila/0000-0003-0074-3472; Hsieh, Tusty-Jiuan/0000-0001-5387-6522; Zupko, Istvan/0000-0003-3243-5300	COST Action [CM0804]; Hungarian National Research Fund [OTKA PD75383]; New Hungary Development Plan [TAMOP-4.2.1/B-09/1/KONV-2010-0005]; Baross Gabor Program [MFB-00339/2010]; National Science Council of Taiwan [NSC 982314B037011MY3]; Fundacao para a Ciencia e para a Tecnologia, Portugal [SFRH/BPD/81118/2011]	COST Action(European Cooperation in Science and Technology (COST)); Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New Hungary Development Plan; Baross Gabor Program; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Fundacao para a Ciencia e para a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was carried out within the framework of COST Action CM0804, Chemical Biology with Natural Products. The project was supported by the Hungarian National Research Fund (OTKA PD75383), the New Hungary Development Plan (TAMOP-4.2.1/B-09/1/KONV-2010-0005), the Baross Gabor Program (MFB-00339/2010) and by the grant from the National Science Council of Taiwan (NSC 982314B037011MY3). AM was supported by the Fundacao para a Ciencia e para a Tecnologia, Portugal, with the grant SFRH/BPD/81118/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amezqueta S, 2012, ANAL BIOANAL CHEM, V402, P1953, DOI 10.1007/s00216-011-5639-2; Andallu B, 2001, CLIN CHIM ACTA, V314, P47, DOI 10.1016/S0009-8981(01)00632-5; Andrade-Cetto A, 2001, J ETHNOPHARMACOL, V78, P145, DOI 10.1016/S0378-8741(01)00335-X; Asano N, 2001, J AGR FOOD CHEM, V49, P4208, DOI 10.1021/jf010567e; ASANO N, 1994, CARBOHYD RES, V259, P243, DOI 10.1016/0008-6215(94)84060-1; BASNET P, 1993, CHEM PHARM BULL, V41, P1238, DOI 10.1248/cpb.41.1238; CHEN FJ, 1995, YAKUGAKU ZASSHI, V115, P476, DOI 10.1248/yakushi1947.115.6_476; HIKINO H, 1985, PLANTA MED, V51, P159, DOI 10.1055/s-2007-969435; Hunyadi A, 2010, PLANTA MED, V76, P1217; Hunyadi A, 2013, PHYTOTHER RES, V27, P847, DOI 10.1002/ptr.4803; Kamalakkannan N, 2006, BASIC CLIN PHARMACOL, V98, P97, DOI 10.1111/j.1742-7843.2006.pto_241.x; Kim ES, 1999, ARCH PHARM RES, V22, P9, DOI 10.1007/BF02976428; Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g; Lafont R, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.7; Lemus I, 1999, PHYTOTHER RES, V13, P91, DOI 10.1002/(SICI)1099-1573(199903)13:2&lt;91::AID-PTR350&gt;3.0.CO;2-8; Miyahara C, 2004, J NUTR SCI VITAMINOL, V50, P161, DOI 10.3177/jnsv.50.161; Mudra M, 2007, DIABETES CARE, V30, P1272, DOI 10.2337/dc06-2120; Murata K, 2003, FOCUS ALTERNAT COMPL, V8, P4524; PORTHA B, 1974, DIABETES, V23, P889, DOI 10.2337/diab.23.11.889; Qaseem A, 2012, ANN INTERN MED, V157, P76, DOI 10.7326/0003-4819-157-1-201207030-00019; Qingyi M, 2006, SHIPIN KEXUE BEIJING, V27, P108; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Singa ANB, 2005, J ETHNOPHARMACOL, V100, P333, DOI 10.1016/j.jep.2005.03.013; Spiegl G, 2009, CLIN EXP PHARMACOL P, V36, P884, DOI 10.1111/j.1440-1681.2009.05162.x; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Takemoto T, 1967, YAKUGAKU ZASSHI, V87, P748; Taniguchi S, 1998, HORM METAB RES, V30, P679, DOI 10.1055/s-2007-978957; Vichasilp C, 2012, LWT-FOOD SCI TECHNOL, V45, P226, DOI 10.1016/j.lwt.2011.09.008; Vogel HG, 2002, DRUG DISCOVERY EVALU; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; YAGI M, 1976, J AGR CHEM SOC JPN, V50, P571, DOI 10.1271/nogeikagaku1924.50.11_571	31	128	140	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50619	10.1371/journal.pone.0050619	http://dx.doi.org/10.1371/journal.pone.0050619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185641	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000251
J	Lemos, C; Alonso, I; Barros, J; Sequeiros, J; Pereira-Monteiro, J; Mendonca, D; Sousa, A				Lemos, Carolina; Alonso, Isabel; Barros, Jose; Sequeiros, Jorge; Pereira-Monteiro, Jose; Mendonca, Denisa; Sousa, Alda			Assessing Risk Factors for Migraine: Differences in Gender Transmission	PLOS ONE			English	Article							SEX-DIFFERENCES; SUSCEPTIBILITY; PREVALENCE; INVOLVEMENT; POPULATION; HEADACHE; GENETICS; GENES; RATIO; AURA	Aim: Our aim was to assess which specific factors are contributing to an increased risk of migraine in a group of 131 Portuguese families. Methods: We studied 319 first-degree relatives, using a multilevel approach to account for the dependency among members from the same family. We included in the model relative's gender, the proband's gender and age-at-onset, to evaluate if any of these variables were associated with relative's affection status. We also included in the model proband's migraine subtype. We further assessed female and male transmissions within the proband nuclear family. Results: Relatives' gender was found to be a risk factor for migraine (Odds Ratio = 2.86; 95% CI = 1.75-4.67), with females at a higher risk. When splitting probands according to their migraine subtype, we found that none of the variables studied contributed to relatives of MA-probands affection-status. Our results also show a significant difference between proband's transmission and the gender of the parents and offspring. Conclusions: With this study, we showed that gender is truly a risk factor for migraine and that a gender-biased transmission is also observed. This reinforce the importance of identifying genes associated with migraine that are modulated by genes located in the sex chromosomes and the study of mitochondrial DNA or X-chromosome and hormonal-related effects associated with migraine susceptibility.	[Lemos, Carolina; Alonso, Isabel; Sequeiros, Jorge; Pereira-Monteiro, Jose; Sousa, Alda] Univ Porto, Inst Biol Mol Celular, UnIGENe, P-4100 Oporto, Portugal; [Lemos, Carolina; Alonso, Isabel; Sequeiros, Jorge; Pereira-Monteiro, Jose; Mendonca, Denisa; Sousa, Alda] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal; [Barros, Jose; Pereira-Monteiro, Jose] Hosp Santo Antonio, Ctr Hosp Porto, Serv Neurol, Oporto, Portugal; [Mendonca, Denisa] Univ Porto, Inst Saude Publ, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Lemos, C (corresponding author), Univ Porto, Inst Biol Mol Celular, UnIGENe, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	clclemos@ibmc.up.pt	Lemos, Carolina/J-4967-2013; Alonso, Isabel/I-4307-2013; Mendonça, Denisa Maria Melo Vasques/K-5561-2014; Pereira-Monteiro, José/K-6036-2013; Sousa, Alda/K-4372-2013	Lemos, Carolina/0000-0001-9803-9584; Alonso, Isabel/0000-0001-8549-6903; Mendonça, Denisa Maria Melo Vasques/0000-0003-4835-8944; Sousa, Alda/0000-0001-5441-1815; Barros, Jose/0000-0001-6183-5050; Pereira-Monteiro, Jose/0000-0001-8846-0754; Sequeiros, Jorge/0000-0002-9846-1037	Fundacao para a Ciencia e Tecnologia, FCT [POCTI-034390/99/FCT]; Sociedade Portuguesa de Cefaleias; FCT fellowship [SFRH/BD/17761/2004]	Fundacao para a Ciencia e Tecnologia, FCT(Portuguese Foundation for Science and Technology); Sociedade Portuguesa de Cefaleias; FCT fellowship(Portuguese Foundation for Science and Technology)	This study was supported by grants of Fundacao para a Ciencia e Tecnologia, FCT (POCTI-034390/99/FCT) and Sociedade Portuguesa de Cefaleias. CL was the recipient of a FCT fellowship (SFRH/BD/17761/2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aloisi AM, 2003, CLIN J PAIN, V19, P168, DOI 10.1097/00002508-200305000-00004; Anttila V, 2006, AM J HUM GENET, V79, P85, DOI 10.1086/504814; Anttila V, 2008, AM J HUM GENET, V82, P1051, DOI 10.1016/j.ajhg.2008.03.003; Boles RG, 2008, CEPHALALGIA, V28, P1001, DOI 10.1111/j.1468-2982.2008.01665_1.x; Colson NJ, 2005, NEUROGENETICS, V6, P17, DOI 10.1007/s10048-004-0205-0; Colson NJ, 2004, NEUROGENETICS, V5, P129, DOI 10.1007/s10048-004-0181-4; Cucurachi L, 2006, NEUROL SCI, V27, P47, DOI 10.1007/s10072-006-0564-4; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; KIDD KK, 1976, J MED GENET, V13, P290, DOI 10.1136/jmg.13.4.290; Launer LJ, 1999, NEUROLOGY, V53, P537, DOI 10.1212/WNL.53.3.537; Lemos C, 2010, ARCH NEUROL-CHICAGO, V67, P422, DOI 10.1001/archneurol.2010.37; Lemos C, 2009, HEADACHE, V49, P404, DOI 10.1111/j.1526-4610.2008.01177.x; Low NCP, 2007, CEPHALALGIA, V27, P935, DOI 10.1111/j.1468-2982.2007.01378.x; Montagna P, 2000, CEPHALALGIA, V20, P3, DOI 10.1046/j.1468-2982.2000.00003.x; Nyholt DR, 2000, HUM GENET, V107, P18; Nyholt DR, 1998, HUM MOL GENET, V7, P459, DOI 10.1093/hmg/7.3.459; Oterino A, 2008, HEADACHE, V48, P1438, DOI 10.1111/j.1526-4610.2008.01294.x; Radtke A, 2009, HEADACHE, V49, P79, DOI 10.1111/j.1526-4610.2008.01263.x; Rannala B, 2001, Am J Pharmacogenomics, V1, P203, DOI 10.2165/00129785-200101030-00005; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; Russell MB, 1996, CEPHALALGIA, V16, P305, DOI 10.1046/j.1468-2982.1996.1605305.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x; Stewart WF, 2006, NEUROLOGY, V66, P344, DOI 10.1212/01.wnl.0000196640.71600.00; Tellez-Zenteno Jose F, 2005, J Headache Pain, V6, P128, DOI 10.1007/s10194-005-0167-0; Terwindt GM, 2000, NEUROLOGY, V55, P624, DOI 10.1212/WNL.55.5.624; Wang XP, 2008, MED HYPOTHESES, V71, P14, DOI 10.1016/j.mehy.2007.12.015; Wessman M, 2007, LANCET NEUROL, V6, P521, DOI 10.1016/S1474-4422(07)70126-6	29	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50626	10.1371/journal.pone.0050626	http://dx.doi.org/10.1371/journal.pone.0050626			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185642	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000252
J	Lock, FE; McDonald, PC; Lou, Y; Serrano, I; Chafe, SC; Ostlund, C; Aparicio, S; Winum, JY; Supuran, CT; Dedhar, S				Lock, F. E.; McDonald, P. C.; Lou, Y.; Serrano, I.; Chafe, S. C.; Ostlund, C.; Aparicio, S.; Winum, J-Y; Supuran, C. T.; Dedhar, S.			Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche	ONCOGENE			English	Article						CAIX; cancer stem cell; breast cancer; hypoxia; EMT; mTOR	EPITHELIAL-MESENCHYMAL-TRANSITION; TUMOR-INITIATING CELLS; MAMMALIAN TARGET; METASTASIS; EXPRESSION; IDENTIFICATION; PROLIFERATION; INHIBITORS; RAPAMYCIN; OXYGEN	The sub-population of tumor cells termed 'cancer stem cells' (CSCs) possess the capability to generate tumors, undergo epithelial-mesenchymal transition (EMT) and are implicated in metastasis, making treatments to specifically target CSCs an attractive therapeutic strategy. Tumor hypoxia plays a key role in regulating EMT and cancer stem cell function. Carbonic anhydrase IX (CAIX) is a hypoxia-inducible protein that regulates cellular pH to promote cancer cell survival and invasion in hypoxic microenvironments and is a biomarker of poor prognosis for breast cancer metastasis and survival. Here, we demonstrate that inhibition of CAIX expression or activity with novel small-molecule inhibitors in breast cancer cell lines, or in primary metastatic breast cancer cells, results in the inhibition of breast CSC expansion in hypoxia. We identify the mTORC1 axis as a critical pathway downstream of CAIX in the regulation of cancer stem cell function. CAIX is also required for expression of EMT markers and regulators, as well as drivers of 'stemness', such as Notch1 and Jagged1 in isolated CSCs. In addition, treatment of mice bearing orthotopic breast tumors with CAIX-specific small-molecule inhibitors results in significant depletion of CSCs within these tumors. Furthermore, combination treatment with paclitaxel results in enhanced tumor growth delay and eradication of lung metastases. These data demonstrate that CAIX is a critical mediator of the expansion of breast CSCs in hypoxic niches by sustaining the mesenchymal and 'stemness' phenotypes of these cells, making CAIX an important therapeutic target for selectively depleting breast CSCs.	[Lock, F. E.; McDonald, P. C.; Lou, Y.; Serrano, I.; Chafe, S. C.; Ostlund, C.; Dedhar, S.] BC Canc Res Ctr, Dept Integrat Oncol, Vancouver, BC V5Z 1L3, Canada; [Aparicio, S.] BC Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Winum, J-Y] Univ Montpellier 1 & 2, Ecole Natl Super Chim Montpellier, Inst Biomol Max Mousseron, UMR CNRS 5247, Montpellier, France; [Supuran, C. T.] Univ Florence, Dept Lab Chim Bioinorgan, Florence, Italy; [Dedhar, S.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; University of Florence; University of British Columbia	Dedhar, S (corresponding author), BC Canc Res Ctr, Dept Integrat Oncol, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.	sdedhar@bccrc.ca	WINUM, Jean-Yves/AAC-9578-2019; WINUM, Jean-Yves/P-3387-2016	WINUM, Jean-Yves/0000-0003-3197-3414; WINUM, Jean-Yves/0000-0003-3197-3414; Dedhar, Shoukat/0000-0003-4355-1657; Aparicio, Samuel/0000-0002-0487-9599; Supuran, Claudiu/0000-0003-4262-0323	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) to SD.	Abraham BK, 2005, CLIN CANCER RES, V11, P1154; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Balgi AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021549; Barnes EA, 2010, AM J PATHOL, V177, P1765, DOI 10.2353/ajpath.2010.090233; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Chaudary N, 2007, CLIN CANCER RES, V13, P1947, DOI 10.1158/1078-0432.CCR-06-2971; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hartwell KA, 2006, P NATL ACAD SCI USA, V103, P18969, DOI 10.1073/pnas.0608636103; Horree N, 2007, HUM PATHOL, V38, P1232, DOI 10.1016/j.humpath.2007.01.008; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Joo KM, 2012, CANCER RES, V72, P3828, DOI 10.1158/0008-5472.CAN-11-3760; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Knaup KX, 2009, MOL CANCER RES, V7, P88, DOI 10.1158/1541-7786.MCR-08-0288; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lefkovits I, 1999, LIMITING DILUTION AN, pxvi; Liao ND, 2011, CANCER CYTOPATHOL, V119, P346, DOI 10.1002/cncy.20153; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou YM, 2011, CANCER RES, V71, P3364, DOI 10.1158/0008-5472.CAN-10-4261; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Martinez-Moragon E, 1998, RESPIRATION, V65, P108, DOI 10.1159/000029240; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Oloumi A, 2000, CANCER RES, V60, P5747; Pacchiano F, 2011, J MED CHEM, V54, P1896, DOI 10.1021/jm101541x; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reuben JM, 2011, EUR J CANCER, V47, P1527, DOI 10.1016/j.ejca.2011.01.011; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rota LM, 2012, J MAMMARY GLAND BIOL, V17, P119, DOI 10.1007/s10911-012-9258-0; Russell RC, 2011, DEVELOPMENT, V138, P3343, DOI 10.1242/dev.058230; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Shorning BY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016209; Singh SK, 2003, CANCER RES, V63, P5821; Smith KM, 2010, EMBO MOL MED, V2, P371, DOI 10.1002/emmm.201000093; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svastova E, 2003, EXP CELL RES, V290, P332, DOI 10.1016/S0014-4827(03)00351-3; Swietach P, 2010, ONCOGENE, V29, P6509, DOI 10.1038/onc.2010.455; Touisni N, 2011, J MED CHEM, V54, P8271, DOI 10.1021/jm200983e; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Turner FE, 2006, J BIOL CHEM, V281, P21321, DOI 10.1074/jbc.M509731200; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122	60	242	247	4	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 31	2013	32	44					5210	5219		10.1038/onc.2012.550	http://dx.doi.org/10.1038/onc.2012.550			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	245XH	23208505				2022-12-25	WOS:000326497100004
J	Rosano, L; Cianfrocca, R; Tocci, P; Spinella, F; Di Castro, V; Spadaro, F; Salvati, E; Biroccio, AM; Natali, PG; Bagnato, A				Rosano, L.; Cianfrocca, R.; Tocci, P.; Spinella, F.; Di Castro, V.; Spadaro, F.; Salvati, E.; Biroccio, A. M.; Natali, P. G.; Bagnato, A.			beta-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced beta-catenin signaling	ONCOGENE			English	Article						beta-arrestin; beta-catenin; endothelin A receptor; ovarian carcinoma; chromatin remodeling	EXPORT SIGNAL; ARRESTIN; ACTIVATION; RECEPTOR; GROWTH; AXIS; PROLIFERATION; LOCALIZATION; TRANSITIONS; EXPRESSION	Despite the fundamental pathophysiological importance of beta-catenin in tumor progression, the mechanism underlying its final transcriptional output has been partially elucidated. Here, we report that beta-arrestin-1 (beta-arr1) is an epigenetic regulator of endothelin (ET)-1-induced beta-catenin signaling in epithelial ovarian cancer (EOC). In response to ET A receptor (ETAR) activation by ET-1, beta-arr1 increases its nuclear translocation and direct binding to beta-catenin. This in turn enhanced beta-catenin nuclear accumulation and transcriptional activity, which was prevented by expressing a mutant beta-arr1 incapable of nuclear distribution. beta-arr1-beta-catenin interaction controls beta-catenin target gene expressions, such as ET-1, Axin 2, Matrix metalloproteinase 2, and Cyclin D1, by promoting histone deacetylase 1 (HDAC1) dissociation and the recruitment of p300 acetyltransferase on these promoter genes, resulting in enhanced H3 and H4 histone acetylation, and gene transcription, required for cell migration, invasion and epithelial-to-mesenchymal transition. These effects are abrogated by beta-arr1 silencing or by mutant beta-arr1, as well as by beta-catenin or p300 silencing, confirming that nuclear beta-arr1 forms a functional complex capable of regulating epigenetic changes in beta-catenin-driven invasive behavior. In a murine orthotopic model of metastatic human EOC, silencing of beta-arr1 or mutant beta-arr1 expression, as well as ETAR blockade, inhibits metastasis. In human EOC tissues, beta-arr1-beta-catenin nuclear complexes are selectively enriched at beta-catenin target gene promoters, correlating with tumor grade, confirming a direct in vivo beta-arr1-beta-catenin association at specific set of genes involved in EOC progression. Collectively, our study provides insights into how a beta-arr1-mediated epigenetic mechanism controls beta-catenin activity, unraveling new components required for its nuclear function in promoting metastasis.	[Rosano, L.; Cianfrocca, R.; Tocci, P.; Spinella, F.; Di Castro, V.; Natali, P. G.; Bagnato, A.] Regina Elena Inst Canc Res, Lab Mol Pathol, I-00158 Rome, Italy; [Spadaro, F.] Ist Super Sanita, Dept Haematol Oncol & Mol Med, Sect Expt Immunotherapy, I-00161 Rome, Italy; [Salvati, E.; Biroccio, A. M.] Regina Elena Inst Canc Res, Lab Expt Chemotherapy, I-00158 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Rosano, L (corresponding author), Regina Elena Inst Canc Res, Lab Mol Pathol, Via Messi DOro 156, I-00158 Rome, Italy.	rosano@ifo.it; bagnato@ifo.it	ROSANO', Laura/AAK-1424-2020; spinella, francesca/AAZ-8982-2020; Biroccio, Annamaria/B-2861-2018; Tocci, Piera/AAX-9815-2021; Di Castro, Valeriana/H-8873-2017; Spadaro, Francesca/M-7512-2017; Rosanò, Laura/AAB-7821-2019; Rosanò, Laura/B-2863-2018; Tocci, Piera/ABH-7630-2020; Bagnato, Anna/G-9747-2016	ROSANO', Laura/0000-0002-9962-6411; Biroccio, Annamaria/0000-0003-3198-3532; Tocci, Piera/0000-0003-3771-013X; Di Castro, Valeriana/0000-0002-1899-3683; Spadaro, Francesca/0000-0002-6610-350X; Rosanò, Laura/0000-0002-3981-8593; Rosanò, Laura/0000-0002-9962-6411; Bagnato, Anna/0000-0002-7269-9522; Salvati, Erica/0000-0002-3373-7442	Associazione Italiana Ricerca sul Cancro	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We gratefully acknowledge Valentina Caprara and Aldo Lupo for excellent technical assistance, Maria Vincenza Sarcone for secretarial assistance, Dr Maurizio Fanciulli for valuable comments, Dr Robert Lefkowitz (Howard Hughes Medical Institute, Duke University) for his insightful comments and for kindly providing beta-arr1 expression vector; Dr Zhuohua Zhang (University of California San Diego School of Medicine, La Jolla, CA, USA) for ET-1 promoter reporter and its mutant control, and Dr Tania Merlino for the formal revision of the manuscript. This work was supported by the grant funded by the Associazione Italiana Ricerca sul Cancro.	Ahn S, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M808463200; Bagnato A, 2011, BRIT J PHARMACOL, V163, P220, DOI 10.1111/j.1476-5381.2011.01217.x; Bagnato A, 2008, INT J BIOCHEM CELL B, V40, P1443, DOI 10.1016/j.biocel.2008.01.022; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Bonnans C, 2012, P NATL ACAD SCI USA, V109, P3047, DOI 10.1073/pnas.1109457109; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Cianfrocca R, 2010, CAN J PHYSIOL PHARM, V88, P796, DOI 10.1139/Y10-052; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; Hoeppner CZ, 2012, J BIOL CHEM, V287, P8932, DOI 10.1074/jbc.M111.294058; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kim TH, 2005, ONCOGENE, V24, P597, DOI 10.1038/sj.onc.1208237; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Parathath SR, 2010, CELL CYCLE, V9, P4013, DOI 10.4161/cc.9.19.13325; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rosano L, 2006, MOL CANCER THER, V5, P833, DOI 10.1158/1535-7163.MCT-05-0523; Rosano L, 2005, CANCER RES, V65, P11649, DOI 10.1158/0008-5472.CAN-05-2123; Rosano L, 2001, CANCER RES, V61, P8340; Rosano L, 2011, CLIN CANCER RES, V17, P2350, DOI 10.1158/1078-0432.CCR-10-2325; Rosano L, 2009, CELL CYCLE, V8, P1462; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shenoy SK, 2012, ONCOGENE, V31, P282, DOI 10.1038/onc.2011.238; Shenoy Sudha K, 2005, Sci STKE, V2005, pcm10, DOI 10.1126/stke.2005/308/cm10; Shi YF, 2007, NAT IMMUNOL, V8, P817, DOI 10.1038/ni1489; Sun P, 2006, MOL PHARMACOL, V69, P520, DOI 10.1124/mol.105.019620; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; Yue R, 2009, CELL, V139, P535, DOI 10.1016/j.cell.2009.08.038	45	68	68	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2013	32	42					5066	5077		10.1038/onc.2012.527	http://dx.doi.org/10.1038/onc.2012.527			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	238IB	23208497				2022-12-25	WOS:000325937900008
J	Suzuki, K; Harada, N; Yamane, S; Nakamura, Y; Sasaki, K; Nasteska, D; Joo, E; Shibue, K; Harada, T; Hamasaki, A; Toyoda, K; Nagashima, K; Inagaki, N				Suzuki, Kazuyo; Harada, Norio; Yamane, Shunsuke; Nakamura, Yasuhiko; Sasaki, Kazuki; Nasteska, Daniela; Joo, Erina; Shibue, Kimitaka; Harada, Takanari; Hamasaki, Akihiro; Toyoda, Kentaro; Nagashima, Kazuaki; Inagaki, Nobuya			Transcriptional Regulatory Factor X6 (Rfx6) Increases Gastric Inhibitory Polypeptide (GIP) Expression in Enteroendocrine K-cells and Is Involved in GIP Hypersecretion in High Fat Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT-INSULINOTROPIC POLYPEPTIDE; BINDING-PROTEIN; GLUCOSE; ENDOCRINE; RECEPTOR; CARBOHYDRATE; HYPERPLASIA; METABOLISM; DEFECT; GLP-1	Gastric inhibitory polypeptide (GIP) is an incretin released from enteroendocrine K-cells in response to nutrient ingestion. GIP potentiates glucose-stimulated insulin secretion and induces energy accumulation into adipose tissue, resulting in obesity. Plasma GIP levels are reported to be increased in the obese state. However, the molecular mechanisms of GIP secretion and high fat diet (HFD)-induced GIP hypersecretion remain unclear, primarily due to difficulties in separating K-cells from other intestinal epithelial cells in vivo. In this study, GIP-GFP knock-in mice that enable us to visualize K-cells by enhanced GFP were established. Microarray analysis of isolated K-cells from these mice revealed that transcriptional regulatory factor X6 (Rfx6) is expressed exclusively in K-cells. In vitro experiments using the mouse intestinal cell line STC-1 showed that knockdown of Rfx6 decreased mRNA expression, cellular content, and secretion of GIP. Rfx6 bound to the region in the gip promoter that regulates gip promoter activity, and overexpression of Rfx6 increased GIP mRNA expression. HFD induced obesity and GIP hypersecretion in GIP-GFP heterozygous mice in vivo. Immunohistochemical and flow cytometry analysis showed no significant difference in K-cell number between control fat diet-fed (CFD) and HFD-fed mice. However, GIP content in the upper small intestine and GIP mRNA expression in K-cells were significantly increased in HFD-fed mice compared with those in CFD-fed mice. Furthermore, expression levels of Rfx6 mRNA were increased in K-cells of HFD-fed mice. These results suggest that Rfx6 increases GIP expression and content in K-cells and is involved in GIP hypersecretion in HFD-induced obesity.	[Suzuki, Kazuyo; Harada, Norio; Yamane, Shunsuke; Nakamura, Yasuhiko; Sasaki, Kazuki; Nasteska, Daniela; Joo, Erina; Shibue, Kimitaka; Harada, Takanari; Hamasaki, Akihiro; Toyoda, Kentaro; Nagashima, Kazuaki; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Inagaki, N (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet & Clin Nutr, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	inagaki@metab.kuhp.kyoto-u.ac.jp		Nasteska, Daniela/0000-0002-8996-5102; Inagaki, Nobuya/0000-0001-8261-2593; Suzuki, Kazuyo/0000-0001-5716-5242; HARADA, NORIO/0000-0001-8720-1013	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research [22590975] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Diabetes Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by scientific research grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, the Ministry of Health, Labor, and Welfare, Japan, and scientific research grants from the Japan Diabetes Foundation.	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Ait-Lounis A, 2010, DIABETES, V59, P1674, DOI 10.2337/db09-0986; BAILEY CJ, 1986, ACTA ENDOCRINOL-COP, V112, P224, DOI 10.1530/acta.0.1120224; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Brown J C, 1975, Recent Prog Horm Res, V31, P487; CREUTZFELDT W, 1978, DIABETOLOGIA, V14, P15, DOI 10.1007/BF00429703; Dockray JH., 1994, GUT PEPTIDES BIOCH P, P217; Drucker DJ, 1998, DIABETES, V47, P159, DOI 10.2337/diabetes.47.2.159; FALKO JM, 1975, J CLIN ENDOCR METAB, V41, P260, DOI 10.1210/jcem-41-2-260; FLATT PR, 1983, DIABETES, V32, P433, DOI 10.2337/diabetes.32.5.433; Fujita Y, 2008, AM J PHYSIOL-ENDOC M, V295, pE648, DOI 10.1152/ajpendo.90440.2008; Gniuli D, 2010, DIABETOLOGIA, V53, P2233, DOI 10.1007/s00125-010-1830-9; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Harada N, 2008, AM J PHYSIOL-ENDOC M, V294, pE61, DOI 10.1152/ajpendo.00358.2007; Harada N, 2011, J DIABETES INVEST, V2, P193, DOI 10.1111/j.2040-1124.2010.00078.x; HAUNER H, 1988, ANN NUTR METAB, V32, P282, DOI 10.1159/000177467; Jepeal LI, 2005, ENDOCRINOLOGY, V146, P383, DOI 10.1210/en.2004-0223; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Katan-Khaykovich Y, 1998, J BIOL CHEM, V273, P24504, DOI 10.1074/jbc.273.38.24504; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Parker HE, 2009, DIABETOLOGIA, V52, P289, DOI 10.1007/s00125-008-1202-x; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; REITH W, 1989, P NATL ACAD SCI USA, V86, P4200, DOI 10.1073/pnas.86.11.4200; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Seino Y, 2010, J DIABETES INVEST, V1, P8, DOI 10.1111/j.2040-1124.2010.00022.x; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Song DH, 2007, GASTROENTEROLOGY, V133, P1796, DOI 10.1053/j.gastro.2007.09.005; Soyer J, 2010, DEVELOPMENT, V137, P203, DOI 10.1242/dev.041673; Tsukiyama K, 2006, MOL ENDOCRINOL, V20, P1644, DOI 10.1210/me.2005-0187; USDIN TB, 1993, ENDOCRINOLOGY, V133, P2861, DOI 10.1210/en.133.6.2861; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Yamane S, 2012, J DIABETES INVEST, V3, P80, DOI 10.1111/j.2040-1124.2011.00143.x; Yoder SM, 2010, AM J PHYSIOL-GASTR L, V299, pG476, DOI 10.1152/ajpgi.00432.2009	38	65	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1929	1938		10.1074/jbc.M112.423137	http://dx.doi.org/10.1074/jbc.M112.423137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192339	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000313751400046
J	DeGrande, ST; Little, SC; Nixon, DJ; Wright, P; Snyder, J; Dun, W; Murphy, N; Kilic, A; Higgins, R; Binkley, PF; Boyden, PA; Carnes, CA; Anderson, ME; Hund, TJ; Mohler, PJ				DeGrande, Sean T.; Little, Sean C.; Nixon, Derek J.; Wright, Patrick; Snyder, Jedidiah; Dun, Wen; Murphy, Nathaniel; Kilic, Ahmet; Higgins, Robert; Binkley, Philip F.; Boyden, Penelope A.; Carnes, Cynthia A.; Anderson, Mark E.; Hund, Thomas J.; Mohler, Peter J.			Molecular Mechanisms Underlying Cardiac Protein Phosphatase 2A Regulation in Heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANNEL RYANODINE RECEPTOR; ANKYRIN-B; FAILURE PROGRESSION; CATALYTIC SUBUNIT; ION-CHANNEL; C-TERMINUS; KINASE-II; CAMKII; PP2A; DYSFUNCTION	Kinase/phosphatase balance governs cardiac excitability in health and disease. Although detailed mechanisms for cardiac kinase regulation are established, far less is known regarding cardiac protein phosphatase 2A (PP2A) regulation. This is largely due to the complexity of the PP2A holoenzyme structure (combinatorial assembly of three subunit enzyme from >17 subunit genes) and the inability to segregate "global" PP2A function from the activities of multiple "local" holoenzyme populations. Here we report that PP2A catalytic, regulatory, and scaffolding subunits are tightly regulated at transcriptional, translational, and post-translational levels to tune myocyte function at base line and in disease. We show that past global read-outs of cellular PP2A activity more appropriately represent the collective activity of numerous individual PP2A holoenzymes, each displaying a specific subcellular localization (dictated by select PP2A regulatory subunits) as well as local specific post-translational catalytic subunit methylation and phosphorylation events that regulate local and rapid holoenzyme assembly/disassembly (via leucine carboxymethyltransferase 1/phosphatase methylesterase 1 (LCMT-1/PME-1). We report that PP2A subunits are selectively regulated between human and animal models, across cardiac chambers, and even within specific cardiac cell types. Moreover, this regulation can be rapidly tuned in response to cellular activation. Finally, we report that global PP2A is altered in human and experimental models of heart disease, yet each pathology displays its own distinct molecular signature though specific PP2A subunit modulatory events. These new data provide an initial view into the signaling pathways that govern PP2A function in heart but also establish the first step in defining specific PP2A regulatory targets in health and disease.	[DeGrande, Sean T.; Little, Sean C.; Nixon, Derek J.; Wright, Patrick; Snyder, Jedidiah; Murphy, Nathaniel; Kilic, Ahmet; Higgins, Robert; Binkley, Philip F.; Carnes, Cynthia A.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA; [DeGrande, Sean T.; Snyder, Jedidiah; Binkley, Philip F.; Hund, Thomas J.; Mohler, Peter J.] Ohio State Univ, Dept Internal Med, Div Cardiovasc Med, Wexner Med Ctr, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Dept Physiol & Cell Biol, Wexner Med Ctr, Columbus, OH 43210 USA; [Kilic, Ahmet; Higgins, Robert] Ohio State Univ, Div Cardiac Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Snyder, Jedidiah; Hund, Thomas J.] Ohio State Univ, Dept Biomed Engn, Coll Engn, Columbus, OH 43210 USA; [Carnes, Cynthia A.] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Cardiovasc Med, Iowa City, IA 52242 USA; [DeGrande, Sean T.; Anderson, Mark E.] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Dun, Wen; Boyden, Penelope A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Iowa; University of Iowa; Columbia University	Mohler, PJ (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Wexner Med Ctr, 473 W 12th Ave, Columbus, OH 43210 USA.	peter.mohler@osumc.edu	Hund, Thomas/C-9222-2012		National Institutes of Health [HL084583, HL083422, HL079031, HL62494, HL70250, HL089836, HL066140, HL096805, HL114893]; Saving Tiny Hearts Society; American Heart Association Established Investigator Award; Gilead Sciences Research Scholars Program; Fondation Leducq Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089836, R01HL062494, R01HL113001, R01HL114893, R01HL096652, R01HL079031, R00HL096805, R01HL084583, R01HL070250, K99HL096805, R01HL066140, R01HL083422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saving Tiny Hearts Society; American Heart Association Established Investigator Award(American Heart Association); Gilead Sciences Research Scholars Program; Fondation Leducq Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL084583 and HL083422 (to P. J. M.), HL079031, HL62494, and HL70250 (to M. E. A.), HL089836 (to C. A. C.), HL066140 (to P. A. B.), and HL096805 and HL114893 (to T. J. H.). This work was also supported in part by a grant from the Saving Tiny Hearts Society (to P. J. M.), an American Heart Association Established Investigator Award (to P. J. M.), the Gilead Sciences Research Scholars Program (to T. J. H.), and the Fondation Leducq Award to the Alliance for Calmodulin Kinase Signaling in Heart Disease (to P. J. M., M. E. A., and T. J. H.).	Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Ai X, 2011, CARDIOVASC RES, V92, P106, DOI 10.1093/cvr/cvr163; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Baba S, 2005, CIRCULATION, V112, P2386, DOI 10.1161/CIRCULATIONAHA.105.534784; Belevych AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028324; Bers DM, 2011, HEART RHYTHM, V8, P1101, DOI 10.1016/j.hrthm.2011.01.030; Bhasin N, 2007, AM J PHYSIOL-HEART C, V293, pH109, DOI 10.1152/ajpheart.00059.2007; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cunha SR, 2008, J BIOL CHEM, V283, P31968, DOI 10.1074/jbc.M806050200; Cunha SR, 2007, J BIOL CHEM, V282, P4875, DOI 10.1074/jbc.M607096200; Cunha SR, 2011, CIRCULATION, V124, P1212, DOI 10.1161/CIRCULATIONAHA.111.023986; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; DeGrande S, 2012, HEART RHYTHM, V9, P2034, DOI 10.1016/j.hrthm.2012.08.026; Deshmukh PA, 2007, AM J PHYSIOL-HEART C, V292, pH792, DOI 10.1152/ajpheart.00225.2006; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Gergs U, 2004, J BIOL CHEM, V279, P40827, DOI 10.1074/jbc.M405770200; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Gupta RC, 2003, AM J PHYSIOL-HEART C, V285, pH2373, DOI 10.1152/ajpheart.00442.2003; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; Hund TJ, 2009, CARDIOVASC RES, V81, P742, DOI 10.1093/cvr/cvn348; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Kashef F, 2012, J BIOL CHEM, V287, P30268, DOI 10.1074/jbc.M112.368415; Kohr MJ, 2009, NITRIC OXIDE-BIOL CH, V20, P217, DOI 10.1016/j.niox.2009.01.003; Lambrecht C., 2012, FEBS J IN PRESS; Le Scouarnec S, 2008, P NATL ACAD SCI USA, V105, P15617, DOI 10.1073/pnas.0805500105; Lehnart SE, 2007, CIRCULATION, V116, P2325, DOI 10.1161/CIRCULATIONAHA.107.711689; Linck B, 1996, BRIT J PHARMACOL, V119, P545, DOI 10.1111/j.1476-5381.1996.tb15706.x; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Luss H, 2000, J MOL CELL CARDIOL, V32, P2349, DOI 10.1006/jmcc.2000.1265; Marshall M, 2009, CARDIOVASC RES, V82, P67, DOI 10.1093/cvr/cvp037; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Mishra S, 2002, J HEART LUNG TRANSPL, V21, P366, DOI 10.1016/S1053-2498(01)00390-4; Miura T, 2009, CIRC J, V73, P1184, DOI 10.1253/circj.CJ-09-0284; Mohler PJ, 2007, CIRCULATION, V115, P432, DOI 10.1161/CIRCULATIONAHA.106.656512; Mohler PJ, 2005, PLOS BIOL, V3, P2158, DOI 10.1371/journal.pbio.0030423; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; NEUMANN J, 1994, J PHARMACOL EXP THER, V271, P535; NEUMANN J, 1993, AM J PHYSIOL, V265, pH257, DOI 10.1152/ajpheart.1993.265.1.H257; NEUMANN J, 1995, J PHARMACOL EXP THER, V274, P530; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Nicolaou P, 2009, FRONT BIOSCI-LANDMRK, V14, P3571, DOI 10.2741/3472; Nishijima Y, 2005, J CARD FAIL, V11, P638, DOI 10.1016/j.cardfail.2005.05.006; PACKER M, 1985, CIRCULATION, V72, P681, DOI 10.1161/01.CIR.72.4.681; Pathak A, 2005, CIRC RES, V96, P756, DOI 10.1161/01.RES.0000161256.85833.fa; Reiken S, 2001, CIRCULATION, V104, P2843, DOI 10.1161/hc4701.099578; Reiken S, 2003, CIRCULATION, V107, P2459, DOI 10.1161/01.CIR.0000068316.53218.49; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Rudrabhatla P, 2011, CURR ALZHEIMER RES, V8, P623, DOI 10.2174/156720511796717168; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Shelton RJ, 2009, HEART, V95, P924, DOI 10.1136/hrt.2008.158931; Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833; Terentyev D, 2009, CIRC RES, V104, P514, DOI 10.1161/CIRCRESAHA.108.181651; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wijnker PJM, 2011, J MUSCLE RES CELL M, V32, P221, DOI 10.1007/s10974-011-9261-x; Xu H, 2010, BIOCHEMISTRY-US, V49, P10298, DOI 10.1021/bi101018c; Yamada M, 2006, FASEB J, V20, P1197, DOI 10.1096/fj.05-5299fje; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	65	69	70	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1032	1046		10.1074/jbc.M112.426957	http://dx.doi.org/10.1074/jbc.M112.426957			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23204520	hybrid, Green Published			2022-12-25	WOS:000313570300027
J	Sladky, R; Hoflich, A; Atanelov, J; Kraus, C; Baldinger, P; Moser, E; Lanzenberger, R; Windischberger, C				Sladky, Ronald; Hoeflich, Anna; Atanelov, Jacqueline; Kraus, Christoph; Baldinger, Pia; Moser, Ewald; Lanzenberger, Rupert; Windischberger, Christian			Increased Neural Habituation in the Amygdala and Orbitofrontal Cortex in Social Anxiety Disorder Revealed by fMRI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ANTERIOR CINGULATE CORTEX; MEDIAL PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; BASOLATERAL AMYGDALA; FACIAL EXPRESSIONS; MENTAL-DISORDERS; EMOTION; FACES; ACTIVATION	A characterizing symptom of social anxiety disorder (SAD) is increased emotional reactivity towards potential social threat in combination with impaired emotion and stress regulation. While several neuroimaging studies have linked SAD with hyperreactivity in limbic brain regions when exposed to emotional faces, little is known about habituation in both the amygdala and neocortical regulation areas. 15 untreated SAD patients and 15 age- and gender-matched healthy controls underwent functional magnetic resonance imaging during repeated blocks of facial emotion (EDT) and object discrimination tasks (ODT). Emotion processing networks were defined by a task-related contrast (EDT > ODT). Linear regression was employed for assessing habituation effects in these regions. In both groups, the employed paradigm robustly activated the emotion processing and regulation network, including the amygdalae and orbitofrontal cortex (OFC). Statistically significant habituation effects were found in the amygdalae, OFC, and pulvinar thalamus of SAD patients. No such habituation was found in healthy controls. Concurrent habituation in the medial OFC and the amygdalae of SAD patients as shown in this study suggests intact functional integrity and successful short-term down-regulation of neural activation in brain areas responsible for emotion processing. Initial hyperactivation may be explained by an insufficient habituation to new stimuli during the first seconds of exposure. In addition, our results highlight the relevance of the orbitofrontal cortex in social anxiety disorders. Citation: Sladky R, Hoflich A, Atanelov J, Kraus C, Baldinger P, et al. (2012) Increased Neural Habituation in the Amygdala and Orbitofrontal Cortex in Social Anxiety Disorder Revealed by fMRI. PLoS ONE 7(11): e50050. doi:10.1371/journal.pone.0050050	[Sladky, Ronald; Atanelov, Jacqueline; Moser, Ewald; Windischberger, Christian] Med Univ Vienna, MR Ctr Excellence, Vienna, Austria; [Sladky, Ronald; Atanelov, Jacqueline; Moser, Ewald; Windischberger, Christian] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Hoeflich, Anna; Kraus, Christoph; Baldinger, Pia; Lanzenberger, Rupert] Med Univ Vienna, Dept Psychiat & Psychotherapy, Vienna, Austria; [Moser, Ewald] Univ Penn, Med Ctr, Dept Psychiat, Philadelphia, PA 19104 USA	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Pennsylvania	Windischberger, C (corresponding author), Med Univ Vienna, MR Ctr Excellence, Vienna, Austria.	christian.windischberger@meduniwien.ac.at	Lanzenberger, Rupert/I-5438-2019; Sladky, Ronald/ABD-5222-2021; Moser, Ewald/B-3666-2013	Lanzenberger, Rupert/0000-0003-4641-9539; Moser, Ewald/0000-0001-8278-9583; Hoflich, Anna/0000-0002-1759-4381; Windischberger, Christian/0000-0002-9944-0190; Sladky, Ronald/0000-0002-5986-1572; Baldinger-Melich, Pia/0000-0001-8382-6665; Kraus, Christoph/0000-0002-7144-2282	OeNB grant (Austrian National Bank) [P12982]; FWF grant (Austrian Science Fund) [P23021]; AstraZeneca; Lundbeck A/S	OeNB grant (Austrian National Bank); FWF grant (Austrian Science Fund); AstraZeneca(AstraZeneca); Lundbeck A/S	This research was supported by an OeNB grant (Austrian National Bank, P12982; http://oenb.at) awarded to C. Windischberger and a FWF grant (Austrian Science Fund, P23021) awarded to R. Lanzenberger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. R. Lanzenberger received travel grants and conference speaker honoraria from AstraZeneca and Lundbeck A/S. (http://www.astrazeneca.com, http://www.lundbeck.com)	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Arnold M, 1960, EMOTION PERSONALITY, V1, P57; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BARBAS H, 1990, J COMP NEUROL, V300, P549, DOI 10.1002/cne.903000409; Barbas H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-25; Barbas H, 2000, BRAIN RES BULL, V52, P319, DOI 10.1016/S0361-9230(99)00245-2; Baur V, 2013, HUM BRAIN MAPP, V34, P437, DOI 10.1002/hbm.21447; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Birbaumer N, 1998, NEUROREPORT, V9, P1223, DOI 10.1097/00001756-199804200-00048; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Buckner JD, 2008, J PSYCHIATR RES, V42, P230, DOI 10.1016/j.jpsychires.2007.01.002; BUTTER C M, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P525; Calder AJ, 2011, PHILOS T R SOC B, V366, P1684, DOI 10.1098/rstb.2010.0362; Campbell DW, 2007, BIOL PSYCHIAT, V62, P455, DOI 10.1016/j.biopsych.2006.09.017; Cannistraro Paul A, 2003, Psychopharmacol Bull, V37, P8; Clark DM, 2002, BIOL PSYCHIAT, V51, P92, DOI 10.1016/S0006-3223(01)01296-3; Collimore KC, 2010, DEPRESS ANXIETY, V27, P1017, DOI [10.1002/da.20771, 10.1002/da.20759]; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davies M., 1992, AMYGDALA NEUROBIOLOG, P255, DOI DOI 10.1097/00008877-199508000-00037; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Derntl B, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-91; Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007; DESIMONE R, 1990, COLD SPRING HARB SYM, V55, P963; Ding JR, 2011, MAGN RESON IMAGING, V29, P701, DOI 10.1016/j.mri.2011.02.013; Eckman PS, 1997, BEHAV RES THER, V35, P1113, DOI 10.1016/S0005-7967(97)10005-5; Ekman P, 1972, EMOTION HUMAN FACE G, pxii; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2010, CURR TOP BEHAV NEURO, V2, P251, DOI 10.1007/7854_2009_5; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Furmark T, 2005, BIOL PSYCHIAT, V58, P132, DOI 10.1016/j.biopsych.2005.03.029; Furmark T, 2002, ARCH GEN PSYCHIAT, V59, P425, DOI 10.1001/archpsyc.59.5.425; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; Goldin PR, 2009, BIOL PSYCHIAT, V66, P1091, DOI 10.1016/j.biopsych.2009.07.014; Goossens L, 2007, BIOL PSYCHIAT, V62, P1119, DOI 10.1016/j.biopsych.2007.04.024; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Herry C, 2007, J NEUROSCI, V27, P5958, DOI 10.1523/JNEUROSCI.5218-06.2007; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; Johnstone T, 2005, NEUROIMAGE, V25, P1112, DOI 10.1016/j.neuroimage.2004.12.016; Karlsson KAE, 2010, NEUROIMAGE, V51, P324, DOI 10.1016/j.neuroimage.2010.02.029; Kawakami N, 2005, PSYCHIAT CLIN NEUROS, V59, P441, DOI 10.1111/j.1440-1819.2005.01397.x; Kessler RC, 1999, PSYCHOL MED, V29, P555, DOI 10.1017/S0033291799008375; Kim MJ, 2009, J NEUROSCI, V29, P11614, DOI 10.1523/JNEUROSCI.2335-09.2009; Kling A.S., 1992, YALE J BIOL MED, V65, P540; KRETTEK JE, 1977, J COMP NEUROL, V172, P687, DOI 10.1002/cne.901720408; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Labuschagne I, 2012, INT J NEUROPSYCHOPH, V15, P883, DOI 10.1017/S1461145711001489; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lanzenberger R, 2010, INT J NEUROPSYCHOPH, V13, P1129, DOI 10.1017/S1461145710000581; LeDoux J E, 1992, Curr Opin Neurobiol, V2, P191, DOI 10.1016/0959-4388(92)90011-9; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Lorberbaum JP, 2004, NEUROREPORT, V15, P2701; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McClure EB, 2007, ARCH GEN PSYCHIAT, V64, P97, DOI 10.1001/archpsyc.64.1.97; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Morawetz C, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00226; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Padmala S, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00064; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phan KL, 2009, BIOL PSYCHIAT, V66, P691, DOI 10.1016/j.biopsych.2009.02.028; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phan KL, 2003, NEUROPSYCHOPHARMACOL, V28, P1344, DOI 10.1038/sj.npp.1300186; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2001, HUM BRAIN MAPP, V12, P193, DOI 10.1002/1097-0193(200104)12:4<193::AID-HBM1015>3.0.CO;2-A; Pollak DD, 2010, ANN MED, V42, P115, DOI 10.3109/07853890903583666; Price RB, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.46; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Robinson JL, 2008, PSYCHIAT RES-NEUROIM, V164, P106, DOI 10.1016/j.pscychresns.2007.12.004; Robinson S, 2004, NEUROIMAGE, V22, P203, DOI 10.1016/j.neuroimage.2003.12.048; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Schneier FR, 2010, PSYCHOL MED, V40, P977, DOI 10.1017/S0033291709991231; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Sladky R, 2011, EUR PSYCHIAT, V26, P179; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Spielberg JM, 2011, COGNITIVE THER RES, V35, P359, DOI 10.1007/s10608-011-9364-0; Spielberg JM, 2008, SOC PERSONAL PSYCHOL, V2, P135, DOI 10.1111/j.1751-9004.2007.00064.x; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Stein MB, 2001, ARCH GEN PSYCHIAT, V58, P251, DOI 10.1001/archpsyc.58.3.251; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Stein MB, 2009, BIOL PSYCHIAT, V66, P1072, DOI 10.1016/j.biopsych.2009.09.023; Straube T, 2004, BIOL PSYCHIAT, V56, P921, DOI 10.1016/j.biopsych.2004.09.024; Strauss MM, 2005, NEUROIMAGE, V26, P389, DOI 10.1016/j.neuroimage.2005.01.053; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Tillfors M, 2001, AM J PSYCHIAT, V158, P1220, DOI 10.1176/appi.ajp.158.8.1220; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Voncken MJ, 2012, COGNITIVE THER RES, V36, P740, DOI 10.1007/s10608-011-9408-5; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Windischberger C, 2010, NEUROIMAGE, V49, P1161, DOI 10.1016/j.neuroimage.2009.10.013; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wright CI, 2001, NEUROREPORT, V12, P379, DOI 10.1097/00001756-200102120-00039; Zola-Morgan S, 1991, Hippocampus, V1, P207, DOI 10.1002/hipo.450010208	110	60	62	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50050	10.1371/journal.pone.0050050	http://dx.doi.org/10.1371/journal.pone.0050050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209643	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900022
J	Tsou, YA; Chen, KC; Lin, HC; Chang, SS; Chen, CYC				Tsou, Yung-An; Chen, Kuan-Chung; Lin, Hung-Che; Chang, Su-Sen; Chen, Calvin Yu-Chian			Uroporphyrinogen Decarboxylase as a Potential Target for Specific Components of Traditional Chinese Medicine: A Virtual Screening and Molecular Dynamics Study	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MINIMIZATION; ASSIGNMENT; PROGRAM; HEAD	Uroporphyrinogen decarboxylase (UROD) has been suggested as a protectant against radiation for head and neck cancer (HNC). In this study, we employed traditional Chinese medicine (TCM) compounds from TCM Database@Taiwan (http://tcm.cmu.edu.tw/) to screen for drug-like candidates with potential UROD inhibition characteristics using virtual screening techniques. Isopraeroside IV, scopolin, and nodakenin exhibited the highest Dock Scores, and were predicted to have good Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties. Two common moieties, 2H-chromen-2-one and glucoside, were observed among the top TCM candidates. Cross comparison of the docking poses indicated that candidates formed stable interactions with key binding and catalytic residues of UROD through these two moieties. The 2Hchromen-2- one moiety enabled pi-cation interactions with Arg37 and H-bonds with Tyr164. The glucoside moiety was involved in forming H-bonds with Arg37 and Asp86. From our computational results, we propose isopraeroside IV, scopolin, and nodakenin as ligands that might exhibit drug-like inhibitory effects on UROD. The glucoside and 2H-chromen-2-one moieties may potentially be used for designing inhibitors of UROD. Citation: Tsou Y-A, Chen K-C, Lin H-C, Chang S-S, Chen CY-C (2012) Uroporphyrinogen Decarboxylase as a Potential Target for Specific Components of Traditional Chinese Medicine: A Virtual Screening and Molecular Dynamics Study. PLoS ONE 7(11): e50087. doi:10.1371/journal.pone.0050087	[Chang, Su-Sen; Chen, Calvin Yu-Chian] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Tsou, Yung-An] China Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Tsou, Yung-An] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Chen, Kuan-Chung] China Med Univ, Grad Inst Pharmaceut Chem, Taichung, Taiwan; [Lin, Hung-Che] China Med Univ, Sch Pharm, Taichung, Taiwan; [Chen, Calvin Yu-Chian] China Med Univ, Lab Computat & Syst Biol, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Chen, Calvin Yu-Chian] China Med Univ, Beigang Hosp, Yunlin, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; Asia University Taiwan; China Medical University Taiwan	Chen, CYC (corresponding author), China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	ycc929@MIT.EDU	Chen, Kuan-Chung/G-2737-2011; Chen, Calvin Yu-Chian/E-9402-2010	Chen, Kuan-Chung/0000-0003-0223-1577; Chen, Calvin Yu-Chian/0000-0003-3306-250X; Chen, Calvin Yu-Chian/0000-0001-9213-9832	National Science Council of Taiwan [NSC101-2325-B-039-001]; Asia University [100-asia-56]; China Medical University and Asia University [DMR-101-094]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH101-TD-C-111-005]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Asia University; China Medical University and Asia University; Taiwan Department of Health Clinical Trial and Research Center of Excellence; Taiwan Department of Health Cancer Research Center of Excellence	The research was supported by grants from the National Science Council of Taiwan (NSC101-2325-B-039-001), Asia University (100-asia-56), and China Medical University and Asia University (DMR-101-094). This study was also supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004) and Taiwan Department of Health Cancer Research Center of Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chang SS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002315; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen KC, 2011, SOFT MATTER, V7, P4001, DOI 10.1039/c0sm01548b; DUBART A, 1986, HUM GENET, V73, P277, DOI 10.1007/BF00401245; Fan J, 2007, J BACTERIOL, V189, P3573, DOI 10.1128/JB.01083-06; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; Fletcher R, 1969, OPTIMIZATION; Gil Z, 2009, ISR MED ASSOC J, V11, P296; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Ito E, 2011, FUTURE ONCOL, V7, P595, DOI [10.2217/fon.11.27, 10.2217/FON.11.27]; Ito E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001922; JACKSON AH, 1976, PHILOS T ROY SOC B, V273, P191, DOI 10.1098/rstb.1976.0009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kappas A, 1995, METABOLIC MOL BASES, P2103; Lambrecht RW, 2007, SEMIN LIVER DIS, V27, P99, DOI 10.1055/s-2006-960173; Lin TL, 2011, PROTEINS, V79, P2475, DOI 10.1002/prot.23071; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; LUO J, 1993, BIOCHEM J, V289, P529, DOI 10.1042/bj2890529; MCLELLAN T, 1985, CYTOGENET CELL GENET, V39, P224, DOI 10.1159/000132139; MUKERJI SK, 1987, BIOCHEM BIOPH RES CO, V146, P1196, DOI 10.1016/0006-291X(87)90775-3; Phillips JD, 2003, EMBO J, V22, P6225, DOI 10.1093/emboj/cdg606; Phillips JD, 1997, PROTEIN SCI, V6, P1343, DOI 10.1002/pro.5560060624; Phillips JD, 2001, P NATL ACAD SCI USA, V98, P259, DOI 10.1073/pnas.011481398; Phillips JD, 2009, J MOL BIOL, V389, P306, DOI 10.1016/j.jmb.2009.04.013; Ridge JA, 2011, CANC MANAGEMENT MULT; SMITH AG, 1979, BIOCHEM J, V183, P455, DOI 10.1042/bj1830455; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Whitby FG, 1998, EMBO J, V17, P2463, DOI 10.1093/emboj/17.9.2463; Yang SC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002189	32	28	28	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50087	10.1371/journal.pone.0050087	http://dx.doi.org/10.1371/journal.pone.0050087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209648	Green Published, gold, Green Submitted			2022-12-25	WOS:000312104900023
J	Ali, Z; Zhang, DY; Xu, ZL; Xu, L; Yi, JX; He, XL; Huang, YH; Liu, XQ; Khan, AA; Trethowan, RM; Ma, HX				Ali, Zulfiqar; Zhang, Da Yong; Xu, Zhao Long; Xu, Ling; Yi, Jin Xin; He, Xiao Lan; Huang, Yi Hong; Liu, Xiao Qing; Khan, Asif Ali; Trethowan, Richard M.; Ma, Hong Xiang			Uncovering the Salt Response of Soybean by Unraveling Its Wild and Cultivated Functional Genomes Using Tag Sequencing	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; ABSCISIC-ACID; DROUGHT; TOLERANCE; KINASE; STRESS; PHOSPHORYLATION; IDENTIFICATION; RESISTANCE	Soil salinity has very adverse effects on growth and yield of crop plants. Several salt tolerant wild accessions and cultivars are reported in soybean. Functional genomes of salt tolerant Glycine soja and a salt sensitive genotype of Glycine max were investigated to understand the mechanism of salt tolerance in soybean. For this purpose, four libraries were constructed for Tag sequencing on Illumina platform. We identify around 490 salt responsive genes which included a number of transcription factors, signaling proteins, translation factors and structural genes like transporters, multidrug resistance proteins, antiporters, chaperons, aquaporins etc. The gene expression levels and ratio of up/down-regulated genes was greater in tolerant plants. Translation related genes remained stable or showed slightly higher expression in tolerant plants under salinity stress. Further analyses of sequenced data and the annotations for gene ontology and pathways indicated that soybean adapts to salt stress through ABA biosynthesis and regulation of translation and signal transduction of structural genes. Manipulation of these pathways may mitigate the effect of salt stress thus enhancing salt tolerance.	[Ali, Zulfiqar; Zhang, Da Yong; Xu, Zhao Long; Xu, Ling; Yi, Jin Xin; He, Xiao Lan; Huang, Yi Hong; Liu, Xiao Qing; Ma, Hong Xiang] Jiangsu Acad Agr Sci, Inst Agrobiotechnol, Nanjing, Jiangsu, Peoples R China; [Ali, Zulfiqar; Khan, Asif Ali] Univ Agr Faisalabad, Dept Plant Breeding & Genet, Faisalabad, Punjab, Pakistan; [Trethowan, Richard M.] Univ Sydney, Plant Breeding Inst, Sydney, NSW, Australia	Jiangsu Academy of Agricultural Sciences; University of Agriculture Faisalabad; University of Sydney	Ali, Z (corresponding author), Jiangsu Acad Agr Sci, Inst Agrobiotechnol, Nanjing, Jiangsu, Peoples R China.	zulfiqarpbg@hotmail.com; yij@jaas.ac.cn	Ali, Zulfiqar/AAF-4171-2021; Asif, Ali/P-9684-2017; Ali, Zulfiqar/AAF-2663-2019; Trethowan, Richard/ADZ-7680-2022	Ali, Zulfiqar/0000-0003-1228-3338; Asif, Ali/0000-0002-4474-164X; Trethowan, Richard/0000-0003-0105-875X	National Science Foundation of China [30971798, 31101166]; Jiangsu Natural Science Foundation, China [BK2010474]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Foundation, China(Natural Science Foundation of Jiangsu Province)	This study was sponsored by the National Science Foundation of China (#30971798 and 31101166) and the Jiangsu Natural Science Foundation, China (#BK2010474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Chen L, 2010, ACTA BIOCH BIOPH SIN, V42, P154, DOI 10.1093/abbs/gmp113; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Chinchilla D, 2009, TRENDS PLANT SCI, V14, P535, DOI 10.1016/j.tplants.2009.08.002; Chun J, 2002, BIOCHEM BIOPH RES CO, V298, P207, DOI 10.1016/S0006-291X(02)02428-2; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Dana MD, 2006, PLANT PHYSIOL, V142, P722, DOI 10.1104/pp.106.086140; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P6; Estrada-Navarrete G, 2007, NAT PROTOC, V2, P1819, DOI 10.1038/nprot.2007.259; Flowers TJ, 1995, AUST J PLANT PHYSIOL, V22, P875, DOI 10.1071/PP9950875; Flowers TJ, 2000, J EXP BOT, V51, P99, DOI 10.1093/jexbot/51.342.99; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Gomes MMA, 2003, PLANT GROWTH REGUL, V39, P263, DOI 10.1023/A:1022854405898; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; Grosshans H, 2000, GENE DEV, V14, P830; He K, 2007, CURR BIOL, V17, P1109, DOI 10.1016/j.cub.2007.05.036; Hong SW, 1997, PLANT PHYSIOL, V113, P1203, DOI 10.1104/pp.113.4.1203; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; Khacho M, 2008, MOL BIOL CELL, V19, P5296, DOI 10.1091/mbc.E08-06-0562; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; Liao Y, 2008, CELL RES, V18, P1047, DOI 10.1038/cr.2008.280; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Manaa A, 2011, J EXP BOT, V62, P2797, DOI 10.1093/jxb/erq460; Mao X, 2011, FUNCTIONAL INTEGRATI, DOI [10.1007/s10142-10011-10218-10143, DOI 10.1007/S10142-10011-10218-10143]; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Morino M, 2010, J BIOL CHEM, V285, P30942, DOI 10.1074/jbc.M110.118661; Morris PC, 2010, NEW PHYTOL, V188, P641, DOI 10.1111/j.1469-8137.2010.03507.x; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; O'Rourke JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-376; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Stolf-Moreira R, 2010, GENET MOL RES, V9, P858, DOI 10.4238/vol9-2gmr701; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Takenaka Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1066, DOI 10.1271/bbb.80837; Tomy S, 2009, GEN COMP ENDOCR, V161, P123, DOI 10.1016/j.ygcen.2008.12.003; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Wang D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-149; Wang YC, 2006, PLANT SCI, V171, P655, DOI 10.1016/j.plantsci.2006.06.011; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	52	24	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e48819	10.1371/journal.pone.0048819	http://dx.doi.org/10.1371/journal.pone.0048819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209559	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700006
J	Laudanski, J; Edeline, JM; Huetz, C				Laudanski, Jonathan; Edeline, Jean-Marc; Huetz, Chloe			Differences between Spectro-Temporal Receptive Fields Derived from Artificial and Natural Stimuli in the Auditory Cortex	PLOS ONE			English	Article							GUINEA-PIG; REVERSE-CORRELATION; FEATURE SELECTIVITY; PRIMATE PRIMARY; RESPONSES; NEURONS; VOCALIZATIONS; PLASTICITY; THALAMUS; BURST	Spectro-temporal properties of auditory cortex neurons have been extensively studied with artificial sounds but it is still unclear whether they help in understanding neuronal responses to communication sounds. Here, we directly compared spectro-temporal receptive fields (STRFs) obtained from the same neurons using both artificial stimuli (dynamic moving ripples, DMRs) and natural stimuli (conspecific vocalizations) that were matched in terms of spectral content, average power and modulation spectrum. On a population of auditory cortex neurons exhibiting reliable tuning curves when tested with pure tones, significant STRFs were obtained for 62% of the cells with vocalizations and 68% with DMR. However, for many cells with significant vocalization-derived STRFs (STRFvoc) and DMR-derived STRFs (STRFdmr), the BF, latency, bandwidth and global STRFs shape differed more than what would be predicted by spiking responses simulated by a linear model based on a non-homogenous Poisson process. Moreover STRFvoc predicted neural responses to vocalizations more accurately than STRFdmr predicted neural response to DMRs, despite similar spike-timing reliability for both sets of stimuli. Cortical bursts, which potentially introduce nonlinearities in evoked responses, did not explain the differences between STRFvoc and STRFdmr. Altogether, these results suggest that the nonlinearity of auditory cortical responses makes it difficult to predict responses to communication sounds from STRFs computed from artificial stimuli.	[Laudanski, Jonathan; Edeline, Jean-Marc; Huetz, Chloe] CNRS UMR 8195, Ctr Neurosci Paris Sud CNPS, Orsay, France; [Laudanski, Jonathan; Edeline, Jean-Marc; Huetz, Chloe] Univ Paris 11, Ctr Neurosci Paris Sud, Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite Jean Monnet; UDICE-French Research Universities; Universite Paris Saclay	Edeline, JM (corresponding author), CNRS UMR 8195, Ctr Neurosci Paris Sud CNPS, Orsay, France.	jean-marc.edeline@u-psud.fr			National Research Agency (ANR); Federation pour la Recherche sur le Cerveau (FRC)	National Research Agency (ANR)(French National Research Agency (ANR)); Federation pour la Recherche sur le Cerveau (FRC)	This work was supported by grants from the National Research Agency (ANR program Neuro2006) and from the Federation pour la Recherche sur le Cerveau (FRC) to JME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1981, BIOL CYBERN, V42, P133, DOI 10.1007/BF00336731; Ahrens MB, 2008, J NEUROSCI, V28, P1929, DOI 10.1523/JNEUROSCI.3377-07.2008; Andoni S, 2007, J NEUROSCI, V27, P4882, DOI 10.1523/JNEUROSCI.4342-06.2007; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Atencio CA, 2008, NEURON, V58, P956, DOI 10.1016/j.neuron.2008.04.026; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; BERRYMAN JC, 1976, Z TIERPSYCHOL, V41, P80; Berryman JC, 1970, GUINEA PIG NEWSLETTE, V2, P9; Bitterman Y, 2008, NATURE, V451, P197, DOI 10.1038/nature06476; Christianson GB, 2008, J NEUROSCI, V28, P446, DOI 10.1523/JNEUROSCI.1775-07.2007; Coombes S, 2005, BURSTING: THE GENESIS OF RHYTHM IN THE NERVOUS SYSTEM, pV; David SV, 2009, J NEUROSCI, V29, P3374, DOI 10.1523/JNEUROSCI.5249-08.2009; DEBOER E, 1978, J ACOUST SOC AM, V63, P115, DOI 10.1121/1.381704; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; DiMattina C, 2006, J NEUROPHYSIOL, V95, P1244, DOI 10.1152/jn.00818.2005; Edeline JM, 2000, J NEUROPHYSIOL, V84, P934, DOI 10.1152/jn.2000.84.2.934; Edeline JM, 2001, EUR J NEUROSCI, V14, P1865, DOI 10.1046/j.0953-816x.2001.01821.x; EDELINE JM, 1993, BEHAV NEUROSCI, V107, P539, DOI 10.1037/0735-7044.107.4.539; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; Escabi MA, 2005, J NEUROSCI, V25, P9524, DOI 10.1523/JNEUROSCI.1804-05.2005; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Gourevitch B, 2007, J NEUROSCI METH, V160, P349, DOI 10.1016/j.jneumeth.2006.09.024; Gourevitch B, 2009, CEREB CORTEX, V19, P1448, DOI 10.1093/cercor/bhn184; GUIDO W, 1992, J NEUROPHYSIOL, V68, P2199, DOI 10.1152/jn.1992.68.6.2199; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; Huetz C, 2006, EUR J NEUROSCI, V24, P1091, DOI 10.1111/j.1460-9568.2006.04967.x; Huetz C, 2009, J NEUROSCI, V29, P334, DOI 10.1523/JNEUROSCI.3269-08.2009; Issa EB, 2011, J NEUROSCI, V31, P2965, DOI 10.1523/JNEUROSCI.4920-10.2011; Issa EB, 2008, J NEUROSCI, V28, P14467, DOI 10.1523/JNEUROSCI.3086-08.2008; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; KING JA, 1956, ECOLOGY, V37, P221, DOI 10.2307/1933134; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lesica NA, 2008, J NEUROSCI, V28, P5412, DOI 10.1523/JNEUROSCI.0073-08.2008; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Manunta Y, 2004, J NEUROPHYSIOL, V92, P1445, DOI 10.1152/jn.00079.2004; Manunta Y, 1999, EUR J NEUROSCI, V11, P2134, DOI 10.1046/j.1460-9568.1999.00633.x; Manunta Y, 2000, NEUROREPORT, V11, P23, DOI 10.1097/00001756-200001170-00005; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Massaux A, 2004, J NEUROPHYSIOL, V91, P2117, DOI 10.1152/jn.00970.2003; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Nagel KI, 2008, NEURON, V58, P938, DOI 10.1016/j.neuron.2008.04.028; Philibert B, 2005, HEARING RES, V209, P97, DOI 10.1016/j.heares.2005.07.004; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; RINZEL J, 1998, METHODS NEURONAL MOD, P251; Rutkowski RG, 2002, AUDIOL NEURO-OTOL, V7, P214, DOI 10.1159/000063738; SAHANI M, 2003, ADV NEURAL INFORM PR, V15, P109; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; Shih JY, 2011, J NEUROPHYSIOL, V105, P1908, DOI 10.1152/jn.01055.2010; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Slaney M., 1998, AUDITORY TOOLBOX, P2; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Valentine PA, 2004, HEARING RES, V196, P119, DOI 10.1016/j.heares.2004.05.011; Wallace MN, 2008, EXP BRAIN RES, V184, P179, DOI 10.1007/s00221-007-1092-z; Wallace MN, 2000, EXP BRAIN RES, V132, P445, DOI 10.1007/s002210000362; Woolley SMN, 2006, J NEUROSCI, V26, P2499, DOI 10.1523/JNEUROSCI.3731-05.2006; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536	66	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50539	10.1371/journal.pone.0050539	http://dx.doi.org/10.1371/journal.pone.0050539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209771	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800080
J	Wu, XL; Xiong, EH; An, SF; Gong, FP; Wang, W				Wu, XiaoLin; Xiong, ErHui; An, SuFang; Gong, FangPing; Wang, Wei			Sequential Extraction Results in Improved Proteome Profiling of Medicinal Plant Pinellia ternata Tubers, Which Contain Large Amounts of High-Abundance Proteins	PLOS ONE			English	Article							ELECTROPHORESIS; IDENTIFICATION; EXPRESSION; PREFRACTIONATION; PRINCIPLE; BACTERIAL; BINDING; CLONING; LECTIN; TISSUE	Pinellia ternata tuber is one of the well-known Chinese traditional medicines. In order to understand the pharmacological properties of tuber proteins, it is necessary to perform proteome analysis of P. ternata tubers. However, a few high-abundance proteins (HAPs), mainly mannose-binding lectin (agglutinin), exist in aggregates of various sizes in the tubers and seriously interfere with proteome profiling by two-dimensional electrophoresis (2-DE). Therefore, selective depletion of these HAPs is a prerequisite for enhanced proteome analysis of P. ternata tubers. Based on differential protein solubility, we developed a novel protocol involving two sequential extractions for depletion of some HAPs and prefractionation of tuber proteins prior to 2-DE. The first extraction using 10% acetic acid selectively extracted acid-soluble HAPs and the second extraction using the SDS-containing buffer extracted remaining acid-insoluble proteins. After application of the protocol, 2-DE profiles of P. ternata tuber proteins were greatly improved and more protein spots were detected, especially low-abundance proteins. Moreover, the subunit composition of P. ternata lectin was analyzed by electrophoresis. Native lectin consists of two hydrogen-bonded subunits (11 kDa and 25 kDa) and the 11 kDa subunit was a glycoprotein. Subsequently, major HAPs in the tubers were analyzed by mass spectrometry, with nine protein spots being identified as lectin isoforms. The methodology was easy to perform and required no specialized apparatus. It would be useful for proteome analysis of other tuber plants of Araceae.	[Wu, XiaoLin; Xiong, ErHui; An, SuFang; Gong, FangPing; Wang, Wei] Henan Agr Univ, Coll Life Sci, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China	Henan Agricultural University	Wang, W (corresponding author), Henan Agr Univ, Coll Life Sci, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	proteome@163.com						Bachner D, 1999, FEBS LETT, V457, P522, DOI 10.1016/S0014-5793(99)01092-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JH, 2003, PHYTOCHEMISTRY, V64, P903, DOI 10.1016/S0031-9422(03)00421-7; Cordwell Stuart J., 2008, V424, P139, DOI 10.1007/978-1-60327-064-9_12; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Doud MK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-25; Fountoulakis M, 2002, METHOD ENZYMOL, V358, P288; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Han MH, 2006, CHROMATOGRAPHIA, V64, P647, DOI 10.1365/s10337-006-0103-8; Horth P, 2006, MOL CELL PROTEOMICS, V5, P1968, DOI 10.1074/mcp.T600037-MCP200; Jin SX, 2012, PLANT BIOTECHNOL J, V10, P313, DOI 10.1111/j.1467-7652.2011.00663.x; Kim YJ, 2006, BIOL PHARM BULL, V29, P1278, DOI 10.1248/bpb.29.1278; Kurata K, 1998, PLANTA MED, V64, P645, DOI 10.1055/s-2006-957539; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lenkei Z, 2000, J HISTOCHEM CYTOCHEM, V48, P1553, DOI 10.1177/002215540004801112; Lin J, 2003, MOL BIOTECHNOL, V25, P215, DOI 10.1385/MB:25:3:215; MARKI T, 1987, PLANTA MED, V53, P410; Ohtaki T, 1999, J BIOL CHEM, V274, P37041, DOI 10.1074/jbc.274.52.37041; Pan YH, 1998, NAT SCI PROG, V8, P502; Righetti PG, 2005, ELECTROPHORESIS, V26, P297, DOI 10.1002/elps.200406189; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Wang KY, 1993, CHINESE BIOCH J, V9, P545; Wang W, 2004, SEX PLANT REPROD, V17, P41, DOI 10.1007/s00497-004-0207-y; Wang W, 2003, ELECTROPHORESIS, V24, P2369, DOI 10.1002/elps.200305500; WARDI AH, 1972, ANAL BIOCHEM, V49, P607, DOI 10.1016/0003-2697(72)90472-1; WEN TN, 1985, PLANT PHYSIOL, V78, P172, DOI 10.1104/pp.78.1.172; Wu XL, 2011, ACTA PHYSIOL PLANT, V33, P181, DOI 10.1007/s11738-010-0536-4; Yao JH, 2003, CELL RES, V13, P301, DOI 10.1038/sj.cr.7290175	28	7	9	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50497	10.1371/journal.pone.0050497	http://dx.doi.org/10.1371/journal.pone.0050497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185632	gold, Green Published, Green Submitted			2022-12-25	WOS:000311535700087
J	Katter, K; Geurts, AM; Hoffmann, O; Mates, L; Landa, V; Hiripi, L; Moreno, C; Lazar, J; Bashir, S; Zidek, V; Popova, E; Jerchow, B; Becker, K; Devaraj, A; Walter, I; Grzybowksi, M; Corbett, M; Rangel, A; Hodges, MR; Bader, M; Ivics, Z; Jacob, HJ; Pravenec, M; Bosze, Z; Rulicke, T; Izsvak, Z				Katter, Katharina; Geurts, Aron M.; Hoffmann, Orsolya; Mates, Lajos; Landa, Vladimir; Hiripi, Laszlo; Moreno, Carol; Lazar, Jozef; Bashir, Sanum; Zidek, Vaclav; Popova, Elena; Jerchow, Boris; Becker, Katja; Devaraj, Anantharam; Walter, Ingrid; Grzybowksi, Michael; Corbett, Molly; Rangel Filho, Artur; Hodges, Matthew R.; Bader, Michael; Ivics, Zoltan; Jacob, Howard J.; Pravenec, Michal; Bosze, Zsuzsanna; Ruelicke, Thomas; Izsvak, Zsuzsanna			Transposon-mediated transgenesis, transgenic rescue, and tissue-specific gene expression in rodents and rabbits	FASEB JOURNAL			English	Article						SB100X; Sleeping Beauty; mosaicism; piggy-Pac; silencing	SLEEPING-BEAUTY TRANSPOSON; HUMAN-CELLS; PRONUCLEAR MICROINJECTION; LENTIVIRAL VECTORS; BAC TRANSGENESIS; STEM-CELLS; MICE; DNA; MOUSE; INTEGRATION	Germline transgenesis is an important procedure for functional investigation of biological pathways, as well as for animal biotechnology. We have established a simple, nonviral protocol in three important biomedical model organisms frequently used in physiological studies. The protocol is based on the hyperactive Sleeping Beauty transposon system, SB100X, which reproducibly promoted generation of transgenic founders at frequencies of 50-64, 14-72, and 15% in mice, rats, and rabbits, respectively. The SB100X-mediated transgene integrations are less prone to genetic mosaicism and gene silencing as compared to either the classical pronuclear injection or to lentivirus-mediated transgenesis. The method was successfully applied to a variety of transgenes and animal models, and can be used to generate founders with single-copy integrations. The transposon vector also allows the generation of transgenic lines with tissue-specific expression patterns specified by promoter elements of choice, exemplified by a rat reporter strain useful for tracking serotonergic neurons. As a proof of principle, we rescued an inborn genetic defect in the fawn-hooded hypertensive rat by SB100X transgenesis. A side-by-side comparison of the SB100X- and piggyBac-based protocols revealed that the two systems are complementary, offering new opportunities in genome manipulation.-Katter, K., Geurts, A. M., Hoffmann, O., Mates, L., Landa, V., Hiripi, L., Moreno, C., Lazar, J., Bashir, S., Zidek, V., Popova, E., Jerchow, B., Becker, K., Devaraj, A., Walter, I., Grzybowksi, M., Corbett, M., Rangel Filho, A., Hodges, M. R., Bader, M., Ivics, Z., Jacob, H. J., Pravenec, M., Bosze, Z., Rulicke, T., Izsvak, Z. Transposon-mediated transgenesis, transgenic rescue, and tissue-specific gene expression in rodents and rabbits. FASEB J. 27, 930-941 (2013). www.fasebj.org	[Katter, Katharina; Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vienna, Austria; [Walter, Ingrid] Univ Vet Med Vienna, Inst Anat Histol & Embryol, Vienna, Austria; [Geurts, Aron M.; Mates, Lajos; Moreno, Carol; Grzybowksi, Michael; Corbett, Molly; Hodges, Matthew R.; Jacob, Howard J.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Geurts, Aron M.; Grzybowksi, Michael; Corbett, Molly] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; [Geurts, Aron M.; Moreno, Carol; Lazar, Jozef; Jacob, Howard J.] Med Coll Wisconsin, Human Mol Genet Ctr, Milwaukee, WI 53226 USA; [Hodges, Matthew R.] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA; [Hoffmann, Orsolya; Bosze, Zsuzsanna] Agr Biotechnol Ctr, Inst Anim Biotechnol, H-2101 Godollo, Hungary; [Mates, Lajos] Hungarian Acad Sci, Biol Res Ctr, H-6726 Szeged, Hungary; [Landa, Vladimir; Hiripi, Laszlo; Zidek, Vaclav; Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; [Bashir, Sanum; Popova, Elena; Jerchow, Boris; Becker, Katja; Devaraj, Anantharam; Bader, Michael; Ivics, Zoltan; Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Ivics, Zoltan] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany; [Rangel Filho, Artur] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Paul Ehrlich Institute; University of Miami	Izsvak, Z (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.	mates@brc.hu; zizsvak@mdc-berlin.de	Hodges, Matthew R/N-8567-2013; Zidek, Vaclav/C-6685-2012; Pravenec, Michal/B-1666-2012; Hiripi, Laszlo/AAL-8243-2021; Bosze, Zsuzsanna/N-9689-2019; Hodges, Matthew/GZB-0433-2022; Bader, Michael/K-2124-2013; Landa, Vladimir/B-8908-2012	Pravenec, Michal/0000-0001-9197-5871; Hiripi, Laszlo/0000-0002-1023-0112; Popova, Elena/0000-0002-3043-9650; Jerchow, Boris-Alexander/0000-0002-7031-8730; Mates, Lajos/0000-0002-0058-470X; Bader, Michael/0000-0003-4780-4164; Izsvak, Zsuzsanna/0000-0002-2053-2384; Devaraj, Anantharam/0000-0002-8685-6728	U.S. National Institutes of Health, National Heart, Lung and Blood Institute [P30HL101353, R01HL069321, P301/10/0290]; Grant Agency of the Czech Republic [LH12061, LL1204]; Ministry of Education, Youth, and Sports of the Czech Republic [OM-00118/2008, DFG IZ52/1-2, HEALTH-F4-2010-241504]; Austrian Genome Research Programme, GEN-AU II and III; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101353, R00HL097033, R01HL069321] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008396] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Austrian Genome Research Programme, GEN-AU II and III; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Drs. Mingyu Liang, Allen Cowley, Jr., Duann Pu, Elias Lianos, and Richard Roman for allowing us to share our experiences with their transgenic rat projects. Many thanks also to Tien Yin Yau, Lill Andersen and Dieter Fink for technical assistance and fruitful discussions. This work was supported by the U.S. National Institutes of Health, National Heart, Lung and Blood Institute, grants P30HL101353 (A.G.), R01HL069321 (H.J.), and P301/10/0290 (M.P); the Grant Agency of the Czech Republic, grants LH12061 (V.L.) and LL1204 (within the ERC CZ program; M.P.); the Ministry of Education, Youth, and Sports of the Czech Republic, grants OM-00118/2008 (Z.B.), DFG IZ52/1-2 (Z.Iz.), and HEALTH-F4-2010-241504 (Z.Iz., H.J., M.P., and M.B.); and the Austrian Genome Research Programme, GEN-AU II and III (Austromouse; T. R.). Author contributions: L.M., A.G., Z.Iz., Z.B., M.P., M.B., and T.R designed research, K.K., T.R., I.W., L.M., V.L., L.H., C.M., J.L., I.H., S.B., V.Z., L.P., K.B., A.D., M.H., E.P., M.G., M.C., and A. R.F. performed research; B.J., Z.Iz., M.P., M.B., H.J., Z.B., and T.R. analyzed data; Z.Iz., A.G., Z.Iv., L. M., T.R., and Z.B. wrote the paper.	Ammar I, 2012, NUCLEIC ACIDS RES, V40, P6693, DOI 10.1093/nar/gks317; BESENFELDER U, 1993, J REPROD FERTIL, V99, P53, DOI 10.1530/jrf.0.0990053; Bodrogi L, 2006, TRANSGENIC RES, V15, P627, DOI 10.1007/s11248-006-9015-5; Bosze Z, 2006, WORLD RABBIT SCI, V14, P1; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Carlson DF, 2011, TRANSGENIC RES, V20, P29, DOI 10.1007/s11248-010-9386-5; Charreau B, 1996, TRANSGENIC RES, V5, P223, DOI 10.1007/BF01972876; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Datta YH, 2003, THROMB HAEMOSTASIS, V89, P1031; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Ellis J, 2005, CURR GENE THER, V5, P367, DOI 10.2174/1566523054546233; Filipiak WE, 2006, TRANSGENIC RES, V15, P673, DOI 10.1007/s11248-006-9002-x; Galvan DL, 2009, J IMMUNOTHER, V32, P837, DOI 10.1097/CJI.0b013e3181b2914c; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Hirabayashi M, 2001, EXP ANIM TOKYO, V50, P125, DOI 10.1538/expanim.50.125; Hiripi L, 2003, DNA CELL BIOL, V22, P41, DOI 10.1089/104454903321112488; Hiripi L, 2010, TRANSGENIC RES, V19, P799, DOI 10.1007/s11248-009-9356-y; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2011, METHODS, V53, P356, DOI 10.1016/j.ymeth.2010.12.014; Izsvak Z, 2010, BIOESSAYS, V32, P756, DOI 10.1002/bies.201000027; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/NMETH.1461, 10.1038/nmeth.1461]; Kolacsek O, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-5; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Marks MS, 2006, J CELL BIOL, V175, P199, DOI 10.1083/jcb.200608058; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; McHenry JZ, 1998, ONCOGENE, V17, P1131, DOI 10.1038/sj.onc.1202044; Moldt B, 2007, HUM GENE THER, V18, P1193, DOI 10.1089/hum.2007.099; Ninkovic I, 2008, J THROMB HAEMOST, V6, P2143, DOI 10.1111/j.1538-7836.2008.03178.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; Rostovskaya M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks643; Rulicke T, 2000, EXP PHYSIOL, V85, P589, DOI 10.1017/S0958067000020923; Rulicke T, 2004, METH MOL B, V254, P165; Sauvain MO, 2008, J VIROL, V82, P7111, DOI 10.1128/JVI.00623-08; Scott MM, 2005, J NEUROSCI, V25, P2628, DOI 10.1523/JNEUROSCI.4979-04.2005; Sultana F, 2009, J AM ASSOC LAB ANIM, V48, P52; Sumiyama K, 2010, GENOMICS, V95, P306, DOI 10.1016/j.ygeno.2010.02.006; Suster ML, 2011, NAT PROTOC, V6, P1998, DOI 10.1038/nprot.2011.416; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Walisko O, 2008, MOL THER, V16, P359, DOI 10.1038/sj.mt.6300366; Wall R J, 2001, Cloning Stem Cells, V3, P209, DOI 10.1089/15362300152725936; WHITELAW CBA, 1993, TRANSGENIC RES, V2, P29, DOI 10.1007/BF01977678; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Witschi, 1956, DEV VERTEBRATES; Yant SR, 2002, NAT BIOTECHNOL, V20, P999, DOI 10.1038/nbt738; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568	56	65	69	1	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					930	941		10.1096/fj.12-205526	http://dx.doi.org/10.1096/fj.12-205526			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23195032	Green Published			2022-12-25	WOS:000315585200009
J	Gupta, A; Wodziak, D; Tun, M; Bouley, DM; Lowe, AW				Gupta, Aparna; Wodziak, Dariusz; Tun, May; Bouley, Donna M.; Lowe, Anson W.			Loss of Anterior Gradient 2 (Agr2) Expression Results in Hyperplasia and Defective Lineage Maturation in the Murine Stomach	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE STOMACH; GLYCOCONJUGATE HISTOCHEMISTRY; TRANSGENIC OVEREXPRESSION; SPASMOLYTIC POLYPEPTIDE; INTESTINAL METAPLASIA; CELL-PROLIFERATION; EPITHELIAL-CELLS; PROGENITOR-CELL; PARIETAL-CELL; HUMAN HOMOLOG	Recent studies of epithelial tissues have revealed the presence of tissue-specific stem cells that are able to establish multiple cell lineages within an organ. The stem cells give rise to progenitors that replicate before differentiating into specific cell lineages. The mechanism by which homeostasis is established between proliferating stem or progenitor cells and terminally differentiated cells is unclear. This study demonstrates that Agr2 expression by mucous neck cells in the stomach promotes the differentiation of multiple cell lineages while also inhibiting the proliferation of stem or progenitor cells. When Agr2 expression is absent, gastric mucous neck cells increased in number as does the number of proliferating cells. Agr2 expression loss also resulted in the decline of terminally differentiated cells, which was supplanted by cells that exhibited nuclear SOX9 labeling. Sox9 expression has been associated with progenitor and stem cells. Similar effects of the Agr2 null on cell proliferation in the intestine were also observed. Agr2 consequently serves to maintain the balance between proliferating and differentiated epithelial cells.	[Gupta, Aparna; Wodziak, Dariusz; Tun, May; Lowe, Anson W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Bouley, Donna M.] Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Lowe, AW (corresponding author), Alway Bldg,Rm M211,300 Pasteur Dr, Stanford, CA 94305 USA.	lowe@stanford.edu			National Institutes of Health [DK063624]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK063624 (to A. W. L.).	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Bai ZG, 2011, INT J ONCOL, V38, P375, DOI 10.3892/ijo.2010.873; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034408; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Ebisu S, 1978, Methods Enzymol, V50, P350; Edgell TA, 2010, CLIN SCI, V118, P717, DOI 10.1042/CS20090537; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Fritzsche FR, 2007, HISTOL HISTOPATHOL, V22, P703, DOI 10.14670/HH-22.703; Fukuhara H, 2010, LAB INVEST, V90, P556, DOI 10.1038/labinvest.2010.42; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; GERDES J, 1984, J IMMUNOL, V133, P1710; Goldenring JR, 2010, GASTROENTEROLOGY, V138, P2207, DOI 10.1053/j.gastro.2010.04.023; Gupta A, 2012, J BIOL CHEM, V287, P4773, DOI 10.1074/jbc.M111.301531; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Huh WJ, 2012, GASTROENTEROLOGY, V142, P21, DOI 10.1053/j.gastro.2011.09.050; IHIDA K, 1988, AM J ANAT, V182, P250, DOI 10.1002/aja.1001820306; JEFFREY GP, 1994, GASTROENTEROLOGY, V106, P336, DOI 10.1016/0016-5085(94)90590-8; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Karam SM, 1997, AM J PHYSIOL-GASTR L, V272, pG1209, DOI 10.1152/ajpgi.1997.272.5.G1209; KATAOKA K, 1990, CELL TISSUE RES, V261, P211, DOI 10.1007/BF00318662; Keeley TM, 2010, AM J PHYSIOL-GASTR L, V299, pG1241, DOI 10.1152/ajpgi.00239.2010; Kimura MS, 2011, J GASTROENTEROL, V46, P1292, DOI 10.1007/s00535-011-0443-5; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; LEE ER, 1985, AM J ANAT, V172, P187, DOI 10.1002/aja.1001720303; LEE ER, 1982, AM J ANAT, V164, P187, DOI 10.1002/aja.1001640302; Lee S, 2006, ONCOL REP, V16, P747; LEFEBVRE O, 1993, J CELL BIOL, V122, P191, DOI 10.1083/jcb.122.1.191; Li QT, 1996, J BIOL CHEM, V271, P3671, DOI 10.1074/jbc.271.7.3671; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; Lowe AW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000323; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Mills JC, 2011, GASTROENTEROLOGY, V140, P412, DOI 10.1053/j.gastro.2010.12.001; Miyaoka Y, 2004, ONCOGENE, V23, P3572, DOI 10.1038/sj.onc.1207333; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Nomura S, 2005, AM J PHYSIOL-GASTR L, V288, pG362, DOI 10.1152/ajpgi.00160.2004; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nozaki K, 2008, GASTROENTEROLOGY, V134, P511, DOI 10.1053/j.gastro.2007.11.058; OINUMA T, 1991, ANAT REC, V230, P502, DOI 10.1002/ar.1092300409; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Quante M, 2010, GASTROENTEROLOGY, V139, P2018, DOI 10.1053/j.gastro.2010.08.003; Ramsey VG, 2007, DEVELOPMENT, V134, P211, DOI 10.1242/dev.02700; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Schmidt PH, 1999, LAB INVEST, V79, P639; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; Steele IA, 2007, AM J PHYSIOL-GASTR L, V293, pG347, DOI 10.1152/ajpgi.00076.2007; Thompson DA, 1998, BIOCHEM BIOPH RES CO, V251, P111, DOI 10.1006/bbrc.1998.9440; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; WORKMAN C, 2002, GENOME BIOL, V0003; Yamaoka T, 2000, BIOCHEM BIOPH RES CO, V278, P368, DOI 10.1006/bbrc.2000.3813; Zalzali H, 2008, ONCOGENE, V27, P7131, DOI 10.1038/onc.2008.331; Zhang JS, 2005, GENE CHROMOSOME CANC, V43, P249, DOI 10.1002/gcc.20188; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020	58	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4321	4333		10.1074/jbc.M112.433086	http://dx.doi.org/10.1074/jbc.M112.433086			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23209296	hybrid, Green Published			2022-12-25	WOS:000314845000060
J	De Arras, L; Seng, A; Lackford, B; Keikhaee, MR; Bowerman, B; Freedman, JH; Schwartz, DA; Alper, S				De Arras, Lesly; Seng, Amara; Lackford, Brad; Keikhaee, Mohammad R.; Bowerman, Bruce; Freedman, Jonathan H.; Schwartz, David A.; Alper, Scott			An Evolutionarily Conserved Innate Immunity Protein Interaction Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; C. ELEGANS; TRANSLATIONAL INHIBITION; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; UBIQUITIN LIGASE	The innate immune response plays a critical role in fighting infection; however, innate immunity also can affect the pathogenesis of a variety of diseases, including sepsis, asthma, cancer, and atherosclerosis. To identify novel regulators of innate immunity, we performed comparative genomics RNA interference screens in the nematode Caenorhabditis elegans and mouse macrophages. These screens have uncovered many candidate regulators of the response to lipopolysaccharide (LPS), several of which interact physically in multiple species to form an innate immunity protein interaction network. This protein interaction network contains several proteins in the canonical LPS-responsive TLR4 pathway as well as many novel interacting proteins. Using RNAi and overexpression studies, we show that almost every gene in this network can modulate the innate immune response in mouse cell lines. We validate the importance of this network in innate immunity regulation in vivo using available mutants in C. elegans and mice.	[De Arras, Lesly; Seng, Amara; Alper, Scott] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [De Arras, Lesly; Seng, Amara; Alper, Scott] Univ Colorado, Denver, CO 80206 USA; [De Arras, Lesly; Seng, Amara; Schwartz, David A.; Alper, Scott] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA; [Lackford, Brad] NIEHS, Mol Carcinogenesis Lab, NIH, Durham, NC 27709 USA; [Keikhaee, Mohammad R.; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Freedman, Jonathan H.] NIEHS, Lab Toxicol & Pharmacol, NIH, Durham, NC 27709 USA; [Schwartz, David A.] Univ Colorado, Dept Med, Aurora, CO 80045 USA	National Jewish Health; University of Colorado System; University of Colorado Denver; National Jewish Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Oregon; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Colorado System; University of Colorado Anschutz Medical Campus	Alper, S (corresponding author), Natl Jewish Hlth, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.	alpers@njhealth.org			National Institutes of Health from NIEHS [R21ES019256, Z01ES102045, Z01ES101946]; NHLBI; NIGMS [GM049869]; American Lung Association [RG-169529-N]; NCRR, National Institutes of Health; National Bioresource Project; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019256, Z01ES102045, ZIAES102045, Z01ES101946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Lung Association; NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Bioresource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21ES019256, Z01ES102045, and Z01ES101946 from NIEHS, Intramural Research Programs of NHLBI, and Grant GM049869 from NIGMS. This work was also supported by American Lung Association Grant RG-169529-N.; C. elegans strains were provided by the Caenorhabditis Genetics Center, which is funded by NCRR, National Institutes of Health, and by Dr. Shohei Mitani at the National Bioresource Project. We thank Dr. Ronald Liem for providing the conditional Macf1 knock-out mice and Macf1 overexpression construct.	Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Alper S, 2008, P NATL ACAD SCI USA, V105, P7016, DOI 10.1073/pnas.0802405105; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Bocca SN, 2001, BIOCHEM BIOPH RES CO, V286, P357, DOI 10.1006/bbrc.2001.5394; Bottero V, 2001, J BIOL CHEM, V276, P21317, DOI 10.1074/jbc.M005850200; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Burgo A, 2012, DEV CELL, V23, P166, DOI 10.1016/j.devcel.2012.04.019; Burke B., 2002, MACROPHAGE; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Chae M, 2008, BIOCHEM BIOPH RES CO, V370, P519, DOI 10.1016/j.bbrc.2008.03.136; Chaudhuri N, 2005, CLIN SCI, V109, P125, DOI 10.1042/CS20050044; Chen YC, 2010, NAT METHODS, V7, P667, DOI 10.1038/nmeth0910-667; Childs KS, 2003, NUCLEIC ACIDS RES, V31, P3016, DOI 10.1093/nar/gkg431; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collins LJ, 2009, J HERED, V100, P597, DOI 10.1093/jhered/esp064; Connolly DJ, 2012, CURR OPIN PHARMACOL, V12, P510, DOI 10.1016/j.coph.2012.06.002; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Cuesta N, 2003, J IMMUNOL, V170, P5739, DOI 10.4049/jimmunol.170.11.5739; De Arras L, 2012, J IMMUNOL, V188, P2905, DOI 10.4049/jimmunol.1102595; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Feng ZH, 2001, NEUROSCI LETT, V305, P17, DOI 10.1016/S0304-3940(01)01793-1; Fernandez-Botran R., 2001, METHODS CELLULAR IMM, P8; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guruharsha KG, 2011, CELL, V147, P690, DOI 10.1016/j.cell.2011.08.047; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; HODGES PE, 1994, CURR BIOL, V4, P264, DOI 10.1016/S0960-9822(00)00061-0; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Irazoqui JE, 2010, CLIN EXP IMMUNOL, V160, P48, DOI 10.1111/j.1365-2249.2010.04122.x; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Jaresova I, 2007, MICROBES INFECT, V9, P1359, DOI 10.1016/j.micinf.2007.06.009; Kakinuma T, 2004, EXP CELL RES, V298, P388, DOI 10.1016/j.yexcr.2004.04.047; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KAUFMANN SHE, 2004, INNATE IMMUNE RESPON; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Leung CL, 1999, J CELL BIOL, V147, P1275, DOI 10.1083/jcb.147.6.1275; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Manderson AP, 2007, J CELL BIOL, V178, P57, DOI 10.1083/jcb.200612131; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Moerman Donald G., 2008, Briefings in Functional Genomics & Proteomics, V7, P195, DOI 10.1093/bfgp/eln016; Muhammed M, 2012, MED MYCOL, V50, P488, DOI 10.3109/13693786.2011.648217; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Neufeld TP, 1998, GENETICS, V148, P277; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Osman F, 1999, GENE DEV, V13, P3280, DOI 10.1101/gad.13.24.3280; Phan HH, 2006, GENE, V371, P121, DOI 10.1016/j.gene.2005.11.019; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Polekhina G, 2002, NAT STRUCT BIOL, V9, P68, DOI 10.1038/nsb743; Pukkila-Worley R, 2012, CURR OPIN IMMUNOL, V24, P3, DOI 10.1016/j.coi.2011.10.004; Pukkila-Worley R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002074; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; Rott R, 2008, J BIOL CHEM, V283, P3316, DOI 10.1074/jbc.M704809200; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salkowski CA, 1999, J IMMUNOL, V163, P1529; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Sperling J, 2008, STRUCTURE, V16, P1605, DOI 10.1016/j.str.2008.08.011; Stanley AC, 2012, J LEUKOCYTE BIOL, V92, P1227, DOI 10.1189/jlb.0412191; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Stow JL, 2009, IMMUNOBIOLOGY, V214, P601, DOI 10.1016/j.imbio.2008.11.005; Strack P, 2000, ONCOGENE, V19, P3529, DOI 10.1038/sj.onc.1203647; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van Wijk SJL, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.55; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vigneshkumar B, 2012, ARCH MICROBIOL, V194, P229, DOI 10.1007/s00203-011-0750-5; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Wiles AM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-36; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Wood WB, 1988, NEMATODE CAENORHABDI; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Yang IV, 2011, MOL IMMUNOL, V48, P1886, DOI 10.1016/j.molimm.2011.05.015; Yang IV, 2011, AM J RESP CELL MOL, V45, P393, DOI 10.1165/rcmb.2010-0342OC; Yang IV, 2009, GENETICS, V183, P1535, DOI 10.1534/genetics.109.107540; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]	117	23	23	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1967	1978		10.1074/jbc.M112.407205	http://dx.doi.org/10.1074/jbc.M112.407205			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23209288	Green Published, hybrid			2022-12-25	WOS:000313751400049
J	Xie, FQ; Wu, CG; Weiland, E; Lohman, TM				Xie, Fuqian; Wu, Colin G.; Weiland, Elizabeth; Lohman, Timothy M.			Asymmetric Regulation of Bipolar Single-stranded DNA Translocation by the Two Motors within Escherichia coli RecBCD Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; SITE-DIRECTED MUTAGENESIS; RECOMBINATION HOTSPOT CHI; CONSERVED LYSINE RESIDUE; RECA PROTEIN; HOMOLOGOUS RECOMBINATION; TURNOVER KINETICS; LOOP FORMATION; STEP-SIZE; ENZYME	Repair of double-stranded DNA breaks in Escherichia coli is initiated by the RecBCD helicase that possesses two superfamily-1 motors, RecB (3' to 5' translocase) and RecD (5' to 3' translocase), that operate on the complementary DNA strands to unwind duplex DNA. However, it is not known whether the RecB and RecD motors act independently or are functionally coupled. Here we show by directly monitoring ATP-driven single-stranded DNA translocation of RecBCD that the 5' to 3' rate is always faster than the 3' to 5' rate on DNA without a crossover hotspot instigator site and that the translocation rates are coupled asymmetrically. That is, RecB regulates both 3' to 5' and 5' to 3' translocation, whereas RecD only regulates 5' to 3' translocation. We show that the recently identified RecBC secondary translocase activity functions within RecBCD and that this contributes to the coupling. This coupling has implications for how RecBCD activity is regulated after it recognizes a crossover hotspot instigator sequence during DNA unwinding.	[Xie, Fuqian; Weiland, Elizabeth; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Wu, Colin G.] Univ Iowa, Dept Biochem, Iowa City, IA 52240 USA	Washington University (WUSTL); University of Iowa	Lohman, TM (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	lohman@biochem.wustl.edu			National Institutes of Health [GM045948]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM045948 (to T. M. L.).	AMUNDSEN SK, 1990, GENETICS, V126, P25; Amundsen SK, 2007, GENE DEV, V21, P3296, DOI 10.1101/gad.1605807; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Anderson DG, 1997, GENES CELLS, V2, P117, DOI 10.1046/j.1365-2443.1997.1130311.x; Arnold DA, 2000, J BIOL CHEM, V275, P12261, DOI 10.1074/jbc.275.16.12261; Bianco PR, 1997, P NATL ACAD SCI USA, V94, P6706, DOI 10.1073/pnas.94.13.6706; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Dillingham MS, 2005, J BIOL CHEM, V280, P37069, DOI 10.1074/jbc.M505520200; Dillingham MS, 2003, NATURE, V423, P893, DOI 10.1038/nature01673; Farah JA, 1997, J MOL BIOL, V272, P699, DOI 10.1006/jmbi.1997.1259; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8583, DOI 10.1093/nar/14.21.8583; FINCH PW, 1986, NUCLEIC ACIDS RES, V14, P8573, DOI 10.1093/nar/14.21.8573; Handa N, 2005, MOL CELL, V17, P745, DOI 10.1016/j.molcel.2005.02.011; HSIEH S, 1992, NUCLEIC ACIDS RES, V20, P5647, DOI 10.1093/nar/20.21.5647; KORANGY F, 1992, J BIOL CHEM, V267, P1727; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Lucius AL, 2004, J MOL BIOL, V339, P751, DOI 10.1016/j.jmb.2004.04.010; Lucius AL, 2004, J MOL BIOL, V339, P731, DOI 10.1016/j.jmb.2004.04.009; Lucius AL, 2003, BIOPHYS J, V85, P2224, DOI 10.1016/S0006-3495(03)74648-7; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; MASCOTTI DP, 1995, BIOCHEMISTRY-US, V34, P2908, DOI 10.1021/bi00009a022; Rigden DJ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-9; Saikrishnan K, 2008, EMBO J, V27, P2222, DOI 10.1038/emboj.2008.144; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Smith GR, 2012, MICROBIOL MOL BIOL R, V76, P217, DOI 10.1128/MMBR.05026-11; SMITH GR, 1989, GENOME, V31, P520, DOI 10.1139/g89-100; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Spies M, 2007, CELL, V131, P694, DOI 10.1016/j.cell.2007.09.023; TAYLOR AF, 1995, J BIOL CHEM, V270, P24451, DOI 10.1074/jbc.270.41.24451; Taylor AF, 2003, NATURE, V423, P889, DOI 10.1038/nature01674; Tomko EJ, 2010, METHODS, V51, P269, DOI 10.1016/j.ymeth.2010.03.010; Williams DJ, 2000, METHOD ENZYMOL, V321, P330; Wong CJ, 2008, J MOL BIOL, V378, P761, DOI 10.1016/j.jmb.2008.03.023; Wong CJ, 2006, J MOL BIOL, V362, P26, DOI 10.1016/j.jmb.2006.07.016; Wong CJ, 2005, J MOL BIOL, V352, P765, DOI 10.1016/j.jmb.2005.07.056; Wu CG, 2008, J MOL BIOL, V382, P312, DOI 10.1016/j.jmb.2008.07.012; Wu CG, 2012, J MOL BIOL, V423, P303, DOI 10.1016/j.jmb.2012.07.009; Wu CG, 2010, NAT STRUCT MOL BIOL, V17, P1210, DOI 10.1038/nsmb.1901; Yu M, 1998, J MOL BIOL, V283, P797, DOI 10.1006/jmbi.1998.2127	41	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1055	1064		10.1074/jbc.M112.423384	http://dx.doi.org/10.1074/jbc.M112.423384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23192341	hybrid, Green Published			2022-12-25	WOS:000313570300029
J	Besteiro, MAG; Ulm, R				Besteiro, Marina A. Gonzalez; Ulm, Roman			Phosphorylation and Stabilization of Arabidopsis MAP Kinase Phosphatase 1 in Response to UV-B Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFICITY PROTEIN PHOSPHATASE; SALICYLIC-ACID; PHOSPHOPROTEOMIC ANALYSIS; GENE-EXPRESSION; THALIANA; ACTIVATION; CALMODULIN; YEAST; IDENTIFICATION; TRANSCRIPTION	MAP kinase phosphatases (MKPs) are important regulators of the activation levels and kinetics of MAP kinases. This is crucial for a large number of physiological processes during development and growth, as well as interactions with the environment, including the response to ultraviolet-B (UV-B) stress. Arabidopsis MKP1 is a key regulator of MAP kinases MPK3 and MPK6 in response to UV-B stress. However, virtually nothing is presently known about the post-translational regulation of plant MKPs in vivo. Here, we provide evidence that MKP1 is a phosphoprotein in vivo and that MKP1 accumulates in response to UV-B stress. Moreover, proteasome inhibitor experiments suggest that MKP1 is constantly turned-over under non-stress conditions and that MKP1 is stabilized upon stress treatment. Stress-responsive phosphorylation and stabilization of MKP1 demonstrate the post-translational regulation of a plant MKP in vivo, adding an additional regulatory layer to MAP kinase signaling in plants.	[Besteiro, Marina A. Gonzalez; Ulm, Roman] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva 4, Switzerland; [Besteiro, Marina A. Gonzalez] Univ Freiburg, Inst Biol 2, Fac Biol, D-79104 Freiburg, Germany; [Besteiro, Marina A. Gonzalez] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany	University of Geneva; University of Freiburg; University of Freiburg	Ulm, R (corresponding author), Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva 4, Switzerland.	roman.ulm@unige.ch		Gonzalez Besteiro, Marina Alejandra/0000-0002-9269-792X	Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); Emmy Noether Programme; Swiss National Science Foundation	Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); Emmy Noether Programme(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School), the Emmy Noether Programme, and the Swiss National Science Foundation.	Anderson JR, 2011, PSYCHOL REV, V118, P1, DOI 10.1037/a0022225; Bartels S, 2010, TRENDS PLANT SCI, V15, P322, DOI 10.1016/j.tplants.2010.04.003; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Besteiro MAG, 2011, PLANT J, V68, P727, DOI 10.1111/j.1365-313X.2011.04725.x; Bethke G, 2012, MOL PLANT MICROBE IN, V25, P471, DOI 10.1094/MPMI-11-11-0281; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Flandez M, 2004, J BIOL CHEM, V279, P11027, DOI 10.1074/jbc.M306412200; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Jones AME, 2009, J PROTEOMICS, V72, P439, DOI 10.1016/j.jprot.2009.02.004; Kalbina I, 2006, PLANT CELL ENVIRON, V29, P1783, DOI 10.1111/j.1365-3040.2006.01555.x; Katou S, 2005, J BIOL CHEM, V280, P39569, DOI 10.1074/jbc.M508115200; Katou S, 2007, PLANT CELL PHYSIOL, V48, P332, DOI 10.1093/pcp/pcm007; Lee K, 2008, J BIOL CHEM, V283, P23581, DOI 10.1074/jbc.M801549200; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; Li H, 2009, PROTEOMICS, V9, P1646, DOI 10.1002/pmic.200800420; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Park HC, 2011, PLANT CELL REP, V30, P1523, DOI 10.1007/s00299-011-1064-4; Peck SC, 2006, PLANT J, V45, P512, DOI 10.1111/j.1365-313X.2005.02613.x; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Safrany J, 2008, PLANT J, V54, P402, DOI 10.1111/j.1365-313X.2008.03435.x; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Sohaskey ML, 2002, MOL BIOL CELL, V13, P454, DOI 10.1091/mbc.01-11-0553; Sorensson C, 2012, BIOCHEM J, V446, P271, DOI 10.1042/BJ20111809; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Ulm R, 2002, EMBO J, V21, P6483, DOI 10.1093/emboj/cdf646; Ulm R, 2001, GENE DEV, V15, P699, DOI 10.1101/gad.192601; Wang HC, 2008, PLANT CELL, V20, P602, DOI 10.1105/tpc.108.058032; Wang HC, 2007, PLANT CELL, V19, P63, DOI 10.1105/tpc.106.048298; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yamakawa H, 2004, J BIOL CHEM, V279, P928, DOI 10.1074/jbc.M310277200; Yoo JH, 2004, J BIOL CHEM, V279, P848, DOI 10.1074/jbc.M310709200; Zaidi I, 2010, PLANT MOL BIOL, V73, P325, DOI 10.1007/s11103-010-9617-4	43	34	35	2	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					480	486		10.1074/jbc.M112.434654	http://dx.doi.org/10.1074/jbc.M112.434654			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23188831	hybrid, Green Published			2022-12-25	WOS:000313197200048
J	Salawu, A; Ul-Hassan, A; Hammond, D; Fernando, M; Reed, M; Sisley, K				Salawu, Abdulazeez; Ul-Hassan, Aliya; Hammond, David; Fernando, Malee; Reed, Malcolm; Sisley, Karen			High Quality Genomic Copy Number Data from Archival Formalin-Fixed Paraffin-Embedded Leiomyosarcoma: Optimisation of Universal Linkage System Labelling	PLOS ONE			English	Article							ARRAY-CGH; HYBRIDIZATION; DNA; CANCER; AMPLIFICATION; MICROARRAY	Most soft tissue sarcomas are characterized by genetic instability and frequent genomic copy number aberrations that are not subtype-specific. Oligonucleotide microarray-based Comparative Genomic Hybridisation (array CGH) is an important technique used to map genome-wide copy number aberrations, but the traditional requirement for high-quality DNA typically obtained from fresh tissue has limited its use in sarcomas. Although large archives of Formalin-fixed Paraffin-embedded (FFPE) tumour samples are available for research, the degradative effects of formalin on DNA from these tissues has made labelling and analysis by array CGH technically challenging. The Universal Linkage System (ULS) may be used for a one-step chemical labelling of such degraded DNA. We have optimised the ULS labelling protocol to perform aCGH on archived FFPE leiomyosarcoma tissues using the 180k Agilent platform. Preservation age of samples ranged from a few months to seventeen years and the DNA showed a wide range of degradation (when visualised on agarose gels). Consistently high DNA labelling efficiency and low microarray probe-to-probe variation (as measured by the derivative log ratio spread) was seen. Comparison of paired fresh and FFPE samples from identical tumours showed good correlation of CNAs detected. Furthermore, the ability to macro-dissect FFPE samples permitted the detection of CNAs that were masked in fresh tissue. Aberrations were visually confirmed using Fluorescence in situ Hybridisation. These results suggest that archival FFPE tissue, with its relative abundance and attendant clinical data may be used for effective mapping for genomic copy number aberrations in such rare tumours as leiomyosarcoma and potentially unravel clues to tumour origins, progression and ultimately, targeted treatment. Citation: Salawu A, Ul-Hassan A, Hammond D, Fernando M, Reed M, et al. (2012) High Quality Genomic Copy Number Data from Archival Formalin-Fixed Paraffin-Embedded Leiomyosarcoma: Optimisation of Universal Linkage System Labelling. PLoS ONE 7(11): e50415. doi: 10.1371/journal.pone.0050415	[Salawu, Abdulazeez; Ul-Hassan, Aliya; Hammond, David; Reed, Malcolm; Sisley, Karen] Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England; [Fernando, Malee] Royal Hallamshire Hosp, Sheffield Teaching Hosp, Dept Histopathol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield	Salawu, A (corresponding author), Univ Sheffield, Sch Med, Dept Oncol, Sheffield, S Yorkshire, England.	asalawu@me.com	Reed, Malcolm Walter/AAG-9219-2020; Salawu, Abdulazeez/AAY-1728-2020; Sisley, Karen/B-7296-2019	Reed, Malcolm Walter/0000-0001-7442-2132; Salawu, Abdulazeez/0000-0002-4420-0958; Sisley, Karen/0000-0002-5565-2618	Sarcoma Trust/Sarcoma UK; The Betty Waind Trust, Weston Park Hospital Cancer charity; Sarcoma UK [SUK04.2009] Funding Source: researchfish	Sarcoma Trust/Sarcoma UK; The Betty Waind Trust, Weston Park Hospital Cancer charity; Sarcoma UK	This work was supported by funds from Sarcoma Trust/Sarcoma UK and also The Betty Waind Trust, Weston Park Hospital Cancer charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers JC, 1999, GENE CHROMOSOME CANC, V25, P301, DOI 10.1002/(SICI)1098-2264(199907)25:3<301::AID-GCC13>3.0.CO;2-1; Barretina J, 2010, NAT GENET; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Braggio E, 2011, CLIN CANCER RES, V17, P4245, DOI 10.1158/1078-0432.CCR-11-0395; Chen ZB, 2011, GENE CHROMOSOME CANC, V50, P689, DOI 10.1002/gcc.20891; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; de Jong Danielle, 2011, BMC Res Notes, V4, P1, DOI 10.1186/1756-0500-4-1; Derre J, 2001, LAB INVEST, V81, P211, DOI 10.1038/labinvest.3780229; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirsch D, 2012, GENE CHROMOSOME CANC, V51, P490, DOI 10.1002/gcc.21937; Hostetter G, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp881; Hu J, 2005, CANCER GENET CYTOGEN, V161, P20, DOI 10.1016/j.cancergencyto.2005.01.011; Italiano A, 2008, INT J CANCER, V122, P2233, DOI 10.1002/ijc.23380; Kwek SS, 2009, ONCOGENE, V28, P1892, DOI 10.1038/onc.2009.34; Larramendy ML, 2006, CANCER GENET CYTOGEN, V169, P94, DOI 10.1016/j.cancergencyto.2006.01.008; Mankoo PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024709; Mc Sherry EA, 2007, CLIN GENET, V72, P441, DOI 10.1111/j.1399-0004.2007.00882.x; Oikawa M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-168; Perot G, 2009, CANCER RES, V69, P2269, DOI 10.1158/0008-5472.CAN-08-1443; Rossi E, 2011, HUM PATHOL, V42, P1937, DOI 10.1016/j.humpath.2011.02.016; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Szponar A, 2010, HISTOPATHOLOGY, V56, P212, DOI 10.1111/j.1365-2559.2009.03473.x; Tan DSP, 2007, LAB INVEST, V87, P737, DOI 10.1038/labinvest.3700593; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Ul-Hassan A, 2009, INT J EXP PATHOL, V90, P549, DOI 10.1111/j.1365-2613.2009.00680.x; van Beers EH, 2006, BRIT J CANCER, V94, P333, DOI 10.1038/sj.bjc.6602889; Ylipaa A, 2011, CANCER, V117, P308	29	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50415	10.1371/journal.pone.0050415	http://dx.doi.org/10.1371/journal.pone.0050415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209738	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000312104900051
J	Addamo, AM; Reimer, JD; Taviani, M; Freiwald, A; Machordom, A				Addamo, Anna M.; Reimer, James D.; Taviani, Marco; Freiwald, Andre; Machordom, Annie			Desmophyllum dianthus (Esper, 1794) in the Scleractinian Phylogeny and Its Intraspecific Diversity	PLOS ONE			English	Article							WATER CORALS; SECONDARY STRUCTURE; SEQUENCE EVOLUTION; STONY CORALS; GENE FLOW; DEEP; MITOCHONDRIAL; ANTHOZOA; PATTERNS; ORIGINS	The cosmopolitan solitary deep-water scleractinian coral Desmophyllum dianthus (Esper, 1794) was selected as a representative model species of the polyphyletic Caryophylliidae family to (1) examine phylogenetic relationships with respect to the principal Scleractinia taxa, (2) check population structure, (3) test the widespread connectivity hypothesis and (4) assess the utility of different nuclear and mitochondrial markers currently in use. To carry out these goals, DNA sequence data from nuclear (ITS and 28S) and mitochondrial (16S and COI) markers were analyzed for several coral species and for Mediterranean populations of D. dianthus. Three phylogenetic methodologies (ML, MP and BI), based on data from the four molecular markers, all supported D. dianthus as clearly belonging to the "robust'' clade, in which the species Lophelia pertusa and D. dianthus not only grouped together, but also shared haplotypes for some DNA markers. Molecular results also showed shared haplotypes among D. dianthus populations distributed in regions separated by several thousands of kilometers and by clear geographic barriers. These results could reflect limited molecular and morphological taxonomic resolution rather than real widespread connectivity. Additional studies are needed in order to find molecular markers and morphological features able to disentangle the complex phylogenetic relationship in the Order Scleractinia and to differentiate isolated populations, thus avoiding the homoplasy found in some morphological characters that are still considered in the literature.	[Addamo, Anna M.; Machordom, Annie] CSIC, Dept Biodiversidad & Biol Evolutiva, Museo Nacl Ciencias Nat, Madrid, Spain; [Reimer, James D.] Univ Ryukyus, Rising Star Program Trans Disciplinary Org Subtro, Nishihara, Okinawa 90301, Japan; [Taviani, Marco] CNR, Ist Sci Marine, Bologna, Italy; [Taviani, Marco] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Freiwald, Andre] Senckenberg Meer, Dept Marine Res, Wilhelmshaven, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of the Ryukyus; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Woods Hole Oceanographic Institution; Senckenberg Gesellschaft fur Naturforschung (SGN)	Addamo, AM (corresponding author), CSIC, Dept Biodiversidad & Biol Evolutiva, Museo Nacl Ciencias Nat, Madrid, Spain.	annamaria@mncn.csic.es	Freiwald, Andre/C-2061-2018; Machordom, Annie/K-1737-2014; Reimer, James Davis/AAP-1331-2020; Taviani, Marco/AAF-2168-2020; Addamo, Anna Maria/R-9014-2018; CNR, Ismar/P-1247-2014	Freiwald, Andre/0000-0002-2335-4042; Machordom, Annie/0000-0003-0341-0809; Taviani, Marco/0000-0003-0414-4274; Addamo, Anna Maria/0000-0002-1228-2143; CNR, Ismar/0000-0001-5351-1486	"Ministerio de Ciencia e Innovacion'' (Spain) [CTM2009-00496, CGL2011-23306]; European Commission [GOCE-CT-2005-511234-1, 287844]; EU [226354]; Regione Puglia	"Ministerio de Ciencia e Innovacion'' (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); EU(European Commission); Regione Puglia(Regione Puglia)	This study was funded by CTM2009-00496 and CGL2011-23306 projects of the "Ministerio de Ciencia e Innovacion'' (Spain). Research at sea was partly supported by the European Commission F. P.VI Project HERMES Contract No. GOCE-CT-2005-511234-1) and the EU F.P. VII Project HERMIONE(contract number no. 226354). It is a contribution to European Commission COCONET F.P. VII Project(Grant agreement no: 287844), and P. O FESR 2007/2013-ASSE IV. Linea 4.4 BIOMAP project of the Regione Puglia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JF, 2004, EARTH PLANET SC LETT, V227, P481, DOI 10.1016/j.epsl.2004.08.022; Barbeitos MS, 2010, P NATL ACAD SCI USA, V107, P11877, DOI 10.1073/pnas.0914380107; Bininda-Emonds Olaf R. P., 2010, Palaeodiversity, P99; Boyle EA, 2006, SCIENCE, V312, P1758, DOI 10.1126/science.1129723; Brandao SN, 2010, MOL PHYLOGENET EVOL, V55, P1055, DOI 10.1016/j.ympev.2010.01.014; Budd AF, 2010, INTEGR COMP BIOL, V50, P411, DOI 10.1093/icb/icq062; Burgess SC, 2011, MAR ECOL PROG SER, V440, P151, DOI 10.3354/meps09374; Cairns S.D., 1982, Antarctic Research Series, V34, P1; Cairns SD, 2007, B MAR SCI, V81, P311; Cairns Stephen D., 1997, Memoires du Museum National d'Histoire Naturelle, V172, P27; Calvo M, 2009, BIOL J LINN SOC, V96, P898, DOI 10.1111/j.1095-8312.2008.01167.x; Carlon DB, 2002, EVOLUTION, V56, P2227; Chen CA, 2004, ZOOL STUD, V43, P759; Chen IP, 2009, MAR BIOTECHNOL, V11, P141, DOI 10.1007/s10126-008-9129-2; Coleman AW, 2008, J MOL EVOL, V67, P389, DOI 10.1007/s00239-008-9160-y; Combosch DJ, 2008, MOL ECOL, V17, P1304, DOI 10.1111/j.1365-294X.2007.03672.x; Costantini F, 2010, MAR ECOL-EVOL PERSP, V31, P261, DOI 10.1111/j.1439-0485.2009.00333.x; Cuif JP, 2003, ZOOL SCR, V32, P459, DOI 10.1046/j.1463-6409.2003.00133.x; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duenas LF, 2009, MAR ECOL PROG SER, V397, P11, DOI 10.3354/meps08307; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Eytan RI, 2009, MOL ECOL, V18, P2375, DOI 10.1111/j.1365-294X.2009.04202.x; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; Faure B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006485; Fink HG, 2012, DEEP-SEA RES PT I, V62, P89, DOI 10.1016/j.dsr.2011.12.013; Forsterra F, 2008, MAR ECOL PROG SER, V370, P121, DOI 10.3354/meps07630; Foersterra G., 2003, Zoologische Verhandelingen (Leiden), V345, P117; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Freiwald A, 2009, OCEANOGRAPHY, V22, P58, DOI 10.5670/oceanog.2009.06; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Gage J. D., 1991, DEEP SEA BIOL NATURA; Graham EM, 2008, CORAL REEFS, V27, P529, DOI 10.1007/s00338-008-0361-z; GRANGE KR, 1981, NEW ZEAL J ZOOL, V8, P209, DOI 10.1080/03014223.1981.10427963; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Guinotte JM, 2008, ANN NY ACAD SCI, V1134, P320, DOI 10.1196/annals.1439.013; Harrison LP, 2011, CORAL REEFS ECOSYSTE; Hellberg ME, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-24; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Huang DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034459; Hugall A, 1999, MOL BIOL EVOL, V16, P157, DOI 10.1093/oxfordjournals.molbev.a026098; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Kitahara MV, 2010, SYST BIODIVERS, V8, P91, DOI 10.1080/14772000903571088; Knowles LL, 2002, MOL ECOL, V11, P2623, DOI 10.1046/j.1365-294X.2002.01637.x; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Le Goff-Vitry MC, 2004, MOL ECOL, V13, P537, DOI 10.1046/j.1365-294X.2004.2079.x; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Mastrototaro F., 2002, Biologia Marina Mediterranea, V9, P616; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miller K, 2010, MAR ECOL-EVOL PERSP, V31, P144, DOI 10.1111/j.1439-0485.2010.00380.x; Miller K, 2011, TLS-TIMES LIT SUPPL, P6; Millot C, 2005, HANDB ENVIRON CHEM, V5, P29, DOI 10.1007/b107143; Montagna P, 2006, SCIENCE, V312, P1788, DOI 10.1126/science.1125781; Nunes FLD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022298; Orejas C, 2009, MAR ECOL PROG SER, V397, P37, DOI 10.3354/meps08314; PECHENIK JA, 1990, OPHELIA, V32, P63, DOI 10.1080/00785236.1990.10422025; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5; Rambaut A., 2002, SE AL ALIGNMENT EDIT; Raupach MJ, 2007, DEEP SEA RES 2, V54, P304; Reithdorf JR, 2008, THESIS; Ren FR, 2009, GENE, V441, P119, DOI 10.1016/j.gene.2008.04.002; Risk MJ, 2002, HYDROBIOLOGIA, V471, P125, DOI 10.1023/A:1016557405185; Roberts J.M., 2009, COLD WATER CORALS BI; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rodriguez-Lanetty M, 2002, MOL ECOL, V11, P1177, DOI 10.1046/j.1365-294X.2002.01511.x; Rogers AD, 2000, DEEP-SEA RES PT II, V47, P119, DOI 10.1016/S0967-0645(99)00107-1; Romano SL, 2000, B MAR SCI, V67, P1043; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHELTEMA RS, 1986, B MAR SCI, V39, P290; Schembri PJ, 2007, CAH BIOL MAR, V48, P77; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; SORAUF J E, 1977, Palaeontology (Oxford), V20, P1; Stefani F, 2008, ZOOL SCR, V37, P71, DOI 10.1111/j.1463-6409.2007.00309.x; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Swofford DL, 2002, PAUP PHYLOGENY ANAL; Taviani M., 2011, MAR RES CNR, V6, P705; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trewick SA, 2001, EVOLUTION, V55, P2170; Trincardi F, 2007, MAR GEOL, V246, P208, DOI 10.1016/j.margeo.2007.01.013; Vollmer SV, 2004, MOL ECOL, V13, P2763, DOI 10.1111/j.1365-294X.2004.02265.x; von Haeseler A, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-13; Waller RG, 2005, CORAL REEFS, V24, P594, DOI 10.1007/s00338-005-0031-3; Wang S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r126; Zardus JD, 2006, MOL ECOL, V15, P639, DOI 10.1111/j.1365-294X.2005.02832.x; ZIBROWIUS H, 1980, Memoires de l'Institut Oceanographique (Monaco), P1	90	17	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50215	10.1371/journal.pone.0050215	http://dx.doi.org/10.1371/journal.pone.0050215			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209679	Green Published, gold			2022-12-25	WOS:000312601700043
J	Janssen, MJ; Salomon, J; te Morsche, RHM; Drenth, JPH				Janssen, Manoe J.; Salomon, Jody; te Morsche, Rene H. M.; Drenth, Joost P. H.			Loss of Heterozygosity Is Present in SEC63 Germline Carriers with Polycystic Liver Disease	PLOS ONE			English	Article							KIDNEY-DISEASE; CYST FORMATION; SOMATIC MUTATIONS; 2-HIT MODEL; PRKCSH; GENES; CYSTOGENESIS; SECONDARY; SUPPORTS; REGION	Polycystic liver disease (PCLD) is an autosomal dominant disorder characterised by multiple fluid filled cysts in the liver. This rare disease is caused by heterozygous germline mutations in PRKCSH and SEC63. We previously found that, in patients with a PRKCSH mutation, over 76% of the cysts acquired a somatic 'second-hit' mutation in the wild type PRKCSH allele. We hypothesise that somatic second-hit mutations are a general mechanism of cyst formation in PCLD which also plays a role in PCLD patients carrying a SEC63 germline mutation. We collected cyst epithelial cells from 52 liver cysts from three different SEC63 patients using laser microdissection. DNA samples were sequenced to identify loss of heterozygosity (LOH) mutations and other somatic mutations in cyst epithelial DNA. We discovered somatic SEC63 mutations in patient 3 (1/14 cysts), but not in patient 1 and 2 (38 cysts). Upon review we found that the germline mutation of patient 1 and 2 (SEC63 c.1703_1705delAAG) was present in the same frequency in DNA samples from healthy controls, suggesting that this variant is not causative of PCLD. In conclusion, as somatic second-hit mutations also play a role in cyst formation in patients with a SEC63 germline mutation, this appears to be a general mechanism of cyst formation in PCLD.	[Janssen, Manoe J.; Salomon, Jody; te Morsche, Rene H. M.; Drenth, Joost P. H.] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Drenth, JPH (corresponding author), Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	joostphdrenth@cs.com	Janssen, Manoe/AAM-5579-2020; Drenth, Joost/V-7436-2019; te Morsche, R/P-9143-2015; Janssen, Manoe/C-4606-2011; Drenth, J.P.H./H-8025-2014	Janssen, Manoe/0000-0002-0544-8096; Janssen, Manoe/0000-0002-0544-8096; 	Institute for Genetic and Metabolic Diseases (Radboud University Nijmegen Medical Center)	Institute for Genetic and Metabolic Diseases (Radboud University Nijmegen Medical Center)	Funding for this study was provided by the Institute for Genetic and Metabolic Diseases (Radboud University Nijmegen Medical Center). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Burnichon N, 2010, HUM MOL GENET, V19, P3011, DOI 10.1093/hmg/ddq206; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; Diouf B, 2011, NAT MED, V17, P1298, DOI 10.1038/nm.2430; Drenth JPH, 2005, TRENDS MOL MED, V11, P37, DOI 10.1016/j.molmed.2004.11.004; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Janssen MJ, 2011, GASTROENTEROLOGY, V141, P2056, DOI 10.1053/j.gastro.2011.08.004; Janssen MJ, 2010, J HEPATOL, V52, P432, DOI 10.1016/j.jhep.2009.12.011; Koptides M, 1999, HUM MOL GENET, V8, P509, DOI 10.1093/hmg/8.3.509; Koptides M, 1998, HUM GENET, V103, P709, DOI 10.1007/s004390050896; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pei Y, 1999, J AM SOC NEPHROL, V10, P1524; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; van Dijk MCRF, 2003, J CLIN PATHOL-MOL PA, V56, P240, DOI 10.1136/mp.56.4.240; van Keimpema L, 2008, J GASTROINTEST SURG, V12, P477, DOI 10.1007/s11605-007-0376-8; van Keimpema L, 2011, LIVER INT, V31, P92, DOI 10.1111/j.1478-3231.2010.02247.x; Waanders E, 2010, CLIN GENET, V78, P47, DOI 10.1111/j.1399-0004.2009.01353.x; Waanders E, 2008, MODERN PATHOL, V21, P1293, DOI 10.1038/modpathol.2008.115; Waanders E, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9441; Waanders E, 2008, HISTOCHEM CELL BIOL, V129, P301, DOI 10.1007/s00418-008-0381-3; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137	27	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50324	10.1371/journal.pone.0050324	http://dx.doi.org/10.1371/journal.pone.0050324			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209713	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700059
J	Liu, J; Zhao, MR; Zhuang, SL; Yang, Y; Yang, Y; Liu, WP				Liu, Jing; Zhao, Meirong; Zhuang, Shulin; Yang, Yan; Yang, Ye; Liu, Weiping			Low Concentrations of o,p '-DDT Inhibit Gene Expression and Prostaglandin Synthesis by Estrogen Receptor-Independent Mechanism in Rat Ovarian Cells	PLOS ONE			English	Article							HUMAN FOLLICULAR-FLUID; SIDE-CHAIN CLEAVAGE; GRANULOSA-CELLS; IN-VITRO; ORGANOCHLORINE COMPOUNDS; METHOXYCHLOR METABOLITE; SERUM CONCENTRATIONS; ORGANIC POLLUTANTS; SOUTH-AFRICA; BISPHENOL-A	o,p'-DDT is an infamous xenoestrogen as well as a ubiquitous and persistent pollutant. Biomonitoring studies show that women have been internally exposed to o, p'-DDT at range of 0.3-500 ng/g (8.46 x 10(-10) M-1.41 x 10(-6) M) in blood and other tissues. However, very limited studies have investigated the biological effects and mechanism(s) of o, p'-DDT at levels equal to or lower than current exposure levels in human. In this study, using primary cultures of rat ovarian granulosa cells, we determined that very low doses of o,p'-DDT (10(-12)-10(-8) M) suppressed the expression of ovarian genes and production of prostaglandin E2 (PGE2). In vivo experiments consistently demonstrated that o,p'-DDT at 0.5-1 mg/kg inhibited the gene expression and PGE2 levels in rat ovary. The surprising results from the receptor inhibitors studies showed that these inhibitory effects were exerted independently of either classical estrogen receptors (ERs) or G protein-coupled receptor 30 (GPR30). Instead, o,p'-DDT altered gene expression or hormone action via inhibiting the activation of protein kinase A (PKA), rather than protein kinase C (PKC). We further revealed that o,p'-DDT directly interfered with the PKA catalytic subunit. Our novel findings support the hypothesis that exposure to low concentrations of o,p'-DDT alters gene expression and hormone synthesis through signaling mediators beyond receptor binding, and imply that the current exposure levels of o,p'-DDT observed in the population likely poses a health risk to female reproduction.	[Liu, Jing; Zhuang, Shulin; Yang, Ye; Liu, Weiping] Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Meirong; Yang, Yan] Zhejiang Univ Technol, Coll Biol & Environm Engn, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University of Technology	Liu, WP (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	wliu@zju.edu.cn	Liu, Weiping/E-9208-2010; Jing, Liu/K-8655-2014; Zhuang, Shulin/L-1999-2013; Zhao, Meirong/E-9679-2014	Liu, Weiping/0000-0002-1173-892X; Jing, Liu/0000-0001-8892-036X; Zhuang, Shulin/0000-0002-7774-7239; Zhao, Meirong/0000-0003-3132-9223	National Basic Research Program of China [2009CB421603]; National Natural Science Foundation of China [21007056, 20837002]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2009CB421603, http://www.most.gov.cn/) and the National Natural Science Foundation of China (21007056 and 20837002, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul Y, 2008, REPROD TOXICOL, V25, P67, DOI 10.1016/j.reprotox.2007.10.007; Axmon A, 2006, HUM REPROD, V21, P657, DOI 10.1093/humrep/dei397; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; Beard J, 2006, SCI TOTAL ENVIRON, V355, P78, DOI 10.1016/j.scitotenv.2005.02.022; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; BULGER WH, 1983, AM J IND MED, V4, P163, DOI 10.1002/ajim.4700040115; Cohn BA, 2003, LANCET, V361, P2205, DOI 10.1016/S0140-6736(03)13776-2; Damstra T, 2002, GLOBAL ASSESSMENT ST, P51; Darnerud PO, 2011, SCI TOTAL ENVIRON, V409, P4048, DOI 10.1016/j.scitotenv.2011.05.054; De Felip E, 2004, CHEMOSPHERE, V54, P1445, DOI 10.1016/j.chemosphere.2003.10.040; Eskenazi B, 2009, ENVIRON HEALTH PERSP, V117, P1359, DOI 10.1289/ehp.11748; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Frigo DE, 2002, ENVIRON HEALTH PERSP, V110, P1239, DOI 10.1289/ehp.021101239; GELLERT RJ, 1972, ENDOCRINOLOGY, V91, P1095, DOI 10.1210/endo-91-4-1095; Gershon E, 2007, FASEB J, V21, P1893, DOI 10.1096/fj.06-7688com; Ghosh D, 1999, ENDOCRINOLOGY, V140, P3526, DOI 10.1210/en.140.8.3526; Glynn A, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-2; Guo Y, 2009, ENVIRON POLLUT, V157, P1753, DOI 10.1016/j.envpol.2008.12.026; Han EH, 2010, TOXICOL LETT, V198, P331, DOI 10.1016/j.toxlet.2010.07.015; HANEY AF, 1990, REPROD TOXICOL, V4, P3, DOI 10.1016/0890-6238(90)90072-4; Harvey CN, 2009, TOXICOL SCI, V110, P95, DOI 10.1093/toxsci/kfp089; HEINRICH.WL, 1971, SCIENCE, V173, P642, DOI 10.1126/science.173.3997.642; Itoh H, 2009, CANCER CAUSE CONTROL, V20, P567, DOI 10.1007/s10552-008-9265-z; Jirsova S, 2010, FERTIL STERIL, V93, P1831, DOI 10.1016/j.fertnstert.2008.12.063; Jo M, 2006, MOL ENDOCRINOL, V20, P2156, DOI 10.1210/me.2005-0512; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Khan K, 2005, CORE CLIN CASES OBST, P152; Kiyosawa N, 2008, TOXICOL SCI, V101, P350, DOI 10.1093/toxsci/kfm275; Kojima H, 2004, ENVIRON HEALTH PERSP, V112, P524, DOI 10.1289/ehp.6649; Kozul D, 2009, B ENVIRON CONTAM TOX, V83, P880, DOI 10.1007/s00128-009-9833-2; Kristensen DM, 2011, ENVIRON HEALTH PERSP, V119, P534, DOI 10.1289/ehp.1002635; Law DCG, 2005, AM J EPIDEMIOL, V162, P523, DOI 10.1093/aje/kwi240; LEE HT, 1990, ENDOCRINOLOGY, V126, P779, DOI 10.1210/endo-126-2-779; Lee YM, 2007, J VET SCI, V8, P27, DOI 10.4142/jvs.2007.8.1.27; Li FX, 2011, MOL ENDOCRINOL, V25, P445, DOI 10.1210/me.2010-0250; Li FX, 2009, ENDOCRINOLOGY, V150, P3894, DOI 10.1210/en.2008-1650; Liu J, 2011, TOXICOLOGY, V290, P42, DOI 10.1016/j.tox.2011.08.016; Liu J, 2011, TOXICOLOGY, V282, P47, DOI 10.1016/j.tox.2011.01.007; Liu J, 2010, MOL ENDOCRINOL, V24, P1203, DOI 10.1210/me.2009-0325; Liu J, 2009, ENDOCRINOLOGY, V150, P3291, DOI 10.1210/en.2008-1527; Lundholm CE, 1997, COMP BIOCHEM PHYS C, V118, P113, DOI 10.1016/S0742-8413(97)00105-9; Mishra K, 2011, SCI TOTAL ENVIRON, V409, P4939, DOI 10.1016/j.scitotenv.2011.07.038; Niswender GD, 2002, REPRODUCTION, V123, P333, DOI 10.1530/rep.0.1230333; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Pescador N, 1997, BIOL REPROD, V57, P660, DOI 10.1095/biolreprod57.3.660; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Robker RL, 1998, BIOL REPROD, V59, P476, DOI 10.1095/biolreprod59.3.476; Robker RL, 2000, STEROIDS, V65, P559, DOI 10.1016/S0039-128X(00)00114-8; Rollin HB, 2009, SCI TOTAL ENVIRON, V408, P146, DOI 10.1016/j.scitotenv.2009.08.049; Sholtz RI, 2011, ENVIRON INT, V37, P709, DOI 10.1016/j.envint.2011.01.013; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Tiemann U, 2008, REPROD TOXICOL, V25, P316, DOI 10.1016/j.reprotox.2008.03.002; Toft G, 2008, HUM REPROD, V23, P193, DOI 10.1093/humrep/dem349; Ulrich EM, 2000, ENVIRON HEALTH PERSP, V108, P973, DOI 10.2307/3435057; Waclawik A, 2011, REPRODUCTION, V142, P389, DOI 10.1530/REP-11-0033; Wang YR, 2008, SCI TOTAL ENVIRON, V396, P34, DOI 10.1016/j.scitotenv.2008.02.060; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wojtowicz AK, 2004, POL J PHARMACOL, V56, P465; Wu YL, 2002, BIOL REPROD, V66, P1505, DOI 10.1095/biolreprod66.5.1505; Younglai EV, 2002, ARCH ENVIRON CON TOX, V43, P121, DOI 10.1007/s00244-001-0048-8	60	26	27	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49916	10.1371/journal.pone.0049916	http://dx.doi.org/10.1371/journal.pone.0049916			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209616	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800032
J	Plageman, TF; Lang, RA				Plageman, Timothy F., Jr.; Lang, Richard A.			Generation of an Rx-tTA: TetOp-Cre Knock-In Mouse Line for Doxycycline Regulated Cre Activity in the Rx Expression Domain	PLOS ONE			English	Article							RETINAL PROGENITOR CELLS; TRANSGENIC MICE; GENE-EXPRESSION; EYE DEVELOPMENT; PROTEIN; PAX6; RECOMBINATION; REPORTER	Genetic deletion of mouse genes has played a crucial role in our understanding of embryonic eye development. Transgenic, tissue specific Cre recombinase expression in various eye structures has facilitated these experiments. However, an early expressing, temporally-regulated, optic vesicle-specific Cre line has not been available. In this report, we detail the generation and analysis of a knock-in, inducible Cre line designed to drive recombination specifically within the Rx expression domain. Crossing this line with a reporter line demonstrates that recombination can be mediated within the early optic vesicle and throughout retinal development. Recombination can also be mediated in the Rx-expressing, ventral diencephalon and future posterior pituitary gland. Furthermore, it was demonstrated that dietary doxycycline could effectively modulate Cre activity. This line has the potential to facilitate conditional knock-out experimentation to study early retina and/or posterior pituitary development.	[Plageman, Timothy F., Jr.; Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Childrens Hosp Res Fdn, Visual Syst Grp, Cincinnati, OH USA; [Plageman, Timothy F., Jr.; Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Childrens Hosp Res Fdn, Div Pediat Ophthalmol, Cincinnati, OH USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Lang, Richard A.] Univ Cincinnati, Dept Ophthalmol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Cincinnati	Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Childrens Hosp Res Fdn, Visual Syst Grp, Cincinnati, OH USA.	Richard.Lang@cchmc.org	Plageman, Timothy/C-6638-2013	Plageman, Timothy/0000-0001-6565-2577; Lang, Richard/0000-0002-5212-254X	National Institutes of Health (NIH) [R01 EY17848]; Abrahamson Pediatric Eye Institute Endowment at Children's Hospital Medical Center of Cincinnati; NATIONAL EYE INSTITUTE [R01EY017848, R01EY016241] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abrahamson Pediatric Eye Institute Endowment at Children's Hospital Medical Center of Cincinnati; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work received grant support from the National Institutes of Health (NIH) (R01 EY17848) and from the Abrahamson Pediatric Eye Institute Endowment at Children's Hospital Medical Center of Cincinnati to R. A. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Cai ZG, 2010, J NEUROSCI, V30, P4110, DOI 10.1523/JNEUROSCI.4364-09.2010; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Jaisser F, 2000, J AM SOC NEPHROL, V11, pS95; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Mori M, 2002, INVEST OPHTH VIS SCI, V43, P1384; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Pinter R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010021; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Swindell EC, 2006, GENESIS, V44, P361, DOI 10.1002/dvg.20225; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Zhang L, 2000, GENESIS, V28, P135, DOI 10.1002/1526-968X(200011/12)28:3/4<135::AID-GENE70>3.0.CO;2-P	18	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50426	10.1371/journal.pone.0050426	http://dx.doi.org/10.1371/journal.pone.0050426			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209739	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800071
J	Schell, H; Boden, C; Chagas, AM; Kahle, PJ				Schell, Heinrich; Boden, Cindy; Chagas, Andre Maia; Kahle, Philipp J.			Impaired c-Fos and Polo-Like Kinase 2 Induction in the Limbic System of Fear-conditioned alpha-Synuclein Transgenic Mice	PLOS ONE			English	Article							PARKINSONS-DISEASE; SYNAPTIC PLASTICITY; LEWY BODIES; MOUSE MODEL; PHOSPHORYLATION; MUTATION; PROTEIN; BRAIN; LOCALIZATION; EXPRESSION	alpha-Synuclein (alpha SYN) is genetically and neuropathologically linked to a spectrum of neurodegenerative diseases including Parkinson's disease, dementia with Lewy bodies, and related disorders. Cognitive impairment is recapitulated in several alpha SYN transgenic mouse lines. However, the mechanisms of dysfunction in affected neurons are largely unknown. Here we measured neuronal activity induced gene products in the limbic system of alpha SYN transgenic mice upon fear conditioning (FC). Induction of the synaptic plasticity marker c-Fos was significantly reduced in the amygdala and hippocampus of (Thy1)-h[A30P]alpha SYN transgenic mice in an age-dependent manner. Similarly, the neuronal activity inducible polo-like kinase 2 (Plk2) that can phosphorylate alpha SYN at the pathological site serine-129 was up-regulated in both brain regions upon FC. Plk2 inductions were also significantly impaired in aged (Thy1)-h[A30P] alpha SYN transgenic mice, both in the amygdala and hippocampus. Plk2 inductions in the amygdala after FC were paralleled by a small but significant increase in the number of neuronal cell bodies immunopositive for serine-129 phosphorylated alpha SYN in young but not aged (Thy1)-h[A30P] alpha SYN transgenic mice. In addition, we observed in the aged hippocampus a distinct type of apparently unmodified transgenic alpha SYN profiles resembling synaptic accumulations of alpha SYN. Thus, the cognitive decline observed in aged alpha SYN transgenic mice might be due to impairment of neurotransmission and synaptic plasticity in the limbic system by distinct alpha SYN species.	[Schell, Heinrich; Kahle, Philipp J.] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany; [Schell, Heinrich; Boden, Cindy; Kahle, Philipp J.] Univ Tubingen, German Ctr Neurodegenerat Dis, Tubingen, Germany; [Chagas, Andre Maia; Kahle, Philipp J.] Univ Tubingen, Grad Sch Cellular & Mol Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen	Kahle, PJ (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Lab Funct Neurogenet, Tubingen, Germany.	philipp.kahle@uni-tuebingen.de			Helmholtz Alliance "Aging Brain"; German Center for Neurodegenerative Diseases; Hertie Foundation	Helmholtz Alliance "Aging Brain"; German Center for Neurodegenerative Diseases; Hertie Foundation	This work was supported by the Helmholtz Alliance "Aging Brain," the German Center for Neurodegenerative Diseases and the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braithwaite SP, 2012, REV NEUROSCIENCE, V23, P191, DOI 10.1515/revneuro-2011-0067; Dewachter I, 2009, NEUROBIOL AGING, V30, P241, DOI 10.1016/j.neurobiolaging.2007.06.011; Dickson DW, 2010, MOVEMENT DISORD, V25, pS78, DOI 10.1002/mds.22637; Diogenes MJ, 2012, J NEUROSCI, V32, P11750, DOI 10.1523/JNEUROSCI.0234-12.2012; Eriksen JL, 2003, NEURON, V40, P453, DOI 10.1016/S0896-6273(03)00684-6; Freichel C, 2007, NEUROBIOL AGING, V28, P1421, DOI 10.1016/j.neurobiolaging.2006.06.013; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Goers J, 2003, BIOCHEMISTRY-US, V42, P8465, DOI 10.1021/bi0341152; Gureviciene I, 2009, J NEURAL TRANSM, V116, P13, DOI 10.1007/s00702-008-0149-x; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Jellinger KA, 2003, ACTA NEUROPATHOL, V106, P191, DOI 10.1007/s00401-003-0725-y; Kahle PJ, 2008, ACTA NEUROPATHOL, V115, P87, DOI 10.1007/s00401-007-0302-x; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kurz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011464; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lelos MJ, 2012, NEUROBIOL LEARN MEM, V98, P1, DOI 10.1016/j.nlm.2012.03.001; Lim Y, 2011, J NEUROSCI, V31, P10076, DOI 10.1523/JNEUROSCI.0618-11.2011; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martin ZS, 2012, J NEUROCHEM, V120, P440, DOI 10.1111/j.1471-4159.2011.07576.x; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Milanovic S, 1998, BRAIN RES, V784, P37, DOI 10.1016/S0006-8993(97)01266-3; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Price DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014020; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Samson RD, 2005, J NEUROSCI, V25, P1847, DOI 10.1523/JNEUROSCI.3713-04.2005; Schell H, 2009, NEUROSCIENCE, V160, P796, DOI 10.1016/j.neuroscience.2009.03.002; Seeburg DP, 2008, J NEUROSCI, V28, P6583, DOI 10.1523/JNEUROSCI.1853-08.2008; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanji K, 2010, ACTA NEUROPATHOL, V120, P145, DOI 10.1007/s00401-010-0676-z; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	36	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50245	10.1371/journal.pone.0050245	http://dx.doi.org/10.1371/journal.pone.0050245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209687	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800057
J	Wible, JR; Spaulding, M				Wible, John R.; Spaulding, Michelle			A Reexamination of the Carnivora Malleus (Mammalia, Placentalia)	PLOS ONE			English	Article							MIDDLE-EAR; NEURAL CREST; EVOLUTION; ORIGIN	Authoritative anatomical references depict domestic dogs and cats as having a malleus with a short rostral (anterior) process that is connected via a ligament to the ectotympanic of the auditory bulla. Similar mallei have been reported for representatives of each of the 15 extant families of Carnivora, the placental order containing dogs and cats. This morphology is in contrast to a malleus with a long rostral process anchored to the ectotympanic that is considered to be primitive for mammals. Our reexamination of extant carnivorans found representatives from 12 families that possess an elongate rostral process anchored to the ectotympanic. Consequently, the malleus also is a component of the bulla. In a subset of our carnivoran sample, we confirmed that the elongate rostral process on the ectotympanic is continuous with the rest of the malleus through a thin osseous lamina. This morphology is reconstructed as primitive for Carnivora. Prior inaccurate descriptions of the taxa in our sample having mallei continuous with the bulla were based on damaged mallei. In addition to coupling to the ectotympanic, the rostral process of the malleus was found to have a hook-like process that fits in a facet on the skull base in representatives from seven families (felids, nandiniids, viverrids, canids, ursids, procyonids, and mustelids); its occurrence in the remaining families could not be ascertained. This feature is named herein the mallear hook and is likewise reconstructed to be primitive for Carnivora. We also investigated mallei in one additional placental order reported to have mallei not connected to the ectotympanic, Pholidota (pangolins), the extant sister group of Carnivora. We found pholidotans to also have anchored mallei with long rostral processes, but lacking mallear hooks. In light of our results, other mammals previously reported to have short rostral processes should be reexamined.	[Wible, John R.; Spaulding, Michelle] Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA USA		Wible, JR (corresponding author), Carnegie Museum Nat Hist, Sect Mammals, Pittsburgh, PA USA.	wiblej@carnegiemnh.org			R. K. Mellon North American Mammal Research Institute; Carnegie Museum of Natural History; Frick Fund of the Department of Paleontology of the American Museum of Natural History; Assembling the Tree of Life initiative of the National Science Foundation [0629959]; Direct For Biological Sciences [0946430] Funding Source: National Science Foundation	R. K. Mellon North American Mammal Research Institute; Carnegie Museum of Natural History; Frick Fund of the Department of Paleontology of the American Museum of Natural History; Assembling the Tree of Life initiative of the National Science Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for the research is from the R. K. Mellon North American Mammal Research Institute, the James and Julia Rea Postdoctoral Fellowship of Carnegie Museum of Natural History, the Frick Fund of the Department of Paleontology of the American Museum of Natural History, and grant 0629959 from the Assembling the Tree of Life initiative of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIN EF, 1975, J MORPHOL, V147, P403, DOI 10.1002/jmor.1051470404; [Anonymous], 2005, NOMINA ANATOMICA VET; Bast TH., 1949, TEMPORAL BONE EAR; Chapla ME, 2007, HEARING RES, V228, P123, DOI 10.1016/j.heares.2007.01.029; Davis DD, 1943, FIELD MUS NAT HIST Z, V28, P1; de Beer G., 1937, DEV VERTEBRATE SKULL; DECRAEMER WF, 1994, HEARING RES, V72, P1, DOI 10.1016/0378-5955(94)90199-6; doRan a.h.g., 1878, T LINNEAN SOC LONDON, V1, P391; Drews M., 1933, Gegenbaurs Morphologisches Jahrbuch, V73, P185; ELLENBERGER W, 1891, SYSTEMATISCHE TOPOGR; Evans H.E., 1993, MILLERS ANATOMY DOG; FLEISCHER G, 1973, Saeugetierkundliche Mitteilungen, V21, P131; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; Flynn John J., 2010, P25; Gaubert P, 2005, SYST BIOL, V54, P865, DOI 10.1080/10635150500232769; Gaudin TJ, 2009, J MAMM EVOL, V16, P235, DOI 10.1007/s10914-009-9119-9; Gaudin Timothy J., 1996, Journal of Mammalian Evolution, V3, P31, DOI 10.1007/BF01454253; Gross JB, 2008, DEV BIOL, V317, P389, DOI 10.1016/j.ydbio.2008.02.046; Henson O aposD.W., 1961, Kansas University Science Bulletin, V42, P151; Herrington SJ, 1986, THESIS U KANSAS LAWR; HUNT RM, 1974, J MORPHOL, V143, P21, DOI 10.1002/jmor.1051430103; Jayne H., 1898, MAMMALIAN ANATOMY PA; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kontges G, 1996, DEVELOPMENT, V122, P3229; Lavender D, 2011, HEARING RES, V282, P97, DOI 10.1016/j.heares.2011.09.003; Luo ZX, 2011, ANNU REV ECOL EVOL S, V42, P355, DOI 10.1146/annurev-ecolsys-032511-142302; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; MAIER W, 1990, NETH J ZOOL, V40, P55, DOI 10.1163/156854289X00183; Mason MJ, 2010, J MORPHOL, V271, P462, DOI 10.1002/jmor.10810; Mason MJ, 2006, J MORPHOL, V267, P678, DOI 10.1002/jmor.10430; McClain JA, 1938, J MORPHOL, V64, P211; McCrady E., 1938, American Anatomical Memoir Philadelphia (Wistar Inst), Vno. 16, P1; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mivart GJ, 1881, CAT; NOVACEK MJ, 1977, MAMMAL REV, V7, P131, DOI 10.1111/j.1365-2907.1977.tb00366.x; O'Gorman S, 2005, DEV DYNAM, V234, P124, DOI 10.1002/dvdy.20402; Puria S, 2010, HEARING RES, V263, P183, DOI 10.1016/j.heares.2009.10.013; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Ruf I, 2010, J MORPHOL, V271, P612, DOI 10.1002/jmor.10820; Salih WHM, 2012, HEARING RES, V284, P1, DOI 10.1016/j.heares.2011.12.004; Salles LO., 1992, AM MUS NOVIT, V3047, P1; Schliemann H, 1966, MORPH JB, V109, P501; SEGALL W, 1973, ACTA ANAT, V86, P96; Segall Walter, 1943, FIELD MUS NAT HIST ZOOL SER, V29, P33; TERRY RJ, 1942, MORRIS HUMAN ANATOMY, P77; Toeplitz C., 1920, ZOOLOGICA, V27, P1; Vallancian B, 1972, TRAITE ZOOL, VXVI, P505; van der Klaauw CJ, 1931, B AM MUS NAT HIST, V62, P1; Wesley-Hunt GD, 2005, J SYST PALAEONTOL, V3, P1; Wible JR, 2011, ANN CARNEGIE MUS, V79, P149, DOI 10.2992/007.079.0301; Wible JR, 2008, ANN CARNEGIE MUS, V77, P321, DOI 10.2992/0097-4463-77.3.321; Wilkie HC, 1926, P ZOOL SOC LOND, V1926, P815; Wozencraft WC, 2005, MAMMAL SPECIES WORLD, P532; WYSS A R, 1987, American Museum Novitates, P1	57	14	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50485	10.1371/journal.pone.0050485	http://dx.doi.org/10.1371/journal.pone.0050485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209753	gold, Green Submitted, Green Published			2022-12-25	WOS:000311885800076
J	Jin, J; Allison, BZ; Kaufmann, T; Kubler, A; Zhang, Y; Wang, XY; Cichocki, A				Jin, Jing; Allison, Brendan Z.; Kaufmann, Tobias; Kuebler, Andrea; Zhang, Yu; Wang, Xingyu; Cichocki, Andrzej			The Changing Face of P300 BCIs: A Comparison of Stimulus Changes in a P300 BCI Involving Faces, Emotion, and Movement	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; COMMUNICATION; RECOGNITION; POTENTIALS; AMPLITUDE	Background: One of the most common types of brain-computer interfaces (BCIs) is called a P300 BCI, since it relies on the P300 and other event-related potentials (ERPs). In the canonical P300 BCI approach, items on a monitor flash briefly to elicit the necessary ERPs. Very recent work has shown that this approach may yield lower performance than alternate paradigms in which the items do not flash but instead change in other ways, such as moving, changing colour or changing to characters overlaid with faces. Methodology/Principal Findings: The present study sought to extend this research direction by parametrically comparing different ways to change items in a P300 BCI. Healthy subjects used a P300 BCI across six different conditions. Three conditions were similar to our prior work, providing the first direct comparison of characters flashing, moving, and changing to faces. Three new conditions also explored facial motion and emotional expression. The six conditions were compared across objective measures such as classification accuracy and bit rate as well as subjective measures such as perceived difficulty. In line with recent studies, our results indicated that the character flash condition resulted in the lowest accuracy and bit rate. All four face conditions (mean accuracy >91%) yielded significantly better performance than the flash condition (mean accuracy = 75%). Conclusions/Significance: Objective results reaffirmed that the face paradigm is superior to the canonical flash approach that has dominated P300 BCIs for over 20 years. The subjective reports indicated that the conditions that yielded better performance were not considered especially burdensome. Therefore, although further work is needed to identify which face paradigm is best, it is clear that the canonical flash approach should be replaced with a face paradigm when aiming at increasing bit rate. However, the face paradigm has to be further explored with practical applications particularly with locked-in patients.	[Jin, Jing; Zhang, Yu; Wang, Xingyu] E China Univ Sci & Technol, Minist Educ, Key Lab Adv Control & Optimizat Chem Proc, Shanghai 200237, Peoples R China; [Allison, Brendan Z.] Graz Univ Technol, Inst Knowledge Discovery, Lab Brain Comp Interfaces, A-8010 Graz, Austria; [Kaufmann, Tobias; Kuebler, Andrea] Univ Wurzburg, Dept Psychol 1, Wurzburg, Germany; [Zhang, Yu; Cichocki, Andrzej] RIKEN, Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama, Japan; [Allison, Brendan Z.] Univ Calif San Diego, Dept Cognit Sci, Cognit Neurosci Lab, La Jolla, CA 92093 USA	East China University of Science & Technology; Graz University of Technology; University of Wurzburg; RIKEN; University of California System; University of California San Diego	Jin, J (corresponding author), E China Univ Sci & Technol, Minist Educ, Key Lab Adv Control & Optimizat Chem Proc, Shanghai 200237, Peoples R China.	Jinjingat@gmail.com	Jin, Jing/AAN-1711-2020; Cichocki, Andrzej/A-1545-2015; Zhang, Yu/J-1796-2015; Cichocki, Andrzej/AAI-4209-2020; Kaufmann, Tobias/M-8972-2017	Jin, Jing/0000-0002-6133-5491; Cichocki, Andrzej/0000-0002-8364-7226; Zhang, Yu/0000-0003-4087-6544; Kaufmann, Tobias/0000-0002-4003-1018; Kubler, Andrea/0000-0003-4876-0415	National Natural Science Foundation of China [61074113, 61203127]; Shanghai Leading Academic Discipline Project [B504]; European Commission [ICT-2010-247447]; Fundamental Research Funds for the Central Universities [WH1114038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by the Grant National Natural Science Foundation of China, under Grant Numbers 61074113 and 61203127, and supported in part by Shanghai Leading Academic Discipline Project, Project Number B504. This work was also supported by the Information and Communication Technologies Collaborative Project action "BrainAble" within the Seventh Framework of the European Commission, Project number ICT-2010-247447, and Fundamental Research Funds for the Central Universities, WH1114038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2008, CLIN NEUROPHYSIOL, V119, P399, DOI 10.1016/j.clinph.2007.09.121; Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; Allison BZ, 2003, IEEE T NEUR SYS REH, V11, P110, DOI 10.1109/TNSRE.2003.814448; Allison BZ, 2004, SOC NEUR C SAN DIEG; Aloise F, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025025; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Blain-Moraes S, 2012, ERGONOMICS, V55, P516, DOI 10.1080/00140139.2012.661082; Brunner C, 2011, MED BIOL ENG COMPUT, V49, P1337, DOI 10.1007/s11517-011-0828-x; Curran T, 2007, NEUROIMAGE, V36, P464, DOI 10.1016/j.neuroimage.2006.12.016; Dal Seno Bernardo, 2010, Computational Intelligence & Neuroscience, DOI 10.1155/2010/307254; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai R, 2007, P ANN INT IEEE EMBS, P2516, DOI 10.1109/IEMBS.2007.4352840; Fazel-Rezai Reza, 2012, Front Neuroeng, V5, P14, DOI 10.3389/fneng.2012.00014; Frye GE, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025024; Gonsalvez CJ, 2002, PSYCHOPHYSIOLOGY, V39, P388, DOI 10.1017/S0048577201393137; Guo F, 2008, J NEURAL ENG, V5, P477, DOI 10.1088/1741-2560/5/4/011; Hoffmann U, 2008, J NEUROSCI METH, V167, P115, DOI 10.1016/j.jneumeth.2007.03.005; Holz E. M., 2012, PRACTICAL BRAIN COMP, P155, DOI [10.1007/978-3-642-29746-5_8, DOI 10.1007/978-3-642-29746-5_8]; Hong B, 2009, CLIN NEUROPHYSIOL, V120, P1658, DOI 10.1016/j.clinph.2009.06.026; Huggins JE, 2011, AMYOTROPH LATERAL SC, V12, P318, DOI 10.3109/17482968.2011.572978; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Jansen BH, 2004, IEEE T BIO-MED ENG, V51, P975, DOI 10.1109/TBME.2004.826684; Jin J, 2012, MED BIOL ENG COMPUT, V50, P289, DOI 10.1007/s11517-012-0868-x; Jin J, 2012, J NEUROSCI METH, V205, P265, DOI 10.1016/j.jneumeth.2012.01.004; Jin J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036006; Jin J, 2011, MED BIOL ENG COMPUT, V49, P181, DOI 10.1007/s11517-010-0689-8; Jin J, 2010, BIOMED TECH, V55, P203, DOI 10.1515/BMT.2010.029; JOHNSON R, 1978, ELECTROEN CLIN NEURO, V44, P424, DOI 10.1016/0013-4694(78)90027-5; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2011, P 5 INT BRAIN COMP I, P136; Kelly SP, 2005, IEEE T NEUR SYS REH, V13, P172, DOI 10.1109/TNSRE.2005.847369; Kleih S, 2011, INT J BIOELECTROMAGN, V13, P46; Kleih SC, 2010, CLIN NEUROPHYSIOL, V121, P1023, DOI 10.1016/j.clinph.2010.01.034; Kolev V, 1997, NEUROREPORT, V8, P2061, DOI 10.1097/00001756-199705260-00050; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Li YQ, 2010, IEEE T BIO-MED ENG, V57, P2495, DOI 10.1109/TBME.2010.2055564; Liu T, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036003; Mak JN, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025003; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; Martens SMM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026003; Martens U, 2010, COGN AFFECT BEHAV NE, V10, P505, DOI 10.3758/CABN.10.4.505; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Munssinger JI, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00182; Mugler E., 2008, INT J BIOELECTROMAGN, V10, P56; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ravden D, 1998, INT J PSYCHOPHYSIOL, V30, P359, DOI 10.1016/S0167-8760(98)00039-7; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Shishkin SL, 2011, NEUROSCI LETT, V496, P95, DOI 10.1016/j.neulet.2011.03.089; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zhang Y, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026018; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236, DOI 10.1177/155005941104200409	55	95	100	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49688	10.1371/journal.pone.0049688	http://dx.doi.org/10.1371/journal.pone.0049688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048RI	23189154	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800031
J	Lo, WS; Ho, SY; Mak, KK; Lam, TH				Lo, Wing-Sze; Ho, Sai-Yin; Mak, Kwok-Kei; Lam, Tai-Hing			The Use of Stunkard's Figure Rating Scale to Identify Underweight and Overweight in Chinese Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; WAIST CIRCUMFERENCE; HEIGHT RATIO; OBESITY; CHILDREN; WEIGHT; RELIABILITY; ACCURACY; DRAWINGS; VALIDITY	Background: To compare the performance of Stunkard's current body size (CBS) with self-reported body mass index (BMI), waist circumference (WC) and waist to stature ratio (WSR) in predicting weight status in Chinese adolescents, and to determine the CBS cutoffs for overweight/obesity and underweight. Methodology: This cross-sectional study was conducted in a sample of 5,418 secondary school students (45.2% boys; mean age 14.7 years). Height and weight were measured by trained teachers or researchers. Subjects were classified as underweight, normal weight, or overweight/obese according to the International Obesity Task Force cutoffs. Subjects were asked to select the figure that best resembled their CBS on the Stunkard's figure rating scale. Self-reported height, weight, WC and WSR were also obtained. The performance of CBS, self-reported BMI, WC and WSR as a weight status indicator was analysed by sex-specific receiver operating characteristic curves. The optimal CBS cutoffs for underweight and overweight/obesity were determined based on the Youden Index. Principal Findings: Apart from self-reported BMI, CBS had the greatest area under curve (AUC) for underweight in boys (0.82) and girls (0.81). For overweight/obesity, CBS also had a greater AUC (0.85) than self-reported WC and WSR in boys, and an AUC (0.81) comparable to self-reported WC and WSR in girls. In general, CBS values of 3 and 5 appeared to be the optimal cutoffs for underweight and overweight/obesity, respectively, in different sex-age subgroups. Conclusions/Significance: CBS is a potentially useful indicator to assess weight status of adolescents when measured and self-reported BMI are not available.	[Lo, Wing-Sze; Ho, Sai-Yin; Mak, Kwok-Kei; Lam, Tai-Hing] Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong	Ho, SY (corresponding author), Univ Hong Kong, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China.	syho@hku.hk	Ho, Daniel Sai Yin/C-4307-2009; Lam, Tai Hing/C-4317-2009	Ho, Daniel Sai Yin/0000-0001-9485-0273; Lam, Tai Hing/0000-0002-2033-9971	University Research Committee, Strategic Research Theme on Public Health, University of Hong Kong	University Research Committee, Strategic Research Theme on Public Health, University of Hong Kong(University of Hong Kong)	This study was supported by the University Research Committee, Strategic Research Theme on Public Health, University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2009, OBESITY, V17, P1056, DOI 10.1038/oby.2008.635; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Bohning D, 2008, STAT METHODS MED RES, V17, P543, DOI 10.1177/0962280207081867; Bosy-Westphal A, 2010, J NUTR, V140, P954, DOI 10.3945/jn.109.118737; Brener ND, 2003, J ADOLESCENT HEALTH, V32, P281, DOI 10.1016/S1054-139X(02)00708-5; Bulik CM, 2001, INT J OBESITY, V25, P1517, DOI 10.1038/sj.ijo.0801742; Centers for Disease Control and Prevention: National Health and Nutrition Examination Survey, 2000, NAT HLTH NUTR EX SUR; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; CRAWLEY HF, 1995, INT J OBESITY, V19, P579; Deurenberg-Yap M, 2009, ANN ACAD MED SINGAP, V38, P3; Garnett SP, 2008, INT J OBESITY, V32, P1028, DOI 10.1038/ijo.2008.51; GRANT JP, 1994, SURGERY, V115, P718; Howell S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-96; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Li CY, 2006, PEDIATRICS, V118, pE1390, DOI 10.1542/peds.2006-1062; Liu AL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-82; Lo WS, 2011, INT J PEDIATR OBES, V6, pE107, DOI 10.3109/17477166.2011.575146; Lo WS, 2011, INT J PEDIATR OBES, V6, pE381, DOI 10.3109/17477166.2010.514342; Lo WS, 2009, ACTA PAEDIATR, V98, P1959, DOI 10.1111/j.1651-2227.2009.01472.x; Mak KK, 2010, INT J PEDIATR OBES, V5, P390, DOI 10.3109/17477161003728451; Morimoto A, 2007, DIABETES RES CLIN PR, V75, P96, DOI 10.1016/j.diabres.2006.05.022; Munoz-Cachon MJ, 2009, OBESITY, V17, P545, DOI 10.1038/oby.2008.541; Must A, 2002, INT J OBESITY, V26, P876, DOI 10.1038/sj.ijo.0801986; Neovius M, 2008, EUR J CLIN NUTR, V62, P1201, DOI 10.1038/sj.ejcn.1602846; Panjikkaran Seeja Thomachan, 2009, Indian J Community Med, V34, P135, DOI 10.4103/0970-0218.51233; SHANNON B, 1991, J AM DIET ASSOC, V91, P675; SPSS Inc, 2009, SPSS WIND REL 17 0; Spurrier NJ, 2006, J PAEDIATR CHILD H, V42, P411, DOI 10.1111/j.1440-1754.2006.00890.x; Stunkard A, 2000, PERCEPT MOTOR SKILL, V90, P930, DOI 10.2466/PMS.90.3.930-930; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Truby H, 2002, BRIT J CLIN PSYCHOL, V41, P185, DOI 10.1348/014466502163967; Tybor DJ, 2011, AM J CLIN NUTR, V93, P392, DOI 10.3945/ajcn.110.001719; Wong BYM, 2010, INT J PEDIATR OBES, V5, P169, DOI 10.3109/17477160903159432; Wu Q, 2006, OBES REV, V7, P201, DOI 10.1111/j.1467-789X.2006.00232.x	37	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50017	10.1371/journal.pone.0050017	http://dx.doi.org/10.1371/journal.pone.0050017			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189177	gold, Green Submitted, Green Published			2022-12-25	WOS:000311929800054
J	Lim, TC; Rokkappanavar, S; Toh, WS; Wang, LS; Kurisawa, M; Spector, M				Lim, Teck Chuan; Rokkappanavar, Swetha; Toh, Wei Seong; Wang, Li-Shan; Kurisawa, Motoichi; Spector, Myron			Chemotactic recruitment of adult neural progenitor cells into multifunctional hydrogels providing sustained SDF-1 alpha release and compatible structural support	FASEB JOURNAL			English	Article						tissue engineering; cavitary brain lesion; injectable biomaterials; nanoparticles; matrix metalloproteinases	GROWTH-FACTOR; STEM-CELLS; NEUROBLAST MIGRATION; FACTOR-I; NEUROGENESIS; REGENERATION; NEURONS; STROKE; BRAIN; RAT	Without chemotactic cues and structural support, cavitary brain lesions typically fail to recruit endogenous neural progenitor cells (NPCs). Toward resolving this, we engineered multifunctional biomaterials comprising injectable gelatin-hydroxyphenylpropionic acid (Gtn-HPA) hydrogels and dextran sulfate/chitosan polyelectrolyte complex nanoparticles (PCNs) that delivered stromal cell-derived factor-1 alpha (SDF-1 alpha). Over 7 d of interface with in vitro tissue simulant containing adult rat hippocampal NPCs (aNPCs) and their neuronal progeny, Gtn-HPA/SDF-1 alpha-PCN hydrogels promoted chemotactic recruitment to enhance infiltration of aNPCs by 3- to 45-fold relative to hydrogels that lacked SDF-1 alpha or vehicles to sustain SDF-1 alpha release. When cross-linked with 0.85-0.95mM H2O2, Gtn-HPA/SDF-1 alpha-PCN hydrogels provided optimally permissive structural support for migration of aNPCs. Specific matrix metalloproteinase (MMP) inhibitors revealed that 42, 30, and 55% of cell migration into Gtn-HPA/SDF-1 alpha-PCN hydrogels involved MMP-2, 3, and 9, respectively, demonstrating the hydrogels to be compatible toward homing endogenous NPCs, given their expression of similar MMPs. Interestingly, PCNs utilized FGF-2 found in situ to induce chemokinesis, potentiate SDF-1 alpha chemotactic recruitment, and increase proliferation of recruited cells, which collectively orchestrated a higher number of migrated aNPCs. Overall, Gtn-HPA/SDF-1 alpha-PCN hydrogels prove to be promising biomaterials for injection into cavitary brain lesions to recruit endogenous NPCs and enhance neural tissue repair/regeneration.-Lim, T. C., Rokkappanavar, S., Toh, W. S., Wang, L.-S., Kurisawa, M., Spector, M. Chemotactic recruitment of adult neural progenitor cells into multifunctional hydrogels providing sustained SDF-1 alpha release and compatible structural support. FASEB J. 27, 1023-1033 (2013). www.fasebj.org	[Lim, Teck Chuan; Spector, Myron] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lim, Teck Chuan; Rokkappanavar, Swetha; Toh, Wei Seong; Spector, Myron] VA Boston Healthcare Syst, Tissue Engn Labs, Boston, MA 02130 USA; [Rokkappanavar, Swetha; Toh, Wei Seong; Spector, Myron] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA; [Wang, Li-Shan; Kurisawa, Motoichi] Inst Bioengn & Nanotechnol, Singapore, Singapore	Harvard University; Massachusetts Institute of Technology (MIT); US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN)	Spector, M (corresponding author), VA Boston Healthcare Syst, Tissue Engn Labs, Mail Stop 151 Res,150 S Huntington Ave, Boston, MA 02130 USA.	mspector@rics.bwh.harvard.edu	KURISAWA, MOTOICHI/C-1325-2014; Wang, Li Shan/F-9460-2013; Toh, Wei Seong/K-7720-2013	KURISAWA, MOTOICHI/0000-0003-2413-6933; Toh, Wei Seong/0000-0001-9147-6423; Spector, Myron/0000-0003-3328-4858; Lim, Teck Chuan/0000-0002-4062-6046	U.S. Department of Veterans Affairs and Agency for Science, Technology and Research, Singapore	U.S. Department of Veterans Affairs and Agency for Science, Technology and Research, Singapore	The authors thank Marsha Doudna Guy for technical assistance and Chyan Ying Ke for critical reading of the manuscript. This work was supported by the Rehabilitation Research and Development Service of the U.S. Department of Veterans Affairs and Agency for Science, Technology and Research, Singapore ( to T.C.L., W.S.T., L.W., and M.K.).	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Guerra-Crespo M, 2009, NEUROSCIENCE, V160, P470, DOI 10.1016/j.neuroscience.2009.02.029; Haider HK, 2008, J MOL CELL CARDIOL, V45, P554, DOI 10.1016/j.yjmcc.2008.05.004; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954; Khorana AA, 2003, ARTERIOSCL THROM VAS, V23, P2110, DOI 10.1161/01.ATV.0000090671.56682.D7; Lauten EH, 2010, BIOMACROMOLECULES, V11, P1863, DOI 10.1021/bm100384z; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Lim TC, 2012, BIOMATERIALS, V33, P3446, DOI 10.1016/j.biomaterials.2012.01.037; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Masuda T, 2007, NEUROSCI LETT, V425, P114, DOI 10.1016/j.neulet.2007.08.039; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Padera R, 1999, FASEB J, V13, P1677, DOI 10.1096/fasebj.13.13.1677; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Pickering JG, 1997, CIRC RES, V80, P627, DOI 10.1161/01.RES.80.5.627; Salcedo R, 2003, MICROCIRCULATION, V10, P359, DOI 10.1038/sj.mn.7800200; Sasisekharan R, 1997, Angiogenesis, V1, P45, DOI 10.1023/A:1018318914258; Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107; Speliotes EK, 1996, MOL BRAIN RES, V39, P31, DOI 10.1016/0169-328X(95)00351-R; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Wang LS, 2010, BIOMATERIALS, V31, P8608, DOI 10.1016/j.biomaterials.2010.07.075; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yu T, 2010, J NEUROSCI RES, V88, P2775, DOI 10.1002/jnr.22454; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zhang RL, 2011, J CEREBR BLOOD F MET, V31, P614, DOI 10.1038/jcbfm.2010.134	33	47	48	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2013	27	3					1023	1033		10.1096/fj.12-221515	http://dx.doi.org/10.1096/fj.12-221515			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23193174				2022-12-25	WOS:000315585200017
J	Martin, D; Charpilienne, A; Parent, A; Boussac, A; D'Autreaux, B; Poupon, J; Poncet, D				Martin, Davy; Charpilienne, Annie; Parent, Auberie; Boussac, Alain; D'Autreaux, Benoit; Poupon, Joel; Poncet, Didier			The rotavirus nonstructural protein NSP5 coordinates a [2Fe-2S] iron-sulfur cluster that modulates interaction to RNA	FASEB JOURNAL			English	Article						metalloprotein; CXXC motif	VIROPLASM-LIKE STRUCTURES; DOUBLE-STRANDED-RNA; ESCHERICHIA-COLI; RIBONUCLEOTIDE REDUCTASE; MICROSCALE THERMOPHORESIS; PHOSPHOPROTEIN NSP5; VIRUS-REPLICATION; HUMAN FERREDOXIN; MESSENGER-RNA; IN-VITRO	During rotavirus infection, replication and packaging of the viral genome occur in viral factories, termed viroplasms. The viral nonstructural protein NSP5 is a major building block of viroplasms; it recruits the viral polymerase VP1, the core protein VP2, and the ATPase NSP2 inside the viroplasm to form the viral replication complex. Here we report that NSP5 is a unique viral metalloprotein that coordinates a [2Fe-2S] iron-sulfur cluster as demonstrated by the metal and labile sulfide contents, UV-visible light absorption, and electron paramagnetic resonance. Point mutations in NSP5 allowed us to identify C171 and C174, arranged in a CX2C motif, as essential residues for cluster coordination. When coexpressed with NSP2, an NSP5 mutant devoid of the iron-sulfur cluster still forms viroplasm-like structures. The cluster is therefore neither involved in the interaction with NSP2 nor in the formation of viroplasm-like structures and thus presumably in viroplasm formation. Finally, we show using microscale thermophoresis that the iron-sulfur cluster modulates the affinity of NSP5 for single-stranded RNA. Because the cluster is near the binding sites of both the polymerase VP1 and the ATPase NSP2, we anticipate that this cluster is crucial for NSP5 functions, in either packaging or replication of the viral genome.-Martin, D., Charpilienne, A., Parent, A., Boussac, A., D'Autreaux, B., Poupon, J., Poncet, D. The rotavirus nonstructural protein NSP5 coordinates a [2Fe-2S] iron-sulfur cluster that modulates interaction to RNA. FASEB J. 27, 1074-1083 (2013). www.fasebj.org	[Martin, Davy; Charpilienne, Annie; Poncet, Didier] CNRS, USC, UPR 3296, INRA,Ctr Rech Gif,Virol Mol & Struct, Av Terrasse, F-91198 Gif Sur Yvette, France; [Parent, Auberie; D'Autreaux, Benoit] CNRS, Ctr Rech Gif, UPR 2301, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France; [Boussac, Alain] Commissariat Energie Atom & Energies Alternat CEA, Inst Biol & Technol Saclay IBiTec S, Serv Bioenerget Biol Struct & Mecanismes SB2SM, UMR 8221,CNRS, Gif Sur Yvette, France; [Poupon, Joel] Hop Lariboisiere, AP HP, Lab Toxicol Biol, F-75475 Paris, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Martin, D (corresponding author), CNRS, USC, UPR 3296, INRA,Ctr Rech Gif,Virol Mol & Struct, Av Terrasse, F-91198 Gif Sur Yvette, France.	davy.martin@vms.cnrs-gif.fr	Poncet, Didier/AAV-6583-2021; D'Autreaux, Benoit/M-8520-2018	Poncet, Didier/0000-0001-7689-0175; D'Autreaux, Benoit/0000-0002-1276-3019; Martin, Davy/0000-0003-2421-716X	Conseil General de l'Essonne	Conseil General de l'Essonne	The authors thank Dr. S. Duhr (NanoTemper Technologies, Munich, Germany) for his expert support with microscale thermophoresis. The authors are grateful to Drs. H. Rezaei, L. Oliveira, Y. Gaudin, and A. Pastore for helpful discussions. This work has benefited from the facilities and expertise of IMAGIF (Centre de Recherche de Gif), which is supported by the Conseil General de l'Essonne.	Afrikanova I, 1998, J GEN VIROL, V79, P2679, DOI 10.1099/0022-1317-79-11-2679; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Bar-Magen T, 2007, VIROLOGY, V369, P389, DOI 10.1016/j.virol.2007.07.029; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Berois M, 2003, J VIROL, V77, P1757, DOI 10.1128/JVI.77.3.1757-1763.2003; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Campagna M, 2005, J GEN VIROL, V86, P1481, DOI 10.1099/vir.0.80598-0; Chnaiderman J, 2002, ARCH VIROL, V147, P1899, DOI 10.1007/s00705-002-0856-9; COGHLAN VM, 1989, P NATL ACAD SCI USA, V86, P835, DOI 10.1073/pnas.86.3.835; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Eichwald C, 2004, P NATL ACAD SCI USA, V101, P16304, DOI 10.1073/pnas.0406691101; Eichwald C, 2002, J VIROL, V76, P3461, DOI 10.1128/JVI.76.7.3461-3470.2002; Fabbretti E, 1999, J GEN VIROL, V80, P333, DOI 10.1099/0022-1317-80-2-333; GONZALEZ SA, 1991, VIROLOGY, V182, P8, DOI 10.1016/0042-6822(91)90642-O; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; Hirata A, 2009, CURR OPIN STRUC BIOL, V19, P724, DOI 10.1016/j.sbi.2009.10.006; HOWELL ML, 1992, J BIOL CHEM, V267, P1705; Iwasaki T, 2009, J AM CHEM SOC, V131, P13659, DOI 10.1021/ja903228w; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; KATTOURA MD, 1994, VIROLOGY, V202, P803, DOI 10.1006/viro.1994.1402; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; Lopez T, 2005, J GEN VIROL, V86, P1609, DOI 10.1099/vir.0.80827-0; Martin D, 2011, J MOL BIOL, V413, P209, DOI 10.1016/j.jmb.2011.08.008; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; McDonald SM, 2011, J VIROL, V85, P3095, DOI 10.1128/JVI.02360-10; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Poncet D, 1997, J VIROL, V71, P34, DOI 10.1128/JVI.71.1.34-41.1997; POTSCH S, 1995, FEBS LETT, V374, P95, DOI 10.1016/0014-5793(95)01082-P; Sen A, 2006, J VIROL, V80, P1807, DOI 10.1128/JVI.80.4.1807-1816.2006; Sen A, 2007, J VIROL, V81, P11758, DOI 10.1128/JVI.01124-07; Silvestri LS, 2004, J VIROL, V78, P7763, DOI 10.1128/JVI.78.14.7763-7774.2004; Taraporewala ZF, 2001, J VIROL, V75, P4519, DOI 10.1128/JVI.75.10.4519-4527.2001; Torres-Vega MA, 2000, J GEN VIROL, V81, P821, DOI 10.1099/0022-1317-81-3-821; Trask SD, 2012, NAT REV MICROBIOL, V10, P165, DOI 10.1038/nrmicro2673; Vende P, 2002, J VIROL, V76, P5291, DOI 10.1128/JVI.76.10.5291-5299.2002; WELCH SKW, 1989, J VIROL, V63, P3974, DOI 10.1128/JVI.63.9.3974-3982.1989; White MF, 2012, CURR OPIN STRUC BIOL, V22, P94, DOI 10.1016/j.sbi.2011.11.004; Wu YL, 2012, NUCLEIC ACIDS RES, V40, P4247, DOI 10.1093/nar/gks039; Xia B, 1996, BIOCHEMISTRY-US, V35, P9488, DOI 10.1021/bi960467f; Young P, 1996, J BIOL CHEM, V271, P20770, DOI 10.1074/jbc.271.34.20770; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18	47	15	19	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2013	27	3					1074	1083		10.1096/fj.12-217182	http://dx.doi.org/10.1096/fj.12-217182			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	098YO	23193175				2022-12-25	WOS:000315585200021
J	Bosch, DE; Siderovski, DP				Bosch, Dustin E.; Siderovski, David P.			Structural Determinants of Ubiquitin Conjugation in Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; INSIGHTS; COMPLEX; ENZYME; DOMAIN; ACTIVATION; PROTEINS; FEATURES; SYSTEM; LIGASE	Ubiquitination is important for numerous cellular processes in most eukaryotic organisms, including cellular proliferation, development, and protein turnover by the proteasome. The intestinal parasite Entamoeba histolytica harbors an extensive ubiquitin-proteasome system. Proteasome inhibitors are known to impair parasite proliferation and encystation, suggesting the ubiquitin-proteasome pathway as a viable therapeutic target. However, no functional studies of the E. histolytica ubiquitination enzymes have yet emerged. Here, we have cloned and characterized multiple E. histolytica ubiquitination components, spanning ubiquitin and its activating (E1), conjugating (E2), and ligating (E3) enzymes. Crystal structures of EhUbiquitin reveal a clustering of unique residues on the alpha 1 helix surface, including an eighth surface lysine not found in other organisms, which may allow for a unique polyubiquitin linkage in E. histolytica. EhUbiquitin is activated by and forms a thioester bond with EhUba1( E1) in vitro, in an ATP- and magnesium-dependent fashion. EhUba1 exhibits a greater maximal initial velocity of pyrophosphate: ATP exchange than its human homolog, suggesting different kinetics of ubiquitin activation in E. histolytica. EhUba1 engages the E2 enzyme EhUbc5 through its ubiquitin-fold domain to transfer the EhUbiquitin thioester. However, EhUbc5 has a >10-fold preference for EhUba1 similar to Ub compared with unconjugated EhUba1. A crystal structure of EhUbc5 allowed prediction of a noncovalent "backside" interaction with EhUbiquitin and E3 enzymes. EhUbc5 selectively engages EhRING1 (E3) to the exclusion of two HECT family E3 ligases, and mutagenesis indicates a conserved mode of E2/RING-E3 interaction in E. histolytica.	[Bosch, Dustin E.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Robert C Byrd Hlth Sci Ctr, Morgantown, WV 26506 USA	University of North Carolina; University of North Carolina Chapel Hill; West Virginia University	Siderovski, DP (corresponding author), W Virginia Univ, Sch Med, Dept Physiol & Pharmacol, Robert C Byrd Hlth Sci Ctr, 3051A Hlth Sci N,POB 9229, Morgantown, WV 26506 USA.	dpsiderovski@hsc.wvu.edu	, PEP-MX Core/AGV-4051-2022; Siderovski, David Peter/AAA-9603-2019	Siderovski, David Peter/0000-0002-0688-8210; Bosch, Dustin/0000-0002-7430-2939	National Institutes of Health [R01 GM082892]; independent F30 NRSA National Institutes of Health, NIDDK [DK091978]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); independent F30 NRSA National Institutes of Health, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM082892 (to D. P. S.).; Supported by independent F30 NRSA National Institutes of Health, NIDDK Grant DK091978.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arya S, 2012, PARASITOL RES, V111, P37, DOI 10.1007/s00436-011-2799-0; Bosanac I, 2011, J MOL BIOL, V408, P420, DOI 10.1016/j.jmb.2011.03.011; Bosch DE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003040; Bosch DE, 2011, J BIOL CHEM, V286, P39236, DOI 10.1074/jbc.M111.253898; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Burroughs AM, 2012, METHODS MOL BIOL, V832, P15, DOI 10.1007/978-1-61779-474-2_2; Calabrese MF, 2011, NAT STRUCT MOL BIOL, V18, P947, DOI 10.1038/nsmb.2086; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edelmann MJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002031; Emmerich CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002187; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gilchrist CA, 2006, MOL BIOCHEM PARASIT, V147, P163, DOI 10.1016/j.molbiopara.2006.02.007; HAAS AL, 1982, J BIOL CHEM, V257, P329; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stoll KE, 2011, J BIOL CHEM, V286, P15165, DOI 10.1074/jbc.M110.203968; WOSTMANN C, 1992, FEBS LETT, V308, P54, DOI 10.1016/0014-5793(92)81049-R; Wostmann C, 1996, MOL BIOCHEM PARASIT, V82, P81, DOI 10.1016/0166-6851(96)02725-9; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605	43	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2290	2302		10.1074/jbc.M112.417337	http://dx.doi.org/10.1074/jbc.M112.417337			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209297	Green Published, hybrid			2022-12-25	WOS:000314211500019
J	Jevnikar, Z; Rojnik, M; Jamnik, P; Doljak, B; Fonovic, UP; Kos, J				Jevnikar, Zala; Rojnik, Matija; Jamnik, Polona; Doljak, Bojan; Fonovic, Ursa Pecar; Kos, Janko			Cathepsin H Mediates the Processing of Talin and Regulates Migration of Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-LIKE DOMAIN; INTEGRIN ACTIVATION; CYSTEINE CATHEPSINS; STRUCTURAL BASIS; EXPRESSION; ENZYME; HEAD; INHIBITORS; INVASION; REVEALS	The cytoskeletal protein talin, an actin-and beta-integrin tail-binding protein, plays an important role in cell migration by promoting integrin activation and focal adhesion formation. Here, we show that talin is a substrate for cathepsin H (CtsH), a lysosomal cysteine protease with a strong aminopeptidase activity. Purified active CtsH sequentially cleaved a synthetic peptide representing the N terminus of the talin F0 head domain. The processing of talin by CtsH was determined also in the metastatic PC-3 prostate cancer cell line, which exhibits increased expression of CtsH. The attenuation of CtsH aminopeptidase activity by a specific inhibitor or siRNA-mediated silencing significantly reduced the migration of PC-3 cells on fibronectin and invasion through Matrigel. We found that in migrating PC-3 cells, CtsH was co-localized with talin in the focal adhesions. Furthermore, specific inhibition of CtsH increased the activation of alpha(v)beta(3)-integrin on PC-3 cells. We propose that CtsH-mediated processing of talin might promote cancer cell progression by affecting integrin activation and adhesion strength.	[Jevnikar, Zala; Rojnik, Matija; Doljak, Bojan; Fonovic, Ursa Pecar; Kos, Janko] Univ Ljubljana, Fac Pharm, Dept Pharmaceut Biol, SI-1000 Ljubljana, Slovenia; [Jamnik, Polona] Univ Ljubljana, Biotech Fac, SI-1000 Ljubljana, Slovenia; [Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, SI-1000 Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Jevnikar, Z (corresponding author), Univ Ljubljana, Fac Pharm, Dept Pharmaceut Biol, Askerceva 7, SI-1000 Ljubljana, Slovenia.	zala.jevnikar@ffa.uni-lj.si			Slovenian Research Agency [P4 0127, J4 4123]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency Grants P4 0127 and J4 4123 (to J. K.).	ANGLIKER H, 1989, BIOCHEM J, V262, P63, DOI 10.1042/bj2620063; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Claus V, 1998, J BIOL CHEM, V273, P9842, DOI 10.1074/jbc.273.16.9842; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; del Re EC, 2000, BRIT J CANCER, V82, P1317; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedrich B, 1999, EUR J CANCER, V35, P138, DOI 10.1016/S0959-8049(98)00273-1; GABRIJELCIC D, 1992, EUR J CLIN CHEM CLIN, V30, P69; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Gopal P, 2006, ONCOL REP, V16, P313; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Jevnikar Z, 2009, CELL MOTIL CYTOSKEL, V66, P1030, DOI 10.1002/cm.20413; KAIGHN ME, 1979, INVEST UROL, V17, P16; KOGA H, 1992, CHEM PHARM BULL, V40, P965; Kos J, 1997, CLIN CANCER RES, V3, P1815; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; McCabe NP, 2007, ONCOGENE, V26, P6238, DOI 10.1038/sj.onc.1210429; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Podgorski I, 2005, NEOPLASIA, V7, P207, DOI 10.1593/neo.04349; Premzl A, 2003, EXP CELL RES, V283, P206, DOI 10.1016/S0014-4827(02)00055-1; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Riou P, 2006, FASEB J, V20, P2291, DOI 10.1096/fj.06-6085com; Roberts Gordon C. K., 2009, Biophysical Reviews, V1, P61, DOI 10.1007/s12551-009-0009-4; Rojnik M, 2012, EUR J CELL BIOL, V91, P757, DOI 10.1016/j.ejcb.2012.05.004; Rojnik M, 2011, RADIOL ONCOL, V45, P259, DOI 10.2478/v10019-011-0034-3; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Schweiger A, 1997, J IMMUNOL METHODS, V201, P165, DOI 10.1016/S0022-1759(96)00218-9; Sivaparvathi M, 1996, CANCER LETT, V104, P121, DOI 10.1016/0304-3835(96)04242-5; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAKAHASHI T, 1988, J BIOL CHEM, V263, P10952; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; TSUSHIMA H, 1991, INT J CANCER, V48, P726, DOI 10.1002/ijc.2910480516; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Waghray A, 2002, J BIOL CHEM, V277, P11533, DOI 10.1074/jbc.M109557200; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Zako T, 2009, BIOCHEM BIOPH RES CO, V381, P54, DOI 10.1016/j.bbrc.2009.02.004; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zheng DQ, 1999, CANCER RES, V59, P1655	52	33	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2201	2209		10.1074/jbc.M112.436394	http://dx.doi.org/10.1074/jbc.M112.436394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23204516	Green Published, hybrid			2022-12-25	WOS:000314211500011
J	Shimizu, A; Nakayama, H; Wang, P; Konig, C; Akino, T; Sandlund, J; Coma, S; Italiano, JE; Mammoto, A; Bielenberg, DR; Klagsbrun, M				Shimizu, Akio; Nakayama, Hironao; Wang, Priscilla; Koenig, Courtney; Akino, Tomoshige; Sandlund, Johanna; Coma, Silvia; Italiano, Joseph E., Jr.; Mammoto, Akiko; Bielenberg, Diane R.; Klagsbrun, Michael			Netrin-1 Promotes Glioblastoma Cell Invasiveness and Angiogenesis by Multiple Pathways Including Activation of RhoA, Cathepsin B, and cAMP-response Element-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; UNC5B RECEPTOR; TUMOR; EXPRESSION; GROWTH; SURFACE; PHOSPHORYLATION; NEUROPILIN-1; MECHANISMS; COLLAPSE	Glioblastomas are very difficult tumors to treat because they are highly invasive and disseminate within the normal brain, resulting in newly growing tumors. We have identified netrin-1 as a molecule that promotes glioblastoma invasiveness. As evidence, netrin-1 stimulates glioblastoma cell invasion directly through Matrigel-coated transwells, promotes tumor cell sprouting and enhances metastasis to lymph nodes in vivo. Furthermore, netrin-1 regulates angiogenesis as shown in specific angiogenesis assays such as enhanced capillary endothelial cells (EC) sprouting and by increased EC infiltration into Matrigel plugs in vivo, as does VEGF-A. This netrin-1 signaling pathway in glioblastoma cells includes activation of RhoA and cyclic AMP response element-binding protein (CREB). A novel finding is that netrin-1-induced glioblastoma invasiveness and angiogenesis are mediated by activated cathepsin B (CatB), a cysteine protease that translocates to the cell surface as an active enzyme and co-localizes with cell surface annexin A2 (ANXA2). The specific CatB inhibitor CA-074Me inhibits netrin-1-induced cell invasion, sprouting, and Matrigel plug angiogenesis. Silencing of CREB suppresses netrin-1-induced glioblastoma cell invasion, sprouting, and CatB expression. It is concluded that netrin-1 plays an important dual role in glioblastoma progression by promoting both glioblastoma cell invasiveness and angiogenesis in a RhoA-, CREB-, and CatB-dependent manner. Targeting netrin-1 pathways may be a promising strategy for brain cancer therapy.	[Shimizu, Akio; Nakayama, Hironao; Wang, Priscilla; Koenig, Courtney; Akino, Tomoshige; Sandlund, Johanna; Coma, Silvia; Italiano, Joseph E., Jr.; Mammoto, Akiko; Bielenberg, Diane R.; Klagsbrun, Michael] Harvard Univ, Sch Med, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Shimizu, Akio; Nakayama, Hironao; Akino, Tomoshige; Coma, Silvia; Mammoto, Akiko; Bielenberg, Diane R.; Klagsbrun, Michael] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Klagsbrun, Michael] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Italiano, Joseph E., Jr.] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Nakayama, Hironao] Ehime Univ, Grad Sch Med, Toon, Ehime 7910295, Japan; [Nakayama, Hironao] Ehime Univ, Proteomed Res Ctr, Toon, Ehime 7910295, Japan	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Ehime University; Ehime University	Klagsbrun, M (corresponding author), Karp Family Res Labs 12-210,1 Blackfan Circle, Boston, MA 02115 USA.	michael.klagsbrun@childrens.harvard.edu	Wang, Priscilla/GXV-9402-2022	Wang, Priscilla/0000-0002-7314-7092	National Institutes of Health from the NCI [CA37392, CA45548]; Japan Society for the Promotion of Science, Japan [S2207]; NATIONAL CANCER INSTITUTE [R37CA037392, R01CA037392, P01CA045548, R56CA037392] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA37392 and CA45548 from the NCI (to M. K.). H. N. is supported by the Strategic Young Researcher Overseas Visiting Program for Accelerating Brain Circulation (No. S2207 to Dr. Shigeki Higashiyama, Ehime University Proteo-Medicine Research Center), Japan Society for the Promotion of Science, Japan.	Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bielenberg DR, 2008, METHOD ENZYMOL, V443, P299, DOI 10.1016/S0076-6879(08)02015-6; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Cavallo-Medved D, 2003, NEOPLASIA, V5, P507, DOI 10.1016/S1476-5586(03)80035-0; Cavallo-Medved D, 2003, CURR TOP DEV BIOL, V54, P313, DOI 10.1016/S0070-2153(03)54013-3; Coma S, 2011, CELL ADHES MIGR, V5, P266, DOI 10.4161/cam.5.3.16294; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Dumartin L, 2010, GASTROENTEROLOGY, V138, P1595, DOI 10.1053/j.gastro.2009.12.061; Eveno C, 2011, AM J PATHOL, V178, P1861, DOI 10.1016/j.ajpath.2010.12.019; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Fitamant J, 2008, P NATL ACAD SCI USA, V105, P4850, DOI 10.1073/pnas.0709810105; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerszten RE, 2012, NEW ENGL J MED, V366, P1734, DOI 10.1056/NEJMcibr1200164; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Jarjour AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025408; Kaufmann S, 2009, CELL ONCOL, V31, P415, DOI 10.3233/CLO-2009-0491; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Lambert E, 2012, J BIOL CHEM, V287, P3987, DOI 10.1074/jbc.M111.289371; Larrivee B, 2007, GENE DEV, V21, P2433, DOI 10.1101/gad.437807; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Mantamadiotis T, 2012, BIOESSAYS, V34, P293, DOI 10.1002/bies.201100133; Mayo LD, 2001, J BIOL CHEM, V276, P25184, DOI 10.1074/jbc.M102932200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mehlen P, 2005, CELL MOL LIFE SCI, V62, P2599, DOI 10.1007/s00018-005-5191-3; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nakayama H, 2012, MOL BIOL CELL, V23, P1964, DOI 10.1091/mbc.E11-08-0683; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Ramesh G, 2011, BIOMARKERS, V16, P172, DOI 10.3109/1354750X.2010.541564; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; ReyesMugica M, 1997, CANCER RES, V57, P382; Rodrigues S, 2007, ONCOGENE, V26, P5615, DOI 10.1038/sj.onc.1210347; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Shi Y, 2011, INT J BIOCHEM CELL B, V43, P682, DOI 10.1016/j.biocel.2011.01.016; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Uciechowski P, 2000, BRIT J CANCER, V83, P1664, DOI 10.1054/bjoc.2000.1501; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704	50	70	74	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2210	2222		10.1074/jbc.M112.397398	http://dx.doi.org/10.1074/jbc.M112.397398			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23195957	hybrid, Green Published			2022-12-25	WOS:000314211500012
J	Zhu, YY; Massen, S; Terenzio, M; Lang, V; Chen-Lindner, S; Eils, R; Novak, I; Dikic, I; Hamacher-Brady, A; Brady, NR				Zhu, Yanyan; Massen, Stefan; Terenzio, Marco; Lang, Verena; Chen-Lindner, Silu; Eils, Roland; Novak, Ivana; Dikic, Ivan; Hamacher-Brady, Anne; Brady, Nathan R.			Modulation of Serines 17 and 24 in the LC3-interacting Region of Bnip3 Determines Pro-survival Mitophagy versus Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; BCL-X-L; BH3 DOMAIN; CELL-DEATH; ENDOPLASMIC-RETICULUM; INDUCED AUTOPHAGY; PROTEIN BNIP3; OKADAIC ACID; NIX; PHOSPHORYLATION	BH3-only proteins integrate apoptosis and autophagy pathways, yet regulation and functional consequences of pathway cross-talk are not fully resolved. The BH3-only protein Bnip3 is an autophagy receptor that signals autophagic degradation of mitochondria (mitophagy) via interaction of its LC3-interacting region (LIR) with Atg8 proteins. Here we report that phosphorylation of serine residues 17 and 24 flanking the Bnip3 LIR promotes binding to specific Atg8 members LC3B and GATE-16. Using quantitative multispectral image-based flow cytometry, we demonstrate that enhancing Bnip3-Atg8 interactions via phosphorylation-mimicked LIR mutations increased mitochondrial sequestration, lysosomal delivery, and degradation. Importantly, mitochondria were targeted by mitophagy prior to cytochrome c release, resulting in reduced cellular cytochrome c release capacity. Intriguingly, pro-survival Bcl-xL positively regulated Bnip3 binding to LC3B, sequestration, and mitochondrial autophagy, further supporting an anti-apoptotic role for Bnip3-induced mitophagy. The ensemble of these results demonstrates that the phosphorylation state of the Bnip3 LIR signals either the induction of apoptosis or pro-survival mitophagy.	[Eils, Roland; Hamacher-Brady, Anne] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Zhu, Yanyan; Terenzio, Marco; Chen-Lindner, Silu; Brady, Nathan R.] Heidelberg Univ, Fac Med, Dept Surg, D-69120 Heidelberg, Germany; [Novak, Ivana] Univ Split, Sch Med, HR-21000 Split, Croatia; [Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Split; Goethe University Frankfurt; Goethe University Frankfurt	Hamacher-Brady, A (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Neuenheimer Feld 267, D-69120 Heidelberg, Germany.	a.brady@dkfz.de; n.brady@dkfz.de	Dikic, Ivan/O-4650-2015; Brady, Nathan/H-2452-2013; Eils, Roland/B-6121-2009; Hamacher-Brady, Anne/G-4268-2013; Novak, Ivana/D-4852-2017	Dikic, Ivan/0000-0001-8156-9511; Eils, Roland/0000-0002-0034-4036; Novak, Ivana/0000-0003-0682-7052; Hamacher-Brady, Anne/0000-0001-5042-1338; Terenzio, Marco/0000-0002-4480-5746; Brady, Nathan/0000-0002-1901-5996	SBCancer within the Helmholtz Alliance on Systems Biology; Initiative and Networking Fund of the Helmholtz Association; MedSys Project Multi-Scale Models [FKZ 0315416C]; FORSYS-ViroQuant [0313923]; e:Bio [0316191]; Federal Ministry of Education and Research (BMBF), Germany	SBCancer within the Helmholtz Alliance on Systems Biology; Initiative and Networking Fund of the Helmholtz Association; MedSys Project Multi-Scale Models; FORSYS-ViroQuant; e:Bio; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	This work was supported through SBCancer within the Helmholtz Alliance on Systems Biology funded by the Initiative and Networking Fund of the Helmholtz Association and through the MedSys Project Multi-Scale Models (FKZ 0315416C), FORSYS-ViroQuant (0313923), and e:Bio (0316191) funded by the Federal Ministry of Education and Research (BMBF), Germany.	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Brady NR, 2007, FEBS J, V274, P3184, DOI 10.1111/j.1742-4658.2007.05849.x; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Chen G, 1999, J BIOL CHEM, V274, P7, DOI 10.1074/jbc.274.1.7; Chen Y, 2010, P NATL ACAD SCI USA, V107, P9035, DOI 10.1073/pnas.0914013107; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Graham RM, 2007, ANTIOXID REDOX SIGN, V9, P1309, DOI 10.1089/ars.2007.1726; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; HOLEN I, 1993, EUR J BIOCHEM, V215, P113, DOI 10.1111/j.1432-1033.1993.tb18013.x; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kwon KY, 2011, BIOCHEM BIOPH RES CO, V416, P343, DOI 10.1016/j.bbrc.2011.11.038; Leo C, 2006, INT J GYNECOL CANCER, V16, P1314, DOI 10.1111/j.1525-1438.2006.00394.x; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Morishima N, 2004, J BIOL CHEM, V279, P50375, DOI 10.1074/jbc.M408493200; NAKANISHI S, 1986, J ANTIBIOT, V39, P1066; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Tan EY, 2007, CLIN CANCER RES, V13, P467, DOI 10.1158/1078-0432.CCR-06-1466; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yasuda M, 1998, J BIOL CHEM, V273, P12415, DOI 10.1074/jbc.273.20.12415; Yasuda M, 1999, CANCER RES, V59, P533; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Yoon SY, 2008, J NEUROSCI RES, V86, P3230, DOI 10.1002/jnr.21760; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	57	265	287	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1099	1113		10.1074/jbc.M112.399345	http://dx.doi.org/10.1074/jbc.M112.399345			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209295	Green Published, hybrid			2022-12-25	WOS:000313570300033
J	Adeosun, SO; Hou, X; Jiao, Y; Zheng, BY; Henry, S; Hill, R; He, Z; Pani, A; Kyle, P; Ou, XM; Mosley, T; Farley, JM; Stockmeier, C; Paul, I; Bigler, S; Brinton, RD; Smeyne, R; Wang, JM				Adeosun, Samuel O.; Hou, Xu; Jiao, Yun; Zheng, Baoying; Henry, Sherry; Hill, Rosanne; He, Zhi; Pani, Amar; Kyle, Patrick; Ou, Xiaoming; Mosley, Thomas; Farley, Jerry M.; Stockmeier, Craig; Paul, Ian; Bigler, Steven; Brinton, Roberta Diaz; Smeyne, Richard; Wang, Jun Ming			Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; NEUROSTEROID ALLOPREGNANOLONE; DOPAMINERGIC-NEURONS; ADULT NEUROGENESIS; CELL-DEATH; BRAIN; REGENERATION; PROGESTERONE; MIDBRAIN; DEFICITS	Restorative/protective therapies to restore dopamine neurons in the substantia nigra pars compacta (SNpc) are greatly needed to effectively change the debilitating course of Parkinson's disease. In this study, we tested the therapeutic potential of a neurogenic neurosteroid, allopregnanolone, in the restoration of the components of the nigrostriatal pathway in MPTP-lesioned mice by measuring striatal dopamine levels, total and tyrosine hydroxylase immunoreactive neuron numbers and BrdU-positive cells in the SNpc. An acute treatment (once/week for two weeks) with allopregnanolone restored the number of tyrosine hydroxylase-positive and total cell numbers in the SNpc of MPTP-lesioned mice, even though this did not increase striatal dopamine. It was also noted that MPTP treated mice to which allopregnanolone was administered had an increase in BrdU-positive cells in the SNpc. The effects of allopregnanolone in MPTP-lesioned mice were more apparent in mice that underwent behavioral tests. Interestingly, mice treated with allopregnanolone after MPTP lesion were able to perform at levels similar to that of non-lesioned control mice in a rotarod test. These data demonstrate that allopregnanolone promotes the restoration of tyrosine hydroxylase immunoreactive neurons and total cells in the nigrostriatal tract, improves the motor performance in MPTP-treated mice, and may serve as a therapeutic strategy for Parkinson's disease.	[Adeosun, Samuel O.; Hou, Xu; Ou, Xiaoming; Farley, Jerry M.; Stockmeier, Craig; Paul, Ian; Wang, Jun Ming] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Zheng, Baoying; Henry, Sherry; He, Zhi; Kyle, Patrick; Bigler, Steven; Wang, Jun Ming] Univ Mississippi, Med Ctr, Program Neurosci, Jackson, MS 39216 USA; [Hill, Rosanne; Ou, Xiaoming; Stockmeier, Craig; Paul, Ian; Wang, Jun Ming] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; [Farley, Jerry M.; Wang, Jun Ming] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Mosley, Thomas; Wang, Jun Ming] Univ Mississippi, Med Ctr, Memory Impairment Neurodegenerat Dementia Res Ctr, Jackson, MS 39216 USA; [Jiao, Yun; Pani, Amar; Smeyne, Richard] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN USA; [Brinton, Roberta Diaz] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; St Jude Children's Research Hospital; University of Southern California	Wang, JM (corresponding author), Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA.	Jwang@umc.edu		Adeosun, Samuel/0000-0002-2331-7911; Brinton, Roberta/0000-0001-8450-772X; Smeyne, Richard/0000-0002-8459-5472	Michael J FOX Foundation; Carraway foundation; Alzheimer's Association; NCRR [RR17701]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020103] Funding Source: NIH RePORTER	Michael J FOX Foundation; Carraway foundation; Alzheimer's Association(Alzheimer's Association); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by grants from the Michael J FOX Foundation, the Carraway foundation, NCRR RR17701, and the Alzheimer's Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; Antzoulatos E, 2010, PHARMACOL BIOCHEM BE, V95, P466, DOI 10.1016/j.pbb.2010.03.009; Arias-Carrion O, 2009, J NEURAL TRANSM-SUPP, P279, DOI 10.1007/978-3-211-92660-4_23; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Berg DA, 2011, CELL STEM CELL, V8, P426, DOI 10.1016/j.stem.2011.02.001; Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541; Bonfanti L, 2008, VET J, V175, P310, DOI 10.1016/j.tvjl.2007.01.023; Boyd JD, 2007, BRAIN RES, V1175, P107, DOI 10.1016/j.brainres.2007.07.067; Cabras S, 2010, INT J NEUROPSYCHOPH, V13, P603, DOI 10.1017/S1461145710000210; Carter R J, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0812s15; Charalampopoulos I, 2006, ANN NY ACAD SCI, V1088, P139, DOI 10.1196/annals.1366.003; Charalampopoulos I, 2008, J NEUROCHEM, V107, P1457, DOI 10.1111/j.1471-4159.2008.05732.x; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; Chen SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024293; Daadi MM, 1999, J NEUROSCI, V19, P4484; de Michele F, 2003, NEUROL SCI, V24, P172, DOI 10.1007/s10072-003-0115-1; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Gago N, 2004, J NEUROSCI RES, V78, P770, DOI 10.1002/jnr.20348; Gerecke KM, 2010, BRAIN RES, V1341, P72, DOI 10.1016/j.brainres.2010.01.053; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Gorton LM, 2010, BEHAV BRAIN RES, V213, P253, DOI 10.1016/j.bbr.2010.05.009; Hajihosseini MK, 2008, MOL CELL NEUROSCI, V37, P857, DOI 10.1016/j.mcn.2008.01.008; Ikeda K, 2009, EUR J PHARMACOL, V620, P42, DOI 10.1016/j.ejphar.2009.08.013; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Kamigaichi R, 2009, EUR J NEUROL, V16, pE6, DOI 10.1111/j.1468-1331.2008.02357.x; Keller EA, 2004, DEV BRAIN RES, V153, P13, DOI 10.1016/j.devbrainres.2004.07.009; Lauber ME, 1996, ENDOCRINOLOGY, V137, P2718, DOI 10.1210/en.137.7.2718; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Luchetti S, 2010, BRAIN PATHOL, V20, P945, DOI 10.1111/j.1750-3639.2010.00396.x; Marx CE, 2006, BIOL PSYCHIAT, V60, P1287, DOI 10.1016/j.biopsych.2006.06.017; Matsuura N, 2001, J NEUROSCI, V21, P4326, DOI 10.1523/JNEUROSCI.21-12-04326.2001; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mochizuki Hideki, 2009, Brain and Nerve (Tokyo), V61, P485; Naylor JC, 2010, BBA-MOL CELL BIOL L, V1801, P951, DOI 10.1016/j.bbalip.2010.05.006; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Parish CL, 2007, DEVELOPMENT, V134, P2881, DOI 10.1242/dev.002329; Peng J, 2008, NEUROSCIENCE, V153, P664, DOI 10.1016/j.neuroscience.2008.02.063; Peng J, 2011, AGING CELL, V10, P255, DOI 10.1111/j.1474-9726.2010.00656.x; Peng J, 2010, J NEUROCHEM, V115, P1363, DOI 10.1111/j.1471-4159.2010.07036.x; Pinna Graziano, 2004, Critical Reviews in Neurobiology, V16, P75, DOI 10.1615/CritRevNeurobiol.v16.i12.80; Pomata PE, 2000, DEV BRAIN RES, V120, P83, DOI 10.1016/S0165-3806(99)00181-9; Ponti G, 2005, NEUROSCIENCE, V133, P105, DOI 10.1016/j.neuroscience.2005.02.014; Ponti G, 2010, ARCH ITAL BIOL, V148, P147; Ponti G, 2006, DEV BIOL, V294, P168, DOI 10.1016/j.ydbio.2006.02.037; Ponti G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002366; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Rommelfanger KS, 2007, BIOCHEM PHARMACOL, V74, P177, DOI 10.1016/j.bcp.2007.01.036; Rozas G, 1998, J NEUROSCI METH, V83, P165, DOI 10.1016/S0165-0270(98)00078-8; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Shan XY, 2006, STEM CELLS, V24, P1280, DOI 10.1634/stemcells.2005-0487; Singh C, 2011, NEUROBIOLOG IN PRESS; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; Sun C, 2012, CURR ALZHEI IN PRESS; Tajiri N, 2010, BRAIN RES, V1310, P200, DOI 10.1016/j.brainres.2009.10.075; Viaro R, 2010, EXP NEUROL, V223, P473, DOI 10.1016/j.expneurol.2010.01.014; Wang JM, 2005, J NEUROSCI, V25, P4706, DOI 10.1523/JNEUROSCI.4520-04.2005; Wang JM, 2008, BRAIN RES REV, V57, P398, DOI 10.1016/j.brainresrev.2007.08.010; Wang JM, 2007, CURR ALZHEIMER RES, V4, P510, DOI 10.2174/156720507783018262; Wang JM, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00194; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Wang JM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S11; Williams CA, 2009, REGEN MED, V4, P865, DOI 10.2217/RME.09.62; Yasuda T, 2011, J NEUROPATH EXP NEUR, V70, P686, DOI 10.1097/NEN.0b013e3182269ecd; Yasuda T, 2009, J NEUROCHEM, V108, P932, DOI 10.1111/j.1471-4159.2008.05827.x; Yoshimi K, 2005, ANN NEUROL, V58, P31, DOI 10.1002/ana.20506; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337; Zhao M, 2003, P NATL ACAD SCI USA, V100, P7925, DOI 10.1073/pnas.1131955100	68	40	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50040	10.1371/journal.pone.0050040	http://dx.doi.org/10.1371/journal.pone.0050040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209637	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900019
J	Palazzolo, G; Horvath, P; Zenobi-Wong, M				Palazzolo, Gemma; Horvath, Peter; Zenobi-Wong, Marcy			The Flavonoid Isoquercitrin Promotes Neurite Elongation by Reducing RhoA Activity	PLOS ONE			English	Article							NEUROBLASTOMA-CELLS; CANCER-CELLS; IN-VITRO; INHIBITION; PROTEIN; OUTGROWTH; BRAIN; DIFFERENTIATION; REGENERATION; METABOLITES	Background: Neurite formation and synaptic patterning are fundamental to the development of a functional nervous system. Flavonoids are natural molecules known for having beneficial effects on brain health through diverse molecular pathways. Cytoskeletal changes occurring during neuritogenesis and synapse formation often involve Rho GTPases. Here we hypothesized that the flavonoid isoquercitrin promotes neuronal differentiation through Rho signalling. Methodology/Principal Findings: We performed time lapse imaging of NG108-15 cells during incubation with/without isoquercitrin. Isoquercitrin stimulated extensive neurites enriched in the synaptic vesicle protein synaptotagmin-1. Neurite extension was augmented by the ROCK inhibitor Y-27632 suggesting an inactivation of RhoA/Rho kinase as the mechanism. To test this, we first measured the dose-dependent effect of isoquercitrin on RhoA activity and found a 47% reduction in RhoA activity at concentrations which induced neurites (>= 40 mu M). Secondly, we tested the ability of isoquercitrin to rescue the neural phenotype in a model of RhoA-induced neurite retraction and found that 40 mu M isoquercitrin added to cultures previously treated with the RhoA activator calpeptin produced significantly more neurite length/cell than calpeptin alone. Finally, we tested the hypothesis that isoquercitrin may affect RhoA localization preventing the translocation to the plasma membrane. Unexpectedly, immunolocalization studies showed that RhoA was present in nuclear compartments of control NG108-cells, but underwent translocation to the cytoplasm upon treatment with isoquercitrin. DNA microarrays and reverse transcription - quantitative PCR (RT-qPCR) revealed differences in global gene expression of Rho GTPase family members. These data taken together indicate that isoquercitrin is a potential stimulator of neuronal differentiation, through multiple Rho GTPase mediated mechanisms. Conclusions/Significance: As several members of the Rho GTPase family are implicated in human neurological disorders/injuries, our results suggest that isoquercitrin could be used in the treatment of these pathological states through its effect on this family of molecular switches.	[Palazzolo, Gemma; Zenobi-Wong, Marcy] Swiss Fed Inst Technol, Cartilage Engn Regenerat Dept Hlth Sci & Technol, Zurich, Switzerland; [Horvath, Peter] Swiss Fed Inst Technol, Light Microscopy & Screening Ctr, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Palazzolo, G (corresponding author), Swiss Fed Inst Technol, Cartilage Engn Regenerat Dept Hlth Sci & Technol, Zurich, Switzerland.	zmarcy@ethz.ch	Palazzolo, Gemma/K-1718-2017; Zenobi-Wong, Marcy/J-5398-2013	Palazzolo, Gemma/0000-0003-4070-1971; Zenobi-Wong, Marcy/0000-0002-8522-9909	Marie Heim-Vogtlin grant from the Swiss National Science Foundation [PMPDP2_122997]	Marie Heim-Vogtlin grant from the Swiss National Science Foundation	This study was funded by a Marie Heim-Vogtlin grant from the Swiss National Science Foundation (PMPDP2_122997 to MZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; Baek I, 2009, KOREAN J PHYSIOL PHA, V13, P201, DOI 10.4196/kjpp.2009.13.3.201; Busca R, 1998, MOL BIOL CELL, V9, P1367, DOI 10.1091/mbc.9.6.1367; Condello S, 2008, BRAIN RES, V1207, P1, DOI 10.1016/j.brainres.2008.02.044; Dubash AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017380; Dupraz S, 2009, J NEUROSCI, V29, P13292, DOI 10.1523/JNEUROSCI.3907-09.2009; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/JNEUROSCI.4353-06.2007; Galli RL, 2002, ANN NY ACAD SCI, V959, P128, DOI 10.1111/j.1749-6632.2002.tb02089.x; Gao SY, 2004, NEPHRON EXP NEPHROL, V97, pE49, DOI 10.1159/000078406; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; GREENE LA, 1982, DEV BIOL, V91, P305, DOI 10.1016/0012-1606(82)90037-9; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Horvath P, 2011, J BIOMOL SCREEN, V16, P1059, DOI 10.1177/1087057111414878; Jung SH, 2010, NEUROCHEM INT, V57, P713, DOI 10.1016/j.neuint.2010.08.005; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kopp MA, 2012, CELL TISSUE RES, V349, P119, DOI 10.1007/s00441-012-1334-7; Leong SY, 2011, STEM CELLS, V29, P332, DOI 10.1002/stem.577; Li M, 2009, NEUROBIOL DIS, V36, P413, DOI 10.1016/j.nbd.2009.06.011; Li RJ, 2011, N-S ARCH PHARMACOL, V383, P437, DOI 10.1007/s00210-011-0613-2; Li YY, 2011, MOL MED REP, V4, P1115, DOI 10.3892/mmr.2011.556; Li YY, 2010, ONCOL REP, V24, P1005, DOI 10.3892/or_00000948; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Maher P, 2008, ARCH BIOCHEM BIOPHYS, V476, P139, DOI 10.1016/j.abb.2008.03.023; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Nakajima K, 2011, CELL PHYSIOL BIOCHEM, V28, P147, DOI 10.1159/000331723; Negishi M, 2002, J BIOCHEM, V132, P157, DOI 10.1093/oxfordjournals.jbchem.a003205; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; Paulke A, 2008, PHARMAZIE, V63, P296, DOI 10.1691/ph.2008.7751; Paulke A, 2006, J CHROMATOGR B, V832, P109, DOI 10.1016/j.jchromb.2005.12.043; Postma FR, 1996, EMBO J, V15, P2388, DOI 10.1002/j.1460-2075.1996.tb00595.x; Samuel F, 2010, MOL NEUROBIOL, V42, P133, DOI 10.1007/s12035-010-8144-2; Sayas CL, 1999, J BIOL CHEM, V274, P37046, DOI 10.1074/jbc.274.52.37046; Scaife RM, 2003, MOL BIOL CELL, V14, P4605, DOI 10.1091/mbc.E02-11-0739; Schroeter H, 2001, BIOCHEM J, V358, P547, DOI 10.1042/0264-6021:3580547; Seidman KJN, 1996, J NEUROCHEM, V66, P1011; Silva CG, 2009, PHYTOMEDICINE, V16, P761, DOI 10.1016/j.phymed.2008.12.019; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Sommer C., 2011, ILASTIK INTERACTIVE; Soundararajan R, 2008, J BIOL CHEM, V283, P2231, DOI 10.1074/jbc.M703583200; Spencer JPE, 2009, GENES NUTR, V4, P243, DOI 10.1007/s12263-009-0136-3; Spencer JPE, 2004, ARCH BIOCHEM BIOPHYS, V423, P148, DOI 10.1016/j.abb.2003.11.010; Tanabe K, 2000, J NEUROSCI, V20, P4138; Tao Y, 2008, WORLD J GASTROENTERO, V14, P1175, DOI 10.3748/wjg.14.1175; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Yamamoto M, 2003, NEUROCHEM INT, V42, P231, DOI 10.1016/S0197-0186(02)00092-X; Zhou ZG, 2011, MOL CELL NEUROSCI, V48, P29, DOI 10.1016/j.mcn.2011.06.002	48	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49979	10.1371/journal.pone.0049979	http://dx.doi.org/10.1371/journal.pone.0049979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209630	Green Submitted, Green Published, gold			2022-12-25	WOS:000312104900015
J	Ruotsalainen, H; Risteli, M; Wang, CG; Wang, Y; Karppinen, M; Bergmann, U; Kvist, AP; Pospiech, H; Herzig, KH; Myllyla, R				Ruotsalainen, Heli; Risteli, Maija; Wang, Chunguang; Wang, Yu; Karppinen, Marjo; Bergmann, Ulrich; Kvist, Ari-Pekka; Pospiech, Helmut; Herzig, Karl-Heinz; Myllyla, Raili			The Activities of Lysyl Hydroxylase 3 (LH3) Regulate the Amount and Oligomerization Status of Adiponectin	PLOS ONE			English	Article							CONSERVED LYSINE RESIDUES; INSULIN-RESISTANCE; COLLAGENOUS DOMAIN; ADIPOSE-TISSUE; POSTTRANSLATIONAL MODIFICATIONS; EXTRACELLULAR-SPACE; PLASMA ADIPONECTIN; METABOLIC SYNDROME; GLYCOSYLATION; MICE	Lysyl hydroxylase 3 (LH3) has lysyl hydroxylase, galactosyltransferase, and glucosyltransferase activities, which are sequentially required for the formation of glucosylgalactosyl hydroxylysines in collagens. Here we demonstrate for the first time that LH3 also modifies the lysine residues in the collagenous domain of adiponectin, which has important roles in glucose and lipid metabolism and inflammation. Hydroxylation and, especially, glycosylation of the lysine residues of adiponectin have been shown to be essential for the formation of the more active high molecular weight adiponectin oligomers and thus for its function. In cells that totally lack LH3 enzyme, the galactosylhydroxylysine residues of adiponectin were not glucosylated to glucosylgalactosylhydroxylysine residues and the formation of high and middle molecular weight adiponectin oligomers was impaired. Circulating adiponectin levels in mutant mice lacking the lysyl hydroxylase activity of LH3 were significantly reduced, which indicates that LH3 is required for complete modification of lysine residues in adiponectin and the loss of some of the glycosylated hydroxylysine residues severely affects the secretion of adiponectin. LH mutant mice with reduced adiponectin level showed a high fat diet-induced increase in glucose, triglyceride, and LDL-cholesterol levels, hallmarks of the metabolic syndrome in humans. Our results reveal the first indication that LH3 is an important regulator of adiponectin biosynthesis, secretion and activity and thus might be a potential candidate for therapeutic applications in diseases associated with obesity and insulin resistance. Citation: Ruotsalainen H, Risteli M, Wang C, Wang Y, Karppinen M, et al. (2012) The Activities of Lysyl Hydroxylase 3 (LH3) Regulate the Amount and Oligomerization Status of Adiponectin. PLoS ONE 7(11): e50045. doi:10.1371/journal.pone.0050045	[Ruotsalainen, Heli; Risteli, Maija; Wang, Chunguang; Karppinen, Marjo; Bergmann, Ulrich; Kvist, Ari-Pekka; Pospiech, Helmut; Myllyla, Raili] Univ Oulu, Dept Biochem, Oulu, Finland; [Wang, Yu] Univ Hong Kong, Fac Med Complexes, Dept Pharmacol & Pharm, Pokfulam, Hong Kong, Peoples R China; [Herzig, Karl-Heinz] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Univ Oulu, Dept Physiol, Inst Biomed, Oulu, Finland; [Herzig, Karl-Heinz] Kuopio Univ Hosp, Dept Psychiat, SF-70210 Kuopio, Finland	Finland National Institute for Health & Welfare; University of Oulu; University of Hong Kong; University of Oulu; University of Oulu; Kuopio University Hospital; University of Eastern Finland	Ruotsalainen, H (corresponding author), Univ Oulu, Dept Biochem, Oulu, Finland.	heli.ruotsalainen@oulu.fi	Wang, Chunguang/AAE-6997-2020; Wang, Chunguang/AAE-7054-2020; Pospiech, Helmut/J-8598-2015	Wang, Chunguang/0000-0001-5569-321X; wang, yu/0000-0001-8697-2940; Ruotsalainen, Heli/0000-0003-4923-5196	Academy of Finland [109784, 110525, 121700, 127243, 129568, 137659]; Biocenter Oulu; Sigrid Juselius Foundation; Diabetes Research Foundation; Orion-Farmos research foundation; Glugal Research/IP Finland	Academy of Finland(Academy of Finland); Biocenter Oulu; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Diabetes Research Foundation; Orion-Farmos research foundation; Glugal Research/IP Finland	Funders are the Academy of Finland (grants 109784, 110525, 121700, 127243, 129568 and 137659; http://www.aka.fi/en-GB/A/); Biocenter Oulu (http://www.oulu.fi/biocenter/); Sigrid Juselius Foundation (http://www.sigridjuselius.fi/foundation); Diabetes Research Foundation (http://www.diabetestutkimus.fi/en); Orion-Farmos research foundation (http://www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio/); and Glugal Research/IP Finland (http://www.ipfinland.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Combs TP, 2003, DIABETES, V52, P268, DOI 10.2337/diabetes.52.2.268; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kangas-Kontio T, 2010, ATHEROSCLEROSIS, V210, P479, DOI 10.1016/j.atherosclerosis.2009.12.022; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lara-Castro C, 2007, CURR OPIN LIPIDOL, V18, P263, DOI 10.1097/MOL.0b013e32814a645f; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Miinalainen IJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000543; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Myllyla R, 2007, J CELL PHYSIOL, V212, P323, DOI 10.1002/jcp.21036; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Plaisance EP, 2009, METABOLISM, V58, P1557, DOI 10.1016/j.metabol.2009.04.038; Qiao LP, 2008, DIABETES, V57, P1824, DOI 10.2337/db07-0435; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2006, MATRIX BIOL, V25, P475, DOI 10.1016/j.matbio.2006.08.260; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Sheng TX, 2008, J GENET GENOMICS, V35, P321, DOI 10.1016/S1673-8527(08)60047-8; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Vlasova M, 2010, ACTA PHYSIOL, V200, P107, DOI 10.1111/j.1748-1716.2010.02171.x; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2012, J CELL PHYSIOL, V227, P668, DOI 10.1002/jcp.22774; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; WU GY, 1981, BIOCHEMISTRY-US, V20, P4321, DOI 10.1021/bi00518a013; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; Yun JE, 2009, DIABETES-METAB RES, V25, P259, DOI 10.1002/dmrr.946	45	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50045	10.1371/journal.pone.0050045	http://dx.doi.org/10.1371/journal.pone.0050045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209641	Green Published, Green Submitted, gold			2022-12-25	WOS:000312104900021
J	Chang, SJ; Liu, N; Wang, XY; Zhang, YJ; Xie, Y				Chang, Shujuan; Liu, Nan; Wang, Xiaoya; Zhang, Yingjun; Xie, Yue			Alfalfa Carbon and Nitrogen Sequestration Patterns and Effects of Temperature and Precipitation in Three Agro-Pastoral Ecotones of Northern China	PLOS ONE			English	Article							LAND-USE CHANGE; SOIL CARBON; ELEVATION GRADIENT; NORTHWEST CHINA; ORGANIC-CARBON; FORAGE LAND; DYNAMICS; STORAGE; VEGETATION; CONVERSION	Alfalfa (Medicago sativa L.) is a primary and widely cultivated forage crop in China. As a perennial leguminous grass, continuous planted alfalfa may influence carbon and nitrogen sequestration in soils. We evaluated the effect of alfalfa, planted for different lengths of time, and temperature and precipitation on soil organic carbon (SOC) and total nitrogen (TN) contents, and estimated soil SOC and TN inventories from 0-60 cm in three agro-pastoral ecotones of northern China. Alfalfa SOC and TN storage patterns were significantly different with increasing soil depths between the three regions of northern China. Continuous alfalfa grassland planted had a positive effect on accumulation of both SOC and TN in the Northwest region, whereas SOC storage peaked 6-7 years after planting in the Northeast and North region. Moreover, relatively higher TN storage appeared 7 years after planting in the Northeast and North regions. This study controlled as many factors as possible, but we caution that such temporal inferences could be artifacts of site selection. The regression analysis indicated that SOC and TN accumulation was mainly dependent on temperature (>= 10 degrees C of effective total accumulated temperature) in the North region. Precipitation in the growing season was the main limiting factor for SOC storage in the Northwest region and TN accumulation in the North regions. Therefore, the different climate factors affecting SOC and TN sequestration in alfalfa occurred at a regional scale.	[Chang, Shujuan; Liu, Nan; Wang, Xiaoya; Zhang, Yingjun; Xie, Yue] China Agr Univ, Inst Grassland Sci, Beijing 100094, Peoples R China; [Chang, Shujuan] Inner Mongolia Rangeland Survey & Design Inst, Hohhot, Inner Mongolia, Peoples R China	China Agricultural University	Zhang, YJ (corresponding author), China Agr Univ, Inst Grassland Sci, Beijing 100094, Peoples R China.	zhangyj@cau.edu.cn	Xie, Yue/ABA-7641-2021; Zhang, Yingjun/A-2400-2015	Xie, Yue/0000-0002-3474-8530; Zhang, Yingjun/0000-0001-5776-4392	China Forage and Grass Research System [CARS-35]; Beijing Key Laboratory of Grassland Science	China Forage and Grass Research System; Beijing Key Laboratory of Grassland Science	This research was supported by the China Forage and Grass Research System (CARS-35) and the Beijing Key Laboratory of Grassland Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABER JD, 1990, CAN J BOT, V68, P2201, DOI 10.1139/b90-287; [Anonymous], 1980, SOIL RESOURCE ORIGIN; Breshears DD, 1997, J ECOL, V85, P289, DOI 10.2307/2960502; Bruce JP, 1999, J SOIL WATER CONSERV, V54, P382; Burke IC, 1997, SOIL ORGANIC MATTER, P85; Cheddadi R, 2001, LANDSCAPE ECOL, V16, P667, DOI 10.1023/A:1013149831734; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; DORAN JW, 1994, SSSA SPEC PUBL, P3; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Fantappie M, 2011, GEOMORPHOLOGY, V135, P343, DOI 10.1016/j.geomorph.2011.02.006; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Grunzweig JM, 2004, GLOBAL CHANGE BIOL, V10, P452, DOI 10.1111/j.1365-2486.2004.00738.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; JENNY H, 1980, ECOL STUD, V37, P377, DOI DOI 10.1007/978-1-4612-6112-4; Jenny H., 1941, FACTORS SOIL FORMATI, P281, DOI DOI 10.2307/211491; Jiang HM, 2006, SOIL BIOL BIOCHEM, V38, P2350, DOI 10.1016/j.soilbio.2006.02.008; Jimenez JJ, 2006, CRIT REV PLANT SCI, V25, P337, DOI 10.1080/0735268060094240; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; [康俊梅 Kang Junmei], 2010, [中国草地学报, Chinese Journal of Grassland], V32, P5; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Lal R, 1999, J SOIL WATER CONSERV, V54, P374; Lemenih M, 2004, GEODERMA, V123, P177, DOI 10.1016/j.geoderma.2004.02.004; Li XG, 2006, SOIL TILL RES, V91, P22, DOI 10.1016/j.still.2005.10.004; MCCLAUGHERTY CA, 1985, ECOLOGY, V66, P266, DOI 10.2307/1941327; NELSON DW, 1982, AGRON MONOGR, P102; Paustian K., 1997, SOIL ORGANIC MATTER; Percival HJ, 2000, SOIL SCI SOC AM J, V64, P1623, DOI 10.2136/sssaj2000.6451623x; Posada JM, 2011, OECOLOGIA, V165, P783, DOI 10.1007/s00442-010-1881-0; POST WM, 1985, NATURE, V317, P613, DOI 10.1038/317613a0; RUTHERFORD MC, 1980, S AFR J SCI, V76, P53; Schmitt A, 2011, SOIL BIOL BIOCHEM, V43, P478, DOI 10.1016/j.soilbio.2010.09.037; Shi XZ, 2009, SOIL TILL RES, V105, P322, DOI 10.1016/j.still.2008.12.016; SKARPE C, 1992, J VEG SCI, V3, P293, DOI 10.2307/3235754; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Su YZ, 2007, SOIL TILL RES, V92, P181, DOI 10.1016/j.still.2006.03.001; Su YZ, 2009, ENVIRON MANAGE, V43, P1061, DOI 10.1007/s00267-009-9284-x; Upadhyay TP, 2005, AGR ECOSYST ENVIRON, V105, P449, DOI 10.1016/j.agee.2004.09.007; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; [王春春 Wang Chunchun], 2010, [南京农业大学学报, Journal of Nanjing Agricultural University], V33, P19; WILSON AT, 1978, NATURE, V273, P40, DOI 10.1038/273040a0; Yan PJ, 2011, INNER MONGOLIA SCI T, V235, P63; Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y	45	9	14	8	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50544	10.1371/journal.pone.0050544	http://dx.doi.org/10.1371/journal.pone.0050544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209775	gold, Green Submitted, Green Published			2022-12-25	WOS:000312601700078
J	McCarrey, AC; Henry, JD; von Hippel, W; Weidemann, G; Sachdev, PS; Wohl, MJA; Williams, M				McCarrey, Anna C.; Henry, Julie D.; von Hippel, William; Weidemann, Gabrielle; Sachdev, Perminder S.; Wohl, Michael J. A.; Williams, Mark			Age Differences in Neural Activity during Slot Machine Gambling: An fMRI Study	PLOS ONE			English	Article							PATHOLOGICAL GAMBLERS; OLDER-ADULTS; EXECUTIVE FUNCTIONS; DECISION-MAKING; PREFRONTAL CORTEX; SEX-DIFFERENCES; BRAIN ACTIVITY; TASK; PERFORMANCE; RISK	This study aimed to assess the potential association between age-related prefrontal brain changes and slot machine gambling, an activity that has become increasingly popular among older adults. Functional magnetic resonance imaging was used to assess healthy older and younger adults whilst playing a slot machine. Results revealed that the older group over-recruited several bilateral and contralateral brain structures relative to the younger group. Specifically, older adults exhibited increased neural activation in the superior prefrontal cortex and left orbitofrontal cortex, indicating greater reliance on these structures. These results suggest a compensatory mechanism, by which older adults recruit a greater number of neural networks from both hemispheres to complete the same gambling task as their younger peers. The broader implications of these findings are discussed in relation to theories of neurocognitive and degenerative change that occurs in late adulthood.	[Henry, Julie D.; von Hippel, William] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [McCarrey, Anna C.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [McCarrey, Anna C.] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Weidemann, Gabrielle] Univ Western Sydney, Sch Psychol, Penrith, NSW 1797, Australia; [Sachdev, Perminder S.] Univ New S Wales, Sch Psychiat, Brain & Ageing Res Program, Sydney, NSW, Australia; [Sachdev, Perminder S.] Prince Wales Hosp, Inst Neuropsychiat, Sydney, NSW, Australia; [Wohl, Michael J. A.] Carleton Univ, Dept Psychol, Ottawa, ON K1S 5B6, Canada; [Williams, Mark] Macquarie Univ, Macquarie Ctr Cognit Sci, Sydney, NSW 2109, Australia	University of Queensland; University of Cambridge; Western Sydney University; University of New South Wales Sydney; Carleton University; Macquarie University	Henry, JD (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	julie.henry@uq.edu.au	Sachdev, Perminder/ABC-1137-2020; Von Hippel, Bill/L-4729-2019; Wohl, Michael/AAS-5819-2021	Sachdev, Perminder/0000-0002-9595-3220; Wohl, Michael/0000-0001-6945-5562; Henry, Julie/0000-0002-2081-3717; Williams, Mark/0000-0002-3897-5167; Weidemann, Gabrielle/0000-0002-1469-8089; VON HIPPEL, William/0000-0001-9900-0868	Australian Research Council [DP1093234]	Australian Research Council(Australian Research Council)	This research was supported by grant DP1093234 from the Australian Research Council www.arc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; [Anonymous], 2005, INT J MENTAL HLTH AD, DOI DOI 10.5072/PRISM/9488; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Blanco C, 2006, PSYCHOL MED, V36, P943, DOI 10.1017/S0033291706007410; Brewer JA, 2007, RES MEASUREMENT ISSU; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Coffey CE, 1998, ARCH NEUROL-CHICAGO, V55, P169, DOI 10.1001/archneur.55.2.169; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; Dowling N, 2005, ADDICTION, V100, P33, DOI 10.1111/j.1360-0443.2005.00962.x; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; Grant JE, 2003, PSYCHOPATHOLOGY, V36, P200, DOI 10.1159/000072790; Jacobs D., 1986, J GAMBLING BEHAV, P15, DOI [10.1007/bf01019931, DOI 10.1007/BF01043526, DOI 10.1007/BF01019931]; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Krendl AC, 2009, PSYCHOL AGING, V24, P530, DOI 10.1037/a0016065; Ladouceur R, 1991, J Gambl Stud, V7, P109, DOI 10.1007/BF01014526; Lamar M, 2004, NEUROIMAGE, V21, P1368, DOI 10.1016/j.neuroimage.2003.11.018; Lee TMC, 2008, SOC COGN AFFECT NEUR, V3, P7, DOI 10.1093/scan/nsm033; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Marschner A, 2005, BRAIN RES BULL, V67, P382, DOI 10.1016/j.brainresbull.2005.06.010; McCormack J, 2003, AUSTRALAS J AGEING, V22, P120, DOI 10.1111/j.1741-6612.2003.tb00481.x; Moscovitch M., 1992, HDB AGING COGNITION, P315; Northoff G, 2006, HUM BRAIN MAPP, V27, P572, DOI 10.1002/hbm.20202; Nower L, 2008, PSYCHOL AGING, V23, P577, DOI 10.1037/a0013233; Petry NM, 2002, GERONTOLOGIST, V42, P92, DOI 10.1093/geront/42.1.92; Potenza MN, 2003, ARCH GEN PSYCHIAT, V60, P828, DOI 10.1001/archpsyc.60.8.828; Potenza MN, 2003, AM J PSYCHIAT, V160, P1990, DOI 10.1176/appi.ajp.160.11.1990; Productivity Commission, 2010, 50 PROD COMM; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Robbins TW, 1996, PHILOS T ROY SOC B, V351, P1463, DOI 10.1098/rstb.1996.0131; Roca M, 2008, COGN BEHAV NEUROL, V21, P1, DOI 10.1097/WNN.0b013e3181684358; Rogalsky C, 2012, SOC NEUROSCI-UK, V7, P178, DOI 10.1080/17470919.2011.588340; Samanez-Larkin GR, 2007, NAT NEUROSCI, V10, P787, DOI 10.1038/nn1894; Sheline YI, 2010, BIOL PSYCHIAT, V67, P584, DOI 10.1016/j.biopsych.2009.08.024; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Stewart MJ, PSYCHOL ADD IN PRESS; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Talairach J., 1988, COPLANAR STEREOTAXIC; Verhaeghen P, 2002, NEUROSCI BIOBEHAV R, V26, P849, DOI 10.1016/S0149-7634(02)00071-4; VEROFF AE, 1980, PSYCHOL RES-PSYCH FO, V41, P259, DOI 10.1007/BF00308661; von Hippel W, 2009, AGING NEUROPSYCHOL C, V16, P654, DOI 10.1080/13825580902871018; Wechsler D., 1999, WECHSLER ABBREVIATED; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Wood S, 2005, PSYCHOL AGING, V20, P220, DOI 10.1037/0882-7974.20.2.220; Young MM, 2009, PSYCHOL ADDICT BEHAV, V23, P512, DOI 10.1037/a0015043; Zaranek RR, 2008, J AGING STUD, V22, P13, DOI 10.1016/j.jaging.2007.11.001	57	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49787	10.1371/journal.pone.0049787	http://dx.doi.org/10.1371/journal.pone.0049787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209599	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700018
J	Vall, O; Gomez-Culebras, M; Garcia-Algar, O; Joya, X; Velez, D; Rodriguez-Carrasco, E; Puig, C				Vall, Oriol; Gomez-Culebras, Mario; Garcia-Algar, Oscar; Joya, Xavier; Velez, Dinoraz; Rodriguez-Carrasco, Eva; Puig, Carme			Assessment of Prenatal Exposure to Arsenic in Tenerife Island	PLOS ONE			English	Article							DRINKING-WATER; PREGNANCY OUTCOMES; FETAL EXPOSURE; BIRTH; MORTALITY	Introduction: Increasing awareness of the potential chronic health effects of arsenic (As) at low exposure levels has motivated efforts to better understand impaired child development during pregnancy by biomarkers of exposure. The aims of this study were to evaluate the prenatal exposure to As by analysis of an alternative matrix (meconium), to examine its effects on neonatal outcomes and investigate the association with maternal lifestyle and dietary habits during pregnancy. Methods: A transversal descriptive study was conducted in Tenerife (Spain). A total of 96 mother-child pairs participated in the study. A questionnaire on sociodemographic, lifestyle and dietary habits during pregnancy was administered the day after the delivery. Analysis of total As in meconium was performed by inductively coupled plasma-optical emission spectrometer. Results: Total As was detected in 37 (38.5%) meconium samples. The univariate logistic regression model indicates that prenatal exposure to As was associated with a low intake of eggs per week (OR 0.56; CI (95%): 0.34-0.94) during pregnancy. Conversely, frequent intake of vegetables was associated with prenatal As exposure (OR: 1.19; CI (95%): 1.01-1.41) and frequent intake of processed meat (as bacon, Frankfurt's sausage, and hamburger) shows a trend to As prenatal exposure (OR: 8.54; CI (95%): 0.80-90.89). The adjusted multivariate logistic regression model indicates that only frequent intake of vegetables maintains the association (OR: 1.31; CI (95%): 1.02-1.68). Conclusion: The studied population presented a low As exposure and was not associated with neonatal effects. Maternal consumption of vegetables during pregnancy was associated with detectable meconium As levels; however the concentration detected in meconium was too low to be considered a major public health concern in this geographical area.	[Vall, Oriol; Garcia-Algar, Oscar; Joya, Xavier; Puig, Carme] Inst Hosp Mar Invest Med IMIM, URIE, Barcelona, Spain; [Vall, Oriol; Garcia-Algar, Oscar; Joya, Xavier; Puig, Carme] Inst Salud Carlos III, Madrid, Spain; [Vall, Oriol; Garcia-Algar, Oscar] Hosp del Mar, Serv Pediat, Barcelona, Spain; [Vall, Oriol; Garcia-Algar, Oscar] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Gomez-Culebras, Mario; Rodriguez-Carrasco, Eva] Univ Tenerife, Dept Cirugia Pediat, Tenerife, Spain; [Velez, Dinoraz] CSIC, Inst Agroquim & Tecnol Alimentos, E-46010 Valencia, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Garcia-Algar, O (corresponding author), Inst Hosp Mar Invest Med IMIM, URIE, Barcelona, Spain.	90458@hospitaldelmar.cat	Joya, Xavier/B-2533-2013	Velez Pacios, Dinoraz/0000-0001-8679-5622; GARCIA-ALGAR, OSCAR/0000-0001-5708-4362				Agency for Toxic Substances and Disease Registry (ATSDR's), TOXICOLOGICAL PROFIL; Ahmad SA, 2011, ENV HLTH PERSPECT, V109, P629; Ahmed S, 2011, ENVIRON HEALTH PERSP, V119, P258, DOI 10.1289/ehp.1002086; [Anonymous], 2009, EFSA J, V7, DOI 10.2903/j.efsa.2009.1376; Codex Alimentarius Commission, 2012, POSITION PAPER ON AR; Concha G, 1998, TOXICOL SCI, V44, P185, DOI 10.1006/toxs.1998.2486; Domingo-Salvany A, 2000, Aten Primaria, V25, P350; Farias S, 2007, CHEMOSPHERE, V69, P1017, DOI 10.1016/j.chemosphere.2007.04.049; Fontcuberta M, 2011, J AGR FOOD CHEM, V59, P10013, DOI 10.1021/jf2013502; Guan HA, 2010, BIOMED ENVIRON SCI, V23, P458, DOI 10.1016/S0895-3988(11)60008-1; Hindmarsh JT, 2002, CLIN BIOCHEM, V35, P1, DOI 10.1016/S0009-9120(01)00282-X; HINDMARSH JT, 1986, CRC CR REV CL LAB SC, V23, P315, DOI 10.3109/10408368609167122; Hopenhayn C, 2003, EPIDEMIOLOGY, V14, P593, DOI 10.1097/01.ede.0000072104.65240.69; Huyck KL, 2007, J OCCUP ENVIRON MED, V49, P1097, DOI 10.1097/JOM.0b013e3181566ba0; International Agency for Research on Cancer (IARC), 2012, IARC MONOGRAPHS ON T, V84; Meliker JR, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-4; Milton AH, 2005, EPIDEMIOLOGY, V16, P82, DOI 10.1097/01.ede.0000147105.94041.e6; Moyano A, 2009, J ENVIRON MONITOR, V11, P498, DOI 10.1039/b817634e; Mumford JL, 2007, ENVIRON HEALTH PERSP, V115, P690, DOI 10.1289/ehp.9686; National Research Council, 1999, ARS DRINK WAT, P310; Ostrea EM, 2002, NEUROTOXICOLOGY, V23, P329, DOI 10.1016/S0161-813X(02)00077-3; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Rossman TG, 2004, TOXICOL APPL PHARM, V198, P394, DOI 10.1016/j.taap.2003.10.016; Smith AH, 2009, ANNU REV PUBL HEALTH, V30, P107, DOI 10.1146/annurev.publhealth.031308.100143; States JC, 2009, TOXICOL SCI, V107, P312, DOI 10.1093/toxsci/kfn236; Tofail F, 2009, ENVIRON HEALTH PERSP, V117, P288, DOI 10.1289/ehp.11670; USEPA, 2012, TECHNICAL FACT SHEET; Vahter M, 2009, ANNU REV NUTR, V29, P381, DOI 10.1146/annurev-nutr-080508-141102; Vahter ME, 2007, J NUTR, V137, P2798, DOI 10.1093/jn/137.12.2798; von Ehrenstein OS, 2006, AM J EPIDEMIOL, V163, P662, DOI 10.1093/aje/kwj089; WHO, 2008, GUID DRINK WAT QUAL, V1; Yang CY, 2003, ENVIRON RES, V91, P29, DOI 10.1016/S0013-9351(02)00015-4; Zadorozhnaja TD, 2000, J TOXICOL ENV HEAL A, V61, P255, DOI 10.1080/00984100050136571	34	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50463	10.1371/journal.pone.0050463	http://dx.doi.org/10.1371/journal.pone.0050463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209747	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700073
J	Mangin, I; Leveque, C; Magne, F; Suau, A; Pochart, P				Mangin, Irene; Leveque, Christophe; Magne, Fabien; Suau, Antonia; Pochart, Philippe			Long-Term Changes in Human Colonic Bifidobacterium Populations Induced by a 5-Day Oral Amoxicillin-Clavulanic Acid Treatment	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; HUMAN FECAL FLORA; ANTIMICROBIAL SUSCEPTIBILITY; GUT MICROBIOTA; HUMAN FECES; PCR; DIVERSITY; HYBRIDIZATION; RESISTANCE; CYTOKINES	The objective of this study was to assess the possible modifications due to amoxicillin-clavulanic acid (AMC) treatment on total bacteria and on Bifidobacterium species balance in human colonic microbiota. Eighteen healthy volunteers (19 to 36 years old) were given a 875/125 mg dose of AMC twice a day for 5 days. Fecal samples were obtained before and after antibiotic exposure. After total DNA extraction, total bacteria and bifidobacteria were specifically quantified using real-time PCR. Dominant species were monitored over time using bacterial and bifidobacterial Temporal Temperature Gradient gel Electrophoresis (TTGE). At the end of AMC exposure, total bacterial concentrations as well as bifidobacteria concentrations were significantly reduced compared to before AMC exposure: 10.7 +/- 0.1 log(10) 16S rRNA gene copies/g vs 11.1 +/- 0.1 log(10) (p = 0.003) and 8.1 +/- 0.5 log(10) 16S rRNA gene copies/g vs 9.4 +/- 0.3 log(10) (p = 0.003), respectively. At the same time, the mean similarity percentages of TTGE bacteria and TTGE bifidobacteria profiles were significantly reduced compared to before AMC exposure: 51.6%+/- 3.5% vs 81.4%+/- 2.1% and 55.8%+/- 7.6% vs 84.5%+/- 4.1%, respectively. Occurrence of B. adolescentis, B. bifidum and B. pseudocatenulatum/B. catenulatum species significantly decreased. Occurrence of B. longum remained stable. Moreover, the number of distinct Bifidobacterium species per sample significantly decreased (1.5 +/- 0.3 vs 2.3 +/- 0.3; p = 0.01). Two months after AMC exposure, the mean similarity percentage of TTGE profiles was 55.6% for bacteria and 62.3% for bifidobacteria. These results clearly demonstrated that a common antibiotic treatment may qualitatively alter the colonic microbiota. Such modifications may have potential long-term physiological consequences.	[Mangin, Irene; Leveque, Christophe; Magne, Fabien; Suau, Antonia; Pochart, Philippe] Conservatoire Natl Arts & Metiers, Biol Lab, Paris, France; [Mangin, Irene; Leveque, Christophe; Pochart, Philippe] Univ Paris 05, Fac Sci Pharmaceut & Biol, EA 4065, Paris, France; [Suau, Antonia] Univ Grenoble 1, Lab Adaptat & Pathogenie Microorganisme, Grenoble, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Mangin, I (corresponding author), Conservatoire Natl Arts & Metiers, Biol Lab, Paris, France.	irene.mangin@cnam.fr	Magne, Fabien/F-1393-2014; Suau, antonia/M-6587-2014	Magne, Fabien/0000-0002-8210-4561; 	French Ministry of Health	French Ministry of Health	This work was supported by a grant from the French Ministry of Health (regional hospital project of clinical research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Barc MC, 2004, ANTIMICROB AGENTS CH, V48, P1365, DOI 10.1128/AAC.48.4.1365-1368.2004; Bergogne-Berezin E, 2000, INT J ANTIMICROB AG, V16, P521, DOI 10.1016/S0924-8579(00)00293-4; Bertrand X, 2007, J APPL MICROBIOL, V102, P1052, DOI 10.1111/j.1365-2672.2006.03148.x; CHACHATY E, 1993, ANTIMICROB AGENTS CH, V37, P1432, DOI 10.1128/AAC.37.7.1432; De La Cochetiere MF, 2005, J CLIN MICROBIOL, V43, P5588, DOI 10.1128/JCM.43.11.5588-5592.2005; Delgado S, 2005, CURR MICROBIOL, V50, P202, DOI 10.1007/s00284-004-4431-3; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Donskey CJ, 2003, J MICROBIOL METH, V54, P249, DOI 10.1016/S0167-7012(03)00059-9; Finegold S.M., 1983, HUMAN INTESTINAL MIC, P3, DOI DOI 10.1016/B978-0-12-341280-5.50007-0; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Gronvold AMR, 2010, FEMS MICROBIOL ECOL, V71, P313, DOI 10.1111/j.1574-6941.2009.00808.x; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; He F, 2002, MICROBIOL IMMUNOL, V46, P781, DOI 10.1111/j.1348-0421.2002.tb02765.x; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Lee JH, 2011, APPL ENVIRON MICROB, V77, P5879, DOI 10.1128/AEM.00571-11; LEONARD F, 1989, J INFECT DIS, V160, P274, DOI 10.1093/infdis/160.2.274; LIM KS, 1993, J DAIRY SCI, V76, P2168, DOI 10.3168/jds.S0022-0302(93)77553-0; Lode H, 2001, SCAND J INFECT DIS, V33, P899, DOI 10.1080/00365540110076714; Magne F, 2006, FEMS MICROBIOL ECOL, V58, P563, DOI 10.1111/j.1574-6941.2006.00182.x; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Mangin I, 2006, FEMS MICROBIOL ECOL, V55, P28, DOI 10.1111/j.1574-6941.2005.00005.x; Mangin I, 2010, ANAEROBE, V16, P433, DOI 10.1016/j.anaerobe.2010.06.005; Mangin I, 1999, RES MICROBIOL, V150, P343, DOI 10.1016/S0923-2508(99)80060-6; Masco L, 2006, J ANTIMICROB CHEMOTH, V58, P85, DOI 10.1093/jac/dkl197; Matsuki T, 1999, APPL ENVIRON MICROB, V65, P4506; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Menard O, 2008, APPL ENVIRON MICROB, V74, P660, DOI 10.1128/AEM.01261-07; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Moubareck C, 2005, J ANTIMICROB CHEMOTH, V55, P38, DOI 10.1093/jac/dkh495; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Satokari RM, 2001, APPL ENVIRON MICROB, V67, P504, DOI 10.1128/AEM.67.2.504-513.2001; SNEATH PHA, 1962, NATURE, V193, P855, DOI 10.1038/193855a0; Sullivan A, 2001, Lancet Infect Dis, V1, P101, DOI 10.1016/S1473-3099(01)00066-4; Vanhoutte T, 2004, FEMS MICROBIOL ECOL, V48, P437, DOI 10.1016/j.femsec.2004.03.001; Vasquez N, 2009, APPL ENVIRON MICROB, V75, P381, DOI 10.1128/AEM.01731-08; Wlodarska M, 2010, MUCOSAL IMMUNOL, V3, P100, DOI 10.1038/mi.2009.135; Yoshimura K, 2010, ANTON LEEUW INT J G, V97, P107, DOI 10.1007/s10482-009-9391-y; Young SL, 2004, CLIN DIAGN LAB IMMUN, V11, P686, DOI 10.1128/CDLI.11.4.686-690.2004; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004	47	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50257	10.1371/journal.pone.0050257	http://dx.doi.org/10.1371/journal.pone.0050257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209691	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800059
J	Todorova, VK; Beggs, ML; Delongchamp, RR; Dhakal, I; Makhoul, I; Wei, JY; Klimberg, VS				Todorova, Valentina K.; Beggs, Marjorie L.; Delongchamp, Robert R.; Dhakal, Ishwori; Makhoul, Issam; Wei, Jeanne Y.; Klimberg, V. Suzanne			Transcriptome Profiling of Peripheral Blood Cells Identifies Potential Biomarkers for Doxorubicin Cardiotoxicity in a Rat Model	PLOS ONE			English	Article							ANTHRACYCLINE-INDUCED CARDIOTOXICITY; B SIGNALING PATHWAY; NF-KAPPA-B; GENE-EXPRESSION; HEART-FAILURE; CHEMOTHERAPEUTIC-AGENTS; IN-VIVO; PROTEASOME PATHWAY; MYOCARDIAL DAMAGE; UBIQUITIN	Aims: Doxorubicin (DOX), a widely used anticancer agent, can cause an unpredictable cardiac toxicity which remains a major limitation in cancer chemotherapy. There is a need for noninvasive, sensitive and specific biomarkers which will allow identifying patients at risk for DOX-induced cardiotoxicity to prevent permanent cardiac damage. The aim of this study was to investigate whether the expression of specific genes in the peripheral blood can be used as surrogate marker(s) for DOX-induced cardiotoxicity. Methods/Results: Rats were treated with a single dose of DOX similar to one single dose that is often administered in humans. The cardiac and peripheral blood mononuclear cells (PBMCs) genome-wide expression profiling were examined using Illumina microarrays. The results showed 4,409 differentially regulated genes (DRG) in the hearts and 4,120 DRG in PBMC. Of these 2411 genes were similarly DRG (SDRG) in both the heart and PBMC. Pathway analysis of the three datasets of DRG using Gene Ontology (GO) enrichment analysis and Ingenuity Pathways Analysis (IPA) showed that most of the genes in these datasets fell into pathways related to oxidative stress response and protein ubiquination. IPA search for potential eligible biomarkers for cardiovascular disease within the SDRG list revealed 188 molecules. Conclusions: We report the first in-depth comparison of DOX-induced global gene expression profiles of hearts and PBMCs. The high similarity between the gene expression profiles of the heart and PBMC induced by DOX indicates that the PBMC transcriptome may serve as a surrogate marker of DOX-induced cardiotoxicity. Future directions of this research will include analysis of PBMC expression profiles of cancer patients treated with DOX-based chemotherapy to identify the cardiotoxicity risk, predict DOX-treatment response and ultimately to allow individualized anti-cancer therapy.	[Todorova, Valentina K.; Klimberg, V. Suzanne] Univ Arkansas Med Sci, Dept Surg Breast Surg Oncol, Little Rock, AR 72205 USA; [Todorova, Valentina K.; Klimberg, V. Suzanne] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Beggs, Marjorie L.; Dhakal, Ishwori] Univ Arkansas Med Sci, Dept Med Genet, Little Rock, AR 72205 USA; [Delongchamp, Robert R.] Univ Arkansas Med Sci, Dept Epidemiol, Little Rock, AR 72205 USA; [Makhoul, Issam] Univ Arkansas Med Sci, Dept Hematol Oncol Hematol, Little Rock, AR 72205 USA; [Wei, Jeanne Y.] Univ Arkansas Med Sci, Dept Geriatr, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Todorova, VK (corresponding author), Univ Arkansas Med Sci, Dept Surg Breast Surg Oncol, Little Rock, AR 72205 USA.	vtodorova@uams.edu			Arkansas Breast Cancer Research Program; University of Arkansas for Medical Sciences Translational Research Institute (CTSA) [1UL1RR029884]; Tenenbaum Breast Cancer Research Fund, Little Rock, Arkansas; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028718] Funding Source: NIH RePORTER	Arkansas Breast Cancer Research Program; University of Arkansas for Medical Sciences Translational Research Institute (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Tenenbaum Breast Cancer Research Fund, Little Rock, Arkansas; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a grant from the Arkansas Breast Cancer Research Program and the University of Arkansas for Medical Sciences Translational Research Institute (CTSA Grant Award #1UL1RR029884) to VKT and by the Tenenbaum Breast Cancer Research Fund, Little Rock, Arkansas to VSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; [Anonymous], 2005, GUID IND EST MAX SAF; Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Barry E, 2007, EXPERT OPIN PHARMACO, V8, P1039, DOI 10.1517/14656566.8.8.1039; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthiaume JM, 2007, CARDIOVASC TOXICOL, V7, P178, DOI 10.1007/s12012-007-0026-0; Blanco JG, 2012, J CLIN ONCOL, V30, P1415, DOI 10.1200/JCO.2011.34.8987; Bovelli D, 2010, ANN ONCOL, V21, pv277, DOI 10.1093/annonc/mdq200; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Bueno OF, 2001, CIRC RES, V88, P88, DOI 10.1161/01.RES.88.1.88; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Croce K, 2010, CIRC J, V74, P626, DOI 10.1253/circj.CJ-10-0192; Croce K, 2009, CIRCULATION, V120, P427, DOI 10.1161/CIRCULATIONAHA.108.814582; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Delongchamp R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S11; Delongchamp RR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S13; Delongchamp RR, 2004, BIOMETRICS, V60, P774, DOI 10.1111/j.0006-341X.2004.00228.x; Dolci A, 2008, AM J CLIN PATHOL, V130, P688, DOI 10.1309/AJCPB66LRIIVMQDR; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Elliott P, 2006, SEMIN ONCOL, V33, pS2, DOI 10.1053/j.seminoncol.2006.04.020; Floyd JD, 2005, J CLIN ONCOL, V23, P7685, DOI 10.1200/JCO.2005.08.789; Gharib MI, 2002, EUR J HEART FAIL, V4, P235, DOI 10.1016/S1388-9842(01)00201-X; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Giantris A, 1998, CRIT REV ONCOL HEMAT, V27, P53, DOI 10.1016/S1040-8428(97)10007-5; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Golden HB, 2009, FRONT BIOSCI-LANDMRK, V14, P2335, DOI 10.2741/3382; Gooch JL, 2006, AM J PHYSIOL-RENAL, V290, pF769, DOI 10.1152/ajprenal.00281.2005; HARVEY RA, 1992, LIPPINCOTTS ILLUSTRA; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Hayward R, 2007, J AM ASSOC LAB ANIM, V46, P20; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Herman EH, 1998, SEMIN ONCOL, V25, P15; Herman EH, 2003, PATHOL LAB MED, P87; Hershman DL, 2009, ONCOLOGY, V23, P1; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Iarussi D, 2001, CURR MED CHEM, V8, P1649, DOI 10.2174/0929867013371888; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Islam KN, 2012, J BIOL CHEM, V287, P12771, DOI 10.1074/jbc.M111.324566; Jaffe AS, 2000, CIRCULATION, V102, P1216, DOI 10.1161/01.CIR.102.11.1216; Jain D, 2000, J NUCL CARDIOL, V7, P53, DOI 10.1067/mnc.2000.103324; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kremer LCM, 2002, ANN ONCOL, V13, P819, DOI 10.1093/annonc/mdf167; Kresh JY, 2011, PFLUG ARCH EUR J PHY, V462, P75, DOI 10.1007/s00424-011-0954-1; Kumarapeli ARK, 2005, FASEB J, V19, P2051, DOI 10.1096/fj.05-3973fje; Lee T, 2008, BMC BIOINFORM S9, V9, pS20; Li HW, 2008, FASEB J, V22, P3175, DOI 10.1096/fj.08-108662; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2005, SEMIN NUCL MED, V35, P197, DOI 10.1053/j.semnuclmed.2005.02.005; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Merten KE, 2006, J PHARMACOL EXP THER, V319, P934, DOI 10.1124/jpet.106.108845; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Pai VB, 2000, DRUG SAFETY, V22, P263, DOI 10.2165/00002018-200022040-00002; Perera C, 2010, IMMUNOL CELL BIOL, V88, P41, DOI 10.1038/icb.2009.88; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Purcell NH, 2001, P NATL ACAD SCI USA, V98, P6668, DOI 10.1073/pnas.111155798; Purcell NH, 2007, P NATL ACAD SCI USA, V104, P14074, DOI 10.1073/pnas.0610906104; Reis RJS, 2012, J GERONTOL A-BIOL, V67, P366, DOI 10.1093/gerona/glr186; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Sekhar KR, 2002, ONCOGENE, V21, P6829, DOI 10.1038/sj.onc.1205905; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Sheikh F, 2006, CIRCULATION, V114, P1046, DOI 10.1161/CIRCULATIONAHA.106.634469; Shi Y, 2011, HERZ, V36, P296, DOI 10.1007/s00059-011-3470-3; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; Staratschek-Jox A, 2009, EXPERT REV MOL DIAGN, V9, P271, DOI 10.1586/ERM.09.9; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Todorova VK, 2010, CANCER CHEMOTH PHARM, V66, P315, DOI 10.1007/s00280-009-1165-8; Todorova VK, 2010, J NUTR, V140, P44, DOI 10.3945/jn.109.113415; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Umbright C, 2010, MOL CELL BIOCHEM, V335, P223, DOI 10.1007/s11010-009-0272-5; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; VanBuren P, 2011, PHYSIOL GENOMICS, V43, P392, DOI 10.1152/physiolgenomics.00175.2010; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; WEI JY, 1995, SEMIN ONCOL, V22, P9; Wexler LH, 1996, J CLIN ONCOL, V14, P362, DOI 10.1200/JCO.1996.14.2.362; Widder JD, 2009, HYPERTENSION, V54, P338, DOI 10.1161/HYPERTENSIONAHA.108.127928; Wojcik C, 2002, J CELL MOL MED, V6, P25, DOI 10.1111/j.1582-4934.2002.tb00309.x; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wright WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030120; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; Yi XM, 2006, AM J PHYSIOL-HEART C, V290, pH1098, DOI 10.1152/ajpheart.00832.2005; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039016	100	29	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e48398	10.1371/journal.pone.0048398	http://dx.doi.org/10.1371/journal.pone.0048398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209553	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800005
J	Wu, L; Sun, Y; Hu, YJ; Yang, Y; Yao, LL; Zhou, XX; Wang, H; Zhang, R; Huang, X; Kong, WJ				Wu, Lisa; Sun, Yu; Hu, Yu-Juan; Yang, Yang; Yao, Ling-Li; Zhou, Xing-Xing; Wang, Hao; Zhang, Rui; Huang, Xiang; Kong, Wei-Jia			Increased p66Shc in the Inner Ear of D-Galactose-Induced Aging Mice with Accumulation of Mitochondrial DNA 3873-bp Deletion: p66Shc and mtDNA Damage in the Inner Ear during Aging	PLOS ONE			English	Article							SPAN DETERMINANT P66(SHC); OXIDATIVE STRESS; LIFE-SPAN; SIGNALING PATHWAY; INDUCED APOPTOSIS; HEARING-LOSS; MOUSE-BRAIN; BP DELETION; ACTIVATION; GENE	Aging has been associated with mitochondrial DNA damage. P66Shc is an age-related adaptor protein that has a substantial impact on mitochondrial metabolism through regulation of the cellular response to oxidative stress. Our study aimed to establish a D-galactose (D-gal)-induced inner ear aging mouse model and to investigate the potential role of p66Shc and its serine 36-phosphorylated form in the inner ear during aging by using this model. Real-time PCR was performed to detect the mtDNA 3873-bp deletion and the level of p66Shc mRNA in the cochlear lateral wall. Western blot analysis was performed to analyze the total and mitochondrial protein levels of p66Shc and the level of Ser36-P-p66Shc in the cochlear lateral wall. Immunofluoresence was performed to detect the location of the Ser36-P-p66Shc expression in the cochlear lateral wall. The results showed that the accumulation of the mtDNA 3873-bp deletion, total and mitochondrial protein levels of p66Shc and level of Ser36-P-p66Shc were significantly increased in the cochlear lateral wall of the D-gal-treated group when compared to the control group and that Ser36-P-p66Shc was mainly localized in the cytoplasm of the cells in the stria vascularis. During aging, the oxidative stress-related increase of p66Shc and Ser36-P-p66Shc might be associated with the accumulation of the mtDNA 3873-bp deletion in the inner ear.	[Wu, Lisa; Sun, Yu; Hu, Yu-Juan; Yang, Yang; Yao, Ling-Li; Zhou, Xing-Xing; Wang, Hao; Zhang, Rui; Kong, Wei-Jia] Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Wu, Lisa] Cent S Univ, Dept Otolaryngol Head & Neck Surg, Xiangya Hosp, Changsha, Peoples R China; [Huang, Xiang; Kong, Wei-Jia] Huazhong Univ Sci & Technol, Inst Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Kong, Wei-Jia] Minist Educ, Key Lab Neurol Dis, Wuhan, Peoples R China	Huazhong University of Science & Technology; Central South University; Huazhong University of Science & Technology	Kong, WJ (corresponding author), Huazhong Univ Sci & Technol, Dept Otorhinolaryngol, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	entwjkong@yahoo.com.cn	Sun, Yu/AAX-9942-2021	Kong, Wei-Jia/0000-0001-5410-2297; Sun, Yu/0000-0002-1771-3715	Major State Basic Research Development Program of China (973 Program) [2011CB504504]; National Nature Science Foundation of China [30730094, 81000408]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program) (2011CB504504) and the National Nature Science Foundation of China (30730094 and 81000408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Berry A, 2007, EXP GERONTOL, V42, P37, DOI 10.1016/j.exger.2006.05.018; Boguski MS, 2002, NATURE, V420, P515, DOI 10.1038/420515a; BROSSAS JY, 1994, BIOCHEM BIOPH RES CO, V202, P654, DOI 10.1006/bbrc.1994.1980; Chen B, 2011, MOL BIOL REP, V38, P3635, DOI 10.1007/s11033-010-0476-5; Chen B, 2010, BRAIN RES, V1344, P43, DOI 10.1016/j.brainres.2010.04.082; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Eshaghian A, 2006, J INVEST DERMATOL, V126, P336, DOI 10.1038/sj.jid.5700088; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gong YS, 2008, BEHAV BRAIN RES, V194, P100, DOI 10.1016/j.bbr.2008.06.029; Gopalakrishna R, 2000, FREE RADICAL BIO MED, V28, P1349, DOI 10.1016/S0891-5849(00)00221-5; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206; Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8; Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006; Kong WJ, 2006, EXP GERONTOL, V41, P628, DOI 10.1016/j.exger.2006.04.008; Kong WJ, 2006, BIOCHEM BIOPH RES CO, V344, P425, DOI 10.1016/j.bbrc.2006.03.060; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; Lebiedzinska M, 2009, ARCH BIOCHEM BIOPHYS, V486, P73, DOI 10.1016/j.abb.2009.03.007; Liu CM, 2010, FOOD CHEM TOXICOL, V48, P2809, DOI 10.1016/j.fct.2010.07.011; Ljubicic V, 2010, MECH AGEING DEV, V131, P79, DOI 10.1016/j.mad.2009.12.004; Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002; Lu J, 2010, BRAIN PATHOL, V20, P952, DOI 10.1111/j.1750-3639.2010.00397.x; Lu J, 2010, NEUROBIOL LEARN MEM, V93, P157, DOI 10.1016/j.nlm.2009.09.006; Meissner C, 2008, EXP GERONTOL, V43, P645, DOI 10.1016/j.exger.2008.03.004; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mohamed SA, 2006, EXP GERONTOL, V41, P508, DOI 10.1016/j.exger.2006.03.014; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Nicklas JA, 2004, ENVIRON MOL MUTAGEN, V44, P313, DOI 10.1002/em.20050; Orsini F, 2004, J BIOL CHEM, V279, P25689, DOI 10.1074/jbc.M401844200; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Percy CJ, 2009, MECH AGEING DEV, V130, P129, DOI 10.1016/j.mad.2008.10.003; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Rajendran M, 2010, CANCER METAST REV, V29, P207, DOI 10.1007/s10555-010-9213-8; Rota M, 2006, CIRC RES, V99, P42, DOI 10.1161/01.RES.0000231289.63468.08; Seidman MD, 1996, LARYNGOSCOPE, V106, P777, DOI 10.1097/00005537-199606000-00021; Seidman MD, 2000, AM J OTOL, V21, P161, DOI 10.1016/S0196-0709(00)80003-4; Seidman MD, 1997, ARCH OTOLARYNGOL, V123, P1039; Shan Q, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/564737; Someya S, 2010, MECH AGEING DEV, V131, P480, DOI 10.1016/j.mad.2010.04.006; Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6; Sun Y, 2009, J COMP NEUROL, V516, P569, DOI 10.1002/cne.22117; Trinei M, 2002, ONCOGENE, V21, P3872, DOI 10.1038/sj.onc.1205513; Ventura A, 2004, J BIOL CHEM, V279, P2299, DOI 10.1074/jbc.M307655200; VOSTEEN KH, 1960, T SE SECT AM UROL AS, V1960, P230; Wu DM, 2008, NEUROBIOL LEARN MEM, V90, P19, DOI 10.1016/j.nlm.2008.01.010; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004; Yao XF, 1996, HEARING RES, V96, P199, DOI 10.1016/0378-5955(96)00050-0; Zeng ZH, 1999, J CELL BIOCHEM, V73, P545, DOI 10.1002/(SICI)1097-4644(19990615)73:4<545::AID-JCB12>3.3.CO;2-H; Zhang WY, 2011, TOXICOL IN VITRO, V25, P979, DOI 10.1016/j.tiv.2011.03.009; Zhang XX, 2002, CHINESE MED J-PEKING, V115, P1390; Zhang XX, 2002, CHINESE MED J-PEKING, V115, P258; Zhang ZF, 2010, FOOD CHEM TOXICOL, V48, P2500, DOI 10.1016/j.fct.2010.06.023; Zhong Y, 2011, FEBS J, V278, P2500, DOI 10.1111/j.1742-4658.2011.08176.x; Zhong Y, 2011, MUTAT RES-FUND MOL M, V712, P11, DOI 10.1016/j.mrfmmm.2011.03.013	58	18	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50483	10.1371/journal.pone.0050483	http://dx.doi.org/10.1371/journal.pone.0050483			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209752	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800075
J	Goossens, S; Bekele, Y; Yun, O; Harczi, G; Ouannes, M; Shepherd, S				Goossens, Sylvie; Bekele, Yodit; Yun, Oliver; Harczi, Geza; Ouannes, Marie; Shepherd, Susan			Mid-Upper Arm Circumference Based Nutrition Programming: Evidence for a New Approach in Regions with High Burden of Acute Malnutrition	PLOS ONE			English	Article							WEIGHT-FOR-HEIGHT; SEVERELY MALNOURISHED CHILDREN; GROWTH STANDARDS; HEALTH-WORKERS; RISK; MUAC; ANTHROPOMETRY; INDICATORS; COMMUNITY; ACCURACY	Background: In therapeutic feeding programs ( TFP), mid-upper arm circumference (MUAC) shows advantages over weight-for-height Z score (WHZ) and is recommended by the World Health Organization (WHO) as an independent criterion for screening children 6-59 months old. Here we report outcomes and treatment response from a TFP using MUAC <= 118 mm or oedema as sole admission criteria for severe acute malnutrition (SAM). Methods: Patient data from September 2007 to March 2009 for children admitted by MUAC <= 118 mm or oedema to a Medecins Sans Frontieres (MSF) TFP in Burkina Faso were retrospectively analyzed. Analysis included anthropometric measurements at admission and discharge, program outcomes and treatment response. Results: Of 24,792 patient outcomes analyzed, nearly half (48.8%; n = 12,090) were admitted with MUAC 116-118 mm. Most patients (88.7%; n = 21,983) were 6-24 months old. At admission, 52.7% (n = 5,041) of those with MUAC 116-118 mm had a WHZ <-3 SD. At discharge, 89.1% (n = 22,094) recovered (15% weight gain or oedema resolution), 7.9% (n = 1,961) defaulted, 1.5% (n = 384) failed to respond to treatment, and 1.0% (n = 260) died. Average weight gain was 5.4 g/kg/day, and average MUAC gain was 0.42 mm/day. Patients with MUAC <= 114 mm at admission had higher average daily weight and MUAC gains at discharge compared to those admitted with MUAC 116-118 mm, but those in the latter category required longer lengths of stay to achieve recovery (P<0.001). Conclusion: This analysis suggests that MUAC <= 118 mm as TFP admission criterion is a useful alternative to WHZ. Regarding treatment response, rates of weight and MUAC gain were acceptable. Applying 15% weight gain as discharge criterion resulted in longer lengths of stay for less malnourished children. Since MUAC gain parallels weight gain, it may be feasible to use MUAC as both an admission and discharge criterion.	[Yun, Oliver; Shepherd, Susan] Medecins Sans Frontieres, New York, NY USA; [Goossens, Sylvie; Bekele, Yodit; Harczi, Geza; Ouannes, Marie] Medecins Sans Frontieres, Paris, France	Doctors Without Borders	Shepherd, S (corresponding author), Medecins Sans Frontieres, New York, NY USA.	susan.shepherd@paris.msf.org			Medecins Sans Frontieres (MSF)	Medecins Sans Frontieres (MSF)	This study was supported entirely by Medecins Sans Frontieres (MSF). MSF reviewed the final study protocol, had a role in the design and conduct of the study, collection, management, analysis and interpretation of the data, decision to publish and preparation of the manuscript. Epicentre verified the data collection and analysis.	ALAM N, 1989, AM J CLIN NUTR, V49, P884, DOI 10.1093/ajcn/49.5.884; [Anonymous], 2009, WHO CHILD GROWTH STA; BRIEND A, 1986, BRIT MED J, V293, P373, DOI 10.1136/bmj.293.6543.373; BRIEND A, 1989, EUR J CLIN NUTR, V43, P715; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Collins S, 2002, LANCET, V360, P1824, DOI 10.1016/S0140-6736(02)11770-3; Collins S, 2007, ARCH DIS CHILD, V92, P453, DOI 10.1136/adc.2006.098327; deOnis M, 1997, B WORLD HEALTH ORGAN, V75, P11; Enquete Nationale sur l'Insecurite Alimentaire et la Malnutrition, 2009, MIN AGR HYDR RESS HA, V75; Fernandez MAL, 2010, PEDIATRICS, V126, pE195, DOI 10.1542/peds.2009-2175; Isanaka S, 2009, PEDIATRICS, V123, pE54, DOI 10.1542/peds.2008-1375; Manary MJ, 2004, ARCH DIS CHILD, V89, P557, DOI 10.1136/adc.2003.034306; Matilsky DK, 2009, J NUTR, V139, P773, DOI 10.3945/jn.108.104018; Mei Z, 1997, B WORLD HEALTH ORGAN, V75, P333; Mwangome MK, 2012, TROP MED INT HEALTH, V17, P622, DOI 10.1111/j.1365-3156.2012.02959.x; Myatt M, 2009, ANN HUM BIOL, V36, P5, DOI 10.1080/03014460802471205; Myatt M, 2006, FOOD NUTR BULL, V27, pS7, DOI 10.1177/15648265060273S302; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; The Sphere Project, 2011, HUM CHART MIN STAND; VELLA V, 1994, EUR J CLIN NUTR, V48, P189; VELZEBOER MI, 1983, J TROP PEDIATRICS, V29, P159, DOI 10.1093/tropej/29.3.159; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; WHO/UNICEF/WFP/SCN Joint Statement, 2007, COMM BAS MAN SEV AC	24	60	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49320	10.1371/journal.pone.0049320	http://dx.doi.org/10.1371/journal.pone.0049320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189140	Green Published, gold			2022-12-25	WOS:000311929800019
J	Bandyopadhyay, K; Li, PC; Gjerset, RA				Bandyopadhyay, Keya; Li, Pingchuan; Gjerset, Ruth A.			CK2-Mediated Hyperphosphorylation of Topoisomerase I Targets Serine 506, Enhances Topoisomerase I-DNA Binding, and Increases Cellular Camptothecin Sensitivity	PLOS ONE			English	Article							PROTEIN-KINASE CK2; ILLEGITIMATE RECOMBINATION; RELAXATION ACTIVITY; CASEIN KINASE-2; CALF THYMUS; PHOSPHORYLATION; CELLS; DRUGS; ACTIVATION; EXPRESSION	Topoisomerase I is the target for a potent class of chemotherapeutic drugs derived from the plant alkaloid camptothecin that includes irinotecan and topotecan. In this study we have identified a novel site of CK2-mediated topoisomerase I (topo I) phosphorylation at serine 506 (PS506) that is relevant to topo I function and to cellular responses to these topo I-targeted drugs. CK2 treatment induced hyperphosphorylation of recombinant topo I and expression of the PS506 epitope, and resulted in increased binding of topo I to supercoiled plasmid DNA. Hyperphosphorylated topo I was approximately three times more effective than the basal phosphorylated enzyme at relaxing plasmid supercoils but had similar DNA cleavage activity once bound to DNA. The PS506 epitope was expressed in cancer cell lines with elevated CK2 activity, hyperphosphorylated topo I, and increased sensitivity to camptothecin. In contrast, PS506 was not detected in normal cells or cancer cell lines with lower levels of CK2 activity. By experimentally manipulating CK2 activity in cancer cell lines, we demonstrate a cause and effect relationship between CK2 activity, PS506 expression, camptothecin-induced cellular DNA damage, and cellular camptothecin sensitivity. Our results show that the PS506 epitope is an indicator of dysregulated, hyperphosphorylated topo I in cancer cells, and may thus serve as a diagnostic or prognostic biomarker and predict tumor responsiveness to widely used topo I-targeted therapies.	[Bandyopadhyay, Keya; Li, Pingchuan; Gjerset, Ruth A.] Torrey Pines Inst Mol Studies, San Diego, CA USA	Torrey Pines Institute for Molecular Studies, California	Gjerset, RA (corresponding author), Torrey Pines Inst Mol Studies, San Diego, CA USA.	rgjerset@tpims.org			United States National Institutes of Health/National Cancer Institute [CA111868, CA135369]; NATIONAL CANCER INSTITUTE [R01CA135369, R01CA111868] Funding Source: NIH RePORTER	United States National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the United States National Institutes of Health/National Cancer Institute(CA111868 and CA135369); http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt MF, 2010, DNA REPAIR, V9, P678, DOI 10.1016/j.dnarep.2010.03.005; Bandyopadhyay K, 2007, BIOCHEMISTRY-US, V46, P14325, DOI 10.1021/bi7013618; Bandyopadhyay K, 2011, BIOCHEMISTRY-US, V50, P704, DOI 10.1021/bi101110e; Barry OP, 2001, J BIOL CHEM, V276, P15537, DOI 10.1074/jbc.M010847200; Bomgaars L, 2001, ONCOLOGIST, V6, P506, DOI 10.1634/theoncologist.6-6-506; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CODERONI S, 1990, INT J BIOCHEM, V22, P737, DOI 10.1016/0020-711X(90)90009-R; CODERONI S, 1990, MOL BIOL REP, V14, P35, DOI 10.1007/BF00422713; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; Dingemans AMC, 1998, BBA-GENE STRUCT EXPR, V1400, P275, DOI 10.1016/S0167-4781(98)00141-9; Faust RA, 1999, INT J BIOCHEM CELL B, V31, P941, DOI 10.1016/S1357-2725(99)00050-3; Faust RA, 1996, CANCER LETT, V101, P31, DOI 10.1016/0304-3835(96)04110-9; GAPANY M, 1995, MOL MED, V1, P659, DOI 10.1007/BF03401606; Hackbarth JS, 2008, J BIOL CHEM, V283, P16711, DOI 10.1074/jbc.M802246200; Karayan L, 2001, ONCOGENE, V20, P836, DOI 10.1038/sj.onc.1204170; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Larsen AK, 1998, BBA-GENE STRUCT EXPR, V1400, P257, DOI 10.1016/S0167-4781(98)00140-7; Lee C, 2005, CANCER RES, V65, P9834, DOI 10.1158/0008-5472.CAN-05-1759; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; LIU LF, 1983, J BIOL CHEM, V258, P5365; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; MCCONAUGHY BL, 1981, BIOCHIM BIOPHYS ACTA, V655, P1, DOI 10.1016/0005-2787(81)90059-9; O-charoenrat P, 2004, CLIN CANCER RES, V10, P5792, DOI 10.1158/1078-0432.CCR-03-0317; Olivier A, 2003, ONCOGENE, V22, P1945, DOI 10.1038/sj.onc.1206214; OLNES MJ, 1994, BIOTECHNIQUES, V17, P828; POMMIER Y, 1990, J BIOL CHEM, V265, P9418; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Reikhardt B A, 2003, Neurosci Behav Physiol, V33, P799, DOI 10.1023/A:1025101516128; ROECKLEIN BA, 1995, BLOOD, V85, P997, DOI 10.1182/blood.V85.4.997.bloodjournal854997; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rothenberg ML, 2001, ONCOLOGIST, V6, P66, DOI 10.1634/theoncologist.6-1-66; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHUMAN S, 1989, P NATL ACAD SCI USA, V86, P3489, DOI 10.1073/pnas.86.10.3489; SHUMAN S, 1992, J BIOL CHEM, V267, P8620; Soe K, 2003, NUCLEIC ACIDS RES, V31, P6585, DOI 10.1093/nar/gkg846; Soe K, 2001, NUCLEIC ACIDS RES, V29, P3195, DOI 10.1093/nar/29.15.3195; STALTER G, 1994, BIOCHEM BIOPH RES CO, V202, P141, DOI 10.1006/bbrc.1994.1904; Staron K, 1996, CARCINOGENESIS, V17, P383, DOI 10.1093/carcin/17.3.383; STARON K, 1995, BBA-GENE STRUCT EXPR, V1260, P35, DOI 10.1016/0167-4781(94)00175-3; STEVNSNER T, 1989, J BIOL CHEM, V264, P10110; SUGIMOTO Y, 1990, CANCER RES, V50, P6925; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; TSAO YP, 1993, CANCER RES, V53, P5908; Tuduri S, 2009, NAT CELL BIOL, V11, P1315, DOI 10.1038/ncb1984; TURMAN MA, 1993, BIOCHEM MED METAB B, V50, P210, DOI 10.1006/bmmb.1993.1063; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wong ET, 2004, ONCOLOGIST, V9, P68, DOI 10.1634/theoncologist.9-1-68; YENICE S, 1994, PROSTATE, V24, P11, DOI 10.1002/pros.2990240105; Zhu J, 1996, MOL CELL BIOL, V16, P1805	51	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50427	10.1371/journal.pone.0050427	http://dx.doi.org/10.1371/journal.pone.0050427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185622	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000235
J	Schoustra, SE; Punzalan, D; Dali, R; Rundle, HD; Kassen, R				Schoustra, Sijmen E.; Punzalan, David; Dali, Rola; Rundle, Howard D.; Kassen, Rees			Multivariate Phenotypic Divergence Due to the Fixation of Beneficial Mutations in Experimentally Evolved Lineages of a Filamentous Fungus	PLOS ONE			English	Article							VARIANCE-COVARIANCE MATRICES; GENETIC CONSTRAINTS; LIFE-HISTORY; EVOLUTION; FITNESS; ADAPTATION; SELECTION; TRAITS; DIMENSIONALITY; CHARACTERS	The potential for evolutionary change is limited by the availability of genetic variation. Mutations are the ultimate source of new alleles, yet there have been few experimental investigations of the role of novel mutations in multivariate phenotypic evolution. Here, we evaluated the degree of multivariate phenotypic divergence observed in a long-term evolution experiment whereby replicate lineages of the filamentous fungus Aspergillus nidulans were derived from a single genotype and allowed to fix novel (beneficial) mutations while maintained at two different population sizes. We asked three fundamental questions regarding phenotypic divergence following approximately 800 generations of adaptation: (1) whether divergence was limited by mutational supply, (2) whether divergence proceeded in relatively many (few) multivariate directions, and (3) to what degree phenotypic divergence scaled with changes in fitness (i.e. adaptation). We found no evidence that mutational supply limited phenotypic divergence. Divergence also occurred in all possible phenotypic directions, implying that pleiotropy was either weak or sufficiently variable among new mutations so as not to constrain the direction of multivariate evolution. The degree of total phenotypic divergence from the common ancestor was positively correlated with the extent of adaptation. These results are discussed in the context of the evolution of complex phenotypes through the input of adaptive mutations.	[Schoustra, Sijmen E.; Punzalan, David; Dali, Rola; Rundle, Howard D.; Kassen, Rees] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Schoustra, Sijmen E.] Wageningen Univ, Genet Lab, Wageningen, Netherlands; [Punzalan, David] Royal Ontario Museum, Toronto, ON M5S 2C6, Canada; [Dali, Rola] McGill Univ, Montreal, PQ, Canada	University of Ottawa; Wageningen University & Research; Royal Ontario Museum; McGill University	Schoustra, SE (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	sijmen.schoustra@wur.nl	Schoustra, Sijmen E/H-3882-2012	Rundle, Howard/0000-0002-8288-8888; Punzalan, David/0000-0003-2105-4561	Natural Sciences and Engineering Research Council (Canada); European Union	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Union(European Commission)	This work was funded by the Natural Sciences and Engineering Research Council (Canada) through grants to RK and HDR and by a European Union Marie Curie grant to SES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster WS, 1996, J EVOLUTION BIOL, V9, P261, DOI 10.1046/j.1420-9101.1996.9030261.x; Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; Berner D, 2010, EVOLUTION, V64, P2265, DOI 10.1111/j.1558-5646.2010.00982.x; Blows MW, 2007, J EVOLUTION BIOL, V20, P1, DOI 10.1111/j.1420-9101.2006.01164.x; Blows MW, 2003, AM NAT, V161, P240, DOI 10.1086/345783; Braendle C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000877; Camara MD, 1999, EVOLUTION, V53, P1692, DOI 10.1111/j.1558-5646.1999.tb04554.x; Casselton L, 2002, NAT REV GENET, V3, P683, DOI 10.1038/nrg889; Chenoweth SF, 2010, AM NAT, V175, P186, DOI 10.1086/649594; Clutterbuck A.J, 1974, HDB GENETICS, V1, P447; deVisser JAGM, 1997, GENETICS, V145, P815; Estes S, 2005, GENETICS, V170, P645, DOI 10.1534/genetics.104.040022; Estes S, 2006, EVOLUTION, V60, P2655, DOI 10.1111/j.0014-3820.2006.tb01897.x; Fernandez J, 1996, GENETICS, V143, P829; Fisher R.A., 1930, GENETICAL THEORY NAT; Fitzsimmons JM, 2010, EVOL ECOL, V24, P227, DOI 10.1007/s10682-009-9302-8; Flury B, 1988, COMMON PRINCIPAL COM; Gifford DR, 2012, J THEORETIC IN PRESS; Hereford J, 2004, EVOLUTION, V58, P2133; Hine E, 2006, GENETICS, V173, P1135, DOI 10.1534/genetics.105.054627; Hohenlohe PA, 2008, AM NAT, V171, P366, DOI 10.1086/527498; Hohenlohe PA, 2010, P NATL ACAD SCI USA, V107, P16583, DOI 10.1073/pnas.1003537107; HOULE D, 1991, EVOLUTION, V45, P630, DOI 10.1111/j.1558-5646.1991.tb04334.x; HOULE D, 1994, GENETICS, V138, P773; Jones AG, 2007, EVOLUTION, V61, P727, DOI 10.1111/j.1558-5646.2007.00071.x; Kirkpatrick M, 2004, GENETICS, V168, P2295, DOI 10.1534/genetics.104.029181; Kolbe JJ, 2011, EVOLUTION, V65, P3608, DOI 10.1111/j.1558-5646.2011.01416.x; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; LANDE R, 1980, AM NAT, V116, P463, DOI 10.1086/283642; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; MacLean RC, 2003, P ROY SOC B-BIOL SCI, V270, P1645, DOI 10.1098/rspb.2003.2408; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Martin G, 2006, GENETICS, V172, P593, DOI 10.1534/genetics.104.039982; Martin G, 2008, GENETICS, V179, P907, DOI 10.1534/genetics.108.087122; Martin G, 2006, EVOLUTION, V60, P893; McGuigan K, 2005, AM NAT, V165, P32, DOI 10.1086/426600; Melnyk AH, 2011, EVOLUTION, V65, P3048, DOI 10.1111/j.1558-5646.2011.01333.x; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Phillips PC, 1999, EVOLUTION, V53, P1506, DOI 10.2307/2640896; PONTECORVO G, 1953, J GEN MICROBIOL, V8, P198, DOI 10.1099/00221287-8-1-198; Pringle A, 2002, TRENDS MICROBIOL, V10, P474, DOI 10.1016/S0966-842X(02)02447-2; Salverda MLM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001321; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Schoustra SE, 2006, J EVOLUTION BIOL, V19, P1115, DOI 10.1111/j.1420-9101.2006.01102.x; Schoustra S, 2012, FUNGAL BIOL-UK, V116, P630, DOI 10.1016/j.funbio.2012.03.002; Schoustra S, 2010, CURR BIOL, V20, P1350, DOI 10.1016/j.cub.2010.05.060; Schoustra SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000250; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Todd RB, 2007, NAT PROTOC, V2, P822, DOI 10.1038/nprot.2007.113; TRAVISANO M, 1995, SCIENCE, V267, P87, DOI 10.1126/science.7809610; Velicer GJ, 2003, NATURE, V425, P75, DOI 10.1038/nature01908; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; ZENG ZB, 1988, EVOLUTION, V42, P363, DOI [10.2307/2409239, 10.1111/j.1558-5646.1988.tb04139.x]	55	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50305	10.1371/journal.pone.0050305	http://dx.doi.org/10.1371/journal.pone.0050305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185601	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000214
J	Tahvanainen, J; Kylaniemi, MK; Kanduri, K; Gupta, B; Lahteenmaki, H; Kallonen, T; Rajavuori, A; Rasool, O; Koskinen, PJ; Rao, KVS; Lahdesmaki, H; Lahesmaa, R				Tahvanainen, Johanna; Kylaniemi, Minna K.; Kanduri, Kartiek; Gupta, Bhawna; Lahteenmaki, Hanna; Kallonen, Teemu; Rajavuori, Anna; Rasool, Omid; Koskinen, Paivi J.; Rao, Kanury V. S.; Lahdesmaki, Harri; Lahesmaa, Riitta			Proviral Integration Site for Moloney Murine Leukemia Virus (PIM) Kinases Promote Human T Helper 1 Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD4(+) T-CELLS; NF-KAPPA-B; INTERFERON-GAMMA; IFN-GAMMA; TGF-BETA; GENE-EXPRESSION; PROTEIN-KINASE; TRANSCRIPTIONAL ACTIVITY; SUBUNIT EXPRESSION; NUCLEAR-FACTOR	The differentiation of human primary T helper 1 (Th1) cells from naive precursor cells is regulated by a complex, interrelated signaling network. The identification of factors regulating the early steps of Th1 cell polarization can provide important insight in the development of therapeutics for many inflammatory and autoimmune diseases. The serine/threonine-specific proviral integration site for Moloney murine leukemia virus (PIM) kinases PIM1 and PIM2 have been implicated in the cytokine-dependent proliferation and survival of lymphocytes. We have established that the third member of this family, PIM3, is also expressed in human primary Th cells and identified a new function for the entire PIM kinase family in T lymphocytes. Although PIM kinases are expressed more in Th1 than Th2 cells, we demonstrate here that these kinases positively influence Th1 cell differentiation. Our RNA interference results from human primary Th cells also suggest that PIM kinases promote the production of IFN gamma, the hallmark cytokine produced by Th1 cells. Consistent with this, they also seem to be important for the up-regulation of the critical Th1-driving factor, T box expressed in T cells (T-BET), and the IL-12/STAT4 signaling pathway during the early Th1 differentiation process. In summary, we have identified PIM kinases as new regulators of human primary Th1 cell differentiation, thus providing new insights into the mechanisms controlling the selective development of human Th cell subsets.	[Tahvanainen, Johanna; Kylaniemi, Minna K.; Kanduri, Kartiek; Gupta, Bhawna; Rajavuori, Anna; Rasool, Omid; Koskinen, Paivi J.; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Tahvanainen, Johanna; Kylaniemi, Minna K.; Kanduri, Kartiek; Gupta, Bhawna; Rajavuori, Anna; Rasool, Omid; Koskinen, Paivi J.; Lahesmaa, Riitta] Abo Akad Univ, Turku 20520, Finland; [Kallonen, Teemu] Univ Turku, Dept Med Microbiol & Immunol, SF-20500 Turku, Finland; [Koskinen, Paivi J.] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland; [Kylaniemi, Minna K.] Abo Akad Univ, Natl Doctoral Programme Informat & Struct Biol, Turku 20520, Finland; [Lahteenmaki, Hanna] Univ Oulu, Dept Biol, FIN-90570 Oulu, Finland; [Rao, Kanury V. S.] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India; [Lahdesmaki, Harri] Aalto Univ, Dept Informat & Comp Sci, Sch Sci, Espoo 02150, Finland	University of Turku; Abo Akademi University; University of Turku; University of Turku; Abo Akademi University; University of Oulu; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Aalto University	Lahesmaa, R (corresponding author), Turku Ctr Biotechnol, Tykistokatu 6A, FIN-20520 Turku, Finland.	riitta.lahesmaa@btk.fi	Koskinen, Päivi J/G-8939-2014; Kallonen, Teemu/B-5507-2008	Kallonen, Teemu/0000-0003-1741-6486; Kylaniemi, Minna/0000-0001-7374-9862; Kanduri, Kartiek/0000-0002-5639-0701; Koskinen, Paivi/0000-0002-6864-4457	Academy of Finland; European Union; Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research) [250114]; Sigrid Juselius Foundation; Department of Biotechnology, The Government of India; National Technology Agency of Finland (TEKES); Finnish Cultural Foundation; Turku University Hospital Research Fund (EVO); Vaino and Laina Kivi Foundation; Foundation for Finnish Society against Tuberculosis; Oskar Oflund Foundation; Research Foundation of the Pulmonary Diseases; Ida Montin Foundation	Academy of Finland(Academy of Finland); European Union(European Commission); Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research)(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Department of Biotechnology, The Government of India(Department of Biotechnology (DBT) India); National Technology Agency of Finland (TEKES)(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Turku University Hospital Research Fund (EVO); Vaino and Laina Kivi Foundation; Foundation for Finnish Society against Tuberculosis; Oskar Oflund Foundation; Research Foundation of the Pulmonary Diseases; Ida Montin Foundation	This work was supported by The Academy of Finland, European Union FP7 Grant "Systems Biology of T-cell activation in health and disease" (SYBILLA), the Academy of Finland (Centre of Excellence in Molecular Systems Immunology and Physiology Research, 2012-2017, Decision 250114), The Sigrid Juselius Foundation, The Department of Biotechnology, The Government of India, The National Technology Agency of Finland (TEKES), The Finnish Cultural Foundation, The Turku University Hospital Research Fund (EVO), The Vaino and Laina Kivi Foundation, The Foundation for Finnish Society against Tuberculosis, Oskar Oflund Foundation, The Research Foundation of the Pulmonary Diseases, and The Ida Montin Foundation.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Aho TL, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-21; Aho TLT, 2005, IMMUNOLOGY, V116, P82, DOI 10.1111/j.1365-2567.2005.02201.x; Aronica MA, 1999, J IMMUNOL, V163, P5116; Bachmann M, 2005, INT J BIOCHEM CELL B, V37, P726, DOI 10.1016/j.biocel.2004.11.005; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Barbulescu K, 1998, J IMMUNOL, V160, P3642; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chang JT, 1999, J EXP MED, V189, P969, DOI 10.1084/jem.189.6.969; Chen WG, 2004, J ALLERGY CLIN IMMUN, V114, P476, DOI 10.1016/j.jaci.2004.06.042; Chen XP, 2002, P NATL ACAD SCI USA, V99, P2175, DOI 10.1073/pnas.042035699; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Eichmann A, 2000, ONCOGENE, V19, P1215, DOI 10.1038/sj.onc.1203355; Feldman JD, 1998, J BIOL CHEM, V273, P16535, DOI 10.1074/jbc.273.26.16535; Filen S, 2010, J IMMUNOL, V184, P4990, DOI 10.4049/jimmunol.0903106; Fox CJ, 2005, J EXP MED, V201, P259, DOI 10.1084/jem.20042020; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson LJ, 2012, CELL IMMUNOL, V272, P200, DOI 10.1016/j.cellimm.2011.10.011; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones B, 2006, EMBO J, V25, P2443, DOI 10.1038/sj.emboj.7601148; Kiani A, 2001, BLOOD, V98, P1480, DOI 10.1182/blood.V98.5.1480; Komine O, 2003, J EXP MED, V198, P51, DOI 10.1084/jem.20021200; Lawless VA, 2000, J IMMUNOL, V165, P6803, DOI 10.4049/jimmunol.165.12.6803; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lund R, 2003, J IMMUNOL, V171, P5328, DOI 10.4049/jimmunol.171.10.5328; Lund RJ, 2003, EUR J IMMUNOL, V33, P1105, DOI 10.1002/eji.200323899; McCracken SA, 2007, EUR J IMMUNOL, V37, P1386, DOI 10.1002/eji.200636322; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nishikomori R, 2002, J IMMUNOL, V169, P4388, DOI 10.4049/jimmunol.169.8.4388; Palaty CK, 1997, BIOCHEM CELL BIOL, V75, P153, DOI 10.1139/bcb-75-2-153; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Peng C, 2007, J BIOCHEM, V141, P353, DOI 10.1093/jb/mvm040; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Porter CM, 2002, J IMMUNOL, V168, P4936, DOI 10.4049/jimmunol.168.10.4936; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Rautajoki KJ, 2008, ANN MED, V40, P322, DOI 10.1080/07853890802068582; Schulz EG, 2009, IMMUNITY, V30, P673, DOI 10.1016/j.immuni.2009.03.013; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Tahvanainen J, 2006, J IMMUNOL METHODS, V310, P30, DOI 10.1016/j.jim.2005.11.024; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang Z, 2001, J Vet Sci, V2, P167; White E, 2003, GENE DEV, V17, P1813, DOI 10.1101/gad.1123103; Yamamoto J, 2000, J LEUKOCYTE BIOL, V68, P568; Ylikoski E, 2005, EUR J IMMUNOL, V35, P3297, DOI 10.1002/eji.200526101; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	60	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 1	2013	288	5					3048	3058		10.1074/jbc.M112.361709	http://dx.doi.org/10.1074/jbc.M112.361709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	082NE	23209281	Green Published, hybrid			2022-12-25	WOS:000314397900015
J	Hussain, I; Fabregue, J; Anderes, L; Ousson, S; Borlat, F; Eligert, V; Berger, S; Dimitrov, M; Alattia, JR; Fraering, PC; Beher, D				Hussain, Ishrut; Fabregue, Julien; Anderes, Laurence; Ousson, Solenne; Borlat, Frederic; Eligert, Valerie; Berger, Sebastien; Dimitrov, Mitko; Alattia, Jean-Rene; Fraering, Patrick C.; Beher, Dirk			The Role of gamma-Secretase Activating Protein (GSAP) and Imatinib in the Regulation of gamma-Secretase Activity and Amyloid-beta Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; INHIBITOR; PRECURSOR; PURIFICATION; MODULATION; COMPLEX	gamma-Secretase is a large enzyme complex comprising presenilin, nicastrin, presenilin enhancer 2, and anterior pharynx-defective 1 that mediates the intramembrane proteolysis of a large number of proteins including amyloid precursor protein and Notch. Recently, a novel gamma-secretase activating protein (GSAP) was identified that interacts with gamma-secretase and the C-terminal fragment of amyloid precursor protein to selectively increase amyloid-beta production. In this study we have further characterized the role of endogenous and exogenous GSAP in the regulation of gamma-secretase activity and amyloid-beta production in vitro. Knockdown of GSAP expression in N2a cells decreased amyloid-beta levels. In contrast, overexpression of GSAP in HEK cells expressing amyloid precursor protein or in N2a cells had no overt effect on amyloid-beta generation. Likewise, purified recombinant GSAP had no effect on amyloid-beta generation in two distinct in vitro gamma-secretase assays. In subsequent cellular studies with imatinib, a kinase inhibitor that reportedly prevents the interaction of GSAP with the C-terminal fragment of amyloid precursor protein, a concentration-dependent decrease in amyloid-beta levels was observed. However, no interaction between GSAP and the C-terminal fragment of amyloid precursor protein was evident in co-immunoprecipitation studies. In addition, subchronic administration of imatinib to rats had no effect on brain amyloid-beta levels. In summary, these findings suggest the roles of GSAP and imatinib in the regulation of gamma-secretase activity and amyloid-beta generation are uncertain.	[Hussain, Ishrut; Fabregue, Julien; Anderes, Laurence; Ousson, Solenne; Eligert, Valerie; Beher, Dirk] Merck Serono SA, Dept Therapeut Area Neurodegenerat Dis, CH-1202 Geneva, Switzerland; [Borlat, Frederic] Merck Serono SA, Dept Prot & Cell Sci, CH-1202 Geneva, Switzerland; [Berger, Sebastien] Merck Serono SA, Dept Quantitat Bioanalyt, D-64293 Darmstadt, Germany; [Dimitrov, Mitko; Alattia, Jean-Rene; Fraering, Patrick C.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Merck KGaA; EMD Serono Inc.; Merck KGaA; EMD Serono Inc.; Merck KGaA; EMD Serono Inc.; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hussain, I (corresponding author), Merck Serono SA, Dept Therapeut Area Neurodegenerat Dis, Chemin Mines 9, CH-1202 Geneva, Switzerland.	ishruthssn@gmail.com		Beher, Dirk/0000-0001-8005-5359; Fraering, Patrick/0000-0002-5841-5327	Swiss National Science Foundation Grant [31003A_134938/1]; Ecole Polytechnique Federale de Lausanne (EPFL)-Merck Serono grant	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); Ecole Polytechnique Federale de Lausanne (EPFL)-Merck Serono grant	This work was supported by Swiss National Science Foundation Grant 31003A_134938/1 (to P. C. F.) and an Ecole Polytechnique Federale de Lausanne (EPFL)-Merck Serono grant (to J. R. A. and M. D.).	Alattia JR, 2011, FASEB J, V25, P2287, DOI 10.1096/fj.10-174078; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bauer C, 2011, J ALZHEIMERS DIS, V27, P511, DOI 10.3233/JAD-2011-110746; Beckett C, 2012, CELL SIGNAL, V24, P402, DOI 10.1016/j.cellsig.2011.10.007; Beher D, 2003, BIOCHEMISTRY-US, V42, P8133, DOI 10.1021/bi034045z; Beher D, 2008, CURR TOP MED CHEM, V8, P34, DOI 10.2174/156802608783334051; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Deatherage CL, 2012, BIOCHEMISTRY-US, V51, P5153, DOI 10.1021/bi300605u; Eisele YS, 2007, MOL BIOL CELL, V18, P3591, DOI 10.1091/mbc.E07-01-0035; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Imbimbo BP, 2011, EXPERT OPIN INV DRUG, V20, P325, DOI 10.1517/13543784.2011.550572; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P28634, DOI 10.1074/jbc.M109.059345; Schor NF, 2011, ANN NEUROL, V69, P237, DOI 10.1002/ana.22365; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; Sutcliffe JG, 2011, J NEUROSCI RES, V89, P808, DOI 10.1002/jnr.22603; Takayama N, 2002, BRIT J HAEMATOL, V119, P106, DOI 10.1046/j.1365-2141.2002.03881.x; Wolfe MS, 2007, CURR ALZHEIMER RES, V4, P571, DOI 10.2174/156720507783018299; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Wu F, 2010, FASEB J, V24, P2464, DOI 10.1096/fj.09-148031; Xu XM, 2009, J ALZHEIMERS DIS, V16, P211, DOI 10.3233/JAD-2009-0957; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	29	37	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2521	2531		10.1074/jbc.M112.370924	http://dx.doi.org/10.1074/jbc.M112.370924			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209290	Green Published, hybrid			2022-12-25	WOS:000314211500038
J	Mehne, FMP; Gunka, K; Eilers, H; Herzberg, C; Kaever, V; Stulke, J				Mehne, Felix M. P.; Gunka, Katrin; Eilers, Hinnerk; Herzberg, Christina; Kaever, Volkhard; Stuelke, Joerg			Cyclic Di-AMP Homeostasis in Bacillus subtilis BOTH LACK AND HIGH LEVEL ACCUMULATION OF THE NUCLEOTIDE ARE DETRIMENTAL FOR CELL GROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT PROTEIN; TRANSCRIPTION; RNA; GMP; IDENTIFICATION; STRESS; BACTERIA; REVEALS; OPERON; GENES	The genome of the Gram-positive soil bacterium Bacillus subtilis encodes three potential diadenylate cyclases that may synthesize the signaling nucleotide cyclic di-AMP (c-di-AMP). These enzymes are expressed under different conditions in different cell compartments, and they localize to distinct positions in the cell. Here we demonstrate the diadenylate cyclase activity of the so far uncharacterized enzymes CdaA (previously known as YbbP) and CdaS (YojJ). Our work confirms that c-di-AMP is essential for the growth of B. subtilis and shows that an excess of the molecule is also harmful for the bacteria. Several lines of evidence suggest that the diadenylate cyclase CdaA is part of the conserved essential cda-glm module involved in cell wall metabolism. In contrast, the CdaS enzyme seems to provide c-di-AMP for spores. Accumulation of large amounts of c-di-AMP impairs the growth of B. subtilis and results in the formation of aberrant curly cells. This phenotype can be partially suppressed by elevated concentrations of magnesium. These observations suggest that c-di-AMP interferes with the peptidoglycan synthesis machinery. The activity of the diadenylate cyclases is controlled by distinct molecular mechanisms. CdaA is stimulated by a regulatory interaction with the CdaR (YbbR) protein. In contrast, the activity of CdaS seems to be intrinsically restricted, and a single amino acid substitution is sufficient to drastically increase the activity of the enzyme. Taken together, our results support the idea of an important role for c-di-AMP in B. subtilis and suggest that the levels of the nucleotide have to be tightly controlled.	[Mehne, Felix M. P.; Gunka, Katrin; Eilers, Hinnerk; Herzberg, Christina; Stuelke, Joerg] Univ Gottingen, Dept Gen Microbiol, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Mass Spectrometry Metab, D-30625 Hannover, Germany; [Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany	University of Gottingen; Hannover Medical School; Hannover Medical School	Stulke, J (corresponding author), Univ Gottingen, Dept Gen Microbiol, Inst Microbiol & Genet, Grisebachstr 8, D-37077 Gottingen, Germany.	jstuelk@gwdg.de	Kaever, Volkhard/G-3280-2013; Stülke, Jörg/AAD-1600-2021	Stulke, Jorg/0000-0001-5881-5390	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to J. S.).	Barb AW, 2011, PROTEIN SCI, V20, P396, DOI 10.1002/pro.571; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Cannon W, 1999, GENE DEV, V13, P357, DOI 10.1101/gad.13.3.357; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Chen Y, 2012, J BACTERIOL, V194, P5080, DOI 10.1128/JB.01092-12; Collins JA, 2007, GENE DEV, V21, P3356, DOI 10.1101/gad.1605307; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; DAHL MK, 1994, J MOL BIOL, V243, P413, DOI 10.1006/jmbi.1994.1669; Diethmaier C, 2011, J BACTERIOL, V193, P5997, DOI 10.1128/JB.05360-11; Formstone A, 2005, MOL MICROBIOL, V55, P1646, DOI 10.1111/j.1365-2958.2005.04506.x; Gardan R, 1997, MOL MICROBIOL, V24, P825, DOI 10.1046/j.1365-2958.1997.3881754.x; GARTNER D, 1992, MOL GEN GENET, V232, P415; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Gongadze GM, 1999, FEBS LETT, V451, P51, DOI 10.1016/S0014-5793(99)00538-4; Gorke B, 2005, MICROBIOL-SGM, V151, P3777, DOI 10.1099/mic.0.28172-0; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; Hahne H, 2008, PROTEOMICS, V8, P4123, DOI 10.1002/pmic.200800258; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; Jervis AJ, 2007, J BACTERIOL, V189, P4534, DOI 10.1128/JB.00130-07; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kawai Y, 2009, MOL MICROBIOL, V71, P1131, DOI 10.1111/j.1365-2958.2009.06601.x; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Kruger E, 1996, MOL MICROBIOL, V20, P713, DOI 10.1111/j.1365-2958.1996.tb02511.x; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Lehnik-Habrink M, 2011, MOL MICROBIOL, V81, P1459, DOI 10.1111/j.1365-2958.2011.07777.x; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; Murray T, 1998, J BACTERIOL, V180, P4555, DOI 10.1128/JB.180.17.4555-4563.1998; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Petsko G., 2004, PROTEIN STRUCTURE FU, P86; Pottathil M, 2003, FRONT BIOSCI-LANDMRK, V8, pD32, DOI 10.2741/913; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sambrook J, 2001, MOL CLONING LAB MANU; Schilling O, 2007, APPL ENVIRON MICROB, V73, P499, DOI 10.1128/AEM.02084-06; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmalisch M, 2002, J MOL MICROB BIOTECH, V4, P495; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Song JH, 2005, MOL CELLS, V19, P365; Spangler C, 2010, J MICROBIOL METH, V81, P226, DOI 10.1016/j.mimet.2010.03.020; Stulke J, 1997, MOL MICROBIOL, V25, P65, DOI 10.1046/j.1365-2958.1997.4351797.x; Thoendel M, 2010, ADV APPL MICROBIOL, V71, P91, DOI 10.1016/S0065-2164(10)71004-2; Tojo S, 2010, J BACTERIOL, V192, P1573, DOI 10.1128/JB.01394-09; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	54	142	156	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					2004	2017		10.1074/jbc.M112.395491	http://dx.doi.org/10.1074/jbc.M112.395491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192352	hybrid, Green Published			2022-12-25	WOS:000313751400052
J	Trickey, M; Fujimitsu, K; Yamano, H				Trickey, Michelle; Fujimitsu, Kazuyuki; Yamano, Hiroyuki			Anaphase-promoting Complex/Cyclosome-mediated Proteolysis of Ams2 in the G(1) Phase Ensures the Coupling of Histone Gene Expression to DNA Replication in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; S-PHASE; TRANSCRIPTION FACTOR; CHROMOSOME SEGREGATION; LYSINE-56 ACETYLATION; UBIQUITIN LIGASE; MEIOSIS; APC/C; DESTRUCTION; CHECKPOINT	Histone transcription and deposition are tightly regulated with the DNA replication cycle to maintain genetic integrity. Ams2 is a GATA-containing transcription factor responsible for core histone gene expression and for CENP-A loading at centromeres in fission yeast. Ams2 levels are cell cycle-regulated, and after the S phase Ams2 is degraded by the SCFpof3 ubiquitin ligase; however, the regulation of Ams2 in G(1) or meiosis is poorly understood. Here we show that another ubiquitin ligase, the anaphase-promoting complex/cyclosome (APC/C) targets Ams2 for destruction in G(1). Ubiquitylation and destruction of Ams2 is dependent upon a coactivator Cdh1/Ste9 and the KEN box in the C terminus of Ams2. We also find that stabilization of Ams2 sensitizes cells to the anti-microtubule drug thiabendazole and the histone deacetylase inhibitor tricostatin A when a histone deacetylase gene hst4 is deleted, suggesting that histone acetylation together with Ams2 stability ensures the coupling of mitosis to DNA replication. Furthermore, in meiosis, the failure of the APC/C-mediated destruction of Ams2 is deleterious, and pre-meiotic DNA replication is barely completed. These data suggest that Ams2 destruction via both the APC/C and the SCF ubiquitin ligases underlies the coordination of histone expression and DNA replication.	[Trickey, Michelle; Fujimitsu, Kazuyuki; Yamano, Hiroyuki] UCL, Cell Cycle Control Grp, UCL Canc Inst, London WC1E 6BT, England	University of London; University College London	Yamano, H (corresponding author), UCL, Cell Cycle Control Grp, UCL Canc Inst, Mortimer St, London WC1E 6BT, England.	h.yamano@ucl.ac.uk			Marie Curie Cancer Care; Association for International Cancer Research; Cancer Research UK; Cancer Research UK [13586] Funding Source: researchfish; Worldwide Cancer Research [09-0658] Funding Source: researchfish	Marie Curie Cancer Care; Association for International Cancer Research; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	This work was supported by Marie Curie Cancer Care, the Association for International Cancer Research and Cancer Research UK.	Beckerman R, 2009, GENE DEV, V23, P1364, DOI 10.1101/gad.1795709; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Blackwell C, 2004, MOL CELL BIOL, V24, P4309, DOI 10.1128/MCB.24.10.4309-4320.2004; Borgne A, 2002, MOL BIOL CELL, V13, P2080, DOI 10.1091/mbc.01-10-0507; Boyes J, 1998, NATURE, V396, P594, DOI 10.1038/25166; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; de Bruin RAM, 2009, CELL CYCLE, V8, P214, DOI 10.4161/cc.8.2.7412; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Grewal SIS, 1998, GENETICS, V150, P563; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Haldar D, 2008, EUKARYOT CELL, V7, P800, DOI 10.1128/EC.00379-07; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Izawa D, 2005, NATURE, V434, P529, DOI 10.1038/nature03406; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Koseoglu MM, 2010, CELL CYCLE, V9, P3857, DOI 10.4161/cc.9.19.13300; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Mallory MJ, 2007, MOL CELL, V27, P951, DOI 10.1016/j.molcel.2007.08.019; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Murakami-Tonami Y, 2007, P NATL ACAD SCI USA, V104, P14688, DOI 10.1073/pnas.0702906104; MURRAY AW, 1989, J CELL SCI, P65; Ors A, 2009, J BIOL CHEM, V284, P23989, DOI 10.1074/jbc.M109.018309; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Perkins G, 2001, EMBO J, V20, P4836, DOI 10.1093/emboj/20.17.4836; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Takayama Y, 2007, NUCLEIC ACIDS RES, V35, P3223, DOI 10.1093/nar/gkm213; Takayama Y, 2010, DEV CELL, V18, P385, DOI 10.1016/j.devcel.2009.12.024; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Trickey M, 2008, MOL CELL BIOL, V28, P3905, DOI 10.1128/MCB.02116-07; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; Wurtele H, 2012, MOL CELL BIOL, V32, P154, DOI 10.1128/MCB.05415-11; Xhemalce B, 2007, J BIOL CHEM, V282, P15040, DOI 10.1074/jbc.M701197200; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Yamano H, 2004, J BIOL CHEM, V279, P18974, DOI 10.1074/jbc.M311060200; Yamano H, 1998, EMBO J, V17, P5670, DOI 10.1093/emboj/17.19.5670; Yamano H, 2000, MOL CELL, V6, P1377, DOI 10.1016/S1097-2765(00)00135-0	58	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					928	937		10.1074/jbc.M112.410241	http://dx.doi.org/10.1074/jbc.M112.410241			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23195958	Green Published, hybrid			2022-12-25	WOS:000313570300017
J	Tsuruoka, N; Arima, M; Yoshida, N; Okada, S; Sakamoto, A; Hatano, M; Satake, H; Arguni, E; Wang, JY; Yang, JH; Nishikura, K; Sekiya, S; Shozu, M; Tokuhisa, T				Tsuruoka, Nobuhide; Arima, Masafumi; Yoshida, Nobuya; Okada, Seiji; Sakamoto, Akemi; Hatano, Masahiko; Satake, Hisae; Arguni, Eggi; Wang, Ji-Yang; Yang, Jing-Hua; Nishikura, Kazuko; Sekiya, Souei; Shozu, Makio; Tokuhisa, Takeshi			ADAR1 Protein Induces Adenosine-targeted DNA Mutations in Senescent Bcl6 Gene-deficient Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; GERMINAL-CENTER FORMATION; CYTIDINE DEAMINASE AID; CENTER B-CELLS; ACTIVATION-INDUCED DEAMINASE; CLASS SWITCH RECOMBINATION; RNA-EDITING ENZYME; CD8(+) T-CELLS; SOMATIC HYPERMUTATION; POLYMERASE-ETA	Somatic mutations accumulate in senescent cells. Bcl6, which functions as a transcriptional repressor, has been identified as a potent inhibitor of cell senescence, but a role of Bcl6 in the accumulation of somatic mutations has remained unclear. Ig class-switch recombination simultaneously induces somatic mutations in an IgM class-switch (Ig-S mu) region of IgG B cells. Surprisingly, mutations were detected in the Ig-S mu region of Bcl6-deficient IgM B cells without class-switch recombination, and these mutations were mainly generated by conversion of adenosine to guanosine, suggesting a novel DNA mutator in the B cells. The ADAR1 (adenosine deaminase acting on RNA1) gene was overexpressed in Bcl6-deficient cells, and its promoter analysis revealed that ADAR1 is a molecular target of Bcl6. Exogenous ADAR1 induced adenosine-targeted DNA mutations in IgM B cells from ADAR1-transgenic mice and in wild-type mouse embryonic fibroblasts (MEFs). These mutations accumulated in senescent MEFs accompanied with endogenous ADAR1 expression, and the frequency in senescent Bcl6-deficient MEFs was higher than senescent wild-type MEFs. Thus, Bcl6 protects senescent cells from accumulation of adenosine-targeted DNA mutations induced by ADAR1.	[Tokuhisa, Takeshi] Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chuo Ku, Chiba 2608670, Japan; [Tsuruoka, Nobuhide; Sekiya, Souei; Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med G4, Chiba 2608670, Japan; [Hatano, Masahiko] Chiba Univ, Grad Sch Med, Dept Biomed Sci M14, Chiba 2608670, Japan; [Okada, Seiji] Kumamoto Univ, Ctr AIDS Res, Div Hematopoiesis, Kumamoto, Japan; [Wang, Ji-Yang] RIKEN Res Ctr Allergy & Immunol, Lab Immune Divers, Yokohama, Kanagawa, Japan; [Yang, Jing-Hua] Boston Univ, Sch Med, Dept Surg, Boston, MA 02130 USA; [Nishikura, Kazuko] Wistar Inst Anat & Biol, Dept Gene Express & Regulat, Philadelphia, PA 19104 USA	Chiba University; Chiba University; Chiba University; Kumamoto University; RIKEN; Boston University; The Wistar Institute	Tokuhisa, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Dev Genet H2, Chuo Ku, Inohana 1-8-1, Chiba 2608670, Japan.	tokuhisa@faculty.chiba-u.jp	Arima, Masafumi/L-1951-2018; Arguni, Eggi/AFO-5492-2022; Okada, Seiji/F-5785-2013	Arima, Masafumi/0000-0002-5169-7536; Arguni, Eggi/0000-0001-7462-7904; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan; National Institutes of Health; Ellison Medical Foundation; Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health; Grants-in-Aid for Scientific Research [25460380, 25460604] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan. The work was also supported by grants from the National Institutes of Health, the Ellison Medical Foundation, and the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health (to K. N.).	Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; DUNNICK W, 1993, NUCLEIC ACIDS RES, V21, P365, DOI 10.1093/nar/21.3.365; Eckmann CR, 2001, MOL BIOL CELL, V12, P1911, DOI 10.1091/mbc.12.7.1911; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; George CX, 1999, GENE, V229, P203, DOI 10.1016/S0378-1119(99)00017-7; Goodman Myron F, 2007, Adv Immunol, V94, P127, DOI 10.1016/S0065-2776(06)94005-X; Ichii H, 2002, NAT IMMUNOL, V3, P558, DOI 10.1038/ni802; Karanjawala ZE, 2004, MECH AGEING DEV, V125, P405, DOI 10.1016/j.mad.2004.04.003; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Liu Y, 1999, J BIOL CHEM, V274, P18351, DOI 10.1074/jbc.274.26.18351; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Maas S, 2003, J BIOL CHEM, V278, P1391, DOI 10.1074/jbc.R200025200; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muramatsu Masamichi, 2007, Adv Immunol, V94, P1, DOI 10.1016/S0065-2776(06)94001-2; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Odegard VH, 2005, IMMUNITY, V23, P101, DOI 10.1016/j.immuni.2005.05.007; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Steele EJ, 2006, DNA REPAIR, V5, P1346, DOI 10.1016/j.dnarep.2006.06.002; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Takeda N, 2003, J IMMUNOL, V171, P426, DOI 10.4049/jimmunol.171.1.426; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Vijg J, 2000, MUTAT RES-FUND MOL M, V447, P117, DOI 10.1016/S0027-5107(99)00202-X; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; WILDIN RS, 1995, J IMMUNOL, V155, P1286; Wolf FI, 2002, EXP GERONTOL, V37, P647, DOI 10.1016/S0531-5565(02)00005-0; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9; Yang JH, 2003, J BIOL CHEM, V278, P45833, DOI 10.1074/jbc.M308612200; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Yoshida K, 2006, EUR J IMMUNOL, V36, P3146, DOI 10.1002/eji.200636165; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	53	10	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					826	836		10.1074/jbc.M112.365718	http://dx.doi.org/10.1074/jbc.M112.365718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23209284	Green Published, hybrid			2022-12-25	WOS:000313570300008
J	Muller-Molina, AJ; Scholer, HR; Arauzo-Bravo, MJ				Mueller-Molina, Arnoldo J.; Schoeler, Hans R.; Arauzo-Bravo, Marcos J.			Comprehensive Human Transcription Factor Binding Site Map for Combinatory Binding Motifs Discovery	PLOS ONE			English	Article							REGULATORY MOTIFS; SYSTEMATIC DISCOVERY; STEM-CELLS; DNA; GENE; EXPRESSION; PLURIPOTENCY; HIERARCHY; ELEMENTS; REVEALS	To know the map between transcription factors (TFs) and their binding sites is essential to reverse engineer the regulation process. Only about 10%-20% of the transcription factor binding motifs (TFBMs) have been reported. This lack of data hinders understanding gene regulation. To address this drawback, we propose a computational method that exploits never used TF properties to discover the missing TFBMs and their sites in all human gene promoters. The method starts by predicting a dictionary of regulatory "DNA words.'' From this dictionary, it distills 4098 novel predictions. To disclose the crosstalk between motifs, an additional algorithm extracts TF combinatorial binding patterns creating a collection of TF regulatory syntactic rules. Using these rules, we narrowed down a list of 504 novel motifs that appear frequently in syntax patterns. We tested the predictions against 509 known motifs confirming that our system can reliably predict ab initio motifs with an accuracy of 81%-far higher than previous approaches. We found that on average, 90% of the discovered combinatorial binding patterns target at least 10 genes, suggesting that to control in an independent manner smaller gene sets, supplementary regulatory mechanisms are required. Additionally, we discovered that the new TFBMs and their combinatorial patterns convey biological meaning, targeting TFs and genes related to developmental functions. Thus, among all the possible available targets in the genome, the TFs tend to regulate other TFs and genes involved in developmental functions. We provide a comprehensive resource for regulation analysis that includes a dictionary of "DNA words,'' newly predicted motifs and their corresponding combinatorial patterns. Combinatorial patterns are a useful filter to discover TFBMs that play a major role in orchestrating other factors and thus, are likely to lock/unlock cellular functional clusters.	[Mueller-Molina, Arnoldo J.; Arauzo-Bravo, Marcos J.] Max Planck Inst Mol Biomed, Computat Biol & Bioinformat Grp, Munster, Germany; [Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, Munster, Germany	Max Planck Society; Max Planck Society; University of Munster	Arauzo-Bravo, MJ (corresponding author), Max Planck Inst Mol Biomed, Computat Biol & Bioinformat Grp, Munster, Germany.	marcos.arauzo@mpi-muenster.mpg.de	, HS/AAB-4434-2019; Marcos, Arauzo-Bravo/A-1706-2011	, HS/0000-0003-2643-5136; Marcos, Arauzo-Bravo/0000-0002-3264-464X				Aggarwal C. C., 2000, Proceedings. KDD-2000. Sixth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P119, DOI 10.1145/347090.347116; Al-Kadi IA, 1998, ORIGINS CRYPTOLOGY A, P93; [Anonymous], 2006, P 32 INT C VER LARG; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Chavez E, 2001, ACM COMPUT SURV, V33, P273, DOI 10.1145/502807.502808; Chavez E, 2008, IEEE T PATTERN ANAL, V30, P1647, DOI 10.1109/TPAMI.2007.70815; D'haeseleer P, 2006, NAT BIOTECHNOL, V24, P423, DOI 10.1038/nbt0406-423; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Deza M. M., 2009, ENCY DISTANCES; Elemento O, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r18; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Ettwiller L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r104; Ferraris L, 2011, GENOME RES, V21, P1055, DOI 10.1101/gr.115824.110; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Fujita P, 2010, NUCLEIC ACIDS RES, V39, P1; Gansner ER, 2010, LECT NOTES COMPUT SC, V5849, P405, DOI 10.1007/978-3-642-11805-0_38; Gusfield D., 1997, ALGORITHMS STRINGS T; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kumar L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-208; Laury AR, 2011, AM J SURG PATHOL, V35, P816, DOI 10.1097/PAS.0b013e318216c112; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; LOBE CG, 1992, CURR TOP DEV BIOL, V27, P351, DOI 10.1016/S0070-2153(08)60539-6; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Masui S, 2010, INT J HEMATOL, V91, P360, DOI 10.1007/s12185-010-0517-9; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Muller-Molina AJ, 2009, SISAP 2009: 2009 SECOND INTERNATIONAL WORKSHOP ON SIMILARITY SEARCH AND APPLICATIONS, PROCEEDINGS, P30, DOI 10.1109/SISAP.2009.22; MULLERMOLINA AJ, 2009, P 2009 2 INT WORKSH, P143, DOI DOI 10.1109/SISAP.2009.23; Newberg LA, 2007, BIOINFORMATICS, V23, P1718, DOI 10.1093/bioinformatics/btm241; Nomenclature Committee for the International Union of Biochemistry (NC-IUB), 1986, MOL BIOL EVOL, V3, P99; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Sadit Tellez Eric, 2011, Pattern Recognition. Proceedings Third Mexican Conference, MCPR 2011, P75, DOI 10.1007/978-3-642-21587-2_9; Samet Hanan, 2005, FDN MULTIDIMENSIONAL; Sarkar D, 2008, ARCH MICROBIOL, V190, P559, DOI 10.1007/s00203-008-0406-2; Scholkopf B, 2000, NEURAL COMPUT, V12, P1207, DOI 10.1162/089976600300015565; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Singh H, 1996, CURR OPIN IMMUNOL, V8, P160, DOI 10.1016/S0952-7915(96)80053-7; Skala M, 2009, J DISCRET ALGORITHMS, V7, P49, DOI 10.1016/j.jda.2008.09.011; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Syed Z, 2010, ACM T KNOWL DISCOV D, V4, DOI 10.1145/1644873.1644875; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tellez E.S., 2010, P 3 INT C SIM SEARCH, P67, DOI [10.1145/1862344. 1862355, DOI 10.1145/1862344.1862355]; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vogel JH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-230; Wu J, 2008, BIOINFORMATICS, V24, P1843, DOI 10.1093/bioinformatics/btn348; Wunderlich Z, 2009, TRENDS GENET, V25, P434, DOI 10.1016/j.tig.2009.08.003; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zezula P, 2005, SIMILARITY SEARCH ME	68	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49086	10.1371/journal.pone.0049086	http://dx.doi.org/10.1371/journal.pone.0049086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209563	Green Submitted, Green Published, gold			2022-12-25	WOS:000312601700008
J	Ohmori, R; Tsuruyama, T				Ohmori, Rei; Tsuruyama, Tatsuaki			In Vitro HIV-1 LTR Integration into T-Cell Activation Gene CD27 Segment and the Decoy Effect of Modified-Sequence DNA	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN GENOME; TARGET	Integration into the host genome is an essential step in the HIV-1 life cycle. However, the host genome sequence that is favored by HIV-1 during integration has never been documented. Here, we report that CD27, a T cell activation gene, includes a sequence that is a target for in vitro HIV-1 cDNA integration. This sequence has a high affinity for integrase, and the target nucleotides responsible for this higher affinity were identified using a crystal microbalance assay. In experiments involving a segment of the CD27 gene, integration converged in the target nucleotides and flanking sequence DNA, indicating that integration is probably dependent upon the secondary structure of the substrate DNA. Notably, decoy modified CD27 sequence DNAs in which the target nucleotides were replaced suppressed integration when accompanying the original CD27 sequence DNA. Our identified CD27 sequence DNA is useful for investigating the biochemistry of integrase and for in vitro assessment of integrase-binding inhibitors.	[Tsuruyama, Tatsuaki] Kyoto Univ, Dept Pathol, Ctr Anat, Kyoto, Japan; Kyoto Univ, Forens Med Study, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University	Tsuruyama, T (corresponding author), Kyoto Univ, Dept Pathol, Ctr Anat, Kyoto, Japan.	tsuruyam@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan [17013086]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a grant from the Ministry of Health, Labor and Welfare of Japan. Grant number 17013086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady T, 2009, AIDS, V23, P1461, DOI 10.1097/QAD.0b013e32832caf28; BUSHMAN FD, 1990, J VIROL, V64, P5645, DOI 10.1128/JVI.64.11.5645-5648.1990; CARTEAU S, 1993, ARCH BIOCHEM BIOPHYS, V300, P756, DOI 10.1006/abbi.1993.1105; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Katz RA, 1998, J BIOL CHEM, V273, P24190, DOI 10.1074/jbc.273.37.24190; Katz RA, 2011, J BIOL CHEM, V286, P25710, DOI 10.1074/jbc.M111.229179; KITAMURA Y, 1992, P NATL ACAD SCI USA, V89, P5532, DOI 10.1073/pnas.89.12.5532; Libregts S, 2011, IMMUNOL LETT, V136, P177, DOI 10.1016/j.imlet.2011.01.008; Mojumdar K, 2012, CYTOM PART B-CLIN CY, V82B, P43, DOI 10.1002/cyto.b.20610; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Tsai H, 2008, BIOSENS BIOELECTRON, V24, P485, DOI 10.1016/j.bios.2008.06.015; Tsuruyama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031533; Tsuruyama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013841; VINK C, 1990, J VIROL, V64, P5219, DOI 10.1128/JVI.64.10.5219-5222.1990; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Xiao YL, 2008, J IMMUNOL, V181, P1071, DOI 10.4049/jimmunol.181.2.1071; YOSHINAGA T, 1995, J VIROL, V69, P3233, DOI 10.1128/JVI.69.5.3233-3236.1995; Yue FY, 2004, J IMMUNOL, V172, P2476, DOI 10.4049/jimmunol.172.4.2476; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49960	10.1371/journal.pone.0049960	http://dx.doi.org/10.1371/journal.pone.0049960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209625	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700029
J	Etienne, KA; Gillece, J; Hilsabeck, R; Schupp, JM; Colman, R; Lockhart, SR; Gade, L; Thompson, EH; Sutton, DA; Neblett-Fanfair, R; Park, BJ; Turabelidze, G; Keim, P; Brandt, ME; Deak, E; Engelthaler, DM				Etienne, Kizee A.; Gillece, John; Hilsabeck, Remy; Schupp, Jim M.; Colman, Rebecca; Lockhart, Shawn R.; Gade, Lalitha; Thompson, Elizabeth H.; Sutton, Deanna A.; Neblett-Fanfair, Robyn; Park, Benjamin J.; Turabelidze, George; Keim, Paul; Brandt, Mary E.; Deak, Eszter; Engelthaler, David M.			Whole Genome Sequence Typing to Investigate the Apophysomyces Outbreak following a Tornado in Joplin, Missouri, 2011	PLOS ONE			English	Article							ELEGANS; ZYGOMYCOSIS; EPIDEMIOLOGY	Case reports of Apophysomyces spp. in immunocompetent hosts have been a result of traumatic deep implantation of Apophysomyces spp. spore-contaminated soil or debris. On May 22, 2011 a tornado occurred in Joplin, MO, leaving 13 tornado victims with Apophysomyces trapeziformis infections as a result of lacerations from airborne material. We used whole genome sequence typing (WGST) for high-resolution phylogenetic SNP analysis of 17 outbreak Apophysomyces isolates and five additional temporally and spatially diverse Apophysomyces control isolates (three A. trapeziformis and two A. variabilis isolates). Whole genome SNP phylogenetic analysis revealed three clusters of genotypically related or identical A. trapeziformis isolates and multiple distinct isolates among the Joplin group; this indicated multiple genotypes from a single or multiple sources. Though no linkage between genotype and location of exposure was observed, WGST analysis determined that the Joplin isolates were more closely related to each other than to the control isolates, suggesting local population structure. Additionally, species delineation based on WGST demonstrated the need to reassess currently accepted taxonomic classifications of phylogenetic species within the genus Apophysomyces.	[Etienne, Kizee A.; Lockhart, Shawn R.; Gade, Lalitha; Neblett-Fanfair, Robyn; Park, Benjamin J.; Brandt, Mary E.; Deak, Eszter] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Gillece, John; Hilsabeck, Remy; Schupp, Jim M.; Colman, Rebecca; Keim, Paul; Engelthaler, David M.] Translat Genom Res Inst, Flagstaff, AZ USA; [Thompson, Elizabeth H.; Sutton, Deanna A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Turabelidze, George] Missouri Dept Hlth, St Louis, MO USA	Centers for Disease Control & Prevention - USA; Translational Genomics Research Institute; University of Texas System; University of Texas Health San Antonio	Etienne, KA (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	ketienne@cdc.gov	Colman, Rebecca/AAI-2112-2019	Colman, Rebecca/0000-0002-6854-2100				Alexander BD, 2010, AM J TRANSPLANT, V10, P2161, DOI 10.1111/j.1600-6143.2010.03216.x; Alvarez E, 2009, J CLIN MICROBIOL, V47, P1650, DOI 10.1128/JCM.00036-09; Alvarez E, 2010, REV IBEROAM MICOL, V27, P80, DOI 10.1016/j.riam.2010.01.006; Benedict K., 2011, Morbidity and Mortality Weekly Report, V60, P992; Chakrabarti A, 2010, J CLIN MICROBIOL, V48, P4580, DOI 10.1128/JCM.01420-10; Chakrabarti A, 2003, J CLIN MICROBIOL, V41, P783, DOI 10.1128/JCM.41.2.783-788.2003; COOTER RD, 1990, J CLIN MICROBIOL, V28, P2151, DOI 10.1128/JCM.28.9.2151-2153.1990; Engelthaler DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001347; Engelthaler DM, 2011, EMERG INFECT DIS, V17, P227, DOI 10.3201/eid1702.100620; Gillece JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028550; Gomes MZR, 2011, CLIN MICROBIOL REV, V24, P411, DOI 10.1128/CMR.00056-10; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Kimura M, 1999, ARCH PATHOL LAB MED, V123, P386; Kindo A J, 2007, Indian J Med Microbiol, V25, P285; LAKSHMI V, 1993, J CLIN MICROBIOL, V31, P1368, DOI 10.1128/JCM.31.5.1368-1369.1993; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang KP, 2006, J CLIN MICROBIOL, V44, P892, DOI 10.1128/JCM.44.3.892-898.2006; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meis JF, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2009.02973.x; Neblett Fanfair R, 2012, N ENGL J ME IN PRESS; NOAA, 2011, NAT WEATH SERV SPRIN; PADHYE AA, 1988, J CLIN MICROBIOL, V26, P1861, DOI 10.1128/JCM.26.9.1861-1863.1988; Page R, 2001, AUST NZ J SURG, V71, P184, DOI 10.1046/j.1440-1622.2001.02054.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Ruiz Carmen Elena, 2004, Biomed., V24, P239; Saravia-Flores M, 2010, MYCOSES, V53, P259, DOI 10.1111/j.1439-0507.2009.01698.x; Snell BJ, 2007, PLAST RECONSTR SURG, V119, P448, DOI 10.1097/01.prs.0000233624.34950.f8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	31	45	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49989	10.1371/journal.pone.0049989	http://dx.doi.org/10.1371/journal.pone.0049989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209631	Green Submitted, Green Published			2022-12-25	WOS:000311885800039
J	Leone, L; Vetrano, M; Ranieri, D; Raffa, S; Vulpiani, MC; Ferretti, A; Torrisi, MR; Visco, V				Leone, Laura; Vetrano, Mario; Ranieri, Danilo; Raffa, Salvatore; Vulpiani, Maria Chiara; Ferretti, Andrea; Torrisi, Maria Rosaria; Visco, Vincenzo			Extracorporeal Shock Wave Treatment (ESWT) Improves In Vitro Functional Activities of Ruptured Human Tendon-Derived Tenocytes	PLOS ONE			English	Article							HUMAN ACHILLES-TENDON; GENE-EXPRESSION; BASIC SCIENCE; ROTATOR CUFF; III COLLAGEN; PROLIFERATION; DIFFERENTIATION; TENDINOPATHY; CULTURE; INJURY	In vitro models of human tenocytes derived from healthy as well as from ruptured tendons were established, characterized and used at very early passage (P1) to evaluate the effects of Extracorporeal Shock Wave Treatment (ESWT). The molecular analysis of traditional tenocytic markers, including Scleraxis (Scx), Tenomodulin (Tnm), Tenascin-C (Tn-C) and Type I and III Collagens (Col I and Col III), permitted us to detect in our samples the simultaneous expression of all these genes and allowed us to compare their levels of expression in relationship to the source of the cells and treatments. In untreated conditions, higher molecular levels of Scx and Col I in tenocytes from pathological compared to healthy samples have been detected, suggesting - in the cells from injured tendon - the natural trigger of an early differentiation and repairing program, which depends by Scx and requires an increase in collagen expression. When ESWT (at the dose of 0.14 mJ/mm(2)) was applied to cultured tenocytes explanted from injured source, Scx and Col I were significantly diminished compared to healthy counterpart, indicating that such natural trigger maybe delayed by the treatment, in order to promote cellular repair. Herein, we show for the first time that ESWT enhances in vitro functional activities of ruptured tendon-derived tenocytes, such as proliferation and migration, which could probably contributes to tendon healing in vivo.	[Leone, Laura; Ranieri, Danilo; Raffa, Salvatore; Torrisi, Maria Rosaria; Visco, Vincenzo] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dept Clin & Mol Med, Rome, Italy; [Vetrano, Mario; Vulpiani, Maria Chiara; Ferretti, Andrea] Univ Roma La Sapienza, Dept Ortophaed & Traumatol, Rome, Italy; [Vetrano, Mario; Vulpiani, Maria Chiara; Ferretti, Andrea; Torrisi, Maria Rosaria; Visco, Vincenzo] StAndrea Hosp, Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea	Visco, V (corresponding author), Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, Dept Clin & Mol Med, Rome, Italy.	vincenzo.visco1@uniroma1.it	RAFFA, SALVATORE/AAL-5514-2020; Raffa, Salvatore/GPX-5723-2022; Vetrano, Mario/ABE-5885-2020; FERRETTI, ANDREA/AAM-6448-2020; Raffa, Salvatore/AAW-7060-2020	Raffa, Salvatore/0000-0001-9501-7638; Vetrano, Mario/0000-0002-8680-4004; 	Minstero dell'Instruzione, dell'Universita e della Ricerca; Associazione Italiana per la Ricerca sul Cancro, Italy [IG 10272]	Minstero dell'Instruzione, dell'Universita e della Ricerca; Associazione Italiana per la Ricerca sul Cancro, Italy(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by grants from the Minstero dell'Instruzione, dell'Universita e della Ricerca and from Associazione Italiana per la Ricerca sul Cancro (IG 10272), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi Onays, 2011, Muscles Ligaments Tendons J, V1, P68; BernardBeaubois K, 1997, CELL BIOL TOXICOL, V13, P103, DOI 10.1023/B:CBTO.0000010395.51944.2a; Berta L, 2009, ACTA ORTHOP, V80, P612, DOI 10.3109/17453670903316793; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Buhrmann C, 2011, J BIOL CHEM, V286, P28556, DOI 10.1074/jbc.M111.256180; Ceccarelli S, 2007, EXP CELL RES, V313, P1758, DOI 10.1016/j.yexcr.2007.03.013; Chang HN, 2012, J ORTHOP RES, V30, P764, DOI 10.1002/jor.21576; Chao YH, 2008, ULTRASOUND MED BIOL, V34, P841, DOI 10.1016/j.ultrasmedbio.2007.11.002; Chow IHW, 2007, CLIN REHABIL, V21, P131, DOI 10.1177/0269215506069244; Corps AN, 2008, MATRIX BIOL, V27, P393, DOI 10.1016/j.matbio.2008.02.002; CSERJESI P, 1995, DEVELOPMENT, V121, P1099; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; de Mos M, 2009, AM J SPORT MED, V37, P1214, DOI 10.1177/0363546508331137; Del Buono A, 2011, INT J IMMUNOPATH PH, V24, P45, DOI 10.1177/03946320110241S209; Del Buono A, 2012, J SHOULDER ELB SURG, V21, P200, DOI 10.1016/j.jse.2011.10.020; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Doroski DM, 2007, BIOMATERIALS, V28, P187, DOI 10.1016/j.biomaterials.2006.08.040; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Frairia R, 2011, MLTJ, V1, P137; Hofmann A, 2008, J TRAUMA, V65, P1402, DOI 10.1097/TA.0b013e318173e7c2; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017531; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Luo Q, 2009, CYTOTECHNOLOGY, V61, P1, DOI 10.1007/s10616-009-9233-9; Maffulli N, 2000, AM J SPORT MED, V28, P499, DOI 10.1177/03635465000280040901; Mazzocca AD., 2011, KNEE SURG SPORTS TRA; Notarnicola Angela, 2012, Muscles Ligaments Tendons J, V2, P33; Oliva F, 2012, MED SPORT SCI, V57, P53, DOI 10.1159/000328878; Oliva F, 2011, EUR CELLS MATER, V21, P548, DOI 10.22203/eCM.v021a41; Scherb Michael B, 2009, Orthopedics, V32, P26; Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Tsai WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038235; Vetrano M, 2011, KNEE SURG SPORT TR A, V19, P2159, DOI 10.1007/s00167-011-1534-9; Wang X, 2012, J ORTHOP RES, V30, P982, DOI 10.1002/jor.22016; Waterston SW, 1997, BRIT J SPORT MED, V31, P285, DOI 10.1136/bjsm.31.4.285; Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843; Zafar MS, 2009, SPORTS MED ARTHROSC, V17, P190, DOI 10.1097/JSA.0b013e3181b37eb7	42	33	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49759	10.1371/journal.pone.0049759	http://dx.doi.org/10.1371/journal.pone.0049759			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189160	Green Published, gold			2022-12-25	WOS:000311929800037
J	Schnell, C; Hagos, Y; Hulsmann, S				Schnell, Christian; Hagos, Yohannes; Huelsmann, Swen			Active Sulforhodamine 101 Uptake into Hippocampal Astrocytes	PLOS ONE			English	Article							TRANSGENIC MICE; DEHYDROEPIANDROSTERONE-SULFATE; DEVELOPMENTAL PROFILE; NEUROACTIVE STEROIDS; GABA(A) RECEPTOR; RAT HIPPOCAMPUS; IN-VIVO; BRAIN; TRANSPORTERS; RESISTANCE	Sulforhodamine 101 (SR101) is widely used as a marker of astrocytes. In this study we investigated labeling of astrocytes by SR101 in acute slices from the ventrolateral medulla and the hippocampus of transgenic mice expressing EGFP under the control of the astrocyte-specific human GFAP promoter. While SR101 efficiently and specifically labeled EGFP-expressing astrocytes in hippocampus, we found that the same staining procedure failed to label astrocytes efficiently in the ventrolateral medulla. Although carbenoxolone is able to decrease the SR101-labeling of astrocytes in the hippocampus, it is unlikely that SR101 is taken up via gap-junction hemichannels because mefloquine, a blocker for pannexin and connexin hemichannels, was unable to prevent SR101-labeling of hippocampal astrocytes. However, SR101-labeling of the hippocampal astrocytes was significantly reduced by substrates of organic anion transport polypeptides, including estron-3-sulfate and dehydroepiandrosterone sulfate, suggesting that SR101 is actively transported into hippocampal astrocytes.	[Schnell, Christian; Huelsmann, Swen] Univ Gottingen, Zentrum Physiol & Pathophysiol, Abt Neurophysiol & Zellulare Biophys, Gottingen, Germany; [Schnell, Christian; Huelsmann, Swen] DFG Res Ctr Mol Physiol Brain CMPB, Gottingen, Germany; [Hagos, Yohannes] Univ Gottingen, Zentrum Physiol & Pathophysiol, Abt Vegetat Physiol, Gottingen, Germany	University of Gottingen; German Research Foundation (DFG); University of Gottingen	Hulsmann, S (corresponding author), Univ Gottingen, Zentrum Physiol & Pathophysiol, Abt Neurophysiol & Zellulare Biophys, Gottingen, Germany.	shuelsm2@uni-goettingen.de	Hülsmann, Swen/F-7169-2010; Schnell, Christian/E-3140-2014	Hülsmann, Swen/0000-0001-5042-8724; Schnell, Christian/0000-0002-3499-9217	Deutsche Forschungsgemeinschaft [DFG Hu 797/5-1]; DFG-Research Center Molecular Physiology of the Brain (CMPB)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-Research Center Molecular Physiology of the Brain (CMPB)(German Research Foundation (DFG))	The work was founded by the "Deutsche Forschungsgemeinschaft" (DFG Hu 797/5-1 and the DFG-Research Center Molecular Physiology of the Brain (CMPB)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appaix F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035169; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bahn A, 2005, AM J PHYSIOL-CELL PH, V289, pC1075, DOI 10.1152/ajpcell.00619.2004; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; CHVATAL A, 1991, PFLUG ARCH EUR J PHY, V419, P263, DOI 10.1007/BF00371105; Cina C, 2000, J COMP NEUROL, V423, P590, DOI 10.1002/1096-9861(20000807)423:4<590::AID-CNE5>3.0.CO;2-L; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; DELCERRO S, 1995, GLIA, V14, P65; DEMIRGOREN S, 1991, NEUROSCIENCE, V45, P127, DOI 10.1016/0306-4522(91)90109-2; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; Dong Y, 2012, J NEUROENDOCRINOL, V24, P215, DOI 10.1111/j.1365-2826.2011.02256.x; EHINGER B, 1994, GLIA, V10, P40, DOI 10.1002/glia.440100106; Franco R, 2006, J BIOL CHEM, V281, P29542, DOI 10.1074/jbc.M602500200; Garcia Segura LM, 1996, FRONT NEUROENDOCRIN, V17, P180; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Grass D, 2004, J NEUROSCI, V24, P1358, DOI 10.1523/JNEUROSCI.4022-03.2004; Grube M, 2006, MOL PHARMACOL, V70, P1735, DOI 10.1124/mol.106.026450; Hartel K, 2007, CELL CALCIUM, V42, P271, DOI 10.1016/j.ceca.2006.12.004; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Hirrlinger J, 2005, NEUROCHEM RES, V30, P1237, DOI 10.1007/s11064-005-8795-y; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Ishikawa Y, 2010, BIOL PHARM BULL, V33, P504, DOI 10.1248/bpb.33.504; Janneh O, 2007, J ANTIMICROB CHEMOTH, V60, P987, DOI 10.1093/jac/dkm353; Kafitz KW, 2008, J NEUROSCI METH, V169, P84, DOI 10.1016/j.jneumeth.2007.11.022; Kang J, 2010, NEUROSCIENCE, V169, P1601, DOI 10.1016/j.neuroscience.2010.06.020; Kaufmann AM, 2008, MOL PHARMACEUT, V5, P787, DOI 10.1021/mp8000205; Kettenmann H, 2008, TRENDS NEUROSCI, V31, P653, DOI 10.1016/j.tins.2008.09.003; LeFoll F, 1997, EUR J PHARMACOL, V331, P303, DOI 10.1016/S0014-2999(97)01042-X; Letschert K, 2006, TOXICOL SCI, V91, P140, DOI 10.1093/toxsci/kfj141; Loscher W, 2005, NAT REV NEUROSCI, V6, P591, DOI 10.1038/nrn1728; Manzini I, 2003, J PHYSIOL-LONDON, V546, P375, DOI 10.1113/jphysiol.2002.033175; McCaslin AFH, 2011, J CEREBR BLOOD F MET, V31, P795, DOI 10.1038/jcbfm.2010.204; McDougal DH, 2011, J NEUROSCI, V31, P14037, DOI 10.1523/JNEUROSCI.2855-11.2011; Meier SD, 2008, GLIA, V56, P1127, DOI 10.1002/glia.20684; Miller DS, 2002, AM J PHYSIOL-REG I, V282, pR774, DOI 10.1152/ajpregu.00333.2001; MONNET FP, 1995, P NATL ACAD SCI USA, V92, P3774, DOI 10.1073/pnas.92.9.3774; Mortaud S, 2010, BEHAV GENET, V40, P211, DOI 10.1007/s10519-010-9340-6; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nimmerjahn A, 2012, COLD SPRING HARB PRO, P326; Nishimura T, 2007, PHARM RES-DORDR, V24, P90, DOI 10.1007/s11095-006-9127-x; Nolte C, 2001, GLIA, V33, P72; PARKE DV, 1973, ANN NY ACAD SCI, V226, P200, DOI 10.1111/j.1749-6632.1973.tb20482.x; Schnell C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00053; Schnell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026309; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Winter SM, 2009, PFLUG ARCH EUR J PHY, V458, P459, DOI 10.1007/s00424-009-0647-1; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349	49	49	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49398	10.1371/journal.pone.0049398	http://dx.doi.org/10.1371/journal.pone.0049398			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189143	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000311929800022
J	Yazdani, S; Poosti, F; Kramer, AB; Mirkovic, K; Kwakernaak, AJ; Hovingh, M; Slagman, MCJ; Sjollema, KA; de Borst, MH; Navis, G; van Goor, H; van den Born, J				Yazdani, Saleh; Poosti, Fariba; Kramer, Andrea B.; Mirkovic, Katarina; Kwakernaak, Arjan J.; Hovingh, Menno; Slagman, Maartje C. J.; Sjollema, Klaas A.; de Borst, Martin H.; Navis, Gerjan; van Goor, Harry; van den Born, Jacob			Proteinuria Triggers Renal Lymphangiogenesis Prior to the Development of Interstitial Fibrosis	PLOS ONE			English	Article							PROXIMAL TUBULAR CELLS; NF-KAPPA-B; LYMPHATIC VESSELS; ALBUMIN; INJURY; INFLAMMATION; INHIBITION; EXPRESSION; MODEL; ENDOTHELIN-1	Proteinuria is an important cause of progressive tubulo-interstitial damage. Whether proteinuria could trigger a renal lymphangiogenic response has not been established. Moreover, the temporal relationship between development of fibrosis, inflammation and lymphangiogenesis in chronic progressive kidney disease is not clear yet. Therefore, we evaluated the time course of lymph vessel (LV) formation in relation to proteinuria and interstitial damage in a rat model of chronic unilateral adriamycin nephrosis. Proteinuria and kidneys were evaluated up to 30 weeks after induction of nephrosis. LVs were identified by podoplanin/VEGFR3 double staining. After 6 weeks proteinuria was well-established, without influx of interstitial macrophages and myofibroblasts, collagen deposition, osteopontin expression (tubular activation) or LV formation. At 12 weeks, a similar to 3-fold increase in cortical LV density was found (p<0.001), gradually increasing over time. This corresponded with a significant increase in tubular osteopontin expression (p<0.01) and interstitial myofibroblast numbers (p<0.05), whereas collagen deposition and macrophage numbers were not yet increased. VEGF-C was mostly expressed by tubular cells rather than interstitial cells. Cultured tubular cells stimulated with FCS showed a dose-dependent increase in mRNA and protein expression of VEGF-C which was not observed by human albumin stimulation. We conclude that chronic proteinuria provoked lymphangiogenesis in temporal conjunction with tubular osteopontin expression and influx of myofibroblasts, that preceded interstitial fibrosis.	[Yazdani, Saleh; Kramer, Andrea B.; Mirkovic, Katarina; Kwakernaak, Arjan J.; Hovingh, Menno; Slagman, Maartje C. J.; de Borst, Martin H.; Navis, Gerjan; van den Born, Jacob] Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Med, Groningen, Netherlands; [Poosti, Fariba; van Goor, Harry] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands; [Sjollema, Klaas A.] Univ Groningen, Univ Med Ctr Groningen, Microscopy & Imaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Yazdani, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Nephrol, Dept Med, Groningen, Netherlands.	s.yazdani@umcg.nl	van+Goor, Harry/AAS-7712-2020; Yazdani, Saleh/K-9640-2015	Yazdani, Saleh/0000-0002-5162-9904; De Borst, Martin/0000-0002-4127-8733; Sjollema, Klaas/0000-0001-8840-2087; van Goor, Harry/0000-0002-6670-1577	JAN KORNELIS DE COCK-STICHTING; Graduate University Institute for Drug Exploration	JAN KORNELIS DE COCK-STICHTING; Graduate University Institute for Drug Exploration	This study was supported by research grants by JAN KORNELIS DE COCK-STICHTING and Graduate University Institute for Drug Exploration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2002, KIDNEY INT, V61, P2066, DOI 10.1046/j.1523-1755.2002.00380.x; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; AUKLAND K, 1994, AM J PHYSIOL, V266, pF175, DOI 10.1152/ajprenal.1994.266.2.F175; Avraham T, 2009, PLAST RECONSTR SURG, V124, P438, DOI 10.1097/PRS.0b013e3181adcf4b; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; BERTANI T, 1986, KIDNEY INT, V30, P488, DOI 10.1038/ki.1986.212; Cheung L, 2006, BIODRUGS, V20, P363, DOI 10.2165/00063030-200620060-00007; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; DIAMOND JR, 1991, AM J PHYSIOL, V260, pF779, DOI 10.1152/ajprenal.1991.260.6.F779; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; Flister MJ, 2010, BLOOD, V115, P418, DOI 10.1182/blood-2008-12-196840; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Hirschberg R, 2005, CURR OPIN NEPHROL HY, V14, P43, DOI 10.1097/00041552-200501000-00008; Hos D, 2008, INVEST OPHTH VIS SCI, V49, P1836, DOI 10.1167/iovs.07-1314; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kramer AB, 2005, J PATHOL, V207, P483, DOI 10.1002/path.1856; Kramer AB, 2003, J PATHOL, V201, P160, DOI 10.1002/path.1405; Liersch R, 2012, INT J ONCOL IN PRESS; Linares PM, 2011, INFLAMM BOWEL DIS, V17, P1814, DOI 10.1002/ibd.21554; Lokmic Z, 2011, HISTOL HISTOPATHOL, V26, P781, DOI 10.14670/HH-26.781; Matsui K, 2003, J AM SOC NEPHROL, V14, P1981, DOI 10.1097/01.ASN.0000076078.50889.43; Meinecke AK, 2012, BLOOD, V119, P5931, DOI 10.1182/blood-2011-12-396895; Nykanen AI, 2010, CIRCULATION, V121, P1413, DOI 10.1161/CIRCULATIONAHA.109.910703; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; Reich H, 2005, J AM SOC NEPHROL, V16, P1266, DOI 10.1681/ASN.2004030222; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Rodriguez-Iturbe B, 2002, KIDNEY INT, V62, P1379, DOI 10.1111/j.1523-1755.2002.kid561.x; Sakamoto I, 2009, KIDNEY INT, V75, P828, DOI 10.1038/ki.2008.661; Sean Eardley K, 2005, KIDNEY INT, V68, P437, DOI 10.1111/j.1523-1755.2005.00422.x; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Taal MW, 2000, KIDNEY INT, V57, P1803, DOI 10.1046/j.1523-1755.2000.00031.x; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Wang YP, 1997, J AM SOC NEPHROL, V8, P1537; WEHRMANN M, 1990, CLIN NEPHROL, V33, P115; Yard BA, 2001, NEPHROL DIAL TRANSPL, V16, P1769, DOI 10.1093/ndt/16.9.1769; Yin N, 2011, TRANSPLANTATION, V92, P25, DOI 10.1097/TP.0b013e31821d2661; Zhang TY, 2008, NEPHROLOGY, V13, P128, DOI 10.1111/j.1440-1797.2007.00851.x; Zhang TY, 2009, J NEPHROL, V22, P109; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x; Zoja C, 1995, AM J KIDNEY DIS, V26, P934, DOI 10.1016/0272-6386(95)90058-6	52	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50209	10.1371/journal.pone.0050209	http://dx.doi.org/10.1371/journal.pone.0050209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189189	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800066
J	Hassani, Z; O'Reilly, J; Pearse, Y; Stroemer, P; Tang, E; Sinden, J; Price, J; Thuret, S				Hassani, Zahra; O'Reilly, Joanna; Pearse, Yewande; Stroemer, Paul; Tang, Ellen; Sinden, John; Price, Jack; Thuret, Sandrine			Human Neural Progenitor Cell Engraftment Increases Neurogenesis and Microglial Recruitment in the Brain of Rats with Stroke	PLOS ONE			English	Article							ADULT BRAIN; INFLAMMATION; DISEASE; HIPPOCAMPUS; PRECURSORS; MIGRATION; NEURONS; LINE	Main Objectives: Stem cell transplantation is to date one of the most promising therapies for chronic ischemic stroke. The human conditionally immortalised neural stem cell line, CTX0E03, has demonstrable efficacy in a rodent model of stroke and is currently in clinical trials. Nonetheless, the mechanisms by which it promotes brain repair are not fully characterised. This study investigated the cellular events occurring after CTX0E03 transplantation in the brains of rats that underwent ischemic stroke. Methods: We focused on the endogenous proliferative activity of the host brain in response to cell transplantation and determined the identity of the proliferating cells using markers for young neurons (doublecortin, Dcx) and microglia (CD11b). So as to determine the chronology of events occurring post-transplantation, we analysed the engrafted brains one week and four weeks post-transplantation. Results: We observed a significantly greater endogenous proliferation in the striatum of ischemic brains receiving a CTX0E03 graft compared to vehicle-treated ischemic brains. A significant proportion of these proliferative cells were found to be Dcx+ striatal neuroblasts. Further, we describe an enhanced immune response after CTX0E03 engraftment, as shown by a significant increase of proliferating CD11b+ microglial cells. Conclusions: Our study demonstrates that few Dcx+ neuroblasts are proliferative in normal conditions, and that this population of proliferative neuroblasts is increased in response to stroke. We further show that CTX0E03 transplantation after stroke leads to the maintenance of this proliferative activity. Interestingly, the preservation of neuronal proliferative activity upon CTX0E03 transplantation is preceded and accompanied by a high rate of proliferating microglia. Our study suggests that microglia might mediate in part the effect of CTX0E03 transplantation on neuronal proliferation in ischemic stroke conditions.	[Hassani, Zahra; O'Reilly, Joanna; Pearse, Yewande; Price, Jack; Thuret, Sandrine] Kings Coll London, James Black Ctr, Inst Psychiat, Ctr Cellular Basis Behav, London WC2R 2LS, England; [Stroemer, Paul; Tang, Ellen; Sinden, John] ReNeuron Grp Plc, Guildford, Surrey, England	University of London; King's College London	Price, J (corresponding author), Kings Coll London, James Black Ctr, Inst Psychiat, Ctr Cellular Basis Behav, London WC2R 2LS, England.	jack.price@kcl.ac.uk; sandrine.1.thuret@kcl.ac.uk	Price, Jack/G-9510-2011; Thuret, Sandrine/Y-5784-2019	Thuret, Sandrine/0000-0003-1260-8083; Price, Jack/0000-0003-2235-9180	Wolfson Charitable Trust; US NIH; RCUK	Wolfson Charitable Trust; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RCUK(UK Research & Innovation (UKRI))	This work was supported by Wolfson Charitable Trust, the US NIH, and RCUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; ANDERSSON PB, 1991, IMMUNOL LETT, V30, P177, DOI 10.1016/0165-2478(91)90022-3; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Basu A, 2002, J NEUROSCI, V22, P6071; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Eve DJ, 2008, CELL TRANSPLANT, V17, P464; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Itoh T, 2007, NEUROL RES, V29, P734, DOI 10.1179/016164107X208086; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Liu B, 2003, ENVIRON HEALTH PERSP, V111, P1065, DOI 10.1289/ehp.6361; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Modo M, 2000, BEHAV BRAIN RES, V111, P213, DOI 10.1016/S0166-4328(00)00160-1; Plane JM, 2008, EXP NEUROL, V214, P125, DOI 10.1016/j.expneurol.2008.08.006; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Price J, 2011, BIOSOCIETIES, V6, P299, DOI 10.1057/biosoc.2011.6; Stevanato L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-86; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Thuret S, 2009, HIPPOCAMPUS, V19, P658, DOI 10.1002/hipo.20550; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007	29	48	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50444	10.1371/journal.pone.0050444	http://dx.doi.org/10.1371/journal.pone.0050444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185625	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000238
J	Kishore, D; Kundu, S; Kayastha, AM				Kishore, Devesh; Kundu, Suman; Kayastha, Arvind M.			Thermal, Chemical and pH Induced Denaturation of a Multimeric beta-Galactosidase Reveals Multiple Unfolding Pathways	PLOS ONE			English	Article							CIRCULAR-DICHROISM; CONFORMATIONAL STABILITY; GUANIDINE-HYDROCHLORIDE; ESCHERICHIA-COLI; MOLTEN GLOBULE; ALPHA-AMYLASES; PROTEINS; AGGREGATION; INTERMEDIATE; FLUORESCENCE	Background: In this case study, we analysed the properties of unfolded states and pathways leading to complete denaturation of a multimeric chick pea beta-galactosidase (CpGAL), as obtained from treatment with guanidium hydrochloride, urea, elevated temperature and extreme pH. Methodology/Principal Findings: CpGAL, a heterodimeric protein with native molecular mass of 85 kDa, belongs to alpha+beta class of protein. The conformational stability and thermodynamic parameters of CpGAL unfolding in different states were estimated and interpreted using circular dichroism and fluorescence spectroscopic measurements. The enzyme was found to be structurally and functionally stable in the entire pH range and upto 50 degrees C temperature. Further increase in temperature induces unfolding followed by aggregation. Chemical induced denaturation was found to be cooperative and transitions were irreversible, non-coincidental and sigmoidal. Free energy of protein unfolding (Delta G(0)) and unfolding constant (K-obs) were also calculated for chemically denatured CpGAL. Significance: The protein seems to use different pathways for unfolding in different environments and is a classical example of how the environment dictates the path a protein might take to fold while its amino acid sequence only defines its final three-dimensional conformation. The knowledge accumulated could be of immense biotechnological significance as well.	[Kishore, Devesh; Kayastha, Arvind M.] Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India; [Kundu, Suman] Univ Delhi, Dept Biochem, New Delhi, India	Banaras Hindu University (BHU); University of Delhi	Kundu, S (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	suman.kundu@south.du.ac.in; kayasthabhu@gmail.com			Department of Biotechnology (DBT), New Delhi; University of Delhi; University Grants Commission	Department of Biotechnology (DBT), New Delhi(Department of Biotechnology (DBT) India); University of Delhi(University of Delhi); University Grants Commission(University Grants Commission, India)	DK would like to acknowledge the financial assistance from the Department of Biotechnology (DBT), New Delhi, in the form of Junior and Senior research fellowships to carry out this work. SK thanks University of Delhi and University Grants Commission for financial assistance through R&D and SAP programme, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Dubey VK, 2003, BIOCHEMISTRY-US, V42, P12287, DOI 10.1021/bi035047m; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Dwevedi A, 2010, APPL BIOCHEM BIOTECH, V162, P2294, DOI 10.1007/s12010-010-9003-3; FINK AL, 1994, BIOCHEMISTRY-US, V33, P12504, DOI 10.1021/bi00207a018; Fitter J, 2004, BIOCHEMISTRY-US, V43, P9589, DOI 10.1021/bi0493362; Fitter J, 2003, BIOPHYS J, V84, P3924, DOI 10.1016/S0006-3495(03)75120-0; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229; HALFMAN CJ, 1971, BIOCHIM BIOPHYS ACTA, V243, P284, DOI 10.1016/0005-2795(71)90085-7; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Kaplan J, 2004, P NATL ACAD SCI USA, V101, P11566, DOI 10.1073/pnas.0404387101; KHURANA R, 1994, BIOCHEMISTRY-US, V33, P106, DOI 10.1021/bi00167a014; Kishore D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040708; Kishore D, 2012, FOOD CHEM, V134, P1650, DOI 10.1016/j.foodchem.2012.03.055; Kishore D, 2012, FOOD CHEM, V134, P1113, DOI 10.1016/j.foodchem.2012.03.032; Lassila JK, 2006, P NATL ACAD SCI USA, V103, P16710, DOI 10.1073/pnas.0607691103; LEPOCK JR, 1992, BIOCHEMISTRY-US, V31, P12706, DOI 10.1021/bi00165a023; MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Nichtl A, 1998, J MOL BIOL, V282, P1083, DOI 10.1006/jmbi.1998.2075; Pribila BA, 2000, J AM DIET ASSOC, V100, P524, DOI 10.1016/S0002-8223(00)00162-0; Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sundd M, 2002, J BIOCHEM MOL BIOL, V35, P143; Tripathi P, 2008, BIOPHYS CHEM, V137, P95, DOI 10.1016/j.bpc.2008.07.007; Vogl T, 1997, BIOCHEMISTRY-US, V36, P1657, DOI 10.1021/bi962163z; WONG KP, 1973, J BIOL CHEM, V248, P8518; Yadav SC, 2009, EUR BIOPHYS J BIOPHY, V38, P981, DOI 10.1007/s00249-009-0490-5; Yan YB, 2004, BIOPHYS J, V86, P1682, DOI 10.1016/S0006-3495(04)74237-X	35	70	73	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50380	10.1371/journal.pone.0050380	http://dx.doi.org/10.1371/journal.pone.0050380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185611	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000224
J	Ngugi, DK; Stingl, U				Ngugi, David Kamanda; Stingl, Ulrich			Combined Analyses of the ITS Loci and the Corresponding 16S rRNA Genes Reveal High Micro- and Macrodiversity of SAR11 Populations in the Red Sea	PLOS ONE			English	Article							ATLANTIC TIME-SERIES; NORTH-ATLANTIC; COMMUNITY STRUCTURE; MARINE-BACTERIA; EILAT AQABA; OCEAN; BACTERIOPLANKTON; DIVERSITY; PATTERNS; NUTRIENT	Bacteria belonging to the SAR11 clade are among the most abundant prokaryotes in the pelagic zone of the ocean. 16S rRNA gene-based analyses indicate that they constitute up to 60% of the bacterioplankton community in the surface waters of the Red Sea. This extremely oligotrophic water body is further characterized by an epipelagic zone, which has a temperature above 24 degrees C throughout the year, and a remarkable uniform temperature (similar to 22 degrees C) and salinity (similar to 41 psu) from the mixed layer (similar to 200 m) to the bottom at over 2000 m depth. Despite these conditions that set it apart from other marine environments, the microbiology of this ecosystem is still vastly understudied. Prompted by the limited phylogenetic resolution of the 16S rRNA gene, we extended our previous study by sequencing the internal transcribed spacer (ITS) region of SAR11 in different depths of the Red Sea's water column together with the respective 16S fragment. The overall diversity captured by the ITS loci was ten times higher than that of the corresponding 16S rRNA genes. Moreover, species estimates based on the ITS showed a highly diverse population of SAR11 in the mixed layer that became diminished in deep isothermal waters, which was in contrast to results of the related 16S rRNA genes. While the 16S rRNA gene-based sequences clustered into three phylogenetic subgroups, the related ITS fragments fell into several phylotypes that showed clear depth-dependent shifts in relative abundances. Blast-based analyses not only documented the observed vertical partitioning and universal co-occurrence of specific phylotypes in five other distinct oceanic provinces, but also highlighted the influence of ecosystem-specific traits (e. g., temperature, nutrient availability, and concentration of dissolved oxygen) on the population dynamics of this ubiquitous marine bacterium.	[Ngugi, David Kamanda; Stingl, Ulrich] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology	Ngugi, DK (corresponding author), King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia.	david.ngugi@kaust.edu.sa	Ngugi, David Kamanda/F-7496-2014; Stingl, Uli/H-1191-2014	Stingl, Uli/0000-0002-0684-2597; Ngugi, David Kamanda/0000-0002-0442-4279	King Abdullah University of Science and Technology (KAUST)	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	Baseline funds were kindly provided by King Abdullah University of Science and Technology (KAUST) in the context of research and development for the Kingdom of Saudi Arabia. Baseline funds include monies allocated annually by KAUST to each PI as part of the lab budget. The support did not however have any influence on the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2006, APPL ENVIRON MICROB, V72, P5806, DOI 10.1128/AEM.00597-06; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Boelen P, 2002, MICROBIAL ECOL, V44, P164, DOI 10.1007/s00248-002-1002-7; Brown MV, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.28; Brown MV, 2005, AQUAT MICROB ECOL, V41, P15, DOI 10.3354/ame041015; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Bryant JA, 2012, ECOLOGY; Buesseler KO, 2004, SCIENCE, V304, P414, DOI 10.1126/science.1086895; CAMPBELL L, 1993, DEEP-SEA RES PT I, V40, P2043, DOI 10.1016/0967-0637(93)90044-4; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; CEMBER RP, 1988, J GEOPHYS RES-OCEANS, V93, P8175, DOI 10.1029/JC093iC07p08175; Clarke A, 2003, TRENDS ECOL EVOL, V18, P573, DOI 10.1016/j.tree.2003.08.007; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; De Corte D, 2009, ISME J, V3, P147, DOI 10.1038/ismej.2008.94; Dishon G, 2012, INT J REMOTE SENS, V33, P2683, DOI 10.1080/01431161.2011.619209; Dupont CL, 2011, ISME J; DuRand MD, 2001, DEEP-SEA RES PT II, V48, P1983, DOI 10.1016/S0967-0645(00)00166-1; Edwards F.J., 1987, KEY ENV RED SEA, P45, DOI [10.1016/B978-0-08-028873-4.50008-6, DOI 10.1016/B978-0-08-028873-4.50008-6]; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; FAITH DP, 1992, CLADISTICS, V8, P361, DOI 10.1111/j.1096-0031.1992.tb00078.x; FALCON LI, 2008, GENOMICS, V1, P55, DOI DOI 10.1016/J.MARGEN.2008.06.005; Farias L, 2007, DEEP-SEA RES PT I, V54, P164, DOI 10.1016/j.dsr.2006.11.003; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Galan A, 2009, DEEP-SEA RES PT II, V56, P1125, DOI 10.1016/j.dsr2.2008.09.016; Garcia-Martinez J, 2000, MOL ECOL, V9, P935, DOI 10.1046/j.1365-294x.2000.00953.x; Gilbert JA, 2008, ISME J, V2, P790, DOI 10.1038/ismej.2008.49; Giovannoni SJ, 2005, NATURE, V438, P82, DOI 10.1038/nature04032; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Haverkamp THA, 2009, ISME J, V3, P397, DOI 10.1038/ismej.2008.118; Hu AY, 2011, APPL ENVIRON MICROB, V77, P7469, DOI 10.1128/AEM.00294-11; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; KIRCHMAN DL, 2007, OCEANOGRAPHY, V52, P495; Lami R, 2009, ENVIRON MICROBIOL, V11, P3201, DOI 10.1111/j.1462-2920.2009.02028.x; Logares R, 2010, MOL BIOL EVOL, V27, P347, DOI 10.1093/molbev/msp239; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mackey KRM, 2009, MAR BIOL, V156, P1531, DOI 10.1007/s00227-009-1185-2; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Manasrah R, 2004, OCEANOLOGIA, V46, P5; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Martiny AC, 2011, HDB MOL MICROBIAL EC, VII, P269; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P1340, DOI 10.1111/j.1462-2920.2009.01860.x; Moigis AG, 2000, J PLANKTON RES, V22, P713, DOI 10.1093/plankt/22.4.713; Morcos SA, 1970, OCEANOGRAPHY MARINE, V8; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; Ngugi DK, 2012, MOL ECOL, V21, P388, DOI 10.1111/j.1365-294X.2011.05378.x; Oh HM, 2011, J BACTERIOL, V193, P3379, DOI 10.1128/JB.05033-11; Paytan A, 2009, P NATL ACAD SCI USA, V106, P4601, DOI 10.1073/pnas.0811486106; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Qian PY, 2011, ISME J, V5, P507, DOI 10.1038/ismej.2010.112; Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Ruiz-Gonzalez C, 2012, FEMS MICROBIOL ECOL, V79, P661, DOI 10.1111/j.1574-6941.2011.01247.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sabehi G, 2007, ISME J, V1, P48, DOI 10.1038/ismej.2007.10; Salcher MM, 2011, ISME J, V5, P1242, DOI 10.1038/ismej.2011.8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwalbach MS, 2010, ENVIRON MICROBIOL, V12, P490, DOI 10.1111/j.1462-2920.2009.02092.x; Sohm JA, 2011, NAT REV MICROBIOL, V9, P499, DOI 10.1038/nrmicro2594; Sowell SM, 2008, APPL ENVIRON MICROB, V74, P4091, DOI 10.1128/AEM.00599-08; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Stambler N, 2005, J SEA RES, V54, P186, DOI 10.1016/j.seares.2005.04.006; Stein M, 2007, EARTH PLANET SC LETT, V261, P104, DOI 10.1016/j.epsl.2007.06.008; Stewart FJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r26; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Straza TRA, 2011, AQUAT MICROB ECOL, V62, P267, DOI 10.3354/ame01469; Sun J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023973; Suzuki MT, 2001, ENVIRON MICROBIOL, V3, P323, DOI 10.1046/j.1462-2920.2001.00198.x; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Trommer G, 2009, ORG GEOCHEM, V40, P724, DOI 10.1016/j.orggeochem.2009.03.001; Vergin KL, 2007, ENVIRON MICROBIOL, V9, P2430, DOI 10.1111/j.1462-2920.2007.01361.x; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Wilhelm LJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-27; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Wu JF, 2001, SCIENCE, V293, P847, DOI 10.1126/science.1059251; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zaballos M, 2006, FEMS MICROBIOL ECOL, V56, P389, DOI 10.1111/j.1574-6941.2006.00060.x; Zwart G, 1998, SYST APPL MICROBIOL, V21, P546, DOI 10.1016/S0723-2020(98)80067-2	92	27	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50274	10.1371/journal.pone.0050274	http://dx.doi.org/10.1371/journal.pone.0050274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185592	Green Submitted, gold, Green Published			2022-12-25	WOS:000311535700081
J	Rindler, PM; Plafker, SM; Szweda, LI; Kinter, M				Rindler, Paul M.; Plafker, Scott M.; Szweda, Luke I.; Kinter, Michael			High Dietary Fat Selectively Increases Catalase Expression within Cardiac Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; INSULIN-RESISTANCE; HYDROGEN-PEROXIDE; INDUCED OBESITY; CARDIOVASCULAR-DISEASE; TRANSCRIPTION FACTOR; MICE LACKING; HEART; ACID; INFLAMMATION	Obesity is a predictor of diabetes and cardiovascular disease. One consequence of obesity is dyslipidemia characterized by high blood triglycerides. It has been proposed that oxidative stress, driven by utilization of lipids for energy, contributes to these diseases. The effects of oxidative stress are mitigated by an endogenous antioxidant enzyme network, but little is known about its response to high fat utilization. Our experiments used a multiplexed quantitative proteomics method to measure antioxidant enzyme expression in heart tissue in a mouse model of diet-induced obesity. This experiment showed a rapid and specific up-regulation of catalase protein, with subsequent assays showing increases in activity and mRNA. Catalase, traditionally considered a peroxisomal protein, was found to be present in cardiac mitochondria and significantly increased in content and activity during high fat feeding. These data, coupled with the fact that fatty acid oxidation enhances mitochondrial H2O2 production, suggest that a localized catalase increase is needed to consume excessive mitochondrial H2O2 produced by increased fat metabolism. To determine whether the catalase-specific response is a common feature of physiological conditions that increase blood triglycerides and fatty acid oxidation, we measured changes in antioxidant expression in fasted versus fed mice. Indeed, a similar specific catalase increase was observed in mice fasted for 24 h. Our findings suggest a fundamental metabolic process in which catalase expression is regulated to prevent damage while preserving an H2O2-mediated sensing of diet composition that appropriately adjusts insulin sensitivity in the short term as needed to prioritize lipid metabolism for complete utilization.	[Rindler, Paul M.; Plafker, Scott M.; Szweda, Luke I.; Kinter, Michael] Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, Oklahoma City, OK 73104 USA; [Szweda, Luke I.; Kinter, Michael] Univ Oklahoma, Hlth Sci Ctr, Reynolds Oklahoma Ctr Aging, Oklahoma City, OK 73104 USA; [Szweda, Luke I.; Kinter, Michael] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Plafker, Scott M.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kinter, M (corresponding author), Oklahoma Med Res Fdn, Free Rad Biol & Aging Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	mike-kinter@omrf.org		Kinter, Michael/0000-0001-7409-8918	National Institutes of Health from NIGMS [AG016339, GM092900]; Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016339] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oklahoma Medical Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG016339 (to L. I. S.) and GM092900 from NIGMS (to S. M. P.). This work was also supported by the Oklahoma Medical Research Foundation.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Aebi H, 1984, Methods Enzymol, V105, P121; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Anderson EJ, 2012, BIOCHEM J, V441, P359, DOI 10.1042/BJ20110626; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bhandari U, 2011, HUM EXP TOXICOL, V30, P1313, DOI 10.1177/0960327110389499; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; DECRAEMER D, 1994, J LIPID RES, V35, P1241; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fang CX, 2008, AM J PHYSIOL-HEART C, V295, pH1206, DOI 10.1152/ajpheart.00319.2008; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Fox CS, 2007, CIRCULATION, V115, P1544, DOI 10.1161/CIRCULATIONAHA.106.658948; Gaetani GF, 1996, BLOOD, V87, P1595, DOI 10.1182/blood.V87.4.1595.bloodjournal8741595; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200; Horton TJ, 2001, J APPL PHYSIOL, V90, P155, DOI 10.1152/jappl.2001.90.1.155; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Iwakami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027401; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kinter CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050016; Liu TJ, 2007, J ENDOCRINOL, V192, P149, DOI 10.1677/joe.1.07020; Loo AEK, 2011, FREE RADICAL BIO MED, V51, P884, DOI 10.1016/j.freeradbiomed.2011.06.001; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Ludwig C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013987; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; Nicholls P, 2001, ADV INORG CHEM, V51, P51; Noeman SA, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-17; ORFALI KA, 1993, FEBS LETT, V336, P501, DOI 10.1016/0014-5793(93)80864-Q; Penckofer Sue, 2002, J Cardiovasc Nurs, V16, P68; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; RADI R, 1991, J BIOL CHEM, V266, P22028; RANDLE PJ, 1964, BIOCHEM J, V93, P652, DOI 10.1042/bj0930652; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Seifert EL, 2010, J BIOL CHEM, V285, P5748, DOI 10.1074/jbc.M109.026203; Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tsutsui H, 2006, ANTIOXID REDOX SIGN, V8, P1737, DOI 10.1089/ars.2006.8.1737; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Verhoeven NM, 1998, J LIPID RES, V39, P66; Vincent HK, 2001, INT J OBESITY, V25, P378, DOI 10.1038/sj.ijo.0801536; Wang HT, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-145; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Zhu H, 2008, CARDIOVASC TOXICOL, V8, P71, DOI 10.1007/s12012-008-9016-0	56	96	97	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1979	1990		10.1074/jbc.M112.412890	http://dx.doi.org/10.1074/jbc.M112.412890			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23204527	hybrid, Green Published			2022-12-25	WOS:000313751400050
J	Mochizuki, Y; Ohashi, R; Kawamura, T; Iwanari, H; Kodama, T; Naito, M; Hamakubo, T				Mochizuki, Yasuhiro; Ohashi, Riuko; Kawamura, Takeshi; Iwanari, Hiroko; Kodama, Tatsuhiko; Naito, Makoto; Hamakubo, Takao			Phosphatidylinositol 3-Phosphatase Myotubularin-related Protein 6 (MTMR6) Is Regulated by Small GTPase Rab1B in the Early Secretory and Autophagic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; MICE DEFICIENT; GRAM DOMAIN; PHOSPHATASE; MEMBRANE; GENE; PSEUDOPHOSPHATASE; 3,5-BISPHOSPHATE; IDENTIFICATION; ASSOCIATION	A large family of myotubularin phosphatases dephosphorylates phosphatidylinositol 3-phosphate and phosphatidylinositol 3,5-bisphosphate, which are known to play important roles in vesicular trafficking and autophagy. The family is composed of 16 members, and understanding their regulatory mechanisms is important to understand their functions and related genetic diseases. We prepared anti-myotubularin-related protein 6 (MTMR6) monoclonal antibody and used it to study the regulatory mechanism of MTMR6. Endogenous MTMR6 was present in the cytoplasm and was condensed in the perinuclear region in a microtubule-dependent manner. MTMR6 preferentially interacted with GDP-bound Rab1B via the GRAM domain and partly overlapped with Rab1B in the pericentrosomal and peri-Golgi regions in normal rat kidney cells. Overexpression of GDP-bound Rab1B and the reduction of Rab1B disrupted the localization of MTMR6, suggesting that Rab1B regulates the localization of MTMR6. The reduction of MTMR6 accelerated the transport of vesicular stomatitis virus glycoprotein in which Rab1B is involved. Furthermore, reduction of MTMR6 or Rab1B inhibited the formation of the tubular omegasome that is induced by overexpression of DFCP1 in autophagy. Our results indicate that the cellular localization of MTMR6 is regulated by Rab1B in the early secretory and autophagic pathways. We propose a new regulatory mechanism of myotubularin phosphatase by the small GTPase Rab1B.	[Mochizuki, Yasuhiro] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Mol Biol & Med, Meguro Ku, Tokyo 1538904, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Syst Biol & Med, Tokyo 1538904, Japan; [Ohashi, Riuko; Naito, Makoto] Niigata Univ, Grad Sch Med & Dent Sci, Div Cellular & Mol Pathol, Dept Cellular Funct, Niigata 9518510, Japan	University of Tokyo; University of Tokyo; Niigata University	Mochizuki, Y (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Mol Biol & Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	mochizuki@lsbm.org	Ohashi, Riuko/AAH-1415-2019	Ohashi, Riuko/0000-0001-5820-7870	development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO); Funding Program for World-Leading Innovative R&D on Science and Technology (First Program); Ministry of Education, Culture, Sports, Science and Technology [20221010]	development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Funding Program for World-Leading Innovative R&D on Science and Technology (First Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the development of New Functional Antibody Technologies of the New Energy and Industrial Technology Development Organization (NEDO), the Funding Program for World-Leading Innovative R&D on Science and Technology (First Program), and Ministry of Education, Culture, Sports, Science and Technology Grant-in-aid for Scientific Research 20221010.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alvarez C, 2003, SYNTHESE, V134, P1; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Berger P, 2003, P NATL ACAD SCI USA, V100, P12177, DOI 10.1073/pnas.2132732100; Bolino A, 2000, NAT GENET, V25, P17, DOI 10.1038/75542; Choudhury P, 2006, J BIOL CHEM, V281, P31762, DOI 10.1074/jbc.M606344200; Clague MJ, 2009, EXP CELL RES, V315, P1627, DOI 10.1016/j.yexcr.2008.10.005; Daigo K, 2011, J BIOL CHEM, V286, P674, DOI 10.1074/jbc.M110.154732; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Firestein R, 2002, J CLIN INVEST, V109, P1165, DOI [10.1172/JCI200212589, 10.1172/JCI0212589]; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Hotta K, 2011, J HUM GENET, V56, P647, DOI 10.1038/jhg.2011.74; Huang J, 2011, AUTOPHAGY, V7, P17, DOI 10.4161/auto.7.1.13840; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Jones DR, 1999, J BIOL CHEM, V274, P18407, DOI 10.1074/jbc.274.26.18407; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Lorenzo O, 2005, J CELL SCI, V118, P2005, DOI 10.1242/jcs.02325; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Marie M, 2009, MOL BIOL CELL, V20, P4458, DOI 10.1091/mbc.E08-12-1229; Zoppino FCM, 2010, TRAFFIC, V11, P1246, DOI 10.1111/j.1600-0854.2010.01086.x; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Robinson FL, 2005, J BIOL CHEM, V280, P31699, DOI 10.1074/jbc.M505159200; Robinson FL, 2006, TRENDS CELL BIOL, V16, P403, DOI 10.1016/j.tcb.2006.06.001; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Saitoh R, 2007, J IMMUNOL METHODS, V322, P104, DOI 10.1016/j.jim.2007.02.005; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Seaman MNJ, 2008, CELL MOL LIFE SCI, V65, P2842, DOI 10.1007/s00018-008-8354-1; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Silhankova M, 2010, EMBO J, V29, P4094, DOI 10.1038/emboj.2010.278; Srivastava S, 2005, MOL CELL BIOL, V25, P3630, DOI 10.1128/MCB.25.9.3630-3638.2005; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Tanaka Toshiya, 2002, J Atheroscler Thromb, V9, P233; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Yanagiya T, 2007, HUM MOL GENET, V16, P3017, DOI 10.1093/hmg/ddm260; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010; Zou J, 2012, P NATL ACAD SCI USA, V109, P9539, DOI 10.1073/pnas.1207021109; Zou J, 2009, J BIOL CHEM, V284, P2064, DOI 10.1074/jbc.M804292200	60	31	33	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1009	1021		10.1074/jbc.M112.395087	http://dx.doi.org/10.1074/jbc.M112.395087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188820	Green Published, hybrid			2022-12-25	WOS:000313570300025
J	Cheung, A; Hiby, L; Narendra, A				Cheung, Allen; Hiby, Lex; Narendra, Ajay			Ant Navigation: Fractional Use of the Home Vector	PLOS ONE			English	Article							AUSTRALIAN DESERT ANT; PATH-INTEGRATION; SYSTEMATIC SEARCH; MELOPHORUS-BAGOTI; ANIMAL NAVIGATION; HOMING STRATEGIES; FORMICA-JAPONICA; WOOD ANTS; BEHAVIOR; INFORMATION	Home is a special location for many animals, offering shelter from the elements, protection from predation, and a common place for gathering of the same species. Not surprisingly, many species have evolved efficient, robust homing strategies, which are used as part of each and every foraging journey. A basic strategy used by most animals is to take the shortest possible route home by accruing the net distances and directions travelled during foraging, a strategy well known as path integration. This strategy is part of the navigation toolbox of ants occupying different landscapes. However, when there is a visual discrepancy between test and training conditions, the distance travelled by animals relying on the path integrator varies dramatically between species: from 90% of the home vector to an absolute distance of only 50 cm. We here ask what the theoretically optimal balance between PI-driven and landmark-driven navigation should be. In combination with well-established results from optimal search theory, we show analytically that this fractional use of the home vector is an optimal homing strategy under a variety of circumstances. Assuming there is a familiar route that an ant recognizes, theoretically optimal search should always begin at some fraction of the home vector, depending on the region of familiarity. These results are shown to be largely independent of the search algorithm used. Ant species from different habitats appear to have optimized their navigation strategy based on the availability and nature of navigational information content in their environment. Citation: Cheung A, Hiby L, Narendra A (2012) Ant Navigation: Fractional Use of the Home Vector. PLoS ONE 7(11): e50451. doi: 10.1371/journal.pone.0050451	[Narendra, Ajay] Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; [Cheung, Allen] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hiby, Lex] Conservat Res Ltd, Gt Shelford, Cambridge, England	Australian National University; University of Queensland	Narendra, A (corresponding author), Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia.	ajay.narendra@anu.edu.au	Cheung, Allen/C-8305-2009; Narendra, Ajay/A-4960-2008	Cheung, Allen/0000-0001-9770-217X; Narendra, Ajay/0000-0002-1286-5373	Discovery Early Career Research Fellowship from the Australian Research Council [DE120100019]; Australian Research Council under the Centre of Excellence Schemes	Discovery Early Career Research Fellowship from the Australian Research Council(Australian Research Council); Australian Research Council under the Centre of Excellence Schemes(Australian Research Council)	AN is supported by a Discovery Early Career Research Fellowship from the Australian Research Council (#DE120100019) and acknowledges the support from the Australian Research Council under the Centre of Excellence Schemes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002336; Beugnon G, 2005, J INSECT BEHAV, V18, P415, DOI 10.1007/s10905-005-3700-8; CARTWRIGHT BA, 1983, J COMP PHYSIOL, V151, P521, DOI 10.1007/BF00605469; Cheng K, 2012, J EXP BIOL, V215, P3169, DOI 10.1242/jeb.070417; Cheung A, 2008, BIOL CYBERN, V99, P197, DOI 10.1007/s00422-008-0251-z; Cheung A, 2007, BIOL CYBERN, V97, P47, DOI 10.1007/s00422-007-0158-0; Collett M, 2000, BIOL CYBERN, V83, P245, DOI 10.1007/s004220000168; Collett M, 2012, CURR BIOL, V22, P927, DOI 10.1016/j.cub.2012.03.049; COLLETT TS, 1992, J COMP PHYSIOL A, V170, P435; Cruse H, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002009; Fukushi T, 2004, J EXP BIOL, V207, P3431, DOI 10.1242/jeb.01159; Fukushi T, 2001, J EXP BIOL, V204, P2063; HOFFMANN G, 1983, BEHAV ECOL SOCIOBIOL, V13, P81, DOI 10.1007/BF00293798; HOFFMANN G, 1983, BEHAV ECOL SOCIOBIOL, V13, P93, DOI 10.1007/BF00293799; Kohler M, 2005, NEUROBIOL LEARN MEM, V83, P1, DOI 10.1016/j.nlm.2004.05.011; Koopman B.O., 1980, SEARCH SCREENING GEN; KOOPMAN BO, 1957, OPER RES, V5, P613, DOI 10.1287/opre.5.5.613; KOOPMAN BO, 1956, OPER RES, V4, P503, DOI 10.1287/opre.4.5.503; Mangan M, 2012, BEHAV ECOLOGY, DOI [10.1093/beheco/ars1051, DOI 10.1093/BEHECO/ARS1051]; Merkle T, 2006, J EXP BIOL, V209, P3545, DOI 10.1242/jeb.02395; Merkle T, 2009, BEHAV ECOL SOCIOBIOL, V63, P391, DOI 10.1007/s00265-008-0673-6; MITTELSTAEDT H, 1983, FORTS ZOOL, V28, P197; MULLER M, 1994, J COMP PHYSIOL A, V175, P525, DOI 10.1007/BF00199474; MULLER M, 1988, P NATL ACAD SCI USA, V85, P5287, DOI 10.1073/pnas.85.14.5287; Narendra A, 2008, J COMP PHYSIOL A, V194, P929, DOI 10.1007/s00359-008-0365-8; Narendra A, 2007, J EXP BIOL, V210, P1804, DOI 10.1242/jeb.02769; Narendra A, 2007, J EXP BIOL, V210, P1798, DOI 10.1242/jeb.02768; Philippides A, 2011, J EXP BIOL, V214, P445, DOI 10.1242/jeb.046755; Reid SF, 2011, J EXP BIOL, V214, P363, DOI 10.1242/jeb.049338; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Schultheiss P, 2011, ANIM BEHAV, V81, P1031, DOI 10.1016/j.anbehav.2011.02.008; Sturzl W, 2007, BIOL CYBERN, V96, P519, DOI 10.1007/s00422-007-0147-3; Vickerstaff RJ, 2012, J THEOR BIOL, V307, P1, DOI 10.1016/j.jtbi.2012.04.034; Vickerstaff RJ, 2010, J THEOR BIOL, V263, P242, DOI 10.1016/j.jtbi.2009.11.021; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Wehner R, 1996, J EXP BIOL, V199, P129; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; Wehner Ruediger, 2003, P9	38	13	13	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50451	10.1371/journal.pone.0050451	http://dx.doi.org/10.1371/journal.pone.0050451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209744	gold, Green Published, Green Submitted			2022-12-25	WOS:000312104900052
J	de la Rosa-Zamboni, D; Vazquez-Perez, JA; Avila-Rios, S; Carranco-Arenas, AP; Ormsby, CE; Cummings, CA; Soto-Nava, M; Hernandez-Hernandez, VA; Orozco-Sanchez, CO; Alvarado-de la Barrera, C; Perez-Padilla, R; Reyes-Teran, G				de la Rosa-Zamboni, Daniela; Vazquez-Perez, Joel A.; Avila-Rios, Santiago; Paola Carranco-Arenas, Ana; Ormsby, Christopher E.; Cummings, Craig A.; Soto-Nava, Maribel; Hernandez-Hernandez, Victor A.; Orozco-Sanchez, Carmen O.; Alvarado-de la Barrera, Claudia; Perez-Padilla, Rogelio; Reyes-Teran, Gustavo			Molecular Characterization of the Predominant Influenza A(H1N1)pdm09 Virus in Mexico, December 2011-February 2012	PLOS ONE			English	Article							A H1N1; VACCINE	When the A(H1N1)pdm09 pandemic influenza virus moved into the post-pandemic period, there was a worldwide predominance of the seasonal influenza A(H3N2) and B viruses. However, A(H1N1)pdm09 became the prevailing subtype in the 2011-2012 influenza season in Mexico and most of Central America. During this season, we collected nasopharyngeal swabs of individuals presenting with influenza-like illness at our institution in Mexico City. Samples were tested for seasonal A(H3N2) and B influenza viruses, as well as A(H1N1)pdm09 by real-time reverse transcription-polymerase chain reaction. Of 205 samples tested, 46% were positive to influenza, all of them A(H1N1)pdm09. The clinical characteristics of patients showed a similar pattern to the 2009 pandemic cases. Using next generation sequencing, we obtained whole genome sequences of viruses from 4 different patients, and in 8 additional viruses we performed partial Sanger sequencing of the HA segment. Non-synonymous changes found in the Mexican isolates with respect to the prototype isolate H1N1 (A/California/04/2009) included HA S69T, K163R and N260D unique to 2012 Mexican and North American isolates and located within or adjacent to HA antigenic sites; HA S143G, S185T, A197T and S203T previously reported in viruses from the 2010-2011 season, located within or adjacent to HA antigenic sites; and HA E374K located in a relevant site for membrane fusion. All Mexican isolates had an oseltamivir-sensitive genotype. Phylogenetic analysis with all 8 influenza gene segments showed that 2012 Mexican sequences formed a robust, distinct cluster. In all cases, 2012 Mexican sequences tended to group with 2010-2011 Asian and European sequences, but not with 2009 Mexican sequences, suggesting a possible recent common ancestor between these latter regions and the 2012 Mexican viruses. It remains to be defined if these viral changes represent an important antigenic drift that would enable viral immune evasion and/or affect influenza vaccine effectiveness. Citation: de la Rosa-Zamboni D, Vazquez-Perez JA, Avila-Rios S, Carranco-Arenas AP, Ormsby CE, et al. (2012) Molecular Characterization of the Predominant Influenza A(H1N1)pdm09 Virus in Mexico, December 2011-February 2012. PLoS ONE 7(11): e50116. doi: 10.1371/journal.pone.0050116	[de la Rosa-Zamboni, Daniela; Vazquez-Perez, Joel A.; Avila-Rios, Santiago; Paola Carranco-Arenas, Ana; Ormsby, Christopher E.; Soto-Nava, Maribel; Hernandez-Hernandez, Victor A.; Orozco-Sanchez, Carmen O.; Alvarado-de la Barrera, Claudia; Perez-Padilla, Rogelio; Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico; [Cummings, Craig A.] Life Technol Corp, Foster City, CA USA	Thermo Fisher Scientific	Reyes-Teran, G (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico.	gustavo.reyesteran@gmail.com	Avila-Rios, Santiago/AAB-4383-2020; Vazquez-Perez, Joel/F-3476-2019	Vazquez-Perez, Joel/0000-0002-8508-3698; Soto-Nava, Maribel/0000-0001-5405-8855; Reyes-Teran, Gustavo/0000-0002-4115-4888; Carranco, Morgana/0000-0002-2520-2560	Comision de Equidad y Genero de la Honorable Camara de Diputados de la LXI Legislatura de Mexico; Fundacion Mexico Vivo; Instituto Nacional de Ciencia y Tecnologia del Distrito Federal [ICyTDF 141849]	Comision de Equidad y Genero de la Honorable Camara de Diputados de la LXI Legislatura de Mexico; Fundacion Mexico Vivo; Instituto Nacional de Ciencia y Tecnologia del Distrito Federal	This work was supported by the Comision de Equidad y Genero de la Honorable Camara de Diputados de la LXI Legislatura de Mexico; Fundacion Mexico Vivo (http://www.mexicovivo.org/); and a grant from the Instituto Nacional de Ciencia y Tecnologia del Distrito Federal (ICyTDF 141849) to JAVP with a scholarship to COOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr IG, 2010, EURO SURVEILL, V15; Beaute J, 2012, EUROSURVEILLANCE, V17; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P435; Chowell Gerardo, 2012, PLoS Curr, V4, pRRN1306, DOI 10.1371/currents.RRN1306; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Ellis J, 2011, EURO SURVEILL, V16, P19760; Galiano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023779; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; Inoue E, 2012, MICROBIOL IMMUNOL, V56, P273, DOI 10.1111/j.1348-0421.2012.00432.x; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak G, 2011, EURO SURVEILL, V16; Maurer-Stroh Sebastian, 2010, PLoS Curr, V2, pRRN1162; Mir MA, 2012, J MED VIROL, V84, P386, DOI 10.1002/jmv.23205; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Munster VJ, 2007, J INFECT DIS, V196, P258, DOI 10.1086/518792; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sominina A. A., 2011, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P20; Squires RB, 2012, INFLUENZA RES DATABA; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trejo-Valdivia B, 2012, SALUD PUBLICA MEXICO, V54, P39, DOI 10.1590/s0036-36342012000100006; WHO, PAND INFL A IN PRESS; WHO, REC COMP INFL VIR VA; WHO, FLUNET CHARTS; World Health Organization, INFL TRANSM ZON; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	36	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50116	10.1371/journal.pone.0050116	http://dx.doi.org/10.1371/journal.pone.0050116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209653	Green Published, gold, Green Submitted			2022-12-25	WOS:000312104900026
J	Shi, TY; Yang, G; Tu, XY; Yang, JM; Qian, J; Wu, XH; Zhou, XY; Cheng, X; Wei, QY				Shi, Ting-Yan; Yang, Gong; Tu, Xiao-Yu; Yang, Jing-Min; Qian, Ji; Wu, Xiao-Hua; Zhou, Xiao-Yan; Cheng, Xi; Wei, Qingyi			RAD52 Variants Predict Platinum Resistance and Prognosis of Cervical Cancer	PLOS ONE			English	Article							DNA-REPAIR GENES; NEOADJUVANT CHEMOTHERAPY; CISPLATIN RESISTANCE; TUMOR-CELLS; POLYMORPHISMS; ASSOCIATION; VALIDATION; MECHANISMS; EXPRESSION; RADIATION	RAD52 is an important but not well characterized homologous recombination repair gene that can bind to single-stranded DNA ends and mediate the DNA-DNA interaction necessary for the annealing of complementary DNA strands. To evaluate the role of RAD52 variants in the response of tumor cells to platinum agents, we investigated their associations with platinum resistance and prognosis in cervical cancer patients. We enrolled 154 patients with cervical squamous cell carcinoma, who had radical surgery between 2008 and 2009, and genotyped three potentially functional RAD52 variants by the SNaPshot assay. We tested in vitro platinum resistance and RAD52 expression by using the MTT and immunohistochemistry methods, respectively. In 144 cases who had genotyping data, we found that both the rs1051669 variant and RAD52 protein expression were significantly associated with carboplatin resistance (P = 0.024 and 0.028, respectively) and rs10774474 with nedaplatin resistance (P = 0.018). The rs1051669 variant was significantly associated with RAD52 protein expression (adjusted OR = 4.7, 95% CI = 1.4216.1, P = 0.013). When these three RAD52 variants were combined, progression-free survival was lower in patients who carried at least one (>= 1) variant allele compared to those without any of the variant alleles (P = 0.047). Therefore, both RAD52 variants and protein expression can predict platinum resistance, and RAD52 variants appeared to predict prognosis in cervical cancer patients. Large studies are warranted to validate these findings. Citation: Shi T-Y, Yang G, Tu X-Y, Yang J-M, Qian J, et al. (2012) RAD52 Variants Predict Platinum Resistance and Prognosis of Cervical Cancer. PLoS ONE 7(11): e50461. doi: 10.1371/journal.pone.0050461	[Wu, Xiao-Hua; Cheng, Xi] Fudan Univ, Shanghai Med Coll, Dept Oncol, Dept Gynecol Oncol,Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Shi, Ting-Yan; Yang, Gong; Zhou, Xiao-Yan; Wei, Qingyi] Fudan Univ, Shanghai Med Coll, Dept Oncol, Canc Res Lab,Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Tu, Xiao-Yu; Zhou, Xiao-Yan] Fudan Univ, Shanghai Med Coll, Dept Oncol, Dept Pathol,Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Yang, Jing-Min; Qian, Ji] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Shi, Ting-Yan] Shanghai Inst Planned Parenthood Res, Natl Populat & Family Planning Key Lab Contracept, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Cheng, X (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Dept Gynecol Oncol,Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	cheng_xi1@hotmail.com		Shi, Tingyan/0000-0002-5356-0365	Science Foundation for Young Scholars of Fudan University	Science Foundation for Young Scholars of Fudan University	This study was supported by Science Foundation for Young Scholars of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beesley J, 2007, CANCER EPIDEM BIOMAR, V16, P2557, DOI 10.1158/1055-9965.EPI-07-0542; Brozovic A, 2009, MUTAT RES-FUND MOL M, V670, P32, DOI 10.1016/j.mrfmmm.2009.07.002; Burger H, 2011, DRUG RESIST UPDATE, V14, P22, DOI 10.1016/j.drup.2010.12.002; Cadron I, 2007, GYNECOL ONCOL, V107, pS113, DOI 10.1016/j.ygyno.2007.07.004; Cheng X, 2011, GYNECOL ONCOL, V121, P323, DOI 10.1016/j.ygyno.2010.12.360; Dubay RA, 2004, GYNECOL ONCOL, V94, P121, DOI 10.1016/j.ygyno.2004.03.034; Feng ZH, 2011, P NATL ACAD SCI USA, V108, P686, DOI 10.1073/pnas.1010959107; Frit P, 1999, MOL PHARMACOL, V56, P141, DOI 10.1124/mol.56.1.141; Ishino Y, 2006, CHEM REV, V106, P324, DOI 10.1021/cr0404803; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jewell R, 2010, CLIN CANCER RES, V16, P5211, DOI 10.1158/1078-0432.CCR-10-1521; Kawanishi K, 2001, CANCER CHEMOTH PHARM, V47, P303, DOI 10.1007/s002800000238; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim K, 2008, GYNECOL ONCOL, V111, P509, DOI 10.1016/j.ygyno.2008.08.034; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Koshiyama M, 2005, ANTICANCER RES, V25, P4499; Koshiyama M, 2001, ANTICANCER RES, V21, P2925; Lettier G, 2006, PLOS GENET, V2, P1773, DOI 10.1371/journal.pgen.0020194; Li D, 2011, MED ONCOL, V29, P1266; Li F, 2010, AM J CLIN ONCOL-CANC, V33, P489, DOI 10.1097/COC.0b013e3181b9cedc; Lissoni AA, 2009, ANN ONCOL, V20, P660, DOI 10.1093/annonc/mdn690; Liu C, 2006, CHINA PHARM, V17, P1399; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Morrison JG, 2000, J PHARMACEUT BIOMED, V24, P1, DOI 10.1016/S0731-7085(00)00377-0; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Park JS, 2011, GYNECOL ONCOL, V120, P275, DOI 10.1016/j.ygyno.2010.10.034; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; SASAKI Y, 1989, CANCER CHEMOTH PHARM, V23, P243, DOI 10.1007/BF00451649; SCHEITHAUER W, 1986, CANCER TREAT REP, V70, P1379; Siraj AK, 2008, J ENDOCRINOL INVEST, V31, P893, DOI 10.1007/BF03346438; Tassone P, 2009, CANCER BIOL THER, V8, P648, DOI 10.4161/cbt.8.7.7968; Wang HB, 2009, NEURO-ONCOLOGY, V11, P790, DOI 10.1215/15228517-2009-015; Watari H, 2010, PATHOL ONCOL RES, V16, P345, DOI 10.1007/s12253-009-9235-0; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Xu ZY, 2005, J PHARMACOL EXP THER, V314, P495, DOI 10.1124/jpet.105.084053; YAMAUE H, 1991, EUR J CANCER, V27, P1258, DOI 10.1016/0277-5379(91)90093-S; YAMAUE H, 1992, BRIT J CANCER, V66, P794, DOI 10.1038/bjc.1992.362; Yin M, 2011, CLIN CANCER RES, V17, P1632, DOI 10.1158/1078-0432.CCR-10-2169	39	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50461	10.1371/journal.pone.0050461	http://dx.doi.org/10.1371/journal.pone.0050461			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209746	Green Submitted, gold, Green Published			2022-12-25	WOS:000312104900053
J	Li, JY; Shariff, A; Wiking, M; Lundberg, E; Rohde, GK; Murphy, RF				Li, Jieyue; Shariff, Aabid; Wiking, Mikaela; Lundberg, Emma; Rohde, Gustavo K.; Murphy, Robert F.			Estimating Microtubule Distributions from 2D Immunofluorescence Microscopy Images Reveals Differences among Human Cultured Cell Lines	PLOS ONE			English	Article							CYTOPLASMIC MICROTUBULES; DYNAMICS; INTERPHASE; NUMBER	Microtubules are filamentous structures that are involved in several important cellular processes, including cell division, cellular structure and mechanics, and intracellular transportation. Little is known about potential differences in microtubule distributions within and across cell lines. Here we describe a method to estimate information pertaining to 3D microtubule distributions from 2D fluorescence images. Our method allows for quantitative comparisons of microtubule distribution parameters (number of microtubules, mean length) between different cell lines. Among eleven cell lines compared, some showed differences that could be accounted for by differences in the total amount of tubulin per cell while others showed statistically significant differences in the balance between number and length of microtubules. We also observed that some cell lines that visually appear different in their microtubule distributions are quite similar when the model parameters are considered. The method is expected to be generally useful for comparing microtubule distributions between cell lines and for a given cell line after various perturbations. The results are also expected to enable analysis of the differences in gene expression underlying the observed differences in microtubule distributions among cell types.	[Li, Jieyue; Shariff, Aabid; Rohde, Gustavo K.; Murphy, Robert F.] Carnegie Mellon Univ, Ctr Bioimage Informat, Pittsburgh, PA 15213 USA; [Shariff, Aabid; Rohde, Gustavo K.; Murphy, Robert F.] Carnegie Mellon Univ, Lane Ctr Computat Biol, Pittsburgh, PA 15213 USA; [Li, Jieyue; Rohde, Gustavo K.; Murphy, Robert F.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Rohde, Gustavo K.] Carnegie Mellon Univ, Dept Elect & Comp Engn, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Carnegie Mellon Univ, Dept Machine Learning, Pittsburgh, PA 15213 USA; [Murphy, Robert F.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Murphy, Robert F.] Univ Freiburg, Freiburg Inst Adv Studies, D-79106 Freiburg, Germany; [Wiking, Mikaela; Lundberg, Emma] Royal Inst Technol, Sci Life Lab, Dept Biotechnol, Solna, Sweden	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; University of Freiburg; University of Freiburg; Royal Institute of Technology	Rohde, GK (corresponding author), Carnegie Mellon Univ, Ctr Bioimage Informat, Pittsburgh, PA 15213 USA.	gustavor@cmu.edu; murphy@cmu.edu	Lundberg, Emma S K/F-3891-2010	Rohde, Gustavo/0000-0003-1703-9035; Wiking, Mikaela/0000-0002-6368-6690; Kaller Lundberg, Emma/0000-0001-7034-0850	National Institutes of Health (NIH) [GM090033, GM075205]; Knut and Alice Wallenberg Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090033, R01GM075205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) grants GM090033 (GKR) and GM075205 (RFM) and by the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barbe L, 2008, MOL CELL PROTEOMICS, V7, P499, DOI 10.1074/mcp.M700325-MCP200; Boland MV, 2001, BIOINFORMATICS, V17, P1213, DOI 10.1093/bioinformatics/17.12.1213; BRINKLEY BR, 1981, J CELL BIOL, V90, P554, DOI 10.1083/jcb.90.3.554; DUERR A, 1981, CELL, V24, P203, DOI 10.1016/0092-8674(81)90516-X; GONIAKOWSKAWITALINSKA L, 1976, J CELL SCI, V22, P397; LETOURNEAU PC, 1982, J NEUROSCI, V2, P806; Luo B, 1997, DSP 97: 1997 13TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING PROCEEDINGS, VOLS 1 AND 2, P1083, DOI 10.1109/ICDSP.1997.628553; OSBORN M, 1978, J CELL BIOL, V77, pR27, DOI 10.1083/jcb.77.3.R27; REAVEN E, 1982, METHOD CELL BIOL, V25, P273, DOI 10.1016/S0091-679X(08)61429-6; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Shariff A, 2011, I S BIOMED IMAGING, P1330, DOI 10.1109/ISBI.2011.5872646; Shariff A, 2010, CYTOM PART A, V77A, P457, DOI 10.1002/cyto.a.20854; SHELDEN E, 1993, J CELL BIOL, V120, P935, DOI 10.1083/jcb.120.4.935; Shestakova E, 1998, EUR J CELL BIOL, V75, P309, DOI 10.1016/S0171-9335(98)80064-2; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Velliste M, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS, P867, DOI 10.1109/ISBI.2002.1029397; WADSWORTH P, 1990, J CELL SCI, V95, P23; WOLF KW, 1995, CELL BIOL INT, V19, P43, DOI 10.1006/cbir.1995.1006; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947	20	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50292	10.1371/journal.pone.0050292	http://dx.doi.org/10.1371/journal.pone.0050292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209697	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700052
J	de Mola, CL; Pillay, TD; Diez-Canseco, F; Gilman, RH; Smeeth, L; Miranda, JJ				Loret de Mola, Christian; Pillay, Timesh D.; Diez-Canseco, Francisco; Gilman, Robert H.; Smeeth, Liam; Jaime Miranda, J.			Body Mass Index and Self-Perception of Overweight and Obesity in Rural, Urban and Rural-to-Urban Migrants: PERU MIGRANT Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ADOLESCENT GIRLS; WEIGHT; INDICATORS; GENDER; ADULTS; WOMEN	Objective: This study aimed to compare self-reported weight and body mass index (BMI) in order to determine discrepancies between subjective and objective obesity-related markers, and possible explanatory factors of overweight and obesity underestimation, in urban, rural and migrant populations. Materials and Methods: Data from the PERU MIGRANT study, a cross-sectional study, in low-income settings, of urban, migrant (rural-to-urban), and rural groups, including BMI, self-reported weight and socio-demographic indicators were analyzed. Percentage of concurrences between BMI and self-reported weight and Kappa coefficients for inter-rater agreement were calculated. Univariate and standardized descriptive analyses were performed to identify potential explanatory variables for weight underestimation in only overweight and obese individuals, using established BMI and waist circumference cut offs. Results: 983 Participants-199 urban, 583 migrants and 201 rural-were analyzed. Based on BMI, overall prevalence of obesity was 20.1% (95% CI 17.6%-22.6%), and overweight was 38.3% (95% CI 35.2%-41.2%), with differences between study groups (p<0.001). Only 43% of the whole sample had matching self-reported weight and BMI status, whereas 54% underestimated and 3% overestimated their BMI category. Kappa coefficient, between BMI and self-reported weight, for the entire sample was 0.16, rural residents had the lowest coefficient (0.01) and the most underestimation, especially in the overweight category. In overweight and obese individuals, deprivation index (p = 0.016), age (p = 0.014) and waist circumference (p<0.001) were associated with weight underestimation. Discussion: Overall, high levels of overweight, obesity, and underestimation of BMI status were found, with poor agreement between BMI and self-reported weight, showing the unawareness of weight status severity in this low-income setting.	[Loret de Mola, Christian; Pillay, Timesh D.; Diez-Canseco, Francisco; Gilman, Robert H.; Smeeth, Liam; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Loret de Mola, Christian] Univ Fed Pelotas, Programa Pos Grad Epidemiol, Ctr Pesquisas Epidemiol, Pelotas, Brazil; [Loret de Mola, Christian] Org Latinoamer Fomento Invest Salud, Grp Latinoamer Invest Epidemiol, Bucaramanga, Colombia; [Pillay, Timesh D.] UCL, Sch Med, London W1N 8AA, England; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gilman, Robert H.] AB PRISMA, Area Invest & Desarrollo, Lima, Peru; [Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Dept Med, Sch Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidade Federal de Pelotas; University of London; University College London; UCL Medical School; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	de Mola, CL (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	christian.loret.de.mola.z@upch.pe	de Mola, Christian Loret/C-9534-2012; Smeeth, Liam/X-5862-2018	de Mola, Christian Loret/0000-0002-5264-5914; Miranda, J. Jaime/0000-0002-4738-5468; Diez-Canseco, Francisco/0000-0002-7611-8190; Smeeth, Liam/0000-0002-9168-6022; Pillay, Timesh/0000-0001-8608-8880	Wellcome Trust [GR074833MA]; National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]; MRC [MR/K007467/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The PERU MIGRANT Study was funded by a Wellcome Trust Masters Research Training Fellowship and a Wellcome Trust PhD Studentship to JJM (GR074833MA). LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science. All authors and the CRONICAS Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia is funded by the National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services, under contract no. HHSN268200900033C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altabe M, 1998, INT J EAT DISORDER, V23, P153, DOI 10.1002/(SICI)1098-108X(199803)23:2&lt;153::AID-EAT5&gt;3.0.CO;2-J; Araujo CL, 2010, REV PANAM SALUD PUBL, V27, P360, DOI 10.1590/S1020-49892010000500006; Bhanji S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-363; Brewis A, 2003, AM J HUM BIOL, V15, P446, DOI 10.1002/ajhb.10161; Creed-Kanashiro HM, 2003, J NUTR, V133, p3987S, DOI 10.1093/jn/133.11.3987S; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Deepa M, 2009, EUR J CLIN NUTR, V63, P259, DOI 10.1038/sj.ejcn.1602920; Dowd JB, 2010, ANN EPIDEMIOL, V20, P743, DOI 10.1016/j.annepidem.2010.06.007; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Fuke Y, 2007, DIABETES RES CLIN PR, V77, pS224, DOI 10.1016/j.diabres.2007.01.062; George JBE, 2010, J PEDIATR PSYCHOL, V35, P231, DOI 10.1093/jpepsy/jsp064; Harris CV, 2008, INT J OBESITY, V32, P336, DOI 10.1038/sj.ijo.0803704; Herrera VM, 2009, INT J OBESITY, V33, P568, DOI 10.1038/ijo.2009.35; *I NAC EST INF, 2007, CENS NAC 2007 11 POB; Jacoby E, 2003, PREV MED, V37, P396, DOI 10.1016/S0091-7435(03)00159-2; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Lobera IJ, 2008, NUTR HOSP, V23, P624; Kuchler F, 2003, INT J OBESITY, V27, P856, DOI 10.1038/sj.ijo.0802293; Lemon SC, 2009, BODY IMAGE, V6, P90, DOI 10.1016/j.bodyim.2008.11.004; Mascie-Taylor C. G. Nicholas, 2007, Journal of Physiological Anthropology, V26, P109, DOI 10.2114/jpa2.26.109; Mehio-Sibai A, 2003, SOZ PRAVENTIV MED, V48, P234, DOI 10.1007/s00038-003-2061-3; Miranda JJ, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-23; Mispireta ML, 2007, REV PERU MED EXP SAL, V24, P129; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Mujica V, 2009, REV MED CHILE, V137, P76, DOI /S0034-98872009000100011; Neumark-Sztainer D, 2002, J PSYCHOSOM RES, V53, P963, DOI 10.1016/S0022-3999(02)00486-5; Organizacion Panamericana de la Salud, 2010, PROYECT INF AN SAL I; Pedersen D, 2008, SOC SCI MED, V67, P205, DOI 10.1016/j.socscimed.2008.03.040; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Poterico JA, 2011, OBESITY SILVER SPRIN; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Subramanian SV, 2010, B WORLD HEALTH ORGAN, V88, P131, DOI 10.2471/BLT.09.067058; Wardle J, 2006, INT J OBESITY, V30, P644, DOI 10.1038/sj.ijo.0803050; World Health Organisation, 2003, DIET PREV PREV NONC; World Health Organization, 2008, WAIST CIRCUMFERENCE; Yancey AK, 2006, OBESITY, V14, P980, DOI 10.1038/oby.2006.112	36	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50252	10.1371/journal.pone.0050252	http://dx.doi.org/10.1371/journal.pone.0050252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057YW	23209688	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000312601700048
J	Huy, NT; Nguyen, THT; Tuan, NA; Khiem, NT; Moore, CC; Doan, TND; Hirayama, K				Nguyen Tien Huy; Nguyen Thanh Hong Thao; Nguyen Anh Tuan; Nguyen Tuan Khiem; Moore, Christopher C.; Doan Thi Ngoc Diep; Hirayama, Kenji			Performance of Thirteen Clinical Rules to Distinguish Bacterial and Presumed Viral Meningitis in Vietnamese Children	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PLEOCYTOSIS; C-REACTIVE PROTEIN; ASEPTIC-MENINGITIS; DIFFERENTIAL-DIAGNOSIS; HAEMOPHILUS-INFLUENZAE; DECISION RULE; MULTIVARIATE APPROACH; SERUM PROCALCITONIN; PREDICTIVE MODEL; LOW-RISK	Background and Purpose: Successful outcomes from bacterial meningitis require rapid antibiotic treatment; however, unnecessary treatment of viral meningitis may lead to increased toxicities and expense. Thus, improved diagnostics are required to maximize treatment and minimize side effects and cost. Thirteen clinical decision rules have been reported to identify bacterial from viral meningitis. However, few rules have been tested and compared in a single study, while several rules are yet to be tested by independent researchers or in pediatric populations. Thus, simultaneous test and comparison of these rules are required to enable clinicians to select an optimal diagnostic rule for bacterial meningitis in settings and populations similar to ours. Methods: A retrospective cross-sectional study was conducted at the Infectious Department of Pediatric Hospital Number 1, Ho Chi Minh City, Vietnam. The performance of the clinical rules was evaluated by area under a receiver operating characteristic curve (ROC-AUC) using the method of DeLong and McNemar test for specificity comparison. Results: Our study included 129 patients, of whom 80 had bacterial meningitis and 49 had presumed viral meningitis. Spanos's rule had the highest AUC at 0.938 but was not significantly greater than other rules. No rule provided 100% sensitivity with a specificity higher than 50%. Based on our calculation of theoretical sensitivity and specificity, we suggest that a perfect rule requires at least four independent variables that posses both sensitivity and specificity higher than 85-90%. Conclusions: No clinical decision rules provided an acceptable specificity (>50%) with 100% sensitivity when applying our data set in children. More studies in Vietnam and developing countries are required to develop and/or validate clinical rules and more very good biomarkers are required to develop such a perfect rule.	[Nguyen Tien Huy; Hirayama, Kenji] Nagasaki Univ, Dept Immunogenet, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Nguyen Thanh Hong Thao; Nguyen Anh Tuan; Doan Thi Ngoc Diep] Univ Med & Pharm Ho Chi Minh City, Dept Pediat, Ho Chi Minh City, Vietnam; [Nguyen Anh Tuan; Doan Thi Ngoc Diep] Childrens Hosp 1, Ho Chi Minh City, Vietnam; [Nguyen Tuan Khiem] Pham Ngoc Thach Univ Med, Dept Pediat, Ho Chi Minh City, Vietnam; [Moore, Christopher C.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Hirayama, Kenji] Nagasaki Univ, Global COE Program, Nagasaki 852, Japan	Nagasaki University; Hochiminh City University of Medicine & Pharmacy; University of Virginia; Nagasaki University	Doan, TND (corresponding author), Univ Med & Pharm Ho Chi Minh City, Dept Pediat, Ho Chi Minh City, Vietnam.	diepkhanh93@vnn.vn; hiraken@nagasaki-u.ac.jp	Huy, Nguyen Tien/B-2573-2010; Hirayama, Kenji/AAN-7065-2021	Huy, Nguyen Tien/0000-0002-9543-9440; Hirayama, Kenji/0000-0001-9467-1777	Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan) [17301870]; Nagasaki University; Global COE Program; Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)	Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagasaki University; Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases (J-GRID)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Young Scientists (17301870, 2008-2010 for NTH) from Ministry of Education, Culture, Sports, Science and Technology (MEXT, Japan), and was supported in part by a Grant-in-Aid for Scientific Research from Nagasaki University to NTH (2007-2009). This study was also supported in part by Global COE Program (2008-2012) and Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) for KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguero G, 2010, ARCH ARGENT PEDIATR, V108, P40, DOI 10.1590/S0325-00752010000100008; Anh DD, 2006, AM J TROP MED HYG, V74, P509, DOI 10.4269/ajtmh.2006.74.509; Bonsu BK, 2008, ACAD EMERG MED, V15, P437, DOI 10.1111/j.1553-2712.2008.00099.x; Bonsu BK, 2004, PEDIATR INFECT DIS J, V23, P511, DOI 10.1097/01.inf.0000129689.58211.9e; Bonsu BK, 2006, PEDIATR INFECT DIS J, V25, P8, DOI 10.1097/01.inf.0000195624.34981.36; Boulanger C, 2009, P EUR SOC PAED INF D; Brivet FG, 2005, INTENS CARE MED, V31, P1654, DOI 10.1007/s00134-005-2811-1; Chavanet P, 2007, J INFECTION, V54, P328, DOI 10.1016/j.jinf.2006.06.009; Cunha BA, 2006, INTENS CARE MED, V32, P1272, DOI 10.1007/s00134-006-0210-x; De Cauwer HG, 2007, EUR J EMERG MED, V14, P343, DOI 10.1097/MEJ.0b013e328270366b; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doolittle Benjamin R, 2009, Hosp Pract (1995), V37, P93, DOI 10.3810/hp.2009.12.259; Dubos F, 2006, ARCH DIS CHILD, V91, P647, DOI 10.1136/adc.2005.085704; Dubos F, 2007, ARCH PEDIATRIE, V14, P434, DOI 10.1016/j.arcped.2006.12.009; Dubos F, 2008, ARCH PEDIAT ADOL MED, V162, P1157, DOI 10.1001/archpedi.162.12.1157; Dubos F, 2008, J PEDIATR-US, V152, P378, DOI 10.1016/j.jpeds.2007.07.012; Dubos F, 2006, J PEDIATR-US, V149, P72, DOI 10.1016/j.jpeds.2006.02.034; Freedman SB, 2001, ARCH PEDIAT ADOL MED, V155, P1301, DOI 10.1001/archpedi.155.12.1301; Gerdes LU, 1998, SCAND J CLIN LAB INV, V58, P383, DOI 10.1080/00365519850186364; Greenlee J E, 1990, Infect Dis Clin North Am, V4, P583; Haruda FD, 2003, PEDIATRICS, V112, P447, DOI 10.1542/peds.112.2.447; HOEN B, 1995, EUR J CLIN MICROBIOL, V14, P267, DOI 10.1007/BF02116518; Huy NT, 2010, CRIT CARE, V14, DOI 10.1186/cc9268; Jaeger F, 2000, EUR J CLIN MICROBIOL, V19, P418, DOI 10.1007/s100960000292; Jones CM, 2005, ANN THORAC SURG, V79, P16, DOI 10.1016/j.athoracsur.2004.09.040; Lussiana C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025706; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Nigrovic LE, 2002, PEDIATRICS, V110, P712, DOI 10.1542/peds.110.4.712; Nigrovic LE, 2007, JAMA-J AM MED ASSOC, V297, P52, DOI 10.1001/jama.297.1.52; Oostenbrink R, 2004, EUR J EPIDEMIOL, V19, P109, DOI 10.1023/B:EJEP.0000017828.13995.76; Oostenbrink R, 2004, PEDIATR INFECT DIS J, V23, P1070, DOI 10.1097/01.inf.0000143501.15066.db; Parasuraman TV, 2001, PHARMACOECONOMICS, V19, P3, DOI 10.2165/00019053-200119010-00001; Pierart J, 2006, Rev Med Liege, V61, P581; Prasad K, 2011, CRIT CARE, V15, DOI 10.1186/cc9396; Rais G, 2002, CLIN CHEM, V48, P591; Raymond J, 2000, PATHOL BIOL, V48, P879; Saez-Llorens X, 2003, LANCET, V361, P2139, DOI 10.1016/S0140-6736(03)13693-8; Saez-Llorens X, 1990, Infect Dis Clin North Am, V4, P623; Sakushima K, 2011, J INFECT; Schmidt H, 2006, BRAIN, V129, P333, DOI 10.1093/brain/awh711; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; THOME J, 1980, PEDIATRIE, V35, P225; Tokuda Y, 2009, INTERNAL MED, V48, P537, DOI 10.2169/internalmedicine.48.1832; Toll DB, 2008, J CLIN EPIDEMIOL, V61, P1085, DOI 10.1016/j.jclinepi.2008.04.008; Torres OL, 2011, REV MED ELECTRON, V33, P293; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609; Zimmerli W, 2005, INTENS CARE MED, V31, P1608, DOI 10.1007/s00134-005-2810-2	47	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50341	10.1371/journal.pone.0050341	http://dx.doi.org/10.1371/journal.pone.0050341			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209715	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700061
J	Scerri, TS; Darki, F; Newbury, DF; Whitehouse, AJO; Peyrard-Janvid, M; Matsson, H; Ang, QW; Pennell, CE; Ring, S; Stein, J; Morris, AP; Monaco, AP; Kere, J; Talcott, JB; Klingberg, T; Paracchini, S				Scerri, Thomas S.; Darki, Fahimeh; Newbury, Dianne F.; Whitehouse, Andrew J. O.; Peyrard-Janvid, Myriam; Matsson, Hans; Ang, Qi W.; Pennell, Craig E.; Ring, Susan; Stein, John; Morris, Andrew P.; Monaco, Anthony P.; Kere, Juha; Talcott, Joel B.; Klingberg, Torkel; Paracchini, Silvia			The Dyslexia Candidate Locus on 2p12 Is Associated with General Cognitive Ability and White Matter Structure	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN INTELLIGENCE; WORKING-MEMORY; LANGUAGE; CHILDREN; SPEECH; GENETICS; MICROSTRUCTURE; ARCHITECTURE; POPULATION	Independent studies have shown that candidate genes for dyslexia and specific language impairment (SLI) impact upon reading/language-specific traits in the general population. To further explore the effect of disorder-associated genes on cognitive functions, we investigated whether they play a role in broader cognitive traits. We tested a panel of dyslexia and SLI genetic risk factors for association with two measures of general cognitive abilities, or IQ, (verbal and non-verbal) in the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort (N>5,000). Only the MRPL19/C2ORF3 locus showed statistically significant association (minimum P = 0.00009) which was further supported by independent replications following analysis in four other cohorts. In addition, a fifth independent sample showed association between the MRPL19/C2ORF3 locus and white matter structure in the posterior part of the corpus callosum and cingulum, connecting large parts of the cortex in the parietal, occipital and temporal lobes. These findings suggest that this locus, originally identified as being associated with dyslexia, is likely to harbour genetic variants associated with general cognitive abilities by influencing white matter structure in localised neuronal regions.	[Scerri, Thomas S.; Newbury, Dianne F.; Morris, Andrew P.; Monaco, Anthony P.; Paracchini, Silvia] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Darki, Fahimeh; Klingberg, Torkel] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Whitehouse, Andrew J. O.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, Australia; [Peyrard-Janvid, Myriam; Matsson, Hans; Kere, Juha] Karolinska Inst, Dept Biosci & Nutr, Novum, Stockholm, Sweden; [Ang, Qi W.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Crawley, Australia; [Ring, Susan] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Stein, John] Univ Oxford, Dept Physiol, Oxford, England; [Kere, Juha] Univ Helsinki, Mol Med Res Programme, Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Kere, Juha] Karolinska Inst, Sci Life Lab, Stockholm, Sweden; [Talcott, Joel B.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Paracchini, Silvia] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland	University of Oxford; Wellcome Centre for Human Genetics; Karolinska Institutet; Telethon Kids Institute; University of Western Australia; Karolinska Institutet; University of Western Australia; University of Bristol; University of Oxford; University of Helsinki; Karolinska Institutet; Aston University; University of St Andrews	Paracchini, S (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	sp58@st-andrews.ac.uk	Pennell, Craig/ABD-6902-2020; Matsson, Hans/A-2502-2013; Monaco, Anthony P/A-4495-2010; Kere, Juha/A-9179-2008; Whitehouse, Andrew J.O./AGJ-2519-2022; Study, Raine/G-9547-2015; Paracchini, Silvia/AAU-6813-2021; Study, Raine/K-4517-2013; Matsson, Hans/A-5787-2019; Kere, Juha/AAX-9117-2021	Pennell, Craig/0000-0002-0937-6165; Matsson, Hans/0000-0002-8193-4029; Monaco, Anthony P/0000-0001-7480-3197; Kere, Juha/0000-0003-1974-0271; Whitehouse, Andrew J.O./0000-0001-8722-1575; Paracchini, Silvia/0000-0001-9934-8602; Matsson, Hans/0000-0001-6161-1559; Kere, Juha/0000-0003-1974-0271; Darki, Fahimeh/0000-0002-4739-5180; Klingberg, Torkel/0000-0002-3175-2171	UK Medical Research Council [G0800523/86473, 74882]; Wellcome Trust [075491/Z/04, 090532/Z/09/Z, 076467]; University of Bristol; National Health and Medical Research Council (NHMRC); UWA Faculty of Medicine, Dentistry and Health Sciences; Raine Medical Research Foundation; Telethon Institute for Child Health Research; Women and Infants Research Foundation; Knut and Alice Wallenberg Foundation; Swedish Royal Bank Tercentennial Foundation [KAW 2005.0179, 2010.0105, K2010-61X-21441-01-3, PDOKJ028/2006:12]; National Health Service (NHS) Anglia & Oxford Regional R&D Strategic Investment Award; NHS Eastern Region R&D Training Fellowship Award; University of Western Australia (UWA); Curtin University; Swedish Research Council; British Telecom; Isaac Newton Trust; Medical Research Council [G9815508, G1000569] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); UWA Faculty of Medicine, Dentistry and Health Sciences; Raine Medical Research Foundation; Telethon Institute for Child Health Research; Women and Infants Research Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Royal Bank Tercentennial Foundation; National Health Service (NHS) Anglia & Oxford Regional R&D Strategic Investment Award; NHS Eastern Region R&D Training Fellowship Award; University of Western Australia (UWA); Curtin University; Swedish Research Council(Swedish Research CouncilEuropean Commission); British Telecom; Isaac Newton Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council (G0800523/86473 to SP) and was supported by a Wellcome Trust core grant (075491/Z/04, 090532/Z/09/Z). The UK Medical Research Council (74882) the Wellcome Trust (076467) and the University of Bristol provided core support for ALSPAC. The RAINE study is supported by the National Health and Medical Research Council (NHMRC) the University of Western Australia (UWA), the UWA Faculty of Medicine, Dentistry and Health Sciences, the Raine Medical Research Foundation, Curtin University, the Telethon Institute for Child Health Research, and the Women and Infants Research Foundation. The imaging study was supported by Knut and Alice Wallenberg Foundation, The Swedish Research Council and a Swedish Royal Bank Tercentennial Foundation grant in the program "Learning and Memory in Children and Young Adults" (KAW 2005.0179, 2010.0105, K2010-61X-21441-01-3 and PDOKJ028/2006:12 to TK and JK). All laboratory work and the collection of Guy's and Manchester's families of the SLIC collection were funded by The Wellcome Trust. The collection of families from Cambridge (CLASP) was funded by The Wellcome Trust, British Telecom, The Isaac Newton Trust, a National Health Service (NHS) Anglia & Oxford Regional R&D Strategic Investment Award, and an NHS Eastern Region R&D Training Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Anthoni H, 2007, HUM MOL GENET, V16, P667, DOI 10.1093/hmg/ddm009; Bates TC, 2011, BEHAV GENET, V41, P50, DOI 10.1007/s10519-010-9402-9; BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071; Burden V, 1996, DEV MED CHILD NEUROL, V38, P613; Chabris CF, 2012, PSYCHOL SCI IN PRESS; Chiang MC, 2009, J NEUROSCI, V29, P2212, DOI 10.1523/JNEUROSCI.4184-08.2009; Clark A, 2007, ARCH DIS CHILD, V92, P614, DOI 10.1136/adc.2006.101758; Conti-Ramsden G, 1999, INT J LANG COMM DIS, V34, P359; ContiRamsden G, 1997, J SPEECH LANG HEAR R, V40, P765, DOI 10.1044/jslhr.4004.765; Darki F, 2012, BIOL PSYCHIAT; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Deary IJ, 2006, NEUROLOGY, V66, P505, DOI 10.1212/01.wnl.0000199954.81900.e2; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Dumontheil I, 2011, BIOL PSYCHIAT, V70, P222, DOI 10.1016/j.biopsych.2011.02.027; Dunn L.M., 2007, PEABODY PICTURE VOCA; Elliot C.D., 1983, BRIT ABILITIES SCALE; Falcaro M, 2008, GENES BRAIN BEHAV, V7, P393, DOI 10.1111/j.1601-183X.2007.00364.x; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Frye RE, 2008, NEUROREPORT, V19, P1627, DOI 10.1097/WNR.0b013e328314b8ee; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hasan KM, 2012, NMR BIOMED; Haworth CMA, 2009, BEHAV GENET, V39, P437, DOI 10.1007/s10519-009-9271-2; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Luders E, 2011, NEUROIMAGE, V54, P1823, DOI 10.1016/j.neuroimage.2010.09.083; McArthur GM, 2000, J CHILD PSYCHOL PSYC, V41, P869, DOI 10.1111/1469-7610.00674; Melville SA, 2012, ANN NEUROL, V72, P65, DOI 10.1002/ana.23644; Newbury DF, 2011, BEHAV GENET, V41, P90, DOI 10.1007/s10519-010-9424-3; Newbury DF, 2010, NEURON, V68, P309, DOI 10.1016/j.neuron.2010.10.001; Newbury DF, 2004, AM J HUM GENET, V74, P1225, DOI 10.1086/421529; Newbury DF, 2002, AM J HUM GENET, V70, P384; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Odegard TN, 2009, NEUROPSYCHOLOGIA, V47, P1972, DOI 10.1016/j.neuropsychologia.2009.03.009; Pan Y, 2011, PROG NEURO-PSYCHOPH, V35, P154, DOI 10.1016/j.pnpbp.2010.10.016; Paracchini S, 2011, GENES BRAIN BEHAV, V10, P158, DOI 10.1111/j.1601-183X.2010.00651.x; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; Pinel P, 2012, J NEUROSCI, V32, P817, DOI 10.1523/JNEUROSCI.5996-10.2012; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Plomin R, 1999, NATURE, V402, pC25, DOI 10.1038/35011520; Plomin R, 2002, TRENDS COGN SCI, V6, P169, DOI 10.1016/S1364-6613(00)01853-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raven JC, 1976, RAVNES COLOURED PROG; Rice ML, 2009, J NEURODEV DISORD, V1, P264, DOI 10.1007/s11689-009-9031-x; Richlan F, 2011, NEUROIMAGE, V56, P1735, DOI 10.1016/j.neuroimage.2011.02.040; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Rust J, 1993, WORD WECHSLER OBJECT; Scerri TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013712; Scerri TS, 2010, EUR CHILD ADOLES PSY, V19, P179, DOI 10.1007/s00787-009-0081-0; Scerri TS, 2011, BIOL PSYCHIAT, V70, P237, DOI 10.1016/j.biopsych.2011.02.005; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Snowling M, 2000, J CHILD PSYCHOL PSYC, V41, P587, DOI 10.1111/1469-7610.00651; Soderqvist S, 2010, BIOL PSYCHIAT, V68, P1120, DOI 10.1016/j.biopsych.2010.07.036; Stein JL, 2012, NAT GENET; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; Wechsler D, 1992, WISC 3UK WECHSLER IN; Whitehouse AJ, 2011, GENES BRAIN BEHAV	64	33	34	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50321	10.1371/journal.pone.0050321	http://dx.doi.org/10.1371/journal.pone.0050321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209710	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000312601700058
J	Dutel, H; Maisey, JG; Schwimmer, DR; Janvier, P; Herbin, M; Clement, G				Dutel, Hugo; Maisey, John G.; Schwimmer, David R.; Janvier, Philippe; Herbin, Marc; Clement, Gael			The Giant Cretaceous Coelacanth (Actinistia, Sarcopterygii) Megalocoelacanthus dobiei Schwimmer, Stewart & Williams, 1994, and Its Bearing on Latimerioidei Interrelationships	PLOS ONE			English	Article							FOSSIL COELACANTH; DEFINITIONS; CHALUMNAE; TAXONOMY; NOV	We present a redescription of Megalocoelacanthus dobiei, a giant fossil coelacanth from Upper Cretaceous strata of North America. Megalocoelacanthus has been previously described on the basis of composite material that consisted of isolated elements. Consequently, many aspects of its anatomy have remained unknown as well as its phylogenetic relationships with other coelacanths. Previous studies have suggested that Megalocoelacanthus is closer to Latimeria and Macropoma than to Mawsonia. However, this assumption was based only on the overall similarity of few anatomical features, rather than on a phylogenetic character analysis. A new, and outstandingly preserved specimen from the Niobrara Formation in Kansas allows the detailed description of the skull of Megalocoelacanthus and elucidation of its phylogenetic relationships with other coelacanths. Although strongly flattened, the skull and jaws are well preserved and show many derived features that are shared with Latimeriidae such as Latimeria, Macropoma and Libys. Notably, the parietonasal shield is narrow and flanked by very large, continuous vacuities forming the supraorbital sensory line canal. Such an unusual morphology is also known in Libys. Some other features of Megalocoelacanthus, such as its large size and the absence of teeth are shared with the mawsoniid genera Mawsonia and Axelrodichthys. Our cladistic analysis supports the sister-group relationship of Megalocoelacanthus and Libys within Latimeriidae. This topology suggests that toothless, large-sized coelacanths evolved independently in both Latimeriidae and Mawsoniidae during the Mesozoic. Based on previous topologies and on ours, we then review the high-level taxonomy of Latimerioidei and propose new systematic phylogenetic definitions.	[Dutel, Hugo; Janvier, Philippe] Museum Natl Hist Nat, Ctr Rech Paleobiodiversite & Palecoenvironm CR2P, Dept Hist Terre, UMR CNRS MNHN 7207, F-75231 Paris, France; [Dutel, Hugo; Herbin, Marc] Museum Natl Hist Nat, UMR CNRS MNHN 7179, Dept Ecol & Gest Biodiversite, F-75231 Paris, France; [Maisey, John G.; Clement, Gael] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Schwimmer, David R.] Columbus State Univ, Dept Earth & Space Sci, Columbus, GA USA	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); American Museum of Natural History (AMNH); University System of Georgia; Columbus State University	Dutel, H (corresponding author), Museum Natl Hist Nat, Ctr Rech Paleobiodiversite & Palecoenvironm CR2P, Dept Hist Terre, UMR CNRS MNHN 7207, F-75231 Paris, France.	dutel@mnhn.fr	Dutel, Hugo/D-1474-2014; Janvier, Philippe/Q-5268-2019	Dutel, Hugo/0000-0002-1908-5150	American Museum of Natural History (AMNH) Axelrod Fund; French Agence Nationale de la Recherche under the TERRES Project [ANR-2010-BLAN-607-03]	American Museum of Natural History (AMNH) Axelrod Fund; French Agence Nationale de la Recherche under the TERRES Project(French National Research Agency (ANR))	GC and DS were supported by the American Museum of Natural History (AMNH) Axelrod Fund for his visit in the AMNH fossil fish collection to work on the herein described material. This work was partly supported by the French Agence Nationale de la Recherche under the TERRES Project (ANR-2010-BLAN-607-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agassiz L., 1844, RECHERCHES POISSONS; Anthony J., 1965, ANATOMIE LATIMERIA C; Berg L.S., 1940, TRAVAUX I ZOOLOGIQUE, V5, P1; Brito PM, 2010, PALAEONTOLOGY, V53, P1281, DOI 10.1111/j.1475-4983.2010.01015.x; Cavin L., 2004, MESOZOIC FISHES, P493; Clement G, 2006, J VERTEBR PALEONTOL, V26, P461, DOI 10.1671/0272-4634(2006)26[461:SNNARN]2.0.CO;2; Clement G, 1999, J VERTEBR PALEONTOL, V19, P234, DOI 10.1080/02724634.1999.10011137; Clement G, 2005, J VERTEBR PALEONTOL, V25, P481, DOI 10.1671/0272-4634(2005)025[0481:ANCASF]2.0.CO;2; CLOUTIER R, 1991, ENVIRON BIOL FISH, V32, P23, DOI 10.1007/BF00007444; Cloutier Richard, 1996, P227; Cope E.D, 1871, T AM PHILOS SOC, V14, P445, DOI [10.2307/1005256, DOI 10.2307/1005256]; De Carvalho MSS, 2008, GEOL SOC SPEC PUBL, V295, P109, DOI 10.1144/SP295.8; DEQUEIROZ K, 1990, SYST ZOOL, V39, P307, DOI 10.2307/2992353; DEQUEIROZ K, 1992, ANNU REV ECOL SYST, V23, P449, DOI 10.1146/annurev.ecolsys.23.1.449; DEQUEIROZ K, 1994, TRENDS ECOL EVOL, V9, P27, DOI 10.1016/0169-5347(94)90231-3; Forey P.L., 1998, HIST COELACANTH FISH; FOREY PL, 1991, ENVIRON BIOL FISH, V32, P75, DOI 10.1007/BF00007446; Franzosa EA, 2007, TREEROT VERSION 3; Friedman M, 2006, P ROY SOC B-BIOL SCI, V273, P245, DOI 10.1098/rspb.2005.3316; Friedman M, 2007, J SYST PALAEONTOL, V5, P289, DOI 10.1017/S1477201907002052; Gallo Valeria, 2010, Boletim do Museu Paraense Emilio Goeldi Ciencias Naturais, V5, P195; GHISELIN MT, 1984, SYST ZOOL, V33, P104, DOI 10.2307/2413135; HENNIG E., 1951, NEUES JAHRB F GEOL U PALSONTOL ABHANDL, V94, P67; HENSEL K, 1986, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V8, P379; Hensel K, 2001, ENVIRON BIOL FISH, V61, P117, DOI 10.1023/A:1011062609192; Huxley TH., 1880, P R SOC LOND, V43, P649, DOI DOI 10.1111/J.1469-7998.1869.TB07343.X; *ICZN, 1999, INT COD ZOOL NOM; JAIN SL, 1974, J PALEONTOL, V48, P49; Jin F., 2009, VERT PALAS, V47, P311; Lambers P.H., 1992, THESIS RIJKSUUNIVERS; Lund R., 1985, Bulletin of Carnegie Museum of Natural History, P1; LUND R, 1984, GEOBIOS-LYON, V17, P237, DOI 10.1016/S0016-6995(84)80145-X; Maddison WP, 2017, MESQUITE MODULAR SYS; Maisey J.G., 1986, American Museum Novitates, P1; Maisey J.G., 1991, SANTANA FOSSILS ILLU, P317; Medeiros MA, 2011, PALEONTOLOGIA CENARI, P575; Millot J., 1958, ANATOMIE LATIMERIA C; Nelson G.J., 1969, B AM MUS NAT HIST, V141, P475; Nixon K.C., 2002, WINCLADA VERSION 1 0; RIEPPEL O, 1980, Eclogae Geologicae Helvetiae, V73, P921; ROMER AS, 1955, NATURE, V176, P126, DOI 10.1038/176126a0; ROWE T, 1987, SYST ZOOL, V36, P208, DOI 10.2307/2413270; Schaeffer B., 1952, B AM MUS NAT HIST, V99, P29; SCHAEFFER BOBB, 1961, AMER MUS NOVITATES, V2036, P1; Schultze H.-P., 1993, P657; Schultze HP, 2010, PALAEONTOLOGY, V53, P689, DOI 10.1111/j.1475-4983.2010.00943.x; Schwimmer D, 2006, J VERTEBR PALEONTOL, V26, p122A; SCHWIMMER DR, 1994, GEOLOGY, V22, P503, DOI 10.1130/0091-7613(1994)022<0503:GFCOTL>2.3.CO;2; Schwimmer DR, 2009, GEOL SOC AM SE M, V41, P6; Sereno P.C., 1998, NEUES JB GEOLOGIE PA, V210, P41, DOI DOI 10.1127/NJGPA/210/1998/41; Sereno PC, 1999, SYST BIOL, V48, P329, DOI 10.1080/106351599260328; Sereno PC, 2005, SYST BIOL, V54, P595, DOI 10.1080/106351591007453; Soto M, 2012, J VERTEBR PALEONTOL, V32, P350; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Wendruff AJ, 2012, J VERTEBR PALEONTOL, V32, P499, DOI 10.1080/02724634.2012.657317; Wenz S., 1981, Annales de Paleontologie Vertebres, V67, P1; Wenz S, 1980, MEMOIRE SOC GEOLOGIQ, V139, P187; Yabumoto Y, 2008, PALEONTOL RES, V12, P329, DOI 10.2517/prpsj.12.329; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871	59	44	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49911	10.1371/journal.pone.0049911	http://dx.doi.org/10.1371/journal.pone.0049911			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209614	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885800030
J	Larsson, HM; Lee, ST; Roccio, M; Velluto, D; Lutolf, MP; Frey, P; Hubbell, JA				Larsson, Hans M.; Lee, Seung Tae; Roccio, Marta; Velluto, Diana; Lutolf, Matthias P.; Frey, Peter; Hubbell, Jeffrey A.			Sorting Live Stem Cells Based on Sox2 mRNA Expression	PLOS ONE			English	Article							MOLECULAR BEACONS; HYBRIDIZATION; PLURIPOTENCY; PREDICTION	While cell sorting usually relies on cell-surface protein markers, molecular beacons (MBs) offer the potential to sort cells based on the presence of any expressed mRNA and in principle could be extremely useful to sort rare cell populations from primary isolates. We show here how stem cells can be purified from mixed cell populations by sorting based on MBs. Specifically, we designed molecular beacons targeting Sox2, a well-known stem cell marker for murine embryonic (mES) and neural stem cells (NSC). One of our designed molecular beacons displayed an increase in fluorescence compared to a nonspecific molecular beacon both in vitro and in vivo when tested in mES and NSCs. We sorted Sox2-MB(+)SSEA1(+) cells from a mixed population of 4-day retinoic acid-treated mES cells and effectively isolated live undifferentiated stem cells. Additionally, Sox2-MB+ cells isolated from primary mouse brains were sorted and generated neurospheres with higher efficiency than Sox2-MB- cells. These results demonstrate the utility of MBs for stem cell sorting in an mRNA-specific manner.	[Larsson, Hans M.; Lee, Seung Tae; Velluto, Diana; Frey, Peter; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Regenerat Med & Pharmacobiol, Lausanne, Switzerland; [Larsson, Hans M.; Lee, Seung Tae; Velluto, Diana; Frey, Peter; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland; [Lee, Seung Tae] Kangwon Natl Univ, Dept Anim Biotechnol, Lab Stem Cell Biomodulat, Chunchon, South Korea; [Roccio, Marta; Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Stem Cell Bioengn, Lausanne, Switzerland; [Velluto, Diana] Univ London, Sch Biol & Chem Sci, London, England; [Frey, Peter] CHU Vaudois, Dept Pediat Urol, Lab Expt Pediat Urol, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Kangwon National University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lab Regenerat Med & Pharmacobiol, Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch	Lutolf, Matthias P/E-5914-2010; Hubbell, Jeffrey A/A-9266-2008	Hubbell, Jeffrey A/0000-0003-0276-5456; Roccio, Marta/0000-0001-7568-9429; Lee, Seung Tae/0000-0002-8952-3881	European Framework Program 6 EuroSTEC [LSHB-CT-2006-037409]	European Framework Program 6 EuroSTEC	This work was funded by a European Framework Program 6 EuroSTEC (Soft tissue engineering for congenital birth defects in children; reference: LSHB-CT-2006-037409, URL: http://ec.europa.eu/research/fp6/index_en.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Giachino Claudio, 2009, V482, P143, DOI 10.1007/978-1-59745-060-7_9; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; King FW, 2011, STEM CELLS DEV, V20, P475, DOI 10.1089/scd.2010.0219; Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Nitin N, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh063; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Rhee WJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-30; Rhee WJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn039; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Velluto D, 2011, BIOMATERIALS, V32, P9839, DOI 10.1016/j.biomaterials.2011.08.079; Viswanathan S, 2003, BIOTECHNOL BIOENG, V84, P505, DOI 10.1002/bit.10799; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	19	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49874	10.1371/journal.pone.0049874	http://dx.doi.org/10.1371/journal.pone.0049874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209609	gold, Green Published			2022-12-25	WOS:000311885800027
J	Lin, HY; Yeh, WL; Huang, BR; Lin, CJ; Lai, CH; Lin, H; Lu, DY				Lin, Hsiao-Yun; Yeh, Wei-Lan; Huang, Bor-Ren; Lin, Chingju; Lai, Chih-Ho; Lin, Ho; Lu, Dah-Yuu			Desipramine Protects Neuronal Cell Death and Induces Heme Oxygenase-1 Expression in Mes23.5 Dopaminergic Neurons	PLOS ONE			English	Article							SUPPRESSES NEUROINFLAMMATORY RESPONSES; PARKINSONS-DISEASE; OXIDATIVE STRESS; SIGNALING PATHWAY; UP-REGULATION; ENDOTHELIAL-CELLS; ANXIETY DISORDERS; MAJOR DEPRESSION; PROMISING TARGET; BV-2 MICROGLIA	Background: Desipramine is known principally as a tricyclic antidepressant drug used to promote recovery of depressed patients. It has also been used in a number of other psychiatric and medical conditions. The present study is the first to investigate the neuroprotective effect of desipramine. Methodology/Principal Findings: Mes23.5 dopaminergic cells were used to examine neuroprotective effect of desipramine. Western blot, reverse transcription-PCR, MTT assay, siRNA transfection and electrophoretic mobility shift assay (EMSA) were carried out to assess the effects of desipramine. Desipramine induces endogenous anti-oxidative enzyme, heme oxygenase-1 (HO-1) protein and mRNA expression in concentration-and time-dependent manners. A different type of antidepressant SSRI (selective serotonin reuptake inhibitor), fluoxetine also shows similar effects of desipramine on HO-1 expression. Moreover, desipramine induces HO-1 expression through activation of ERK and JNK signaling pathways. Desipramine also increases NF-E2-related factor-2 (Nrf2) accumulation in the nucleus and enhances Nrf2-DNA binding activity. Moreover, desipramine-mediated increase of HO-1 expression is reduced by transfection with siRNA against Nrf2. On the other hand, pretreatment of desipramine protects neuronal cells against rotenone-and 6-hydroxydopamine (6-OHDA)-induced neuronal death. Furthermore, inhibition of HO-1 activity by a HO-1 pharmacological inhibitor, ZnPP IX, attenuates the neuroprotective effect of desipramine. Otherwise, activation of HO-1 activity by HO-1 activator and inducer protect 6-OHDA-induced neuronal death. Conclusions/Significance: These findings suggest that desipramine-increased HO-1 expression is mediated by Nrf2 activation through the ERK and JNK signaling pathways. Our results also suggest that desipramine provides a novel effect of neuroprotection, and neurodegenerative process might play an important role in depression disorder.	[Lin, Hsiao-Yun; Lin, Ho] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Yeh, Wei-Lan] Changhua Christian Hosp, Dept Med Res, Canc Res Ctr, Changhua, Taiwan; [Huang, Bor-Ren] Buddhist Tzu Chi Gen Hosp, Taichung Branch, Dept Neurosurg, Taichung, Taiwan; [Lin, Chingju] China Med Univ, Sch Med, Dept Physiol, Taichung, Taiwan; [Lai, Chih-Ho] China Med Univ, Sch Med, Dept Microbiol, Taichung, Taiwan; [Lu, Dah-Yuu] China Med Univ, Grad Inst Neural & Cognit Sci, Taichung, Taiwan	National Chung Hsing University; Changhua Christian Hospital; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Lin, H (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	hlin@dragon.nchu.edu.tw; dahyuu@mail.cmu.edu.tw	Lai, Chih-Ho/M-2433-2013; Lu, Dah-Yuu/P-2563-2015	Lai, Chih-Ho/0000-0001-9229-818X; Lin, Ho/0000-0001-7849-9137	National Science Council [NSC 101-2320-B-039-048-MY2]; Taichung Tzu Chi General Hospital [TTCRD 101-03]	National Science Council(Ministry of Science and Technology, Taiwan); Taichung Tzu Chi General Hospital	This work was supported by grants from the National Science Council (NSC 101-2320-B-039-048-MY2), and Taichung Tzu Chi General Hospital (TTCRD 101-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alexopoulos GS, 1999, ARCH GEN PSYCHIAT, V56, P1048, DOI 10.1001/archpsyc.56.11.1048; Antkiewicz-Michaluk L, 2004, INT J NEUROPSYCHOPH, V7, P155, DOI 10.1017/S1461145703004036; Appleby BS, 2007, MOVEMENT DISORD, V22, P1722, DOI 10.1002/mds.21551; Barone MC, 2011, DIS MODEL MECH, V4, P701, DOI 10.1242/dmm.007575; Behr GA, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/609421; Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003; Boyce-Rustay JM, 2008, NEUROPHARMACOLOGY, V55, P803, DOI 10.1016/j.neuropharm.2008.06.032; Bravo JA, 2009, BEHAV PHARMACOL, V20, P273, DOI 10.1097/FBP.0b013e32832c70d9; Chen G, 2006, CURR OPIN PSYCHIATR, V19, P313, DOI 10.1097/01.yco.0000218604.63463.cd; Chen JH, 2012, INT IMMUNOPHARMACOL, V12, P94, DOI 10.1016/j.intimp.2011.10.019; Chen Z, 2005, NEUROSCI LETT, V389, P173, DOI 10.1016/j.neulet.2005.07.040; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; CHOPRA VS, 1995, MOL BRAIN RES, V31, P173, DOI 10.1016/0169-328X(95)00049-X; CRAWFORD GD, 1992, J NEUROSCI, V12, P3392; CUMMINGS JL, 1992, AM J PSYCHIAT, V149, P443; D'Amelio M, 2009, ANN NY ACAD SCI, V1155, P324, DOI 10.1111/j.1749-6632.2008.03681.x; De Backer O, 2009, GUT, V58, P347, DOI 10.1136/gut.2008.155481; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Dwivedi Y, 2001, J NEUROCHEM, V77, P916, DOI 10.1046/j.1471-4159.2001.00300.x; Dwivedi Y, 2009, INT J NEUROPSYCHOPH, V12, P1337, DOI 10.1017/S1461145709990575; Ewing JF, 2006, J NEURAL TRANSM, V113, P439, DOI 10.1007/s00702-005-0408-z; Feng PF, 2003, BRAIN RES, V991, P195, DOI 10.1016/j.brainres.2003.08.018; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Ghattas MH, 2002, INT J BIOCHEM CELL B, V34, P1619, DOI 10.1016/S1357-2725(02)00097-3; Guzman-Beltran S, 2008, NEUROSCI LETT, V447, P167, DOI 10.1016/j.neulet.2008.09.079; HESSELINK JMK, 1993, NEUROLOGY, V43, P1624, DOI 10.1212/WNL.43.8.1624-a; Hseu YC, 2012, FOOD CHEM TOXICOL, V50, P1245, DOI 10.1016/j.fct.2012.02.020; Hsu JT, 2008, AM J PHYSIOL-REG I, V294, pR1825, DOI 10.1152/ajpregu.00112.2008; Huang JY, 2010, FREE RADICAL BIO MED, V49, P1099, DOI 10.1016/j.freeradbiomed.2010.06.026; Huang YN, 2009, TOXICOL APPL PHARM, V240, P315, DOI 10.1016/j.taap.2009.06.021; Hurtado-Lorenzo A, 2004, MOL THER, V10, P507, DOI 10.1016/j.ymthe.2004.05.021; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Larsson B, 2002, LAKARTIDNINGEN, V99, P1810; Le W, 1999, J NEUROSCI RES, V56, P652; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lee YM, 2011, J ETHNOPHARMACOL, V135, P179, DOI 10.1016/j.jep.2011.03.009; Leentjens AFG, 2003, MOVEMENT DISORD, V18, P414, DOI 10.1002/mds.10387; LESTER D, 1992, PSYCHOL REP, V70, P1106, DOI 10.2466/PR0.70.4.1106-1106; Levkovitz Y, 2002, BRAIN RES BULL, V58, P345, DOI 10.1016/S0361-9230(01)00780-8; Li L, 2000, INHAL TOXICOL, V12, P1225; Li-ying Zhan, 2007, Chin J Traumatol, V10, P269; Lin HY, 2011, J CELL PHYSIOL, V226, P1573, DOI 10.1002/jcp.22489; Livingston G, 1997, J AFFECT DISORDERS, V46, P255, DOI 10.1016/S0165-0327(97)00155-9; Lu DY, 2010, NEUROPSYCHOPHARMACOL, V35, P2238, DOI 10.1038/npp.2010.98; Lu DY, 2010, J CELL BIOCHEM, V110, P697, DOI 10.1002/jcb.22580; Maes Michael, 2012, Inflammopharmacology, V20, P127, DOI 10.1007/s10787-011-0111-7; MAINES MD, 1993, MOL CELL NEUROSCI, V4, P398, DOI 10.1006/mcne.1993.1050; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; Minelli A, 2009, J NEUROCHEM, V111, P956, DOI 10.1111/j.1471-4159.2009.06376.x; O'Brien ES, 2011, NEUROPSYCHOPHARMACOL, V36, P1518, DOI 10.1038/npp.2011.37; Oh GS, 2004, BIOCHEM BIOPH RES CO, V320, P1156, DOI 10.1016/j.bbrc.2004.06.061; Palhagen SE, 2009, J NEUROL, V256, P1510, DOI 10.1007/s00415-009-5155-x; Parfenova H, 2006, AM J PHYSIOL-CELL PH, V290, pC1399, DOI 10.1152/ajpcell.00386.2005; Perez V, 2009, J NEURAL TRANSM, V116, P1257, DOI 10.1007/s00702-009-0291-0; Quesada A, 2011, J NEUROSCI RES, V89, P394, DOI 10.1002/jnr.22543; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Richard, 2000, Curr Treat Options Neurol, V2, P263, DOI 10.1007/s11940-000-0008-z; Richard Irene Hegeman, 2007, Neuropsychiatr Dis Treat, V3, P903; Roth S, 2010, NEUROSCI LETT, V478, P5, DOI 10.1016/j.neulet.2010.04.055; SACERDOTE P, 1994, GEN PHARMACOL, V25, P409, DOI 10.1016/0306-3623(94)90188-0; Scapagnini G, 2004, ANTIOXID REDOX SIGN, V6, P811, DOI 10.1089/ars.2004.6.811; Scapagnini G, 2011, MOL NEUROBIOL, V44, P192, DOI 10.1007/s12035-011-8181-5; Schipper HM, 1999, NEUROTOX RES, V1, P57, DOI 10.1007/BF03033339; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Shiba M, 2000, MOVEMENT DISORD, V15, P669, DOI 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5; Shin TK, 2009, KOREAN J PHYSIOL PHA, V13, P257, DOI 10.4196/kjpp.2009.13.3.257; Shulman LM, 2002, PARKINSONISM RELAT D, V8, P193, DOI 10.1016/S1353-8020(01)00015-3; STEWART JW, 1980, J AFFECT DISORDERS, V2, P165, DOI 10.1016/0165-0327(80)90003-8; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Tai YH, 2009, ANESTHESIOLOGY, V110, P1379, DOI 10.1097/ALN.0b013e31819fccd5; Takeshita S, 2005, NEUROSURG REV, V28, P179, DOI 10.1007/s10143-005-0387-4; Temel Y, 2006, EXP BRAIN RES, V169, P389, DOI 10.1007/s00221-005-0151-6; Terry CM, 1998, AM J PHYSIOL-HEART C, V274, pH883, DOI 10.1152/ajpheart.1998.274.3.H883; TRAKSHEL GM, 1988, ARCH BIOCHEM BIOPHYS, V260, P732, DOI 10.1016/0003-9861(88)90503-6; Tufekci KU, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/314082; TURKER RK, 1967, EXPERIENTIA, V23, P252, DOI 10.1007/BF02135664; Valjent E, 2004, EUR J NEUROSCI, V19, P1826, DOI 10.1111/j.1460-9568.2004.03278.x; Wille SMR, 2008, CRIT REV CL LAB SCI, V45, P25, DOI [10.1080/10408360701713112, 10.1080/10408360701713112 ]; Xu CJ, 2006, MOL CANCER THER, V5, P1918, DOI 10.1158/1535-7163.MCT-05-0497; Yamamoto N, 2010, J NEUROSCI RES, V88, P1934, DOI 10.1002/jnr.22363; Yuan XL, 2006, MOL CARCINOGEN, V45, P841, DOI 10.1002/mc.20234; Zhang Feng, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS213, DOI 10.1016/S1353-8020(11)70066-9; Zhang YL, 2008, FREE RADICAL RES, V42, P362, DOI 10.1080/10715760801993076	86	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50138	10.1371/journal.pone.0050138	http://dx.doi.org/10.1371/journal.pone.0050138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209658	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885800049
J	Poliakov, E; Gubin, AN; Stearn, O; Li, Y; Campos, MM; Gentleman, S; Rogozin, IB; Redmond, TM				Poliakov, Eugenia; Gubin, Alexander N.; Stearn, Olivia; Li, Yan; Campos, Maria Mercedes; Gentleman, Susan; Rogozin, Igor B.; Redmond, T. Michael			Origin and Evolution of Retinoid Isomerization Machinery in Vertebrate Visual Cycle: Hint from Jawless Vertebrates	PLOS ONE			English	Article							LONG-BRANCH ATTRACTION; SWISS-MODEL; DUPLICATED GENES; RPE65; DIVERGENCE; MUTATIONS; DIVERSITY; ESTERS; EYE; ISOMEROHYDROLASE	In order to maintain visual sensitivity at all light levels, the vertebrate eye possesses a mechanism to regenerate the visual pigment chromophore 11-cis retinal in the dark enzymatically, unlike in all other taxa, which rely on photoisomerization. This mechanism is termed the visual cycle and is localized to the retinal pigment epithelium (RPE), a support layer of the neural retina. Speculation has long revolved around whether more primitive chordates, such as tunicates and cephalochordates, anticipated this feature. The two key enzymes of the visual cycle are RPE65, the visual cycle all-trans retinyl ester isomerohydrolase, and lecithin: retinol acyltransferase (LRAT), which generates RPE65's substrate. We hypothesized that the origin of the vertebrate visual cycle is directly connected to an ancestral carotenoid oxygenase acquiring a new retinyl ester isomerohydrolase function. Our phylogenetic analyses of the RPE65/BCMO and N1pC/P60 (LRAT) superfamilies show that neither RPE65 nor LRAT orthologs occur in tunicates (Ciona) or cephalochordates (Branchiostoma), but occur in Petromyzon marinus (Sea Lamprey), a jawless vertebrate. The closest homologs to RPE65 in Ciona and Branchiostoma lacked predicted functionally diverged residues found in all authentic RPE65s, but lamprey RPE65 contained all of them. We cloned RPE65 and LRATb cDNAs from lamprey RPE and demonstrated appropriate enzymatic activities. We show that Ciona beta-carotene monooxygenase a (BCMOa) (previously annotated as an RPE65) has carotenoid oxygenase cleavage activity but not RPE65 activity. We verified the presence of RPE65 in lamprey RPE by immunofluorescence microscopy, immunoblot and mass spectrometry. On the basis of these data we conclude that the crucial transition from the typical carotenoid double bond cleavage functionality (BCMO) to the isomerohydrolase functionality (RPE65), coupled with the origin of LRAT, occurred subsequent to divergence of the more primitive chordates (tunicates, etc.) in the last common ancestor of the jawless and jawed vertebrates.	[Poliakov, Eugenia; Gubin, Alexander N.; Stearn, Olivia; Li, Yan; Gentleman, Susan; Redmond, T. Michael] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Campos, Maria Mercedes] NEI, Biol Imaging Core, NIH, Bethesda, MD 20892 USA; [Rogozin, Igor B.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Redmond, TM (corresponding author), NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA.	redmondd@helix.nih.gov		Rogozin, Igor/0000-0003-0802-4851; Redmond, T. Michael/0000-0002-1813-5291	National Institutes of Health Intramural Research Program of the National Eye Institute; National Library of Medicine at the National Institutes of Health (US Department Health and Human Services); NATIONAL EYE INSTITUTE [ZIAEY000260] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the National Eye Institute; National Library of Medicine at the National Institutes of Health (US Department Health and Human Services); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the National Institutes of Health Intramural Research Program of the National Eye Institute and the Intramural Research Program of the National Library of Medicine at the National Institutes of Health (US Department Health and Human Services). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat R, 2012, MOL BIOL EVOL; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Chernikova D, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-26; CLARKE ND, 1995, PROTEIN SCI, V4, P2269, DOI 10.1002/pro.5560041104; Collin SP, 2009, PHILOS T R SOC B, V364, P2925, DOI 10.1098/rstb.2009.0099; Davies WL, 2009, MOL BIOL EVOL, V26, P1803, DOI 10.1093/molbev/msp089; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P5809, DOI 10.1021/bi0341004; Gu G, 2004, J BIOL CHEM, V279, P18608, DOI 10.1074/jbc.M400323200; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; HOLMBERG K, 1971, Z ZELLFORSCH MIK ANA, V121, P249, DOI 10.1007/BF00340676; Hu KQ, 2006, J BIOL CHEM, V281, P19327, DOI 10.1074/jbc.M512095200; Janvier P, 2010, P NATL ACAD SCI USA, V107, P19137, DOI 10.1073/pnas.1014583107; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; KIMURA M, 1979, P NATL ACAD SCI USA, V76, P2858, DOI 10.1073/pnas.76.6.2858; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kusakabe T, 2001, FEBS LETT, V506, P69, DOI 10.1016/S0014-5793(01)02877-0; Kusakabe TG, 2009, PHILOS T R SOC B, V364, P2897, DOI 10.1098/rstb.2009.0043; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Lamb Trevor D., 2008, Evolution Education and Outreach, V1, P415, DOI 10.1007/s12052-008-0091-2; LANDERS GM, 1988, J CHROMATOGR, V438, P383, DOI 10.1016/S0021-9673(00)90269-3; Lynch M, 2000, GENETICS, V154, P459; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Muradov H, 2008, VISION RES, V48, P2302, DOI 10.1016/j.visres.2008.07.006; Muradov H, 2007, BIOCHEMISTRY-US, V46, P9992, DOI 10.1021/bi700535s; Nakashima Y, 2003, J COMP NEUROL, V460, P180, DOI 10.1002/cne.10645; NILSSON DE, 1994, P ROY SOC B-BIOL SCI, V256, P53, DOI 10.1098/rspb.1994.0048; Ohno S., 1970, EVOLUTION GENE DUPLI; Orland MD, 2005, BBA-MOL CELL BIOL L, V1737, P76, DOI 10.1016/j.bbalip.2005.09.003; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Philippe H, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-50; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2000, METHOD ENZYMOL, V316, P705; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Reyes A, 2000, GENE, V259, P177, DOI 10.1016/S0378-1119(00)00438-8; Rogers JS, 1998, SYST BIOL, V47, P77, DOI 10.1080/106351598261049; Saari JC, 2012, ANNU REV NUTR, V32, P125, DOI 10.1146/annurev-nutr-071811-150748; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Takimoto N, 2007, PHOTOCHEM PHOTOBIOL, V83, P242, DOI 10.1562/2006-06-30-IR-957; Takimoto N, 2006, PHOTOCHEM PHOTOBIOL, V82, P1468, DOI 10.1562/2006-01-14-RA-775; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; von Lintig J, 2001, P NATL ACAD SCI USA, V98, P1130, DOI 10.1073/pnas.031576398; Wagner A, 1998, BIOESSAYS, V20, P785, DOI 10.1002/(SICI)1521-1878(199810)20:10<785::AID-BIES2>3.3.CO;2-D; WALSH JB, 1995, GENETICS, V139, P421; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200	68	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49975	10.1371/journal.pone.0049975	http://dx.doi.org/10.1371/journal.pone.0049975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209628	Green Submitted, Green Published, gold			2022-12-25	WOS:000311885800037
J	Ross, SH; Spanjaard, E; Post, A; Vliem, MJ; Kristyanto, H; Bos, JL; de Rooij, J				Ross, Sarah H.; Spanjaard, Emma; Post, Anneke; Vliem, Marjolein J.; Kristyanto, Hendy; Bos, Johannes L.; de Rooij, Johan			Rap1 Can Bypass the FAK-Src-Paxillin Cascade to Induce Cell Spreading and Focal Adhesion Formation	PLOS ONE			English	Article							ENDOTHELIAL BARRIER FUNCTION; EXTRACELLULAR-MATRIX; NEURITE OUTGROWTH; EXCHANGE FACTOR; CALDAG-GEFI; TALIN ROD; ACTIVATION; KINASE; VINCULIN; INTEGRINS	We developed new image analysis tools to analyse quantitatively the extracellular-matrix-dependent cell spreading process imaged by live-cell epifluorescence microscopy. Using these tools, we investigated cell spreading induced by activation of the small GTPase, Rap1. After replating and initial adhesion, unstimulated cells exhibited extensive protrusion and retraction as their spread area increased, and displayed an angular shape that was remodelled over time. In contrast, activation of endogenous Rap1, via 007-mediated stimulation of Epac1, induced protrusion along the entire cell periphery, resulting in a rounder spread surface, an accelerated spreading rate and an increased spread area compared to control cells. Whereas basal, anisotropic, spreading was completely dependent on Src activity, Rap1-induced spreading was refractory to Src inhibition. Under Src inhibited conditions, the characteristic Src-induced tyrosine phosphorylations of FAK and paxillin did not occur, but Rap1 could induce the formation of actomyosin-connected adhesions, which contained vinculin at levels comparable to that found in unperturbed focal adhesions. From these results, we conclude that Rap1 can induce cell adhesion and stimulate an accelerated rate of cell spreading through mechanisms that bypass the canonical FAK-Src-Paxillin signalling cascade.	[Ross, Sarah H.; Post, Anneke; Vliem, Marjolein J.; Kristyanto, Hendy; Bos, Johannes L.] Univ Med Ctr, Dept Mol Canc Res, Ctr Biomed Genet, Utrecht, Netherlands; [Ross, Sarah H.; Post, Anneke; Vliem, Marjolein J.; Kristyanto, Hendy; Bos, Johannes L.] Univ Med Ctr, Canc Genom Ctr, Utrecht, Netherlands; [Spanjaard, Emma; de Rooij, Johan] Hubrecht Inst Dev Biol & Stem Cell Res, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Ross, SH (corresponding author), Univ Med Ctr, Dept Mol Canc Res, Ctr Biomed Genet, Utrecht, Netherlands.	s.h.ross@outlook.com; j.derooij@hubrecht.eu	de rooij, johan/C-1325-2019; Kristyanto, Hendy/U-4762-2017	Kristyanto, Hendy/0000-0002-8022-6637; Ross, Sarah/0000-0001-7302-6875; de rooij, johan/0000-0001-6101-7875	FEBS; Centre of Biomedical Genetics; Netherlands Consortium for Systems Biology (NCSB); Dutch Cancer Society (KWF Kankerbestrijding) [2009-4317]; Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research	FEBS; Centre of Biomedical Genetics; Netherlands Consortium for Systems Biology (NCSB); Dutch Cancer Society (KWF Kankerbestrijding)(KWF Kankerbestrijding); Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research	SHR was supported by a FEBS Long-Term Fellowship. ES was funded by a grant from the Centre of Biomedical Genetics and the Netherlands Consortium for Systems Biology (NCSB), and AP was funded by a grant (2009-4317) from the Dutch Cancer Society (KWF Kankerbestrijding). This work was further supported by the Netherlands Genomics Initiative of the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aivatiadou E, 2009, MOL REPROD DEV, V76, P407, DOI 10.1002/mrd.20963; Arthur WT, 2004, J CELL BIOL, V167, P111, DOI 10.1083/jcb.200404068; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Carey SP, 2011, STUD MECHANOBIOL TIS, V4, P29, DOI 10.1007/8415_2010_22; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jarvelainen H, 2009, PHARMACOL REV, V61, P198, DOI 10.1124/pr.109.001289; Jeon CY, 2010, J CELL PHYSIOL, V224, P786, DOI 10.1002/jcp.22184; Jeon CY, 2010, EXP MOL MED, V42, P335, DOI 10.3858/emm.2010.42.5.035; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; Krugmann S, 2004, CURR BIOL, V14, P1380, DOI 10.1016/j.cub.2004.07.058; Kurooka T, 2011, J BIOL CHEM, V286, P6832, DOI 10.1074/jbc.M110.183772; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lafuente E, 2006, METHOD ENZYMOL, V407, P345, DOI 10.1016/S0076-6879(05)07029-1; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li LM, 2002, MOL CELL BIOL, V22, P1203, DOI 10.1128/MCB.22.4.1203-1217.2002; Lock FE, 2009, PLOS ONE, V7; Lock FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008190; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Lyle KS, 2008, CELL SIGNAL, V20, P1104, DOI 10.1016/j.cellsig.2008.01.018; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mierke CT, 2009, CELL BIOCHEM BIOPHYS, V53, P115, DOI 10.1007/s12013-009-9047-6; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Niola F, 2012, NAT CELL BIOL, V14, P477, DOI 10.1038/ncb2490; Ohba Y, 2001, SEIKAGAKU, V73, P1; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095; Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Raaijmakers JH, 2007, CELL SIGNAL, V19, P1249, DOI 10.1016/j.cellsig.2006.12.015; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ross SH, 2011, J CELL SCI, V124, P1808, DOI 10.1242/jcs.079830; SCHWARTZ MA, 1994, J BIOL CHEM, V269, P11133; Sonnenberg A, 2007, EXP CELL RES, V313, P2189, DOI 10.1016/j.yexcr.2007.03.039; Springett GM, 2004, BIOESSAYS, V26, P730, DOI 10.1002/bies.20057; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Sun YY, 2012, J ELECTRON MATER, V41, P519, DOI 10.1007/s11664-011-1800-0; Tamada M, 2004, DEV CELL, V7, P709, DOI 10.1016/j.devcel.2004.08.021; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Zieba BJ, 2011, J BIOL CHEM, V286, P16681, DOI 10.1074/jbc.M110.205062	74	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50072	10.1371/journal.pone.0050072	http://dx.doi.org/10.1371/journal.pone.0050072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209645	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885800045
J	Seitz, S; Keller, J; Schilling, AF; Jeschke, A; Marshall, RP; Stride, BD; Wintermantel, T; Beil, FT; Amling, M; Schutz, G; Tuckermann, J; Schinke, T				Seitz, Sebastian; Keller, Johannes; Schilling, Arndt F.; Jeschke, Anke; Marshall, Robert P.; Stride, Brenda D.; Wintermantel, Tim; Beil, Frank T.; Amling, Michael; Schuetz, Guenther; Tuckermann, Jan; Schinke, Thorsten			Pharmacological Estrogen Administration Causes a FSH-Independent Osteo-Anabolic Effect Requiring ER Alpha in Osteoblasts	PLOS ONE			English	Article							RECEPTOR-ALPHA; BONE-FORMATION; CANCELLOUS BONE; DIFFERENTIATION; PROLIFERATION; PATHOGENESIS; MECHANISMS; HORMONE; HEALTH; CELLS	Postmenopausal osteoporosis is characterized by declining estrogen levels, and estrogen replacement therapy has been proven beneficial for preventing bone loss in affected women. While the physiological functions of estrogen in bone, primarily the inhibition of bone resorption, have been studied extensively, the effects of pharmacological estrogen administration are still poorly characterized. Since elevated levels of follicle-stimulating hormone (FSH) have been suggested to be involved in postmenopausal bone loss, we investigated whether the skeletal response to pharmacological estrogen administration is mediated in a FSH-dependent manner. Therefore, we treated wildtype and FSH beta-deficicent (Fshb(-/-)) mice with estrogen for 4 weeks and subsequently analyzed their skeletal phenotype. Here we observed that estrogen treatment resulted in a significant increase of trabecular and cortical bone mass in both, wildtype and Fshb(-/-) mice. Unexpectedly, this FSH-independent pharmacological effect of estrogen was not caused by influencing bone resorption, but primarily by increasing bone formation. To understand the cellular and molecular nature of this osteo-anabolic effect we next administered estrogen to mouse models carrying cell specific mutant alleles of the estrogen receptor alpha (ER alpha). Here we found that the response to pharmacological estrogen administration was not affected by ER alpha inactivation in osteoclasts, while it was blunted in mice lacking the ER alpha in osteoblasts or in mice carrying a mutant ER alpha incapable of DNA binding. Taken together, our findings reveal a previously unknown osteo-anabolic effect of pharmacological estrogen administration, which is independent of FSH and requires DNA-binding of ER alpha in osteoblasts.	[Tuckermann, Jan] Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany; [Stride, Brenda D.; Wintermantel, Tim; Schuetz, Guenther] German Canc Res Ctr, Div Mol Biol Cell 1, D-6900 Heidelberg, Germany; [Schilling, Arndt F.] Tech Univ Munich, Dept Plast & Hand Surg, Munich, Germany; [Seitz, Sebastian; Keller, Johannes; Schilling, Arndt F.; Jeschke, Anke; Marshall, Robert P.; Beil, Frank T.; Amling, Michael; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany	Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Tuckermann, J (corresponding author), Fritz Lipmann Inst, Leibniz Inst Age Res, Jena, Germany.	jan@fli-leibniz.de; schinke@uke.de	Marshall, Robert Percy/AAD-5269-2022	Marshall, Robert Percy/0000-0003-4247-1006; Keller, Johannes/0000-0002-8925-7288	Deutsche Forschungsgemeinschaft [SE 1755/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft given to SS (SE 1755/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: http://www.dfg.de/index.jsp.	Ahlbory-Dieker DL, 2009, MOL ENDOCRINOL, V23, P1544, DOI 10.1210/me.2009-0045; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Baron R, 2006, CELL METAB, V3, P302, DOI 10.1016/j.cmet.2006.04.007; CHOW J, 1992, J CLIN INVEST, V89, P74, DOI 10.1172/JCI115588; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cummings-Vaughn LA, 2011, MED CLIN N AM, V95, P495, DOI 10.1016/j.mcna.2011.03.003; Falkenstein E, 2000, EUR J CLIN INVEST, V30, P51, DOI 10.1046/j.1365-2362.2000.0300s3051.x; Goltzman D, 2002, NAT REV DRUG DISCOV, V1, P784, DOI 10.1038/nrd916; KEETING PE, 1991, J BONE MINER RES, V6, P297; Krum SA, 2011, J CELL BIOCHEM, V112, P401, DOI 10.1002/jcb.22970; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; Lindsay R, 2004, ENDOCRINE, V24, P223, DOI 10.1385/ENDO:24:3:223; Maggiolini M, 2010, J ENDOCRINOL, V204, P105, DOI 10.1677/JOE-09-0242; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Martin TJ, 2009, CRIT REV EUKAR GENE, V19, P73, DOI 10.1615/CritRevEukarGeneExpr.v19.i1.40; Martin TJ, 2006, NAT MED, V12, P612, DOI 10.1038/nm0606-612; McCauley LK, 2002, CRIT REV EUKAR GENE, V12, P89, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.10; McDougall KE, 2003, ENDOCRINOLOGY, V144, P1994, DOI 10.1210/en.2002-0074; Mosekilde L, 2011, CURR DRUG SAF, V6, P62, DOI 10.2174/157488611795684712; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; O'Brien JE, 2006, J BIOL CHEM, V281, P26683, DOI 10.1074/jbc.M601522200; Pacifici R, 1996, J BONE MINER RES, V11, P1043; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Qu Q, 1998, BONE, V22, P201, DOI 10.1016/S8756-3282(97)00276-7; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Robinson JA, 1997, ENDOCRINOLOGY, V138, P2919, DOI 10.1210/en.138.7.2919; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Samuels A, 2000, BONE, V27, P41, DOI 10.1016/S8756-3282(00)00289-1; SCHEVEN BAA, 1992, BIOCHEM BIOPH RES CO, V186, P54, DOI 10.1016/S0006-291X(05)80774-0; Schinke T, 2009, NAT MED, V15, P674, DOI 10.1038/nm.1963; Schulze J, 2011, J BONE MINER RES, V26, P704, DOI 10.1002/jbmr.269; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Takada I, 2010, ANN NY ACAD SCI, V1192, P201, DOI 10.1111/j.1749-6632.2009.05215.x; Tobias JH, 1999, BONE, V24, P121, DOI 10.1016/S8756-3282(98)00156-2; Windahl SH, 2002, TRENDS ENDOCRIN MET, V13, P195, DOI 10.1016/S1043-2760(02)00594-5; Wintermantel TM, 2006, NEURON, V52, P271, DOI 10.1016/j.neuron.2006.07.023; Yeh JK, 1997, BONE, V20, P413, DOI 10.1016/S8756-3282(97)00027-6; Yeh JK, 1996, BONE, V18, P443, DOI 10.1016/8756-3282(96)00045-2; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593	41	15	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50301	10.1371/journal.pone.0050301	http://dx.doi.org/10.1371/journal.pone.0050301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209701	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800063
J	Welzel, AT; Williams, AD; McWilliams-Koeppen, HP; Acero, L; Weber, A; Blinder, V; Mably, A; Bunk, S; Hermann, C; Farrell, MA; Ehrlich, HJ; Schwarz, HP; Walsh, DM; Solomon, A; O'Nuallain, B				Welzel, Alfred T.; Williams, Angela D.; McWilliams-Koeppen, Helen P.; Acero, Luis; Weber, Alfred; Blinder, Veronika; Mably, Alex; Bunk, Sebastian; Hermann, Corinna; Farrell, Michael A.; Ehrlich, Hartmut J.; Schwarz, Hans P.; Walsh, Dominic M.; Solomon, Alan; O'Nuallain, Brian			Human Anti-A beta IgGs Target Conformational Epitopes on Synthetic Dimer Assemblies and the AD Brain-Derived Peptide	PLOS ONE			English	Article							HUMAN INTRAVENOUS IMMUNOGLOBULIN; ALZHEIMERS-DISEASE; AMYLOID-BETA; MOUSE MODEL; SYNAPTIC PLASTICITY; HUMAN-ANTIBODIES; IMMUNOTHERAPY; MECHANISMS; CLEARANCE; OLIGOMERS	Soluble non-fibrillar assemblies of amyloid-beta (A beta) and aggregated tau protein are the proximate synaptotoxic species associated with Alzheimer's disease (AD). Anti-A beta immunotherapy is a promising and advanced therapeutic strategy, but the precise A beta species to target is not yet known. Previously, we and others have shown that natural human IgGs (NAbs) target diverse A beta conformers and have therapeutic potential. We now demonstrate that these antibodies bound with nM avidity to conformational epitopes on plate-immobilized synthetic A beta dimer assemblies, including synaptotoxic protofibrils, and targeted these conformers in solution. Importantly, NAbs also recognized A beta extracted from the water-soluble phase of human AD brain, including species that migrated on denaturing PAGE as SDS-stable dimers. The critical reliance on A beta's conformational state for NAb binding, and not a linear sequence epitope, was confirmed by the antibody's nM reactivity with plate-immobilized protofibrills, and weak uM binding to synthetic A beta monomers and peptide fragments. The antibody's lack of reactivity against a linear sequence epitope was confirmed by our ability to isolate anti-A beta NAbs from intravenous immunoglobulin using affinity matrices, immunoglobulin light chain fibrils and Cibacron blue, which had no sequence similarity with the peptide. These findings suggest that further investigations on the molecular basis and the therapeutic/diagnostic potential of anti-A beta NAbs are warranted.	[Welzel, Alfred T.; Mably, Alex; Walsh, Dominic M.; O'Nuallain, Brian] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Williams, Angela D.; McWilliams-Koeppen, Helen P.; Acero, Luis; Solomon, Alan; O'Nuallain, Brian] Univ Tennessee, Grad Sch Med, Dept Med, Human Immunol & Canc Program, Knoxville, TN USA; [Weber, Alfred; Bunk, Sebastian; Hermann, Corinna; Ehrlich, Hartmut J.; Schwarz, Hans P.] Baxter BioSci, Vienna, Austria; [Blinder, Veronika; Mably, Alex; Walsh, Dominic M.; O'Nuallain, Brian] Brigham & Womens Hosp, Harvard Inst Med, Lab Neurodegenerat Res, Boston, MA 02115 USA; [Farrell, Michael A.] Beaumont Hosp, Dept Pathol, Dublin Brain Bank, Dublin 9, Ireland	University College Dublin; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	O'Nuallain, B (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 2, Ireland.	bonuallain@partners.org			Baxter AG; European Community [200611]; Baxter BioScience	Baxter AG; European Community(European Commission); Baxter BioScience	This work was supported in part by funding from Baxter AG (BO and AS), and the European Community 7th Framework Programme (FP7/2007-2013) under grant agreement No. 200611 (DMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by funding from Baxter BioScience, the employer of AW, HJE and HPS, and the European Community 7th Framework Programme (FP7/2007-2013) under grant agreement No. 200611 (DMW). Intravenous immunoglobulin (IVIg; Gammagard liquid (R)) was provided by Baxter BioScience (Vienna, Austria), and is a Baxter Bioscience product. BO has served as a member of a Baxter preclinical Scientific Advisory Board. DMW is a consultant, shareholder and member of the scientific advisory board of Senexis plc. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Avrameas S, 2007, J AUTOIMMUN, V29, P213, DOI 10.1016/j.jaut.2007.07.010; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Britschgi M, 2009, P NATL ACAD SCI USA, V106, P12145, DOI 10.1073/pnas.0904866106; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodel R, 2002, ANN NEUROL, V52, P253, DOI 10.1002/ana.10253; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Gandy S, 2010, LANCET NEUROL, V9, P333, DOI 10.1016/S1474-4422(10)70055-7; Giacomelli CE, 2005, MACROMOL BIOSCI, V5, P401, DOI 10.1002/mabi.200400189; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Golde TE, 2009, CNS NEUROL DISORD-DR, V8, P31, DOI 10.2174/187152709787601830; Klaver AC, 2010, INT IMMUNOPHARMACOL, V10, P115, DOI 10.1016/j.intimp.2009.10.005; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Levites Y, 2006, FASEB J, V20, P2576, DOI 10.1096/fj.06-6463fje; Li QY, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-22; Magga J, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-90; Mc Donald JM, 2010, BRAIN, V133, P1328, DOI 10.1093/brain/awq065; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Negi VS, 2007, J CLIN IMMUNOL, V27, P233, DOI 10.1007/s10875-007-9088-9; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2008, BIOCHEMISTRY-US, V47, P12254, DOI 10.1021/bi801767k; O'Nuallain B, 2006, J IMMUNOL, V176, P7071, DOI 10.4049/jimmunol.176.11.7071; O'Nuallain B, 2011, J NEUROCHEM, V119, P189, DOI 10.1111/j.1471-4159.2011.07389.x; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; O'Nuallain B, 2010, J CLIN IMMUNOL, V30, pS37, DOI 10.1007/s10875-010-9413-6; Puli L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-105; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Seubert P, 2008, NEURODEGENER DIS, V5, P65, DOI 10.1159/000112834; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shankar GM, 2011, METHODS MOL BIOL, V670, P33, DOI 10.1007/978-1-60761-744-0_3; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sloane PD, 2002, ANNU REV PUBL HEALTH, V23, P213, DOI 10.1146/annurev.publhealth.23.100901.140525; Solomon B, 2007, CURR OPIN MOL THER, V9, P79; Szabo P, 2008, AUTOIMMUN REV, V7, P415, DOI 10.1016/j.autrev.2008.03.007; Szabo P, 2010, J NEUROIMMUNOL, V227, P167, DOI 10.1016/j.jneuroim.2010.06.010; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Town T, 2001, NEUROSCI LETT, V307, P101, DOI 10.1016/S0304-3940(01)01951-6; Villemagne VL, 2010, J NEUROSCI, V30, P6315, DOI 10.1523/JNEUROSCI.5180-09.2010; Wahlstrom A, 2008, FEBS J, V275, P5117, DOI 10.1111/j.1742-4658.2008.06643.x; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weber A, 2009, ALZHEIMERS DEMENT, P146; Wilcox KC, 2011, CELL MOL NEUROBIOL, V31, P939, DOI 10.1007/s10571-011-9691-4	52	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50317	10.1371/journal.pone.0050317	http://dx.doi.org/10.1371/journal.pone.0050317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209707	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800064
J	Campbell, DJ; Somaratne, JB; Jenkins, AJ; Prior, DL; Yii, M; Kenny, JF; Newcomb, AE; Schalkwijk, CG; Black, MJ; Kelly, DJ				Campbell, Duncan J.; Somaratne, Jithendra B.; Jenkins, Alicia J.; Prior, David L.; Yii, Michael; Kenny, James F.; Newcomb, Andrew E.; Schalkwijk, Casper G.; Black, Mary Jane; Kelly, Darren J.			Diastolic Dysfunction of Aging Is Independent of Myocardial Structure but Associated with Plasma Advanced Glycation End-Product Levels	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE ENTERPRISES; LEFT-VENTRICULAR HYPERTROPHY; HEART-FAILURE; MAJOR SHAREHOLDERS; STEREOLOGICAL METHODS; CARBOXYMETHYL-LYSINE; METABOLIC SYNDROME; CARDIAC FIBROSIS; ARTERIAL; IMPACT	Background: Heart failure is associated with abnormalities of myocardial structure, and plasma levels of the advanced glycation end-product (AGE) N-epsilon-(carboxymethyl) lysine (CML) correlate with the severity and prognosis of heart failure. Aging is associated with diastolic dysfunction and increased risk of heart failure, and we investigated the hypothesis that diastolic dysfunction of aging humans is associated with altered myocardial structure and plasma AGE levels. Methods: We performed histological analysis of non-ischemic left ventricular myocardial biopsies and measured plasma levels of the AGEs CML and low molecular weight fluorophores (LMWFs) in 26 men undergoing coronary artery bypass graft surgery who had transthoracic echocardiography before surgery. None had previous cardiac surgery, myocardial infarction, atrial fibrillation, or heart failure. Results: The patients were aged 43-78 years and increasing age was associated with echocardiographic indices of diastolic dysfunction, with higher mitral Doppler flow velocity A wave (r = 0.50, P = 0.02), lower mitral E/A wave ratio (r = 0.64, P = 0.001), longer mitral valve deceleration time (r = 0.42, P = 0.03) and lower early diastolic peak velocity of the mitral septal annulus, e' (r = 0.55, P = 0.008). However, neither mitral E/A ratio nor mitral septal e' was correlated with myocardial total, interstitial or perivascular fibrosis (picrosirius red), immunostaining for collagens I and III, CML, and receptor for AGEs (RAGE), cardiomyocyte width, capillary length density, diffusion radius or arteriolar dimensions. Plasma AGE levels were not associated with age. However, plasma CML levels were associated with E/A ratio (r = 0.44, P = 0.04) and e' (r = 0.51, P = 0.02) and LMWF levels were associated with E/A ratio (r = 0.49, P = 0.02). Moreover, the mitral E/A ratio remained correlated with plasma LMWF levels in all patients (P = 0.04) and the mitral septal e' remained correlated with plasma CML levels in nondiabetic patients (P = 0.007) when age was a covariate. Conclusions: Diastolic dysfunction of aging was independent of myocardial structure but was associated with plasma AGE levels.	[Campbell, Duncan J.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Campbell, Duncan J.; Jenkins, Alicia J.; Prior, David L.; Kelly, Darren J.] Univ Melbourne, Dept Med, St Vincents Hlth, Fitzroy, Vic 3065, Australia; [Somaratne, Jithendra B.; Prior, David L.] St Vincents Hlth, Dept Cardiol, Fitzroy, Vic, Australia; [Yii, Michael; Newcomb, Andrew E.] Univ Melbourne, Dept Surg, St Vincents Hlth, Fitzroy, Vic 3065, Australia; [Yii, Michael; Kenny, James F.; Newcomb, Andrew E.] St Vincents Hlth, Dept Cardiothorac Surg, Fitzroy, Vic, Australia; [Schalkwijk, Casper G.] Univ Maastricht, Dept Internal Med, Maastricht, Netherlands; [Black, Mary Jane] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	St. Vincent's Institute of Medical Research; University of Melbourne; University of Melbourne; Maastricht University; Monash University	Campbell, DJ (corresponding author), St Vincents Inst Med Res, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	dcampbell@svi.edu.au	Jenkins, Alicia/N-2482-2015; Newcomb, Andrew/ABD-9220-2021	Newcomb, Andrew/0000-0002-0465-3602; Kelly, Darren/0000-0003-4850-3929; Jenkins, Alicia/0000-0003-0583-3717; Somaratne, Jithendra/0000-0002-5165-4077; Black, Mary Jane/0000-0002-9253-3773; Schalkwijk, Casper G/0000-0003-0190-2690	National Health and Medical Research Council of Australia; National Heart Foundation of Australia; National Health and Medical Research Council of Australia [395508, 566867]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was funded by grants from the National Health and Medical Research Council of Australia and from the National Heart Foundation of Australia. D.J.C. (Grant ID 395508) and D.J.K. (Grant ID 566867) are recipients of Senior Research Fellowships from the National Health and Medical Research Council of Australia. St Vincent's Institute of Medical Research is supported in part by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; ANVERSA P, 1990, CIRC RES, V67, P871, DOI 10.1161/01.RES.67.4.871; ANVERSA P, 1994, AM J PHYSIOL, V267, pH1062, DOI 10.1152/ajpheart.1994.267.3.H1062; Barlovic DP, 2011, CLIN SCI, V121, P43, DOI 10.1042/CS20100501; Black MJ, 2001, J HYPERTENS, V19, P785, DOI 10.1097/00004872-200104000-00016; Campbell DJ, 2013, INT J CARDIOL, V167, P1027, DOI 10.1016/j.ijcard.2012.03.075; Campbell DJ, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-80; Campbell DJ, 2011, HYPERTENSION, V57, P186, DOI 10.1161/HYPERTENSIONAHA.110.165043; Dai DF, 2012, ANTIOXID REDOX SIGN, V16, P1492, DOI 10.1089/ars.2011.4179; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gordon H, 1936, AM J PATHOL, V12, P545; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hartog JWL, 2007, EUR J HEART FAIL, V9, P1146, DOI 10.1016/j.ejheart.2007.09.009; Hartog JWL, 2007, EUR HEART J, V28, P2879, DOI 10.1093/eurheartj/ehm486; Hollingsworth KG, 2012, AM J PHYSIOL-HEART C, V302, pH885, DOI 10.1152/ajpheart.00985.2011; Januszewski AS, 2005, ANN NY ACAD SCI, V1043, P655, DOI 10.1196/annals.1333.074; Kane GC, 2011, JAMA-J AM MED ASSOC, V306, P856, DOI 10.1001/jama.2011.1201; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; Kass DA, 2001, CIRCULATION, V104, P1464, DOI 10.1161/hc3801.097806; KITZMAN DW, 1991, J AM COLL CARDIOL, V18, P1243, DOI 10.1016/0735-1097(91)90542-H; Kostler H, 2006, MAGN RESON MED, V56, P907, DOI 10.1002/mrm.21027; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim KJ, 2006, PEDIATR RES, V60, P83, DOI 10.1203/01.pdr.0000220361.08181.c3; Linke WA, 2008, CARDIOVASC RES, V77, P637, DOI 10.1016/j.cardiores.2007.03.029; Okada M, 1998, MAGNET RESON MED, V39, P772, DOI 10.1002/mrm.1910390515; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Perseghin G, 2009, HEART, V95, P630, DOI 10.1136/hrt.2008.154716; Prasad A, 2005, CIRCULATION, V111, P1499, DOI 10.1161/01.CIR.0000159353.31271.F2; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; RAKUSAN K, 1964, GERONTOLOGY, V9, P107, DOI 10.1159/000211244; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; RITTHALER U, 1995, AM J PATHOL, V146, P688; Roberts JT, 1941, AM HEART J, V21, P617, DOI 10.1016/S0002-8703(41)90726-3; Schalkwijk CG, 2004, BBA-MOL CELL BIOL L, V1636, P82, DOI 10.1016/j.bbalip.2003.07.002; Schocke MFH, 2003, MAGN RESON IMAGING, V21, P553, DOI 10.1016/S0730-725X(03)00079-1; Semba RD, 2009, J AM GERIATR SOC, V57, P1874, DOI 10.1111/j.1532-5415.2009.02438.x; Semba RD, 2009, AM J HYPERTENS, V22, P74, DOI 10.1038/ajh.2008.320; Shapiro BP, 2008, CIRCULATION, V118, P1002, DOI 10.1161/CIRCULATIONAHA.108.777326; Tang Y, 2009, ANAT REC, V292, P1630, DOI 10.1002/ar.20952; Tikellis C, 2008, AM J PHYSIOL-ENDOC M, V295, pE323, DOI 10.1152/ajpendo.00024.2008; TOMANEK RJ, 1991, CIRC RES, V69, P1068, DOI 10.1161/01.RES.69.4.1068; Tomita H, 1998, HYPERTENSION, V32, P273, DOI 10.1161/01.HYP.32.2.273; Tsagalou EP, 2008, J AM COLL CARDIOL, V52, P1391, DOI 10.1016/j.jacc.2008.05.064; UNVERFERTH DV, 1986, GERONTOLOGY, V32, P241, DOI 10.1159/000212798; UNVERFERTH DV, 1983, CIRCULATION, V68, P1194, DOI 10.1161/01.CIR.68.6.1194; van Heerebeek L, 2006, CIRCULATION, V113, P1966, DOI 10.1161/CIRCULATIONAHA.105.587519; Van Heerebeek L, 2012, CURR HEART FAIL REP; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yamakado T, 1997, CIRCULATION, V95, P917; Zhu SK, 2004, OBES RES, V12, P633, DOI 10.1038/oby.2004.73	57	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49813	10.1371/journal.pone.0049813	http://dx.doi.org/10.1371/journal.pone.0049813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189164	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800041
J	Na, R; Jiang, HW; Kim, ST; Wu, YS; Tong, SJ; Zhang, LM; Xu, JF; Sun, YH; Ding, Q				Na, Rong; Jiang, Haowen; Kim, Seong-Tae; Wu, Yishuo; Tong, Shijun; Zhang, Limin; Xu, Jianfeng; Sun, Yinghao; Ding, Qiang			Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011	PLOS ONE			English	Article							GLEASON GRADING SYSTEM; INTERNATIONAL-SOCIETY; NEEDLE-BIOPSY; IMPACT; ANTIGEN; MORTALITY; SEXTANT; CARCINOMA; CONSENSUS; NUMBER	Background: Prostate-specific antigen (PSA) screening is growing in popularity in China, but its impact on biopsy characteristics and outcomes are poorly understood. Objective: Our objective was to characterize prostate biopsy outcomes and trends in Chinese men over a 10-year period, since the increasing use of PSA tests. Methods: All men (n = 1,650) who underwent prostate biopsy for PCa at Huashan Hospital, Shanghai, China from 2003-2011 were evaluated. Demographic and clinical information was collected for each patient, including age, digital rectal examination (DRE), transrectal ultrasound (prostate volume and nodule), total prostate-specific antigen (tPSA) levels and free PSA ratio (fPSA/tPSA) prior to biopsy. Prostate biopsy was performed using six cores before October 2007 or ten cores thereafter. Logistic regression and multivariate analysis were used to evaluate our data. Results: The overall positive rate of prostate biopsy for PCa was 47% and the rate decreased significantly over the years from 74% in 2003 to 33% in 2011 (P-trend = 0.004). Age at diagnosis was slightly increased (P-trend = 0.04) while fPSA/tPSA was significantly decreased (P-trend = 1.11610-5). A statistically significant trend was not observed for tPSA levels, prostate volume, or proportion of positive nodule. The model including multiple demographic and clinical variables (i.e., age, DRE, tPSA, fPSA/tPSA and transrectal ultrasound results) (AUC = 0.93) statistically outperformed models that included only PSA (AUC = 0.85) or fPSA/tPSA (AUC = 0.66) to predict PCa risks (P < 0.05). Similar results were observed in a subgroup of men whose tPSA levels were lower than 20 ng/mL (AUC = 0.87, vs. AUC of tPSA = 0.62, P < 0.05). Conclusions: Detection rates of PCa and high-grade PCa among men that underwent prostate biopsy at the institution has decreased significantly in the past 10 years, likely due to increasing use of PSA tests. Predictive performance of demographic and clinical variables of PCa was excellent. These variables should be used in clinics to determine the need for prostate biopsy.	[Na, Rong; Jiang, Haowen; Wu, Yishuo; Tong, Shijun; Zhang, Limin; Xu, Jianfeng; Ding, Qiang] Fudan Univ, Dept Urol, Huashan Hosp, Shanghai 200433, Peoples R China; [Na, Rong; Kim, Seong-Tae; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA; [Na, Rong; Jiang, Haowen; Wu, Yishuo; Tong, Shijun; Zhang, Limin; Xu, Jianfeng; Ding, Qiang] Fudan Univ, Fudan Inst Urol, Huashan Hosp, Shanghai 200433, Peoples R China; [Sun, Yinghao] Changhai Hosp, Dept Urol, Shanghai, Peoples R China	Fudan University; Wake Forest University; Wake Forest Baptist Medical Center; Fudan University; Naval Medical University	Ding, Q (corresponding author), Fudan Univ, Dept Urol, Huashan Hosp, Shanghai 200433, Peoples R China.	qiangd.urol@gmail.com	Kim, Seong-Tae/E-4474-2017; Na, Rong/AAN-8655-2021	Kim, Seong-Tae/0000-0001-7436-1405; Na, Rong/0000-0001-7470-5108				Babaian RJ, 2000, J UROLOGY, V163, P152, DOI 10.1016/S0022-5347(05)67993-1; Bartsch G, 2008, BJU INT, V101, P809, DOI 10.1111/j.1464-410X.2008.07502.x; Billis A, 2008, J UROLOGY, V180, P52; Billis A, 2008, J UROLOGY, V180, P548, DOI 10.1016/j.juro.2008.04.018; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P1691, DOI 10.1001/jama.270.14.1691; Chan TY, 2001, J UROLOGY, V166, P2181, DOI 10.1016/S0022-5347(05)65530-9; Delahunt B, 2012, HISTOPATHOLOGY, V60, P75, DOI 10.1111/j.1365-2559.2011.04003.x; Dong F, 2012, AM J SURG PATHOL, V36, P838, DOI 10.1097/PAS.0b013e3182486faf; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Egevad L, 2012, ARCH PATHOL LAB MED, V136, P426, DOI 10.5858/arpa.2011-0495-RA; Eskew LA, 1997, J UROLOGY, V157, P203; Eskew LA, 1997, J UROLOGY, V157, P199, DOI 10.1016/S0022-5347(01)65322-9; Gore JL, 2001, J UROLOGY, V165, P1554, DOI 10.1016/S0022-5347(05)66347-1; Hankey BF, 1999, JNCI-J NATL CANCER I, V91, P1017, DOI 10.1093/jnci/91.12.1017; KEETCH DW, 1994, J UROLOGY, V151, P1571, DOI 10.1016/S0022-5347(17)35304-1; Kim JW, 2004, YONSEI MED J, V45, P671, DOI 10.3349/ymj.2004.45.4.671; Naughton CK, 1998, UROLOGY, V52, P808, DOI 10.1016/S0090-4295(98)00344-6; Naughton CK, 2000, J UROLOGY, V164, P388, DOI 10.1016/S0022-5347(05)67367-3; Ravery V, 2000, J UROLOGY, V164, P393, DOI 10.1016/S0022-5347(05)67368-5; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schwartz KL, 1999, UROLOGY, V53, P769, DOI 10.1016/S0090-4295(98)00575-5; Schwartz MJ, 2008, CANCER-AM CANCER SOC, V112, P1718, DOI 10.1002/cncr.23353; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Ung JO, 2003, J UROLOGY, V169, P130, DOI 10.1016/S0022-5347(05)64052-9; Vickers AJ, 2010, CLIN CANCER RES, V16, P4374, DOI 10.1158/1078-0432.CCR-10-1328; Zareba P, 2009, HISTOPATHOLOGY, V55, P384, DOI 10.1111/j.1365-2559.2009.03405.x; Zaytoun OM, 2011, UROLOGY, V78, P392, DOI 10.1016/j.urology.2011.04.042; Zhu Gang, 2009, Zhonghua Yi Xue Za Zhi, V89, P955	29	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49914	10.1371/journal.pone.0049914	http://dx.doi.org/10.1371/journal.pone.0049914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189170	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800047
J	Namountougou, M; Simard, F; Baldet, T; Diabate, A; Ouedraogo, JB; Martin, T; Dabire, RK				Namountougou, Moussa; Simard, Frederic; Baldet, Thierry; Diabate, Abdoulaye; Ouedraogo, Jean Bosco; Martin, Thibaud; Dabire, Roch K.			Multiple Insecticide Resistance in Anopheles gambiae s.l. Populations from Burkina Faso, West Africa	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; MALARIA VECTOR; PYRETHROID RESISTANCE; CULEX-QUINQUEFASCIATUS; CARBAMATE RESISTANCE; ACE-1(R) MUTATION; MOLECULAR-FORMS; KDR MUTATION; AREA; IDENTIFICATION	Malaria control programs are being jeopardized by the spread of insecticide resistance in mosquito vector populations. The situation in Burkina Faso is emblematic with Anopheles gambiae populations showing high levels of resistance to most available compounds. Although the frequency of insecticide target-site mutations including knockdown resistance (kdr) and insensitive acetylcholinesterase (Ace-1(R)) alleles has been regularly monitored in the area, it is not known whether detoxifying enzymes contribute to the diversity of resistance phenotypes observed in the field. Here, we propose an update on the phenotypic diversity of insecticide resistance in An. gambiae populations sampled from 10 sites in Burkina Faso in 2010. Susceptibility to deltamethrin, permethrin, DDT, bendiocarb and fenithrotion was assessed. Test specimens (N = 30 per locality) were identified to species and molecular form and their genotype at the kdr and Ace-1 loci was determined. Detoxifying enzymes activities including non-specific esterases (NSEs), oxydases (cytochrome P450) and Glutathione S-Transferases (GSTs) were measured on single mosquitoes (N = 50) from each test locality and compared with the An. gambiae Kisumu susceptible reference strain. In all sites, mosquitoes demonstrated multiple resistance phenotypes, showing reduced mortality to several insecticidal compounds at the same time, although with considerable site-to-site variation. Both the kdr 1014L and Ace-1(R) 119S resistant alleles were detected in the M and the S forms of An. gambiae, and were found together in specimens of the S form. Variation in detoxifying enzyme activities was observed within and between vector populations. Elevated levels of NSEs and GSTs were widespread, suggesting multiple resistance mechanisms segregate within An. gambiae populations from this country. By documenting the extent and diversity of insecticide resistance phenotypes and the putative combination of their underlying mechanisms in An. gambiae mosquitoes, our work prompts for new alternative strategies to be urgently developed for the control of major malaria vectors in Burkina Faso.	[Namountougou, Moussa; Simard, Frederic; Diabate, Abdoulaye; Ouedraogo, Jean Bosco; Dabire, Roch K.] Inst Rech Sci Sante, Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Simard, Frederic; Baldet, Thierry; Martin, Thibaud] Inst Rech Dev, Montpellier, France; [Baldet, Thierry; Martin, Thibaud] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Baldet, Thierry; Martin, Thibaud] Ctr Cooperat Int Rech Agron Dev, Montpellier, France	Centre Muraz; Institut de Recherche pour le Developpement (IRD); Entomological Research Center of Cotonou (CREC); CIRAD	Namountougou, M (corresponding author), Inst Rech Sci Sante, Ctr Muraz, Bobo Dioulasso, Burkina Faso.	namountougou_d@yahoo.fr	Frederic, SIMARD/AFV-5001-2022; SIMARD, Frederic/J-9489-2016; Dabire, Roch Kounbobr/ABF-3525-2020	Frederic, SIMARD/0000-0002-2871-5329; SIMARD, Frederic/0000-0002-2871-5329; DIABATE, Abdoulaye/0000-0002-9666-9395; Ouedraogo, Jean Bosco/0000-0003-0412-8733	Corus project [6015]; IRD through the JEAI-RISA program; IRD/DSF	Corus project; IRD through the JEAI-RISA program; IRD/DSF	The study was supported by Corus project ref. 6015 and the IRD through the JEAI-RISA program. Corus project is a program of french research agency funding research in Southern universities and research institutes. MN was supported by a PhD scholarship from the IRD/DSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akogbeto M, 2011, AM J TROP MED HYG, V85, P586, DOI 10.4269/ajtmh.2011.10-0668; Akogbeto MC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-22; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Casimiro S, 2006, J MED ENTOMOL, V43, P276, DOI 10.1603/0022-2585(2006)043[0276:IRIAAA]2.0.CO;2; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; Chandre F, 1997, J MED ENTOMOL, V34, P664, DOI 10.1093/jmedent/34.6.664; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Dabire KR, 2012, INSECTICIDES - PEST ENGINEERING, P479; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2009, TROP MED INT HEALTH, V14, P396, DOI 10.1111/j.1365-3156.2009.02243.x; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; Djogbenou L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-70; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Etang J, 2007, J VECTOR ECOL, V32, P123, DOI 10.3376/1081-1710(2007)32[123:SOMRTD]2.0.CO;2; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Gillies B.B., 1968, PUBLICATION S AFR I, V343; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; Hamon J, 1968, Med Trop (Mars), V28, P221; HAMON J, 1968, Medecine Tropicale, V28, P521; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; HEMINGWAY J, 1990, MED VET ENTOMOL, V4, P275, DOI 10.1111/j.1365-2915.1990.tb00440.x; HEMINGWAY J, 1984, B WORLD HEALTH ORGAN, V62, P445; HEMINGWAY J, 1983, Parassitologia (Rome), V25, P1; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Janeira F, 2008, J MED ENTOMOL, V45, P237, DOI 10.1603/0022-2585(2008)45[237:APRACR]2.0.CO;2; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Labbe P, 2007, MOL BIOL EVOL, V24, P1056, DOI 10.1093/molbev/msm025; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; MITTAL P K, 1991, Indian Journal of Malariology, V28, P167; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Nwane P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-163; Ouedraogo M, 2011, PESTICIDES IN THE MODERN WORLD - PESTICIDES USE AND MANAGEMENT, P35; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Prapanthadara LA, 1996, INSECT BIOCHEM MOLEC, V26, P277, DOI 10.1016/0965-1748(95)00090-9; Prapanthadara LA, 1993, BIOCHEM SOC T, V21, p304S; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2002, INSECT MOL BIOL, V11, P409, DOI 10.1046/j.1365-2583.2002.00350.x; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Scott JG, 1996, J PESTIC SCI, V21, P241; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; *WHO, 1998, WHOCDSCPCMAL98; Willoughby L, 2007, PEST MANAG SCI, V63, P803, DOI 10.1002/ps.1391; World Health Organization, 2012, LAUNCH GLOB PLAN INS; Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x	66	76	77	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e48412	10.1371/journal.pone.0048412	http://dx.doi.org/10.1371/journal.pone.0048412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189131	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800010
J	Coulombe, P; Qualls, C; Kruszynski, R; Nerlich, A; Bianucci, R; Harris, R; Mermier, C; Appenzeller, O				Coulombe, Patrick; Qualls, Clifford; Kruszynski, Robert; Nerlich, Andreas; Bianucci, Raffaella; Harris, Richard; Mermier, Christine; Appenzeller, Otto			Network Science in Egyptology	PLOS ONE			English	Article								Egyptology relies on traditional descriptive methods. Here we show that modern, Internet-based science and statistical methods can be applied to Egyptology. Two four-thousand-year-old sarcophagi in one tomb, one within the other, with skeletal remains of a woman, gave us the opportunity to diagnose a congenital nervous system disorder in the absence of a living nervous system. The sarcophagi were discovered near Thebes, Egypt. They were well preserved and meticulously restored. The skeletal remains suggested that the woman, aged between 50 and 60 years, was Black, possibly of Nubian descent and suffered from syringobulbia, a congenital cyst in the brain stem and upper spinal cord. We employed crowd sourcing, the anonymous responses of 204 Facebook users who performed a matching task of living persons' iris color with iris color of the Udjat eyes, a decoration found on Egyptian sarcophagi, to confirm the ethnicities of the sarcophagus occupants. We used modern fMRI techniques to illustrate the putative extent of her lesion in the brain stem and upper spinal cord deduced from her skeletal remains. We compared, statistically, the right/left ratios, a non-dimensional number, of the orbit height, orbit width, malar height and the infraorbital foramena with the same measures obtained from 32 ancient skulls excavated from the Fayum, North of Thebes. We found that these ratios were significantly different in this skull indicating atrophy of cranial bones on the left. In this instance, Internet science and the use of modern neurologic research tools showed that ancient sarcophagus makers shaped and decorated their wares to fit the ethnicity of the prospective occupants of the sarcophagi. We also showed that, occasionally, human nervous system disease may be recognizable in the absence of a living nervous system.	[Bianucci, Raffaella; Appenzeller, Otto] New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM USA; [Coulombe, Patrick; Harris, Richard] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Qualls, Clifford] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Kruszynski, Robert] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Nerlich, Andreas] Klinikum Munchen Bogenhausen, Sect Paleopathol, Inst Pathol, Munich, Germany; [Bianucci, Raffaella] Univ Turin, Lab Criminalist Sci, Dept Anat Pharmacol & Legal Med, Turin, Italy; [Mermier, Christine] Univ New Mexico, Exercise Physiol Lab, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; Natural History Museum London; Munchen Klinik; University of Turin; University of New Mexico	Appenzeller, O (corresponding author), New Mexico Hlth Enhancement & Marathon Clin Res F, Albuquerque, NM USA.	OttoArun12@aol.com	Bianucci, Raffaella/AAW-1433-2020	Nerlich, Andreas/0000-0001-6562-1017	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000041, UL1 TR001449] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Appenzeller O, 2001, J NEUROL NEUROSUR PS, V70, P524, DOI 10.1136/jnnp.70.4.524; GRIFFIN CJ, 1979, AUST DENT J, V24, P94, DOI 10.1111/j.1834-7819.1979.tb03615.x; Ikram S, 2003, DEATH BURIAL ANCIENT, P207; Komisaruk BR, 2002, AM J NEURORADIOL, V23, P609; Losch S., 2012, BAR INT SERIES, V2359, P37; Nerlich AG, 2010, BAR INT SERIES, V2141, P113; Nielsen M, 2012, REINVENTING DISCOVER, P264; Polz D, 2007, EWIGKEIT GESCHAFFEN, P139; Remler P., 2010, EGYPTIAN MYTHOLOGY A	9	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50382	10.1371/journal.pone.0050382	http://dx.doi.org/10.1371/journal.pone.0050382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185613	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000226
J	Watanabe, S; Sato, K; Ponganis, PJ				Watanabe, Shinichi; Sato, Katsufumi; Ponganis, Paul J.			Activity Time Budget during Foraging Trips of Emperor Penguins	PLOS ONE			English	Article							DIVING BEHAVIOR; CLIMATE-CHANGE; ISLAND; OCEAN; SEALS	We developed an automated method using depth and one axis of body acceleration data recorded by animal-borne data loggers to identify activities of penguins over long-term deployments. Using this technique, we evaluated the activity time budget of emperor penguins (n = 10) both in water and on sea ice during foraging trips in chick-rearing season. During the foraging trips, emperor penguins alternated dive bouts (4.8 +/- 4.5 h) and rest periods on sea ice (2.5 +/- 2.3 h). After recorder deployment and release near the colony, the birds spent 17.9 +/- 8.4% of their time traveling until they reached the ice edge. Once at the ice edge, they stayed there more than 4 hours before the first dive. After the first dive, the mean proportions of time spent on the ice and in water were 30.8 +/- 7.4% and 69.2 +/- 7.4%, respectively. When in the water, they spent 67.9 +/- 3.1% of time making dives deeper than 5 m. Dive activity had no typical diurnal pattern for individual birds. While in the water between dives, the birds had short resting periods (1.2 +/- 1.7 min) and periods of swimming at depths shallower than 5 m (0.25 +/- 0.38 min). When the birds were on the ice, they primarily used time for resting (90.3 +/- 4.1% of time) and spent only 9.7 +/- 4.1% of time traveling. Thus, it appears that, during foraging trips at sea, emperor penguins traveled during dives >5 m depth, and that sea ice was primarily used for resting. Sea ice probably provides refuge from natural predators such as leopard seals. We also suggest that 24 hours of sunlight and the cycling of dive bouts with short rest periods on sea ice allow emperor penguins to dive continuously throughout the day during foraging trips to sea.	[Watanabe, Shinichi] Fukuyama Univ, Fac Life Sci & Biotechnol, Fukuyama, Hiroshima, Japan; [Sato, Katsufumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Int Coastal Res Ctr, Kashiwa, Chiba, Japan; [Ponganis, Paul J.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA	Fukuyama University; University of Tokyo; University of California System; University of California San Diego; Scripps Institution of Oceanography	Watanabe, S (corresponding author), Fukuyama Univ, Fac Life Sci & Biotechnol, Fukuyama, Hiroshima, Japan.	watanabe@ma.fuma.fukuyama-u.ac.jp		Chiaradia, Andre/0000-0002-6178-4211	NSF [OPP 0229638, 0538594, 0944220]; Japanese Society for the Promotion of Science [A19255001]; program "Bio-Logging Science of The University of Tokyo (UTBLS)"	NSF(National Science Foundation (NSF)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); program "Bio-Logging Science of The University of Tokyo (UTBLS)"	This work was supported by NSF Grants OPP 0229638, 0538594 and 0944220, and by funds from the Japanese Society for the Promotion of Science (A19255001), and the program "Bio-Logging Science of The University of Tokyo (UTBLS)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2012, POLAR BIOL, V35, P1, DOI 10.1007/s00300-011-1042-x; AINLEY DG, 1972, IBIS, V114, P388, DOI 10.1111/j.1474-919X.1972.tb00836.x; Alexander RM, 1999, NATURE, V397, P651, DOI 10.1038/17687; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CHAPPELL MA, 1993, ECOLOGY, V74, P1204, DOI 10.2307/1940491; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; DEWASMES G, 1980, J APPL PHYSIOL, V49, P888, DOI 10.1152/jappl.1980.49.5.888; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; KOOYMAN GL, 1995, CONDOR, V97, P536, DOI 10.2307/1369039; Lynch HJ, 2012, ECOLOGY, V93, P1367; ROGERS T, 1995, CAN J ZOOL, V73, P1001, DOI 10.1139/z95-119; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sarkar D., 2019, NLME LINEAR NONLINEA; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2011, J EXP BIOL, V214, P2854, DOI 10.1242/jeb.055723; Shiomi K, 2008, AQUAT BIOL, V3, P265, DOI 10.3354/ab00087; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Takahashi A, 2004, J ETHOL, V22, P5, DOI 10.1007/s10164-003-0111-1; Takahashi A, 2003, MAR ECOL PROG SER, V250, P279, DOI 10.3354/meps250279; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Williams T.D., 1995, PENGUINS; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Yoda K, 2001, J EXP BIOL, V204, P685	29	12	12	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50357	10.1371/journal.pone.0050357	http://dx.doi.org/10.1371/journal.pone.0050357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185608	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000221
J	Schultz, AL; Malcolm, HA; Bucher, DJ; Smith, SDA				Schultz, Arthur L.; Malcolm, Hamish A.; Bucher, Daniel J.; Smith, Stephen D. A.			Effects of Reef Proximity on the Structure of Fish Assemblages of Unconsolidated Substrata	PLOS ONE			English	Article							SNAPPER PAGRUS-AURATUS; SELECTING MARINE RESERVES; UNDERWATER VIDEO STATIONS; DEMERSAL FISH; BAITED VIDEO; COMMUNITY STRUCTURE; RELATIVE DENSITY; HABITAT; SEAGRASS; PATTERNS	Fish assemblages of unconsolidated sedimentary habitats on continental shelves are poorly described when compared to those of hard substrata. This lack of data restricts the objective management of these extensive benthic habitats. In the context of protecting representative areas of all community types, one important question is the nature of the transition from reefal to sedimentary fish assemblages. We addressed this question using Baited Remote Underwater Videos (BRUVs) to assess fish assemblages of sedimentary habitats at six distances from rocky reefs (0, 25, 50, 100, 200, and 400 m) at four sites in subtropical eastern Australia. Distance from reef was important in determining fish assemblage structure, and there was no overlap between reef sites and sedimentary sites 400 m from reef. While there was a gradient in assemblage structure at intermediate distances, this was not consistent across sites. All sites, however, supported a mixed 'halo' assemblage comprising both reef and sediment species at sampling stations close to reef. BRUVs used in conjunction with high-resolution bathymetric and backscatter spatial data can resolve differences in assemblage structure at small spatial scales (10s to 100s of metres), and has further application in unconsolidated habitats. Unless a 'reef halo' assemblage is being examined, a minimum of 200 m but preferably 400 m distance from any hard substrate is recommended when designing broader-scale assessments of fish assemblages of sedimentary habitats.	[Schultz, Arthur L.; Smith, Stephen D. A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Malcolm, Hamish A.] Aquat Ecosyst Res, NSW Dept Primary Ind, Coffs Harbour, NSW, Australia; [Schultz, Arthur L.; Bucher, Daniel J.; Smith, Stephen D. A.] So Cross Univ, Sch Environm Sci & Engn, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia	Southern Cross University; NSW Department of Primary Industries; Southern Cross University	Schultz, AL (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	a.schultz.22@student.scu.edu.au	Smith, Stephen D A/I-1945-2012	Smith, Stephen D A/0000-0002-3372-5441; Bucher, Daniel/0000-0002-7640-4496	Southern Cross University	Southern Cross University	All funding for this project was supplied by a postgraduate (PhD) research budget from Southern Cross University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Barnes LM, 2011, ENVIRON BIOL FISH, V90, P429, DOI 10.1007/s10641-010-9752-4; Bortone SA, 1998, ITAL J ZOOL, V65, P265, DOI 10.1080/11250009809386830; BURKE NC, 1995, ENVIRON BIOL FISH, V42, P365, DOI 10.1007/BF00001467; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Cappo M., 2006, AUSTR SOC FISH BIOL, VVol. 1, P101, DOI DOI 10.1007/978-1-62703-724-2_1; Cappo M, 2007, MAR ECOL PROG SER, V350, P209, DOI 10.3354/meps07189; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Connell SD, 1999, ESTUAR COAST SHELF S, V48, P483, DOI 10.1006/ecss.1998.0438; Curley BG, 2002, MAR FRESHWATER RES, V53, P1197, DOI 10.1071/MF01199; Day J.C., 2000, PLANNING REPRESENTAT; DECCW, 2010, SEAB MAPP CONT SHELF; Dorenbosch M, 2005, MAR ECOL PROG SER, V299, P277, DOI 10.3354/meps299277; Edgar GJ, 1999, J EXP MAR BIOL ECOL, V242, P107, DOI 10.1016/S0022-0981(99)00098-2; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Gladstone W, 2002, BIOL CONSERV, V104, P211, DOI 10.1016/S0006-3207(01)00167-7; GRAY CA, 1994, AUST J MAR FRESH RES, V45, P665; Grober-Dunsmore R, 2007, CORAL REEFS, V26, P201, DOI 10.1007/s00338-006-0180-z; HARRIOTT VJ, 1994, MAR ECOL PROG SER, V109, P67, DOI 10.3354/meps109067; Harvey ES, 2012, J EXP MAR BIOL ECOL, V426, P78, DOI 10.1016/j.jembe.2012.05.019; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Hyndes GA, 1999, MAR BIOL, V134, P335, DOI 10.1007/s002270050551; Hyndes GA, 2005, ESTUAR COAST SHELF S, V63, P633, DOI 10.1016/j.ecss.2005.01.008; Jenkins GP, 1998, J EXP MAR BIOL ECOL, V221, P147, DOI 10.1016/S0022-0981(97)00121-4; Jones Geoffrey P., 2002, P81, DOI 10.1016/B978-012615185-5/50006-2; Kingsford M., 1998, STUDYING TEMPERATE M; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Langlois TJ, 2006, OECOLOGIA, V147, P134, DOI 10.1007/s00442-005-0148-7; Langlois TJ, 2005, ECOLOGY, V86, P1508, DOI 10.1890/04-0234; Lindberg WJ, 1996, FUNDAMENTAL DESIGN P; MACINTYRE IG, 1987, CORAL REEFS, V6, P1, DOI 10.1007/BF00302206; Malcolm HA, 2012, OCEAN COAST MANAGE, V59, P1, DOI 10.1016/j.ocecoaman.2011.12.001; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2011, AQUAT CONSERV, V21, P173, DOI 10.1002/aqc.1165; Malcolm Hamish A., 2010, Marine Biodiversity, V40, P181, DOI 10.1007/s12526-010-0042-3; Malcolm HA, 2010, AQUAT CONSERV, V20, P83, DOI 10.1002/aqc.1055; Moore CH, 2010, MAR BIOL, V157, P2717, DOI 10.1007/s00227-010-1531-4; NSW Marine Park Authority, 2010, SEABED HABITAT MAPPI; Owen V, 2010, 2010 M AUSTR MAR SCI; Parsons DM, 2003, MAR ECOL PROG SER, V262, P253, DOI 10.3354/meps262253; POSEY MH, 1994, MAR BIOL, V118, P745, DOI 10.1007/BF00347524; Priede IG, 1998, FISH RES, V36, P133, DOI 10.1016/S0165-7836(98)00105-2; Priede IG, 1996, J FISH BIOL, V49, P207, DOI 10.1111/j.1095-8649.1996.tb06077.x; Roberts CM, 2003, ECOL APPL, V13, pS215; ROBERTSON AI, 1984, J EXP MAR BIOL ECOL, V84, P265, DOI 10.1016/0022-0981(84)90185-0; SAINTE-MARIE B, 1987, MAR BIOL, V94, P431, DOI 10.1007/BF00428250; Smith SDA, 2005, BIODIVERS CONSERV, V14, P3565, DOI 10.1007/s10531-004-0828-3; Smith SDA, 2008, MAR POLLUT BULL, V56, P525, DOI 10.1016/j.marpolbul.2007.11.016; Snelgrove P, 1997, AMBIO, V26, P578; Stevens T, 2004, BIOL CONSERV, V119, P351, DOI 10.1016/j.biocon.2003.12.001; Swainston R., 2011, FISHES AUSTR COMPLET; Valentine JF, 2007, MAR ECOL PROG SER, V333, P37, DOI 10.3354/meps333037; Valesini FJ, 2004, ESTUAR COAST SHELF S, V60, P737, DOI 10.1016/j.ecss.2004.03.012; Vanderklift MA, 2007, MAR ECOL PROG SER, V340, P235, DOI 10.3354/meps340235; Ward TJ, 1999, ECOL APPL, V9, P691; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Wernberg T, 2006, OECOLOGIA, V147, P692, DOI 10.1007/s00442-005-0318-7; Williams A, 2001, MAR FRESHWATER RES, V52, P513, DOI 10.1071/MF00017; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Willis TJ, 2001, NEW ZEAL J MAR FRESH, V35, P581, DOI 10.1080/00288330.2001.9517024	67	29	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49437	10.1371/journal.pone.0049437	http://dx.doi.org/10.1371/journal.pone.0049437			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23189145	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885300040
J	Hawinkels, LJAC; Paauwe, M; Verspaget, HW; Wiercinska, E; van der Zon, JM; van der Ploeg, K; Koelink, PJ; Lindeman, JHN; Mesker, W; ten Dijke, P; Sier, CFM				Hawinkels, L. J. A. C.; Paauwe, M.; Verspaget, H. W.; Wiercinska, E.; van der Zon, J. M.; van der Ploeg, K.; Koelink, P. J.; Lindeman, J. H. N.; Mesker, W.; ten Dijke, P.; Sier, C. F. M.			Interaction with colon cancer cells hyperactivates TGF-beta signaling in cancer-associated fibroblasts	ONCOGENE			English	Article						CAF; colorectal cancer; MMP; signaling; TGF-beta; tumor microenvironment	GROWTH-FACTOR-BETA; MUSCLE ACTIN EXPRESSION; MYOFIBROBLAST DIFFERENTIATION; CELLULAR-LOCALIZATION; MAMMARY-GLAND; BREAST-CANCER; TUMOR-CELLS; ACTIVATION; TGF-BETA-1; CARCINOMA	The interaction between epithelial cancer cells and cancer-associated fibroblasts (CAFs) has a major role in cancer progression and eventually in metastasis. In colorectal cancer (CRC), CAFs are present in high abundance, but their origin and functional interaction with epithelial tumor cells has not been elucidated. In this study we observed strong activation of the transforming growth factor-beta (TGF-beta)/ Smad signaling pathway in CRC CAFs, accompanied by decreased signaling in epithelial tumor cells. We evaluated the TGF-beta 1 response and the expression of target genes including matrix metalloproteinases (MMPs) and plasminogen activator inhibitor (PAI)-1 of various epithelial CRC cell lines and primary CAFs in vitro. TGF-beta 1 stimulation caused high upregulation of MMPs, PAI-1 and TGF-beta 1 itself. Next we showed that incubation of CAFs with conditioned medium (CM) from epithelial cancer cells led to hyperactivation of the TGF-beta signaling pathway, enhanced expression of target genes like PAI-1, and the expression of alpha-smooth muscle actin (alpha-SMA). We propose that the interaction of tumor cells with resident fibroblasts results in hyperactivated TGF-beta 1 signaling and subsequent transdifferentiation of the fibroblasts into alpha-SMA-positive CAFs. In turn this leads to cumulative production of TGF-beta and proteinases within the tumor microenvironment, creating a cancer-promoting feedback loop.	[Hawinkels, L. J. A. C.; Verspaget, H. W.; van der Zon, J. M.; Koelink, P. J.; Sier, C. F. M.] Leiden Univ, Med Ctr, Dept Gastroenterol Hepatol, NL-2300 RC Leiden, Netherlands; [Hawinkels, L. J. A. C.; Paauwe, M.; Wiercinska, E.; van der Ploeg, K.; ten Dijke, P.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands; [Hawinkels, L. J. A. C.; Paauwe, M.; Wiercinska, E.; van der Ploeg, K.; ten Dijke, P.] Leiden Univ, Med Ctr, Ctr Biomed Genet, NL-2300 RC Leiden, Netherlands; [Lindeman, J. H. N.] Leiden Univ, Med Ctr, Dept Vasc Surg, NL-2300 RC Leiden, Netherlands; [Mesker, W.; Sier, C. F. M.] Leiden Univ, Med Ctr, Dept Surg, NL-2300 RC Leiden, Netherlands; [ten Dijke, P.] Uppsala Univ, Ludwig Inst Canc Res, Uppsala, Sweden	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ludwig Institute for Cancer Research; Uppsala University	Hawinkels, LJAC (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Bldg 2,S1-P,POB 9600, NL-2300 RC Leiden, Netherlands.	L.J.A.C.Hawinkels@LUMC.nl	Hawinkels, Lukas/Q-5098-2019; Paauwe, Madelon/C-8244-2018; Sier, Cornelis/A-7664-2008; Dijke, Peter ten/AAG-4660-2021	Hawinkels, Lukas/0000-0002-2274-9325; Sier, Cornelis/0000-0002-4337-2758; Dijke, Peter ten/0000-0002-7234-342X; Wiercinska, Eliza/0000-0002-8434-6492	EC [090773]; Bas Mulder Award [UL2011-5051]	EC(European CommissionEuropean Commission Joint Research Centre); Bas Mulder Award	We thank Dr R Hanemaaijer (TNO Quality of Life BioSciences, Leiden, The Netherlands) for helpful suggestions and reagents. Eveline de Jonge-Muller (Department of Gastroenterology-Hepatology, LUMC), Adri Mulder-Stapel (TNO) and Gabi van Pelt (Department Surgery, LUMC) are acknowledged for excellent technical support. This work was supported by the EC Tumor-host genomic project, the Centre for Biomedical Genetics, the Swedish Cancer Fonden 090773 (EW, PtD) and the Bas Mulder Award 2011 (LJACH, MP, UL2011-5051).	Adegboyega PA, 2002, ARCH PATHOL LAB MED, V126, P829; Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Barcellos-Hoff MH, 2000, BREAST CANCER RES, V2, P92, DOI 10.1186/bcr40; BARCELLOSHOFF MH, 1994, J CLIN INVEST, V93, P892, DOI 10.1172/JCI117045; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Hawinkels LJAC, 2007, BRIT J CANCER, V97, P398, DOI 10.1038/sj.bjc.6603877; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hawinkels LJAC, 2007, BIOCHEM BIOPH RES CO, V364, P549, DOI 10.1016/j.bbrc.2007.10.032; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hawinkels LJAC, 2009, CANCER SCI, V100, P663, DOI 10.1111/j.1349-7006.2009.01100.x; Huet E, 2008, FASEB J, V22, P1144, DOI 10.1096/fj.07-8748com; Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kankuri E, 2005, CANCER RES, V65, P9914, DOI 10.1158/0008-5472.CAN-05-1559; Kankuri E, 2008, INT J CANCER, V122, P1243, DOI 10.1002/ijc.23179; Kunz-Schughart LA, 2001, EXP CELL RES, V266, P74, DOI 10.1006/excr.2001.5210; Leivonen SK, 2007, INT J CANCER, V121, P2119, DOI 10.1002/ijc.23113; Lewis MP, 2004, BRIT J CANCER, V90, P822, DOI 10.1038/sj.bjc.6601611; Lieubeau B, 1999, INT J CANCER, V81, P629, DOI 10.1002/(SICI)1097-0215(19990517)81:4<629::AID-IJC20>3.3.CO;2-#; Lindeman JHN, 2004, AM J PATHOL, V165, P593, DOI 10.1016/S0002-9440(10)63323-8; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Mesker WE, 2007, CELL ONCOL, V29, P387; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Micke P, 2004, LUNG CANCER, V45, pS163, DOI 10.1016/j.lungcan.2004.07.977; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; Nishimura SL, 2009, AM J PATHOL, V175, P1362, DOI 10.2353/ajpath.2009.090393; Pardali E, 2011, ONCOGENE, V30, P334, DOI 10.1038/onc.2010.418; Park CC, 2000, MOL MED TODAY, V6, P324, DOI 10.1016/S1357-4310(00)01756-1; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pourreyron C, 2003, INT J CANCER, V104, P28, DOI 10.1002/ijc.10898; Powell DW, 2005, AM J PHYSIOL-GASTR L, V289, pG2, DOI 10.1152/ajpgi.00075.2005; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; Ruiter D, 2002, LANCET ONCOL, V3, P35, DOI 10.1016/S1470-2045(01)00620-9; Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9; Sier CFM, 2008, MATRIX BIOL, V27, P267, DOI 10.1016/j.matbio.2007.10.006; Stolle K, 2005, GENE, V351, P119, DOI 10.1016/j.gene.2005.03.012; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Woodford-Richens KL, 2001, P NATL ACAD SCI USA, V98, P9719, DOI 10.1073/pnas.171321498; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105	51	154	159	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2014	33	1					97	107		10.1038/onc.2012.536	http://dx.doi.org/10.1038/onc.2012.536			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	282YU	23208491				2022-12-25	WOS:000329212000011
J	Nietzel, T; Dudkina, NV; Haase, C; Denolf, P; Semchonok, DA; Boekema, EJ; Braun, HP; Sunderhaus, S				Nietzel, Thomas; Dudkina, Natalya V.; Haase, Christin; Denolf, Peter; Semchonok, Dmitry A.; Boekema, Egbert J.; Braun, Hans-Peter; Sunderhaus, Stephanie			The Native Structure and Composition of the Cruciferin Complex in Brassica napus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEED STORAGE PROTEINS; POLYACRYLAMIDE GELS; CRYSTAL-STRUCTURE; 11S GLOBULIN; BLUE DYES; ARABIDOPSIS; RAPESEED; POLYPEPTIDES; PROTEASES; VACUOLES	Globulins are an important group of seed storage proteins in dicotyledonous plants. They are synthesized during seed development, assembled into very compact protein complexes, and finally stored in protein storage vacuoles (PSVs). Here, we report a proteomic investigation on the native composition and structure of cruciferin, the 12 S globulin of Brassica napus. PSVs were directly purified from mature seeds by differential centrifugations. Upon analyses by blue native (BN) PAGE, two major types of cruciferin complexes of similar to 300-390 kDa and of similar to 470 kDa are resolved. Analyses by two-dimensional BN/SDS-PAGE revealed that both types of complexes are composed of several copies of the cruciferin alpha and beta polypeptide chains, which are present in various isoforms. Protein analyses by two-dimensional isoelectric focusing (IEF)/SDS-PAGE not only revealed different alpha and beta isoforms but also several further versions of the two polypeptide chains that most likely differ with respect to posttranslational modifications. Overall, more than 30 distinct forms of cruciferin were identified by mass spectrometry. To obtain insights into the structure of the cruciferin holocomplex, a native PSV fraction was analyzed by single particle electron microscopy. More than 20,000 images were collected, classified, and used for the calculation of detailed projection maps of the complex. In contrast to previous reports on globulin structure in other plant species, the cruciferin complex of Brassica napus has an octameric barrel-like structure, which represents a very compact building block optimized for maximal storage of amino acids within minimal space.	[Nietzel, Thomas; Haase, Christin; Braun, Hans-Peter; Sunderhaus, Stephanie] Leibniz Univ Hannover, Dept Plant Prote, Inst Plant Genet, Fac Nat Sci, D-30419 Hannover, Germany; [Dudkina, Natalya V.; Semchonok, Dmitry A.; Boekema, Egbert J.] Univ Groningen, Electron Microscopy Grp, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Denolf, Peter] Bayer CropSci NV, Oilseeds Res, BioSci, B-9052 Zwijnaarde, Belgium	Leibniz University Hannover; University of Groningen; Bayer AG; Bayer CropScience	Braun, HP (corresponding author), Leibniz Univ Hannover, Dept Plant Prote, Inst Plant Genet, Fac Nat Sci, Herrenhauser Str 2, D-30419 Hannover, Germany.	braun@genetik.uni-hannover.de	Braun, Hans-Peter/E-7149-2011; Semchonok, Dmitry/E-1461-2017	Braun, Hans-Peter/0000-0002-4459-9727; Nietzel, Thomas/0000-0002-1934-1732; Semchonok, Dmitry A./0000-0003-1622-9443	HARVEST Marie Curie Research Training Network Grant [PITN-GA-2009-238017]	HARVEST Marie Curie Research Training Network Grant	Supported by HARVEST Marie Curie Research Training Network Grant PITN-GA-2009-238017.	Adachi M, 2003, P NATL ACAD SCI USA, V100, P7395, DOI 10.1073/pnas.0832158100; Adachi M, 2001, J MOL BIOL, V305, P291, DOI 10.1006/jmbi.2000.4310; Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; BADLEY RA, 1975, BIOCHIM BIOPHYS ACTA, V412, P214, DOI 10.1016/0005-2795(75)90036-7; BHATTY RS, 1968, CAN J BIOCHEM CELL B, V46, P1191, DOI 10.1139/o68-178; BREEN JP, 1992, PLANT MOL BIOL, V19, P1049, DOI 10.1007/BF00040536; CHRISPEELS MJ, 1982, J CELL BIOL, V93, P306, DOI 10.1083/jcb.93.2.306; CROUCH ML, 1981, PLANTA, V153, P64, DOI 10.1007/BF00385319; DICKINSON CD, 1989, PLANT CELL, V1, P459, DOI 10.1105/tpc.1.4.459; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; EREKENTUMER N, 1982, J BIOL CHEM, V257, P4016; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; INQUELLO V, 1993, EUR J BIOCHEM, V217, P891, DOI 10.1111/j.1432-1033.1993.tb18318.x; Jiang LW, 2000, J CELL BIOL, V150, P755, DOI 10.1083/jcb.150.4.755; Jung R, 1998, PLANT CELL, V10, P343, DOI 10.1105/tpc.10.3.343; Kruft V, 2001, PLANT PHYSIOL, V127, P1694, DOI 10.1104/pp.010474; LAWRENCE MC, 1990, EMBO J, V9, P9, DOI 10.1002/j.1460-2075.1990.tb08074.x; MARCONE MF, 1994, J AGR FOOD CHEM, V42, P2675, DOI 10.1021/jf00048a005; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; MOREIRA MA, 1979, J BIOL CHEM, V254, P9921; Muntz K, 1996, J EXP BOT, V47, P605, DOI 10.1093/jxb/47.5.605; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; NEUHOFF V, 1990, ELECTROPHORESIS, V11, P101, DOI 10.1002/elps.1150110202; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; Otegui MS, 2006, PLANT CELL, V18, P2567, DOI 10.1105/tpc.106.040931; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PLIETZ P, 1983, EUR J BIOCHEM, V130, P315, DOI 10.1111/j.1432-1033.1983.tb07154.x; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; RODIN J, 1990, J BIOL CHEM, V265, P2720; RODIN J, 1992, PLANT MOL BIOL, V20, P559, DOI 10.1007/BF00040615; Rossmann MG, 2000, ACTA CRYSTALLOGR D, V56, P1341, DOI 10.1107/S0907444900009562; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schagger H., 2003, MEMBRANE PROTEIN PUR, P105; SCHWENKE KD, 1983, NAHRUNG, V27, P165, DOI 10.1002/food.19830270208; SENGUPTA C, 1981, Plant Molecular Biology, V1, P19, DOI 10.1007/BF00023011; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; SJODAHL S, 1991, EUR J BIOCHEM, V196, P617, DOI 10.1111/j.1432-1033.1991.tb15857.x; Sunderhaus S, 2010, PLANT PHYSIOL BIOCH, V48, P265, DOI 10.1016/j.plaphy.2010.01.010; Tandang MRG, 2004, BIOTECHNOL LETT, V26, P385, DOI 10.1023/B:BILE.0000018256.90457.ee; Tandang-Silvas MRG, 2010, BBA-PROTEINS PROTEOM, V1804, P1432, DOI 10.1016/j.bbapap.2010.02.016; Vitale A, 2005, TRENDS PLANT SCI, V10, P316, DOI 10.1016/j.tplants.2005.05.001; Wan LL, 2007, BIOCHEM J, V404, P247, DOI 10.1042/BJ20061569; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	44	15	16	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2238	2245		10.1074/jbc.M112.356089	http://dx.doi.org/10.1074/jbc.M112.356089			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23192340	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000314211500014
J	Bavan, S; Straub, VA; Webb, TE; Ennion, SJ				Bavan, Selvan; Straub, Volko A.; Webb, Tania E.; Ennion, Steven J.			Cloning and Characterization of a P2X Receptor Expressed in the Central Nervous System of Lymnaea stagnalis	PLOS ONE			English	Article							ATP-INDUCED CURRENTS; GATED ION CHANNELS; MOLECULAR-MECHANISM; HISTIDINE-RESIDUES; CYSTEINE RESIDUES; DIVALENT-CATIONS; EXTRACELLULAR PH; CELL-SURFACE; BINDING-SITE; ZINC	P2X receptors are membrane ion channels gated by extracellular ATP. Mammals possess seven distinct P2X subtypes (P2X-17) that have important functions in a wide array of physiological processes including roles in the central nervous system (CNS) where they have been linked to modulation of neurotransmitter release. We report here the cloning and functional characterization of a P2X receptor from the mollusc Lymnaea stagnalis. This model organism has a relatively simple CNS consisting of large readily identifiable neurones, a feature which together with a well characterized neuronal circuitry for important physiological processes such as feeding and respiration makes it an attractive potential model to examine P2X function. Using CODEHOP PCR we identified a single P2X receptor (LymP2X) in Lymnaea CNS which was subsequently cloned by RT-PCR. When heterologously expressed in Xenopus oocytes, LymP2X exhibited ATP evoked inward currents (EC50 6.2 mu M) which decayed during the continued presence of agonist. UTP and ADP did not activate the receptor whereas alpha beta meATP was a weak agonist. BzATP was a partial agonist with an EC50 of 2.4 mu M and a maximal response 33% smaller than that of ATP. The general P2 receptor antagonists PPADS and suramin both inhibited LymP2X currents with IC50 values of 8.1 and 27.4 mu M respectively. LymP2X is inhibited by acidic pH whereas Zn2+ and Cu2+ ions exhibited a biphasic effect, potentiating currents up to 100 mu M and inhibiting at higher concentrations. Quantitative RT-PCR and in situ hybridization detected expression of LymP2X mRNA in neurones of all CNS ganglia suggesting this ion channel may have widespread roles in Lymnaea CNS function.	[Bavan, Selvan; Straub, Volko A.; Ennion, Steven J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Webb, Tania E.] De Montfort Univ, Leicester Sch Pharm, Leicester LE1 9BH, Leics, England	University of Leicester; De Montfort University	Ennion, SJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	se15@le.ac.uk	Webb, Tania/AAT-9554-2020; Straub, Volko/M-9994-2015	Straub, Volker/0000-0001-9046-3540; Straub, Volko/0000-0003-0437-7449	Biotechnology and Biological Sciences Research Council; Wellcome Trust [WT081601MA]	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	SB was funded by a studentship from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx). SJE was funded by project grant WT081601MA from the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Bavan S, 2011, MOL PHARMACOL, V79, P776, DOI 10.1124/mol.110.070037; Bavan S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-17; Benjamin P.R., 1985, P87; Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; BENJAMIN PR, 1979, J EXP BIOL, V80, P93; BO XN, 1995, FEBS LETT, V375, P129, DOI 10.1016/0014-5793(95)01203-Q; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2009, ACTA PHYSIOL, V195, P415, DOI 10.1111/j.1748-1716.2009.01957.x; Cai XJ, 2012, PURINERG SIGNAL, V8, P11, DOI 10.1007/s11302-011-9261-8; Cai XJ, 2012, MOL BIOL EVOL, V29, P91, DOI 10.1093/molbev/msr149; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Coddou C, 2003, J BIOL CHEM, V278, P36777, DOI 10.1074/jbc.M305177200; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; El-Ajouz S, 2012, BRIT J PHARMACOL, V165, P390, DOI 10.1111/j.1476-5381.2011.01534.x; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Fountain SJ, 2008, J BIOL CHEM, V283, P15122, DOI 10.1074/jbc.M801512200; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fountain SJ, 2009, PURINERG SIGNAL, V5, P269, DOI 10.1007/s11302-008-9127-x; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Gruenhagen JA, 2004, J NEUROSCI METH, V139, P145, DOI 10.1016/j.jneumeth.2004.03.008; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Jelinkova I, 2008, PFLUG ARCH EUR J PHY, V456, P939, DOI 10.1007/s00424-008-0450-4; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kanjhan R, 1999, J COMP NEUROL, V407, P11; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Khakh BS, 1998, MOL PHARMACOL, V54, P372, DOI 10.1124/mol.54.2.372; King BF, 1997, BRIT J PHARMACOL, V121, P1445, DOI 10.1038/sj.bjp.0701286; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Kucenas S, 2003, NEUROSCIENCE, V121, P935, DOI 10.1016/S0306-4522(03)00566-9; Lorca RA, 2005, J NEUROCHEM, V95, P499, DOI 10.1111/j.1471-4159.2005.03387.x; Ludlow MJ, 2009, J BIOL CHEM, V284, P35227, DOI 10.1074/jbc.M109.045674; Mahaut-Smith MP, 2000, BRIT J PHARMACOL, V131, P108, DOI 10.1038/sj.bjp.0703517; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; Munno DW, 2003, J NEUROSCI, V23, P4146; Muskhelishvili L, 2001, J HISTOCHEM CYTOCHEM, V49, P229, DOI 10.1177/002215540104900210; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Nakazawa K, 1997, EUR J PHARMACOL, V325, P101, DOI 10.1016/S0014-2999(97)00107-6; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Pankratov YV, 2002, J NEUROSCI, V22, P8363; Punthambaker S, 2012, J BIOL CHEM, V287, P22099, DOI 10.1074/jbc.M112.369157; Raouf R, 2005, BBA-BIOMEMBRANES, V1669, P135, DOI 10.1016/j.bbamem.2005.01.009; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sim JA, 2008, J BIOL CHEM, V283, P29841, DOI 10.1074/jbc.M802523200; Sim JA, 2006, J NEUROSCI, V26, P9006, DOI 10.1523/JNEUROSCI.2370-06.2006; Sivaramakrishnan V, 2012, J BIOL CHEM; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; Stoop R, 1997, J NEUROPHYSIOL, V78, P1837, DOI 10.1152/jn.1997.78.4.1837; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Ueno T, 2001, J NEUROCHEM, V78, P1009, DOI 10.1046/j.1471-4159.2001.00473.x; Vorobjev VS, 2003, BRIT J PHARMACOL, V139, P919, DOI 10.1038/sj.bjp.0705321; Wan HM, 2010, J NEUROSCI, V30, P56, DOI 10.1523/JNEUROSCI.2577-09.2010; Wildman SS, 1999, BRIT J PHARMACOL, V128, P486, DOI 10.1038/sj.bjp.0702802	62	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50487	10.1371/journal.pone.0050487	http://dx.doi.org/10.1371/journal.pone.0050487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209755	Green Published, gold			2022-12-25	WOS:000312104900056
J	Song, JN; Tan, H; Perry, AJ; Akutsu, T; Webb, GI; Whisstock, JC; Pike, RN				Song, Jiangning; Tan, Hao; Perry, Andrew J.; Akutsu, Tatsuya; Webb, Geoffrey I.; Whisstock, James C.; Pike, Robert N.			PROSPER: An Integrated Feature-Based Tool for Predicting Protease Substrate Cleavage Sites	PLOS ONE			English	Article							SVM-BASED PREDICTION; SECONDARY STRUCTURE; EVOLUTIONARY INFORMATION; DISULFIDE CONNECTIVITY; UNSTRUCTURED PROTEINS; WIDE IDENTIFICATION; PROTEOLYTIC EVENTS; DISORDERED REGIONS; RESIDUE DEPTH; SEQUENCE	The ability to catalytically cleave protein substrates after synthesis is fundamental for all forms of life. Accordingly, site-specific proteolysis is one of the most important post-translational modifications. The key to understanding the physiological role of a protease is to identify its natural substrate(s). Knowledge of the substrate specificity of a protease can dramatically improve our ability to predict its target protein substrates, but this information must be utilized in an effective manner in order to efficiently identify protein substrates by in silico approaches. To address this problem, we present PROSPER, an integrated feature-based server for in silico identification of protease substrates and their cleavage sites for twenty-four different proteases. PROSPER utilizes established specificity information for these proteases (derived from the MEROPS database) with a machine learning approach to predict protease cleavage sites by using different, but complementary sequence and structure characteristics. Features used by PROSPER include local amino acid sequence profile, predicted secondary structure, solvent accessibility and predicted native disorder. Thus, for proteases with known amino acid specificity, PROSPER provides a convenient, pre-prepared tool for use in identifying protein substrates for the enzymes. Systematic prediction analysis for the twenty-four proteases thus far included in the database revealed that the features we have included in the tool strongly improve performance in terms of cleavage site prediction, as evidenced by their contribution to performance improvement in terms of identifying known cleavage sites in substrates for these enzymes. In comparison with two state-of-the-art prediction tools, PoPS and SitePrediction, PROSPER achieves greater accuracy and coverage. To our knowledge, PROSPER is the first comprehensive server capable of predicting cleavage sites of multiple proteases within a single substrate sequence using machine learning techniques. It is freely available at http://lightning.med.monash.edu.au/PROSPER/.	[Song, Jiangning; Tan, Hao; Perry, Andrew J.; Whisstock, James C.; Pike, Robert N.] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia; [Song, Jiangning] Chinese Acad Sci, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Inst Ind Biotechnol, Tianjin, Peoples R China; [Akutsu, Tatsuya] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan; [Webb, Geoffrey I.] Monash Univ, Fac Informat Technol, Melbourne, Vic 3004, Australia; [Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3004, Australia	Monash University; Chinese Academy of Sciences; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Kyoto University; Monash University; Monash University	Song, JN (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia.	Jiangning.Song@monash.edu; James.Whisstock@monash.edu; Rob.Pike@monash.edu	Perry, Andrew/E-5607-2010; Webb, Geoff i/R-9967-2017; Song, Jiangning/F-9787-2010; Webb, Geoffrey/Q-7270-2019	Perry, Andrew/0000-0001-9256-6068; Webb, Geoff i/0000-0001-9963-5169; Song, Jiangning/0000-0001-8031-9086; Webb, Geoffrey/0000-0001-9963-5169; Pike, Robert/0000-0002-2083-0269; Whisstock, James/0000-0003-4200-5611; Akutsu, Tatsuya/0000-0001-9763-797X	National Health and Medical Research Council of Australia (NHMRC) [490989]; Australian Research Council (ARC) [LP110200333]; Chinese Academy of Sciences (CAS) [KSCX2-EW-G-8]; Japan Society for the Promotion of Science [S11156]; Tianjin Municipal Science & Technology Commission [10ZCKFSY05600]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tianjin Municipal Science & Technology Commission	This work was supported by grants from the National Health and Medical Research Council of Australia (NHMRC) (490989), the Australian Research Council (ARC) (LP110200333), the Chinese Academy of Sciences (CAS), the Japan Society for the Promotion of Science (S11156), the Knowledge Innovation Program of CAS (KSCX2-EW-G-8) and Tianjin Municipal Science & Technology Commission (10ZCKFSY05600). JS is an NHMRC Peter Doherty Fellow and a Recipient of the Hundred Talents Program of CAS. AJP is an NHMRC Peter Doherty Fellow. JCW is an ARC Federation Fellow and an honorary NHMRC Principal Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000916; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Asur S, 2007, BIOINFORMATICS, V23, pI29, DOI 10.1093/bioinformatics/btm212; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Barkan DT, 2010, BIOINFORMATICS, V26, P1714, DOI 10.1093/bioinformatics/btq267; Baumgartner R, 2009, BIOCHEM J, V423, P429, DOI 10.1042/BJ20090540; Bock JR, 2002, MOL CELL PROTEOMICS, V1, P904, DOI 10.1074/mcp.M200054-MCP200; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen CT, 2008, BIOINFORMATICS, V24, P2691, DOI 10.1093/bioinformatics/btn538; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chen K, 2007, BIOINFORMATICS, V23, P2843, DOI 10.1093/bioinformatics/btm475; Chen L, 2010, BIOINFORMATICS, V26, P1416, DOI 10.1093/bioinformatics/btq144; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Demon D, 2009, MOL CELL PROTEOMICS, V8, P2700, DOI 10.1074/mcp.M900310-MCP200; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Edwards YJK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r50; Enoksson M, 2007, J PROTEOME RES, V6, P2850, DOI 10.1021/pr0701052; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Garay-Malpartida HM, 2005, BIOINFORMATICS, V21, pI169, DOI 10.1093/bioinformatics/bti1034; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hauske P, 2008, CHEMBIOCHEM, V9, P2920, DOI 10.1002/cbic.200800528; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Igarashi Y, 2009, NUCLEIC ACIDS RES, V37, pD611, DOI 10.1093/nar/gkn683; Impens F, 2010, CURR OPIN CELL BIOL, V22, P859, DOI 10.1016/j.ceb.2010.08.021; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Joachims T., 1999, ADV KERNEL METHODS S; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Ju WJ, 2007, P NATL ACAD SCI USA, V104, P14294, DOI 10.1073/pnas.0702251104; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lobley AE, 2008, NUCLEIC ACIDS RES, V36, pW297, DOI 10.1093/nar/gkn193; Lobley A, 2007, PLOS COMPUT BIOL, V3, P1567, DOI 10.1371/journal.pcbi.0030162; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Ng NM, 2009, BIOL CHEM, V390, P401, DOI 10.1515/BC.2009.065; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Palidwor GA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000304; Piippo M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-320; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Qian J, 2003, BIOINFORMATICS, V19, P1917, DOI 10.1093/bioinformatics/btg347; Quesada V, 2009, NUCLEIC ACIDS RES, V37, pD239, DOI 10.1093/nar/gkn570; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rana S, 2011, P NATL ACAD SCI USA, V108, P5221, DOI 10.1073/pnas.1018860108; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2010, NAT METHODS, V7, P508, DOI [10.1038/NMETH.1467, 10.1038/nmeth.1467]; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Song JN, 2008, BIOINFORMATICS, V24, P1489, DOI 10.1093/bioinformatics/btn222; Song JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-425; Song JN, 2007, BIOINFORMATICS, V23, P3147, DOI 10.1093/bioinformatics/btm505; Song JN, 2011, J BIOINF COMPUT BIOL, V9, P149, DOI 10.1142/S0219720011005288; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Song JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007072; Song JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-124; Thornberry NA, 1997, BRIT MED BULL, V53, P478; Timmer JC, 2009, NAT STRUCT MOL BIOL, V16, P1101, DOI 10.1038/nsmb.1668; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Van Damme P, 2010, NAT METHODS, V7, P512, DOI [10.1038/NMETH.1469, 10.1038/nmeth.1469]; Vapnik V.N., 1995, NATURE STAT LEARNING; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Wang MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043847; Wang XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026767; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wee LJK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S14; Wee LJK, 2007, BIOINFORMATICS, V23, P3241, DOI 10.1093/bioinformatics/btm334; Wee LJK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S6; Yang ZR, 2005, BIOINFORMATICS, V21, P1831, DOI 10.1093/bioinformatics/bti281; Yanover C, 2009, BIOINFORMATICS, V25, P868, DOI 10.1093/bioinformatics/btp090; Zhang H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-388; Zhu L, 2010, J COMPUT CHEM, V31, P1478, DOI 10.1002/jcc.21433	96	146	150	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50300	10.1371/journal.pone.0050300	http://dx.doi.org/10.1371/journal.pone.0050300			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209700	Green Submitted, Green Published, gold			2022-12-25	WOS:000312104900037
J	Song, WT; Pang, RY; Niu, YZ; Gao, FT; Zhao, YW; Zhang, J; Sun, J; Shao, CW; Liao, XL; Wang, L; Tian, YS; Chen, SL				Song, Wentao; Pang, Renyi; Niu, Yuze; Gao, Fengtao; Zhao, Yongwei; Zhang, Jing; Sun, Jian; Shao, Changwei; Liao, Xiaolin; Wang, Lei; Tian, Yongsheng; Chen, Songlin			Construction of High-Density Genetic Linkage Maps and Mapping of Growth-Related Quantitative Trail Loci in the Japanese Flounder (Paralichthys olivaceus)	PLOS ONE			English	Article							COMPARATIVE GENOME ANALYSIS; TROUT ONCORHYNCHUS-MYKISS; SEA-BASS; SEGREGATION DISTORTION; MICROSATELLITE MARKERS; FISH; POLYMORPHISM; RESISTANCE; DISEASE; SIZE	High-density genetic linkage maps were constructed for the Japanese flounder (Paralichthys olivaceus). A total of 1624 microsatellite markers were polymorphic in the reference family. Linkage analysis using JoinMap 4.0 resulted in the mapping of 1487 markers to 24 linkage groups, a result which was consistent with the 24 chromosomes seen in chromosome spreads. The female map was composed of 1257 markers, covering a total of 1663.8 cM with an average interval 1.35 cM between markers. The male map consisted of 1224 markers, spanning 1726.5 cM, with an average interval of 1.44 cM. The genome length in the Japanese flounder was estimated to be 1730.3 cM for the females and 1798.0 cM for the males, a coverage of 96.2% for the female and 96.0% for the male map. The mean recombination at common intervals throughout the genome revealed a slight difference between sexes, i.e. 1.07 times higher in the male than female. High-density genetic linkage maps are very useful for marker-assisted selection (MAS) programs for economically valuable traits in this species and for further evolutionary studies in flatfish and vertebrate species. Furthermore, four quantiative trait loci (QTL) associated with growth traits were mapped on the genetic map. One QTL was identified for body weight on LG 14 f, which explained 14.85% of the total variation of the body weight. Three QTL were identified for body width on LG14f and LG14m, accounting for 16.75%, 13.62% and 13.65% of the total variation in body width, respectively. The additive effects were evident as negative values. There were four QTL for growth traits clustered on LG14, which should prove to be very useful for improving growth traits using molecular MAS.	[Song, Wentao; Pang, Renyi; Niu, Yuze; Gao, Fengtao; Zhao, Yongwei; Zhang, Jing; Sun, Jian; Shao, Changwei; Liao, Xiaolin; Wang, Lei; Tian, Yongsheng; Chen, Songlin] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Song, Wentao] Weihai Vocat Coll, Dept Biol & Chem Engn, Weihai, Peoples R China; [Niu, Yuze; Zhang, Jing] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Shanghai Ocean University	Chen, SL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.	chensl@ysfri.ac.cn	Shao, Changwei/I-2054-2016	Shao, Changwei/0000-0002-6953-2203	National Major Basic Research Program [2010CB126303]; State 863 High-Technology R&D Project of China [2012AA092208, 2012AA092203]; Taishan Scholar Project of Shandong Province	National Major Basic Research Program(National Basic Research Program of China); State 863 High-Technology R&D Project of China(National High Technology Research and Development Program of China); Taishan Scholar Project of Shandong Province	The work was supported by grants from the National Major Basic Research Program (2010CB126303), the State 863 High-Technology R&D Project (2012AA092208; 2012AA092203) of China, and the Taishan Scholar Project of Shandong Province. The funders had an important role in study design and the decision to publish.	BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bouza C, 2007, GENETICS, V177, P2457, DOI 10.1534/genetics.107.075416; Castano-Sanchez C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-554; Chen SongLin, 2008, Journal of Fisheries of China, V32, P665; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Chistiakov DA, 2005, GENETICS, V170, P1821, DOI 10.1534/genetics.104.039719; Cnaani A, 2003, AQUACULTURE, V223, P117, DOI 10.1016/S0044-8486(03)00163-7; Coimbra MRM, 2003, AQUACULTURE, V220, P203, DOI 10.1016/S0044-8486(02)00353-8; Du M, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/613629; Falconer D. S., 1996, Introduction to quantitative genetics.; Faris JD, 1998, GENETICS, V149, P319; Franch R, 2006, GENETICS, V174, P851, DOI 10.1534/genetics.106.059014; Fuji K, 2006, AQUACULTURE, V254, P203, DOI 10.1016/j.aquaculture.2005.11.024; Gilbey J, 2004, ANIM GENET, V35, P98, DOI 10.1111/j.1365-2052.2004.01091.x; Guyomard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-302; Hubert S, 2004, GENETICS, V168, P351, DOI 10.1534/genetics.104.027342; Kai W, 2005, GENETICS, V171, P227, DOI 10.1534/genetics.105.042051; Kang JH, 2008, INT J BIOL SCI, V4, P143, DOI 10.7150/ijbs.4.143; Kondo M, 2001, GENET RES, V78, P23, DOI 10.1017/S0016672301005109; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022; Li L, 2004, MAR BIOTECHNOL, V6, P26, DOI 10.1007/s10126-003-0001-0; Liao XL, 2009, MAR BIOTECHNOL, V11, P699, DOI 10.1007/s10126-009-9184-3; Liu Z.J., 2007, AQUACULTURE GENOME T; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Liu ZJ, 2003, GENETICS, V165, P687; Ma HY, 2011, MOL BIOL REP, V38, P4749, DOI 10.1007/s11033-010-0612-2; Massault C, 2010, ANIM GENET, V41, P337, DOI 10.1111/j.1365-2052.2009.02010.x; Moen T, 2004, ANIM GENET, V35, P81, DOI 10.1111/j.1365-2052.2004.01097.x; Nikaido A, 1999, GENES GENET SYST, V74, P55, DOI 10.1266/ggs.74.55; Oblessuc PR, 2009, PESQUI AGROPECU BRAS, V44, P638, DOI 10.1590/S0100-204X2009000600013; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; PLOMION C, 1995, THEOR APPL GENET, V90, P1028, DOI 10.1007/BF00222917; Reid DP, 2007, GENETICS, V177, P1193, DOI 10.1534/genetics.107.075374; Reid DP, 2005, HEREDITY, V94, P166, DOI 10.1038/sj.hdy.6800590; Rexroad CE, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-74; Sakamoto T, 2000, GENETICS, V155, P1331; Sambrook J., 2001, MOL CLONING LAB MAMU; Senger F, 2006, GENOMICS, V87, P793, DOI 10.1016/j.ygeno.2005.11.019; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Tripathi N, 2009, P ROY SOC B-BIOL SCI, V276, P2195, DOI 10.1098/rspb.2008.1930; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Wang CM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-174; Wang WJ, 2010, AQUACULT INT, V18, P825, DOI 10.1007/s10499-009-9303-1; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-135; Xu TJ, 2008, FISH SHELLFISH IMMUN, V25, P213, DOI 10.1016/j.fsi.2008.05.007; You EM, 2010, ANIM GENET, V41, P365, DOI 10.1111/j.1365-2052.2009.02014.x; Young WP, 1998, GENETICS, V148, P839; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602; Zhang LS, 2007, GENETICA, V131, P37, DOI 10.1007/s10709-006-9111-8	50	28	41	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50404	10.1371/journal.pone.0050404	http://dx.doi.org/10.1371/journal.pone.0050404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209734	gold, Green Published, Green Submitted			2022-12-25	WOS:000312104900049
J	Mansion, G; Parolly, G; Crowl, AA; Mavrodiev, E; Cellinese, N; Oganesian, M; Fraunhofer, K; Kamari, G; Phitos, D; Haberle, R; Akaydin, G; Ikinci, N; Raus, T; Borsch, T				Mansion, Guilhem; Parolly, Gerald; Crowl, Andrew A.; Mavrodiev, Evgeny; Cellinese, Nico; Oganesian, Marine; Fraunhofer, Katharina; Kamari, Georgia; Phitos, Dimitrios; Haberle, Rosemarie; Akaydin, Galip; Ikinci, Nursel; Raus, Thomas; Borsch, Thomas			How to Handle Speciose Clades? Mass Taxon-Sampling as a Strategy towards Illuminating the Natural History of Campanula (Campanuloideae)	PLOS ONE			English	Article							LUSITANICA COMPLEX CAMPANULACEAE; WESTERN MEDITERRANEAN REGION; GROUP-II INTRON; LARGE DATA SETS; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR EVOLUTION; BIOGEOGRAPHIC IMPLICATIONS; RETICULATE EVOLUTION; LIKELIHOOD APPROACH; BASAL ANGIOSPERMS	Background: Speciose clades usually harbor species with a broad spectrum of adaptive strategies and complex distribution patterns, and thus constitute ideal systems to disentangle biotic and abiotic causes underlying species diversification. The delimitation of such study systems to test evolutionary hypotheses is difficult because they often rely on artificial genus concepts as starting points. One of the most prominent examples is the bellflower genus Campanula with some 420 species, but up to 600 species when including all lineages to which Campanula is paraphyletic. We generated a large alignment of petD group II intron sequences to include more than 70% of described species as a reference. By comparison with partial data sets we could then assess the impact of selective taxon sampling strategies on phylogenetic reconstruction and subsequent evolutionary conclusions. Methodology/Principal Findings: Phylogenetic analyses based on maximum parsimony (PAUP, PRAP), Bayesian inference (MrBayes), and maximum likelihood (RAxML) were first carried out on the large reference data set (D680). Parameters including tree topology, branch support, and age estimates, were then compared to those obtained from smaller data sets resulting from "classification-guided'' (D088) and "phylogeny-guided sampling'' (D101). Analyses of D088 failed to fully recover the phylogenetic diversity in Campanula, whereas D101 inferred significantly different branch support and age estimates. Conclusions/Significance: A short genomic region with high phylogenetic utility allowed us to easily generate a comprehensive phylogenetic framework for the speciose Campanula clade. Our approach recovered 17 well-supported and circumscribed sub-lineages. Knowing these will be instrumental for developing more specific evolutionary hypotheses and guide future research, we highlight the predictive value of a mass taxon-sampling strategy as a first essential step towards illuminating the detailed evolutionary history of diverse clades.	[Mansion, Guilhem; Parolly, Gerald; Fraunhofer, Katharina; Raus, Thomas; Borsch, Thomas] Free Univ Berlin, Bot Garten & Bot Museum, Berlin, Germany; [Crowl, Andrew A.; Mavrodiev, Evgeny; Cellinese, Nico] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Oganesian, Marine] Natl Acad Sci, Inst Bot, Erevan, Armenia; [Kamari, Georgia; Phitos, Dimitrios] Univ Patras, Dept Biol, Patras, Greece; [Haberle, Rosemarie] Pacific Lutheran Univ, Dept Biol, Tacoma, WA 98447 USA; [Akaydin, Galip] Hacettepe Univ, Dept Biol Educ, Ankara, Turkey; [Ikinci, Nursel] Abant Izzet Baysal Univ, Dept Biol, Bolu, Turkey; [Crowl, Andrew A.] Univ Florida, Dept Biol, Gainesville, FL USA	Free University of Berlin; State University System of Florida; University of Florida; National Academy of Sciences of Armenia; Institute of Botany after A.L. Takhtajyan - NAS RA; University of Patras; Pacific Lutheran University; Hacettepe University; Abant Izzet Baysal University; State University System of Florida; University of Florida	Mansion, G (corresponding author), Free Univ Berlin, Bot Garten & Bot Museum, Berlin, Germany.	g.mansion@bgbm.org	Mansion, Guilhem/G-2123-2010	Cellinese, Nico/0000-0002-7157-9414	German Research Foundation (DFG, via the Open Access Publication Fund of the Free University of Berlin); VolkswagenStiftung through the project "Developing Tools for Conserving the Plant Diversity of the Transcaucasus''; National Science Foundation [DEB-0953677]	German Research Foundation (DFG, via the Open Access Publication Fund of the Free University of Berlin)(German Research Foundation (DFG)); VolkswagenStiftung through the project "Developing Tools for Conserving the Plant Diversity of the Transcaucasus''; National Science Foundation(National Science Foundation (NSF))	The authors thank the Mattfeld-Quadbeck foundation (Guilhem Mansion), the Verein der Freunde des BGBM (lab facilities), and the German Research Foundation (DFG, via the Open Access Publication Fund of the Free University of Berlin). Part of the field collection was supported by the VolkswagenStiftung through the project "Developing Tools for Conserving the Plant Diversity of the Transcaucasus''. The work of Nico Cellinese, Evgeny Mavrodiev, and Andrew Crowl was funded by a grant from the National Science Foundation (DEB-0953677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GJ, 2000, AM J BOT, V87, P1871, DOI 10.2307/2656839; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Boissier E, 1875, FLORA ORIENTALIS; Borsch T, 2009, PLANT SYST EVOL, V282, P169, DOI 10.1007/s00606-009-0210-8; Borsch T, 2009, PLANT SYST EVOL, V282, P107, DOI 10.1007/s00606-008-0115-y; Borsch Thomas, 2009, Willdenowia, V39, P7, DOI 10.3372/wi.39.39101; Bramwell D., 1972, Taxonomy, phytogeography and evolution., P141; Buser R, 1894, B HERBIER BOISSIER, V2, P501; Cano-Maqueda J, 2011, AN JARDIN BOT MADRID, V68, P15, DOI 10.3989/ajbm.2274; Cano-Maqueda J, 2008, TAXON, V57, P1252, DOI 10.1002/tax.574016; Carine MA, 2005, TAXON, V54, P895, DOI 10.2307/25065476; Carlstrom A., 1986, WILLDENOWIA, V15, P375; Cellinese N, 2009, J BIOGEOGR, V36, P1253, DOI 10.1111/j.1365-2699.2008.02077.x; CONTANDRIOPOLOUS J, 1973, B SOC BOT FR, V120, P331, DOI 10.1080/00378941.1973.10839174; Contandriopolous J, 1984, B I SCI, V8, P101; CONTANDRIOPOULOS J., 1964, BULL SOC BOT FRANCE, V111, P222; CONTANDRIOPOULOS J, 1984, B SOC BOT FR-LETT, V131, P315, DOI 10.1080/01811797.1984.10824641; Crook HC, 1977, CAMPANULAS THEIR CUL; DAMBOLDT J, 1976, Notes from the Royal Botanic Garden Edinburgh, V35, P39; Damboldt J, 1978, FLORA TURKEY E AEGEA, P2; DAMBOLDT JURGEN, 1965, BOT JAHRBUECHER SYST PFLANZENGESCH PFLANZENGEOGR, V84, P302; DAMBOLDT JURGEN, 1965, OESTERR BOT Z, V112, P392, DOI 10.1007/BF01372959; Davies TJ, 2004, PHILOS T R SOC B, V359, P1645, DOI 10.1098/rstb.2004.1524; De Candolle, 1830, MONOGRAPHIE CAMPANUL, DOI 10.5962/bhl.title.111415; de Queiroz A, 2002, SYST BIOL, V51, P917, DOI 10.1080/10635150290155980; de Sequeira Miguel Menezes, 2007, Anales del Jardin Botanico de Madrid, V64, P135; DeCandolle A., 1839, CAMPANULACEAE PRODRO; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Doyle JJ, 1998, MOL SYSTEMATICS PLAN, P101; Drummond CS, 2008, MOL PHYLOGENET EVOL, V48, P408, DOI 10.1016/j.ympev.2008.03.009; Eddie WMM, 2003, ANN MO BOT GARD, V90, P554, DOI 10.2307/3298542; Eddie WMM, 1999, NORD J BOT, V19, P153, DOI 10.1111/j.1756-1051.1999.tb00659.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Federov AA, 1957, FLORA SSSR, P92; Fedorov A. A., 1976, FLORA EUROPAEA, V4, P74; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frajman B, 2009, SYST BOT, V34, P595, DOI 10.1600/036364409789271173; FRIZZI G, 1991, PLANT SYST EVOL, V174, P67, DOI 10.1007/BF00937694; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Gadella T.W.J., 1964, WENTIA, V11, P1, DOI [10.1111/j.1438-8677.1964.tb00014.x, DOI 10.1111/J.1438-8677.1964.TB00014.X]; GESLOT A, 1973, PHYTON-ANN REI BOT A, V15, P127; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Greuter W, 1984, MED CHECKLIST, P123; Guggisberg A, 2006, SYST BOT, V31, P368, DOI 10.1600/036364406777585937; Guggisberg A, 2006, NEW PHYTOL, V171, P617, DOI 10.1111/j.1469-8137.2006.01722.x; Guggisberg A, 2009, SYST BIOL, V58, P55, DOI 10.1093/sysbio/syp010; Haberle RC, 2009, TAXON, V58, P715, DOI 10.1002/tax.583003; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Hillis DM, 2003, SYST BIOL, V52, P124, DOI 10.1080/10635150390132911; Horandl E, 2010, TAXON, V59, P1641, DOI 10.1002/tax.596001; Hohmann S, 2006, TAXON, V55, P67, DOI 10.2307/25065529; Hong DY, 2010, NOVON, V20, P426, DOI 10.3417/2010001; Hong DY, 2011, FLORA CHINA, P505; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys AM, 2009, TAXON, V58, P1054, DOI 10.1002/tax.584002; Jablonski D, 2009, P NATL ACAD SCI USA, V106, P8262, DOI 10.1073/pnas.0902973106; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P554, DOI 10.1098/rspb.2010.1004; Kelchner SA, 2002, AM J BOT, V89, P1651, DOI 10.3732/ajb.89.10.1651; Koch M, 2004, AM J BOT, V91, P115, DOI 10.3732/ajb.91.1.115; Kolakovskii A. A., 1994, Botanicheskii Zhurnal (St. Petersburg), V79, P109; Korotkova N, 2011, AM J BOT, V98, P1549, DOI 10.3732/ajb.1000502; Korotkova N, 2009, PLANT SYST EVOL, V282, P201, DOI 10.1007/s00606-008-0099-7; KOVANDA M, 1968, Folia Geobotanica and Phytotaxonomica, V3, P407; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Lammers T.G., 2007, WORLD CHECKLIST BIBL; LAMMERS TG, 1993, BOT BULL ACAD SINICA, V34, P287; LANCUCKASRODONI.M, 1979, ACTA PALAEOBOT, V20, P74; Leyens T., 1994, WILLDENOWIA, V25, P215; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Lohne C, 2005, MOL BIOL EVOL, V22, P317, DOI 10.1093/molbev/msi019; LOVASEN-EBERHARDT Z, 1978, BIOSISTEMATIKA, V4, P273; Mansion G, 2005, TAXON, V54, P931, DOI 10.2307/25065479; Mansion G, 2004, AM J BOT, V91, P2069, DOI 10.3732/ajb.91.12.2069; Mansion G, 2004, MOL PHYLOGENET EVOL, V32, P951, DOI 10.1016/j.ympev.2004.03.016; Mansion G, 2009, J BIOGEOGR, V36, P1282, DOI 10.1111/j.1365-2699.2009.02082.x; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; Marrero A, 1998, BOT J LINN SOC, V128, P291; McVaugh Rogers, 1945, WRIGHTIA, V1, P13; Montes-Moreno N, 2010, TAXON, V59, P1654, DOI 10.1002/tax.596002; MORIN N, 1980, MADRONO, V27, P149; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Muller K., 2005, PHYDE 0 995 PHYLOGEN; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; NICKRENT DL, 1995, ANN MO BOT GARD, V82, P208, DOI 10.2307/2399878; Nylander JAA, 2004, MRMODELTEST 2 1; Oganesian Marine, 1995, Candollea, V50, P275; Park JM, 2006, SYST BOT, V31, P862, DOI 10.1600/036364406779695924; Podlech D., 1964, BERICHTE DTSCH BOT G, V7, P360; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; QUEZEL P, 1978, ANN MO BOT GARD, V65, P479, DOI 10.2307/2398860; QUEZEL P., 1953, FEDDES REP SPEC NOV REG VEG, V56, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rambaut, 2008, FIGTREE V1 1 1 TREE; Rechinger K.H., 1965, FLORA IRANICA; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ronsted N, 2006, TREE LIFE TAXONOMY S, P129; Roquet C, 2008, SYST BOT, V33, P203, DOI 10.1600/036364408783887465; Saez L, 2003, BOT J LINN SOC, V141, P215, DOI 10.1046/j.1095-8339.2003.00133.x; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sanmartin I, 2010, BIOL LETTERS, V6, P703, DOI 10.1098/rsbl.2010.0095; SHETLER SG, 1986, ANN MO BOT GARD, V73, P653, DOI 10.2307/2399199; Smith SA, 2009, P NATL ACAD SCI USA, V106, pE97, DOI 10.1073/pnas.0906918106; Snogerup S., 2001, BOT CHRON, V14, P188; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Tan K., 2001, ENDEMIC PLANTS GREEC; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Townsend JP, 2010, SYST BIOL, V59, P446, DOI 10.1093/sysbio/syq025; Turner AH, 2009, J BIOGEOGR, V36, P612, DOI 10.1111/j.1365-2699.2008.02020.x; Tutin TG, 1976, FLORA EUROPAEA, P94; VALDES B, 2002, CATALOGUE PLANTES VA, P1007; Weigend M, 2009, MOL PHYLOGENET EVOL, V52, P755, DOI 10.1016/j.ympev.2009.05.013; Wendel J. F, 1998, MOL SYSTEMATICS PLAN, P265, DOI DOI 10.1007/978-1-4615-5419-6_10; Wendling BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023559; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wikstrom N, 2003, SYST ASSOC SPEC VOL, P142; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	123	70	72	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50076	10.1371/journal.pone.0050076	http://dx.doi.org/10.1371/journal.pone.0050076			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209646	Green Submitted, gold, Green Published			2022-12-25	WOS:000312601700032
J	D'Aiuto, L; Di Maio, R; Heath, B; Raimondi, G; Milosevic, J; Watson, AM; Bamne, M; Parks, WT; Yang, L; Lin, B; Miki, T; Mich-Basso, JD; Arav-Boger, R; Sibille, E; Sabunciyan, S; Yolken, R; Nimgaonkar, V				D'Aiuto, Leonardo; Di Maio, Roberto; Heath, Brianna; Raimondi, Giorgio; Milosevic, Jadranka; Watson, Annie M.; Bamne, Mikhil; Parks, W. Tony; Yang, Lei; Lin, Bo; Miki, Toshio; Mich-Basso, Jocelyn Danielle; Arav-Boger, Ravit; Sibille, Etienne; Sabunciyan, Sarven; Yolken, Robert; Nimgaonkar, Vishwajit			Human Induced Pluripotent Stem Cell-Derived Models to Investigate Human Cytomegalovirus Infection in Neural Cells	PLOS ONE			English	Article							PROGENITOR CELLS; IPS CELLS; GENE; REPLICATION; EXPRESSION; DIFFERENTIATION; SUSCEPTIBILITY; PROGRESSION; NEURONS; PROTEIN	Human cytomegalovirus (HCMV) infection is one of the leading prenatal causes of congenital mental retardation and deformities world-wide. Access to cultured human neuronal lineages, necessary to understand the species specific pathogenic effects of HCMV, has been limited by difficulties in sustaining primary human neuronal cultures. Human induced pluripotent stem (iPS) cells now provide an opportunity for such research. We derived iPS cells from human adult fibroblasts and induced neural lineages to investigate their susceptibility to infection with HCMV strain Ad169. Analysis of iPS cells, iPS-derived neural stem cells (NSCs), neural progenitor cells (NPCs) and neurons suggests that (i) iPS cells are not permissive to HCMV infection, i. e., they do not permit a full viral replication cycle; (ii) Neural stem cells have impaired differentiation when infected by HCMV; (iii) NPCs are fully permissive for HCMV infection; altered expression of genes related to neural metabolism or neuronal differentiation is also observed; (iv) most iPS-derived neurons are not permissive to HCMV infection; and (v) infected neurons have impaired calcium influx in response to glutamate.	[D'Aiuto, Leonardo; Watson, Annie M.; Bamne, Mikhil; Sibille, Etienne; Nimgaonkar, Vishwajit] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15260 USA; [Di Maio, Roberto; Heath, Brianna] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA USA; [Di Maio, Roberto; Heath, Brianna] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Heath, Brianna; Nimgaonkar, Vishwajit] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Di Maio, Roberto] Ri MED Fdn, Palermo, Italy; [Raimondi, Giorgio] Univ Pittsburgh, Dept Immunol, Starzl Inst, Pittsburgh, PA USA; [Milosevic, Jadranka] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Parks, W. Tony] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Yang, Lei; Lin, Bo; Miki, Toshio; Mich-Basso, Jocelyn Danielle] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA; [Arav-Boger, Ravit] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Sabunciyan, Sarven; Yolken, Robert] Johns Hopkins Sch Med, Stanley Div Dev Neurovirol, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Nimgaonkar, V (corresponding author), Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15260 USA.	VishwajitNL@upmc.edu	Di Maio, Roberto/G-1788-2015; yolken, robert/AAW-2556-2021; Yang, Lei/D-7462-2015	Sabunciyan, Sarven/0000-0002-7231-0820; Heath, Brianna/0000-0003-4843-541X; Miki, Toshio/0000-0001-5546-6770; Parks, W. Tony/0000-0001-7341-3277; Di Maio, Roberto/0000-0003-2162-1781; lin, bo/0000-0002-2108-2696; Milosevic, Jadranka/0000-0003-0002-8727; D'Aiuto, Leonardo/0000-0002-7102-2093	Department of Psychiatry, University of Pittsburgh; Stanley Medical Research Institute [07R-1712]; National Institute of Mental Health (NIMH) [RC2 MH089859, MH62480, U01MH85269]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [1 UL1 RR024153]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062480, RC2MH089859, R01MH042191, U01MH085269] Funding Source: NIH RePORTER	Department of Psychiatry, University of Pittsburgh; Stanley Medical Research Institute; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funds from the Department of Psychiatry, University of Pittsburgh, and grants to VN from the Stanley Medical Research Institute (#07R-1712), and National Institute of Mental Health (NIMH) (RC2 MH089859, MH62480, U01MH85269). The authors acknowledge grant 1 UL1 RR024153 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri-Haber N, 2002, J PHYSIOL-LONDON, V541, P25, DOI 10.1113/jphysiol.2001.013371; Challacombe JF, 2004, PHYSIOL GENOMICS, V18, P51, DOI 10.1152/physiolgenomics.00155.2003; Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08; D'Aiuto L, 2011, DIFFERENTIATION, V82, P9, DOI 10.1016/j.diff.2011.03.003; D'Aiuto L, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-52; Elkabetz Y, 2008, COLD SH Q B, V73, P377, DOI 10.1101/sqb.2008.73.052; Fukuda S, 2003, J NEUROSCI, V23, P9357; Hattori S, 2003, J NEUROPHYSIOL, V90, P175, DOI 10.1152/jn.00990.2002; Isomura H, 2003, J VIROL, V77, P3602, DOI 10.1128/JVI.77.6.3602-3614.2003; KASHIWAI A, 1992, ARCH VIROL, V127, P37, DOI 10.1007/BF01309573; Kasparov S, 2007, NAT METHODS, V4, P379, DOI 10.1038/nmeth0507-379a; Kassahn KS, 2011, INTEGR BIOL-UK, V3, P522, DOI 10.1039/c0ib00062k; Kawasaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017492; Kim KS, 2010, NEUROPSYCHOPHARMACOL, V35, P346, DOI 10.1038/npp.2009.108; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kosugi I, 2005, ACTA NEUROPATHOL, V109, P475, DOI 10.1007/s00401-005-0987-7; Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Lin B, 2012, CARDIOVASC RES, V95, P327, DOI 10.1093/cvr/cvs185; Luo MH, 2008, J VIROL, V82, P9994, DOI 10.1128/JVI.00943-08; Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09; Mutnal MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016211; NEIGHBOUR PA, 1978, J REPROD FERTIL, V54, P15, DOI 10.1530/jrf.0.0540015; Nelson CT, 1997, CLIN PERINATOL, V24, P151, DOI 10.1016/S0095-5108(18)30189-1; Odeberg J, 2006, J VIROL, V80, P8929, DOI 10.1128/JVI.00676-06; Ogawa T, 1997, INT J DEV BIOL, V41, P111; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; RAUCHER S, 1994, J PHYSIOL-LONDON, V479, P77, DOI 10.1113/jphysiol.1994.sp020279; Sampaio KL, 2005, J VIROL, V79, P2754, DOI 10.1128/JVI.79.5.2754-2767.2005; Saussede-aim J., 2009, INT J MED MED SCI, V1, P290; Shechter D, 2004, J BIOL CHEM, V279, P45586, DOI 10.1074/jbc.M407772200; Wu D, 2009, J VIS EXP; Wu RL, 1998, J NEUROSCI, V18, P6261; Xu YY, 2004, J VIROL, V78, P11664, DOI 10.1128/JVI.78.21.11664-11677.2004	36	42	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49700	10.1371/journal.pone.0049700	http://dx.doi.org/10.1371/journal.pone.0049700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209593	Green Published, gold			2022-12-25	WOS:000311885800018
J	Kannen, V; Hintzsche, H; Zanette, DL; Silva, WA; Garcia, SB; Waaga-Gasser, AM; Stopper, H				Kannen, Vinicius; Hintzsche, Henning; Zanette, Dalila L.; Silva, Wilson A., Jr.; Garcia, Sergio B.; Waaga-Gasser, Ana Maria; Stopper, Helga			Antiproliferative Effects of Fluoxetine on Colon Cancer Cells and in a Colonic Carcinogen Mouse Model	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; NITRO-N-NITROSOGUANIDINE; STEM-CELLS; COLORECTAL-CANCER; BONE-MARROW; IN-VITRO; RATS; GROWTH; MICE; PROLIFERATION	The antidepressant fluoxetine has been under discussion because of its potential influence on cancer risk. It was found to inhibit the development of carcinogen-induced preneoplastic lesions in colon tissue, but the mechanisms of action are not well understood. Therefore, we investigated anti-proliferative effects, and used HT29 colon tumor cells in vitro, as well as C57BL/6 mice exposed to intra-rectal treatment with the carcinogen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) as models. Fluoxetine increased the percentage of HT29 cells in the G(0)/G(1) phase of cell-cycle, and the expression of p27 protein. This was not related to an induction of apoptosis, reactive oxygen species or DNA damage. In vivo, fluoxetine reduced the development of MNNG-induced dysplasia and vascularization-related dysplasia in colon tissue, which was analyzed by histopathological techniques. An anti-proliferative potential of fluoxetine was observed in epithelial and stromal areas. It was accompanied by a reduction of VEGF expression and of the number of cells with angiogenic potential, such as CD133, CD34, and CD31-positive cell clusters. Taken together, our findings suggest that fluoxetine treatment targets steps of early colon carcinogenesis. This confirms its protective potential, explaining at least partially the lower colon cancer risk under antidepressant therapy.	[Kannen, Vinicius; Hintzsche, Henning; Stopper, Helga] Univ Wurzburg, Dept Toxicol, Wurzburg, Germany; [Kannen, Vinicius; Garcia, Sergio B.] Univ Sao Paulo, Dept Pathol, Med Sch Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil; [Zanette, Dalila L.; Silva, Wilson A., Jr.] Univ Sao Paulo, Dept Genet, Natl Inst Sci & Technol Stem Cell & Cell Therapy, Med Sch Ribeirao Preto,CNPq FAPESP, BR-14049 Ribeirao Preto, Brazil; [Waaga-Gasser, Ana Maria] Univ Wurzburg, Dept Surg 1, Wurzburg, Germany	University of Wurzburg; Universidade de Sao Paulo; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Universidade de Sao Paulo; University of Wurzburg	Stopper, H (corresponding author), Univ Wurzburg, Dept Toxicol, Wurzburg, Germany.	stopper@toxi.uni-wuerzburg.de	ZANETTE, DALILA/Q-3541-2016; Kannen, Vinicius/L-5972-2016; Garcia, sergio/O-6025-2016; Silva Jr, Wilson Araújo/E-9487-2011; Kannen, Vinicius/AAQ-6452-2020	Kannen, Vinicius/0000-0001-6290-8063; Garcia, sergio/0000-0003-1630-3543; Silva Jr, Wilson Araújo/0000-0001-9364-2886; zanette, dalila l./0000-0001-9397-4127	DAAD (Deutscher Akademischer Austausch Dienst); CAPES (Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior); CNPQ (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)	DAAD (Deutscher Akademischer Austausch Dienst)(Deutscher Akademischer Austausch Dienst (DAAD)); CAPES (Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors disclosed receipt of the following financial support for the research of this article: DAAD (Deutscher Akademischer Austausch Dienst), CAPES (Coordenacao de Aperfeicoamento de Pessoa de Nivel Superior), CNPQ (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), and FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2010, ONCOLOGY-NY, V24, P417; Coogan PF, 2006, EXPERT REV NEUROTHER, V6, P1363, DOI 10.1586/14737175.6.9.1363; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Frick LR, 2008, BIOCHEM PHARMACOL, V75, P1817, DOI 10.1016/j.bcp.2008.01.015; Garcia SB, 2006, CANCER LETT, V240, P221, DOI 10.1016/j.canlet.2005.09.011; Hristov M, 2003, ARTERIOSCL THROM VAS, V23, P1185, DOI 10.1161/01.ATV.0000073832.49290.B5; Jaiswal AS, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-3; Jaiswal AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016691; Jia L, 2008, WORLD J GASTROENTERO, V14, P4377, DOI 10.3748/wjg.14.4377; Jiang XY, 2009, J DIGEST DIS, V10, P293, DOI 10.1111/j.1751-2980.2009.00398.x; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kannen V, 2011, TOXICOL LETT, V204, P134, DOI 10.1016/j.toxlet.2011.04.024; Kannen V, 2011, BIOCHEM BIOPH RES CO, V405, P593, DOI 10.1016/j.bbrc.2011.01.074; Kirkova M, 2010, CELL BIOCHEM FUNCT, V28, P497, DOI 10.1002/cbf.1682; Koh SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG9, DOI 10.1152/ajpgi.00267.2010; Kornhuber J, 2009, EUR ARCH PSY CLIN N, V259, P199, DOI 10.1007/s00406-009-0061-x; Krause DS, 1996, BLOOD, V87, P1; Krishnan A, 2008, BIOCHEM PHARMACOL, V75, P1924, DOI 10.1016/j.bcp.2008.02.013; Kubera M, 2009, PHARMACOL REP, V61, P1113, DOI 10.1016/S1734-1140(09)70174-4; Li H, 2011, PLAST RECONSTR SURG, V128, P663, DOI 10.1097/PRS.0b013e318221db33; Liao ZM, 2002, CARCINOGENESIS, V23, P1701, DOI 10.1093/carcin/23.10.1701; Maurin N, 2007, INT J CANCER, V120, P477, DOI 10.1002/ijc.22302; Mazucato VM, 2011, J HISTOCHEM CYTOCHEM, V59, P428, DOI 10.1369/0022155411400868; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Meregalli M, 2010, EXPERT OPIN BIOL TH, V10, P1521, DOI 10.1517/14712598.2010.528386; Meurette O, 2005, CLIN CANCER RES, V11, P3075, DOI 10.1158/1078-0432.CCR-04-1764; Miguel C, 2011, PHARMACOLOGY, V88, P333, DOI 10.1159/000334738; Muller JC, 2012, REPROD TOXICOL, V34, P80, DOI 10.1016/j.reprotox.2012.04.001; Ngan BY, 2008, ARCH OTOLARYNGOL, V134, P1170, DOI 10.1001/archotol.134.11.1170; Park SW, 2011, J PHARMACOL EXP THER, V336, P516, DOI 10.1124/jpet.110.173278; Paulsen JE, 2005, CANCER RES, V65, P121; RESHEF R, 1990, CANCER RES, V50, P1764; Cardoso JFR, 2011, NUTR CANCER, V63, P1029, DOI 10.1080/01635581.2011.596647; Schmid U, 2008, DIABETES-METAB RES, V24, P371, DOI 10.1002/dmrr.860; Sovalat H, 2011, EXP HEMATOL, V39, P495, DOI 10.1016/j.exphem.2011.01.003; Stepulak A, 2008, CANCER BIOL THER, V7, P1685, DOI 10.4161/cbt.7.10.6664; Taketo MM, 2009, J GASTROENTEROL, V44, P93, DOI 10.1007/s00535-008-2321-3; Tammali R, 2011, ANGIOGENESIS, V14, P209, DOI 10.1007/s10456-011-9206-4; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; TUTTON PJM, 1986, ANTICANCER RES, V6, P1123; TUTTON PJM, 1982, BRIT J CANCER, V46, P260, DOI 10.1038/bjc.1982.191; Waldner MJ, 2010, J EXP MED, V207, P2855, DOI 10.1084/jem.20100438; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; Ye C, 2008, CLIN BIOMECH, V23, pS118, DOI 10.1016/j.clinbiomech.2007.08.018; Zhang B, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-56	46	42	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50043	10.1371/journal.pone.0050043	http://dx.doi.org/10.1371/journal.pone.0050043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209640	Green Published, gold, Green Submitted			2022-12-25	WOS:000311885800042
J	Meng, WJ; Zhang, CQ; Zhang, Q; Song, XH; Lin, HY; Zhang, DZ; Zhang, YY; Zhu, ZX; Wu, S; Liu, YX; Tang, F; Yang, XW; Xue, FZ				Meng, Wenjia; Zhang, Chengqi; Zhang, Qian; Song, Xinhong; Lin, Haiyan; Zhang, Dongzhi; Zhang, Yongyuan; Zhu, Zhenxin; Wu, Shuo; Liu, Yanxun; Tang, Fang; Yang, Xiaowei; Xue, Fuzhong			Association between Leukocyte and Metabolic Syndrome in Urban Han Chinese: A Longitudinal Cohort Study	PLOS ONE			English	Article							BLOOD-CELL COUNT; C-REACTIVE PROTEIN; MALE OFFICE WORKERS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; INFLAMMATION; POPULATION; JAPANESE; RISK	Background: Although cross-sectional studies have shown that leukocyte is linked with metabolic syndrome (MetS), few longitudinal or cohort studies have been used to confirm this relationship. We therefore conducted a large-scale health check-up longitudinal cohort in urban Chinese population from middle to upper socioeconomic strata to investigate and prove the association between the total leukocyte/its subtypes and MetS/its components (obesity, hyperglycemia, dyslipidemia, and hypertension). Methods: A longitudinal cohort study was established in 2005 on individuals who were middle-to-upper class urban Chinese. Data used in this investigation was based on 6,513 participants who had at least three routine health check-ups over a period of six-year follow-up. Data analysis was conducted through generalized estimating equation (GEE) model. Results: A total of 255 cases of MetS occurred over the six-year follow-up, leading to a total incidence density of 11.45 per 1,000 person-years (255/22279 person-years). The total leukocyte was markedly associated with MetS (RR = 2.66, 95%CI = 1.81-3.90], p < 0.0001) and a dose-response existed. Similar trends can be found in monocytes, lymphocytes, and neutrophils compared with the total leukocyte. The total leukocyte, neutrophil, monocyte and eosinophil levels were strong and independent risk factors to obesity, total leukocyte and neutrophil to dyslipidemia and hyperglycemia, while neither total leukocyte nor its subtypes to hypertension. Conclusion: Total leukocyte/its subtype were associated with MetS/its components (obesity, dyslipidemia and hyperglycemia), they might provide convenient and useful markers for further risk appraisal of MetS, and be the earlier biomarkers for predicting cardiovascular disease than the components of MetS.	[Meng, Wenjia; Zhang, Qian; Zhang, Yongyuan; Zhu, Zhenxin; Wu, Shuo; Liu, Yanxun; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Zhang, Chengqi; Tang, Fang] Shandong Prov QianFoShan Hosp, Hlth Management Ctr, Jinan, Peoples R China; [Song, Xinhong; Lin, Haiyan; Zhang, Dongzhi] Shandong Univ, Prov Hosp, Ctr Hlth Management, Jinan 250100, Peoples R China; [Yang, Xiaowei] Univ Calif Davis, Dept Publ Hlth Sci, Sch Med, Davis, CA 95616 USA	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of California System; University of California Davis	Xue, FZ (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China.	xuefzh@sdu.edu.cn	Xue, Fuzhong/AAG-4808-2020; zhang, chi/GRX-3610-2022	Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [31071155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by No. 31071155 of the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belfki H, 2012, EUR J INTERN MED, V23, pE5, DOI 10.1016/j.ejim.2011.10.011; Benagiano M, 2003, P NATL ACAD SCI USA, V100, P6658, DOI 10.1073/pnas.1135726100; Chen W, 2010, DIABETES CARE, V33, P2474, DOI 10.2337/dc10-0619; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cuevas A, 2011, CURR OPIN ENDOCRINOL, V18, P134, DOI 10.1097/MED.0b013e3283449167; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fan XD, 2010, SCHIZOPHR RES, V118, P211, DOI 10.1016/j.schres.2010.02.1028; Fernandez-Real JM, 1999, DIABETOLOGIA, V42, P1367, DOI 10.1007/s001250051451; Fernandez-Real JM, 2003, DIABETES CARE, V26, P1362, DOI 10.2337/diacare.26.5.1362; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Frohlich M, 2000, DIABETES CARE, V23, P1835, DOI 10.2337/diacare.23.12.1835; Hagita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019871; Halle M, 1998, EXERC IMMUNOL REV, V4, P77; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Janszky I, 2011, ANN AGR ENV MED, V18, P270; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Kim JA, 2006, ENDOCR J, V53, P133, DOI 10.1507/endocrj.53.133; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Lao XQ, 2008, ATHEROSCLEROSIS, V201, P418, DOI 10.1016/j.atherosclerosis.2007.12.053; Lee JH, 2007, ADDICT BEHAV, V32, P187, DOI 10.1016/j.addbeh.2006.03.030; Lee YJ, 2010, NUTR METAB CARDIOVAS, V20, P165, DOI 10.1016/j.numecd.2009.03.017; Li JB, 2010, J INT MED RES, V38, P1142, DOI 10.1177/147323001003800343; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Lin KC, 2008, STAT MED, V27, P4428, DOI 10.1002/sim.3315; Lu Yan-hui, 2006, Zhonghua Yi Xue Za Zhi, V86, P386; Mahajan A, 2012, ATHEROSCLEROSIS, V220, P275, DOI 10.1016/j.atherosclerosis.2011.10.031; McCullough AJ, 2011, J DIGEST DIS, V12, P333, DOI 10.1111/j.1751-2980.2010.00469.x; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Nakanishi N, 2002, OCCUP MED-OXFORD, V52, P213, DOI 10.1093/occmed/52.4.213; Nakanishi N, 2002, IND HEALTH, V40, P273, DOI 10.2486/indhealth.40.273; Oda E, 2008, HYPERTENS RES, V31, P1283, DOI 10.1291/hypres.31.1283; Oda E, 2010, INTERNAL MED, V49, P117, DOI 10.2169/internalmedicine.49.2670; Oda E, 2009, INTERNAL MED, V48, P1127, DOI 10.2169/internalmedicine.48.2138; Odagiri K, 2011, INTERNAL MED, V50, P2491, DOI 10.2169/internalmedicine.50.5877; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Park JT, 2009, METABOLISM, V58, P1379, DOI 10.1016/j.metabol.2009.05.002; Razani B, 2008, ENDOCRIN METAB CLIN, V37, P603, DOI 10.1016/j.ecl.2008.05.001; Rochon J, 1998, STAT MED, V17, P1643, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1643::AID-SIM869>3.0.CO;2-3; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Szigethy E, 2012, PUBLIC HEALTH, V126, P143, DOI 10.1016/j.puhe.2011.11.003; Tamakoshi K, 2003, INT J OBESITY, V27, P443, DOI 10.1038/sj.ijo.0802260; Wang YY, 2004, J DIABETES COMPLICAT, V18, P322, DOI 10.1016/S1056-8727(04)00003-0; Wu CZ, 2010, ACTA DIABETOL, V47, P65, DOI 10.1007/s00592-009-0101-z; Wu CZ, 2009, PEDIATR INT, V51, P14, DOI 10.1111/j.1442-200X.2008.02658.x; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zuliani G, 2009, ATHEROSCLEROSIS, V203, P626, DOI 10.1016/j.atherosclerosis.2008.07.038	48	22	23	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49875	10.1371/journal.pone.0049875	http://dx.doi.org/10.1371/journal.pone.0049875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048BS	23209610	Green Submitted, gold, Green Published			2022-12-25	WOS:000311885800028
J	Powell, T; Williams, EM				Powell, Thomas; Williams, Edgar Mark			Effect of Resistive Load on the Inspiratory Work and Power of Breathing during Exertion	PLOS ONE			English	Article							EXERCISE	The resistive work of breathing against an external load during inspiration (WRI) was measured at the mouth, during sub-maximal exercise in healthy participants. This measure (which excludes the elastic work component) allows the relationship between resistive work and power, ventilation and exercise modality to be explored. A total of 45 adult participants with healthy lung function took part in a series of exercise protocols, in which the relationship between WRI, power of breathing, PRI and minute ventilation, (V) over dot(E) were assessed during rest, while treadmill walking or ergometer cycling, over a range of exercise intensities (up to 150 Watts) and ventilation rates (up to 48 L min(-1)) with applied constant resistive loads of 0.75 and 1.5 kPa.L.sec(-1). Resting WRI was 0.12 JL(-1) and PRI was 0.9 W. At each resistive load, independent of the breathing pattern or exercise mode, the WRI increased in a linear fashion at 20 mJ per litre of (V) over dot(E), while PRI increased exponentially. With increasing resistive load the work and power at any given (V) over dot(E) increased exponentially. Calculation of the power to work ratio during loaded breathing suggests that loads above 1.5 kPa. L. sec(-1) make the work of resistive breathing become inhibitive at even a moderate (V) over dot(E) (>30 L sec(-1)). The relationship between work done and power generated while breathing against resistive loads is independent of the exercise mode (cycling or walking) and that ventilation is limited by the work required to breathe, rather than an inability to maintain or generate power.	[Powell, Thomas; Williams, Edgar Mark] Univ Glamorgan, Fac Hlth Sport & Sci, Pontypridd CF37 1DL, M Glam, Wales	University of South Wales	Williams, EM (corresponding author), Univ Glamorgan, Fac Hlth Sport & Sci, Pontypridd CF37 1DL, M Glam, Wales.	mwill15@glam.ac.uk		Powell, Tom/0000-0001-5144-0485	MicroMedical UK	MicroMedical UK	A PhD bursary for TP was provided by MicroMedical UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	British Thoracic Society, 1994, RESP MED, V38, P165; Burki NK, 2010, CHEST, V138, P1196, DOI 10.1378/chest.10-0534; Cabello B, 2006, INTENS CARE MED, V32, P1311, DOI 10.1007/s00134-006-0278-3; Cibella F, 1999, J APPL PHYSIOL, V86, P1785, DOI 10.1152/jappl.1999.86.6.1785; CLANTON TL, 1995, PHYS THER, V75, P983, DOI 10.1093/ptj/75.11.983; Dominelli PB, 2012, RESP PHYSIOL NEUROBI, V180, P147, DOI 10.1016/j.resp.2011.10.005; Fessler Henry E, 2008, Proc Am Thorac Soc, V5, P416, DOI 10.1513/pats.200708-117ET; FREEDMAN S, 1965, J APPL PHYSIOL, V20, P469, DOI 10.1152/jappl.1965.20.3.469; Guenette JA, 2007, J SCI MED SPORT, V10, P341, DOI 10.1016/j.jsams.2007.02.003; JOHNSON BD, 1992, J APPL PHYSIOL, V73, P874, DOI 10.1152/jappl.1992.73.3.874; Kift J, 2007, J SPORT SCI, V25, P1599, DOI 10.1080/02640410701275201; MANCEBO J, 1995, EUR RESPIR J, V8, P1901, DOI 10.1183/09031936.95.08111901; MANNING H, 1992, J APPL PHYSIOL, V73, P825, DOI 10.1152/jappl.1992.73.3.825; Mediavilla FAM., 2008, J APPL BUS EC, P1261; MILICEMILI G, 1962, J APPL PHYSIOL, V17, P43, DOI 10.1152/jappl.1962.17.1.43; OTIS AB, 1950, J APPL PHYSIOL, V2, P592, DOI 10.1152/jappl.1950.2.11.592; OTIS AB, 1954, PHYSIOL REV, V34, P449, DOI 10.1152/physrev.1954.34.3.449; Powell T, 2009, RESP MED, V103, P1239, DOI 10.1016/j.rmed.2009.01.027; Ray AD, 2010, EUR J APPL PHYSIOL, V108, P811, DOI 10.1007/s00421-009-1275-3; Sheel AW, 2010, EXP PHYSIOL, V95, P422, DOI 10.1113/expphysiol.2009.047571; Sheel AW, 2002, SPORTS MED, V32, P567, DOI 10.2165/00007256-200232090-00003; Shoemaker Michael J, 2009, Cardiopulm Phys Ther J, V20, P5	22	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49681	10.1371/journal.pone.0049681	http://dx.doi.org/10.1371/journal.pone.0049681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209590	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000311885800016
J	Santer, RD; Rind, FC; Simmons, PJ				Santer, Roger D.; Rind, F. Claire; Simmons, Peter J.			Predator versus Prey: Locust Looming-Detector Neuron and Behavioural Responses to Stimuli Representing Attacking Bird Predators	PLOS ONE			English	Article							COLLISION-AVOIDANCE BEHAVIOR; RECEPTIVE-FIELD PROPERTIES; ORTHOPTERAN DCMD NEURON; ESCAPE BEHAVIOR; VISUAL INTERNEURON; SENSITIVE NEURON; OBJECT APPROACH; WIDE-FIELD; AVIAN PREDATION; MOVING-OBJECTS	Many arthropods possess escape-triggering neural mechanisms that help them evade predators. These mechanisms are important neuroethological models, but they are rarely investigated using predator-like stimuli because there is often insufficient information on real predator attacks. Locusts possess uniquely identifiable visual neurons (the descending contralateral movement detectors, DCMDs) that are well-studied looming motion detectors. The DCMDs trigger 'glides' in flying locusts, which are hypothesised to be appropriate last-ditch responses to the looms of avian predators. To date it has not been possible to study glides in response to stimuli simulating bird attacks because such attacks have not been characterised. We analyse video of wild black kites attacking flying locusts, and estimate kite attack speeds of 10.8 +/- 1.4 m/s. We estimate that the loom of a kite's thorax towards a locust at these speeds should be characterised by a relatively low ratio of half size to speed (l/vertical bar v vertical bar) in the range 4-17 ms. Peak DCMD spike rate and gliding response occurrence are known to increase as l/vertical bar v vertical bar decreases for simple looming shapes. Using simulated looming discs, we investigate these trends and show that both DCMD and behavioural responses are strong to stimuli with kite-like l/vertical bar v vertical bar ratios. Adding wings to looming discs to produce a more realistic stimulus shape did not disrupt the overall relationships of DCMD and gliding occurrence to stimulus l/vertical bar v vertical bar. However, adding wings to looming discs did slightly reduce high frequency DCMD spike rates in the final stages of object approach, and slightly delay glide initiation. Looming discs with or without wings triggered glides closer to the time of collision as l/vertical bar v vertical bar declined, and relatively infrequently before collision at very low l/vertical bar v vertical bar. However, the performance of this system is in line with expectations for a last-ditch escape response. Citation: Santer RD, Rind FC, Simmons PJ (2012) Predator versus Prey: Locust Looming-Detector Neuron and Behavioural Responses to Stimuli Representing Attacking Bird Predators. PLoS ONE 7(11): e50146. doi:10.1371/journal.pone.0050146	[Santer, Roger D.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Santer, Roger D.] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Rind, F. Claire; Simmons, Peter J.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Limerick; Newcastle University - UK	Santer, RD (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	rds5@aber.ac.uk	Rind, Claire/AAR-4071-2021	Rind, Claire/0000-0002-8466-4597; Simmons, Peter/0000-0002-1630-5082	Aberystwyth University; University of Limerick	Aberystwyth University; University of Limerick	Funding was provided by internal grants to RDS from Aberystwyth University and from the University of Limerick. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER PS, 1981, J COMP PHYSIOL, V141, P233, DOI 10.1007/BF01342669; BLAKE RW, 1990, CAN J ZOOL, V68, P1, DOI 10.1139/z90-001; Brigham RM, 1998, AM MIDL NAT, V139, P325; Bruderer B, 2001, IBIS, V143, P178, DOI 10.1111/j.1474-919X.2001.tb04475.x; BURROWS M, 1973, J COMP PHYSIOL, V85, P221, DOI 10.1007/BF00694231; CAMHI JM, 1978, J COMP PHYSIOL, V128, P203, DOI 10.1007/BF00656853; Card GM, 2012, CURR OPIN NEUROBIOL, V22, P180, DOI 10.1016/j.conb.2011.12.009; Casas J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002116; Chatterjee S, 2007, P NATL ACAD SCI USA, V104, P12398, DOI 10.1073/pnas.0702040104; Cooper WE, 2006, BEHAVIOUR, V143, P1201, DOI 10.1163/156853906778691595; Cramp S., 1988, BIRDS W PALEARCTIC, V5; Cramp S., 1985, HDB BIRDS EUROPE MID, VIV; Curtis LK, 2008, WILDLIFE AUSTR M WIN, P41; Dangles O, 2006, ANIM BEHAV, V72, P603, DOI 10.1016/j.anbehav.2005.11.018; Dangles O, 2006, J EXP BIOL, V209, P393, DOI 10.1242/jeb.02000; de Vries SEJ, 2012, CURR BIOL, V22, P353, DOI 10.1016/j.cub.2012.01.007; Dupuy F, 2011, J INSECT PHYSIOL, V57, P865, DOI 10.1016/j.jinsphys.2011.03.020; Ferguson-Lees J, 2001, RAPTORS WORLD; Fotowat H, 2007, J NEUROSCI, V27, P10047, DOI 10.1523/JNEUROSCI.1515-07.2007; Fotowat H, 2011, ANNU REV NEUROSCI, V34, P1, DOI 10.1146/annurev-neuro-061010-113632; Fotowat H, 2011, NEURON, V69, P147, DOI 10.1016/j.neuron.2010.12.007; Gabbiani F, 2004, J PHYSIOLOGY-PARIS, V98, P19, DOI 10.1016/j.jphysparis.2004.03.001; Gabbiani F, 2002, NATURE, V420, P320, DOI 10.1038/nature01190; Gabbiani F, 1999, J NEUROSCI, V19, P1122; Gabbiani F, 2001, J NEUROSCI, V21, P314, DOI 10.1523/JNEUROSCI.21-01-00314.2001; Gray JR, 2005, J EXP BIOL, V208, P2515, DOI 10.1242/jeb.01640; Gray JR, 2001, J COMP PHYSIOL A, V187, P115, DOI 10.1007/s003590100182; GREATHEAD DJ, 1966, J APPL ECOL, V3, P239, DOI 10.2307/2401249; Herberholz J, 2004, J EXP BIOL, V207, P1855, DOI 10.1242/jeb.00992; Irschick DJ, 2003, INTEGR COMP BIOL, V43, P396, DOI 10.1093/icb/43.3.396; JOERN A, 1986, OIKOS, V46, P243, DOI 10.2307/3565473; JOERN A, 1992, OIKOS, V64, P458, DOI 10.2307/3545161; Judge SJ, 1997, J EXP BIOL, V200, P2209; Kayser C, 2004, CURR OPIN NEUROBIOL, V14, P468, DOI 10.1016/j.conb.2004.06.002; Krapp HG, 2005, J NEUROPHYSIOL, V93, P2240, DOI 10.1152/jn.00965.2004; Liu YJ, 2011, BRAIN BEHAV EVOLUT, V77, P193, DOI 10.1159/000327045; Matheson T, 2004, J NEUROPHYSIOL, V91, P1, DOI 10.1152/jn.00795.2003; McMillan GA, 2012, J NEUROPHYSIOL, V108, P1052, DOI 10.1152/jn.00847.2011; Middleton W.E.K., 2019, VISION ATMOSPHERE; Munch TA, 2009, NAT NEUROSCI, V12, P1308, DOI 10.1038/nn.2389; Nakagawa H, 2010, J NEUROPHYSIOL, V104, P2487, DOI 10.1152/jn.01055.2009; Nickerson B., 1958, Ibis, V100, P454, DOI 10.1111/j.1474-919X.1958.tb00410.x; Oliva D, 2007, J EXP BIOL, V210, P865, DOI 10.1242/jeb.02707; OSHEA M, 1974, J COMP PHYSIOL, V91, P257, DOI 10.1007/BF00698057; OSHEA M, 1974, J EXP BIOL, V60, P1; Preuss T, 2006, J NEUROSCI, V26, P3454, DOI 10.1523/JNEUROSCI.5259-05.2006; Reinagel P, 2001, CURR OPIN NEUROBIOL, V11, P437, DOI 10.1016/S0959-4388(00)00231-2; Ribak G, 2012, J COMP PHYSIOL A, V198, P541, DOI 10.1007/s00359-012-0728-z; Rind FC, 2008, J NEUROPHYSIOL, V100, P670, DOI 10.1152/jn.01055.2007; Rind FC, 2004, P ROY SOC B-BIOL SCI, V271, pS27, DOI 10.1098/rsbl.2003.0096; RIND FC, 1984, J EXP BIOL, V110, P143; Rind FC, 1998, J COMP NEUROL, V395, P405; Rind FC, 1996, J NEUROPHYSIOL, V75, P967, DOI 10.1152/jn.1996.75.3.967; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; ROBERTSON RM, 1992, J EXP BIOL, V163, P231; ROBERTSON RM, 1993, J EXP BIOL, V183, P35; Rogers SM, 2010, J NEUROPHYSIOL, V103, P779, DOI 10.1152/jn.00855.2009; Sanchez-Zapata JA, 2007, J APPL ECOL, V44, P323, DOI 10.1111/j.1365-2664.2007.01279.x; Santer RD, 2006, J NEUROPHYSIOL, V95, P3391, DOI 10.1152/jn.00024.2006; Santer RD, 2005, J COMP PHYSIOL A, V191, P61, DOI 10.1007/s00359-004-0572-x; Santer RD, 2008, J COMP PHYSIOL A, V194, P69, DOI 10.1007/s00359-007-0289-8; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; SIMMONS P, 1980, J EXP BIOL, V86, P87; Simmons PJ, 2010, J INSECT PHYSIOL, V56, P876, DOI 10.1016/j.jinsphys.2010.04.015; SIMMONS PJ, 1992, J NEUROPHYSIOL, V68, P1667, DOI 10.1152/jn.1992.68.5.1667; SMITH K. D., 1953, ENTOMOLOGIST, V86, P3; Spaar R, 1997, IBIS, V139, P523, DOI 10.1111/j.1474-919X.1997.tb04669.x; Stafford R, 2007, ANIM BEHAV, V74, P1813, DOI 10.1016/j.anbehav.2007.07.015; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; Sun HJ, 1998, NAT NEUROSCI, V1, P296, DOI 10.1038/1110; Sword GA, 2005, NATURE, V433, P703, DOI 10.1038/433703a; Triblehorn JD, 2008, J EXP BIOL, V211, P555, DOI 10.1242/jeb.005736; Triblehorn JD, 2006, J EXP BIOL, V209, P1430, DOI 10.1242/jeb.02132; Unwin D. M., 1980, MICROCLIMATE MEASURE; Yamamoto K, 2003, BRAIN BEHAV EVOLUT, V62, P201, DOI 10.1159/000073272; Yamawaki Y, 2011, J INSECT PHYSIOL, V57, P1510, DOI 10.1016/j.jinsphys.2011.08.003; Yamawaki Y, 2009, J COMP PHYSIOL A, V195, P253, DOI 10.1007/s00359-008-0403-6	77	21	21	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50146	10.1371/journal.pone.0050146	http://dx.doi.org/10.1371/journal.pone.0050146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209660	gold, Green Published, Green Submitted			2022-12-25	WOS:000311885800051
J	Zhang, XA; Cheng, YL; Xiong, YW; Ye, CY; Zheng, H; Sun, H; Zhao, HQ; Ren, ZH; Xu, JG				Zhang, Xiaoai; Cheng, Yuli; Xiong, Yanwen; Ye, Changyun; Zheng, Han; Sun, Hui; Zhao, Hongqing; Ren, Zhihong; Xu, Jianguo			Enterohemorrhagic Escherichia coli Specific Enterohemolysin Induced IL-1 beta in Human Macrophages and EHEC-Induced IL-1 beta Required Activation of NLRP3 Inflammasome	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; TUMOR-NECROSIS-FACTOR; SHIGA TOXIN; ENDOTHELIAL-CELLS; VIRULENCE FACTORS; LARGE PLASMID; O157 STRAINS; EXPRESSION; SURVIVAL; GENES	Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a major foodborne pathogen causing hemorrhagic colitis and hemolytic-uremic syndrome. The role of EHEC O157:H7-enterohemolysin (Ehx) in the pathogenesis of infections remains poorly defined. In this study, we used gene deletion and complement methods to confirm its putative functions. Results demonstrated that, in THP-1 cells, EHEC O157:H7-Ehx is associated with greater production of extracellular interleukin (IL)-1 beta than other cytokines. The data also showed that EHEC O157:H7-Ehx contributed to cytotoxicity in THP-1 cells, causing the release of lactate dehydrogenase (LDH). Although we observed a positive correlation between IL-1 beta production and cytotoxicity in THP-1 cells infected with different EHEC O157:H7 strains, our immunoblot results showed that the majority of IL-1 beta in the supernatant was mature IL-1 beta and not the pro-IL-1 beta that can be released after cell death. However, EHEC O157:H7-Ehx had no detectable effect on biologically inactive pro-IL-1 beta at the mRNA or protein synthesis levels. Neither did it affect the expression of apoptosis-associated speck-like protein containing a CARD (ASC), caspase-1, or NOD-like receptor family pyrin domain containing 3 (NLRP3). RNA interference experiments showed that EHEC O157:H7-induced IL-1 beta production required the involvement of ASC, caspase-1, and NLRP3 expression in THP-1 cells. Our results demonstrate that Ehx plays a crucial role in EHEC O157:H7-induced IL-1 beta production and its cytotoxicity to THP-1 cells. NLRP3 inflammasome activation is also involved in EHEC O157:H7-stimulated IL-1 beta release.	[Zhang, Xiaoai; Cheng, Yuli; Xiong, Yanwen; Ye, Changyun; Zheng, Han; Sun, Hui; Zhao, Hongqing; Ren, Zhihong; Xu, Jianguo] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhang, Xiaoai] Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Ren, ZH (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	renzhihong@icdc.cn; xujianguo@icdc.cn	Zheng, Han/AAH-6977-2019		Ministry of Science and Technology [2011CB504901, 2008ZX10004-008, 2008ZX10004-009, 2009ZX10004-203, 2011SKLID203, 2008SKLID106]; State Key Laboratory for Infectious Disease Prevention and Control, People's Republic of China	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); State Key Laboratory for Infectious Disease Prevention and Control, People's Republic of China	This work was supported by grants (2011CB504901, 2008ZX10004-008, 2008ZX10004-009, 2009ZX10004-203, 2011SKLID203, and 2008SKLID106) from the Ministry of Science and Technology and State Key Laboratory for Infectious Disease Prevention and Control, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldick T, 2007, MICROBES INFECT, V9, P282, DOI 10.1016/j.micinf.2006.12.001; Bauer ME, 1996, INFECT IMMUN, V64, P167, DOI 10.1128/IAI.64.1.167-175.1996; Berin MC, 2002, CELL MICROBIOL, V4, P635, DOI 10.1046/j.1462-5822.2002.00218.x; Brigotti M, 2006, J CLIN MICROBIOL, V44, P313, DOI 10.1128/JCM.44.2.313-317.2006; Brunder W, 1996, MICROBIOL-SGM, V142, P3305, DOI 10.1099/13500872-142-11-3305; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046/j.1365-2958.1997.3871751.x; Burland V, 1998, NUCLEIC ACIDS RES, V26, P4196, DOI 10.1093/nar/26.18.4196; Craven RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007446; Daigle F, 2001, MOL MICROBIOL, V41, P1211, DOI 10.1046/j.1365-2958.2001.02593.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Fernandez-Prada C, 1998, INFECT IMMUN, V66, P3918, DOI 10.1128/IAI.66.8.3918-3924.1998; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Inward CD, 1997, ARCH DIS CHILD, V77, P145, DOI 10.1136/adc.77.2.145; Khan MA, 2008, INFECT IMMUN, V76, P1410, DOI 10.1128/IAI.01141-07; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lim JY, 2007, APPL ENVIRON MICROB, V73, P2037, DOI 10.1128/AEM.02643-06; Litalien C, 1999, PEDIATR NEPHROL, V13, P840, DOI 10.1007/s004670050712; LOUISE CB, 1991, INFECT IMMUN, V59, P4173, DOI 10.1128/IAI.59.11.4173-4179.1991; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Menestrina G, 1996, J MEMBRANE BIOL, V149, P113, DOI 10.1007/s002329900012; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Proulx F, 2002, PEDIATR RES, V52, P928, DOI 10.1203/01.PDR.0000034233.75228.0B; Puttamreddy S, 2010, INFECT IMMUN, V78, P2377, DOI 10.1128/IAI.00156-10; Rogers TJ, 2003, INFECT IMMUN, V71, P5623, DOI 10.1128/IAI.71.10.5623-5632.2003; SCHMIDT H, 1994, FEMS MICROBIOL LETT, V117, P189, DOI 10.1016/0378-1097(94)90193-7; Schmidt H, 1997, FEMS MICROBIOL LETT, V148, P265, DOI 10.1016/S0378-1097(97)00047-5; SCHMIDT H, 1995, INFECT IMMUN, V63, P1055, DOI 10.1128/IAI.63.3.1055-1061.1995; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Tanabe K, 2009, BRAIN RES, V1274, P11, DOI 10.1016/j.brainres.2009.03.063; Tatsuno I, 2001, INFECT IMMUN, V69, P6660, DOI 10.1128/IAI.69.11.6660-6669.2001; VANDEKAR NCAJ, 1992, BLOOD, V80, P2755; Wang GH, 2002, J CLIN MICROBIOL, V40, P3613, DOI 10.1128/JCM.40.10.3613-3619.2002; Yamasaki C, 1999, FEBS LETT, V442, P231, DOI 10.1016/S0014-5793(98)01667-6; Yoon JW, 2005, INFECT IMMUN, V73, P2367, DOI 10.1128/IAI.73.4.2367-2378.2005; Zhou X, 2003, INFECT IMMUN, V71, P2120, DOI 10.1128/IAI.71.4.2120-2129.2003	41	22	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50288	10.1371/journal.pone.0050288	http://dx.doi.org/10.1371/journal.pone.0050288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209696	Green Submitted, gold, Green Published			2022-12-25	WOS:000311885800060
J	Magalhaes, TR; Casey, JP; Conroy, J; Regan, R; Fitzpatrick, DJ; Shah, N; Sobral, J; Ennis, S				Magalhaes, Tiago R.; Casey, Jillian P.; Conroy, Judith; Regan, Regina; Fitzpatrick, Darren J.; Shah, Naisha; Sobral, Joao; Ennis, Sean			HGDP and HapMap Analysis by Ancestry Mapper Reveals Local and Global Population Relationships	PLOS ONE			English	Article							GENETIC-STRUCTURE; DEMOGRAPHIC HISTORY; MITOCHONDRIAL-DNA; DIVERSITY; ADMIXTURE; INFERENCE; ASSOCIATION; LANDSCAPE; HAPLOTYPE; GENOTYPE	Knowledge of human origins, migrations, and expansions is greatly enhanced by the availability of large datasets of genetic information from different populations and by the development of bioinformatic tools used to analyze the data. We present Ancestry Mapper, which we believe improves on existing methods, for the assignment of genetic ancestry to an individual and to study the relationships between local and global populations. The principle function of the method, named Ancestry Mapper, is to give each individual analyzed a genetic identifier, made up of just 51 genetic coordinates, that corresponds to its relationship to the HGDP reference population. As a consequence, the Ancestry Mapper Id (AMid) has intrinsic biological meaning and provides a tool to measure similarity between world populations. We applied Ancestry Mapper to a dataset comprised of the HGDP and HapMap data. The results show distinctions at the continental level, while simultaneously giving details at the population level. We clustered AMids of HGDP/HapMap and observe a recapitulation of human migrations: for a small number of clusters, individuals are grouped according to continental origins; for a larger number of clusters, regional and population distinctions are evident. Calculating distances between AMids allows us to infer ancestry. The number of coordinates is expandable, increasing the power of Ancestry Mapper. An R package called Ancestry Mapper is available to apply this method to any high density genomic data set.	[Magalhaes, Tiago R.; Casey, Jillian P.; Conroy, Judith; Regan, Regina; Fitzpatrick, Darren J.; Shah, Naisha; Ennis, Sean] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Casey, Jillian P.; Regan, Regina] Our Ladys Childrens Hosp Crumlin, Natl Childrens Res Ctr, Dublin, Ireland; [Sobral, Joao] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Fitzpatrick, Darren J.] Univ Coll Dublin, Sch Comp Sci & Informat, Dublin 2, Ireland; [Shah, Naisha] Univ Coll Dublin, Complex & Adapt Syst Lab, Dublin 2, Ireland; [Shah, Naisha] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Instituto Gulbenkian de Ciencia; University College Dublin; University College Dublin; University College Dublin	Ennis, S (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland.	sean.ennis@ucd.ie	Sobral, João/M-5195-2015	Sobral, João/0000-0002-7161-0661; Ennis, Sean/0000-0002-4330-1386; R Magalhaes, Tiago/0000-0002-5528-2119	University College of Dublin, Ireland	University College of Dublin, Ireland	This work was funded with internal funding from University College of Dublin, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ayub Q, 2003, AM J PHYS ANTHROPOL, V122, P259, DOI 10.1002/ajpa.10234; Barbujani G, 2001, P NATL ACAD SCI USA, V98, P22, DOI 10.1073/pnas.98.1.22; Bastos-Rodrigues L, 2006, ANN HUM GENET, V70, P658, DOI 10.1111/j.1469-1809.2006.00287.x; Batini C, 2011, MOL BIOL EVOL, V28, P1099, DOI 10.1093/molbev/msq294; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cann HM, 2002, SCIENCE, V296, P261; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; Cavalli-Sforza LL., 2000, GENES PEOPLES LANGUA; Cavalli-Sforza LL, 2007, ANNU REV GENOM HUM G, V8, P1, DOI 10.1146/annurev.genom.8.080706.092403; CAVALLISFORZA LL, 1991, GENOMICS, V11, P490, DOI 10.1016/0888-7543(91)90169-F; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Fadhlaoui-Zid K, 2004, ANN HUM GENET, V68, P222, DOI 10.1046/j.1529-8817.2004.00096.x; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Firasat S, 2007, EUR J HUM GENET, V15, P121, DOI 10.1038/sj.ejhg.5201726; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedlaender JS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040019; Gayan J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-326; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Haiman CA, 2008, HUM MOL GENET, V17, P825, DOI 10.1093/hmg/ddm354; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kaufman L, 2005, FINDING GROUPS DATA, P342, DOI DOI 10.1002/9780470316801; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, AM J HUM GENET, V85, P934, DOI 10.1016/j.ajhg.2009.10.024; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loudianos G, 1999, HUM MUTAT, V14, P294, DOI 10.1002/(SICI)1098-1004(199910)14:4<294::AID-HUMU4>3.0.CO;2-9; Manni F, 2010, HUM BIOL, V82, P245, DOI 10.3378/027.082.0301; Mansoor A, 2004, HUM GENET, V114, P484, DOI 10.1007/s00439-004-1094-x; Novembre J, 2011, ANNU REV GENOM HUM G, V12, P245, DOI 10.1146/annurev-genom-090810-183123; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; R Core Development Team, 2011, R LANG ENV STAT COMP; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reich D, 2008, NAT GENET, V40, P491, DOI 10.1038/ng0508-491; Rodriguez-Ezpeleta N, 2010, HUM GENET, V128, P113, DOI 10.1007/s00439-010-0833-4; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002105; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Xing JC, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r113; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhang F, 2007, PHILOS T R SOC B, V362, P987, DOI 10.1098/rstb.2007.2028	51	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49438	10.1371/journal.pone.0049438	http://dx.doi.org/10.1371/journal.pone.0049438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189146	gold, Green Submitted, Green Published			2022-12-25	WOS:000311929800024
J	Kobza, S; Ferrea, S; Schnitzler, A; Pollok, B; Sudmeyer, M; Bellebaum, C				Kobza, Stefan; Ferrea, Stefano; Schnitzler, Alfons; Pollok, Bettina; Suedmeyer, Martin; Bellebaum, Christian			Dissociation between Active and Observational Learning from Positive and Negative Feedback in Parkinsonism	PLOS ONE			English	Article							REWARD PREDICTION; HUMAN STRIATUM; SUBSTANTIA-NIGRA; DORSAL STRIATUM; NEURONS ENCODE; BASAL GANGLIA; DOPAMINE; DISEASE; BRAIN; TASK	Feedback to both actively performed and observed behaviour allows adaptation of future actions. Positive feedback leads to increased activity of dopamine neurons in the substantia nigra, whereas dopamine neuron activity is decreased following negative feedback. Dopamine level reduction in unmedicated Parkinson's Disease patients has been shown to lead to a negative learning bias, i.e. enhanced learning from negative feedback. Recent findings suggest that the neural mechanisms of active and observational learning from feedback might differ, with the striatum playing a less prominent role in observational learning. Therefore, it was hypothesized that unmedicated Parkinson's Disease patients would show a negative learning bias only in active but not in observational learning. In a between-group design, 19 Parkinson's Disease patients and 40 healthy controls engaged in either an active or an observational probabilistic feedback-learning task. For both tasks, transfer phases aimed to assess the bias to learn better from positive or negative feedback. As expected, actively learning patients showed a negative learning bias, whereas controls learned better from positive feedback. In contrast, no difference between patients and controls emerged for observational learning, with both groups showing better learning from positive feedback. These findings add to neural models of reinforcement-learning by suggesting that dopamine-modulated input to the striatum plays a minor role in observational learning from feedback. Future research will have to elucidate the specific neural underpinnings of observational learning.	[Kobza, Stefan; Bellebaum, Christian] Ruhr Univ Bochum, Fac Psychol, Inst Cognit Neurosci, Dept Neuropsychol, Bochum, Germany; [Ferrea, Stefano; Schnitzler, Alfons; Suedmeyer, Martin] Univ Dusseldorf, Fac Med, Dept Neurol, D-40225 Dusseldorf, Germany; [Ferrea, Stefano; Schnitzler, Alfons; Pollok, Bettina; Suedmeyer, Martin] Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany	Ruhr University Bochum; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Kobza, S (corresponding author), Ruhr Univ Bochum, Fac Psychol, Inst Cognit Neurosci, Dept Neuropsychol, Univ Str 150, Bochum, Germany.	stefan.kobza@ruhr-uni-bochum.de	Ferrea, Stefano/AAP-5169-2020; Schnitzler, Alfons/K-4625-2014; Schnitzler, Alfons/AAT-1054-2021; Schnitzler, Alfons/Q-5520-2019; Pollok, Bettina/B-5290-2012	Schnitzler, Alfons/0000-0002-6414-7939; Schnitzler, Alfons/0000-0002-6414-7939; 	Ministry of Innovation, Science and Research of the federal state of Nordrhein-Westfalen, Germany (Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen) [334-4]; Helmholtz Research Alliance HelMA; Research Commission of the Medical Faculty, Heinrich-Heine-University [977 2467]	Ministry of Innovation, Science and Research of the federal state of Nordrhein-Westfalen, Germany (Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen); Helmholtz Research Alliance HelMA; Research Commission of the Medical Faculty, Heinrich-Heine-University	This research was funded by the Ministry of Innovation, Science and Research of the federal state of Nordrhein-Westfalen, Germany (Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen; http://www.wissenschaft.nrw.de) (334-4); the "Helmholtz Research Alliance HelMA" (http://www.neuro-ageing.de) and the Research Commission of the Medical Faculty, Heinrich-Heine-University (https://www.uni-duesseldorf.de/MedFak/forschungskommission) (977 2467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Backman L, 2006, NEUROSCI BIOBEHAV R, V30, P791, DOI 10.1016/j.neubiorev.2006.06.005; Bandura A., 1971, SOCIAL LEARNING THEO; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bellebaum C, 2012, BEHAV BRAIN RES, V227, P241, DOI 10.1016/j.bbr.2011.10.042; Bellebaum C, 2012, AGING NEUROPSYCHOL C, V19, P402, DOI 10.1080/13825585.2011.629289; Bellebaum C, 2010, CEREB CORTEX, V20, P2874, DOI 10.1093/cercor/bhq038; Burke CJ, 2010, P NATL ACAD SCI USA, V107, P14431, DOI 10.1073/pnas.1003111107; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Eppinger B, 2011, J COGNITIVE NEUROSCI, V23, P41, DOI 10.1162/jocn.2009.21364; Frank MJ, 2008, PSYCHOL AGING, V23, P392, DOI 10.1037/0882-7974.23.2.392; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Joel D, 2000, NEUROSCIENCE, V96, P451, DOI 10.1016/S0306-4522(99)00575-8; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Kobza S, 2011, BEHAV BRAIN RES, V225, P396, DOI 10.1016/j.bbr.2011.07.059; Kuhner C., 2006, DTSCH BEARBEITUNG HD, VII; Lehericy S, 2004, ANN NEUROL, V55, P522, DOI 10.1002/ana.20030; MacDonald PA, 2011, BRAIN, V134, P1447, DOI 10.1093/brain/awr075; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Pagnoni G, 2002, NAT NEUROSCI, V5, P97, DOI 10.1038/nn802; Raz N, 2003, AM J NEURORADIOL, V24, P1849; Rolls ET, 2008, CEREB CORTEX, V18, P652, DOI 10.1093/cercor/bhm097; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Shiner T, 2012, BRAIN, V135, P1871, DOI 10.1093/brain/aws083; Volkow ND, 1998, ANN NEUROL, V44, P143, DOI 10.1002/ana.410440125; Williams SM, 1998, CEREB CORTEX, V8, P321, DOI 10.1093/cercor/8.4.321; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yu RJ, 2006, NEUROREPORT, V17, P1747, DOI 10.1097/01.wnr.0000239960.98813.50; Zaghloul KA, 2009, SCIENCE, V323, P1496, DOI 10.1126/science.1167342	41	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50250	10.1371/journal.pone.0050250	http://dx.doi.org/10.1371/journal.pone.0050250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	047ER	23185586	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000206
J	Vanderstocken, G; Van de Paar, E; Robaye, B; di Pietrantonio, L; Bondue, B; Boeynaems, JM; Desmecht, D; Communi, D				Vanderstocken, Gilles; Van de Paar, Els; Robaye, Bernard; di Pietrantonio, Larissa; Bondue, Benjamin; Boeynaems, Jean-Marie; Desmecht, Daniel; Communi, Didier			Protective Role of P2Y(2) Receptor against Lung Infection Induced by Pneumonia Virus of Mice	PLOS ONE			English	Article							DENDRITIC CELLS; EXPRESSION; PNEUMOVIRUS; BRAK/CXCL14; TISSUE; MODEL; BRAK	ATP released in the early inflammatory processes acts as a danger signal by binding to purinergic receptors expressed on immune cells. A major contribution of the P2Y(2) receptor of ATP/UTP to dendritic cell function and Th2 lymphocyte recruitment during asthmatic airway inflammation was previously reported. We investigated here the involvement of P2Y(2) receptor in lung inflammation initiated by pneumonia virus of mice infection. We demonstrated that P2Y(2)(-/-) mice display a severe increase in morbidity and mortality rate in response to the virus. Lower survival of P2Y(2)(-/-) mice was not significantly correlated with excessive inflammation despite the higher level of neutrophil recruiters in their bronchoalveolar fluids. Interestingly, we observed reduced ATP level and lower numbers of dendritic cells, CD4(+) T cells and CD8(+) T cells in P2Y(2)(-/-) compared to P2Y(2)(+/+) infected lungs. Lower level of IL-12 and higher level of IL-6 in bronchoalveolar fluid support an inhibition of Th1 response in P2Y(2)(-/-) infected mice. Quantification of DC recruiter expression revealed comparable IP-10 and MIP-3 alpha levels but a reduced BRAK level in P2Y(2)(-/-) compared to P2Y(2)(+/+) bronchoalveolar fluids. The increased morbidity and mortality of P2Y(2)(-/-) mice could be the consequence of a lower viral clearance leading to a more persistent viral load correlated with the observed higher viral titer. The decreased viral clearance could result from the defective Th1 response to PVM with a lack of DC and T cell infiltration. In conclusion, P2Y(2) receptor, previously described as a target in cystic fibrosis therapy and as a mediator of Th2 response in asthma, may also regulate Th1 response protecting mice against lung viral infection.	[Vanderstocken, Gilles; di Pietrantonio, Larissa; Bondue, Benjamin; Boeynaems, Jean-Marie; Communi, Didier] Univ Libre Bruxelles, IRIBHM, Inst Interdisciplinary Res, Brussels, Belgium; [Van de Paar, Els; Desmecht, Daniel] Univ Liege, Dept Pathol, Fac Med Vet, Liege, Belgium; [Robaye, Bernard] Univ Libre Bruxelles, IRIBHM, Inst Interdisciplinary Res, Gosselies, Belgium; [Bondue, Benjamin] Univ Libre Bruxelles, Erasme Hosp, Dept Pneumol, Brussels, Belgium; [Boeynaems, Jean-Marie] Univ Libre Bruxelles, Erasme Hosp, Dept Lab Med, Brussels, Belgium	Universite Libre de Bruxelles; University of Liege; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Communi, D (corresponding author), Univ Libre Bruxelles, IRIBHM, Inst Interdisciplinary Res, Brussels, Belgium.	communid@ulb.ac.be			Action de Recherche Concertee of the Communaute Francaise de Belgique; Politique Scientifique Federale [IAP-P6/30]; Prime Minister's Office; Federal Service for Science, Technology and Culture; Fonds de la Recherche Scientifique Medicale (F.R.S.M.); Fonds d'Encouragement a la Recherche (F.E.R.); Fonds Emile DEFAY; Fonds de la Recherche Scientifique Medicale of Belgium; Walloon Region (Programme d'Excellence CIBLES); European Community [LSHB-2003-503337]; F.N.R.S./FRIA; Fonds Van Buuren, Belgium	Action de Recherche Concertee of the Communaute Francaise de Belgique; Politique Scientifique Federale; Prime Minister's Office; Federal Service for Science, Technology and Culture; Fonds de la Recherche Scientifique Medicale (F.R.S.M.)(Fonds de la Recherche Scientifique - FNRS); Fonds d'Encouragement a la Recherche (F.E.R.); Fonds Emile DEFAY; Fonds de la Recherche Scientifique Medicale of Belgium(Fonds de la Recherche Scientifique - FNRS); Walloon Region (Programme d'Excellence CIBLES); European Community(European Commission); F.N.R.S./FRIA(Fonds de la Recherche Scientifique - FNRS); Fonds Van Buuren, Belgium	This work was supported by an Action de Recherche Concertee of the Communaute Francaise de Belgique, an Interuniversity Attraction Pole grant from the Politique Scientifique Federale (IAP-P6/30), Prime Minister's Office, Federal Service for Science, Technology and Culture, by grants of the Fonds de la Recherche Scientifique Medicale (F.R.S.M.), the Fonds d'Encouragement a la Recherche (F.E.R.), the Fonds Emile DEFAY, the Fonds de la Recherche Scientifique Medicale of Belgium, the Walloon Region (Programme d'Excellence CIBLES), and the LifeSciHealth programme of the European Community (grant LSHB-2003-503337). D. Communi is Senior Research Associate of the Fonds National de la Recherche Scientifique (F.N.R.S.), Belgium. G. Vanderstocken is supported by the F.N.R.S./FRIA and the Fonds Van Buuren, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Anh DBT, 2006, AM J PHYSIOL-LUNG C, V291, pL426, DOI 10.1152/ajplung.00483.2005; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Bonville CA, 2006, VIROLOGY, V349, P87, DOI 10.1016/j.virol.2006.02.017; Burnstock G, 2006, NOVARTIS FDN S, V276, P48; Burnstock G, 2006, NOVART FDN SYMP, V57, P275; Burnstock Geoffrey, 2006, Novartis Found Symp, V276, P26; Buxton ILO, 2001, AM J PHYSIOL-HEART C, V281, pH1657, DOI 10.1152/ajpheart.2001.281.4.H1657; Dermine M, 2012, J INTERF CYTOK RES, V32, P332, DOI 10.1089/jir.2011.0123; Dodge IL, 2003, J IMMUNOL, V170, P4457, DOI 10.4049/jimmunol.170.9.4457; Domachowske JB, 2000, CELL IMMUNOL, V200, P98, DOI 10.1006/cimm.2000.1620; Domachowske Joseph B, 2004, Pediatr Infect Dis J, V23, pS228, DOI 10.1097/01.inf.0000144672.81955.a4; Easton AJ, 2004, CLIN MICROBIOL REV, V17, P390, DOI 10.1128/CMR.17.2.390-412.2004; Frey S, 2008, J VIROL, V82, P11619, DOI 10.1128/JVI.00375-08; Geary C, 2005, AM J PHYSIOL-LUNG C, V289, pL890, DOI 10.1152/ajplung.00428.2004; Hall C, 2009, TXB PEDIAT INFECT DI, P2462; Horsfall FL, 1940, J EXP MED, V71, P391, DOI 10.1084/jem.71.3.391; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Ikoma T, 2012, BIOCHEM BIOPH RES CO, V420, P217, DOI 10.1016/j.bbrc.2012.01.157; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; LUSTIG KD, 1993, P NATL ACAD SCI USA, V90, P5113, DOI 10.1073/pnas.90.11.5113; Muller T, 2010, ALLERGY, V65, P1545, DOI 10.1111/j.1398-9995.2010.02426.x; PARR CE, 1994, P NATL ACAD SCI USA, V91, P13067, DOI 10.1073/pnas.91.26.13067; Rosenberg HF, 2008, IMMUNOL LETT, V118, P6, DOI 10.1016/j.imlet.2008.03.013; Rosenberg HF, 2005, PHARMACOL THERAPEUT, V105, P1, DOI 10.1016/j.pharmthera.2004.09.001; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Siegle JS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-14; Vanderstocken G, 2010, J IMMUNOL, V185, P3702, DOI 10.4049/jimmunol.0903908; Zhang M, 2012, J PHYSIOL-LONDON, V590, P4335, DOI 10.1113/jphysiol.2012.236265	31	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50385	10.1371/journal.pone.0050385	http://dx.doi.org/10.1371/journal.pone.0050385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185614	Green Published, Green Submitted, gold			2022-12-25	WOS:000311821000227
J	Yang, L; Liu, TY; Li, B; Sui, Y; Chen, JF; Shi, JF; Wing, RA; Chen, MS				Yang, Lu; Liu, Tieyan; Li, Bo; Sui, Yi; Chen, Jinfeng; Shi, Jinfeng; Wing, Rod A.; Chen, Mingsheng			Comparative Sequence Analysis of the Ghd7 Orthologous Regions Revealed Movement of Ghd7 in the Grass Genomes	PLOS ONE			English	Article							COPY NUMBER VARIATION; RICE GENOME; GENE-EXPRESSION; WHOLE-GENOME; EVOLUTION; ORYZA; DNA; DUPLICATION; PLANTS; BARLEY	Ghd7 is an important rice gene that has a major effect on several agronomic traits, including yield. To reveal the origin of Ghd7 and sequence evolution of this locus, we performed a comparative sequence analysis of the Ghd7 orthologous regions from ten diploid Oryza species, Brachypodium distachyon, sorghum and maize. Sequence analysis demonstrated high gene collinearity across the genus Oryza and a disruption of collinearity among non-Oryza species. In particular, Ghd7 was not present in orthologous positions except in Oryza species. The Ghd7 regions were found to have low gene densities and high contents of repetitive elements, and that the sizes of orthologous regions varied tremendously. The large transposable element contents resulted in a high frequency of pseudogenization and gene movement events surrounding the Ghd7 loci. Annotation information and cytological experiments have indicated that Ghd7 is a heterochromatic gene. Ghd7 orthologs were identified in B. distachyon, sorghum and maize by phylogenetic analysis; however, the positions of orthologous genes differed dramatically as a consequence of gene movements in grasses. Rather, we identified sequence remnants of gene movement of Ghd7 mediated by illegitimate recombination in the B. distachyon genome.	[Yang, Lu; Liu, Tieyan; Li, Bo; Sui, Yi; Chen, Jinfeng; Shi, Jinfeng; Chen, Mingsheng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Wing, Rod A.] Univ Arizona, Inst BIO5, Sch Plant Sci, Arizona Genom Inst, Tucson, AZ USA	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; University of Arizona	Chen, MS (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China.	mschen@genetics.ac.cn	Chen, Jinfeng/K-4024-2015; Wing, Rod A/Z-2885-2019; Chen, Jinfeng/ABE-4816-2020	Wing, Rod A/0000-0001-6633-6226; Chen, Jinfeng/0000-0002-5628-6322	National Natural Science Foundation of China [30770143, 30621001, 31171231]; State Key Laboratory of Plant Genomics [2012B0301-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Plant Genomics	This work was supported by the National Natural Science Foundation of China (grant numbers 30770143, 30621001, 31171231) and the State Key Laboratory of Plant Genomics (grant number 2012B0301-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2007, PLANT J, V52, P342, DOI 10.1111/j.1365-313X.2007.03242.x; Ammiraju JSS, 2010, PLANT J, V63, P430, DOI 10.1111/j.1365-313X.2010.04251.x; Ammiraju JSS, 2008, PLANT CELL, V20, P3191, DOI 10.1105/tpc.108.063727; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Bennetzen JL, 2007, CURR OPIN PLANT BIOL, V10, P176, DOI 10.1016/j.pbi.2007.01.010; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; BROWN SW, 1966, SCIENCE, V151, P417, DOI 10.1126/science.151.3709.417; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chen M, 2010, DARWINS HERITAGE TOD, P76; Cheng ZK, 2001, GENOME RES, V11, P2133, DOI 10.1101/gr.194601; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Ducrocq S, 2009, GENETICS, V183, P1555, DOI 10.1534/genetics.109.106922; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan CZ, 2011, PLANT CELL, V23, P2821, DOI 10.1105/tpc.111.085605; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Gorbunova V, 1999, TRENDS PLANT SCI, V4, P263, DOI 10.1016/S1360-1385(99)01430-2; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; Guyot R, 2005, PLANT PHYSIOL, V138, P1205, DOI 10.1104/pp.104.058099; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; JIANG JM, 1995, P NATL ACAD SCI USA, V92, P4487, DOI 10.1073/pnas.92.10.4487; John B, 1988, HETEROCHROMATIN MOL, P1; Kim H, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r45; Kim H, 2007, GENETICS, V176, P379, DOI 10.1534/genetics.106.068783; Lai JS, 2004, GENOME RES, V14, P1924, DOI 10.1101/gr.2701104; Lu F, 2009, P NATL ACAD SCI USA, V106, P2071, DOI 10.1073/pnas.0812798106; Ma JX, 2007, GENETICS, V177, P1217, DOI 10.1534/genetics.107.078709; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mudge JM, 2005, CYTOGENET GENOME RES, V108, P47, DOI 10.1159/000080801; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Ohmido N, 2010, P JPN ACAD B-PHYS, V86, P103, DOI 10.2183/pjab.86.103; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pfeiffer P, 2000, MUTAGENESIS, V15, P289, DOI 10.1093/mutage/15.4.289; Piegu B, 2006, GENOME RES, V16, P1262, DOI 10.1101/gr.5290206; Puchta H, 2005, J EXP BOT, V56, P1, DOI 10.1093/jxb/eri025; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Sanyal A, 2010, MOL BIOL EVOL, V27, P2487, DOI 10.1093/molbev/msq133; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shirasu K, 2000, GENOME RES, V10, P908, DOI 10.1101/gr.10.7.908; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan FJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002633; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tian Chao-Guang, 2005, Acta Genetica Sinica, V32, P519; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000715; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wicker T, 2010, GENOME RES, V20, P1229, DOI 10.1101/gr.107284.110; Wu YF, 2008, MOL BIOL EVOL, V25, P1003, DOI 10.1093/molbev/msn052; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Xu JH, 2012, MOL BIOL EVOL, V29, P861, DOI 10.1093/molbev/msr261; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang LX, 2009, P NATL ACAD SCI USA, V106, P19922, DOI 10.1073/pnas.0908008106; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhang S, 2007, PLANT MOL BIOL, V64, P589, DOI 10.1007/s11103-007-9178-3; Zhang Y, 2004, NUCLEIC ACIDS RES, V32, P2023, DOI 10.1093/nar/gkh521; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	71	11	12	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50236	10.1371/journal.pone.0050236	http://dx.doi.org/10.1371/journal.pone.0050236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185584	Green Published, gold, Green Submitted			2022-12-25	WOS:000311821000205
J	Garbers, C; Spudy, B; Aparicio-Siegmund, S; Waetzig, GH; Sommer, J; Holscher, C; Rose-John, S; Grotzinger, J; Lorenzen, I; Scheller, J				Garbers, Christoph; Spudy, Bjoern; Aparicio-Siegmund, Samadhi; Waetzig, Georg H.; Sommer, Jan; Hoelscher, Christoph; Rose-John, Stefan; Groetzinger, Joachim; Lorenzen, Inken; Scheller, Juergen			An Interleukin-6 Receptor-dependent Molecular Switch Mediates Signal Transduction of the IL-27 Cytokine Subunit p28 (IL-30) via a gp130 Protein Receptor Homodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY NEUROTROPHIC FACTOR; INHIBITION; ANTAGONIST; COMPLEX; BINDING; WSX-1	IL-27 consists of the cytokine subunit p28 and the non-signaling alpha-receptor EBI3. p28 was shown to additionally act via the non-signaling membrane-bound IL-6 alpha-receptor (IL-6R) as an agonistic cytokine but also as a gp130 beta-receptor antagonist, leading to inhibition of IL-6 signaling. Here, we developed a strategy for bacterial expression, purification, and refolding of murine p28. We show that p28 did not interfere with IL-6- or IL-27-induced signaling, indicating that p28 has no antagonistic properties. Moreover, we demonstrate that murine p28 acts as an agonistic cytokine via the murine and human IL-6R, indicating that p28 exhibits no species specificity. p28 was able to induce p28-trans-signaling via the soluble IL-6R (sIL-6R), a characteristic property that was initially described for trans-signaling of IL-6 via the sIL-6R. Of notice, p28/sIL-6R trans-signaling was inhibited by the IL-6 trans-signaling antagonist, soluble gp130. At higher concentrations, p28 but not IL-6 was able to induce signaling even in the absence of IL-6R or EBI3. Although IL-27 signals via a heterodimer of the beta-receptor chains gp130 and Wsx-1, p28/IL-6R specifically recruits two gp130 beta-receptor chains for signal transduction. The binding of p28 to a gp130/Wsx-1 heterodimer or a gp130 homodimer is highly selective and controlled by a novel molecular switch induced by EBI3 or IL-6R, respectively.	[Garbers, Christoph; Aparicio-Siegmund, Samadhi; Sommer, Jan; Scheller, Juergen] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Spudy, Bjoern; Rose-John, Stefan; Groetzinger, Joachim; Lorenzen, Inken] Univ Kiel, Inst Biochem, Kiel, Germany; [Waetzig, Georg H.] CONARIS Res Inst AG, Kiel, Germany; [Hoelscher, Christoph] Res Ctr Borstel, Borstel, Germany; [Waetzig, Georg H.; Hoelscher, Christoph; Rose-John, Stefan; Groetzinger, Joachim] Cluster Excellence Inflammat Interfaces, Borstel, Germany	Heinrich Heine University Dusseldorf; University of Kiel; Forschungszentrum Borstel	Scheller, J (corresponding author), Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Univ Str 1, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Waetzig, Georg/AAV-7486-2021; Scheller, Jürgen/K-5290-2015; Rose-John, Stefan/A-7998-2010; Hölscher, Christoph/O-1732-2018; Garbers, Christoph/D-9932-2015	Rose-John, Stefan/0000-0002-7519-3279; Hölscher, Christoph/0000-0002-7520-9146; Garbers, Christoph/0000-0003-4939-6950	Deutsche Forschungsgemeinschaft (Bonn, Germany) [DFG SCHE 907/2-1, SFB877]; Research Commission of the Medical Faculty of the Heinrich-Heine-University	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Research Commission of the Medical Faculty of the Heinrich-Heine-University	This work was funded by Deutsche Forschungsgemeinschaft (Bonn, Germany) Grant DFG SCHE 907/2-1, SFB877 (A1, A6; SR-J, AC, JG), and by the Research Commission of the Medical Faculty of the Heinrich-Heine-University (to C. G. and J. S.).	Adam N, 2009, J VIROL, V83, P5117, DOI 10.1128/JVI.01601-08; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Crabe S, 2009, J IMMUNOL, V183, P7692, DOI 10.4049/jimmunol.0901464; Dams-Kozlowska H, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-8; Dibra D, 2012, HEPATOLOGY, V55, P1204, DOI 10.1002/hep.24814; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Garbers C, 2012, CYTOKINE GROWTH F R, V23, P85, DOI 10.1016/j.cytogfr.2012.04.001; Garbers C, 2011, J BIOL CHEM, V286, P42959, DOI 10.1074/jbc.M111.295758; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Gu ZJ, 1996, J IMMUNOL METHODS, V190, P21, DOI 10.1016/0022-1759(95)00232-4; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Koch M, 2007, BIOCHEM BIOPH RES CO, V364, P483, DOI 10.1016/j.bbrc.2007.10.053; MACKIEWICZ A, 1992, J IMMUNOL, V149, P2021; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Scheller J, 2005, BIOCHEM BIOPH RES CO, V326, P724, DOI 10.1016/j.bbrc.2004.11.098; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schroers A, 2005, PROTEIN SCI, V14, P783, DOI 10.1110/ps.041117105; Schuster B, 2003, J BIOL CHEM, V278, P9528, DOI 10.1074/jbc.M210044200; Stumhofer JS, 2010, NAT IMMUNOL, V11, P1119, DOI 10.1038/ni.1957; Suthaus J, 2011, EUR J CELL BIOL, V90, P495, DOI 10.1016/j.ejcb.2010.10.016; Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200; Wijdenes J, 1995, EUR J IMMUNOL, V25, P3474, DOI 10.1002/eji.1830251240; Wojno EDT, 2012, TRENDS IMMUNOL, V33, P91, DOI 10.1016/j.it.2011.11.003; Yoshida H, 2001, IMMUNITY, V15, P569, DOI 10.1016/S1074-7613(01)00206-0	28	96	98	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2013	288	6					4346	4354		10.1074/jbc.M112.432955	http://dx.doi.org/10.1074/jbc.M112.432955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	088OP	23209286	hybrid, Green Published			2022-12-25	WOS:000314845000062
J	Baldzizhar, R; Fedorchuk, C; Jha, M; Rathinam, C; Henegariu, O; Czyzyk, J				Baldzizhar, Raman; Fedorchuk, Christine; Jha, Mithilesh; Rathinam, Chozhavendan; Henegariu, Octavian; Czyzyk, Jan			Anti-serpin Antibody-mediated Regulation of Proteases in Autoimmune Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATHEPSIN-L; EXPRESSION; ONSET; AUTOANTIBODY; INHIBITION; PREVENTION; MELLITUS; IMMUNITY; HEADPIN; EMBRYO	Secretion of anti-serpin B13 autoantibodies in young diabetes-prone nonobese diabetic mice is associated with reduced inflammation in pancreatic islets and a slower progression to autoimmune diabetes. Injection of these mice with a monoclonal antibody (mAb) against serpin B13 also leads to fewer inflammatory cells in the islets and more rapid recovery from recent-onset diabetes. The exact mechanism by which anti-serpin activity is protective remains unclear. We found that serpin B13 is expressed in the exocrine component of the mouse pancreas, including the ductal cells. We also found that anti-serpin B13 mAb blocked the inhibitory activity of serpin B13, thereby allowing partial preservation of the function of its target protease. Consistent with the hypothesis that anti-clade B serpin activity blocks the serpin from binding, exposure to exogenous anti-serpin B13 mAb or endogenous anti-serpin B13 autoantibodies resulted in cleavage of the surface molecules CD4 and CD19 in lymphocytes that accumulated in the pancreatic islets and pancreatic lymph nodes but not in the inguinal lymph nodes. This cleavage was inhibited by an E64 protease inhibitor. Consequently, T cells with the truncated form of CD4 secreted reduced levels of interferon-gamma. We conclude that anti-serpin antibodies prevent serpin B13 from neutralizing proteases, thereby impairing leukocyte function and reducing the severity of autoimmune inflammation.	[Baldzizhar, Raman; Fedorchuk, Christine; Czyzyk, Jan] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Jha, Mithilesh] Trudeau Inst Inc, Saranac Lake, NY 12983 USA; [Rathinam, Chozhavendan] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Henegariu, Octavian] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	University of Rochester; Trudeau Institute; Columbia University; Yale University	Czyzyk, J (corresponding author), Univ Rochester, Dept Pathol & Lab Med, 601 Elmwood Ave, Rochester, NY 14692 USA.	jan_czyzyk@URMC.rochester.edu			Diabetes Endocrinology Research Center; Yale University	Diabetes Endocrinology Research Center; Yale University	This work was supported by a Diabetes Endocrinology Research Center grant (to J. C.) and a Translational and Interdisciplinary Research pilot grant from Yale University (to J. C. and O. H.).	Afonso S, 1997, DEVELOPMENT, V124, P3415; ALSENZ J, 1987, NEW ENGL J MED, V316, P1360, DOI 10.1056/NEJM198705283162202; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Boyce BF, 2006, ANN NY ACAD SCI, V1068, P447, DOI 10.1196/annals.1346.042; Buhling F, 1999, AM J RESP CELL MOL, V20, P612; Casciola-Rosen L, 1999, J EXP MED, V190, P815, DOI 10.1084/jem.190.6.815; Czyzyk J, 2012, J IMMUNOL, V188, P6319, DOI 10.4049/jimmunol.1200467; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; GAWRYL MS, 1982, BLOOD, V60, P1103; Haeckel C, 1999, DEV DYNAM, V216, P89, DOI 10.1002/(SICI)1097-0177(199910)216:2<89::AID-DVDY1>3.0.CO;2-9; Higgins WJ, 2010, J BIOL CHEM, V285, P3722, DOI 10.1074/jbc.M109.037358; Hsing LC, 2010, J AUTOIMMUN, V34, P96, DOI 10.1016/j.jaut.2009.07.003; Hugues S, 2002, IMMUNITY, V16, P169, DOI 10.1016/S1074-7613(02)00273-X; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Ishimaru N, 2004, ADV ENZYME REGUL, V44, P309, DOI 10.1016/j.advenzreg.2003.11.004; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; Jayakumar A, 2003, ARCH BIOCHEM BIOPHYS, V409, P367, DOI 10.1016/S0003-9861(02)00635-5; Koczwara K, 2004, DIABETES, V53, P1; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Lazarski CA, 2008, IMMUNITY, V29, P511, DOI 10.1016/j.immuni.2008.09.012; Lu YQ, 2006, HUM GENE THER, V17, P625, DOI 10.1089/hum.2006.17.625; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Maehr R, 2005, J CLIN INVEST, V115, P2934, DOI 10.1172/JCI25485; Menard V, 1999, PHARMACEUT RES, V16, P1059, DOI 10.1023/A:1018939900961; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Nakashima T, 2000, BBA-GENE STRUCT EXPR, V1492, P441, DOI 10.1016/S0167-4781(00)00100-7; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Reinhold D, 2008, FRONT BIOSCI-LANDMRK, V13, P2356, DOI 10.2741/2849; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Roep BO, 2002, DIABETOLOGIA, V45, P686, DOI 10.1007/s00125-002-0797-6; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; She JX, 1999, P NATL ACAD SCI USA, V96, P8116, DOI 10.1073/pnas.96.14.8116; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Solomon M, 2004, ADV IMMUNOL, V84, P239, DOI 10.1016/S0065-2776(04)84007-0; SPITZER RE, 1969, SCIENCE, V164, P436, DOI 10.1126/science.164.3878.436; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Targoni OS, 1999, J AUTOIMMUN, V12, P191, DOI 10.1006/jaut.1999.0271; Welss T, 2003, BIOCHEMISTRY-US, V42, P7381, DOI 10.1021/bi027307q; Wiest-Ladenburger U, 1997, INT J IMMUNOTHER, V13, P75; Yamada A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012894; Yoshifuji H, 2005, INT IMMUNOL, V17, P1327, DOI 10.1093/intimm/dxh311	44	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1612	1619		10.1074/jbc.M112.409664	http://dx.doi.org/10.1074/jbc.M112.409664			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23195956	Green Published, hybrid			2022-12-25	WOS:000313751400017
J	Fontana, S; Keshavmurthy, S; Hsieh, HJ; Denis, V; Kuo, CY; Hsu, CM; Leung, JKL; Tsai, WS; Wallace, CC; Chen, CA				Fontana, Silvia; Keshavmurthy, Shashank; Hsieh, Hernyi Justin; Denis, Vianney; Kuo, Chao-Yang; Hsu, Chia-Ming; Leung, Julia K. L.; Tsai, Wan-Sen; Wallace, Carden C.; Chen, Chaolun Allen			Molecular Evidence Shows Low Species Diversity of Coral-Associated Hydroids in Acropora Corals	PLOS ONE			English	Article							CNIDARIA HYDROZOA; SULAWESI SEA; PHYLOGENETICS; EVOLUTION; ZANCLEA; MODEL; DNA	A novel symbiosis between scleractinians and hydroids (Zanclea spp.) was recently discovered using taxonomic approaches for hydroid species identification. In this study, we address the question whether this is a species-specific symbiosis or a cosmopolitan association between Zanclea and its coral hosts. Three molecular markers, including mitochondrial 16S and nuclear 28S ribosomal genes, and internal transcribed spacer (ITS), were utilized to examine the existence of Zanclea species from 14 Acropora species and 4 other Acroporidae genera including 142 coral samples collected from reefs in Kenting and the Penghu Islands, Taiwan, Togian Island, Indonesia, and Osprey Reef and Orpheus Island on the Great Barrier Reef, Australia. Molecular phylogenetic analyses of the 16S and 28S genes showed that Acropora-associated Zanclea was monophyletic, but the genus Zanclea was not. Analysis of the ITS, and 16S and 28S genes showed either identical or extremely low genetic diversity (with mean pairwise distances of 0.009 and 0.006 base substitutions per site for the 16S and 28S genes, respectively) among Zanclea spp. collected from diverse Acropora hosts in different geographic locations, suggesting that a cosmopolitan and probably genus-specific association occurs between Zanclea hydroids and their coral hosts. Citation: Fontana S, Keshavmurthy S, Hsieh HJ, Denis V, Kuo C-Y, et al. (2012) Molecular Evidence Shows Low Species Diversity of Coral-Associated Hydroids in Acropora Corals. PLoS ONE 7(11): e50130. doi:10.1371/journal.pone.0050130	[Fontana, Silvia; Keshavmurthy, Shashank; Denis, Vianney; Kuo, Chao-Yang; Hsu, Chia-Ming; Leung, Julia K. L.; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Fontana, Silvia; Chen, Chaolun Allen] Acad Sinica, Int Taiwan Grad Program TIGP Biodivers, Taipei 115, Taiwan; [Hsieh, Hernyi Justin; Tsai, Wan-Sen] Penghu Marine Biol Res Ctr, Makong, Penghu County, Taiwan; [Hsu, Chia-Ming; Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Wallace, Carden C.] Museum Trop Queensland, Townsville, Qld, Australia	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Chen, CA (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	cac@gate.sinica.edu.tw	Denis, Vianney/E-6868-2013; Keshavmurthy, Shashank/C-3672-2013	Denis, Vianney/0000-0002-0914-5586; Keshavmurthy, Shashank/0000-0002-2235-9132	Fondazione Cariplo, Milano, Italy; Academia Sinica, Taiwan; TIGP PhD fellowship for Biodiversity Research Centre, Academia Sinica, Taiwan; Academia Sinica; National Science Council (NSC), Taiwan; Academia Sinica Thematic Grant [AS-100-TP2-A02]; NSC [NSC99-2621-B-001-006-MY3, NSC98-2313-B-056-001-MY3]	Fondazione Cariplo, Milano, Italy(Fondazione Cariplo); Academia Sinica, Taiwan(Academia Sinica - Taiwan); TIGP PhD fellowship for Biodiversity Research Centre, Academia Sinica, Taiwan; Academia Sinica(Academia Sinica - Taiwan); National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica Thematic Grant; NSC(Ministry of Science and Technology, Taiwan)	SF is the recipient of a year 2011 Extra-plus exchange program scholarship from Fondazione Cariplo, Milano, Italy, and a 2012 summer internship (TIG-PIIP) scholarship from Academia Sinica, Taiwan, and a TIGP PhD fellowship for Biodiversity Research Centre, Academia Sinica, Taiwan. CMH and JKL are recipients of a PhD fellowship, and SK is the recipient of a postdoctoral fellowship from Academia Sinica (2010-2012). VD is the recipient of a postdoctoral fellowship from the National Science Council (NSC), Taiwan. This study was made possible by an Academia Sinica Thematic Grant (AS-100-TP2-A02) and grants from the NSC (NSC99-2621-B-001-006-MY3) to CAC and (NSC98-2313-B-056-001-MY3) HJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bo M, 2011, ITAL J ZOOL, V78, P487, DOI 10.1080/11250003.2011.568015; Boero F, 2000, ITAL J ZOOL, V67, P93, DOI 10.1080/11250000009356301; BOERO F, 1984, MAR ECOL-P S Z N I, V5, P93, DOI 10.1111/j.1439-0485.1984.tb00310.x; Cartwright P, 2008, J MAR BIOL ASSOC UK, V88, P1663, DOI 10.1017/S0025315408002257; Collins AG, 2005, ZOOL SCR, V34, P91, DOI 10.1111/j.1463-6409.2005.00172.x; Ferrara GB, 2006, CELL MOL BIOL LETT, V11, P155, DOI 10.2478/s11658-006-0013-7; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hirose M, 2012, J MAR BIOL ASSOC UK, V92, P877, DOI 10.1017/S0025315411001238; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Millard N.A.H., 1973, Annales Mus r Afr cent (Ser 8 Sci zool), VNo.206, P1; Millard NAH, 1975, ANN S AFR MUS, V68, P1; Nawrocki AM, 2010, ZOOL SCR, V39, P290, DOI 10.1111/j.1463-6409.2009.00419.x; Pantos O, 2010, CORAL REEFS, V29, P761, DOI 10.1007/s00338-010-0622-5; Pantos O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020946; PETERSEN KW, 1990, ZOOL J LINN SOC-LOND, V100, P101, DOI 10.1111/j.1096-3642.1990.tb01862.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puce S, 2002, J MAR BIOL ASSOC UK, V82, P943, DOI 10.1017/S0025315402006434; Puce S, 2008, J MAR BIOL ASSOC UK, V88, P1715, DOI 10.1017/S0025315408002233; Puce S, 2008, J MAR BIOL ASSOC UK, V88, P1643, DOI 10.1017/S0025315408001094; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	23	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50130	10.1371/journal.pone.0050130	http://dx.doi.org/10.1371/journal.pone.0050130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209655	gold, Green Published, Green Submitted			2022-12-25	WOS:000312104900028
J	Jaafar, TNAM; Taylor, MI; Nor, SAM; de Bruyn, M; Carvalho, GR				Jaafar, Tun Nurul Aimi Mat; Taylor, Martin I.; Nor, Siti Azizah Mohd; de Bruyn, Mark; Carvalho, Gary R.			DNA Barcoding Reveals Cryptic Diversity within Commercially Exploited Indo-Malay Carangidae (Teleosteii: Perciformes)	PLOS ONE			English	Article							COD GADUS-MORHUA; PHYLOGENETIC-RELATIONSHIPS; PACIFIC; SEA; BIODIVERSITY; BIOGEOGRAPHY; DIVERGENCE; PISCES; GENERA; MODEL	Background: DNA barcodes, typically focusing on the cytochrome oxidase I gene (COI) in many animals, have been used widely as a species-identification tool. The ability of DNA barcoding to distinguish species from a range of taxa and to reveal cryptic species has been well documented. Despite the wealth of DNA barcode data for fish from many temperate regions, there are relatively few available from the Southeast Asian region. Here, we target the marine fish Family Carangidae, one of the most commercially-important families from the Indo-Malay Archipelago (IMA), to produce an initial reference DNA barcode library. Methodology/Principal Findings: Here, a 652 bp region of COI was sequenced for 723 individuals from 36 putative species of Family Carangidae distributed within IMA waters. Within the newly-generated dataset, three described species exhibited conspecific divergences up to ten times greater (4.32-4.82%) than mean estimates (0.24-0.39%), indicating a discrepancy with assigned morphological taxonomic identification, and the existence of cryptic species. Variability of the mitochondrial DNA COI region was compared within and among species to evaluate the COI region's suitability for species identification. The trend in range of mean K2P distances observed was generally in accordance with expectations based on taxonomic hierarchy: 0% to 4.82% between individuals within species, 0% to 16.4% between species within genera, and 8.64% to 25.39% between genera within families. The average Kimura 2-parameter (K2P) distance between individuals, between species within genera, and between genera within family were 0.37%, 10.53% and 16.56%, respectively. All described species formed monophyletic clusters in the Neighbour-joining phylogenetic tree, although three species representing complexes of six potential cryptic species were detected in Indo-Malay Carangidae; Atule mate, Selar crumenophthalmus and Seriolina nigrofasciata. Conclusion/Significance: This study confirms that COI is an effective tool for species identification of Carangidae from the IMA. There were moderate levels of cryptic diversity among putative species within the central IMA. However, to explain the hypothesis of species richness in the IMA, it is necessary to sample the whole family across their broad geographic range. Such insights are helpful not only to document mechanisms driving diversification and recruitment in Carangidae, but also to provide a scientific framework for management strategies and conservation of commercially-important fisheries resources.	[Jaafar, Tun Nurul Aimi Mat; Taylor, Martin I.; de Bruyn, Mark; Carvalho, Gary R.] Bangor Univ, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales; [Nor, Siti Azizah Mohd] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Jaafar, Tun Nurul Aimi Mat] Univ Malaysia Terengganu, Fac Fisheries & Aqua Ind, Terengganu, Malaysia	Bangor University; Universiti Sains Malaysia; Universiti Malaysia Terengganu	Jaafar, TNAM (corresponding author), Bangor Univ, Environm Ctr Wales, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales.	g.r.carvalho@bangor.ac.uk	Taylor, Martin I/B-4298-2013; Mat Jaafar, Tun Nurul Aimi/ABG-9790-2021; Nor, Siti Azizah Mohd/A-8275-2011; de Bruyn, Mark/C-5568-2008	de Bruyn, Mark/0000-0003-1528-9604	Ministry of Higher Education Malaysia; Universiti Malaysia Terengganu [KPT BS 850424086532]; Canadian Centre for DNA Barcoding (CCDB); University of Guelph Ontario, Canada	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); Universiti Malaysia Terengganu; Canadian Centre for DNA Barcoding (CCDB); University of Guelph Ontario, Canada	We would like to thank the Ministry of Higher Education Malaysia and Universiti Malaysia Terengganu for providing a doctoral fellowship to Tun Nurul Aimi Mat Jaafar. We are grateful to acknowledge local and national governments in Malaysia and State Planning Unit Sarawak for permission to carry out field work in the country and for allowing the collection and export of tissue samples. Thanks are also due to many colleagues and their respective institutions: Adelyna Akib, Tan Min Pau, Jamsari Amirul Firdaus Jamaluddin and Ahmad Lutfi Yusoff from Universiti Sains Malaysia (USM); Nurhidayah Mohd Razif and Suhana Mohd Hanidun from Universiti Malaysia Terengganu (UMT); Dr. Yuzine Esa from Universiti Malaysia Sarawak (UNIMAS), Department of Fisheries Malaysia and Fisheries Development Authority Malaysia for their sampling contribution; for the taxonomy work Abdul Rahman Majid from Fisheries Research Institute, Penang. We also acknowledge the support from Canadian Centre for DNA Barcoding (CCDB), University of Guelph Ontario, Canada for the majority of the specimen processing.; Ministry of Higher Education Malaysia and Universiti Malaysia Terengganu provided a doctoral fellowship (KPT BS 850424086532) to Tun Nurul Aimi Mat Jaafar. This research was partially supported by Canadian Centre of DNA Barcoding (CCDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annie LPK, 2009, FIELD GUIDE MARINE E; Aquilino SVL, 2011, MOL ECOL RESOUR, V11, P612, DOI 10.1111/j.1755-0998.2011.03000.x; Asgharian H, 2011, MOL ECOL RESOUR, V11, P461, DOI 10.1111/j.1755-0998.2011.02989.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bohlke JE, 1993, REV BIOL FAMILY CARA; Briggs JC, 2005, J BIOGEOGR, V32, P1517, DOI 10.1111/j.1365-2699.2005.01266.x; Brunel P, 2005, VERTIG O, V6, P1; Carpenter KE, 2005, ENVIRON BIOL FISH, V72, P467, DOI 10.1007/s10641-004-3154-4; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858; COSTA FO, 2007, GENOMICS SOC POLICY, V3, P29, DOI DOI 10.1186/1746-5354-3-2-29; Fischer W, 1974, FAO SPECIES IDENTIFI; Fox CJ, 2005, MOL ECOL, V14, P879, DOI 10.1111/j.1365-294X.2005.02439.x; Fox CJ, 2008, P ROY SOC B-BIOL SCI, V275, P1543, DOI 10.1098/rspb.2008.0201; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; GUSHIKEN S, 1988, JPN J ICHTHYOL, V34, P443; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huang J, 2007, PEDOBIOLOGIA, V51, P301, DOI 10.1016/j.pedobi.2007.05.003; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JOKIEL P, 1992, J BIOGEOGR, V19, P449, DOI 10.2307/2845572; Kijima A., 1986, P840; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2004, BIOTECHNOL LETT, V26, P1, DOI 10.1023/B:BILE.0000009469.69116.03; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lakra WS, 2009, MOL BIOL REP, V36, P831, DOI 10.1007/s11033-008-9252-1; Laroche W.A., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P510; LEIS JM, 1989, LARVAE INDOPACIFIC S; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; Mansor MI., 1998, FIELD GUIDE IMPORTAN; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller JM, 1979, UNIHISEAGRANTMR0802; Mischaux B, 1991, AUSTR SYSTEMATIC BOT, V4, P37; Mohsin AKM, 1996, MARINE FISHES FISHER; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Randall J. E., 1995, COASTAL FISHES OMAN, P439; Randall JE, 1990, FISHES GREAT BARRIER; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reaka ML, 2008, P NATL ACAD SCI USA, V105, P11474, DOI 10.1073/pnas.0802594105; Reed DL, 2002, MOL PHYLOGENET EVOL, V23, P513, DOI 10.1016/S1055-7903(02)00036-2; Santini F, 2002, J BIOGEOGR, V29, P189, DOI 10.1046/j.1365-2699.2002.00669.x; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Smith-Vaniz W.F., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P522; SPRINGER VG, 1990, B MAR SCI, V47, P631; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, AQUAT BIOL, V3, P71, DOI 10.3354/ab00068; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; WOODLAND DJ, 1983, B MAR SCI, V33, P713; Zemlak TS, 2009, MOL ECOL RESOUR, V9, P237, DOI 10.1111/j.1755-0998.2009.02649.x; Zhang JB, 2011, BIOCHEM SYST ECOL, V39, P31, DOI 10.1016/j.bse.2010.12.017	58	61	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49623	10.1371/journal.pone.0049623	http://dx.doi.org/10.1371/journal.pone.0049623			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209586	gold, Green Submitted, Green Published			2022-12-25	WOS:000312104900011
J	Guerra, E; Lattanzio, R; La Sorda, R; Dini, F; Tiboni, GM; Piantelli, M; Alberti, S				Guerra, Emanuela; Lattanzio, Rossano; La Sorda, Rossana; Dini, Francesca; Tiboni, Gian Mario; Piantelli, Mauro; Alberti, Saverio			mTrop1/Epcam Knockout Mice Develop Congenital Tufting Enteropathy through Dysregulation of Intestinal E-cadherin/beta-catenin	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BREAST-CANCER; EPCAM; GENE; ADHESION; MIGRATION; CAM; ESTABLISHMENT; GLYCOPROTEIN; MAINTENANCE	Congenital tufting enteropathy (CTE) is a life-threatening hereditary disease that is characterized by enteric mucosa tufting degeneration and early onset, severe diarrhea. Loss-of-function mutations of the human EPCAM gene (TROP1, TACSTD1) have been indicated as the cause of CTE. However, loss of mTrop1/Epcam in mice appeared to lead to death in utero, due to placental malformation. This and indications of residual Trop-1/EpCAM expression in cases of CTE cast doubt on the role of mTrop1/Epcam in this disease. The aim of this study was to determine the role of TROP1/EPCAM in CTE and to generate an animal model of this disease for molecular investigation and therapy development. Using a rigorous gene-trapping approach, we obtained mTrop1/Epcam -null (knockout) mice. These were born alive, but failed to thrive, and died soon after birth because of hemorrhagic diarrhea. The intestine from the mTrop1/Epcam knockout mice showed intestinal tufts, villous atrophy and colon crypt hyperplasia, as in human CTE. No structural defects were detected in other organs. These results are consistent with TROP1/EPCAM loss being the cause of CTE, thus providing a viable animal model for this disease, and a benchmark for its pathogenetic course. In the affected enteric mucosa, E-cadherin and beta-catenin were shown to be dysregulated, leading to disorganized transition from crypts to villi, with progressive loss of membrane localization and increasing intracellular accumulation, thus unraveling an essential role for Trop-1/EpCAM in the maintenance of intestinal architecture and functionality. Supporting information is available for this article.	[Guerra, Emanuela; Lattanzio, Rossano; La Sorda, Rossana; Dini, Francesca; Piantelli, Mauro; Alberti, Saverio] Univ G dAnnunzio Fdn, CeSI, Unit Canc Pathol, Chieti, Italy; [Tiboni, Gian Mario] Univ G DAnnunzio, Sch Med, Dept Med & Res Aging, Chieti, Italy; [Piantelli, Mauro] Univ G DAnnunzio, Dept Biomed Sci, Chieti, Italy; [Alberti, Saverio] Univ G DAnnunzio, BAMS, Dept Neurosci & Imaging, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Guerra, E (corresponding author), Univ G dAnnunzio Fdn, CeSI, Unit Canc Pathol, Chieti, Italy.	emanuela.guerra5@gmail.com	Lattanzio, Rossano/K-1927-2018; Alberti, Saverio/M-4511-2014	Lattanzio, Rossano/0000-0001-9803-4476; Alberti, Saverio/0000-0002-4647-6042; Guerra, Emanuela/0000-0002-7091-8621; Tiboni, Gian Mario/0000-0002-3030-5230; Piantelli, Mauro/0000-0003-0154-482X	Telethon [GP0353Y02]; Fondazione of the Cassa di Risparmio della Provincia di Chieti	Telethon(Fondazione Telethon); Fondazione of the Cassa di Risparmio della Provincia di Chieti	The support of Telethon (Grant Nu GP0353Y02) and of the Fondazione of the Cassa di Risparmio della Provincia di Chieti is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mayouf SM, 2009, J PEDIATR GASTR NUTR, V49, P642, DOI 10.1097/MPG.0b013e3181acaeae; ALBERTI S, 1994, P NATL ACAD SCI USA, V91, P5833, DOI 10.1073/pnas.91.13.5833; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; BERGSAGEL PL, 1992, J IMMUNOL, V148, P590; Biganzoli E, 2011, JPN J CLIN ONCOL, V41, P172, DOI 10.1093/jjco/hyq227; Blazar M, 2001, MOL CELL BIOL, V21, P2570, DOI 10.1128/MCB.21.7.2570-2580.2001; Bondow BJ, 2012, DEV BIOL; Calabrese G, 2001, CYTOGENET CELL GENET, V92, P164, DOI 10.1159/000056891; Casaletto JB, 2011, P NATL ACAD SCI USA, V108, P11924, DOI 10.1073/pnas.1103418108; El Sewedy T, 1998, INT J CANCER, V75, P324, DOI 10.1002/(SICI)1097-0215(19980119)75:2<324::AID-IJC24>3.3.CO;2-5; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Gaiser MR, 2012, P NATL ACAD SCI USA, V109, pE889, DOI 10.1073/pnas.1117674109; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Goulet O, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-20; Guerra E, 2013, ONCOGENE, V32, P1594, DOI 10.1038/onc.2012.151; Hiscox S, 1999, J CELL SCI, V112, P3081; Ko JS, 2010, GUT LIVER, V4, P407, DOI 10.5009/gnl.2010.4.3.407; Lin Y, 2009, FERTIL STERIL, V91, P2687, DOI 10.1016/j.fertnstert.2008.01.109; LINNENBACH AJ, 1993, MOL CELL BIOL, V13, P1507, DOI 10.1128/MCB.13.3.1507; LIPINSKI M, 1981, P NATL ACAD SCI-BIOL, V78, P5147, DOI 10.1073/pnas.78.8.5147; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Nagao K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008543; Patey N, 1997, GASTROENTEROLOGY, V113, P833, DOI 10.1016/S0016-5085(97)70178-1; Pujuguet P, 2003, MOL BIOL CELL, V14, P2181, DOI 10.1091/mbc.E02-07-0410; Querzoli P, 2010, BRIT J CANCER, V103, P1835, DOI 10.1038/sj.bjc.6605991; Rossi C, 2008, EUR J CANCER, V44, P2696, DOI 10.1016/j.ejca.2008.08.021; Salomon J, 2011, EUR J MED GENET, V54, P319, DOI 10.1016/j.ejmg.2011.01.009; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Sivagnanam M, 2008, GASTROENTEROLOGY, V135, P429, DOI 10.1053/j.gastro.2008.05.036; Sivagnanam M, 2010, AM J MED GENET A, V152A, P222, DOI 10.1002/ajmg.a.33186; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Teller I C, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003623; Trerotola M, 2013, ONCOGENE, V32, P222, DOI 10.1038/onc.2012.36; Trzpis M, 2008, FRONT BIOSCI-LANDMRK, V13, P5050, DOI 10.2741/3063; Villablanca EJ, 2006, DEV DYNAM, V235, P1578, DOI 10.1002/dvdy.20743; Wang DH, 2011, P NATL ACAD SCI USA, V108, P10272, DOI 10.1073/pnas.1017668108; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Winter MJ, 2003, EXP CELL RES, V285, P50, DOI 10.1016/S0014-4827(02)00045-9; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zanna P, 2007, CANCER-AM CANCER SOC, V110, P452, DOI 10.1002/cncr.22785	43	56	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e49302	10.1371/journal.pone.0049302	http://dx.doi.org/10.1371/journal.pone.0049302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209569	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700011
J	Bustad, HJ; Skjaerven, L; Ying, M; Halskau, O; Baumann, A; Rodriguez-Larrea, D; Costas, M; Underhaug, J; Sanchez-Ruiz, JM; Martinez, A				Bustad, Helene J.; Skjaerven, Lars; Ying, Ming; Halskau, Oyvind; Baumann, Anne; Rodriguez-Larrea, David; Costas, Miguel; Underhaug, Jarl; Sanchez-Ruiz, Jose M.; Martinez, Aurora			The Peripheral Binding of 14-3-3 gamma to Membranes Involves Isoform-Specific Histidine Residues	PLOS ONE			English	Article							AMPHITROPIC PROTEINS; HOFMEISTER SERIES; STRUCTURAL BASIS; SUBCELLULAR-LOCALIZATION; ALPHA-LACTALBUMIN; FYVE DOMAIN; 14-3-3-PROTEINS; RECOGNITION; STABILITY; COMPLEXES	Mammalian 14-3-3 protein scaffolds include seven conserved isoforms that bind numerous phosphorylated protein partners and regulate many cellular processes. Some 14-3-3-isoforms, notably gamma, have elevated affinity for membranes, which might contribute to modulate the subcellular localization of the partners and substantiate the importance of investigating molecular mechanisms of membrane interaction. By applying surface plasmon resonance we here show that the binding to phospholipid bilayers is stimulated when 14-3-3 gamma is complexed with its partner, a peptide corresponding to the Ser19-phosphorylated N-terminal region of tyrosine hydroxylase. Moreover, membrane interaction is dependent on salts of kosmotropic ions, which also stabilize 14-3-3 gamma. Electrostatic analysis of available crystal structures of gamma and of the non-membrane-binding zeta-isoform, complemented with molecular dynamics simulations, indicate that the electrostatic potential distribution of phosphopeptide-bound 14-3-3 gamma is optimal for interaction with the membrane through amphipathic helices at the N-terminal dimerization region. In addition, His158, and especially His195, both specific to 14-3-3 gamma and located at the convex lateral side, appeared to be pivotal for the ligand induced membrane interaction, as corroborated by site-directed mutagenesis. The participation of these histidine residues might be associated to their increased protonation upon membrane binding. Overall, these results reveal membrane-targeting motifs and give insights on mechanisms that furnish the 14-3-3 gamma scaffold with the capacity for tuned shuffling from soluble to membrane-bound states.	[Bustad, Helene J.; Skjaerven, Lars; Ying, Ming; Halskau, Oyvind; Baumann, Anne; Underhaug, Jarl; Martinez, Aurora] Univ Bergen, Dept Biomed, Bergen, Norway; [Rodriguez-Larrea, David; Costas, Miguel; Sanchez-Ruiz, Jose M.] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain; [Rodriguez-Larrea, David] Univ Oxford, Dept Chem, Oxford, England; [Costas, Miguel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Quim Fis, Lab Biofis Quim, Mexico City 04510, DF, Mexico	University of Bergen; University of Granada; University of Oxford; Universidad Nacional Autonoma de Mexico	Martinez, A (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	aurora.martinez@biomed.uib.no	Skjærven, Lars/C-1919-2017; Sanchez-Ruiz, Jose/H-2849-2015; Martinez, Aurora/M-3088-2019; Rodriguez-Larrea, David/ABH-3171-2020	Skjærven, Lars/0000-0002-8176-4891; Sanchez-Ruiz, Jose/0000-0002-9056-3928; Martinez, Aurora/0000-0003-1643-6506; Rodriguez-Larrea, David/0000-0002-5580-7413; Underhaug, Jarl/0000-0003-0346-3986; Costas, Miguel/0000-0001-8604-6381; Bustad, Helene J./0000-0002-4746-1563; Halskau, Oyvind/0000-0003-2517-1060	Norwegian Cancer Society; Junta de Andalucia [CVI-02483]; Research Council of Norway [185181]; Western Norway Health Authorities [911618]; Kristian Gerhard Jebsen Foundation	Norwegian Cancer Society(Norwegian Cancer Society); Junta de Andalucia(Junta de Andalucia); Research Council of Norway(Research Council of Norway); Western Norway Health Authorities; Kristian Gerhard Jebsen Foundation	This work was supported by grants from the Norwegian Cancer Society (to OH), Junta de Andalucia, grant CVI-02483 (to JMSR), The Research Council of Norway (grant 185181 to A.M.), the Western Norway Health Authorities (grant 911618 to A.M.) and The Kristian Gerhard Jebsen Foundation (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasoster AV, 2003, J BIOL CHEM, V278, P21790, DOI 10.1074/jbc.M211466200; Ahmad A, 2001, BIOCHEMISTRY-US, V40, P1945, DOI 10.1021/bi001933a; Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; [Anonymous], 2008, AMBER 10; Aroti A, 2007, BIOPHYS J, V93, P1580, DOI 10.1529/biophysj.106.094482; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; Bustad HJ, 2011, FEBS LETT, V585, P1163, DOI 10.1016/j.febslet.2011.03.027; Cacace MG, 1997, Q REV BIOPHYS, V30, P241, DOI 10.1017/S0033583597003363; Chen R, 2003, J BIOMED SCI, V10, P774, DOI 10.1159/000073965; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; COOPER A, 1993, PHILOS T R SOC A, V345, P23, DOI 10.1098/rsta.1993.0114; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Halskau O, 2002, J MOL BIOL, V321, P99, DOI 10.1016/S0022-2836(02)00565-X; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; Halskau O, 2009, J BIOL CHEM, V284, P32758, DOI 10.1074/jbc.M109.027706; Hekman M, 2006, J BIOL CHEM, V281, P17321, DOI 10.1074/jbc.M600292200; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kampmann T, 2006, STRUCTURE, V14, P1481, DOI 10.1016/j.str.2006.07.011; Kaufman S, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P103; Kleppe R, 2011, SEMIN CELL DEV BIOL, V22, P713, DOI 10.1016/j.semcdb.2011.08.008; KUHN DM, 1990, J BIOL CHEM, V265, P5780; Kutateladze TG, 2006, BBA-MOL CELL BIOL L, V1761, P868, DOI 10.1016/j.bbalip.2006.03.011; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; MARTIN H, 1994, J NEUROCHEM, V63, P2259; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; Musiani F, 2011, J PROTEOME RES, V10, P968, DOI 10.1021/pr101178k; Novokmet S, 2005, INORG CHEM, V44, P4796, DOI 10.1021/ic0500053; Obsil T, 2011, SEMIN CELL DEV BIOL; Okamoto Y, 2011, J BIOL CHEM, V286, P7171, DOI 10.1074/jbc.M110.199695; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Perez-Jimenez R, 2004, BIOPHYS J, V86, P2414, DOI 10.1016/S0006-3495(04)74298-8; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Polzien L, 2009, J BIOL CHEM, V284, P28004, DOI 10.1074/jbc.M109.010702; Ramakrishnan M, 2003, BIOCHEMISTRY-US, V42, P12919, DOI 10.1021/bi035048e; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; ROTH D, 1994, BIOCHEM J, V301, P305, DOI 10.1042/bj3010305; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Strochlic L, 2004, P NATL ACAD SCI USA, V101, P18189, DOI 10.1073/pnas.0406905102; Tadeo X, 2007, BIOCHEMISTRY-US, V46, P917, DOI 10.1021/bi0613426; van Heusden GPH, 2005, IUBMB LIFE, V57, P623, DOI 10.1080/15216540500252666; VANDERGOOT FG, 1991, NATURE, V354, P408, DOI 10.1038/354408a0; Vogel R, 2001, BIOCHEMISTRY-US, V40, P483, DOI 10.1021/bi001855r; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yamamoto T, 2008, BIOCHEMISTRY-US, V47, P11647, DOI 10.1021/bi801117t; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zhang XQ, 2007, BIOCHEMISTRY-US, V46, P5252, DOI 10.1021/bi602483p; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012	71	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49671	10.1371/journal.pone.0049671	http://dx.doi.org/10.1371/journal.pone.0049671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189152	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800029
J	Chantepie, S; Bochem, AE; Chapman, MJ; Hovingh, GK; Kontush, A				Chantepie, Sandrine; Bochem, Andrea E.; Chapman, M. John; Hovingh, G. Kees; Kontush, Anatol			High-Density Lipoprotein (HDL) Particle Subpopulations in Heterozygous Cholesteryl Ester Transfer Protein (CETP) Deficiency: Maintenance of Antioxidative Activity	PLOS ONE			English	Article							ELEVATED OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; APOLIPOPROTEINS AI; LDL OXIDATION; HEART-DISEASE; LIPID-LEVELS; RAISING HDL; RISK; GENE; PLASMA	Cholesteryl ester transfer protein (CETP) deficiency causes elevated high-density lipoprotein-cholesterol (HDL-C) levels; its impact on HDL functionality however remains elusive. We compared functional and compositional properties of HDL derived from 9 Caucasian heterozygous CETP mutation carriers (splice-site mutation in intron 7 resulting in premature truncation) with those of 9 age-and sex-matched normolipidemic family controls. As expected, HDL-C levels were increased 1.5-fold, and CETP mass and activity were decreased by -31% and -38% respectively, in carriers versus non-carriers. HDL particles from carriers were enriched in CE (up to +19%, p<0.05) and depleted of triglycerides (TG; up to -54%, p<0.01), resulting in a reduced TG/CE ratio (up to 2.5-fold, p<0.01). In parallel, the apoA-I content was increased in HDL from carriers (up to +22%, p<0.05). Both the total HDL fraction and small, dense HDL3 particles from CETP-deficient subjects displayed normal antioxidative activity by attenuating low-density lipoprotein oxidation with similar efficacy on a particle mass basis as compared to control HDL3. Consistent with these data, circulating levels of systemic biomarkers of oxidative stress (8-isoprostanes) were similar between the two groups. These findings support the contention that HDL functionality is maintained in heterozygous CETP deficiency despite modifications in lipid and protein composition.	[Chantepie, Sandrine; Chapman, M. John; Kontush, Anatol] Pitie Salpetriere Univ Hosp, INSERM, UMRS 939, Paris, France; [Bochem, Andrea E.; Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Chapman, M. John; Kontush, Anatol] Univ Paris 06, Dept Sci Res, Paris, France; [Chapman, M. John; Kontush, Anatol] Grp Hosp Pitie Salpetriere, AP HP, F-75634 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Amsterdam; Academic Medical Center Amsterdam; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Chantepie, S (corresponding author), Univ Paris Est Creteil, Creteil, France.	sandrine.chantepie@u-pec.fr	chapman, john/Y-2742-2019; Kontush, Anatol/J-2198-2016	CHANTEPIE, Sandrine/0000-0003-1652-432X				Agerholm-Larsen B, 2000, CIRCULATION, V101, P1907, DOI 10.1161/01.CIR.101.16.1907; Anand SS, 2009, CIRC-CARDIOVASC GENE, V2, P16, DOI 10.1161/CIRCGENETICS.108.813709; Barter PJ, 2003, ARTERIOSCL THROM VAS, V23, P160, DOI 10.1161/01.ATV.0000054658.91146.64; Bisoendial RJ, 2005, ARTERIOSCL THROM VAS, V25, pE133, DOI 10.1161/01.ATV.0000179009.60612.28; Boekholdt SM, 2005, CIRCULATION, V111, P278, DOI 10.1161/01.CIR.0000153341.46271.40; Boekholdt SM, 2003, J LIPID RES, V44, P1080, DOI 10.1194/jlr.R200018-JLR200; Calabresi L, 2009, ATHEROSCLEROSIS, V205, P506, DOI 10.1016/j.atherosclerosis.2009.01.006; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Cefalu AB, 2009, ATHEROSCLEROSIS, V204, P202, DOI 10.1016/j.atherosclerosis.2008.08.031; Chapman MJ, 2010, EUR HEART J, V31, P149, DOI 10.1093/eurheartj/ehp399; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; CHRISTISON JK, 1995, J LIPID RES, V36, P2017; Curb JD, 2004, J LIPID RES, V45, P948, DOI 10.1194/jlr.M300520-JLR200; DULLAART RPF, 1994, EUR J CLIN INVEST, V24, P188, DOI 10.1111/j.1365-2362.1994.tb00987.x; Duriez P, 2007, LANCET, V370, P1882, DOI 10.1016/S0140-6736(07)61788-7; Egloff M, 1999, ANN BIOL CLIN-PARIS, V57, P561; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; Gaut JP, 2001, TRENDS CARDIOVAS MED, V11, P103, DOI 10.1016/S1050-1738(01)00101-3; Hansel B, 2004, J CLIN ENDOCR METAB, V89, P4963, DOI 10.1210/jc.2004-0305; Huang JM, 1998, CLIN BIOCHEM, V31, P537, DOI 10.1016/S0009-9120(98)00060-5; Joy T, 2008, NAT REV DRUG DISCOV, V7, P143, DOI 10.1038/nrd2489; Klos KLE, 2007, CURR OPIN CARDIOL, V22, P344, DOI 10.1097/HCO.0b013e3281a8acad; Kolovou G, 2010, OPEN CARDIOVASC MED, V4, P14, DOI 10.2174/1874192401004010014; Kontush A, 2005, ATHEROSCLEROSIS, V182, P277, DOI 10.1016/j.atherosclerosis.2005.03.001; Kontush A, 2004, ARTERIOSCL THROM VAS, V24, P526, DOI 10.1161/01.ATV.0000118276.87061.00; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Kontush A., 2012, HIGH DENSITY LIPOPRO; Kontush A, 2008, NAT CLIN PRACT CARD, V5, P329, DOI 10.1038/ncpcardio1191; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Kontush A, 2010, CURR OPIN LIPIDOL, V21, P312, DOI 10.1097/MOL.0b013e32833bcdc1; Koropatnick TA, 2008, J GERONTOL A-BIOL, V63, P1235, DOI 10.1093/gerona/63.11.1235; Kronenberg F, 2002, EUR J HUM GENET, V10, P367, DOI 10.1038/sj.ejhg.5200818; Masson D, 2009, J LIPID RES, V50, pS201, DOI 10.1194/jlr.R800061-JLR200; Mezzetti A, 2000, CARDIOVASC RES, V47, P475, DOI 10.1016/S0008-6363(00)00118-8; Miller M, 2003, CURR OPIN LIPIDOL, V14, P273, DOI 10.1097/00041433-200306000-00007; Miwa K, 2009, CLIN CHIM ACTA, V402, P19, DOI 10.1016/j.cca.2008.12.012; Niemeijer-Kanters SDJM, 2001, ATHEROSCLEROSIS, V156, P209, DOI 10.1016/S0021-9150(00)00642-0; Niesor EJ, 2010, J LIPID RES, V51, P3443, DOI 10.1194/jlr.M008706; Niesor EJ, 2009, CIRCULATION, V120, pS468; Orloff DG, 2007, AM J CARDIOL, V100, p10N, DOI 10.1016/j.amjcard.2007.08.007; Perusse L, 1997, ARTERIOSCL THROM VAS, V17, P3263, DOI 10.1161/01.ATV.17.11.3263; Pietilainen KH, 2009, OBESITY, V17, P1208, DOI 10.1038/oby.2008.675; Plengpanich W, 2011, ATHEROSCLEROSIS, V216, P370, DOI 10.1016/j.atherosclerosis.2011.01.051; Plengpanich W, 2009, METABOLISM, V58, P1178, DOI 10.1016/j.metabol.2009.03.020; Qi GF, 2005, LIFE SCI, V77, P2690, DOI 10.1016/j.lfs.2005.05.037; Regieli JJ, 2008, EUR HEART J, V29, P2792, DOI 10.1093/eurheartj/ehn465; Ridker PM, 2009, CIRC-CARDIOVASC GENE, V2, P26, DOI 10.1161/CIRCGENETICS.108.817304; Rotllan N, 2008, ATHEROSCLEROSIS, V196, P505, DOI 10.1016/j.atherosclerosis.2007.05.007; RUMSEY SC, 1994, J LIPID RES, V35, P1592; SATTLER W, 1995, FREE RADICAL BIO MED, V18, P421, DOI 10.1016/0891-5849(94)00170-O; Sugano M, 2000, J LIPID RES, V41, P126; Tall AR, 2009, AM J CARDIOL, V104, p39E, DOI 10.1016/j.amjcard.2009.09.018; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Thompson JF, 2007, J LIPID RES, V48, P434, DOI 10.1194/jlr.M600372-JLR200; Tsai MY, 2008, ATHEROSCLEROSIS, V200, P359, DOI 10.1016/j.atherosclerosis.2007.12.038; Tsimikas S, 2011, CURR PHARM DESIGN, V17, P27, DOI 10.2174/138161211795049831; van der Steeg WA, 2007, J LIPID RES, V48, P674, DOI 10.1194/jlr.M600405-JLR200; Weissglas-Volkov D, 2010, J LIPID RES, V51, P2032, DOI 10.1194/jlr.R004739; Weissglas-Volkov D, 2010, CIRC-CARDIOVASC GENE, V3, P31, DOI 10.1161/CIRCGENETICS.109.908004; Wilson PWF, 2008, JAMA-J AM MED ASSOC, V299, P2795, DOI 10.1001/jama.299.23.2795; Yoshida H, 2010, CLIN CHIM ACTA, V411, P1875, DOI 10.1016/j.cca.2010.08.038; Yoshikawa M, 1997, CLIN BIOCHEM, V30, P221, DOI 10.1016/S0009-9120(97)00031-3; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142; Zerrad-Saadi A, 2009, ARTERIOSCL THROM VAS, V29, P2169, DOI 10.1161/ATVBAHA.109.194555	66	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49336	10.1371/journal.pone.0049336	http://dx.doi.org/10.1371/journal.pone.0049336			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189141	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800020
J	Jansen, KB; Baker, SL; Sousa, MC				Jansen, Katarina Bartos; Baker, Susan Lynn; Sousa, Marcelo Carlos			Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features	PLOS ONE			English	Article							BARREL ASSEMBLY MACHINERY; OUTER-MEMBRANE; ESCHERICHIA-COLI; ESSENTIAL COMPONENT; BACTERIAL PROTEIN; YAET COMPLEX; LIPOPROTEINS; FLEXIBILITY; BIOGENESIS; SECRETION	The assembly of beta-barrel Outer Membrane Proteins (OMPs) in the outer membrane is essential for Gram-negative bacteria. The process requires the beta-Barrel Assembly Machine (BAM), a multiprotein complex that, in E. coli, is composed of the OMP BamA and four lipoproteins BamB-E. Whereas BamA and BamD are essential, deletion of BamB, C or E produce membrane permeability defects. Here we present the high-resolution structure of BamB from Pseudomonas aeruginosa. This protein can complement the deletion of bamB in E. coli indicating that they are functionally equivalent. Conserved structural features include an eight-bladed beta-propeller fold stabilized by tryptophan docking motifs with a central pore about 8 angstrom in diameter at the narrowest point. This pore distinguishes BamB from related beta-propellers, such as quinoprotein dehydrogenases. However, a double mutation designed to block this pore was fully functional indicating that the opening is not essential. Two loops protruding from the bottom of the propeller are conserved and mediate binding to BamA. Conversely, an additional loop only present in E. coli BamB is not required for function. A cluster of highly conserved residues in a groove between blades 6 and 7 is crucial for proper BamB folding or biogenesis. It has been proposed that BamB may bind nascent OMPs by beta-augmentation to its propeller outer strands, or recognize the aromatic residue signature at the C-terminus of OMPs. However, Isothermal Titration Calorimetry experiments and structural analysis do not support these proposals. The structural and mutagenesis analysis suggests that the main function of BamB is to bind and modulate BamA, rather than directly interact with nascent OMPs.	[Jansen, Katarina Bartos; Baker, Susan Lynn; Sousa, Marcelo Carlos] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Sousa, MC (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	Marcelo.Sousa@colorado.edu			Department of Energy; National Institutes of Health (NIH) [R01 AI080709]; NIH [T32 GM065103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. An Tran for help in the preparation of the E. coli Delta bamB strain and Sandra Metzner for assistance in cloning. Part of this work was performed at the Advanced Light Source, funded by the Department of Energy.; This research was supported by National Institutes of Health (NIH) grant R01 AI080709 to MCS. KBJ was supported in part by NIH Training Grant T32 GM065103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht R, 2011, J BIOL CHEM; Anthony C, 1998, PROG BIOPHYS MOL BIO, V69, P1, DOI 10.1016/S0079-6107(97)00020-5; Anwari K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008619; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eddy Sean R, 2009, Genome Inform, V23, P205; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo T, 2011, EMBO REP; Fardini Y, 2009, MICROBIOL-SGM, V155, P1613, DOI 10.1099/mic.0.025155-0; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x; GHOSH M, 1995, STRUCTURE, V3, P177, DOI 10.1016/S0969-2126(01)00148-4; Gruber J, 2007, ACTA CRYSTALLOGR D, V63, P50, DOI 10.1107/S0907444906046762; Hagan CL, 2010, SCIENCE, V328, P890, DOI 10.1126/science.1188919; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim KH, 2011, J BIOL CHEM; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Onufryk C, 2005, J BACTERIOL, V187, P4552, DOI 10.1128/JB.187.13.4552-4561.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Schulz GE, 2003, ADV PROTEIN CHEM, V63, P47; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Voulhoux R, 2004, RES MICROBIOL, V155, P129, DOI 10.1016/j.resmic.2003.11.007; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Webb C, 2012, J MOL BIOL; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	47	21	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49749	10.1371/journal.pone.0049749	http://dx.doi.org/10.1371/journal.pone.0049749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189157	gold, Green Submitted, Green Published			2022-12-25	WOS:000311929800034
J	Zuo, CS; Sung, YH; Simonson, DC; Habecker, E; Wang, J; Haws, C; Villafuerte, RA; Henry, ME; Dobbins, RL; Hodge, RJ; Nunez, DJR; Renshaw, PF				Zuo, Chun S.; Sung, Young-Hoon; Simonson, Donald C.; Habecker, Erin; Wang, Jian; Haws, Charlotte; Villafuerte, Rosemond A.; Henry, Michael E.; Dobbins, Robert L.; Hodge, Rebecca J.; Nunez, Derek J. R.; Renshaw, Perry F.			Reduced T2*Values in Soleus Muscle of Patients with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							SKELETAL-MUSCLE; BOLD CONTRAST; OXYGENATION; PERFUSION; EXERCISE	Tissue water transverse relaxation times (T2) are highly sensitive to fluid and lipid accumulations in skeletal muscles whereas the related T2* is sensitive to changes in tissue oxygenation in addition to factors affecting T2. Diabetes mellitus (DM) affects muscles of lower extremities progressively by impairing blood flow at the macrovascular and microvascular levels. This study is to investigate whether T2 and T2* are sensitive enough to detect abnormalities in skeletal muscles of diabetic patients in the resting state. T2 and T2* values in calf muscle of 18 patients with type 2 DM (T2DM), 22 young healthy controls (YHC), and 7 age-matched older healthy controls (OHC) were measured at 3T using multi-TE spin echo and gradient echo sequences. Regional lipid levels of the soleus muscle were also measured using the Dixon method in a subset of the subjects. Correlations between T2, T2*, lipid levels, glycated hemoglobin (HbA1c) and presence of diabetes were evaluated. We found that T2 values were significantly higher in calf muscles of T2DM subjects, as were T2* values in anterior tibialis, and gastrocnemius muscles of T2DM participants. However, soleus T2* values of the T2DM subjects were significantly lower than those of the older, age-matched HC cohort (22.9 +/- 0.5 vs 26.7 +/- 0.4 ms, p<0.01). The soleus T2* values in the T2DM cohort were inversely correlated with the presence of diabetes (t = -3.46, p<0.001) and with an increase in HbA1c, but not with body mass index or regional lipid levels. Although multiple factors may contribute to changes in T2* values, the lowered T2* value observed in the T2DM soleus muscle is most consistent with a combination of high oxygen consumption and poor regional perfusion. This finding is consistent with results of previous perfusion studies and suggests that the soleus in individuals with T2DM is likely under tissue oxygenation stress.	[Zuo, Chun S.; Sung, Young-Hoon; Habecker, Erin; Haws, Charlotte; Villafuerte, Rosemond A.; Henry, Michael E.; Renshaw, Perry F.] Harvard Univ, McLean Hosp, Brain Imaging Ctr, Belmont, MA 02178 USA; [Simonson, Donald C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [Dobbins, Robert L.; Hodge, Rebecca J.; Nunez, Derek J. R.] GlaxoSmithKline, Res & Dev, Res Triangle Pk, NC USA	Harvard University; McLean Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Army Medical University; GlaxoSmithKline	Zuo, CS (corresponding author), Harvard Univ, McLean Hosp, Brain Imaging Ctr, Belmont, MA 02178 USA.	chun@mclean.harvard.edu; jianwang376@yahoo.com	Renshaw, Perry/O-1384-2018		GlaxoSmithKline; National Institutes of Health [MH081076]; NIH [DA015116]; GSK; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH081076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA015116, K05DA031247] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GSK(GlaxoSmithKline); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported in part by a grant from GlaxoSmithKline. CZ was supported in part by a grant from National Institutes of Health (MH081076). PFR is supported in part by grants from NIH (DA015116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Although the study was supported in part by a research grant from GSK, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Barth M, 1997, CELL MOL BIOL, V43, P783; Baudelet C, 2002, MAGN RESON MED, V48, P980, DOI 10.1002/mrm.10318; Bulte DP, 2006, J MAGN RESON IMAGING, V24, P886, DOI 10.1002/jmri.20690; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; CAMERON NE, 1991, AM J PHYSIOL, V261, pE1, DOI 10.1152/ajpendo.1991.261.1.E1; Copray S, 2000, EXP NEUROL, V161, P597, DOI 10.1006/exnr.1999.7306; Cosson E, 2001, DIABETES CARE, V24, P870, DOI 10.2337/diacare.24.5.870; DIXON WT, 1984, RADIOLOGY, V153, P189, DOI 10.1148/radiology.153.1.6089263; Duteil S, 2006, MAGN RESON MED, V55, P450, DOI 10.1002/mrm.20760; FEWELL JG, 1995, MOL CELL BIOCHEM, V148, P147, DOI 10.1007/BF00928152; Frank LR, 1999, MAGN RESON MED, V42, P258, DOI 10.1002/(SICI)1522-2594(199908)42:2<258::AID-MRM7>3.0.CO;2-E; Jelinek JS, 1999, RADIOLOGY, V211, P241, DOI 10.1148/radiology.211.1.r99ap44241; Jordan BF, 2004, MAGNETIC RESONANCE M, P52; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Ledermann HP, 2006, CIRCULATION, V113, P2929, DOI 10.1161/CIRCULATIONAHA.105.605717; LOGERFO FW, 1984, NEW ENGL J MED, V311, P1615, DOI 10.1056/NEJM198412203112506; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; McArdle WD, 2010, EXERCISE PHYSL NUTR, V7th; Noseworthy Michael D, 2003, Semin Musculoskelet Radiol, V7, P307; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Padilla DJ, 2006, AM J PHYSIOL-HEART C, V291, pH2439, DOI 10.1152/ajpheart.00290.2006; Prasad PV, 2012, CURR MED IMAGING REV, V8, P122; Prasad PV, 1996, CIRCULATION, V94, P3271, DOI 10.1161/01.CIR.94.12.3271; Sung Y, 2009, DIFFERENTIAL PROFILE, P4098; Tortora G. J., 1990, PRINCIPLES ANATOMY P; Towse TF, 2005, J APPL PHYSIOL, V99, P715, DOI 10.1152/japplphysiol.00272.2005; Zuo CS, 2003, J MAGN RESON IMAGING, V17, P676, DOI 10.1002/jmri.10314	28	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49337	10.1371/journal.pone.0049337	http://dx.doi.org/10.1371/journal.pone.0049337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189142	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800021
J	Pandey, PR; Xing, F; Sharma, S; Watabe, M; Pai, SK; Iiizumi-Gairani, M; Fukuda, K; Hirota, S; Mo, YY; Watabe, K				Pandey, P. R.; Xing, F.; Sharma, S.; Watabe, M.; Pai, S. K.; Iiizumi-Gairani, M.; Fukuda, K.; Hirota, S.; Mo, Y-Y; Watabe, K.			Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer	ONCOGENE			English	Article						lipogenesis; ductal carcinoma in situ; breast cancer; stem-like cells; apoptosis; resveratrol	FATTY-ACID SYNTHASE; ACTIVATION; EXPRESSION; RAS; PROGRESSION; APOPTOSIS; RECEPTOR; PATHWAY; GENE; GROWTH	Upregulation of lipogenesis is a hallmark of cancer and blocking the lipogenic pathway is known to cause tumor cell death by apoptosis. However, the exact role of lipogenesis in tumor initiation is as yet poorly understood. We examined the expression profile of key lipogenic genes in clinical samples of ductal carcinoma in situ (DCIS) of breast cancer and found that these genes were significantly upregulated in DCIS. We also isolated cancer stem-like cells (CSCs) from DCIS.com cell line using cell surface markers (CS24(-)CD44(+)ESA(+)) and found that this cell population has significantly higher tumor-initiating ability to generate DCIS compared with the non-stem-like population. Furthermore, the CSCs showed significantly higher level of expression of all lipogenic genes than the counterpart population from non-tumorigenic breast cancer cell line, MCF10A. Importantly, ectopic expression of SREBP1, the master regulator of lipogenic genes, in MCF10A significantly enhanced lipogenesis in stem-like cells and promoted cell growth as well as mammosphere formation. Moreover, SREBP1 expression significantly increased the ability of cell survival of CSCs from MCF10AT, another cell line that is capable of generating DCIS, in mouse and in cell culture. These results indicate that upregulation of lipogenesis is a pre-requisite for DCIS formation by endowing the ability of cell survival. We have also shown that resveratrol was capable of blocking the lipogenic gene expression in CSCs and significantly suppressed their ability to generate DCIS in animals, which provides us with a strong rationale to use this agent for chemoprevention against DCIS.	[Pandey, P. R.; Xing, F.; Sharma, S.; Watabe, M.; Pai, S. K.; Iiizumi-Gairani, M.; Fukuda, K.; Watabe, K.] So Illinois Univ, Sch Med, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL USA; [Hirota, S.] Iwate Med Univ, Sch Med, Dept Gastroenterol & Hepatol, Morioka, Iwate 020, Japan; [Xing, F.; Mo, Y-Y; Watabe, K.] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA	Southern Illinois University System; Southern Illinois University; Iwate Medical University; University of Mississippi; University of Mississippi Medical Center	Watabe, K (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, 2500 N State St,Arthur Guyton Res Bldg G654, Jackson, MS 39216 USA.	kwatabe@umc.edu	Mo, Yin-Yuan/R-8255-2019; Xia, Bo/P-9380-2016		National Institutes of Health [R01CA124650, R01CA129000, R01CA124650-04S1]; US Department of Defense [BC096982]; McElroy Foundation; NATIONAL CANCER INSTITUTE [R01CA124650, R01CA129000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); McElroy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (Grants R01CA124650, R01CA129000 and R01CA124650-04S1 to KW), the US Department of Defense (BC096982 to KW) and McElroy Foundation (to KW).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alberola-Ila J, 2003, IMMUNOL REV, V191, P79, DOI 10.1034/j.1600-065X.2003.00012.x; Allan Alison L, 2006, Breast Dis, V26, P87; Bandyopadhyay S, 2006, CANCER RES, V66, P5934, DOI 10.1158/0008-5472.CAN-05-3197; Barnes NLP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e797; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Caron RW, 2005, CELL CYCLE, V4, P456, DOI 10.4161/cc.4.3.1249; Chuthapisith S, 2010, SURG ONCOL, V19, P27, DOI 10.1016/j.suronc.2009.01.004; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Damonte P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2104; Dawson PJ, 1996, AM J PATHOL, V148, P313; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Esslimani-Sahla M, 2007, INT J CANCER, V120, P224, DOI 10.1002/ijc.22202; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Gu GY, 2007, CANCER RES, V67, P4807, DOI 10.1158/0008-5472.CAN-06-4608; Guillet-Deniau I, 2004, J CELL SCI, V117, P1937, DOI 10.1242/jcs.01069; Heppner Gloria H., 1999, Breast J, V5, P122, DOI 10.1046/j.1524-4741.1999.00136.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang WC, 2012, MOL CANCER RES, V10, P133, DOI 10.1158/1541-7786.MCR-11-0206; JANES PW, 1994, ONCOGENE, V9, P3601; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Lee CM, 2005, GYNECOL ONCOL, V99, P415, DOI 10.1016/j.ygyno.2005.05.045; Liu W, 2011, BREAST CANCER RES TR, V128, P57, DOI 10.1007/s10549-010-1076-8; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Menendez JA, 2006, CURR OPIN CLIN NUTR, V9, P346, DOI 10.1097/01.mco.0000232893.21050.15; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; Pandey PR, 2012, RECENT PAT ANTI-CANC, V7, P185; Pandey PR, 2011, BREAST CANCER RES TR, V130, P387, DOI 10.1007/s10549-010-1300-6; Piyathilake CJ, 2000, HUM PATHOL, V31, P1068, DOI 10.1053/hupa.2000.9842; Pizer ES, 1998, CANCER RES, V58, P4611; Porter DA, 2001, CANCER RES, V61, P5697; Ramjaun AR, 2007, CELL CYCLE, V6, P2902, DOI 10.4161/cc.6.23.4996; Rashid A, 1997, AM J PATHOL, V150, P201; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Uttarwar L, 2012, AM J PHYSIOL-RENAL, V302, pF329, DOI 10.1152/ajprenal.00136.2011; Valverde AM, 1998, EXP CELL RES, V243, P274, DOI 10.1006/excr.1998.4154; Vazquez-Martin A, 2008, CELL PROLIFERAT, V41, P59, DOI 10.1111/j.1365-2184.2007.00498.x; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036	46	58	59	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 17	2013	32	42					5111	5122		10.1038/onc.2012.519	http://dx.doi.org/10.1038/onc.2012.519			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	238IB	23208501				2022-12-25	WOS:000325937900012
J	Buchwald, M; Pietschmann, K; Brand, P; Gunther, A; Mahajan, NP; Heinzel, T; Kramer, OH				Buchwald, M.; Pietschmann, K.; Brand, P.; Guenther, A.; Mahajan, N. P.; Heinzel, T.; Kraemer, O. H.			SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation	ONCOGENE			English	Article						ACK1; estrogen; proteasome; SIAH1; SIAH2; TNK2	BREAST-CANCER-CELLS; ANDROGEN RECEPTOR; DOWN-REGULATION; E3 LIGASE; STABILITY; PATHWAY; ACTIVATION; EXPRESSION; PROTEINS; PHOSPHORYLATION	Activated Cdc42-associated kinase 1 (ACK1) is a nonreceptor tyrosine kinase linked to cellular transformation. The aberrant regulation of ACK1 promotes tumor progression and metastasis. Therefore, ACK1 is regarded as a valid target in cancer therapy. Seven in absentia homolog (SIAH) ubiquitin ligases facilitate substrate ubiquitinylation that targets proteins to the proteasomal degradation pathway. Here we report that ACK1 and SIAH1 from Homo sapiens interact in a yeast two-hybrid screen. Protein-protein interaction studies and protein degradation analyses using deletion and point mutants of ACK1 verify that SIAH1 and the related SIAH2 interact with ACK1. The association between SIAHs and ACK1 depends on the integrity of a highly conserved SIAH-binding motif located in the far C-terminus of ACK1. Furthermore, we demonstrate that the interaction of ACK1 with SIAH1 and the induction of proteasomal degradation of ACK1 by SIAH1 are independent of ACK1's kinase activity. Chemical inhibitors blocking proteasomal activity corroborate that SIAH1 and SIAH2 destabilize the ACK1 protein by inducing its proteasomal turnover. This mechanism apparently differs from the lysosomal pathway targeting ACK1 after stimulation with the epidermal growth factor. Our data also show that ACK1, but not ACK1 mutants lacking the SIAH binding motif, has a discernable negative effect on SIAH levels. Additionally, knockdown approaches targeting the SIAH2 mRNA uncover specifically that the induction of SIAH2 expression, by hormonally-induced estrogen receptor (ER) activation, decreases the levels of ACK1 in luminal human breast cancer cells. Collectively, our data provide novel insights into the molecular mechanisms modulating ACK1 and they position SIAH ubiquitin ligases as negative regulators of ACK1 in transformed cells.	[Buchwald, M.; Pietschmann, K.; Brand, P.; Heinzel, T.; Kraemer, O. H.] Univ Jena, Ctr Mol Biomed, Inst Biochem & Biophys, D-07745 Jena, Germany; [Guenther, A.] Univ Giessen, Lung Ctr, Dept Internal Med 2, D-35390 Giessen, Germany; [Mahajan, N. P.] Univ S Florida, H Lee Moffitt Canc Ctr, Drug Discovery Dept, Tampa, FL 33682 USA	Friedrich Schiller University of Jena; Justus Liebig University Giessen; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Kramer, OH (corresponding author), Univ Jena, Ctr Mol Biomed, Inst Biochem & Biophys, Hans Knoll St 2, D-07745 Jena, Germany.	Oliver.Kraemer@uni-jena.de	Heinzel, Thorsten/B-1013-2015; Krämer, Oliver H/L-9266-2015	Krämer, Oliver H/0000-0003-3973-045X	German Cancer Aid [FKZ102362]; Wilhelm-Sander Foundation [2010.078.1]; NATIONAL CANCER INSTITUTE [R01CA135328] Funding Source: NIH RePORTER	German Cancer Aid(Deutsche Krebshilfe); Wilhelm-Sander Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. Kosan, M. Korfei and S. Scheiding for their discussions and their excellent help. We are grateful to M. Kogl, N. Varin-Blank, Z. Ronai, R. Marschalek, H. Bursen, A. Baniahmad, O. Werz and O. Huber for providing material. Grant support: German Cancer Aid (FKZ102362); Wilhelm-Sander Foundation (No. 2010.078.1).	Ahmed AU, 2008, JNCI-J NATL CANCER I, V100, P1606, DOI 10.1093/jnci/djn365; Buchwald M, 2010, LEUKEMIA, V24, P1412, DOI 10.1038/leu.2010.114; Bursen A, 2004, ONCOGENE, V23, P6237, DOI 10.1038/sj.onc.1207837; Calzado MA, 2009, NAT CELL BIOL, V11, P85, DOI 10.1038/ncb1816; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Chua BT, 2010, MOL ONCOL, V4, P323, DOI 10.1016/j.molonc.2010.03.001; Depaux A, 2006, BIOCHEM BIOPH RES CO, V348, P857, DOI 10.1016/j.bbrc.2006.07.092; Frasor J, 2005, P NATL ACAD SCI USA, V102, P13153, DOI 10.1073/pnas.0502782102; Fukushima T, 2006, IMMUNITY, V24, P29, DOI 10.1016/j.immuni.2005.12.002; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; House CM, 2006, STRUCTURE, V14, P695, DOI 10.1016/j.str.2005.12.013; House CM, 2009, CANCER RES, V69, P8835, DOI 10.1158/0008-5472.CAN-09-1676; Howlin J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2087; Jansen MPHM, 2009, BREAST CANCER RES TR, V116, P263, DOI 10.1007/s10549-008-0125-z; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Korzeniewski N, 2010, MOL BIOL CELL, V21, P3942, DOI 10.1091/mbc.E09-12-1049; Kramer OH, 2008, FASEB J, V22, P1369, DOI 10.1096/fj.06-8050com; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Kramer OH, 2012, LEUKEMIA IN PRESS; Li C, 2004, ONCOGENE, V23, P9336, DOI 10.1038/sj.onc.1208114; Lin Qi, 2010, Bulletin of Botanical Research, V30, P4; Liu M, 2012, MOL CELL, V46, P325, DOI 10.1016/j.molcel.2012.03.007; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Mahajan K, 2012, AM J PATHOL, V180, P1386, DOI 10.1016/j.ajpath.2011.12.028; Mahajan K, 2010, PROSTATE, V70, P1274, DOI 10.1002/pros.21163; Mahajan K, 2010, J CELL PHYSIOL, V224, P327, DOI 10.1002/jcp.22162; Mahajan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009646; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Nagano Y, 2011, CELL CYCLE, V10, P2592, DOI 10.4161/cc.10.15.16912; Osborne CK, 2011, CLIN CANCER RES, V17, P1147, DOI 10.1158/1078-0432.CCR-10-1869; Pao-Chun L, 2009, J BIOL CHEM, V284, P34954, DOI 10.1074/jbc.M109.072660; Perissi V, 2008, MOL CELL, V29, P755, DOI 10.1016/j.molcel.2008.01.020; Pietschmann K, 2012, MOL CANC TH IN PRESS; Pietschmann K, 2012, INT J BIOCHEM CELL B, V44, P132, DOI 10.1016/j.biocel.2011.10.008; Prieto-Echagile V., 2011, J SIGNAL TRANSDUCT, V2011; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; Stebbing J, 2012, ONCOGENE IN PRESS; Twomey E, 2010, EXP CELL RES, V316, P68, DOI 10.1016/j.yexcr.2009.09.001; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Venables JP, 2004, HUM MOL GENET, V13, P1525, DOI 10.1093/hmg/ddh165; Wen YY, 2010, MOL CARCINOGEN, V49, P440, DOI 10.1002/mc.20615; Wen YY, 2010, CANCER SCI, V101, P73, DOI 10.1111/j.1349-7006.2009.01339.x; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; Wu HL, 2010, BIOCHEM BIOPH RES CO, V397, P391, DOI 10.1016/j.bbrc.2010.05.024; Xu ZH, 2006, J BIOL CHEM, V281, P303, DOI 10.1074/jbc.M509060200; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Yun S, 2008, J BIOL CHEM, V283, P1034, DOI 10.1074/jbc.M705874200; Zhao HL, 2010, BIOCHEM BIOPH RES CO, V399, P623, DOI 10.1016/j.bbrc.2010.07.127	53	26	29	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 10	2013	32	41					4913	4920		10.1038/onc.2012.515	http://dx.doi.org/10.1038/onc.2012.515			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	235KQ	23208506	Green Accepted			2022-12-25	WOS:000325717800007
J	Lopez-Castejon, G; Luheshi, NM; Compan, V; High, S; Whitehead, RC; Flitsch, S; Kirov, A; Prudovsky, I; Swanton, E; Brough, D				Lopez-Castejon, Gloria; Luheshi, Nadia M.; Compan, Vincent; High, Stephen; Whitehead, Roger C.; Flitsch, Sabine; Kirov, Aleksandr; Prudovsky, Igor; Swanton, Eileithyia; Brough, David			Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1 beta Secretion via Assembly of the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION; ACTIVATION; UBIQUITIN; INHIBITORS; CYTOKINE; RELEASE; RECEPTORS; MECHANISM; MOLECULE	IL-1 beta is a potent pro-inflammatory cytokine produced in response to infection or injury. It is synthesized as an inactive precursor that is activated by the protease caspase-1 within a cytosolic molecular complex called the inflammasome. Assembly of this complex is triggered by a range of structurally diverse damage or pathogen associated stimuli, and the signaling pathways through which these act are poorly understood. Ubiquitination is a post-translational modification essential for maintaining cellular homeostasis. It can be reversed by deubiquitinase enzymes (DUBs) that remove ubiquitin moieties from the protein thus modifying its fate. DUBs present specificity toward different ubiquitin chain topologies and are crucial for recycling ubiquitin molecules before protein degradation as well as regulating key cellular processes such as protein trafficking, gene transcription, and signaling. We report here that small molecule inhibitors of DUB activity inhibit inflammasome activation. Inhibition of DUBs blocked the processing and release of IL-1 beta in both mouse and human macrophages. DUB activity was necessary for inflammasome association as DUB inhibition also impaired ASC oligomerization and caspase-1 activation without directly blocking caspase-1 activity. These data reveal the requirement for DUB activity in a key reaction of the innate immune response and highlight the therapeutic potential of DUB inhibitors for chronic auto-inflammatory diseases.	[Lopez-Castejon, Gloria; Luheshi, Nadia M.; Compan, Vincent; High, Stephen; Swanton, Eileithyia; Brough, David] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Whitehead, Roger C.; Flitsch, Sabine] Univ Manchester, Sch Chem, Manchester M13 9PT, Lancs, England; [Kirov, Aleksandr; Prudovsky, Igor] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA	University of Manchester; University of Manchester; Maine Medical Center	Brough, D (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	david.brough@manchester.ac.uk	Lopez-Castejon, Gloria/F-6985-2015; Compan, Vincent/M-6977-2017; Flitsch, Sabine/AAJ-6812-2020; Prudovsky, Igor/GVU-1521-2022; Whitehead, Roger/AAE-9077-2020	Lopez-Castejon, Gloria/0000-0002-8585-3381; Compan, Vincent/0000-0001-6805-1179; Brough, David/0000-0002-2250-2381; Flitsch, Sabine/0000-0003-3974-646X; Whitehead, Roger/0000-0003-2910-4033; High, Stephen/0000-0002-4532-8152; Swanton, Eileithyia/0000-0002-3299-4228	National Institutes of Health [8P30 GM103392, HL035627]; Maine Cancer Foundation; Wellcome Trust; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; BBSRC [BB/D005752/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D005752/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maine Cancer Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Prof. Stig Linder (Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden) for b-AP15. We are also grateful to Dr. Vishva Dixit of Genentech for the NLRP3 KO mice. I. P. used the services of the Maine Medical Center Research Institute Viral Core supported by National Institutes of Health Grant 8P30 GM103392 (to R. Friesel).; This work was supported, in whole or in part, by National Institutes of Health Grant HL035627 (to I. P.). This work was also supported by a grant from the Maine Cancer Foundation (to I. P.) and by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Berndtsson M, 2009, INT J CANCER, V124, P1463, DOI 10.1002/ijc.24004; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Besemer J, 2005, NATURE, V436, P290, DOI 10.1038/nature03670; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Ferrari D, 1997, J IMMUNOL, V159, P1451; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kumar Y, 2010, BIOCHEM J, V427, P91, DOI 10.1042/BJ20091349; Labbe K, 2011, IMMUNITY, V35, P897, DOI 10.1016/j.immuni.2011.10.016; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lindauer M, 2010, TOXINS, V2, P1500, DOI 10.3390/toxins2061500; Lopez-Castejon G, 2012, EXPERT OPIN INV DRUG, V21, P995, DOI 10.1517/13543784.2012.690032; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Luheshi NM, 2012, EUR J IMMUNOL, V42, P716, DOI 10.1002/eji.201142079; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McKibbin C, 2012, BIOCHEM J, V442, P639, DOI 10.1042/BJ20111220; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miao EA, 2010, J CLIN IMMUNOL, V30, P502, DOI 10.1007/s10875-010-9386-5; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Prudovsky I, 2003, J CELL SCI, V116, P4871, DOI 10.1242/jcs.00872; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Sanchez-Pulido L, 2012, BIOINFORMATICS, V28, P1953, DOI 10.1093/bioinformatics/bts319; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Squires RC, 2007, J BIOL CHEM, V282, P34260, DOI 10.1074/jbc.M705687200; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TARANTINI F, 1995, J BIOL CHEM, V270, P29039, DOI 10.1074/jbc.270.49.29039; Tarantini F, 2001, J BIOL CHEM, V276, P5147, DOI 10.1074/jbc.C000714200; Valle CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029073; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Vyleta ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036044; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang QY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015479; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Watkins LR, 1999, LIFE SCI, V65, P449, DOI 10.1016/S0024-3205(99)00095-8	66	134	140	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2721	2733		10.1074/jbc.M112.422238	http://dx.doi.org/10.1074/jbc.M112.422238			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23209292	Green Published, hybrid			2022-12-25	WOS:000314211500056
J	Patil, VA; Fox, JL; Gohil, VM; Winge, DR; Greenberg, ML				Patil, Vinay A.; Fox, Jennifer L.; Gohil, Vishal M.; Winge, Dennis R.; Greenberg, Miriam L.			Loss of Cardiolipin Leads to Perturbation of Mitochondrial and Cellular Iron Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFUR PROTEIN BIOGENESIS; OXIDATIVE STRESS-RESPONSE; CLUSTER SCAFFOLD PROTEIN; ABC TRANSPORTER ATM1P; SACCHAROMYCES-CEREVISIAE; YEAST FRATAXIN; RESPIRATORY-CHAIN; METHIONINE BIOSYNTHESIS; SUCCINATE-DEHYDROGENASE; ACONITASE DEFICIENCY	Cardiolipin (CL) is the signature phospholipid of mitochondrial membranes, where it is synthesized locally and plays a critical role in mitochondrial bioenergetic functions. The importance of CL in human health is underscored by the observation that perturbation of CL biosynthesis causes the severe genetic disorder Barth syndrome. To fully understand the cellular response to the loss of CL, we carried out genome-wide expression profiling of the yeast CL mutant crd1 Delta. Our results show that the loss of CL in this mutant leads to increased expression of iron uptake genes accompanied by elevated levels of mitochondrial iron and increased sensitivity to iron and hydrogen peroxide. Previous studies have shown that increased mitochondrial iron levels result from perturbations in iron-sulfur (Fe-S) cluster biogenesis. Consistent with an Fe-S defect, deletion of ISU1, one of two ISU genes that encode the mitochondrial Fe-S scaffolding protein essential for the synthesis of Fe-S clusters, led to synthetic growth defects with the crd1 Delta mutant. We further show that crd1 Delta cells have reduced activities of mitochondrial Fe-S enzymes (aconitase, succinate dehydrogenase, and ubiquinol-cytochrome c oxidoreductase), as well as cytosolic Fe-S enzymes (sulfite reductase and isopropylmalate isomerase). Increased expression of ATM1 or YAP1 did not rescue the Fe-S defects in crd1 Delta. These findings show for the first time that CL is required for Fe-S biogenesis to maintain mitochondrial and cellular iron homeostasis.	[Patil, Vinay A.; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Fox, Jennifer L.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Fox, Jennifer L.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Gohil, Vishal M.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Wayne State University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Texas A&M University System; Texas A&M University College Station	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu		Gohil, Vishal/0000-0002-9920-2563	National Institutes of Health from NIEHS [R21 HL 084218, R01 ES03817]; National Institutes of Health [T32 HL007576-25]; Barth Syndrome Foundation; Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL084218, T32HL007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 HL 084218 (to M. L. G.), R01 ES03817 from NIEHS (to D. R. W.), and T32 HL007576-25 (to J. L. F.). This work was also supported by the Barth Syndrome Foundation (to M. L. G.) and graduate enhancement research funds from Wayne State University (to V. A. P.).	Acehan D, 2007, LAB INVEST, V87, P40, DOI 10.1038/labinvest.3700480; Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; Atkinson A, 2011, MOL CELL BIOL, V31, P3988, DOI 10.1128/MCB.05673-11; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Barros MH, 1999, GENE, V233, P197, DOI 10.1016/S0378-1119(99)00137-7; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879; Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Burri L, 2004, J BIOL CHEM, V279, P50243, DOI 10.1074/jbc.M409194200; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Crane BR, 1997, BIOCHEMISTRY-US, V36, P12101, DOI 10.1021/bi971065q; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; de la Loza MDD, 2011, NUCLEIC ACIDS RES, V39, P6002, DOI 10.1093/nar/gkr193; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; FRY M, 1980, BIOCHEM BIOPH RES CO, V93, P1238, DOI 10.1016/0006-291X(80)90622-1; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLER RG, 1991, J CLIN INVEST, V88, P1197, DOI 10.1172/JCI115422; Hausmann A, 2008, J BIOL CHEM, V283, P8318, DOI 10.1074/jbc.M705570200; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HSU YP, 1984, J BIOL CHEM, V259, P3714; Inoue Y, 1999, J BIOL CHEM, V274, P27002, DOI 10.1074/jbc.274.38.27002; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2009, BBA-MOL CELL RES, V1793, P212, DOI 10.1016/j.bbamcr.2008.07.024; Kaplan J, 2006, BBA-MOL CELL RES, V1763, P646, DOI 10.1016/j.bbamcr.2006.03.008; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li J, 1999, J BIOL CHEM, V274, P33025, DOI 10.1074/jbc.274.46.33025; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Lucau-Danila A, 2005, MOL CELL BIOL, V25, P1860, DOI 10.1128/MCB.25.5.1860-1868.2005; Ma LN, 2004, J BIOL CHEM, V279, P44394, DOI 10.1074/jbc.M405479200; Manzella L, 1998, YEAST, V14, P839, DOI 10.1002/(SICI)1097-0061(19980630)14:9<839::AID-YEA283>3.0.CO;2-A; MASSELOT M, 1975, MOL GEN GENET, V139, P121, DOI 10.1007/BF00264692; MASSELOT M, 1977, MOL GEN GENET, V154, P23, DOI 10.1007/BF00265572; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Morales JG, 2010, BIOCHEMISTRY-US, V49, P5436, DOI 10.1021/bi100558z; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Muhlenhoff U, 2004, J BIOL CHEM, V279, P36906, DOI 10.1074/jbc.M406516200; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; R Development Core Team, 2005, R LANG ENV STAT COMP; Radisky DC, 1997, P NATL ACAD SCI USA, V94, P5662, DOI 10.1073/pnas.94.11.5662; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Rissler M, 2005, J MOL BIOL, V353, P485, DOI 10.1016/j.jmb.2005.08.051; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; ROBINSON NC, 1993, J BIOENERG BIOMEMBR, V25, P153, DOI 10.1007/BF00762857; Runkoa AP, 2008, FEBS LETT, V582, P715, DOI 10.1016/j.febslet.2008.01.046; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schulz TJ, 2010, AGING-US, V2, P843, DOI 10.18632/aging.100234; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; SKALA J, 1991, YEAST, V7, P281, DOI 10.1002/yea.320070310; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sugiyama K, 2000, J BIOL CHEM, V275, P15535, DOI 10.1074/jbc.275.20.15535; Szklarz LKS, 2005, J MOL BIOL, V351, P206, DOI 10.1016/j.jmb.2005.05.068; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vanoni MA, 1999, CELL MOL LIFE SCI, V55, P617, DOI 10.1007/s000180050319; Vasquez-Vivar J, 2000, J BIOL CHEM, V275, P14064, DOI 10.1074/jbc.275.19.14064; WEMMIE JA, 1994, J BIOL CHEM, V269, P32592; Wemmie JA, 1997, J BIOL CHEM, V272, P7908, DOI 10.1074/jbc.272.12.7908; Wiedemann N, 2006, EMBO J, V25, P184, DOI 10.1038/sj.emboj.7600906; Yamamoto H, 2005, FEBS LETT, V579, P507, DOI 10.1016/j.febslet.2004.12.018; YOSHIMOTO A, 1968, BIOCHIM BIOPHYS ACTA, V153, P555, DOI 10.1016/0005-2728(68)90185-0; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200; ZHENG LM, 1994, BIOCHEMISTRY-US, V33, P4714, DOI 10.1021/bi00181a031; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200	112	58	63	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 18	2013	288	3					1696	1705		10.1074/jbc.M112.428938	http://dx.doi.org/10.1074/jbc.M112.428938			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	073OC	23192348	hybrid, Green Published			2022-12-25	WOS:000313751400026
J	Han, Y; Li, XZ; Zhou, SM; Meng, GL; Xiao, YJ; Zhang, W; Wang, ZY; Xie, LP; Liu, Z; Lu, H; Ji, Y				Han, Yi; Li, Xiaozhen; Zhou, Suming; Meng, Guoliang; Xiao, Yujiao; Zhang, Wen; Wang, Zhuoying; Xie, Liping; Liu, Zhen; Lu, Hui; Ji, Yong			17 beta-Estradiol Antagonizes the Down-Regulation of ER alpha/NOS-3 Signaling in Vascular Endothelial Dysfunction of Female Diabetic Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ESTROGEN-RECEPTOR-ALPHA; GLYCATION END-PRODUCTS; IN-VIVO; RESISTANCE ARTERIES; VENOUS CONSTRICTION; INSULIN-RESISTANCE; OXIDATIVE STRESS; PROTEIN-KINASE; CAROTID-ARTERY	Previous studies indicated that estrogen could improve endothelial function. However, whether estrogen protects vascular complications of diabetes has yet to be clarified. The study was designed to investigate the action of 17 beta-estradiol on vascular endothelium in streptozotocin (STZ)-induced diabetic rats. Ovariectomized female Sprague-Dawley rats were administered with streptozotocin to produce an ovariectomized-diabetic (OVS) model which manifested as dysfunction of aortic dilation and contraction ability. Meanwhile, OVS animals with 17 beta-estradiol supplementation significantly improved aortic function. Accordingly, nitric oxide synthase-3 (NOS-3), Akt, PI3K and estrogen receptor alpha (ER alpha) protein expression in aorta declined in the OVS group. Such effects were partially restored by estrogen replacement. The presence of 17 beta-estradiol similarly counteracted the reduction of cyclic guanosine monophosphate (cGMP), the enhanced expression of inducible NOS (NOS-2) and NO metabolites (nitrite and nitrate), as well as the increase of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 (MMP-9/TIMP-1), which is an index of arterial compliance. 17 beta-estradiol could also decrease ROS production in vascular endothelium. In EA hy 926 cells we found that ER antagonist, wortmannin and Akt inhibitor could block improvement effects of 17 beta-estradiol. These results strongly suggest that functional impairment of the ER alpha/NOS-3 signaling network in OVS animals was partially restored by 17 beta-estradiol administration, which provides experimental support for estrogen recruitment to improve vascular outcomes in female diabetes after endogenous hormone depletion.	[Han, Yi; Zhou, Suming] Nanjing Med Univ, Dept Geriatr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Li, Xiaozhen; Meng, Guoliang; Xiao, Yujiao; Zhang, Wen; Wang, Zhuoying; Xie, Liping; Liu, Zhen; Lu, Hui; Ji, Yong] Nanjing Med Univ, State Key Lab Reprod Med, Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Ji, Y (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China.	yongji@njmu.edu.cn			Major Program of Universities Natural Science Research Project of Jiangsu Province [10KJA310033]; PAPD; National Natural Science Foundation of China [81200196, 81170083]	Major Program of Universities Natural Science Research Project of Jiangsu Province; PAPD; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Major Program of Universities Natural Science Research Project of Jiangsu Province (10KJA310033), PAPD and the National Natural Science Foundation of China ( 81200196 and 81170083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe W, 2007, J CARDIOVASC PHARM, V50, P590, DOI 10.1097/FJC.0b013e318150d104; Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; Baba T, 2005, J BIOL CHEM, V280, P16417, DOI 10.1074/jbc.M500924200; Bernier SG, 2000, J BIOL CHEM, V275, P30707, DOI 10.1074/jbc.M005116200; Bracamonte MP, 2001, TRENDS ENDOCRIN MET, V12, P204, DOI 10.1016/S1043-2760(01)00406-4; Brouchet L, 2001, CIRCULATION, V103, P423; Cheng X, 2003, EUR J PHARMACOL, V458, P299, DOI 10.1016/S0014-2999(02)02762-0; Chung AWY, 2009, CARDIOVASC RES, V84, P494, DOI 10.1093/cvr/cvp242; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Csanyi G, 2007, PHARMACOL REP, V59, P447; Darblade B, 2002, CIRC RES, V90, P413, DOI 10.1161/hh0402.105096; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; de Chantemele EJB, 2009, CARDIOVASC RES, V81, P788, DOI 10.1093/cvr/cvn334; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Denizalti M, 2011, N-S ARCH PHARMACOL, V383, P509, DOI 10.1007/s00210-011-0601-6; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dumont O, 2007, ARTERIOSCL THROM VAS, V27, P317, DOI 10.1161/01.ATV.0000254684.80662.44; Favre J, 2010, ARTERIOSCL THROM VAS, V30, P2562, DOI 10.1161/ATVBAHA.110.213637; Felaco M, 2001, ANN CLIN LAB SCI, V31, P179; Gavin KM, 2009, J CLIN ENDOCR METAB, V94, P3513, DOI 10.1210/jc.2009-0278; Haynes MP, 2000, CIRC RES, V87, P677, DOI 10.1161/01.RES.87.8.677; Hisamoto K, 2001, J BIOL CHEM, V276, P47642, DOI 10.1074/jbc.M103853200; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Kim KH, 2008, STEROIDS, V73, P864, DOI 10.1016/j.steroids.2008.01.008; Kleinert H, 1998, HYPERTENSION, V31, P582, DOI 10.1161/01.HYP.31.2.582; Kobayashi T, 2006, AM J PHYSIOL-HEART C, V291, pH846, DOI 10.1152/ajpheart.01349.2005; Kobayashi T, 2009, AM J PHYSIOL-HEART C, V297, pH1767, DOI 10.1152/ajpheart.00536.2009; Li L, 2007, P NATL ACAD SCI USA, V104, P16468, DOI 10.1073/pnas.0704315104; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Miyazaki-Akita A, 2007, J PHARMACOL EXP THER, V320, P591, DOI 10.1124/jpet.106.111641; Ordonez P, 2008, J STEROID BIOCHEM, V111, P287, DOI 10.1016/j.jsbmb.2008.07.001; Paul RJ, 2007, AM J PHYSIOL-REG I, V292, pR751, DOI 10.1152/ajpregu.00167.2006; Pinna C, 2008, HYPERTENSION, V51, P1210, DOI 10.1161/HYPERTENSIONAHA.107.106807; Song DZ, 2006, N-S ARCH PHARMACOL, V373, P451, DOI 10.1007/s00210-006-0088-8; Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662; Tamura K, 2000, LIFE SCI, V66, pPL259, DOI 10.1016/S0024-3205(00)00488-4; Tan J, 2007, HYPERTENS RES, V30, P959, DOI 10.1291/hypres.30.959; Tayebjee MH, 2004, DIABETES CARE, V27, P2049, DOI 10.2337/diacare.27.8.2049; Toutain CE, 2009, ARTERIOSCL THROM VAS, V29, P1543, DOI 10.1161/ATVBAHA.109.192849; Tronc F, 1996, ARTERIOSCL THROM VAS, V16, P1256, DOI 10.1161/01.ATV.16.10.1256; Vasudevan H, 2005, AM J PHYSIOL-HEART C, V289, pH1335, DOI 10.1152/ajpheart.00399.2005; Woodman OL, 2009, LIFE SCI, V85, P54, DOI 10.1016/j.lfs.2009.04.012; Xu B, 2005, CLIN SCI, V109, P439, DOI 10.1042/CS20050183; Xu B, 2003, FASEB J, V17, P1289, DOI 10.1096/fj.02-0490fje; Yasmin, 2005, ARTERIOSCL THROM VAS, V25, P372, DOI 10.1161/01.ATV.0000151373.33830.41	47	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50402	10.1371/journal.pone.0050402	http://dx.doi.org/10.1371/journal.pone.0050402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209733	Green Published, gold, Green Submitted			2022-12-25	WOS:000312104900048
J	Neto, SC; Salti, A; Puschban, Z; Stefanova, N; Nat, R; Dechant, G; Wenning, GK				Neto, Sonya Carvalho; Salti, Ahmad; Puschban, Zoe; Stefanova, Nadia; Nat, Roxana; Dechant, Georg; Wenning, Gregor K.			Cell Fate Analysis of Embryonic Ventral Mesencephalic Grafts in the 6-OHDA Model of Parkinson's Disease	PLOS ONE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; FIBROBLAST-GROWTH-FACTOR; FETAL NIGRAL TRANSPLANTATION; DOPA-INDUCED DYSKINESIAS; NEURAL TRANSPLANTATION; RAT MODEL; TRANSCRIPTIONAL CONTROL; BRAIN; SURVIVAL; SYSTEM	Evidence from carefully conducted open label clinical trials suggested that therapeutic benefit can be achieved by grafting fetal dopaminergic (DAergic) neurons derived from ventral mesencephalon (VM) into the denervated striatum of Parkinson's disease (PD) patients. However, two double-blind trials generated negative results reporting deleterious side effects such as prominent dyskinesias. Heterogeneous composition of VM grafts is likely to account for suboptimal clinical efficacy. We consider that gene expression patterns of the VM tissue needs to be better understood by comparing the genetic signature of the surviving and functioning grafts with the cell suspensions used for transplantation. In addition, it is crucial to assess whether the grafted cells exhibit the DAergic phenotype of adult substantia nigra pars compacta (SNpc). To investigate this further, we used a GFP reporter mouse as source of VM tissue that enabled the detection and dissection of the grafts 6 weeks post implantation. A comparative gene expression analysis of the VM cell suspension and grafts revealed that VM grafts continue to differentiate post-implantation. In addition, implanted grafts showed a mature SNpc-like molecular DAergic phenotype with similar expression levels of TH, Vmat2 and Dat. However, by comparing gene expression of the adult SNpc with dissected grafts we detected a higher expression of progenitor markers in the grafts. Finally, when compared to the VM cell suspension, post-grafting there was a higher expression of markers inherent to glia and other neuronal populations. In summary, our data highlight the dynamic development of distinctive DAergic and non-DAergic gene expression markers associated with the maturation of VM grafts in vivo. The molecular signature of VM grafts and its functional relevance should be further explored in future studies aimed at the optimization of DAergic cell therapy approaches in PD.	[Neto, Sonya Carvalho; Stefanova, Nadia; Wenning, Gregor K.] Med Univ Innsbruck, Div Neurobiol, Dept Neurol, Innsbruck, Austria; [Salti, Ahmad; Puschban, Zoe; Nat, Roxana; Dechant, Georg] Med Univ Innsbruck, Inst Neurosci, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Neto, SC (corresponding author), Med Univ Innsbruck, Div Neurobiol, Dept Neurol, Innsbruck, Austria.	sonya.neto@gmail.com	Stefanova, Nadia/ABF-5664-2020; Salti, Ahmad/AFR-7386-2022	Stefanova, Nadia/0000-0001-8188-639X; Salti, Ahmad/0000-0002-7678-0125; Wenning, Gregor/0000-0001-9077-1666; Deleanu, Irina-Roxana/0000-0002-6543-2336; Neto, Sonya/0000-0002-4675-2940	Integrierte Forschungs und Therapiezentrum (IFTZ) [2008]; Austrian Science Fund (FWF) [W 1206-B18]; Signaling Processing in Neurons (SPIN) program	Integrierte Forschungs und Therapiezentrum (IFTZ); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Signaling Processing in Neurons (SPIN) program	This research was supported by the Integrierte Forschungs und Therapiezentrum (IFTZ) through grant 2008, the Austrian Science Fund (FWF):[W 1206-B18] and the Signaling Processing in Neurons (SPIN) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2007, DEV BIOL, V304, P447, DOI 10.1016/j.ydbio.2007.01.032; Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; BAYER SA, 1995, EXP BRAIN RES, V105, P191; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Carlsson T, 2007, J NEUROSCI, V27, P8011, DOI 10.1523/JNEUROSCI.2079-07.2007; Carlsson T, 2009, BRAIN, V132, P319, DOI 10.1093/brain/awn305; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; DATE I, 1993, BRAIN RES, V621, P150, DOI 10.1016/0006-8993(93)90312-B; Dunnett S, 2001, NATURE REV, V2, P5; Dunnett SB, 1997, BRAIN RES PROTOC, V1, P91, DOI 10.1016/S1385-299X(96)00015-3; Dunnett SB, 2006, HANDBOOK OF EXPERIMENTAL NEUROLOGY: METHODS AND TECHNIQUES IN ANIMAL RESEARCH, P269, DOI 10.1017/CBO9780511541742.017; FERRARA N, 1988, BRAIN RES, V462, P223, DOI 10.1016/0006-8993(88)90550-1; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freeman T, 2006, IMPORTANT ASPECTS SU, P131; Gale E, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-8; Gates MA, 2006, EUR J NEUROSCI, V23, P1384, DOI 10.1111/j.1460-9568.2006.04637.x; Hagell P, 2005, BRAIN RES BULL, V68, P4, DOI 10.1016/j.brainresbull.2004.10.013; Hagell P, 2002, NAT NEUROSCI, V5, P627, DOI 10.1038/nn863; Hahn M, 2009, J NEUROSCI RES, V87, P2006, DOI 10.1002/jnr.22031; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jonsson ME, 2009, EXP NEUROL, V219, P341, DOI 10.1016/j.expneurol.2009.06.006; Larsson LC, 2001, EXP NEUROL, V172, P100, DOI 10.1006/exnr.2001.7738; Lindvall O, 2004, AM SOC EXPT NEUROTHE, V49, P890; MAYER E, 1993, NEUROSCIENCE, V56, P389, DOI 10.1016/0306-4522(93)90340-L; Nikkhah G, 2000, NEUROMETH, V36, P207, DOI 10.1007/978-1-59259-690-4_12; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5; Paul G, 2006, HANDB EXP PHARM, V174, P361; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649; Politis M, 2011, MOVEMENT DISORD, V26, P1997, DOI 10.1002/mds.23743; Politis M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-80; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Puschban Z, 2000, NEUROSCIENCE, V95, P377; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Schapira AHV, 2009, EUR J NEUROL, V16, P982, DOI 10.1111/j.1468-1331.2009.02697.x; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Sinclair SR, 1999, EUR J NEUROSCI, V11, P4341, DOI 10.1046/j.1460-9568.1999.00867.x; Smits SM, 2006, PROG NEUROBIOL, V78, P1, DOI 10.1016/j.pneurobio.2005.12.003; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Thompson LH, 2008, EXP NEUROL, V213, P220, DOI 10.1016/j.expneurol.2008.06.005; Torres EM, 2008, NEUROSCIENCE, V154, P631, DOI 10.1016/j.neuroscience.2008.03.048; Torres EM, 2007, NEUROSCIENCE, V146, P1606, DOI 10.1016/j.neuroscience.2007.03.037; Wallen A, 2003, ANN NY ACAD SCI, V991, P48; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006	47	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50178	10.1371/journal.pone.0050178	http://dx.doi.org/10.1371/journal.pone.0050178			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209667	gold, Green Published, Green Submitted			2022-12-25	WOS:000312104900031
J	Strube-Bloss, MF; Herrera-Valdez, MA; Smith, BH				Strube-Bloss, Martin F.; Herrera-Valdez, Marco A.; Smith, Brian H.			Ensemble Response in Mushroom Body Output Neurons of the Honey Bee Outpaces Spatiotemporal Odor Processing Two Synapses Earlier in the Antennal Lobe	PLOS ONE			English	Article							DUAL OLFACTORY PATHWAY; MORPHOLOGICAL CHARACTERIZATION; TRANSIENT DYNAMICS; EXTRINSIC NEURONS; APIS-MELLIFERA; DROSOPHILA; REPRESENTATIONS; BRAIN; ORGANIZATION; INTERNEURONS	Neural representations of odors are subject to computations that involve sequentially convergent and divergent anatomical connections across different areas of the brains in both mammals and insects. Furthermore, in both mammals and insects higher order brain areas are connected via feedback connections. In order to understand the transformations and interactions that this connectivity make possible, an ideal experiment would compare neural responses across different, sequential processing levels. Here we present results of recordings from a first order olfactory neuropile - the antennal lobe (AL) - and a higher order multimodal integration and learning center - the mushroom body (MB) - in the honey bee brain. We recorded projection neurons (PN) of the AL and extrinsic neurons (EN) of the MB, which provide the outputs from the two neuropils. Recordings at each level were made in different animals in some experiments and simultaneously in the same animal in others. We presented two odors and their mixture to compare odor response dynamics as well as classification speed and accuracy at each neural processing level. Surprisingly, the EN ensemble significantly starts separating odor stimuli rapidly and before the PN ensemble has reached significant separation. Furthermore the EN ensemble at the MB output reaches a maximum separation of odors between 84-120 ms after odor onset, which is 26 to 133 ms faster than the maximum separation at the AL output ensemble two synapses earlier in processing. It is likely that a subset of very fast PNs, which respond before the ENs, may initiate the rapid EN ensemble response. We suggest therefore that the timing of the EN ensemble activity would allow retroactive integration of its signal into the ongoing computation of the AL via centrifugal feedback.	[Strube-Bloss, Martin F.] Max Planck Inst Chem Ecol, Dept Evolutionary, Jena, Germany; [Herrera-Valdez, Marco A.] Univ Puerto Rico Cayey, Dept Matemat & Fis, Inst Invest Interdisciplinarias, Cayey, PR USA; [Strube-Bloss, Martin F.; Smith, Brian H.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Max Planck Society; University of Puerto Rico; University of Puerto Rico at Cayey; Arizona State University; Arizona State University-Tempe	Strube-Bloss, MF (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary, Jena, Germany.	mstrube-bloss@ice.mpg.de	Herrera-Valdez, Marco Arieli/J-5782-2019	Herrera-Valdez, Marco Arieli/0000-0001-8224-9077; Strube-Bloss, Martin Fritz/0000-0001-8264-7534	National Institutes of Health NCRR grant [RR014166]; NIDCD grant [DC007997]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR014166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007997, R01DC011422] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006144] Funding Source: NIH RePORTER	National Institutes of Health NCRR grant; NIDCD grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded from the National Institutes of Health NCRR grant RR014166 and NIDCD grant DC007997 to BHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel R, 2001, J COMP NEUROL, V437, P363, DOI 10.1002/cne.1289; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; BICKER G, 1993, J COMP NEUROL, V335, P413, DOI 10.1002/cne.903350310; Demmer H, 2009, J NEUROPHYSIOL, V102, P1538, DOI 10.1152/jn.00183.2009; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Galizia CG, 2004, J COMP PHYSIOL A, V190, P21, DOI 10.1007/s00359-003-0469-0; Gebhardt S, 2004, CELL TISSUE RES, V317, P195, DOI 10.1007/s00441-003-0841-y; Gronenberg W, 2001, J COMP NEUROL, V435, P474, DOI 10.1002/cne.1045; Grunewald B, 1999, J COMP PHYSIOL A, V185, P565, DOI 10.1007/s003590050417; Gupta N, 2011, CURR BIOL, V21, pR504, DOI 10.1016/j.cub.2011.05.044; Hammer M, 1998, LEARN MEMORY, V5, P146; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Hoel P, 1971, INTRO STAT THEORY, P237; Hu AQ, 2010, P NATL ACAD SCI USA, V107, P10262, DOI 10.1073/pnas.0914912107; Huerta R, 2004, NEURAL COMPUT, V16, P1601, DOI 10.1162/089976604774201613; Ignell R, 2005, J COMP NEUROL, V492, P214, DOI 10.1002/cne.20691; Ito I, 2008, NAT NEUROSCI, V11, P1177, DOI 10.1038/nn.2192; Iwama A, 1998, J INSECT PHYSIOL, V44, P1191, DOI 10.1016/S0022-1910(98)00084-5; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; KENT KS, 1987, J NEUROBIOL, V18, P451, DOI 10.1002/neu.480180506; Kirschner S, 2006, J COMP NEUROL, V499, P933, DOI 10.1002/cne.21158; Krofczik S, 2009, FRONT COMPUT NEUROSC, V2, DOI 10.3389/neuro.10.009.2008; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; MAUELSHAGEN J, 1993, J NEUROPHYSIOL, V69, P609, DOI 10.1152/jn.1993.69.2.609; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Menzel R, 2005, J EXP BIOL, V208, P4317, DOI 10.1242/jeb.01908; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Mood A. M., 1974, INTRO THEORY STAT, P577; Muller D, 2002, J COMP PHYSIOL A, V188, P359, DOI 10.1007/s00359-002-0310-1; Namiki S, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.001.2008; Nawrot MP, 2009, NEUROSCIENCE, P1; Nawrot MP, 2012, APIDOLOGIE; Nowotny T, 2005, BIOL CYBERN, V93, P436, DOI 10.1007/s00422-005-0019-7; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Rath L, 2011, EUR J NEUROSCI, V34, P352, DOI 10.1111/j.1460-9568.2011.07753.x; Rossler W, 2011, ARTHROPOD STRUCT DEV, V40, P349, DOI 10.1016/j.asd.2010.12.001; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; SALECKER I, 1990, HISTOCHEMISTRY, V94, P463, DOI 10.1007/BF00272608; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; SMITH BH, 1989, ETHOLOGY, V82, P68; Staudacher EM, 2009, J NEUROSCI METH, V180, P208, DOI 10.1016/j.jneumeth.2009.03.019; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Strube-Bloss MF, 2011, J NEUROSCI, V31, P3129, DOI 10.1523/JNEUROSCI.2583-10.2011; Szyszka P, 2005, J NEUROPHYSIOL, V94, P3303, DOI 10.1152/jn.00397.2005; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wright GA, 2009, BEHAV NEUROSCI, V123, P36, DOI 10.1037/a0014040; Yamagata N, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.016.2009	59	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50322	10.1371/journal.pone.0050322	http://dx.doi.org/10.1371/journal.pone.0050322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209711	Green Published, gold			2022-12-25	WOS:000312104900040
J	Thangapandian, S; John, S; Lee, Y; Arulalapperumal, V; Lee, KW				Thangapandian, Sundarapandian; John, Shalini; Lee, Yuno; Arulalapperumal, Venkatesh; Lee, Keun Woo			Molecular Modeling Study on Tunnel Behavior in Different Histone Deacetylase Isoforms	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; HUMAN HDAC8; INHIBITORS; BINDING; DESIGN; SUBSTRATE; PROTEINS; DYNAMICS; THERAPY; DOCKING	Histone deacetylases (HDACs) have emerged as effective therapeutic targets in the treatment of various diseases including cancers as these enzymes directly involved in the epigenetic regulation of genes. However the development of isoform-selective HDAC inhibitors has been a challenge till date since all HDAC enzymes possess conserved tunnel-like active site. In this study, using molecular dynamics simulation we have analyzed the behavior of tunnels present in HDAC8, 10, and 11 enzymes of class I, II, and IV, respectively. We have identified the equivalent tunnel forming amino acids in these three isoforms and found that they are very much conserved with subtle differences to be utilized in selective inhibitor development. One amino acid, methionine of HDAC8, among six tunnel forming residues is different in isoforms of other classes (glutamic acid (E) in HDAC10 and leucine (L) in HDAC 11) based on which mutations were introduced in HDAC11, the less studied HDAC isoform, to observe the effects of this change. The HDAC8-like (L268M) mutation in the tunnel forming residues has almost maintained the deep and narrow tunnel as present in HDAC8 whereas HDAC10-like (L268E) mutation has changed the tunnel wider and shallow as observed in HDAC10. These results explained the importance of the single change in the tunnel formation in different isoforms. The observations from this study can be utilized in the development of isoform-selective HDAC inhibitors.	[Thangapandian, Sundarapandian; John, Shalini; Lee, Yuno; Arulalapperumal, Venkatesh; Lee, Keun Woo] Gyeongsang Natl Univ GNU, RINS, PMBBRC, Div Appl Life Sci,Program BK21,SSAC, Gazwa Dong, Jinju, South Korea	Gyeongsang National University	Thangapandian, S (corresponding author), Gyeongsang Natl Univ GNU, RINS, PMBBRC, Div Appl Life Sci,Program BK21,SSAC, Gazwa Dong, Jinju, South Korea.	kwlee@gnu.ac.kr			Basic Science Research Program [2009-0073267]; Pioneer Research Center Program [2009-0081539]; Management of Climate Change Program through the National Research Foundation of Korea (NRF) [2010-0029084]; Ministry of Education, Science and Technology (MEST) of Republic of Korea; Rural Development Administration (RDA) of Republic of Korea [PJ008038]	Basic Science Research Program; Pioneer Research Center Program; Management of Climate Change Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology (MEST) of Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Rural Development Administration (RDA) of Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by Basic Science Research Program (2009-0073267), Pioneer Research Center Program (2009-0081539), and Management of Climate Change Program (2010-0029084) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) of Republic of Korea. And this work was also supported by the Next-Generation BioGreen 21 Program (PJ008038) from Rural Development Administration (RDA) of Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Cheng F, 2008, PROTEINS, V70, P1228, DOI 10.1002/prot.21615; Estiu G, 2008, J MED CHEM, V51, P2898, DOI 10.1021/jm7015254; Estiu G, 2010, BIOORGAN MED CHEM, V18, P4103, DOI 10.1016/j.bmc.2010.03.080; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hildmann C, 2006, J BIOTECHNOL, V124, P258, DOI 10.1016/j.jbiotec.2006.01.030; Hodawadekar SC, 2007, ONCOGENE, V26, P5528, DOI 10.1038/sj.onc.1210619; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297; Lamblin M, 2010, BIOORGAN MED CHEM, V18, P4119, DOI 10.1016/j.bmc.2010.03.078; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin HY, 2006, MED RES REV, V26, P397, DOI 10.1002/med.20056; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Paris M, 2008, J MED CHEM, V51, P1505, DOI 10.1021/jm7011408; Park JH, 2004, CLIN CANCER RES, V10, P5271, DOI 10.1158/1078-0432.CCR-03-0709; Raghuram N, 2010, BIOCHEMISTRY-US, V49, P4420, DOI 10.1021/bi100296z; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Sundarapandian T, 2010, J MOL GRAPH MODEL, V29, P382, DOI 10.1016/j.jmgm.2010.07.007; Thangapandian S, 2010, EUR J MED CHEM, V45, P4409, DOI 10.1016/j.ejmech.2010.06.024; Timmermann S, 2001, CELL MOL LIFE SCI, V58, P728, DOI 10.1007/PL00000896; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Wang DF, 2005, J MED CHEM, V48, P6936, DOI 10.1021/jm0505011; Wang DF, 2009, CURR TOP MED CHEM, V9, P241, DOI 10.2174/156802609788085287; Warrell RP, 1998, JNCI-J NATL CANCER I, V90, P1621, DOI 10.1093/jnci/90.21.1621; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Woodcock CL, 2006, CURR OPIN STRUC BIOL, V16, P213, DOI 10.1016/j.sbi.2006.02.005; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	39	17	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49327	10.1371/journal.pone.0049327	http://dx.doi.org/10.1371/journal.pone.0049327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209570	gold, Green Published			2022-12-25	WOS:000312104900007
J	Calvo, J; BenYoucef, A; Baijer, J; Rouyez, MC; Pflumio, F				Calvo, Julien; BenYoucef, Aissa; Baijer, Jan; Rouyez, Marie-Christine; Pflumio, Francoise			Assessment of Human Multi-Potent Hematopoietic Stem/Progenitor Cell Potential Using a Single In Vitro Screening System	PLOS ONE			English	Article							HUMAN CORD BLOOD; STEM-CELLS; PROGENITOR CELLS; NOTCH; IDENTIFICATION; EXPRESSION; HIERARCHY; LYMPHOPOIESIS; INDUCTION; DELTA-1	Hematopoietic stem cells are responsible for the generation of the entire blood system through life. This characteristic relies on their ability to self renew and on their multi-potentiality. Thus quantification of the number of hematopoietic stem cells in a given cell population requires to show both properties in the studied cell populations. Although xenografts models that support human hematopoietic stem cells have been described, such in vivo experimental systems remain restrictive for high throughput screening purposes for example. In this work we developed a conditional tetracycline inducible system controlling the expression of the human NOTCH ligand Delta-like 1 in the murine stromal MS5 cells. We cultured hematopoietic immature cells enriched in progenitor/stem cells in contact with MS5 cells that conditionally express Delta-like 1, in conditions designed to generate multipotential lineage differentiation. We show that upon induction or repression of DL1 expression during co-culture, human immature CD34(+)CD38(-/low) (CD45RA(-)CD90(+)) cells can express their B, T, NK, granulo/monocytic and erythroid potentials in a single well, and at the single cell level. We also document the interference of low NOTCH activation with human B and myelo/erythroid lymphoid differentiation. This system represents a novel tool to precisely quantify human hematopoietic immature cells with both lymphoid and myeloid potentials.	[Calvo, Julien; BenYoucef, Aissa; Pflumio, Francoise] CEA, Lab Cellules Souches Hematopoit & Leucem, IRCM, Fontenay Aux Roses, France; [Calvo, Julien; BenYoucef, Aissa; Pflumio, Francoise] INSERM, UMR 967, Fontenay Aux Roses, France; [Calvo, Julien; BenYoucef, Aissa; Pflumio, Francoise] Univ Paris Diderot, UMR 967, Fontenay Aux Roses, France; [Calvo, Julien; BenYoucef, Aissa; Pflumio, Francoise] Univ Paris 11, UMR 967, Fontenay Aux Roses, France; [Baijer, Jan] CEA, IRCM, Cytometry Serv, Fontenay Aux Roses, France; [Rouyez, Marie-Christine] INSERM, U1016, Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Pflumio, F (corresponding author), CEA, Lab Cellules Souches Hematopoit & Leucem, IRCM, Fontenay Aux Roses, France.	francoise.pflumio@cea.fr		BENYOUCEF, Aissa/0000-0003-1369-6820; Pflumio, Francoise/0000-0001-8995-596X	Institut National pour la Sante et la Recherche Medicale; Commissariat a l'Energie Atomique et aux Energies Alternatives; Universite Paris Diderot and Universite Paris Sud; Institut National du Cancer; Canceropole d'Ile de France; StemPole; Ligue Nationale contre le Cancer; Association Laurette Fugain; Ministere de la Recherche et de l'Enseignement Superieur; Societe Francaise d'Hematologie	Institut National pour la Sante et la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Commissariat a l'Energie Atomique et aux Energies Alternatives; Universite Paris Diderot and Universite Paris Sud; Institut National du Cancer(Institut National du Cancer (INCA) France); Canceropole d'Ile de France(Region Ile-de-France); StemPole; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association Laurette Fugain; Ministere de la Recherche et de l'Enseignement Superieur; Societe Francaise d'Hematologie	This work was supported by grants from Institut National pour la Sante et la Recherche Medicale, Commissariat a l'Energie Atomique et aux Energies Alternatives, Universite Paris Diderot and Universite Paris Sud, Institut National du Cancer, Canceropole d'Ile de France, StemPole, the Ligue Nationale contre le Cancer, and the Association Laurette Fugain. ABY was supported by the Ministere de la Recherche et de l'Enseignement Superieur, Societe Francaise d'Hematologie and Ligue Nationale contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem S, 2002, MOL THER, V6, P673, DOI 10.1006/mthe.2002.0718; Armstrong F, 2009, BLOOD, V113, P1730, DOI 10.1182/blood-2008-02-138172; Berardi AC, 1997, BLOOD, V89, P3554, DOI 10.1182/blood.V89.10.3554.3554_3554_3564; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Boisset JC, 2012, STEM CELL RES, V8, P1, DOI 10.1016/j.scr.2011.07.002; Coulombel L, 2004, ONCOGENE, V23, P7210, DOI 10.1038/sj.onc.1207941; Ditadi A, 2009, BLOOD, V113, P3953, DOI 10.1182/blood-2008-10-182105; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Gerby B, 2011, LEUKEMIA, V25, P1249, DOI 10.1038/leu.2011.93; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Mohtashami M, 2010, J IMMUNOL, V185, P867, DOI 10.4049/jimmunol.1000782; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Olivier A, 2006, BLOOD, V107, P2694, DOI 10.1182/blood-2005-03-0970; Plum J, 2000, ANN NY ACAD SCI, V917, P724; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Robin C, 1999, J EXP MED, V189, P1601, DOI 10.1084/jem.189.10.1601; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Takakura N, 1996, J EXP MED, V184, P2301, DOI 10.1084/jem.184.6.2301; Van de Walle I, 2009, BLOOD, V113, P2988, DOI 10.1182/blood-2008-06-164871; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003	27	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50495	10.1371/journal.pone.0050495	http://dx.doi.org/10.1371/journal.pone.0050495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209758	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700075
J	Cao, Q; Ju, XB; Li, P; Meng, XX; Shao, PF; Cai, HZ; Wang, ML; Zhang, ZD; Qin, C; Yin, CJ				Cao, Qiang; Ju, Xiaobing; Li, Pu; Meng, Xiaoxin; Shao, Pengfei; Cai, Hongzhou; Wang, Meilin; Zhang, Zhengdong; Qin, Chao; Yin, Changjun			A Functional Variant in the MTOR Promoter Modulates Its Expression and Is Associated with Renal Cell Cancer Risk	PLOS ONE			English	Article							MAMMALIAN TARGET; RAPAMYCIN MTOR; CARCINOMA; PATHWAY; OVEREXPRESSION; TUMORIGENESIS; POLYMORPHISMS; ANGIOGENESIS; ACTIVATION; PROGNOSIS	Background: The mTOR signaling pathway plays a crucial role in the carcinogenesis of renal cell cancer (RCC). We sought to investigate the influence of genetic variations in the mTOR pathway-related genes on the risk of RCC. Methods: We genotyped 8 potentially functional polymorphisms in AKT1, AKT2, PTEN and MTOR genes using the TaqMan method in a case-control study of 710 RCC patients and 760 cancer-free subjects. Unconditional logistic regression, adjusted for potential confounding factors, was used to assess the risk associations. We then examined the functionality of the important polymorphisms. Results: Of the 8 polymorphisms, after adjusting for multiple comparisons, we found a significant association between one variant (rs2295080) in the promoter of MTOR and reduced RCC risk (P = 0.005, OR = 0.74, 95% CI = 0.59-0.91, TG/GG vs. TT). Another variant (rs701848) in the region of PTEN was associated with increased RCC risk (P = 0.014, OR = 1.45, 95% CI = 1.08-1.96, CC vs. TT); however, the association was not significant after adjusting for multiple comparisons. Furthermore, we observed lower MTOR mRNA levels in the presence of the rs2295080G allele in normal renal tissues. The luciferase reporter assay showed that the rs2295080G allele significantly decreased luciferase activity. No other significant association between the selected polymorphisms and RCC risk was observed. Conclusions: Our results suggest that the functional MTOR promoter rs2295080 variant affects RCC susceptibility by modulating the endogenous MTOR expression level. The risk effects and the functional impact of the MTOR rs2295080 variant need further validation.	[Cao, Qiang; Ju, Xiaobing; Li, Pu; Meng, Xiaoxin; Shao, Pengfei; Cai, Hongzhou; Qin, Chao; Yin, Changjun] Nanjing Med Univ, State Key Lab Reprod Med, Dept Urol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Dept Mol & Genet Toxicol, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Qin, C (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Dept Urol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	urology_qinchao@163.com; drcjyin@gmail.com	Cao, Qiang/K-2349-2019; zhang, zheng/HCH-9684-2022	Cai, Hongzhou/0000-0001-6915-564X	Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China [81171963, 81102089]; Natural Science Foundation of Jiangsu Province [BK2008473, BK2011773]	Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University; Provincial Initiative Program for Excellency Disciplines of Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the Program for Development of Innovative Research Team in the First Affiliated Hospital of Nanjing Medical University, Provincial Initiative Program for Excellency Disciplines of Jiangsu Province, by the National Natural Science Foundation of China [grant number 81171963 and 81102089] and the Natural Science Foundation of Jiangsu Province [grant number BK2008473 and BK2011773]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Baldewijns MM, 2010, J PATHOL, V221, P125, DOI 10.1002/path.2689; Bruyere F, 2010, J UROLOGY, V184, P1273, DOI 10.1016/j.juro.2010.06.009; Cao Q., 2011, MUTAGENESIS; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Elfiky AA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-133; Gately K, 2012, LUNG CANCER, V75, P217, DOI 10.1016/j.lungcan.2011.06.012; Hainsworth JD, 2010, J CLIN ONCOL, V28, P2131, DOI 10.1200/JCO.2009.26.3152; Herberger B, 2007, CLIN CANCER RES, V13, P4795, DOI 10.1158/1078-0432.CCR-07-0738; Hildebrandt MAT, 2009, J CLIN ONCOL, V27, P857, DOI 10.1200/JCO.2008.17.6297; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kruck S, 2010, ONCOL REP, V23, P159, DOI 10.3892/or_00000617; Ljungberg B, 2011, EUR UROL; Marioni G, 2011, HISTOPATHOLOGY, V58, P1148, DOI 10.1111/j.1365-2559.2011.03864.x; Ollerenshaw M, 2004, CANCER GENET CYTOGEN, V153, P122, DOI 10.1016/j.cancergencyto.2004.01.014; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Qin C, 2012, ANN ONCOL, V23, P981, DOI 10.1093/annonc/mdr325; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; van der Veldt AAM, 2011, CLIN CANCER RES, V17, P620, DOI 10.1158/1078-0432.CCR-10-1828; Wang ML, 2008, CLIN CANCER RES, V14, P3633, DOI 10.1158/1078-0432.CCR-07-5155; Wang W, 2012, MOL CARCINOG; Xu CF, 2011, J CLIN ONCOL, V29, P2557, DOI 10.1200/JCO.2010.32.9110; Zhou XY, 2004, CLIN CANCER RES, V10, P6779, DOI 10.1158/1078-0432.CCR-04-0112	29	41	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50302	10.1371/journal.pone.0050302	http://dx.doi.org/10.1371/journal.pone.0050302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209702	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700053
J	Dalcq, J; Pasque, V; Ghaye, A; Larbuisson, A; Motte, P; Martial, JA; Muller, M				Dalcq, Julia; Pasque, Vincent; Ghaye, Aurelie; Larbuisson, Arnaud; Motte, Patrick; Martial, Joseph A.; Muller, Marc			RUNX3, EGR1 and SOX9B Form a Regulatory Cascade Required to Modulate BMP-Signaling during Cranial Cartilage Development in Zebrafish	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EGR-1; ENDODERM FORMATION; GENE-EXPRESSION; OSTEOCLAST FORMATION; MICE LACKING; NGFI-A; C-FOS; FOLLISTATIN; ENCODES; DIFFERENTIATION	The cartilaginous elements forming the pharyngeal arches of the zebrafish derive from cranial neural crest cells. Their proper differentiation and patterning are regulated by reciprocal interactions between neural crest cells and surrounding endodermal, ectodermal and mesodermal tissues. In this study, we show that the endodermal factors Runx3 and Sox9b form a regulatory cascade with Egr1 resulting in transcriptional repression of the fsta gene, encoding a BMP antagonist, in pharyngeal endoderm. Using a transgenic line expressing a dominant negative BMP receptor or a specific BMP inhibitor (dorsomorphin), we show that BMP signaling is indeed required around 30 hpf in the neural crest cells to allow cell differentiation and proper pharyngeal cartilage formation. Runx3, Egr1, Sox9b and BMP signaling are required for expression of runx2b, one of the key regulator of cranial cartilage maturation and bone formation. Finally, we show that egr1 depletion leads to increased expression of fsta and inhibition of BMP signaling in the pharyngeal region. In conclusion, we show that the successive induction of the transcription factors Runx3, Egr1 and Sox9b constitutes a regulatory cascade that controls expression of Follistatin A in pharyngeal endoderm, the latter modulating BMP signaling in developing cranial cartilage in zebrafish.	[Dalcq, Julia; Pasque, Vincent; Ghaye, Aurelie; Larbuisson, Arnaud; Martial, Joseph A.; Muller, Marc] Univ Liege, Lab Mol Biol & Genet Engn, GIGA R, Liege, Belgium; [Motte, Patrick] Univ Liege, Ctr Assistance Technol Microscopy, Liege, Belgium	University of Liege; University of Liege	Muller, M (corresponding author), Univ Liege, Lab Mol Biol & Genet Engn, GIGA R, Liege, Belgium.	m.muller@ulg.ac.be	Pasque, Vincent/M-8231-2017; Pasque, Vincent/X-6720-2019	Pasque, Vincent/0000-0002-5129-0146; Pasque, Vincent/0000-0002-5129-0146	Fonds de la Recherche Fondamentale Collective [2.4555.99/2.4542.00/2.4561.10]; Pole d'Attraction InterUniversitaire (PAI) [P5/35]; University of Liege, GAME project; European Space Agency (ESA); Belgian Space Agency Prodex; Special Fund for Research; Fonds National de la Recherche Scientifique; ESA	Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); Pole d'Attraction InterUniversitaire (PAI); University of Liege, GAME project; European Space Agency (ESA)(European Space Agency); Belgian Space Agency Prodex; Special Fund for Research; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); ESA(European Space Agency)	This work was supported by the "Fonds de la Recherche Fondamentale Collective" projects 2.4555.99/2.4542.00/2.4561.10, the "Pole d'Attraction InterUniversitaire (PAI): P5/35, the University of Liege, GAME project; the European Space Agency (ESA), the Belgian Space Agency Prodex and the Special Fund for Research to PM. JD was supported by the "Fonds National de la Recherche Scientifique" and ESA and MM is a "Chercheur Qualifie du "Fonds National de la Recherche Scientifique". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Balczerski B, 2011, DEV BIOL, V362, P230; Bauer H, 1998, DEV BIOL, V204, P488, DOI 10.1006/dbio.1998.9003; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Cenci S, 2000, J CLIN INVEST, V105, P1279, DOI 10.1172/JCI8672; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Close R, 2002, MECH DEVELOP, V118, P269, DOI 10.1016/S0925-4773(02)00283-6; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; David NB, 2002, DEVELOPMENT, V129, P4457; de Kretser DM, 2002, HUM REPROD UPDATE, V8, P529, DOI 10.1093/humupd/8.6.529; Dickmeis T, 2001, GENE DEV, V15, P1487, DOI 10.1101/gad.196901; Dong PDS, 2007, NAT GENET, V39, P397, DOI 10.1038/ng1961; DRUMMOND IA, 1994, DNA CELL BIOL, V13, P1047, DOI 10.1089/dna.1994.13.1047; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Eid MA, 1998, CANCER RES, V58, P2461; Erickson T, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-22; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Gajos-Michniewicz A, 2010, BIOMARKERS, V15, P563, DOI 10.3109/1354750X.2010.495786; Granet C, 2001, BIOCHEM BIOPH RES CO, V284, P622, DOI 10.1006/bbrc.2001.5023; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Holzschuh J, 2005, DEVELOPMENT, V132, P3731, DOI 10.1242/dev.01936; Hu CY, 2006, MOL VIS, V12, P1250; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; HUANG RP, 1995, CANCER RES, V55, P5054; Kikuchi Y, 2000, GENE DEV, V14, P1279; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knight RD, 2005, DEVELOPMENT, V132, P3127, DOI 10.1242/dev.01879; Ko SO, 2007, DEV BIOL, V312, P435, DOI 10.1016/j.ydbio.2007.09.050; Kukita T, 1997, ENDOCRINOLOGY, V138, P4384, DOI 10.1210/en.138.10.4384; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Liu W, 2005, DEV BIOL, V283, P282, DOI 10.1016/j.ydbio.2005.04.019; Lopez M, 2006, GENE EXPR PATTERNS, V6, P156, DOI 10.1016/j.modgep.2005.06.010; Maeno T, 2011, BONE, V49, P673, DOI 10.1016/j.bone.2011.07.023; MartinezBarbera JP, 1997, GENE, V198, P53, DOI 10.1016/S0378-1119(97)00292-8; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; MCMAHON AP, 1990, DEVELOPMENT, V108, P281; Miller CT, 2000, DEVELOPMENT, V127, P3815; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Nie XG, 2006, INT J DEV BIOL, V50, P511, DOI 10.1387/ijdb.052101.xn; Pinto JP, 2005, J BONE MINER RES, V20, P1440, DOI 10.1359/JBMR.050318; Piotrowski T, 2003, DEVELOPMENT, V130, P5043, DOI 10.1242/dev.00704; Piotrowski T, 2000, DEV BIOL, V225, P339, DOI 10.1006/dbio.2000.9842; Poulain M, 2006, DEVELOPMENT, V133, P2189, DOI 10.1242/dev.02387; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Quiroz Y, 2012, MOL ENDOCRINOL, V26, P1014, DOI 10.1210/me.2011-1319; Rockel JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2595; Schilling TF, 1996, DEVELOPMENT, V123, P329; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Paiva KBS, 2010, ACTA HISTOCHEM, V112, P508, DOI 10.1016/j.acthis.2009.05.007; Sirotkin AV, 2011, INT J BIOCHEM CELL B, V43, P857, DOI 10.1016/j.biocel.2011.03.001; Slade JP, 2000, J NEUROENDOCRINOL, V12, P671; Sperber SM, 2008, DEV BIOL, V314, P59, DOI 10.1016/j.ydbio.2007.11.005; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; Srivastava S, 1998, J CLIN INVEST, V102, P1850, DOI 10.1172/JCI4561; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; SUVA LJ, 1991, MOL CELL BIOL, V11, P2503, DOI 10.1128/MCB.11.5.2503; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tang SY, 2010, DEV BIOL, V344, P233, DOI 10.1016/j.ydbio.2010.05.004; Thisse B, 2001, ZFIN; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Walshe J, 2003, DEV BIOL, V264, P522, DOI 10.1016/j.ydbio.2003.08.010; Wang FL, 2000, OSTEOARTHR CARTILAGE, V8, P161, DOI 10.1053/joca.1999.0295; Wilson J, 2004, DEV BIOL, V266, P138, DOI 10.1016/j.ydbio.2003.10.012; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Yan YL, 2002, DEVELOPMENT, V129, P5065; Yanagisawa H, 2003, DEVELOPMENT, V130, P1069, DOI 10.1242/dev.00337; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	76	28	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50140	10.1371/journal.pone.0050140	http://dx.doi.org/10.1371/journal.pone.0050140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209659	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800050
J	Poulsen, EG; Steinhauer, C; Lees, M; Lauridsen, AM; Ellgaard, L; Hartmann-Petersen, R				Poulsen, Esben G.; Steinhauer, Cornelia; Lees, Michael; Lauridsen, Anne-Marie; Ellgaard, Lars; Hartmann-Petersen, Rasmus			HUWE1 and TRIP12 Collaborate in Degradation of Ubiquitin-Fusion Proteins and Misframed Ubiquitin	PLOS ONE			English	Article							PROTEASOMAL DEGRADATION; PROTEOLYTIC PATHWAY; LIGASE	In eukaryotic cells an uncleavable ubiquitin moiety conjugated to the N-terminus of a protein signals the degradation of the fusion protein via the proteasome-dependent ubiquitin fusion degradation (UFD) pathway. In yeast the molecular mechanism of the UFD pathway has been well characterized. Recently the human E3 ubiquitin-protein ligase TRIP12 was connected with the UFD pathway, but little is otherwise known about this system in mammalian cells. In the present work, we utilized high-throughput imaging on cells transfected with a targeted siRNA library to identify components involved in degradation of the UFD substrate Ub(G76V)-YFP. The most significant hits from the screen were the E3 ubiquitin-protein ligase HUWE1, as well as PSMD7 and PSMD14 that encode proteasome subunits. Accordingly, knock down of HUWE1 led to an increase in the steady state level and a retarded degradation of the UFD substrate. Knock down of HUWE1 also led to a stabilization of the physiological UFD substrate UBB+1. Precipitation experiments revealed that HUWE1 is associated with both the Ub(G76V)-YFP substrate and the 26S proteasome, indicating that it functions late in the UFD pathway. Double knock down of HUWE1 and TRIP12 resulted in an additive stabilization of the substrate, suggesting that HUWE1 and TRIP12 function in parallel during UFD. However, even when both HUWE1 and TRIP12 are downregulated, ubiquitylation of the UFD substrate was still apparent, revealing functional redundancy between HUWE1, TRIP12 and yet other ubiquitin-protein ligases.	[Poulsen, Esben G.; Lauridsen, Anne-Marie; Ellgaard, Lars; Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Steinhauer, Cornelia; Lees, Michael] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Hartmann-Petersen, R (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	rhpetersen@bio.ku.dk	Ellgaard, Lars/I-9034-2014; Hartmann-Petersen, Rasmus/K-4434-2014	Ellgaard, Lars/0000-0002-7018-0137; Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Steinhauer, Cornelia/0000-0002-5390-4893	Lundbeck Foundation; Danish Natural Science Research Council	Lundbeck Foundation(Lundbeckfonden); Danish Natural Science Research Council(Danish Natural Science Research Council)	This work has been supported financially by grants to RHP and LE from the Lundbeck Foundation and the Danish Natural Science Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Brooks CL, 2011, FEBS LETT, V585, P2803, DOI 10.1016/j.febslet.2011.05.022; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Downes B, 2005, BIOCHEM SOC T, V33, P393, DOI 10.1042/BST0330393; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Liu ZQ, 2007, DEV DYNAM, V236, P2889, DOI 10.1002/dvdy.21302; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Pegoraro G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031684; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; van Leeuwen FW, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P319; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; van Tijn P, 2007, J CELL SCI, V120, P1615, DOI 10.1242/jcs.03438; Xie YM, 2000, P NATL ACAD SCI USA, V97, P2497, DOI 10.1073/pnas.060025497; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	30	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50548	10.1371/journal.pone.0050548	http://dx.doi.org/10.1371/journal.pone.0050548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209776	gold, Green Submitted, Green Published			2022-12-25	WOS:000311885800082
J	Salvianti, F; Pinzani, P; Verderio, P; Ciniselli, CM; Massi, D; De Giorgi, V; Grazzini, M; Pazzagli, M; Orlando, C				Salvianti, Francesca; Pinzani, Pamela; Verderio, Paolo; Ciniselli, Chiara Maura; Massi, Daniela; De Giorgi, Vincenzo; Grazzini, Marta; Pazzagli, Mario; Orlando, Claudio			Multiparametric Analysis of Cell-Free DNA in Melanoma Patients	PLOS ONE			English	Article							FREE CIRCULATING DNA; BRAF MUTATIONS; EPIGENETIC INACTIVATION; METHYLATED DNA; NUCLEIC-ACIDS; TUMOR-MARKERS; PLASMA; CANCER; INTEGRITY; RASSF1A	Cell-free DNA in blood (cfDNA) represents a promising biomarker for cancer diagnosis. Total cfDNA concentration showed a scarce discriminatory power between patients and controls. A higher specificity in cancer diagnosis can be achieved by detecting tumor specific alterations in cfDNA, such as DNA integrity, genetic and epigenetic modifications. The aim of the present study was to identify a sequential multi-marker panel in cfDNA able to increase the predictive capability in the diagnosis of cutaneous melanoma in comparison with each single marker alone. To this purpose, we tested total cfDNA concentration, cfDNA integrity, BRAF(V600E) mutation and RASSF1A promoter methylation associated to cfDNA in a series of 76 melanoma patients and 63 healthy controls. The chosen biomarkers were assayed in cfDNA samples by qPCR. Comparison of biomarkers distribution in cases and controls was performed by a logistic regression model in both univariate and multivariate analysis. The predictive capability of each logistic model was investigated by means of the area under the ROC curve (AUC). To aid the reader to interpret the value of the AUC, values between 0.6 and 0.7, between 0.71 and 0.8 and greater than 0.8 were considered as indicating a weak predictive, satisfactory and good predictive capacity, respectively. The AUC value for each biomarker (univariate logistic model) was weak/satisfactory ranging between 0.64 (BRAF(V600E)) to 0.85 (total cfDNA). A good overall predictive capability for the final logistic model was found with an AUC of 0.95. The highest predictive capability was given by total cfDNA (AUC:0.86) followed by integrity index 180/67 (AUC:0.90) and methylated RASSF1A (AUC:0.89). An approach based on the simultaneous determination of three biomarkers (total cfDNA, integrity index 180/67 and methylated RASSF1A) could improve the diagnostic performance in melanoma.	[Salvianti, Francesca; Pinzani, Pamela; Pazzagli, Mario; Orlando, Claudio] Univ Florence, Dept Clin Physiopathol, Clin Biochem Unit, Florence, Italy; [Verderio, Paolo; Ciniselli, Chiara Maura] Fdn IRCCS, Ist Nazl Tumori, Unit Med Stat & Biometry, Milan, Italy; [Massi, Daniela] Univ Florence, Div Anat Pathol, Dept Crit Care Med & Surg, Florence, Italy; [De Giorgi, Vincenzo; Grazzini, Marta] Univ Florence, Dept Crit Care Med & Surg, Dermatol Unit, Florence, Italy	University of Florence; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Florence; University of Florence	Pinzani, P (corresponding author), Univ Florence, Dept Clin Physiopathol, Clin Biochem Unit, Florence, Italy.	p.pinzani@dfc.unifi.it	Pinzani, P./K-7022-2018; Ciniselli, Chiara M/C-4518-2017; Verderio, Paolo/B-5034-2017; de giorgi, vincenzo/H-7511-2012; Salvianti, Francesca/K-8513-2018	Pinzani, P./0000-0003-4017-3574; Ciniselli, Chiara M/0000-0003-4488-885X; Verderio, Paolo/0000-0002-9231-1281; Salvianti, Francesca/0000-0003-3235-4033; de giorgi, vincenzo/0000-0001-6531-7998; Pupilli, Cinzia/0000-0002-9099-7494; Pazzagli, Mario/0000-0003-3673-691X	Istituto Toscano Tumori (ITT)	Istituto Toscano Tumori (ITT)	This study was funded by the Istituto Toscano Tumori (ITT; www.ittumori.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Daniotti M, 2007, INT J CANCER, V120, P2439, DOI 10.1002/ijc.22598; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Gasparini G, 1996, INT J CANCER, V69, P205, DOI 10.1002/(SICI)1097-0215(19960621)69:3<205::AID-IJC10>3.0.CO;2-6; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hanley R, 2006, CLIN CANCER RES, V12, P4569, DOI 10.1158/1078-0432.CCR-06-0130; Hauser S, 2010, ANTICANCER RES, V30, P2785; Hodgson DR, 2010, DRUG DISCOV TODAY, V15, P98, DOI 10.1016/j.drudis.2009.12.006; Hollander M, 1973, NONPARAMETRIC STAT M; Hoon DSB, 2000, CANCER RES, V60, P2253; HOSMER DW, 1989, APPL LOGISTIC REGRES; Huang PH, 2009, NATURE, V459, P336, DOI 10.1038/459336a; Jiang WW, 2006, INT J CANCER, V119, P2673, DOI 10.1002/ijc.22250; Jung K, 2010, CLIN CHIM ACTA, V411, P1611, DOI 10.1016/j.cca.2010.07.032; Koyanagi K, 2006, CANCER RES, V66, P6111, DOI 10.1158/0008-5472.CAN-05-4198; Lehmann U, 2000, AM J PATHOL, V156, P1855, DOI 10.1016/S0002-9440(10)65059-6; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Marini A, 2006, J INVEST DERMATOL, V126, P422, DOI 10.1038/sj.jid.5700073; Mead R, 2011, BRIT J CANCER, V105, P239, DOI 10.1038/bjc.2011.230; Mori T, 2005, J CLIN ONCOL, V23, P9351, DOI 10.1200/JCO.2005.02.9876; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Pinsky PF, 2011, BIOMARK INSIGHTS, V6, P83, DOI 10.4137/BMI.S7513; Pinzani P, 2011, CLIN CHIM ACTA, V412, P2141, DOI 10.1016/j.cca.2011.07.027; Pinzani P, 2010, CLIN CHIM ACTA, V411, P1319, DOI 10.1016/j.cca.2010.05.024; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Schneider E, 2006, CANCER INFORM, V2, P44; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Spugnardi M, 2003, CANCER RES, V63, P1639; Tanemura A, 2009, CLIN CANCER RES, V15, P1801, DOI 10.1158/1078-0432.CCR-08-1361; Tomita H, 2007, ANTICANCER RES, V27, P2737; Umetani N, 2006, J CLIN ONCOL, V24, P4270, DOI 10.1200/JCO.2006.05.9493; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; Verderio P, 2010, BREAST CARE, V5, P62, DOI 10.1159/000303956; Wang BG, 2003, CANCER RES, V63, P3966; Yancovitz M, 2007, J MOL DIAGN, V9, P178, DOI 10.2353/jmoldx.2007.060135	40	53	55	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49843	10.1371/journal.pone.0049843	http://dx.doi.org/10.1371/journal.pone.0049843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209607	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800025
J	Jiang, J; Karimi, O; Ouburg, S; Champion, CI; Khurana, A; Liu, GC; Freed, A; Pleijster, J; Rozengurt, N; Land, JA; Surcel, HM; Tiitinen, A; Paavonen, J; Kronenberg, M; Morre, SA; Kelly, KA				Jiang, Janina; Karimi, Ouafae; Ouburg, Sander; Champion, Cheryl I.; Khurana, Archana; Liu, Guangchao; Freed, Amanda; Pleijster, Jolein; Rozengurt, Nora; Land, Jolande A.; Surcel, Helja-Marja; Tiitinen, Aila'; Paavonen, Jorma; Kronenberg, Mitchell; Morre, Servaas A.; Kelly, Kathleen A.			Interruption of CXCL13-CXCR5 Axis Increases Upper Genital Tract Pathology and Activation of NKT Cells following Chlamydial Genital Infection	PLOS ONE			English	Article							KILLER T-CELLS; TRACHOMATIS INFECTIONS; ANTIGEN PRESENTATION; IMMUNE-RESPONSE; EXPRESSION; CD1D; MICE; POLYMORPHISMS; SPHINGOLIPIDS; SEVERITY	Background: Regulation of immune responses is critical for controlling inflammation and disruption of this process can lead to tissue damage. We reported that CXCL13 was induced in fallopian tube tissue following C. trachomatis infection. Here, we examined the influence of the CXCL13-CXCR5 axis in chlamydial genital infection. Methodology and Principal Findings: Disruption of the CXCL13-CXCR5 axis by injecting anti-CXCL13 Ab to BALB/c mice or using Cxcr5-/- mice increased chronic inflammation in the upper genital tract (UGT; uterine horns and oviducts) after Chlamydia muridarum genital infection (GT). Further studies in Cxcr5-/- mice showed an elevation in bacterial burden in the GT and increased numbers of neutrophils, activated DCs and activated NKT cells early after infection. After resolution, we noted increased fibrosis and the accumulation of a variety of T cells subsets (CD4-IFN gamma, CD4-IL-17, CD4-IL-10 & CD8-TNF alpha) in the oviducts. NKT cell depletion in vitro reduced IL-17 alpha and various cytokines and chemokines, suggesting that activated NKT cells modulate neutrophils and DCs through cytokine/chemokine secretion. Further, chlamydial glycolipids directly activated two distinct types of NKT cell hybridomas in a cell-free CD1d presentation assay and genital infection of Cd1d-/- mice showed reduced oviduct inflammation compared to WT mice. CXCR5 involvement in pathology was also noted using single-nucleotide polymorphism analysis in C. trachomatis infected women attending a sub-fertility clinic. Women who developed tubal pathology after a C. trachomatis infection had a decrease in the frequency of CXCR5 SNP +10950 T>C (rs3922). Conclusions/Significance: These experiments indicate that disruption of the CXCL13-CXCR5 axis permits increased activation of NKT cells by type I and type II glycolipids of Chlamydia muridarum and results in UGT pathology potentially through increased numbers of neutrophils and T cell subsets associated with UGT pathology. In addition, CXCR5 appears to contribute to inter-individual differences in human tubal pathology following C. trachomatis infection.	[Jiang, Janina; Champion, Cheryl I.; Liu, Guangchao; Freed, Amanda; Rozengurt, Nora; Kelly, Kathleen A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Rozengurt, Nora] Univ Calif Los Angeles, CURE DDRC Morphol & Images Core, Los Angeles, CA 90095 USA; [Karimi, Ouafae; Ouburg, Sander; Morre, Servaas A.] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Immunogenet Lab, Med Ctr, Amsterdam, Netherlands; [Morre, Servaas A.] Univ Maastricht, Fac Hlth Med & Life Sci,Res Inst, Sch Publ Hlth & Primary Care CAPHRI & Growth & De, Dept Genet & Cell Biol,Inst Publ Hlth Genom, Maastricht, Netherlands; [Khurana, Archana; Kronenberg, Mitchell] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Pleijster, Jolein; Land, Jolande A.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, NL-9713 AV Groningen, Netherlands; [Surcel, Helja-Marja] Kastelli Res Ctr, Natl Inst Hlth & Welf, Oulu, Finland; [Tiitinen, Aila'; Paavonen, Jorma] Univ Helsinki, Dept Obstet & Gynecol, Univ Hosp, Helsinki, Finland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Vrije Universiteit Amsterdam; Maastricht University; La Jolla Institute for Immunology; University of Groningen; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Kelly, KA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kkelly@mednet.ucla.edu	Ouburg, Sander/H-5775-2019; Kronenberg, Mitchell/AAT-6078-2021	Ouburg, Sander/0000-0002-2092-0002; Paavonen, Jorma/0000-0003-4775-606X	National Institutes of Health [AI026238, AI45053]; Abraxis Bioscience, Inc; European Commission within the Sixth Framework Program [LSHG-CT-2007-037637]; Abraxis Bioscience, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045053, R15AI026238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abraxis Bioscience, Inc; European Commission within the Sixth Framework Program(European Commission); Abraxis Bioscience, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was sponsored by grants from the National Institutes of Health, AI026238 (KAK) and AI45053 (MK) plus a sponsored research award from Abraxis Bioscience, Inc (KAK). The human studies were performed by members of the EpiGenChlamydia Consortium funded by the European Commission within the Sixth Framework Program through contract no. LSHG-CT-2007-037637. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: KAK received a sponsored research award from Abraxis Bioscience, Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bailey RL, 2009, DRUG TODAY, V45, P45; Barr Erika L., 2005, Journal of Microbiology Immunology and Infection, V38, P244; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bilenki L, 2005, J IMMUNOL, V175, P3197, DOI 10.4049/jimmunol.175.5.3197; Brossay L, 1998, J IMMUNOL, V161, P5124; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Burstein GR, 1998, JAMA-J AM MED ASSOC, V280, P521, DOI 10.1001/jama.280.6.521; Chan AC, 2009, CLIN EXP IMMUNOL, V156, P238, DOI 10.1111/j.1365-2249.2009.03888.x; Chang PP, 2012, NAT IMMUNOL, V13, P35, DOI 10.1038/ni.2166; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; DALAKER K, 1981, BRIT J VENER DIS, V57, P41; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Igietseme JU, 2000, J IMMUNOL, V164, P4212, DOI 10.4049/jimmunol.164.8.4212; International S, 2011, BIOCYC DAT COLL CHLA; Jiang JN, 2012, JOVE-J VIS EXP, DOI 10.3791/4391; Johnston B, 2003, J IMMUNOL, V171, P2960, DOI 10.4049/jimmunol.171.6.2960; Joyee AG, 2010, J IMMUNOL, V184, P2095, DOI 10.4049/jimmunol.0901348; Junt T, 2005, J IMMUNOL, V175, P7109, DOI 10.4049/jimmunol.175.11.7109; Kawana K, 2008, INFECT IMMUN, V76, P3011, DOI 10.1128/IAI.01672-07; Kawana K, 2007, J BIOL CHEM, V282, P7368, DOI 10.1074/jbc.M610754200; Kelly KA, 2000, INFECT IMMUN, V68, P1519, DOI 10.1128/IAI.68.3.1519-1528.2000; King M., 2009, DRUGS TODAY BARC, V45, P105; Kinjo Y, 2011, NAT IMMUNOL, V12, P966, DOI 10.1038/ni.2096; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kronenberg M, 2009, CURR OPIN IMMUNOL, V21, P391, DOI 10.1016/j.coi.2009.07.002; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Maxion HK, 2004, INFECT IMMUN, V72, P6330, DOI 10.1128/IAI.72.11.6330-6340.2004; Maxion HK, 2002, INFECT IMMUN, V70, P1538, DOI 10.1128/IAI.70.3.1538-1546.2002; Mazzucchelli L, 1999, J CLIN INVEST, V104, pR49, DOI 10.1172/JCI7830; Moniz RJ, 2009, FEMS IMMUNOL MED MIC, V55, P226, DOI 10.1111/j.1574-695X.2008.00523.x; Moore BB, 2000, J IMMUNOL, V165, P4032, DOI 10.4049/jimmunol.165.7.4032; Morre SA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/095646202762226092; Morre SA, 1999, J CLIN MICROBIOL, V37, P3092; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Murillo LS, 2003, HUM REPROD, V18, P2309, DOI 10.1093/humrep/deg436; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Ohl L, 2003, J EXP MED, V197, P1199, DOI 10.1084/jem.20030169; Ohman H, 2011, HUM IMMUNOL, V72, P278, DOI 10.1016/j.humimm.2010.12.012; Ohman H, 2009, J INFECT DIS, V199, P1353, DOI 10.1086/597620; Peng Y, 2012, CELL MOL IMMUNOL, V9, P361, DOI 10.1038/cmi.2012.19; Ramsey KH, 2005, INFECT IMMUN, V73, P6962, DOI 10.1128/IAI.73.10.6962-6973.2005; Rank RG, 2010, J INFECT DIS, V201, pS168, DOI 10.1086/652399; Rupprecht TA, 2005, NEUROLOGY, V65, P448, DOI 10.1212/01.wnl.0000171349.06645.79; Satterwhite C. L., 2011, Morbidity and Mortality Weekly Report, V60, P370; Scurlock AM, 2011, INFECT IMMUN, V79, P1349, DOI 10.1128/IAI.00984-10; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Shirato K, 2004, J MED VIROL, V74, P507, DOI 10.1002/jmv.20205; US Department of Health and Human Services DoSP, 2007, SEX TRANSM DIS SURV; van Doornum GJJ, 2001, J CLIN MICROBIOL, V39, P829, DOI 10.1128/JCM.39.3.829-835.2001; van Ooij C, 2000, CELL MICROBIOL, V2, P627, DOI 10.1046/j.1462-5822.2000.00077.x; Vermi W, 2005, BLOOD; Wang H, 2012, FEMS IMMUNOL MED MIC; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; World Health Organization, 2001, GLOB PREV INC SEL CU; Wylie JL, 1997, J BACTERIOL, V179, P7233, DOI 10.1128/jb.179.23.7233-7242.1997; Yang X, 2007, ADV EXP MED BIOL, V601, P243; Zheng B, 2005, ARTHRITIS RHEUM-US, V52, P620, DOI 10.1002/art.20768	68	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e47487	10.1371/journal.pone.0047487	http://dx.doi.org/10.1371/journal.pone.0047487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189125	gold, Green Published, Green Submitted			2022-12-25	WOS:000311929800006
J	Pan, YW; Storm, DR; Xia, ZG				Pan, Yung-Wei; Storm, Daniel R.; Xia, Zhengui			The Maintenance of Established Remote Contextual Fear Memory Requires ERK5 MAP Kinase and Ongoing Adult Neurogenesis in the Hippocampus	PLOS ONE			English	Article							RETROGRADE-AMNESIA; BASOLATERAL AMYGDALA; CA3 OUTPUT; CONSOLIDATION; DAMAGE; INHIBITION; DELETION; NEURONS; RATS	Adult neurogenesis in the dentate gyrus of the hippocampal formation has been implicated in several forms of hippocampus-dependent memory. However, its role in the persistence of remote memory is unknown. Furthermore, whether the hippocampus plays a role in maintaining remote contextual memories is controversial. Here we used an inducible gene-specific approach for conditional deletion of erk5 in the adult neurogenic regions of the mouse brain to specifically impair adult neurogenesis. The erk5 gene was conditionally deleted under three different experimental conditions: prior to training for contextual fear, 6 days after training, or 5 weeks after training, We present evidence that remote memory was impaired under all three conditions. These data demonstrate that ongoing adult neurogenesis is required both for the initial establishment and the continued maintenance of remote contextual fear memory, even after the remote memory has transferred into extra-hippocampal regions of the brain 5 weeks after training.	[Pan, Yung-Wei; Storm, Daniel R.; Xia, Zhengui] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Storm, Daniel R.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Xia, Zhengui] Univ Washington, Dept Environm & Occupat Hlth Sci, Toxicol Program, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA.	dstorm@u.washington.edu; zxia@u.washington.edu			National Institute of Health [MH095840, NS20498, T32HD007183, F31DC011216]; National Institute of Child Health and Human Development [P30 HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183, P30HD002274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC011216] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute of Health (MH095840 to Z.X., NS20498 to D. R. S, T32HD007183 and F31DC011216 to Y.W.P.) and facilitated by grant P30 HD02274 from the National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Arruda-Carvalho M, 2011, J NEUROSCI, V31, P15113, DOI 10.1523/JNEUROSCI.3432-11.2011; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; Lehmann H, 2007, EUR J NEUROSCI, V25, P1278, DOI 10.1111/j.1460-9568.2007.05374.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakashiba T, 2009, NEURON, V62, P781, DOI 10.1016/j.neuron.2009.05.013; Pan YW, 2012, J BIOL CHEM, V287, P23306, DOI 10.1074/jbc.M112.344762; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Poulos AM, 2009, P NATL ACAD SCI USA, V106, P11737, DOI 10.1073/pnas.0905257106; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Sparks FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027426; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Sutherland RJ, 2011, CURR OPIN NEUROBIOL, V21, P446, DOI 10.1016/j.conb.2011.04.007; Sutherland RJ, 2008, HIPPOCAMPUS, V18, P710, DOI 10.1002/hipo.20431; Wang SH, 2009, NAT NEUROSCI, V12, P253, DOI 10.1038/nn.2263; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068	25	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50455	10.1371/journal.pone.0050455	http://dx.doi.org/10.1371/journal.pone.0050455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189204	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800081
J	Pollak, CN; Delpino, MV; Fossati, CA; Baldi, PC				Pollak, Cora N.; Victoria Delpino, M.; Fossati, Carlos A.; Baldi, Pablo C.			Outer Membrane Vesicles from Brucella abortus Promote Bacterial Internalization by Human Monocytes and Modulate Their Innate Immune Response	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PSEUDOMONAS-AERUGINOSA; SECRETION SYSTEMS; INTERFERON-GAMMA; EXPRESSION; LIPOPOLYSACCHARIDE; MACROPHAGES; INFECTION; ALPHA	Outer membrane vesicles (OMVs) released by some Gram-negative bacteria have been shown to exert immunomodulatory effects that favor the establishment of the infection. The aim of the present study was to assess the interaction of OMVs from Brucella abortus with human epithelial cells (HeLa) and monocytes (THP-1), and the potential immunomodulatory effects they may exert. Using confocal microscopy and flow cytometry, FITC-labeled OMVs were shown to be internalized by both cell types. Internalization was shown to be partially mediated by clathrin-mediated endocytosis. Pretreatment of THP-1 cells with Brucella OMVs inhibited some cytokine responses (TNF-alpha and IL-8) to E. coli LPS, Pam3Cys or flagellin (TLR4, TLR2 and TLR5 agonists, respectively). Similarly, pretreatment with Brucella OMVs inhibited the cytokine response of THP-1 cells to B. abortus infection. Treatment of THP-1 cells with OMVs during IFN-gamma stimulation reduced significantly the inducing effect of this cytokine on MHC-II expression. OMVs induced a dose-dependent increase of ICAM-1 expression on THP-1 cells and an increased adhesion of these cells to human endothelial cells. The addition of OMVs to THP-1 cultures before the incubation with live B. abortus resulted in increased numbers of adhered and internalized bacteria as compared to cells not treated with OMVs. Overall, these results suggest that OMVs from B. abortus exert cellular effects that promote the internalization of these bacteria by human monocytes, but also downregulate the innate immune response of these cells to Brucella infection. These effects may favor the persistence of Brucella within host cells.	[Pollak, Cora N.; Victoria Delpino, M.; Fossati, Carlos A.; Baldi, Pablo C.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral IDEHU, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Baldi, PC (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Inst Estudios Inmunidad Humoral IDEHU, RA-1113 Buenos Aires, DF, Argentina.	pablobal@ffyb.uba.ar	Baldi, Pablo/AAS-4736-2020	Baldi, Pablo/0000-0002-2500-6682; Delpino, M. Victoria/0000-0003-2077-8509	Agencia Nacional of Promocion Cientifica y Tecnologica (ANPCYT, Argentina) [PICT2006-0517, PICT2008-0764]	Agencia Nacional of Promocion Cientifica y Tecnologica (ANPCYT, Argentina)(ANPCyT)	This work was supported by Grants PICT2006-0517 and PICT2008-0764 from Agencia Nacional of Promocion Cientifica y Tecnologica (ANPCYT, Argentina. www.agencia.mincyt.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Amano A, 2010, MICROBES INFECT, V12, P791, DOI 10.1016/j.micinf.2010.05.008; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Baldwin CL, 2002, VET MICROBIOL, V90, P367, DOI 10.1016/S0378-1135(02)00222-5; Barrionuevo P, 2008, INFECT IMMUN, V76, P250, DOI 10.1128/IAI.00949-07; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Crespo Leon F, 1994, BRUCELOSIS OVINA CAP, P117; Cullell-Young M, 2001, IMMUNOGENETICS, V53, P136, DOI 10.1007/s002510100312; DETILLEUX PG, 1991, AM J VET RES, V52, P1658; Duncan L, 2004, MICROB PATHOGENESIS, V36, P319, DOI 10.1016/j.micpath.2004.02.004; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Fernandez-Moreira E, 2006, INFECT IMMUN, V74, P3285, DOI 10.1128/IAI.01382-05; Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; GAMAZO C, 1989, INFECT IMMUN, V57, P1419, DOI 10.1128/IAI.57.5.1419-1426.1989; GAMAZO C, 1987, INFECT IMMUN, V55, P609, DOI 10.1128/IAI.55.3.609-615.1987; Samartino CG, 2010, AM J PATHOL, V176, P1323, DOI 10.2353/ajpath.2010.090503; Giambartolomei GH, 2004, J IMMUNOL, V173, P4635, DOI 10.4049/jimmunol.173.7.4635; Gorvel JP, 2002, VET MICROBIOL, V90, P281, DOI 10.1016/S0378-1135(02)00214-6; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Jubier-Maurin V, 2001, INFECT IMMUN, V69, P4823, DOI 10.1128/IAI.69.8.4823-4830.2001; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kohler S, 2003, TRENDS MICROBIOL, V11, P215, DOI 10.1016/S0966-842X(03)00078-7; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee HSW, 2007, INFECT IMMUN, V75, P4449, DOI 10.1128/IAI.00222-07; MADKOUR MM, 2001, MADKOURS BRUCELLOSIS, P21; MEYER DH, 1994, INFECT IMMUN, V62, P928, DOI 10.1128/IAI.62.3.928-935.1994; Namork E, 2002, LANCET, V360, P1741, DOI 10.1016/S0140-6736(02)11721-1; Naroeni A, 2002, INFECT IMMUN, V70, P1640, DOI 10.1128/IAI.70.3.1640-1644.2002; Parker H, 2010, INFECT IMMUN, V78, P5054, DOI 10.1128/IAI.00299-10; Schaar V, 2011, CELL MICROBIOL, V13, P432, DOI 10.1111/j.1462-5822.2010.01546.x; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Srisatjaluk R, 2002, INFECT IMMUN, V70, P1185, DOI 10.1128/IAI.70.3.1185-1192.2002; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Vidakovics MLAP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000724; Xie H, 2008, CELL MICROBIOL, V10, P1453, DOI 10.1111/j.1462-5822.2008.01138.x; ZHAN YF, 1995, INFECT IMMUN, V63, P1387, DOI 10.1128/IAI.63.4.1387-1390.1995; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525	49	49	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50214	10.1371/journal.pone.0050214	http://dx.doi.org/10.1371/journal.pone.0050214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189190	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800067
J	Ribeiro, CC; Monteiro, RM; Freitas, FP; Retamal, C; Teixeira, LRS; Palma, LM; Silva, FE; Facanha, AR; Okorokova-Facanha, AL; Okorokov, LA				Ribeiro, Camila C.; Monteiro, Renan M.; Freitas, Flavia P.; Retamal, Claudio; Teixeira, Layz R. S.; Palma, Livia M.; Silva, Flavia E.; Facanha, Arnoldo R.; Okorokova-Facanha, Anna L.; Okorokov, Lev A.			Extracellular Glucose Increases the Coupling Capacity of the Yeast V H+-ATPase and the Resistance of Its H+ Transport Activity to Nitrate Inhibition	PLOS ONE			English	Article							P-TYPE ATPASE; PLASMA-MEMBRANE; PROTON PUMP; SACCHAROMYCES-CARLSBERGENSIS; NONHOMOLOGOUS REGION; VACUOLAR ATPASE; SUBUNIT; CELL; BINDING; KINASE	V H+-ATPase has an important role in a variety of key physiological processes. This enzyme is reversibly activated/partly inactivated by the addition/exhaustion of extracellular glucose. The current model of its regulation assumes the reversible disassembly/reassembly of similar to 60-70% of the V1 and V0 membrane complexes, which are responsible for ATP hydrolysis and H+ conductance, respectively. The number of assembled complexes determines the pump activity because disassembled complexes are inactive. The model predicts the identical catalytic properties for the activated and semi-active enzymes molecules. To verify the model predictions we have isolated total membranes from yeast spheroplasts that were pre-incubated either with or without glucose. Nitrate treatment of membranes revealed the similar ATPase inhibition for two enzyme states, suggesting that they have identical structures that are essential for ATP hydrolysis. However, H+ transport was inhibited more than the ATPase activities, indicating a nitrate uncoupling action, which was significantly higher for the nonactivated enzyme. This finding suggests that the structure of the non-activated enzyme, which is essential for H+ transport, is less stable than that of the activated enzyme. Moreover, the glucose activation of the pump increases i) its coupling capacity; ii) its K-M for ATP hydrolysis and ATP affinity for H+ transport; iii) the Vmax for H+ transport in comparison with the Vmax for ATP hydrolysis and iv) the immune reactivity of catalytic subunit A and regulatory subunit B by 9.3 and 2.4 times, respectively. The protein content of subunits A and B was not changed by extracellular glucose. We propose that instead of the dissociation/reassociation of complexes V1 and V0, changes in the extracellular glucose concentration cause reversible and asymmetrical modulations in the immune reactivity of subunits A and B by their putative biochemical modifications. This response asymmetrically modulates H+-transport and ATP hydrolysis, exhibiting distinct properties for the activated versus non-activated enzymes.	[Ribeiro, Camila C.; Monteiro, Renan M.; Freitas, Flavia P.; Teixeira, Layz R. S.; Palma, Livia M.; Silva, Flavia E.; Okorokova-Facanha, Anna L.; Okorokov, Lev A.] Univ Estadual Norte Fluminense, Ctr Biociencia & Biotecnol, Lab Fisiol & Bioquim Microrganismos, Campos Dos Goytacazes, Brazil; [Ribeiro, Camila C.; Retamal, Claudio; Facanha, Arnoldo R.] Univ Estadual Norte Fluminense, Ctr Biociencia & Biotecnol, Lab Biol Celular & Tecidual, Campos Dos Goytacazes, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Okorokov, LA (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencia & Biotecnol, Lab Fisiol & Bioquim Microrganismos, Campos Dos Goytacazes, Brazil.	okorokov@uenf.br	Facanha, Arnoldo Rocha/A-2833-2008	Okorokova-Facanha, Anna/0000-0002-6856-7711; Okorokov, Lev/0000-0002-8469-0701; Rocha Facanha, Arnoldo/0000-0002-5641-6852	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Universidade Esdadual do Norte Fluminense(UENF)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Universidade Esdadual do Norte Fluminense(UENF)	This work has been funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Universidade Esdadual do Norte Fluminense(UENF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PhD students FPF, CCR and FES were scholarship holders of these scientific organizations and RMM and LRST are scholarship holders of the same organizations, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Blake-Palmer KG, 2009, CURR OPIN NEPHROL HY, V18, P433, DOI 10.1097/MNH.0b013e32832e9c58; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; BOWMAN BJ, 1989, J BIOL CHEM, V264, P15606; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Cipriano DJ, 2008, BBA-BIOENERGETICS, V1777, P599, DOI 10.1016/j.bbabio.2008.03.013; DAVIES JM, 1994, P NATL ACAD SCI USA, V91, P8547, DOI 10.1073/pnas.91.18.8547; De Milito Angelo, 2005, Future Oncol, V1, P779, DOI 10.2217/14796694.1.6.779; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Duby G, 2009, PFLUG ARCH EUR J PHY, V457, P645, DOI 10.1007/s00424-008-0457-x; Eraso P, 2006, BBA-BIOMEMBRANES, V1758, P164, DOI 10.1016/j.bbamem.2006.01.010; Facanha ALO, 2002, J CELL BIOL, V157, P1029, DOI 10.1083/jcb.200111012; Graham LA, 2000, J EXP BIOL, V203, P61; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; KANE PM, 1989, J BIOL CHEM, V264, P19236; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kettner C, 2003, BIOPHYS J, V85, P3730, DOI 10.1016/S0006-3495(03)74789-4; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Kontani K, 2005, DEV CELL, V8, P787, DOI 10.1016/j.devcel.2005.02.018; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Moriyama Y, 1988, Prog Clin Biol Res, V273, P387; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; MORIYAMA Y, 1987, J BIOL CHEM, V262, P9175; Muller ML, 1999, J BIOL CHEM, V274, P10706, DOI 10.1074/jbc.274.16.10706; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; NICOLAY K, 1982, ARCH MICROBIOL, V133, P83, DOI 10.1007/BF00413516; Okorokov LA, 1998, FEMS MICROBIOL LETT, V162, P83, DOI 10.1111/j.1574-6968.1998.tb12982.x; OKOROKOV LA, 1983, FEBS LETT, V155, P102, DOI 10.1016/0014-5793(83)80218-X; Okorokov LA, 2001, FEBS LETT, V505, P321, DOI 10.1016/S0014-5793(01)02852-6; OKOROKOV LA, 1980, J BACTERIOL, V144, P661, DOI 10.1128/JB.144.2.661-665.1980; OKOROKOV LA, 1985, BIOCH FUNCTION VACUO, P203; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Rein J, 2008, AM J PHYSIOL-CELL PH, V294, pC56, DOI 10.1152/ajpcell.00041.2007; Samarao SS, 2009, BBA-BIOMEMBRANES, V1788, P303, DOI 10.1016/j.bbamem.2008.11.006; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Schumacher K, 2006, CURR OPIN PLANT BIOL, V9, P595, DOI 10.1016/j.pbi.2006.09.001; SERRANO R, 1978, MOL CELL BIOCHEM, V22, P51; SERRANO R, 1983, FEBS LETT, V156, P11, DOI 10.1016/0014-5793(83)80237-3; SERRANO R, 1993, FEBS LETT, V325, P108, DOI 10.1016/0014-5793(93)81424-X; Shao E, 2004, J BIOL CHEM, V279, P48663, DOI 10.1074/jbc.M408278200; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sze H, 1999, PLANT CELL, V11, P677, DOI 10.1105/tpc.11.4.677; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; Yabe I, 1999, J BIOL CHEM, V274, P34903, DOI 10.1074/jbc.274.49.34903	61	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49580	10.1371/journal.pone.0049580	http://dx.doi.org/10.1371/journal.pone.0049580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189149	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800026
J	Roatt, BM; Aguiar-Soares, RDD; Vitoriano-Souza, J; Coura-Vital, W; Braga, SL; Correa-Oliveira, R; Martins, OA; Teixeira-Carvalho, A; de Lana, M; Gontijo, NF; Marques, MJ; Giunchetti, RC; Reis, AB				Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian; Vitoriano-Souza, Juliana; Coura-Vital, Wendel; Braga, Samuel Leoncio; Correa-Oliveira, Rodrigo; Martins-Filho, Olindo Assis; Teixeira-Carvalho, Andrea; de Lana, Marta; Gontijo, Nelder Figueiredo; Marques, Marcos Jose; Giunchetti, Rodolfo Cordeiro; Reis, Alexandre Barbosa			Performance of LBSap Vaccine after Intradermal Challenge with L. infantum and Saliva of Lu. longipalpis: Immunogenicity and Parasitological Evaluation	PLOS ONE			English	Article							CANINE VISCERAL LEISHMANIASIS; EXCRETED-SECRETED ANTIGENS; LONG-LASTING PROTECTION; TISSUE PARASITE DENSITY; NATURALLY INFECTED-DOGS; NITRIC-OXIDE PRODUCTION; SAND FLY SALIVA; REAL-TIME PCR; IMMUNE-RESPONSE; CLINICAL STATUS	In the last decade, the search for new vaccines against canine visceral leishmaniasis has intensified. However, the pattern related to immune protection during long periods after experimental infection in vaccine trials is still not fully understood. Herein, we investigated the immunogenicity and parasitological levels after intradermal challenge with Leishmania infantum plus salivary gland extract in dogs immunized with a vaccine composed of L. braziliensis antigens plus saponin as an adjuvant (LBSap vaccine). The LBSap vaccine elicited higher levels of total anti-Leishmania IgG as well as both IgG1 and IgG2. Furthermore, dogs vaccinated had increased levels of lymphocytes, particularly circulating B cells (CD21(+)) and both CD4(+) and CD8(+) T lymphocytes. LBSap also elicited an intense in vitro cell proliferation associated with higher levels of CD4(+) T lymphocytes specific for vaccine soluble antigen and soluble lysate of L. infantum antigen even 885 days after experimental challenge. Furthermore, LBSap vaccinated dogs presented high IFN-gamma and low IL-10 and TGF-beta 1 expression in spleen with significant reduction of parasite load in this tissue. Overall, our results validate the potential of LBSap vaccine to protect against L. infantum experimental infection and strongly support further evaluation of efficiency of LBSap against CVL in natural infection conditions.	[Roatt, Bruno Mendes; de Oliveira Aguiar-Soares, Rodrigo Dian; Vitoriano-Souza, Juliana; Coura-Vital, Wendel; Braga, Samuel Leoncio; Giunchetti, Rodolfo Cordeiro; Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil; [Correa-Oliveira, Rodrigo] Fundaco Oswaldo Cruz, Inst Pesquisas Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Martins-Filho, Olindo Assis; Teixeira-Carvalho, Andrea] Fundaco Oswaldo Cruz, Inst Rene Rachou, Lab Biomarcadores Diag & Monitoracao, Belo Horizonte, MG, Brazil; [de Lana, Marta] Univ Fed Ouro Preto, Lab Doenca Chagas, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil; [Gontijo, Nelder Figueiredo] Univ Fed Minas Gerais, Dept Parasitol, Lab Fisiol Insetos Hematofagos, Belo Horizonte, MG, Brazil; [Marques, Marcos Jose] Univ Fed Alfenas, Dept Biociencias, Lab Biol Mol & Biotecnol, Alfenas, MG, Brazil; [Giunchetti, Rodolfo Cordeiro] Univ Fed Minas Gerais, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil; [Reis, Alexandre Barbosa] Univ Fed Ouro Preto, Escola Farm, Dept Anal Clin, Ouro Preto, MG, Brazil	Universidade Federal de Ouro Preto; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto; Universidade Federal de Minas Gerais; Universidade Federal de Alfenas; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto	Reis, AB (corresponding author), Univ Fed Ouro Preto, Lab Imunopatol, Nucleo Pesquisas Ciencias Biol, Ouro Preto, MG, Brazil.	alexreis@nupeb.ufop.br	Marques, Marcos José/G-8384-2012; Reis, Alexandre Barbosa/I-9945-2014; Gontijo, Nelder F/D-2539-2013; Roatt, Bruno M/R-5502-2016; Marques, Marcos/AAR-3672-2021; de Oliveira Aguiar-Soares, Rodrigo Dian/ABB-7973-2020; Coura-Vital, Wendel/AAP-9624-2021; Giunchetti, Rodolfo/O-9878-2014; Martins-Filho, Olindo Assis/ABE-6278-2021	Reis, Alexandre Barbosa/0000-0001-8123-4164; Gontijo, Nelder F/0000-0003-3357-2497; Roatt, Bruno M/0000-0001-5281-3263; Marques, Marcos/0000-0003-3459-3169; de Oliveira Aguiar-Soares, Rodrigo Dian/0000-0001-8705-7357; Martins-Filho, Olindo Assis/0000-0002-5494-4889; /0000-0002-1434-7676; Correa-Oliveira, Rodrigo/0000-0001-6419-9459; Lana, Marta/0000-0002-1565-4707; Cordeiro Giunchetti, Rodolfo/0000-0003-4181-7546	CNPq; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Federal de Ouro Preto (UFOP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	ML, RCO, OAMF, ATC, WCV and ABR are grateful to CNPq for fellowships. The authors are also grateful for the use of the facilities at Animal Center Science/UFOP, Rede Mineira de Bioterismo (FAPEMIG), and to Agrohealth Corporation and Chemitec Agro-Veterinaria LTDA for support with the provision of medications.; This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Universidade Federal de Ouro Preto (UFOP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2004, ADV PARASIT, V57, P1, DOI 10.1016/S0065-308X(04)57001-X; Alves CF, 2009, VET IMMUNOL IMMUNOP, V128, P349, DOI 10.1016/j.vetimm.2008.11.020; Araujo MSS, 2008, VACCINE, V26, P2211, DOI 10.1016/j.vaccine.2008.02.044; Ashford DA, 1998, AM J TROP MED HYG, V59, P53, DOI 10.4269/ajtmh.1998.59.53; Baneth G, 2002, VET PARASITOL, V106, P315, DOI 10.1016/S0304-4017(02)00115-2; Borj-Cabrera GP, 2002, VACCINE, V20, P3277, DOI 10.1016/S0264-410X(02)00294-3; Borja-Cabrera GP, 2008, VACCINE, V26, P4991, DOI 10.1016/j.vaccine.2008.07.029; Bourdoiseau G, 1997, VET IMMUNOL IMMUNOP, V59, P21, DOI 10.1016/S0165-2427(97)00072-X; Bretagne S, 2001, CLIN DIAGN LAB IMMUN, V8, P828, DOI 10.1128/CDLI.8.4.828-831.2001; Brodskyn Claudia, 2003, Expert Rev Vaccines, V2, P705, DOI 10.1586/14760584.2.5.705; Carcelen J, 2009, VACCINE, V27, P5964, DOI 10.1016/j.vaccine.2009.07.069; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; da Costa-Val AP, 2007, VET J, V174, P636, DOI 10.1016/j.tvjl.2006.11.006; da Silva VO, 2000, VACCINE, V19, P1082, DOI 10.1016/S0264-410X(00)00339-X; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; Fujiwara RT, 2005, VET RES, V36, P827, DOI 10.1051/vetres:2005033; Giunchetti RC, 2008, RES VET SCI, V85, P106, DOI 10.1016/j.rvsc.2007.09.008; Giunchetti RC, 2008, VACCINE, V26, P623, DOI 10.1016/j.vaccine.2007.11.057; Giunchetti RC, 2007, VACCINE, V25, P7674, DOI 10.1016/j.vaccine.2007.08.009; Gradoni L, 2001, VET PARASITOL, V100, P87, DOI 10.1016/S0304-4017(01)00486-1; Gradoni L, 2005, VACCINE, V23, P5245, DOI 10.1016/j.vaccine.2005.07.001; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Guerra LL, 2009, PARASITOL RES, V104, P611, DOI 10.1007/s00436-008-1237-4; Holzmuller P, 2005, VET IMMUNOL IMMUNOP, V106, P247, DOI 10.1016/j.vetimm.2005.03.001; Khamesipour A, 2006, INDIAN J MED RES, V123, P423; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Lasri S, 1999, VET RES, V30, P441; Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083; Lemesre JL, 2005, VACCINE, V23, P2825, DOI 10.1016/j.vaccine.2004.11.061; MAGALHAES P A, 1980, Revista do Instituto de Medicina Tropical de Sao Paulo, V22, P197; Manna L, 2006, VET PARASITOL, V142, P271, DOI 10.1016/j.vetpar.2006.06.028; Mayrink W, 1996, MEM I OSWALDO CRUZ, V91, P695, DOI 10.1590/S0074-02761996000600006; Melby PC, 1998, INFECT IMMUN, V66, P18, DOI 10.1128/IAI.66.1.18-27.1998; Miro G, 2009, VET DERMATOL, V20, P397, DOI 10.1111/j.1365-3164.2009.00824.x; Molano I, 2003, VET IMMUNOL IMMUNOP, V92, P1, DOI 10.1016/S0165-2427(02)00315-X; Moreira ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047907; MULLER I, 1991, INT IMMUNOL, V3, P587, DOI 10.1093/intimm/3.6.587; Oliva G, 2010, JAVMA-J AM VET MED A, V236, P1192, DOI 10.2460/javma.236.11.1192; Panaro MA, 2001, COMP IMMUNOL MICROB, V24, P187, DOI 10.1016/S0147-9571(00)00026-6; Paranhos-Silva M, 2003, VET PARASITOL, V114, P97, DOI 10.1016/S0304-4017(03)00132-8; PINELLI E, 1994, TISSUE ANTIGENS, V43, P189, DOI 10.1111/j.1399-0039.1994.tb02321.x; PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994; Poot J, 2006, VACCINE, V24, P2460, DOI 10.1016/j.vaccine.2005.12.039; Rafati S, 2005, VACCINE, V23, P3716, DOI 10.1016/j.vaccine.2005.02.009; Ramos I, 2008, VACCINE, V26, P333, DOI 10.1016/j.vaccine.2007.11.021; Ravindran R, 2004, CURR MOL MED, V4, P697, DOI 10.2174/1566524043360212; Reis AB, 2006, CLIN EXP IMMUNOL, V146, P303, DOI 10.1111/j.1365-2249.2006.03206.x; Reis AB, 2005, VET IMMUNOL IMMUNOP, V103, P173, DOI 10.1016/j.vetimm.2004.08.014; Reis AB, 2006, VET IMMUNOL IMMUNOP, V112, P102, DOI 10.1016/j.vetimm.2006.02.001; Reis AB, 2006, RES VET SCI, V81, P68, DOI 10.1016/j.rvsc.2005.09.011; Reis AB, 2010, TRENDS PARASITOL, V26, P341, DOI 10.1016/j.pt.2010.04.005; Reis AB, 2009, VET IMMUNOL IMMUNOP, V128, P87, DOI 10.1016/j.vetimm.2008.10.307; Saldarriaga OA, 2006, VACCINE, V24, P1928, DOI 10.1016/j.vaccine.2005.10.052; Araujo MSS, 2009, VACCINE, V27, P1008, DOI 10.1016/j.vaccine.2008.11.104; Solano-Gallego L, 2001, J CLIN MICROBIOL, V39, P560, DOI 10.1128/JCM.39.2.560-563.2001; Vercammen F, 2002, ACTA TROP, V84, P175, DOI 10.1016/S0001-706X(02)00178-X; Vitoriano-Souza J, 2008, VACCINE, V26, P3922, DOI 10.1016/j.vaccine.2008.04.084; World Health Organization, 2010, WHO TECH REP SER	61	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49780	10.1371/journal.pone.0049780	http://dx.doi.org/10.1371/journal.pone.0049780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189161	gold, Green Published			2022-12-25	WOS:000311929800038
J	Ward, MG; Ajuwon, KM				Ward, Meliza G.; Ajuwon, Kolapo M.			Biglycan Deletion Alters Adiponectin Expression in Murine Adipose Tissue and 3T3-L1 Adipocytes	PLOS ONE			English	Article							HIGH-FAT DIET; NF-KAPPA-B; LEUCINE-RICH PROTEOGLYCANS; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; INSULIN-RESISTANCE; COLLAGEN-VI; TOLL-LIKE; PROTEIN; OBESITY	Obesity promotes increased secretion of a number of inflammatory factors from adipose tissue. These factors include cytokines and very lately, extracellular matrix components (ECM). Biglycan, a small leucine rich proteoglycan ECM protein, is up-regulated in obesity and has recently been recognized as a pro-inflammatory molecule. However, it is unknown whether biglycan contributes to adipose tissue dysfunction. In the present study, we characterized biglycan expression in various adipose depots in wild-type mice fed a low fat diet (LFD) or obesity-inducing high fat diet (HFD). High fat feeding induced biglycan mRNA expression in multiple adipose depots. Adiponectin is an adipokine with anti-inflammatory and insulin sensitizing effects. Due to the importance of adiponectin, we examined the effect of biglycan on adiponectin expression. Comparison of adiponectin expression in biglycan knockout (bgn(-/0)) and wild-type (bgn(+/0)) reveals higher adiponectin mRNA and protein in epididymal white adipose tissue in bgn(-/0) mice, as well higher serum concentration of adiponectin, and lower serum insulin concentration. On the contrary, knockdown of biglycan in 3T3-L1 adipocytes led to decreased expression and secretion of adiponectin. Furthermore, treatment of 3T3-L1 adipocytes with conditioned medium from biglycan treated macrophages resulted in an increase in adiponectin mRNA expression. These data suggest a link between biglycan and adiponectin expression. However, the difference in the pattern of regulation between in vivo and in vitro settings reveals the complexity of this relationship.	[Ward, Meliza G.; Ajuwon, Kolapo M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ajuwon, KM (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	kajuwon@purdue.edu			Purdue Research Foundation; College of Agriculture, Purdue University	Purdue Research Foundation; College of Agriculture, Purdue University	The work was funded through funds from the Purdue Research Foundation and the College of Agriculture, Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adapala VJ, 2012, J NUTR BIOCHEM, V23, P567, DOI 10.1016/j.jnutbio.2011.02.013; Adapala VJ, 2011, J INFLAMM-LOND, V8, DOI [10.1186/1476-9255-8-5, 10.1186/1476-9255-9-15]; Ajuwon KM, 2005, J NUTR, V135, P1841, DOI 10.1093/jn/135.8.1841; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427; Barnea M, 2006, OBESITY, V14, P2145, DOI 10.1038/oby.2006.251; Bolton K, 2012, BIOL-TARGETS THER, V6, P67, DOI 10.2147/BTT.S27925; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Combs TP, 2002, ENDOCRINOLOGY, V143, P998, DOI 10.1210/endo.143.3.8662; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Hausman GJ, 2004, J ANIM SCI, V82, P925; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Huang JH, 2007, J BIOL CHEM, V282, P37501, DOI 10.1074/jbc.M703625200; Huber J, 2007, INT J OBESITY, V31, P1004, DOI 10.1038/sj.ijo.0803511; Hung SC, 2004, GENE, V340, P141, DOI 10.1016/j.gene.2004.06.028; Iozzo RV, 1999, J BIOL CHEM, V274, P18843, DOI 10.1074/jbc.274.27.18843; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kobayashi K, 2005, BIOCHEM BIOPH RES CO, V335, P66, DOI 10.1016/j.bbrc.2005.07.048; Kumazawa M, 2007, J LIPID RES, V48, P2039, DOI 10.1194/jlr.M700222-JLR200; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Melchior-Becker A, 2011, J BIOL CHEM, V286, P17365, DOI 10.1074/jbc.M110.192682; Molina H, 2009, J PROTEOME RES, V8, P48, DOI 10.1021/pr800650r; Nielsen KL, 2003, J BONE MINER RES, V18, P2152, DOI 10.1359/jbmr.2003.18.12.2152; Phan LK, 2002, J CLIN INVEST, V110, P1449, DOI 10.1172/JC1200216131; Qiao LP, 2011, AM J PHYSIOL-ENDOC M, V300, pE809, DOI 10.1152/ajpendo.00004.2011; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; Ward M, 2011, CELL PROLIFERAT, V44, P343, DOI 10.1111/j.1365-2184.2011.00763.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang WS, 2001, J CLIN ENDOCR METAB, V86, P3815, DOI 10.1210/jc.86.8.3815; Young MF, 2002, GLYCOCONJUGATE J, V19, P257, DOI 10.1023/A:1025336114352; Zamboni M, 2007, INT J OBESITY, V31, P1104, DOI 10.1038/sj.ijo.0803563; Zhong J, 2010, J PROTEOME RES, V9, P5228, DOI 10.1021/pr100521c	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50554	10.1371/journal.pone.0050554	http://dx.doi.org/10.1371/journal.pone.0050554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189205	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800082
J	Yuan, SG; Ghoshdastider, U; Trzaskowski, B; Latek, D; Debinski, A; Pulawski, W; Wu, RL; Gerke, V; Filipek, S				Yuan, Shuguang; Ghoshdastider, Umesh; Trzaskowski, Bartosz; Latek, Dorota; Debinski, Aleksander; Pulawski, Wojciech; Wu, Rongliang; Gerke, Volker; Filipek, Slawomir			The Role of Water in Activation Mechanism of Human N-Formyl Peptide Receptor 1 (FPR1) Based on Molecular Dynamics Simulations	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; FORMYLPEPTIDE RECEPTOR; ACCURATE DOCKING; LIGAND-BINDING; CONSTRUCTION; ANTAGONIST; EXPRESSION; PREDICTION	The Formyl Peptide Receptor 1 (FPR1) is an important chemotaxis receptor involved in various aspects of host defense and inflammatory processes. We constructed a model of FPR1 using as a novel template the chemokine receptor CXCR4 from the same branch of the phylogenetic tree of G-protein-coupled receptors. The previously employed template of rhodopsin contained a bulge at the extracellular part of TM2 which directly influenced binding of ligands. We also conducted molecular dynamics (MD) simulations of FPR1 in the apo form as well as in a form complexed with the agonist fMLF and the antagonist tBocMLF in the model membrane. During all MD simulation of the fMLF-FPR1 complex a water molecule transiently bridged the hydrogen bond between W254(6.48) and N108(3.35) in the middle of the receptor. We also observed a change in the cytoplasmic part of FPR1 of a rotamer of the Y301(7.53) residue (tyrosine rotamer switch). This effect facilitated movement of more water molecules toward the receptor center. Such rotamer of Y301(7.53) was not observed in any crystal structures of GPCRs which can suggest that this state is temporarily formed to pass the water molecules during the activation process. The presence of a distance between agonist and residues R201(5.38) and R205(5.42) on helix TM5 may suggest that the activation of FPR1 is similar to the activation of beta-adrenergic receptors since their agonists are separated from serine residues on helix TM5. The removal of water molecules bridging these interactions in FPR1 can result in shrinking of the binding site during activation similarly to the shrinking observed in beta-ARs. The number of GPCR crystal structures with agonists is still scarce so the designing of new ligands with agonistic properties is hampered, therefore homology modeling and docking can provide suitable models. Additionally, the MD simulations can be beneficial to outline the mechanisms of receptor activation and the agonist/antagonist sensing.	[Trzaskowski, Bartosz; Debinski, Aleksander; Pulawski, Wojciech; Filipek, Slawomir] Univ Warsaw, Fac Chem, Warsaw, Poland; [Yuan, Shuguang; Ghoshdastider, Umesh; Latek, Dorota; Wu, Rongliang] Int Inst Mol & Cell Biol, Warsaw, Poland; [Yuan, Shuguang] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland; [Gerke, Volker] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, Munster, Germany	University of Warsaw; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Munster	Filipek, S (corresponding author), Univ Warsaw, Fac Chem, Warsaw, Poland.	sfilipek@chem.uw.edu.pl	YUAN, SHUGUANG/S-9686-2019; Yuan, Shuguang/C-3615-2013; Ghoshdastider, Umesh/O-5327-2015; Trzaskowski, Bartosz/B-1881-2008; Filipek, Slawomir/A-2985-2008	YUAN, SHUGUANG/0000-0001-9858-4742; Trzaskowski, Bartosz/0000-0003-2385-1476; Latek, Dorota/0000-0002-0429-0637; Ghoshdastider, Umesh/0000-0003-4471-9394; Filipek, Slawomir/0000-0003-3147-3858	European Community [211800]; Interdisciplinary Centre for Mathematical and Computational Modelling in Warsaw [G07-13]	European Community(European Commission); Interdisciplinary Centre for Mathematical and Computational Modelling in Warsaw	The research leading to these results has received funding from the European Community's Seventh Framework Program (FP7/2007-2013) under grant agreement no. 211800. Calculations were partly done at Interdisciplinary Centre for Mathematical and Computational Modelling in Warsaw grant no. G07-13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys Software Inc, 2011, DISC STUD MOD ENV RE; [Anonymous], PYMOL MOL GRAPH SYST; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; Brandenburg LO, 2009, MOL MEMBR BIOL, V26, P371, DOI 10.1080/09687680903188340; Capra V, 2010, J LIPID RES, V51, P1075, DOI 10.1194/jlr.M003236; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Dupradeau FY, 2010, PHYS CHEM CHEM PHYS, V12, P7821, DOI 10.1039/c0cp00111b; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filep JG, 2009, J CELL BIOCHEM, V108, P1039, DOI 10.1002/jcb.22351; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fu HM, 2006, J LEUKOCYTE BIOL, V79, P247, DOI 10.1189/jlb.0905498; Fujita H, 2011, ARCH BIOCHEM BIOPHYS, V516, P121, DOI 10.1016/j.abb.2011.09.017; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jin YP, 2009, INVEST OPHTH VIS SCI, V50, P4743, DOI 10.1167/iovs.08-2462; Khlebnikov AI, 2012, J MOL MODEL, V18, P2831, DOI 10.1007/s00894-011-1307-x; Kolinski M., 2009, TOSBJ, V3, P51, DOI DOI 10.2174/1874199100903010051; Kolinski M., 2008, TOSBJ, V2, P8, DOI DOI 10.2174/1874199100802010008; Kolinski M, 2010, J MOL MODEL, V16, P1567, DOI 10.1007/s00894-010-0678-8; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; LALA A, 1993, BIOCHIM BIOPHYS ACTA, V1178, P302, DOI 10.1016/0167-4889(93)90208-7; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacroModel, MACROMODEL VERS 9 9; Maestro, MAESTR VERS 9 2; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Mills JS, 1998, J BIOL CHEM, V273, P10428, DOI 10.1074/jbc.273.17.10428; Mills JS, 2000, J BIOL CHEM, V275, P39012, DOI 10.1074/jbc.M003081200; Movitz C, 2010, J BIOL CHEM, V285, P14338, DOI 10.1074/jbc.M109.080465; MURPHY PM, 1992, J BIOL CHEM, V267, P7637; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PROSSNITZ ER, 1993, J IMMUNOL, V151, P5704; QUEHENBERGER O, 1993, J BIOL CHEM, V268, P18167; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Raval A, 2012, PROTEINS, V80, P2071, DOI 10.1002/prot.24098; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Trzaskowski B, 2012, CURR MED CHEM, V19, P1090, DOI 10.2174/092986712799320556; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053; Walther A, 2000, MOL CELL, V5, P831, DOI 10.1016/S1097-2765(00)80323-8; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; YE RD, 1992, BIOCHEM BIOPH RES CO, V184, P582, DOI 10.1016/0006-291X(92)90629-Y; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Yousefi S, 2001, J LEUKOCYTE BIOL, V69, P1045; Zhang Y, 2003, GENES IMMUN, V4, P22, DOI 10.1038/sj.gene.6363900	62	19	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e47114	10.1371/journal.pone.0047114	http://dx.doi.org/10.1371/journal.pone.0047114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189124	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800005
J	Kerchner, GA; Racine, CA; Hale, S; Wilheim, R; Laluz, V; Miller, BL; Kramer, JH				Kerchner, Geoffrey A.; Racine, Caroline A.; Hale, Sandra; Wilheim, Reva; Laluz, Victor; Miller, Bruce L.; Kramer, Joel H.			Cognitive Processing Speed in Older Adults: Relationship with White Matter Integrity	PLOS ONE			English	Article							DIFFUSION-TENSOR ANALYSIS; SPATIAL STATISTICS; FRACTIONAL ANISOTROPY; EXECUTIVE FUNCTION; AGE-DIFFERENCES; BRINLEY PLOTS; HUMAN BRAIN; LIFE-SPAN; DECLINE; MICROSTRUCTURE	Cognitive processing slows with age. We sought to determine the importance of white matter integrity, assessed by diffusion tensor imaging (DTI), at influencing cognitive processing speed among normal older adults, assessed using a novel battery of computerized, non-verbal, choice reaction time tasks. We studied 131 cognitively normal adults aged 55-87 using a cross-sectional design. Each participant underwent our test battery, as well as MRI with DTI. We carried out cross-subject comparisons using tract-based spatial statistics. As expected, reaction time slowed significantly with age. In diffuse areas of frontal and parietal white matter, especially the anterior corpus callosum, fractional anisotropy values correlated negatively with reaction time. The genu and body of the corpus callosum, superior longitudinal fasciculus, and inferior fronto-occipital fasciculus were among the areas most involved. This relationship was not explained by gray or white matter atrophy or by white matter lesion volume. In a statistical mediation analysis, loss of white matter integrity mediated the relationship between age and cognitive processing speed.	[Kerchner, Geoffrey A.] Stanford Univ, Stanford Ctr Memory Disorders, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Racine, Caroline A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Racine, Caroline A.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Hale, Sandra] Washington Univ, Dept Psychol, Cognit Dev Lab, St Louis, MO 63130 USA; [Wilheim, Reva; Laluz, Victor; Miller, Bruce L.; Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL); University of California System; University of California San Francisco	Kerchner, GA (corresponding author), Stanford Univ, Stanford Ctr Memory Disorders, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA.	kerchner@stanford.edu			Larry L. Hillblom Foundation; Alzheimer's Association [NIRG-11-205493]; NIH [P50AG023501, R01AG032289]; NATIONAL INSTITUTE ON AGING [P50AG023501, R01AG032289] Funding Source: NIH RePORTER	Larry L. Hillblom Foundation; Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Kerchner was supported by grants from the Larry L. Hillblom Foundation and the Alzheimer's Association (NIRG-11-205493). Dr. Racine was supported by a grant from a private, anonymous foundation and it is unrestricted research funding for projects generally related to "Myelin and Aging" at the UCSF Memory & Aging Center. There is no competing interest. Dr. Kramer was supported by grants from the NIH (P50AG023501, R01AG032289) and the Larry L. Hillblom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Barrick TR, 2010, NEUROIMAGE, V51, P565, DOI 10.1016/j.neuroimage.2010.02.033; Bendlin BB, 2010, DEV NEUROPSYCHOL, V35, P257, DOI 10.1080/87565641003696775; Bennett IJ, 2010, NEUROBIOLOG IN PRESS; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bucur B, 2008, NEUROBIOL AGING, V29, P1070, DOI 10.1016/j.neurobiolaging.2007.02.008; Burgmans S, 2011, NEUROIMAGE, V55, P1287, DOI 10.1016/j.neuroimage.2011.01.002; Burzynska AZ, 2010, NEUROIMAGE, V49, P2104, DOI 10.1016/j.neuroimage.2009.09.041; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; Charlton RA, 2008, NEUROBIOL AGING, V29, P1547, DOI 10.1016/j.neurobiolaging.2007.03.017; Charlton RA, 2010, J NEUROL NEUROSUR PS, V81, P13, DOI 10.1136/jnnp.2008.167288; Charlton RA, 2006, NEUROLOGY, V66, P217, DOI 10.1212/01.wnl.0000194256.15247.83; Chen J, 2007, PSYCHON B REV, V14, P534, DOI 10.3758/BF03194103; Edwards JD, 2010, GERONTOLOGIST, V50, P393, DOI 10.1093/geront/gnp127; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gold BT, 2010, NEUROBIOL AGING, V31, P512, DOI 10.1016/j.neurobiolaging.2008.04.005; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Hale S, 1996, AGING NEUROPSYCHOL C, V3, P154, DOI 10.1080/13825589608256621; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hugenschmidt CE, 2008, CEREB CORTEX, V18, P433, DOI 10.1093/cercor/bhm080; Jenkins L, 2000, PSYCHOL AGING, V15, P157, DOI 10.1037//0882-7974.15.1.157; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kochunov P, 2007, NEUROIMAGE, V35, P478, DOI 10.1016/j.neuroimage.2006.12.021; Lawrence B, 1998, AGING NEUROPSYCHOL C, V5, P129, DOI 10.1076/anec.5.2.129.600; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Myerson J, 2003, PSYCHON B REV, V10, P224, DOI 10.3758/BF03196489; MYERSON J, 1994, J GERONTOL, V49, pP72, DOI 10.1093/geronj/49.2.P72; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; Oakes TR, 2007, NEUROIMAGE, V34, P500, DOI 10.1016/j.neuroimage.2006.10.007; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; Penny W, 2006, STAT PARAMETRIC MAPP; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Salami A, 2012, BBA-MOL BASIS DIS, V1822, P408, DOI 10.1016/j.bbadis.2011.09.001; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Sasson E, 2011, BRAIN STRUCTURE FUNC, P1; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Sullivan EV, 2003, EUR J RADIOL, V45, P244, DOI 10.1016/S0720-048X(02)00313-3; Vernooij MW, 2008, NEUROIMAGE, V43, P470, DOI 10.1016/j.neuroimage.2008.07.052; Yoon B, 2008, ARCH GERONTOL GERIAT, V47, P129, DOI 10.1016/j.archger.2007.07.004; Ystad M, 2011, NEUROIMAGE, V55, P24, DOI 10.1016/j.neuroimage.2010.11.016	48	148	149	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2012	7	11							e50425	10.1371/journal.pone.0050425	http://dx.doi.org/10.1371/journal.pone.0050425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	047ER	23185621	Green Submitted, Green Published, gold			2022-12-25	WOS:000311821000234
J	Torrens-Spence, MP; Liu, PY; Ding, HZ; Harich, K; Gillaspy, G; Li, JY				Torrens-Spence, Michael P.; Liu, Pingyang; Ding, Haizhen; Harich, Kim; Gillaspy, Glenda; Li, Jianyong			Biochemical Evaluation of the Decarboxylation and Decarboxylation-Deamination Activities of Plant Aromatic Amino Acid Decarboxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION-CULTURES; DOPA DECARBOXYLASE; TYROSINE DECARBOXYLASE; SUBSTRATE-SPECIFICITY; AUXIN BIOSYNTHESIS; SYNTHASE; PURIFICATION; EXPRESSION; ENZYMES; GENES	Plant aromatic amino acid decarboxylase (AAAD) enzymes are capable of catalyzing either decarboxylation or decarboxylation-deamination on various combinations of aromatic amino acid substrates. These two different activities result in the production of arylalkylamines and the formation of aromatic acetaldehydes, respectively. Variations in product formation enable individual enzymes to play different physiological functions. Despite these catalytic variations, arylalkylamine and aldehyde synthesizing AAADs are indistinguishable without protein expression and characterization. In this study, extensive biochemical characterization of plant AAADs was performed to identify residues responsible for differentiating decarboxylation AAADs from aldehyde synthase AAADs. Results demonstrated that a tyrosine residue located on a catalytic loop proximal to the active site of plant AAADs is primarily responsible for dictating typical decarboxylase activity, whereas a phenylalanine at the same position is primarily liable for aldehyde synthase activity. Mutagenesis of the active site phenylalanine to tyrosine in Arabidopsis thaliana and Petroselinum crispum aromatic acetaldehyde synthases primarily converts the enzymes activity from decarboxylation-deamination to decarboxylation. The mutation of the active site tyrosine to phenylalanine in the Catharanthus roseus and Papaver somniferum aromatic amino acid decarboxylases changes the enzymes decarboxylation activity to a primarily decarboxylation-deamination activity. Generation of these mutant enzymes enables the production of unusual AAAD enzyme products including indole-3-acetaldehyde, 4-hydroxyphenylacetaldehyde, and phenylethylamine. Our data indicates that the tyrosine and phenylalanine in the catalytic loop region could serve as a signature residue to reliably distinguish plant arylalkylamine and aldehyde synthesizing AAADs. Additionally, the resulting data enables further insights into the mechanistic roles of active site residues.	[Torrens-Spence, Michael P.; Liu, Pingyang; Ding, Haizhen; Harich, Kim; Gillaspy, Glenda; Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Li, JY (corresponding author), Virginia Tech, Dept Biochem, Engel Hall 204, Blacksburg, VA 24061 USA.	lij@vt.edu	Liu, Pingyang/G-7796-2014	Liu, Pingyang/0000-0001-5060-5807	Virginia Tech Department of Biochemistry, College of Agriculture and Life Sciences; Direct For Biological Sciences [1051646] Funding Source: National Science Foundation	Virginia Tech Department of Biochemistry, College of Agriculture and Life Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Virginia Tech Department of Biochemistry, College of Agriculture and Life Sciences.	BERLIN J, 1994, PLANT CELL TISS ORG, V38, P289, DOI 10.1007/BF00033889; Bertoldi M, 2002, J BIOL CHEM, V277, P36357, DOI 10.1074/jbc.M204867200; Bertoldi M, 1996, J BIOL CHEM, V271, P23954, DOI 10.1074/jbc.271.39.23954; Bertoldi M, 1998, BIOCHEMISTRY-US, V37, P6552, DOI 10.1021/bi9718898; BUTEAU C, 1984, J CHROMATOGR, V284, P201, DOI 10.1016/S0021-9673(01)87816-X; Dai XH, 2013, J BIOL CHEM, V288, P1448, DOI 10.1074/jbc.M112.424077; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ELLIS BE, 1983, PHYTOCHEMISTRY, V22, P1941, DOI 10.1016/0031-9422(83)80018-1; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; Gutensohn M, 2011, PLANT J, V66, P591, DOI 10.1111/j.1365-313X.2011.04515.x; Han Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008826; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; KAWALLECK P, 1993, J BIOL CHEM, V268, P2189; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; KOGA J, 1992, J BIOL CHEM, V267, P15823; Komori H, 2012, J BIOL CHEM, V287, P29175, DOI 10.1074/jbc.M112.381897; LEETE E, 1952, CAN J CHEM, V30, P749, DOI 10.1139/v52-090; Lehmann T, 2009, FEBS LETT, V583, P1895, DOI 10.1016/j.febslet.2009.05.017; MARQUES IA, 1988, PLANT PHYSIOL, V88, P46, DOI 10.1104/pp.88.1.46; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; MEIJER AH, 1993, J PLANT RES, P145; NOE W, 1984, PLANT MOL BIOL, V3, P281, DOI 10.1007/BF00017782; Park S, 2009, PLANTA, V230, P1197, DOI 10.1007/s00425-009-1015-2; Rontein D, 2001, J BIOL CHEM, V276, P35523, DOI 10.1074/jbc.M106038200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sekimoto H, 1998, PLANT CELL PHYSIOL, V39, P433, DOI 10.1093/oxfordjournals.pcp.a029387; Seo M, 1998, PLANT PHYSIOL, V116, P687, DOI 10.1104/pp.116.2.687; SRINIVASAN K, 1978, BIOCHIM BIOPHYS ACTA, V526, P597, DOI 10.1016/0005-2744(78)90150-X; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Stepanova AN, 2011, PLANT CELL, V23, P3961, DOI 10.1105/tpc.111.088047; Tieman D, 2006, P NATL ACAD SCI USA, V103, P8287, DOI 10.1073/pnas.0602469103; Torrens-Spence MP, 2012, BIOCHEM BIOPH RES CO, V418, P211, DOI 10.1016/j.bbrc.2011.12.124; TREZZINI GF, 1993, PLANT MOL BIOL, V21, P385, DOI 10.1007/BF00019954; UDENFRIEND S, 1953, J AM CHEM SOC, V75, P501, DOI 10.1021/ja01098a520; Vavricka C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016124; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	37	44	47	6	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2013	288	4					2376	2387		10.1074/jbc.M112.401752	http://dx.doi.org/10.1074/jbc.M112.401752			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	079ZS	23204519	Green Published, hybrid			2022-12-25	WOS:000314211500026
J	Silverstein, N; Crisman, TJ; Forrest, LR; Kanner, BI				Silverstein, Nechama; Crisman, Thomas J.; Forrest, Lucy R.; Kanner, Baruch I.			Cysteine Scanning Mutagenesis of Transmembrane Helix 3 of a Brain Glutamate Transporter Reveals Two Conformationally Sensitive Positions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC-ACID TRANSPORTER; CONTROLS CATION INTERACTIONS; RAT-BRAIN; SUBSTRATE INTERACTIONS; MEMBRANE-VESICLES; BINDING; GLT-1; RESIDUE; SODIUM; MUTATION	Glutamate transporters in the brain remove the neurotransmitter from the synapse by cotransport with three sodium ions into the surrounding cells. Recent structural work on an archaeal homolog suggests that, during substrate translocation, the transport domain, including the peripheral transmembrane helix 3 (TM3), moves relative to the trimerization domain in an elevator-like process. Moreover, two TM3 residues have been proposed to form part of a transient Na3' site, and another, Tyr-124, appears close to both Na3' and Na1. To obtain independent evidence for the role of TM3 in glutamate transport, each of its 31 amino acid residues from the glial GLT-1 transporter was individually mutated to cysteine. Except for six mutants, substantial transport activity was detected. Aqueous accessibility of the introduced cysteines was probed with membrane-permeant and membrane-impermeant sulfhydryl reagents under a variety of conditions. Transport of six single cysteine mutants, all located on the intracellular side of TM3, was affected by membrane-permeant sulfhydryl reagents. However, only at two positions could ligands modulate the reactivity. A120C reactivity was diminished under conditions expected to favor the outward-facing conformation of the transporter. Sulfhydryl modification of Y124C by 2-aminoethyl methanethiosulfonate, but not by N-ethylmaleimide, was fully protected in the presence of sodium. Our data are consistent with the idea that TM3 moves during transport. Moreover, computational modeling indicated that electrostatic repulsion between the positive charge introduced at position 124 and the sodium ions bound at Na3' and Na1 underlies the protection by sodium.	[Silverstein, Nechama; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel; [Crisman, Thomas J.; Forrest, Lucy R.] Max Planck Inst Biophys, Computat Struct Biol Grp, D-60438 Frankfurt, Germany	Hebrew University of Jerusalem; Max Planck Society	Forrest, LR (corresponding author), Max Planck Inst Biophys, Computat Struct Biol Grp, Max von Laue Str 3, D-60438 Frankfurt, Germany.	lucy.forrest@biophys.mpg.de; baruch.kanner@mail.huji.ac.il	Forrest, Lucy/E-8113-2016	Forrest, Lucy/0000-0003-1855-7985; Crisman, Thomas/0000-0001-6235-8110	National Institutes of Health from NINDS [NS16708]; United States-Israel Binational Science Foundation [2007051]; German Research Council (DFG) Collaborative Research Group 807 "Transport and Communication across Membranes"; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); German Research Council (DFG) Collaborative Research Group 807 "Transport and Communication across Membranes"(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS16708 from NINDS (to B. I. K). This work was also supported by United States-Israel Binational Science Foundation Grant 2007051 (to B. I. K.) and by German Research Council (DFG) Collaborative Research Group 807 "Transport and Communication across Membranes" (to L. R. F.).	Bastug T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033058; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Forrest LR, 2005, PROTEINS, V61, P296, DOI 10.1002/prot.20601; Frisch M. J., 2009, GAUSSIAN 09 REVISION; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Groeneveld M, 2010, BIOCHEMISTRY-US, V49, P3511, DOI 10.1021/bi100430s; GRUNEWALD M, 1995, J BIOL CHEM, V270, P17017, DOI 10.1074/jbc.270.28.17017; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; Holley DC, 2009, PHILOS T R SOC B, V364, P155, DOI 10.1098/rstb.2008.0246; Huang ZJ, 2010, BIOPHYS J, V99, P1416, DOI 10.1016/j.bpj.2010.06.052; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KLEINBERGERDORON N, 1994, J BIOL CHEM, V269, P3063; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Larsson HP, 2010, P NATL ACAD SCI USA, V107, P13912, DOI 10.1073/pnas.1006289107; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Menaker D, 2006, J NEUROCHEM, V99, P20, DOI 10.1111/j.1471-4159.2006.04003.x; NELSON PJ, 1983, BIOCHEMISTRY-US, V22, P5459, DOI 10.1021/bi00292a030; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Rosental N, 2006, J BIOL CHEM, V281, P27905, DOI 10.1074/jbc.M600331200; Rosental N, 2011, J BIOL CHEM, V286, P41381, DOI 10.1074/jbc.M111.291021; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Teichman S, 2012, J BIOL CHEM, V287, P17198, DOI 10.1074/jbc.M112.355040; Teichman S, 2009, P NATL ACAD SCI USA, V106, P14297, DOI 10.1073/pnas.0904625106; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	54	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					964	973		10.1074/jbc.M112.403576	http://dx.doi.org/10.1074/jbc.M112.403576			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23188832	Green Published, hybrid			2022-12-25	WOS:000313570300021
J	Choi, KS; Jun, JK; Park, EC; Park, S; Jung, KW; Han, MA; Choi, IJ; Lee, HY				Choi, Kui Son; Jun, Jae Kwan; Park, Eun-Cheol; Park, Sohee; Jung, Kyu Won; Han, Mi Ah; Choi, Il Ju; Lee, Hoo-Yeon			Performance of Different Gastric Cancer Screening Methods in Korea: A Population-Based Study	PLOS ONE			English	Article							DIAGNOSTIC-TEST; STOMACH-CANCER; MORTALITY; PROGRAM; ENDOSCOPY; IMPACT; CURVE; JAPAN	Background: There is a lack of agreement on which gastric cancer screening method is the most effective in the general population. The present study compared the relative performance of upper-gastrointestinal series (UGIS) and endoscopy screening for gastric cancer. Methods: A population-based study was conducted using the National Cancer Screening Program (NCSP) database. We analyzed data on 2,690,731 men and women in Korea who underwent either UGIS or endoscopy screening for gastric cancer between January 1, 2002 and December 31, 2005. Final gastric cancer diagnosis was ascertained through linkage with the Korean Central Cancer Registry. We calculated positivity rate, gastric cancer detection rate, interval cancer rate, sensitivity, specificity, and positive predictive value of UGIS and endoscopy screening. Results: The positivity rates for UGIS and endoscopy screening were 39.7 and 42.1 per 1,000 screenings, respectively. Gastric cancer detection rates were 0.68 and 2.61 per 1,000 screenings, respectively. In total, 2,067 interval cancers occurred within 1 year of a negative UGIS screening result (rate, 1.17/1,000) and 1,083 after a negative endoscopy screening result (rate, 1.17/1,000). The sensitivity of UGIS and endoscopy screening to detect gastric cancer was 36.7 and 69.0%, respectively, and specificity was 96.1 and 96.0%. The sensitivity of endoscopy screening to detect localized gastric cancer was 65.7%, which was statistically significantly higher than that of UGIS screening. Conclusion: Overall, endoscopy performed better than UGIS in the NCSP for gastric cancer. Further evaluation of the impact of these screening methods should take into account the corresponding costs and reduction in mortality.	[Choi, Kui Son; Jun, Jae Kwan; Jung, Kyu Won] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sohee] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; [Han, Mi Ah] Chosun Univ, Coll Med, Dept Prevent Med, Kwangju, South Korea; [Choi, Il Ju] Natl Canc Ctr, Res Inst & Hosp, Gastr Canc Branch, Goyang, South Korea; [Lee, Hoo-Yeon] Dankook Univ, Coll Med, Dept Social Med, Chungnam, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chosun University; National Cancer Center - Korea (NCC); Dankook University	Lee, HY (corresponding author), Dankook Univ, Coll Med, Dept Social Med, Chungnam, South Korea.	hylee@dankook.ac.kr	Park, Eun-Cheol/O-5644-2019	Park, Eun-Cheol/0000-0002-2306-5398; Park, Sohee/0000-0001-8513-5163	National Cancer Center, Korea [1010200]	National Cancer Center, Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center, Korea (grant number 1010200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2000, J GASTROENTEROL MASS, V38, P475; Choi KS, 2011, CANCER SCI, V102, P1559, DOI 10.1111/j.1349-7006.2011.01982.x; Dan YY, 2006, CLIN GASTROENTEROL H, V4, P709, DOI 10.1016/j.cgh.2006.03.025; Ferlay J., 2010, IARC CANC BASE; FUJITA S, 1978, PATHOL RES PRACT, V163, P297, DOI 10.1016/S0344-0338(78)80028-4; FUKAO A, 1995, INT J CANCER, V60, P45, DOI 10.1002/ijc.2910600106; Fukao A, 1992, J GASTRENTEROLOGY MA, V97; Gotoda T, 2007, GASTRIC CANCER, V10, P1, DOI 10.1007/s10120-006-0408-1; Hamashima C, 2008, JPN J CLIN ONCOL, V38, P259, DOI 10.1093/jjco/hyn017; HISAMICHI S, 1989, WORLD J SURG, V13, P31, DOI 10.1007/BF01671151; HISAMICHI S, 1988, CANCER DETECT PREV, V11, P323; HISAMICHI S, 1984, JPN J CLIN ONCOL, V14, P211; Hosokawa O, 2004, JPN J GASTROENTEROL, V42, P33; Hosokawa O, 2008, SCAND J GASTROENTERO, V43, P1112, DOI 10.1080/00365520802085395; HUNT RH, 1989, CANCER RES, V49, P6822; Inaba S, 1999, PREV MED, V29, P102; Ishida T, 1994, J GASTROENTEROL MASS, V32, P9; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim CW, 2008, PUBLIC HEALTH, V122, P229, DOI 10.1016/j.puhe.2007.07.003; Kubota H, 2000, SURGERY, V128, P41, DOI 10.1067/msy.2000.106812; Lee KJ, 2006, INT J CANCER, V118, P2315, DOI 10.1002/ijc.21664; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Mizoue T, 2003, INT J CANCER, V106, P103, DOI 10.1002/ijc.11183; MOSES LE, 1993, STAT MED, V12, P1293, DOI 10.1002/sim.4780121203; MURAKAMI R, 1990, CANCER, V65, P1255, DOI 10.1002/1097-0142(19900301)65:5<1255::AID-CNCR2820650536>3.0.CO;2-P; NISHIZAWA M, 1982, ENDOSCOPY, V14, P19, DOI 10.1055/s-2007-1021565; Ogura M, 2008, SCAND J GASTROENTERO, V43, P574, DOI 10.1080/00365520701813954; OSHIMA A, 1986, INT J CANCER, V38, P829, DOI 10.1002/ijc.2910380608; OTSUJI M, 1989, Stomach and Intestine (Tokyo), V24, P1291; PISANI P, 1994, BRIT J CANCER, V69, P1102, DOI 10.1038/bjc.1994.216; Riecken B, 2002, PREV MED, V34, P22, DOI 10.1006/pmed.2001.0925; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Tashiro A, 2006, WORLD J GASTROENTERO, V12, P4873; Tsubono Yoshitaka, 2000, Asian Pac J Cancer Prev, V1, P57; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Won YJ, 2009, CANCER RES TREAT, V41, P122, DOI 10.4143/crt.2009.41.3.122; WOODMAN CBJ, 1995, BRIT MED J, V310, P224, DOI 10.1136/bmj.310.6974.224; Yoo KY, 2008, JPN J CLIN ONCOL, V38, P327, DOI 10.1093/jjco/hyn026; Young JL, 2001, NIH PUB	39	80	82	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50041	10.1371/journal.pone.0050041	http://dx.doi.org/10.1371/journal.pone.0050041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209638	Green Published, gold, Green Submitted			2022-12-25	WOS:000312104900020
J	Wong, RY; Ramsey, ME; Cummings, ME				Wong, Ryan Y.; Ramsey, Mary E.; Cummings, Molly E.			Localizing Brain Regions Associated with Female Mate Preference Behavior in a Swordtail	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; AUDITORY FOREBRAIN; SEXUAL SELECTION; SAILFIN MOLLIES; GENE PROFILES; CICHLID FISH; CHOICE; EXPRESSION; NETWORK; MEMORY	Female mate choice behavior is a critical component of sexual selection, yet identifying the neural basis of this behavior is largely unresolved. Previous studies have implicated sensory processing and hypothalamic brain regions during female mate choice and there is a conserved network of brain regions (Social Behavior Network, SBN) that underlies sexual behaviors. However, we are only beginning to understand the role this network has in pre-copulatory female mate choice. Using in situ hybridization, we identify brain regions associated with mate preference in female Xiphophorus nigrensis, a swordtail species with a female choice mating system. We measure gene expression in 10 brain regions (linked to sexual behavior, reward, sensory integration or other processes) and find significant correlations between female preference behavior and gene expression in two telencephalic areas associated with reward, learning and multi-sensory processing (medial and lateral zones of the dorsal telencephalon) as well as an SBN region traditionally associated with sexual response (preoptic area). Network analysis shows that these brain regions may also be important in mate preference and that correlated patterns of neuroserpin expression between regions co-vary with differential compositions of the mate choice environment. Our results expand the emerging network for female preference from one that focused on sensory processing and midbrain sexual response centers to a more complex coordination involving forebrain areas that integrate primary sensory processing and reward.	[Wong, Ryan Y.; Ramsey, Mary E.; Cummings, Molly E.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Wong, RY (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	ryan_wong@ncsu.edu	Wong, Ryan Y/AAR-3162-2020	Wong, Ryan Y/0000-0003-0236-672X	University of Texas (UT) Ecology, Evolution and Behavior graduate program; Reeder Fellowship; UT SRA; UT StartUp funds; National Science Foundation SGER [IOS-0813742, IOS-0843000]; Division Of Integrative Organismal Systems [0843000] Funding Source: National Science Foundation	University of Texas (UT) Ecology, Evolution and Behavior graduate program; Reeder Fellowship; UT SRA; UT StartUp funds; National Science Foundation SGER(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by research fellowships from the University of Texas (UT) Ecology, Evolution and Behavior graduate program (to RYW), along with a Reeder Fellowship, UT SRA, UT StartUp funds, National Science Foundation SGER IOS-0813742 and IOS-0843000 (to MEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 1998, AM ZOOL, V38, P166; Adkins-Regan E, 2011, FRONT NEUROENDOCRINO; Ambroggi F, 2008, NEURON, V59, P648, DOI 10.1016/j.neuron.2008.07.004; Andersson Malte, 1994; Anken R. H., 1994, BRAIN ATLAS ADULT SW; Bailey DJ, 2002, J NEUROBIOL, V52, P43, DOI 10.1002/neu.10070; Ball GF, 2004, PHYSIOL BEHAV, V83, P329, DOI 10.1016/j.physbeh.2004.08.020; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Berger P, 1999, MOL CELL NEUROSCI, V14, P455, DOI 10.1006/mcne.1999.0804; Borgatti SP, 2002, UCINET 6 WINDOWS SOF; Broglio C, 2005, BRAIN RES BULL, V66, P277, DOI 10.1016/j.brainresbull.2005.03.021; Bruce L.L., 2009, ENCY NEUROSCIENCE, P43, DOI DOI 10.1016/B978-008045046-9.00965-7; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Chakraborty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012898; Chapman PF, 2003, ANN NY ACAD SCI, V985, P114; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J, 1988, STAT POWER ANAL BEHA, Vxxi; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; Cummings M, 2006, ANIM BEHAV, V72, P217, DOI 10.1016/j.anbehav.2006.01.009; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; Desjardins JK, 2010, P NATL ACAD SCI USA, V107, P21176, DOI 10.1073/pnas.1010442107; Earley RL, 2006, PHYSIOL BEHAV, V88, P353, DOI 10.1016/j.physbeh.2006.04.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Galliciotti G, 2006, FRONT BIOSCI-LANDMRK, V11, P33, DOI 10.2741/1778; Gentner TQ, 2001, J NEUROBIOL, V46, P48, DOI 10.1002/1097-4695(200101)46:1<48::AID-NEU5>3.0.CO;2-3; Goodson JL, 2006, P NATL ACAD SCI USA, V103, P17013, DOI 10.1073/pnas.0606278103; Goodson JL, 2009, FRONT NEUROENDOCRIN, V30, P429, DOI 10.1016/j.yfrne.2009.05.007; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Harvey-Girard E, 2010, J COMP NEUROL, V518, P2666, DOI 10.1002/cne.22358; Heimovics SA, 2007, BEHAV BRAIN RES, V176, P333, DOI 10.1016/j.bbr.2006.10.023; Hoke KL, 2005, P NATL ACAD SCI USA, V102, P10712, DOI 10.1073/pnas.0502361102; Hoke KL, 2004, J NEUROSCI, V24, P11264, DOI 10.1523/JNEUROSCI.2079-04.2004; HOUDE AE, 1990, SCIENCE, V248, P1405, DOI 10.1126/science.248.4961.1405; KENDRICK AM, 1995, BRAIN RES, V680, P226, DOI 10.1016/0006-8993(95)00191-R; Kidd CE, 2010, GEN COMP ENDOCR, V165, P277, DOI 10.1016/j.ygcen.2009.07.008; KONDO Y, 1993, BRAIN RES BULL, V32, P635, DOI 10.1016/0361-9230(93)90166-9; Lampert KP, 2010, CURR BIOL, V20, P1729, DOI 10.1016/j.cub.2010.08.029; LARSSON LI, 1991, HISTOCHEMISTRY, V95, P209; Lau BYB, 2011, P NATL ACAD SCI USA, V108, P2581, DOI 10.1073/pnas.1018275108; Lee TW, 2012, J NEUROCHEM, V121, P561, DOI 10.1111/j.1471-4159.2011.07639.x; Leitner S, 2005, J NEUROBIOL, V64, P275, DOI 10.1002/neu.20135; Liley NR, 1965, BEHAVIOUR S3, pIII; Loebrich S, 2009, PHYSIOL REV, V89, P1079, DOI 10.1152/physrev.00013.2009; Lynch KS, 2012, GENES BRAIN BEHAV, V11, P222, DOI 10.1111/j.1601-183X.2011.00742.x; Madani R, 2003, MOL CELL NEUROSCI, V23, P473, DOI 10.1016/S1044-7431(03)00077-0; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; Miranda E, 2006, CELL MOL LIFE SCI, V63, P709, DOI 10.1007/s00018-005-5077-4; Morris MR, 2006, BIOL LETTERS, V2, P8, DOI 10.1098/rsbl.2005.0387; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Northcutt RG, 2008, BRAIN RES BULL, V75, P191, DOI 10.1016/j.brainresbull.2007.10.058; Northcutt RG, 2006, J COMP NEUROL, V494, P903, DOI 10.1002/cne.20853; O'Connell LA, 2011, J NEUROENDOCRINOL, V23, P244, DOI 10.1111/j.1365-2826.2010.02099.x; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; O'Connell LA, 2011, J COMP NEUROL, V519, P75, DOI 10.1002/cne.22506; Okuno H, 2011, NEUROSCI RES, V69, P175, DOI 10.1016/j.neures.2010.12.007; Okuyama T, 2011, BIOCHEM BIOPH RES CO, V404, P453, DOI 10.1016/j.bbrc.2010.11.143; Petrulis A, 2000, BEHAV NEUROSCI, V114, P184, DOI 10.1037/0735-7044.114.1.184; Pfaus JG, 1997, BRAIN RES BULL, V44, P397, DOI 10.1016/S0361-9230(97)00219-0; Ramsey ME, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00062; Ramsey ME, 2011, GEN COMP ENDOCR, V170, P381, DOI 10.1016/j.ygcen.2010.10.012; Rebar D, 2011, BEHAV ECOL, V22, P303, DOI 10.1093/beheco/arq195; Rick IP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025554; Ryan MJ, 2001, MG BEH ECOL, P133; RYAN MJ, 1990, BEHAV ECOL SOCIOBIOL, V26, P231; Sakata JT, 2005, BRAIN RES REV, V48, P1, DOI 10.1016/j.brainresrev.2004.07.017; SCHLUPP I, 1994, SCIENCE, V263, P373, DOI 10.1126/science.8278809; Scott AP, 2008, BEHAVIOUR, V145, P1307, DOI 10.1163/156853908785765854; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shoemaker CM, 2007, MOL ENDOCRINOL, V21, P2750, DOI 10.1210/me.2007-0263; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Sockman KW, 2002, P ROY SOC B-BIOL SCI, V269, P2479, DOI 10.1098/rspb.2002.2180; Tracy AL, 2001, BEHAV BRAIN RES, V127, P13, DOI 10.1016/S0166-4328(01)00364-3; Verzijden MN, 2012, TRENDS ECOL EVOL, V27, P511, DOI 10.1016/j.tree.2012.05.007; Wig GS, 2011, ANN NY ACAD SCI, V1224, P126, DOI 10.1111/j.1749-6632.2010.05947.x; Wilczynski W, 2001, BRAIN BEHAV EVOLUT, V58, P137, DOI 10.1159/000047268; Wilczynski W, 2011, HORM BEHAV, V59, P630, DOI 10.1016/j.yhbeh.2010.08.015; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Witte K, 2002, BEHAV ECOL SOCIOBIOL, V52, P194, DOI 10.1007/s00265-002-0503-1; Wong RY, 2011, ANIM BEHAV, V82, P691, DOI 10.1016/j.anbehav.2011.06.024; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062; Yepes M, 2004, TRENDS CARDIOVAS MED, V14, P173, DOI 10.1016/j.tcm.2004.03.004; Zhao C, 2008, CELL TISSUE RES, V332, P381, DOI 10.1007/s00441-008-0606-8	87	26	26	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e50355	10.1371/journal.pone.0050355	http://dx.doi.org/10.1371/journal.pone.0050355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209722	gold, Green Published, Green Submitted			2022-12-25	WOS:000312104900043
J	Yang, ZM; Zhou, T; Hui, PM; Ke, JH				Yang, Zimo; Zhou, Tao; Hui, Pak Ming; Ke, Jian-Hong			Instability in Evolutionary Games	PLOS ONE			English	Article							ECONOMIC NETWORKS; COOPERATION	Background: Phenomena of instability are widely observed in many dissimilar systems, with punctuated equilibrium in biological evolution and economic crises being noticeable examples. Recent studies suggested that such instabilities, quantified by the abrupt changes of the composition of individuals, could result within the framework of a collection of individuals interacting through the prisoner's dilemma and incorporating three mechanisms: (i) imitation and mutation, (ii) preferred selection on successful individuals, and (iii) networking effects. Methodology/Principal Findings: We study the importance of each mechanism using simplified models. The models are studied numerically and analytically via rate equations and mean-field approximation. It is shown that imitation and mutation alone can lead to the instability on the number of cooperators, and preferred selection modifies the instability in an asymmetric way. The co-evolution of network topology and game dynamics is not necessary to the occurrence of instability and the network topology is found to have almost no impact on instability if new links are added in a global manner. The results are valid in both the contexts of the snowdrift game and prisoner's dilemma. Conclusions/Significance: The imitation and mutation mechanism, which gives a heterogeneous rate of change in the system's composition, is the dominating reason of the instability on the number of cooperators. The effects of payoffs and network topology are relatively insignificant. Our work refines the understanding on the driving forces of system instability.	[Yang, Zimo; Zhou, Tao] Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China; [Yang, Zimo; Hui, Pak Ming] Chinese Univ Hong Kong, Dept Phys, Shatin, Hong Kong, Peoples R China; [Ke, Jian-Hong] Wenzhou Univ, Coll Phys & Elect Informat Engn, Wenzhou, Peoples R China	University of Electronic Science & Technology of China; Chinese University of Hong Kong; Wenzhou University	Yang, ZM (corresponding author), Univ Elect Sci & Technol China, Web Sci Ctr, Chengdu 610054, Peoples R China.	zhutou@ustc.edu; pmhui@phy.cuhk.edu.hk	zhou, tao/GQA-3572-2022; Hui, Pak Ming/S-2586-2017	Hui, Pak Ming/0000-0002-5201-8689	Research Grants Council of the Hong Kong SAR Government [CUHK-401109]; Fundamental Research Funds for the Central Universities	Research Grants Council of the Hong Kong SAR Government(Hong Kong Research Grants Council); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	PMH acknowledges the support from the Research Grants Council of the Hong Kong SAR Government under Grant No. CUHK-401109. TZ and ZMY acknowledge the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades A., 1997, J ECON GROWTH, V2, P279, DOI DOI 10.1023/A:1009782809329; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alesina Alberto, 1996, J ECON GROWTH, V1, P189, DOI DOI 10.1007/BF00138862; BAK P, 1993, PHYS REV LETT, V71, P4083, DOI 10.1103/PhysRevLett.71.4083; BECKER GS, 1977, J POLIT ECON, V85, P1141, DOI 10.1086/260631; Billio M, 2010, 16223 NEBR; BRANSON WH, 1980, J DEV ECON, V7, P49, DOI 10.1016/0304-3878(80)90027-9; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Cavaliere M, 2012, J THEOR BIOL, V299, P126, DOI 10.1016/j.jtbi.2011.09.005; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Garlaschelli D, 2007, NAT PHYS, V3, P813, DOI 10.1038/nphys729; GOULD S J, 1977, Paleobiology, V3, P115; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Jackson MO, 2007, AM ECON REV, V97, P890, DOI 10.1257/aer.97.3.890; Kim BJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021907; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LEWONTIN RC, 1961, J THEOR BIOL, V1, P382, DOI 10.1016/0022-5193(61)90038-8; Li W, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.045102; Malkiel Burton Gordon., 1985, RANDOM WALK WALL STR; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Moran P., 1962, STAT PROCESSES EVOLU; Morgenstern O., 2007, THEORY GAMES EC BEHA; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; RAUP DM, 1986, SCIENCE, V231, P1528, DOI 10.1126/science.11542058; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schweitzer F, 2009, ADV COMPLEX SYST, V12, P407, DOI 10.1142/S0219525909002337; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Serrano M. A., 2007, J ECON INTERACT COOR, V2, P111, DOI DOI 10.1007/S11403-007-0026-Y; Skyrms B., 2004, STAG HUNT EVOLUTION, DOI DOI 10.1017/CBO9781139165228; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sornette D, 2010, ECONOPHYSICS APPROACHES TO LARGE-SCALE BUSINESS DATA AND FINANCIAL CRISIS, P101, DOI 10.1007/978-4-431-53853-0_6; Sysi-Aho M, 2005, EUR PHYS J B, V44, P129, DOI 10.1140/epjb/e2005-00108-5; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Weibull J W, 1997, EVOLUTIONARY GAME TH; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648	44	4	4	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2012	7	11							e49663	10.1371/journal.pone.0049663	http://dx.doi.org/10.1371/journal.pone.0049663			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	051DI	23209587	Green Submitted, gold, Green Published			2022-12-25	WOS:000312104900012
J	Grasemann, C; Devlin, MJ; Rzeczkowska, PA; Herrmann, R; Horsthemke, B; Hauffa, BP; Grynpas, M; Alm, C; Bouxsein, ML; Palmert, MR				Grasemann, Corinna; Devlin, Maureen J.; Rzeczkowska, Paulina A.; Herrmann, Ralf; Horsthemke, Bernhard; Hauffa, Berthold P.; Grynpas, Marc; Alm, Christina; Bouxsein, Mary L.; Palmert, Mark R.			Parental Diabetes: The Akita Mouse as a Model of the Effects of Maternal and Paternal Hyperglycemia in Wildtype Offspring	PLOS ONE			English	Article							INSULIN-RESISTANCE; GENE-EXPRESSION; FEMALE; DIET; BONE; FAT; OBESITY; RATS; CHROMOSOME-7; PREGNANCY	Aim/Hypothesis: Maternal diabetes and high-fat feeding during pregnancy have been linked to later life outcomes in offspring. To investigate the effects of both maternal and paternal hyperglycemia on offspring phenotypes, we utilized an autosomal dominant mouse model of diabetes (hypoinsulinemic hyperglycemia in Akita mice). We determined metabolic and skeletal phenotypes in wildtype offspring of Akita mothers and fathers. Results: Both maternal and paternal diabetes resulted in phenotypic changes in wildtype offspring. Phenotypic changes were more pronounced in male offspring than in female offspring. Maternal hyperglycemia resulted in metabolic and skeletal phenotypes in male wildtype offspring. Decreased bodyweight and impaired glucose tolerance were observed as were reduced whole body bone mineral density and reduced trabecular bone mass. Phenotypic changes in offspring of diabetic fathers differed in effect size from changes in offspring of diabetic mothers. Male wildtype offspring developed a milder metabolic phenotype, but a more severe skeletal phenotype. Female wildtype offspring of diabetic fathers were least affected. Conclusions: Both maternal and paternal diabetes led to the development of metabolic and skeletal changes in wildtype offspring, with a greater effect of maternal diabetes on metabolic parameters and of paternal diabetes on skeletal development. The observed changes are unlikely to derive from Mendelian inheritance, since the investigated offspring did not inherit the Akita mutation. While fetal programming may explain the phenotypic changes in offspring exposed to maternal diabetes in-utero, the mechanism underlying the effect of paternal diabetes on wildtype offspring is unclear.	[Grasemann, Corinna; Herrmann, Ralf; Hauffa, Berthold P.] UK Essen, Kinderklin 2, Div Paediat Endocrinol, Essen, Germany; [Grasemann, Corinna; Herrmann, Ralf; Horsthemke, Bernhard; Hauffa, Berthold P.] Univ Duisburg Essen, Essen, Germany; [Grasemann, Corinna; Rzeczkowska, Paulina A.; Alm, Christina; Palmert, Mark R.] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Grasemann, Corinna; Rzeczkowska, Paulina A.; Alm, Christina; Palmert, Mark R.] Univ Toronto, Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada; [Devlin, Maureen J.; Bouxsein, Mary L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Orthoped Surg, Boston, MA 02215 USA; [Herrmann, Ralf] UK Essen, Kinderklin 1, Div Neonatol, Essen, Germany; [Horsthemke, Bernhard] UK Essen, Dept Human Genet, Essen, Germany; [Grynpas, Marc] Univ Toronto, Toronto, ON, Canada; [Grynpas, Marc] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Palmert, Mark R.] Univ Toronto, Hosp Sick Children, Dept Physiol, Toronto, ON M5G 1X8, Canada	University of Duisburg Essen; University of Duisburg Essen; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Harvard University; Beth Israel Deaconess Medical Center; University of Duisburg Essen; University of Duisburg Essen; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Grasemann, C (corresponding author), UK Essen, Kinderklin 2, Div Paediat Endocrinol, Essen, Germany.	corinna.grasemann@uk-essen.de	Grynpas, Marc/E-4576-2013; Grynpas, Marc/ABG-7096-2020; Devlin, Maureen/E-9387-2013; Grasemann, Corinna/AAG-3861-2021	Devlin, Maureen/0000-0003-0845-3090; Grasemann, Corinna/0000-0003-1793-4603	Hospital for Sick Children Research Institute and Department of Pediatrics; Mary and Harry Hunter Diabetes Research Fund Restracomp Program Sick Kids Research Institute; NIH [F32HD060419, RC1AR058389, S10RR017868, T32DK007028]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD060419] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC1AR058389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007028] Funding Source: NIH RePORTER	Hospital for Sick Children Research Institute and Department of Pediatrics; Mary and Harry Hunter Diabetes Research Fund Restracomp Program Sick Kids Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: Hospital for Sick Children Research Institute and Department of Pediatrics (MP); Mary and Harry Hunter Diabetes Research Fund (MP) Restracomp Program Sick Kids Research Institute (CG); IFORES Programm UK-Essen (CG) NIH Grant F32HD060419 (MD), T32DK007028 (MD), and RC1AR058389 (MB), and S10RR017868 (MB) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond H, 2005, PEDIATR RES, V57, P890, DOI 10.1203/01.PDR.0000157720.50808.97; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; Bush NC, 2011, J CLIN ENDOCR METAB, V96, pE803, DOI 10.1210/jc.2010-2902; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; GAUGUIER D, 1990, DIABETES, V39, P734, DOI 10.2337/diabetes.39.6.734; GAUGUIER D, 1991, DIABETES, V40, P109, DOI 10.2337/diab.40.2.S109; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Harder T, 1999, Endocr Regul, V33, P25; Karsenty G, 2010, J CLIN ENDOCR METAB, V95, P4795, DOI 10.1210/jc.2010-1030; Kayo T, 1998, J CLIN INVEST, V101, P2112, DOI 10.1172/JCI1842; Koukkou E, 1998, CIRCULATION, V98, P2899, DOI 10.1161/01.CIR.98.25.2899; Lanham SA, 2010, OSTEOPOROSIS INT, V21, P1703, DOI 10.1007/s00198-009-1118-4; Lau SM, 2011, DIABETOLOGIA, V54, P910, DOI 10.1007/s00125-010-1998-z; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Nusken KD, 2011, ENDOCRINOLOGY, V152, P1327, DOI 10.1210/en.2010-1116; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Riant E, 2009, ENDOCRINOLOGY, V150, P2109, DOI 10.1210/en.2008-0971; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; SELKER F, 1989, J BIOMECH, V22, P1175, DOI 10.1016/0021-9290(89)90219-4; Simmons Rebecca A, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P13, DOI 10.1097/MED.0b013e328013da5b; Strakovsky RS, 2011, J PHYSIOL-LONDON, V589, P2707, DOI 10.1113/jphysiol.2010.203950; Van Assche FA, 2001, BRIT MED BULL, V60, P173, DOI 10.1093/bmb/60.1.173; Van Huyen JPD, 2010, DIABETES, V59, P2597, DOI 10.2337/db10-0311; Yamashita H, 2003, PEDIATR RES, V53, P411, DOI 10.1203/01.PDR.0000049667.58071.7D; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462	29	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50210	10.1371/journal.pone.0050210	http://dx.doi.org/10.1371/journal.pone.0050210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209676	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700042
J	Kannan, NN; Varma, V; De, J; Sharma, VK				Kannan, Nisha N.; Varma, Vishwanath; De, Joydeep; Sharma, Vijay Kumar			Stability of Adult Emergence and Activity/Rest Rhythms in Fruit Flies Drosophila melanogaster under Semi-Natural Condition	PLOS ONE			English	Article							CIRCADIAN CLOCK; ENTRAINMENT; LIGHT; PRECISION; SELECTION; ACCURACY; PHASE; TIME	Here we report the results of a study aimed at examining stability of adult emergence and activity/rest rhythms under seminatural conditions (henceforth SN), in four large outbred fruit fly Drosophila melanogaster populations, selected for emergence in a narrow window of time under laboratory (henceforth LAB) light/dark (LD) cycles. When assessed under LAB, selected flies display enhanced stability in terms of higher amplitude, synchrony and accuracy in emergence and activity rhythms compared to controls. The present study was conducted to assess whether such differences in stability between selected and control populations, persist under SN where several gradually changing time-cues are present in their strongest form. The study revealed that under SN, emergence waveform of selected flies was modified, with even more enhanced peak and narrower gate-width compared to those observed in the LAB and compared to control populations in SN. Furthermore, flies from selected populations continued to exhibit enhanced synchrony and accuracy in their emergence and activity rhythms under SN compared to controls. Further analysis of zeitgeber effects revealed that enhanced stability in the rhythmicity of selected flies under SN was primarily due to increased sensitivity to light because emergence and activity rhythms of selected flies were as stable as controls under temperature cycles. These results thus suggest that stability of circadian rhythms in fruit flies D. melanogaster, which evolved as a consequence of selection for emergence in a narrow window of time under weak zeitgeber condition of LAB, persists robustly in the face of day-to-day variations in cycling environmental factors of nature.	[Kannan, Nisha N.; Varma, Vishwanath; De, Joydeep; Sharma, Vijay Kumar] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Chronobiol Lab, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Sharma, VK (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Chronobiol Lab, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India.	vsharma@jncasr.ac.in	sharma, Vijay K/A-6733-2009; sharma, Vijay/T-5286-2019	sharma, Vijay K/0000-0002-8976-5696; sharma, Vijay/0000-0002-8976-5696; Varma, Vishwanath/0000-0002-1599-8286; N Kannan, Nisha/0000-0002-2285-4088				ASCHOFF J, 1972, NATURWISSENSCHAFTEN, V59, P276, DOI 10.1007/BF00610214; Aschoff J, 1971, BIOCHRONOMETRY, P212; Beersma DGM, 1999, J BIOL RHYTHM, V14, P320, DOI 10.1177/074873099129000740; Boulos Z, 2005, J BIOL RHYTHM, V20, P132, DOI 10.1177/0748730404272907; Currie J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-49; Daan S., 2002, P24; Daan S, 2002, J BIOL RHYTHM, V17, P107, DOI 10.1177/074873002129002375; De J, 2012, J BIOL RHYTHM, V27, P280, DOI 10.1177/0748730412448360; GABRIEL KR, 1978, J AM STAT ASSOC, V73, P724, DOI 10.2307/2286265; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; IVES PT, 1970, EVOLUTION, V24, P507, DOI 10.1111/j.1558-5646.1970.tb01785.x; Joshi A, 1996, EVOL ECOL, V10, P463, DOI 10.1007/BF01237879; Kannan NN, 2012, J EXP BIOL, V215, P3527, DOI 10.1242/jeb.074534; Kannan NN, 2012, CHRONOBIOL IN PRESS; LAAKSO ML, 1992, PHYSIOL BEHAV, V52, P621, DOI 10.1016/0031-9384(92)90388-I; MCFARLAND WN, 1975, LIGHT ECOLOGICAL FAC, P00249; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Moore-Ede MC, 1982, CLOCKS TIME US PHYSL, P60; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Rensing L, 2002, CHRONOBIOL INT, V19, P807, DOI 10.1081/CBI-120014569; Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; ROSE MR, 1981, GENETICS, V97, P172; SERVICE PM, 1988, EVOLUTION, V42, P708, DOI 10.1111/j.1558-5646.1988.tb02489.x; Sharma VK, 2003, CHRONOBIOL INT, V20, P901, DOI 10.1081/CBI-120026099; Sharma VK, 1999, NATURWISSENSCHAFTEN, V86, P333; Sheeba V, 1998, J BIOSCIENCE, V23, P93, DOI 10.1007/BF02703000; Sokal RR, 1995, BIOMETRY PRINCIPLES, P240; StatSoft, 1995, STAT, VI; Tang IH, 1999, AM J PHYSIOL-REG I, V276, pR1195; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Vaze KM, 2012, NATURWISSEN IN PRESS; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551	33	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50379	10.1371/journal.pone.0050379	http://dx.doi.org/10.1371/journal.pone.0050379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209729	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000312601700066
J	Lei, KY; Chen, L; Georgiou, EX; Sooranna, SR; Khanjani, S; Brosens, JJ; Bennett, PR; Johnson, MR				Lei, Kaiyu; Chen, Li; Georgiou, Ektoras X.; Sooranna, Suren R.; Khanjani, Shirin; Brosens, Jan J.; Bennett, Phillip R.; Johnson, Mark R.			Progesterone Acts via the Nuclear Glucocorticoid Receptor to Suppress IL-1 beta-Induced COX-2 Expression in Human Term Myometrial Cells	PLOS ONE			English	Article							PRETERM BIRTH; KAPPA-B; DOUBLE-BLIND; PREGNANCY; LABOR; PREVENTION; WOMEN; RISK; ACTIVATION; OXYTOCIN	Progesterone is widely used to prolong gestation in women at risk of preterm labour (PTL), and acts at least in part via the inhibition of inflammatory cytokine-induced prostaglandin synthesis. This study investigates the mechanisms responsible for this inhibition in human myometrial cells. We used reporter constructs to demonstrate that interleukin 1beta (IL-1 beta) inhibits progesterone driven PRE activation via p65 activation and that IL-1 beta reduced progesterone driven gene expression (FKBP5). Conversely, we found that the activity of a p65-driven NF kappa B reporter construct was reduced by overexpression of progesterone receptor B (PRB) alone and that this was enhanced by the addition of MPA and that both MPA and progesterone suppressed IL-1 beta-driven cyclo-oxygenase-2 (COX-2) expression. We found that over-expressed Halo-tagged PRB, but not PRA, bound to p65 and that in IL-1 beta-treated cells, with no overexpression of either PR or p65, activated p65 bound to PR. However, we found that the ability of MPA to repress IL-1 beta-driven COX-2 expression was not enhanced by overexpression of either PRB or PRA and that although the combined PR and GR antagonist Ru486 blocked the effects of progesterone and MPA, the specific PR antagonist, Org31710, did not, suggesting that progesterone and MPA act via GR and not PR. Knockdown using siRNA confirmed that both MPA and progesterone acted via GR and not PR or AR to repress IL-1 beta-driven COX-2 expression. We conclude that progesterone acts via GR to repress IL-1 beta-driven COX-2 activation and that although the interaction between p65 and PRB may be involved in the repression of progesterone driven gene expression it does not seem to be responsible for progesterone repression of IL-1 beta-induced COX-2 expression.	[Lei, Kaiyu; Chen, Li; Georgiou, Ektoras X.; Sooranna, Suren R.; Johnson, Mark R.] Chelsea & Westminster Hosp, London, England; [Lei, Kaiyu; Sooranna, Suren R.; Khanjani, Shirin; Brosens, Jan J.; Bennett, Phillip R.; Johnson, Mark R.] Inst Reprod & Dev Biol, London, England; [Chen, Li; Brosens, Jan J.] Third Mil Med Univ, Dept Obstet & Gynecol, Southwest Hosp, Chongqing, Peoples R China	Imperial College London; Imperial College London; Army Medical University	Johnson, MR (corresponding author), Chelsea & Westminster Hosp, London, England.	mark.johnson@imperial.ac.uk	Georgiou, Ektoras/S-2419-2019	Bennett, Phillip/0000-0002-6253-4919; Lei, Kaiyu/0000-0003-1455-3880; Georgiou, Ektoras/0000-0003-3884-3129; Brosens, Jan/0000-0003-0116-9329	Action Medical Research [SP3879]; National Institute for Health Research [ACF-2012-21-018] Funding Source: researchfish	Action Medical Research; National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: Action Medical Research SP3879. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Condon JC, 2003, P NATL ACAD SCI USA, V100, P9518, DOI 10.1073/pnas.1633616100; CSAPO AI, 1973, PROSTAG OTH LIPID M, V4, P421, DOI 10.1016/0090-6980(73)90030-0; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; FRYDMAN R, 1991, LANCET, V337, P488, DOI 10.1016/0140-6736(91)93421-5; Guinn DA, 2001, JAMA-J AM MED ASSOC, V286, P1581, DOI 10.1001/jama.286.13.1581; Hardy DB, 2006, MOL ENDOCRINOL, V20, P2724, DOI 10.1210/me.2006-0112; Jones LA, 2008, IMMUNOLOGY, V125, P59, DOI 10.1111/j.1365-2567.2008.02820.x; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; KLOOSTERBOER HJ, 1994, HUM REPROD, V9, P47, DOI 10.1093/humrep/9.suppl_1.47; Lei K, 2011, J CLIN ENDOCR METAB, V96, pE1013, DOI 10.1210/jc.2010-2310; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mendelson CR, 2009, MOL ENDOCRINOL, V23, P947, DOI 10.1210/me.2009-0016; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Ou CW, 1997, ENDOCRINOLOGY, V138, P5398, DOI 10.1210/en.138.12.5398; Ou CW, 1998, BIOL REPROD, V59, P1055, DOI 10.1095/biolreprod59.5.1055; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Ruddock NK, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.085; Sooranna SR, 2004, MOL HUM REPROD, V10, P109, DOI 10.1093/molehr/gah021; Sugino N, 1997, ENDOCRINOLOGY, V138, P4497, DOI 10.1210/en.138.10.4497; TUCKER L, 1995, AUST NZ J OBSTET GYN, V35, P390, DOI 10.1111/j.1479-828X.1995.tb02149.x; Wu W, 2011, MOL HUM REPROD, V17, P233, DOI 10.1093/molehr/gaq096; Yeshaya A, 1996, EUR J OBSTET GYN R B, V67, P139, DOI 10.1016/0301-2115(96)02453-0	25	57	57	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50167	10.1371/journal.pone.0050167	http://dx.doi.org/10.1371/journal.pone.0050167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209664	gold, Green Published, Green Submitted			2022-12-25	WOS:000312601700037
J	Sacheli, LM; Candidi, M; Pavone, EF; Tidoni, E; Aglioti, SM				Sacheli, Lucia Maria; Candidi, Matteo; Pavone, Enea Francesco; Tidoni, Emmanuele; Aglioti, Salvatore Maria			And Yet They Act Together: Interpersonal Perception Modulates Visuo-Motor Interference and Mutual Adjustments during a Joint-Grasping Task	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; SOCIAL-INTERACTION; COGNITIVE NEUROSCIENCE; COORDINATION; IMITATION; INTENTION; MOVEMENT; DYNAMICS; HUMANS; COMPATIBILITY	Prediction of "when'' a partner will act and "what'' he is going to do is crucial in joint-action contexts. However, studies on face-to-face interactions in which two people have to mutually adjust their movements in time and space are lacking. Moreover, while studies on passive observation have shown that somato-motor simulative processes are disrupted when the observed actor is perceived as an out-group or unfair individual, the impact of interpersonal perception on joint-actions has never been directly addressed. Here we explored this issue by comparing the ability of pairs of participants who did or did not undergo an interpersonal perception manipulation procedure to synchronise their reach-to-grasp movements during: i) a guided interaction, requiring pure temporal reciprocal coordination, and ii) a free interaction, requiring both time and space adjustments. Behavioural results demonstrate that while in neutral situations free and guided interactions are equally challenging for participants, a negative interpersonal relationship improves performance in guided interactions at the expense of the free interactive ones. This was paralleled at the kinematic level by the absence of movement corrections and by low movement variability in these participants, indicating that partners cooperating within a negative interpersonal bond executed the cooperative task on their own, without reciprocally adapting to the partner's motor behaviour. Crucially, participants' performance in the free interaction improved in the manipulated group during the second experimental session while partners became interdependent as suggested by higher movement variability and by the appearance of interference between the self-executed actions and those observed in the partner. Our study expands current knowledge about on-line motor interactions by showing that visuo-motor interference effects, mutual motor adjustments and motor-learning mechanisms are influenced by social perception.	[Sacheli, Lucia Maria; Candidi, Matteo; Pavone, Enea Francesco; Tidoni, Emmanuele; Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Sacheli, Lucia Maria; Candidi, Matteo; Pavone, Enea Francesco; Tidoni, Emmanuele; Aglioti, Salvatore Maria] Fdn Santa Lucia, IRCCS, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Sacheli, LM (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	lucia.sacheli@uniroma1.it; matteo.candidi@uniroma1.it	Aglioti, Salvatore M/E-9829-2012; Candidi, Matteo/K-9245-2016; Tidoni, Emmanuele/I-3189-2014; Sacheli, Lucia Maria/C-8922-2014	Tidoni, Emmanuele/0000-0001-9079-2862; Sacheli, Lucia Maria/0000-0003-2608-708X; Aglioti, Salvatore Maria/0000-0001-8175-7563; CANDIDI, MATTEO/0000-0001-8201-7954; Pavone, Enea Francesco/0000-0002-8263-3594	European Commission [249858]; Istituto Italiano di Tecnologia (IIT) SEED [21538]; Ministero Istruzione Universita e Ricerca; Progetto di Ricerca 2011 University of Rome "Sapienza'' [C26A115CM5]	European Commission(European CommissionEuropean Commission Joint Research Centre); Istituto Italiano di Tecnologia (IIT) SEED; Ministero Istruzione Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Progetto di Ricerca 2011 University of Rome "Sapienza''	SMA was funded by the Future and Emerging Technologies (FET) programme within FP7 of the European Commission, under FET-Open grant number: 249858, "Tango''; Istituto Italiano di Tecnologia (IIT) SEED (Prot. Num. 21538); the Ministero Istruzione Universita e Ricerca (PRIN 2009). MC was funded by Progetto di Ricerca 2011 University of Rome "Sapienza'' (prot. C26A115CM5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Ansuini C, 2006, J NEUROPHYSIOL, V95, P2456, DOI 10.1152/jn.01107.2005; Atmaca S, 2011, EXP BRAIN RES, V211, P371, DOI 10.1007/s00221-011-2709-9; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; Blakemore SJ, 2005, NEUROPSYCHOLOGIA, V43, P260, DOI 10.1016/j.neuropsychologia.2004.11.012; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Braun D, 2011, EXP BRAIN RES, V211, P631, DOI 10.1007/s00221-011-2642-y; BRIGGS G G, 1975, Cortex, V11, P230; Candidi M, CEREB CORTE IN PRESS; Caprara GV, 2007, POLIT PSYCHOL, V28, P609, DOI 10.1111/j.1467-9221.2007.00592.x; CAPRARA GV, 1994, EUR J PERSONALITY, V8, P357, DOI 10.1002/per.2410080502; CAPRARA GV, 1987, PERS INDIV DIFFER, V8, P885, DOI 10.1016/0191-8869(87)90140-1; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 2002, COMMON MECH PERCEPTI; Catmur C, 2007, CURR BIOL, V17, P1527, DOI 10.1016/j.cub.2007.08.006; Catmur C, 2009, PHILOS T R SOC B, V364, P2369, DOI 10.1098/rstb.2009.0048; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Clark H.H., 1996, USING LANGUAGE; Cloninger RC., 1994, TEMPERAMENT CHARACTE; Cosmides L, 2003, TRENDS COGN SCI, V7, P173, DOI 10.1016/S1364-6613(03)00057-3; DEDIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417; Degner J, 2010, J PERS SOC PSYCHOL, V98, P356, DOI 10.1037/a0017993; Desy MC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000971; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Egetemeir J, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00095; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Frith C., 2007, MAKING MIND BRAIN CR; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Gibson JJ, 1979, ECOLOGICAL APPROACH; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Hampton AN, 2008, P NATL ACAD SCI USA, V105, P6741, DOI 10.1073/pnas.0711099105; Hari R, 2009, PHYSIOL REV, V89, P453, DOI 10.1152/physrev.00041.2007; Heyes C, 2005, COGNITIVE BRAIN RES, V22, P233, DOI 10.1016/j.cogbrainres.2004.09.009; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hommel B, 2009, PSYCHOL SCI, V20, P794, DOI 10.1111/j.1467-9280.2009.02367.x; Iani C, 2011, EXP BRAIN RES, V211, P439, DOI 10.1007/s00221-011-2651-x; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jeannerod M., 1981, ATTENTION PERFORM, P153; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Kilner JM, 2007, NEUROREPORT, V18, P619, DOI 10.1097/WNR.0b013e3281139ed0; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Kokal I, 2009, NEUROIMAGE, V47, P2046, DOI 10.1016/j.neuroimage.2009.06.010; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025117; Losin EAR, 2012, NEUROIMAGE, V59, P3594, DOI 10.1016/j.neuroimage.2011.10.074; Marsh KL, 2009, TOP COGN SCI, V1, P320, DOI 10.1111/j.1756-8765.2009.01022.x; Molnar-Szakacs I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000626; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Ocampo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026945; Ocampo B, 2010, EXP BRAIN RES, V201, P743, DOI 10.1007/s00221-009-2089-6; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Pavan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025608; Perugini M, 2003, EUR J PERSONALITY, V17, P251, DOI 10.1002/per.474; Pezzulo G, 2011, EXP BRAIN RES, V211, P613, DOI 10.1007/s00221-011-2712-1; Poljac E, 2009, PSYCHOL RES-PSYCH FO, V73, P578, DOI 10.1007/s00426-009-0238-y; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; Sartori L, 2011, EXP BRAIN RES, V211, P557, DOI 10.1007/s00221-011-2650-y; Sartori L, 2009, CONSCIOUS COGN, V18, P766, DOI 10.1016/j.concog.2009.06.004; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Schmidt RC, 2011, HUM MOVEMENT SCI, V30, P834, DOI 10.1016/j.humov.2010.05.014; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2005, J EXP PSYCHOL HUMAN, V31, P1234, DOI 10.1037/0096-1523.31.6.1234; Sebanz N, 2003, COGNITION, V88, pB11, DOI 10.1016/S0010-0277(03)00043-X; Sebanz N, 2007, SOC NEUROSCI-UK, V2, P81, DOI 10.1080/17470910701237989; Sebanz N, 2009, TOP COGN SCI, V1, P353, DOI 10.1111/j.1756-8765.2009.01024.x; Serino A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004930; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tsai CC, 2008, J COGNITIVE NEUROSCI, V20, P2015, DOI 10.1162/jocn.2008.20144; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Urgesi C, 2006, EUR J NEUROSCI, V23, P2522, DOI 10.1111/j.1460-9568.2006.04772.x; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; van Schie HT, 2008, J EXP PSYCHOL HUMAN, V34, P1493, DOI 10.1037/a0011750; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Vesper C, 2010, NEURAL NETWORKS, V23, P998, DOI 10.1016/j.neunet.2010.06.002; Wenke D, 2011, REV PHILOS PSYCHOL, V2, P147, DOI 10.1007/s13164-011-0057-0; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	96	44	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50223	10.1371/journal.pone.0050223	http://dx.doi.org/10.1371/journal.pone.0050223			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057YW	23209680	Green Published, gold, Green Submitted			2022-12-25	WOS:000312601700044
J	Sibiude, J; Guibourdenche, J; Dionne, MD; Le Ray, C; Anselem, O; Serreau, R; Goffinet, F; Tsatsaris, V				Sibiude, Jeanne; Guibourdenche, Jean; Dionne, Marie-Danielle; Le Ray, Camille; Anselem, Olivia; Serreau, Raphael; Goffinet, Francois; Tsatsaris, Vassilis			Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction	PLOS ONE			English	Article							CIRCULATING ANGIOGENIC FACTORS; MATERNAL PLASMA-CONCENTRATIONS; TYROSINE KINASE 1; EXPECTANT MANAGEMENT; GESTATIONAL HYPERTENSION; BIOCHEMICAL MARKERS; SOLUBLE ENDOGLIN; EARLY-ONSET; RISK; COMPLICATIONS	Background: The circulating concentration of PlGF is reported to be lower in patients experiencing preeclampsia and patients delivering a small for gestational age (SGA) neonate. To evaluate the predictive value of circulating PlGF for preeclampsia and adverse outcome in patients with suspected preeclampsia or intrauterine growth restriction (IUGR). Methodology/Principal Findings: A double blind prospective study. We enrolled 96 women for suspected preeclampsia or IUGR, and measured plasma levels of PlGF (Triage (R)) at enrolment. We defined adverse outcome as severe preeclampsia, SGA neonate (< 10th centile) or elective delivery for maternal or fetal complication. Severe adverse outcome was studied among patients included < 34 weeks gestation (WG) and defined as eclampsia, HELLP syndrome, very SGA (< 3rd centile) or elective delivery < 34 WG. The mean logtransformed PlGF level was lower for women who experienced preeclampsia (2.9 vs 3.7, p = 0.02), and was markedly lower for patients who experienced adverse outcome (2.9 vs 4.3, p < 0.001). The odds of presenting an adverse outcome were higher for the lowest tertile of PlGF compared to the higher (OR = 13, 95% CI [3-50]). For severe adverse outcome, odds were respectively for the lowest and intermediate tertile as compared with the higher tertile : OR = 216, 95% CI [18-2571]; and OR = 17, 95% CI [3-94]. When included < 34 WG, patients with a PlGF level < 12 pg/ml experienced a severe adverse outcome in 96% of cases (24/25), and only 1 of 20 patients with a PlGF level > 5th centile experienced a severe adverse outcome within 15 days (5%). Conclusions/Significance: Among women with suspected preeclampsia or IUGR, PlGF helps identify women who will experience an adverse outcome and those who will not within a time period of 15 days.	[Sibiude, Jeanne; Guibourdenche, Jean; Dionne, Marie-Danielle; Le Ray, Camille; Anselem, Olivia; Serreau, Raphael; Goffinet, Francois; Tsatsaris, Vassilis] Paris Descartes Univ, Cochin Hosp, APHP, Paris, France; [Guibourdenche, Jean; Le Ray, Camille; Anselem, Olivia; Goffinet, Francois; Tsatsaris, Vassilis] PremUP Fdn, Paris, France; [Guibourdenche, Jean; Le Ray, Camille; Anselem, Olivia; Goffinet, Francois; Tsatsaris, Vassilis] DHU Risks & Pregnancy, Paris, France; [Dionne, Marie-Danielle] Univ Montreal, Montreal, PQ, Canada; [Le Ray, Camille; Goffinet, Francois] INSERM Unit U953, Epidemiol Res Unit Perinatal Hlth & Womens & Chil, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm)	Sibiude, J (corresponding author), Paris Descartes Univ, Cochin Hosp, APHP, Paris, France.	jeannesibiude@yahoo.fr	Serreau, Raphael/ABC-7602-2021; Sibiude, Jeanne/GRS-5411-2022	Serreau, Raphael/0000-0003-4430-2046; GOFFINET, Francois/0000-0001-9643-0299; Le Ray, Camille/0000-0003-0891-1063				[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Belghiti J, 2011, AM J OBSTET GYNECOL, V205; Chaiworapongsa T, 2011, J MATERN-FETAL NEO M, V24, P1187, DOI 10.3109/14767058.2011.589932; Chien PFW, 2000, BRIT J OBSTET GYNAEC, V107, P196, DOI 10.1111/j.1471-0528.2000.tb11690.x; CHITTY LS, 1994, BRIT J OBSTET GYNAEC, V101, P35, DOI 10.1111/j.1471-0528.1994.tb13007.x; Dekker G, 2001, LANCET, V357, P209, DOI 10.1016/S0140-6736(00)03599-6; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Ganzevoort W, 2006, AM J OBSTET GYNECOL, V195, P495, DOI 10.1016/j.ajog.2006.02.012; Haddad B, 2009, SEMIN PERINATOL, V33, P143, DOI 10.1053/j.semperi.2009.02.002; Hall DR, 2000, BRIT J OBSTET GYNAEC, V107, P1258, DOI 10.1111/j.1471-0528.2000.tb11617.x; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knudsen UB, 2012, PREGNANCY HYPERTENS, V2, P8, DOI 10.1016/j.preghy.2011.08.117; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; Masuyama H, 2006, AM J OBSTET GYNECOL, V194, P551, DOI 10.1016/j.ajog.2005.08.034; Maulik D, 2010, CLIN OBSTET GYNECOL, V53, P869, DOI 10.1097/GRF.0b013e3181fbb5f5; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; ODENDAAL HJ, 1990, OBSTET GYNECOL, V76, P1070; Ohkuchi A, 2009, HYPERTENS PREGNANCY, V28, P95, DOI 10.1080/10641950802419895; Palm M, 2011, ACTA OBSTET GYN SCAN, V90, P1244, DOI 10.1111/j.1600-0412.2011.01186.x; Poon LCY, 2010, ULTRASOUND OBST GYN, V35, P662, DOI 10.1002/uog.7628; Quant H, 2012, HYPERTENS PREGNANCY; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2007, AM J OBSTET GYNECOL, V197, P218, DOI 10.1016/j.ajog.2007.03.078; Shibata E, 2005, J CLIN ENDOCR METAB, V90, P4895, DOI 10.1210/jc.2004-1955; Shokry M, 2010, ACTA OBSTET GYN SCAN, V89, P143, DOI 10.3109/00016340903289892; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 2011, AM J OBSTET GYNECOL, V205, P191, DOI 10.1016/j.ajog.2011.07.017; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Stamilio DM, 2000, AM J OBSTET GYNECOL, V182, P589, DOI 10.1067/mob.2000.103890; StataCorporation, 2009, STAT 11 0 WIND; Thangaratinam S, 2006, BJOG-INT J OBSTET GY, V113, P369, DOI 10.1111/j.1471-0528.2006.00908.x; Thangaratinam S, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-10; Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528; Urato A, 2011, J PERINATOL; von Dadelszen P, 2011, LANCET, V377, P219, DOI 10.1016/S0140-6736(10)61351-7; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Woodham PC, 2011, HYPERTENSION, V58, P1120, DOI 10.1161/HYPERTENSIONAHA.111.179069; Young B, 2010, J MATERN-FETAL NEO M, V23, P366, DOI [10.1080/14767050903184207, 10.3109/14767050903184207]	42	61	63	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2012	7	11							e50208	10.1371/journal.pone.0050208	http://dx.doi.org/10.1371/journal.pone.0050208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057YW	23209675	Green Published, Green Submitted, gold			2022-12-25	WOS:000312601700041
J	Fiorini, A; Sultana, R; Barone, E; Cenini, G; Perluigi, M; Mancuso, C; Cai, J; Klein, JB; St Clair, D; Butterfield, DA				Fiorini, Ada; Sultana, Rukhsana; Barone, Eugenio; Cenini, Giovanna; Perluigi, Marzia; Mancuso, Cesare; Cai, Jian; Klein, Jon B.; St Clair, Daret; Butterfield, D. Allan			Lack of p53 Affects the Expression of Several Brain Mitochondrial Proteins: Insights from Proteomics into Important Pathways Regulated by p53	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE BRAIN; STRESS-INDUCED APOPTOSIS; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; CELLULAR-RESPONSE; REDOX PROTEOMICS; GENE-EXPRESSION; RAT-BRAIN	The tumor suppressor protein p53 has been described "as the guardian of the genome" for its crucial role in regulating the transcription of numerous genes responsible for cells cycle arrest, senescence, or apoptosis in response to various stress signals. Although p53 promotes longevity by decreasing the risk of cancer through activation of apoptosis or cellular senescence, several findings suggest that an increase of its activity may have deleterious effects leading to selected aspects of the aging phenotype and neurodegenerative diseases. There is the link between p53 and oxidative stress, the latter a crucial factor that contributes to neurodegenerative processes like Alzheimer disease (AD). In the present study, using a proteomics approach, we analyzed the impact of lack of p53 on the expression of several brain mitochondrial proteins involved in different pathways, and how lack of p53 may present a target to restore neuronal impairments. Our investigation on isolated brain mitochondria from p53((-/-)) mice also provides a better understanding of the p53-mitochondria relationship and its involvement in the development of many diseases.	[Fiorini, Ada; Sultana, Rukhsana; Cenini, Giovanna; Butterfield, D. Allan] Univ Kentucky, Dept Chem, Ctr Membrane Sci, Sanders Brown Ctr Aging, Lexington, KY 40506 USA; [Fiorini, Ada; Barone, Eugenio; Perluigi, Marzia] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Barone, Eugenio; Mancuso, Cesare] Catholic Univ, Sch Med, Inst Pharmacol, Rome, Italy; [Cai, Jian; Klein, Jon B.] Univ Louisville, Dept Med, Div Nephrol, Louisville, KY 40292 USA; [Cai, Jian; Klein, Jon B.] Univ Louisville, Prote Ctr, Louisville, KY 40292 USA; [St Clair, Daret] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY USA	University of Kentucky; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Louisville; University of Louisville; University of Kentucky	Butterfield, DA (corresponding author), Univ Kentucky, Dept Chem, Ctr Membrane Sci, Sanders Brown Ctr Aging, Lexington, KY 40506 USA.	dabcns@uky.edu	Mancuso, Cesare/GLQ-7160-2022; Barone, Eugenio/AAJ-6020-2020; perluigi, marzia/D-3260-2009; Barone, Eugenio/AAC-1686-2019	Mancuso, Cesare/0000-0001-6532-483X; Barone, Eugenio/0000-0002-7028-4251; Barone, Eugenio/0000-0002-7028-4251; Cenini, Giovanna/0000-0003-1547-7007	National Institutes of Health [AG 05119, CA 139843]; NATIONAL CANCER INSTITUTE [R01CA139843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health grants (www.nih.gov) to DAB [AG 05119] and DSC [CA 139843]. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; Barone E, 2012, ANTIOXID REDOX SIGN, V16, P1407, DOI 10.1089/ars.2011.4124; Boyd-Kimball D, 2005, BRAIN RES, V1044, P206, DOI 10.1016/j.brainres.2005.02.086; Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Buizza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029789; Butterfield DA, 2007, FREE RADICAL BIO MED, V43, P658, DOI 10.1016/j.freeradbiomed.2007.05.037; Butterfield DA, 2010, BBA-MOL CELL BIOL L, V1801, P924, DOI 10.1016/j.bbalip.2010.02.005; Butterfield DA, 2006, NEUROBIOL DIS, V22, P223, DOI 10.1016/j.nbd.2005.11.002; Butterfield DA, 2001, TRENDS MOL MED, V7, P548, DOI 10.1016/S1471-4914(01)02173-6; Castegna A, 2003, J NEUROCHEM, V85, P1394, DOI 10.1046/j.1471-4159.2003.01786.x; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Cenini G, 2008, J CELL MOL MED, V12, P987, DOI 10.1111/j.1582-4934.2008.00163.x; Cenini G, 2008, FREE RADICAL BIO MED, V45, P81, DOI 10.1016/j.freeradbiomed.2008.03.015; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Di Domenico F, 2009, NEUROCHEM RES, V34, P727, DOI 10.1007/s11064-009-9924-9; Drane P, 2001, ONCOGENE, V20, P430, DOI 10.1038/sj.onc.1204101; DWORNICZAK B, 1987, NUCLEIC ACIDS RES, V15, P5181, DOI 10.1093/nar/15.13.5181; Ferecatu I, 2009, BIOCHEM BIOPH RES CO, V387, P772, DOI 10.1016/j.bbrc.2009.07.111; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Holley AK, 2010, ANN NY ACAD SCI, V1201, P72, DOI 10.1111/j.1749-6632.2010.05612.x; Holley AK, 2009, FUTURE ONCOL, V5, P117, DOI 10.2217/14796694.5.1.117; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Kim SH, 2001, J NEURAL TRANSM-SUPP, P223; Kouchi Z, 1999, BIOCHEM BIOPH RES CO, V254, P804, DOI 10.1006/bbrc.1998.9977; Lim YP, 2007, ONCOGENE, V26, P1517, DOI 10.1038/sj.onc.1209952; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Macellaro A, 1998, INFECT IMMUN, V66, P5882, DOI 10.1128/IAI.66.12.5882-5888.1998; Maddocks ODK, 2011, J MOL MED, V89, P237, DOI 10.1007/s00109-011-0735-5; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Minamino T, 1999, P NATL ACAD SCI USA, V96, P15127, DOI 10.1073/pnas.96.26.15127; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Murphy TC, 2003, J NEUROCHEM, V86, P298, DOI 10.1046/j.1471-4159.2003.01839.x; Murphy TC, 2003, J NEUROCHEM, V84, P1313, DOI 10.1046/j.1471-4159.2003.01628.x; Nonn L, 2003, MOL CANCER RES, V1, P682; Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pani G, 2000, CANCER RES, V60, P4654; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Perluigi M, 2005, MOL CELL PROTEOMICS, V4, P1849, DOI 10.1074/mcp.M500090-MCP200; Perluigi M, 2010, J NEUROSCI RES, V88, P3498, DOI 10.1002/jnr.22500; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Puzio-Kuter Anna M, 2011, Genes Cancer, V2, P385, DOI 10.1177/1947601911409738; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reddy PH, 2009, CNS SPECTRUMS, V14, P8, DOI 10.1017/S1092852900024901; Rhee SG, 1999, BIOFACTORS, V10, P207, DOI 10.1002/biof.5520100218; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SCHAGGER H, 1995, EUR J BIOCHEM, V227, P916, DOI 10.1111/j.1432-1033.1995.tb20219.x; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Sompol P, 2008, NEUROSCIENCE, V153, P120, DOI 10.1016/j.neuroscience.2008.01.044; Sultana R, 2012, FREE RADIC IN PRESS; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Yoon KA, 2004, J HUM GENET, V49, P134, DOI 10.1007/s10038-003-0122-3	68	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e49846	10.1371/journal.pone.0049846	http://dx.doi.org/10.1371/journal.pone.0049846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209608	Green Published, gold			2022-12-25	WOS:000311885800026
J	MacTavish, T; Stenton-Dozey, J; Vopel, K; Savage, C				MacTavish, Thomas; Stenton-Dozey, Jeanie; Vopel, Kay; Savage, Candida			Deposit-Feeding Sea Cucumbers Enhance Mineralization and Nutrient Cycling in Organically-Enriched Coastal Sediments	PLOS ONE			English	Article							BENTHIC COMMUNITIES; CORAL-REEF; OXYGEN; BIOTURBATION; BACTERIA; ENUMERATION; DISTURBANCE; AQUACULTURE; DETERMINES; OMNIVORY	Background: Bioturbators affect multiple biogeochemical interactions and have been suggested as suitable candidates to mitigate organic matter loading in marine sediments. However, predicting the effects of bioturbators at an ecosystem level can be difficult due to their complex positive and negative interactions with the microbial community. Methodology/Principal Findings: We quantified the effects of deposit-feeding sea cucumbers on benthic algal biomass (microphytobenthos, MPB), bacterial abundance, and the sediment-seawater exchange of dissolved oxygen and nutrients. The sea cucumbers increased the efflux of inorganic nitrogen (ammonium, NH4+) from organically enriched sediments, which stimulated algal productivity. Grazing by the sea cucumbers on MPB (evidenced by pheopigments), however, caused a net negative effect on primary producer biomass and total oxygen production. Further, there was an increased abundance of bacteria in sediment with sea cucumbers, suggesting facilitation. The sea cucumbers increased the ratio of oxygen consumption to production in surface sediment by shifting the microbial balance from producers to decomposers. This shift explains the increased efflux of inorganic nitrogen and concordant reduction in organic matter content in sediment with bioturbators. Conclusions/Significance: Our study demonstrates the functional role and potential of sea cucumbers to ameliorate some of the adverse effects of organic matter enrichment in coastal ecosystems.	[MacTavish, Thomas; Savage, Candida] Univ Otago, Dept Marine Sci, Dunedin, New Zealand; [Stenton-Dozey, Jeanie] Natl Inst Water & Atmospher Res NIWA, Christchurch, New Zealand; [Vopel, Kay] Auckland Univ Technol, Sch Appl Sci, Auckland, New Zealand	University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Auckland University of Technology	Savage, C (corresponding author), Univ Otago, Dept Marine Sci, Dunedin, New Zealand.	candida.savage@otago.ac.nz	Vopel, Kay/AAZ-5474-2020		New Zealand Ministry of Science and Innovation (MSI)	New Zealand Ministry of Science and Innovation (MSI)	The authors thank the New Zealand Ministry of Science and Innovation (MSI) for funding the project and the University of Otago for a publishing bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2008, SOIL BIOL BIOCHEM, V40, P2511, DOI 10.1016/j.soilbio.2008.06.010; ALLER JY, 1986, DEEP-SEA RES, V33, P755, DOI 10.1016/0198-0149(86)90088-9; AMON RMW, 1991, PSZNI MAR ECOL, V12, P163; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burdige DJ, 2006, GEOCHEMISTRY MARINE, DOI DOI 10.2307/J.CTV131BW7S; Christensen PB, 2003, AQUACULTURE, V218, P567, DOI 10.1016/S0044-8486(02)00587-2; Dalsgaard T, 2003, LIMNOL OCEANOGR, V48, P2138, DOI 10.4319/lo.2003.48.6.2138; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Diehl S, 2003, ECOLOGY, V84, P2557, DOI 10.1890/02-0399; EPSTEIN SS, 1995, MAR ECOL PROG SER, V117, P289, DOI 10.3354/meps117289; Giles H, 2007, CONT SHELF RES, V27, P2373, DOI 10.1016/j.csr.2007.06.007; Giles H, 2006, MAR BIOL, V150, P261, DOI 10.1007/s00227-006-0348-7; Godbold JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007423; Goldburg R, 2005, FRONT ECOL ENVIRON, V3, P21, DOI 10.2307/3868441; Hartstein ND, 2005, AQUACULT ENG, V33, P192, DOI 10.1016/j.aquaeng.2005.01.002; HilleRisLambers R, 2006, OIKOS, V113, P23, DOI 10.1111/j.0030-1299.2006.14217.x; Karlson AML, 2010, ECOLOGY, V91, P1414, DOI 10.1890/09-0660.1; KASPAR HF, 1985, MAR BIOL, V85, P127, DOI 10.1007/BF00397431; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P1725; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Lohrer AM, 2008, ECOLOGY, V89, P1299, DOI 10.1890/07-0421.1; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; Marcus NH, 1998, LIMNOL OCEANOGR, V43, P763, DOI 10.4319/lo.1998.43.5.0763; Marinelli RL, 2002, MAR ECOL PROG SER, V235, P1, DOI 10.3354/meps235001; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Meysman FJR, 2005, GEOCHIM COSMOCHIM AC, V69, P3601, DOI 10.1016/j.gca.2005.01.004; Michener WK, 2001, BIOSCIENCE, V51, P1018, DOI 10.1641/0006-3568(2001)051[1018:DAUB]2.0.CO;2; Middelburg JJ, 2009, BIOGEOSCIENCES, V6, P1273, DOI 10.5194/bg-6-1273-2009; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P18040, DOI 10.1073/pnas.0910577106; Neori A, 2007, ENVIRONMENT, V49, P37; Nizzoli D, 2005, HYDROBIOLOGIA, V550, P183, DOI 10.1007/s10750-005-4378-9; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; PLANTE CJ, 1990, ANNU REV ECOL SYST, V21, P93, DOI 10.1146/annurev.es.21.110190.000521; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; Pugnaire FI, 2001, OIKOS, V93, P42, DOI 10.1034/j.1600-0706.2001.930104.x; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; Roberts D, 2000, OCEANOGR MAR BIOL, V38, P257; Slater MJ, 2007, AQUACULTURE, V272, P389, DOI 10.1016/j.aquaculture.2007.07.230; Slater MJ, 2009, MAR POLLUT BULL, V58, P1123, DOI 10.1016/j.marpolbul.2009.04.008; Soetaert K, 2000, EARTH-SCI REV, V51, P173, DOI 10.1016/S0012-8252(00)00004-0; Sun MY, 1999, J MAR RES, V57, P775, DOI 10.1357/002224099321560573; SUNDBY B, 1992, LIMNOL OCEANOGR, V37, P1129, DOI 10.4319/lo.1992.37.6.1129; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Thrush SF, 2006, ECOSYSTEMS, V9, P1029, DOI 10.1007/s10021-005-0068-8; Troell M, 1999, J APPL PHYCOL, V11, P89, DOI 10.1023/A:1008070400208; Uthicke S, 1999, B MAR SCI, V64, P129; Uthicke S, 2001, J EXP MAR BIOL ECOL, V265, P153, DOI 10.1016/S0022-0981(01)00329-X; Uthicke S, 1998, MAR ECOL PROG SER, V169, P1, DOI 10.3354/meps169001; van Nugteren P, 2009, LIMNOL OCEANOGR, V54, P1413, DOI 10.4319/lo.2009.54.5.1413	52	76	81	12	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2012	7	11							e50031	10.1371/journal.pone.0050031	http://dx.doi.org/10.1371/journal.pone.0050031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BS	23209636	Green Published, Green Submitted, gold			2022-12-25	WOS:000311885800040
J	Hao, XL; Chen, T				Hao, Xiaolin; Chen, Ting			OTU Analysis Using Metagenomic Shotgun Sequencing Data	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; RARE BIOSPHERE; DIVERSITY; MICROBIOME; WRINKLES; GENES	Because of technological limitations, the primer and amplification biases in targeted sequencing of 16S rRNA genes have veiled the true microbial diversity underlying environmental samples. However, the protocol of metagenomic shotgun sequencing provides 16S rRNA gene fragment data with natural immunity against the biases raised during priming and thus the potential of uncovering the true structure of microbial community by giving more accurate predictions of operational taxonomic units (OTUs). Nonetheless, the lack of statistically rigorous comparison between 16S rRNA gene fragments and other data types makes it difficult to interpret previously reported results using 16S rRNA gene fragments. Therefore, in the present work, we established a standard analysis pipeline that would help confirm if the differences in the data are true or are just due to potential technical bias. This pipeline is built by using simulated data to find optimal mapping and OTU prediction methods. The comparison between simulated datasets revealed a relationship between 16S rRNA gene fragments and full-length 16S rRNA sequences that a 16S rRNA gene fragment having a length >150 bp provides the same accuracy as a full-length 16S rRNA sequence using our proposed pipeline, which could serve as a good starting point for experimental design and making the comparison between 16S rRNA gene fragment-based and targeted 16S rRNA sequencing-based surveys possible.	[Hao, Xiaolin; Chen, Ting] Univ So Calif, Los Angeles, CA 90089 USA	University of Southern California	Chen, T (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	tingchen@usc.edu			National Science Foundation Directorate for Mathematical and Physical Sciences (NSF/DMS) [ATD 7031026]; Center of Excellence of Genome Sciences [NIH/HG 2 P50 HG002790-06]; Directorate For Geosciences [1136818] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER	National Science Foundation Directorate for Mathematical and Physical Sciences (NSF/DMS); Center of Excellence of Genome Sciences; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This project is supported by National Science Foundation Directorate for Mathematical and Physical Sciences (NSF/DMS) ATD 7031026, and Center of Excellence of Genome Sciences (NIH/HG 2 P50 HG002790-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.2307/1165312; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Karp R.M., 1972, PROC S COMPLEXITY CO, P85, DOI 10.1007/978-1-4684-2001-2_9.; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lan RT, 2000, TRENDS MICROBIOL, V8, P396, DOI 10.1016/S0966-842X(00)01791-1; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	25	17	17	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49785	10.1371/journal.pone.0049785	http://dx.doi.org/10.1371/journal.pone.0049785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189163	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800040
J	Kobuchi, H; Moriya, K; Ogino, T; Fujita, H; Inoue, K; Shuin, T; Yasuda, T; Utsumi, K; Utsumi, T				Kobuchi, Hirotsugu; Moriya, Koko; Ogino, Tetsuya; Fujita, Hirofumi; Inoue, Keiji; Shuin, Taro; Yasuda, Tatsuji; Utsumi, Kozo; Utsumi, Toshihiko			Mitochondrial Localization of ABC Transporter ABCG2 and Its Function in 5-Aminolevulinic Acid-Mediated Protoporphyrin IX Accumulation	PLOS ONE			English	Article							PHOTODYNAMIC DIAGNOSIS; CELL-LINE; MECHANISMS; BLADDER; CANCER; TUMOR; GROWTH; MYRISTOYLATION; TRAFFICKING; EXPRESSION	Accumulation of protoporphyrin IX (PpIX) in malignant cells is the basis of 5-aminolevulinic acid (ALA)-mediated photodynamic therapy. We studied the expression of proteins that possibly affect ALA-mediated PpIX accumulation, namely oligopeptide transporter-1 and -2, ferrochelatase and ATP-binding cassette transporter G2 (ABCG2), in several tumor cell lines. Among these proteins, only ABCG2 correlated negatively with ALA-mediated PpIX accumulation. Both a subcellular fractionation study and confocal laser microscopic analysis revealed that ABCG2 was distributed not only in the plasma membrane but also intracellular organelles, including mitochondria. In addition, mitochondrial ABCG2 regulated the content of ALA-mediated PpIX in mitochondria, and Ko143, a specific inhibitor of ABCG2, enhanced mitochondrial PpIX accumulation. To clarify the possible roles of mitochondrial ABCG2, we characterized stably transfected-HEK (ST-HEK) cells overexpressing ABCG2. In these ST-HEK cells, functionally active ABCG2 was detected in mitochondria, and treatment with Ko143 increased ALA-mediated mitochondrial PpIX accumulation. Moreover, the mitochondria isolated from ST-HEK cells exported doxorubicin probably through ABCG2, because the export of doxorubicin was inhibited by Ko143. The susceptibility of ABCG2 distributed in mitochondria to proteinase K, endoglycosidase H and peptide-N-glycosidase F suggested that ABCG2 in mitochondrial fraction is modified by N-glycans and trafficked through the endoplasmic reticulum and Golgi apparatus and finally localizes within the mitochondria. Thus, it was found that ABCG2 distributed in mitochondria is a functional transporter and that the mitochondrial ABCG2 regulates ALA-mediated PpIX level through PpIX export from mitochondria to the cytosol.	[Kobuchi, Hirotsugu; Yasuda, Tatsuji] Okayama Univ, Dept Cell Chem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Moriya, Koko; Utsumi, Toshihiko] Yamaguchi Univ, Grad Sch Med, Yamaguchi, Japan; [Ogino, Tetsuya] Okayama Prefectural Univ, Dept Nursing Sci, Fac Hlth & Welf Sci, Soja, Japan; [Fujita, Hirofumi; Utsumi, Kozo] Okayama Univ, Dept Cytol & Histol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Inoue, Keiji; Shuin, Taro] Kochi Med Sch, Dept Urol, Nankoku, Kochi, Japan	Okayama University; Yamaguchi University; Okayama Prefectural University; Okayama University; Kochi University	Kobuchi, H (corresponding author), Okayama Univ, Dept Cell Chem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	hkobuchi@md.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23659122]; Grants-in-Aid for Scientific Research [23659122] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid (No. 23659122) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amo T, 2009, CELL BIOCHEM FUNCT, V27, P503, DOI 10.1002/cbf.1603; Ardehali H, 2005, CIRC RES, V97, P740, DOI 10.1161/01.RES.0000186277.12336.11; Arita K, 2003, FREE RADICAL BIO MED, V35, P189, DOI 10.1016/S0891-5849(03)00310-1; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chapman JM, 2002, CANCER RES, V62, P5083; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Claros MG, 1997, CURR OPIN STRUC BIOL, V7, P394, DOI 10.1016/S0959-440X(97)80057-7; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Fromme JC, 2008, TRENDS CELL BIOL, V18, P330, DOI 10.1016/j.tcb.2008.04.006; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Fukuhara H, 2011, INT J UROL, V18, P585, DOI 10.1111/j.1442-2042.2011.02789.x; Hamza I, 2006, ACS CHEM BIOL, V1, P627, DOI 10.1021/cb600442b; Hirai K, 2007, INT J CANCER, V120, P500, DOI 10.1002/ijc.22287; Hu C, 2008, CARCINOGENESIS, V29, P2289, DOI 10.1093/carcin/bgn223; Inoue K, 2012, CANCER-AM CANCER SOC, V118, P1062, DOI 10.1002/cncr.26378; Ishizuka M, 2011, INT IMMUNOPHARMACOL, V11, P358, DOI 10.1016/j.intimp.2010.11.029; Kim G, 2010, J BIOL CHEM, V285, P18085, DOI 10.1074/jbc.M110.119701; Kim HJ, 2001, FEBS LETT, V505, P264, DOI 10.1016/S0014-5793(01)02836-8; Krieg RC, 2002, PHOTOCHEM PHOTOBIOL, V76, P518, DOI 10.1562/0031-8655(2002)076<0518:MCOTCS>2.0.CO;2; Krieg RC, 2000, PHOTOCHEM PHOTOBIOL, V72, P226, DOI 10.1562/0031-8655(2000)072<0226:CTSPIM>2.0.CO;2; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Liesa M, 2011, CIRCULATION, V124, P806, DOI 10.1161/CIRCULATIONAHA.110.003418; Novotny A, 2000, J NEUROCHEM, V75, P321, DOI 10.1046/j.1471-4159.2000.0750321.x; Ogino T, 2011, MOL CELL BIOCHEM, V358, P297, DOI 10.1007/s11010-011-0980-5; Ohgari Y, 2005, BIOCHEM PHARMACOL, V71, P42, DOI 10.1016/j.bcp.2005.10.019; Ostermeier C, 1996, CURR OPIN STRUC BIOL, V6, P460, DOI 10.1016/S0959-440X(96)80110-2; Paterson JK, 2007, EXP CELL RES, V313, P3100, DOI 10.1016/j.yexcr.2007.04.019; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; RIGBY CC, 1970, BRIT J CANCER, V24, P746, DOI 10.1038/bjc.1970.89; Rocchi E, 2000, BIOCHEM BIOPH RES CO, V271, P42, DOI 10.1006/bbrc.2000.2590; Rodriguez L, 2006, BRIT J PHARMACOL, V147, P825, DOI 10.1038/sj.bjp.0706668; Rud E, 2000, PHOTOCHEM PHOTOBIOL, V71, P640, DOI 10.1562/0031-8655(2000)071<0640:AABNAA>2.0.CO;2; Sakurai N, 2006, J BIOL CHEM, V281, P14288, DOI 10.1074/jbc.M510338200; Schauder A, 2011, PHOTOCH PHOTOBIO SCI, V10, P1310, DOI 10.1039/c1pp05085k; Sharma S, 2007, J PHOTOCH PHOTOBIO B, V88, P156, DOI 10.1016/j.jphotobiol.2007.07.005; Solazzo M, 2006, EXP CELL RES, V312, P4070, DOI 10.1016/j.yexcr.2006.09.005; Solazzo M, 2009, CANCER RES, V69, P7235, DOI 10.1158/0008-5472.CAN-08-4315; Susanto J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004023; Xu Y, 2009, J BIOL CHEM, V284, P29230, DOI 10.1074/jbc.M109.016642; Yavari N, 2011, CAN J UROL, V18, P5778; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	41	81	83	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50082	10.1371/journal.pone.0050082	http://dx.doi.org/10.1371/journal.pone.0050082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189181	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800058
J	Parreira, VR; Costa, M; Eikmeyer, F; Blom, J; Prescott, JF				Parreira, Valeria R.; Costa, Marcio; Eikmeyer, Felix; Blom, Jochen; Prescott, John F.			Sequence of Two Plasmids from Clostridium perfringens Chicken Necrotic Enteritis Isolates and Comparison with C. perfringens Conjugative Plasmids	PLOS ONE			English	Article							ENCODING PLASMIDS; DIVERSITY; SYSTEM; TOXIN; SEGREGATION; SOFTWARE; PCW3; DNA	Twenty-six isolates of Clostridium perfringens of different MLST types from chickens with necrotic enteritis (NE) (15 netB-positive) or from healthy chickens (6 netB-positive, 5 netB-negative) were found to contain 1-4 large plasmids, with most netB-positive isolates containing 3 large and variably sized plasmids which were more numerous and larger than plasmids in netB-negative isolates. NetB and cpb2 were found on different plasmids consistent with previous studies. The pathogenicity locus NELoc1, which includes netB, was largely conserved in these plasmids whereas NeLoc3, present in the cpb2 containing plasmids, was less well conserved. A netB-positive and a cpb2-positive plasmid were likely to be conjugative, and the plasmids were completely sequenced. Both plasmids possessed the intact tcp conjugative region characteristic of C. perfringens conjugative plasmids. Comparative genomic analysis of nine CpCPs, including the two plasmids described here, showed extensive gene rearrangements including pathogenicity locus and accessory gene insertions around rather than within the backbone region. The pattern that emerges from this analysis is that the major toxin-containing regions of the variety of virulence-associated CpCPs are organized as complex pathogenicity loci. How these different but related CpCPs can co-exist in the same host has been an unanswered question. Analysis of the replication-partition region of these plasmids suggests that this region controls plasmid incompatibility, and that CpCPs can be grouped into at least four incompatibility groups.	[Parreira, Valeria R.; Costa, Marcio; Prescott, John F.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Eikmeyer, Felix] Univ Bielefeld, Ctr Biotechnol, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Blom, Jochen] Univ Bielefeld, Ctr Biotechnol, Bioinformat Resource Facil, D-33594 Bielefeld, Germany	University of Guelph; University of Bielefeld; University of Bielefeld	Prescott, JF (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	prescott@uoguelph.ca	Eikmeyer, Felix/H-3328-2013	Eikmeyer, Felix/0000-0003-1623-172X; Costa, Marcio/0000-0001-5067-7501	Canadian Poultry Research Council; Agriculture and Agri-Food Canada; Ontario Ministry of Agriculture and Food; Natural Sciences and Engineering Research Council; CLIB-Graduate Cluster Industrial Biotechnology; Ministry of Innovation of North Rhine-Westphalia; German Federal Ministry of Education and Research [0315599A, 0315599B]	Canadian Poultry Research Council; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Ontario Ministry of Agriculture and Food; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); CLIB-Graduate Cluster Industrial Biotechnology; Ministry of Innovation of North Rhine-Westphalia; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding provided by Canadian Poultry Research Council and the Agriculture and Agri-Food Canada Poultry Research Cluster program, by the Ontario Ministry of Agriculture and Food, and by the Natural Sciences and Engineering Research Council. FE acknowledges scholarship from the CLIB-Graduate Cluster Industrial Biotechnology co-financed by the Ministry of Innovation of North Rhine-Westphalia. JB acknowledges funding by the German Federal Ministry of Education and Research (grants 0315599A & 0315599B "GenoMik-Transfer"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Bannam TL, 2011, MBIO, V2, DOI 10.1128/mBio.00190-11; Bantwal R, 2012, PLASMID, V67, P139, DOI 10.1016/j.plasmid.2011.12.016; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Bouet JY, 2007, MOL MICROBIOL, V65, P1405, DOI 10.1111/j.1365-2958.2007.05882.x; Chalmers G, 2008, J CLIN MICROBIOL, V46, P3957, DOI 10.1128/JCM.01548-08; Cooper KK, 2009, ANAEROBE, V15, P55, DOI 10.1016/j.anaerobe.2009.01.006; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Eikmeyer F, 2012, PLASMID; Funnell BE, 2004, PLASMID BIOLOGY, P81; Gurjar A, 2010, INFECT IMMUN, V78, P4860, DOI 10.1128/IAI.00715-10; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Li JH, 2007, INFECT IMMUN, V75, P1811, DOI 10.1128/IAI.01981-06; Miyamoto K, 2006, J BACTERIOL, V188, P1585, DOI 10.1128/JB.188.4.1585-1598.2006; Miyamoto K, 2008, J BACTERIOL, V190, P7178, DOI 10.1128/JB.00939-08; Miyamoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020376; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; Popoff MR, 2009, FUTURE MICROBIOL, V4, P1021, DOI 10.2217/FMB.09.72; Porter CJ, 2012, MOL MICROBIOL, V83, P275, DOI 10.1111/j.1365-2958.2011.07930.x; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salje J, 2010, NAT REV MICROBIOL, V8, P683, DOI 10.1038/nrmicro2425; Sayeed S, 2007, INFECT IMMUN, V75, P2391, DOI 10.1128/IAI.02014-06; Sayeed S, 2010, INFECT IMMUN, V78, P495, DOI 10.1128/IAI.00838-09; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Steen JA, 2009, J BACTERIOL, V191, P2926, DOI 10.1128/JB.00032-09; Thompson DR, 2006, VET MICROBIOL, V113, P25, DOI 10.1016/j.vetmic.2005.10.015; Treangen TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-433; Van Immerseel F, 2009, TRENDS MICROBIOL, V17, P32, DOI 10.1016/j.tim.2008.09.005	35	40	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e49753	10.1371/journal.pone.0049753	http://dx.doi.org/10.1371/journal.pone.0049753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189158	Green Published, gold, Green Submitted			2022-12-25	WOS:000311929800035
J	Plumb, AW; Patton, DT; Seo, JH; Loveday, EK; Jean, F; Ziegler, SF; Abraham, N				Plumb, Adam W.; Patton, Daniel T.; Seo, Jung Hee; Loveday, Emma-Kate; Jean, Francois; Ziegler, Steven F.; Abraham, Ninan			Interleukin-7, but Not Thymic Stromal Lymphopoietin, Plays a Key Role in the T Cell Response to Influenza A Virus	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; GAMMA-CHAIN; RECEPTOR; TSLP; A(H1N1); MEMORY; IL-7; EXPANSION; EFFECTOR; CD4(+)	The immune response to viral infection is ideally rapid and specific, resulting in viral clearance and establishment of immune memory. Some viruses such as HIV can evade such responses leading to chronic infection, while others like Influenza A can elicit a severe inflammatory response with immune-related complications including death. Cytokines play a major role in shaping the appropriate outcomes to infection. While Interleukin-7 (IL-7) has a critical role in T and B cell development, treatment with IL-7 has recently been shown to aid the adaptive T cell response in clearance of chronic viral infection. In contrast, the IL-7-related cytokine thymic stromal lymphopoietin (TSLP) has a limited role in lymphocyte development but is important in the immune response to parasitic worms and allergens. The role for these cytokines in the immune response to an acute viral infection is unclear. IL-7 and TSLP share IL-7R alpha as part of their heterodimeric receptors with the gamma common chain (gamma c) and TSLPR, respectively. We investigated the role of IL-7 and TSLP in the primary immune response to influenza A infection using hypomorphic IL-7R alpha (IL-7R alpha(449F)) and TSLPR-/- mice. We found that IL-7, but not TSLP, plays an important role in control of influenza A virus. We also showed that IL-7 signaling was necessary for the generation of a robust influenza A-specific CD4 and CD8 T cell response and that this requirement is intrinsic to CD8 T cells. These findings demonstrate a significant role for IL-7 during acute viral infection.	[Plumb, Adam W.; Patton, Daniel T.; Seo, Jung Hee; Loveday, Emma-Kate; Jean, Francois; Abraham, Ninan] Univ British Columbia, Infect Inflammat & Immun Res Grp, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada; [Abraham, Ninan] Univ British Columbia, Dept Zool, Inst Life Sci, Vancouver, BC, Canada; [Ziegler, Steven F.] Benaroya Res Inst, Program Immunol, Seattle, WA USA	University of British Columbia; University of British Columbia; Benaroya Research Institute	Abraham, N (corresponding author), Univ British Columbia, Infect Inflammat & Immun Res Grp, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V5Z 1M9, Canada.	ninan@mail.ubc.ca	Abraham, Ninan/K-5572-2012	Abraham, Ninan/0000-0002-2747-1246	Canadian Institutes for Health Research (CIHR) [MOP-84532, TPA-90195]; CIHR; Michael Smith Foundation for Health Research; CIHR/MSFHR; National Science Foundation; Stem Cell Technologies	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR/MSFHR(Michael Smith Foundation for Health ResearchCanadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); Stem Cell Technologies	This work was supported by the Canadian Institutes for Health Research (CIHR) (MOP-84532 to NA; and CIHR Team grant on Functional Infectomics of influenza A virus TPA-90195 to FJ). NA holds CIHR New Investigator and Michael Smith Foundation for Health Research Career Investigator awards. DTP holds a Michael Smith Foundation for Health Research Post Doctoral award and was supported by the CIHR/MSFHR Transplant Research Training Program. E-KL acknowledges generous support from a National Science Foundation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Drs. Marc Horwitz, Georgia Perona-Wright and Pauline Johnson for critical reading of the manuscript and helpful discussions, the Centre for Disease Modelling staff for animal husbandry and the UBC Flow Cytometry facility. We thank Dr. Tania Watts for providing influenza-specific protocols and expertise, Dr. James Ihle for permission to use the TSLPR<SUP>-/-</SUP> mice and Dr. David Artis for shipping these mice, Dr. John Pasick for providing influenza primer and probe sequences and in vitro transcribed influenza A matrix gene RNA, the NIH Tetramer facility for D<SUP>b</SUP>/NP and D<SUP>b</SUP>/PA tetramers and Stem Cell Technologies for supporting our research. We thank Dr. Angelika Schwanninger for her unprecedented contributions to our laboratory.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Akamatsu T, 2008, CLIN EXP IMMUNOL, V154, P98, DOI 10.1111/j.1365-2249.2008.03731.x; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Bridges C. B., 2000, Morbidity and Mortality Weekly Report, V49; Bridges C B, 2000, MMWR Recomm Rep, V49, P1; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Day EB, 2007, J IMMUNOL, V179, P2187, DOI 10.4049/jimmunol.179.4.2187; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fadell SA, 2008, EUR J IMMUNOL, V38, P3376, DOI 10.1002/eji.200838628; Fewkes NM, 2010, CANCER J, V16, P392, DOI 10.1097/PPO.0b013e3181eacbc4; Francis T, 1934, SCIENCE, V80, P457, DOI 10.1126/science.80.2081.457-a; Gilliet M, 2003, J EXP MED, V197, P1059, DOI 10.1084/jem.20030240; Hand TW, 2010, P NATL ACAD SCI USA, V107, P16601, DOI 10.1073/pnas.1003457107; KONDO M, 1994, SCIENCE, V263, P1453, DOI 10.1126/science.8128231; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Osborne LC, 2007, J EXP MED, V204, P619, DOI 10.1084/jem.20061871; Park LS, 2000, J EXP MED, V192, P659, DOI 10.1084/jem.192.5.659; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rochman Y, 2008, J IMMUNOL, V181, P7699, DOI 10.4049/jimmunol.181.11.7699; Sedgmen BJ, 2006, INT IMMUNOL, V18, P797, DOI 10.1093/intimm/dxl016; Sugimoto H, 2010, CLIN IMMUNOL, V136, P205, DOI 10.1016/j.clim.2010.04.006; Thatte J, 2003, BLOOD, V101, P4916, DOI 10.1182/blood-2002-10-3159; Unsinger J, 2010, J IMMUNOL, V184, P3768, DOI 10.4049/jimmunol.0903151; Watanabe N, 2004, NAT IMMUNOL, V5, P426, DOI 10.1038/ni1048; Webster RG, 2000, VACCINE, V18, P1686, DOI 10.1016/S0264-410X(99)00507-1; Yadava K, 2013, MUCOSAL IMMUNOL, V6, P83, DOI 10.1038/mi.2012.50; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	36	21	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50199	10.1371/journal.pone.0050199	http://dx.doi.org/10.1371/journal.pone.0050199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189186	Green Submitted, Green Published, gold			2022-12-25	WOS:000311929800063
J	Sol, A; Blotnick, E; Bachrach, G; Muhlrad, A				Sol, Asaf; Blotnick, Edna; Bachrach, Gilad; Muhlrad, Andras			LL-37 Induces Polymerization and Bundling of Actin and Affects Actin Structure	PLOS ONE			English	Article							CYSTIC-FIBROSIS SPUTUM; F-ACTIN; CATHELICIDIN LL-37; CONFORMATIONAL-CHANGES; MUSCLE CONTRACTION; PEPTIDE LL-37; IN-VITRO; DNASE-I; BINDING; PHOSPHORYLATION	Actin exists as a monomer (G-actin) which can be polymerized to filaments) F-actin) that under the influence of actin-binding proteins and polycations bundle and contribute to the formation of the cytoskeleton. Bundled actin from lysed cells increases the viscosity of sputum in lungs of cystic fibrosis patients. The human host defense peptide LL-37 was previously shown to induce actin bundling and was thus hypothesized to contribute to the pathogenicity of this disease. In this work, interactions between actin and the cationic LL-37 were studied by optical, proteolytic and surface plasmon resonance methods and compared to those obtained with scrambled LL-37 and with the cationic protein lysozyme. We show that LL-37 binds strongly to CaATP-G-actin while scrambled LL-37 does not. While LL-37, at superstoichiometric LL-37/actin concentrations polymerizes MgATP-G-actin, at lower non-polymerizing concentrations LL-37 inhibits actin polymerization by MgCl2 or NaCl. LL-37 bundles Mg-F-actin filaments both at low and physiological ionic strength when in equimolar or higher concentrations than those of actin. The LL-37 induced bundles are significantly less sensitive to increase in ionic strength than those induced by scrambled LL-37 and lysozyme. LL-37 in concentrations lower than those needed for actin polymerization or bundling, accelerates cleavage of both monomer and polymer actin by subtilisin. Our results indicate that the LL-37-actin interaction is partially electrostatic and partially hydrophobic and that a specific actin binding sequence in the peptide is responsible for the hydrophobic interaction. LL-37-induced bundles, which may contribute to the accumulation of sputum in cystic fibrosis, are dissociated very efficiently by DNase-1 and also by cofilin.	[Sol, Asaf; Bachrach, Gilad; Muhlrad, Andras] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel; [Blotnick, Edna] Hebrew Univ Jerusalem, Dept Med Neurobiol, Inst Med Res Israel Canada, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Bachrach, G (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel.	giladba@ekmd.huji.ac.il		Bachrach, Gilad/0000-0003-1350-2280; Sol, Asaf/0000-0002-8731-2490	Israel Science Foundation [208/10]	Israel Science Foundation(Israel Science Foundation)	This work was supported by the Israel Science Foundation (grant No. 208/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Beall B, 2001, BIOCHEMISTRY-US, V40, P14252, DOI 10.1021/bi011806u; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN SS, 1979, J CELL BIOL, V80, P499, DOI 10.1083/jcb.80.2.499; Bubb MR, 1999, J BIOL CHEM, V274, P36472, DOI 10.1074/jbc.274.51.36472; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Byfield FJ, 2011, J IMMUNOL, V187, P6402, DOI 10.4049/jimmunol.1102185; CANFIELD RE, 1963, J BIOL CHEM, V238, P2698; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Furukawa R, 1997, INT REV CYTOL, V175, P29, DOI 10.1016/S0074-7696(08)62125-7; Grintsevich EE, 2010, BIOCHEMISTRY-US, V49, P3919, DOI 10.1021/bi1002663; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Muhlrad A, 2004, J MOL BIOL, V342, P1559, DOI 10.1016/j.jmb.2004.08.010; Muhlrad A, 2011, BIOPHYS CHEM, V155, P45, DOI 10.1016/j.bpc.2011.02.008; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; ORIOLAUDIT C, 1978, EUR J BIOCHEM, V87, P371, DOI 10.1111/j.1432-1033.1978.tb12386.x; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pavlov D, 2006, CELL MOTIL CYTOSKEL, V63, P533, DOI 10.1002/cm.20142; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Sanders LK, 2007, P NATL ACAD SCI USA, V104, P15994, DOI 10.1073/pnas.0705898104; Schroeter M, 2004, BIOCHEMISTRY-US, V43, P13875, DOI 10.1021/bi0487490; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; Sowa GZ, 2006, J PHYS CHEM B, V110, P22279, DOI 10.1021/jp063371w; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; Tang JX, 1997, EUR J BIOCHEM, V247, P432, DOI 10.1111/j.1432-1033.1997.00432.x; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; Ulmer JS, 1996, P NATL ACAD SCI USA, V93, P8225, DOI 10.1073/pnas.93.16.8225; VASCONCELLOS CA, 1994, SCIENCE, V263, P969, DOI 10.1126/science.8310295; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yarmola EG, 2001, J BIOL CHEM, V276, P22351, DOI 10.1074/jbc.M101457200	47	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2012	7	11							e50078	10.1371/journal.pone.0050078	http://dx.doi.org/10.1371/journal.pone.0050078			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048RI	23189180	Green Published, Green Submitted, gold			2022-12-25	WOS:000311929800057
J	Bertolo, A; Blanchet, FG; Magnan, P; Brodeur, P; Mingelbier, M; Legendre, P				Bertolo, Andrea; Blanchet, F. Guillaume; Magnan, Pierre; Brodeur, Philippe; Mingelbier, Marc; Legendre, Pierre			Inferring Processes from Spatial Patterns: The Role of Directional and Non-Directional Forces in Shaping Fish Larvae Distribution in a Freshwater Lake System	PLOS ONE			English	Article							PERCH PERCA-FLAVESCENS; YELLOW PERCH; HABITAT SHIFTS; SELECTION; MATRICES; LIFE; KIN	Larval dispersal is a crucial factor for fish recruitment. For fishes with relatively small-bodied larvae, drift has the potential to play a more important role than active habitat selection in determining larval dispersal; therefore, we expect small-bodied fish larvae to be poorly associated with habitat characteristics. To test this hypothesis, we used as model yellow perch (Perca flavescens), whose larvae are among the smallest among freshwater temperate fishes. Thus, we analysed the habitat association of yellow perch larvae at multiple spatial scales in a large shallow fluvial lake by explicitly modelling directional (e. g. due to water currents) and non-directional (e. g. due to aggregation) spatial patterns. This allowed us to indirectly assess the relative roles of drift (directional process) and potential habitat choice on larval dispersal. Our results give weak support to the drift hypothesis, whereas yellow perch show a strong habitat association at unexpectedly small sizes, when compared to other systems. We found consistent non-directional patterns in larvae distributions at both broad and medium spatial scales but only few significant directional components. The environmental variables alone (e. g. vegetation) generally explained a significant and biologically relevant fraction of the variation in fish larvae distribution data. These results suggest that (i) drift plays a minor role in this shallow system, (ii) larvae display spatial patterns that only partially covary with environmental variables, and (iii) larvae are associated to specific habitats. By suggesting that habitat association potentially includes an active choice component for yellow perch larvae, our results shed new light on the ecology of freshwater fish larvae and should help in building more realistic recruitment models.	[Bertolo, Andrea; Blanchet, F. Guillaume; Magnan, Pierre; Legendre, Pierre] Interuniv Res Grp Limnol & Aquat Environm GRIL, Quebec City, PQ, Canada; [Bertolo, Andrea; Magnan, Pierre] Univ Quebec Trois Rivieres, Res Ctr Watershed Aquat Ecosyst Interact RIVE, Trois Rivieres, PQ GA9 5H7, Canada; [Blanchet, F. Guillaume; Legendre, Pierre] Univ Montreal, Dept Sci Biol, Montreal, PQ H3C 3J7, Canada; [Blanchet, F. Guillaume] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Blanchet, F. Guillaume] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Brodeur, Philippe] Direct Expertise Mauricie, Minist Ressources Nat & Faune, Trois Rivieres, PQ, Canada; [Brodeur, Philippe] Ctr du Quebec, Trois Rivieres, PQ, Canada; [Mingelbier, Marc] Serv Faune Aquat, Minist Ressources Nat & Faune, Quebec City, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres; Universite de Montreal; University of Alberta; University of Turku	Bertolo, A (corresponding author), Interuniv Res Grp Limnol & Aquat Environm GRIL, Quebec City, PQ, Canada.	andrea.bertolo@uqtr.ca	Magnan, Pierre/U-9342-2019; Legendre, Pierre/U-9266-2019; Legendre, Pierre/C-8279-2013	Magnan, Pierre/0000-0003-3122-7163; Legendre, Pierre/0000-0002-3838-3305; Legendre, Pierre/0000-0002-3838-3305; Blanchet, F. Guillaume/0000-0001-5149-2488; Bertolo, Andrea/0000-0002-6018-816X; Mingelbier, Marc/0000-0002-1471-8297	Natural Sciences and Engineering Research Council of Canada; Canada Research Chair in Freshwater Ecology; MRNF	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair in Freshwater Ecology; MRNF	This project was supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Canada Research Chair in Freshwater Ecology to P. Magnan and from funds from the MRNF to M. Mingelbier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; Behrmann-Godel J, 2006, BEHAV ECOL SOCIOBIOL, V59, P461, DOI 10.1007/s00265-005-0070-3; Bergek S, 2007, EVOLUTION, V61, P2035, DOI 10.1111/j.1558-5646.2007.00163.x; Blanchet F. G., 2009, AEM TOOLS CONSTRUCT; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blanchet FG, 2008, ECOL MODEL, V215, P325, DOI 10.1016/j.ecolmodel.2008.04.001; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Dettmers JM, 2005, CAN J FISH AQUAT SCI, V62, P2683, DOI 10.1139/F05-173; Dray S., 2008, SPACEMAKER SPATIAL M; Dray S., 2007, PACKFOR FORWARD SELE; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Frenette JJ, 2006, LIMNOL OCEANOGR, V51, P2632, DOI 10.4319/lo.2006.51.6.2632; Frenette JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035891; Gerlach G, 2001, HEREDITY, V86, P213, DOI 10.1046/j.1365-2540.2001.00825.x; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; HOUDE ED, 1969, J FISH RES BOARD CAN, V26, P1647, DOI 10.1139/f69-148; Hudon C, 2008, CAN J FISH AQUAT SCI, V65, P1165, DOI 10.1139/F08-069; Kjellman J, 1996, ANN ZOOL FENN, V33, P363; Laviolette N., 2003, CARACTERISATION COMM; Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8; Leung C., 2011, J AQUACULTURE RES DE, VS6, P1, DOI [10.4172/2155-9546.S6-001, DOI 10.4172/2155-9546.S6-001]; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Miehls SM, 2011, T AM FISH SOC, V140, P1317, DOI 10.1080/00028487.2011.620484; Mingelbier M., 2005, RECOMMANDATIONS CONC; Montgomery JC, 2001, FISH FISH, V2, P261, DOI 10.1046/j.1467-2960.2001.00053.x; Morin J., 2006, WATER AVAILABILITY I, P25; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Paradis Y, 2008, N AM J FISH MANAGE, V28, P1554, DOI 10.1577/M07-122.1; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; POST JR, 1988, CAN J FISH AQUAT SCI, V45, P1820, DOI 10.1139/f88-214; R Development Core Team, 2009, R FDN STAT COMP; Sale PF, 2004, INTEGR COMP BIOL, V44, P390, DOI 10.1093/icb/44.5.390; Schiemer F., 2001, Archiv fuer Hydrobiologie Supplement, V135, P509; TREASURER JW, 1988, ENVIRON BIOL FISH, V21, P37, DOI 10.1007/BF02984441; Urho L, 1996, ANN ZOOL FENN, V33, P329; WANG N, 1994, HYDROBIOLOGIA, V277, P135, DOI 10.1007/BF00007295; WHITESIDE MC, 1985, ENVIRON BIOL FISH, V12, P47, DOI 10.1007/BF00007709; Wolter C, 2008, RIVER RES APPL, V24, P661, DOI 10.1002/rra.1146	41	26	26	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2012	7	11							e50239	10.1371/journal.pone.0050239	http://dx.doi.org/10.1371/journal.pone.0050239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043II	23185585	Green Submitted, Green Published, gold			2022-12-25	WOS:000311535700080
J	Wang, X; Zhang, AX; Liu, Y; Chen, S; Feng, ZQ; Shang, WB; Maziarz, M; Radtke, J; Hampe, CS				Wang, Xin; Zhang, Aixia; Liu, Yu; Chen, Shi; Feng, Zhenqing; Shang, Wenbin; Maziarz, Marlena; Radtke, Jared; Hampe, Christiane S.			Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIRIBOSOMAL P AUTOANTIBODIES; ANTIGEN-PRESENTING CELLS; ACID DECARBOXYLASE GAD; GRAVES-DISEASE; DNA ANTIBODIES; B-LYMPHOCYTES; MONOCLONAL-ANTIBODIES; IDIOTYPIC ANTIBODIES; NETWORK THEORY	Overt autoantibodies to the smaller isoform of glutamate decarboxylase (GAD65Ab) are a characteristic in patients with Type 1 diabetes (T1D). Anti-idiotypic antibodies (anti-Id) directed to GAD65Ab effectively prevent the binding of GAD65 to GAD65Ab in healthy individuals. Levels of GAD65Ab-specific anti-Id are significantly lower in patients with T1D, leading to overt GAD65Ab in these patients. To determine the possible protective role of GAD65Ab-specific anti-Id in T1D pathogenesis, we developed the monoclonal anti-Id MAb 8E6G4 specifically targeting human monoclonal GAD65Ab b96.11. MAb 8E6G4 was demonstrated as a specific anti-Id directed to the antigen binding site of b96.11. MAb 8E6G4 recognized human antibodies in sera from healthy individuals, T2D patients, and T1D patients as established by ELISA. We confirmed these MAb 8E6G4-bound human antibodies to contain GAD65Ab by testing the eluted antibodies for binding to GAD65 in radioligand binding assays. These findings confirm that GAD65Ab are present in sera of individuals, who test GAD65Ab-negative in conventional detection assays. To test our hypothesis that GAD65Ab-specific anti-Id have an immune modulatory role in T1D, we injected young Non Obese Diabetic (NOD) mice with MAb 8E6G4. The animals were carefully monitored for development of T1D for 40 weeks. Infiltration of pancreatic islets by mononuclear cells (insulitis) was determined to establish the extent of an autoimmune attack on the pancreatic islets. Administration of MAb 8E6G4 significantly reduced the cumulative incidence rate of T1D and delayed the time of onset. Insulitis was significantly less severe in animals that received MAb 8E6G4 as compared to control animals. These results support our hypothesis that anti-Id specific to GAD65Ab have a protective role in T1D.	[Wang, Xin; Chen, Shi] Jiangsu Prov Hosp TCM, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Zhang, Aixia] Nanjing Med Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China; [Liu, Yu] Jilin Univ, Hosp 2, Dept Endocrinol, Changchun 130023, Jilin, Peoples R China; [Feng, Zhenqing] Nanjing Med Univ, Minist Hlth, Key Lab Antibody Technol, Nanjing, Jiangsu, Peoples R China; [Shang, Wenbin] Nanjing Univ Chinese Med, Coll Clin Med 1, Med Res Ctr, Nanjing, Jiangsu, Peoples R China; [Maziarz, Marlena; Radtke, Jared; Hampe, Christiane S.] Univ Washington, Seattle, WA 98195 USA	Nanjing University of Chinese Medicine; Nanjing Medical University; Jilin University; Nanjing Medical University; Nanjing University of Chinese Medicine; University of Washington; University of Washington Seattle	Wang, X (corresponding author), Jiangsu Prov Hosp TCM, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	drwangxin@gmail.com; champe@u.washington.edu	Maziarz, Marlena/F-1746-2019; Maziarz, Marlena/AAL-3798-2021; Hampe, Christiane Susanne/GSD-7679-2022; Maziarz, Marlena/N-4255-2018; Shang, Wenbin/E-6682-2011; Wallinga, Jacco/C-4382-2018	Maziarz, Marlena/0000-0003-1417-6050; Maziarz, Marlena/0000-0003-1417-6050; Maziarz, Marlena/0000-0003-1417-6050; Shang, Wenbin/0000-0002-0317-5928; Bogaert, Debby/0000-0003-2651-7000; Trzcinski, Krzysztof/0000-0002-5433-8846; Wallinga, Jacco/0000-0003-1725-5627; Hampe, Christiane/0000-0001-9111-6671	National Institutes of Health [DK26190, DK17047, DK53456]; American Diabetes Association [1-09-RA-64]; Ministry of Science and Technology of China [2006BAI04A03]; Natural Science Foundation of China [NSF-C 81100555/H0707]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Institutes of Health (www2.niddk.nih.gov/) (grant numbers DK26190, DK17047, and DK53456), a basic science grant from the American Diabetes Association (www.diabetes.org)/(1-09-RA-64 to CSH), grant 2006BAI04A03 of the Ministry of Science and Technology of China (www.most.cn/eng/), and a grant from the Natural Science Foundation of China (www.nsfc.gov.cn/Portal0/default106.htm) NSF-C 81100555/H0707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOU NI, 1989, J CLIN IMMUNOL, V9, P16, DOI 10.1007/BF00917123; ABDOU NI, 1981, J CLIN INVEST, V67, P1297, DOI 10.1172/JCI110158; Aly Theresa, 2005, Am J Ther, V12, P481, DOI 10.1097/01.mjt.0000178782.97413.79; Anderson CJ, 1998, ARTHRITIS RHEUM, V41, P33, DOI 10.1002/1529-0131(199801)41:1<33::AID-ART5>3.0.CO;2-5; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Bach JF, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar554; Brooks-Worrell B, 2012, CLIN EXP IMMUNOL, V167, P40, DOI 10.1111/j.1365-2249.2011.04501.x; DWYER DS, 1983, NATURE, V301, P611, DOI 10.1038/301611a0; ERTL HCJ, 1988, VACCINE, V6, P80, DOI 10.1016/S0264-410X(88)80003-3; Falcone M, 1998, J IMMUNOL, V161, P1163; Goudy KS, 2005, INT REV IMMUNOL, V24, P307, DOI 10.1080/08830180500379721; Hall TR, 2008, IMMUNOLOGY, V123, P547, DOI 10.1111/j.1365-2567.2007.02724.x; Hampe CS, 2000, J CLIN ENDOCR METAB, V85, P4671, DOI 10.1210/jc.85.12.4671; Hampe CS, 2001, J NEUROIMMUNOL, V113, P63, DOI 10.1016/S0165-5728(00)00423-9; Harbers SO, 2007, J CLIN INVEST, V117, P1361, DOI 10.1172/JCI29470; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; KIM J, 1993, DIABETES, V42, P1799, DOI 10.2337/diabetes.42.12.1799; Knip M, 2008, AUTOIMMUN REV, V7, P550, DOI 10.1016/j.autrev.2008.04.008; NILSON BHK, 1992, J BIOL CHEM, V267, P2234; O'Neill SK, 2009, CURR OPIN ENDOCRINOL, V16, P293, DOI 10.1097/MED.0b013e32832e06a7; Oak S, 2008, P NATL ACAD SCI USA, V105, P5471, DOI 10.1073/pnas.0800578105; Padoa CJ, 2003, DIABETES, V52, P2689, DOI 10.2337/diabetes.52.11.2689; Pan ZJ, 1998, J CLIN INVEST, V102, P215, DOI 10.1172/JCI1969; PASCHKE R, 1990, J AUTOIMMUN, V3, P441, DOI 10.1016/S0896-8411(05)80011-3; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Quinn A, 1996, J AUTOIMMUN, V9, P365, DOI 10.1006/jaut.1996.0049; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Routsias JG, 2003, J AUTOIMMUN, V21, P17, DOI 10.1016/S0896-8411(03)00063-5; Sanjeevi CB, 1996, DIABETES NUTR METAB, V9, P167; Sapir T, 2005, CLIN REV ALLERG IMMU, V29, P185, DOI 10.1385/CRIAI:29:3:185; Serreze DV, 1998, J IMMUNOL, V161, P3912; SIKORSKA HM, 1986, J IMMUNOL, V137, P3786; Silveira PA, 2002, EUR J IMMUNOL, V32, P3657, DOI 10.1002/1521-4141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E; SILVESTRIS F, 1984, ARTHRITIS RHEUM, V27, P1387, DOI 10.1002/art.1780271209; STAFFORD HA, 1995, J IMMUNOL, V155, P2754; Tada H, 2001, ENDOCR J, V48, P703, DOI 10.1507/endocrj.48.703; TANIGUCHI O, 1984, J RHEUMATOL, V11, P291; Tremble J, 1997, J CLIN ENDOCR METAB, V82, P2664, DOI 10.1210/jc.82.8.2664; Usuki S, 2010, J NEUROSCI RES, V88, P1651, DOI 10.1002/jnr.22330; VALDERRAMA R, 1988, J NEUROIMMUNOL, V20, P269, DOI 10.1016/0165-5728(88)90174-9; WILLIAMS RC, 1995, J RHEUMATOL, V22, P1075; Williams WM, 1998, LUPUS, V7, P164, DOI 10.1191/096120398678919958; Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878; ZOUALI M, 1983, CELL IMMUNOL, V76, P137, DOI 10.1016/0008-8749(83)90356-8	44	78	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e32515	10.1371/journal.pone.0032515	http://dx.doi.org/10.1371/journal.pone.0032515			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	23189192	Green Submitted, gold, Green Published			2022-12-25	WOS:000302916800042
J	Lee, BR; Huseby, S; Koprivova, A; Chetelat, A; Wirtz, M; Mugford, ST; Navid, E; Brearley, C; Saha, S; Mithen, R; Hell, R; Farmer, EE; Kopriva, S				Lee, Bok-Rye; Huseby, Stine; Koprivova, Anna; Chetelat, Aurore; Wirtz, Markus; Mugford, Sam T.; Navid, Emily; Brearley, Charles; Saha, Shikha; Mithen, Richard; Hell, Ruediger; Farmer, Edward E.; Kopriva, Stanislav			Effects of fou8/fry1 Mutation on Sulfur Metabolism: Is Decreased Internal Sulfate the Trigger of Sulfate Starvation Response?	PLOS ONE			English	Article							ADENOSINE 5'-PHOSPHOSULFATE REDUCTASE; INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; OF-FUNCTION ALLELE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; 5-PHOSPHOSULFATE REDUCTASE; TRANSCRIPTOME ANALYSIS; GLUTATHIONE-DEFICIENT; NEGATIVE REGULATOR; SALT TOLERANCE	The fou8 loss of function allele of adenosine bisphosphate phosphatase FIERY1 results in numerous phenotypes including the increased enzymatic oxygenation of fatty acids and increased jasmonate synthesis. Here we show that the mutation causes also profound alterations of sulfur metabolism. The fou8 mutants possess lower levels of sulfated secondary compounds, glucosinolates, and accumulate the desulfo-precursors similar to previously described mutants in adenosine 5'phosphosulfate kinase. Transcript levels of genes involved in sulfate assimilation differ in fou8 compared to wild type Col-0 plants and are similar to plants subjected to sulfate deficiency. Indeed, independent microarray analyses of various alleles of mutants in FIERY1 showed similar patterns of gene expression as in sulfate deficient plants. This was not caused by alterations in signalling, as the fou8 mutants contained significantly lower levels of sulfate and glutathione and, consequently, of total elemental sulfur. Analysis of mutants with altered levels of sulfate and glutathione confirmed the correlation of sulfate deficiency-like gene expression pattern with low internal sulfate but not low glutathione. The changes in sulfur metabolism in fou8 correlated with massive increases in 3'-phosphoadenosine 5'-phosphate levels. The analysis of fou8 thus revealed that sulfate starvation response is triggered by a decrease in internal sulfate as opposed to external sulfate availability and that the presence of desulfo-glucosinolates does not induce the glucosinolate synthesis network. However, as well as resolving these important questions on the regulation of sulfate assimilation in plants, fou8 has also opened an array of new questions on the links between jasmonate synthesis and sulfur metabolism.	[Lee, Bok-Rye; Huseby, Stine; Koprivova, Anna; Mugford, Sam T.; Kopriva, Stanislav] Norwich Res Pk, John Innes Ctr, Norwich, Norfolk, England; [Huseby, Stine] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway; [Chetelat, Aurore; Navid, Emily; Farmer, Edward E.] Univ Lausanne, Dept Plant Mol Biol, Lausanne, Switzerland; [Wirtz, Markus; Hell, Ruediger] Heidelberg Inst Plant Sci HIP, Heidelberg, Germany; [Brearley, Charles] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Saha, Shikha; Mithen, Richard] Norwich Res Pk, Inst Food Res, Norwich, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Norwegian University of Life Sciences; University of Lausanne; Ruprecht Karls University Heidelberg; University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Lee, BR (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	stanislav.kopriva@jic.ac.uk	Hell, Ruediger/E-5436-2014; Wirtz, Markus/G-5917-2010; Kopriva, Stanislav/C-7401-2013; Farmer, Edward E/H-1635-2011	Wirtz, Markus/0000-0001-7790-4022; Kopriva, Stanislav/0000-0002-7416-6551; Brearley, Charles/0000-0001-6179-9109; Hell, Ruediger/0000-0002-6238-4818; Mugford, Sam/0000-0002-8537-5578; Mithen, Richard/0000-0001-7307-4324; Ryu, Choong-Min/0000-0002-7276-1189; Saha, Shikha/0000-0002-5010-5105	British Biotechnology and Biological Sciences Research Council (BBSRC); Swiss National Science Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044431] Funding Source: researchfish; BBSRC [BBS/E/F/00044431] Funding Source: UKRI	British Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SK's research is supported by British Biotechnology and Biological Sciences Research Council (BBSRC). EEF is supported by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball L, 2004, PLANT CELL, V16, P2448, DOI 10.1105/tpc.104.022608; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Bonaventure G, 2007, PLANT CELL PHYSIOL, V48, P1775, DOI 10.1093/pcp/pcm151; Bonaventure G, 2007, PLANT J, V49, P889, DOI 10.1111/j.1365-313X.2006.03002.x; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Burstenbinder K, 2007, PLANT J, V49, P238, DOI 10.1111/j.1365-313X.2006.02942.x; Caldelari D, 1998, PHYTOCHEMISTRY, V47, P599, DOI 10.1016/S0031-9422(97)00443-3; Carland F, 2009, PLANT J, V59, P895, DOI 10.1111/j.1365-313X.2009.03920.x; Chen H, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026661, 10.1093/ecam/neq002]; Chen H, 2010, PLANT CELL ENVIRON, V33, P2180, DOI 10.1111/j.1365-3040.2010.02218.x; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Cobbett CS, 1998, PLANT J, V16, P73, DOI 10.1046/j.1365-313x.1998.00262.x; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Fan J, 2011, SCIENCE, V331, P1185, DOI 10.1126/science.1199707; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Harada E, 2000, J PLANT PHYSIOL, V156, P272, DOI 10.1016/S0176-1617(00)80317-X; Hartmann T, 2004, J EXP BOT, V55, P837, DOI 10.1093/jxb/erh094; Hirai MY, 2003, PLANT J, V33, P651, DOI 10.1046/j.1365-313X.2003.01658.x; Hirsch J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016724; Jost R, 2005, PHOTOSYNTH RES, V86, P491, DOI 10.1007/s11120-005-7386-8; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Klein M, 2006, FEBS J, V273, P122, DOI 10.1111/j.1742-4658.2005.05048.x; Kopriva S, 1999, PLANT J, V20, P37, DOI 10.1046/j.1365-313X.1999.00573.x; Koprivova A, 2008, PLANT PHYSIOL, V146, P1408, DOI 10.1104/pp.107.113175; Koprivova A, 2010, PLANT CELL REP, V29, P1157, DOI 10.1007/s00299-010-0902-0; Lee BR, 2011, PLANT J, V67, P1042, DOI 10.1111/j.1365-313X.2011.04656.x; Malitsky S, 2008, PLANT PHYSIOL, V148, P2021, DOI 10.1104/pp.108.124784; Maruyama-Nakashita A, 2003, PLANT PHYSIOL, V132, P597, DOI 10.1104/pp.102.019802; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Mugford SG, 2011, PLANT J, V65, P96, DOI 10.1111/j.1365-313X.2010.04410.x; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; Nikiforova V, 2003, PLANT J, V33, P633, DOI 10.1046/j.1365-313X.2003.01657.x; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Piotrowski M, 2004, J BIOL CHEM, V279, P50717, DOI 10.1074/jbc.M407681200; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Rodriguez VM, 2010, PLANT PHYSIOL, V152, P1335, DOI 10.1104/pp.109.150474; Scheerer U, 2010, J EXP BOT, V61, P609, DOI 10.1093/jxb/erp327; Schlaeppi K, 2008, PLANT J, V55, P774, DOI 10.1111/j.1365-313X.2008.03545.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Traka M, 2005, J NUTR, V135, P1865, DOI 10.1093/jn/135.8.1865; Troufflard S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-172; Underhill E. W., 1973, BIOCH SOC S, V38, P303; Vauclare P, 2002, PLANT J, V31, P729, DOI 10.1046/j.1365-313X.2002.01391.x; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Wirtz M, 2003, AMINO ACIDS, V24, P195, DOI 10.1007/s00726-002-0313-9; Xiong LM, 2004, PLANT J, V40, P536, DOI 10.1111/j.1365-313X.2004.02225.x; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x	58	148	155	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2012	7	6							e39425	10.1371/journal.pone.0039425	http://dx.doi.org/10.1371/journal.pone.0039425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	962XO	23209558	gold, Green Submitted, Green Published			2022-12-25	WOS:000305583300140
J	Shen, HN; Lu, CL; Li, CY				Shen, Hsiu-Nien; Lu, Chin-Li; Li, Chung-Yi			Dementia Increases the Risks of Acute Organ Dysfunction, Severe Sepsis and Mortality in Hospitalized Older Patients: A National Population-Based Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; END; PREVALENCE; TAIWAN; STATES; TREND; LIFE	Background: Dementia increases the risk of death in older patients hospitalized for acute illnesses. However, the effect of dementia on the risks of developing acute organ dysfunction and severe sepsis as well as on the risk of hospital mortality in hospitalized older patients remains unknown, especially when treatments for these life-threatening situations are considered. Methods: In this population-based cohort study, we analyzed 41,672 older (>= 65 years) patients, including 3,487 (8.4%) with dementia, from the first-time admission claim data between 2005 and 2007 for a nationally representative sample of one million beneficiaries enrolled in the Taiwan National Health Insurance Research Database. Outcomes included acute organ dysfunction, severe sepsis, and hospital mortality. The effect of dementia on outcomes was assessed using multivariable logistic regression. Results: Dementia was associated with a 32% higher risk of acute organ dysfunction (adjusted odds ratio [aOR] 1.32, 95% confidence interval [CI] 1.19-1.46), a 50% higher risk of severe sepsis (aOR 1.50, 95% CI 1.32-1.69) and a 28% higher risk of hospital mortality (aOR 1.28, 95% CI 1.10-1.48) after controlling age, sex, surgical condition, comorbidity, principal diagnosis, infection status, hospital level, and length of hospital stay. However, the significant adverse effect of dementia on hospital mortality disappeared when life-support treatments, including vasopressor use, hemodialysis, mechanical ventilation, and intensive care, were also controlled. Conclusions: In hospitalized older patients, the presence of dementia increased the risks of acute organ dysfunction, severe sepsis and hospital mortality. However, after intervention using life-support treatments, dementia only exhibited a minor role on short-term mortality.	[Shen, Hsiu-Nien] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Shen, Hsiu-Nien; Lu, Chin-Li; Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Lu, Chin-Li] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Li, Chung-Yi] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Chi Mei Hospital; National Cheng Kung University; Chi Mei Hospital; China Medical University Taiwan	Shen, HN (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	hsiunian@gmail.com	Shen, Hsiu-Nien/H-2803-2019; LI, CHUNG-YI/ABI-1419-2020	LI, CHUNG-YI/0000-0002-0321-8908; Lu, Chin-Li/0000-0002-0818-4823	Chi Mei Medical Center [CMFHR9855]	Chi Mei Medical Center	The study was performed in Chi Mei Medical Center and supported by grant CMFHR9855 from the hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Campbell ML, 2004, CRIT CARE MED, V32, P1839, DOI 10.1097/01.CCM.0000138560.56577.88; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chien IC, 2008, J GERIATR PSYCH NEUR, V21, P142, DOI 10.1177/0891988708316859; Demond DW, 2002, NEUROLOGY, V59, P537, DOI 10.1212/WNL.59.4.537; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Esper AM, 2009, CRIT CARE, V13, DOI 10.1186/cc7717; Foreman MG, 2003, CHEST, V124, P1016, DOI 10.1378/chest.124.3.1016; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Jin P, 2004, NEUROLOGY, V63, P739, DOI 10.1212/01.WNL.0000134604.48018.97; Kimata T, 2008, INT HEART J, V49, P533, DOI 10.1536/ihj.49.533; Laditka James N, 2005, Am J Alzheimers Dis Other Demen, V20, P27, DOI 10.1177/153331750502000109; Marengoni A, 2011, INT J GERIATR PSYCH, V26, P930, DOI 10.1002/gps.2627; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Morrison RS, 2000, JAMA-J AM MED ASSOC, V284, P47, DOI 10.1001/jama.284.1.47; Pisani MA, 2005, CRIT CARE MED, V33, P1371, DOI 10.1097/01.CCM.0000165558.83676.48; Richardson SS, 2007, HEALTH SERV RES, V42, P183, DOI 10.1111/j.1475-6773.2006.00608.x; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Shah SM, 2012, AGE AGEING, V41, P64, DOI 10.1093/ageing/afr135; Shen HN, 2011, PSYCHOSOM MED, V73, P620, DOI 10.1097/PSY.0b013e3182280016; Shen HN, 2010, CHEST, V138, P298, DOI 10.1378/chest.09-2205; Stevenson CG, 2001, CAN MED ASSOC J, V164, P1413; Taylor DH, 2002, J CLIN EPIDEMIOL, V55, P929, DOI 10.1016/S0895-4356(02)00452-3; Wu CS, 2011, AM J GERIAT PSYCHIAT, V19, P151, DOI 10.1097/JGP.0b013e3181e049ca; Wu CS, 2009, AM J GERIAT PSYCHIAT, V17, P614, DOI 10.1097/JGP.0b013e3181a65210	27	50	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2012	7	8							e42751	10.1371/journal.pone.0042751	http://dx.doi.org/10.1371/journal.pone.0042751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	986GX	22905169	gold, Green Published, Green Submitted			2022-12-25	WOS:000307331100062
J	Zhang, RL; Chopp, M; Roberts, C; Wei, M; Wang, XL; Liu, XS; Lu, M; Zhang, ZG				Zhang, Rui Lan; Chopp, Michael; Roberts, Cynthia; Wei, Min; Wang, Xinli; Liu, Xianshuang; Lu, Mei; Zhang, Zheng Gang			Sildenafil Enhances Neurogenesis and Oligodendrogenesis in Ischemic Brain of Middle-Aged Mouse	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SUBVENTRICULAR ZONE; PROGENITOR CELLS; FUNCTIONAL RECOVERY; EMBOLIC STROKE; WHITE-MATTER; OLIGODENDROCYTES; DIFFERENTIATION; ANGIOGENESIS; RATS	Adult neural stem cells give rise to neurons, oligodendrocytes and astrocytes. Aging reduces neural stem cells. Using an inducible nestin-CreER(T2)/R26R-yellow fluorescent protein (YFP) mouse, we investigated the effect of Sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, on nestin lineage neural stem cells and their progeny in the ischemic brain of the middle-aged mouse. We showed that focal cerebral ischemia induced nestin lineage neural stem cells in the subventricular zone (SVZ) of the lateral ventricles and nestin expressing NeuN positive neurons and adenomatous polyposis coli (APC) positive mature oligodendrocytes in the ischemic striatum and corpus callosum in the aged mouse. Treatment of the ischemic middle-aged mouse with Sildenafil increased nestin expressing neural stem cells, mature neurons, and oligodendrocytes by 33, 75, and 30%, respectively, in the ischemic brain. These data indicate that Sildenafil amplifies nestin expressing neural stem cells and their neuronal and oligodendrocyte progeny in the ischemic brain of the middle-aged mouse.	[Zhang, Rui Lan; Chopp, Michael; Roberts, Cynthia; Wei, Min; Wang, Xinli; Liu, Xianshuang; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University; Henry Ford Health System; Henry Ford Hospital	Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	zhang, zheng/HCH-9684-2022		National Institute of Neurological Disorders and Stroke [PO1 NS23392, RO1 AG037506, RO1 NS75156]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023392, R01NS075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	PO1 NS23392, RO1 AG037506, RO1 NS75156 (National Institute of Neurological Disorders and Stroke Grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Basak O, 2012, J NEUROSCI, V32, P5654, DOI 10.1523/JNEUROSCI.0455-12.2012; Bouab M, 2011, NEUROSCIENCE, V173, P135, DOI 10.1016/j.neuroscience.2010.11.032; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; CARROLL WM, 1990, BRAIN, V113, P953, DOI 10.1093/brain/113.4.953; Chalimoniuk M, 1998, MOL CHEM NEUROPATHOL, V35, P77, DOI 10.1007/BF02815117; Chen J, 2006, NEUROSCIENCE, V141, P737, DOI 10.1016/j.neuroscience.2006.04.042; Chen J, 2009, GENESIS, V47, P122, DOI 10.1002/dvg.20465; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dewar D, 1999, EUR J PHARMACOL, V375, P41, DOI 10.1016/S0014-2999(99)00280-0; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Ding GL, 2008, J CEREBR BLOOD F MET, V28, P1440, DOI 10.1038/jcbfm.2008.33; Doetsch F, 1997, J NEUROSCI, V17, P5046; Franklin KBJ, 2008, MOUSE BRAIN STEREOTA, V3rd; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Li L, 2010, GLIA, V58, P1610, DOI 10.1002/glia.21033; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Ness JK, 2005, GLIA, V50, P321, DOI 10.1002/glia.20206; Olariu A, 2007, J COMP NEUROL, V501, P659, DOI 10.1002/cne.21268; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Pelvig DP, 2008, NEUROBIOL AGING, V29, P1754, DOI 10.1016/j.neurobiolaging.2007.04.013; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; SHEN S, 2008, NAT NEUROSCI; Shen SM, 2008, NEUROBIOL AGING, V29, P452, DOI 10.1016/j.neurobiolaging.2006.10.026; Shruster A, 2010, APOPTOSIS, V15, P1415, DOI 10.1007/s10495-010-0491-y; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang L, 2006, BRAIN RES; Zhang L.N., 2010, IEEE T MAGN, V2010, P5, DOI DOI 10.1371/J0URNAL.P0NE.0011016; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2006, J NEUROSCI RES, V83, P1213, DOI 10.1002/jnr.20813; Zhang RL, 2011, J CEREBR BLOOD F MET, V31, P614, DOI 10.1038/jcbfm.2010.134; Zhang ZG, 1998, BRAIN RES, V784, P210, DOI 10.1016/S0006-8993(97)01317-6; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	45	68	70	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48141	10.1371/journal.pone.0048141	http://dx.doi.org/10.1371/journal.pone.0048141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23118941	Green Submitted, Green Published, gold			2022-12-25	WOS:000310600500072
J	Lee, HP; Pancholi, N; Esposito, L; Previll, LA; Wang, XL; Zhu, XW; Smith, MA; Lee, HG				Lee, Hyun-Pil; Pancholi, Neel; Esposito, Luke; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon			Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity	PLOS ONE			English	Article							LIPID-PEROXIDATION; TRANSGENIC MICE; NEURODEGENERATIVE DISEASES; PLAQUE-FORMATION; DNA-DAMAGE; IN-VIVO; REDUCTION; PATHOLOGY; PROTEINS; DYSFUNCTION	While oxidative stress has been linked to Alzheimer's disease, the underlying pathophysiological relationship is unclear. To examine this relationship, we induced oxidative stress through the genetic ablation of one copy of mitochondrial antioxidant superoxide dismutase 2 (Sod2) allele in mutant human amyloid precursor protein (hAPP) transgenic mice. The brains of young (5-7 months of age) and old (25-30 months of age) mice with the four genotypes, wild-type (Sod2(+/+)), hemizygous Sod2 (Sod2(+/-)), hAPP/wild-type (Sod2(+/+)), and hAPP/hemizygous (Sod2(+/-)) were examined to assess levels of oxidative stress markers 4-hydroxy-2-nonenal and heme oxygenase-1. Sod2 reduction in young hAPP mice resulted in significantly increased oxidative stress in the pyramidal neurons of the hippocampus. Interestingly, while differences resulting from hAPP expression or Sod2 reduction were not apparent in the neurons in old mice, oxidative stress was increased in astrocytes in old, but not young hAPP mice with either Sod2(+/+) or Sod2(+/-). Our study shows the specific changes in oxidative stress and the causal relationship with the pathological progression of these mice. These results suggest that the early neuronal susceptibility to oxidative stress in the hAPP/Sod2(+/-) mice may contribute to the pathological and behavioral changes seen in this animal model.	[Lee, Hyun-Pil; Pancholi, Neel; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Esposito, Luke] Univ Calif San Francisco, Dept Neurol & Neurosci, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA	Case Western Reserve University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Lee, HP (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	hyoung-gon.lee@case.edu	Lee, Hyoung-gon/A-9637-2009; Meyer, Axel/C-9826-2009	Wang, Xinglong/0000-0001-8657-0159; Meyer, Axel/0000-0002-0888-8193; WU, LI-TZY/0000-0002-5909-2259; Oh, Yu-Kyoung/0000-0002-0969-3339; Previll, Laura/0000-0001-5541-8111	National Institutes of Health [AG028679]; Alzheimer's Association [NIRG-09-132727]; Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING [R01AG028679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work in the authors' laboratories is supported by the National Institutes of Health (AG028679 to Dr. Hyoung-gon Lee), the Alzheimer's Association (NIRG-09-132727 to Dr. Hyoung-gon Lee), and the Dr. Robert M. Kohrman Memorial Fund (to Dr. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Massaad CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010561; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Omar Rawhi A., 1999, J Alzheimers Dis, V1, P139; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pappolla MA, 1998, AM J PATHOL, V152, P871; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Sayre LM, 1996, CHEM RES TOXICOL, V9, P1194, DOI 10.1021/tx960094j; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; SMITH MA, 1994, AM J PATHOL, V145, P42; Smith MA, 2010, J ALZHEIMERS DIS, V19, P363, DOI 10.3233/JAD-2010-1239; STEELE ML, 2010, NEUROBIOL A IN PRESS; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	36	113	115	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e28033	10.1371/journal.pone.0028033	http://dx.doi.org/10.1371/journal.pone.0028033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22970282	Green Submitted, Green Published, gold			2022-12-25	WOS:000301457200001
